data_1xxe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xxe _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.593 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.31 0.576 . . . . 0.0 109.793 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.421 ' CB ' ' HZ1' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -117.79 134.63 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.667 -0.646 . . . . 0.0 109.458 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -133.62 170.96 14.77 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.4 m -81.94 132.68 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.665 -1.272 . . . . 0.0 110.199 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.61 ' HZ1' ' CB ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -61.8 -49.09 77.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 0.0 109.724 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.549 ' CG ' HD21 ' A' ' 113' ' ' ASN . 8.4 pt-20 -128.51 158.24 38.93 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.454 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.65 138.73 56.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.573 -0.704 . . . . 0.0 110.254 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.94 161.86 24.55 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -157.91 150.02 22.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.985 -1.072 . . . . 0.0 110.374 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -137.48 160.49 38.99 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.803 . . . . 0.0 109.948 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.11 138.9 24.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.563 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.19 158.56 16.63 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.46 161.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -1.128 . . . . 0.0 111.069 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.32 140.29 14.96 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 197' ' ' GLY . 14.8 tt -57.57 -52.87 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.133 -1.216 . . . . 0.0 112.451 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -86.63 -37.67 17.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.175 -1.578 . . . . 0.0 111.195 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m -75.01 -35.29 61.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.016 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 26.53 71.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.09 152.56 33.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.936 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.5 OUTLIER -71.75 129.56 38.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.953 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.6 t -135.86 156.43 48.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 108.943 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -135.55 148.26 49.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.065 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.18 143.88 50.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.063 -1.023 . . . . 0.0 109.072 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.3 mt -126.19 134.17 67.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mt -116.79 130.23 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.059 . . . . 0.0 109.619 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.1 154.02 74.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.71 154.23 75.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.284 1.99 . . . . 0.0 111.353 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.1 mm-40 -133.61 -174.33 3.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.0 ttpt -87.57 149.36 24.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -47.68 152.2 0.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 110.084 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 20.63 53.24 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.338 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.4 m -80.68 -42.97 21.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.641 -1.505 . . . . 0.0 108.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.46 -172.07 27.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.7 mm -99.64 121.38 50.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.979 . . . . 0.0 108.562 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -135.64 145.97 47.39 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.744 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -102.68 150.0 23.88 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.528 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.9 t80 -132.29 138.67 47.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.566 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 16.0 tttm -167.19 141.29 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.566 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 1.3 m120 54.23 29.53 10.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 30.11 68.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.86 125.17 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -1.059 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.53 139.18 30.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 108.977 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.45 94.16 17.81 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 110.052 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -48.69 144.41 14.63 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.251 1.967 . . . . 0.0 111.919 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.64 84.92 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.413 HH11 ' HB3' ' A' ' 49' ' ' ARG . 3.1 mmm180 -136.33 154.88 50.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 109.15 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 4.8 p80 -50.54 -50.15 54.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.007 -1.058 . . . . 0.0 109.496 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.9 mt-10 -43.97 -32.48 1.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 109.48 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.65 3.32 19.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.325 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 50' ' ' HIS . 2.9 t -63.17 118.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 108.796 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.05 -29.19 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.444 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.0 t-80 -150.18 123.4 8.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.616 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -112.44 136.78 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 59' ' ' SER . 45.2 t30 -166.68 -154.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -50.79 -10.03 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.0 108.17 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.593 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -137.76 166.84 22.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.462 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 m -105.43 122.04 45.15 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.4 OUTLIER -120.32 140.86 50.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 111.529 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.6 mt -123.02 154.92 37.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -169.21 141.61 6.82 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.876 -1.631 . . . . 0.0 110.683 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -144.38 150.7 38.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.495 -1.003 . . . . 0.0 110.028 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.76 13.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.717 . . . . 0.0 110.758 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.36 1.02 79.07 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.541 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 28.9 mm-40 -99.79 143.96 29.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.951 -1.323 . . . . 0.0 108.668 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -138.55 149.92 45.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 111.269 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.3 mt -135.33 134.51 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -107.85 156.41 19.19 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.302 -0.874 . . . . 0.0 111.055 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.1 m 53.04 68.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.697 -0.627 . . . . 0.0 110.827 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 m -113.06 -5.21 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.081 -1.012 . . . . 0.0 109.039 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.2 OUTLIER -68.55 -39.19 81.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 110.414 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -54.64 -60.73 2.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.09 -43.59 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.825 -1.172 . . . . 0.0 109.147 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 76.4 mt -57.28 -35.79 70.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.536 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.1 t -62.27 -50.26 72.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.984 . . . . 0.0 109.567 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.89 -51.2 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 0.0 108.451 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.4 mt -51.79 -45.4 63.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.781 . . . . 0.0 109.4 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 9.3 t-160 -54.92 -51.69 65.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.8 mt -63.26 -37.19 86.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.93 . . . . 0.0 110.625 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.7 mt -82.06 -6.82 59.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.044 -1.035 . . . . 0.0 111.091 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.82 53.99 2.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.299 . . . . 0.0 110.543 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mm -90.0 126.5 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 75.5 p -109.75 -26.86 9.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 111.705 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.408 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 5.0 m-80 -131.33 112.7 12.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.817 -1.177 . . . . 0.0 110.715 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -164.04 134.88 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.758 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.547 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 12.1 m -106.03 103.82 13.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -92.35 103.9 15.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 109.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.76 120.45 23.43 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.16 105.8 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.446 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.92 109.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.29 -159.81 23.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.65 -10.13 12.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.536 -0.979 . . . . 0.0 110.77 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -151.98 155.34 37.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.672 -1.268 . . . . 0.0 111.056 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 mm -73.24 124.58 90.71 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.741 -0.6 . . . . 0.0 110.164 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -45.8 134.46 13.8 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.069 1.846 . . . . 0.0 112.177 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -80.44 -29.5 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.481 -0.762 . . . . 0.0 110.714 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 65.1 mt 57.59 -126.13 1.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.72 -23.96 39.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 110.242 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.51 -8.66 13.38 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -116.44 -171.34 1.98 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.419 -1.048 . . . . 0.0 109.786 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.76 -2.62 30.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 63.5 t-105 -46.58 -41.8 15.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.87 . . . . 0.0 110.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.67 -52.23 65.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.011 -1.056 . . . . 0.0 110.499 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -64.81 -43.27 93.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 108.894 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -63.72 -36.79 85.03 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.363 0.601 . . . . 0.0 109.958 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.488 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 4.8 mm-40 -68.41 -52.62 30.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.772 . . . . 0.0 111.873 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.71 -50.91 21.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.888 -1.132 . . . . 0.0 110.822 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.36 -43.19 89.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.66 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -53.61 -31.51 47.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 110.13 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.549 HD21 ' CG ' ' A' ' 9' ' ' GLU . 2.6 m120 -122.84 28.4 7.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.337 -0.852 . . . . 0.0 111.401 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.2 mt -85.73 147.19 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.636 -1.29 . . . . 0.0 109.617 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -131.23 153.71 49.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.768 . . . . 0.0 109.098 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -101.46 143.93 30.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.053 -1.029 . . . . 0.0 109.548 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.596 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 8.6 mt-30 -108.29 -166.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -116.73 70.7 0.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.797 . . . . 0.0 110.565 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -168.19 146.98 4.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.149 -0.969 . . . . 0.0 109.587 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -86.69 135.18 33.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 58.6 mt -81.71 149.76 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.463 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -97.24 100.29 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -71.74 147.08 47.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 110.748 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -96.77 121.83 39.06 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.47 135.24 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.396 -0.815 . . . . 0.0 110.316 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.85 133.57 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.5 -10.75 13.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 109.301 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -142.89 143.45 25.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.44 171.88 16.82 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.38 2.053 . . . . 0.0 112.997 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 tt -165.74 142.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.699 -0.625 . . . . 0.0 109.694 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.76 125.86 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.509 -0.744 . . . . 0.0 109.833 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.1 m -121.96 120.06 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.725 . . . . 0.0 109.364 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.68 137.44 52.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.17 147.99 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.013 . . . . 0.0 110.829 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 56.84 24.83 9.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.6 -0.688 . . . . 0.0 110.955 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.39 85.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -109.33 169.65 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 7.6 tt -159.48 152.36 21.79 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.18 -1.575 . . . . 0.0 109.108 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.496 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 41.6 mt -148.72 139.87 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.0 108.363 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -128.08 142.66 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 110.106 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.01 144.91 48.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -143.13 138.87 16.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 108.622 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.32 148.08 73.2 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.415 1.41 . . . . 0.0 111.735 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -167.2 155.9 9.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.1 0.05 55.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -136.44 150.46 48.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.9 tp -81.74 116.88 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -138.65 134.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.63 124.6 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.2 137.55 50.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.02 129.72 49.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.488 -0.757 . . . . 0.0 110.117 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -111.82 103.89 12.18 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.15 140.72 15.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -116.46 101.53 8.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.42 ' CB ' ' ND2' ' A' ' 157' ' ' ASN . 48.8 m-85 -100.9 142.98 31.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 109.939 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.94 1.86 56.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 0.0 109.561 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.696 HD21 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -84.38 -166.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -62.7 -25.17 68.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 110.272 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.434 ' HB2' HD22 ' A' ' 157' ' ' ASN . 76.8 mt -66.41 -25.34 66.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.009 -1.057 . . . . 0.0 109.398 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.81 47.78 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -93.11 144.99 24.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.995 . . . . 0.0 109.837 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -150.18 137.07 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 147.23 47.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.072 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.687 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 58.3 t80 -136.62 124.11 22.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.8 m -101.64 121.92 42.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.964 . . . . 0.0 109.705 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.55 135.42 41.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.74 151.4 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 109.507 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.536 ' OE2' ' NZ ' ' A' ' 243' ' ' LYS . 19.4 mt-10 -51.67 116.56 2.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.311 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.66 7.42 15.76 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.544 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 14.6 m-80 -134.85 28.39 3.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.179 -1.189 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.4 mp0 -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.752 -0.593 . . . . 0.0 110.582 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.89 -15.51 31.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.624 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -94.91 -4.23 47.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.956 -1.09 . . . . 0.0 110.898 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.546 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 4.2 pt -121.46 13.65 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.946 -1.096 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.87 -25.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.958 -1.089 . . . . 0.0 109.6 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -91.26 2.02 56.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.989 -1.069 . . . . 0.0 110.533 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.48 109.38 16.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.013 -1.054 . . . . 0.0 108.895 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.503 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -82.07 153.4 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 109.917 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.8 t -54.3 156.65 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.778 . . . . 0.0 109.338 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.76 170.68 15.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.875 -1.141 . . . . 0.0 110.119 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.409 ' SG ' ' CD1' ' A' ' 189' ' ' ILE . 3.5 t -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 109.469 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.625 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.5 m-85 -105.47 144.71 31.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.559 -0.713 . . . . 0.0 109.286 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.22 -21.86 62.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.703 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.625 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.2 p90 -81.66 -33.94 31.02 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.625 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.6 pt-20 -88.83 -14.86 35.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.865 -1.147 . . . . 0.0 110.088 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.8 mt -54.79 -52.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.169 -0.957 . . . . 0.0 110.515 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.27 -47.11 62.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 109.544 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -53.65 55.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.975 . . . . 0.0 109.201 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.409 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 66.6 mt -55.43 -34.29 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 108.921 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.581 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 10.5 mmtm -77.04 -30.19 55.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.645 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -71.55 -22.24 61.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.5 m -91.6 13.31 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.941 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 69.68 27.33 73.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.76 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.87 159.22 27.27 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.251 . . . . 0.0 109.797 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 78.63 28.1 55.73 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.31 -0.948 . . . . 0.0 110.817 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.82 -20.39 63.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.691 -1.476 . . . . 0.0 109.066 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.28 -3.12 51.03 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.86 124.74 33.38 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 203' ' ' THR . 12.0 p -138.92 174.48 10.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.755 -0.85 . . . . 0.0 109.258 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.37 -15.87 60.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.485 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.431 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.2 tttm -87.79 -18.8 28.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 201' ' ' LYS . 1.8 m-20 -124.65 -8.6 7.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.649 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 199' ' ' SER . 0.7 OUTLIER -132.47 119.47 20.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -81.09 117.04 21.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.925 . . . . 0.0 108.9 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.3 t -104.66 128.43 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.81 148.45 30.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 109.73 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.39 156.05 16.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 207' ' ' GLY . 9.8 tttm -42.13 -33.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -1.141 . . . . 0.0 109.856 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -147.76 16.16 1.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -144.59 153.17 41.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 110.28 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.6 t -103.12 128.45 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.549 -0.719 . . . . 0.0 109.139 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -71.35 -53.97 12.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 0.0 109.996 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.67 133.75 86.17 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 109.411 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.43 -8.0 21.87 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.378 2.052 . . . . 0.0 112.708 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.16 -7.81 54.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 0.0 109.918 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.22 -167.68 48.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 55.4 mt -83.1 145.74 29.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.497 -1.002 . . . . 0.0 110.003 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -86.02 -20.08 29.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 221' ' ' ASN . 71.7 m-85 -146.22 133.19 20.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 108.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 31.7 mp0 -46.5 -16.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 108.865 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -131.63 33.54 4.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.617 0.722 . . . . 0.0 109.151 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 4.7 tt0 -53.66 -57.31 17.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_endo -54.21 -38.95 88.19 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.902 1.735 . . . . 0.0 113.036 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.1 m -79.77 -26.46 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.528 -1.357 . . . . 0.0 108.8 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 40.3 mtt-85 -64.69 -41.15 96.24 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -65.41 -43.45 90.54 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -48.36 76.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 108.979 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.07 -42.74 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 108.467 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 89.2 t80 -58.72 -39.21 80.19 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 1.0 OUTLIER -73.03 -39.51 65.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.55 -0.718 . . . . 0.0 109.696 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.2 tp -56.62 -36.36 69.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.221 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.486 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 94.0 mt -70.67 -48.31 59.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.7 -33.28 18.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.44 -26.56 32.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.258 . . . . 0.0 109.897 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.49 -23.19 40.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.762 -1.212 . . . . 0.0 110.11 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.516 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 10.1 t80 -71.65 -8.59 55.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 68.9 mt -52.52 -28.03 18.93 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.27 -13.92 3.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 108.507 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 14.9 81.61 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 84.1 p -158.99 144.67 12.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.829 -1.395 . . . . 0.0 109.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -43.36 129.3 6.35 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.077 1.851 . . . . 0.0 111.662 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.6 t -96.3 135.25 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.971 . . . . 0.0 110.148 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.536 ' NZ ' ' OE2' ' A' ' 168' ' ' GLU . 26.8 mmtt -120.16 125.27 47.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.53 171.73 24.77 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -102.65 112.27 24.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.068 -1.254 . . . . 0.0 109.769 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.4 m-85 -112.67 146.75 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.825 0.821 . . . . 0.0 111.354 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -128.61 143.06 50.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.69 125.71 21.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.57 -1.331 . . . . 0.0 110.144 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 250' ' ' ARG . 8.9 t80 -109.77 115.22 29.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 17.2 mtt180 44.0 56.0 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -91.92 157.8 24.55 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.593 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -120.3 -171.56 14.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 87.5 m-70 -74.91 -52.09 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -1.207 . . . . 0.0 110.044 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.0 m -55.1 -56.12 23.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.077 -1.014 . . . . 0.0 109.406 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.1 tp -54.26 -42.57 70.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.487 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -59.07 -55.32 36.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.031 . . . . 0.0 108.7 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 7.3 t -52.28 -39.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.895 . . . . 0.0 109.158 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -54.7 -47.79 73.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 108.643 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.66 -50.16 63.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.25 -42.29 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.548 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -52.39 65.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.805 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.62 -40.84 96.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.987 -1.071 . . . . 0.0 109.786 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 30.1 mt -61.89 -45.99 91.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.07 -27.63 61.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 110.627 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? . . . . . 0 N--CA 1.488 1.445 0 O-C-N 120.687 -1.258 . . . . 0.0 109.039 179.26 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 14.7 mt-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.63 134.33 54.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.568 -0.707 . . . . 0.0 110.121 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -139.2 179.04 6.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 108.766 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 m -87.58 138.06 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.27 . . . . 0.0 110.456 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -73.74 -43.77 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.75 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -125.04 150.04 47.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.177 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 140.04 58.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.814 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -122.27 168.04 12.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.586 -0.696 . . . . 0.0 109.198 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.26 148.4 23.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.06 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -135.46 158.02 45.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.498 -0.751 . . . . 0.0 109.588 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -147.89 137.73 22.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.022 -1.049 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.0 160.1 18.69 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 9.4 p -81.51 138.61 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -1.186 . . . . 0.0 110.507 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.47 145.28 43.79 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -62.53 -47.88 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.452 -1.028 . . . . 0.0 112.682 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.8 m-70 -87.08 -38.69 16.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.02 -1.675 . . . . 0.0 111.486 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.4 HG22 HD21 ' A' ' 94' ' ' ASN . 3.5 m -74.74 -35.95 62.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.894 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 68.15 22.42 74.34 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -110.13 148.75 31.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.443 -1.033 . . . . 0.0 109.116 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -71.59 130.98 42.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 110.026 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -140.09 156.47 46.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -135.31 147.13 49.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -0.974 . . . . 0.0 109.098 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mt -128.19 144.53 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.964 -1.085 . . . . 0.0 109.428 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.4 mt -122.14 140.71 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.3 mt -121.03 118.84 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.109 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -117.4 154.08 50.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.2 164.04 35.53 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.296 1.997 . . . . 0.0 111.24 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 13.3 mm-40 -134.36 -175.95 4.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.993 . . . . 0.0 109.842 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' O ' ' OG1' ' A' ' 35' ' ' THR . 15.6 tttm -91.67 158.73 16.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.613 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -51.61 145.4 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.58 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 63.97 23.35 67.56 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.575 -0.703 . . . . 0.0 111.855 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 93.2 m -82.06 -46.36 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.365 -1.667 . . . . 0.0 109.199 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.6 -171.19 23.79 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mm -96.67 123.42 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -1.151 . . . . 0.0 108.375 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.03 140.26 32.58 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.04 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -100.52 152.32 20.53 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.4 t80 -132.22 137.76 47.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 15.6 tttt -165.76 140.21 4.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 109.478 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.6 29.35 13.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.56 12.62 82.38 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.36 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.02 139.35 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -1.141 . . . . 0.0 109.75 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -98.74 141.46 31.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.095 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.45 94.76 19.0 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.2 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -51.4 147.15 22.88 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.261 1.974 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.82 84.83 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.893 -1.129 . . . . 0.0 110.605 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -137.6 153.97 49.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.688 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 2.4 p80 -50.62 -49.36 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.564 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.688 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 86.5 mt-10 -44.38 -33.41 1.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 109.104 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -80.15 0.49 32.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.414 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' HIS . 4.0 t -59.25 126.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 108.746 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.59 -32.25 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 0.0 110.153 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.71 124.36 7.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.708 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 p -112.35 134.03 54.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.612 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -166.63 -153.89 0.17 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' ASN . 6.5 m80 -48.59 -11.4 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.97 -1.081 . . . . 0.0 108.455 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 57' ' ' ASN . 8.5 t -138.16 166.24 24.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.497 -0.752 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.7 m -104.14 122.55 45.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.895 . . . . 0.0 108.717 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.34 141.98 50.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.266 -0.896 . . . . 0.0 111.446 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -125.12 156.43 38.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -170.32 140.44 6.02 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.607 -1.759 . . . . 0.0 110.886 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -144.58 150.61 37.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.963 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt 55.28 32.85 19.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.37 -0.831 . . . . 0.0 110.519 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.83 3.1 89.56 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.346 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 73.8 mm-40 -96.76 140.95 30.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.998 -1.295 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -135.52 144.39 46.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 111.147 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.3 mt -133.7 139.43 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.1 154.79 28.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.341 -0.849 . . . . 0.0 111.161 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m 52.41 70.35 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.602 -0.686 . . . . 0.0 110.63 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.3 m -113.54 -8.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 109.508 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -68.16 -20.38 64.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.371 -179.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -71.92 -60.7 2.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.926 -1.109 . . . . 0.0 109.266 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.9 -43.98 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 108.755 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 89.6 mt -58.89 -37.53 76.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.809 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.6 t -61.12 -48.71 80.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.975 . . . . 0.0 109.904 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.61 -53.56 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.95 -1.094 . . . . 0.0 108.611 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -52.45 -44.76 65.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.299 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.469 ' ND1' ' CG2' ' A' ' 232' ' ' ILE . 15.8 t-160 -54.29 -57.72 10.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.6 mt -57.36 -36.08 70.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.665 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -82.75 0.54 43.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.72 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.4 27.5 16.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.858 -1.151 . . . . 0.0 110.708 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.3 mm -73.91 121.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.138 . . . . 0.0 108.351 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.493 ' HG1' ' H ' ' A' ' 86' ' ' ASN . 1.0 OUTLIER -104.28 -74.63 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 111.227 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.735 ' H ' HD21 ' A' ' 86' ' ' ASN . 0.5 OUTLIER -80.19 114.11 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 111.685 -176.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 6.0 m -163.95 142.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.492 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 28.2 m -111.86 101.8 10.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.98 105.97 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.639 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.84 128.5 33.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.845 -1.159 . . . . 0.0 108.329 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 68.6 t -111.52 110.68 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.438 -0.789 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.34 110.27 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.525 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 129.96 -158.14 22.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.4 HD21 HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER -120.39 -10.14 9.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.492 -1.005 . . . . 0.0 110.483 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 3.3 pm0 -145.56 150.21 35.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.68 -1.263 . . . . 0.0 110.821 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 mm -74.75 122.55 87.74 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.629 -0.67 . . . . 0.0 110.045 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -45.97 131.67 13.89 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.118 1.879 . . . . 0.0 112.341 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.6 tp -77.39 -24.85 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -0.798 . . . . 0.0 109.981 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.49 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 19.0 mt 58.35 -113.49 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.798 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.74 -19.24 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.982 -1.074 . . . . 0.0 110.855 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.05 -11.49 20.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.42 -170.35 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.379 -1.071 . . . . 0.0 109.657 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.8 -4.15 21.46 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -46.62 -40.79 13.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.743 -0.857 . . . . 0.0 110.119 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.52 -51.88 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.048 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 60.1 m-85 -63.59 -44.08 95.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 10.4 t80 -63.05 -37.72 88.32 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.465 0.65 . . . . 0.0 109.824 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.96 -49.95 53.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.544 -0.722 . . . . 0.0 111.473 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.6 -51.86 11.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.858 -1.151 . . . . 0.0 110.644 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.16 -43.41 81.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 120.976 -1.077 . . . . 0.0 110.233 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -55.58 -31.29 62.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.457 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -81.85 -5.32 58.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.583 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -127.03 35.31 4.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.425 -0.797 . . . . 0.0 110.887 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.9 mt -90.27 145.43 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.801 -1.187 . . . . 0.0 110.548 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.7 tp -131.08 156.6 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.682 ' N ' HD21 ' A' ' 116' ' ' ASN . 0.6 OUTLIER -111.6 141.94 44.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.866 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -102.66 -161.19 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.317 -0.864 . . . . 0.0 108.975 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -118.61 2.29 11.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.214 -0.929 . . . . 0.0 111.094 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 4' ' ' GLU . 10.8 ttp85 -100.24 155.99 17.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.796 -1.19 . . . . 0.0 110.136 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 121' ' ' ILE . 13.9 tm-20 -89.07 136.79 32.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.499 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 19.6 mt -76.63 142.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.74 . . . . 0.0 110.694 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -85.22 88.26 7.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.44 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 45.6 m-85 -63.23 144.96 56.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.412 -0.805 . . . . 0.0 110.651 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -102.0 125.16 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 t -129.97 143.98 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.0 135.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.7 -12.78 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.764 . . . . 0.0 109.171 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.91 142.56 28.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 108.941 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.85 159.34 52.07 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.907 1.738 . . . . 0.0 113.122 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 tt -155.41 138.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.1 mt -127.59 125.71 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.18 113.08 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -117.09 126.91 53.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.493 -0.754 . . . . 0.0 109.707 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -173.67 155.09 2.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.52 20.52 9.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.583 -0.698 . . . . 0.0 110.728 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.3 3.06 88.37 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -104.8 172.46 6.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.3 tt -160.04 150.39 18.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.335 -1.478 . . . . 0.0 109.015 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.2 mt -148.05 131.87 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.085 -1.01 . . . . 0.0 109.066 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -120.16 138.97 53.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 109.894 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.97 134.84 52.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -133.5 137.76 29.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.56 147.54 29.98 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.291 1.327 . . . . 0.0 111.96 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.44 158.22 9.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.31 2.2 56.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.782 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.2 p -131.91 139.0 48.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 0.0 109.634 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 tp -73.76 116.6 14.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.711 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -137.71 137.1 37.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 108.738 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 75.6 t -140.2 123.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 109.415 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 m -115.56 145.15 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -130.75 130.93 44.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.721 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.11 140.98 48.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.28 144.47 16.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.67 84.49 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.566 -0.961 . . . . 0.0 108.971 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 160' ' ' GLY . 13.6 m-85 -87.02 148.67 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.727 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -93.33 -5.83 48.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 110.037 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.2 p30 -70.43 -167.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.893 -1.13 . . . . 0.0 109.158 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -56.9 -21.59 30.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.005 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.463 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.3 mt -61.74 -57.46 11.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.28 -99.31 2.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.421 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.4 OUTLIER -125.89 136.7 53.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -1.111 . . . . 0.0 109.059 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -145.74 159.43 43.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.721 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -160.2 150.4 18.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -138.32 127.47 24.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.3 m -102.12 123.44 45.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.144 -0.973 . . . . 0.0 109.509 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.3 135.99 39.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.103 -0.998 . . . . 0.0 109.537 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.519 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -133.19 154.25 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.735 . . . . 0.0 109.337 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -57.6 118.4 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -0.965 . . . . 0.0 109.666 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.68 1.27 21.4 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.77 31.42 3.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.161 -1.2 . . . . 0.0 108.883 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -64.69 -33.52 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 110.719 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.23 -14.54 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 0.0 110.935 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.528 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 25.7 mt-10 -89.97 -3.95 57.73 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.29 -10.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.035 -1.041 . . . . 0.0 111.105 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -29.92 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.514 -1.366 . . . . 0.0 110.316 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.47 2.73 43.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.797 -1.189 . . . . 0.0 110.282 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.68 130.26 35.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.776 -1.202 . . . . 0.0 108.681 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.681 HH21 ' N ' ' A' ' 203' ' ' THR . 15.4 ptm180 -104.84 155.12 19.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -0.891 . . . . 0.0 110.463 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.471 ' CA ' ' CE1' ' A' ' 226' ' ' HIS . 3.0 t -56.17 156.71 5.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.249 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.03 166.7 24.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.061 . . . . 0.0 110.527 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.56 ' SG ' ' OE2' ' A' ' 185' ' ' GLU . 0.5 OUTLIER -156.9 162.06 39.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.507 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -104.76 144.67 31.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 39.7 p30 -60.59 -21.59 62.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 111.562 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.9 p90 -76.58 -34.7 58.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.659 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.59 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.5 pt-20 -96.7 -8.3 31.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.476 -1.39 . . . . 0.0 110.261 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.5 mt -55.37 -51.12 59.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.0 -1.062 . . . . 0.0 109.819 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -51.41 -51.82 51.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.237 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -49.22 66.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.157 -0.964 . . . . 0.0 108.794 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.442 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 63.8 mt -57.46 -33.96 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.918 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -77.21 -25.91 52.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 110.02 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -77.12 -30.45 55.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.938 . . . . 0.0 109.886 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.08 8.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.188 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.472 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . . . 75.77 22.88 73.86 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.524 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 66.0 mt -118.58 157.62 27.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -1.153 . . . . 0.0 109.682 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.47 21.11 65.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.472 ' NZ ' ' O ' ' A' ' 193' ' ' GLY . 23.2 mttt -66.14 -25.04 66.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.849 -1.383 . . . . 0.0 109.705 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.4 -4.89 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.36 127.91 35.38 Favored Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.132 -1.217 . . . . 0.0 110.622 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -135.37 170.43 15.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.645 -0.915 . . . . 0.0 109.091 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.71 -36.03 81.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.074 -1.017 . . . . 0.0 109.575 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.546 ' C ' HD21 ' A' ' 202' ' ' ASN . 30.3 ttmt -73.32 -27.64 61.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.217 -0.927 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.743 HD21 ' N ' ' A' ' 202' ' ' ASN . 0.6 OUTLIER -107.41 5.4 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.892 . . . . 0.0 110.084 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.681 ' N ' HH21 ' A' ' 178' ' ' ARG . 3.4 m -153.05 122.12 6.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.918 -1.114 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.9 tp -79.35 110.8 14.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 108.693 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.6 128.41 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.973 -1.079 . . . . 0.0 109.528 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.0 mt -106.38 148.46 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.97 149.13 16.62 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 207' ' ' GLY . 23.2 tptt -42.59 -27.38 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -1.161 . . . . 0.0 110.108 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 209' ' ' ASP . 52.6 p-10 -149.96 10.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.929 -1.107 . . . . 0.0 110.272 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.9 pttm -143.67 152.83 41.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.7 t -101.44 129.58 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.889 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.95 -54.41 8.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -57.86 134.65 83.31 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.828 -1.17 . . . . 0.0 109.428 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.92 -14.22 29.36 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.337 2.024 . . . . 0.0 112.695 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -83.85 -6.46 59.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.42 -166.17 54.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.0 148.76 31.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -1.122 . . . . 0.0 109.704 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 -22.76 23.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.656 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 77.0 m-85 -149.14 134.19 18.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.0 108.839 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 219' ' ' TYR . 11.0 tt0 -45.47 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.978 -1.076 . . . . 0.0 108.607 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -130.36 35.6 4.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.466 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 3.4 tt0 -56.81 -50.78 86.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.483 -0.761 . . . . 0.0 111.743 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 27.7 Cg_endo -65.82 -39.04 21.25 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.582 1.521 . . . . 0.0 113.457 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.09 -26.82 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.524 -1.36 . . . . 0.0 108.324 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 18.2 mtp180 -68.74 -44.11 74.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.471 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 17.3 t60 -59.87 -43.9 94.47 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.515 -0.741 . . . . 0.0 109.038 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -56.25 -41.43 75.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.807 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.42 -46.4 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.58 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.2 t80 -55.12 -41.71 72.04 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -70.67 -39.39 73.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.466 -0.771 . . . . 0.0 109.676 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.97 -35.62 69.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.463 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.469 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 95.2 mt -71.15 -48.78 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.36 -31.95 13.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.99 -28.43 29.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -1.224 . . . . 0.0 110.267 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.9 mt -79.49 -22.87 43.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.229 . . . . 0.0 109.79 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -68.64 -8.24 40.46 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.331 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 239' ' ' GLY . 36.4 mt -52.86 -32.58 45.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.851 . . . . 0.0 109.194 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.4 mt -52.61 -11.92 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.952 -1.093 . . . . 0.0 109.212 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.08 13.45 83.65 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.7 p -158.74 143.74 11.79 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.133 -1.216 . . . . 0.0 109.434 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -41.25 135.0 2.82 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 112.149 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.3 136.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 131.02 50.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.38 -0.825 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.79 -178.39 31.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.74 112.77 25.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.149 -1.207 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -115.16 145.5 42.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.027 0.918 . . . . 0.0 110.959 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -131.22 144.02 51.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.0 t -139.65 128.28 23.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.77 -1.206 . . . . 0.0 110.642 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 250' ' ' ARG . 46.0 t80 -108.98 117.18 33.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.4 mmm180 44.76 56.29 5.34 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.56 147.16 21.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -115.69 178.7 17.75 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -68.47 -50.59 51.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.276 . . . . 0.0 109.704 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 66.1 m -55.39 -55.26 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.031 -1.043 . . . . 0.0 109.367 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.9 tp -51.38 -39.32 56.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.315 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 10.9 m120 -59.71 -53.81 53.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 108.722 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 16.8 t -50.07 -43.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -55.21 -46.86 75.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.031 -1.043 . . . . 0.0 108.89 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 56.4 tp -52.6 -44.72 66.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.214 -0.928 . . . . 0.0 108.569 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.04 -56.26 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -46.97 -40.74 14.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -70.51 -46.53 63.48 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.909 -1.119 . . . . 0.0 110.037 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 39.4 mt -65.74 -37.5 86.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.903 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.4 66.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.1 mttp . . . . . 0 N--CA 1.489 1.478 0 O-C-N 120.793 -1.192 . . . . 0.0 108.754 179.182 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.14 135.65 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.554 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.7 t -135.03 175.32 9.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 109.342 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.4 m -85.68 135.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.258 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -66.73 -44.19 82.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.41 152.55 48.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.825 . . . . 0.0 109.88 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 136.03 56.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.59 168.34 10.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 p -157.97 148.69 20.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.116 -0.99 . . . . 0.0 110.242 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -129.96 158.73 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 109.285 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.66 135.62 21.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.97 -1.081 . . . . 0.0 109.212 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.13 159.98 18.56 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 2.5 p -70.7 161.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.265 . . . . 0.0 110.908 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -95.4 140.79 15.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 197' ' ' GLY . 12.6 tt -56.99 -52.2 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.135 -1.215 . . . . 0.0 112.246 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.405 ' HD1' ' HA2' ' A' ' 195' ' ' GLY . 4.6 m-70 -86.46 -38.15 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.281 -1.512 . . . . 0.0 111.197 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.415 ' OG1' ' CD ' ' A' ' 95' ' ' GLU . 16.0 p -72.48 -35.03 68.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.762 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.6 24.76 68.21 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -117.52 155.09 30.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.885 . . . . 0.0 108.87 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.0 t80 -71.65 132.17 44.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 30.9 t -138.66 157.86 45.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 108.845 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -137.18 151.9 49.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 109.503 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -127.21 151.22 48.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.174 -0.954 . . . . 0.0 109.737 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.497 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.4 mt -137.69 127.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.4 mt -112.14 118.51 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.562 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 1.3 m-70 -116.98 149.25 43.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.97 162.44 19.11 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.187 1.925 . . . . 0.0 111.323 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.4 mm-40 -133.94 -177.48 4.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 0.0 109.87 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 6.8 tttm -82.3 149.69 27.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 11.5 mp0 -48.48 147.27 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 110.39 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.26 24.78 61.63 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.6 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 13.6 m -81.23 -46.43 14.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.734 -1.451 . . . . 0.0 109.445 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.62 -167.23 17.41 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mm -100.75 124.09 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.139 -1.212 . . . . 0.0 107.865 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -140.54 141.51 35.27 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.643 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -101.13 153.15 19.83 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.581 ' CG ' ' OE1' ' A' ' 90' ' ' GLU . 3.3 t80 -120.31 154.92 34.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -176.06 126.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.669 -1.27 . . . . 0.0 110.192 -179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.84 37.22 16.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.31 77.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -126.23 128.77 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -1.086 . . . . 0.0 109.66 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -89.52 141.75 28.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.4 mt -136.49 95.59 12.74 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.46 144.52 9.97 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.975 1.783 . . . . 0.0 111.472 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.46 85.29 4.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.953 -1.092 . . . . 0.0 110.66 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.74 154.14 49.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' VAL . 9.7 p80 -50.62 -48.81 57.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 109.694 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 50.3 mt-10 -43.2 -33.33 0.9 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.347 -0.846 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -77.78 1.85 18.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.241 -0.912 . . . . 0.0 110.275 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 50' ' ' HIS . 4.1 t -63.01 119.08 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 108.77 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.66 -30.92 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.232 -0.918 . . . . 0.0 110.524 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.583 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.3 t-160 -145.71 118.64 8.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.062 . . . . 0.0 109.63 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.1 p -112.34 132.03 55.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.445 0.64 . . . . 0.0 109.455 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.593 ' CG ' ' H ' ' A' ' 58' ' ' HIS . 4.8 t-20 -166.0 -154.32 0.19 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.593 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 1.4 m-70 -48.32 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.835 -1.166 . . . . 0.0 108.329 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' ASN . 16.0 t -136.66 166.03 24.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.451 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 27.0 m -106.88 122.87 47.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 108.965 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.99 138.61 54.36 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.08 0.943 . . . . 0.0 111.218 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 mt -117.34 156.42 27.87 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.6 142.74 6.74 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.347 -1.883 . . . . 0.0 111.309 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -143.24 148.75 36.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.865 . . . . 0.0 109.199 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt 56.27 39.86 30.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.0 110.597 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.24 5.63 77.38 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.745 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.7 mm-40 -102.04 140.33 36.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.951 -1.323 . . . . 0.0 108.317 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.603 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -139.37 151.86 46.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.069 -1.019 . . . . 0.0 111.568 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 mt -134.26 145.33 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -114.6 150.2 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 111.245 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 m 55.25 69.03 0.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.708 -0.62 . . . . 0.0 111.047 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.26 -7.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 109.275 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.0 pt-20 -68.65 -36.21 78.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.578 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 26.4 m170 -58.6 -59.98 4.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 110.111 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.1 tp -57.16 -42.17 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.808 -1.183 . . . . 0.0 109.07 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.47 -35.91 77.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.582 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -60.61 -47.3 86.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.577 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.99 -51.7 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.064 . . . . 0.0 108.681 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.7 mt -51.27 -44.28 61.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.498 -0.752 . . . . 0.0 109.418 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.444 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 14.0 t-160 -56.23 -57.83 10.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 0.0 109.832 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.7 -38.55 72.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 110.449 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.8 -0.84 36.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.979 -1.076 . . . . 0.0 110.68 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 59.81 42.58 16.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.803 -1.186 . . . . 0.0 110.027 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.37 125.82 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.402 ' H ' ' HG1' ' A' ' 85' ' ' THR . 7.7 p -106.34 -76.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.51 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.774 HD21 HE22 ' A' ' 117' ' ' GLN . 69.5 m-20 -81.49 113.28 19.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 111.812 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.13 141.73 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.406 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 61.1 m -111.5 103.92 12.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.477 -0.764 . . . . 0.0 109.397 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.18 114.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.202 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.581 ' OE1' ' CG ' ' A' ' 40' ' ' PHE . 1.6 mt-10 -93.07 123.79 36.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 0.0 108.75 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.66 106.79 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.52 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.13 107.71 18.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.58 -162.85 24.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -13.63 14.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.388 -1.066 . . . . 0.0 110.428 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -150.54 155.16 38.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.709 -1.245 . . . . 0.0 110.674 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -69.89 125.71 92.12 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.699 -0.625 . . . . 0.0 110.04 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -46.23 134.71 15.41 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.85 1.7 . . . . 0.0 112.017 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 99' ' ' LEU . 11.1 tp -76.85 -35.25 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.469 -0.769 . . . . 0.0 109.967 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.411 ' N ' ' CG2' ' A' ' 98' ' ' ILE . 51.2 mt 55.32 -105.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.431 -0.793 . . . . 0.0 109.631 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.58 ' OD1' ' NE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -94.55 -27.67 15.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.582 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.3 -1.49 28.11 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 p -123.98 -166.78 1.54 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.969 . . . . 0.0 109.292 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.44 -0.34 21.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -46.77 -43.93 18.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.723 -0.869 . . . . 0.0 110.662 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.46 -52.1 62.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.061 -1.025 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 97.3 m-85 -62.45 -45.61 92.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.896 -1.128 . . . . 0.0 108.594 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -59.55 -40.72 88.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.456 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -45.6 58.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.487 -0.758 . . . . 0.0 111.464 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.62 -49.75 20.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.201 . . . . 0.0 110.777 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.31 -42.54 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.01 -1.056 . . . . 0.0 111.085 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -56.6 -28.96 61.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.885 -1.134 . . . . 0.0 109.992 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -82.21 -10.16 59.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.958 -1.089 . . . . 0.0 110.047 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -123.02 32.24 5.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.401 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.3 mt -86.28 146.82 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.681 -1.262 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.4 tp -132.23 161.55 33.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.29 128.88 55.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.776 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.774 HE22 HD21 ' A' ' 86' ' ' ASN . 4.1 mt-30 -96.39 -166.36 1.41 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.898 . . . . 0.0 110.009 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -124.46 69.31 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.601 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -158.8 137.71 11.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.027 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 26.9 tt0 -47.88 167.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.776 0.798 . . . . 0.0 110.965 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.445 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 31.4 mt -126.23 120.5 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.2 76.98 8.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.602 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -58.54 147.6 31.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -106.83 125.65 51.29 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.7 t -130.49 145.1 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 73.0 t -83.68 136.37 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 0.0 109.363 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.13 -12.9 9.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.51 144.57 42.97 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.84 169.05 23.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.106 1.871 . . . . 0.0 113.174 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 tt -165.24 136.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.784 -0.572 . . . . 0.0 109.485 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.21 124.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.0 109.141 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.36 114.87 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.456 -0.778 . . . . 0.0 109.812 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.41 131.97 55.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -173.18 152.96 2.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 55.89 23.56 6.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.596 -0.69 . . . . 0.0 110.973 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.02 2.75 83.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -104.61 172.99 6.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.2 tt -160.06 151.41 19.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.157 -1.589 . . . . 0.0 109.3 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 8.4 mt -147.56 130.28 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.957 . . . . 0.0 108.678 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -119.89 142.4 48.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 109.929 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.07 141.34 51.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.507 -0.745 . . . . 0.0 109.157 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -140.31 137.2 17.53 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.93 147.07 26.94 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.445 1.43 . . . . 0.0 112.256 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.33 152.3 10.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.922 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.69 0.66 46.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p -137.74 145.79 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.151 -0.968 . . . . 0.0 109.803 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.98 117.32 17.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -138.02 136.22 36.66 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.1 t -137.31 122.03 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -107.51 130.14 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.343 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -116.58 128.97 55.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.88 106.43 14.16 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.25 150.64 19.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -129.35 88.23 2.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.492 -1.004 . . . . 0.0 109.204 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -95.21 146.83 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.591 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -94.89 -2.03 51.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 182' ' ' PHE . 6.9 p30 -70.15 -166.64 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.779 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -65.71 -22.09 66.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.092 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 mt -66.66 -38.7 87.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.048 -1.033 . . . . 0.0 109.137 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.11 -137.95 19.23 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.11 145.34 28.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 109.421 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.483 ' OE1' ' ND2' ' A' ' 221' ' ' ASN . 0.9 OUTLIER -148.81 166.55 28.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.539 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 150.31 23.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -139.79 131.86 27.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.193 -0.942 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.4 t -102.15 123.17 45.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.184 -0.948 . . . . 0.0 109.801 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.5 t80 -101.2 134.46 44.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 108.986 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.43 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -132.67 151.2 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 109.472 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -50.54 120.76 4.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.87 6.8 26.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -134.53 27.25 3.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.206 -1.173 . . . . 0.0 108.522 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -61.68 -35.49 78.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 110.57 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.24 -18.35 10.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.951 -1.093 . . . . 0.0 110.283 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.9 -3.64 58.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 0.0 110.837 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 3.0 pt -130.49 19.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 111.947 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.53 -29.13 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.803 -1.186 . . . . 0.0 109.908 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.06 2.53 53.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 110.684 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.03 127.13 32.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.605 -1.309 . . . . 0.0 109.109 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.58 ' NE ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.02 152.51 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.3 t -53.65 161.32 1.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 109.177 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.63 164.01 31.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.786 -1.196 . . . . 0.0 110.2 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 189' ' ' ILE . 0.3 OUTLIER -149.3 160.29 43.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 109.673 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.565 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.4 m-85 -104.35 144.97 30.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.721 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.25 -26.98 65.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.958 -1.089 . . . . 0.0 110.488 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.565 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.4 p90 -81.14 -27.59 35.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.825 -1.172 . . . . 0.0 110.668 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.8 pt-20 -93.14 -14.21 27.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 109.818 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.9 mt -56.76 -52.61 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.62 -52.71 45.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.123 . . . . 0.0 109.79 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -52.82 -44.42 66.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 91.0 mt -65.51 -33.86 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -77.01 -26.88 54.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.042 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -81.0 -27.98 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.087 -1.008 . . . . 0.0 110.517 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.0 m -80.16 8.54 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.509 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.21 24.44 68.63 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.811 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 62.9 mt -121.19 159.82 25.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.24 -1.153 . . . . 0.0 109.691 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 76.94 27.7 59.99 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.03 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -71.18 -19.41 62.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.667 -1.49 . . . . 0.0 109.292 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.5 -4.19 49.75 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.14 128.74 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.273 -1.134 . . . . 0.0 110.896 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.25 -173.81 3.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.747 -0.855 . . . . 0.0 109.157 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.99 -5.59 57.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.051 -1.031 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -98.09 -13.69 20.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.339 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -127.18 -3.6 6.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -136.24 117.34 14.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.26 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.2 tp -79.42 110.54 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.54 127.56 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.08 -1.013 . . . . 0.0 109.839 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.28 146.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.363 -0.836 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.66 150.47 17.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -44.38 -28.65 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.132 . . . . 0.0 110.242 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 35.0 t0 -143.8 8.46 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 110.127 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 207' ' ' GLY . 68.4 tttt -146.01 154.72 42.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.062 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.71 128.96 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -71.98 -53.09 14.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.095 -1.003 . . . . 0.0 109.908 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' HD21 ' A' ' 213' ' ' ASN . 1.0 OUTLIER -54.72 133.55 65.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.119 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.88 -24.97 20.48 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.281 1.987 . . . . 0.0 112.511 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.89 -6.65 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 109.792 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.92 -167.54 48.37 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.45 141.8 39.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -1.084 . . . . 0.0 109.63 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -83.7 -15.66 47.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.097 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.572 ' C ' ' H ' ' A' ' 221' ' ' ASN . 70.1 m-85 -144.26 135.43 25.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.5 ' O ' ' ND2' ' A' ' 221' ' ' ASN . 1.5 tm-20 -49.34 -10.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 219' ' ' TYR . 1.4 m-80 -143.11 35.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.525 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 56.1 tt0 -56.1 -36.46 46.43 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 111.919 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 10.2 Cg_exo -69.27 -43.92 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.731 1.621 . . . . 0.0 112.907 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 24.5 m -77.81 -25.7 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 120.706 -1.246 . . . . 0.0 108.544 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -65.12 -45.67 84.14 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.456 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 47.1 t60 -62.16 -43.15 99.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -49.85 74.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 109.335 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 19.2 t -56.26 -48.18 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 108.767 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.582 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 85.0 t80 -50.5 -44.6 56.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.632 -0.668 . . . . 0.0 109.607 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.578 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 28.4 m-20 -71.48 -35.22 70.75 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 109.994 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.7 tp -56.46 -37.54 70.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.025 . . . . 0.0 108.857 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.444 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 55.4 mt -71.49 -47.52 58.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.13 -33.73 15.32 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.57 -26.18 32.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -1.171 . . . . 0.0 109.808 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.7 mt -82.27 -24.55 34.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.826 -1.171 . . . . 0.0 110.193 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.443 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 28.7 t80 -69.98 -7.38 40.26 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 109.148 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 239' ' ' GLY . 34.8 mt -51.04 -31.55 18.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 108.775 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.2 mt -53.79 -12.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 108.681 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 74.53 17.21 79.86 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.5 p -157.63 143.32 12.55 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.338 . . . . 0.0 109.812 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -43.12 131.13 6.21 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.15 1.9 . . . . 0.0 111.944 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.58 141.25 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 109.821 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -130.61 133.37 46.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.311 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.56 179.49 30.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -107.54 110.45 22.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.103 -1.233 . . . . 0.0 109.719 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.7 m-85 -112.18 146.96 37.17 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.928 . . . . 0.0 111.059 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -128.1 144.17 51.1 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.2 t -142.05 126.94 18.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.711 -1.243 . . . . 0.0 110.501 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.7 t80 -110.19 116.94 32.41 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 249' ' ' PHE . 6.4 mmm180 46.81 55.91 7.26 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.84 140.95 23.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.52 171.24 13.72 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 22.1 m-70 -63.99 -45.21 90.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.244 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -55.73 26.33 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.094 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.5 tp -52.06 -39.88 60.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.117 -0.989 . . . . 0.0 109.351 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.23 -55.82 30.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 108.784 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.85 -41.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.47 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -49.45 71.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.067 -1.02 . . . . 0.0 109.039 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 43.8 tp -52.66 -49.65 64.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 0.0 108.677 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.62 -49.93 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.477 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -51.65 17.93 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.63 -44.34 90.84 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.89 -1.131 . . . . 0.0 109.781 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.64 -46.29 90.41 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.69 -32.78 66.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.704 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.534 ' CB ' ' HZ3' ' A' ' 265' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 O-C-N 120.845 -1.16 . . . . 0.0 109.157 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 36.0 mt-10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 132.16 56.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.565 -0.709 . . . . 0.0 109.316 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -136.44 175.29 9.74 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.35 -0.843 . . . . 0.0 109.271 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.3 m -83.24 138.13 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.727 -1.233 . . . . 0.0 110.367 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' HB2' ' HZ1' ' A' ' 8' ' ' LYS . 6.8 ttmm -71.95 -47.02 55.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.734 . . . . 0.0 109.543 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.66 156.44 41.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.854 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 135.16 55.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.473 -0.767 . . . . 0.0 110.415 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.1 mt -117.54 163.46 16.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -153.92 147.3 24.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.009 . . . . 0.0 110.098 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.28 161.61 31.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.254 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -149.59 136.65 19.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.915 -1.116 . . . . 0.0 108.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.09 161.27 20.28 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 4.7 p -73.75 161.24 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.11 -1.23 . . . . 0.0 111.176 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.466 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -92.54 140.09 14.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.8 tt -56.11 -52.25 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -1.218 . . . . 0.0 111.816 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -86.97 -38.63 16.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.309 -1.494 . . . . 0.0 110.879 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.488 ' HG1' ' CB ' ' A' ' 95' ' ' GLU . 2.6 m -68.68 -36.6 78.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 110.054 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.61 23.09 66.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.99 154.98 31.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.692 -0.887 . . . . 0.0 108.722 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.5 t80 -71.73 136.3 47.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 110.181 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.583 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 1.9 t -144.02 157.55 44.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 108.974 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 24' ' ' SER . 1.1 ttmt -137.22 147.16 45.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.098 -1.001 . . . . 0.0 109.292 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.401 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 2.3 mt -123.41 151.1 42.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.629 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.8 mt -134.84 129.44 51.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.57 110.76 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 109.812 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -106.75 150.23 39.43 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 108.901 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.56 161.88 22.91 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.226 1.95 . . . . 0.0 110.816 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.558 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -140.56 159.34 42.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.886 -1.134 . . . . 0.0 110.69 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.51 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 tttt -59.7 149.31 31.06 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.516 0.674 . . . . 0.0 109.987 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 2.3 mp0 -48.76 148.38 2.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 110.612 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.73 25.85 59.38 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.413 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -80.46 -37.57 31.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.618 -1.519 . . . . 0.0 109.031 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.27 -177.03 33.36 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.8 mm -98.8 125.41 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 140.13 32.71 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.969 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -97.48 152.22 19.2 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.9 t80 -133.54 140.13 47.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -170.7 143.75 2.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 54.86 29.13 11.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.955 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.85 21.16 78.05 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.8 t -124.42 135.62 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.161 -1.2 . . . . 0.0 109.545 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -94.6 142.06 27.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 109.039 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.9 mt -135.01 94.43 16.19 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.395 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -48.7 143.3 16.86 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.324 2.016 . . . . 0.0 111.747 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.99 79.74 5.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.069 -1.019 . . . . 0.0 110.158 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.3 mtt-85 -138.7 156.38 47.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.447 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.3 p80 -52.86 -50.12 64.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -45.26 -15.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 110.264 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.2 m-85 -100.19 2.64 43.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.669 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 t -57.73 133.35 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 108.955 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 m -120.66 -36.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 109.91 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.454 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.1 t-160 -151.19 122.11 7.61 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.348 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 p -110.75 132.6 54.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.4 t-20 -166.47 -154.71 0.19 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -48.03 -11.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 108.604 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.6 t -135.89 165.61 25.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 m -101.64 119.73 39.23 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -116.94 135.5 53.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 111.169 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.9 mt -124.22 158.91 31.34 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -177.83 145.62 7.15 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.963 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -144.71 151.16 38.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.883 . . . . 0.0 109.51 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 57.37 23.81 9.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 110.971 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.15 1.26 72.74 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.556 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 55.5 mm-40 -99.24 139.84 34.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.989 -1.301 . . . . 0.0 108.284 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.633 ' HE ' ' HZ3' ' A' ' 70' ' ' LYS . 16.9 ptt-85 -136.28 149.72 48.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.025 . . . . 0.0 111.426 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.84 141.68 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.633 ' HZ3' ' HE ' ' A' ' 68' ' ' ARG . 15.3 mttp -114.48 151.02 33.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.185 -0.947 . . . . 0.0 111.456 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 56.45 65.84 1.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.798 -0.564 . . . . 0.0 111.284 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.08 -3.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.041 -1.037 . . . . 0.0 109.043 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pt-20 -70.63 -28.4 64.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 110.533 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -64.35 -60.52 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.907 -1.121 . . . . 0.0 109.723 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -58.74 -44.51 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.952 -1.092 . . . . 0.0 109.129 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 65.4 mt -55.8 -41.46 74.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.927 . . . . 0.0 109.456 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -56.82 -46.32 81.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.292 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.88 -53.69 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.963 . . . . 0.0 108.652 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.6 mt -51.55 -44.58 62.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.279 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.524 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.4 t-160 -53.93 -55.38 27.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.249 -0.907 . . . . 0.0 109.726 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.36 -37.24 84.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.1 mt -78.94 -9.84 59.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.01 -1.056 . . . . 0.0 110.098 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 63.41 60.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.851 -1.156 . . . . 0.0 110.514 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 4.8 mm -104.18 133.99 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -119.87 -17.1 8.59 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.269 -0.895 . . . . 0.0 111.943 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 34' ' ' GLY . 4.0 m-80 -130.11 111.83 12.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.699 -1.25 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -165.26 136.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 110.01 178.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.558 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 23.3 m -107.21 99.53 9.06 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 mt -87.95 117.83 32.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.91 119.64 34.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.787 -1.196 . . . . 0.0 107.992 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 t -104.61 104.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 111.344 -178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mt -87.49 107.78 17.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.74 -161.32 24.03 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -116.85 -14.52 10.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -1.045 . . . . 0.0 110.506 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.488 ' CB ' ' HG1' ' A' ' 20' ' ' THR . 36.2 tt0 -142.18 146.34 35.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.741 -1.224 . . . . 0.0 111.076 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.23 124.88 91.37 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.803 -0.561 . . . . 0.0 109.674 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -46.37 129.4 13.33 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.774 1.649 . . . . 0.0 111.754 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.4 tp -77.6 -29.18 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.488 -0.757 . . . . 0.0 110.188 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.587 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 95.0 mt 55.24 -111.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.44 ' OD1' ' NH2' ' A' ' 178' ' ' ARG . 2.5 t0 -89.28 -28.58 19.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.613 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.13 -14.98 11.02 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -109.93 -166.78 1.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.37 -2.76 21.34 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -47.44 -42.37 22.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.808 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.95 -51.96 64.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.002 -1.062 . . . . 0.0 110.356 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 93.6 m-85 -63.5 -44.81 93.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 108.632 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 6.9 t80 -62.36 -38.2 88.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.718 -0.614 . . . . 0.0 109.961 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.3 -46.28 61.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.366 -0.834 . . . . 0.0 110.807 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.42 -51.56 12.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.992 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.68 -45.52 79.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.043 -1.036 . . . . 0.0 110.557 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -55.51 -29.36 58.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.209 -0.932 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -81.24 -12.96 58.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -0.992 . . . . 0.0 109.992 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -120.09 33.09 5.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.385 -0.822 . . . . 0.0 111.125 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.9 mt -90.55 148.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 110.494 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.7 tp -131.18 158.18 41.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.27 140.22 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -103.86 -163.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.487 HD21 ' H ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -116.47 -1.38 12.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.41 ' CD ' ' OE2' ' A' ' 4' ' ' GLU . 10.2 ttm180 -94.13 149.21 21.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 109.903 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.53 136.83 32.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 94.8 mt -77.52 144.32 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.411 -0.805 . . . . 0.0 110.459 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.5 89.97 8.07 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -62.88 145.64 54.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.235 -0.916 . . . . 0.0 110.518 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.27 123.4 46.03 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.18 141.12 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.89 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.1 t -84.43 138.34 19.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.493 -0.755 . . . . 0.0 109.096 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -119.12 -11.15 9.66 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -140.18 144.17 36.59 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.86 173.52 12.61 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.113 1.875 . . . . 0.0 113.109 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.9 tt -165.3 142.17 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.685 -0.634 . . . . 0.0 109.703 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.71 125.31 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 m -121.52 114.07 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -113.47 141.8 46.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.42 -0.8 . . . . 0.0 109.845 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -175.26 137.93 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 111.074 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 57.49 29.51 17.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.642 -0.662 . . . . 0.0 111.412 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.46 9.06 86.09 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -110.39 157.71 19.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -158.69 156.13 29.37 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.953 -1.717 . . . . 0.0 109.536 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.536 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 13.9 mt -149.03 133.02 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -120.91 143.01 49.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 109.901 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.23 143.97 49.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -142.03 138.47 16.9 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.9 144.9 42.85 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.473 1.449 . . . . 0.0 112.276 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.06 149.83 9.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -1.88 53.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 109.61 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.8 p -134.78 142.42 46.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.45 118.78 20.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -137.73 136.82 37.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.98 122.53 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.014 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 m -107.84 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.337 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -127.42 129.59 47.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.793 . . . . 0.0 109.72 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -115.52 103.51 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.72 135.45 12.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -111.18 93.23 4.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.498 -1.001 . . . . 0.0 109.343 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.452 ' CB ' ' ND2' ' A' ' 157' ' ' ASN . 20.5 m-85 -95.16 148.66 22.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.446 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -97.07 -3.75 40.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.745 ' H ' HD21 ' A' ' 157' ' ' ASN . 0.0 OUTLIER -73.74 -169.4 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.675 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -60.71 -20.8 61.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.97 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.425 ' HB2' HD22 ' A' ' 157' ' ' ASN . 31.2 mt -70.46 -28.36 64.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.0 109.042 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.69 -132.13 31.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.18 145.11 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -1.037 . . . . 0.0 109.556 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -146.35 156.04 43.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.583 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -139.23 145.0 38.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.249 -0.907 . . . . 0.0 109.332 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -136.28 126.58 26.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.061 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.474 ' O ' ' CG2' ' A' ' 165' ' ' THR . 7.3 t -103.78 123.85 47.83 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -100.22 136.03 40.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.159 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.512 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.5 t -131.82 153.5 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -57.08 118.91 5.49 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.43 -3.79 21.79 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -125.54 31.22 5.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.259 -1.142 . . . . 0.0 108.711 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.3 -32.84 74.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.543 -0.723 . . . . 0.0 110.605 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -58.2 -15.64 10.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.937 -1.102 . . . . 0.0 111.059 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -92.7 -4.13 53.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.85 -1.156 . . . . 0.0 110.894 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.23 -6.56 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.103 -0.998 . . . . 0.0 110.721 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.85 -29.14 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.698 -1.252 . . . . 0.0 109.933 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.03 1.99 51.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.68 -1.262 . . . . 0.0 110.415 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.07 115.62 18.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.914 -1.116 . . . . 0.0 108.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.44 ' NH2' ' OD1' ' A' ' 100' ' ' ASP . 1.9 ptm180 -86.59 154.62 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.05 . . . . 0.0 110.066 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -53.34 159.46 1.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.63 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.502 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 38.6 p90 -145.93 169.42 18.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.911 -1.118 . . . . 0.0 109.906 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.502 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -164.39 163.89 22.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.612 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 96.0 m-85 -103.7 146.08 29.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.613 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.96 -20.69 64.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 111.076 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.612 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.3 p90 -81.0 -26.85 36.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.646 -1.284 . . . . 0.0 110.643 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.499 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 23.4 pt-20 -97.74 -15.85 20.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.859 -1.151 . . . . 0.0 109.474 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 9.7 mt -57.39 -52.12 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 110.045 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.15 -49.21 61.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.078 . . . . 0.0 109.43 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -54.46 -52.36 62.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 108.922 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 59.5 mt -57.72 -33.84 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.407 -0.808 . . . . 0.0 109.346 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -77.89 -28.95 49.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.639 ' HZ2' ' CB ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -72.69 -26.8 61.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.573 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.3 m -84.79 13.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.604 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.24 25.68 72.52 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.072 -1.061 . . . . 0.0 110.592 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.03 156.59 28.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.267 -1.137 . . . . 0.0 109.732 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.72 25.55 60.32 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.408 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.6 mtmm -69.04 -20.88 64.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.465 -1.609 . . . . 0.0 109.051 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.88 -7.28 44.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.93 129.31 43.82 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.24 -1.153 . . . . 0.0 110.771 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.4 p -143.72 169.93 16.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.79 -0.829 . . . . 0.0 109.466 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 17.0 mt -71.25 -16.46 62.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.455 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 48.5 tttp -86.08 -9.65 56.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 6.1 m120 -138.26 12.07 2.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.648 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.475 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 28.1 m -152.97 131.69 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.57 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.5 tp -89.98 114.85 26.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.414 ' H ' ' ND2' ' A' ' 213' ' ' ASN . 63.4 t -100.65 125.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.063 -1.023 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.9 mt -100.73 146.13 27.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.867 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.43 150.3 16.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -46.33 -25.88 0.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.136 -1.214 . . . . 0.0 109.86 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -152.56 11.44 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 0.0 110.67 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -146.99 155.35 42.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.89 -1.131 . . . . 0.0 110.281 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.77 123.36 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -70.84 -54.35 11.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.935 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 205' ' ' VAL . 47.0 m-80 -53.49 131.36 54.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.098 -1.002 . . . . 0.0 109.391 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -24.95 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.311 2.007 . . . . 0.0 112.457 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -4.51 39.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.955 . . . . 0.0 109.289 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.89 -169.16 53.85 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.05 149.81 23.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 0.0 109.745 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -60.67 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.0 108.722 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 221' ' ' ASN . 7.7 m-85 -116.86 152.52 34.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 109.165 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.6 mp0 -60.65 -3.93 0.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 109.423 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.746 HD21 ' HE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -137.48 29.77 2.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.867 . . . . 0.0 108.983 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.603 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.0 tt0 -54.45 -42.03 92.31 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.76 . . . . 0.0 110.863 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.5 Cg_exo -70.83 -38.52 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.508 2.139 . . . . 0.0 113.156 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.66 -26.87 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.675 -1.266 . . . . 0.0 108.539 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.746 ' HE ' HD21 ' A' ' 221' ' ' ASN . 38.1 mtt180 -67.35 -39.82 85.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.572 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 19.1 t60 -66.6 -41.03 89.06 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -42.05 76.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.036 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.06 -44.6 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.572 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -55.26 -40.83 71.43 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.605 0.717 . . . . 0.0 109.067 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -71.74 -39.99 69.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.575 -0.703 . . . . 0.0 109.907 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.8 tp -56.55 -35.1 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.373 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 81.2 mt -72.15 -49.08 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.924 -1.11 . . . . 0.0 108.144 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.34 -30.95 12.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.74 -28.33 30.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -1.187 . . . . 0.0 109.854 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.3 mt -79.17 -22.85 44.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.743 -1.223 . . . . 0.0 109.782 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.524 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 16.6 t80 -69.99 -8.0 45.46 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.068 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 31.1 mt -49.76 -28.57 6.38 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.69 -20.59 65.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 108.957 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.41 17.91 76.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.9 p -154.01 138.8 11.52 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.235 . . . . 0.0 109.652 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -41.82 134.11 3.88 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.165 1.91 . . . . 0.0 111.872 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.81 136.14 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.023 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -122.3 125.71 46.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.306 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.45 26.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -102.5 112.54 25.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -1.198 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.6 m-85 -112.58 146.9 37.75 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.976 0.893 . . . . 0.0 111.048 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -126.99 144.29 51.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.0 t -138.87 126.76 22.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.684 -1.26 . . . . 0.0 110.112 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 250' ' ' ARG . 61.8 t80 -113.16 113.1 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 249' ' ' PHE . 52.8 mtp180 47.66 56.72 6.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.71 145.86 21.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.422 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -113.5 175.94 16.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.511 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.5 m-70 -66.99 -47.77 70.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -1.134 . . . . 0.0 109.998 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -55.14 37.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 109.801 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 51.6 tp -51.68 -37.86 52.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 16.1 m120 -58.68 -55.37 35.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.119 -0.988 . . . . 0.0 108.746 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 18.5 t -49.14 -41.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.415 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -55.22 -47.37 75.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 108.803 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.86 -50.56 63.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.63 -41.2 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 109.856 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -51.93 67.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.421 -0.799 . . . . 0.0 110.43 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -64.65 -45.4 86.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.845 -1.159 . . . . 0.0 109.73 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.8 mt -58.83 -45.72 89.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.17 73.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.832 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 47.4 mttt . . . . . 0 N--CA 1.488 1.457 0 O-C-N 120.85 -1.156 . . . . 0.0 109.101 179.386 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.88 139.67 52.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 109.485 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -141.15 177.57 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.468 -0.77 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.33 149.69 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 110.21 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -86.27 -42.13 14.02 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.662 -0.649 . . . . 0.0 109.758 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 10' ' ' LYS . 13.0 tt0 -129.32 153.98 47.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.517 -0.739 . . . . 0.0 109.992 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -59.98 135.64 57.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.305 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.5 mt -124.8 166.52 16.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.473 -0.767 . . . . 0.0 109.267 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 150.24 22.34 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 110.115 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -131.21 158.43 40.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.695 -0.628 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.81 134.81 23.87 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.941 -1.1 . . . . 0.0 108.869 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.85 156.79 14.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.094 -1.603 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.12 141.02 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -1.229 . . . . 0.0 110.804 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.61 138.12 37.71 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.6 tt -57.91 -48.16 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.089 . . . . 0.0 112.042 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 16.3 m-70 -86.75 -37.6 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.276 -1.515 . . . . 0.0 111.017 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.457 ' H ' ' HG1' ' A' ' 20' ' ' THR . 0.7 OUTLIER -72.25 -32.86 67.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 110.119 -179.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.33 65.89 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -113.83 151.25 32.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.948 . . . . 0.0 108.956 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -70.62 130.94 43.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.89 . . . . 0.0 110.063 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 31.5 t -138.63 157.55 45.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.063 -1.023 . . . . 0.0 109.381 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -137.09 152.03 49.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.132 -0.98 . . . . 0.0 109.541 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mt -127.72 145.95 50.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 mt -131.35 129.05 62.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mt -117.89 133.35 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.087 -1.008 . . . . 0.0 110.139 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -126.6 150.01 69.66 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.71 161.78 20.32 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.104 1.869 . . . . 0.0 111.028 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.493 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 53.5 mt-10 -133.96 -174.68 3.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -89.73 154.92 19.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.195 -0.94 . . . . 0.0 109.248 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -47.93 145.2 3.08 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 110.058 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.55 23.52 54.78 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.382 -0.824 . . . . 0.0 111.791 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 55.5 m -75.45 -46.29 33.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.589 -1.536 . . . . 0.0 109.094 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.75 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 105.23 174.94 24.32 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 37' ' ' ILE . 12.9 mm -92.98 121.79 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.446 -1.032 . . . . 0.0 108.749 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.27 138.23 34.84 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -97.22 153.0 18.28 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.1 t80 -130.98 139.95 50.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.155 -0.965 . . . . 0.0 109.063 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 10.7 ttmt -170.0 139.46 1.86 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.483 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.91 29.02 18.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.04 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 28.09 70.63 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.3 t -134.28 139.18 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -1.12 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -97.67 144.43 27.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.096 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.9 mt -136.91 97.62 10.99 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.306 -0.871 . . . . 0.0 110.33 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.61 143.13 29.4 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.093 1.862 . . . . 0.0 111.341 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.46 83.15 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.0 -1.062 . . . . 0.0 110.481 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -138.53 154.9 48.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.332 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.9 p80 -53.47 -49.37 67.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.24 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' CG ' ' CE1' ' A' ' 50' ' ' HIS . 8.2 mt-10 -45.55 -16.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' HIS . 89.8 m-85 -96.89 6.66 48.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.961 -1.087 . . . . 0.0 109.868 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.14 126.2 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 108.652 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.21 -32.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -149.87 119.99 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.068 -1.02 . . . . 0.0 109.63 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.4 p -112.68 131.36 55.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.427 0.632 . . . . 0.0 109.359 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 2.1 t-20 -166.07 -154.3 0.19 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 57' ' ' ASN . 10.8 m-70 -47.81 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.922 -1.111 . . . . 0.0 108.357 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.602 ' HG ' ' N ' ' A' ' 60' ' ' THR . 1.6 t -136.6 166.11 24.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.602 ' N ' ' HG ' ' A' ' 59' ' ' SER . 40.2 m -107.83 123.45 48.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 108.971 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.02 141.68 51.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.928 0.87 . . . . 0.0 110.971 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.2 mt -118.64 168.58 10.57 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.25 145.07 5.43 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.801 -1.666 . . . . 0.0 110.824 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -144.46 150.58 37.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? 55.85 23.22 6.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.751 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.62 68.08 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.741 -1.219 . . . . 0.0 111.075 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.499 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 1.5 mm100 -92.33 144.87 24.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.483 . . . . 0.0 108.456 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.635 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -141.6 153.23 44.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.937 -1.102 . . . . 0.0 111.5 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 147.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -113.63 151.75 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.206 -0.934 . . . . 0.0 111.383 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m 52.52 68.23 0.86 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.776 -0.578 . . . . 0.0 111.037 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.02 -10.28 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.49 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.8 pt-20 -65.56 -24.22 67.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.413 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -67.64 -60.32 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.871 -1.143 . . . . 0.0 109.764 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.2 tp -58.32 -42.32 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.002 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 19.5 mt -58.85 -37.99 77.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.489 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.6 t -58.35 -47.47 83.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.931 -1.106 . . . . 0.0 108.956 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.88 -51.58 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.547 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.5 mt -51.27 -44.1 61.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.417 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 4.6 t-160 -52.62 -56.95 11.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.404 -0.81 . . . . 0.0 109.918 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.83 -35.71 79.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 110.559 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.4 mt -79.68 -9.65 59.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.021 -1.05 . . . . 0.0 110.595 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 62.74 50.35 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.781 -1.199 . . . . 0.0 110.372 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 3.3 mm -94.14 125.64 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.468 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.8 p -113.83 -18.74 11.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.168 -0.958 . . . . 0.0 112.034 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.75 HD21 ' H ' ' A' ' 36' ' ' GLY . 10.5 m120 -130.75 112.15 12.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.886 -1.134 . . . . 0.0 110.409 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -164.57 148.69 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 0.0 110.023 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.493 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 2.3 m -115.69 102.09 9.42 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.1 104.79 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.21 118.88 24.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 108.401 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.27 112.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 111.05 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.487 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.0 mp -92.5 110.9 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.21 -163.16 24.87 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -116.57 -15.18 10.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -1.013 . . . . 0.0 110.101 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 19.1 tt0 -138.05 143.01 40.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 0.0 110.291 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.9 mm -69.36 124.71 91.06 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.468 -0.77 . . . . 0.0 109.392 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.85 126.46 11.0 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.547 1.498 . . . . 0.0 111.416 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 tp -79.52 -21.45 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 3.7 mt 57.06 -110.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -95.5 -8.16 36.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.046 -1.034 . . . . 0.0 111.919 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.23 -12.04 48.13 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.2 p -119.04 -168.84 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -1.01 . . . . 0.0 109.537 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.55 -4.08 23.51 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.543 ' NE1' ' CD ' ' A' ' 108' ' ' GLU . 60.5 t-105 -46.92 -42.5 17.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.664 -0.903 . . . . 0.0 110.455 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.15 -51.51 68.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.924 -1.11 . . . . 0.0 109.783 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.5 m-85 -62.29 -43.81 97.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.112 -0.993 . . . . 0.0 108.588 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -61.98 -39.3 91.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.543 ' CD ' ' NE1' ' A' ' 104' ' ' TRP . 19.0 mt-10 -68.91 -46.39 68.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 111.437 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.97 -51.82 9.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.83 -1.169 . . . . 0.0 110.97 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.72 -43.37 87.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.814 -1.178 . . . . 0.0 110.558 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -59.55 -30.28 68.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.971 -1.08 . . . . 0.0 109.317 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -83.73 11.14 7.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.695 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -144.37 32.18 1.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.8 mt -91.5 148.73 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.891 -1.13 . . . . 0.0 110.717 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.64 153.73 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 2.3 m-20 -105.64 146.36 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.06 -1.025 . . . . 0.0 110.012 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.479 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.4 mt-30 -105.41 -162.36 0.87 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.837 . . . . 0.0 109.09 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -117.74 2.09 12.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.092 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -97.84 152.53 19.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.858 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -94.43 147.54 23.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.898 . . . . 0.0 109.485 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.9 mt -89.37 153.93 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.356 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -96.84 101.81 13.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -72.42 145.21 47.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.962 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -95.89 123.04 39.31 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.53 138.2 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.48 136.86 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -112.56 -7.27 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.28 147.82 24.67 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 109.188 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.35 145.48 38.44 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.173 1.915 . . . . 0.0 112.888 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.6 tt -130.73 150.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.27 117.85 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.629 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.8 m -118.09 109.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 109.36 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.7 131.64 55.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 0.0 109.293 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -179.98 159.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.062 . . . . 0.0 110.469 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 134' ' ' ASP . 11.6 mm-40 56.61 19.74 4.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.708 -0.62 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 -0.4 82.68 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 250' ' ' ARG . 0.6 OUTLIER -101.04 176.79 5.14 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.01 . . . . 0.0 108.302 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.1 tt -160.35 145.97 15.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.512 -1.367 . . . . 0.0 108.769 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.458 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 3.6 mt -144.97 130.99 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.076 -1.015 . . . . 0.0 108.28 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -121.39 137.37 54.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 109.814 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -113.71 149.35 34.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -145.4 136.61 12.58 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.53 144.94 99.29 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.493 1.462 . . . . 0.0 112.014 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.56 156.19 7.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 12.4 p-10 -88.82 3.28 51.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.5 p -135.43 147.1 48.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.0 118.73 22.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -135.94 139.03 42.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 79.8 t -137.7 122.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 109.685 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.468 ' O ' ' OG ' ' A' ' 248' ' ' SER . 1.4 m -112.37 138.67 48.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -127.82 131.57 49.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.695 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -117.31 119.11 34.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -114.82 137.73 14.23 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -112.24 85.44 2.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.416 -1.049 . . . . 0.0 109.241 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 160' ' ' GLY . 18.5 m-85 -86.2 148.45 25.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 109.915 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -97.22 -3.01 41.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 0.0 109.852 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.649 ' ND2' ' H ' ' A' ' 159' ' ' LEU . 11.4 p-10 -76.35 -169.94 1.33 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.084 -1.01 . . . . 0.0 109.687 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -55.7 -24.22 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.649 ' H ' ' ND2' ' A' ' 157' ' ' ASN . 9.1 mt -66.49 -40.21 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.18 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 75.5 -124.98 7.81 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -114.14 145.32 41.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.955 . . . . 0.0 109.819 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.573 ' NE2' ' ND2' ' A' ' 221' ' ' ASN . 22.8 tt0 -162.21 162.14 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 0.0 109.738 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -147.86 159.81 43.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -139.39 131.65 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.096 -1.003 . . . . 0.0 109.667 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' A' ' 165' ' ' THR . 13.8 t -103.7 123.22 46.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 5.9 t80 -100.53 138.56 37.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.441 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 t -137.53 150.02 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.804 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -50.43 118.2 2.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.2 6.17 18.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.85 28.41 2.64 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.17 -1.194 . . . . 0.0 108.716 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.42 -37.01 79.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.425 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.83 -16.63 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 110.45 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -88.33 -3.86 58.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.081 -1.012 . . . . 0.0 110.919 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.77 5.65 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.085 -1.009 . . . . 0.0 111.417 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -32.39 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.456 -1.403 . . . . 0.0 110.057 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.52 2.68 50.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.009 -1.057 . . . . 0.0 110.994 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.06 117.31 20.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.685 -1.259 . . . . 0.0 108.698 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -91.54 152.86 20.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.102 -0.999 . . . . 0.0 110.334 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -57.77 131.19 49.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.372 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -109.36 163.9 12.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -0.992 . . . . 0.0 110.115 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.71 162.36 36.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 110.495 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.554 ' N ' ' OE2' ' A' ' 185' ' ' GLU . 57.7 m-85 -105.37 144.65 31.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -60.79 -26.5 67.32 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.829 -1.17 . . . . 0.0 110.213 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.482 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.1 p90 -81.31 -26.24 35.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 111.095 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 182' ' ' PHE . 10.3 pt-20 -92.7 -14.59 27.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.663 -1.273 . . . . 0.0 109.568 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 9.3 mt -56.19 -53.37 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.235 -0.916 . . . . 0.0 110.145 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.0 -53.32 54.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.989 -1.069 . . . . 0.0 109.449 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -52.12 -41.49 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.833 . . . . 0.0 109.214 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.86 -33.88 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -0.967 . . . . 0.0 108.862 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -79.52 -25.74 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -27.72 42.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 109.89 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.89 8.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.2 70.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.1 mt -123.85 163.17 21.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 0.0 109.664 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.434 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 75.29 24.43 71.07 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -70.83 -20.66 62.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.282 . . . . 0.0 109.691 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.04 -2.51 51.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.65 128.55 35.36 Favored Glycine 0 N--CA 1.492 2.387 0 O-C-N 121.204 -1.174 . . . . 0.0 111.07 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.5 p -132.45 -173.67 3.23 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.9 -12.88 29.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -91.4 -4.89 55.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 109.559 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 99' ' ' LEU . 42.5 m-20 -139.22 12.11 2.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.885 . . . . 0.0 109.375 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.76 122.13 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.249 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.2 tp -82.25 112.83 19.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 t -103.67 127.88 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.957 -1.09 . . . . 0.0 109.215 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 78.6 mt -111.15 141.95 43.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 110.136 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -96.37 149.29 19.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -42.48 -25.17 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -1.222 . . . . 0.0 110.106 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.2 OUTLIER -150.49 10.12 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.833 -1.167 . . . . 0.0 110.596 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -143.21 151.83 41.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 110.098 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.6 t -96.54 123.22 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.488 -0.757 . . . . 0.0 109.066 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -72.85 -54.36 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 110.129 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -55.33 134.36 69.66 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.872 -1.142 . . . . 0.0 109.618 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.55 -23.01 20.41 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.393 2.062 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.63 -5.1 49.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 110.043 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.58 -161.56 53.66 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.2 mt -89.94 146.92 24.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.495 -1.003 . . . . 0.0 110.294 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.75 -20.99 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.631 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 48.3 m-85 -142.52 167.91 20.97 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.57 -21.44 35.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 108.412 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.573 ' ND2' ' NE2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -125.18 37.55 4.37 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.591 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 30.1 tt0 -58.95 -35.76 35.65 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.447 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.5 Cg_exo -73.88 -45.52 0.38 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.714 1.61 . . . . 0.0 113.001 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.43 -25.19 16.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.754 -1.216 . . . . 0.0 108.554 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.631 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 11.6 mtp180 -67.06 -46.01 75.63 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -58.29 -43.25 87.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -45.59 82.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 108.737 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.91 -48.63 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.573 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -54.32 -41.31 68.88 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.96 -39.67 79.34 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.513 -0.742 . . . . 0.0 109.671 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.66 -36.21 73.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.374 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.3 -34.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -63.34 -34.42 89.92 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 3.0 m-20 -82.94 -26.77 31.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -1.143 . . . . 0.0 110.135 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.48 -25.92 35.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.853 -1.154 . . . . 0.0 109.772 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.505 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 27.8 t80 -66.85 -8.8 31.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 108.923 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 71.5 mt -49.95 -30.12 9.76 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.18 -15.8 27.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 108.98 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 53.4 p -156.01 137.53 9.61 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.247 . . . . 0.0 109.503 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -42.81 130.4 5.53 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.049 1.833 . . . . 0.0 112.184 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.88 135.98 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.815 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -118.62 123.34 44.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.755 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.22 169.86 20.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.74 114.47 28.55 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.197 -1.178 . . . . 0.0 110.047 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -111.36 150.97 28.98 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.918 0.866 . . . . 0.0 110.976 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -128.44 144.14 51.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 150' ' ' THR . 0.9 OUTLIER -137.26 127.01 25.46 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.731 -1.231 . . . . 0.0 110.475 -178.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.468 ' O ' ' C ' ' A' ' 250' ' ' ARG . 52.4 t80 -111.83 113.9 26.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.47 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 11.5 mmm180 44.45 56.12 5.23 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.427 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -83.47 146.99 23.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.587 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -119.84 177.05 16.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.539 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 29.1 m-70 -67.63 -38.21 83.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -1.154 . . . . 0.0 109.787 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.1 t -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.065 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.2 tp -72.66 -37.29 67.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.937 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 75.5 m-20 -60.57 -51.76 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 80.4 t -51.92 -44.13 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 109.138 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -55.23 -47.08 75.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.052 -1.03 . . . . 0.0 109.018 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 54.1 tp -52.66 -49.67 64.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.4 -47.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -52.24 54.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.576 -0.703 . . . . 0.0 110.23 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.09 -50.65 73.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.982 -1.074 . . . . 0.0 110.515 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.63 -39.73 92.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.19 -34.29 72.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.336 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.0 mttp . . . . . 0 N--CA 1.486 1.36 0 O-C-N 121.025 -1.047 . . . . 0.0 108.527 179.071 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.581 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 7.0 mm-40 . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.19 138.82 54.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.066 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 115' ' ' LEU . 13.5 t -134.15 171.43 14.24 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 m -82.24 140.87 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.79 -1.194 . . . . 0.0 110.484 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -75.84 -46.54 29.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -126.54 154.48 43.78 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.744 0.783 . . . . 0.0 111.054 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -54.37 135.23 45.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.698 -0.626 . . . . 0.0 109.977 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mt -121.22 152.91 38.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -151.99 146.44 25.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 110.042 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -128.25 162.4 27.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.58 -0.7 . . . . 0.0 109.304 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.73 132.52 17.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.914 -1.116 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.6 157.9 16.46 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 2.4 p -77.7 164.28 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.943 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -91.32 137.61 13.91 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.4 tt -58.57 -48.41 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.229 -1.16 . . . . 0.0 111.928 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.443 ' HD1' ' HA2' ' A' ' 195' ' ' GLY . 7.1 m-70 -86.78 -38.18 17.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.205 -1.56 . . . . 0.0 110.98 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -74.47 -40.0 62.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 0.0 109.867 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.77 23.08 78.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -112.11 151.04 29.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.528 -0.983 . . . . 0.0 108.621 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -71.16 134.43 46.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 109.88 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 11.5 t -141.17 158.49 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' N ' ' HG ' ' A' ' 24' ' ' SER . 4.2 ttpp -133.15 155.07 49.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.502 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.6 mt -128.65 152.35 48.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.955 . . . . 0.0 109.665 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.455 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.1 mt -142.05 126.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.491 -0.756 . . . . 0.0 109.014 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mt -115.29 117.72 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 0.0 109.924 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.455 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 11.7 m-70 -113.04 149.38 41.24 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.6 163.1 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 111.143 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.0 mm-40 -136.84 -175.17 3.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.08 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -86.6 152.07 22.91 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.432 -0.792 . . . . 0.0 109.028 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -51.66 151.04 3.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 110.407 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.569 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 63.62 19.64 62.9 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.27 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 51.9 m -81.94 -46.75 13.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.498 -1.589 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -171.77 23.26 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mm -97.52 122.12 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -1.137 . . . . 0.0 108.159 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.61 144.3 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 110.544 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.83 154.33 20.68 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.7 t80 -129.86 142.06 50.72 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 12.9 ttpt -172.35 138.24 0.92 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.95 29.76 19.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.466 -0.771 . . . . 0.0 109.824 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.99 74.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.61 139.75 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -94.04 146.83 23.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.122 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.0 mt -139.56 98.91 7.89 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.92 140.93 37.9 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.174 1.916 . . . . 0.0 111.453 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.34 79.89 8.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.91 -1.119 . . . . 0.0 110.866 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.62 155.07 49.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.914 . . . . 0.0 109.223 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.59 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 2.6 p80 -54.56 -49.58 69.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.171 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -46.56 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 109.909 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' HIS . 80.0 m-85 -98.51 7.99 45.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 50' ' ' HIS . 4.8 t -63.76 132.86 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.81 -34.06 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.0 110.119 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.45 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.6 t-80 -150.37 122.95 8.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.034 -1.041 . . . . 0.0 109.963 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.2 p -112.36 129.49 56.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 11.1 t-20 -166.67 -153.6 0.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 57' ' ' ASN . 19.2 m-70 -44.85 -16.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.218 -0.926 . . . . 0.0 108.704 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.2 t -136.19 165.56 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.48 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -102.97 121.32 42.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 108.778 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -119.39 138.22 53.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 111.033 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.6 mt -118.34 163.52 16.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.77 146.21 6.23 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.482 -1.818 . . . . 0.0 111.211 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -145.03 151.81 39.15 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.629 -0.924 . . . . 0.0 109.579 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt 57.57 23.66 9.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.88 . . . . 0.0 110.93 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.96 -2.22 75.57 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.888 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.469 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 96.8 mm-40 -98.93 143.75 28.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.842 -1.387 . . . . 0.0 108.258 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -142.86 155.71 44.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 111.801 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.12 145.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -110.88 150.29 29.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.112 -0.993 . . . . 0.0 111.668 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 m 54.55 68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.764 -0.585 . . . . 0.0 111.294 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.41 -9.58 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.718 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' OE2' ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER -66.28 -19.04 65.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 0.0 110.698 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -72.32 -60.86 2.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.841 -1.162 . . . . 0.0 109.641 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -56.74 -42.65 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.864 -1.148 . . . . 0.0 108.554 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 74.1 mt -55.05 -40.12 69.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.594 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 37.6 t -60.49 -48.74 80.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.554 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -56.55 -54.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 108.606 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.6 mt -51.43 -44.38 62.29 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -54.81 -56.5 18.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.049 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.92 -37.48 87.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.255 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.0 mt -77.2 -6.12 51.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.993 -1.067 . . . . 0.0 110.057 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 62.96 42.37 7.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.967 -1.083 . . . . 0.0 110.096 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.444 HD12 HG23 ' A' ' 84' ' ' ILE . 16.2 mm -90.01 126.1 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.1 p -107.47 -76.41 0.61 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 111.577 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.704 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -81.27 113.81 19.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.06 -1.025 . . . . 0.0 111.9 -176.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.71 144.37 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.541 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 3.8 m -110.93 101.65 10.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.499 -0.751 . . . . 0.0 109.27 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.99 111.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -92.21 120.0 32.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.043 -1.036 . . . . 0.0 108.633 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.32 112.37 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.991 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.485 ' O ' ' OG ' ' A' ' 24' ' ' SER . 2.5 mp -91.44 109.67 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.35 -160.79 23.52 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.4 -15.97 9.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.979 . . . . 0.0 109.959 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -135.64 142.56 45.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.977 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -67.96 126.75 93.02 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -46.28 127.82 11.46 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.709 1.606 . . . . 0.0 111.735 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.56 -25.75 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.302 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 96.4 mt 54.77 -116.65 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -94.85 -8.13 38.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 0.0 110.751 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.87 -13.38 59.15 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -109.94 -171.97 1.94 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -1.059 . . . . 0.0 109.619 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.94 -7.62 16.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -46.42 -38.57 9.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.976 . . . . 0.0 110.128 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.525 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -61.85 -51.81 66.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.007 -1.058 . . . . 0.0 109.818 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 78.2 m-85 -63.34 -43.78 96.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -60.93 -39.66 90.28 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.447 0.641 . . . . 0.0 109.84 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.57 -46.6 53.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 111.829 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.09 -51.25 12.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.779 -1.201 . . . . 0.0 110.828 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.55 -42.67 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.043 -1.035 . . . . 0.0 110.708 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -57.27 -28.56 63.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 110.038 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -80.16 -12.07 59.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.221 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -123.09 34.88 5.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.836 . . . . 0.0 110.927 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.9 mt -85.98 147.16 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.48 -1.388 . . . . 0.0 110.674 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' THR . 31.9 tp -132.26 145.53 51.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.618 -0.677 . . . . 0.0 109.478 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -92.68 146.2 23.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.106 -0.996 . . . . 0.0 110.356 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -108.85 -168.23 1.32 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -119.74 69.94 0.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.418 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -170.21 122.04 0.66 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.225 -0.922 . . . . 0.0 109.91 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.87 134.69 56.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.49 143.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.462 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -86.4 89.68 7.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -63.67 147.01 52.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 110.555 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -104.77 125.09 50.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.29 142.59 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.7 t -83.65 139.88 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.459 -0.775 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -118.87 -11.05 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 109.046 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -142.56 144.95 32.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.261 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.61 160.24 44.44 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.163 1.908 . . . . 0.0 113.349 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 tt -153.22 140.82 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 18.1 mt -130.0 124.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.478 -0.764 . . . . 0.0 109.846 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.3 117.72 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.507 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.87 156.89 16.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 109.737 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 137' ' ' ARG . 49.6 t0 -165.92 110.22 0.82 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 0.0 111.369 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 41.06 51.13 3.3 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.54 -0.725 . . . . 0.0 112.244 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.91 6.97 88.89 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.708 -1.245 . . . . 0.0 110.274 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 134' ' ' ASP . 12.5 mtt85 -118.2 132.28 56.33 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 139' ' ' ILE . 4.8 tt -144.71 160.81 40.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.349 -1.469 . . . . 0.0 109.776 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.438 ' H ' ' HG ' ' A' ' 138' ' ' LEU . 48.9 mt -144.57 129.63 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -116.0 142.32 46.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.36 -0.837 . . . . 0.0 110.131 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.97 143.74 50.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -142.02 138.92 17.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.93 146.16 58.67 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.394 1.396 . . . . 0.0 112.088 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -166.11 151.97 8.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.398 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 -1.29 56.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -134.1 146.25 50.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 109.259 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.46 120.18 24.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -1.0 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.95 137.96 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.4 t -137.23 118.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.711 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 m -106.03 143.91 33.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -132.06 130.94 41.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.93 105.97 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.74 155.54 20.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.401 ' HB3' ' HE ' ' A' ' 250' ' ' ARG . 3.2 tt0 -132.79 98.01 4.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -1.028 . . . . 0.0 109.116 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' GLY . 20.8 m-85 -101.38 148.6 24.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.844 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 mmtm -93.16 -5.99 48.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.992 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.7 p30 -74.44 -173.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.032 -1.042 . . . . 0.0 109.48 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -53.58 -17.05 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.783 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.569 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 31.7 mt -67.1 -49.98 63.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 109.506 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 82.86 -114.59 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.45 ' O ' ' CD ' ' A' ' 162' ' ' GLN . 12.4 mtm-85 -116.98 139.55 50.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.481 -1.011 . . . . 0.0 109.294 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 161' ' ' ARG . 4.3 mp0 -142.31 155.65 45.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 109.526 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 142.18 31.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.079 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -136.35 125.72 24.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.191 -0.943 . . . . 0.0 109.257 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -103.6 122.94 46.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.045 -1.034 . . . . 0.0 109.802 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -100.01 136.96 39.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.178 -0.951 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.89 156.08 41.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.556 -0.715 . . . . 0.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.28 118.9 6.47 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.145 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.83 1.32 21.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -131.42 29.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -1.112 . . . . 0.0 108.806 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -64.01 -33.58 76.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.603 -0.686 . . . . 0.0 110.611 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -52.81 -13.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 110.638 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.87 -4.12 44.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 111.139 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.1 -8.15 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.022 -1.049 . . . . 0.0 110.785 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.33 -33.11 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.66 -1.275 . . . . 0.0 109.943 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.96 1.28 54.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.797 -1.189 . . . . 0.0 110.603 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.82 116.93 20.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.927 -1.108 . . . . 0.0 108.657 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.54 153.26 20.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.034 -1.041 . . . . 0.0 110.361 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.6 t -62.07 147.66 46.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.531 -0.73 . . . . 0.0 109.457 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -130.31 176.26 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 110.402 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.89 163.09 32.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.463 -0.773 . . . . 0.0 109.581 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.63 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 89.6 m-85 -104.69 146.34 29.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 109.937 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -61.7 -22.05 65.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 0.0 110.804 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.63 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.4 p90 -81.19 -28.41 34.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.793 -1.192 . . . . 0.0 110.653 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 13.6 pt-20 -95.1 -14.32 24.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.897 -1.127 . . . . 0.0 109.51 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.62 -53.12 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.238 -0.914 . . . . 0.0 110.129 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.22 -52.97 49.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.773 -1.204 . . . . 0.0 109.107 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.62 -47.98 66.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -0.966 . . . . 0.0 108.707 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 76.5 mt -58.7 -34.36 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -78.55 -27.04 45.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.53 -0.731 . . . . 0.0 110.166 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -74.84 -26.82 59.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -0.999 . . . . 0.0 109.883 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 m -84.18 9.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.34 66.92 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.821 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 3.8 mt -120.02 158.29 27.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.136 -1.214 . . . . 0.0 109.688 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.443 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 80.02 21.41 65.58 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.462 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -68.8 -22.34 64.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.577 -1.543 . . . . 0.0 109.664 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.41 -4.75 52.8 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.05 125.98 33.23 Favored Glycine 0 N--CA 1.49 2.273 0 O-C-N 121.186 -1.184 . . . . 0.0 110.539 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -131.08 -173.64 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.768 -0.842 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.4 -2.03 57.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 1.3 ttpp -100.17 -3.56 31.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 4.3 m120 -139.26 -7.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.97 . . . . 0.0 109.871 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.5 m -130.26 128.41 41.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 109.81 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.98 115.93 26.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 108.927 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.01 127.88 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 30.5 mt -103.6 147.34 27.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.809 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.07 150.63 17.44 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -44.89 -22.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.141 . . . . 0.0 110.058 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.0 OUTLIER -155.13 12.74 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.948 -1.095 . . . . 0.0 110.343 -179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -146.67 155.44 42.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.85 125.56 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.03 -54.74 7.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -47.89 135.89 10.95 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.812 -1.18 . . . . 0.0 109.389 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 216' ' ' GLY . 43.0 Cg_endo -71.7 -41.16 2.37 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 112.05 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -65.12 -0.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.863 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 73.31 -166.93 54.49 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 43.5 mt -83.89 149.83 26.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.442 -1.034 . . . . 0.0 109.803 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -76.7 -61.37 1.99 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.947 . . . . 0.0 108.755 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -117.09 163.1 16.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.362 -0.837 . . . . 0.0 109.293 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.79 -14.6 62.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.664 ' ND2' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -133.55 32.77 3.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.339 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 5.8 tt0 -58.69 -37.39 53.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 111.126 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.6 Cg_exo -70.63 -43.22 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.971 1.781 . . . . 0.0 112.576 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.3 m -78.71 -25.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.755 -1.216 . . . . 0.0 108.604 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.664 ' NH2' ' ND2' ' A' ' 221' ' ' ASN . 27.4 mtt180 -66.7 -40.71 88.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -64.81 -41.29 95.9 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -48.64 78.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.675 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.8 t -58.3 -49.27 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.594 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.0 t80 -49.99 -38.29 36.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.502 0.667 . . . . 0.0 109.299 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.477 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 7.9 m-20 -72.68 -40.01 66.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 110.141 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 tp -56.46 -37.48 70.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.343 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 88.9 mt -70.92 -48.49 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.886 -1.134 . . . . 0.0 108.057 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.81 -33.87 13.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.29 -26.76 32.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -1.199 . . . . 0.0 110.176 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.05 -21.03 43.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.668 -1.27 . . . . 0.0 110.074 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -70.59 -8.32 50.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 109.143 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 90.6 mt -53.18 -26.07 15.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.358 -0.839 . . . . 0.0 108.829 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.11 -20.0 62.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.973 -1.08 . . . . 0.0 108.939 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.93 15.35 70.28 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 70.9 p -158.47 149.49 16.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.909 -1.348 . . . . 0.0 109.824 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -44.32 130.16 8.73 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.216 1.944 . . . . 0.0 111.749 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.0 t -98.88 133.16 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.005 -1.059 . . . . 0.0 109.697 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -121.84 125.83 47.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.73 172.59 26.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -103.58 112.9 26.03 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -1.184 . . . . 0.0 109.656 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 5.6 m-85 -113.5 148.45 35.98 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.06 0.933 . . . . 0.0 111.558 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.8 t80 -129.65 144.28 51.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.414 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 36.2 t -139.52 127.67 22.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.701 -1.249 . . . . 0.0 110.466 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 4.3 t80 -111.71 114.6 27.72 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.2 mtt-85 45.76 56.44 5.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.37 151.13 21.74 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.848 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.7 -176.24 16.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -71.03 -52.35 20.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -1.228 . . . . 0.0 110.107 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -55.01 33.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.181 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.6 tp -51.03 -41.63 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -57.87 -54.29 48.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 108.863 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.1 -43.22 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.647 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.61 -46.72 73.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.078 -1.014 . . . . 0.0 108.718 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.7 tp -55.73 -47.92 76.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.8 . . . . 0.0 109.048 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.99 -42.6 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.808 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.609 ' HZ1' ' CE ' ' A' ' 265' ' ' LYS . 0.2 OUTLIER -54.17 -48.36 70.98 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 110.671 -179.058 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.19 -45.05 70.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.841 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.45 -45.41 93.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.42 89.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.827 . . . . 0.0 109.732 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.609 ' CE ' ' HZ1' ' A' ' 261' ' ' LYS . 28.3 mttm . . . . . 0 N--CA 1.49 1.542 0 O-C-N 120.962 -1.086 . . . . 0.0 109.214 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 119' ' ' ARG . 16.1 mm-40 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.25 127.67 56.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.432 -0.792 . . . . 0.0 109.128 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -135.09 173.3 11.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 m -82.97 133.92 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.004 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -58.98 -48.38 81.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -133.65 163.07 30.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 132.28 48.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.521 -0.737 . . . . 0.0 109.974 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.3 mt -117.74 164.07 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -152.97 147.59 26.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.029 . . . . 0.0 110.198 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -132.06 161.55 32.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.463 -0.773 . . . . 0.0 109.74 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.43 134.88 20.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.12 . . . . 0.0 109.365 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.09 158.92 17.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 4.2 p -74.96 163.02 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -1.103 . . . . 0.0 111.263 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.485 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -93.47 139.98 14.84 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.3 tt -57.81 -50.85 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.128 -1.219 . . . . 0.0 112.396 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.409 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 11.6 m-70 -86.44 -37.66 18.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.188 -1.57 . . . . 0.0 111.203 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -73.92 -34.66 64.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.0 110.215 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.49 21.33 66.64 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -109.76 149.95 29.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.544 -0.974 . . . . 0.0 109.274 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.84 132.43 45.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.891 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -139.63 157.51 45.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -133.69 155.21 50.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.274 -0.891 . . . . 0.0 109.291 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mt -131.04 146.67 52.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.044 -1.035 . . . . 0.0 109.373 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 mt -136.0 123.91 35.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mt -111.8 122.99 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.543 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.614 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -118.03 139.24 26.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.463 -0.773 . . . . 0.0 109.354 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -53.46 162.6 3.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.439 1.426 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.5 mm-40 -135.96 -171.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.1 ttmt -91.92 156.53 17.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.586 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -50.46 146.35 5.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 110.548 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 64.09 24.48 68.73 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.567 -0.708 . . . . 0.0 112.204 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.552 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 91.3 m -81.64 -46.44 14.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.346 -1.679 . . . . 0.0 109.112 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.714 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 101.52 -174.66 24.99 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mm -94.86 122.65 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.189 -1.183 . . . . 0.0 108.354 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 137.28 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.077 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -98.58 154.59 17.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.7 t80 -130.12 136.99 49.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 108.815 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 4.0 ttmm -167.45 136.85 2.73 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.115 -0.991 . . . . 0.0 109.594 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.33 28.6 17.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.922 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 28.19 71.76 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.4 t -133.42 132.12 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.161 -1.199 . . . . 0.0 109.727 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -85.34 140.4 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.2 mt -134.45 94.75 16.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.398 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.58 141.06 27.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.21 1.94 . . . . 0.0 111.494 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.09 84.39 5.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.812 -1.18 . . . . 0.0 110.374 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -139.06 155.35 48.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' VAL . 6.9 p80 -52.32 -49.43 64.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.286 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.3 mt-10 -44.62 -30.96 1.0 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.153 -0.967 . . . . 0.0 109.151 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 46.1 m-85 -81.48 2.42 28.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.413 -0.804 . . . . 0.0 110.176 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' HIS . 8.3 t -59.46 127.44 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.015 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.62 -31.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.502 ' HD1' ' NZ ' ' A' ' 70' ' ' LYS . 7.5 t-160 -151.97 123.07 7.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.891 -1.131 . . . . 0.0 109.975 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.9 p -111.77 131.61 55.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.725 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -166.66 -153.64 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -48.31 -11.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.019 -1.051 . . . . 0.0 108.537 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.9 t -139.94 166.25 25.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 m -105.39 121.39 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 108.773 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.32 141.94 48.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 111.122 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.1 mt -121.83 160.23 25.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.5 142.92 6.15 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.715 -1.707 . . . . 0.0 110.692 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -144.86 151.19 38.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.53 -0.982 . . . . 0.0 109.708 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt 56.96 23.77 8.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.833 . . . . 0.0 110.865 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.67 -2.04 69.54 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.704 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.9 mm-40 -97.05 145.46 25.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.928 -1.336 . . . . 0.0 108.482 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -141.71 151.7 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 0.0 111.601 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.8 mt -134.29 144.46 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' HD1' ' A' ' 55' ' ' HIS . 11.7 mttt -114.67 154.85 27.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 110.976 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 m 51.36 67.99 0.86 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.641 -0.662 . . . . 0.0 110.8 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.55 -15.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -63.74 -15.59 58.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 110.248 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 8.7 m170 -72.11 -60.57 2.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.022 . . . . 0.0 109.511 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.7 tp -59.65 -42.81 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.992 -1.068 . . . . 0.0 108.772 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.466 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 39.3 mt -54.82 -39.21 68.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.543 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -61.7 -49.77 75.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.538 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.24 -54.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.006 . . . . 0.0 108.559 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 mt -51.75 -43.82 63.07 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.488 -0.757 . . . . 0.0 109.586 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.3 -56.79 13.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.0 mt -56.64 -35.55 68.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 110.976 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.4 mt -88.06 -2.68 58.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.864 -1.148 . . . . 0.0 111.207 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.34 58.52 1.73 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.683 -1.261 . . . . 0.0 110.945 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.496 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 5.0 mm -96.79 122.57 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 4' ' ' GLU . 21.1 p -104.1 -77.47 0.57 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 111.047 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.714 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 2.5 m120 -82.24 113.6 20.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 111.452 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.9 m -163.79 138.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.684 -0.635 . . . . 0.0 109.327 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.5 m -106.53 101.18 10.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.38 107.51 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.657 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 40' ' ' PHE . 2.0 mm-40 -84.49 121.18 27.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.818 -1.177 . . . . 0.0 108.629 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.4 110.09 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.839 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.47 108.24 20.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.506 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 134.05 -163.37 24.55 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER -112.94 -14.97 12.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -1.034 . . . . 0.0 110.171 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.16 147.5 36.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.257 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.429 HG21 HD12 ' A' ' 96' ' ' ILE . 18.0 mm -70.88 130.57 88.3 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.474 -0.766 . . . . 0.0 109.746 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.23 128.7 12.31 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.022 1.815 . . . . 0.0 112.278 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -76.88 -29.68 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 110.015 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 50.8 mt 57.62 -116.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.0 109.942 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.28 -6.86 43.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 110.533 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.87 -10.61 52.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -117.09 -169.26 1.62 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -1.085 . . . . 0.0 109.797 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.05 -1.37 25.31 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 68.1 t-105 -46.39 -41.33 13.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.753 -0.851 . . . . 0.0 110.305 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 3.4 mp0 -61.34 -51.97 66.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.999 -1.063 . . . . 0.0 110.131 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -65.02 -43.98 90.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.973 -1.079 . . . . 0.0 108.928 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 10.9 t80 -61.63 -37.73 85.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.4 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 20.9 mm-40 -67.0 -51.79 50.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.542 -0.724 . . . . 0.0 111.598 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 -51.98 11.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.761 -1.212 . . . . 0.0 110.871 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.54 -44.6 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 0.0 110.409 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -55.61 -31.27 62.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.116 -0.99 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -81.59 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 109.906 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -124.09 34.05 5.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.431 -0.793 . . . . 0.0 110.905 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -87.73 140.5 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.708 -1.245 . . . . 0.0 110.575 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.6 tp -133.3 159.79 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.97 145.28 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.499 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -106.48 -162.67 0.87 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 109.31 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -121.0 72.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 110.735 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 4' ' ' GLU . 8.0 ttm-85 -168.02 123.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.14 126.36 27.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.474 -0.766 . . . . 0.0 110.316 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 2.5 mt -78.55 150.48 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.376 -0.827 . . . . 0.0 109.695 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.8 86.28 6.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -60.23 147.21 40.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -101.37 120.14 39.82 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.1 t -123.34 139.96 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.0 138.79 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 109.546 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.71 143.22 34.19 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.557 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.25 174.65 11.73 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.358 2.039 . . . . 0.0 112.64 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.2 tt -166.07 146.04 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.493 -0.754 . . . . 0.0 109.792 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.54 120.12 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.583 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 33.1 m -119.81 114.99 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.804 . . . . 0.0 109.836 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.51 153.99 18.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.067 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 137' ' ' ARG . 19.8 t70 -168.56 114.96 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.788 -1.195 . . . . 0.0 111.501 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 46.51 46.65 14.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.513 -0.742 . . . . 0.0 112.204 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 7.11 87.03 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.195 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.9 mtt85 -116.13 137.54 52.04 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.404 ' CG ' ' N ' ' A' ' 139' ' ' ILE . 2.6 tt -147.04 159.54 43.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.055 -1.653 . . . . 0.0 109.864 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.404 ' N ' ' CG ' ' A' ' 138' ' ' LEU . 35.6 mt -144.51 135.75 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.64 139.32 52.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 109.984 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.19 147.56 44.77 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -148.24 137.58 12.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 108.524 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.31 147.42 36.47 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.624 1.549 . . . . 0.0 112.15 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.7 153.01 8.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.336 -0.853 . . . . 0.0 109.363 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -85.72 -3.4 58.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.348 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.5 p -131.26 147.46 52.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.362 -0.836 . . . . 0.0 109.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.2 tp -81.26 120.07 24.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -139.72 134.89 32.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.47 122.09 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.1 m -110.74 145.87 37.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -131.85 129.87 40.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -114.41 108.73 17.27 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.64 140.51 15.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -118.04 92.83 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.547 -0.973 . . . . 0.0 108.705 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLY . 24.0 m-85 -96.25 148.39 22.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 110.331 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -91.65 -6.1 52.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.822 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 18.5 p-10 -73.4 -166.78 0.37 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -61.78 -17.61 56.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.792 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.408 HD12 HD22 ' A' ' 157' ' ' ASN . 25.5 mt -69.84 -38.86 76.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 109.341 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 70.64 -118.15 7.53 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -112.67 140.45 47.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -1.012 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.54 152.45 30.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.596 ' HZ1' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.39 152.85 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.586 ' CE1' ' CZ ' ' A' ' 225' ' ' ARG . 64.3 t80 -136.23 125.53 24.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -0.914 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 m -101.87 122.33 43.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.099 -1.001 . . . . 0.0 110.066 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -100.06 137.48 38.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.47 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.2 t -136.2 152.42 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.356 -0.84 . . . . 0.0 109.563 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.84 116.23 2.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.376 -0.827 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.9 8.67 13.3 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -137.49 27.91 2.77 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 0.0 108.71 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 16.4 mp0 -62.73 -37.32 86.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.616 -0.678 . . . . 0.0 110.997 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.58 -16.35 2.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.008 -1.057 . . . . 0.0 110.366 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.435 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 1.5 mt-10 -90.58 -4.33 56.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 0.0 110.795 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 174' ' ' ILE . 1.8 pt -123.99 -2.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.099 -1.001 . . . . 0.0 110.757 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -29.11 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.605 -1.309 . . . . 0.0 110.018 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.9 2.14 54.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.914 -1.116 . . . . 0.0 110.608 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.75 119.86 23.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.206 . . . . 0.0 108.783 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -92.66 152.94 19.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.0 t -50.07 158.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.513 -0.742 . . . . 0.0 109.347 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.497 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 51.5 p90 -143.29 165.55 27.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.497 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -158.99 161.48 36.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.071 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.613 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 73.6 m-85 -104.35 144.79 31.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 0.0 109.266 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 21.0 p30 -59.27 -20.19 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 111.502 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.613 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.4 p90 -79.42 -33.24 42.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.494 -1.379 . . . . 0.0 111.529 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.593 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -94.21 -9.19 37.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.483 -1.386 . . . . 0.0 109.915 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 11.9 mt -60.98 -53.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.119 -0.988 . . . . 0.0 110.243 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -51.18 -45.94 61.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.587 -1.321 . . . . 0.0 109.611 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -53.86 46.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.108 -0.995 . . . . 0.0 108.968 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.89 -34.54 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 108.655 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -71.49 -25.71 62.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.307 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -76.04 -23.93 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.023 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.52 15.34 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 110.271 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 68.77 27.71 73.65 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.264 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 22.2 mt -120.13 157.73 28.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -1.228 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 80.77 23.15 60.38 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.902 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -67.18 -23.09 65.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.746 -1.444 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.98 -6.63 48.65 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.96 124.67 28.88 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 121.099 -1.236 . . . . 0.0 110.112 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.66 174.62 10.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.746 -0.855 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.93 -12.12 59.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.355 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 1.0 OUTLIER -86.05 -4.31 59.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.476 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 4.7 m-80 -150.22 16.35 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.413 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 1.3 m -145.04 123.51 12.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.2 tp -85.76 115.05 23.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 108.833 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.28 124.13 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.9 mt -105.38 148.69 26.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.799 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.49 163.66 13.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -55.68 -25.35 39.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.255 . . . . 0.0 109.341 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.25 12.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.673 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.18 147.88 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 110.106 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.89 128.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.862 . . . . 0.0 108.979 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.44 -55.17 6.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.15 -0.969 . . . . 0.0 110.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -51.53 137.54 31.63 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.992 -1.067 . . . . 0.0 109.81 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.67 -38.73 3.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.473 2.115 . . . . 0.0 112.551 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.52 -6.65 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.32 -166.27 50.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -77.8 141.78 39.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.98 . . . . 0.0 109.736 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -85.49 -15.61 42.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 108.841 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 221' ' ' ASN . 17.8 m-85 -141.94 130.06 22.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -46.5 -12.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 109.153 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.692 HD21 ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -138.13 36.81 2.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.61 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 22.5 tt0 -61.85 -34.42 16.13 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 111.21 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.0 Cg_exo -72.01 -48.06 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.919 1.746 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.6 m -71.91 -22.24 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.838 -1.163 . . . . 0.0 108.071 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.692 ' NH1' HD21 ' A' ' 221' ' ' ASN . 15.2 mtt85 -68.03 -45.84 72.83 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.33 -41.07 92.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -44.14 84.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.902 . . . . 0.0 108.648 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 89.1 t -65.5 -40.28 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.543 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.3 t80 -58.81 -39.56 81.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -73.55 -38.56 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.578 -0.701 . . . . 0.0 109.414 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 tp -56.62 -37.77 71.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.28 -47.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.35 -33.51 16.53 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.6 -27.1 31.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.123 -1.222 . . . . 0.0 110.059 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.65 -24.89 41.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.714 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 35.1 t80 -67.63 -10.06 48.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 26.0 mt -51.05 -26.53 6.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 95.9 mt -57.9 -21.79 45.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 108.745 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.4 13.95 75.12 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 64.5 p -158.96 149.05 15.32 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 109.735 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.34 134.03 4.7 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.396 2.064 . . . . 0.0 112.072 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.1 t -101.5 127.59 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.942 . . . . 0.0 109.97 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -116.13 122.99 46.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.51 178.87 32.93 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -109.09 112.95 25.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.313 -1.11 . . . . 0.0 109.833 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -114.74 146.86 40.49 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.817 0.818 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -131.07 141.4 50.17 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.7 t -135.74 128.54 31.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.791 -1.193 . . . . 0.0 110.563 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 14.3 t80 -111.69 114.53 27.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 3.2 mtp85 44.78 55.74 5.75 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.19 148.85 22.52 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -112.63 -177.61 19.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -70.5 -47.21 61.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.091 -1.241 . . . . 0.0 109.752 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 68.3 p -61.03 -54.5 44.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.308 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.3 tp -51.71 -39.65 58.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 109.384 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.72 -55.87 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -0.975 . . . . 0.0 108.865 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 41.0 t -49.19 -41.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.232 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -48.47 75.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.67 -44.81 66.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 108.804 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.4 t -68.23 -49.18 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.318 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.37 -50.74 38.81 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.695 -0.628 . . . . 0.0 110.509 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.41 -50.97 65.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.987 -1.071 . . . . 0.0 109.961 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.64 -44.21 81.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.35 83.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.725 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 108.989 179.513 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.588 ' CD ' HD22 ' A' ' 86' ' ' ASN . 30.6 mt-10 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.382 0.611 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -113.18 130.93 56.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 115' ' ' LEU . 14.2 t -131.23 169.68 15.62 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.376 -0.828 . . . . 0.0 109.31 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.401 ' H ' ' HG1' ' A' ' 6' ' ' THR . 4.6 m -81.58 136.26 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.826 -1.171 . . . . 0.0 110.516 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.498 ' CB ' ' HZ3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -69.78 -47.11 64.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.664 -0.648 . . . . 0.0 109.978 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -128.42 156.88 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.492 -0.755 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -62.82 134.61 56.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.591 ' CG ' HD21 ' A' ' 113' ' ' ASN . 19.7 mt -118.66 160.8 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -149.55 145.97 27.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.941 -1.1 . . . . 0.0 110.046 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -128.83 164.62 22.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.475 -0.766 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.8 12.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 109.004 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.64 159.43 17.86 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 2.4 p -76.07 164.32 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.047 -1.266 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -95.21 142.45 16.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.3 tt -61.23 -47.78 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.053 -1.263 . . . . 0.0 112.136 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.406 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.2 m-70 -86.99 -39.86 15.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 119.984 -1.697 . . . . 0.0 110.793 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 m -71.76 -36.79 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.383 -0.823 . . . . 0.0 110.168 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 24.22 70.09 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -115.07 152.5 32.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.632 -0.922 . . . . 0.0 108.715 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -72.35 131.61 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.889 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 15.4 t -138.35 158.91 43.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.216 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 7.8 ttmt -133.13 159.59 39.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.478 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.5 mt -133.31 144.12 49.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.178 -0.951 . . . . 0.0 109.235 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.437 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.5 mt -134.49 123.43 42.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.54 126.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 0.0 109.926 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.577 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 1.3 m-70 -122.18 149.19 53.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.14 160.16 16.73 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.055 1.837 . . . . 0.0 111.229 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 2.7 mm-40 -133.79 -176.0 4.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.599 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' OG1' ' A' ' 35' ' ' THR . 10.0 ttpp -88.01 152.31 22.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.92 145.44 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.422 -0.799 . . . . 0.0 110.227 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.586 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.42 25.55 60.71 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.213 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.6 m -80.88 -41.4 23.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.648 -1.501 . . . . 0.0 108.703 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.71 178.95 30.85 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.56 123.31 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -140.3 145.79 37.7 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.033 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -100.68 152.25 20.68 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 11.0 t80 -133.35 141.95 48.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.225 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -176.5 145.94 0.59 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.55 28.89 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.85 28.92 72.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.48 142.57 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -1.215 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.41 143.59 31.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.237 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.04 95.81 14.87 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.35 145.53 21.02 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.052 1.834 . . . . 0.0 111.267 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 82.14 5.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.93 -1.107 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.84 153.92 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.3 p80 -51.81 -49.61 62.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.8 mm-40 -43.87 -33.02 1.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.196 -0.94 . . . . 0.0 109.234 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -80.45 2.46 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' HIS . 2.6 t -60.7 126.16 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.021 -1.049 . . . . 0.0 108.695 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.09 -34.11 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.478 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t-80 -149.67 123.18 9.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.943 -1.098 . . . . 0.0 109.913 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -110.71 131.52 54.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.2 t-20 -166.38 -154.2 0.18 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.568 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 8.1 m170 -48.05 -11.65 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 108.513 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 43.6 t -138.15 165.94 25.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.563 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.4 m -102.92 121.14 41.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.6 OUTLIER -120.4 141.56 50.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.563 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.1 mt -123.51 155.98 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -172.88 142.28 6.65 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.944 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -144.86 151.48 38.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.631 -0.923 . . . . 0.0 109.704 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm 56.51 27.86 12.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.495 -0.753 . . . . 0.0 110.839 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.55 81.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.315 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.504 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 92.7 mm-40 -99.26 143.5 29.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.286 . . . . 0.0 108.361 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -141.99 151.24 42.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 0.0 111.198 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.51 144.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -114.27 153.73 29.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 110.896 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 53.24 68.05 0.9 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.645 -0.659 . . . . 0.0 110.812 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.12 -5.77 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 109.464 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.571 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.5 OUTLIER -67.76 -29.27 68.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.985 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -62.63 -60.29 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.91 . . . . 0.0 109.91 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 9.6 tp -59.13 -44.29 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.035 . . . . 0.0 109.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 9.8 mt -59.58 -38.1 80.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.126 -0.984 . . . . 0.0 109.771 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.455 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -59.71 -48.03 83.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 109.531 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.53 -53.56 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.5 mt -50.91 -43.06 59.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.065 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.51 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 11.8 t-160 -55.1 -56.97 13.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 109.815 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 43.0 mt -57.52 -38.54 74.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.5 mt -80.12 -5.88 56.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.957 -1.089 . . . . 0.0 110.892 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER 62.8 63.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.706 -1.246 . . . . 0.0 110.528 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.452 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 9.7 mm -102.8 132.87 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 108.708 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.24 -23.6 7.24 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.339 -0.85 . . . . 0.0 111.633 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.588 HD22 ' CD ' ' A' ' 4' ' ' GLU . 70.9 m-20 -132.21 112.76 12.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.763 -1.211 . . . . 0.0 110.453 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.7 m -164.05 137.71 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.882 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.538 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 47.2 m -106.52 100.21 9.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.76 116.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.698 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -94.29 117.88 30.77 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.675 -1.265 . . . . 0.0 108.127 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.48 107.49 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.723 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.433 ' O ' ' OG ' ' A' ' 24' ' ' SER . 2.8 mt -89.69 110.47 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.24 -164.49 25.06 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -109.02 -11.41 14.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -1.054 . . . . 0.0 110.2 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -153.15 155.89 37.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.917 -1.114 . . . . 0.0 110.306 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 96' ' ' ILE . 44.6 mm -71.57 131.91 85.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.751 . . . . 0.0 109.606 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -45.88 138.46 11.91 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.295 1.997 . . . . 0.0 112.283 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.7 tp -75.91 -39.18 37.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.571 -0.706 . . . . 0.0 110.264 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 101' ' ' GLY . 80.3 mt 54.92 -155.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.481 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.95 -1.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.147 -0.971 . . . . 0.0 111.027 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 99' ' ' LEU . . . 88.27 -10.4 71.37 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.69 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.3 p -112.09 -168.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -1.082 . . . . 0.0 109.77 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -1.22 21.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.589 ' CD2' ' OE1' ' A' ' 108' ' ' GLU . 69.1 t-105 -46.81 -41.36 15.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.841 -0.799 . . . . 0.0 110.696 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -62.39 -52.04 65.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 110.303 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.6 m-85 -62.01 -45.38 93.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.924 -1.11 . . . . 0.0 108.758 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -59.68 -41.33 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.676 -0.64 . . . . 0.0 109.811 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -74.64 -41.68 59.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 111.418 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -48.68 25.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.858 -1.151 . . . . 0.0 110.357 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.4 mt -67.66 -40.51 84.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.12 -0.987 . . . . 0.0 110.392 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -53.05 -31.79 43.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 109.593 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -85.3 -5.89 59.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 110.102 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.591 HD21 ' CG ' ' A' ' 11' ' ' LEU . 71.7 m-20 -125.47 30.29 5.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 111.385 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.89 146.79 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.661 -1.274 . . . . 0.0 109.941 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' THR . 15.1 tp -131.93 161.13 33.81 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -108.1 144.91 34.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 110.076 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -106.0 -163.77 0.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.26 -3.42 13.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.344 -0.848 . . . . 0.0 110.58 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -89.98 143.48 26.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 0.0 110.274 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -83.03 128.56 34.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.36 -0.838 . . . . 0.0 109.859 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.5 mt -67.49 137.35 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.768 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.69 91.09 8.68 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -65.47 146.83 54.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.455 -0.778 . . . . 0.0 110.936 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -100.26 122.65 43.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.71 139.18 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.6 t -84.21 138.86 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.429 -0.794 . . . . 0.0 108.929 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -117.72 -8.67 10.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.522 -0.736 . . . . 0.0 109.444 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -144.0 144.12 25.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.953 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.91 150.66 55.59 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.196 1.931 . . . . 0.0 113.096 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.2 tt -140.96 144.61 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.87 125.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.81 111.27 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.778 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -113.47 133.59 55.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -179.08 156.38 0.78 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.011 -1.056 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 57.0 mm-40 56.16 20.14 4.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.54 88.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.423 ' HE ' ' C ' ' A' ' 251' ' ' GLY . 1.4 mtp85 -104.02 171.21 7.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.6 tt -159.86 146.06 15.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.503 -1.373 . . . . 0.0 108.589 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.7 mt -147.59 126.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.024 -1.047 . . . . 0.0 108.511 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 147.06 43.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.75 151.87 48.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -150.11 139.14 12.9 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -51.52 144.19 33.36 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.707 1.605 . . . . 0.0 112.146 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.71 11.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.21 -0.931 . . . . 0.0 109.472 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 24.7 p-10 -86.21 -0.4 55.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.67 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.3 p -135.14 145.54 47.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.1 tp -79.72 118.03 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.92 . . . . 0.0 109.838 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -138.17 142.16 40.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 108.871 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 71.1 t -140.35 131.87 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.997 -1.064 . . . . 0.0 109.935 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 m -117.73 135.85 53.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.348 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -123.88 128.54 49.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.6 109.46 17.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.01 122.75 6.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 1.1 pm0 -102.88 114.65 29.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -1.138 . . . . 0.0 108.659 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -109.42 147.73 32.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.576 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -93.31 0.12 56.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.786 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.429 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 12.8 p30 -79.3 -171.54 2.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 12.2 p90 -61.68 -26.55 68.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.61 -50.57 69.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.465 ' C ' HE22 ' A' ' 162' ' ' GLN . . . 87.34 -136.09 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.521 ' C ' ' NE2' ' A' ' 162' ' ' GLN . 38.3 mtp180 -98.68 140.35 33.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -1.1 . . . . 0.0 109.575 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 161' ' ' ARG . 1.7 mp0 -139.33 131.06 27.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.368 -0.833 . . . . 0.0 109.03 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.33 52.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.527 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 71.9 t80 -138.35 126.69 23.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.183 -0.948 . . . . 0.0 109.787 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.474 ' O ' ' CG2' ' A' ' 165' ' ' THR . 7.0 t -106.03 123.93 48.77 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -97.67 133.45 42.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.93 . . . . 0.0 108.716 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.81 148.34 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.522 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -48.06 114.89 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.639 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.406 ' N ' ' OE2' ' A' ' 171' ' ' GLU . . . 115.61 10.33 11.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.429 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 27.3 m-20 -136.81 26.9 3.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.988 -1.301 . . . . 0.0 108.853 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.429 ' OE2' ' N ' ' A' ' 170' ' ' ASN . 1.9 mp0 -63.0 -37.82 88.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.749 . . . . 0.0 110.768 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.19 -16.33 13.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -90.29 -3.67 57.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.077 . . . . 0.0 110.917 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.85 4.67 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.047 -1.033 . . . . 0.0 111.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.27 -27.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.779 -1.2 . . . . 0.0 109.799 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.65 2.47 50.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.797 -1.189 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.1 109.52 17.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.774 -1.204 . . . . 0.0 109.036 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -79.69 153.52 29.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -55.83 154.49 7.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 108.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.544 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 39.5 p90 -135.35 170.45 15.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 109.728 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.633 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -159.29 161.94 35.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.23 -0.919 . . . . 0.0 109.754 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.535 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 61.5 m-85 -103.79 146.46 28.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -21.13 64.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.047 -1.033 . . . . 0.0 110.868 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.3 p90 -81.53 -29.6 33.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.552 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.1 pt-20 -92.15 -15.84 27.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.896 -1.128 . . . . 0.0 109.699 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 12.1 mt -58.76 -53.25 49.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 110.431 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -52.43 -47.58 66.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.579 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.22 -47.55 83.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.977 . . . . 0.0 109.137 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.96 -33.11 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 108.99 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -78.27 -31.4 49.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -74.98 -28.76 60.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.019 -1.051 . . . . 0.0 110.218 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 31.4 m -78.51 8.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.173 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.47 20.95 73.73 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 22.9 mt -119.16 157.82 27.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.67 24.34 62.78 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -67.71 -21.72 65.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.744 -1.445 . . . . 0.0 109.436 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.34 -6.12 48.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.99 126.66 42.29 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.044 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 203' ' ' THR . 60.6 p -140.88 160.76 39.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.895 . . . . 0.0 109.309 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.43 -27.76 69.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 109.968 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -76.23 -15.86 59.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 109.927 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 29.0 m120 -132.81 11.12 4.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.633 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 39.3 m -148.97 115.36 5.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.163 -0.961 . . . . 0.0 109.777 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 68.9 tp -75.5 112.19 11.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.58 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.2 t -103.4 128.35 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 109.223 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.8 mt -110.67 146.29 36.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -101.19 154.14 19.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.45 -26.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 10.8 0.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.0 110.325 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -141.12 148.68 40.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.305 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.92 123.55 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.53 -54.79 7.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.394 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -59.34 134.31 88.34 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.703 -1.248 . . . . 0.0 109.341 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.15 -7.32 20.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.357 2.038 . . . . 0.0 112.761 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -86.47 -7.58 58.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 0.0 110.316 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.07 -158.85 53.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.4 144.13 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -1.059 . . . . 0.0 109.949 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 109.517 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.578 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 68.1 m-85 -140.08 129.47 24.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.895 . . . . 0.0 109.042 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -52.99 -11.02 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 108.502 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 219' ' ' TYR . 5.9 m120 -133.07 35.28 3.52 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.462 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 8.7 tt0 -59.26 -55.35 47.05 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.729 . . . . 0.0 111.579 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 19.6 Cg_endo -60.75 -42.14 41.06 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.73 1.62 . . . . 0.0 113.305 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.5 m -76.99 -25.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 108.363 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.578 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 46.9 mtt180 -67.0 -43.47 82.83 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.28 -41.24 98.32 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.45 -46.26 80.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.76 -51.03 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.455 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 81.6 t80 -50.45 -39.85 48.99 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.886 0.85 . . . . 0.0 108.725 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.455 ' OD2' ' OE1' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.98 -39.66 69.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.65 -0.656 . . . . 0.0 109.681 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 28.5 tp -57.9 -35.36 70.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.905 . . . . 0.0 109.385 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.51 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 86.9 mt -71.12 -48.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.41 -32.1 14.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.8 -27.03 31.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -82.94 -24.3 33.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.775 -1.203 . . . . 0.0 109.86 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.452 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 44.5 t80 -68.14 -8.56 39.48 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 239' ' ' GLY . 43.9 mt -52.21 -30.26 26.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 109.163 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.5 mt -55.02 -7.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.169 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 71.92 14.78 75.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.7 p -158.13 144.62 12.87 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -1.21 . . . . 0.0 109.402 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -42.38 134.71 4.61 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.148 1.899 . . . . 0.0 111.873 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.04 129.53 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.616 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -118.1 124.65 48.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 109.373 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.36 -178.5 31.96 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -105.08 138.12 41.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -1.077 . . . . 0.0 110.039 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.5 m-85 -140.21 143.46 36.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.062 0.934 . . . . 0.0 111.263 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -126.31 144.25 50.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.1 t -140.11 127.47 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 110.631 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 0.9 OUTLIER -111.71 114.2 27.06 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.46 ' CG ' ' OE1' ' A' ' 154' ' ' GLU . 2.6 mmm180 47.72 55.79 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.423 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -77.6 140.52 24.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -111.05 174.19 16.66 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.571 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 15.1 m-70 -68.58 -41.97 78.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.048 -1.266 . . . . 0.0 109.659 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -55.18 25.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 57.2 tp -51.7 -39.04 57.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 71.3 m-20 -58.71 -55.48 34.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.995 . . . . 0.0 109.018 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.73 -43.35 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.732 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -48.7 74.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.093 -1.004 . . . . 0.0 109.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 38.9 tp -52.81 -43.38 65.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.358 -0.839 . . . . 0.0 109.039 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 20.2 t -71.13 -45.73 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.14 -51.45 64.23 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 109.917 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -61.04 -51.48 69.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.941 -1.099 . . . . 0.0 109.637 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.66 -43.9 80.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.49 -33.11 73.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 25.5 mttt . . . . . 0 N--CA 1.488 1.469 0 O-C-N 120.81 -1.181 . . . . 0.0 108.937 179.415 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 66.4 mt-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -120.87 138.35 54.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.414 -0.804 . . . . 0.0 109.466 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 t -139.54 177.89 7.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.78 144.7 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -74.78 -46.92 33.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.667 -0.645 . . . . 0.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.32 160.47 34.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.71 . . . . 0.0 110.219 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -64.92 135.56 55.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -0.768 . . . . 0.0 110.104 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mt -122.29 171.38 9.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -158.49 150.74 21.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 0.0 110.442 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -133.93 160.91 36.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.483 -0.761 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.12 137.21 21.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.962 -1.086 . . . . 0.0 109.141 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.73 160.79 20.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.512 -1.328 . . . . 0.0 109.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 4.9 p -76.3 162.98 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 0.0 111.424 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.476 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -94.76 141.4 15.53 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -59.75 -48.18 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -1.138 . . . . 0.0 112.937 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.5 m-70 -86.33 -36.51 19.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.013 -1.679 . . . . 0.0 112.374 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -80.41 -34.06 36.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.824 -1.172 . . . . 0.0 110.091 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.15 74.87 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.29 152.82 30.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.983 . . . . 0.0 108.867 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -73.81 140.92 46.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 110.202 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 9.7 t -147.88 157.64 43.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.047 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -132.21 154.71 49.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.286 -0.884 . . . . 0.0 109.239 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.402 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.2 mt -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 0.0 108.724 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 mt -127.95 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mt -123.91 120.88 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -117.23 149.3 44.23 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 161.19 22.71 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.112 1.874 . . . . 0.0 111.258 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.6 mm-40 -134.72 -173.73 3.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.072 -1.017 . . . . 0.0 110.081 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.8 tttm -91.94 155.75 17.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.701 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -48.07 143.63 4.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 110.62 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.589 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.84 26.17 60.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.543 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.613 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 33.0 m -79.98 -34.93 38.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.709 -1.465 . . . . 0.0 108.595 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.747 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 91.88 -173.35 36.4 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mm -102.03 123.74 55.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.323 -1.104 . . . . 0.0 108.271 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -137.28 139.83 41.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.511 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.03 152.84 19.38 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.533 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.9 t80 -131.32 142.78 50.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.832 . . . . 0.0 109.02 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.554 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 14.0 tttm -172.54 138.92 0.92 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.48 29.8 13.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.912 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.54 19.1 77.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.45 136.91 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.282 -1.128 . . . . 0.0 109.692 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -96.79 140.53 31.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.895 . . . . 0.0 109.178 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.5 mt -132.68 95.6 19.69 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.7 142.48 24.79 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.206 1.937 . . . . 0.0 111.607 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.35 80.67 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.961 -1.087 . . . . 0.0 110.307 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.04 153.41 51.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 109.649 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' VAL . 7.7 p80 -54.68 -49.29 71.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.4 mm-40 -44.67 -31.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.989 -1.07 . . . . 0.0 109.318 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.83 4.06 15.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.922 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 7.9 t -59.37 124.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.31 -32.0 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.412 -0.805 . . . . 0.0 109.944 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.531 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.8 t-160 -152.25 123.87 7.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.688 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.3 p -111.1 134.66 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.592 ' C ' ' H ' ' A' ' 59' ' ' SER . 20.3 p-10 -166.39 -154.44 0.18 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -10.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.942 -1.099 . . . . 0.0 108.479 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -138.85 166.96 23.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -0.8 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.1 m -101.99 120.56 40.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.05 136.93 52.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.34 -0.85 . . . . 0.0 111.199 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.5 mt -123.39 157.67 32.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.7 143.49 6.89 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 118.484 -1.817 . . . . 0.0 111.214 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -144.29 148.99 35.54 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.747 -0.855 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm 56.62 38.33 29.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 110.783 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.55 4.4 84.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.8 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.554 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 94.0 mm-40 -102.85 140.56 36.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.934 -1.333 . . . . 0.0 108.418 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -141.91 154.31 45.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.47 146.25 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -115.1 154.63 28.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 111.113 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 m 52.38 68.85 0.76 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.734 -0.604 . . . . 0.0 111.111 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.8 -10.72 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.179 -0.95 . . . . 0.0 109.727 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 5.7 pt-20 -67.73 -16.98 64.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.439 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -72.45 -60.59 2.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.012 -1.055 . . . . 0.0 109.424 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 5.0 tp -58.92 -41.14 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.99 -1.069 . . . . 0.0 108.945 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 84.4 mt -59.78 -36.49 76.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.587 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.6 t -60.44 -48.69 80.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.044 -1.035 . . . . 0.0 108.841 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.31 -51.26 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.453 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.0 mt -51.87 -44.91 63.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.513 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 8.4 t-160 -57.1 -48.46 78.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.831 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.34 -39.73 95.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 110.414 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.2 mt -80.7 -5.56 57.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.053 -1.03 . . . . 0.0 110.738 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.77 54.64 2.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.896 -1.127 . . . . 0.0 110.723 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 8.0 mm -92.69 123.85 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.4 p -109.78 -23.8 11.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.274 -0.891 . . . . 0.0 111.492 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.747 HD21 ' H ' ' A' ' 36' ' ' GLY . 11.6 m120 -128.8 111.9 13.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.972 -1.08 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.03 143.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.246 -0.909 . . . . 0.0 109.898 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.519 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.7 m -113.77 100.59 8.57 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.51 105.38 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.348 -0.845 . . . . 0.0 109.985 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.54 121.73 26.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -104.21 115.14 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.456 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 2.3 mp -97.11 109.62 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.19 -160.62 23.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.15 -12.25 11.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.071 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.504 ' OE2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -142.76 147.73 36.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.984 -1.073 . . . . 0.0 110.584 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 124.42 90.89 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.505 -0.747 . . . . 0.0 108.993 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.74 131.36 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.032 1.822 . . . . 0.0 112.344 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.55 -27.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.418 -0.801 . . . . 0.0 109.675 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.45 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 22.8 mt 54.89 -112.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.274 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.36 -13.85 25.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.987 . . . . 0.0 110.699 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.74 -15.35 41.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -113.1 -168.89 1.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -1.063 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.09 -1.32 23.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -46.92 -44.39 19.8 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.788 -0.83 . . . . 0.0 110.573 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.09 -51.91 66.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.0 -1.062 . . . . 0.0 110.129 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 69.8 m-85 -61.33 -44.21 97.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 109.057 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.499 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 5.6 t80 -67.14 -37.46 83.86 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.324 0.583 . . . . 0.0 110.491 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.14 -50.98 42.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 111.351 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.84 -44.7 61.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.867 -1.145 . . . . 0.0 110.622 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.88 -39.89 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 110.033 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -53.75 -30.94 46.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.309 -0.869 . . . . 0.0 109.165 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -84.75 -11.5 55.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.32 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -119.96 29.54 7.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.238 -0.914 . . . . 0.0 111.405 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.66 147.23 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.592 -1.317 . . . . 0.0 109.827 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.8 tp -131.58 159.96 36.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -109.52 144.6 37.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.404 ' NE2' ' OD1' ' A' ' 86' ' ' ASN . 4.0 mt-30 -107.01 -166.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 p30 -118.73 72.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.529 -0.732 . . . . 0.0 110.187 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 4' ' ' GLU . 20.9 ttt180 -166.04 143.98 5.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 109.42 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.32 131.45 35.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.09 -1.006 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.8 mt -74.98 141.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.732 . . . . 0.0 110.571 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -84.04 88.53 7.17 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -61.47 145.69 51.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.6 120.51 40.43 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.18 140.71 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.266 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 97.1 t -84.24 136.3 23.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.462 -0.774 . . . . 0.0 109.212 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -113.94 -10.26 12.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.12 146.58 40.59 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.08 178.02 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.19 1.927 . . . . 0.0 112.779 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.2 tt -165.32 147.76 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.495 -0.753 . . . . 0.0 109.799 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 53.2 mt -134.91 122.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.23 116.69 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -104.23 155.01 19.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.265 -0.897 . . . . 0.0 109.896 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 137' ' ' ARG . 13.3 t0 -165.52 110.98 0.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.978 -1.076 . . . . 0.0 111.499 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 41.19 51.76 3.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.427 -0.796 . . . . 0.0 112.46 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.48 6.77 88.87 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.645 -1.285 . . . . 0.0 110.448 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.8 mtt85 -118.6 130.18 55.73 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 139' ' ' ILE . 3.7 tt -144.33 160.02 41.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.416 -1.428 . . . . 0.0 110.16 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.415 ' H ' ' HG ' ' A' ' 138' ' ' LEU . 52.5 mt -146.26 133.01 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -118.96 144.86 46.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -118.37 147.82 43.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -145.05 135.03 11.7 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.57 147.46 58.75 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.402 . . . . 0.0 112.031 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.21 154.76 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.232 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.557 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.6 OUTLIER -86.98 1.39 52.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.506 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.5 p -135.7 146.94 48.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.2 tp -79.58 119.83 23.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.02 134.15 32.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 108.877 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.05 118.16 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 109.339 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -107.35 135.72 48.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.094 -1.004 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -123.6 129.15 50.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.47 -0.769 . . . . 0.0 109.827 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -113.92 109.64 18.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.3 155.96 19.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.556 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -134.2 91.24 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -1.089 . . . . 0.0 109.485 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.76 148.76 22.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 -10.26 35.52 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.403 -0.81 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.6 p30 -69.65 -167.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.186 -0.947 . . . . 0.0 109.521 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.99 -21.44 58.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.907 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.7 mt -64.48 -47.61 78.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.82 -126.23 7.43 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.7 mtt85 -109.44 141.09 42.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.533 -0.981 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -153.9 150.4 28.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 109.713 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -136.71 151.35 49.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.407 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 62.9 t80 -135.12 122.89 22.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 108.872 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.424 ' O ' ' CG2' ' A' ' 165' ' ' THR . 15.2 t -99.83 122.35 42.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -100.44 132.86 45.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.351 -0.843 . . . . 0.0 109.164 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.45 151.91 34.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.454 -0.779 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -51.67 116.4 2.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 8.32 14.37 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -134.04 26.24 3.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.19 -1.183 . . . . 0.0 108.312 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.6 -31.72 73.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.64 -0.662 . . . . 0.0 110.735 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.68 -15.53 58.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.275 -0.89 . . . . 0.0 111.627 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.34 -4.15 49.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.587 -1.321 . . . . 0.0 111.212 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.3 pt -117.11 -9.99 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.05 -1.032 . . . . 0.0 111.132 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.11 -28.11 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.548 -1.345 . . . . 0.0 110.133 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 2.29 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.896 -1.127 . . . . 0.0 110.452 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.37 110.18 17.28 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.94 -1.1 . . . . 0.0 109.001 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 154.58 20.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.085 -1.01 . . . . 0.0 110.066 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.435 ' CA ' ' CE1' ' A' ' 226' ' ' HIS . 5.0 t -52.73 156.9 1.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -0.799 . . . . 0.0 109.537 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.524 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 34.1 p90 -141.47 167.8 21.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.087 -1.008 . . . . 0.0 109.826 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.524 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -163.82 164.12 23.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -0.931 . . . . 0.0 109.918 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.433 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 91.2 m-85 -103.14 144.43 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.354 -0.842 . . . . 0.0 109.127 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -65.45 -18.75 65.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.386 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -77.58 -29.04 51.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.548 -1.345 . . . . 0.0 111.003 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -101.39 -11.45 19.37 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.853 -1.154 . . . . 0.0 110.15 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.7 mt -58.93 -51.21 75.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 110.371 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -51.01 -49.43 60.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.919 -1.113 . . . . 0.0 109.54 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -49.39 70.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 109.005 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.41 -33.81 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.966 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -75.18 -26.13 58.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 110.179 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 193' ' ' GLY . 0.6 OUTLIER -76.52 -33.83 58.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 110.004 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.1 m -74.6 10.07 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 109.037 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 76.82 22.06 72.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.18 155.63 30.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -1.178 . . . . 0.0 109.997 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.83 23.71 61.46 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.365 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -67.45 -22.17 65.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.686 -1.479 . . . . 0.0 109.618 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.83 -5.82 50.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 128.34 41.44 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.848 -1.384 . . . . 0.0 110.106 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -136.22 -177.49 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.519 -0.989 . . . . 0.0 109.605 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.2 -21.97 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.65 -6.26 58.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.861 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.467 ' C ' ' HG1' ' A' ' 203' ' ' THR . 7.1 m-20 -141.26 13.85 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.04 -1.037 . . . . 0.0 110.017 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.467 ' HG1' ' C ' ' A' ' 202' ' ' ASN . 1.1 m -149.3 118.96 6.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.015 -1.053 . . . . 0.0 110.058 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.33 111.58 14.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.897 . . . . 0.0 108.909 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.2 t -103.7 127.89 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.225 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.78 151.89 28.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.72 160.98 14.11 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -48.62 -28.08 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.78 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -152.59 13.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.038 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 207' ' ' GLY . 73.6 tttt -141.19 149.36 41.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.021 -1.05 . . . . 0.0 110.068 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.2 t -99.08 125.92 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 109.038 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -72.96 -54.46 8.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 110.104 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.03 137.02 80.21 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.996 -1.065 . . . . 0.0 109.746 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.74 -13.23 26.91 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.412 2.075 . . . . 0.0 112.622 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -85.59 -7.28 58.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 110.1 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.68 -160.83 53.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.95 145.73 30.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.991 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -88.84 -24.94 22.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 108.815 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 221' ' ' ASN . 56.6 m-85 -145.99 139.37 26.09 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.75 -12.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.951 -1.093 . . . . 0.0 108.507 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.581 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.88 37.68 1.98 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.768 0.794 . . . . 0.0 109.122 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.592 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -55.75 -41.48 91.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_exo -69.11 -42.83 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.429 2.086 . . . . 0.0 112.966 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.1 m -76.25 -24.81 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.735 -1.228 . . . . 0.0 108.691 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.471 ' NH2' ' ND2' ' A' ' 221' ' ' ASN . 38.6 mtt180 -69.03 -45.17 71.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.435 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 37.0 t60 -59.2 -45.06 92.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.471 -0.768 . . . . 0.0 108.959 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -56.58 -47.81 78.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 108.989 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 95.6 t -58.46 -51.18 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.587 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -50.69 -39.33 50.97 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -72.05 -40.87 68.04 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.588 -0.695 . . . . 0.0 109.855 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 tp -57.02 -35.01 68.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.377 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 25.0 mt -71.62 -48.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.32 20.55 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.87 -28.8 29.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.263 -1.139 . . . . 0.0 109.854 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.0 mt -79.75 -22.92 42.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.773 -1.204 . . . . 0.0 109.701 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 24.5 t80 -69.0 -10.0 55.26 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 81.2 mt -51.44 -26.59 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 0.0 108.869 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.95 -21.59 61.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.89 14.57 69.5 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 56.1 p -158.41 147.12 14.29 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.045 -1.268 . . . . 0.0 109.813 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -42.66 130.87 5.41 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.203 1.935 . . . . 0.0 111.961 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 51.3 t -95.26 127.04 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.579 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -117.08 123.85 47.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.365 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.67 177.95 30.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -110.35 111.17 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.242 -1.152 . . . . 0.0 110.352 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.9 m-85 -111.82 147.6 35.37 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.853 0.835 . . . . 0.0 110.695 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -128.35 143.25 50.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.0 t -138.13 126.18 22.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.682 -1.261 . . . . 0.0 110.219 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 250' ' ' ARG . 11.9 t80 -111.64 112.61 24.43 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.556 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 12.3 mtt180 47.39 56.67 6.67 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.47 155.14 22.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.48 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -118.24 -175.42 16.66 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.444 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 90.9 m-70 -72.28 -51.82 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -1.21 . . . . 0.0 109.66 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.3 t -55.57 -34.12 64.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.706 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 44.0 tp -72.99 -37.47 66.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 108.99 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 4.8 m120 -62.71 -49.71 74.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 108.922 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.79 -44.18 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.354 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -54.98 -48.53 73.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.942 -1.099 . . . . 0.0 108.844 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.82 -47.05 67.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.56 -50.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.682 0.753 . . . . 0.0 109.574 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.82 -50.54 18.23 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 110.417 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.91 -47.98 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.09 . . . . 0.0 110.29 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 72.2 mt -61.76 -43.99 97.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 109.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.59 96.74 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.381 -0.824 . . . . 0.0 109.486 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp . . . . . 0 N--CA 1.49 1.527 0 O-C-N 120.93 -1.106 . . . . 0.0 109.159 179.558 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.5 mt-10 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -126.5 141.87 51.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.69 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 4.0 t -138.61 177.79 7.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.69 ' H ' ' HG1' ' A' ' 6' ' ' THR . 2.0 m -83.06 140.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.818 -1.176 . . . . 0.0 110.163 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -77.05 -43.67 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -126.2 153.23 44.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 109.842 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 139.49 58.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 110.236 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -123.32 168.65 12.22 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -157.94 148.7 20.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 110.105 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -132.44 159.94 37.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -147.82 135.03 20.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.964 -1.085 . . . . 0.0 108.603 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.0 157.58 15.12 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 p -81.53 141.03 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.216 -1.167 . . . . 0.0 110.755 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.18 144.92 40.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -63.89 -46.04 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.225 -1.162 . . . . 0.0 112.627 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.426 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.6 m-70 -86.8 -40.42 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 119.961 -1.712 . . . . 0.0 111.46 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 20' ' ' THR . 1.7 m -70.27 -31.64 69.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 109.954 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.04 23.89 68.16 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -116.87 152.28 34.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -1.019 . . . . 0.0 109.469 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -70.69 132.72 45.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.72 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.669 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 2.1 t -140.89 158.0 44.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.0 109.252 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.669 ' N ' ' HG ' ' A' ' 24' ' ' SER . 7.9 ttpp -130.7 158.65 39.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.875 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.9 mt -135.44 141.12 45.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 108.766 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mt -126.41 135.66 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mt -118.77 112.75 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -111.97 154.58 44.13 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -68.67 162.2 42.08 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.372 2.048 . . . . 0.0 110.883 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.6 mm-40 -137.37 -177.4 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.016 -1.052 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.482 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -83.13 148.79 27.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.418 -0.801 . . . . 0.0 109.236 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.84 149.77 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.984 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.592 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.21 21.59 53.83 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.292 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.69 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 19.1 m -80.58 -37.35 31.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.625 -1.515 . . . . 0.0 108.803 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.534 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 94.75 -175.56 34.16 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -98.81 123.23 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.449 -1.03 . . . . 0.0 108.294 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -137.22 145.74 44.0 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.859 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -103.72 152.26 22.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.1 t80 -133.81 141.36 47.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.499 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.3 143.27 1.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.87 29.55 16.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.973 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.35 27.15 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.01 135.05 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -1.079 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.8 140.5 32.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.5 mt -135.2 95.38 14.95 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.882 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.18 145.41 7.81 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.018 1.812 . . . . 0.0 111.743 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.41 82.35 5.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.0 110.292 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -139.14 156.25 47.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 109.58 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.1 p80 -52.78 -49.64 65.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -44.79 -16.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 25.4 m-85 -97.03 4.67 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.941 -1.099 . . . . 0.0 109.897 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.24 126.11 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.24 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.18 -34.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.374 -0.829 . . . . 0.0 110.0 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -148.42 119.11 7.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 109.384 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -114.01 130.64 56.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 59' ' ' SER . 66.8 t30 -166.61 -153.63 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.572 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 4.8 m-70 -46.11 -15.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.383 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 57' ' ' ASN . 36.8 t -134.69 166.09 23.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.459 -0.776 . . . . 0.0 109.369 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m -109.85 125.04 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.369 -0.832 . . . . 0.0 109.225 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.2 145.98 48.99 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.958 0.885 . . . . 0.0 111.078 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.4 mt -127.21 159.55 33.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -178.55 148.25 8.3 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 118.422 -1.847 . . . . 0.0 111.572 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.2 149.68 36.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.157 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp 55.79 37.61 29.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.947 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 6.1 84.92 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.79 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 18.9 mm100 -105.4 135.08 47.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -1.229 . . . . 0.0 108.018 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -142.23 159.77 41.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.943 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mt -136.47 147.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -114.67 154.35 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.433 -0.792 . . . . 0.0 110.949 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m 52.33 69.03 0.73 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.671 -0.643 . . . . 0.0 111.005 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.14 -11.26 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.166 -0.959 . . . . 0.0 109.28 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.562 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.1 pt-20 -66.9 -21.09 66.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.902 . . . . 0.0 110.535 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -71.28 -59.85 2.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.925 -1.109 . . . . 0.0 109.74 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.5 tp -57.87 -40.65 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.089 . . . . 0.0 108.962 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.426 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 8.2 mt -61.55 -35.74 78.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.639 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.595 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.6 t -61.32 -48.74 79.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.032 -1.042 . . . . 0.0 109.244 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.9 t -58.59 -54.05 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.7 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.6 mt -51.19 -43.44 61.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.536 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 13.2 t-160 -54.61 -52.32 62.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.784 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.53 -36.9 85.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.0 mt -78.08 -5.7 52.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.554 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 62.72 54.28 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.819 -1.175 . . . . 0.0 110.557 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.506 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 11.5 mm -96.02 126.16 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -113.19 -24.13 9.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 112.21 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.69 ' ND2' ' H ' ' A' ' 35' ' ' THR . 10.5 m120 -130.63 112.36 13.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.76 -1.212 . . . . 0.0 110.418 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.7 m -165.22 141.19 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.548 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 82.6 m -109.22 100.02 9.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.07 111.46 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -84.7 124.7 31.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.87 -1.144 . . . . 0.0 108.374 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 t -107.85 111.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 2.4 mp -98.13 109.06 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.88 -162.43 24.19 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.486 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -115.38 -15.42 11.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.147 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.98 144.73 37.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.019 -1.051 . . . . 0.0 110.004 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.56 127.67 92.58 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 109.5 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -45.6 128.37 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.887 1.724 . . . . 0.0 111.814 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.4 tp -79.8 -26.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.408 -0.808 . . . . 0.0 109.849 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.6 mt 55.42 -110.59 0.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -94.86 -18.74 20.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.081 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.87 -10.36 27.5 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -114.49 -169.67 1.58 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.429 -1.042 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -3.08 21.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -46.91 -42.04 16.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.842 -0.799 . . . . 0.0 110.649 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.57 -52.02 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.987 -1.071 . . . . 0.0 110.171 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 74.3 m-85 -62.27 -44.03 97.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.112 -0.993 . . . . 0.0 108.715 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 9.9 t80 -61.35 -39.46 90.66 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.44 0.638 . . . . 0.0 109.842 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.11 -46.73 40.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.465 -0.772 . . . . 0.0 111.906 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.42 -48.38 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.778 -1.201 . . . . 0.0 110.674 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.53 -40.75 89.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.359 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 1.1 ttm-85 -54.62 -29.5 52.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -0.963 . . . . 0.0 109.978 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -82.57 -8.88 59.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -123.18 33.96 5.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.318 -0.864 . . . . 0.0 111.279 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.4 mt -93.46 147.83 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.4 tp -131.02 163.55 27.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -112.97 144.03 43.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.95 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -161.45 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.169 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -122.77 1.03 9.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.255 -0.903 . . . . 0.0 110.856 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -82.66 135.46 35.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.797 -1.189 . . . . 0.0 109.849 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -74.94 124.1 26.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mt -71.82 140.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 111.278 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.81 91.18 8.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -63.53 146.08 54.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.459 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -102.21 125.78 49.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 t -129.96 143.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 92.3 t -82.94 137.85 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -119.7 -11.3 9.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.45 140.71 23.46 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 0.0 108.868 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -72.17 149.74 52.39 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.884 1.722 . . . . 0.0 113.043 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.95 124.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 109.64 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.22 115.65 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.116 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -105.42 142.5 35.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.332 -0.855 . . . . 0.0 109.225 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.46 123.8 1.91 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.766 -1.209 . . . . 0.0 111.944 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 48.08 41.56 15.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.775 -0.578 . . . . 0.0 112.319 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.48 4.23 90.46 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.045 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.2 mtt-85 -104.17 161.46 14.0 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.7 tt -160.33 150.44 18.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.16 -1.588 . . . . 0.0 109.052 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.493 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 3.3 mt -147.6 132.2 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -123.43 139.24 54.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.838 . . . . 0.0 109.797 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.36 148.03 43.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -147.11 137.77 12.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.65 143.1 47.86 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.4 1.4 . . . . 0.0 112.115 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.68 146.21 13.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.329 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -80.2 -1.69 41.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 p -135.72 144.7 46.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.394 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.4 118.74 19.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.96 138.26 40.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.83 121.69 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.013 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -110.66 129.76 55.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.527 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -114.77 129.92 56.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.615 -0.678 . . . . 0.0 109.517 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.426 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 8.1 tt0 -117.06 112.91 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.53 ' C ' HH21 ' A' ' 250' ' ' ARG . . . -110.7 161.06 12.98 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.834 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.413 ' OE1' ' NH1' ' A' ' 250' ' ' ARG . 12.7 pt-20 -131.92 114.78 15.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.674 -0.898 . . . . 0.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 157' ' ' ASN . 23.9 m-85 -118.77 148.49 42.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.886 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.03 -6.62 47.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.98 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.702 ' H ' HD21 ' A' ' 157' ' ' ASN . 0.0 OUTLIER -73.45 -168.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.02 . . . . 0.0 109.504 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -63.84 -16.87 62.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.125 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.438 ' CD2' HE22 ' A' ' 162' ' ' GLN . 6.2 mt -73.85 -24.83 59.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.977 -1.077 . . . . 0.0 109.109 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.73 -134.53 49.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -110.63 151.1 28.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.967 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.438 HE22 ' CD2' ' A' ' 159' ' ' LEU . 0.1 OUTLIER -169.06 160.82 10.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.831 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.64 160.12 39.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.9 126.38 25.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.41 -0.806 . . . . 0.0 108.874 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.0 m -97.05 121.94 39.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.886 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -96.71 138.69 33.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.872 . . . . 0.0 108.801 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.47 151.8 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.78 120.38 7.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.62 -1.59 21.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.459 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 15.5 m-80 -131.52 31.77 4.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -1.158 . . . . 0.0 108.87 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.62 -34.39 75.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.562 -0.711 . . . . 0.0 110.244 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 172' ' ' GLU . 2.8 mp0 -51.68 -14.55 0.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.062 -1.024 . . . . 0.0 110.577 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.516 ' CD ' ' N ' ' A' ' 173' ' ' GLU . 9.9 mp0 -93.5 -3.96 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.971 -1.081 . . . . 0.0 111.003 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.466 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -121.33 7.0 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.029 -1.044 . . . . 0.0 111.286 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.39 -32.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.711 -1.243 . . . . 0.0 110.271 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.37 1.98 51.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.873 -1.142 . . . . 0.0 110.689 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.13 108.54 15.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.875 -1.141 . . . . 0.0 109.085 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -82.18 154.49 25.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.087 -1.008 . . . . 0.0 109.352 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 t -61.77 138.91 58.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -117.32 173.48 6.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 110.208 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.78 159.79 27.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 0.0 109.229 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.588 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.6 m-85 -104.3 146.92 28.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.144 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 8.1 p30 -61.24 -17.89 55.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 111.218 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.3 p90 -80.13 -33.93 38.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.604 -1.31 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.602 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 pt-20 -92.88 -11.97 32.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.583 -1.323 . . . . 0.0 109.786 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.2 mt -58.03 -52.29 60.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.135 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.23 -51.24 55.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.846 -1.159 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -52.82 -52.17 57.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.961 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.56 -33.85 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -77.36 -25.47 51.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.613 -0.679 . . . . 0.0 110.268 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -78.26 -29.41 48.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 110.344 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.09 12.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.991 -1.068 . . . . 0.0 109.397 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.91 23.95 77.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.7 mt -117.3 155.28 29.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -1.12 . . . . 0.0 109.698 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.2 28.12 56.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -70.74 -20.63 62.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.738 -1.448 . . . . 0.0 109.23 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.25 -4.04 50.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.68 127.73 37.0 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.207 -1.172 . . . . 0.0 110.655 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.413 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 77.7 p -135.51 -173.9 3.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.717 -0.872 . . . . 0.0 109.249 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -82.99 -23.16 33.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -81.82 -24.36 35.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.585 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.473 ' C ' ' HG1' ' A' ' 203' ' ' THR . 0.6 OUTLIER -115.23 2.88 14.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.157 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 202' ' ' ASN . 0.7 OUTLIER -145.55 124.87 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.912 -1.118 . . . . 0.0 109.99 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.11 116.88 25.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 108.631 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.7 t -104.45 127.85 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.989 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 81.0 mt -105.54 151.62 24.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.86 154.04 17.04 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.8 OUTLIER -41.91 -33.24 0.51 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -1.156 . . . . 0.0 109.829 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 19.02 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 110.251 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -150.32 160.16 43.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.88 130.41 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -73.27 -54.23 8.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.133 -0.979 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.2 135.37 75.03 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.965 -1.085 . . . . 0.0 109.378 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.31 -8.97 23.64 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.489 2.126 . . . . 0.0 112.877 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 215' ' ' GLU . 0.0 OUTLIER -92.09 -9.33 43.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 0.0 109.97 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.64 -166.2 51.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 12.7 mt -85.68 147.78 26.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -1.038 . . . . 0.0 110.282 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.635 ' HE ' ' CA ' ' A' ' 218' ' ' ARG . 0.0 OUTLIER -83.46 -15.75 48.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.6 m-85 -149.42 151.67 34.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.036 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -63.02 -15.7 57.32 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.069 -1.019 . . . . 0.0 108.472 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.36 35.89 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.536 -0.728 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -60.45 -36.0 32.15 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.499 -0.751 . . . . 0.0 111.071 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.3 Cg_exo -70.34 -48.13 0.65 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.927 1.751 . . . . 0.0 112.547 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.4 m -73.3 -23.53 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.632 -1.292 . . . . 0.0 108.39 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -67.87 -45.03 75.68 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -59.86 -41.15 90.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.948 . . . . 0.0 109.249 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.88 -47.22 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 92.7 t80 -53.13 -38.72 62.9 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.697 0.761 . . . . 0.0 109.151 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 24.0 m-20 -68.76 -43.84 74.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.456 -0.778 . . . . 0.0 110.202 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.83 -39.23 73.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 0.0 109.235 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.406 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 77.0 mt -67.13 -34.28 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.2 -33.14 77.52 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -83.04 -26.21 31.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -1.12 . . . . 0.0 110.142 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mt -81.89 -27.33 33.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.833 -1.167 . . . . 0.0 109.732 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.3 t80 -66.94 -8.52 30.08 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.074 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 87.7 mt -52.62 -25.67 11.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.64 -23.85 59.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.894 -1.129 . . . . 0.0 108.846 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 89.18 14.64 60.15 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.2 p -158.51 146.28 13.6 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.939 -1.33 . . . . 0.0 109.637 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -42.64 131.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.289 1.992 . . . . 0.0 111.784 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.43 134.93 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 109.457 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.66 128.47 48.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.89 178.82 30.46 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -107.37 111.59 24.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -1.183 . . . . 0.0 109.954 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -112.31 148.0 35.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 122.021 0.915 . . . . 0.0 111.167 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.426 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 44.8 t80 -127.78 144.42 51.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.9 128.6 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.816 -1.177 . . . . 0.0 110.361 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.624 ' CE2' ' NH1' ' A' ' 250' ' ' ARG . 38.2 t80 -113.85 107.36 15.62 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.624 ' NH1' ' CE2' ' A' ' 249' ' ' PHE . 0.0 OUTLIER 45.78 57.18 5.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.9 148.54 21.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -116.22 171.07 13.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.562 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 82.7 m-70 -59.91 -46.13 90.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -1.224 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -55.34 35.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.358 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 60.0 tp -51.58 -39.42 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -57.8 -55.86 29.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.169 -0.957 . . . . 0.0 108.933 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 94.4 t -49.16 -41.51 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.29 -50.53 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.048 . . . . 0.0 109.062 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.8 tp -53.15 -43.13 66.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.027 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.04 -40.26 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.343 -0.848 . . . . 0.0 109.428 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -52.53 64.3 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 110.025 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.6 -43.14 94.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.613 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.02 -47.88 84.02 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.16 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.17 75.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.457 -0.777 . . . . 0.0 110.24 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 120.676 -1.265 . . . . 0.0 108.95 179.4 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.529 ' CB ' ' OE2' ' A' ' 33' ' ' GLU . 5.4 mt-10 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.421 0.629 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.0 139.13 54.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.388 0.613 . . . . 0.0 110.04 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 t -135.01 173.81 11.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 m -83.54 142.04 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.84 -1.162 . . . . 0.0 110.212 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -77.58 -41.81 37.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.488 -0.757 . . . . 0.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -133.25 157.48 45.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.64 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -59.61 132.3 53.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.734 -0.604 . . . . 0.0 110.015 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.37 153.56 34.97 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -150.72 147.47 27.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -135.65 162.49 32.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.557 -0.714 . . . . 0.0 109.76 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.88 139.09 26.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.914 -1.116 . . . . 0.0 109.515 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.28 159.19 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 p -85.88 143.7 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.999 -1.295 . . . . 0.0 111.264 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 143.33 36.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.0 OUTLIER -65.6 -38.71 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -1.079 . . . . 0.0 112.666 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.41 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 5.4 m-70 -86.15 -36.71 19.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 119.892 -1.755 . . . . 0.0 112.457 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -84.65 -40.5 17.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.661 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.32 79.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 152.22 20.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -73.24 143.45 47.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.914 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -146.0 157.55 43.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 108.826 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -136.62 146.61 46.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.201 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -121.56 148.64 44.24 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.147 -0.971 . . . . 0.0 109.034 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.441 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -135.6 126.05 43.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -111.65 125.15 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.938 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.441 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 15.8 m-70 -120.63 149.93 51.33 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.87 159.88 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.043 1.829 . . . . 0.0 110.86 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' CG ' ' HG1' ' A' ' 88' ' ' THR . 26.4 mm-40 -134.63 179.25 6.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.027 . . . . 0.0 110.081 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.39 148.16 32.1 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.227 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' OE2' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -47.78 147.0 2.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 -179.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 58.94 25.04 58.89 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.103 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.3 m -80.46 -37.82 31.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.761 -1.435 . . . . 0.0 108.875 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.4 -177.76 32.37 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 37' ' ' ILE . 14.5 mm -97.44 124.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -140.31 139.43 35.45 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.008 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -97.78 153.71 18.09 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.6 t80 -132.28 141.22 48.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.204 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.96 140.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.57 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 58.62 28.42 17.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.406 -0.809 . . . . 0.0 109.706 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.14 30.64 69.55 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.7 t -135.53 132.19 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -1.212 . . . . 0.0 109.967 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -90.06 141.28 28.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 108.942 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.6 mt -137.77 96.98 10.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 110.355 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.75 144.93 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.182 1.921 . . . . 0.0 111.711 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.68 84.82 4.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 0.0 110.089 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -139.65 156.9 46.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 3.5 p80 -53.38 -49.74 66.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.2 mm-40 -47.54 -16.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -0.998 . . . . 0.0 110.353 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' HIS . 22.0 m-85 -97.0 7.07 47.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.918 -1.114 . . . . 0.0 109.556 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.27 127.1 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.06 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.57 -34.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.616 ' CE1' ' ND2' ' A' ' 57' ' ' ASN . 3.1 t-160 -149.54 122.37 8.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -112.35 130.93 55.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -166.84 -153.95 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' ASN . 36.1 m-70 -46.59 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.071 -1.018 . . . . 0.0 108.763 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 57' ' ' ASN . 11.7 t -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.2 m -102.64 120.33 40.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 108.826 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -117.76 136.44 53.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 110.923 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -126.07 159.38 32.97 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.7 150.92 8.84 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.158 -1.972 . . . . 0.0 111.611 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -144.6 152.55 40.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.82 -0.812 . . . . 0.0 109.486 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.5 24.01 11.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.598 -0.689 . . . . 0.0 110.842 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.39 4.69 76.74 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.697 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.451 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 9.0 mm100 -108.59 137.37 46.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -1.199 . . . . 0.0 108.21 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.79 164.29 30.51 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.853 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.4 mt -135.08 149.21 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -114.18 149.78 35.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.896 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 54.41 66.95 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.714 -0.616 . . . . 0.0 110.866 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.74 -1.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 109.179 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 8.5 pt-20 -71.1 -30.85 67.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.048 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 32.5 m170 -64.49 -59.44 4.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -56.87 -45.99 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.733 -1.229 . . . . 0.0 108.733 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 42.2 mt -55.28 -41.07 71.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.7 t -56.96 -45.53 82.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.38 -53.41 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 108.723 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -50.86 -44.66 59.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 108.977 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.497 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 14.7 t-160 -55.65 -47.82 76.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.453 -0.779 . . . . 0.0 110.018 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -66.54 -37.68 85.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.4 mt -81.23 -7.61 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.827 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 63.37 63.32 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.724 -1.235 . . . . 0.0 110.134 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.8 mm -104.94 130.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 4' ' ' GLU . 23.6 p -117.43 -18.86 9.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.852 . . . . 0.0 111.731 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.617 HD21 HE22 ' A' ' 117' ' ' GLN . 8.3 m-80 -133.65 111.39 10.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.639 -1.288 . . . . 0.0 110.233 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 2.3 m -165.1 141.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.551 ' HG1' ' CG ' ' A' ' 31' ' ' GLU . 95.6 m -110.8 100.6 9.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.495 -0.753 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.7 104.42 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.401 -0.812 . . . . 0.0 109.682 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -82.31 119.44 24.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.865 -1.147 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.95 108.26 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 111.087 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.52 108.13 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.31 -160.02 23.28 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.4 -15.25 7.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.56 -0.965 . . . . 0.0 110.21 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.529 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -135.61 142.27 45.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.0 110.44 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 96' ' ' ILE . 38.7 mm -68.6 139.53 91.55 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.76 130.16 37.18 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.843 1.695 . . . . 0.0 111.514 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -78.64 -30.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.52 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 8.0 mt 52.8 -109.78 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.032 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -95.02 -18.59 20.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.573 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.73 -10.22 32.43 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.7 p -113.88 -172.09 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.383 -1.069 . . . . 0.0 109.869 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.48 -3.26 20.84 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -46.71 -39.99 12.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.624 -0.927 . . . . 0.0 110.8 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -63.53 -51.73 64.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 109.95 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -61.9 -45.04 95.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.917 -1.114 . . . . 0.0 108.392 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.88 -39.46 89.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.332 0.587 . . . . 0.0 110.44 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.11 -45.16 64.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.845 . . . . 0.0 111.494 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.24 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.858 -1.151 . . . . 0.0 110.551 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.16 -42.84 88.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 110.233 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -54.29 -29.57 47.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 109.816 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -85.96 -11.53 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -119.78 29.31 7.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.233 -0.917 . . . . 0.0 111.458 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.7 mt -84.4 148.02 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.379 -1.451 . . . . 0.0 110.348 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.0 tp -130.84 158.13 41.02 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -101.06 146.51 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.898 -1.127 . . . . 0.0 110.044 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.617 HE22 HD21 ' A' ' 86' ' ' ASN . 1.1 mt-30 -109.44 -169.06 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.669 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -120.09 66.98 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 110.575 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -169.37 151.04 4.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 109.259 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.42 134.11 33.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.03 -1.044 . . . . 0.0 110.295 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.6 mt -69.87 135.55 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 110.863 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -78.26 80.95 4.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -58.22 141.36 50.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.589 -0.694 . . . . 0.0 110.759 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -98.39 120.45 38.82 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.36 138.18 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 0.0 109.823 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.25 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -114.49 -10.07 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -142.82 145.91 35.6 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.427 -0.796 . . . . 0.0 108.92 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.12 177.24 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.11 1.873 . . . . 0.0 112.805 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.7 tt -165.6 144.61 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.457 0.646 . . . . 0.0 109.624 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.3 mp -132.73 118.9 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.53 113.29 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.375 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.429 ' OE2' ' N ' ' A' ' 134' ' ' ASP . 1.2 tm-20 -115.56 127.2 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.429 ' N ' ' OE2' ' A' ' 133' ' ' GLU . 1.8 t70 -174.74 158.11 2.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 59.09 19.5 7.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 110.206 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.86 2.66 86.72 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -104.01 173.7 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 8.8 tt -160.09 148.07 16.76 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.487 -1.383 . . . . 0.0 109.037 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.419 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 8.8 mt -146.19 141.48 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.639 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -130.35 139.13 50.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.48 145.59 47.11 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -142.19 138.57 16.83 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.14 147.7 63.74 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.471 1.447 . . . . 0.0 112.119 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.05 158.49 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.03 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -93.5 4.13 54.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.942 . . . . 0.0 109.899 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 147.34 46.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.08 -1.013 . . . . 0.0 109.784 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.9 tp -77.37 116.03 17.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.848 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -139.36 135.18 33.44 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.8 t -137.33 127.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.977 . . . . 0.0 110.05 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.7 m -112.28 132.05 55.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.368 -0.833 . . . . 0.0 109.294 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -119.83 129.47 54.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 162' ' ' GLN . 6.4 tp10 -114.72 104.61 12.14 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.0 155.38 21.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.583 ' CD ' HH21 ' A' ' 250' ' ' ARG . 12.9 tt0 -134.11 88.04 2.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.423 -1.045 . . . . 0.0 109.24 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -90.82 148.72 22.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -92.44 -6.92 48.97 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.86 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.9 p30 -73.9 -168.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.748 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.2 p90 -56.02 -17.53 7.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 109.754 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 14.0 mt -65.98 -51.17 60.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.06 -113.48 3.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -125.46 140.51 52.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.518 -0.989 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.48 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 8.8 tt0 -157.02 148.91 22.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -130.79 152.44 50.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -135.46 123.92 23.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 108.891 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 9.9 t -99.53 122.21 42.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 110.097 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.3 t80 -99.85 135.99 40.45 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.382 -0.824 . . . . 0.0 108.897 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.484 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.6 t -133.36 150.28 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.79 . . . . 0.0 109.155 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -53.46 122.81 10.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.77 -12.68 17.84 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -121.38 33.01 5.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.168 -1.195 . . . . 0.0 108.726 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -62.82 -35.95 81.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.699 . . . . 0.0 110.886 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -15.7 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.045 . . . . 0.0 110.829 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.73 -3.56 58.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.985 -1.072 . . . . 0.0 110.939 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.9 pt -124.29 0.85 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.068 -1.02 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -29.87 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.601 -1.312 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.6 mt -87.01 1.95 51.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.782 -1.199 . . . . 0.0 110.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.38 120.0 23.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.777 -1.202 . . . . 0.0 109.013 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.07 153.37 19.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.066 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.41 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.0 t -55.7 154.99 6.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.52 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 47.5 p90 -135.68 167.09 21.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.022 -1.049 . . . . 0.0 109.671 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.52 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 2.7 m -153.69 160.65 42.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.172 -0.955 . . . . 0.0 109.685 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.421 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 78.5 m-85 -102.84 143.41 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.213 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.46 -26.07 66.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.502 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 4.7 p90 -79.01 -25.25 43.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.694 -1.254 . . . . 0.0 110.632 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 11.8 pt-20 -98.88 -13.8 19.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.879 -1.138 . . . . 0.0 109.575 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 9.5 mt -58.51 -52.99 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.154 -0.966 . . . . 0.0 110.063 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.19 -48.56 64.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.882 -1.136 . . . . 0.0 109.097 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.34 -52.1 62.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.967 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 91.2 mt -57.96 -34.48 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.825 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.21 -25.71 51.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -74.96 -31.6 61.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.101 -1.0 . . . . 0.0 109.867 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.8 m -81.0 12.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.17 -0.956 . . . . 0.0 109.347 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.48 24.12 76.79 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.625 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 19.2 mt -121.21 159.08 26.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.15 -1.206 . . . . 0.0 109.993 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.41 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 74.18 22.22 78.01 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.22 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -63.38 -53.73 47.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.33 -1.688 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -69.9 -2.6 39.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.09 134.06 39.91 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.849 -1.383 . . . . 0.0 110.484 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 203' ' ' THR . 68.0 p -141.86 177.72 7.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.493 -1.004 . . . . 0.0 109.319 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.6 -39.3 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.91 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -66.25 -14.46 61.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.222 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.538 ' C ' ' HG1' ' A' ' 203' ' ' THR . 0.8 OUTLIER -131.44 9.14 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.538 ' HG1' ' C ' ' A' ' 202' ' ' ASN . 0.5 OUTLIER -147.96 113.8 5.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.42 116.06 15.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 108.934 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.9 t -106.8 127.1 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 109.857 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.4 mt -110.71 149.91 29.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.14 152.21 17.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 207' ' ' GLY . 35.6 tttm -41.07 -37.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -1.113 . . . . 0.0 110.03 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -141.88 11.56 2.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.935 -1.103 . . . . 0.0 110.084 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.4 pttp -142.59 151.43 41.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.019 . . . . 0.0 109.738 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.56 127.93 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -73.0 -53.16 11.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.07 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.52 139.68 74.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.996 -1.065 . . . . 0.0 109.658 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.68 -33.96 9.72 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.522 2.148 . . . . 0.0 112.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -76.24 -9.1 58.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.046 -1.034 . . . . 0.0 110.28 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.6 -164.22 51.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.82 140.38 47.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -1.088 . . . . 0.0 109.833 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -84.59 -14.59 48.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 109.169 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.636 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 66.0 m-85 -146.09 133.83 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.436 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 1.3 mt-10 -48.03 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 108.501 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -137.19 39.33 2.51 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.9 OUTLIER -62.76 -39.58 55.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 111.935 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.0 Cg_endo -74.17 -40.37 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.997 1.132 . . . . 0.0 112.651 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.2 m -76.68 -24.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.716 -1.24 . . . . 0.0 108.463 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.636 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 36.4 mtt180 -67.4 -47.44 70.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.53 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 44.1 t60 -59.77 -40.67 88.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -46.13 90.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 109.07 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.19 -42.23 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 108.756 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.478 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 59.9 t80 -55.36 -47.32 75.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.67 -0.644 . . . . 0.0 109.433 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.592 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 12.2 m-20 -72.05 -34.56 68.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.1 tp -56.27 -36.17 68.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.707 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.497 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 89.7 mt -72.47 -48.75 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.77 9.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.3 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.105 -1.232 . . . . 0.0 109.769 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.39 -22.84 40.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.852 -1.155 . . . . 0.0 109.187 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.403 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 43.0 t80 -70.74 -8.77 54.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 108.752 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 17.2 mt -50.18 -28.18 7.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.16 -15.82 1.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.2 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 13.53 83.08 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.0 p -158.73 146.05 13.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.211 -1.17 . . . . 0.0 109.309 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -43.19 130.22 6.21 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.066 1.844 . . . . 0.0 111.78 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 3.8 t -97.49 132.13 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.629 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -117.98 123.7 46.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.49 172.66 25.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -104.38 114.38 28.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -1.222 . . . . 0.0 109.696 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.6 m-85 -112.68 148.65 34.22 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.14 0.971 . . . . 0.0 111.486 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -130.42 144.22 51.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.0 t -142.34 129.58 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.656 -1.278 . . . . 0.0 111.077 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -112.18 114.81 27.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.583 HH21 ' CD ' ' A' ' 154' ' ' GLU . 18.2 mtt180 50.42 53.87 12.15 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.82 136.85 20.61 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -111.59 155.48 16.14 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.505 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 62.7 m-70 -52.94 -47.18 68.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -1.215 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.5 t -58.23 -55.34 36.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.056 -1.027 . . . . 0.0 108.869 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 53.6 tp -53.91 -37.12 63.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -61.15 -54.35 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 108.973 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 19.5 t -50.97 -42.67 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -55.83 -49.7 72.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 19.1 tp -52.14 -42.13 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 108.678 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.62 -46.24 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.283 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.13 -51.52 61.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.846 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -53.64 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 90.3 mt -55.53 -42.18 74.21 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.41 90.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.523 -0.736 . . . . 0.0 109.719 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.024 . . . . 0.0 109.11 179.513 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 63.5 mt-10 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HZ2' ' ND2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -121.08 139.37 53.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 110.285 -179.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.529 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 9.0 t -138.2 175.27 9.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.529 ' H ' ' HG1' ' A' ' 6' ' ' THR . 10.4 m -86.51 141.35 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.354 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -73.87 -46.12 46.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.574 -0.704 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -126.88 153.76 45.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.41 -0.806 . . . . 0.0 110.43 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.08 138.76 58.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.62 167.71 12.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 p -156.76 149.34 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.995 -1.066 . . . . 0.0 110.338 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -135.01 155.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 135.48 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 108.759 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.79 156.16 13.0 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.122 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.29 163.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.29 -1.124 . . . . 0.0 111.029 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.64 136.98 13.35 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 197' ' ' GLY . 16.0 tt -56.21 -52.57 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.137 -1.214 . . . . 0.0 111.751 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.477 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 24.8 m-70 -87.08 -38.56 16.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.172 -1.58 . . . . 0.0 110.66 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.6 m -73.9 -35.38 64.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.952 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.07 64.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -107.53 148.55 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.58 -0.953 . . . . 0.0 108.967 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 8.1 t80 -70.83 125.78 27.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.973 . . . . 0.0 109.759 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 36.6 t -135.12 156.41 49.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.118 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -134.81 150.69 50.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 109.138 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mt -127.52 148.45 50.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 0.0 109.622 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -132.04 131.84 61.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -115.83 126.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -120.56 155.06 57.06 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.585 -0.697 . . . . 0.0 109.286 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.53 160.67 48.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.347 2.031 . . . . 0.0 110.861 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 20.4 mm-40 -135.83 -174.83 3.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.104 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.508 ' O ' ' OG1' ' A' ' 35' ' ' THR . 11.0 tptt -86.03 153.3 22.23 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 109.287 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 2.3 mp0 -46.81 145.07 2.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.091 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.582 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.36 26.1 61.32 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.826 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 39.6 m -78.7 -36.94 42.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.562 -1.552 . . . . 0.0 109.134 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.745 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 94.05 -175.56 35.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.7 mm -99.52 121.9 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.297 -1.119 . . . . 0.0 108.277 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -136.33 143.9 44.36 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.975 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.89 151.13 22.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -130.26 142.66 50.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -174.59 138.22 0.51 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -178.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.12 31.59 20.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.616 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.51 74.33 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.624 -1.298 . . . . 0.0 110.034 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.13 139.41 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 109.529 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 m-85 -102.18 138.06 39.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.57 97.94 18.71 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.418 -0.801 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.74 142.75 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.22 1.947 . . . . 0.0 111.718 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.02 82.48 6.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.984 -1.073 . . . . 0.0 110.172 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -139.45 156.03 47.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.583 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.564 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.2 p80 -53.45 -49.5 67.28 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 19.5 mt-10 -44.06 -16.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.072 -1.018 . . . . 0.0 109.995 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 50' ' ' HIS . 96.6 m-85 -98.56 4.21 48.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.058 -1.026 . . . . 0.0 109.994 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 50' ' ' HIS . 6.4 t -60.73 121.02 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 108.477 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.96 -25.36 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.303 -0.873 . . . . 0.0 110.408 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -151.13 118.54 6.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -112.29 131.13 55.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.5 t-20 -166.36 -154.28 0.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 1.6 m-70 -47.96 -12.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 108.372 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -136.84 166.0 24.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.587 -0.696 . . . . 0.0 109.238 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.0 m -108.84 125.1 51.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.335 -0.853 . . . . 0.0 109.132 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.87 143.72 50.18 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.993 0.901 . . . . 0.0 111.25 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.3 mt -124.29 160.52 27.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.85 147.93 7.66 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.343 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -145.01 151.68 38.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.751 -0.852 . . . . 0.0 109.488 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt 57.12 25.36 10.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.289 -0.882 . . . . 0.0 111.196 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.49 1.95 77.18 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.631 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.471 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.2 mm100 -102.41 142.81 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.993 -1.298 . . . . 0.0 107.999 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -145.83 157.23 43.93 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.842 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.8 mt -133.27 144.5 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 9.1 mttm -110.71 155.03 23.03 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.295 -0.878 . . . . 0.0 111.317 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 47.38 72.86 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.765 -0.584 . . . . 0.0 111.169 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 m -113.02 -11.59 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 109.566 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -63.68 -18.53 64.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 110.604 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.595 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 25.6 m170 -71.85 -60.65 2.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.892 -1.13 . . . . 0.0 109.413 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 4.0 tp -60.41 -44.05 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 109.138 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.464 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 12.0 mt -56.2 -38.22 70.7 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.587 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 27.3 t -60.68 -48.58 81.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.614 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.5 t -57.64 -52.99 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.972 -1.08 . . . . 0.0 108.688 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -50.68 -43.79 57.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.462 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.9 t-160 -55.1 -51.33 66.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 110.223 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.8 mt -68.36 -37.27 80.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.329 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.8 mt -76.08 -5.58 47.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.061 -1.024 . . . . 0.0 110.131 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.79 50.99 3.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 110.43 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.502 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 14.6 mm -97.59 122.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 108.501 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.456 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 71.7 p -110.78 -22.01 11.78 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.745 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 9.9 m120 -129.91 112.17 13.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.709 -1.244 . . . . 0.0 110.516 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 2.6 m -164.75 141.78 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 8.1 m -110.23 100.69 9.53 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mp -87.69 108.87 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.889 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -88.18 116.48 26.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.28 117.63 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 110.856 -178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.491 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.1 mp -97.09 112.36 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.437 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 133.93 -162.05 24.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.48 -17.64 8.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.227 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 1.5 tp10 -132.64 141.0 48.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.829 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.2 mm -67.37 125.71 91.5 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.609 -0.682 . . . . 0.0 109.34 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -45.86 131.28 13.39 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.921 1.747 . . . . 0.0 111.887 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.1 tp -76.46 -29.62 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 110.431 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.7 mt 54.89 -113.73 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.61 -15.86 23.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 110.32 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.75 -12.97 46.35 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 p -112.3 -169.18 1.42 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.012 . . . . 0.0 109.493 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.6 -3.09 25.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -47.44 -41.91 21.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.833 -0.804 . . . . 0.0 110.409 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.96 -52.37 63.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.068 . . . . 0.0 110.233 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 87.4 m-85 -61.81 -44.29 97.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.765 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -62.06 -38.91 90.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.311 0.576 . . . . 0.0 109.941 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.15 -44.94 51.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.287 -0.883 . . . . 0.0 111.828 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.25 -47.61 23.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 110.998 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.03 -40.16 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttt85 -57.38 -30.03 64.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 109.877 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 112' ' ' LYS . 24.0 tttm -80.65 -8.21 59.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 109.623 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -123.74 35.03 4.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.987 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.8 mt -90.79 147.03 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.8 -1.187 . . . . 0.0 110.643 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -131.26 159.61 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.429 ' ND2' ' HZ2' ' A' ' 5' ' ' LYS . 8.6 m120 -109.79 146.43 35.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.552 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -108.93 -162.65 0.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.528 -0.733 . . . . 0.0 109.26 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 -1.22 11.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -85.37 138.71 32.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.86 -1.15 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.1 128.03 33.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.272 -0.892 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.92 139.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 111.124 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -94.38 98.48 10.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.74 147.05 51.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -97.33 121.46 39.25 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.02 139.36 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.17 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -113.12 -10.78 13.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.242 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -143.66 146.05 33.63 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.097 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.2 172.74 14.21 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.087 1.858 . . . . 0.0 113.135 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 130' ' ' ILE . 1.3 tt -164.27 140.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.09 126.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.28 114.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.282 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -174.35 150.88 1.51 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.084 -1.01 . . . . 0.0 110.996 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 55.65 24.92 7.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.726 -0.609 . . . . 0.0 111.077 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.98 86.32 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -106.92 169.02 8.8 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.497 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.8 tt -159.73 150.41 19.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.193 -1.567 . . . . 0.0 108.873 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.497 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 7.2 mt -145.83 139.56 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -129.6 139.62 51.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.54 140.36 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -136.47 137.41 24.04 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.9 150.1 48.1 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.56 1.507 . . . . 0.0 112.032 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.94 158.57 8.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -86.97 -1.44 57.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.726 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.4 p -136.46 155.19 50.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 109.405 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.497 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 32.6 tp -87.48 117.15 26.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 110.116 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -134.29 140.35 46.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.6 t -139.19 126.96 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.976 -1.077 . . . . 0.0 109.908 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.3 m -115.16 137.8 51.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.447 -0.783 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -125.97 129.56 49.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.727 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.31 106.18 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.4 141.15 15.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -118.94 86.69 2.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.532 -0.981 . . . . 0.0 109.17 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -91.77 143.01 26.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.732 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -92.14 -1.67 57.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.843 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 22.1 p-10 -73.12 -167.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -61.56 -24.89 66.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.92 . . . . 0.0 109.784 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.21 -46.23 87.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.319 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.61 -132.72 11.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -98.87 139.6 34.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -1.106 . . . . 0.0 109.289 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -146.02 142.64 28.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.518 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -137.29 148.41 46.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.39 127.9 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.089 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.486 ' O ' ' CG2' ' A' ' 165' ' ' THR . 10.9 t -99.87 122.03 42.21 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.013 -1.054 . . . . 0.0 109.718 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.29 136.65 34.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 108.881 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.52 153.25 34.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.645 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 4.7 mp0 -57.13 113.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.288 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.555 ' N ' ' OE2' ' A' ' 171' ' ' GLU . . . 115.89 11.29 10.26 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -137.11 28.4 2.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.183 -1.187 . . . . 0.0 108.761 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.598 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 16.9 mp0 -62.15 -36.93 83.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 110.632 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.565 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 15.6 mp0 -52.45 -15.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.82 -1.175 . . . . 0.0 110.241 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 49.1 mt-10 -91.07 -4.19 56.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 110.927 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.595 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.4 pt -121.72 6.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.14 -34.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.96 1.02 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.779 -1.201 . . . . 0.0 110.745 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.36 123.81 28.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.195 . . . . 0.0 108.962 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 154.38 17.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -51.36 158.12 0.89 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -146.24 168.7 20.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.05 -1.031 . . . . 0.0 110.089 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.08 159.0 15.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 109.595 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.521 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 60.8 m-85 -103.42 146.5 28.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.296 -0.878 . . . . 0.0 109.316 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 2.8 p30 -51.97 -51.08 59.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.794 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.664 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.2 p90 -51.83 -36.84 49.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.926 -1.109 . . . . 0.0 111.481 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.664 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 14.6 pt-20 -89.48 -17.33 28.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.636 -1.29 . . . . 0.0 109.924 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.43 -52.24 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.187 -0.946 . . . . 0.0 110.127 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -50.85 -51.16 53.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.663 -1.273 . . . . 0.0 109.5 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -52.42 -44.87 65.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 108.751 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.99 -34.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -77.65 -27.14 50.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.726 . . . . 0.0 110.216 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.45 -24.07 46.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.005 -1.059 . . . . 0.0 110.217 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.4 m -85.68 11.19 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.548 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.87 24.82 68.52 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 120.077 -1.059 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 39.2 mt -123.53 163.28 21.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 109.921 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.15 23.96 60.32 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -69.09 -22.68 63.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.788 -1.419 . . . . 0.0 109.88 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.54 -0.56 53.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.35 130.0 50.33 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.305 -1.114 . . . . 0.0 110.685 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.2 p -140.01 -173.64 3.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.735 -0.862 . . . . 0.0 108.728 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.46 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -99.48 -4.3 31.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.89 -11.69 1.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.119 -0.988 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.4 m -126.0 116.96 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.9 tp -74.04 110.42 8.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.1 t -100.08 126.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.926 -1.109 . . . . 0.0 109.47 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.1 mt -110.15 148.81 31.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.829 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.25 159.25 15.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -23.45 1.61 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.257 -1.143 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -153.66 12.69 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 0.0 110.724 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -144.11 151.66 39.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.864 -1.148 . . . . 0.0 110.637 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.57 124.86 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -71.95 -54.78 8.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.019 -1.05 . . . . 0.0 110.34 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -55.89 132.88 73.33 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.056 . . . . 0.0 109.428 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.51 -11.19 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.418 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -84.47 -6.64 59.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.09 -162.96 54.56 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -89.45 149.76 22.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.964 . . . . 0.0 110.317 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.6 mtt-85 -94.26 -23.76 17.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -0.798 . . . . 0.0 108.929 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 221' ' ' ASN . 28.3 m-85 -144.57 133.93 23.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 108.993 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.22 -9.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 108.614 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.578 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -135.01 35.66 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.844 0.83 . . . . 0.0 108.878 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.462 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.66 -49.54 88.35 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 111.804 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 20.5 Cg_endo -67.58 -34.56 25.23 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.571 1.514 . . . . 0.0 113.06 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 24.2 m -79.84 -28.22 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.51 -1.369 . . . . 0.0 107.706 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 10.1 mmm-85 -65.1 -46.84 79.41 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.582 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 36.6 t60 -61.35 -42.13 98.19 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -50.84 72.34 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.05 -1.031 . . . . 0.0 108.69 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.94 -43.95 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 79.4 t80 -57.71 -40.04 78.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.582 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.5 m-20 -74.68 -33.93 62.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.595 -0.69 . . . . 0.0 109.487 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.01 -35.85 73.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 108.688 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.43 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 75.7 mt -72.15 -47.77 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -33.27 24.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -82.14 -27.25 32.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.258 . . . . 0.0 109.582 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 mt -83.14 -23.84 32.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.881 -1.137 . . . . 0.0 109.308 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.502 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 38.1 t80 -67.51 -10.71 54.17 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 108.956 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 85.7 mt -50.45 -27.97 7.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 109.101 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 71.3 mt -58.81 -17.68 25.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.177 -0.952 . . . . 0.0 109.179 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 79.41 15.89 79.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.0 p -158.35 144.65 12.68 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.992 -1.299 . . . . 0.0 109.787 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -42.1 128.99 4.34 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.197 1.931 . . . . 0.0 111.839 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.88 130.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.66 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -117.67 123.72 46.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.823 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 174.1 27.91 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.62 113.33 26.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -1.183 . . . . 0.0 109.829 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.86 147.17 37.55 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.928 0.871 . . . . 0.0 111.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -129.67 143.27 50.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 128.11 19.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.646 -1.284 . . . . 0.0 110.687 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.2 t80 -112.31 116.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 249' ' ' PHE . 13.9 mmm180 46.04 55.78 6.77 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.1 152.44 22.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.0 -175.84 18.6 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -70.96 -52.22 21.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -1.215 . . . . 0.0 109.576 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 2.2 p -56.14 -54.41 45.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.162 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.442 ' N ' ' OG ' ' A' ' 254' ' ' SER . 34.1 tp -51.06 -42.37 60.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.229 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.16 -50.96 71.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 108.908 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 59.5 t -53.9 -40.8 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.865 . . . . 0.0 109.423 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -55.3 -48.15 74.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 108.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 13.4 tp -52.78 -45.25 67.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.6 t -65.83 -45.56 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -52.14 58.72 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 110.155 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -64.39 -46.49 83.12 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.062 -1.023 . . . . 0.0 109.707 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 20.4 mt -59.07 -46.38 88.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.797 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.31 -34.4 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm . . . . . 0 N--CA 1.488 1.463 0 O-C-N 120.66 -1.275 . . . . 0.0 109.145 179.508 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 85.8 mt-10 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.306 0.574 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.28 139.36 53.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.9 t -137.47 176.59 8.57 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.45 143.43 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.854 -1.154 . . . . 0.0 110.443 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -76.22 -46.52 27.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.636 -0.665 . . . . 0.0 109.593 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.93 153.69 43.89 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.521 0.676 . . . . 0.0 110.111 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.94 137.91 58.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.483 -0.76 . . . . 0.0 109.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.47 165.1 15.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.579 -0.701 . . . . 0.0 109.176 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -155.59 147.81 23.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 0.0 110.102 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -130.9 162.42 29.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.571 -0.706 . . . . 0.0 109.207 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.96 136.52 16.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.874 -1.141 . . . . 0.0 109.063 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.1 161.4 19.34 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.053 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 4.3 p -74.6 160.67 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 111.447 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.473 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -93.58 142.38 15.97 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -62.73 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.254 . . . . 0.0 112.36 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -86.7 -38.4 17.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 119.821 -1.799 . . . . 0.0 111.654 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.436 ' OG1' ' CB ' ' A' ' 95' ' ' GLU . 2.1 p -78.13 -33.32 50.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.042 -1.036 . . . . 0.0 110.099 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.15 72.02 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -116.13 154.06 30.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.956 . . . . 0.0 108.654 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -73.16 138.12 45.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.993 -1.067 . . . . 0.0 110.075 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 23.2 t -143.76 157.88 44.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 0.0 108.847 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -135.57 148.75 49.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 109.329 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.9 mt -124.98 146.34 49.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.96 130.93 61.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mt -117.02 119.02 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 109.637 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.61 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -116.92 148.64 42.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.34 161.51 23.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.231 1.954 . . . . 0.0 111.45 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -135.96 -174.08 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.9 tttp -85.61 151.66 23.73 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -49.5 150.34 1.97 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.584 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.27 23.61 57.89 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.03 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 17.0 m -80.2 -42.64 22.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.791 -1.417 . . . . 0.0 108.913 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.75 -176.81 30.06 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 37' ' ' ILE . 8.4 mm -97.33 122.57 49.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.374 -1.074 . . . . 0.0 108.122 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -138.45 140.69 39.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.046 -1.034 . . . . 0.0 110.4 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -100.05 152.92 19.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 3.1 t80 -124.93 147.41 48.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -173.78 131.26 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 109.382 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.84 29.58 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.758 -1.211 . . . . 0.0 110.198 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.02 138.55 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -1.171 . . . . 0.0 109.703 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -98.86 137.03 38.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.05 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.3 mt -129.24 97.11 26.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 110.179 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.59 142.3 24.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.156 1.904 . . . . 0.0 111.837 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.64 82.36 5.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.512 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -140.63 156.99 46.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.492 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.3 p80 -53.53 -49.87 66.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.168 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -47.0 -15.79 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.022 . . . . 0.0 109.947 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 50' ' ' HIS . 76.6 m-85 -97.53 4.22 50.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.007 -1.058 . . . . 0.0 109.495 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 t -59.02 130.46 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.198 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.87 -32.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -153.55 122.06 6.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 109.979 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.6 p -112.33 131.93 55.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 7.0 t-20 -166.87 -153.94 0.16 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 57' ' ' ASN . 23.3 m-70 -46.92 -13.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.008 -1.058 . . . . 0.0 108.452 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -137.3 166.06 24.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.485 -0.759 . . . . 0.0 109.371 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.408 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 12.3 m -105.79 123.67 48.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.377 -0.827 . . . . 0.0 108.945 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -122.19 142.43 50.43 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.995 0.902 . . . . 0.0 111.426 -178.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.5 mt -122.56 164.68 17.72 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.54 145.31 5.58 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.4 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -145.18 151.52 38.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.822 -0.811 . . . . 0.0 109.484 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm 57.44 25.59 11.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 111.002 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.03 2.2 78.26 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.49 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 8.6 mm100 -100.65 142.24 32.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.235 . . . . 0.0 108.028 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -143.55 154.05 43.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.796 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mt -133.87 144.07 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 47.8 mttp -114.9 155.01 27.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.364 -0.835 . . . . 0.0 111.256 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 m 50.89 63.86 2.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.79 -0.569 . . . . 0.0 111.152 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 m -112.51 1.05 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.094 -1.004 . . . . 0.0 109.092 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' OE1' ' OD2' ' A' ' 230' ' ' ASP . 0.3 OUTLIER -72.22 -31.09 65.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.944 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -61.49 -60.45 3.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.832 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.8 tp -59.64 -46.13 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 0.0 109.179 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.471 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 61.9 mt -53.79 -41.62 67.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.588 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 2.8 t -58.43 -46.31 86.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.976 . . . . 0.0 109.47 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.95 -54.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.0 mt -51.89 -43.7 63.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 108.923 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.544 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 19.1 t-160 -54.6 -47.72 73.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.63 -37.13 82.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.81 -7.53 56.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.431 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.03 60.48 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 5.8 mm -104.29 131.03 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 108.65 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.468 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 40.7 p -119.71 -19.12 8.15 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.364 -0.835 . . . . 0.0 111.422 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 34' ' ' GLY . 1.2 m-80 -126.98 111.02 13.6 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.891 -1.131 . . . . 0.0 109.637 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -164.57 142.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.132 -0.98 . . . . 0.0 109.949 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.5 m -113.84 99.43 7.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.33 106.35 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.829 . . . . 0.0 109.777 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.66 118.78 25.38 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -105.0 105.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.931 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.459 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.4 mt -83.91 111.33 19.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.17 -179.18 16.23 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.32 -16.83 14.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -1.186 . . . . 0.0 110.66 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -123.77 133.48 53.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 110.41 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.57 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 mm -68.12 126.32 92.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.486 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -46.28 128.48 12.18 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.865 1.71 . . . . 0.0 112.159 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.5 tp -76.43 -25.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.444 -0.785 . . . . 0.0 110.093 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.9 mt 53.66 -113.91 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD2' ' NE ' ' A' ' 178' ' ' ARG . 18.8 t70 -94.37 -21.46 18.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 0.0 110.012 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.5 -7.71 28.29 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.582 ' OG ' ' NE ' ' A' ' 178' ' ' ARG . 5.4 p -116.69 -167.75 1.34 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -1.066 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.5 -5.37 20.98 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.495 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 67.1 t-105 -46.75 -42.0 16.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.681 -0.894 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.59 -52.25 64.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.046 . . . . 0.0 110.015 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 75.3 m-85 -62.42 -44.35 96.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.018 . . . . 0.0 108.557 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -63.49 -37.53 87.64 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.3 mm-40 -71.42 -50.25 33.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -0.824 . . . . 0.0 112.076 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.0 -51.53 13.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.713 -1.242 . . . . 0.0 110.669 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.76 -42.52 85.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.031 -1.043 . . . . 0.0 110.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -54.11 -29.36 44.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -84.79 -11.7 55.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -119.8 31.6 6.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.9 mt -88.83 148.29 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.362 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 tp -130.34 158.47 39.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -109.35 137.53 47.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -161.45 0.87 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.83 . . . . 0.0 109.047 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -121.77 0.63 9.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.86 . . . . 0.0 110.7 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 4' ' ' GLU . 5.6 ttt85 -89.04 144.18 26.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.926 -1.108 . . . . 0.0 109.925 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 132.14 34.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.492 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.31 140.6 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.499 -0.75 . . . . 0.0 111.184 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -83.95 84.08 7.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -57.88 144.84 37.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.713 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -105.37 125.02 50.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.1 t -128.53 142.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.2 t -81.19 134.8 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 108.864 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.52 -11.35 11.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.084 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.76 141.76 23.36 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.337 -0.852 . . . . 0.0 109.171 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.69 169.87 20.89 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.135 1.89 . . . . 0.0 113.377 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 130' ' ' ILE . 3.1 tt -165.4 141.52 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.81 -0.556 . . . . 0.0 109.708 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.7 mt -127.6 124.9 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.402 -0.811 . . . . 0.0 109.83 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.03 120.79 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.443 -0.786 . . . . 0.0 109.438 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -104.33 147.27 27.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.349 -0.844 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.01 112.45 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.816 -1.178 . . . . 0.0 111.882 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 41.1 52.25 3.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.709 -0.619 . . . . 0.0 112.458 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.26 3.69 89.99 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.588 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -105.38 163.08 12.9 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.23 149.64 17.64 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.037 -1.664 . . . . 0.0 109.241 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.473 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 13.0 mt -146.85 133.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -124.88 139.72 53.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -143.57 139.29 16.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 146.47 70.47 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.653 1.568 . . . . 0.0 112.456 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.46 153.17 9.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 0.54 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -136.29 146.34 46.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.49 117.68 19.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.548 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 tt0 -139.52 133.89 31.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.83 . . . . 0.0 108.808 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.9 t -132.75 125.6 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.688 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.9 m -112.77 132.3 55.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -121.58 130.15 53.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.74 . . . . 0.0 109.986 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -114.1 103.23 10.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.07 125.42 8.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.28 84.39 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.42 -1.047 . . . . 0.0 108.865 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.19 148.22 25.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.541 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -95.83 1.31 53.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.209 -0.932 . . . . 0.0 109.782 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 15.0 p-10 -76.24 -167.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.368 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -61.23 -25.21 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.79 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.3 mt -59.57 -51.13 71.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.35 -128.07 9.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.553 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 12.2 mtm180 -104.05 137.28 42.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.392 -1.064 . . . . 0.0 109.23 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 8.3 mp0 -140.73 138.41 34.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.199 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.65 144.27 49.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.808 . . . . 0.0 109.472 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.656 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 52.3 t80 -138.6 128.48 25.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 61.0 m -103.14 123.1 46.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -101.77 137.64 39.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.832 . . . . 0.0 109.395 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.551 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.2 t -134.47 158.32 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.483 -0.76 . . . . 0.0 109.363 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -58.45 117.47 4.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.805 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.39 4.06 20.38 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -134.38 29.8 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.137 -1.213 . . . . 0.0 108.835 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -63.87 -32.83 74.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 110.747 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.91 -17.46 6.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.069 -1.02 . . . . 0.0 110.832 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.2 -3.8 58.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.851 -1.155 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -125.55 -12.45 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.119 -0.988 . . . . 0.0 111.434 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -29.48 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.305 -1.497 . . . . 0.0 110.095 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.62 1.96 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.709 -1.244 . . . . 0.0 110.743 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.66 121.65 24.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 108.794 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.582 ' NE ' ' OG ' ' A' ' 102' ' ' SER . 4.4 mpt_? -88.22 149.15 24.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.83 -1.169 . . . . 0.0 109.832 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.8 t -54.14 166.3 0.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.336 -0.853 . . . . 0.0 109.057 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.74 177.4 9.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.768 -1.207 . . . . 0.0 109.963 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.53 164.22 10.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.586 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.618 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 90.9 m-85 -104.3 145.22 30.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.565 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 18.1 p-10 -63.81 -18.24 63.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.881 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.618 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 4.5 p90 -81.1 -27.42 35.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.667 -1.271 . . . . 0.0 110.452 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 19.6 pt-20 -98.28 -15.17 19.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.888 -1.133 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.1 mt -56.47 -51.51 63.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.255 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 187' ' ' GLU . 2.9 mp0 -51.15 -52.73 41.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.549 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -52.5 -44.86 65.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.0 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.94 -33.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.373 -0.829 . . . . 0.0 109.097 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -79.83 -25.37 40.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -82.25 -25.12 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.057 -1.027 . . . . 0.0 110.219 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.1 m -80.7 8.02 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 82.16 23.24 57.53 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.13 -1.034 . . . . 0.0 110.578 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 47.5 mt -125.6 164.5 20.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.16 -1.2 . . . . 0.0 109.922 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.42 19.59 78.0 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.216 -0.927 . . . . 0.0 111.552 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -68.71 -20.24 64.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.598 -1.531 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.03 -5.26 50.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.77 125.16 34.47 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.072 -1.252 . . . . 0.0 110.321 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -173.73 3.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.834 -0.804 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 73.6 mt -91.56 -13.34 32.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.533 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 40.0 tttp -92.47 -1.4 57.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 201' ' ' LYS . 0.6 OUTLIER -142.48 11.92 1.91 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.27 114.54 6.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 17.0 tp -77.54 106.71 9.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -0.957 . . . . 0.0 109.136 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.1 t -99.94 130.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.001 -1.062 . . . . 0.0 109.498 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 90.7 mt -111.58 149.67 31.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.855 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.4 150.6 16.87 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 207' ' ' GLY . 5.2 tttm -42.98 -27.23 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -1.171 . . . . 0.0 110.091 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 207' ' ' GLY . 3.3 p-10 -148.65 8.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.969 -1.082 . . . . 0.0 110.376 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -141.56 149.15 40.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.017 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.79 125.74 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -72.5 -54.63 8.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 110.47 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -55.85 131.64 72.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 109.804 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.38 -12.28 27.27 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.203 1.935 . . . . 0.0 112.184 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -88.09 -7.77 56.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.66 48.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 36.2 mt -85.64 138.95 31.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.545 -0.973 . . . . 0.0 109.85 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.503 ' CZ ' HH12 ' A' ' 178' ' ' ARG . 0.5 OUTLIER -64.83 -54.71 26.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 221' ' ' ASN . 18.2 m-85 -118.45 146.66 44.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -50.35 -12.5 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.614 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 219' ' ' TYR . 4.3 m-20 -135.89 27.86 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 109.454 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.1 OUTLIER -56.05 -42.65 97.24 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -179.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 22.8 Cg_exo -61.58 -45.44 17.74 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.229 1.953 . . . . 0.0 112.924 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 m -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 120.717 -1.24 . . . . 0.0 108.381 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 11.2 mtt85 -66.79 -40.79 88.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.56 -42.25 95.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 tptp -56.8 -45.62 82.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.01 . . . . 0.0 108.671 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.588 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 77.4 t80 -54.98 -41.95 71.83 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -71.38 -38.12 71.54 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.729 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 27.3 tp -56.72 -35.62 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.352 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.544 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 35.5 mt -72.67 -48.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.25 -32.73 14.19 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.91 -29.5 29.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.228 -1.16 . . . . 0.0 110.143 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.7 mt -78.58 -23.29 46.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.761 -1.212 . . . . 0.0 109.889 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.481 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 22.3 t80 -67.92 -7.27 27.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.138 -0.976 . . . . 0.0 108.815 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -50.06 -32.99 16.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.446 -0.784 . . . . 0.0 108.895 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.45 -12.49 1.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.061 -1.024 . . . . 0.0 109.085 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 73.75 17.13 79.14 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.7 p -157.17 144.94 13.99 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.963 -1.316 . . . . 0.0 109.677 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -42.66 133.27 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.199 1.932 . . . . 0.0 111.82 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.07 134.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -121.24 125.23 46.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 109.448 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.75 167.54 18.88 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 148' ' ' GLU . 10.2 tttp -98.67 112.91 24.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.112 -1.228 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -112.18 148.45 34.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.015 0.912 . . . . 0.0 111.1 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -129.18 143.67 50.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 p -138.34 124.52 20.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.8 -1.188 . . . . 0.0 109.848 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 250' ' ' ARG . 1.5 t80 -112.96 112.1 23.32 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.7 OUTLIER 45.28 56.48 5.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -92.37 156.17 23.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.93 177.75 17.2 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.417 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 79.8 m-70 -66.01 -51.95 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.28 . . . . 0.0 109.552 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 49.1 p -54.53 -54.64 38.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.0 . . . . 0.0 109.117 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 35.8 tp -51.33 -41.83 60.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.54 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -58.71 -55.04 40.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.021 . . . . 0.0 108.816 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.4 t -48.55 -41.25 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -54.93 -47.85 73.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 26.6 tp -52.81 -44.37 66.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.0 t -70.8 -41.66 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -58.9 -48.18 82.36 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 110.411 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.1 -35.19 76.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.053 -1.029 . . . . 0.0 109.57 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.66 -45.61 67.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.11 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.36 -32.79 74.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.715 -0.615 . . . . 0.0 110.27 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt . . . . . 0 N--CA 1.489 1.485 0 O-C-N 120.734 -1.229 . . . . 0.0 108.854 179.251 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.584 ' OE2' ' ND2' ' A' ' 86' ' ' ASN . 8.0 mm-40 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.35 135.46 53.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.519 -0.738 . . . . 0.0 109.889 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -137.26 171.42 14.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.7 m -81.94 130.21 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.94 -1.1 . . . . 0.0 109.964 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -59.29 -45.83 90.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.092 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -129.79 157.76 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.198 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 135.45 56.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 109.858 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.0 mt -116.91 169.97 8.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.438 -0.789 . . . . 0.0 109.08 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -154.04 147.08 24.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.062 . . . . 0.0 110.194 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -132.47 157.81 43.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.403 -0.811 . . . . 0.0 109.448 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.6 pm0 -151.78 136.82 17.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.37 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.2 161.85 20.31 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 7.1 p -72.46 163.94 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.283 -1.128 . . . . 0.0 111.347 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -98.76 142.21 15.96 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 197' ' ' GLY . 15.7 tt -58.97 -52.11 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -1.169 . . . . 0.0 112.5 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.425 ' HD1' ' HA2' ' A' ' 195' ' ' GLY . 7.2 m-70 -86.82 -38.73 16.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.245 -1.535 . . . . 0.0 111.702 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.414 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . 2.5 m -73.97 -33.62 63.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 110.002 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.03 25.83 69.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.72 154.34 31.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.534 -0.98 . . . . 0.0 108.596 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -73.72 137.1 43.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 0.0 110.195 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 t -142.35 156.22 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 22.8 tttt -132.26 156.57 46.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.0 mt -133.9 143.13 48.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.046 -1.033 . . . . 0.0 109.097 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.487 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 22.7 mt -130.8 128.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mt -116.01 129.89 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.069 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.572 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 1.5 m-70 -125.0 148.5 60.28 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.65 159.47 28.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.238 1.959 . . . . 0.0 111.618 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.486 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.4 mm-40 -132.39 -174.13 3.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.48 ' O ' ' OG1' ' A' ' 35' ' ' THR . 69.0 tttt -90.87 155.5 18.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.587 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -50.61 149.23 3.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 110.236 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.7 61.34 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.689 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 87.1 m -81.49 -46.39 14.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.382 -1.658 . . . . 0.0 108.983 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.12 -165.49 18.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mm -103.68 122.31 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.61 149.23 47.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.067 . . . . 0.0 110.608 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -107.84 150.96 26.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.526 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 3.5 t80 -131.04 137.48 49.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.014 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.608 ' HZ1' HE22 ' A' ' 67' ' ' GLN . 16.7 ttpp -169.12 140.41 2.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.447 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.51 28.52 15.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.895 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.15 24.84 76.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.15 138.14 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.21 -1.17 . . . . 0.0 109.758 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 35.9 m-85 -97.13 134.27 40.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.187 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.6 mt -127.25 96.83 32.9 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.485 -0.759 . . . . 0.0 109.839 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -51.79 144.73 33.87 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.259 1.973 . . . . 0.0 111.654 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.2 79.35 7.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.19 149.54 52.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' VAL . 5.8 p80 -52.0 -49.37 63.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.415 -0.803 . . . . 0.0 109.789 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' HIS . 18.8 mt-10 -44.89 -33.18 1.87 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.32 6.16 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 109.902 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 50' ' ' HIS . 3.5 t -63.73 130.81 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.131 -0.981 . . . . 0.0 109.071 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.9 m -115.68 -31.66 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.47 -0.769 . . . . 0.0 110.317 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.484 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -155.0 126.03 7.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 109.602 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 p -113.87 137.07 52.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.553 -0.717 . . . . 0.0 109.107 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.565 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -166.52 -154.58 0.18 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.39 -11.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.565 ' H ' ' C ' ' A' ' 57' ' ' ASN . 40.6 m -134.8 165.75 24.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.608 -0.682 . . . . 0.0 109.294 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -103.28 121.57 42.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 0.0 109.229 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -118.14 135.67 54.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 111.192 -179.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.8 mt -122.04 162.46 21.15 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.56 144.29 5.81 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 118.35 -1.881 . . . . 0.0 111.147 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -144.68 151.18 38.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.721 -0.87 . . . . 0.0 109.506 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 mttp 57.48 23.83 9.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.704 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.68 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.331 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.608 HE22 ' HZ1' ' A' ' 41' ' ' LYS . 28.7 mm100 -97.55 143.83 27.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.311 . . . . 0.0 108.055 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.77 149.25 43.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.502 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.32 137.78 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.98 154.25 25.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.188 -0.945 . . . . 0.0 110.907 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.7 m 53.5 67.88 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.706 -0.621 . . . . 0.0 110.764 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.5 m -113.15 -4.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 109.093 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.3 pt-20 -69.11 -33.49 73.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 110.333 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -61.57 -60.35 3.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 110.135 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.576 ' CD1' ' CD2' ' A' ' 106' ' ' PHE . 2.5 tp -56.98 -42.63 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.904 -1.122 . . . . 0.0 108.808 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.462 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 9.5 mt -59.36 -35.28 73.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.341 -0.85 . . . . 0.0 109.83 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.602 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 11.9 t -64.46 -51.15 64.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 109.902 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.3 t -55.74 -54.74 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 108.408 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -53.28 -44.74 68.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.616 -0.678 . . . . 0.0 109.421 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -53.23 -41.41 65.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt -77.26 -35.85 54.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.449 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.3 mt -80.77 0.76 33.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.025 -1.047 . . . . 0.0 110.61 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 58.24 51.82 8.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.512 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.49 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 19.9 mm -95.73 122.02 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 108.369 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.662 ' HG1' ' H ' ' A' ' 86' ' ' ASN . 8.3 p -101.88 -76.61 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 111.169 -178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.662 ' H ' ' HG1' ' A' ' 85' ' ' THR . 1.7 m-80 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.39 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.25 134.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.491 0.662 . . . . 0.0 109.555 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.486 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.7 m -105.92 100.54 10.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.14 104.49 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -80.49 124.17 28.7 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.2 t -106.21 111.88 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' A' ' 92' ' ' ILE . 2.5 mp -92.46 108.92 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.15 -158.06 21.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.19 -11.46 10.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.586 -0.95 . . . . 0.0 110.233 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -145.81 150.1 35.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.85 -1.157 . . . . 0.0 110.858 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.52 125.13 91.8 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.638 -0.664 . . . . 0.0 109.623 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.28 134.94 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.964 1.776 . . . . 0.0 112.37 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.02 -29.5 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.2 mt 56.77 -110.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.548 -0.72 . . . . 0.0 110.221 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -15.5 22.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.092 . . . . 0.0 111.464 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.49 -8.83 32.66 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.3 p -117.46 -170.74 1.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -1.048 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.87 -3.3 21.91 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -46.8 -39.84 12.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 110.744 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.41 -51.85 67.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.964 -1.085 . . . . 0.0 110.15 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CD2' ' CD1' ' A' ' 75' ' ' ILE . 92.6 m-85 -64.01 -43.78 94.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.024 -1.047 . . . . 0.0 108.779 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -61.51 -38.02 85.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.662 -0.649 . . . . 0.0 109.756 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -71.18 -46.72 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 111.591 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.06 15.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.709 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 110' ' ' ILE . 74.7 mt -59.7 -42.86 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 110.709 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.64 -31.69 57.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.912 -1.117 . . . . 0.0 109.348 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -83.09 -1.11 51.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.93 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -131.4 33.42 4.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.252 -0.905 . . . . 0.0 111.071 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.2 mt -91.35 142.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.473 -1.392 . . . . 0.0 109.642 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.56 162.83 29.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -108.01 146.03 33.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.921 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.587 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 10.7 mt-30 -111.23 -166.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 109.444 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 10.1 t-20 -116.66 70.83 0.77 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.4 -0.812 . . . . 0.0 110.304 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -166.36 143.59 5.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.192 -0.942 . . . . 0.0 109.305 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.73 130.04 35.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.715 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.77 140.36 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.683 . . . . 0.0 110.542 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.45 90.66 8.45 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -64.71 146.66 54.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 110.812 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -102.38 123.7 46.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.13 143.8 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.128 -0.982 . . . . 0.0 110.466 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 67.9 t -84.4 135.73 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.538 -0.726 . . . . 0.0 109.101 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -114.68 -10.47 12.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.233 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.84 146.45 34.64 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.03 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.28 170.7 17.66 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.389 2.059 . . . . 0.0 113.403 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 tt -165.68 144.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.291 0.567 . . . . 0.0 109.793 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.4 mt -130.64 122.28 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.5 111.92 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.354 -0.841 . . . . 0.0 109.634 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -115.87 128.6 55.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -172.39 152.2 2.66 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.959 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HB2' ' HE ' ' A' ' 137' ' ' ARG . 33.7 mm-40 56.8 22.19 6.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.641 -0.662 . . . . 0.0 110.766 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.54 -0.21 89.42 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.411 ' HE ' ' HB2' ' A' ' 135' ' ' GLU . 21.2 mtm180 -100.5 171.8 7.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -1.143 . . . . 0.0 107.984 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.426 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.67 146.57 14.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.429 -1.419 . . . . 0.0 109.249 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.426 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 3.5 mt -147.24 133.27 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 108.671 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -123.78 138.44 54.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 0.0 109.666 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.68 144.59 48.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.5 -0.75 . . . . 0.0 109.105 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 11.4 tm-20 -141.59 135.39 14.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 5.9 Cg_endo -52.82 148.12 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.39 1.393 . . . . 0.0 112.05 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.69 150.87 10.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -79.6 0.8 28.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.5 p -138.43 170.42 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.582 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 30.6 tp -99.88 119.2 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 109.519 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -139.52 137.93 35.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.9 125.67 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 m -112.88 140.93 47.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -126.72 131.39 51.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 106.06 13.51 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.83 158.37 17.8 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 115.66 15.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -1.057 . . . . 0.0 109.148 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.11 148.75 41.27 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.431 -0.793 . . . . 0.0 109.876 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -93.05 -7.02 46.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 109.93 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.478 HD22 ' CD1' ' A' ' 159' ' ' LEU . 20.5 p-10 -75.06 -169.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.011 . . . . 0.0 109.972 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -58.83 -21.22 56.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 110.152 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.478 ' CD1' HD22 ' A' ' 157' ' ' ASN . 6.9 mt -64.76 -54.26 34.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.017 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.06 -131.74 10.69 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -101.37 142.68 32.41 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.235 -1.156 . . . . 0.0 109.517 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -148.67 150.37 33.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.199 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -136.74 147.55 46.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.805 . . . . 0.0 109.323 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -136.06 122.5 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' A' ' 165' ' ' THR . 14.2 t -98.26 120.77 39.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.994 -1.066 . . . . 0.0 109.658 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -95.05 140.44 29.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.232 -0.918 . . . . 0.0 109.44 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.94 150.08 23.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.289 -0.882 . . . . 0.0 109.707 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 96.6 mt-10 -55.59 117.64 3.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.888 . . . . 0.0 109.368 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.501 ' C ' HD21 ' A' ' 170' ' ' ASN . . . 115.86 4.97 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.501 HD21 ' C ' ' A' ' 169' ' ' GLY . 0.8 OUTLIER -134.87 30.27 3.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.142 -1.21 . . . . 0.0 108.958 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.1 mp0 -65.99 -28.64 69.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 110.132 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -57.42 -14.5 4.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.162 -0.962 . . . . 0.0 110.789 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -96.21 -4.35 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.134 . . . . 0.0 110.941 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.414 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -118.98 3.48 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 110.906 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.02 -31.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.804 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.4 2.68 55.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.997 -1.064 . . . . 0.0 110.571 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.25 118.34 21.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.736 -1.228 . . . . 0.0 108.751 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.25 152.09 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.942 -1.099 . . . . 0.0 110.166 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 t -59.11 133.05 55.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.555 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 25.4 p90 -115.03 165.77 12.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.482 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -159.65 161.23 34.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.496 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 42.7 m-85 -103.03 145.15 30.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.052 -1.03 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.12 -17.85 62.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.206 -0.934 . . . . 0.0 111.708 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.668 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.2 p90 -81.61 -38.32 26.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.362 -1.461 . . . . 0.0 111.183 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.668 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -86.85 -14.44 42.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.596 -1.315 . . . . 0.0 109.817 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.8 mt -53.91 -48.15 63.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.144 -0.973 . . . . 0.0 109.893 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.24 -51.35 54.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.103 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -47.04 67.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 30.0 mt -60.77 -34.7 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 109.183 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -78.91 -25.92 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.842 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -75.25 -28.45 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.6 m -81.49 10.66 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.101 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.37 72.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.0 mt -120.84 159.2 25.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.596 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.425 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 78.1 27.58 57.86 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.563 ' HZ1' ' CB ' ' A' ' 196' ' ' LYS . 8.0 mtpm? -71.03 -20.59 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.765 -1.432 . . . . 0.0 109.314 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.29 -1.34 50.86 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.75 126.94 38.21 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.695 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.407 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 1.6 p -140.74 172.02 13.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.716 -0.873 . . . . 0.0 109.114 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.79 -3.56 45.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.979 . . . . 0.0 109.642 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -97.88 -10.55 24.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.407 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 0.8 OUTLIER -135.18 -9.36 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 109.486 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.0 m -126.89 115.04 18.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.713 . . . . 0.0 109.586 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.0 114.64 12.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.31 127.08 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.048 -1.033 . . . . 0.0 109.854 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 11.1 mt -104.29 151.67 23.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.09 150.74 17.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 26.4 ttpt -41.02 -29.4 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -1.123 . . . . 0.0 109.961 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.5 OUTLIER -149.41 17.47 0.93 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 110.339 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 7.4 tttp -151.26 161.88 41.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.054 -1.029 . . . . 0.0 110.122 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.24 129.88 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.08 -54.31 8.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.137 -0.977 . . . . 0.0 109.92 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -54.64 134.22 64.3 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.909 -1.12 . . . . 0.0 109.329 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.81 -9.67 25.17 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.235 1.957 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.32 -7.96 52.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.066 -1.021 . . . . 0.0 109.751 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.18 -165.01 51.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.9 mt -88.66 145.24 25.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.5 -1.0 . . . . 0.0 109.935 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.566 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.7 mmt180 -87.76 -17.02 32.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.465 -0.772 . . . . 0.0 109.558 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 27.0 m-85 -144.17 143.97 31.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.01 -19.79 54.43 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -126.96 35.67 4.56 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -60.05 -40.62 79.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.538 -0.726 . . . . 0.0 110.607 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.11 -47.98 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.43 2.087 . . . . 0.0 112.641 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -23.09 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.757 -1.214 . . . . 0.0 108.696 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -68.74 -44.64 73.34 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -60.13 -43.02 96.01 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.83 -42.18 79.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.092 -1.005 . . . . 0.0 109.071 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.94 -49.31 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.602 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.8 t80 -50.22 -40.33 47.13 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.794 0.807 . . . . 0.0 108.896 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.0 m-20 -69.68 -44.57 70.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.635 -0.666 . . . . 0.0 110.178 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.64 -38.72 72.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.111 -0.993 . . . . 0.0 109.154 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 71.8 mt -68.04 -33.44 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.12 -31.97 79.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.589 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -81.78 -25.49 35.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -1.126 . . . . 0.0 109.912 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 237' ' ' LEU . 6.1 mt -76.07 -24.52 55.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.795 -1.191 . . . . 0.0 110.698 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.49 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -65.38 -5.22 6.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.355 -1.466 . . . . 0.0 108.013 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 235' ' ' LEU . 35.4 mt -55.08 -23.7 21.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.848 -1.158 . . . . 0.0 108.929 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.17 -21.47 64.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.005 . . . . 0.0 109.186 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.76 12.05 67.16 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 21.4 p -158.2 143.99 12.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.144 -1.209 . . . . 0.0 109.578 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -42.42 135.66 4.39 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.263 1.975 . . . . 0.0 112.153 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 76.0 t -98.46 133.03 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.944 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -122.41 127.81 50.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.613 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.0 178.93 28.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -105.93 112.2 25.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -1.207 . . . . 0.0 109.968 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -112.36 148.19 34.8 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.03 0.919 . . . . 0.0 111.125 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -129.89 144.42 51.31 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -139.09 128.81 24.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.732 -1.23 . . . . 0.0 110.722 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.0 t80 -110.67 113.07 25.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 249' ' ' PHE . 42.1 mtm180 48.51 55.48 8.91 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.18 135.31 22.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -109.78 151.2 17.38 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.1 m-70 -49.05 -46.12 43.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -1.205 . . . . 0.0 109.547 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -55.29 35.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 109.413 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.7 tp -51.99 -38.14 55.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -58.64 -55.48 34.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.036 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.42 -42.94 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.754 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.58 -48.89 74.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.089 -1.007 . . . . 0.0 109.087 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 37.9 tp -52.79 -42.02 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 108.772 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.9 t -72.11 -40.17 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -58.91 -51.36 70.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.388 -0.82 . . . . 0.0 110.136 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.79 -44.74 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 109.879 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.5 -44.16 95.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.248 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.28 86.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.498 -0.751 . . . . 0.0 110.368 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.6 mttt . . . . . 0 N--CA 1.49 1.564 0 O-C-N 120.773 -1.204 . . . . 0.0 108.868 179.622 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 119' ' ' ARG . 8.0 mm-40 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.63 126.85 54.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.639 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 6.1 t -130.44 169.37 15.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.639 ' H ' ' HG1' ' A' ' 6' ' ' THR . 6.7 m -83.87 137.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.034 -1.042 . . . . 0.0 110.317 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -67.6 -45.57 75.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.472 -0.767 . . . . 0.0 110.19 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CB ' ' OD1' ' A' ' 113' ' ' ASN . 2.8 tt0 -132.27 156.1 47.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.26 -0.9 . . . . 0.0 110.511 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 133.01 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.728 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.87 165.42 14.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 109.192 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 p -156.65 150.3 24.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.57 161.68 33.23 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.46 134.73 24.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.893 -1.13 . . . . 0.0 108.857 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.04 155.34 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.33 160.66 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.18 . . . . 0.0 111.208 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.65 136.29 13.44 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 197' ' ' GLY . 14.4 tt -53.42 -53.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -1.161 . . . . 0.0 111.657 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.418 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 5.2 m-70 -87.54 -36.78 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.275 -1.516 . . . . 0.0 111.191 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.4 m -71.31 -35.42 71.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.57 65.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -111.77 150.85 29.7 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.667 -0.902 . . . . 0.0 108.86 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.2 t80 -70.25 128.92 37.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.597 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.565 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 12.1 t -135.94 157.47 46.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 109.143 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.565 ' N ' ' HG ' ' A' ' 24' ' ' SER . 4.0 ttmt -135.6 147.2 48.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -0.895 . . . . 0.0 109.307 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 6.4 mt -119.65 145.99 45.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.096 -1.003 . . . . 0.0 108.838 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.458 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 7.9 mt -135.05 126.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mt -113.08 129.1 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.223 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.574 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -128.44 148.75 69.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.54 160.37 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.278 1.986 . . . . 0.0 111.835 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 6.0 mm-40 -134.76 -172.82 3.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.902 . . . . 0.0 109.837 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 54.1 tttm -84.44 149.59 25.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 7.4 mp0 -47.46 145.42 2.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.991 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.68 25.2 63.14 Favored Glycine 0 N--CA 1.493 2.465 0 O-C-N 121.47 -0.769 . . . . 0.0 111.825 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 45.4 m -80.98 -44.58 17.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.546 -1.561 . . . . 0.0 108.951 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.48 -166.55 16.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mm -103.73 125.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.313 -1.11 . . . . 0.0 108.073 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.12 139.64 30.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.162 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.56 152.69 18.2 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 4.1 t80 -135.03 141.26 46.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.609 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 146.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.312 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.07 29.31 14.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.31 23.11 73.25 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.28 133.88 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -1.202 . . . . 0.0 109.51 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -94.41 142.45 27.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.823 . . . . 0.0 109.169 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.4 mt -135.09 94.39 16.09 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -49.26 144.88 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.342 2.028 . . . . 0.0 111.654 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.44 84.32 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.95 -1.094 . . . . 0.0 110.667 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.28 154.57 49.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.552 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 p80 -51.39 -48.15 62.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 109.732 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -46.77 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.0 m-85 -95.35 1.88 54.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 109.762 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.22 127.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.036 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.2 m -117.42 -32.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 109.861 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -151.32 119.28 6.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 p -114.36 127.82 56.04 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.603 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.9 t-20 -167.16 -152.98 0.14 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' ASN . 12.2 m-70 -44.37 -16.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.9 t -136.77 165.6 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.491 -0.755 . . . . 0.0 109.326 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 m -110.61 125.71 53.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 150.42 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.26 -0.9 . . . . 0.0 111.178 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.4 mt -130.15 159.01 38.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.73 146.68 8.02 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.306 -1.902 . . . . 0.0 111.538 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -144.09 148.87 35.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.644 -0.916 . . . . 0.0 109.309 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.1 mttt 59.1 30.62 20.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.262 -0.899 . . . . 0.0 110.75 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.24 4.72 90.11 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.486 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 16.7 mm100 -103.93 139.94 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -1.234 . . . . 0.0 108.094 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -141.71 157.52 44.95 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.704 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.2 mt -133.77 147.26 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -114.21 150.52 34.16 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.153 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 55.05 71.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.666 -0.646 . . . . 0.0 110.995 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.97 -17.41 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.438 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.601 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -61.18 -16.81 48.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.441 -179.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.601 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 7.8 m170 -73.18 -61.39 1.84 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.833 -1.167 . . . . 0.0 109.832 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -58.15 -41.62 81.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.819 -1.175 . . . . 0.0 108.338 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 98.0 mt -56.4 -38.28 71.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 109.466 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.569 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.2 t -61.44 -49.23 77.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.13 -53.07 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 108.515 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.2 mt -51.73 -44.62 63.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 0.0 109.512 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.458 ' ND1' ' CG2' ' A' ' 232' ' ' ILE . 10.6 t-160 -56.16 -49.34 74.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.1 -1.0 . . . . 0.0 110.401 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.49 -37.89 85.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.685 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.437 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 50.2 mt -86.66 -5.43 59.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.913 -1.117 . . . . 0.0 111.151 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 82' ' ' LEU . 1.0 OUTLIER 62.69 63.0 1.03 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.731 -1.231 . . . . 0.0 110.426 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 mm -98.44 129.68 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.422 ' HG1' ' CD ' ' A' ' 4' ' ' GLU . 72.9 p -107.63 -78.21 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.041 -1.037 . . . . 0.0 110.509 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.703 HD21 HE22 ' A' ' 117' ' ' GLN . 1.5 m-80 -81.34 113.27 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.005 -1.059 . . . . 0.0 111.137 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 2.9 m -163.71 131.79 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.546 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.5 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 51.4 m -104.25 100.88 10.6 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.38 103.02 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' OE2' ' CD1' ' A' ' 40' ' ' PHE . 4.0 mt-10 -76.32 122.97 25.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.989 -1.069 . . . . 0.0 108.782 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.06 110.29 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.45 108.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.7 -167.15 24.91 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.16 -15.31 14.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.365 -1.08 . . . . 0.0 109.861 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.5 tt0 -143.71 148.68 36.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 110.034 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -68.2 128.36 93.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.456 -0.777 . . . . 0.0 109.282 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -44.19 130.35 8.49 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.047 1.831 . . . . 0.0 112.116 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.33 -20.31 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.074 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.464 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 6.2 mt 47.57 -116.19 0.72 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.277 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.16 -10.05 31.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.483 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.27 -5.07 57.3 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.4 p -117.14 -171.38 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.454 -1.027 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.9 -6.14 16.97 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -47.71 -40.1 19.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.65 -0.912 . . . . 0.0 110.805 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.83 -52.06 65.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.931 -1.105 . . . . 0.0 109.828 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.4 m-85 -60.62 -43.93 96.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.012 -1.055 . . . . 0.0 108.379 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -60.88 -39.76 90.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.517 0.675 . . . . 0.0 110.051 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.89 -47.97 60.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 112.059 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 -51.19 14.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.749 -1.219 . . . . 0.0 111.105 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.49 -42.81 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -56.49 -29.54 61.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.945 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -81.23 -15.4 55.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.066 . . . . 0.0 110.453 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' CB ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -119.84 32.25 6.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.265 -0.897 . . . . 0.0 111.044 -178.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 mt -80.75 146.69 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.653 -1.28 . . . . 0.0 110.929 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.7 tp -132.09 162.63 30.35 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -123.49 146.6 47.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.235 -0.916 . . . . 0.0 110.446 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.703 HE22 HD21 ' A' ' 86' ' ' ASN . 0.6 OUTLIER -107.75 -157.5 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -0.789 . . . . 0.0 109.245 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.717 HD21 ' H ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 1.72 11.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.011 -1.056 . . . . 0.0 112.124 -178.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 4' ' ' GLU . 3.3 ttm180 -102.24 122.02 43.4 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.573 -1.329 . . . . 0.0 110.237 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -56.73 142.97 38.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.258 -0.901 . . . . 0.0 109.999 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.9 mt -81.19 145.55 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 0.0 110.481 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.58 84.43 7.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -60.72 146.06 47.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 110.552 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -101.22 120.15 39.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.72 138.84 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 109.878 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.2 140.0 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.192 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -119.7 -8.63 9.89 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.19 146.17 41.77 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.42 -0.8 . . . . 0.0 109.072 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.52 177.21 8.97 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.219 1.946 . . . . 0.0 113.08 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.4 tt -165.25 144.78 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.622 -0.674 . . . . 0.0 109.574 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -129.03 123.61 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.59 122.1 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.426 ' C ' ' OE1' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.35 132.02 56.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 17.2 t0 -174.21 157.8 2.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.261 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 44.2 mt-10 57.71 19.93 5.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.676 -0.64 . . . . 0.0 110.773 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.04 4.58 88.84 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -114.07 177.63 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 10.1 tt -157.77 161.09 38.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.351 -1.468 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.516 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 18.6 mt -149.8 144.97 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.952 . . . . 0.0 108.492 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -132.4 140.17 48.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.627 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.69 140.86 51.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 108.998 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.56 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 13.8 tm-20 -137.64 126.55 14.81 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.45 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 88.6 Cg_exo -46.39 152.48 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.563 1.509 . . . . 0.0 112.435 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.05 159.57 6.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -91.79 -0.29 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 p -132.85 146.41 51.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.444 -0.785 . . . . 0.0 109.166 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.9 tp -81.38 117.22 21.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.133 -0.979 . . . . 0.0 109.86 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.07 135.1 39.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 67.5 t -135.98 117.65 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.516 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.3 m -107.92 134.15 51.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -121.51 130.6 53.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -112.31 110.55 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.55 152.84 17.53 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.46 96.11 2.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.436 -1.038 . . . . 0.0 109.138 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 3.5 m-85 -98.98 148.72 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.578 -0.701 . . . . 0.0 110.126 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -85.38 -3.72 58.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.484 -0.76 . . . . 0.0 109.864 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.5 p30 -76.93 -167.64 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.915 -1.115 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -58.0 -22.01 47.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.039 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.486 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 19.8 mt -59.38 -54.73 43.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.834 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.13 -111.71 3.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -124.84 137.18 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -1.112 . . . . 0.0 109.076 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -155.32 139.33 16.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.377 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.614 ' CB ' ' HZ3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -127.69 153.73 46.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 109.169 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.496 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 86.4 t80 -135.17 116.88 14.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.0 t -92.47 120.1 32.62 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.157 -0.964 . . . . 0.0 109.376 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.74 138.38 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.561 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -135.77 153.55 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.0 109.45 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -57.22 122.82 13.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.476 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.49 -7.05 20.59 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.14 32.65 4.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -1.14 . . . . 0.0 108.768 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -66.56 -30.64 70.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.797 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -58.53 -13.6 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.015 . . . . 0.0 110.877 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.26 -4.44 54.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.915 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.39 3.75 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.16 -0.963 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.77 -32.64 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.797 -1.189 . . . . 0.0 109.934 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.55 0.17 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.978 -1.076 . . . . 0.0 110.536 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.34 117.42 18.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.798 -1.188 . . . . 0.0 108.29 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.464 HH12 ' C ' ' A' ' 201' ' ' LYS . 11.2 ttm180 -86.08 148.83 25.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 0.0 110.26 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.4 t -62.55 134.9 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 109.012 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.16 179.74 3.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 110.582 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -164.93 161.32 20.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.578 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.2 m-85 -104.52 144.21 31.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -62.64 -19.27 63.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.689 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.587 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -81.44 -31.46 33.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.755 -1.216 . . . . 0.0 110.534 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.587 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 6.4 pt-20 -91.79 -14.96 28.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.836 -1.165 . . . . 0.0 109.513 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.8 mt -57.42 -52.02 62.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 110.372 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -50.64 -52.39 40.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.912 -1.117 . . . . 0.0 109.92 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -45.62 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.914 -1.116 . . . . 0.0 109.166 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.3 -33.43 61.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 109.079 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -80.52 -26.79 37.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -79.43 -21.13 45.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 110.03 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.3 13.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.752 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.82 24.46 67.0 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.788 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.0 mt -123.9 163.5 21.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.118 -1.225 . . . . 0.0 109.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.409 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 77.37 21.92 71.71 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -68.63 -21.31 64.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.83 -1.394 . . . . 0.0 109.735 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.68 -5.37 51.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.08 125.75 38.78 Favored Glycine 0 N--CA 1.49 2.263 0 O-C-N 121.242 -1.152 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.28 165.1 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.713 -0.875 . . . . 0.0 109.314 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.98 -8.06 50.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.504 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.464 ' C ' HH12 ' A' ' 178' ' ' ARG . 23.5 tttp -93.44 -5.61 48.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 53.8 m-20 -143.54 14.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.719 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.8 m -151.65 119.1 6.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.3 tp -80.4 109.81 15.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.133 -0.979 . . . . 0.0 108.893 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.4 t -98.11 128.56 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.9 mt -110.79 148.41 32.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.896 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.27 156.29 16.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 207' ' ' GLY . 1.6 ttpt -42.9 -30.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.912 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.7 13.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.166 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 207' ' ' GLY . 33.1 mttt -139.23 147.26 41.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.037 -1.04 . . . . 0.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.99 127.05 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -72.91 -54.31 9.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 110.061 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.39 132.42 81.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.926 -1.109 . . . . 0.0 109.44 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.4 -11.5 26.62 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.885 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -90.38 -8.72 49.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.969 -1.082 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.24 -167.94 45.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.2 mt -78.62 141.84 37.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.449 -1.03 . . . . 0.0 109.766 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.584 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.1 tpp180 -79.57 -13.06 59.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 34.3 m-85 -148.24 152.79 37.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 108.899 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 11.6 mp0 -59.25 -19.12 43.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 108.423 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 37.25 3.02 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.621 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.5 OUTLIER -59.91 -38.18 57.36 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.605 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.27 -46.45 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.158 1.906 . . . . 0.0 112.295 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.1 m -74.45 -23.99 18.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.776 -1.202 . . . . 0.0 108.25 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 164' ' ' PHE . 44.9 mtt180 -68.24 -43.21 78.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -61.06 -41.76 97.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -57.49 -43.4 84.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.966 -1.083 . . . . 0.0 108.753 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 28.2 t -60.84 -45.14 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.569 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 75.6 t80 -55.87 -40.56 73.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 1.1 m-20 -73.71 -37.8 65.04 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.612 -0.68 . . . . 0.0 109.597 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 28.4 tp -56.23 -34.86 66.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.458 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 61.0 mt -73.28 -47.93 44.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.66 -34.66 21.44 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.482 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 1.0 OUTLIER -81.59 -27.6 34.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -1.196 . . . . 0.0 109.95 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.6 mt -80.46 -20.92 42.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.796 -1.19 . . . . 0.0 109.631 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -73.1 -9.22 58.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.288 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.423 ' C ' ' H ' ' A' ' 239' ' ' GLY . 67.9 mt -53.5 -28.2 29.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 108.879 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 65.4 mt -55.3 -12.21 0.97 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 108.895 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.65 12.26 84.66 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 30.2 p -158.52 147.61 14.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.946 -1.326 . . . . 0.0 109.857 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -42.9 133.78 5.61 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.283 1.988 . . . . 0.0 112.081 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 42.5 t -100.32 129.03 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 109.615 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.92 123.54 47.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.38 -0.825 . . . . 0.0 109.807 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.35 173.08 26.3 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.56 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -103.14 111.93 24.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.189 -1.183 . . . . 0.0 109.463 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.6 m-85 -112.5 148.26 34.81 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.111 0.958 . . . . 0.0 111.456 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 t -131.79 128.13 38.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.86 -1.15 . . . . 0.0 110.043 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.55 ' O ' ' N ' ' A' ' 251' ' ' GLY . 1.6 t80 -109.49 117.88 35.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.538 -0.726 . . . . 0.0 109.16 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 42.83 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 111.03 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -64.03 172.55 15.82 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.595 -1.316 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -138.91 -169.2 11.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -65.66 -52.37 52.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.131 . . . . 0.0 110.008 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.416 ' H ' ' HG ' ' A' ' 254' ' ' SER . 0.2 OUTLIER -53.74 -42.5 68.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 -179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.71 -36.13 67.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.968 -1.082 . . . . 0.0 109.009 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.8 m-20 -63.59 -44.41 94.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 108.605 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 17.0 t -57.12 -45.04 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 108.844 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -55.18 -47.3 75.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.118 -0.989 . . . . 0.0 108.844 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 17.7 tp -53.52 -44.96 69.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.374 -0.828 . . . . 0.0 109.034 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.57 -43.45 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -48.24 77.37 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -68.01 -39.5 83.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.643 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.2 mt -65.0 -44.85 87.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.76 74.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.429 ' HZ1' ' CB ' ' A' ' 265' ' ' LYS . 7.0 mtmp? . . . . . 0 N--CA 1.489 1.509 0 O-C-N 120.764 -1.21 . . . . 0.0 109.302 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 25.5 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.307 0.575 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -119.9 140.09 51.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.595 -0.691 . . . . 0.0 109.412 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 t -139.14 178.5 7.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.23 -0.919 . . . . 0.0 109.085 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -83.59 151.05 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.8 -1.188 . . . . 0.0 109.75 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.31 -37.62 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.475 -0.766 . . . . 0.0 110.063 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.52 157.76 46.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 133.08 54.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.357 0.598 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.1 mt -123.58 159.22 29.68 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -157.26 150.84 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.11 -0.994 . . . . 0.0 110.51 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 169.01 18.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.563 -0.711 . . . . 0.0 109.718 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.69 137.89 21.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.071 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.75 157.26 14.92 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.29 140.29 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.179 -1.189 . . . . 0.0 110.752 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.94 144.09 37.48 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.5 tt -59.63 -49.11 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -1.102 . . . . 0.0 112.459 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.548 ' CD2' ' OE2' ' A' ' 95' ' ' GLU . 9.6 m-70 -86.52 -38.24 17.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.003 -1.685 . . . . 0.0 111.071 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -67.52 -37.81 83.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.71 21.94 71.41 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -119.16 154.43 33.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.724 -0.868 . . . . 0.0 109.009 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -70.88 133.67 46.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.9 t -142.63 157.25 44.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 108.883 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -126.41 160.47 30.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.232 -0.918 . . . . 0.0 110.01 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.474 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 12.1 mt -127.75 142.15 51.39 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.7 mt -137.26 127.21 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 108.838 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.51 121.24 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.732 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -119.34 149.01 46.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.83 160.78 35.42 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.082 1.854 . . . . 0.0 110.732 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 56.7 mm-40 -136.4 -172.51 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.062 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -86.31 153.27 22.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 109.355 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -47.11 143.34 3.17 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 110.291 -179.297 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 60.08 30.5 70.48 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.384 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.458 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 21.5 m -80.96 -35.83 31.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.592 -1.534 . . . . 0.0 108.584 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.757 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 91.67 179.54 42.01 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -95.43 122.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.279 -1.13 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.4 144.81 46.75 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.773 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -102.57 152.73 20.82 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 3.5 t80 -131.45 141.63 49.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 108.912 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -173.4 138.11 0.69 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.372 -0.83 . . . . 0.0 108.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.8 28.79 17.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.158 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.28 27.63 71.34 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 120.783 -1.198 . . . . 0.0 110.168 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.78 137.83 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -1.227 . . . . 0.0 109.956 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -96.63 135.3 38.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.6 mt -128.79 99.25 23.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.82 142.58 18.86 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.62 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.83 84.5 4.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 110.548 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -141.6 157.91 44.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 109.393 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.6 p80 -54.83 -49.14 71.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -44.9 -16.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.13 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.6 m-85 -96.83 5.89 49.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.971 -1.081 . . . . 0.0 109.891 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -60.01 124.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.163 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.86 -30.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -0.877 . . . . 0.0 109.849 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.507 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -153.56 121.95 6.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 0.0 109.475 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -114.07 133.72 55.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.618 -0.676 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.9 t-20 -166.79 -154.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.484 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 12.0 m-70 -48.08 -12.59 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.897 -1.127 . . . . 0.0 108.294 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' ASN . 84.5 p -135.32 165.26 25.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.491 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 6.4 m -106.32 124.13 49.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -0.909 . . . . 0.0 108.998 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.507 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.04 137.74 54.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 111.381 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.73 159.15 35.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 178.17 151.86 9.76 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.379 -1.867 . . . . 0.0 111.667 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -144.94 152.2 39.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.98 -0.718 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.1 mttt 59.62 24.3 13.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.342 -0.849 . . . . 0.0 110.755 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.53 83.09 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.531 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.441 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 20.1 mm100 -109.87 133.4 53.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 108.061 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.79 165.17 27.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.892 -1.13 . . . . 0.0 111.838 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mt -134.77 148.55 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -114.61 150.72 34.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m 55.32 69.32 0.75 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 110.724 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.22 -12.97 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.975 -1.078 . . . . 0.0 109.356 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 3.4 pt-20 -63.2 -18.37 63.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.452 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -71.91 -60.65 2.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.919 -1.113 . . . . 0.0 109.683 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.4 tp -59.78 -43.04 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.994 -1.066 . . . . 0.0 108.953 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 15.0 mt -55.2 -41.26 71.76 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.174 -0.953 . . . . 0.0 109.331 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.9 t -58.48 -47.85 82.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.35 -54.11 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 108.703 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 mt -52.58 -44.94 66.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.586 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 19.7 t-160 -52.88 -54.32 36.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 110.224 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.16 -34.9 78.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.4 mt -79.49 -4.47 51.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 110.598 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.58 54.45 2.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.98 -1.075 . . . . 0.0 110.305 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 84' ' ' ILE . 11.4 mm -96.3 124.57 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 108.467 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.477 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 5.8 p -112.64 -21.31 11.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.315 -0.866 . . . . 0.0 111.631 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.757 HD21 ' H ' ' A' ' 36' ' ' GLY . 10.8 m120 -132.8 112.36 11.88 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.885 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.3 m -165.01 144.56 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.989 . . . . 0.0 109.839 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 64.9 m -112.85 102.86 10.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mp -92.91 117.99 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.872 . . . . 0.0 109.789 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.94 118.22 32.14 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.373 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.55 104.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.865 . . . . 0.0 110.833 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.14 110.7 19.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.83 -162.92 24.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.7 -13.88 12.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -1.06 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.548 ' OE2' ' CD2' ' A' ' 19' ' ' HIS . 40.5 tt0 -142.0 147.51 37.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.101 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -68.76 126.74 93.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 109.764 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -45.59 129.53 11.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.923 1.749 . . . . 0.0 111.887 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.26 -32.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.498 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 9.6 mt 55.12 -104.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.273 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -94.34 -28.32 15.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.195 -0.94 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.87 -3.54 25.83 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.3 p -123.5 -166.23 1.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.421 -1.047 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -2.28 22.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CD2' HD22 ' A' ' 176' ' ' LEU . 59.4 t-105 -48.69 -43.02 36.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.889 -0.771 . . . . 0.0 110.974 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.55 -52.08 64.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.964 -1.085 . . . . 0.0 110.385 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -62.93 -44.04 97.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.931 -1.105 . . . . 0.0 108.722 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 82.3 t80 -63.74 -37.22 86.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.819 -0.551 . . . . 0.0 110.251 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.74 -49.68 29.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 112.014 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.16 -46.76 40.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.808 -1.182 . . . . 0.0 111.056 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -68.69 -42.57 83.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.96 -1.087 . . . . 0.0 110.971 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 15.8 ttp85 -55.74 -27.76 52.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.0 -1.063 . . . . 0.0 110.091 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -84.19 -18.35 36.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.99 -1.069 . . . . 0.0 109.887 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -113.08 29.26 8.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.8 mt -82.26 149.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 0.0 110.28 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -130.66 160.94 32.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.53 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -105.3 137.36 43.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.093 -1.005 . . . . 0.0 109.977 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -102.6 -170.95 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.489 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -124.97 70.71 1.15 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.471 -0.768 . . . . 0.0 110.16 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -160.61 137.78 9.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.046 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 121' ' ' ILE . 43.5 tt0 -48.12 167.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.678 0.751 . . . . 0.0 111.193 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.407 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 69.6 mt -128.59 122.35 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -79.37 71.93 5.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.348 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -55.58 147.05 18.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.081 -1.012 . . . . 0.0 109.414 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -104.83 123.02 46.96 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.5 t -127.92 143.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.849 . . . . 0.0 109.51 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.81 141.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.5 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.23 -7.6 9.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -142.35 144.31 30.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 0.0 109.062 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.13 168.01 25.83 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.185 1.923 . . . . 0.0 113.536 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 tt -159.77 141.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.343 0.592 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.6 mt -131.56 119.96 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.4 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.3 120.44 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -114.55 136.45 53.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.685 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -174.24 150.1 1.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.599 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 57.05 24.09 9.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.0 110.818 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.09 7.68 86.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.403 ' CG ' HH11 ' A' ' 137' ' ' ARG . 2.9 mtt-85 -106.89 170.25 8.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.0 tt -160.44 149.52 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.185 -1.572 . . . . 0.0 109.232 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.499 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 48.9 mt -145.83 135.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 0.0 108.626 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -124.11 140.5 52.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.971 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.58 142.13 50.96 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -139.64 127.89 13.3 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.73 149.1 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.661 1.574 . . . . 0.0 112.417 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.49 155.11 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -1.43 56.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -135.0 148.18 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 109.353 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.1 tp -84.08 118.63 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -137.3 138.85 40.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 54.7 t -135.52 123.35 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.142 -0.974 . . . . 0.0 110.032 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.0 m -109.87 129.34 55.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.239 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -119.17 131.43 55.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 26.6 tt0 -116.21 104.74 11.82 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.59 146.2 18.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.504 ' H ' HH11 ' A' ' 250' ' ' ARG . 1.8 tm-20 -119.59 86.11 2.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.603 -0.94 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 160' ' ' GLY . 11.7 m-85 -91.91 148.17 22.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -96.56 -4.99 40.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.277 -0.889 . . . . 0.0 109.445 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 19.3 p-10 -74.47 -167.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.8 -18.01 28.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.628 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.74 -29.0 62.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 60.82 -121.39 26.43 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -107.67 140.67 40.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -1.048 . . . . 0.0 108.878 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -149.83 157.85 43.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.096 -1.002 . . . . 0.0 109.638 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -149.05 151.76 35.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.608 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -138.3 130.39 28.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.043 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 165' ' ' THR . 14.0 t -102.05 123.43 45.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -99.08 132.73 44.18 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.333 -0.854 . . . . 0.0 108.838 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.5 147.61 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.0 109.195 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 122.13 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.86 16.39 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -117.04 31.41 6.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.27 . . . . 0.0 108.547 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -59.58 -39.02 82.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 110.673 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 2.1 mp0 -52.5 -14.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.057 -1.027 . . . . 0.0 110.944 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.76 -4.05 48.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.818 -1.176 . . . . 0.0 111.153 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.6 pt -121.04 -7.73 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.046 . . . . 0.0 111.033 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.51 -28.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.552 -1.343 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.401 HD22 ' CD2' ' A' ' 104' ' ' TRP . 0.9 OUTLIER -89.46 1.23 56.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.957 -1.089 . . . . 0.0 110.849 -179.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.51 119.42 22.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.738 -1.227 . . . . 0.0 108.888 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -87.28 151.61 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.007 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -53.15 160.42 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.264 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.525 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 33.0 p90 -142.1 169.76 16.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.864 -1.147 . . . . 0.0 109.794 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.525 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -161.04 159.67 29.6 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.184 -0.948 . . . . 0.0 109.898 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.67 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 70.8 m-85 -103.98 146.04 29.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.334 -0.854 . . . . 0.0 109.376 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -18.89 64.54 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.67 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.2 p90 -79.55 -29.92 41.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.541 -1.35 . . . . 0.0 111.119 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.532 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -98.0 -11.67 22.78 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.754 -1.216 . . . . 0.0 109.764 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.1 mt -58.75 -52.59 58.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.15 -0.969 . . . . 0.0 110.008 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.01 -49.82 59.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 109.565 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -53.74 -52.86 58.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.04 -33.99 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.842 . . . . 0.0 109.074 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -75.98 -25.55 55.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.562 ' HZ1' ' CB ' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -76.92 -25.91 53.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.056 -1.028 . . . . 0.0 109.875 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.62 14.98 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.32 26.88 72.61 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.922 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -119.09 157.4 27.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.21 -1.171 . . . . 0.0 109.829 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.27 24.15 64.14 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.382 -0.914 . . . . 0.0 110.956 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.401 ' CB ' ' HZ3' ' A' ' 196' ' ' LYS . 9.9 mtpm? -69.0 -20.88 64.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.669 -1.489 . . . . 0.0 109.014 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.44 -7.41 48.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.2 124.62 32.45 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.21 -1.17 . . . . 0.0 110.218 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.568 ' HG ' ' H ' ' A' ' 201' ' ' LYS . 1.0 OUTLIER -140.83 169.82 16.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.764 -0.845 . . . . 0.0 109.34 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.91 -5.68 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.634 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.568 ' H ' ' HG ' ' A' ' 199' ' ' SER . 2.0 ttpt -89.91 -4.73 57.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -153.09 18.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.445 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 1.7 m -149.59 128.65 12.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.7 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 68.3 tp -91.21 113.29 25.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.4 t -100.79 127.5 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 109.474 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 61.3 mt -104.02 146.88 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 110.192 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.51 161.23 14.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -51.08 -28.11 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.125 -1.22 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -155.07 14.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.833 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -141.22 149.28 41.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.039 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.18 128.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.2 -54.4 9.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.509 HD21 ' H ' ' A' ' 213' ' ' ASN . 1.5 m-80 -53.3 137.27 49.79 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.24 -36.35 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.435 2.09 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -70.11 -4.29 20.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.797 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.84 -161.56 53.94 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.1 mt -83.37 145.01 29.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -1.005 . . . . 0.0 109.889 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.594 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 14.1 ttt85 -80.72 -17.9 49.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 109.454 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 29.7 m-85 -148.79 164.86 33.16 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -72.79 -14.32 61.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.099 -1.0 . . . . 0.0 108.392 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 33.81 2.96 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.714 0.769 . . . . 0.0 108.96 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -55.87 -39.09 74.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.896 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.02 -41.57 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.091 1.861 . . . . 0.0 112.851 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.7 m -78.32 -25.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.716 -1.24 . . . . 0.0 108.231 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.563 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 48.5 mtt180 -66.75 -41.22 88.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -65.1 -42.74 93.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.541 -0.724 . . . . 0.0 109.156 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -56.68 -48.32 77.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.252 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 70.5 t -58.62 -43.91 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.573 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.3 t80 -57.83 -36.98 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.51 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -73.3 -43.12 61.53 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.648 -0.657 . . . . 0.0 109.968 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 26.2 tp -56.19 -34.3 66.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.586 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 34.4 mt -72.76 -48.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.15 -34.65 17.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.65 -27.16 31.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.144 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.9 -23.76 41.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.739 -1.225 . . . . 0.0 110.133 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -72.45 -5.88 39.76 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.031 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 239' ' ' GLY . 33.6 mt -53.32 -27.88 25.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 108.745 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.3 -9.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.168 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.51 11.73 85.2 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.0 p -156.58 149.12 17.95 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.095 -1.238 . . . . 0.0 109.56 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -48.38 138.48 23.68 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.211 1.941 . . . . 0.0 111.785 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.91 136.26 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -124.55 127.78 47.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.433 -0.792 . . . . 0.0 109.62 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.53 177.2 30.41 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.43 112.7 25.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -1.167 . . . . 0.0 109.861 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.6 m-85 -112.59 148.86 33.67 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.031 0.92 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 25.1 t80 -128.24 144.29 51.11 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.6 t -142.46 128.99 20.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.683 -1.261 . . . . 0.0 110.778 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 250' ' ' ARG . 56.8 t80 -111.96 112.94 24.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.504 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.0 OUTLIER 47.36 56.1 7.39 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.39 149.4 23.68 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -121.69 165.33 14.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 91.3 m-70 -59.47 -44.53 92.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.3 m -59.58 -40.94 89.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.641 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.1 tp -72.26 -35.93 68.9 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.049 -1.032 . . . . 0.0 108.711 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -61.88 -46.8 87.83 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.73 -44.73 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.291 -0.88 . . . . 0.0 108.726 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -55.23 -48.28 74.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 108.927 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 26.2 tp -52.97 -43.07 66.1 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 63.4 t -69.83 -44.92 78.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.373 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -52.37 60.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.605 -0.684 . . . . 0.0 110.025 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -62.2 -46.39 89.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.01 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.2 -44.87 92.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.147 -0.971 . . . . 0.0 109.508 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.89 -30.21 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.0 mttt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 120.813 -1.179 . . . . 0.0 108.778 179.169 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 42.1 mt-10 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.6 141.01 52.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.432 -0.793 . . . . 0.0 109.882 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -137.79 172.74 12.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.21 137.86 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.771 -1.206 . . . . 0.0 110.538 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -69.59 -47.97 61.76 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.658 -0.651 . . . . 0.0 109.785 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.93 158.37 38.03 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.626 0.727 . . . . 0.0 110.32 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -60.71 137.25 58.21 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.555 0.693 . . . . 0.0 110.315 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.07 154.63 31.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -146.71 145.1 29.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.879 -1.138 . . . . 0.0 110.126 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.51 160.45 37.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.68 135.91 22.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.911 -1.118 . . . . 0.0 109.004 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.3 158.6 18.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.17 143.06 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -1.231 . . . . 0.0 110.662 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.69 145.13 43.17 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -65.24 -41.91 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.053 -1.263 . . . . 0.0 112.073 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.526 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 3.9 m-70 -87.3 -38.85 15.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.047 -1.658 . . . . 0.0 111.073 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 p -74.21 -32.34 63.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 109.942 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.88 19.57 63.41 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.87 150.24 28.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.958 . . . . 0.0 108.804 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -70.98 135.65 47.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 109.823 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.63 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 13.0 t -143.45 157.88 44.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.211 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 17.0 tttt -132.62 157.07 45.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.2 mt -134.15 145.29 49.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 109.214 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.447 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -130.45 134.46 62.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.56 118.1 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 42.9 m-70 -115.23 150.11 43.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.74 158.13 48.17 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.194 1.929 . . . . 0.0 111.511 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 14.0 mm-40 -133.43 -178.04 4.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.3 tptt -83.47 149.76 26.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.25 149.64 0.98 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.0 109.748 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.687 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 59.08 23.47 57.29 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.141 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.732 ' H ' HD21 ' A' ' 86' ' ' ASN . 6.7 m -80.29 -41.83 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.735 -1.45 . . . . 0.0 109.278 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.64 -166.64 21.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 37' ' ' ILE . 10.3 mm -107.6 121.54 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.348 -1.09 . . . . 0.0 108.219 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.08 143.62 46.74 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.663 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.09 153.24 20.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.29 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.1 t80 -128.77 145.46 51.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HZ3' ' NE2' ' A' ' 67' ' ' GLN . 16.1 tttm -172.96 135.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 109.603 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.64 29.78 14.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.889 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.58 27.93 70.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.7 t -131.62 134.58 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -94.19 140.39 29.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.221 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.9 mt -134.08 94.53 18.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.059 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 145.37 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.294 1.996 . . . . 0.0 111.599 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.67 84.23 4.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.914 -1.116 . . . . 0.0 110.53 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -136.92 152.59 50.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.977 . . . . 0.0 109.582 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 52' ' ' PHE . 10.2 p80 -51.1 -46.81 61.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -48.39 -17.16 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.059 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' HIS . 51.7 m-85 -95.66 3.53 53.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.814 -1.179 . . . . 0.0 109.641 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.42 119.27 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 108.79 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.28 -26.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 110.573 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.59 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -147.97 117.18 6.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.898 -1.126 . . . . 0.0 110.031 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' OG ' ' A' ' 254' ' ' SER . 30.1 p -113.86 125.36 53.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.612 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 t-20 -167.58 -152.41 0.12 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.593 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 9.8 t-80 -44.13 -15.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -140.27 165.37 27.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.449 -0.782 . . . . 0.0 109.119 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.603 ' N ' ' HG ' ' A' ' 59' ' ' SER . 24.1 m -110.23 126.57 54.29 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.18 -0.95 . . . . 0.0 109.102 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.5 OUTLIER -128.12 147.15 50.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.184 0.992 . . . . 0.0 111.777 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.51 157.48 31.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.2 143.52 7.03 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -143.04 147.79 35.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.926 . . . . 0.0 109.44 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp 53.73 45.07 28.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.271 -0.893 . . . . 0.0 110.711 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.2 6.5 65.03 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.65 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.6 mm100 -101.26 140.91 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.973 -1.31 . . . . 0.0 108.39 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -142.84 149.66 38.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.888 -1.132 . . . . 0.0 111.52 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mt -133.7 143.2 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -114.11 152.02 31.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.235 -0.916 . . . . 0.0 111.208 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 53.57 70.04 0.64 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.778 -0.577 . . . . 0.0 111.152 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.84 -8.16 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.958 -1.089 . . . . 0.0 109.653 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.3 pt-20 -69.32 -20.43 63.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 110.518 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.33 -60.76 2.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.043 -1.036 . . . . 0.0 109.732 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -59.5 -43.77 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.072 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 50.1 mt -55.42 -39.4 70.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.554 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 1.7 t -59.71 -47.57 85.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.202 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.05 -54.45 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 108.718 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.56 -44.06 62.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.472 -0.767 . . . . 0.0 109.277 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.489 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 15.8 t-160 -55.38 -58.17 8.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.792 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.6 mt -58.63 -37.71 76.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.972 . . . . 0.0 110.001 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.5 mt -78.12 -7.18 56.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 110.334 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 61.17 53.2 3.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.87 -1.144 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mm -98.03 130.77 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.459 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -117.0 -19.34 9.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.315 -0.866 . . . . 0.0 112.263 -177.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.732 HD21 ' H ' ' A' ' 35' ' ' THR . 1.0 OUTLIER -126.83 111.13 13.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.72 -1.237 . . . . 0.0 110.464 -179.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.66 137.93 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 109.889 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.518 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.5 m -111.01 99.67 8.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mp -89.86 110.36 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -85.99 123.05 30.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.24 115.66 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.999 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 2.5 mp -99.32 108.76 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.54 -163.16 24.69 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.24 -16.05 11.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.491 -1.005 . . . . 0.0 110.143 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 19' ' ' HIS . 15.7 tt0 -138.47 145.33 40.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 110.219 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.5 mm -67.91 127.13 93.33 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.55 -0.719 . . . . 0.0 109.426 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -45.94 128.9 11.82 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.851 1.701 . . . . 0.0 111.953 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.5 tp -77.45 -28.21 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.299 -0.876 . . . . 0.0 109.672 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.436 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 14.4 mt 55.21 -109.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 110.145 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.54 -19.17 20.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.728 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.61 -12.35 25.44 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.439 ' H ' ' HG ' ' A' ' 102' ' ' SER . 1.3 p -116.46 -169.3 1.59 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -1.047 . . . . 0.0 109.707 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -110.59 -4.72 28.27 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.412 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 52.7 t-105 -46.98 -39.52 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.738 -0.86 . . . . 0.0 110.421 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -61.25 -51.47 68.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.0 110.07 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -65.48 -43.58 89.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.053 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 10.8 t80 -63.25 -37.34 86.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 109.565 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.412 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 5.3 mm-40 -65.58 -54.85 22.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 0.0 111.898 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.5 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.732 -1.23 . . . . 0.0 111.135 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.13 -45.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -57.41 -29.69 64.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -80.19 -12.97 59.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.148 -0.97 . . . . 0.0 109.887 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -120.76 34.62 5.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.831 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 mt -87.47 147.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 110.586 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.43 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -88.69 144.05 26.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.533 ' NE2' ' OE2' ' A' ' 33' ' ' GLU . 9.7 mt-30 -107.27 -160.57 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.796 . . . . 0.0 109.207 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -120.44 3.37 10.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.274 -0.891 . . . . 0.0 110.735 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 151.16 19.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.854 -1.154 . . . . 0.0 109.966 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.5 141.06 29.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -0.941 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.31 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.531 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -90.79 93.14 9.1 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.415 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 51.2 m-85 -66.94 146.92 53.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.797 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -104.62 128.7 52.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.39 142.84 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.96 134.07 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -114.72 -10.74 12.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.35 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -143.1 144.06 27.3 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.15 148.76 39.91 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.223 1.949 . . . . 0.0 113.031 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.05 151.59 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.578 -0.701 . . . . 0.0 109.911 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.03 119.76 37.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.321 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.82 117.28 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.03 142.49 35.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.86 . . . . 0.0 108.96 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.85 120.3 3.41 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.605 -1.31 . . . . 0.0 112.298 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 44.97 42.91 6.75 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.0 112.345 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.64 1.94 85.06 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.387 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -102.76 163.88 11.96 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 2.6 tt -160.14 146.49 15.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.357 -1.464 . . . . 0.0 109.276 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.439 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 8.8 mt -145.91 129.7 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.34 139.39 51.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.34 151.57 36.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 108.925 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -150.34 139.52 13.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.0 145.82 97.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.692 1.595 . . . . 0.0 112.14 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.52 153.28 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.1 4.05 32.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.928 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -141.22 151.35 43.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.73 119.04 23.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.858 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -138.69 135.02 34.37 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.4 t -133.26 117.67 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 109.826 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.83 133.87 48.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.198 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -122.42 130.25 52.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.623 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -115.67 106.97 14.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.8 134.66 11.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -108.07 85.01 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -1.075 . . . . 0.0 109.232 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -92.12 144.14 25.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -95.96 -1.22 49.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 109.187 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -71.32 -167.77 0.26 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.237 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -60.96 -23.25 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.5 mt -71.13 -22.78 62.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.166 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.1 -134.17 52.37 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -98.18 144.36 27.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.462 -1.022 . . . . 0.0 109.005 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -152.46 170.5 19.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.35 153.59 23.75 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.832 . . . . 0.0 109.381 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -138.21 130.31 28.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.447 ' O ' ' CG2' ' A' ' 165' ' ' THR . 14.5 t -102.42 123.13 45.63 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 110.052 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -99.13 134.58 41.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.405 -0.809 . . . . 0.0 108.871 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.89 149.59 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -51.04 116.86 2.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.211 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.18 5.51 17.1 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -134.66 29.97 3.49 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.193 -1.18 . . . . 0.0 108.974 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -64.39 -35.17 80.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.568 -0.708 . . . . 0.0 110.854 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.2 -16.98 37.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.979 -1.076 . . . . 0.0 110.766 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -85.48 -3.71 58.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 110.337 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 174' ' ' ILE . 9.9 pt -124.03 -33.86 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.0 111.411 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -29.98 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.479 -1.388 . . . . 0.0 110.424 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -87.48 2.66 49.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.72 -1.238 . . . . 0.0 110.517 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.56 115.19 20.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.873 -1.142 . . . . 0.0 108.957 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -86.48 153.03 22.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.863 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.0 t -59.93 131.35 50.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 109.848 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -109.89 172.62 6.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 109.855 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.566 ' SG ' ' OE2' ' A' ' 185' ' ' GLU . 0.5 OUTLIER -154.78 159.04 40.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.429 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 58.6 m-85 -104.25 144.35 31.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.5 OUTLIER -60.35 -24.36 65.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 110.535 -179.568 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.597 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.5 p90 -82.07 -32.0 30.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.73 -1.231 . . . . 0.0 110.449 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.597 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 18.3 pt-20 -86.55 -16.65 36.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.815 -1.178 . . . . 0.0 109.566 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 11.7 mt -57.57 -53.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.23 -50.74 58.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.775 -1.203 . . . . 0.0 109.738 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -52.73 -48.11 66.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.008 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.9 mt -60.29 -34.31 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.1 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -77.8 -29.37 50.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -21.97 53.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.047 -1.033 . . . . 0.0 110.201 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.1 m -89.15 11.14 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.958 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.04 25.39 69.15 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.773 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.2 mt -124.52 162.98 22.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.119 -1.224 . . . . 0.0 109.87 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.32 22.93 66.67 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.189 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -69.43 -21.04 63.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.652 -1.499 . . . . 0.0 109.779 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.0 -2.91 51.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.33 129.3 40.08 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.199 -1.177 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.01 176.81 8.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.783 -0.834 . . . . 0.0 109.257 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.34 -11.97 57.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.937 . . . . 0.0 109.72 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 14.0 tttm -92.96 -4.73 52.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 201' ' ' LYS . 10.1 m120 -134.06 -13.82 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 109.736 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.9 m -128.35 126.29 40.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.1 tp -84.4 110.33 18.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 108.866 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.59 132.15 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.587 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.14 152.72 32.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.82 161.56 15.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -50.65 -24.67 3.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.97 12.61 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.4 ttpt -144.43 152.5 40.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.115 -0.991 . . . . 0.0 110.228 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.98 127.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -73.46 -54.1 9.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 110.275 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -56.0 133.51 74.01 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.981 -1.074 . . . . 0.0 109.723 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.58 -13.06 27.3 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.37 -7.82 57.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.99 . . . . 0.0 109.89 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -167.24 51.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.7 144.3 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 110.097 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.595 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -79.86 -20.82 45.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 108.793 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 37.1 m-85 -148.53 154.91 40.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.59 -12.97 4.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 108.754 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.682 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -143.73 36.69 1.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.261 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.599 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -59.84 -35.43 28.84 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.0 Cg_exo -70.89 -46.2 0.82 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.87 1.713 . . . . 0.0 112.562 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.8 m -73.87 -22.63 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.804 -1.185 . . . . 0.0 108.195 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.682 ' NH1' ' ND2' ' A' ' 221' ' ' ASN . 5.5 mtt180 -69.88 -40.65 75.55 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.5 -42.9 95.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 108.911 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -45.62 80.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.452 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 81.3 t -61.42 -45.12 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.554 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.4 t80 -53.77 -36.68 62.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -75.02 -40.05 60.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.632 -0.667 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 27.0 tp -56.32 -37.73 70.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.208 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.489 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 85.3 mt -71.6 -48.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.6 -31.86 23.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -82.98 -26.63 31.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.941 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.39 -23.58 43.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.883 -1.136 . . . . 0.0 110.2 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.466 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 7.0 t80 -70.43 -6.43 35.65 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.033 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.3 mt -53.34 -28.76 30.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.18 -18.06 23.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.0 108.73 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.96 70.64 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.5 p -156.29 150.76 20.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.118 -1.225 . . . . 0.0 109.357 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.84 136.48 59.59 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.092 1.862 . . . . 0.0 111.572 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.4 t -102.24 138.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.221 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.415 ' NZ ' ' CD2' ' A' ' 123' ' ' TYR . 8.6 mttp -125.61 128.42 47.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.768 . . . . 0.0 109.078 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.4 175.99 28.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -106.55 109.68 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.172 . . . . 0.0 109.732 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.0 m-85 -111.41 149.3 31.42 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.771 0.796 . . . . 0.0 110.835 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -126.26 144.43 50.79 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.58 125.55 24.3 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 120.751 -1.218 . . . . 0.0 110.232 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 250' ' ' ARG . 26.8 t80 -112.74 111.86 22.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 249' ' ' PHE . 26.5 mtp180 47.54 56.54 6.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.22 149.29 21.93 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.49 -174.6 15.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.43 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 71.1 m-70 -74.45 -42.41 59.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -1.144 . . . . 0.0 109.687 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.416 ' OG ' ' OG1' ' A' ' 56' ' ' THR . 0.2 OUTLIER -64.18 -34.92 79.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.157 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.8 tp -72.76 -39.22 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.927 -1.108 . . . . 0.0 109.059 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -60.58 -50.6 72.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.298 -0.876 . . . . 0.0 108.897 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.23 -45.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -55.29 -48.87 73.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.134 -0.979 . . . . 0.0 109.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 27.0 tp -52.61 -43.76 65.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 108.921 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.96 -40.71 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -59.53 -50.13 75.08 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 110.132 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.0 -43.91 73.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.175 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 30.0 mt -57.35 -48.8 78.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -55.82 -44.27 77.73 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.608 -0.683 . . . . 0.0 109.664 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.5 mttm . . . . . 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 0.0 109.457 -179.865 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 31.0 mt-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 133.9 55.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 110.102 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -138.33 175.42 9.59 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.42 141.18 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.203 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -72.55 -44.24 62.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.51 -0.744 . . . . 0.0 110.055 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.95 160.16 35.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.738 . . . . 0.0 110.225 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 130.31 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.585 -0.697 . . . . 0.0 109.984 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 mt -114.95 169.81 8.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -0.783 . . . . 0.0 108.998 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -157.98 148.15 20.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.956 -1.09 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -129.69 168.0 17.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -154.93 135.05 13.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 109.182 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.79 158.23 15.41 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.502 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 8.9 p -80.95 141.52 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -1.094 . . . . 0.0 110.749 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.68 148.4 41.73 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -70.02 -40.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.0 113.043 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.401 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.0 m-70 -86.04 -38.58 17.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 119.79 -1.819 . . . . 0.0 111.858 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.462 ' OG1' ' CG ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -85.84 -27.21 25.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.713 -1.242 . . . . 0.0 109.157 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 63.79 25.49 69.16 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -106.26 148.96 27.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.506 -0.996 . . . . 0.0 109.182 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -70.78 129.89 40.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.741 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.5 t -138.9 156.98 46.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.915 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -133.22 153.48 51.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 109.206 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mt -127.84 147.66 50.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.428 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.9 mt -137.91 122.41 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -112.13 127.4 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.554 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 2.4 m-70 -119.98 148.8 47.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.94 161.64 15.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.015 1.81 . . . . 0.0 111.096 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 5.7 mm-40 -135.02 -172.27 3.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -90.69 155.41 18.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.738 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.587 ' OE1' ' N ' ' A' ' 33' ' ' GLU . 40.3 mp0 -46.78 142.68 3.2 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.59 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.69 29.89 64.91 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.372 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 25.9 m -80.66 -37.56 30.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.631 -1.511 . . . . 0.0 108.67 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.03 -177.54 35.37 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.6 mm -100.85 124.67 54.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.02 140.09 36.13 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.311 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.11 150.01 20.71 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.487 ' CD1' ' OE1' ' A' ' 90' ' ' GLU . 16.7 t80 -134.36 139.91 45.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.36 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 16.7 ttpt -174.02 147.33 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.642 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.6 29.45 15.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.8 73.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -135.97 143.01 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 0.0 109.352 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -101.45 146.03 28.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.51 94.55 10.56 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.017 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -48.93 145.0 14.24 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.337 2.025 . . . . 0.0 111.854 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.97 81.28 5.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.92 -1.112 . . . . 0.0 110.463 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.68 155.46 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.026 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.2 p80 -52.22 -49.38 64.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.917 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 11.3 mt-10 -44.0 -16.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.197 -0.939 . . . . 0.0 110.164 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.8 m-85 -97.45 2.9 50.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.1 t -62.83 119.37 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.059 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.56 -29.36 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.855 . . . . 0.0 109.986 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 3.0 t-160 -150.82 120.82 7.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.962 . . . . 0.0 109.652 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.2 p -111.94 133.04 54.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 16.1 p-10 -166.61 -153.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' ASN . 5.2 m170 -47.47 -11.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.118 -0.989 . . . . 0.0 108.694 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -139.22 166.49 24.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.5 m -101.38 120.69 40.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.52 134.97 54.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.189 -0.945 . . . . 0.0 111.238 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.6 mt -123.69 156.5 35.8 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.73 145.44 7.96 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.028 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -144.67 151.5 39.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.539 -0.977 . . . . 0.0 109.891 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 55.47 24.02 6.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -0.834 . . . . 0.0 110.894 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.71 1.23 68.36 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.557 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.494 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 29.9 mm100 -96.59 137.46 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.889 -1.36 . . . . 0.0 108.299 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -130.76 144.62 51.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.23 -0.919 . . . . 0.0 111.358 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.2 mt -130.81 140.22 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -114.13 145.64 41.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 56.06 68.82 0.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.785 -0.572 . . . . 0.0 111.46 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.92 -3.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.097 -1.002 . . . . 0.0 108.99 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.491 ' OE1' ' OD1' ' A' ' 234' ' ' ASP . 10.8 pt-20 -69.45 -33.05 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.456 ' CE1' ' CE1' ' A' ' 226' ' ' HIS . 17.6 m170 -61.9 -59.9 4.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 110.099 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.9 tp -55.47 -41.73 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.669 -1.269 . . . . 0.0 108.515 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.403 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 70.3 mt -60.68 -35.05 75.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.478 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 47.1 t -61.04 -49.25 78.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 t -58.52 -52.81 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.03 -1.044 . . . . 0.0 108.594 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.6 mt -50.77 -43.11 58.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 108.999 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.546 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.0 t-160 -54.28 -56.19 20.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.578 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.35 -36.7 76.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.963 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.2 mt -79.31 -9.38 59.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.14 61.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.431 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.485 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 12.2 mm -102.38 132.29 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 48.4 p -118.82 -22.54 7.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.264 -0.897 . . . . 0.0 111.889 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.587 ' ND2' ' OG1' ' A' ' 85' ' ' THR . 1.4 m-80 -129.39 111.69 13.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.279 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.5 m -164.86 135.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.868 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.48 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 44.1 m -103.28 99.66 9.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 mt -86.82 120.94 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.89 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.487 ' OE1' ' CD1' ' A' ' 40' ' ' PHE . 7.8 mt-10 -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.813 -1.179 . . . . 0.0 108.1 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' ' CD ' ' A' ' 41' ' ' LYS . 60.0 t -105.63 107.22 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.101 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.63 109.14 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.58 -160.25 23.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.24 -15.9 7.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -1.008 . . . . 0.0 110.415 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.5 pm0 -131.94 137.6 48.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.22 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mm -68.75 129.6 92.34 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 109.768 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -46.83 129.07 14.13 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.407 2.072 . . . . 0.0 112.782 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.6 tp -76.93 -25.93 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.221 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.448 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 70.6 mt 55.33 -116.07 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.45 -0.781 . . . . 0.0 109.988 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.03 -18.09 22.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.115 -0.991 . . . . 0.0 110.13 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 -16.74 19.1 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.449 ' HG ' ' N ' ' A' ' 103' ' ' GLY . 8.5 p -108.33 -169.72 1.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -1.098 . . . . 0.0 109.516 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.449 ' N ' ' HG ' ' A' ' 102' ' ' SER . . . -114.97 -3.94 21.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.469 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 64.9 t-105 -46.68 -39.18 10.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.785 -0.832 . . . . 0.0 110.418 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.06 -51.75 66.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 109.728 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 62.5 m-85 -62.61 -45.92 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.828 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.01 -37.41 84.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.693 -0.629 . . . . 0.0 110.097 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.1 mm-40 -69.91 -48.81 57.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.313 -0.867 . . . . 0.0 111.773 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.29 -51.27 13.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.793 -1.192 . . . . 0.0 111.273 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.5 mt -62.81 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.984 -1.073 . . . . 0.0 110.875 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.18 -29.89 61.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 0.0 110.194 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.66 -13.59 56.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.064 -1.023 . . . . 0.0 110.08 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -118.0 32.2 6.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.44 -0.787 . . . . 0.0 111.206 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.6 mt -86.57 148.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.534 -1.354 . . . . 0.0 110.029 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.1 tp -131.26 158.17 41.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -103.09 142.01 34.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.62 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -109.08 -167.09 1.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 110.104 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -118.75 69.05 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.407 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 4' ' ' GLU . 23.4 ttt85 -165.78 143.91 5.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -83.84 128.8 34.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.0 mt -71.09 140.69 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.0 86.7 7.15 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -61.83 146.06 50.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 110.769 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.77 121.83 42.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.72 138.63 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.8 t -81.81 139.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.25 -10.57 8.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.441 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -141.12 125.61 10.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.141 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -51.12 154.33 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.007 1.804 . . . . 0.0 113.124 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 tt -145.49 146.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.649 -0.657 . . . . 0.0 109.638 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.55 119.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.66 120.49 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.257 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -123.0 142.07 51.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 110.517 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 1.5 t70 178.03 153.32 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 58.6 mm-40 56.37 23.55 7.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.868 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.05 7.76 86.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -105.16 168.6 8.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 7.0 tt -160.78 152.42 19.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.117 -1.614 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.505 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 17.9 mt -148.78 142.53 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.036 . . . . 0.0 108.74 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -130.0 137.52 50.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 0.0 109.598 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.98 151.67 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -150.05 137.22 11.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.53 144.97 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.189 1.259 . . . . 0.0 111.964 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.29 149.84 10.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.336 -0.852 . . . . 0.0 109.369 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.46 -0.33 52.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.268 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.4 p -133.29 142.77 48.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.4 tp -78.5 119.64 22.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.764 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -139.43 139.58 37.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.862 . . . . 0.0 108.77 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 t -137.86 122.68 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.169 -0.957 . . . . 0.0 109.543 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 99.8 m -111.37 141.11 45.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.951 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -125.56 130.27 51.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.611 -0.68 . . . . 0.0 109.896 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 16.6 tt0 -113.17 107.39 15.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.44 ' C ' ' OE2' ' A' ' 154' ' ' GLU . . . -107.14 131.37 10.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.547 ' H ' HH11 ' A' ' 250' ' ' ARG . 0.9 OUTLIER -117.8 88.25 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -1.004 . . . . 0.0 109.053 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 3.6 m-30 -85.98 148.67 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.112 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -87.25 -10.49 52.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.687 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 17.8 p-10 -66.18 -167.01 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -64.97 -23.08 67.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.403 HD13 HD22 ' A' ' 157' ' ' ASN . 9.3 mt -56.74 -50.45 72.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.997 -1.065 . . . . 0.0 109.188 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.93 -121.78 6.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 140.2 50.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.534 -0.98 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -153.15 131.66 12.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.839 . . . . 0.0 109.467 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 149.67 39.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.544 -0.722 . . . . 0.0 109.163 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -134.83 121.07 20.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.086 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.1 t -100.9 123.1 44.6 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.14 -0.975 . . . . 0.0 110.199 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.0 t80 -100.88 134.43 43.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 108.852 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.469 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.3 t -130.88 149.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.507 -0.746 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.69 122.68 10.38 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.55 -14.95 17.59 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.93 32.3 6.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 108.555 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.76 -34.33 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 110.474 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.9 -15.36 8.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 110.691 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.596 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 13.7 mm-40 -91.07 -4.01 56.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 110.823 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -125.0 10.22 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.945 -1.097 . . . . 0.0 111.199 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -27.99 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.853 -1.154 . . . . 0.0 109.604 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -88.5 3.72 49.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.082 . . . . 0.0 110.638 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.97 123.01 27.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.808 -1.182 . . . . 0.0 109.018 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -95.56 155.42 16.75 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.12 -0.987 . . . . 0.0 110.23 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 t -56.34 155.31 7.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.784 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.526 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 26.4 p90 -139.66 168.29 20.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.047 -1.033 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.526 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -162.7 162.27 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -102.82 147.55 26.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -64.27 -19.53 65.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.933 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.496 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 2.8 p90 -81.79 -26.01 34.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.67 -1.269 . . . . 0.0 110.449 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.415 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 25.9 pt-20 -96.8 -17.29 20.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.926 -1.109 . . . . 0.0 109.36 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 9.5 mt -56.86 -51.41 68.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.47 -0.769 . . . . 0.0 110.326 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -51.21 -52.26 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.995 -1.066 . . . . 0.0 109.553 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.509 ' HD1' ' H ' ' A' ' 188' ' ' HIS . 7.6 m80 -52.94 -45.03 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.107 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.37 -33.71 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 109.025 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -78.82 -25.7 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.894 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -80.73 -26.68 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.06 7.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.721 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 83.76 20.18 60.22 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.139 -0.976 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.63 163.93 20.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.055 -1.262 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.77 17.83 74.28 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.063 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -66.32 -22.18 66.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.695 -1.473 . . . . 0.0 110.279 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.31 -5.87 51.79 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.38 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.47 124.66 35.35 Favored Glycine 0 N--CA 1.491 2.366 0 O-C-N 121.055 -1.262 . . . . 0.0 110.697 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.0 p -135.44 171.94 13.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.718 -0.872 . . . . 0.0 109.204 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.1 mt -76.48 -13.74 60.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 16.9 tttp -89.05 -8.55 53.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.672 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 37.1 m-20 -141.12 12.83 2.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.5 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 8.2 m -148.99 117.75 6.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 109.564 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.3 tp -79.89 115.38 19.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -0.979 . . . . 0.0 109.185 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.3 t -100.61 125.3 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 mt -103.43 147.05 27.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.28 148.4 16.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 207' ' ' GLY . 51.9 mttm -42.32 -29.66 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -1.191 . . . . 0.0 110.045 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -147.34 11.97 1.03 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.0 110.57 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.5 tttp -147.44 156.69 43.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.023 . . . . 0.0 109.998 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.11 128.25 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.5 -54.28 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.46 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -55.02 137.16 66.63 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.002 -1.062 . . . . 0.0 109.577 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.16 -19.04 26.57 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.346 2.031 . . . . 0.0 112.545 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 109.927 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.61 -165.74 53.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 26.5 mt -79.13 145.05 33.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -1.089 . . . . 0.0 109.639 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -71.49 -57.41 4.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 108.877 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.687 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 13.1 m-85 -117.05 148.85 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.462 -0.774 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.09 -13.98 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.933 . . . . 0.0 109.164 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -132.84 38.77 3.37 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.868 0.842 . . . . 0.0 108.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.48 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.6 tp10 -57.34 -48.48 97.27 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 111.265 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 33.3 Cg_endo -69.47 -37.95 9.12 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.525 1.483 . . . . 0.0 113.218 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.8 m -79.39 -25.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.609 -1.307 . . . . 0.0 108.506 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 16.4 mtp180 -67.72 -43.75 79.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.542 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 56.2 t60 -62.86 -41.59 99.44 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -43.23 81.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 108.779 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.8 -47.54 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 42.5 t80 -49.86 -47.54 51.69 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' CD2' ' A' ' 226' ' ' HIS . 2.8 m-20 -70.61 -35.19 72.83 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.435 ' CD2' ' HG ' ' A' ' 248' ' ' SER . 21.1 tp -55.55 -35.97 66.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 108.41 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.15 -48.16 63.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.03 -34.44 16.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.503 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 6.1 m-20 -80.58 -27.08 37.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.993 -1.298 . . . . 0.0 109.665 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -82.54 -26.31 32.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.111 . . . . 0.0 109.593 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.546 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 21.7 t80 -67.14 -7.69 25.32 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.985 . . . . 0.0 108.635 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.3 mt -50.24 -30.05 10.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.79 -19.88 19.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 108.712 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.83 16.29 73.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 83.1 p -158.79 145.16 12.57 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.991 -1.3 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -41.06 129.49 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.343 2.029 . . . . 0.0 111.924 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 81.9 t -97.11 130.51 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.725 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -117.91 123.09 44.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 172.58 24.86 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.26 112.19 25.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.177 -1.19 . . . . 0.0 109.95 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.2 m-85 -112.22 147.58 35.9 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.989 0.9 . . . . 0.0 110.931 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -131.85 134.71 46.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.435 ' HG ' ' CD2' ' A' ' 231' ' ' LEU . 0.2 OUTLIER -129.17 128.9 44.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.86 -1.15 . . . . 0.0 110.218 -178.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 250' ' ' ARG . 6.6 t80 -112.01 115.17 28.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.547 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.2 mmp_? 48.28 56.28 7.64 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.55 152.54 20.88 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -119.49 -169.9 14.37 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.478 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 89.5 m-70 -78.9 -49.59 12.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.256 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -33.93 71.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 42.6 tp -72.89 -40.0 65.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 108.612 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 88.2 m-20 -60.0 -51.24 70.52 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.31 -43.89 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.41 -0.806 . . . . 0.0 109.148 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -54.4 -47.68 72.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.041 . . . . 0.0 108.832 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.12 -46.35 72.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.3 -44.92 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 109.413 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -51.69 -51.71 53.88 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 110.161 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.57 -49.5 76.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.102 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.94 -42.55 98.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.489 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.4 84.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.336 -0.853 . . . . 0.0 109.858 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.9 mttm . . . . . 0 N--CA 1.489 1.516 0 O-C-N 120.944 -1.098 . . . . 0.0 108.755 179.298 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.583 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 132.82 55.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -133.6 174.41 10.46 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.26 132.3 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.343 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -62.32 -49.21 76.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.541 -0.724 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -126.12 155.58 41.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.548 -0.72 . . . . 0.0 110.42 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -59.53 137.57 57.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.957 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.96 162.16 19.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.56 145.68 25.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.979 -1.075 . . . . 0.0 109.971 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' C ' ' OE1' ' A' ' 14' ' ' GLU . 67.3 m-85 -128.96 161.43 29.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.752 . . . . 0.0 109.158 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 13' ' ' PHE . 4.3 pm0 -151.47 132.47 14.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.871 -1.143 . . . . 0.0 108.73 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.01 157.69 15.44 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.015 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.48 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 3.3 p -74.32 160.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -1.133 . . . . 0.0 111.317 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.05 138.69 14.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.101 -1.235 . . . . 0.0 112.236 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.408 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.2 m-70 -86.57 -37.36 18.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.103 -1.623 . . . . 0.0 110.729 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -76.22 -40.11 52.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.012 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 73.42 4.72 65.46 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.41 152.4 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.37 -1.076 . . . . 0.0 108.985 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 16.0 t80 -73.6 133.49 43.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.01 . . . . 0.0 110.141 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.574 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 18.4 t -137.47 157.82 45.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.175 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' N ' ' HG ' ' A' ' 24' ' ' SER . 9.7 ttmt -132.8 155.7 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.305 -0.872 . . . . 0.0 109.136 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mt -132.17 144.19 50.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.4 mt -134.57 123.35 41.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mt -111.73 127.58 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 109.811 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -119.63 152.67 53.63 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.66 157.8 40.38 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.275 1.983 . . . . 0.0 111.474 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.499 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.2 mm-40 -131.84 -173.15 3.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.233 -0.917 . . . . 0.0 109.832 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' OG1' ' A' ' 35' ' ' THR . 9.5 tttt -91.66 153.77 19.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.587 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 28.1 mp0 -47.99 146.25 2.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.03 59.97 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.685 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.552 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 55.2 m -81.59 -36.96 28.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.516 -1.579 . . . . 0.0 108.875 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.483 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 92.47 -170.24 32.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 mm -100.73 124.2 54.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.26 143.17 44.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -104.26 153.25 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.55 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.8 t80 -129.48 140.79 51.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 136.42 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.021 -1.05 . . . . 0.0 109.681 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.57 29.2 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.891 . . . . 0.0 110.097 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.54 78.51 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.218 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.31 134.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -1.117 . . . . 0.0 109.74 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -86.25 147.59 26.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.5 mt -143.1 94.66 6.28 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.82 142.72 14.22 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.191 1.927 . . . . 0.0 111.848 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.54 87.42 4.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.066 -1.021 . . . . 0.0 110.345 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.51 159.24 42.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 109.418 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.6 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 3.3 p80 -53.3 -49.68 66.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -48.28 -16.14 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.048 -1.033 . . . . 0.0 110.224 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' HIS . 32.8 m-85 -97.45 5.77 49.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 109.597 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 t -64.2 122.71 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.861 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 m -112.61 -29.53 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -146.36 118.17 8.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.867 -1.146 . . . . 0.0 110.354 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -110.88 126.97 55.26 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 40.3 t-20 -166.36 -153.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.533 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 63.6 m-70 -46.69 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.053 . . . . 0.0 108.499 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.4 t -139.18 165.84 26.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.499 -0.751 . . . . 0.0 109.327 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.46 ' OG1' ' CD ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -108.82 125.34 51.86 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.89 146.33 49.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.04 0.924 . . . . 0.0 111.397 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.6 mt -125.92 156.33 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -175.36 147.57 8.96 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 118.203 -1.951 . . . . 0.0 111.446 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -144.48 149.5 36.07 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.773 -0.84 . . . . 0.0 109.282 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.99 32.54 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.322 -0.861 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.82 6.82 89.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.614 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.462 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 86.8 mm-40 -106.63 140.17 39.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -1.227 . . . . 0.0 107.886 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -143.22 159.74 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.031 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.26 139.55 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -108.52 148.09 30.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 0.0 111.243 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m 56.53 70.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.691 -0.63 . . . . 0.0 111.16 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.7 -4.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.022 . . . . 0.0 109.169 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.602 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.0 OUTLIER -68.19 -33.15 73.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 0.0 110.838 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.572 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 35.2 m170 -64.13 -60.25 3.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.845 -1.159 . . . . 0.0 109.988 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 11.3 tp -55.92 -45.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.853 -1.155 . . . . 0.0 108.751 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.472 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 47.1 mt -54.71 -40.92 69.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.551 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.608 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.0 t -59.61 -46.92 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -58.52 -50.84 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.2 mt -51.32 -44.13 61.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.845 . . . . 0.0 109.471 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.503 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 12.1 t-160 -56.89 -49.93 74.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 110.363 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.78 -38.02 89.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.58 -5.59 58.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.0 111.025 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 62.74 59.09 1.47 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.299 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 84' ' ' ILE . 10.6 mm -98.24 125.18 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.468 ' H ' ' HG1' ' A' ' 85' ' ' THR . 0.8 OUTLIER -110.97 -23.09 11.17 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.299 -0.876 . . . . 0.0 111.394 -178.042 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 35' ' ' THR . 3.4 m120 -131.19 112.17 12.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -162.01 138.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.326 -0.859 . . . . 0.0 109.404 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 26.5 m -111.17 99.42 8.27 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.75 112.74 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.396 -0.815 . . . . 0.0 109.536 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -90.29 119.83 30.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.2 t -102.84 106.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 110.936 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.417 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.4 mp -86.75 109.79 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.78 -158.65 22.32 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.13 -14.27 7.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.966 . . . . 0.0 110.137 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -134.86 140.18 45.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 110.452 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.35 126.95 93.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.36 128.52 12.39 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.865 1.71 . . . . 0.0 112.003 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 tp -76.24 -22.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.807 . . . . 0.0 109.724 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 73.5 mt 54.84 -118.36 1.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -94.3 -11.03 30.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 110.225 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.04 32.53 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.4 p -115.51 -169.47 1.58 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -1.039 . . . . 0.0 109.785 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.56 0.62 24.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.575 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 67.5 t-105 -46.52 -44.25 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.737 -0.861 . . . . 0.0 110.584 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -60.21 -51.36 69.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.785 -1.197 . . . . 0.0 109.719 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -61.18 -45.64 93.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 109.154 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -60.56 -39.92 89.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.962 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.575 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -74.24 -42.93 58.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 111.43 -179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.9 35.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.871 -1.143 . . . . 0.0 110.883 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.96 -39.57 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.991 -1.068 . . . . 0.0 110.853 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -56.11 -31.42 63.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.801 -1.187 . . . . 0.0 109.745 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -83.97 -5.29 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 0.0 110.221 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -126.62 31.37 5.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.423 -0.798 . . . . 0.0 111.309 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.7 mt -89.2 145.53 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.474 -1.391 . . . . 0.0 109.601 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.6 tp -131.97 158.64 40.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -106.96 145.5 32.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.113 -0.992 . . . . 0.0 109.525 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -112.39 -163.82 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 109.989 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -118.1 69.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 110.438 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.489 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -161.58 140.69 9.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -81.56 126.4 31.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.07 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.7 mt -73.48 143.0 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 110.55 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -92.9 97.26 10.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.7 146.53 52.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.63 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -99.76 123.53 44.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.5 140.88 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.302 -0.874 . . . . 0.0 110.303 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 51.0 t -83.93 137.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.134 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -116.05 -11.55 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.524 -0.735 . . . . 0.0 109.252 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.05 144.92 39.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.12 172.75 14.12 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.266 1.977 . . . . 0.0 112.814 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -165.24 142.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.619 -0.676 . . . . 0.0 109.53 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.1 mt -127.99 126.86 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 109.555 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.29 119.03 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.772 . . . . 0.0 109.679 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -117.42 138.23 51.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.364 -0.835 . . . . 0.0 109.7 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -172.1 142.69 1.44 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.001 -1.062 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 56.1 28.25 12.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.612 -0.68 . . . . 0.0 111.187 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.53 86.95 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 251' ' ' GLY . 6.7 mtt85 -104.68 168.05 9.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -160.66 149.55 16.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.066 -1.646 . . . . 0.0 109.459 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.499 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 56.0 mt -149.39 136.11 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.02 -1.05 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -126.28 142.74 51.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.68 145.63 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -142.78 136.62 14.47 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.94 146.95 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.552 1.501 . . . . 0.0 112.142 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.72 152.76 8.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.171 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.4 1.75 47.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 109.642 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.4 p -137.44 145.21 42.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.584 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.2 tp -79.09 116.81 19.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.938 . . . . 0.0 109.678 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -137.62 135.95 37.06 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 95.8 t -136.85 127.02 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 109.758 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 m -114.13 128.45 56.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.365 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -115.3 129.42 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.52 -0.738 . . . . 0.0 109.365 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -115.27 105.62 13.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.86 132.88 11.39 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -115.37 84.12 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.992 . . . . 0.0 108.977 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 2.9 m-30 -93.14 148.78 21.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.668 ' HZ2' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -85.18 -13.28 50.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.239 -179.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 159' ' ' LEU . 9.4 p-10 -66.18 -175.23 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.054 -1.029 . . . . 0.0 109.633 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -55.02 -18.37 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.696 ' H ' ' ND2' ' A' ' 157' ' ' ASN . 20.4 mt -66.79 -32.31 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.954 -1.091 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.5 -118.08 12.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -115.11 138.95 50.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.987 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -150.14 153.48 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 150.88 41.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -134.84 124.17 24.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 m -96.96 121.9 39.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.98 -1.075 . . . . 0.0 110.015 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -98.81 135.07 40.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.141 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.55 150.7 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 0.0 109.475 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -53.02 117.05 2.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.394 -0.817 . . . . 0.0 109.248 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.51 5.62 18.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -132.19 27.73 4.47 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.212 -1.17 . . . . 0.0 108.57 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.8 mp0 -64.84 -31.44 72.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.533 -0.73 . . . . 0.0 110.572 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.3 -15.82 39.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.993 -1.067 . . . . 0.0 110.907 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -91.52 -4.28 55.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.694 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.64 16.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.088 -1.007 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.48 -34.29 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.021 -1.049 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.7 2.44 45.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.379 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.99 112.96 18.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.788 -1.195 . . . . 0.0 108.94 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 100' ' ' ASP . 5.8 ptp180 -85.9 152.93 22.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.574 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.4 t -53.98 159.02 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.328 -0.857 . . . . 0.0 109.227 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.3 p90 -139.94 168.09 20.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.019 -1.05 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.521 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -156.72 160.0 38.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.15 -0.969 . . . . 0.0 109.749 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.59 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 93.8 m-85 -103.47 146.6 28.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 0.0 109.746 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -59.99 -24.27 64.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.109 -0.994 . . . . 0.0 110.884 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.1 p90 -80.44 -28.78 37.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.748 -1.22 . . . . 0.0 110.682 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 22.4 pt-20 -93.6 -13.84 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.9 mt -59.32 -53.74 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.83 -38.03 54.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.815 -1.178 . . . . 0.0 109.212 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.17 -59.33 5.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.25 -0.906 . . . . 0.0 108.938 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.5 mt -53.76 -33.19 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -75.0 -25.36 58.76 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -83.1 -31.68 27.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.165 -0.96 . . . . 0.0 111.028 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.97 12.54 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.606 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.65 58.32 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.168 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 5.1 mt -127.09 165.34 19.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.063 -1.257 . . . . 0.0 110.16 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.14 23.0 64.34 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.238 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -68.58 -22.32 64.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.599 -1.53 . . . . 0.0 109.504 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -5.65 50.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.31 126.86 36.7 Favored Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.124 -1.221 . . . . 0.0 110.837 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.78 -173.53 3.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.82 -0.812 . . . . 0.0 109.202 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 29.4 mt -90.18 -12.8 37.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.657 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -89.5 -3.47 58.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -145.12 13.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.696 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.433 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 0.8 OUTLIER -149.26 117.48 6.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.609 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.3 tp -79.0 115.72 18.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.68 123.99 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.1 149.21 24.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.89 153.5 17.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -48.35 -24.96 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -1.203 . . . . 0.0 109.891 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.87 13.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 110.208 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 207' ' ' GLY . 13.5 pttt -149.62 159.7 44.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.958 -1.089 . . . . 0.0 109.734 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 46.2 t -107.45 130.39 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.205 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -73.13 -53.04 12.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.492 HD21 ' H ' ' A' ' 213' ' ' ASN . 2.0 m-80 -54.09 139.74 53.89 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 109.557 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.14 -31.71 11.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.476 2.117 . . . . 0.0 112.796 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.43 -9.91 59.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.135 -0.978 . . . . 0.0 110.185 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.33 -164.49 53.83 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.4 mt -73.6 141.59 46.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 0.0 109.847 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 15.8 mtt180 -81.81 -13.87 57.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 108.956 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.558 ' C ' ' H ' ' A' ' 221' ' ' ASN . 38.5 m-85 -147.8 142.25 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -0.782 . . . . 0.0 109.125 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 2.0 mm-40 -49.66 -11.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.038 . . . . 0.0 108.398 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -141.88 43.49 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.073 0.94 . . . . 0.0 108.803 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.1 tt0 -62.89 -36.87 28.45 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 0.0 111.928 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.4 Cg_endo -76.72 -41.07 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.398 1.398 . . . . 0.0 112.521 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.0 m -75.82 -23.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.869 -1.144 . . . . 0.0 108.231 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -70.36 -46.71 63.55 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.574 ' CE1' ' N ' ' A' ' 179' ' ' THR . 22.5 t60 -58.06 -42.4 85.41 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 108.91 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.68 -43.33 94.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.018 -1.052 . . . . 0.0 109.0 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 52.3 t -60.1 -47.03 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 108.745 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.608 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 47.4 t80 -49.79 -45.2 49.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.742 -0.599 . . . . 0.0 109.513 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 5.9 m-20 -73.82 -33.48 64.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 22.4 tp -56.68 -39.17 73.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 0.0 108.679 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.405 HG23 ' HD1' ' A' ' 80' ' ' HIS . 36.1 mt -71.27 -47.97 57.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.07 -32.87 9.63 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -82.28 -26.81 32.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.199 -1.177 . . . . 0.0 109.798 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.22 -23.58 32.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.851 -1.156 . . . . 0.0 109.908 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.503 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 35.0 t80 -73.52 -9.03 58.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -51.16 -25.95 6.07 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 108.589 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.3 -17.81 5.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.61 13.94 74.55 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 71.9 p -158.79 145.93 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.935 -1.332 . . . . 0.0 110.009 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -41.96 135.36 3.8 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.229 1.953 . . . . 0.0 111.655 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.5 t -103.77 132.77 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.9 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -121.05 125.51 47.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.63 179.47 32.56 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -105.37 138.98 40.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.336 -1.097 . . . . 0.0 109.737 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.7 m-85 -140.67 144.59 35.76 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.066 0.936 . . . . 0.0 111.298 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -129.27 144.23 51.15 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 127.84 20.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.643 -1.286 . . . . 0.0 110.745 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -112.83 114.67 27.31 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 51.18 55.67 9.15 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.468 ' O ' ' NE ' ' A' ' 137' ' ' ARG . . . -63.39 -167.74 0.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -169.59 165.52 38.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.602 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 21.2 m-70 -70.91 -52.32 20.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -1.18 . . . . 0.0 109.68 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -54.32 47.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 108.703 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 48.8 tp -51.45 -40.83 60.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -58.57 -55.19 38.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -0.98 . . . . 0.0 108.592 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 61.7 t -48.94 -42.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.517 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -50.0 71.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.8 tp -52.16 -43.2 63.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.684 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 46.2 t -69.83 -46.2 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.364 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.15 -51.5 64.08 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.652 -0.655 . . . . 0.0 110.147 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.62 -45.43 86.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.013 -1.054 . . . . 0.0 109.571 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 16.5 mt -58.69 -46.91 86.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.745 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.16 -30.12 68.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.79 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 120.602 -1.311 . . . . 0.0 108.856 179.485 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.575 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 9.8 mm-40 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -117.34 132.51 56.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 0.0 109.369 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -134.16 173.71 11.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.373 -0.829 . . . . 0.0 109.106 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -81.78 144.36 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.173 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -78.37 -42.36 30.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.711 . . . . 0.0 110.379 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.92 157.82 43.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.494 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -63.39 133.87 54.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.518 -0.739 . . . . 0.0 109.849 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.4 mt -121.04 163.22 18.66 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.441 ' HG ' ' HZ3' ' A' ' 10' ' ' LYS . 2.5 p -155.31 149.38 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 110.319 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -128.84 164.76 22.36 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -148.28 133.04 17.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 108.573 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.38 163.38 23.32 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.74 149.22 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 148.4 39.65 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -67.06 -41.28 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -1.184 . . . . 0.0 112.58 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 4.6 m-70 -86.93 -39.24 15.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.889 -1.757 . . . . 0.0 111.114 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -31.67 64.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.018 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.83 21.22 65.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.96 151.55 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.65 -0.912 . . . . 0.0 109.338 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -72.4 142.96 48.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 2.1 t -148.2 158.52 44.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -133.42 152.85 51.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.009 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mt -127.81 153.71 46.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.37 128.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.28 124.68 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.163 -0.961 . . . . 0.0 109.699 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -123.62 153.53 66.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.86 163.5 35.25 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.177 1.918 . . . . 0.0 111.171 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 30.2 mm-40 -138.81 -171.81 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.9 ttpm? -88.83 150.54 22.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.478 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 15.5 mp0 -49.34 149.91 2.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.537 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 59.69 23.66 58.92 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.431 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 28.9 m -81.8 -46.3 14.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.498 -1.589 . . . . 0.0 109.214 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.507 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 103.19 -170.63 19.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mm -98.9 126.89 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -1.174 . . . . 0.0 107.987 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -139.61 141.13 37.14 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -105.04 155.28 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.4 t80 -130.7 141.76 50.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -170.26 137.03 1.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.091 -1.005 . . . . 0.0 109.838 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.41 31.93 19.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.921 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.38 21.24 74.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.76 133.33 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.999 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -91.11 143.99 26.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.1 mt -137.75 97.69 10.04 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.09 143.16 32.84 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.169 1.913 . . . . 0.0 111.416 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.84 81.34 5.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.877 -1.139 . . . . 0.0 110.396 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -139.29 156.4 47.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.5 p80 -55.07 -50.04 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -44.9 -15.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.001 -1.062 . . . . 0.0 110.192 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' HIS . 65.5 m-85 -99.14 6.12 46.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.98 -1.075 . . . . 0.0 109.629 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 50' ' ' HIS . 31.7 t -58.65 131.66 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 108.844 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.81 -35.16 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.315 -0.866 . . . . 0.0 109.833 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -152.23 123.1 7.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.496 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -113.3 133.14 55.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.627 -0.67 . . . . 0.0 109.311 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.1 p-10 -166.81 -153.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.521 ' N ' ' CG ' ' A' ' 57' ' ' ASN . 55.8 m-70 -47.07 -12.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.055 -1.028 . . . . 0.0 108.623 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -135.02 165.75 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.553 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.3 m -102.51 121.38 42.24 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -118.49 135.39 54.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 111.52 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -124.1 161.05 26.41 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.55 147.32 7.25 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.395 -1.86 . . . . 0.0 111.454 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -144.68 151.21 38.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.572 -0.958 . . . . 0.0 109.407 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 58.77 24.24 12.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.499 -0.751 . . . . 0.0 110.96 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.26 1.31 75.59 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.642 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.488 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.0 mm-40 -103.15 140.15 37.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.006 -1.29 . . . . 0.0 108.394 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.28 157.17 45.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.51 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.6 mt -133.86 143.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -115.06 155.95 26.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.292 -0.88 . . . . 0.0 111.38 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.418 ' H ' ' HG ' ' A' ' 59' ' ' SER . 3.0 m 53.85 65.09 1.61 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.705 -0.622 . . . . 0.0 111.129 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.85 -4.34 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.045 -1.035 . . . . 0.0 109.475 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.581 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 7.1 pt-20 -65.16 -34.69 79.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.879 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -59.28 -60.07 4.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.0 110.207 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.8 tp -58.46 -46.73 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.825 -1.172 . . . . 0.0 109.197 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 10.8 mt -51.97 -42.18 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.019 -1.051 . . . . 0.0 109.566 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.583 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 44.9 t -59.49 -47.45 85.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.191 -0.943 . . . . 0.0 110.02 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.44 -54.08 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.979 -1.075 . . . . 0.0 108.623 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.9 mt -52.2 -45.23 65.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.321 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -53.11 -58.12 8.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.4 mt -59.61 -35.04 73.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.9 mt -83.02 -1.47 52.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.88 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 61.92 26.7 16.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.729 -1.232 . . . . 0.0 110.75 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 mm -73.36 118.89 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 108.313 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.457 ' HG1' ' H ' ' A' ' 86' ' ' ASN . 47.9 p -101.98 -75.41 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 111.135 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.639 HD21 ' N ' ' A' ' 86' ' ' ASN . 1.4 m120 -81.67 113.52 19.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 111.638 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.1 m -163.86 143.35 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.711 . . . . 0.0 109.283 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.518 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 4.0 m -111.15 104.5 13.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.411 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.74 112.9 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -89.33 118.99 29.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.65 108.63 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 111.142 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.3 mp -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.57 -178.99 16.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -99.96 -10.61 21.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.272 . . . . 0.0 110.962 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -139.35 143.99 38.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.736 -1.227 . . . . 0.0 110.639 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.3 131.34 86.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.349 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -46.65 131.43 15.92 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.005 1.804 . . . . 0.0 112.499 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 tp -79.95 -29.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.424 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 88.8 mt 56.18 -116.0 0.97 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 109.702 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.26 -7.48 41.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.89 -9.71 56.83 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 p -111.18 -172.21 1.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -1.024 . . . . 0.0 109.78 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.84 -2.96 20.43 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -46.53 -41.29 14.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.733 -0.863 . . . . 0.0 111.011 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.89 -51.67 67.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.223 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.3 m-85 -62.95 -45.38 92.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.066 -1.021 . . . . 0.0 109.029 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.67 -39.21 87.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.19 -44.8 59.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 111.397 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.73 -48.35 22.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.035 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.08 -42.53 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.083 . . . . 0.0 111.08 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -57.44 -28.21 63.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.027 -1.046 . . . . 0.0 109.982 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -78.81 -14.63 59.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 109.996 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -120.45 34.14 5.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.439 -0.788 . . . . 0.0 110.809 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.0 mt -87.41 148.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.665 -1.272 . . . . 0.0 111.155 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 tp -131.75 165.48 23.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -118.76 142.58 47.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.29 -0.881 . . . . 0.0 109.92 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.27 -161.65 0.88 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.317 -0.864 . . . . 0.0 109.228 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -117.17 0.37 12.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 0.0 110.401 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 4' ' ' GLU . 24.0 ttm-85 -94.73 150.04 20.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -87.57 135.56 33.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 110.015 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.1 mt -77.63 145.53 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.729 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.46 96.41 9.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -69.64 147.13 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.69 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.16 127.06 47.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.36 145.23 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.17 135.29 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -116.44 -11.84 11.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.778 . . . . 0.0 109.162 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -141.36 141.57 23.68 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 108.849 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.96 145.84 46.02 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.958 1.772 . . . . 0.0 113.007 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 tt -138.01 149.11 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.62 -0.675 . . . . 0.0 109.186 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.95 122.94 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 109.915 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.44 124.94 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -123.64 140.6 52.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.602 -0.686 . . . . 0.0 110.286 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.76 154.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.244 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 56.62 22.75 7.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.601 -0.687 . . . . 0.0 110.872 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.442 ' O ' ' NH2' ' A' ' 250' ' ' ARG . . . 77.37 6.63 86.64 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.459 ' CG ' HH11 ' A' ' 137' ' ' ARG . 2.5 mtt85 -107.84 172.09 7.03 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -159.79 153.22 22.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.213 -1.554 . . . . 0.0 109.563 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.493 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 2.2 mt -144.14 143.87 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.57 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -132.51 136.91 46.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.38 146.1 43.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -144.15 137.73 14.3 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 143.83 77.25 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.406 1.404 . . . . 0.0 111.718 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.03 148.05 11.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.235 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -1.28 46.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -134.91 143.91 47.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.0 tp -76.88 118.24 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.001 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -139.42 138.29 36.37 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.4 t -133.94 129.05 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.6 m -115.8 135.85 53.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.346 -0.846 . . . . 0.0 109.309 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -128.84 131.8 47.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -116.86 107.49 14.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.79 124.23 7.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.66 91.58 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -1.066 . . . . 0.0 109.426 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.434 ' HB2' HD22 ' A' ' 157' ' ' ASN . 21.2 m-85 -88.97 148.5 23.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.631 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -95.88 -2.19 47.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.894 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.605 HD21 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -72.98 -173.36 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 109.461 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -59.53 -27.58 66.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.96 . . . . 0.0 109.917 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.6 mt -57.89 -45.01 87.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 108.938 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.67 -135.95 13.36 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -110.03 144.72 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.533 -0.981 . . . . 0.0 109.68 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -151.44 149.2 29.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.73 150.56 52.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.16 142.74 34.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 108.859 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.8 m -124.18 130.32 52.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.858 . . . . 0.0 110.417 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -99.38 130.81 45.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.6 151.3 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 109.168 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.75 115.67 2.29 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.506 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.56 3.28 20.67 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -130.97 29.58 4.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -1.165 . . . . 0.0 108.898 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -62.65 -35.15 78.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 110.699 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -53.39 -14.72 0.82 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.958 -1.089 . . . . 0.0 110.949 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.532 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 23.4 mt-10 -97.4 -4.24 38.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.75 -1.219 . . . . 0.0 111.543 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.8 pt -119.87 12.51 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.879 -1.138 . . . . 0.0 111.614 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.51 -28.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.891 -1.13 . . . . 0.0 109.854 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 2.65 54.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.979 -1.076 . . . . 0.0 111.259 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.41 132.89 35.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.619 -1.3 . . . . 0.0 108.554 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.64 156.55 18.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.151 -0.968 . . . . 0.0 110.626 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.1 t -57.8 156.16 9.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.643 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 49.6 p90 -140.33 166.36 24.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.192 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.533 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -157.12 160.37 38.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.492 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 71.3 m-85 -103.22 144.63 31.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -60.89 -22.91 64.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 0.0 111.7 -178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.4 p90 -75.16 -38.64 60.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.403 . . . . 0.0 111.172 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.689 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -91.58 -10.07 41.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.536 -1.352 . . . . 0.0 110.224 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.2 mt -53.87 -51.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.961 -1.087 . . . . 0.0 109.449 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -52.33 -46.39 66.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 108.726 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.03 -52.85 63.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 72.3 mt -54.53 -33.99 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -78.77 -27.67 44.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.649 . . . . 0.0 109.713 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -73.49 -26.92 61.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.0 . . . . 0.0 109.71 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 m -83.24 10.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.307 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 25.13 74.01 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.539 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.96 156.99 29.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.103 -1.234 . . . . 0.0 109.856 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.95 25.12 56.63 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.368 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -68.69 -21.61 64.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.589 -1.536 . . . . 0.0 109.58 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.79 -6.37 49.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -58.0 130.64 51.31 Favored Glycine 0 N--CA 1.492 2.422 0 O-C-N 121.207 -1.172 . . . . 0.0 110.582 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 203' ' ' THR . 4.5 p -141.88 163.87 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.7 -0.882 . . . . 0.0 109.089 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.4 mt -64.11 -35.09 79.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.986 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -73.25 -17.31 61.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.35 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.4 m-20 -125.53 6.72 7.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.194 -0.941 . . . . 0.0 109.991 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.533 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 24.2 m -148.94 116.22 6.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.702 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 tp -76.11 113.59 13.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.7 t -103.3 126.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.973 -1.079 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 16.2 mt -108.25 141.75 39.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -97.7 135.7 12.33 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 7.5 ttpt -40.02 -21.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -1.069 . . . . 0.0 110.264 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 207' ' ' GLY . 14.9 t0 -141.67 2.28 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.746 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 207' ' ' GLY . 31.0 mttt -149.25 157.5 43.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 0.0 110.576 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.87 126.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -73.52 -55.2 6.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.413 HD21 ' H ' ' A' ' 213' ' ' ASN . 2.5 m-80 -52.75 110.31 1.89 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -54.63 -11.89 3.8 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.752 1.635 . . . . 0.0 111.924 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.26 -6.82 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.783 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.52 -164.09 51.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.5 mt -82.53 143.32 31.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -1.013 . . . . 0.0 110.041 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -89.29 -19.94 24.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.147 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 141.03 33.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 1.6 pm0 -54.59 -16.65 2.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.04 -1.038 . . . . 0.0 108.597 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.3 40.3 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.797 0.808 . . . . 0.0 109.131 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.447 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 10.6 tt0 -56.4 -56.97 26.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 111.606 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 18.4 Cg_endo -59.42 -37.1 91.87 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.995 1.797 . . . . 0.0 113.406 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.38 -28.2 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 120.549 -1.344 . . . . 0.0 108.756 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 173' ' ' GLU . 6.3 mtp-105 -65.32 -41.14 94.31 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.597 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 21.3 t60 -65.35 -41.34 93.98 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -56.47 -43.83 79.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.076 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.16 -49.35 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 109.115 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 44.6 t80 -50.07 -43.4 51.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.668 0.747 . . . . 0.0 109.067 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.597 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.6 m-20 -72.86 -36.37 67.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.484 -0.76 . . . . 0.0 109.842 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 24.1 tp -56.1 -35.73 67.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.943 -1.098 . . . . 0.0 108.507 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.8 -48.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.65 -32.34 10.74 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.485 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 4.9 m-20 -82.71 -26.76 31.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -1.199 . . . . 0.0 109.908 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.22 -22.62 48.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.8 -1.187 . . . . 0.0 110.088 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -71.63 -7.6 48.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 109.217 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 37.7 mt -52.6 -30.51 31.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.955 . . . . 0.0 108.797 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.1 mt -57.95 -15.8 10.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.148 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.33 14.47 78.64 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 p -155.57 150.43 20.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.153 -1.204 . . . . 0.0 109.256 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -53.67 132.46 49.27 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.145 1.896 . . . . 0.0 111.649 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.62 137.76 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.811 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -127.79 131.28 49.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.382 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.31 -177.84 31.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -108.83 111.1 22.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -1.158 . . . . 0.0 109.66 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.9 m-85 -112.13 149.17 32.55 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.019 0.914 . . . . 0.0 111.171 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -130.13 144.31 51.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.1 t -142.42 128.09 19.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.657 -1.277 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -110.43 115.53 29.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.442 ' NH2' ' O ' ' A' ' 136' ' ' GLY . 5.5 mtm180 49.64 56.15 8.29 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.9 141.45 21.72 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -117.19 -179.69 17.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.581 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 38.7 m-70 -73.95 -52.26 13.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.99 -1.3 . . . . 0.0 109.628 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -35.02 70.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 109.292 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.7 tp -73.34 -41.51 63.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 108.735 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.5 m-20 -60.57 -51.36 69.77 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 46.2 t -51.51 -43.75 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 0.0 109.03 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -55.45 -47.84 75.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.969 -1.082 . . . . 0.0 109.136 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.44 -50.29 62.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.08 -53.77 42.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.716 0.77 . . . . 0.0 109.329 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -46.77 -51.18 16.89 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.694 -0.629 . . . . 0.0 110.314 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.99 -35.62 79.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.7 -1.25 . . . . 0.0 109.89 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.8 -42.92 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.862 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -77.96 -28.02 49.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 110.082 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.6 mttt . . . . . 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 108.921 179.394 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 64.2 mt-10 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -119.94 142.63 48.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -141.86 171.81 13.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.48 -0.762 . . . . 0.0 109.058 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 m -81.68 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.946 -1.096 . . . . 0.0 110.229 -179.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -46.81 63.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 10' ' ' LYS . 1.8 tm-20 -128.66 159.05 36.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.44 -0.787 . . . . 0.0 110.571 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.578 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 5.3 ttpp -59.89 133.94 56.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.6 mt -121.04 160.75 22.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -157.02 149.55 23.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.944 -1.098 . . . . 0.0 110.558 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -129.53 166.38 19.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.02 133.58 11.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.891 -1.13 . . . . 0.0 108.74 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.32 156.64 12.68 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.09 159.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 111.218 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.9 140.61 15.12 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 197' ' ' GLY . 4.4 tt -58.66 -50.53 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.128 -1.219 . . . . 0.0 111.972 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.413 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 18.4 m-70 -86.13 -38.85 17.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.312 -1.492 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.0 p -72.72 -36.54 67.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 110.157 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.57 68.21 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -116.19 153.94 30.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.589 -0.948 . . . . 0.0 108.736 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 25.5 t80 -71.05 129.34 38.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.072 -1.017 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 t -132.14 157.8 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 108.945 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -135.01 152.7 51.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.221 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.14 148.07 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.439 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.6 mt -135.05 129.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.227 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.2 mt -115.03 125.73 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 109.891 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.502 ' CE1' ' CD ' ' A' ' 10' ' ' LYS . 18.8 m-70 -124.23 149.5 60.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.62 160.73 31.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.181 1.921 . . . . 0.0 111.247 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.1 mm-40 -134.3 -179.21 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.762 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 35' ' ' THR . 22.0 tptt -79.97 147.87 31.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -48.32 150.89 1.16 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 -179.701 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.475 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 60.9 20.36 57.34 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.24 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 23.9 m -80.89 -46.01 15.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.611 -1.523 . . . . 0.0 109.053 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.44 -167.19 16.47 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mm -102.53 124.11 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.336 -1.096 . . . . 0.0 108.147 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.07 153.17 49.33 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.8 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CD1' ' HB ' ' A' ' 89' ' ' ILE . 42.4 m-85 -114.64 154.4 28.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.8 t80 -130.83 138.78 50.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.011 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -168.87 138.14 2.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 60.36 28.63 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.929 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.91 30.61 70.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.27 131.11 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.884 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.65 144.5 29.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 108.947 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -140.86 99.16 6.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.398 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.67 145.56 48.28 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.135 1.89 . . . . 0.0 111.324 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.25 86.85 4.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.781 -1.199 . . . . 0.0 110.511 -178.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -138.62 154.59 48.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 0.0 109.391 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -52.1 -45.94 65.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.795 . . . . 0.0 110.262 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -48.27 -30.94 5.28 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.231 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -82.44 4.48 24.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -61.79 128.1 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 108.74 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.34 -30.3 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.23 -0.919 . . . . 0.0 110.487 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -153.61 122.26 6.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.92 -1.113 . . . . 0.0 109.566 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 p -113.67 131.73 56.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.639 -0.663 . . . . 0.0 109.286 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.589 ' CG ' ' H ' ' A' ' 58' ' ' HIS . 43.8 t-20 -167.29 -154.0 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.589 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 73.3 m-70 -45.53 -15.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.106 -0.996 . . . . 0.0 108.643 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.8 t -134.04 165.33 25.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.56 -0.712 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.5 m -103.22 122.06 43.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 108.724 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -120.34 138.42 53.73 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.092 0.948 . . . . 0.0 111.487 -178.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.5 mt -120.19 163.83 17.14 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.8 142.75 5.21 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 118.453 -1.832 . . . . 0.0 111.159 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -144.86 150.35 36.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.856 . . . . 0.0 109.281 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? 55.4 35.92 26.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 110.749 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.14 2.25 88.75 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.493 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.6 mm100 -98.44 144.23 28.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.254 . . . . 0.0 108.44 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -142.11 147.43 36.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.022 -1.049 . . . . 0.0 111.331 -178.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.12 143.1 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -114.08 152.47 31.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.003 -1.06 . . . . 0.0 111.013 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 53.21 66.22 1.29 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.694 -0.629 . . . . 0.0 110.734 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 m -113.48 -3.65 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.004 . . . . 0.0 109.132 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -70.37 -28.24 64.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.497 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 25.0 m170 -66.77 -59.85 3.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.058 -1.026 . . . . 0.0 109.767 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.5 tp -57.75 -45.03 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.845 -1.159 . . . . 0.0 108.764 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.478 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 67.9 mt -57.01 -40.99 77.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 0.0 109.807 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.586 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.6 t -58.35 -47.86 82.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 109.476 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.07 -54.33 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 108.542 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.3 mt -52.14 -45.17 64.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.483 ' ND1' ' CG2' ' A' ' 232' ' ' ILE . 20.3 t-160 -55.99 -58.55 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.566 -0.709 . . . . 0.0 110.066 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.23 -37.02 74.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.3 mt -77.79 -4.78 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 0.0 110.21 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.88 34.55 14.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.424 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.2 mm -80.4 127.0 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 86' ' ' ASN . 5.9 p -105.17 -77.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 111.456 -177.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 85' ' ' THR . 10.9 m-80 -81.38 113.89 19.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.403 -176.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.8 m -162.82 139.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.483 -0.76 . . . . 0.0 109.622 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 30.8 m -109.15 104.46 13.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 2.5 mp -94.16 105.59 17.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 0.0 109.807 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.92 120.32 25.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 108.49 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 t -102.42 110.25 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 111.114 -178.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.49 107.67 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.18 -162.75 24.31 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -114.06 -16.21 12.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -1.045 . . . . 0.0 110.332 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -142.07 147.45 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.54 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.1 mm -69.28 128.74 92.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.77 131.4 13.16 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.838 1.692 . . . . 0.0 111.845 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -77.88 -24.84 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.554 -0.716 . . . . 0.0 110.558 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.5 mt 55.43 -119.17 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 57.6 t0 -94.52 -9.46 35.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.494 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.77 -4.88 32.45 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.4 p -118.47 -173.54 2.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -1.05 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 -3.97 20.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -46.67 -36.57 7.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.775 -0.838 . . . . 0.0 110.932 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 2.7 mp0 -63.0 -52.0 64.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.864 -1.148 . . . . 0.0 110.268 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -62.23 -45.02 95.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.07 . . . . 0.0 108.874 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.44 -40.47 86.91 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.496 0.665 . . . . 0.0 109.625 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -72.8 -43.69 62.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 111.733 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.48 -49.66 15.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 111.075 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.34 -41.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -59.02 -28.48 66.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.946 -1.096 . . . . 0.0 110.122 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -78.28 -17.96 55.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.67 34.5 5.18 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.467 -0.771 . . . . 0.0 110.731 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 114' ' ' ILE . 9.5 mt -82.92 148.07 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.303 . . . . 0.0 110.526 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.1 tp -130.67 151.99 50.51 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.603 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -100.39 136.43 40.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.028 -1.045 . . . . 0.0 109.698 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.578 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 18.9 mt-30 -102.63 -166.45 1.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -120.89 72.26 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.416 -0.802 . . . . 0.0 110.923 -179.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -166.17 145.11 5.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.64 128.88 34.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.149 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.79 139.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.28 72.83 4.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -51.5 142.54 13.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.528 -0.732 . . . . 0.0 110.097 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -103.82 124.09 48.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.87 142.77 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 0.0 109.954 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.8 t -81.27 134.68 26.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -117.26 -11.77 10.59 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -139.74 141.66 28.62 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.412 -0.805 . . . . 0.0 108.916 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.26 169.73 20.0 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.162 1.908 . . . . 0.0 113.029 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 tt -163.67 143.48 2.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.469 0.652 . . . . 0.0 109.618 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.23 121.09 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.29 112.38 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.73 125.84 53.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -173.34 157.86 3.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 0.0 110.652 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.455 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 27.1 mt-10 56.63 18.74 3.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 110.771 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.67 -0.22 89.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER -102.88 172.28 6.92 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 4.8 tt -160.24 145.82 15.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.441 -1.412 . . . . 0.0 108.669 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.456 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 59.3 mt -147.92 134.81 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 108.394 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -124.05 144.16 50.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.71 148.81 44.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -148.82 138.72 12.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.14 146.17 60.99 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.462 1.441 . . . . 0.0 112.129 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.14 147.94 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.49 -1.4 37.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.471 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.7 p -136.92 159.36 42.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 109.304 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.539 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 27.0 tp -88.34 121.0 30.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 0.0 109.748 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -138.65 135.15 34.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 73.4 t -137.19 118.5 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.9 m -106.31 136.51 45.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.752 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -123.67 128.32 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.469 -0.769 . . . . 0.0 109.488 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' CD ' ' CE2' ' A' ' 249' ' ' PHE . 7.2 tt0 -115.16 104.66 12.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.41 126.68 8.98 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -110.93 84.98 2.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -1.08 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 2.3 m-30 -90.38 148.97 22.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.132 -0.98 . . . . 0.0 109.407 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -91.83 -5.81 52.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.856 . . . . 0.0 110.739 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -68.44 -167.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.725 -1.234 . . . . 0.0 109.435 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.8 p90 -59.94 -26.67 66.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.994 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.92 -51.59 69.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 108.812 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.63 -119.17 5.43 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.94 143.12 51.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.622 -0.928 . . . . 0.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -156.09 146.64 21.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.429 -0.794 . . . . 0.0 109.557 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -126.29 150.83 48.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.0 109.673 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -135.09 118.77 17.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.9 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -94.9 121.82 36.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.043 . . . . 0.0 109.735 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 4.2 t80 -99.73 139.18 35.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.356 -0.84 . . . . 0.0 109.486 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.555 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.7 t -138.94 153.06 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.39 -0.819 . . . . 0.0 109.152 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 98.4 mt-10 -53.58 120.43 6.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.597 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.41 6.68 17.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.48 28.67 1.81 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.159 -1.201 . . . . 0.0 108.671 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -63.93 -35.99 82.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 110.4 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.96 -12.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.168 -0.957 . . . . 0.0 110.517 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -90.9 -4.52 56.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.052 -1.03 . . . . 0.0 110.536 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 174' ' ' ILE . 2.8 pt -120.55 -7.13 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.164 -0.96 . . . . 0.0 110.772 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.13 -29.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.574 -1.328 . . . . 0.0 110.011 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.9 mt -90.03 -1.34 57.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.833 -1.167 . . . . 0.0 110.736 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.58 118.18 20.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.706 -1.246 . . . . 0.0 108.374 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.55 153.01 21.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.0 110.296 -179.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.514 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 6.2 t -53.47 158.63 1.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 0.0 109.773 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.545 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 23.3 p90 -143.32 169.44 17.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.635 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -162.09 167.95 23.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 -179.785 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.502 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 86.8 m-85 -104.21 145.08 30.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 109.203 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 51.3 p30 -63.34 -23.49 67.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.277 -0.89 . . . . 0.0 111.426 -178.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.52 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 p90 -79.33 -27.32 42.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.585 -1.322 . . . . 0.0 111.009 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.485 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 26.0 pt-20 -96.45 -13.76 22.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.688 -1.258 . . . . 0.0 109.872 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.56 -51.65 55.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -52.43 -44.5 65.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.668 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -57.6 -51.5 69.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.943 . . . . 0.0 109.41 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.45 -34.31 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.134 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -74.43 -27.09 60.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 110.144 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 193' ' ' GLY . 11.6 mttm -74.8 -33.51 62.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.018 -1.051 . . . . 0.0 109.921 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.42 12.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 109.226 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 74.43 25.35 70.66 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.556 179.001 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 86.5 mt -117.83 155.08 30.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -1.192 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.2 27.81 47.44 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.29 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -68.36 -22.46 64.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.667 -1.49 . . . . 0.0 108.929 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -103.14 -4.92 47.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.65 126.0 29.29 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 121.323 -1.104 . . . . 0.0 110.956 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.18 39.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.858 -0.789 . . . . 0.0 109.074 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.61 -13.32 1.55 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.792 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -83.46 -2.22 55.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.06 -1.025 . . . . 0.0 109.423 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -151.18 17.67 0.75 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 108.826 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.635 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 87.4 m -151.89 115.16 4.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.504 -0.747 . . . . 0.0 109.33 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.6 tp -76.57 109.76 10.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.208 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.17 131.36 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 109.941 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.5 mt -114.28 144.83 42.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.536 -0.728 . . . . 0.0 109.35 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.94 151.07 19.14 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 207' ' ' GLY . 25.7 tttt -41.42 -28.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 110.162 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 209' ' ' ASP . 1.8 p30 -146.4 8.15 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.929 -1.107 . . . . 0.0 110.399 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.6 tttt -141.93 150.61 41.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.832 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.21 127.45 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -70.66 -54.43 11.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.201 -0.937 . . . . 0.0 110.019 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.97 132.86 80.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.05 . . . . 0.0 109.462 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.85 -19.4 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.322 2.015 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.81 -6.04 58.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.669 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.84 -169.29 52.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.53 147.16 42.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.387 -1.066 . . . . 0.0 109.568 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -74.76 -62.64 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 108.848 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 221' ' ' ASN . 11.5 m-85 -117.9 142.78 46.95 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 219' ' ' TYR . 8.6 m-20 -137.7 30.41 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.483 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -60.25 -40.04 73.6 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 16.0 Cg_exo -65.22 -49.6 2.56 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.35 2.034 . . . . 0.0 112.647 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 2.5 m -73.17 -22.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.922 -1.111 . . . . 0.0 108.628 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -70.93 -46.11 63.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.514 ' CE1' ' N ' ' A' ' 179' ' ' THR . 26.0 t60 -58.69 -38.45 78.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.534 ' HZ2' ' CE1' ' A' ' 253' ' ' HIS . 0.7 OUTLIER -62.8 -42.14 99.59 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.11 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.34 -38.9 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.586 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 48.7 t80 -56.48 -51.74 67.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.732 -0.605 . . . . 0.0 109.704 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.497 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 8.2 m-20 -70.14 -30.14 67.24 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.174 -0.954 . . . . 0.0 109.515 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.1 tp -56.56 -37.6 70.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.483 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 66.0 mt -73.01 -48.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.64 8.33 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.35 -29.62 30.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.728 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.8 mt -79.16 -22.41 45.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.725 -1.234 . . . . 0.0 109.253 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.406 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.2 t80 -70.09 -8.96 53.74 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.1 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.3 mt -52.67 -27.93 19.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 108.818 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.6 mt -55.28 -18.47 6.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.021 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.86 12.54 77.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.0 p -158.51 147.6 14.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.139 -1.212 . . . . 0.0 109.551 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -42.99 135.18 5.42 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.344 2.029 . . . . 0.0 111.975 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.7 t -101.75 133.08 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.702 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -122.11 126.81 49.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.581 -0.699 . . . . 0.0 109.261 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 176.61 29.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -107.07 110.21 22.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -1.231 . . . . 0.0 109.833 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.7 m-85 -112.06 147.43 36.02 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.834 0.826 . . . . 0.0 111.038 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -127.42 144.1 51.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.4 m -134.84 128.11 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.704 -1.248 . . . . 0.0 110.679 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.497 ' CE2' ' CD ' ' A' ' 152' ' ' GLU . 3.0 t80 -112.44 110.58 20.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 6.5 mmm180 47.34 55.75 7.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -178.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.27 142.09 23.71 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -178.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -110.63 159.63 13.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.534 ' CE1' ' HZ2' ' A' ' 227' ' ' LYS . 76.8 m-70 -56.07 -48.93 75.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.241 . . . . 0.0 109.534 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 25.3 p -57.21 -55.16 38.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.192 -0.943 . . . . 0.0 109.106 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.5 tp -52.07 -37.29 53.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 4.4 m120 -58.22 -55.7 31.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.093 -1.004 . . . . 0.0 108.855 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.61 -43.1 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.494 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -49.52 71.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.5 tp -52.71 -41.24 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 74.2 t -71.97 -50.43 37.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.76 0.791 . . . . 0.0 109.507 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -49.81 -45.06 49.6 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.641 -0.662 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -42.79 70.36 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.479 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 36.3 mt -62.05 -43.61 98.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.552 -0.718 . . . . 0.0 110.344 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 22.6 mttm . . . . . 0 N--CA 1.49 1.56 0 O-C-N 120.625 -1.297 . . . . 0.0 108.453 178.992 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.424 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 21.7 mm-40 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -121.08 139.64 53.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -141.23 177.84 7.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.28 135.18 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 109.815 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -65.66 -45.51 82.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.766 . . . . 0.0 110.322 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.73 157.38 41.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.46 133.66 52.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.11 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.5 mt -118.24 160.14 22.12 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 p -158.1 150.44 22.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.101 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -132.42 174.88 9.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.628 -0.67 . . . . 0.0 109.707 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -150.46 135.51 17.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 108.589 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.76 156.09 12.87 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.901 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.93 142.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -1.083 . . . . 0.0 110.91 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.24 142.9 36.63 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.0 tt -60.06 -48.01 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -1.145 . . . . 0.0 112.472 -178.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.434 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 9.6 m-70 -86.88 -37.93 17.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.229 -1.544 . . . . 0.0 111.462 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -68.13 -35.1 77.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 0.0 110.135 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.9 71.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -118.92 154.81 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 109.242 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -68.4 140.18 55.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.593 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 3.9 t -147.42 157.08 43.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.041 . . . . 0.0 108.766 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.593 ' N ' ' HG ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -127.58 161.98 27.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.192 -0.942 . . . . 0.0 110.014 -179.236 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.497 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 12.9 mt -130.94 143.65 50.88 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.29 127.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.312 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mt -113.45 125.0 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 109.403 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -121.47 142.71 36.1 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.545 -0.722 . . . . 0.0 109.356 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -53.87 160.07 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.544 1.496 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 76.7 mt-10 -134.77 -178.75 5.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.495 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.3 ttmm -85.91 151.44 23.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.592 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -49.81 147.31 3.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 110.447 -179.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.76 21.84 58.89 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.551 -0.718 . . . . 0.0 111.884 178.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 98.5 m -81.19 -46.51 14.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.45 -1.618 . . . . 0.0 109.027 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.701 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 105.45 -168.2 15.29 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mm -101.63 124.66 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -1.112 . . . . 0.0 108.036 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.16 139.55 30.41 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.765 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -97.16 154.33 17.43 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.555 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.6 t80 -129.47 139.94 51.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.684 ' NZ ' ' NE2' ' A' ' 67' ' ' GLN . 46.3 tttm -168.08 137.76 2.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 -179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.435 HD21 ' HZ2' ' A' ' 41' ' ' LYS . 0.8 OUTLIER 59.14 29.18 18.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 0.0 110.102 179.683 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.01 28.36 70.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.8 t -134.08 138.27 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 109.852 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -92.14 142.45 27.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.19 179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -137.42 95.13 11.65 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.439 -179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -48.27 144.97 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.212 1.941 . . . . 0.0 111.652 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.89 84.61 4.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.542 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -141.16 157.02 45.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.008 -1.058 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.1 p80 -52.92 -50.12 64.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -46.55 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 0.0 109.999 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.7 m-85 -99.67 4.81 45.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.463 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.38 132.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 108.773 179.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -118.09 -33.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.7 t-160 -147.61 118.6 7.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 110.037 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.2 p -112.66 126.37 55.3 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.7 t-20 -167.06 -152.76 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.584 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 10.7 m-70 -44.21 -16.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 108.586 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.1 t -137.19 165.5 25.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.495 -0.753 . . . . 0.0 109.368 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 m -109.24 125.36 52.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.368 -0.832 . . . . 0.0 108.831 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 1.4 m-20 -125.59 148.02 49.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.994 0.902 . . . . 0.0 111.162 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.1 mt -125.78 161.12 28.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.99 143.59 6.37 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.541 -1.79 . . . . 0.0 110.985 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -144.81 151.85 39.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.629 -0.924 . . . . 0.0 109.72 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.81 29.74 12.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.386 -0.821 . . . . 0.0 110.599 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.52 0.54 86.32 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.569 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.684 ' NE2' ' NZ ' ' A' ' 41' ' ' LYS . 15.9 mm100 -97.01 145.44 25.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.307 . . . . 0.0 108.373 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -143.35 149.58 37.95 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.658 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -132.93 143.17 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -114.05 149.71 35.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.124 -0.985 . . . . 0.0 111.611 -178.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.8 m 53.87 71.6 0.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.716 -0.615 . . . . 0.0 111.054 178.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -112.81 -5.83 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 179.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.41 -23.87 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -68.98 -60.88 2.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.996 -1.065 . . . . 0.0 109.723 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.508 ' CD1' ' CG ' ' A' ' 106' ' ' PHE . 11.1 tp -59.63 -45.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 88.3 mt -54.69 -40.77 69.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 0.0 109.68 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.591 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.47 -47.93 83.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.086 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.19 -55.23 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.011 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 mt -52.47 -43.38 64.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.489 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 15.8 t-160 -55.53 -58.08 9.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.127 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.486 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 57.5 mt -55.79 -36.66 67.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.267 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.89 -4.31 51.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 110.461 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER 62.77 38.46 11.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.866 -1.146 . . . . 0.0 110.51 179.628 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.4 mm -83.31 129.74 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.9 p -107.04 -76.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.235 -0.916 . . . . 0.0 111.129 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.701 HD21 ' H ' ' A' ' 36' ' ' GLY . 2.4 m120 -81.22 113.96 19.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -176.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.05 141.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 109.623 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.551 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -109.01 103.84 12.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.488 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.68 106.03 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.87 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.68 122.01 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.075 -1.016 . . . . 0.0 108.936 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -102.96 104.92 17.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.454 -0.779 . . . . 0.0 110.422 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.03 110.84 20.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.176 -0.953 . . . . 0.0 108.582 178.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.32 -179.23 16.38 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -15.32 22.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.138 . . . . 0.0 110.349 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.4 tt0 -136.07 142.7 44.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.986 -1.071 . . . . 0.0 110.272 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mm -68.26 128.41 93.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.765 . . . . 0.0 109.654 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -45.72 127.39 9.89 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.822 1.681 . . . . 0.0 111.834 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 tp -80.1 -22.44 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.76 . . . . 0.0 110.354 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.8 mt 55.72 -118.08 1.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.854 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -94.78 -9.7 33.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.15 -0.968 . . . . 0.0 110.43 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.68 39.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.3 p -115.42 -174.55 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -1.021 . . . . 0.0 109.368 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.23 -6.96 17.55 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.547 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 72.5 t-105 -46.61 -35.21 5.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.678 -0.896 . . . . 0.0 110.09 -179.559 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.24 -51.52 68.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.906 -1.121 . . . . 0.0 109.968 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CG ' ' CD1' ' A' ' 75' ' ' ILE . 63.1 m-85 -65.03 -44.62 88.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.077 -1.014 . . . . 0.0 108.944 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -61.91 -37.81 86.03 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.456 0.646 . . . . 0.0 109.572 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.547 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 24.4 mm-40 -65.38 -52.75 51.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.685 . . . . 0.0 111.595 -178.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.33 -52.24 9.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.216 . . . . 0.0 110.693 -178.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 92.8 mt -50.71 -47.81 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.78 -1.2 . . . . 0.0 110.477 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -57.89 -31.3 66.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -83.78 13.51 4.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -149.46 30.68 0.75 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.0 mt -85.02 147.12 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.949 -1.094 . . . . 0.0 110.426 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.0 tp -131.7 155.69 47.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.488 -0.757 . . . . 0.0 109.161 179.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.8 OUTLIER -110.42 128.2 55.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 179.725 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.498 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -97.02 -165.73 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 118' ' ' ASN . 48.6 p30 -124.77 74.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 110.301 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -161.73 139.93 9.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.057 179.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -47.3 167.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 110.191 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 123' ' ' TYR . 25.4 mt -126.12 104.23 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.94 71.28 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.429 -0.794 . . . . 0.0 110.154 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.577 ' N ' ' O ' ' A' ' 121' ' ' ILE . 93.8 m-85 -57.4 147.18 26.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -104.71 123.65 47.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.4 t -129.2 143.43 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.991 -179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.46 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -113.23 -11.8 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.254 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -141.32 144.71 35.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.8 172.29 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.054 1.836 . . . . 0.0 113.003 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.9 tt -165.92 145.53 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.348 0.594 . . . . 0.0 109.846 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mt -128.28 125.24 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.496 -0.753 . . . . 0.0 109.361 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.73 116.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 110.003 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -107.77 142.26 38.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' CG ' ' OE1' ' A' ' 135' ' ' GLU . 8.4 t70 -168.96 135.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.723 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER 50.94 34.89 11.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 111.509 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.73 8.06 86.2 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -103.15 172.5 6.78 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.452 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 7.2 tt -160.59 148.74 16.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.248 -1.533 . . . . 0.0 109.174 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.452 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 3.4 mt -146.87 133.78 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 108.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -125.21 138.99 54.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.772 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.95 139.55 53.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -136.25 134.04 19.83 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -53.12 148.87 29.52 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.353 1.369 . . . . 0.0 112.326 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.67 158.39 9.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.882 . . . . 0.0 108.944 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.3 2.65 54.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 109.943 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -138.06 150.03 46.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.539 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.492 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 16.8 tp -83.09 115.12 21.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -136.61 141.92 43.27 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.27 133.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.131 -0.981 . . . . 0.0 109.973 -179.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 m -119.1 124.72 47.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -115.1 129.85 56.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 109.983 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 153' ' ' GLY . 4.5 tp10 -113.72 105.29 13.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.562 ' N ' ' OE1' ' A' ' 152' ' ' GLU . . . -101.44 145.4 16.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -132.41 85.32 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -1.04 . . . . 0.0 109.589 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 2.7 m-30 -88.67 148.93 23.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.46 -0.775 . . . . 0.0 109.021 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 mmtt -88.93 -8.72 53.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 11.9 p-10 -66.79 -170.74 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 109.498 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 16.8 p90 -59.4 -24.63 63.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.853 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.5 mt -53.77 -58.39 7.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.005 . . . . 0.0 108.904 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.92 -134.73 11.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.34 142.7 47.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.995 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.438 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 1.3 pt20 -162.12 159.51 26.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 0.0 109.547 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.51 152.97 51.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.469 -0.769 . . . . 0.0 109.315 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -133.75 120.05 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.0 108.815 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 m -98.99 121.93 41.58 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.97 -1.081 . . . . 0.0 110.34 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -95.26 138.12 33.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.57 156.51 42.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.783 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.621 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 4.9 mp0 -60.31 113.69 2.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 109.417 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.4 6.03 18.31 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -130.91 30.23 4.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.294 -1.121 . . . . 0.0 108.836 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 6.1 mp0 -63.75 -34.67 78.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.471 -0.768 . . . . 0.0 110.89 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -16.49 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.918 -1.114 . . . . 0.0 110.98 -178.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.88 -4.02 55.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.91 -1.119 . . . . 0.0 111.146 -178.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.16 -5.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.031 -1.043 . . . . 0.0 111.107 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.59 -28.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.471 -1.393 . . . . 0.0 110.436 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.08 0.95 56.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 0.0 110.964 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.9 123.15 25.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.675 -1.265 . . . . 0.0 108.485 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -91.04 151.73 20.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.673 -1.267 . . . . 0.0 109.797 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 t -62.28 134.37 56.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.45 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.54 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 11.5 p90 -117.33 179.1 4.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 0.0 110.106 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -170.39 166.41 8.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.371 -0.831 . . . . 0.0 109.723 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 31.2 m-85 -103.79 146.11 29.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 0.0 109.244 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -17.73 64.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 111.216 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.3 p90 -80.67 -33.42 35.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.518 -1.364 . . . . 0.0 110.549 -179.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.588 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.1 OUTLIER -90.24 -15.73 30.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.762 -1.212 . . . . 0.0 109.504 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.57 -51.24 74.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 110.224 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.47 -50.24 53.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.858 -1.151 . . . . 0.0 109.292 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.04 -52.0 62.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.172 -0.955 . . . . 0.0 108.83 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 61.7 mt -55.29 -34.2 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -0.917 . . . . 0.0 108.953 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -74.18 -32.71 63.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 109.863 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.05 -30.47 70.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.788 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.7 m -82.82 12.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.97 . . . . 0.0 109.633 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.35 70.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.293 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 20.1 mt -118.3 156.19 29.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.006 -1.291 . . . . 0.0 109.945 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.89 25.12 53.82 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.001 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -67.55 -22.18 65.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.671 -1.488 . . . . 0.0 109.488 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -6.02 50.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.57 124.73 35.38 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.133 -1.216 . . . . 0.0 110.516 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.612 ' HG ' ' ND2' ' A' ' 202' ' ' ASN . 54.2 p -135.35 -179.7 5.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.825 -0.809 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.0 mt -82.65 -12.42 57.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -91.9 -9.93 41.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.612 ' ND2' ' HG ' ' A' ' 199' ' ' SER . 2.0 m-80 -136.37 7.92 3.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.407 ' HG1' ' H ' ' A' ' 199' ' ' SER . 1.2 m -147.28 120.16 8.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.4 tp -84.02 117.87 23.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.984 . . . . 0.0 109.127 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.19 127.67 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 109.593 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.8 mt -107.06 146.95 30.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.488 -0.757 . . . . 0.0 109.65 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.71 148.54 16.51 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 207' ' ' GLY . 20.4 tttt -41.13 -31.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -1.04 . . . . 0.0 109.918 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 31.9 t0 -145.61 10.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 0.0 110.282 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -144.62 153.67 42.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 109.774 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.3 131.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.091 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -72.6 -54.45 9.09 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.225 -0.922 . . . . 0.0 110.044 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.413 HD21 ' H ' ' A' ' 213' ' ' ASN . 3.3 m-80 -56.18 136.35 74.75 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 0.0 109.34 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.88 -25.82 19.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.311 2.008 . . . . 0.0 112.653 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.516 ' OE2' ' NH1' ' A' ' 218' ' ' ARG . 16.4 tm-20 -80.25 -9.82 59.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -165.52 52.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 11.8 mt -76.28 141.78 41.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -1.055 . . . . 0.0 109.858 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.516 ' NH1' ' OE2' ' A' ' 215' ' ' GLU . 0.1 OUTLIER -65.02 -52.23 57.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.63 179.25 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -117.85 176.8 5.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.0 -19.08 58.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.548 ' OD1' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -127.83 35.39 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.469 -0.769 . . . . 0.0 109.104 -179.985 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -59.79 -34.96 24.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 111.126 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.3 Cg_exo -73.87 -43.63 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.808 1.672 . . . . 0.0 112.342 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.09 -25.38 15.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.903 -1.123 . . . . 0.0 108.133 179.196 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.548 ' NH1' ' OD1' ' A' ' 221' ' ' ASN . 8.0 mtt180 -67.13 -44.11 80.69 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -57.65 -50.32 73.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 108.689 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.91 -48.97 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.591 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 64.3 t80 -49.99 -44.19 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -73.02 -35.53 66.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.534 -0.729 . . . . 0.0 109.571 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.46 -36.31 68.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 108.65 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.46 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 44.1 mt -72.42 -48.25 48.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.58 -34.3 13.91 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -81.64 -28.64 33.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -1.2 . . . . 0.0 109.645 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.4 mt -80.26 -21.42 42.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.835 -1.166 . . . . 0.0 109.125 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.489 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.3 t80 -71.08 -9.1 57.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 108.692 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 14.1 mt -50.02 -28.78 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.52 -14.02 2.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.088 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.5 15.95 80.23 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 80.8 p -158.59 144.98 12.64 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.257 . . . . 0.0 109.383 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -42.59 130.54 5.25 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.197 1.931 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 4.0 t -100.36 135.85 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.59 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -123.91 127.57 48.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.664 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.78 172.14 23.72 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -101.14 113.87 27.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.59 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.0 m-85 -112.58 147.08 37.4 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.981 0.896 . . . . 0.0 111.306 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.4 t80 -128.86 144.06 51.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.409 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 28.1 t -139.31 125.39 19.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.697 -1.252 . . . . 0.0 110.005 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 250' ' ' ARG . 71.8 t80 -110.47 113.37 25.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 249' ' ' PHE . 9.6 mmm180 46.43 56.6 6.2 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.73 150.5 21.16 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -118.38 179.82 17.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -68.66 -42.35 78.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -1.143 . . . . 0.0 109.568 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -36.32 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.204 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 57.4 tp -72.54 -36.79 68.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.016 -1.053 . . . . 0.0 108.911 179.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -60.76 -52.41 65.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.352 -0.842 . . . . 0.0 108.81 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 37.2 t -52.53 -44.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.34 -47.54 75.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.007 -1.058 . . . . 0.0 109.167 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 30.8 tp -52.51 -45.07 66.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 108.623 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.36 -53.29 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 109.465 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -46.7 -45.97 19.84 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.682 -0.636 . . . . 0.0 110.636 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.92 -47.96 64.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.906 -1.121 . . . . 0.0 109.503 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.7 mt -57.97 -43.66 86.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.05 74.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.282 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.4 mttt . . . . . 0 N--CA 1.489 1.517 0 O-C-N 120.706 -1.246 . . . . 0.0 108.929 179.307 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 55.3 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.401 0.619 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -114.14 131.33 56.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.496 -0.752 . . . . 0.0 109.061 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -132.77 168.86 17.59 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -81.38 139.79 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 110.226 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -70.12 -46.95 63.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.56 -0.712 . . . . 0.0 109.945 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -132.35 163.11 29.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.356 -0.84 . . . . 0.0 110.41 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.577 ' HZ2' ' CB ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.72 136.31 55.32 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.632 0.73 . . . . 0.0 110.861 -179.162 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.7 mt -117.23 164.99 13.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -150.92 146.49 26.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.813 -1.179 . . . . 0.0 110.192 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -133.69 161.08 35.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.536 -0.727 . . . . 0.0 109.464 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -149.75 136.78 19.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.918 -1.114 . . . . 0.0 109.023 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.87 158.98 18.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.3 p -85.79 144.14 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.103 -1.233 . . . . 0.0 110.996 -178.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.32 143.57 39.38 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.1 tt -63.55 -44.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 112.621 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.446 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.8 m-70 -87.08 -37.1 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.125 -1.609 . . . . 0.0 112.193 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.0 p -81.05 -26.6 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.834 -1.167 . . . . 0.0 109.721 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.95 19.0 62.93 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 23' ' ' TYR . 1.9 tm-20 -104.18 148.75 25.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 4.3 t80 -71.65 134.39 46.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -141.7 158.16 44.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.09 -1.006 . . . . 0.0 109.298 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -137.77 144.85 41.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.258 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -125.25 144.91 50.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.018 . . . . 0.0 109.606 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -126.4 132.08 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mt -113.1 134.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.049 -1.032 . . . . 0.0 109.573 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -128.62 149.72 72.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.031 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.81 160.51 28.79 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.288 1.992 . . . . 0.0 111.226 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.6 mm-40 -135.23 -174.66 3.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 109.914 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.5 tttt -91.0 155.71 18.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.766 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.84 145.23 2.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.251 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.592 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.08 27.4 62.44 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.105 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.2 m -80.85 -38.31 28.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.684 -1.48 . . . . 0.0 108.633 179.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 -174.21 35.11 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.66 123.51 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 139.36 39.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.953 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -95.79 148.73 22.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.7 t80 -130.65 137.34 49.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -165.38 139.67 4.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.383 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.09 29.73 10.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 110.084 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.58 18.51 79.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.51 133.86 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -1.096 . . . . 0.0 109.753 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 15.8 m-85 -97.88 134.53 40.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 108.871 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.4 mt -127.73 94.91 36.23 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.495 -0.753 . . . . 0.0 109.4 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.91 142.3 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.095 1.863 . . . . 0.0 111.602 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.04 80.22 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.977 -1.077 . . . . 0.0 109.94 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -134.59 152.32 51.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.528 ' O ' ' N ' ' A' ' 53' ' ' VAL . 15.1 p80 -54.9 -47.16 74.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 50' ' ' HIS . 4.6 mt-10 -44.01 -20.49 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.939 -1.101 . . . . 0.0 109.706 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' HIS . 97.6 m-85 -90.57 4.66 50.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.854 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' HIS . 23.3 t -60.03 120.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 108.921 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 m -111.88 -28.34 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 110.161 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -153.44 122.66 6.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.008 -1.057 . . . . 0.0 109.907 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -115.69 132.68 56.56 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.5 t-20 -166.87 -153.22 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ASN . 76.1 m-70 -45.64 -15.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -136.73 166.16 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.419 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 2.8 m -108.66 125.77 52.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.354 -0.841 . . . . 0.0 108.878 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 60' ' ' THR . 3.5 m-20 -123.47 140.45 53.0 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.073 0.94 . . . . 0.0 111.46 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.8 mt -122.11 160.24 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.87 141.1 5.83 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.812 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -144.13 149.03 35.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.974 . . . . 0.0 109.236 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.95 38.82 31.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.349 -0.844 . . . . 0.0 110.393 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.95 3.23 80.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.513 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 7.5 mm100 -96.16 144.96 25.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -1.196 . . . . 0.0 108.605 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.81 143.88 37.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.244 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.71 139.29 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -114.36 151.36 33.15 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.276 -0.89 . . . . 0.0 111.179 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m 54.75 70.22 0.64 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 178.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 m -114.29 -8.09 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.068 -1.02 . . . . 0.0 109.846 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -69.52 -19.08 63.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.158 -0.964 . . . . 0.0 111.228 -178.829 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 22.6 m170 -73.5 -58.89 3.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.753 -1.217 . . . . 0.0 109.52 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 4.6 tp -58.52 -42.43 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.844 -1.16 . . . . 0.0 108.691 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 70.5 mt -58.73 -37.53 76.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.2 t -59.91 -48.3 82.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.96 -54.16 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 108.455 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.3 mt -51.68 -45.46 63.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 0.0 109.234 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.583 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 12.1 t-160 -54.98 -51.87 64.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.787 . . . . 0.0 109.902 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.4 mt -64.9 -38.27 90.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 110.629 -179.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.9 mt -79.89 -1.1 37.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 110.612 -178.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 60.14 63.46 1.42 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.013 -1.054 . . . . 0.0 110.401 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 84' ' ' ILE . 13.3 mm -105.51 127.6 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.7 p -115.1 -21.22 10.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.314 -0.866 . . . . 0.0 112.03 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.638 HD21 HE22 ' A' ' 117' ' ' GLN . 12.2 m-80 -128.74 111.6 13.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.787 -1.195 . . . . 0.0 110.295 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.6 m -164.19 139.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.196 -0.94 . . . . 0.0 109.89 179.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 21.5 m -110.42 99.54 8.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.24 104.98 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.92 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.67 128.47 33.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.612 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.71 108.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.06 109.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.81 -155.27 20.09 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -178.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.43 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -123.04 -8.18 8.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.532 -0.981 . . . . 0.0 110.694 -179.555 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.573 ' OE2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -144.58 150.76 38.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.62 -1.3 . . . . 0.0 111.681 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.6 mm -75.88 122.26 86.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.027 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.29 133.52 12.05 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.924 1.75 . . . . 0.0 112.198 179.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.0 tp -76.59 -20.11 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.092 -179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.584 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 75.8 mt 54.99 -121.91 1.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.48 -7.75 40.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.46 -15.63 38.45 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -111.35 -171.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -1.044 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.07 -1.9 23.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -46.43 -40.95 13.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.694 -0.886 . . . . 0.0 110.086 -179.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.84 -52.31 64.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.838 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 57.3 m-85 -63.05 -44.47 95.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 108.762 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -62.94 -37.18 86.04 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.419 0.628 . . . . 0.0 109.77 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -72.06 -48.0 47.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 111.096 -178.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.77 -51.17 14.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.941 -1.099 . . . . 0.0 110.194 -179.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.28 -43.07 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.084 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -54.31 -32.15 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -83.06 -0.87 51.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.139 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.82 33.25 3.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.248 -0.908 . . . . 0.0 111.149 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.0 mt -94.05 144.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.513 -1.367 . . . . 0.0 110.125 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -132.04 161.61 32.78 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.556 HD21 ' H ' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -108.66 146.27 33.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.059 -1.026 . . . . 0.0 110.388 -179.447 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.638 HE22 HD21 ' A' ' 86' ' ' ASN . 1.4 mt-30 -105.09 -162.41 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.078 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.03 -0.01 12.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.299 -0.875 . . . . 0.0 110.629 -179.208 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -93.28 147.49 22.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.832 -1.167 . . . . 0.0 110.043 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -84.1 131.0 34.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.423 -0.798 . . . . 0.0 109.555 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 80.1 mt -71.69 141.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.965 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.15 104.39 16.4 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -78.6 146.68 34.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 111.095 -178.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.84 121.9 33.88 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.82 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.05 136.75 22.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -116.42 -11.22 11.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.735 . . . . 0.0 109.113 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -142.07 142.82 25.77 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.28 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.82 152.64 52.77 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.033 1.822 . . . . 0.0 112.953 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 tt -145.94 141.7 21.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.672 -0.642 . . . . 0.0 109.332 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.29 123.2 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 109.5 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.4 116.69 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.515 -0.74 . . . . 0.0 109.654 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -108.85 140.08 42.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.299 -0.876 . . . . 0.0 109.29 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.41 126.51 2.3 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.735 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.489 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 46.1 mt-10 52.75 39.14 28.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.752 -0.593 . . . . 0.0 112.389 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.52 5.22 89.35 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.424 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.489 ' NH2' ' OE1' ' A' ' 135' ' ' GLU . 5.5 mtt180 -107.05 164.24 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.9 tt -159.75 151.2 19.87 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 119.948 -1.72 . . . . 0.0 109.213 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 13.1 mt -146.97 130.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -122.8 140.28 53.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.161 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.99 148.18 41.66 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -146.19 137.03 12.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.28 144.43 71.38 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.325 1.35 . . . . 0.0 112.166 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.04 148.16 11.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.37 -1.96 43.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.3 p -136.35 150.23 48.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.2 117.43 22.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.952 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -136.24 137.51 40.87 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 74.0 t -136.92 123.65 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 -179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 m -111.15 132.66 54.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.594 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -116.89 129.01 55.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.28 111.59 21.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.06 156.89 15.81 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 250' ' ' ARG . 36.4 mt-10 -138.33 95.16 2.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.349 -1.089 . . . . 0.0 109.387 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -94.78 148.27 22.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 109.616 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -91.17 0.48 57.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.767 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.9 p30 -78.66 -173.6 3.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.355 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -53.21 -18.92 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.208 -179.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 16.7 mt -65.43 -62.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.018 -1.051 . . . . 0.0 109.659 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.94 -125.3 8.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -109.63 139.35 44.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -1.081 . . . . 0.0 109.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.75 150.45 29.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 152.67 48.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.635 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -136.51 124.78 23.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 0.0 109.109 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 165' ' ' THR . 13.7 t -98.35 122.28 41.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.089 -1.007 . . . . 0.0 110.006 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.4 t80 -97.48 137.28 36.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 108.846 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.556 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -133.2 150.24 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -56.1 122.35 11.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.05 -18.85 14.0 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -116.16 36.35 4.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.069 -1.253 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.33 -31.57 72.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 110.525 -179.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.28 -14.06 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.693 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.28 -3.87 57.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 5.3 pt -122.83 10.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.992 -1.067 . . . . 0.0 111.033 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.93 -31.8 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.867 -1.146 . . . . 0.0 109.958 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.89 2.23 46.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.828 -1.17 . . . . 0.0 110.489 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.71 133.3 35.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -105.41 154.08 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 -179.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -55.65 159.6 2.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.43 166.25 25.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.017 -1.052 . . . . 0.0 110.148 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -152.52 163.25 39.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 109.458 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.548 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 70.7 m-85 -104.53 144.03 32.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.633 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -61.28 -25.91 67.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.817 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.548 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.2 p90 -77.52 -25.32 50.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.776 -1.203 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.465 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 10.0 pt-20 -100.96 -11.9 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 109.993 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.9 mt -57.34 -52.36 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.116 -0.99 . . . . 0.0 110.449 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.42 -53.72 33.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 0.0 109.975 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -52.88 -42.33 65.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.073 -1.017 . . . . 0.0 109.187 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 189' ' ' ILE . 97.0 mt -66.07 -33.77 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.021 179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -78.69 -26.06 44.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.783 . . . . 0.0 110.335 -179.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 193' ' ' GLY . 0.4 OUTLIER -80.74 -32.46 35.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.995 -1.065 . . . . 0.0 110.181 -179.448 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.8 m -73.76 8.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.015 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 78.83 20.48 70.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 27.9 mt -117.22 154.86 30.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.196 -1.179 . . . . 0.0 109.764 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 83.3 23.15 55.35 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.421 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -66.2 -23.96 66.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.617 -1.519 . . . . 0.0 109.756 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.07 -5.89 49.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.83 130.69 45.6 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.129 -1.218 . . . . 0.0 110.773 -178.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 6.9 p -134.82 -173.74 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.668 -0.901 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.8 -17.48 29.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -89.11 -8.54 53.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 202' ' ' ASN . 0.5 OUTLIER -127.96 -14.18 5.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.754 -179.627 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -125.4 115.01 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.0 tp -77.14 109.97 11.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 108.668 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.64 125.92 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 110.012 -179.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 28.5 mt -99.1 143.26 29.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.623 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.64 144.46 15.82 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 3.9 pttt -41.52 -23.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -1.191 . . . . 0.0 110.299 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.2 p-10 -152.67 11.92 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.565 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -148.89 157.98 43.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.972 -1.08 . . . . 0.0 110.419 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.55 127.86 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -73.62 -54.86 7.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.028 -1.045 . . . . 0.0 110.55 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.95 111.35 2.9 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.027 . . . . 0.0 110.169 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.45 -8.49 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.864 1.709 . . . . 0.0 112.292 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -88.06 -7.74 56.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 109.869 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.88 -167.36 48.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.06 145.3 25.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.414 -1.05 . . . . 0.0 110.165 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -88.17 -17.55 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.387 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -144.95 134.41 23.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.39 -23.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.062 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.477 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -124.95 35.72 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.078 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.448 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 5.1 tt0 -55.4 -57.97 17.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 111.638 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 10.5 Cg_endo -54.19 -39.96 84.05 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.955 1.77 . . . . 0.0 113.105 -178.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.5 m -80.2 -26.66 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 120.667 -1.27 . . . . 0.0 109.017 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 18.7 mtt180 -66.65 -43.27 85.04 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -62.01 -42.35 99.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -56.78 -39.04 73.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.41 -40.89 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.578 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.7 t80 -59.1 -37.48 77.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 91.0 m-20 -76.07 -40.87 52.18 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.563 -0.711 . . . . 0.0 109.671 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.6 tp -55.47 -36.71 66.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 108.836 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.498 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 77.9 mt -73.15 -47.75 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.77 -33.92 28.31 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.44 -26.81 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -1.225 . . . . 0.0 109.852 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.74 -20.71 45.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.761 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.583 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 11.9 t80 -74.24 -9.02 58.19 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.145 -0.972 . . . . 0.0 109.193 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 18.3 mt -50.91 -28.6 10.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.439 ' O ' ' NH2' ' A' ' 49' ' ' ARG . 62.9 mt -58.11 -11.26 2.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 0.0 108.947 179.211 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.54 16.04 81.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 23.1 p -158.48 150.45 17.3 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.071 -1.252 . . . . 0.0 109.219 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -53.28 139.48 63.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.999 1.799 . . . . 0.0 111.519 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.0 t -102.93 133.45 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.383 -179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -118.38 123.92 46.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.755 . . . . 0.0 109.253 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.34 170.75 22.58 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -101.57 112.72 25.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.188 -1.184 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -112.03 148.15 34.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.921 0.867 . . . . 0.0 111.209 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -130.18 144.19 51.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.8 t -137.77 127.93 26.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.0 110.502 -179.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -111.73 113.89 26.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 154' ' ' GLU . 2.3 mtt85 49.81 56.0 8.54 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.01 142.45 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.94 167.45 13.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -56.5 -45.03 81.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -59.55 -56.01 27.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.83 -36.54 70.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 62.5 m-20 -59.76 -55.5 33.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 108.721 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 36.5 t -51.05 -40.59 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.308 -0.87 . . . . 0.0 109.148 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -54.81 -47.63 73.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 108.916 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 59.3 tp -53.34 -47.31 69.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.98 -43.19 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.407 ' HZ3' ' HB3' ' A' ' 261' ' ' LYS . 0.0 OUTLIER -55.1 -51.9 64.93 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.446 -0.783 . . . . 0.0 110.384 -179.14 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.83 -43.75 95.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.817 -1.177 . . . . 0.0 110.189 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.18 -42.36 96.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.45 -32.71 58.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 110.334 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp . . . . . 0 N--CA 1.489 1.501 0 O-C-N 120.877 -1.139 . . . . 0.0 109.186 179.597 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 33' ' ' GLU . 10.6 mt-10 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 145.9 51.5 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.517 -0.74 . . . . 0.0 109.743 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 177.8 8.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.944 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.66 147.09 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -83.05 -41.17 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.581 -0.699 . . . . 0.0 109.958 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.79 155.18 46.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.955 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -62.9 133.21 54.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.399 -0.813 . . . . 0.0 109.671 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.75 161.96 19.86 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -158.42 152.43 23.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.806 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.8 171.64 14.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.645 -0.66 . . . . 0.0 109.74 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -149.62 137.69 20.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 108.982 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.61 161.0 20.45 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.36 144.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -1.199 . . . . 0.0 111.24 -178.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.53 141.08 39.97 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.2 tt -62.16 -43.52 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -1.233 . . . . 0.0 111.325 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.411 ' H ' HG21 ' A' ' 18' ' ' ILE . 8.2 m-70 -87.98 -39.39 14.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.174 -1.579 . . . . 0.0 111.149 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 p -69.06 -40.43 78.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.27 17.49 78.86 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -114.36 152.58 31.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.989 . . . . 0.0 108.828 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.492 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 5.2 t80 -71.8 139.67 49.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.056 -1.028 . . . . 0.0 110.245 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -146.97 157.72 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 108.819 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 26' ' ' LEU . 25.2 ttpt -127.07 157.71 38.9 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 109.704 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 12.6 mt -126.56 144.86 50.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.982 -1.074 . . . . 0.0 108.397 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.469 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.2 mt -138.62 132.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.015 179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mt -120.97 128.09 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 109.914 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.574 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 1.4 m-70 -125.7 149.02 64.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.56 157.64 35.85 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.179 1.92 . . . . 0.0 111.38 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 41.2 mm-40 -135.83 162.9 31.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -64.77 150.37 47.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -47.81 148.91 1.42 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.573 -179.373 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.488 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 59.86 25.45 61.6 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.527 -0.733 . . . . 0.0 112.089 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.5 m -80.16 -37.07 34.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.467 -1.608 . . . . 0.0 109.068 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.637 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 94.23 -172.69 32.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 HG22 HD12 ' A' ' 37' ' ' ILE . 6.9 mm -100.42 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.164 -1.198 . . . . 0.0 108.338 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -139.4 143.81 37.84 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.392 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.5 153.63 19.54 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.8 t80 -124.3 147.93 47.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 13.5 tttt -173.75 133.48 0.46 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.777 -1.202 . . . . 0.0 109.218 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.639 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER 52.95 29.54 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.493 -0.754 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.71 -9.88 48.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.599 ' CG2' HD22 ' A' ' 42' ' ' ASN . 20.6 t -94.43 139.34 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -1.227 . . . . 0.0 110.22 -179.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -97.36 146.2 25.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.419 -0.801 . . . . 0.0 108.923 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.5 mt -138.1 97.03 9.93 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.47 141.19 33.81 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.243 1.962 . . . . 0.0 111.499 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.19 84.31 5.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.878 -1.139 . . . . 0.0 110.58 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -141.27 157.62 44.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.135 -0.978 . . . . 0.0 109.284 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.69 ' HD1' ' H ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -52.52 -49.74 64.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.117 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.69 ' H ' ' HD1' ' A' ' 50' ' ' HIS . 16.4 mt-10 -48.77 -16.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 110.076 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' HIS . 73.4 m-85 -97.37 6.08 48.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.052 -1.03 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -64.59 129.31 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.951 . . . . 0.0 109.383 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.62 -29.51 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.38 -0.825 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.441 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 7.8 t-80 -152.92 122.61 6.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.788 -1.195 . . . . 0.0 109.814 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.6 p -113.34 133.12 55.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.7 t-20 -166.98 -154.04 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -47.04 -13.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.069 -1.02 . . . . 0.0 108.317 178.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -135.23 165.7 24.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.591 -0.693 . . . . 0.0 109.401 -179.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.446 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 7.4 m -103.93 122.24 44.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 108.604 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -120.2 136.92 54.47 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.053 0.93 . . . . 0.0 111.528 -178.692 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.8 mt -117.69 158.21 25.11 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.77 143.11 6.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.652 -1.737 . . . . 0.0 110.908 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.08 151.55 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.617 -0.931 . . . . 0.0 109.758 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp 56.79 27.61 13.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.521 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.52 -0.43 83.05 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 91.3 mm-40 -94.84 138.77 32.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.968 -1.313 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -134.28 146.7 50.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.963 . . . . 0.0 111.27 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.4 mt -134.89 145.88 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -114.61 152.75 31.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.222 -0.924 . . . . 0.0 111.799 -178.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 71' ' ' THR . 45.7 m 53.94 71.68 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.557 . . . . 0.0 111.307 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -113.5 -1.44 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.033 -1.042 . . . . 0.0 109.286 178.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.54 -39.59 73.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 110.576 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -54.38 -60.59 3.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.066 -1.021 . . . . 0.0 110.241 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -58.54 -46.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 109.232 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 64.8 mt -55.49 -38.72 69.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.074 -1.016 . . . . 0.0 109.43 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -59.01 -48.24 82.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.564 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.2 -54.18 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 108.499 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -52.39 -46.38 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.507 -0.746 . . . . 0.0 109.246 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.618 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 15.4 t-160 -55.58 -53.69 53.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.827 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.89 -38.63 91.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.363 -0.836 . . . . 0.0 110.368 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -78.37 -4.46 48.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.736 -178.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.28 51.55 2.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.729 -1.232 . . . . 0.0 110.405 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.7 mm -98.45 124.46 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 p -111.55 -18.95 12.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.322 -0.861 . . . . 0.0 112.437 -177.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.637 HD21 ' H ' ' A' ' 36' ' ' GLY . 5.6 m120 -129.94 111.86 12.96 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.512 -1.367 . . . . 0.0 110.633 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 2.7 m -164.62 143.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.228 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.542 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.7 m -112.19 101.07 9.34 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mt -92.1 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.579 -0.701 . . . . 0.0 109.706 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.71 123.08 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.736 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 t -107.46 106.27 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 110.954 -178.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.22 111.02 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.12 -161.62 23.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -115.37 -14.51 11.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.534 ' OE1' ' O ' ' A' ' 96' ' ' ILE . 1.2 tm-20 -140.86 146.61 37.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.995 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.534 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 3.3 mm -68.95 124.06 89.49 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 109.97 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.57 130.99 9.64 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.083 1.855 . . . . 0.0 112.171 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.53 -30.27 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.451 -0.78 . . . . 0.0 109.727 -179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt 56.48 -108.77 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.805 . . . . 0.0 110.129 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -94.17 -22.9 18.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 110.736 -178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.49 -10.23 19.48 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.23 -170.95 1.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -1.024 . . . . 0.0 109.757 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.07 -4.67 25.68 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -46.29 -38.8 9.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.707 -0.878 . . . . 0.0 110.302 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.42 -52.04 66.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 110.013 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.56 -43.4 97.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 108.695 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 18.7 t80 -63.64 -36.71 84.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.74 -0.6 . . . . 0.0 110.014 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.75 -49.94 27.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.28 -0.887 . . . . 0.0 111.956 -178.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.38 -44.55 58.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.824 -1.172 . . . . 0.0 110.977 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.2 -39.97 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.073 . . . . 0.0 110.391 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 16.0 tpt180 -54.11 -32.59 55.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 0.0 109.759 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -82.1 -13.41 57.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.929 -1.107 . . . . 0.0 110.14 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -121.37 32.07 6.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 111.018 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.1 mt -82.74 148.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.509 -1.37 . . . . 0.0 110.373 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -128.63 149.57 50.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -97.68 146.14 25.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.042 -1.036 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.56 -168.45 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.0 109.813 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -124.43 72.73 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.513 -0.742 . . . . 0.0 110.589 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 119' ' ' ARG . 6.2 ttm-85 -168.63 149.48 4.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.968 . . . . 0.0 109.461 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -83.3 126.87 33.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.4 mt -67.09 135.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.456 -0.778 . . . . 0.0 110.765 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.52 73.69 1.94 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -52.31 141.31 19.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.538 -0.726 . . . . 0.0 110.479 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -104.99 125.57 51.12 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.8 t -128.75 142.88 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.253 -0.904 . . . . 0.0 110.266 -179.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.13 135.26 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -116.53 -11.43 11.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.214 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.42 143.62 30.8 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.05 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.61 161.51 41.9 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.109 1.873 . . . . 0.0 113.182 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 130' ' ' ILE . 1.9 tt -155.4 140.0 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.65 -0.656 . . . . 0.0 109.584 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.86 124.33 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.36 118.84 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.724 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -115.58 133.6 55.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.417 -0.802 . . . . 0.0 109.583 179.862 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 34.1 t0 -173.43 150.65 1.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.18 -0.95 . . . . 0.0 110.759 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 10.9 mt-10 57.57 22.32 8.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.541 -0.724 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.26 6.99 88.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -105.34 171.64 7.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 7.1 tt -159.63 149.57 18.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.457 -1.402 . . . . 0.0 109.028 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.466 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 12.0 mt -147.69 139.06 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -131.26 142.68 50.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.118 -0.989 . . . . 0.0 109.654 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.35 145.82 48.44 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.34 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -142.48 135.1 13.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.53 147.96 36.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.272 1.315 . . . . 0.0 112.053 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.99 154.23 8.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.364 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.98 0.73 50.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -136.98 151.79 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.1 tp -87.37 117.92 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 110.027 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -136.18 142.93 44.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 69.5 t -135.93 118.31 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 109.907 -179.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.5 m -105.19 127.1 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.178 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -121.36 130.07 53.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -112.27 104.94 13.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.1 129.51 9.93 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.62 97.32 6.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -1.091 . . . . 0.0 109.169 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 160' ' ' GLY . 24.5 m-85 -99.63 148.92 23.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.188 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -92.87 -10.17 37.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.821 . . . . 0.0 109.934 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.691 HD21 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -70.34 -167.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.918 . . . . 0.0 110.103 -179.284 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -60.12 -24.49 64.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.355 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.434 ' HB2' HD22 ' A' ' 157' ' ' ASN . 6.6 mt -64.93 -40.65 95.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.939 -1.101 . . . . 0.0 108.871 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 76.97 -107.52 2.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -122.01 140.69 52.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.937 . . . . 0.0 109.692 -179.577 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -144.44 158.04 43.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -142.89 144.48 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -137.01 123.89 21.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.344 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 9.1 m -104.67 124.55 49.55 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.204 -0.935 . . . . 0.0 110.198 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -99.67 130.13 45.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.24 147.78 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.502 -0.749 . . . . 0.0 109.46 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.04 115.62 1.49 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.349 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.22 4.89 17.75 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.45 28.85 3.98 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.304 -1.115 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.75 -33.26 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.733 -0.604 . . . . 0.0 110.473 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -58.55 -9.97 1.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.085 -1.009 . . . . 0.0 110.697 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.38 -4.84 33.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.791 -1.193 . . . . 0.0 110.793 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.3 pt -117.65 13.05 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 110.722 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.13 -26.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.018 -1.051 . . . . 0.0 110.027 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.6 0.8 57.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.85 -1.156 . . . . 0.0 110.706 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.51 115.39 20.0 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.994 -1.067 . . . . 0.0 109.006 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -84.02 151.68 24.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.135 -0.978 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 t -59.24 132.64 54.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.323 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -110.96 170.2 8.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.983 -179.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 1.8 t -154.21 162.99 40.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.441 -0.787 . . . . 0.0 109.475 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.473 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 71.5 m-85 -104.6 144.6 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.407 -0.808 . . . . 0.0 109.495 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -25.85 67.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.756 -1.215 . . . . 0.0 110.385 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.0 p90 -81.83 -30.09 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.8 -1.188 . . . . 0.0 110.413 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.5 pt-20 -87.41 -16.96 33.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.784 -1.197 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.83 -53.36 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.149 -0.969 . . . . 0.0 110.131 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.52 -53.19 40.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.919 -1.113 . . . . 0.0 109.624 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.87 -44.51 66.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 109.053 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.7 mt -64.85 -33.42 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.065 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -78.3 -27.73 47.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -76.78 -28.15 55.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 109.937 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.4 m -82.61 9.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 109.782 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.56 72.78 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.633 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.8 157.93 27.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.211 -1.17 . . . . 0.0 109.669 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.63 21.64 63.61 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.148 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.36 -22.89 63.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.588 -1.537 . . . . 0.0 109.87 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -100.65 -3.16 55.26 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.6 128.74 35.73 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 121.086 -1.243 . . . . 0.0 110.459 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 202' ' ' ASN . 0.3 OUTLIER -138.29 162.23 34.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.738 -0.86 . . . . 0.0 109.265 179.847 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.93 -31.45 72.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.962 . . . . 0.0 110.105 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -75.47 -14.6 60.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.07 -1.019 . . . . 0.0 110.248 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.496 ' OD1' ' OG ' ' A' ' 199' ' ' SER . 0.3 OUTLIER -130.34 9.87 5.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -179.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.7 m -150.36 123.56 8.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.42 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.16 115.49 22.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.189 -0.944 . . . . 0.0 109.24 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.56 126.75 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.4 mt -102.44 141.91 34.51 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.456 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.06 149.6 19.1 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.1 OUTLIER -42.24 -29.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.895 -179.578 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 8.5 t0 -149.71 14.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 110.163 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 207' ' ' GLY . 9.9 mtpm? -146.85 155.71 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.038 . . . . 0.0 110.272 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.5 t -101.44 127.6 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.78 -54.63 8.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.329 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.14 131.32 68.69 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.938 -1.101 . . . . 0.0 109.325 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.03 -14.57 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.175 1.917 . . . . 0.0 112.574 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.78 -6.12 59.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.126 -0.984 . . . . 0.0 109.724 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.22 -167.93 51.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 49.6 mt -82.79 146.15 29.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -1.013 . . . . 0.0 109.935 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -89.48 -20.74 23.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.241 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 221' ' ' ASN . 69.2 m-85 -141.57 139.51 33.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.377 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -11.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 108.6 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.705 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -141.87 38.03 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.731 0.777 . . . . 0.0 109.066 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.4 OUTLIER -58.18 -36.54 45.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 111.05 -179.472 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.47 -44.3 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.837 1.691 . . . . 0.0 112.54 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.14 -24.45 16.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.765 -1.209 . . . . 0.0 108.49 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.705 HH21 ' ND2' ' A' ' 221' ' ' ASN . 6.3 mtt180 -67.64 -41.87 83.2 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -63.08 -42.78 99.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -56.66 -47.63 79.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.068 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.59 -44.54 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 61.3 t80 -55.13 -37.42 66.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.645 -0.66 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 3.7 m-20 -76.34 -38.84 55.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.499 -0.751 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.92 -37.62 71.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.092 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.422 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 74.2 mt -73.1 -48.61 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.07 -34.56 16.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.22 -26.89 32.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -1.13 . . . . 0.0 110.189 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.5 mt -78.13 -22.62 48.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 109.758 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.618 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 6.6 t80 -70.45 -5.4 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.105 -0.997 . . . . 0.0 108.83 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 14.0 mt -52.24 -30.55 28.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 87.7 mt -56.29 -17.9 9.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 82.96 14.51 74.93 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.4 p -158.31 151.89 19.25 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.245 . . . . 0.0 109.458 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -49.94 131.31 29.64 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.161 1.907 . . . . 0.0 111.511 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.07 135.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 109.877 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.12 126.03 47.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.466 -0.771 . . . . 0.0 109.447 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.61 170.37 21.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -99.79 113.47 26.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.048 -1.266 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.3 m-85 -112.12 148.44 33.97 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.073 0.94 . . . . 0.0 111.148 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -128.15 144.53 51.12 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.1 t -144.86 124.82 13.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.42 -1.425 . . . . 0.0 110.413 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.418 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.3 t80 -109.8 116.55 31.88 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.6 OUTLIER 45.31 56.33 5.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.314 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -88.01 152.66 23.94 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -120.0 -177.81 16.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.15 -51.51 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 0.0 109.714 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -34.54 70.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.985 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 48.6 tp -72.87 -40.34 65.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.016 . . . . 0.0 108.834 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -61.01 -51.06 70.84 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.2 t -51.32 -44.58 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.0 109.171 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -54.88 -49.11 71.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 108.905 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.9 tp -52.93 -40.14 63.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.822 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.72 -41.54 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.442 -0.786 . . . . 0.0 109.708 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.54 -48.16 82.74 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 110.158 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -47.45 73.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.932 -1.105 . . . . 0.0 109.621 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.51 -43.74 89.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.325 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.27 73.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 110.084 -179.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm . . . . . 0 N--CA 1.49 1.553 0 O-C-N 120.725 -1.234 . . . . 0.0 108.865 179.245 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 67.7 mt-10 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.63 139.33 53.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.596 -0.69 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -138.57 173.8 11.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.459 -0.776 . . . . 0.0 108.92 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -84.41 141.39 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.722 -1.236 . . . . 0.0 110.278 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -71.15 -44.47 65.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.661 -0.649 . . . . 0.0 109.957 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.03 159.56 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 136.3 57.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.717 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 157.36 25.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -147.57 145.57 29.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 110.186 -179.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -132.17 163.37 28.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.99 135.57 19.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.889 -1.132 . . . . 0.0 108.718 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 159.13 19.08 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.62 146.8 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.243 . . . . 0.0 110.762 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.71 143.62 38.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.1 tt -67.74 -38.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.149 . . . . 0.0 112.786 -178.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.417 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.9 m-70 -85.93 -35.4 20.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 119.842 -1.786 . . . . 0.0 112.041 -177.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.476 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 5.2 m -85.21 -39.92 17.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.24 16.03 72.79 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -103.39 150.41 23.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -1.125 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.8 t80 -71.34 139.19 49.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.3 t -146.25 157.8 43.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.022 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -132.85 155.78 48.37 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.882 . . . . 0.0 109.533 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.58 144.97 50.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.032 . . . . 0.0 109.103 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.9 129.16 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.3 mt -113.43 123.55 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -117.7 153.32 50.64 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.19 159.28 47.77 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.327 2.018 . . . . 0.0 111.19 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.2 mm-40 -134.12 -178.37 5.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.016 -1.052 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.437 ' O ' ' OG1' ' A' ' 35' ' ' THR . 25.3 tttt -83.04 149.34 27.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.463 -0.773 . . . . 0.0 109.317 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.584 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -46.86 148.27 1.11 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.235 -0.916 . . . . 0.0 110.064 -179.487 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.58 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.49 24.38 59.35 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.18 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.703 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 15.5 m -80.55 -37.64 31.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.673 -1.486 . . . . 0.0 108.961 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.9 -167.09 27.87 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.426 HD12 HG23 ' A' ' 37' ' ' ILE . 2.8 mm -104.02 123.49 57.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -1.103 . . . . 0.0 108.287 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 139.09 42.08 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.969 -1.093 . . . . 0.0 110.863 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -99.7 151.54 21.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.568 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.1 t80 -129.49 139.52 51.55 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -170.86 138.76 1.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.016 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.48 28.65 17.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.85 . . . . 0.0 110.022 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.88 22.13 78.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 t -130.83 146.76 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.246 -1.149 . . . . 0.0 109.46 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -98.7 147.75 24.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.173 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.6 mt -140.7 94.64 8.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.77 142.55 18.72 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.206 1.937 . . . . 0.0 111.841 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.52 83.11 6.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.429 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -137.72 153.44 49.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' VAL . 3.0 p80 -52.78 -49.6 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 110.421 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.2 mt-10 -44.29 -30.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.084 -1.01 . . . . 0.0 109.285 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -79.43 3.94 16.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' HIS . 9.5 t -56.62 131.65 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -122.32 -35.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.341 -0.849 . . . . 0.0 110.428 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.5 t-160 -150.2 119.74 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.272 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.2 p -113.37 131.48 55.96 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.375 0.607 . . . . 0.0 109.465 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.607 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -167.1 -153.25 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.717 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 57' ' ' ASN . 13.6 m-70 -45.55 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.067 -1.02 . . . . 0.0 108.681 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 57' ' ' ASN . 10.9 t -135.41 165.7 24.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.365 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.402 ' HG1' ' CD ' ' A' ' 73' ' ' GLU . 3.8 m -104.08 122.5 45.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.778 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 3.4 m-20 -121.39 139.78 53.0 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.092 0.949 . . . . 0.0 111.434 -178.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.56 158.08 29.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.75 144.82 7.61 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.639 -1.743 . . . . 0.0 110.687 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -144.24 150.9 38.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.53 -0.983 . . . . 0.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm 56.75 23.87 8.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.0 110.941 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.98 70.45 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.718 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.495 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 17.3 mm100 -98.2 142.15 30.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.971 -1.311 . . . . 0.0 108.222 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -138.33 150.99 47.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 111.365 -179.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.63 143.04 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -110.73 149.81 29.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.223 -0.923 . . . . 0.0 111.236 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m 54.21 67.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 111.471 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.48 -3.56 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 108.997 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pt-20 -71.39 -26.0 62.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.318 -179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -65.6 -60.51 2.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 0.0 109.635 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.6 tp -56.74 -44.1 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.124 -0.985 . . . . 0.0 108.922 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.471 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 7.7 mt -55.79 -38.23 69.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.993 . . . . 0.0 109.46 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.8 t -60.84 -49.02 79.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.656 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.0 t -57.19 -54.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.012 . . . . 0.0 108.585 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -51.63 -44.32 62.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 11.7 t-160 -54.42 -53.52 53.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.856 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.85 -36.95 84.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.9 mt -76.36 -7.48 55.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.138 -179.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.06 47.37 4.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.598 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.3 mm -92.4 122.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.7 p -111.26 -21.83 11.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.283 -0.885 . . . . 0.0 112.134 -177.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.703 ' ND2' ' H ' ' A' ' 35' ' ' THR . 5.7 m120 -126.22 111.35 14.49 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.789 -1.195 . . . . 0.0 109.677 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -164.69 140.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.165 -0.959 . . . . 0.0 109.957 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.5 m -110.81 99.58 8.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.03 110.1 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.9 122.27 30.54 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.65 108.44 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 111.003 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.16 110.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.91 -160.06 22.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.43 -15.26 9.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -136.19 142.1 44.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.204 -179.56 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -68.23 126.22 92.44 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.53 -0.731 . . . . 0.0 109.707 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -45.98 131.25 13.73 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.946 1.764 . . . . 0.0 112.388 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.34 -26.34 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.455 -0.778 . . . . 0.0 109.827 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 10.1 mt 54.65 -111.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -95.55 -17.71 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.911 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.03 0.84 33.83 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.406 ' HG ' ' H ' ' A' ' 104' ' ' TRP . 21.0 p -129.27 -167.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.982 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -4.92 19.62 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.568 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 63.0 t-105 -47.1 -41.13 16.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.775 -0.838 . . . . 0.0 110.413 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.63 -51.89 66.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 109.967 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -62.56 -43.99 97.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 108.828 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 10.1 t80 -63.52 -39.21 93.84 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.481 0.658 . . . . 0.0 110.059 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.568 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 18.8 mm-40 -69.78 -48.63 58.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.44 -0.787 . . . . 0.0 111.479 -178.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.45 -51.35 11.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.927 -1.108 . . . . 0.0 110.965 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.92 -43.89 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.009 -1.057 . . . . 0.0 110.967 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -28.88 63.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 109.802 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -13.07 59.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.012 -1.055 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.97 34.3 5.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.594 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 114' ' ' ILE . 12.4 mt -90.77 147.54 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.797 -1.189 . . . . 0.0 110.474 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.1 tp -131.75 158.59 40.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.063 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.702 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -101.75 146.16 28.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.681 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.49 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.2 mt-30 -112.66 -166.42 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 0.0 109.616 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.96 72.53 1.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 110.672 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -163.3 140.68 7.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 109.748 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 121' ' ' ILE . 3.0 tm-20 -78.31 124.09 27.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.343 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.492 ' O ' ' OE2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -71.58 141.04 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.724 -178.894 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -85.36 86.43 7.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -63.24 146.7 52.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.6 122.65 44.24 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.1 138.46 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.333 -0.854 . . . . 0.0 110.461 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.06 136.23 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -117.78 -9.12 10.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.03 143.57 28.63 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.407 -0.808 . . . . 0.0 109.162 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.66 161.63 44.65 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.232 1.955 . . . . 0.0 112.989 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.5 tt -150.64 144.0 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.651 -0.656 . . . . 0.0 109.46 -179.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.17 122.55 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.46 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.55 118.79 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.466 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -120.28 136.32 54.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.49 -0.756 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.19 150.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 110.503 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 55.94 24.45 7.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.653 . . . . 0.0 110.996 179.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.95 87.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -108.77 169.12 8.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.074 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -159.95 153.57 22.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.151 -1.593 . . . . 0.0 109.465 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.525 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 37.5 mt -148.57 136.05 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -126.14 142.1 51.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.996 -179.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.13 148.12 44.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 5.0 tm-20 -145.97 137.48 12.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.487 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 8.3 Cg_endo -53.84 146.5 45.64 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.744 1.63 . . . . 0.0 112.605 -179.147 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.75 11.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.21 1.43 48.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.49 ' OG1' ' OE2' ' A' ' 168' ' ' GLU . 2.4 p -137.88 150.33 47.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.479 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 24.2 tp -81.88 117.16 21.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 110.042 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -138.69 136.3 35.69 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.18 139.62 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.92 . . . . 0.0 109.985 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.0 m -125.15 140.37 52.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.335 -0.853 . . . . 0.0 109.625 179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.402 ' HH ' ' HD2' ' A' ' 227' ' ' LYS . 85.7 t80 -125.51 129.97 50.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.707 . . . . 0.0 109.81 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -115.07 111.17 20.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -106.0 146.87 16.13 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -128.15 86.19 2.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -1.093 . . . . 0.0 109.233 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 2.9 m-30 -94.28 149.2 21.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.95 -9.67 47.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.521 -0.737 . . . . 0.0 110.433 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -66.48 -172.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.022 -1.049 . . . . 0.0 109.616 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -55.2 -24.54 27.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.05 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.93 -43.01 97.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.044 -1.035 . . . . 0.0 109.432 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.78 -119.9 5.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -114.8 140.88 48.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.421 -1.046 . . . . 0.0 109.311 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.02 140.27 16.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.813 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -124.42 151.76 44.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.521 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 81.1 t80 -136.03 121.12 18.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -0.933 . . . . 0.0 109.05 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 48.7 m -99.47 122.72 42.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 167' ' ' VAL . 2.3 t80 -95.79 134.34 38.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.527 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.8 t -129.69 157.5 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.533 -0.73 . . . . 0.0 109.319 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 28.9 mp0 -60.48 116.17 4.12 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.58 6.17 17.72 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -135.87 29.74 3.13 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.037 -1.272 . . . . 0.0 108.918 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.97 -30.7 70.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 110.405 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -54.34 -9.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 110.66 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.88 -4.22 25.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.905 -1.122 . . . . 0.0 111.256 -178.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.563 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.3 pt -116.66 13.4 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.041 -1.037 . . . . 0.0 110.979 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.47 -28.6 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.071 -1.018 . . . . 0.0 109.612 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.08 0.28 57.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.737 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.85 119.51 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 108.239 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -88.45 150.11 23.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.197 . . . . 0.0 109.963 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 179' ' ' THR . 1.9 t -58.06 129.37 41.63 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . 0.488 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 14.6 p90 -109.16 166.53 10.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -153.99 159.79 41.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.498 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.594 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 67.9 m-85 -104.08 147.21 27.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 49.0 p30 -60.07 -22.58 62.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.08 -1.013 . . . . 0.0 110.116 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.8 p90 -81.99 -33.08 30.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.91 -1.119 . . . . 0.0 110.53 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 24.4 pt-20 -85.16 -16.39 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.803 -1.185 . . . . 0.0 109.345 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 11.9 mt -59.24 -53.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.235 -0.915 . . . . 0.0 110.058 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 184' ' ' TRP . 2.9 mp0 -51.49 -53.57 36.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.196 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -47.66 65.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 108.924 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.29 -34.1 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.0 108.76 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -80.13 -25.87 39.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.843 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.01 -21.27 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.7 m -90.7 13.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.43 25.65 72.16 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.15 167.2 16.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.237 -1.155 . . . . 0.0 109.918 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.9 16.98 80.3 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.457 -0.777 . . . . 0.0 111.314 178.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -64.11 -51.97 61.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.601 -1.529 . . . . 0.0 109.235 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -70.2 -4.38 49.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -178.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.66 130.0 39.67 Favored Glycine 0 N--CA 1.493 2.472 0 O-C-N 120.96 -1.318 . . . . 0.0 110.641 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -143.26 173.58 11.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.749 -0.854 . . . . 0.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.71 -1.81 40.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.641 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -97.24 -10.45 25.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -139.44 13.29 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.516 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 18.0 m -149.29 133.18 17.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.139 -0.975 . . . . 0.0 109.935 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.55 117.23 29.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 108.528 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -105.92 126.59 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.962 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.05 144.15 33.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 0.0 109.396 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 208' ' ' LYS . . . -102.91 153.24 18.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 207' ' ' GLY . 18.0 pttm -41.64 -32.52 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -151.32 13.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.951 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -139.24 147.36 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.6 t -98.2 125.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.032 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -73.0 -54.63 8.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -52.41 139.13 38.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.879 -1.138 . . . . 0.0 109.508 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.21 -38.07 4.05 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.386 2.057 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.49 -4.4 22.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.51 -168.88 53.73 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.47 149.05 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -1.12 . . . . 0.0 109.618 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -58.26 3.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 108.958 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -117.5 170.84 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.94 -18.03 60.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.113 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.699 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -128.23 29.98 5.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 109.537 -179.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 pp20? -62.95 -25.06 1.56 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 112.537 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 1.1 Cg_endo -80.57 -46.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.079 1.421 . . . . 0.0 112.082 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.2 m -73.04 -22.1 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.885 -1.135 . . . . 0.0 108.005 179.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.699 HH21 ' ND2' ' A' ' 221' ' ' ASN . 48.8 mtt180 -71.35 -49.63 40.38 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -55.07 -42.57 72.93 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.402 ' HD2' ' HH ' ' A' ' 151' ' ' TYR . 1.0 OUTLIER -57.04 -45.49 83.14 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.288 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 30.9 t -60.76 -50.15 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.584 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 65.2 t80 -49.45 -37.36 25.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 11.1 m-20 -74.65 -39.19 62.22 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.591 -0.693 . . . . 0.0 109.737 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.499 ' CD2' ' HG ' ' A' ' 248' ' ' SER . 25.5 tp -56.64 -36.76 69.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 109.267 -179.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.453 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 96.9 mt -72.33 -48.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.67 -32.79 17.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.41 -28.07 31.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.187 -1.184 . . . . 0.0 109.899 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.1 mt -79.75 -23.04 42.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.876 -1.14 . . . . 0.0 110.055 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.526 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.4 t80 -71.44 -8.21 52.39 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.035 -1.041 . . . . 0.0 109.09 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 35.7 mt -52.85 -25.87 12.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 46.9 mt -58.56 -21.92 54.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 108.845 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.49 65.99 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.1 p -158.19 149.61 16.77 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.561 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -48.16 134.32 24.58 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.12 1.88 . . . . 0.0 111.583 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.2 133.28 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.024 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -120.25 125.07 47.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.46 172.46 23.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -101.63 117.43 34.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.046 -1.267 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -117.49 147.73 42.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.115 0.96 . . . . 0.0 111.185 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -130.08 138.26 50.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.499 ' HG ' ' CD2' ' A' ' 231' ' ' LEU . 0.3 OUTLIER -133.91 127.01 31.59 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.801 -1.187 . . . . 0.0 110.361 -178.956 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.443 ' O ' ' C ' ' A' ' 250' ' ' ARG . 43.1 t80 -109.22 114.45 28.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.2 OUTLIER 44.31 55.95 5.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.799 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.69 145.88 27.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.3 162.84 12.24 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.489 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 69.8 m-70 -56.47 -50.12 72.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 109.825 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 t -59.07 -55.88 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.656 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.56 -39.67 61.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.079 -1.013 . . . . 0.0 109.508 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -58.24 -54.73 43.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.16 -0.963 . . . . 0.0 108.421 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 13.5 t -48.8 -41.63 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.362 -0.836 . . . . 0.0 109.47 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -55.28 -48.96 73.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 108.821 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 27.8 tp -52.36 -41.92 63.5 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.57 -45.31 74.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.596 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -53.62 -51.06 64.27 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.451 -0.78 . . . . 0.0 110.265 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -63.19 -47.59 81.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 109.861 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.79 -44.5 93.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.291 -0.881 . . . . 0.0 109.375 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 108.762 179.252 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.593 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -51.83 136.8 27.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' CB ' ' HZ1' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -117.79 134.63 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.667 -0.646 . . . . 0.0 109.458 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -133.62 170.96 14.77 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.4 m -81.94 132.68 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.665 -1.272 . . . . 0.0 110.199 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.61 ' HZ1' ' CB ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -61.8 -49.09 77.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 0.0 109.724 179.455 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.549 ' CG ' HD21 ' A' ' 113' ' ' ASN . 8.4 pt-20 -128.51 158.24 38.93 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.454 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.65 138.73 56.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.573 -0.704 . . . . 0.0 110.254 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.94 161.86 24.55 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -157.91 150.02 22.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.985 -1.072 . . . . 0.0 110.374 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -137.48 160.49 38.99 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.803 . . . . 0.0 109.948 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.11 138.9 24.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.563 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.19 158.56 16.63 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.46 161.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -1.128 . . . . 0.0 111.069 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.32 140.29 14.96 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 197' ' ' GLY . 14.8 tt -57.57 -52.87 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.133 -1.216 . . . . 0.0 112.451 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -86.63 -37.67 17.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.175 -1.578 . . . . 0.0 111.195 -178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m -75.01 -35.29 61.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.016 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 26.53 71.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.09 152.56 33.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.936 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.5 OUTLIER -71.75 129.56 38.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.953 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.6 t -135.86 156.43 48.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 108.943 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -135.55 148.26 49.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.065 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.18 143.88 50.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.063 -1.023 . . . . 0.0 109.072 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.3 mt -126.19 134.17 67.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mt -116.79 130.23 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.059 . . . . 0.0 109.619 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.1 154.02 74.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.71 154.23 75.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.284 1.99 . . . . 0.0 111.353 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.1 mm-40 -133.61 -174.33 3.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.0 ttpt -87.57 149.36 24.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -47.68 152.2 0.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 110.084 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 20.63 53.24 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.338 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.4 m -80.68 -42.97 21.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.641 -1.505 . . . . 0.0 108.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.46 -172.07 27.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.7 mm -99.64 121.38 50.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.979 . . . . 0.0 108.562 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -135.64 145.97 47.39 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.744 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -102.68 150.0 23.88 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.528 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.9 t80 -132.29 138.67 47.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.566 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 16.0 tttm -167.19 141.29 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.566 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 1.3 m120 54.23 29.53 10.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 30.11 68.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.86 125.17 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -1.059 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.53 139.18 30.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 108.977 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.45 94.16 17.81 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 110.052 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -48.69 144.41 14.63 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.251 1.967 . . . . 0.0 111.919 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.64 84.92 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.413 HH11 ' HB3' ' A' ' 49' ' ' ARG . 3.1 mmm180 -136.33 154.88 50.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 109.15 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 4.8 p80 -50.54 -50.15 54.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.007 -1.058 . . . . 0.0 109.496 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.9 mt-10 -43.97 -32.48 1.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 109.48 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.65 3.32 19.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.325 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 50' ' ' HIS . 2.9 t -63.17 118.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 108.796 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.05 -29.19 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.444 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.0 t-80 -150.18 123.4 8.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.616 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -112.44 136.78 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 59' ' ' SER . 45.2 t30 -166.68 -154.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -50.79 -10.03 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.0 108.17 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.593 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -137.76 166.84 22.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.462 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.0 m -105.43 122.04 45.15 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.4 OUTLIER -120.32 140.86 50.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 111.529 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.6 mt -123.02 154.92 37.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -169.21 141.61 6.82 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.876 -1.631 . . . . 0.0 110.683 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -144.38 150.7 38.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.495 -1.003 . . . . 0.0 110.028 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.76 13.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.717 . . . . 0.0 110.758 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.36 1.02 79.07 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.541 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 28.9 mm-40 -99.79 143.96 29.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.951 -1.323 . . . . 0.0 108.668 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -138.55 149.92 45.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 111.269 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.3 mt -135.33 134.51 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -107.85 156.41 19.19 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.302 -0.874 . . . . 0.0 111.055 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.1 m 53.04 68.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.697 -0.627 . . . . 0.0 110.827 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 m -113.06 -5.21 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.081 -1.012 . . . . 0.0 109.039 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.2 OUTLIER -68.55 -39.19 81.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 110.414 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -54.64 -60.73 2.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.09 -43.59 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.825 -1.172 . . . . 0.0 109.147 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 76.4 mt -57.28 -35.79 70.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.536 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.1 t -62.27 -50.26 72.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.984 . . . . 0.0 109.567 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.89 -51.2 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 0.0 108.451 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.4 mt -51.79 -45.4 63.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.781 . . . . 0.0 109.4 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 9.3 t-160 -54.92 -51.69 65.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.8 mt -63.26 -37.19 86.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.93 . . . . 0.0 110.625 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 20.7 mt -82.06 -6.82 59.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.044 -1.035 . . . . 0.0 111.091 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.82 53.99 2.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.299 . . . . 0.0 110.543 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mm -90.0 126.5 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 75.5 p -109.75 -26.86 9.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 111.705 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.408 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 5.0 m-80 -131.33 112.7 12.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.817 -1.177 . . . . 0.0 110.715 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -164.04 134.88 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.758 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.547 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 12.1 m -106.03 103.82 13.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -92.35 103.9 15.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 109.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.76 120.45 23.43 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.16 105.8 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.446 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.92 109.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.29 -159.81 23.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.65 -10.13 12.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.536 -0.979 . . . . 0.0 110.77 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -151.98 155.34 37.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.672 -1.268 . . . . 0.0 111.056 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 mm -73.24 124.58 90.71 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.741 -0.6 . . . . 0.0 110.164 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -45.8 134.46 13.8 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.069 1.846 . . . . 0.0 112.177 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -80.44 -29.5 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.481 -0.762 . . . . 0.0 110.714 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 65.1 mt 57.59 -126.13 1.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.72 -23.96 39.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 110.242 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.51 -8.66 13.38 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -116.44 -171.34 1.98 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.419 -1.048 . . . . 0.0 109.786 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.76 -2.62 30.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 63.5 t-105 -46.58 -41.8 15.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.87 . . . . 0.0 110.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.67 -52.23 65.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.011 -1.056 . . . . 0.0 110.499 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -64.81 -43.27 93.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 108.894 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -63.72 -36.79 85.03 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.363 0.601 . . . . 0.0 109.958 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 4.8 mm-40 -68.41 -52.62 30.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.772 . . . . 0.0 111.873 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.71 -50.91 21.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.888 -1.132 . . . . 0.0 110.822 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.36 -43.19 89.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.66 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -53.61 -31.51 47.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 110.13 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.549 HD21 ' CG ' ' A' ' 9' ' ' GLU . 2.6 m120 -122.84 28.4 7.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.337 -0.852 . . . . 0.0 111.401 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.2 mt -85.73 147.19 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.636 -1.29 . . . . 0.0 109.617 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -131.23 153.71 49.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.768 . . . . 0.0 109.098 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -101.46 143.93 30.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.053 -1.029 . . . . 0.0 109.548 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.596 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 8.6 mt-30 -108.29 -166.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -116.73 70.7 0.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.797 . . . . 0.0 110.565 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -168.19 146.98 4.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.149 -0.969 . . . . 0.0 109.587 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -86.69 135.18 33.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 58.6 mt -81.71 149.76 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.463 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -97.24 100.29 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -71.74 147.08 47.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 110.748 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -96.77 121.83 39.06 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.47 135.24 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.396 -0.815 . . . . 0.0 110.316 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.85 133.57 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.5 -10.75 13.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 109.301 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -142.89 143.45 25.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.44 171.88 16.82 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.38 2.053 . . . . 0.0 112.997 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.1 tt -165.74 142.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.699 -0.625 . . . . 0.0 109.694 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.76 125.86 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.509 -0.744 . . . . 0.0 109.833 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.1 m -121.96 120.06 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.725 . . . . 0.0 109.364 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.68 137.44 52.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.17 147.99 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.013 . . . . 0.0 110.829 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 56.84 24.83 9.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.6 -0.688 . . . . 0.0 110.955 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.39 85.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -109.33 169.65 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 7.6 tt -159.48 152.36 21.79 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.18 -1.575 . . . . 0.0 109.108 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.496 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 41.6 mt -148.72 139.87 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.0 108.363 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -128.08 142.66 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 110.106 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.01 144.91 48.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -143.13 138.87 16.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 108.622 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.32 148.08 73.2 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.415 1.41 . . . . 0.0 111.735 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -167.2 155.9 9.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.1 0.05 55.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -136.44 150.46 48.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.9 tp -81.74 116.88 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -138.65 134.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.63 124.6 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.2 137.55 50.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.02 129.72 49.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.488 -0.757 . . . . 0.0 110.117 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -111.82 103.89 12.18 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.15 140.72 15.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -116.46 101.53 8.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.42 ' CB ' ' ND2' ' A' ' 157' ' ' ASN . 48.8 m-85 -100.9 142.98 31.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 109.939 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.94 1.86 56.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 0.0 109.561 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.696 HD21 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -84.38 -166.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -62.7 -25.17 68.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 110.272 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.434 ' HB2' HD22 ' A' ' 157' ' ' ASN . 76.8 mt -66.41 -25.34 66.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.009 -1.057 . . . . 0.0 109.398 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.81 47.78 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -93.11 144.99 24.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.995 . . . . 0.0 109.837 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -150.18 137.07 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 147.23 47.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.072 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.687 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 58.3 t80 -136.62 124.11 22.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.8 m -101.64 121.92 42.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.964 . . . . 0.0 109.705 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.55 135.42 41.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.74 151.4 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 109.507 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.536 ' OE2' ' NZ ' ' A' ' 243' ' ' LYS . 19.4 mt-10 -51.67 116.56 2.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.311 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.66 7.42 15.76 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.544 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 14.6 m-80 -134.85 28.39 3.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.179 -1.189 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.4 mp0 -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.752 -0.593 . . . . 0.0 110.582 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.89 -15.51 31.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.624 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -94.91 -4.23 47.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.956 -1.09 . . . . 0.0 110.898 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.546 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 4.2 pt -121.46 13.65 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.946 -1.096 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.87 -25.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.958 -1.089 . . . . 0.0 109.6 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -91.26 2.02 56.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.989 -1.069 . . . . 0.0 110.533 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.48 109.38 16.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.013 -1.054 . . . . 0.0 108.895 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.503 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -82.07 153.4 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 109.917 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.471 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 4.8 t -54.3 156.65 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.778 . . . . 0.0 109.338 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.76 170.68 15.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.875 -1.141 . . . . 0.0 110.119 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.585 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 3.5 t -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 109.469 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.625 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.5 m-85 -105.47 144.71 31.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.559 -0.713 . . . . 0.0 109.286 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.22 -21.86 62.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.703 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.625 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.2 p90 -81.66 -33.94 31.02 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.625 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.6 pt-20 -88.83 -14.86 35.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.865 -1.147 . . . . 0.0 110.088 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.8 mt -54.79 -52.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.169 -0.957 . . . . 0.0 110.515 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.27 -47.11 62.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 109.544 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -53.65 55.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.975 . . . . 0.0 109.201 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.409 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 66.6 mt -55.43 -34.29 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 108.921 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.581 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 10.5 mmtm -77.04 -30.19 55.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.645 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -71.55 -22.24 61.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.5 m -91.6 13.31 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.941 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 69.68 27.33 73.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.76 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.87 159.22 27.27 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.251 . . . . 0.0 109.797 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 78.63 28.1 55.73 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.31 -0.948 . . . . 0.0 110.817 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.82 -20.39 63.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.691 -1.476 . . . . 0.0 109.066 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.28 -3.12 51.03 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.86 124.74 33.38 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 203' ' ' THR . 12.0 p -138.92 174.48 10.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.755 -0.85 . . . . 0.0 109.258 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.37 -15.87 60.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.485 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.431 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.2 tttm -87.79 -18.8 28.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 201' ' ' LYS . 1.8 m-20 -124.65 -8.6 7.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.649 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 199' ' ' SER . 0.7 OUTLIER -132.47 119.47 20.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -81.09 117.04 21.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.925 . . . . 0.0 108.9 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.3 t -104.66 128.43 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.81 148.45 30.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 109.73 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.39 156.05 16.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 207' ' ' GLY . 9.8 tttm -42.13 -33.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -1.141 . . . . 0.0 109.856 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -147.76 16.16 1.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -144.59 153.17 41.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 110.28 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.6 t -103.12 128.45 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.549 -0.719 . . . . 0.0 109.139 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -71.35 -53.97 12.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 0.0 109.996 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.67 133.75 86.17 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 109.411 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.43 -8.0 21.87 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.378 2.052 . . . . 0.0 112.708 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.16 -7.81 54.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 0.0 109.918 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.22 -167.68 48.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 55.4 mt -83.1 145.74 29.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.497 -1.002 . . . . 0.0 110.003 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -86.02 -20.08 29.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 221' ' ' ASN . 71.7 m-85 -146.22 133.19 20.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 108.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 31.7 mp0 -46.5 -16.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 108.865 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -131.63 33.54 4.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.617 0.722 . . . . 0.0 109.151 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 4.7 tt0 -53.66 -57.31 17.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_endo -54.21 -38.95 88.19 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.902 1.735 . . . . 0.0 113.036 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 9.1 m -79.77 -26.46 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.528 -1.357 . . . . 0.0 108.8 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 40.3 mtt-85 -64.69 -41.15 96.24 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -65.41 -43.45 90.54 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -48.36 76.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 108.979 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 34.8 t -61.07 -42.74 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 108.467 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 89.2 t80 -58.72 -39.21 80.19 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 1.0 OUTLIER -73.03 -39.51 65.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.55 -0.718 . . . . 0.0 109.696 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.2 tp -56.62 -36.36 69.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.221 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.486 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 94.0 mt -70.67 -48.31 59.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.7 -33.28 18.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.44 -26.56 32.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.258 . . . . 0.0 109.897 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.49 -23.19 40.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.762 -1.212 . . . . 0.0 110.11 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.516 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 10.1 t80 -71.65 -8.59 55.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 68.9 mt -52.52 -28.03 18.93 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.27 -13.92 3.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 108.507 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 14.9 81.61 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 84.1 p -158.99 144.67 12.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.829 -1.395 . . . . 0.0 109.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -43.36 129.3 6.35 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.077 1.851 . . . . 0.0 111.662 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.6 t -96.3 135.25 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.971 . . . . 0.0 110.148 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.536 ' NZ ' ' OE2' ' A' ' 168' ' ' GLU . 26.8 mmtt -120.16 125.27 47.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.53 171.73 24.77 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -102.65 112.27 24.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.068 -1.254 . . . . 0.0 109.769 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.4 m-85 -112.67 146.75 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.825 0.821 . . . . 0.0 111.354 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -128.61 143.06 50.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.69 125.71 21.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.57 -1.331 . . . . 0.0 110.144 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 250' ' ' ARG . 8.9 t80 -109.77 115.22 29.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 17.2 mtt180 44.0 56.0 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -91.92 157.8 24.55 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.593 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -120.3 -171.56 14.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 87.5 m-70 -74.91 -52.09 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -1.207 . . . . 0.0 110.044 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.0 m -55.1 -56.12 23.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.077 -1.014 . . . . 0.0 109.406 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.1 tp -54.26 -42.57 70.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.487 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -59.07 -55.32 36.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.031 . . . . 0.0 108.7 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 7.3 t -52.28 -39.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.895 . . . . 0.0 109.158 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -54.7 -47.79 73.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 108.643 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.66 -50.16 63.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 53.1 t -61.25 -42.29 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.548 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -52.39 65.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.805 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.62 -40.84 96.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.987 -1.071 . . . . 0.0 109.786 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 30.1 mt -61.89 -45.99 91.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.07 -27.63 61.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 110.627 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -87.26 -26.57 23.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.687 -1.258 . . . . 0.0 109.039 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -74.15 -46.09 44.6 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.185 -0.947 . . . . 0.0 109.318 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 270' ' ' THR . 4.1 mp0 -78.16 12.92 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.615 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -60.55 -33.32 72.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.592 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 44.3 mt -63.0 -30.0 71.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.513 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 267' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.376 -0.827 . . . . 0.0 109.426 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.585 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 14.7 mt-10 -46.94 142.24 3.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.154 -0.966 . . . . 0.0 109.466 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.63 134.33 54.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.568 -0.707 . . . . 0.0 110.121 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -139.2 179.04 6.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 108.766 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 m -87.58 138.06 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.27 . . . . 0.0 110.456 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -73.74 -43.77 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.75 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -125.04 150.04 47.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.177 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 140.04 58.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.814 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -122.27 168.04 12.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.586 -0.696 . . . . 0.0 109.198 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.26 148.4 23.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.06 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -135.46 158.02 45.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.498 -0.751 . . . . 0.0 109.588 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -147.89 137.73 22.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.022 -1.049 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.0 160.1 18.69 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 9.4 p -81.51 138.61 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -1.186 . . . . 0.0 110.507 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.47 145.28 43.79 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -62.53 -47.88 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.452 -1.028 . . . . 0.0 112.682 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.8 m-70 -87.08 -38.69 16.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.02 -1.675 . . . . 0.0 111.486 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.4 HG22 HD21 ' A' ' 94' ' ' ASN . 3.5 m -74.74 -35.95 62.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.894 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 68.15 22.42 74.34 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -110.13 148.75 31.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.443 -1.033 . . . . 0.0 109.116 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -71.59 130.98 42.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 110.026 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -140.09 156.47 46.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 tttm -135.31 147.13 49.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -0.974 . . . . 0.0 109.098 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mt -128.19 144.53 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.964 -1.085 . . . . 0.0 109.428 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.4 mt -122.14 140.71 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.3 mt -121.03 118.84 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.109 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -117.4 154.08 50.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.2 164.04 35.53 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.296 1.997 . . . . 0.0 111.24 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 13.3 mm-40 -134.36 -175.95 4.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.993 . . . . 0.0 109.842 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' O ' ' OG1' ' A' ' 35' ' ' THR . 15.6 tttm -91.67 158.73 16.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.613 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -51.61 145.4 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.58 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 63.97 23.35 67.56 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.575 -0.703 . . . . 0.0 111.855 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 93.2 m -82.06 -46.36 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.365 -1.667 . . . . 0.0 109.199 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.6 -171.19 23.79 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mm -96.67 123.42 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -1.151 . . . . 0.0 108.375 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.03 140.26 32.58 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.04 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -100.52 152.32 20.53 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.4 t80 -132.22 137.76 47.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 15.6 tttt -165.76 140.21 4.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 109.478 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.6 29.35 13.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.56 12.62 82.38 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.36 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.02 139.35 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -1.141 . . . . 0.0 109.75 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -98.74 141.46 31.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.095 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.45 94.76 19.0 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.2 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -51.4 147.15 22.88 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.261 1.974 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.82 84.83 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.893 -1.129 . . . . 0.0 110.605 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -137.6 153.97 49.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.688 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 2.4 p80 -50.62 -49.36 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.564 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.688 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 86.5 mt-10 -44.38 -33.41 1.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 109.104 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -80.15 0.49 32.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.414 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' HIS . 4.0 t -59.25 126.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 108.746 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.59 -32.25 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 0.0 110.153 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.71 124.36 7.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.708 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 p -112.35 134.03 54.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.612 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -166.63 -153.89 0.17 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.581 ' O ' ' NXH' ' A' ' 320' ' ' TUX . 6.5 m80 -48.59 -11.4 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.97 -1.081 . . . . 0.0 108.455 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 57' ' ' ASN . 8.5 t -138.16 166.24 24.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.497 -0.752 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.7 m -104.14 122.55 45.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.895 . . . . 0.0 108.717 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.34 141.98 50.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.266 -0.896 . . . . 0.0 111.446 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -125.12 156.43 38.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -170.32 140.44 6.02 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.607 -1.759 . . . . 0.0 110.886 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -144.58 150.61 37.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.963 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt 55.28 32.85 19.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.37 -0.831 . . . . 0.0 110.519 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.83 3.1 89.56 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.346 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 73.8 mm-40 -96.76 140.95 30.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.998 -1.295 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -135.52 144.39 46.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 111.147 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.3 mt -133.7 139.43 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -115.1 154.79 28.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.341 -0.849 . . . . 0.0 111.161 -179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m 52.41 70.35 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.602 -0.686 . . . . 0.0 110.63 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.3 m -113.54 -8.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 109.508 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -68.16 -20.38 64.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.371 -179.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -71.92 -60.7 2.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.926 -1.109 . . . . 0.0 109.266 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.9 -43.98 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 108.755 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 89.6 mt -58.89 -37.53 76.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.809 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.6 t -61.12 -48.71 80.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.975 . . . . 0.0 109.904 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.61 -53.56 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.95 -1.094 . . . . 0.0 108.611 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -52.45 -44.76 65.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.299 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.469 ' ND1' ' CG2' ' A' ' 232' ' ' ILE . 15.8 t-160 -54.29 -57.72 10.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.6 mt -57.36 -36.08 70.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.665 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -82.75 0.54 43.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.72 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.4 27.5 16.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.858 -1.151 . . . . 0.0 110.708 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.3 mm -73.91 121.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.138 . . . . 0.0 108.351 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.493 ' HG1' ' H ' ' A' ' 86' ' ' ASN . 1.0 OUTLIER -104.28 -74.63 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 111.227 -178.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.735 ' H ' HD21 ' A' ' 86' ' ' ASN . 0.5 OUTLIER -80.19 114.11 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 111.685 -176.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.48 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 6.0 m -163.95 142.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.492 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 28.2 m -111.86 101.8 10.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.98 105.97 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.639 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.84 128.5 33.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.845 -1.159 . . . . 0.0 108.329 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 68.6 t -111.52 110.68 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.438 -0.789 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.34 110.27 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.525 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 129.96 -158.14 22.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.4 HD21 HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER -120.39 -10.14 9.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.492 -1.005 . . . . 0.0 110.483 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 3.3 pm0 -145.56 150.21 35.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.68 -1.263 . . . . 0.0 110.821 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 mm -74.75 122.55 87.74 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.629 -0.67 . . . . 0.0 110.045 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -45.97 131.67 13.89 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.118 1.879 . . . . 0.0 112.341 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.6 tp -77.39 -24.85 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -0.798 . . . . 0.0 109.981 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.49 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 19.0 mt 58.35 -113.49 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.798 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.74 -19.24 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.982 -1.074 . . . . 0.0 110.855 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.05 -11.49 20.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.42 -170.35 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.379 -1.071 . . . . 0.0 109.657 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.8 -4.15 21.46 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -46.62 -40.79 13.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.743 -0.857 . . . . 0.0 110.119 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.52 -51.88 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.048 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 60.1 m-85 -63.59 -44.08 95.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 10.4 t80 -63.05 -37.72 88.32 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.465 0.65 . . . . 0.0 109.824 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.96 -49.95 53.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.544 -0.722 . . . . 0.0 111.473 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.6 -51.86 11.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.858 -1.151 . . . . 0.0 110.644 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.16 -43.41 81.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 120.976 -1.077 . . . . 0.0 110.233 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -55.58 -31.29 62.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.457 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -81.85 -5.32 58.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.583 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -127.03 35.31 4.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.425 -0.797 . . . . 0.0 110.887 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.9 mt -90.27 145.43 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.801 -1.187 . . . . 0.0 110.548 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 26.7 tp -131.08 156.6 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.682 ' N ' HD21 ' A' ' 116' ' ' ASN . 0.6 OUTLIER -111.6 141.94 44.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.866 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -102.66 -161.19 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.317 -0.864 . . . . 0.0 108.975 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -118.61 2.29 11.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.214 -0.929 . . . . 0.0 111.094 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 4' ' ' GLU . 10.8 ttp85 -100.24 155.99 17.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.796 -1.19 . . . . 0.0 110.136 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 121' ' ' ILE . 13.9 tm-20 -89.07 136.79 32.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.499 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 19.6 mt -76.63 142.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.74 . . . . 0.0 110.694 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -85.22 88.26 7.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.44 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 45.6 m-85 -63.23 144.96 56.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.412 -0.805 . . . . 0.0 110.651 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -102.0 125.16 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 t -129.97 143.98 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.0 135.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.7 -12.78 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.764 . . . . 0.0 109.171 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.91 142.56 28.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 108.941 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.85 159.34 52.07 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.907 1.738 . . . . 0.0 113.122 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 tt -155.41 138.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.1 mt -127.59 125.71 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.18 113.08 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -117.09 126.91 53.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.493 -0.754 . . . . 0.0 109.707 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -173.67 155.09 2.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.52 20.52 9.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.583 -0.698 . . . . 0.0 110.728 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.3 3.06 88.37 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.3 mtt85 -104.8 172.46 6.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.3 tt -160.04 150.39 18.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.335 -1.478 . . . . 0.0 109.015 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 3.2 mt -148.05 131.87 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.085 -1.01 . . . . 0.0 109.066 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -120.16 138.97 53.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 109.894 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -124.97 134.84 52.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -133.5 137.76 29.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.56 147.54 29.98 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.291 1.327 . . . . 0.0 111.96 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.44 158.22 9.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.31 2.2 56.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.782 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.2 p -131.91 139.0 48.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 0.0 109.634 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 tp -73.76 116.6 14.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.711 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -137.71 137.1 37.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 108.738 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 75.6 t -140.2 123.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 109.415 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 m -115.56 145.15 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -130.75 130.93 44.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.721 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.11 140.98 48.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.28 144.47 16.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.67 84.49 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.566 -0.961 . . . . 0.0 108.971 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 160' ' ' GLY . 13.6 m-85 -87.02 148.67 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.727 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -93.33 -5.83 48.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 110.037 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.2 p30 -70.43 -167.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.893 -1.13 . . . . 0.0 109.158 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -56.9 -21.59 30.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.005 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.463 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.3 mt -61.74 -57.46 11.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.28 -99.31 2.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.421 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.4 OUTLIER -125.89 136.7 53.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -1.111 . . . . 0.0 109.059 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -145.74 159.43 43.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.721 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -160.2 150.4 18.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -138.32 127.47 24.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 29.3 m -102.12 123.44 45.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.144 -0.973 . . . . 0.0 109.509 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.3 135.99 39.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.103 -0.998 . . . . 0.0 109.537 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.519 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -133.19 154.25 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.735 . . . . 0.0 109.337 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -57.6 118.4 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -0.965 . . . . 0.0 109.666 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.68 1.27 21.4 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.77 31.42 3.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.161 -1.2 . . . . 0.0 108.883 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -64.69 -33.52 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 110.719 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.23 -14.54 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 0.0 110.935 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.528 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 25.7 mt-10 -89.97 -3.95 57.73 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.29 -10.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.035 -1.041 . . . . 0.0 111.105 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -29.92 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.514 -1.366 . . . . 0.0 110.316 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.47 2.73 43.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.797 -1.189 . . . . 0.0 110.282 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.68 130.26 35.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.776 -1.202 . . . . 0.0 108.681 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.681 HH21 ' N ' ' A' ' 203' ' ' THR . 15.4 ptm180 -104.84 155.12 19.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -0.891 . . . . 0.0 110.463 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.471 ' CA ' ' CE1' ' A' ' 226' ' ' HIS . 3.0 t -56.17 156.71 5.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.249 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.03 166.7 24.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.061 . . . . 0.0 110.527 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.56 ' SG ' ' OE2' ' A' ' 185' ' ' GLU . 0.5 OUTLIER -156.9 162.06 39.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.507 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -104.76 144.67 31.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 39.7 p30 -60.59 -21.59 62.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 111.562 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.9 p90 -76.58 -34.7 58.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.659 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.59 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.5 pt-20 -96.7 -8.3 31.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.476 -1.39 . . . . 0.0 110.261 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.5 mt -55.37 -51.12 59.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.0 -1.062 . . . . 0.0 109.819 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -51.41 -51.82 51.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.237 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -49.22 66.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.157 -0.964 . . . . 0.0 108.794 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.442 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 63.8 mt -57.46 -33.96 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.918 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -77.21 -25.91 52.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 110.02 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -77.12 -30.45 55.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.938 . . . . 0.0 109.886 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.08 8.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.188 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.472 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . . . 75.77 22.88 73.86 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.524 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 66.0 mt -118.58 157.62 27.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -1.153 . . . . 0.0 109.682 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.47 21.11 65.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.472 ' NZ ' ' O ' ' A' ' 193' ' ' GLY . 23.2 mttt -66.14 -25.04 66.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.849 -1.383 . . . . 0.0 109.705 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.4 -4.89 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.36 127.91 35.38 Favored Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.132 -1.217 . . . . 0.0 110.622 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -135.37 170.43 15.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.645 -0.915 . . . . 0.0 109.091 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.71 -36.03 81.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.074 -1.017 . . . . 0.0 109.575 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.546 ' C ' HD21 ' A' ' 202' ' ' ASN . 30.3 ttmt -73.32 -27.64 61.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.217 -0.927 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.743 HD21 ' N ' ' A' ' 202' ' ' ASN . 0.6 OUTLIER -107.41 5.4 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.892 . . . . 0.0 110.084 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.681 ' N ' HH21 ' A' ' 178' ' ' ARG . 3.4 m -153.05 122.12 6.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.918 -1.114 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.9 tp -79.35 110.8 14.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 108.693 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.6 128.41 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.973 -1.079 . . . . 0.0 109.528 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.0 mt -106.38 148.46 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.97 149.13 16.62 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 207' ' ' GLY . 23.2 tptt -42.59 -27.38 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -1.161 . . . . 0.0 110.108 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 209' ' ' ASP . 52.6 p-10 -149.96 10.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.929 -1.107 . . . . 0.0 110.272 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.9 pttm -143.67 152.83 41.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.7 t -101.44 129.58 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.889 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.95 -54.41 8.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -57.86 134.65 83.31 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.828 -1.17 . . . . 0.0 109.428 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.92 -14.22 29.36 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.337 2.024 . . . . 0.0 112.695 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -83.85 -6.46 59.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.42 -166.17 54.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.0 148.76 31.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -1.122 . . . . 0.0 109.704 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 -22.76 23.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.656 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 77.0 m-85 -149.14 134.19 18.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.0 108.839 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 219' ' ' TYR . 11.0 tt0 -45.47 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.978 -1.076 . . . . 0.0 108.607 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -130.36 35.6 4.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.466 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 3.4 tt0 -56.81 -50.78 86.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.483 -0.761 . . . . 0.0 111.743 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 27.7 Cg_endo -65.82 -39.04 21.25 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.582 1.521 . . . . 0.0 113.457 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.09 -26.82 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.524 -1.36 . . . . 0.0 108.324 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 18.2 mtp180 -68.74 -44.11 74.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.471 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 17.3 t60 -59.87 -43.9 94.47 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.515 -0.741 . . . . 0.0 109.038 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -56.25 -41.43 75.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.807 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 23.0 t -62.42 -46.4 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.58 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.2 t80 -55.12 -41.71 72.04 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -70.67 -39.39 73.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.466 -0.771 . . . . 0.0 109.676 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.97 -35.62 69.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.463 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.469 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 95.2 mt -71.15 -48.78 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.36 -31.95 13.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.99 -28.43 29.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -1.224 . . . . 0.0 110.267 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.9 mt -79.49 -22.87 43.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.229 . . . . 0.0 109.79 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -68.64 -8.24 40.46 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.331 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 239' ' ' GLY . 36.4 mt -52.86 -32.58 45.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.851 . . . . 0.0 109.194 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.4 mt -52.61 -11.92 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.952 -1.093 . . . . 0.0 109.212 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.08 13.45 83.65 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.7 p -158.74 143.74 11.79 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.133 -1.216 . . . . 0.0 109.434 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -41.25 135.0 2.82 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 112.149 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.3 136.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 131.02 50.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.38 -0.825 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.79 -178.39 31.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.74 112.77 25.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.149 -1.207 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -115.16 145.5 42.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.027 0.918 . . . . 0.0 110.959 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -131.22 144.02 51.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.0 t -139.65 128.28 23.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.77 -1.206 . . . . 0.0 110.642 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 250' ' ' ARG . 46.0 t80 -108.98 117.18 33.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.4 mmm180 44.76 56.29 5.34 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.56 147.16 21.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -115.69 178.7 17.75 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.53 ' NE2' ' OXH' ' A' ' 320' ' ' TUX . 75.4 m-70 -68.47 -50.59 51.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.276 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 66.1 m -55.39 -55.26 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.031 -1.043 . . . . 0.0 109.367 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.9 tp -51.38 -39.32 56.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.315 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 10.9 m120 -59.71 -53.81 53.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 108.722 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 16.8 t -50.07 -43.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -55.21 -46.86 75.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.031 -1.043 . . . . 0.0 108.89 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 56.4 tp -52.6 -44.72 66.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.214 -0.928 . . . . 0.0 108.569 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.04 -56.26 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -46.97 -40.74 14.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -70.51 -46.53 63.48 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.909 -1.119 . . . . 0.0 110.037 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 39.4 mt -65.74 -37.5 86.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.903 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.4 66.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -86.34 -28.07 23.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.793 -1.192 . . . . 0.0 108.754 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.3 -45.07 67.03 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.482 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -79.86 13.61 2.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.849 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -105.13 -6.5 19.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 11.6 mt -45.79 -55.93 5.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.581 ' NXH' ' O ' ' A' ' 58' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 4' ' ' GLU . 12.2 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 3' ' ' LEU . 18.4 mm-40 -41.49 140.81 0.84 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.446 -0.783 . . . . 0.0 109.534 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.14 135.65 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.554 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.7 t -135.03 175.32 9.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 109.342 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.4 m -85.68 135.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.258 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -66.73 -44.19 82.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.41 152.55 48.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.825 . . . . 0.0 109.88 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 136.03 56.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.59 168.34 10.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 p -157.97 148.69 20.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.116 -0.99 . . . . 0.0 110.242 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -129.96 158.73 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 109.285 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.66 135.62 21.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.97 -1.081 . . . . 0.0 109.212 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.13 159.98 18.56 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 2.5 p -70.7 161.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.265 . . . . 0.0 110.908 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -95.4 140.79 15.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 197' ' ' GLY . 12.6 tt -56.99 -52.2 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.135 -1.215 . . . . 0.0 112.246 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.405 ' HD1' ' HA2' ' A' ' 195' ' ' GLY . 4.6 m-70 -86.46 -38.15 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.281 -1.512 . . . . 0.0 111.197 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.415 ' OG1' ' CD ' ' A' ' 95' ' ' GLU . 16.0 p -72.48 -35.03 68.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.762 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.6 24.76 68.21 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -117.52 155.09 30.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.885 . . . . 0.0 108.87 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.0 t80 -71.65 132.17 44.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 30.9 t -138.66 157.86 45.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 108.845 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -137.18 151.9 49.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 109.503 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -127.21 151.22 48.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.174 -0.954 . . . . 0.0 109.737 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.497 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.4 mt -137.69 127.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.4 mt -112.14 118.51 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.562 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 1.3 m-70 -116.98 149.25 43.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.97 162.44 19.11 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.187 1.925 . . . . 0.0 111.323 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.4 mm-40 -133.94 -177.48 4.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 0.0 109.87 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 6.8 tttm -82.3 149.69 27.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 11.5 mp0 -48.48 147.27 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 110.39 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.26 24.78 61.63 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.6 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 13.6 m -81.23 -46.43 14.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.734 -1.451 . . . . 0.0 109.445 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.62 -167.23 17.41 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mm -100.75 124.09 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.139 -1.212 . . . . 0.0 107.865 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -140.54 141.51 35.27 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.643 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -101.13 153.15 19.83 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.581 ' CG ' ' OE1' ' A' ' 90' ' ' GLU . 3.3 t80 -120.31 154.92 34.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -176.06 126.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.669 -1.27 . . . . 0.0 110.192 -179.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.84 37.22 16.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.31 77.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -126.23 128.77 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -1.086 . . . . 0.0 109.66 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -89.52 141.75 28.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.4 mt -136.49 95.59 12.74 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.46 144.52 9.97 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.975 1.783 . . . . 0.0 111.472 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.46 85.29 4.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.953 -1.092 . . . . 0.0 110.66 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.74 154.14 49.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' VAL . 9.7 p80 -50.62 -48.81 57.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 109.694 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 50.3 mt-10 -43.2 -33.33 0.9 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.347 -0.846 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -77.78 1.85 18.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.241 -0.912 . . . . 0.0 110.275 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 50' ' ' HIS . 4.1 t -63.01 119.08 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 108.77 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.66 -30.92 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.232 -0.918 . . . . 0.0 110.524 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.583 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.3 t-160 -145.71 118.64 8.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.062 . . . . 0.0 109.63 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.1 p -112.34 132.03 55.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.445 0.64 . . . . 0.0 109.455 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.593 ' CG ' ' H ' ' A' ' 58' ' ' HIS . 4.8 t-20 -166.0 -154.32 0.19 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.593 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 1.4 m-70 -48.32 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.835 -1.166 . . . . 0.0 108.329 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' ASN . 16.0 t -136.66 166.03 24.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.451 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 27.0 m -106.88 122.87 47.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 108.965 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.99 138.61 54.36 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.08 0.943 . . . . 0.0 111.218 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.1 mt -117.34 156.42 27.87 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.6 142.74 6.74 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.347 -1.883 . . . . 0.0 111.309 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -143.24 148.75 36.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.865 . . . . 0.0 109.199 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt 56.27 39.86 30.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.0 110.597 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.24 5.63 77.38 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.745 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.7 mm-40 -102.04 140.33 36.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.951 -1.323 . . . . 0.0 108.317 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.603 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -139.37 151.86 46.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.069 -1.019 . . . . 0.0 111.568 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 mt -134.26 145.33 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -114.6 150.2 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 111.245 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 m 55.25 69.03 0.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.708 -0.62 . . . . 0.0 111.047 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.26 -7.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 109.275 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.0 pt-20 -68.65 -36.21 78.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.578 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 26.4 m170 -58.6 -59.98 4.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 110.111 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.1 tp -57.16 -42.17 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.808 -1.183 . . . . 0.0 109.07 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.47 -35.91 77.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.582 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -60.61 -47.3 86.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.577 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.99 -51.7 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.064 . . . . 0.0 108.681 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.7 mt -51.27 -44.28 61.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.498 -0.752 . . . . 0.0 109.418 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.444 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 14.0 t-160 -56.23 -57.83 10.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 0.0 109.832 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.7 -38.55 72.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 110.449 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.8 -0.84 36.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.979 -1.076 . . . . 0.0 110.68 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 59.81 42.58 16.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.803 -1.186 . . . . 0.0 110.027 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.37 125.82 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.402 ' H ' ' HG1' ' A' ' 85' ' ' THR . 7.7 p -106.34 -76.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.51 -178.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.774 HD21 HE22 ' A' ' 117' ' ' GLN . 69.5 m-20 -81.49 113.28 19.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 111.812 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.13 141.73 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.406 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 61.1 m -111.5 103.92 12.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.477 -0.764 . . . . 0.0 109.397 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.18 114.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.202 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.581 ' OE1' ' CG ' ' A' ' 40' ' ' PHE . 1.6 mt-10 -93.07 123.79 36.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 0.0 108.75 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.66 106.79 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.52 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.13 107.71 18.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.58 -162.85 24.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -13.63 14.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.388 -1.066 . . . . 0.0 110.428 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -150.54 155.16 38.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.709 -1.245 . . . . 0.0 110.674 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -69.89 125.71 92.12 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.699 -0.625 . . . . 0.0 110.04 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -46.23 134.71 15.41 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.85 1.7 . . . . 0.0 112.017 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 99' ' ' LEU . 11.1 tp -76.85 -35.25 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.469 -0.769 . . . . 0.0 109.967 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.411 ' N ' ' CG2' ' A' ' 98' ' ' ILE . 51.2 mt 55.32 -105.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.431 -0.793 . . . . 0.0 109.631 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.58 ' OD1' ' NE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -94.55 -27.67 15.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.582 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.3 -1.49 28.11 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 p -123.98 -166.78 1.54 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.969 . . . . 0.0 109.292 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.44 -0.34 21.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -46.77 -43.93 18.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.723 -0.869 . . . . 0.0 110.662 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.46 -52.1 62.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.061 -1.025 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 97.3 m-85 -62.45 -45.61 92.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.896 -1.128 . . . . 0.0 108.594 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -59.55 -40.72 88.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.456 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -45.6 58.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.487 -0.758 . . . . 0.0 111.464 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.62 -49.75 20.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.201 . . . . 0.0 110.777 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.31 -42.54 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.01 -1.056 . . . . 0.0 111.085 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -56.6 -28.96 61.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.885 -1.134 . . . . 0.0 109.992 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -82.21 -10.16 59.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.958 -1.089 . . . . 0.0 110.047 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -123.02 32.24 5.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.401 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.3 mt -86.28 146.82 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.681 -1.262 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.4 tp -132.23 161.55 33.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.29 128.88 55.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.776 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.774 HE22 HD21 ' A' ' 86' ' ' ASN . 4.1 mt-30 -96.39 -166.36 1.41 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.898 . . . . 0.0 110.009 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -124.46 69.31 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.601 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -158.8 137.71 11.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.027 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 26.9 tt0 -47.88 167.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.776 0.798 . . . . 0.0 110.965 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.445 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 31.4 mt -126.23 120.5 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.2 76.98 8.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.602 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -58.54 147.6 31.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -106.83 125.65 51.29 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.7 t -130.49 145.1 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 73.0 t -83.68 136.37 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 0.0 109.363 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.13 -12.9 9.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.51 144.57 42.97 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.84 169.05 23.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.106 1.871 . . . . 0.0 113.174 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.4 tt -165.24 136.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.784 -0.572 . . . . 0.0 109.485 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.21 124.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.0 109.141 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.36 114.87 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.456 -0.778 . . . . 0.0 109.812 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.41 131.97 55.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -173.18 152.96 2.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 55.89 23.56 6.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.596 -0.69 . . . . 0.0 110.973 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.02 2.75 83.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -104.61 172.99 6.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.2 tt -160.06 151.41 19.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.157 -1.589 . . . . 0.0 109.3 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.508 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 8.4 mt -147.56 130.28 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.957 . . . . 0.0 108.678 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -119.89 142.4 48.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 109.929 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.07 141.34 51.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.507 -0.745 . . . . 0.0 109.157 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -140.31 137.2 17.53 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.93 147.07 26.94 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.445 1.43 . . . . 0.0 112.256 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.33 152.3 10.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.922 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.69 0.66 46.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p -137.74 145.79 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.151 -0.968 . . . . 0.0 109.803 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.98 117.32 17.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -138.02 136.22 36.66 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.1 t -137.31 122.03 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -107.51 130.14 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.343 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -116.58 128.97 55.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.88 106.43 14.16 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.25 150.64 19.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -129.35 88.23 2.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.492 -1.004 . . . . 0.0 109.204 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -95.21 146.83 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.591 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -94.89 -2.03 51.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 182' ' ' PHE . 6.9 p30 -70.15 -166.64 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.779 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -65.71 -22.09 66.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.092 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 5.1 mt -66.66 -38.7 87.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.048 -1.033 . . . . 0.0 109.137 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.11 -137.95 19.23 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.11 145.34 28.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 109.421 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.483 ' OE1' ' ND2' ' A' ' 221' ' ' ASN . 0.9 OUTLIER -148.81 166.55 28.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.539 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 150.31 23.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -139.79 131.86 27.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.193 -0.942 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 11.4 t -102.15 123.17 45.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.184 -0.948 . . . . 0.0 109.801 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.5 t80 -101.2 134.46 44.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 108.986 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.43 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -132.67 151.2 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 109.472 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -50.54 120.76 4.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.87 6.8 26.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -134.53 27.25 3.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.206 -1.173 . . . . 0.0 108.522 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -61.68 -35.49 78.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 110.57 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.24 -18.35 10.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.951 -1.093 . . . . 0.0 110.283 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.9 -3.64 58.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 0.0 110.837 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 3.0 pt -130.49 19.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 111.947 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.53 -29.13 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.803 -1.186 . . . . 0.0 109.908 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.06 2.53 53.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 110.684 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.03 127.13 32.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.605 -1.309 . . . . 0.0 109.109 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.58 ' NE ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.02 152.51 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.3 t -53.65 161.32 1.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 109.177 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.63 164.01 31.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.786 -1.196 . . . . 0.0 110.2 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 189' ' ' ILE . 0.3 OUTLIER -149.3 160.29 43.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 109.673 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.565 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.4 m-85 -104.35 144.97 30.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.721 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -59.25 -26.98 65.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.958 -1.089 . . . . 0.0 110.488 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.565 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.4 p90 -81.14 -27.59 35.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.825 -1.172 . . . . 0.0 110.668 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.8 pt-20 -93.14 -14.21 27.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 109.818 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.9 mt -56.76 -52.61 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.62 -52.71 45.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.123 . . . . 0.0 109.79 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -52.82 -44.42 66.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 91.0 mt -65.51 -33.86 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -77.01 -26.88 54.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.042 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -81.0 -27.98 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.087 -1.008 . . . . 0.0 110.517 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.0 m -80.16 8.54 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.509 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.21 24.44 68.63 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.811 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 62.9 mt -121.19 159.82 25.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.24 -1.153 . . . . 0.0 109.691 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.405 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 76.94 27.7 59.99 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.03 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -71.18 -19.41 62.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.667 -1.49 . . . . 0.0 109.292 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.5 -4.19 49.75 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.14 128.74 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.273 -1.134 . . . . 0.0 110.896 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.25 -173.81 3.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.747 -0.855 . . . . 0.0 109.157 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.99 -5.59 57.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.051 -1.031 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -98.09 -13.69 20.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.339 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -127.18 -3.6 6.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -136.24 117.34 14.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.26 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.2 tp -79.42 110.54 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.54 127.56 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.08 -1.013 . . . . 0.0 109.839 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.28 146.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.363 -0.836 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.66 150.47 17.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -44.38 -28.65 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.132 . . . . 0.0 110.242 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 35.0 t0 -143.8 8.46 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 110.127 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 207' ' ' GLY . 68.4 tttt -146.01 154.72 42.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.062 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.71 128.96 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -71.98 -53.09 14.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.095 -1.003 . . . . 0.0 109.908 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.479 ' N ' HD21 ' A' ' 213' ' ' ASN . 1.0 OUTLIER -54.72 133.55 65.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.119 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.88 -24.97 20.48 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.281 1.987 . . . . 0.0 112.511 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.89 -6.65 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 109.792 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.92 -167.54 48.37 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.45 141.8 39.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -1.084 . . . . 0.0 109.63 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -83.7 -15.66 47.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.097 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.572 ' C ' ' H ' ' A' ' 221' ' ' ASN . 70.1 m-85 -144.26 135.43 25.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.5 ' O ' ' ND2' ' A' ' 221' ' ' ASN . 1.5 tm-20 -49.34 -10.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.572 ' H ' ' C ' ' A' ' 219' ' ' TYR . 1.4 m-80 -143.11 35.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.525 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 56.1 tt0 -56.1 -36.46 46.43 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 111.919 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 10.2 Cg_exo -69.27 -43.92 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.731 1.621 . . . . 0.0 112.907 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 24.5 m -77.81 -25.7 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 120.706 -1.246 . . . . 0.0 108.544 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -65.12 -45.67 84.14 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.456 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 47.1 t60 -62.16 -43.15 99.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -49.85 74.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 109.335 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 19.2 t -56.26 -48.18 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 108.767 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.582 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 85.0 t80 -50.5 -44.6 56.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.632 -0.668 . . . . 0.0 109.607 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.578 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 28.4 m-20 -71.48 -35.22 70.75 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 109.994 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.7 tp -56.46 -37.54 70.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.025 . . . . 0.0 108.857 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.444 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 55.4 mt -71.49 -47.52 58.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.13 -33.73 15.32 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.57 -26.18 32.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -1.171 . . . . 0.0 109.808 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.7 mt -82.27 -24.55 34.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.826 -1.171 . . . . 0.0 110.193 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.443 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 28.7 t80 -69.98 -7.38 40.26 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 109.148 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 239' ' ' GLY . 34.8 mt -51.04 -31.55 18.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 108.775 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.2 mt -53.79 -12.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 108.681 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 74.53 17.21 79.86 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.5 p -157.63 143.32 12.55 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.338 . . . . 0.0 109.812 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -43.12 131.13 6.21 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.15 1.9 . . . . 0.0 111.944 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.6 t -103.58 141.25 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 109.821 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -130.61 133.37 46.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.311 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.56 179.49 30.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -107.54 110.45 22.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.103 -1.233 . . . . 0.0 109.719 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.7 m-85 -112.18 146.96 37.17 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.928 . . . . 0.0 111.059 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -128.1 144.17 51.1 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.2 t -142.05 126.94 18.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.711 -1.243 . . . . 0.0 110.501 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.7 t80 -110.19 116.94 32.41 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 249' ' ' PHE . 6.4 mmm180 46.81 55.91 7.26 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.84 140.95 23.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.52 171.24 13.72 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 22.1 m-70 -63.99 -45.21 90.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.244 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -55.73 26.33 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.094 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.5 tp -52.06 -39.88 60.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.117 -0.989 . . . . 0.0 109.351 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.23 -55.82 30.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 108.784 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.85 -41.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.47 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -49.45 71.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.067 -1.02 . . . . 0.0 109.039 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 43.8 tp -52.66 -49.65 64.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 0.0 108.677 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 48.8 t -63.62 -49.93 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.477 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -51.65 17.93 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.63 -44.34 90.84 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.89 -1.131 . . . . 0.0 109.781 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.64 -46.29 90.41 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.69 -32.78 66.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.704 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.534 ' CB ' ' HZ3' ' A' ' 265' ' ' LYS . 0.5 OUTLIER -81.7 -28.4 33.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.845 -1.16 . . . . 0.0 109.157 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -66.7 -45.79 77.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.0 109.812 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -88.78 10.87 19.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 0.0 110.176 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -78.87 -27.49 44.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.098 -1.001 . . . . 0.0 109.779 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 5.6 mt -96.21 25.04 5.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 109.549 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.56 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 36.0 mt-10 -52.18 131.03 31.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.977 . . . . 0.0 109.439 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 132.16 56.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.565 -0.709 . . . . 0.0 109.316 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -136.44 175.29 9.74 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.35 -0.843 . . . . 0.0 109.271 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.3 m -83.24 138.13 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.727 -1.233 . . . . 0.0 110.367 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' HB2' ' HZ1' ' A' ' 8' ' ' LYS . 6.8 ttmm -71.95 -47.02 55.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.734 . . . . 0.0 109.543 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.66 156.44 41.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.854 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 135.16 55.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.473 -0.767 . . . . 0.0 110.415 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 19.1 mt -117.54 163.46 16.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -153.92 147.3 24.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.009 . . . . 0.0 110.098 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.28 161.61 31.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.254 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -149.59 136.65 19.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.915 -1.116 . . . . 0.0 108.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.09 161.27 20.28 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 4.7 p -73.75 161.24 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.11 -1.23 . . . . 0.0 111.176 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.466 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -92.54 140.09 14.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.8 tt -56.11 -52.25 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -1.218 . . . . 0.0 111.816 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -86.97 -38.63 16.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.309 -1.494 . . . . 0.0 110.879 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.488 ' HG1' ' CB ' ' A' ' 95' ' ' GLU . 2.6 m -68.68 -36.6 78.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 110.054 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.61 23.09 66.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -117.99 154.98 31.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.692 -0.887 . . . . 0.0 108.722 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.5 t80 -71.73 136.3 47.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 110.181 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.583 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 1.9 t -144.02 157.55 44.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 108.974 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' N ' ' HG ' ' A' ' 24' ' ' SER . 1.1 ttmt -137.22 147.16 45.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.098 -1.001 . . . . 0.0 109.292 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 2.3 mt -123.41 151.1 42.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.629 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.8 mt -134.84 129.44 51.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.57 110.76 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 109.812 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -106.75 150.23 39.43 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 108.901 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.56 161.88 22.91 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.226 1.95 . . . . 0.0 110.816 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.558 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -140.56 159.34 42.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.886 -1.134 . . . . 0.0 110.69 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.51 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 tttt -59.7 149.31 31.06 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.516 0.674 . . . . 0.0 109.987 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 2.3 mp0 -48.76 148.38 2.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 110.612 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.73 25.85 59.38 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.413 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -80.46 -37.57 31.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.618 -1.519 . . . . 0.0 109.031 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.27 -177.03 33.36 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.8 mm -98.8 125.41 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 140.13 32.71 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.969 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -97.48 152.22 19.2 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.9 t80 -133.54 140.13 47.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -170.7 143.75 2.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 54.86 29.13 11.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.955 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.85 21.16 78.05 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.8 t -124.42 135.62 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.161 -1.2 . . . . 0.0 109.545 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -94.6 142.06 27.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 109.039 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.9 mt -135.01 94.43 16.19 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.395 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -48.7 143.3 16.86 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.324 2.016 . . . . 0.0 111.747 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.99 79.74 5.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.069 -1.019 . . . . 0.0 110.158 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.3 mtt-85 -138.7 156.38 47.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.447 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.3 p80 -52.86 -50.12 64.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -45.26 -15.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 110.264 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.2 m-85 -100.19 2.64 43.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.669 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.8 t -57.73 133.35 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 108.955 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 m -120.66 -36.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 109.91 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.454 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.1 t-160 -151.19 122.11 7.61 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.348 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 p -110.75 132.6 54.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.4 t-20 -166.47 -154.71 0.19 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -48.03 -11.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 108.604 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.6 t -135.89 165.61 25.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 m -101.64 119.73 39.23 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -116.94 135.5 53.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 111.169 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 30.9 mt -124.22 158.91 31.34 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -177.83 145.62 7.15 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.963 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -144.71 151.16 38.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.883 . . . . 0.0 109.51 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 57.37 23.81 9.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 110.971 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.15 1.26 72.74 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.556 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 55.5 mm-40 -99.24 139.84 34.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.989 -1.301 . . . . 0.0 108.284 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.633 ' HE ' ' HZ3' ' A' ' 70' ' ' LYS . 16.9 ptt-85 -136.28 149.72 48.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.025 . . . . 0.0 111.426 -178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.84 141.68 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.633 ' HZ3' ' HE ' ' A' ' 68' ' ' ARG . 15.3 mttp -114.48 151.02 33.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.185 -0.947 . . . . 0.0 111.456 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 56.45 65.84 1.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.798 -0.564 . . . . 0.0 111.284 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.8 m -114.08 -3.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.041 -1.037 . . . . 0.0 109.043 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pt-20 -70.63 -28.4 64.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 110.533 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -64.35 -60.52 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.907 -1.121 . . . . 0.0 109.723 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -58.74 -44.51 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.952 -1.092 . . . . 0.0 109.129 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 65.4 mt -55.8 -41.46 74.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.927 . . . . 0.0 109.456 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -56.82 -46.32 81.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.292 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.88 -53.69 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.963 . . . . 0.0 108.652 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.6 mt -51.55 -44.58 62.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.279 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.524 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.4 t-160 -53.93 -55.38 27.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.249 -0.907 . . . . 0.0 109.726 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.1 mt -62.36 -37.24 84.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.1 mt -78.94 -9.84 59.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.01 -1.056 . . . . 0.0 110.098 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 63.41 60.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.851 -1.156 . . . . 0.0 110.514 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 4.8 mm -104.18 133.99 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -119.87 -17.1 8.59 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.269 -0.895 . . . . 0.0 111.943 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 34' ' ' GLY . 4.0 m-80 -130.11 111.83 12.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.699 -1.25 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.405 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -165.26 136.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 110.01 178.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.558 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 23.3 m -107.21 99.53 9.06 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 mt -87.95 117.83 32.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.91 119.64 34.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.787 -1.196 . . . . 0.0 107.992 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 t -104.61 104.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 111.344 -178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mt -87.49 107.78 17.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.74 -161.32 24.03 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -116.85 -14.52 10.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -1.045 . . . . 0.0 110.506 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.488 ' CB ' ' HG1' ' A' ' 20' ' ' THR . 36.2 tt0 -142.18 146.34 35.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.741 -1.224 . . . . 0.0 111.076 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.23 124.88 91.37 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.803 -0.561 . . . . 0.0 109.674 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -46.37 129.4 13.33 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.774 1.649 . . . . 0.0 111.754 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.4 tp -77.6 -29.18 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.488 -0.757 . . . . 0.0 110.188 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.587 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 95.0 mt 55.24 -111.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.44 ' OD1' ' NH2' ' A' ' 178' ' ' ARG . 2.5 t0 -89.28 -28.58 19.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.613 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.13 -14.98 11.02 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -109.93 -166.78 1.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.37 -2.76 21.34 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -47.44 -42.37 22.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.808 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.95 -51.96 64.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.002 -1.062 . . . . 0.0 110.356 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 93.6 m-85 -63.5 -44.81 93.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 108.632 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 6.9 t80 -62.36 -38.2 88.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.718 -0.614 . . . . 0.0 109.961 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.3 -46.28 61.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.366 -0.834 . . . . 0.0 110.807 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.42 -51.56 12.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.992 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.68 -45.52 79.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.043 -1.036 . . . . 0.0 110.557 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -55.51 -29.36 58.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.209 -0.932 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -81.24 -12.96 58.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -0.992 . . . . 0.0 109.992 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -120.09 33.09 5.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.385 -0.822 . . . . 0.0 111.125 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.9 mt -90.55 148.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 110.494 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.7 tp -131.18 158.18 41.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.27 140.22 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -103.86 -163.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.487 HD21 ' H ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -116.47 -1.38 12.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.41 ' CD ' ' OE2' ' A' ' 4' ' ' GLU . 10.2 ttm180 -94.13 149.21 21.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 109.903 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.53 136.83 32.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 94.8 mt -77.52 144.32 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.411 -0.805 . . . . 0.0 110.459 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.5 89.97 8.07 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -62.88 145.64 54.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.235 -0.916 . . . . 0.0 110.518 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.27 123.4 46.03 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.18 141.12 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.89 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.1 t -84.43 138.34 19.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.493 -0.755 . . . . 0.0 109.096 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -119.12 -11.15 9.66 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -140.18 144.17 36.59 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.86 173.52 12.61 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.113 1.875 . . . . 0.0 113.109 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.401 ' HB ' ' HZ2' ' A' ' 266' ' ' LYS . 2.9 tt -165.3 142.17 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.685 -0.634 . . . . 0.0 109.703 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.71 125.31 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 m -121.52 114.07 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -113.47 141.8 46.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.42 -0.8 . . . . 0.0 109.845 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -175.26 137.93 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 111.074 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 57.49 29.51 17.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.642 -0.662 . . . . 0.0 111.412 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.46 9.06 86.09 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -110.39 157.71 19.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -158.69 156.13 29.37 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.953 -1.717 . . . . 0.0 109.536 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.536 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 13.9 mt -149.03 133.02 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -120.91 143.01 49.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 109.901 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.23 143.97 49.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -142.03 138.47 16.9 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.9 144.9 42.85 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.473 1.449 . . . . 0.0 112.276 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.06 149.83 9.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -1.88 53.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 109.61 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.8 p -134.78 142.42 46.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.45 118.78 20.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -137.73 136.82 37.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.98 122.53 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.014 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 m -107.84 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.337 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -127.42 129.59 47.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.793 . . . . 0.0 109.72 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -115.52 103.51 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.72 135.45 12.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -111.18 93.23 4.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.498 -1.001 . . . . 0.0 109.343 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.452 ' CB ' ' ND2' ' A' ' 157' ' ' ASN . 20.5 m-85 -95.16 148.66 22.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.446 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -97.07 -3.75 40.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.745 ' H ' HD21 ' A' ' 157' ' ' ASN . 0.0 OUTLIER -73.74 -169.4 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.675 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -60.71 -20.8 61.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.97 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.425 ' HB2' HD22 ' A' ' 157' ' ' ASN . 31.2 mt -70.46 -28.36 64.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.0 109.042 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.69 -132.13 31.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.18 145.11 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -1.037 . . . . 0.0 109.556 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -146.35 156.04 43.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.583 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -139.23 145.0 38.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.249 -0.907 . . . . 0.0 109.332 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -136.28 126.58 26.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.061 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.474 ' O ' ' CG2' ' A' ' 165' ' ' THR . 7.3 t -103.78 123.85 47.83 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -100.22 136.03 40.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.159 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.512 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.5 t -131.82 153.5 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -57.08 118.91 5.49 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.43 -3.79 21.79 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -125.54 31.22 5.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.259 -1.142 . . . . 0.0 108.711 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.3 -32.84 74.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.543 -0.723 . . . . 0.0 110.605 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -58.2 -15.64 10.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.937 -1.102 . . . . 0.0 111.059 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -92.7 -4.13 53.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.85 -1.156 . . . . 0.0 110.894 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.23 -6.56 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.103 -0.998 . . . . 0.0 110.721 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.85 -29.14 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.698 -1.252 . . . . 0.0 109.933 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.03 1.99 51.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.68 -1.262 . . . . 0.0 110.415 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.07 115.62 18.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.914 -1.116 . . . . 0.0 108.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' NH2' ' OD1' ' A' ' 100' ' ' ASP . 1.9 ptm180 -86.59 154.62 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.05 . . . . 0.0 110.066 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.509 ' HG1' ' CYH' ' A' ' 320' ' ' TUX . 6.1 t -53.34 159.46 1.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.63 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.502 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 38.6 p90 -145.93 169.42 18.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.911 -1.118 . . . . 0.0 109.906 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.518 ' SG ' ' C2A' ' A' ' 320' ' ' TUX . 0.0 OUTLIER -164.39 163.89 22.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.612 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 96.0 m-85 -103.7 146.08 29.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.613 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.96 -20.69 64.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 111.076 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.612 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.3 p90 -81.0 -26.85 36.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.646 -1.284 . . . . 0.0 110.643 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.499 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 23.4 pt-20 -97.74 -15.85 20.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.859 -1.151 . . . . 0.0 109.474 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 9.7 mt -57.39 -52.12 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 110.045 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.15 -49.21 61.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.078 . . . . 0.0 109.43 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -54.46 -52.36 62.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 108.922 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 59.5 mt -57.72 -33.84 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.407 -0.808 . . . . 0.0 109.346 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -77.89 -28.95 49.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.639 ' HZ2' ' CB ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -72.69 -26.8 61.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.573 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.3 m -84.79 13.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.604 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.24 25.68 72.52 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.072 -1.061 . . . . 0.0 110.592 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.03 156.59 28.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.267 -1.137 . . . . 0.0 109.732 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.72 25.55 60.32 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.408 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.6 mtmm -69.04 -20.88 64.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.465 -1.609 . . . . 0.0 109.051 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.88 -7.28 44.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.93 129.31 43.82 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.24 -1.153 . . . . 0.0 110.771 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.4 p -143.72 169.93 16.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.79 -0.829 . . . . 0.0 109.466 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 17.0 mt -71.25 -16.46 62.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.455 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 48.5 tttp -86.08 -9.65 56.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 6.1 m120 -138.26 12.07 2.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.648 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.475 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 28.1 m -152.97 131.69 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.57 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.5 tp -89.98 114.85 26.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.414 ' H ' ' ND2' ' A' ' 213' ' ' ASN . 63.4 t -100.65 125.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.063 -1.023 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.9 mt -100.73 146.13 27.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.867 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.43 150.3 16.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -46.33 -25.88 0.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.136 -1.214 . . . . 0.0 109.86 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -152.56 11.44 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 0.0 110.67 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -146.99 155.35 42.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.89 -1.131 . . . . 0.0 110.281 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.77 123.36 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -70.84 -54.35 11.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.935 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 205' ' ' VAL . 47.0 m-80 -53.49 131.36 54.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.098 -1.002 . . . . 0.0 109.391 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -24.95 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.311 2.007 . . . . 0.0 112.457 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -4.51 39.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.955 . . . . 0.0 109.289 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.89 -169.16 53.85 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.9 mt -88.05 149.81 23.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 0.0 109.745 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -60.67 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.0 108.722 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 221' ' ' ASN . 7.7 m-85 -116.86 152.52 34.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 109.165 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.6 mp0 -60.65 -3.93 0.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 109.423 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.746 HD21 ' HE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -137.48 29.77 2.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.867 . . . . 0.0 108.983 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.603 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.0 tt0 -54.45 -42.03 92.31 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.76 . . . . 0.0 110.863 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.5 Cg_exo -70.83 -38.52 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.508 2.139 . . . . 0.0 113.156 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -81.66 -26.87 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.675 -1.266 . . . . 0.0 108.539 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.746 ' HE ' HD21 ' A' ' 221' ' ' ASN . 38.1 mtt180 -67.35 -39.82 85.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.572 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 19.1 t60 -66.6 -41.03 89.06 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -42.05 76.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.036 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.06 -44.6 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.572 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -55.26 -40.83 71.43 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.605 0.717 . . . . 0.0 109.067 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -71.74 -39.99 69.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.575 -0.703 . . . . 0.0 109.907 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.8 tp -56.55 -35.1 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.373 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 81.2 mt -72.15 -49.08 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.924 -1.11 . . . . 0.0 108.144 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.34 -30.95 12.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.74 -28.33 30.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -1.187 . . . . 0.0 109.854 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.3 mt -79.17 -22.85 44.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.743 -1.223 . . . . 0.0 109.782 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.524 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 16.6 t80 -69.99 -8.0 45.46 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.068 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 31.1 mt -49.76 -28.57 6.38 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.69 -20.59 65.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 108.957 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.41 17.91 76.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.9 p -154.01 138.8 11.52 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.235 . . . . 0.0 109.652 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -41.82 134.11 3.88 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.165 1.91 . . . . 0.0 111.872 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.81 136.14 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.023 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -122.3 125.71 46.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.306 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.45 26.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -102.5 112.54 25.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -1.198 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.6 m-85 -112.58 146.9 37.75 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.976 0.893 . . . . 0.0 111.048 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -126.99 144.29 51.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.0 t -138.87 126.76 22.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.684 -1.26 . . . . 0.0 110.112 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 250' ' ' ARG . 61.8 t80 -113.16 113.1 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 249' ' ' PHE . 52.8 mtp180 47.66 56.72 6.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.71 145.86 21.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.422 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -113.5 175.94 16.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.511 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.5 m-70 -66.99 -47.77 70.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -1.134 . . . . 0.0 109.998 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -55.14 37.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 109.801 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 51.6 tp -51.68 -37.86 52.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 16.1 m120 -58.68 -55.37 35.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.119 -0.988 . . . . 0.0 108.746 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 18.5 t -49.14 -41.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.415 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -55.22 -47.37 75.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 108.803 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.86 -50.56 63.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 42.1 t -63.63 -41.2 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 109.856 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -51.93 67.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.421 -0.799 . . . . 0.0 110.43 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -64.65 -45.4 86.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.845 -1.159 . . . . 0.0 109.73 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 60.8 mt -58.83 -45.72 89.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.17 73.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.832 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -77.89 -29.29 50.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.85 -1.156 . . . . 0.0 109.101 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.401 ' HZ2' ' HB ' ' A' ' 130' ' ' ILE . 20.8 mtmt -71.19 -48.73 49.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.275 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -80.66 4.61 18.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.104 -0.997 . . . . 0.0 110.249 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -68.49 -59.5 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.064 -1.023 . . . . 0.0 109.746 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.5 mt -57.36 -84.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.115 -0.991 . . . . 0.0 109.757 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.271 -0.893 . . . . 0.0 109.502 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.518 ' C2A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -54.32 132.99 44.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.551 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.88 139.67 52.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 109.485 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -141.15 177.57 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.468 -0.77 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.33 149.69 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 110.21 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -86.27 -42.13 14.02 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.662 -0.649 . . . . 0.0 109.758 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 10' ' ' LYS . 13.0 tt0 -129.32 153.98 47.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.517 -0.739 . . . . 0.0 109.992 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -59.98 135.64 57.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.305 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 44.5 mt -124.8 166.52 16.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.473 -0.767 . . . . 0.0 109.267 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 150.24 22.34 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 110.115 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -131.21 158.43 40.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.695 -0.628 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.81 134.81 23.87 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.941 -1.1 . . . . 0.0 108.869 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.85 156.79 14.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.094 -1.603 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.12 141.02 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -1.229 . . . . 0.0 110.804 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.61 138.12 37.71 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.6 tt -57.91 -48.16 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.089 . . . . 0.0 112.042 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 16.3 m-70 -86.75 -37.6 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.276 -1.515 . . . . 0.0 111.017 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.457 ' H ' ' HG1' ' A' ' 20' ' ' THR . 0.7 OUTLIER -72.25 -32.86 67.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 110.119 -179.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.33 65.89 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -113.83 151.25 32.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.948 . . . . 0.0 108.956 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -70.62 130.94 43.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.89 . . . . 0.0 110.063 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.487 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 31.5 t -138.63 157.55 45.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.063 -1.023 . . . . 0.0 109.381 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -137.09 152.03 49.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.132 -0.98 . . . . 0.0 109.541 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 mt -127.72 145.95 50.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 mt -131.35 129.05 62.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mt -117.89 133.35 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.087 -1.008 . . . . 0.0 110.139 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -126.6 150.01 69.66 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.71 161.78 20.32 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.104 1.869 . . . . 0.0 111.028 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.493 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 53.5 mt-10 -133.96 -174.68 3.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -89.73 154.92 19.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.195 -0.94 . . . . 0.0 109.248 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -47.93 145.2 3.08 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 110.058 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.55 23.52 54.78 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.382 -0.824 . . . . 0.0 111.791 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 55.5 m -75.45 -46.29 33.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.589 -1.536 . . . . 0.0 109.094 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.75 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 105.23 174.94 24.32 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 37' ' ' ILE . 12.9 mm -92.98 121.79 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.446 -1.032 . . . . 0.0 108.749 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.27 138.23 34.84 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -97.22 153.0 18.28 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.1 t80 -130.98 139.95 50.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.155 -0.965 . . . . 0.0 109.063 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 10.7 ttmt -170.0 139.46 1.86 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.483 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.91 29.02 18.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.04 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 28.09 70.63 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.3 t -134.28 139.18 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -1.12 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -97.67 144.43 27.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.096 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.9 mt -136.91 97.62 10.99 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.306 -0.871 . . . . 0.0 110.33 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.61 143.13 29.4 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.093 1.862 . . . . 0.0 111.341 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.46 83.15 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.0 -1.062 . . . . 0.0 110.481 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -138.53 154.9 48.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.332 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.9 p80 -53.47 -49.37 67.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.24 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' CG ' ' CE1' ' A' ' 50' ' ' HIS . 8.2 mt-10 -45.55 -16.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' HIS . 89.8 m-85 -96.89 6.66 48.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.961 -1.087 . . . . 0.0 109.868 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.14 126.2 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 108.652 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.21 -32.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -149.87 119.99 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.068 -1.02 . . . . 0.0 109.63 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.4 p -112.68 131.36 55.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.427 0.632 . . . . 0.0 109.359 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 2.1 t-20 -166.07 -154.3 0.19 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 57' ' ' ASN . 10.8 m-70 -47.81 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.922 -1.111 . . . . 0.0 108.357 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.602 ' HG ' ' N ' ' A' ' 60' ' ' THR . 1.6 t -136.6 166.11 24.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.602 ' N ' ' HG ' ' A' ' 59' ' ' SER . 40.2 m -107.83 123.45 48.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 108.971 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.02 141.68 51.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.928 0.87 . . . . 0.0 110.971 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.2 mt -118.64 168.58 10.57 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.25 145.07 5.43 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.801 -1.666 . . . . 0.0 110.824 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -144.46 150.58 37.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? 55.85 23.22 6.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.751 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.62 68.08 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.741 -1.219 . . . . 0.0 111.075 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.499 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 1.5 mm100 -92.33 144.87 24.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.483 . . . . 0.0 108.456 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.635 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -141.6 153.23 44.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.937 -1.102 . . . . 0.0 111.5 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 147.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -113.63 151.75 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.206 -0.934 . . . . 0.0 111.383 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m 52.52 68.23 0.86 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.776 -0.578 . . . . 0.0 111.037 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.02 -10.28 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.49 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.8 pt-20 -65.56 -24.22 67.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.413 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -67.64 -60.32 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.871 -1.143 . . . . 0.0 109.764 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.2 tp -58.32 -42.32 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.002 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 19.5 mt -58.85 -37.99 77.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.489 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.6 t -58.35 -47.47 83.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.931 -1.106 . . . . 0.0 108.956 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.88 -51.58 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.547 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.5 mt -51.27 -44.1 61.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.417 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 4.6 t-160 -52.62 -56.95 11.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.404 -0.81 . . . . 0.0 109.918 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.83 -35.71 79.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 110.559 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.4 mt -79.68 -9.65 59.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.021 -1.05 . . . . 0.0 110.595 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 62.74 50.35 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.781 -1.199 . . . . 0.0 110.372 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 3.3 mm -94.14 125.64 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.468 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.8 p -113.83 -18.74 11.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.168 -0.958 . . . . 0.0 112.034 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.75 HD21 ' H ' ' A' ' 36' ' ' GLY . 10.5 m120 -130.75 112.15 12.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.886 -1.134 . . . . 0.0 110.409 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -164.57 148.69 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 0.0 110.023 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.493 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 2.3 m -115.69 102.09 9.42 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.1 104.79 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.21 118.88 24.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 108.401 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.27 112.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 111.05 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.487 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.0 mp -92.5 110.9 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.21 -163.16 24.87 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -116.57 -15.18 10.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -1.013 . . . . 0.0 110.101 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 19.1 tt0 -138.05 143.01 40.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 0.0 110.291 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.9 mm -69.36 124.71 91.06 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.468 -0.77 . . . . 0.0 109.392 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.85 126.46 11.0 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.547 1.498 . . . . 0.0 111.416 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 tp -79.52 -21.45 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 3.7 mt 57.06 -110.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -95.5 -8.16 36.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.046 -1.034 . . . . 0.0 111.919 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.23 -12.04 48.13 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.2 p -119.04 -168.84 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -1.01 . . . . 0.0 109.537 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.55 -4.08 23.51 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.543 ' NE1' ' CD ' ' A' ' 108' ' ' GLU . 60.5 t-105 -46.92 -42.5 17.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.664 -0.903 . . . . 0.0 110.455 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.15 -51.51 68.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.924 -1.11 . . . . 0.0 109.783 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.5 m-85 -62.29 -43.81 97.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.112 -0.993 . . . . 0.0 108.588 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -61.98 -39.3 91.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.543 ' CD ' ' NE1' ' A' ' 104' ' ' TRP . 19.0 mt-10 -68.91 -46.39 68.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 111.437 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.97 -51.82 9.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.83 -1.169 . . . . 0.0 110.97 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.72 -43.37 87.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.814 -1.178 . . . . 0.0 110.558 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -59.55 -30.28 68.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.971 -1.08 . . . . 0.0 109.317 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -83.73 11.14 7.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.695 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -144.37 32.18 1.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.397 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.8 mt -91.5 148.73 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.891 -1.13 . . . . 0.0 110.717 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.64 153.73 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 2.3 m-20 -105.64 146.36 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.06 -1.025 . . . . 0.0 110.012 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.479 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.4 mt-30 -105.41 -162.36 0.87 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.837 . . . . 0.0 109.09 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -117.74 2.09 12.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.092 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -97.84 152.53 19.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.858 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -94.43 147.54 23.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.898 . . . . 0.0 109.485 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.9 mt -89.37 153.93 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.356 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -96.84 101.81 13.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -72.42 145.21 47.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.962 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -95.89 123.04 39.31 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.53 138.2 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.48 136.86 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -112.56 -7.27 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.28 147.82 24.67 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 109.188 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.35 145.48 38.44 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.173 1.915 . . . . 0.0 112.888 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.6 tt -130.73 150.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.27 117.85 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.629 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.8 m -118.09 109.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 109.36 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.7 131.64 55.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 0.0 109.293 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -179.98 159.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.062 . . . . 0.0 110.469 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 134' ' ' ASP . 11.6 mm-40 56.61 19.74 4.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.708 -0.62 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 -0.4 82.68 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 250' ' ' ARG . 0.6 OUTLIER -101.04 176.79 5.14 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.01 . . . . 0.0 108.302 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.1 tt -160.35 145.97 15.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.512 -1.367 . . . . 0.0 108.769 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.458 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 3.6 mt -144.97 130.99 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.076 -1.015 . . . . 0.0 108.28 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -121.39 137.37 54.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 109.814 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -113.71 149.35 34.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -145.4 136.61 12.58 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.53 144.94 99.29 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.493 1.462 . . . . 0.0 112.014 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.56 156.19 7.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 12.4 p-10 -88.82 3.28 51.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.5 p -135.43 147.1 48.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.0 118.73 22.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -135.94 139.03 42.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 79.8 t -137.7 122.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 109.685 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.468 ' O ' ' OG ' ' A' ' 248' ' ' SER . 1.4 m -112.37 138.67 48.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -127.82 131.57 49.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.695 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -117.31 119.11 34.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -114.82 137.73 14.23 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -112.24 85.44 2.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.416 -1.049 . . . . 0.0 109.241 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 160' ' ' GLY . 18.5 m-85 -86.2 148.45 25.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 109.915 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -97.22 -3.01 41.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 0.0 109.852 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.649 ' ND2' ' H ' ' A' ' 159' ' ' LEU . 11.4 p-10 -76.35 -169.94 1.33 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.084 -1.01 . . . . 0.0 109.687 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -55.7 -24.22 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.649 ' H ' ' ND2' ' A' ' 157' ' ' ASN . 9.1 mt -66.49 -40.21 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.18 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 75.5 -124.98 7.81 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -114.14 145.32 41.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.955 . . . . 0.0 109.819 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.573 ' NE2' ' ND2' ' A' ' 221' ' ' ASN . 22.8 tt0 -162.21 162.14 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 0.0 109.738 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -147.86 159.81 43.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -139.39 131.65 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.096 -1.003 . . . . 0.0 109.667 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' A' ' 165' ' ' THR . 13.8 t -103.7 123.22 46.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 5.9 t80 -100.53 138.56 37.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.441 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 t -137.53 150.02 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.804 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -50.43 118.2 2.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.2 6.17 18.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.85 28.41 2.64 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.17 -1.194 . . . . 0.0 108.716 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.42 -37.01 79.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.425 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.83 -16.63 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 110.45 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -88.33 -3.86 58.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.081 -1.012 . . . . 0.0 110.919 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.77 5.65 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.085 -1.009 . . . . 0.0 111.417 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -32.39 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.456 -1.403 . . . . 0.0 110.057 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.52 2.68 50.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.009 -1.057 . . . . 0.0 110.994 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.06 117.31 20.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.685 -1.259 . . . . 0.0 108.698 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -91.54 152.86 20.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.102 -0.999 . . . . 0.0 110.334 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -57.77 131.19 49.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.372 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -109.36 163.9 12.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -0.992 . . . . 0.0 110.115 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.575 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.0 OUTLIER -144.71 162.36 36.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 110.495 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.554 ' N ' ' OE2' ' A' ' 185' ' ' GLU . 57.7 m-85 -105.37 144.65 31.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -60.79 -26.5 67.32 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.829 -1.17 . . . . 0.0 110.213 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.482 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.1 p90 -81.31 -26.24 35.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 111.095 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 182' ' ' PHE . 10.3 pt-20 -92.7 -14.59 27.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.663 -1.273 . . . . 0.0 109.568 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 9.3 mt -56.19 -53.37 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.235 -0.916 . . . . 0.0 110.145 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.0 -53.32 54.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.989 -1.069 . . . . 0.0 109.449 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -52.12 -41.49 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.833 . . . . 0.0 109.214 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.86 -33.88 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -0.967 . . . . 0.0 108.862 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -79.52 -25.74 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -27.72 42.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 109.89 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.89 8.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.2 70.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.1 mt -123.85 163.17 21.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 0.0 109.664 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.434 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 75.29 24.43 71.07 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -70.83 -20.66 62.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.282 . . . . 0.0 109.691 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.04 -2.51 51.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.65 128.55 35.36 Favored Glycine 0 N--CA 1.492 2.387 0 O-C-N 121.204 -1.174 . . . . 0.0 111.07 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.5 p -132.45 -173.67 3.23 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.9 -12.88 29.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -91.4 -4.89 55.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 109.559 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 99' ' ' LEU . 42.5 m-20 -139.22 12.11 2.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.885 . . . . 0.0 109.375 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.76 122.13 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.249 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.2 tp -82.25 112.83 19.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 t -103.67 127.88 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.957 -1.09 . . . . 0.0 109.215 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 78.6 mt -111.15 141.95 43.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 110.136 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -96.37 149.29 19.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -42.48 -25.17 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -1.222 . . . . 0.0 110.106 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.2 OUTLIER -150.49 10.12 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.833 -1.167 . . . . 0.0 110.596 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -143.21 151.83 41.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 110.098 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.6 t -96.54 123.22 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.488 -0.757 . . . . 0.0 109.066 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -72.85 -54.36 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 110.129 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -55.33 134.36 69.66 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.872 -1.142 . . . . 0.0 109.618 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.55 -23.01 20.41 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.393 2.062 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.63 -5.1 49.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 110.043 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.58 -161.56 53.66 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.2 mt -89.94 146.92 24.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.495 -1.003 . . . . 0.0 110.294 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.75 -20.99 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.631 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 48.3 m-85 -142.52 167.91 20.97 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.57 -21.44 35.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 108.412 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.573 ' ND2' ' NE2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -125.18 37.55 4.37 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.591 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 30.1 tt0 -58.95 -35.76 35.65 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.447 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.5 Cg_exo -73.88 -45.52 0.38 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.714 1.61 . . . . 0.0 113.001 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.43 -25.19 16.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.754 -1.216 . . . . 0.0 108.554 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.631 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 11.6 mtp180 -67.06 -46.01 75.63 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -58.29 -43.25 87.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -45.59 82.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 108.737 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.91 -48.63 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.573 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -54.32 -41.31 68.88 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.96 -39.67 79.34 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.513 -0.742 . . . . 0.0 109.671 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.4 tp -58.66 -36.21 73.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.374 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.3 -34.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -63.34 -34.42 89.92 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 3.0 m-20 -82.94 -26.77 31.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -1.143 . . . . 0.0 110.135 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.48 -25.92 35.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.853 -1.154 . . . . 0.0 109.772 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.505 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 27.8 t80 -66.85 -8.8 31.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 108.923 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 71.5 mt -49.95 -30.12 9.76 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.18 -15.8 27.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 108.98 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 53.4 p -156.01 137.53 9.61 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.247 . . . . 0.0 109.503 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -42.81 130.4 5.53 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.049 1.833 . . . . 0.0 112.184 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.88 135.98 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.815 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -118.62 123.34 44.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.755 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.22 169.86 20.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.74 114.47 28.55 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.197 -1.178 . . . . 0.0 110.047 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -111.36 150.97 28.98 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.918 0.866 . . . . 0.0 110.976 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -128.44 144.14 51.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 150' ' ' THR . 0.9 OUTLIER -137.26 127.01 25.46 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.731 -1.231 . . . . 0.0 110.475 -178.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.468 ' O ' ' C ' ' A' ' 250' ' ' ARG . 52.4 t80 -111.83 113.9 26.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.47 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 11.5 mmm180 44.45 56.12 5.23 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.427 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -83.47 146.99 23.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.587 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -119.84 177.05 16.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.539 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 29.1 m-70 -67.63 -38.21 83.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -1.154 . . . . 0.0 109.787 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.1 t -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.065 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.2 tp -72.66 -37.29 67.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.937 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 75.5 m-20 -60.57 -51.76 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 80.4 t -51.92 -44.13 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 109.138 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -55.23 -47.08 75.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.052 -1.03 . . . . 0.0 109.018 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 54.1 tp -52.66 -49.67 64.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 108.824 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.4 -47.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -52.24 54.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.576 -0.703 . . . . 0.0 110.23 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.09 -50.65 73.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.982 -1.074 . . . . 0.0 110.515 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.63 -39.73 92.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.19 -34.29 72.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.336 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -69.61 -35.2 75.07 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.025 -1.047 . . . . 0.0 108.527 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.463 ' HZ2' ' CB ' ' A' ' 266' ' ' LYS . 2.0 mtpp -58.36 -46.08 86.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.24 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -74.22 10.35 1.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.808 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 266' ' ' LYS . 18.6 tptt -82.07 -31.02 31.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 109.914 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.81 1.7 53.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.128 -0.982 . . . . 0.0 109.459 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.605 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.575 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 4' ' ' GLU . 23.2 mt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.581 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 7.0 mm-40 -47.01 148.39 1.12 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.195 -0.941 . . . . 0.0 108.877 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.19 138.82 54.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.066 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 115' ' ' LEU . 13.5 t -134.15 171.43 14.24 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 m -82.24 140.87 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.79 -1.194 . . . . 0.0 110.484 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -75.84 -46.54 29.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -126.54 154.48 43.78 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.744 0.783 . . . . 0.0 111.054 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -54.37 135.23 45.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.698 -0.626 . . . . 0.0 109.977 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mt -121.22 152.91 38.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -151.99 146.44 25.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 110.042 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -128.25 162.4 27.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.58 -0.7 . . . . 0.0 109.304 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.73 132.52 17.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.914 -1.116 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.6 157.9 16.46 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.499 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 2.4 p -77.7 164.28 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.943 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.499 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -91.32 137.61 13.91 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.4 tt -58.57 -48.41 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.229 -1.16 . . . . 0.0 111.928 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.443 ' HD1' ' HA2' ' A' ' 195' ' ' GLY . 7.1 m-70 -86.78 -38.18 17.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.205 -1.56 . . . . 0.0 110.98 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -74.47 -40.0 62.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 0.0 109.867 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.77 23.08 78.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -112.11 151.04 29.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.528 -0.983 . . . . 0.0 108.621 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -71.16 134.43 46.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 109.88 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 11.5 t -141.17 158.49 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' N ' ' HG ' ' A' ' 24' ' ' SER . 4.2 ttpp -133.15 155.07 49.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.502 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.6 mt -128.65 152.35 48.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.955 . . . . 0.0 109.665 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.455 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.1 mt -142.05 126.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.491 -0.756 . . . . 0.0 109.014 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mt -115.29 117.72 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 0.0 109.924 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.455 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 11.7 m-70 -113.04 149.38 41.24 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.6 163.1 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 111.143 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.0 mm-40 -136.84 -175.17 3.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.08 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -86.6 152.07 22.91 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.432 -0.792 . . . . 0.0 109.028 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -51.66 151.04 3.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 110.407 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.569 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 63.62 19.64 62.9 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.27 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 51.9 m -81.94 -46.75 13.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.498 -1.589 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -171.77 23.26 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mm -97.52 122.12 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -1.137 . . . . 0.0 108.159 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.61 144.3 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 110.544 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.83 154.33 20.68 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.7 t80 -129.86 142.06 50.72 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 12.9 ttpt -172.35 138.24 0.92 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.95 29.76 19.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.466 -0.771 . . . . 0.0 109.824 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.99 74.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.61 139.75 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -94.04 146.83 23.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.122 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.0 mt -139.56 98.91 7.89 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.92 140.93 37.9 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.174 1.916 . . . . 0.0 111.453 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.34 79.89 8.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.91 -1.119 . . . . 0.0 110.866 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.62 155.07 49.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.914 . . . . 0.0 109.223 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.59 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 2.6 p80 -54.56 -49.58 69.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.171 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -46.56 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 109.909 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' HIS . 80.0 m-85 -98.51 7.99 45.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 50' ' ' HIS . 4.8 t -63.76 132.86 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.81 -34.06 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.0 110.119 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.45 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.6 t-80 -150.37 122.95 8.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.034 -1.041 . . . . 0.0 109.963 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.2 p -112.36 129.49 56.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 11.1 t-20 -166.67 -153.6 0.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 57' ' ' ASN . 19.2 m-70 -44.85 -16.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.218 -0.926 . . . . 0.0 108.704 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.2 t -136.19 165.56 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.48 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -102.97 121.32 42.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 108.778 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -119.39 138.22 53.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 111.033 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.6 mt -118.34 163.52 16.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.77 146.21 6.23 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.482 -1.818 . . . . 0.0 111.211 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -145.03 151.81 39.15 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.629 -0.924 . . . . 0.0 109.579 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt 57.57 23.66 9.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.88 . . . . 0.0 110.93 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.96 -2.22 75.57 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.888 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.469 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 96.8 mm-40 -98.93 143.75 28.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.842 -1.387 . . . . 0.0 108.258 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -142.86 155.71 44.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 111.801 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.12 145.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -110.88 150.29 29.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.112 -0.993 . . . . 0.0 111.668 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 m 54.55 68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.764 -0.585 . . . . 0.0 111.294 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.41 -9.58 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.718 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' OE2' ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER -66.28 -19.04 65.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 0.0 110.698 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -72.32 -60.86 2.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.841 -1.162 . . . . 0.0 109.641 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -56.74 -42.65 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.864 -1.148 . . . . 0.0 108.554 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 74.1 mt -55.05 -40.12 69.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.594 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 37.6 t -60.49 -48.74 80.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.554 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -56.55 -54.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 108.606 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.6 mt -51.43 -44.38 62.29 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -54.81 -56.5 18.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.049 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.92 -37.48 87.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.255 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.0 mt -77.2 -6.12 51.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.993 -1.067 . . . . 0.0 110.057 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 62.96 42.37 7.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.967 -1.083 . . . . 0.0 110.096 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.444 HD12 HG23 ' A' ' 84' ' ' ILE . 16.2 mm -90.01 126.1 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 48.1 p -107.47 -76.41 0.61 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 111.577 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.704 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -81.27 113.81 19.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.06 -1.025 . . . . 0.0 111.9 -176.522 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.71 144.37 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.541 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 3.8 m -110.93 101.65 10.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.499 -0.751 . . . . 0.0 109.27 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.99 111.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -92.21 120.0 32.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.043 -1.036 . . . . 0.0 108.633 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.32 112.37 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.991 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.485 ' O ' ' OG ' ' A' ' 24' ' ' SER . 2.5 mp -91.44 109.67 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.35 -160.79 23.52 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.4 -15.97 9.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.979 . . . . 0.0 109.959 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -135.64 142.56 45.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.977 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -67.96 126.75 93.02 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -46.28 127.82 11.46 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.709 1.606 . . . . 0.0 111.735 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.56 -25.75 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.302 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 96.4 mt 54.77 -116.65 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -94.85 -8.13 38.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 0.0 110.751 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.87 -13.38 59.15 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -109.94 -171.97 1.94 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -1.059 . . . . 0.0 109.619 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.94 -7.62 16.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -46.42 -38.57 9.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.976 . . . . 0.0 110.128 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.525 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -61.85 -51.81 66.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.007 -1.058 . . . . 0.0 109.818 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 78.2 m-85 -63.34 -43.78 96.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -60.93 -39.66 90.28 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.447 0.641 . . . . 0.0 109.84 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.57 -46.6 53.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 111.829 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.09 -51.25 12.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.779 -1.201 . . . . 0.0 110.828 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.55 -42.67 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.043 -1.035 . . . . 0.0 110.708 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -57.27 -28.56 63.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 110.038 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -80.16 -12.07 59.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.221 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -123.09 34.88 5.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.836 . . . . 0.0 110.927 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.9 mt -85.98 147.16 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.48 -1.388 . . . . 0.0 110.674 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' THR . 31.9 tp -132.26 145.53 51.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.618 -0.677 . . . . 0.0 109.478 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -92.68 146.2 23.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.106 -0.996 . . . . 0.0 110.356 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -108.85 -168.23 1.32 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -119.74 69.94 0.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.418 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -170.21 122.04 0.66 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.225 -0.922 . . . . 0.0 109.91 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.87 134.69 56.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.49 143.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.462 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -86.4 89.68 7.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -63.67 147.01 52.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 110.555 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -104.77 125.09 50.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.29 142.59 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.7 t -83.65 139.88 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.459 -0.775 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -118.87 -11.05 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 109.046 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -142.56 144.95 32.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.261 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.61 160.24 44.44 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.163 1.908 . . . . 0.0 113.349 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 tt -153.22 140.82 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 18.1 mt -130.0 124.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.478 -0.764 . . . . 0.0 109.846 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.3 117.72 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.507 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.87 156.89 16.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 109.737 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 137' ' ' ARG . 49.6 t0 -165.92 110.22 0.82 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 0.0 111.369 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 41.06 51.13 3.3 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.54 -0.725 . . . . 0.0 112.244 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.91 6.97 88.89 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.708 -1.245 . . . . 0.0 110.274 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 134' ' ' ASP . 12.5 mtt85 -118.2 132.28 56.33 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 139' ' ' ILE . 4.8 tt -144.71 160.81 40.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.349 -1.469 . . . . 0.0 109.776 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.438 ' H ' ' HG ' ' A' ' 138' ' ' LEU . 48.9 mt -144.57 129.63 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -116.0 142.32 46.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.36 -0.837 . . . . 0.0 110.131 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.97 143.74 50.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -142.02 138.92 17.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.93 146.16 58.67 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.394 1.396 . . . . 0.0 112.088 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -166.11 151.97 8.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.398 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 -1.29 56.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -134.1 146.25 50.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 109.259 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.46 120.18 24.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -1.0 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.95 137.96 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.4 t -137.23 118.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.711 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 m -106.03 143.91 33.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -132.06 130.94 41.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.93 105.97 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.74 155.54 20.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.401 ' HB3' ' HE ' ' A' ' 250' ' ' ARG . 3.2 tt0 -132.79 98.01 4.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -1.028 . . . . 0.0 109.116 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' GLY . 20.8 m-85 -101.38 148.6 24.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.844 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 mmtm -93.16 -5.99 48.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.992 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.569 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.7 p30 -74.44 -173.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.032 -1.042 . . . . 0.0 109.48 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -53.58 -17.05 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.783 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.569 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 31.7 mt -67.1 -49.98 63.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 109.506 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 82.86 -114.59 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.45 ' O ' ' CD ' ' A' ' 162' ' ' GLN . 12.4 mtm-85 -116.98 139.55 50.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.481 -1.011 . . . . 0.0 109.294 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 161' ' ' ARG . 4.3 mp0 -142.31 155.65 45.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 109.526 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 142.18 31.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.079 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -136.35 125.72 24.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.191 -0.943 . . . . 0.0 109.257 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -103.6 122.94 46.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.045 -1.034 . . . . 0.0 109.802 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -100.01 136.96 39.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.178 -0.951 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.89 156.08 41.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.556 -0.715 . . . . 0.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.28 118.9 6.47 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.145 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.83 1.32 21.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -131.42 29.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -1.112 . . . . 0.0 108.806 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -64.01 -33.58 76.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.603 -0.686 . . . . 0.0 110.611 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -52.81 -13.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 110.638 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.87 -4.12 44.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 111.139 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.1 -8.15 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.022 -1.049 . . . . 0.0 110.785 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.33 -33.11 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.66 -1.275 . . . . 0.0 109.943 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.96 1.28 54.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.797 -1.189 . . . . 0.0 110.603 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.82 116.93 20.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.927 -1.108 . . . . 0.0 108.657 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.54 153.26 20.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.034 -1.041 . . . . 0.0 110.361 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.6 t -62.07 147.66 46.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.531 -0.73 . . . . 0.0 109.457 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -130.31 176.26 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 110.402 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.562 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.6 OUTLIER -160.89 163.09 32.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.463 -0.773 . . . . 0.0 109.581 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.63 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 89.6 m-85 -104.69 146.34 29.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 109.937 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -61.7 -22.05 65.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 0.0 110.804 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.63 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.4 p90 -81.19 -28.41 34.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.793 -1.192 . . . . 0.0 110.653 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 13.6 pt-20 -95.1 -14.32 24.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.897 -1.127 . . . . 0.0 109.51 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.62 -53.12 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.238 -0.914 . . . . 0.0 110.129 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.22 -52.97 49.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.773 -1.204 . . . . 0.0 109.107 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.62 -47.98 66.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -0.966 . . . . 0.0 108.707 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 76.5 mt -58.7 -34.36 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -78.55 -27.04 45.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.53 -0.731 . . . . 0.0 110.166 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -74.84 -26.82 59.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -0.999 . . . . 0.0 109.883 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 m -84.18 9.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.34 66.92 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.821 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 3.8 mt -120.02 158.29 27.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.136 -1.214 . . . . 0.0 109.688 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.443 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 80.02 21.41 65.58 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.462 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -68.8 -22.34 64.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.577 -1.543 . . . . 0.0 109.664 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.41 -4.75 52.8 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.05 125.98 33.23 Favored Glycine 0 N--CA 1.49 2.273 0 O-C-N 121.186 -1.184 . . . . 0.0 110.539 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -131.08 -173.64 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.768 -0.842 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.4 -2.03 57.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 1.3 ttpp -100.17 -3.56 31.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 4.3 m120 -139.26 -7.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.97 . . . . 0.0 109.871 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.5 m -130.26 128.41 41.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 109.81 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.98 115.93 26.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 108.927 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.01 127.88 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 30.5 mt -103.6 147.34 27.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.809 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.07 150.63 17.44 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -44.89 -22.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.141 . . . . 0.0 110.058 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.0 OUTLIER -155.13 12.74 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.948 -1.095 . . . . 0.0 110.343 -179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -146.67 155.44 42.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.85 125.56 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.03 -54.74 7.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -47.89 135.89 10.95 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.812 -1.18 . . . . 0.0 109.389 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 216' ' ' GLY . 43.0 Cg_endo -71.7 -41.16 2.37 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 112.05 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -65.12 -0.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.863 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 73.31 -166.93 54.49 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 43.5 mt -83.89 149.83 26.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.442 -1.034 . . . . 0.0 109.803 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -76.7 -61.37 1.99 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.947 . . . . 0.0 108.755 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -117.09 163.1 16.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.362 -0.837 . . . . 0.0 109.293 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.79 -14.6 62.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.664 ' ND2' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -133.55 32.77 3.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.339 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 5.8 tt0 -58.69 -37.39 53.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 111.126 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.6 Cg_exo -70.63 -43.22 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.971 1.781 . . . . 0.0 112.576 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.3 m -78.71 -25.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.755 -1.216 . . . . 0.0 108.604 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.664 ' NH2' ' ND2' ' A' ' 221' ' ' ASN . 27.4 mtt180 -66.7 -40.71 88.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -64.81 -41.29 95.9 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -48.64 78.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.675 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 59.8 t -58.3 -49.27 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.594 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.0 t80 -49.99 -38.29 36.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.502 0.667 . . . . 0.0 109.299 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.477 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 7.9 m-20 -72.68 -40.01 66.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 110.141 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 tp -56.46 -37.48 70.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.343 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 88.9 mt -70.92 -48.49 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.886 -1.134 . . . . 0.0 108.057 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.81 -33.87 13.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.29 -26.76 32.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -1.199 . . . . 0.0 110.176 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.05 -21.03 43.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.668 -1.27 . . . . 0.0 110.074 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -70.59 -8.32 50.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 109.143 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 90.6 mt -53.18 -26.07 15.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.358 -0.839 . . . . 0.0 108.829 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.11 -20.0 62.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.973 -1.08 . . . . 0.0 108.939 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.93 15.35 70.28 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 70.9 p -158.47 149.49 16.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.909 -1.348 . . . . 0.0 109.824 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -44.32 130.16 8.73 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.216 1.944 . . . . 0.0 111.749 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 87.0 t -98.88 133.16 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.005 -1.059 . . . . 0.0 109.697 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -121.84 125.83 47.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.73 172.59 26.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -103.58 112.9 26.03 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -1.184 . . . . 0.0 109.656 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 5.6 m-85 -113.5 148.45 35.98 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.06 0.933 . . . . 0.0 111.558 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.8 t80 -129.65 144.28 51.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.414 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 36.2 t -139.52 127.67 22.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.701 -1.249 . . . . 0.0 110.466 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 4.3 t80 -111.71 114.6 27.72 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.2 mtt-85 45.76 56.44 5.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.37 151.13 21.74 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.848 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.7 -176.24 16.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -71.03 -52.35 20.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -1.228 . . . . 0.0 110.107 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -55.01 33.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.181 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.6 tp -51.03 -41.63 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -57.87 -54.29 48.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 108.863 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.1 -43.22 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.647 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.61 -46.72 73.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.078 -1.014 . . . . 0.0 108.718 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.7 tp -55.73 -47.92 76.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.8 . . . . 0.0 109.048 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.99 -42.6 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.808 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.609 ' HZ1' ' CE ' ' A' ' 265' ' ' LYS . 0.2 OUTLIER -54.17 -48.36 70.98 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 110.671 -179.058 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.19 -45.05 70.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.841 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.45 -45.41 93.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.42 89.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.827 . . . . 0.0 109.732 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.609 ' CE ' ' HZ1' ' A' ' 261' ' ' LYS . 28.3 mttm -73.71 -28.11 61.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.962 -1.086 . . . . 0.0 109.214 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -67.53 -48.2 67.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.234 -0.917 . . . . 0.0 110.06 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -85.01 4.11 35.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.115 -0.991 . . . . 0.0 110.24 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -69.87 -64.46 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.063 -1.023 . . . . 0.0 109.791 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 18.5 mt -62.23 -83.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.116 -0.99 . . . . 0.0 109.456 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.477 -0.764 . . . . 0.0 109.457 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.562 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 4' ' ' GLU . 2.2 mt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 119' ' ' ARG . 16.1 mm-40 -41.43 128.87 3.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 109.332 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.25 127.67 56.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.432 -0.792 . . . . 0.0 109.128 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -135.09 173.3 11.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 m -82.97 133.92 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.004 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -58.98 -48.38 81.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -133.65 163.07 30.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 132.28 48.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.521 -0.737 . . . . 0.0 109.974 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.3 mt -117.74 164.07 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -152.97 147.59 26.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.029 . . . . 0.0 110.198 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -132.06 161.55 32.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.463 -0.773 . . . . 0.0 109.74 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.43 134.88 20.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.12 . . . . 0.0 109.365 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.09 158.92 17.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.485 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 4.2 p -74.96 163.02 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -1.103 . . . . 0.0 111.263 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.485 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -93.47 139.98 14.84 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.3 tt -57.81 -50.85 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.128 -1.219 . . . . 0.0 112.396 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.409 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 11.6 m-70 -86.44 -37.66 18.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.188 -1.57 . . . . 0.0 111.203 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -73.92 -34.66 64.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.0 110.215 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.49 21.33 66.64 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -109.76 149.95 29.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.544 -0.974 . . . . 0.0 109.274 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.84 132.43 45.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.891 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -139.63 157.51 45.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -133.69 155.21 50.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.274 -0.891 . . . . 0.0 109.291 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mt -131.04 146.67 52.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.044 -1.035 . . . . 0.0 109.373 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 mt -136.0 123.91 35.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mt -111.8 122.99 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.543 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.614 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -118.03 139.24 26.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.463 -0.773 . . . . 0.0 109.354 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -53.46 162.6 3.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.439 1.426 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.5 mm-40 -135.96 -171.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.1 ttmt -91.92 156.53 17.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.586 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -50.46 146.35 5.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 110.548 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 64.09 24.48 68.73 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.567 -0.708 . . . . 0.0 112.204 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.552 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 91.3 m -81.64 -46.44 14.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.346 -1.679 . . . . 0.0 109.112 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.714 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 101.52 -174.66 24.99 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mm -94.86 122.65 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.189 -1.183 . . . . 0.0 108.354 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 137.28 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.077 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -98.58 154.59 17.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.7 t80 -130.12 136.99 49.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 108.815 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 4.0 ttmm -167.45 136.85 2.73 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.115 -0.991 . . . . 0.0 109.594 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.33 28.6 17.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.922 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 28.19 71.76 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.4 t -133.42 132.12 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.161 -1.199 . . . . 0.0 109.727 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -85.34 140.4 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.2 mt -134.45 94.75 16.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.398 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.58 141.06 27.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.21 1.94 . . . . 0.0 111.494 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.09 84.39 5.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.812 -1.18 . . . . 0.0 110.374 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -139.06 155.35 48.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 53' ' ' VAL . 6.9 p80 -52.32 -49.43 64.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.286 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.3 mt-10 -44.62 -30.96 1.0 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.153 -0.967 . . . . 0.0 109.151 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 46.1 m-85 -81.48 2.42 28.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.413 -0.804 . . . . 0.0 110.176 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' HIS . 8.3 t -59.46 127.44 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.015 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.62 -31.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.502 ' HD1' ' NZ ' ' A' ' 70' ' ' LYS . 7.5 t-160 -151.97 123.07 7.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.891 -1.131 . . . . 0.0 109.975 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.9 p -111.77 131.61 55.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.725 ' N ' HD21 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -166.66 -153.64 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -48.31 -11.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.019 -1.051 . . . . 0.0 108.537 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.9 t -139.94 166.25 25.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 m -105.39 121.39 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 108.773 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.32 141.94 48.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 111.122 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.1 mt -121.83 160.23 25.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.5 142.92 6.15 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.715 -1.707 . . . . 0.0 110.692 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -144.86 151.19 38.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.53 -0.982 . . . . 0.0 109.708 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt 56.96 23.77 8.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.833 . . . . 0.0 110.865 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.67 -2.04 69.54 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.704 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.9 mm-40 -97.05 145.46 25.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.928 -1.336 . . . . 0.0 108.482 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -141.71 151.7 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 0.0 111.601 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.8 mt -134.29 144.46 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' HD1' ' A' ' 55' ' ' HIS . 11.7 mttt -114.67 154.85 27.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 110.976 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 m 51.36 67.99 0.86 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.641 -0.662 . . . . 0.0 110.8 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.55 -15.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -63.74 -15.59 58.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 110.248 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 8.7 m170 -72.11 -60.57 2.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.022 . . . . 0.0 109.511 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.466 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.7 tp -59.65 -42.81 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.992 -1.068 . . . . 0.0 108.772 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.466 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 39.3 mt -54.82 -39.21 68.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.543 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -61.7 -49.77 75.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.538 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.24 -54.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.006 . . . . 0.0 108.559 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.1 mt -51.75 -43.82 63.07 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.488 -0.757 . . . . 0.0 109.586 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.3 -56.79 13.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.0 mt -56.64 -35.55 68.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 110.976 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 26.4 mt -88.06 -2.68 58.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.864 -1.148 . . . . 0.0 111.207 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.34 58.52 1.73 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.683 -1.261 . . . . 0.0 110.945 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.496 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 5.0 mm -96.79 122.57 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 4' ' ' GLU . 21.1 p -104.1 -77.47 0.57 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 111.047 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.714 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 2.5 m120 -82.24 113.6 20.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 111.452 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.9 m -163.79 138.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.684 -0.635 . . . . 0.0 109.327 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.5 m -106.53 101.18 10.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.38 107.51 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.657 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 40' ' ' PHE . 2.0 mm-40 -84.49 121.18 27.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.818 -1.177 . . . . 0.0 108.629 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.4 110.09 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.839 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.47 108.24 20.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.506 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 134.05 -163.37 24.55 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER -112.94 -14.97 12.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -1.034 . . . . 0.0 110.171 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.16 147.5 36.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.257 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG21 HD12 ' A' ' 96' ' ' ILE . 18.0 mm -70.88 130.57 88.3 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.474 -0.766 . . . . 0.0 109.746 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -46.23 128.7 12.31 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.022 1.815 . . . . 0.0 112.278 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -76.88 -29.68 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 110.015 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 50.8 mt 57.62 -116.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.0 109.942 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.28 -6.86 43.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 110.533 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.87 -10.61 52.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -117.09 -169.26 1.62 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -1.085 . . . . 0.0 109.797 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.05 -1.37 25.31 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 68.1 t-105 -46.39 -41.33 13.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.753 -0.851 . . . . 0.0 110.305 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 3.4 mp0 -61.34 -51.97 66.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.999 -1.063 . . . . 0.0 110.131 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -65.02 -43.98 90.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.973 -1.079 . . . . 0.0 108.928 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 10.9 t80 -61.63 -37.73 85.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.4 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 20.9 mm-40 -67.0 -51.79 50.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.542 -0.724 . . . . 0.0 111.598 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 -51.98 11.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.761 -1.212 . . . . 0.0 110.871 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.54 -44.6 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 0.0 110.409 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -55.61 -31.27 62.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.116 -0.99 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -81.59 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 109.906 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -124.09 34.05 5.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.431 -0.793 . . . . 0.0 110.905 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.9 mt -87.73 140.5 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.708 -1.245 . . . . 0.0 110.575 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.6 tp -133.3 159.79 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.97 145.28 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.499 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -106.48 -162.67 0.87 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 109.31 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -121.0 72.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 110.735 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 4' ' ' GLU . 8.0 ttm-85 -168.02 123.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.14 126.36 27.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.474 -0.766 . . . . 0.0 110.316 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 3' ' ' LEU . 2.5 mt -78.55 150.48 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.376 -0.827 . . . . 0.0 109.695 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.8 86.28 6.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -60.23 147.21 40.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -101.37 120.14 39.82 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.1 t -123.34 139.96 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.0 138.79 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 109.546 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.71 143.22 34.19 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.557 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.25 174.65 11.73 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.358 2.039 . . . . 0.0 112.64 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.2 tt -166.07 146.04 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.493 -0.754 . . . . 0.0 109.792 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.54 120.12 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.583 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 33.1 m -119.81 114.99 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.804 . . . . 0.0 109.836 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.51 153.99 18.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.067 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 137' ' ' ARG . 19.8 t70 -168.56 114.96 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.788 -1.195 . . . . 0.0 111.501 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 46.51 46.65 14.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.513 -0.742 . . . . 0.0 112.204 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 7.11 87.03 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.195 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.9 mtt85 -116.13 137.54 52.04 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.404 ' CG ' ' N ' ' A' ' 139' ' ' ILE . 2.6 tt -147.04 159.54 43.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.055 -1.653 . . . . 0.0 109.864 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.404 ' N ' ' CG ' ' A' ' 138' ' ' LEU . 35.6 mt -144.51 135.75 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.64 139.32 52.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 109.984 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.19 147.56 44.77 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -148.24 137.58 12.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 108.524 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.31 147.42 36.47 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.624 1.549 . . . . 0.0 112.15 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.7 153.01 8.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.336 -0.853 . . . . 0.0 109.363 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -85.72 -3.4 58.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.348 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.5 p -131.26 147.46 52.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.362 -0.836 . . . . 0.0 109.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.2 tp -81.26 120.07 24.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -139.72 134.89 32.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.47 122.09 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.1 m -110.74 145.87 37.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -131.85 129.87 40.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -114.41 108.73 17.27 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.64 140.51 15.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -118.04 92.83 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.547 -0.973 . . . . 0.0 108.705 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLY . 24.0 m-85 -96.25 148.39 22.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 110.331 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -91.65 -6.1 52.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.822 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 18.5 p-10 -73.4 -166.78 0.37 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -61.78 -17.61 56.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.792 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.408 HD12 HD22 ' A' ' 157' ' ' ASN . 25.5 mt -69.84 -38.86 76.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 109.341 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 70.64 -118.15 7.53 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -112.67 140.45 47.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -1.012 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.54 152.45 30.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.596 ' HZ1' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.39 152.85 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.586 ' CE1' ' CZ ' ' A' ' 225' ' ' ARG . 64.3 t80 -136.23 125.53 24.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -0.914 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.7 m -101.87 122.33 43.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.099 -1.001 . . . . 0.0 110.066 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -100.06 137.48 38.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.47 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.2 t -136.2 152.42 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.356 -0.84 . . . . 0.0 109.563 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.84 116.23 2.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.376 -0.827 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.9 8.67 13.3 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -137.49 27.91 2.77 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 0.0 108.71 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 16.4 mp0 -62.73 -37.32 86.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.616 -0.678 . . . . 0.0 110.997 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.58 -16.35 2.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.008 -1.057 . . . . 0.0 110.366 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.435 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 1.5 mt-10 -90.58 -4.33 56.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 0.0 110.795 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.41 HG23 HD11 ' A' ' 174' ' ' ILE . 1.8 pt -123.99 -2.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.099 -1.001 . . . . 0.0 110.757 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.53 -29.11 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.605 -1.309 . . . . 0.0 110.018 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.9 2.14 54.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.914 -1.116 . . . . 0.0 110.608 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.75 119.86 23.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.206 . . . . 0.0 108.783 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -92.66 152.94 19.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.451 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 5.0 t -50.07 158.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.513 -0.742 . . . . 0.0 109.347 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.497 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 51.5 p90 -143.29 165.55 27.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.51 ' SG ' ' C2A' ' A' ' 320' ' ' TUX . 0.0 OUTLIER -158.99 161.48 36.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.071 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.613 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 73.6 m-85 -104.35 144.79 31.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 0.0 109.266 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 21.0 p30 -59.27 -20.19 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 111.502 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.613 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.4 p90 -79.42 -33.24 42.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.494 -1.379 . . . . 0.0 111.529 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.593 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -94.21 -9.19 37.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.483 -1.386 . . . . 0.0 109.915 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 11.9 mt -60.98 -53.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.119 -0.988 . . . . 0.0 110.243 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -51.18 -45.94 61.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.587 -1.321 . . . . 0.0 109.611 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -53.86 46.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.108 -0.995 . . . . 0.0 108.968 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.89 -34.54 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 108.655 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -71.49 -25.71 62.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.307 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -76.04 -23.93 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.023 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.52 15.34 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 110.271 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 68.77 27.71 73.65 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.264 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 22.2 mt -120.13 157.73 28.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -1.228 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 80.77 23.15 60.38 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.902 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -67.18 -23.09 65.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.746 -1.444 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.98 -6.63 48.65 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.96 124.67 28.88 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 121.099 -1.236 . . . . 0.0 110.112 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.66 174.62 10.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.746 -0.855 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.93 -12.12 59.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.355 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 1.0 OUTLIER -86.05 -4.31 59.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.476 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 4.7 m-80 -150.22 16.35 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.413 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 1.3 m -145.04 123.51 12.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.2 tp -85.76 115.05 23.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 108.833 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.28 124.13 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.9 mt -105.38 148.69 26.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.799 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.49 163.66 13.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -55.68 -25.35 39.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.255 . . . . 0.0 109.341 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.25 12.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.673 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.18 147.88 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 110.106 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.89 128.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.862 . . . . 0.0 108.979 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.44 -55.17 6.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.15 -0.969 . . . . 0.0 110.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -51.53 137.54 31.63 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.992 -1.067 . . . . 0.0 109.81 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.67 -38.73 3.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.473 2.115 . . . . 0.0 112.551 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.52 -6.65 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.32 -166.27 50.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -77.8 141.78 39.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.98 . . . . 0.0 109.736 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -85.49 -15.61 42.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 108.841 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 221' ' ' ASN . 17.8 m-85 -141.94 130.06 22.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -46.5 -12.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 109.153 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.692 HD21 ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -138.13 36.81 2.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.61 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 22.5 tt0 -61.85 -34.42 16.13 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 111.21 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.0 Cg_exo -72.01 -48.06 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.919 1.746 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.6 m -71.91 -22.24 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.838 -1.163 . . . . 0.0 108.071 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.692 ' NH1' HD21 ' A' ' 221' ' ' ASN . 15.2 mtt85 -68.03 -45.84 72.83 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.33 -41.07 92.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -44.14 84.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.902 . . . . 0.0 108.648 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 89.1 t -65.5 -40.28 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.543 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.3 t80 -58.81 -39.56 81.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -73.55 -38.56 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.578 -0.701 . . . . 0.0 109.414 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.5 tp -56.62 -37.77 71.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.28 -47.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.35 -33.51 16.53 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.6 -27.1 31.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.123 -1.222 . . . . 0.0 110.059 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.65 -24.89 41.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.714 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 35.1 t80 -67.63 -10.06 48.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 26.0 mt -51.05 -26.53 6.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 95.9 mt -57.9 -21.79 45.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 108.745 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.4 13.95 75.12 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 64.5 p -158.96 149.05 15.32 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 109.735 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.34 134.03 4.7 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.396 2.064 . . . . 0.0 112.072 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.1 t -101.5 127.59 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.942 . . . . 0.0 109.97 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -116.13 122.99 46.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 109.426 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.51 178.87 32.93 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -109.09 112.95 25.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.313 -1.11 . . . . 0.0 109.833 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -114.74 146.86 40.49 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.817 0.818 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -131.07 141.4 50.17 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.7 t -135.74 128.54 31.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.791 -1.193 . . . . 0.0 110.563 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 14.3 t80 -111.69 114.53 27.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 3.2 mtp85 44.78 55.74 5.75 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.19 148.85 22.52 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -112.63 -177.61 19.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -70.5 -47.21 61.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.091 -1.241 . . . . 0.0 109.752 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 68.3 p -61.03 -54.5 44.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.308 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.3 tp -51.71 -39.65 58.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 109.384 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.72 -55.87 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -0.975 . . . . 0.0 108.865 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 41.0 t -49.19 -41.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.232 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -48.47 75.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.67 -44.81 66.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 108.804 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.4 t -68.23 -49.18 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.318 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.37 -50.74 38.81 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.695 -0.628 . . . . 0.0 110.509 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.41 -50.97 65.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.987 -1.071 . . . . 0.0 109.961 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 47.8 mt -56.64 -44.21 81.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.35 83.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.725 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -78.91 -26.61 43.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 108.989 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 268' ' ' LYS . 27.0 mttt -68.53 -47.4 67.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.195 -0.94 . . . . 0.0 109.382 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.29 11.63 1.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 266' ' ' LYS . 4.2 tptt -73.88 -10.48 59.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.847 . . . . 0.0 109.771 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 7.4 mt -84.43 18.08 2.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.123 -0.986 . . . . 0.0 109.458 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.441 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.51 ' C2A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 4' ' ' GLU . 5.3 mt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.588 ' CD ' HD22 ' A' ' 86' ' ' ASN . 30.6 mt-10 -43.5 144.88 0.68 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 109.376 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -113.18 130.93 56.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 115' ' ' LEU . 14.2 t -131.23 169.68 15.62 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.376 -0.828 . . . . 0.0 109.31 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.401 ' H ' ' HG1' ' A' ' 6' ' ' THR . 4.6 m -81.58 136.26 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.826 -1.171 . . . . 0.0 110.516 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.498 ' CB ' ' HZ3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -69.78 -47.11 64.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.664 -0.648 . . . . 0.0 109.978 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -128.42 156.88 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.492 -0.755 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -62.82 134.61 56.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.591 ' CG ' HD21 ' A' ' 113' ' ' ASN . 19.7 mt -118.66 160.8 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -149.55 145.97 27.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.941 -1.1 . . . . 0.0 110.046 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -128.83 164.62 22.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.475 -0.766 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.8 12.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 109.004 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.64 159.43 17.86 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 2.4 p -76.07 164.32 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.047 -1.266 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -95.21 142.45 16.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.3 tt -61.23 -47.78 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.053 -1.263 . . . . 0.0 112.136 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.406 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.2 m-70 -86.99 -39.86 15.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 119.984 -1.697 . . . . 0.0 110.793 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 m -71.76 -36.79 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.383 -0.823 . . . . 0.0 110.168 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 24.22 70.09 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -115.07 152.5 32.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.632 -0.922 . . . . 0.0 108.715 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -72.35 131.61 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.889 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 15.4 t -138.35 158.91 43.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.216 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 7.8 ttmt -133.13 159.59 39.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.478 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.5 mt -133.31 144.12 49.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.178 -0.951 . . . . 0.0 109.235 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.437 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.5 mt -134.49 123.43 42.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.54 126.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 0.0 109.926 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.577 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 1.3 m-70 -122.18 149.19 53.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.14 160.16 16.73 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.055 1.837 . . . . 0.0 111.229 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 2.7 mm-40 -133.79 -176.0 4.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.599 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.469 ' O ' ' OG1' ' A' ' 35' ' ' THR . 10.0 ttpp -88.01 152.31 22.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.92 145.44 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.422 -0.799 . . . . 0.0 110.227 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.586 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.42 25.55 60.71 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.213 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.6 m -80.88 -41.4 23.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.648 -1.501 . . . . 0.0 108.703 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.71 178.95 30.85 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.56 123.31 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -140.3 145.79 37.7 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.033 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -100.68 152.25 20.68 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 11.0 t80 -133.35 141.95 48.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.225 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -176.5 145.94 0.59 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.55 28.89 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.85 28.92 72.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.48 142.57 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -1.215 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.41 143.59 31.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.237 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.04 95.81 14.87 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.35 145.53 21.02 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.052 1.834 . . . . 0.0 111.267 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 82.14 5.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.93 -1.107 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.84 153.92 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.3 p80 -51.81 -49.61 62.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.8 mm-40 -43.87 -33.02 1.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.196 -0.94 . . . . 0.0 109.234 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -80.45 2.46 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' HIS . 2.6 t -60.7 126.16 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.021 -1.049 . . . . 0.0 108.695 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.09 -34.11 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.478 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t-80 -149.67 123.18 9.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.943 -1.098 . . . . 0.0 109.913 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -110.71 131.52 54.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.2 t-20 -166.38 -154.2 0.18 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.568 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 8.1 m170 -48.05 -11.65 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 108.513 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 43.6 t -138.15 165.94 25.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.563 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.4 m -102.92 121.14 41.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.6 OUTLIER -120.4 141.56 50.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.563 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.1 mt -123.51 155.98 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -172.88 142.28 6.65 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.944 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -144.86 151.48 38.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.631 -0.923 . . . . 0.0 109.704 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm 56.51 27.86 12.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.495 -0.753 . . . . 0.0 110.839 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.55 81.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.315 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.504 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 92.7 mm-40 -99.26 143.5 29.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.286 . . . . 0.0 108.361 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -141.99 151.24 42.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 0.0 111.198 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.51 144.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -114.27 153.73 29.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 110.896 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 53.24 68.05 0.9 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.645 -0.659 . . . . 0.0 110.812 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.12 -5.77 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 109.464 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.571 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.5 OUTLIER -67.76 -29.27 68.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.985 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -62.63 -60.29 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.91 . . . . 0.0 109.91 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 9.6 tp -59.13 -44.29 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.035 . . . . 0.0 109.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.504 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 9.8 mt -59.58 -38.1 80.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.126 -0.984 . . . . 0.0 109.771 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.455 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -59.71 -48.03 83.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 109.531 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.53 -53.56 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.5 mt -50.91 -43.06 59.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.065 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.51 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 11.8 t-160 -55.1 -56.97 13.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 109.815 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 43.0 mt -57.52 -38.54 74.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.5 mt -80.12 -5.88 56.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.957 -1.089 . . . . 0.0 110.892 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER 62.8 63.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.706 -1.246 . . . . 0.0 110.528 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.452 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 9.7 mm -102.8 132.87 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 108.708 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.24 -23.6 7.24 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.339 -0.85 . . . . 0.0 111.633 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.588 HD22 ' CD ' ' A' ' 4' ' ' GLU . 70.9 m-20 -132.21 112.76 12.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.763 -1.211 . . . . 0.0 110.453 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.7 m -164.05 137.71 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.882 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.538 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 47.2 m -106.52 100.21 9.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.76 116.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.698 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -94.29 117.88 30.77 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.675 -1.265 . . . . 0.0 108.127 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.48 107.49 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.723 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.433 ' O ' ' OG ' ' A' ' 24' ' ' SER . 2.8 mt -89.69 110.47 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.24 -164.49 25.06 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -109.02 -11.41 14.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -1.054 . . . . 0.0 110.2 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -153.15 155.89 37.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.917 -1.114 . . . . 0.0 110.306 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 96' ' ' ILE . 44.6 mm -71.57 131.91 85.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.751 . . . . 0.0 109.606 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -45.88 138.46 11.91 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.295 1.997 . . . . 0.0 112.283 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.7 tp -75.91 -39.18 37.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.571 -0.706 . . . . 0.0 110.264 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 101' ' ' GLY . 80.3 mt 54.92 -155.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.481 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.95 -1.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.147 -0.971 . . . . 0.0 111.027 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 99' ' ' LEU . . . 88.27 -10.4 71.37 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.69 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.3 p -112.09 -168.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -1.082 . . . . 0.0 109.77 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -1.22 21.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.589 ' CD2' ' OE1' ' A' ' 108' ' ' GLU . 69.1 t-105 -46.81 -41.36 15.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.841 -0.799 . . . . 0.0 110.696 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -62.39 -52.04 65.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 110.303 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.6 m-85 -62.01 -45.38 93.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.924 -1.11 . . . . 0.0 108.758 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -59.68 -41.33 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.676 -0.64 . . . . 0.0 109.811 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -74.64 -41.68 59.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 111.418 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -48.68 25.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.858 -1.151 . . . . 0.0 110.357 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.4 mt -67.66 -40.51 84.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.12 -0.987 . . . . 0.0 110.392 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -53.05 -31.79 43.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 109.593 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -85.3 -5.89 59.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 110.102 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.591 HD21 ' CG ' ' A' ' 11' ' ' LEU . 71.7 m-20 -125.47 30.29 5.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 111.385 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.89 146.79 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.661 -1.274 . . . . 0.0 109.941 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' THR . 15.1 tp -131.93 161.13 33.81 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -108.1 144.91 34.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 110.076 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -106.0 -163.77 0.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.26 -3.42 13.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.344 -0.848 . . . . 0.0 110.58 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -89.98 143.48 26.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 0.0 110.274 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -83.03 128.56 34.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.36 -0.838 . . . . 0.0 109.859 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.5 mt -67.49 137.35 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.768 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.69 91.09 8.68 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -65.47 146.83 54.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.455 -0.778 . . . . 0.0 110.936 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -100.26 122.65 43.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.71 139.18 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.6 t -84.21 138.86 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.429 -0.794 . . . . 0.0 108.929 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -117.72 -8.67 10.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.522 -0.736 . . . . 0.0 109.444 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -144.0 144.12 25.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.953 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.91 150.66 55.59 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.196 1.931 . . . . 0.0 113.096 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.2 tt -140.96 144.61 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.87 125.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.81 111.27 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.778 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -113.47 133.59 55.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -179.08 156.38 0.78 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.011 -1.056 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 57.0 mm-40 56.16 20.14 4.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.54 88.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.423 ' HE ' ' C ' ' A' ' 251' ' ' GLY . 1.4 mtp85 -104.02 171.21 7.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.6 tt -159.86 146.06 15.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.503 -1.373 . . . . 0.0 108.589 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 18.7 mt -147.59 126.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.024 -1.047 . . . . 0.0 108.511 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 147.06 43.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -127.75 151.87 48.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -150.11 139.14 12.9 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -51.52 144.19 33.36 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.707 1.605 . . . . 0.0 112.146 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.71 11.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.21 -0.931 . . . . 0.0 109.472 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 24.7 p-10 -86.21 -0.4 55.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.67 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.3 p -135.14 145.54 47.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.1 tp -79.72 118.03 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.92 . . . . 0.0 109.838 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -138.17 142.16 40.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 108.871 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 71.1 t -140.35 131.87 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.997 -1.064 . . . . 0.0 109.935 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 m -117.73 135.85 53.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.348 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -123.88 128.54 49.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.6 109.46 17.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.01 122.75 6.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 1.1 pm0 -102.88 114.65 29.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -1.138 . . . . 0.0 108.659 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -109.42 147.73 32.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.576 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -93.31 0.12 56.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.786 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.429 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 12.8 p30 -79.3 -171.54 2.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 12.2 p90 -61.68 -26.55 68.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.0 mt -55.61 -50.57 69.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.465 ' C ' HE22 ' A' ' 162' ' ' GLN . . . 87.34 -136.09 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.521 ' C ' ' NE2' ' A' ' 162' ' ' GLN . 38.3 mtp180 -98.68 140.35 33.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -1.1 . . . . 0.0 109.575 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 161' ' ' ARG . 1.7 mp0 -139.33 131.06 27.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.368 -0.833 . . . . 0.0 109.03 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.33 52.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.527 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 71.9 t80 -138.35 126.69 23.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.183 -0.948 . . . . 0.0 109.787 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.474 ' O ' ' CG2' ' A' ' 165' ' ' THR . 7.0 t -106.03 123.93 48.77 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -97.67 133.45 42.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.93 . . . . 0.0 108.716 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.81 148.34 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.522 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -48.06 114.89 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.639 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.406 ' N ' ' OE2' ' A' ' 171' ' ' GLU . . . 115.61 10.33 11.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.429 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 27.3 m-20 -136.81 26.9 3.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.988 -1.301 . . . . 0.0 108.853 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.429 ' OE2' ' N ' ' A' ' 170' ' ' ASN . 1.9 mp0 -63.0 -37.82 88.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.749 . . . . 0.0 110.768 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.19 -16.33 13.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -90.29 -3.67 57.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.077 . . . . 0.0 110.917 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.85 4.67 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.047 -1.033 . . . . 0.0 111.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.27 -27.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.779 -1.2 . . . . 0.0 109.799 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.65 2.47 50.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.797 -1.189 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.1 109.52 17.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.774 -1.204 . . . . 0.0 109.036 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -79.69 153.52 29.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -55.83 154.49 7.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 108.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.544 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 39.5 p90 -135.35 170.45 15.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 109.728 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.633 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -159.29 161.94 35.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.23 -0.919 . . . . 0.0 109.754 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.535 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 61.5 m-85 -103.79 146.46 28.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.64 -21.13 64.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.047 -1.033 . . . . 0.0 110.868 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.3 p90 -81.53 -29.6 33.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.552 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.1 pt-20 -92.15 -15.84 27.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.896 -1.128 . . . . 0.0 109.699 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 12.1 mt -58.76 -53.25 49.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 110.431 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -52.43 -47.58 66.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.579 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.22 -47.55 83.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.977 . . . . 0.0 109.137 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.96 -33.11 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 108.99 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -78.27 -31.4 49.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -74.98 -28.76 60.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.019 -1.051 . . . . 0.0 110.218 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 31.4 m -78.51 8.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.173 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.47 20.95 73.73 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 22.9 mt -119.16 157.82 27.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.67 24.34 62.78 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -67.71 -21.72 65.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.744 -1.445 . . . . 0.0 109.436 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.34 -6.12 48.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.99 126.66 42.29 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.044 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 203' ' ' THR . 60.6 p -140.88 160.76 39.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.895 . . . . 0.0 109.309 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.43 -27.76 69.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 109.968 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -76.23 -15.86 59.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 109.927 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 29.0 m120 -132.81 11.12 4.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.633 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 39.3 m -148.97 115.36 5.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.163 -0.961 . . . . 0.0 109.777 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 68.9 tp -75.5 112.19 11.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.58 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.2 t -103.4 128.35 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 109.223 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.8 mt -110.67 146.29 36.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -101.19 154.14 19.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.45 -26.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 10.8 0.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.0 110.325 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -141.12 148.68 40.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.305 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.92 123.55 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.53 -54.79 7.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.394 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -59.34 134.31 88.34 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.703 -1.248 . . . . 0.0 109.341 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.15 -7.32 20.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.357 2.038 . . . . 0.0 112.761 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -86.47 -7.58 58.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 0.0 110.316 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.07 -158.85 53.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.4 144.13 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -1.059 . . . . 0.0 109.949 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 109.517 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.578 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 68.1 m-85 -140.08 129.47 24.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.895 . . . . 0.0 109.042 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -52.99 -11.02 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 108.502 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.503 ' H ' ' C ' ' A' ' 219' ' ' TYR . 5.9 m120 -133.07 35.28 3.52 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.462 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 8.7 tt0 -59.26 -55.35 47.05 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.729 . . . . 0.0 111.579 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 19.6 Cg_endo -60.75 -42.14 41.06 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.73 1.62 . . . . 0.0 113.305 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.5 m -76.99 -25.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 108.363 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.578 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 46.9 mtt180 -67.0 -43.47 82.83 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.28 -41.24 98.32 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.45 -46.26 80.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.9 t -60.76 -51.03 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.455 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 81.6 t80 -50.45 -39.85 48.99 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.886 0.85 . . . . 0.0 108.725 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.455 ' OD2' ' OE1' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.98 -39.66 69.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.65 -0.656 . . . . 0.0 109.681 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 28.5 tp -57.9 -35.36 70.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.905 . . . . 0.0 109.385 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.51 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 86.9 mt -71.12 -48.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.41 -32.1 14.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.8 -27.03 31.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -82.94 -24.3 33.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.775 -1.203 . . . . 0.0 109.86 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.452 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 44.5 t80 -68.14 -8.56 39.48 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 239' ' ' GLY . 43.9 mt -52.21 -30.26 26.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 109.163 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.5 mt -55.02 -7.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.169 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 71.92 14.78 75.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.7 p -158.13 144.62 12.87 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -1.21 . . . . 0.0 109.402 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -42.38 134.71 4.61 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.148 1.899 . . . . 0.0 111.873 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.04 129.53 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.616 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -118.1 124.65 48.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 109.373 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.36 -178.5 31.96 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -105.08 138.12 41.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -1.077 . . . . 0.0 110.039 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.5 m-85 -140.21 143.46 36.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.062 0.934 . . . . 0.0 111.263 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -126.31 144.25 50.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.1 t -140.11 127.47 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 110.631 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 0.9 OUTLIER -111.71 114.2 27.06 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.46 ' CG ' ' OE1' ' A' ' 154' ' ' GLU . 2.6 mmm180 47.72 55.79 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.423 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -77.6 140.52 24.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -111.05 174.19 16.66 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.571 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 15.1 m-70 -68.58 -41.97 78.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.048 -1.266 . . . . 0.0 109.659 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -55.18 25.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 57.2 tp -51.7 -39.04 57.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 71.3 m-20 -58.71 -55.48 34.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.995 . . . . 0.0 109.018 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.73 -43.35 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.732 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -48.7 74.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.093 -1.004 . . . . 0.0 109.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 38.9 tp -52.81 -43.38 65.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.358 -0.839 . . . . 0.0 109.039 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 20.2 t -71.13 -45.73 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.14 -51.45 64.23 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 109.917 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -61.04 -51.48 69.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.941 -1.099 . . . . 0.0 109.637 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.66 -43.9 80.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.49 -33.11 73.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -84.36 -23.04 30.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.81 -1.181 . . . . 0.0 108.937 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.11 -45.4 60.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.363 -0.836 . . . . 0.0 109.642 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.48 10.35 23.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 110.143 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -79.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 109.416 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 60.0 mt -85.02 -66.98 0.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.964 . . . . 0.0 109.477 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.617 ' C1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.589 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 66.4 mt-10 -48.45 141.45 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.072 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -120.87 138.35 54.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.414 -0.804 . . . . 0.0 109.466 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 t -139.54 177.89 7.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.78 144.7 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -74.78 -46.92 33.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.667 -0.645 . . . . 0.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.32 160.47 34.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.71 . . . . 0.0 110.219 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -64.92 135.56 55.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -0.768 . . . . 0.0 110.104 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mt -122.29 171.38 9.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -158.49 150.74 21.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 0.0 110.442 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -133.93 160.91 36.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.483 -0.761 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.12 137.21 21.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.962 -1.086 . . . . 0.0 109.141 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.73 160.79 20.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.512 -1.328 . . . . 0.0 109.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 4.9 p -76.3 162.98 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 0.0 111.424 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.476 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -94.76 141.4 15.53 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -59.75 -48.18 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -1.138 . . . . 0.0 112.937 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.419 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.5 m-70 -86.33 -36.51 19.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.013 -1.679 . . . . 0.0 112.374 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -80.41 -34.06 36.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.824 -1.172 . . . . 0.0 110.091 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.15 74.87 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.29 152.82 30.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.983 . . . . 0.0 108.867 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -73.81 140.92 46.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 110.202 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 9.7 t -147.88 157.64 43.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.047 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -132.21 154.71 49.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.286 -0.884 . . . . 0.0 109.239 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.402 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.2 mt -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 0.0 108.724 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 mt -127.95 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mt -123.91 120.88 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -117.23 149.3 44.23 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 161.19 22.71 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.112 1.874 . . . . 0.0 111.258 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.6 mm-40 -134.72 -173.73 3.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.072 -1.017 . . . . 0.0 110.081 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.8 tttm -91.94 155.75 17.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.701 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -48.07 143.63 4.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 110.62 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.589 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.84 26.17 60.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.543 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.613 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 33.0 m -79.98 -34.93 38.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.709 -1.465 . . . . 0.0 108.595 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.747 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 91.88 -173.35 36.4 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mm -102.03 123.74 55.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.323 -1.104 . . . . 0.0 108.271 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -137.28 139.83 41.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.511 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.03 152.84 19.38 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.533 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.9 t80 -131.32 142.78 50.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.832 . . . . 0.0 109.02 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.554 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 14.0 tttm -172.54 138.92 0.92 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.48 29.8 13.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.912 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.54 19.1 77.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.45 136.91 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.282 -1.128 . . . . 0.0 109.692 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -96.79 140.53 31.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.895 . . . . 0.0 109.178 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.5 mt -132.68 95.6 19.69 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.7 142.48 24.79 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.206 1.937 . . . . 0.0 111.607 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.35 80.67 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.961 -1.087 . . . . 0.0 110.307 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.04 153.41 51.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 109.649 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' VAL . 7.7 p80 -54.68 -49.29 71.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.4 mm-40 -44.67 -31.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.989 -1.07 . . . . 0.0 109.318 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.83 4.06 15.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.922 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 7.9 t -59.37 124.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.31 -32.0 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.412 -0.805 . . . . 0.0 109.944 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.531 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.8 t-160 -152.25 123.87 7.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.688 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.3 p -111.1 134.66 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.592 ' C ' ' H ' ' A' ' 59' ' ' SER . 20.3 p-10 -166.39 -154.44 0.18 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -10.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.942 -1.099 . . . . 0.0 108.479 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -138.85 166.96 23.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -0.8 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.1 m -101.99 120.56 40.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.05 136.93 52.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.34 -0.85 . . . . 0.0 111.199 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.5 mt -123.39 157.67 32.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.7 143.49 6.89 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 118.484 -1.817 . . . . 0.0 111.214 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -144.29 148.99 35.54 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.747 -0.855 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm 56.62 38.33 29.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 110.783 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.55 4.4 84.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.8 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.554 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 94.0 mm-40 -102.85 140.56 36.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.934 -1.333 . . . . 0.0 108.418 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -141.91 154.31 45.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.47 146.25 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -115.1 154.63 28.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 111.113 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 m 52.38 68.85 0.76 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.734 -0.604 . . . . 0.0 111.111 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.8 -10.72 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.179 -0.95 . . . . 0.0 109.727 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 5.7 pt-20 -67.73 -16.98 64.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.439 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -72.45 -60.59 2.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.012 -1.055 . . . . 0.0 109.424 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 5.0 tp -58.92 -41.14 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.99 -1.069 . . . . 0.0 108.945 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 84.4 mt -59.78 -36.49 76.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.587 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.6 t -60.44 -48.69 80.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.044 -1.035 . . . . 0.0 108.841 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.31 -51.26 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.453 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.0 mt -51.87 -44.91 63.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.513 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 8.4 t-160 -57.1 -48.46 78.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.831 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.34 -39.73 95.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 110.414 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 53.2 mt -80.7 -5.56 57.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.053 -1.03 . . . . 0.0 110.738 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.77 54.64 2.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.896 -1.127 . . . . 0.0 110.723 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.487 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 8.0 mm -92.69 123.85 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.4 p -109.78 -23.8 11.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.274 -0.891 . . . . 0.0 111.492 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.747 HD21 ' H ' ' A' ' 36' ' ' GLY . 11.6 m120 -128.8 111.9 13.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.972 -1.08 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.03 143.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.246 -0.909 . . . . 0.0 109.898 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.519 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.7 m -113.77 100.59 8.57 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.51 105.38 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.348 -0.845 . . . . 0.0 109.985 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.54 121.73 26.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -104.21 115.14 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.456 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 2.3 mp -97.11 109.62 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.19 -160.62 23.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.15 -12.25 11.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.071 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.504 ' OE2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -142.76 147.73 36.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.984 -1.073 . . . . 0.0 110.584 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 124.42 90.89 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.505 -0.747 . . . . 0.0 108.993 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -44.74 131.36 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.032 1.822 . . . . 0.0 112.344 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.55 -27.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.418 -0.801 . . . . 0.0 109.675 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.45 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 22.8 mt 54.89 -112.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.274 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.36 -13.85 25.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.987 . . . . 0.0 110.699 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.74 -15.35 41.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -113.1 -168.89 1.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -1.063 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.09 -1.32 23.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -46.92 -44.39 19.8 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.788 -0.83 . . . . 0.0 110.573 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.09 -51.91 66.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.0 -1.062 . . . . 0.0 110.129 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 69.8 m-85 -61.33 -44.21 97.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 109.057 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.499 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 5.6 t80 -67.14 -37.46 83.86 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.324 0.583 . . . . 0.0 110.491 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.14 -50.98 42.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 111.351 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.84 -44.7 61.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.867 -1.145 . . . . 0.0 110.622 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.88 -39.89 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 110.033 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -53.75 -30.94 46.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.309 -0.869 . . . . 0.0 109.165 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -84.75 -11.5 55.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.32 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -119.96 29.54 7.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.238 -0.914 . . . . 0.0 111.405 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.66 147.23 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.592 -1.317 . . . . 0.0 109.827 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.8 tp -131.58 159.96 36.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -109.52 144.6 37.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.404 ' NE2' ' OD1' ' A' ' 86' ' ' ASN . 4.0 mt-30 -107.01 -166.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 p30 -118.73 72.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.529 -0.732 . . . . 0.0 110.187 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 4' ' ' GLU . 20.9 ttt180 -166.04 143.98 5.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 109.42 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.32 131.45 35.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.09 -1.006 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.8 mt -74.98 141.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.732 . . . . 0.0 110.571 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -84.04 88.53 7.17 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -61.47 145.69 51.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.6 120.51 40.43 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.18 140.71 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.266 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 97.1 t -84.24 136.3 23.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.462 -0.774 . . . . 0.0 109.212 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -113.94 -10.26 12.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.12 146.58 40.59 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.08 178.02 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.19 1.927 . . . . 0.0 112.779 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.2 tt -165.32 147.76 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.495 -0.753 . . . . 0.0 109.799 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 53.2 mt -134.91 122.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.23 116.69 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -104.23 155.01 19.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.265 -0.897 . . . . 0.0 109.896 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 137' ' ' ARG . 13.3 t0 -165.52 110.98 0.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.978 -1.076 . . . . 0.0 111.499 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 41.19 51.76 3.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.427 -0.796 . . . . 0.0 112.46 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.48 6.77 88.87 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.645 -1.285 . . . . 0.0 110.448 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.8 mtt85 -118.6 130.18 55.73 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 139' ' ' ILE . 3.7 tt -144.33 160.02 41.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.416 -1.428 . . . . 0.0 110.16 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.415 ' H ' ' HG ' ' A' ' 138' ' ' LEU . 52.5 mt -146.26 133.01 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -118.96 144.86 46.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -118.37 147.82 43.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -145.05 135.03 11.7 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.57 147.46 58.75 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.402 . . . . 0.0 112.031 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.21 154.76 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.232 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.557 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.6 OUTLIER -86.98 1.39 52.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.506 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.5 p -135.7 146.94 48.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.2 tp -79.58 119.83 23.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.02 134.15 32.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 108.877 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.05 118.16 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 109.339 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.0 m -107.35 135.72 48.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.094 -1.004 . . . . 0.0 109.642 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -123.6 129.15 50.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.47 -0.769 . . . . 0.0 109.827 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -113.92 109.64 18.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.3 155.96 19.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.556 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -134.2 91.24 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -1.089 . . . . 0.0 109.485 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.76 148.76 22.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 -10.26 35.52 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.403 -0.81 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.511 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.6 p30 -69.65 -167.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.186 -0.947 . . . . 0.0 109.521 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.99 -21.44 58.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.907 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.7 mt -64.48 -47.61 78.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.82 -126.23 7.43 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.7 mtt85 -109.44 141.09 42.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.533 -0.981 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -153.9 150.4 28.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 109.713 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -136.71 151.35 49.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.407 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 62.9 t80 -135.12 122.89 22.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 108.872 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.424 ' O ' ' CG2' ' A' ' 165' ' ' THR . 15.2 t -99.83 122.35 42.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -100.44 132.86 45.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.351 -0.843 . . . . 0.0 109.164 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.45 151.91 34.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.454 -0.779 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -51.67 116.4 2.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 8.32 14.37 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -134.04 26.24 3.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.19 -1.183 . . . . 0.0 108.312 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.6 -31.72 73.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.64 -0.662 . . . . 0.0 110.735 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.68 -15.53 58.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.275 -0.89 . . . . 0.0 111.627 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.34 -4.15 49.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.587 -1.321 . . . . 0.0 111.212 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.3 pt -117.11 -9.99 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.05 -1.032 . . . . 0.0 111.132 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.11 -28.11 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.548 -1.345 . . . . 0.0 110.133 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 2.29 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.896 -1.127 . . . . 0.0 110.452 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.37 110.18 17.28 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.94 -1.1 . . . . 0.0 109.001 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 154.58 20.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.085 -1.01 . . . . 0.0 110.066 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.493 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 5.0 t -52.73 156.9 1.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -0.799 . . . . 0.0 109.537 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.524 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 34.1 p90 -141.47 167.8 21.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.087 -1.008 . . . . 0.0 109.826 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.524 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -163.82 164.12 23.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -0.931 . . . . 0.0 109.918 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.433 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 91.2 m-85 -103.14 144.43 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.354 -0.842 . . . . 0.0 109.127 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -65.45 -18.75 65.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.386 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -77.58 -29.04 51.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.548 -1.345 . . . . 0.0 111.003 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -101.39 -11.45 19.37 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.853 -1.154 . . . . 0.0 110.15 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.7 mt -58.93 -51.21 75.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 110.371 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -51.01 -49.43 60.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.919 -1.113 . . . . 0.0 109.54 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -49.39 70.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 109.005 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 57.0 mt -57.41 -33.81 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.966 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -75.18 -26.13 58.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 110.179 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 193' ' ' GLY . 0.6 OUTLIER -76.52 -33.83 58.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 110.004 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.1 m -74.6 10.07 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 109.037 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 76.82 22.06 72.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.18 155.63 30.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -1.178 . . . . 0.0 109.997 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.83 23.71 61.46 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.365 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -67.45 -22.17 65.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.686 -1.479 . . . . 0.0 109.618 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.83 -5.82 50.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 128.34 41.44 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.848 -1.384 . . . . 0.0 110.106 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -136.22 -177.49 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.519 -0.989 . . . . 0.0 109.605 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.2 -21.97 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.65 -6.26 58.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.861 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.467 ' C ' ' HG1' ' A' ' 203' ' ' THR . 7.1 m-20 -141.26 13.85 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.04 -1.037 . . . . 0.0 110.017 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.467 ' HG1' ' C ' ' A' ' 202' ' ' ASN . 1.1 m -149.3 118.96 6.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.015 -1.053 . . . . 0.0 110.058 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.33 111.58 14.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.897 . . . . 0.0 108.909 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.2 t -103.7 127.89 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.225 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.78 151.89 28.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.72 160.98 14.11 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -48.62 -28.08 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.78 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -152.59 13.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.038 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 207' ' ' GLY . 73.6 tttt -141.19 149.36 41.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.021 -1.05 . . . . 0.0 110.068 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.2 t -99.08 125.92 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 109.038 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -72.96 -54.46 8.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 110.104 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.03 137.02 80.21 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.996 -1.065 . . . . 0.0 109.746 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.74 -13.23 26.91 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.412 2.075 . . . . 0.0 112.622 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -85.59 -7.28 58.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 110.1 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.68 -160.83 53.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.95 145.73 30.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.991 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -88.84 -24.94 22.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 108.815 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 221' ' ' ASN . 56.6 m-85 -145.99 139.37 26.09 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.75 -12.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.951 -1.093 . . . . 0.0 108.507 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.581 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.88 37.68 1.98 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.768 0.794 . . . . 0.0 109.122 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.592 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -55.75 -41.48 91.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_exo -69.11 -42.83 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.429 2.086 . . . . 0.0 112.966 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.1 m -76.25 -24.81 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.735 -1.228 . . . . 0.0 108.691 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.471 ' NH2' ' ND2' ' A' ' 221' ' ' ASN . 38.6 mtt180 -69.03 -45.17 71.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.435 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 37.0 t60 -59.2 -45.06 92.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.471 -0.768 . . . . 0.0 108.959 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -56.58 -47.81 78.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 108.989 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 95.6 t -58.46 -51.18 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.587 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -50.69 -39.33 50.97 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -72.05 -40.87 68.04 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.588 -0.695 . . . . 0.0 109.855 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 tp -57.02 -35.01 68.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.377 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 25.0 mt -71.62 -48.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.32 20.55 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.87 -28.8 29.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.263 -1.139 . . . . 0.0 109.854 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.0 mt -79.75 -22.92 42.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.773 -1.204 . . . . 0.0 109.701 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 24.5 t80 -69.0 -10.0 55.26 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 81.2 mt -51.44 -26.59 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 0.0 108.869 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 95.5 mt -59.95 -21.59 61.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.89 14.57 69.5 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 56.1 p -158.41 147.12 14.29 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.045 -1.268 . . . . 0.0 109.813 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -42.66 130.87 5.41 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.203 1.935 . . . . 0.0 111.961 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 51.3 t -95.26 127.04 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.579 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -117.08 123.85 47.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.365 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.67 177.95 30.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.5 tttp -110.35 111.17 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.242 -1.152 . . . . 0.0 110.352 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.9 m-85 -111.82 147.6 35.37 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.853 0.835 . . . . 0.0 110.695 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -128.35 143.25 50.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.0 t -138.13 126.18 22.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.682 -1.261 . . . . 0.0 110.219 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 250' ' ' ARG . 11.9 t80 -111.64 112.61 24.43 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.556 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 12.3 mtt180 47.39 56.67 6.67 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.47 155.14 22.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.48 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -118.24 -175.42 16.66 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.444 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 90.9 m-70 -72.28 -51.82 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -1.21 . . . . 0.0 109.66 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.3 t -55.57 -34.12 64.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.706 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 44.0 tp -72.99 -37.47 66.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 108.99 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 4.8 m120 -62.71 -49.71 74.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 108.922 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.79 -44.18 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.354 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -54.98 -48.53 73.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.942 -1.099 . . . . 0.0 108.844 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.82 -47.05 67.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.56 -50.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.682 0.753 . . . . 0.0 109.574 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.82 -50.54 18.23 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 110.417 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.91 -47.98 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.09 . . . . 0.0 110.29 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 72.2 mt -61.76 -43.99 97.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 109.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.59 96.74 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.381 -0.824 . . . . 0.0 109.486 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.721 ' HZ2' ' HZ1' ' A' ' 268' ' ' LYS . 12.7 mtpp -68.83 -23.71 64.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.93 -1.106 . . . . 0.0 109.159 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mttp -70.89 -49.01 50.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.201 -0.937 . . . . 0.0 110.089 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -95.56 1.89 54.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.025 -1.047 . . . . 0.0 111.094 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.721 ' HZ1' ' HZ2' ' A' ' 265' ' ' LYS . 7.2 ttpt -80.07 -41.06 26.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.681 -1.262 . . . . 0.0 109.819 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.02 -84.05 0.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' A' ' 270' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.508 ' C2A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.5 mt-10 -47.87 146.08 2.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 109.326 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -126.5 141.87 51.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.69 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 4.0 t -138.61 177.79 7.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.69 ' H ' ' HG1' ' A' ' 6' ' ' THR . 2.0 m -83.06 140.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.818 -1.176 . . . . 0.0 110.163 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ttpt -77.05 -43.67 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -126.2 153.23 44.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 109.842 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 139.49 58.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 110.236 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.6 mt -123.32 168.65 12.22 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -157.94 148.7 20.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 110.105 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -132.44 159.94 37.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -147.82 135.03 20.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.964 -1.085 . . . . 0.0 108.603 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.0 157.58 15.12 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.2 p -81.53 141.03 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.216 -1.167 . . . . 0.0 110.755 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.18 144.92 40.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -63.89 -46.04 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.225 -1.162 . . . . 0.0 112.627 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.426 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.6 m-70 -86.8 -40.42 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 119.961 -1.712 . . . . 0.0 111.46 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 20' ' ' THR . 1.7 m -70.27 -31.64 69.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 109.954 -178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.04 23.89 68.16 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -116.87 152.28 34.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -1.019 . . . . 0.0 109.469 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -70.69 132.72 45.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.72 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.669 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 2.1 t -140.89 158.0 44.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.0 109.252 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.669 ' N ' ' HG ' ' A' ' 24' ' ' SER . 7.9 ttpp -130.7 158.65 39.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.875 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.9 mt -135.44 141.12 45.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 108.766 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mt -126.41 135.66 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mt -118.77 112.75 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -111.97 154.58 44.13 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -68.67 162.2 42.08 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.372 2.048 . . . . 0.0 110.883 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.6 mm-40 -137.37 -177.4 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.016 -1.052 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.482 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -83.13 148.79 27.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.418 -0.801 . . . . 0.0 109.236 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.579 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.84 149.77 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.984 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.592 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.21 21.59 53.83 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.292 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.69 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 19.1 m -80.58 -37.35 31.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.625 -1.515 . . . . 0.0 108.803 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.534 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 94.75 -175.56 34.16 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -98.81 123.23 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.449 -1.03 . . . . 0.0 108.294 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -137.22 145.74 44.0 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.859 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -103.72 152.26 22.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.538 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.1 t80 -133.81 141.36 47.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.499 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.3 143.27 1.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.87 29.55 16.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.973 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.35 27.15 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.01 135.05 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -1.079 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.8 140.5 32.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.5 mt -135.2 95.38 14.95 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.882 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.18 145.41 7.81 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.018 1.812 . . . . 0.0 111.743 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.41 82.35 5.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.0 110.292 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -139.14 156.25 47.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 109.58 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.1 p80 -52.78 -49.64 65.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -44.79 -16.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 25.4 m-85 -97.03 4.67 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.941 -1.099 . . . . 0.0 109.897 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.24 126.11 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.24 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.18 -34.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.374 -0.829 . . . . 0.0 110.0 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -148.42 119.11 7.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 109.384 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -114.01 130.64 56.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 59' ' ' SER . 66.8 t30 -166.61 -153.63 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.572 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 4.8 m-70 -46.11 -15.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.383 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 57' ' ' ASN . 36.8 t -134.69 166.09 23.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.459 -0.776 . . . . 0.0 109.369 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m -109.85 125.04 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.369 -0.832 . . . . 0.0 109.225 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.2 145.98 48.99 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.958 0.885 . . . . 0.0 111.078 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.4 mt -127.21 159.55 33.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -178.55 148.25 8.3 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 118.422 -1.847 . . . . 0.0 111.572 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.2 149.68 36.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.157 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp 55.79 37.61 29.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.947 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 6.1 84.92 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.79 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 18.9 mm100 -105.4 135.08 47.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -1.229 . . . . 0.0 108.018 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -142.23 159.77 41.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.943 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mt -136.47 147.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -114.67 154.35 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.433 -0.792 . . . . 0.0 110.949 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m 52.33 69.03 0.73 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.671 -0.643 . . . . 0.0 111.005 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.14 -11.26 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.166 -0.959 . . . . 0.0 109.28 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.1 pt-20 -66.9 -21.09 66.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.902 . . . . 0.0 110.535 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -71.28 -59.85 2.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.925 -1.109 . . . . 0.0 109.74 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.5 tp -57.87 -40.65 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.089 . . . . 0.0 108.962 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.426 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 8.2 mt -61.55 -35.74 78.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.639 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.595 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.6 t -61.32 -48.74 79.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.032 -1.042 . . . . 0.0 109.244 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.9 t -58.59 -54.05 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.7 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.6 mt -51.19 -43.44 61.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.536 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 13.2 t-160 -54.61 -52.32 62.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.784 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.53 -36.9 85.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.0 mt -78.08 -5.7 52.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.554 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 62.72 54.28 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.819 -1.175 . . . . 0.0 110.557 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.506 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 11.5 mm -96.02 126.16 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -113.19 -24.13 9.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 112.21 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.69 ' ND2' ' H ' ' A' ' 35' ' ' THR . 10.5 m120 -130.63 112.36 13.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.76 -1.212 . . . . 0.0 110.418 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.7 m -165.22 141.19 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.548 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 82.6 m -109.22 100.02 9.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.07 111.46 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -84.7 124.7 31.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.87 -1.144 . . . . 0.0 108.374 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.9 t -107.85 111.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.493 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 2.4 mp -98.13 109.06 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.88 -162.43 24.19 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.486 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -115.38 -15.42 11.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.147 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.98 144.73 37.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.019 -1.051 . . . . 0.0 110.004 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.56 127.67 92.58 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 109.5 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -45.6 128.37 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.887 1.724 . . . . 0.0 111.814 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.4 tp -79.8 -26.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.408 -0.808 . . . . 0.0 109.849 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.6 mt 55.42 -110.59 0.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -94.86 -18.74 20.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.081 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.87 -10.36 27.5 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -114.49 -169.67 1.58 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.429 -1.042 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -3.08 21.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -46.91 -42.04 16.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.842 -0.799 . . . . 0.0 110.649 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.57 -52.02 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.987 -1.071 . . . . 0.0 110.171 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 74.3 m-85 -62.27 -44.03 97.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.112 -0.993 . . . . 0.0 108.715 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 9.9 t80 -61.35 -39.46 90.66 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.44 0.638 . . . . 0.0 109.842 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.11 -46.73 40.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.465 -0.772 . . . . 0.0 111.906 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.42 -48.38 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.778 -1.201 . . . . 0.0 110.674 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.53 -40.75 89.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.359 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 1.1 ttm-85 -54.62 -29.5 52.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -0.963 . . . . 0.0 109.978 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -82.57 -8.88 59.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -123.18 33.96 5.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.318 -0.864 . . . . 0.0 111.279 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.4 mt -93.46 147.83 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 110.501 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.4 tp -131.02 163.55 27.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -112.97 144.03 43.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.95 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -161.45 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.169 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -122.77 1.03 9.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.255 -0.903 . . . . 0.0 110.856 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -82.66 135.46 35.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.797 -1.189 . . . . 0.0 109.849 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -74.94 124.1 26.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mt -71.82 140.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 111.278 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.81 91.18 8.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -63.53 146.08 54.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.459 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -102.21 125.78 49.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 t -129.96 143.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 92.3 t -82.94 137.85 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -119.7 -11.3 9.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.45 140.71 23.46 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 0.0 108.868 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -72.17 149.74 52.39 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.884 1.722 . . . . 0.0 113.043 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.95 124.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 109.64 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.7 m -120.22 115.65 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.116 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -105.42 142.5 35.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.332 -0.855 . . . . 0.0 109.225 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.46 123.8 1.91 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.766 -1.209 . . . . 0.0 111.944 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 48.08 41.56 15.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.775 -0.578 . . . . 0.0 112.319 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.48 4.23 90.46 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.045 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.2 mtt-85 -104.17 161.46 14.0 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.7 tt -160.33 150.44 18.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.16 -1.588 . . . . 0.0 109.052 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.493 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 3.3 mt -147.6 132.2 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -123.43 139.24 54.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.838 . . . . 0.0 109.797 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.36 148.03 43.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -147.11 137.77 12.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.65 143.1 47.86 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.4 1.4 . . . . 0.0 112.115 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.68 146.21 13.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.329 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -80.2 -1.69 41.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 p -135.72 144.7 46.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.394 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.4 118.74 19.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.96 138.26 40.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.83 121.69 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.013 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -110.66 129.76 55.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.527 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -114.77 129.92 56.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.615 -0.678 . . . . 0.0 109.517 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.426 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 8.1 tt0 -117.06 112.91 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.53 ' C ' HH21 ' A' ' 250' ' ' ARG . . . -110.7 161.06 12.98 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.834 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.413 ' OE1' ' NH1' ' A' ' 250' ' ' ARG . 12.7 pt-20 -131.92 114.78 15.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.674 -0.898 . . . . 0.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 157' ' ' ASN . 23.9 m-85 -118.77 148.49 42.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.886 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.03 -6.62 47.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.98 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.702 ' H ' HD21 ' A' ' 157' ' ' ASN . 0.0 OUTLIER -73.45 -168.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.02 . . . . 0.0 109.504 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -63.84 -16.87 62.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.125 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.438 ' CD2' HE22 ' A' ' 162' ' ' GLN . 6.2 mt -73.85 -24.83 59.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.977 -1.077 . . . . 0.0 109.109 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.73 -134.53 49.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -110.63 151.1 28.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.967 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.438 HE22 ' CD2' ' A' ' 159' ' ' LEU . 0.1 OUTLIER -169.06 160.82 10.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.831 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.64 160.12 39.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.9 126.38 25.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.41 -0.806 . . . . 0.0 108.874 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.0 m -97.05 121.94 39.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.886 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -96.71 138.69 33.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.872 . . . . 0.0 108.801 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.47 151.8 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.78 120.38 7.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.62 -1.59 21.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.459 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 15.5 m-80 -131.52 31.77 4.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -1.158 . . . . 0.0 108.87 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.62 -34.39 75.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.562 -0.711 . . . . 0.0 110.244 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 172' ' ' GLU . 2.8 mp0 -51.68 -14.55 0.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.062 -1.024 . . . . 0.0 110.577 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.516 ' CD ' ' N ' ' A' ' 173' ' ' GLU . 9.9 mp0 -93.5 -3.96 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.971 -1.081 . . . . 0.0 111.003 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.466 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -121.33 7.0 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.029 -1.044 . . . . 0.0 111.286 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.39 -32.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.711 -1.243 . . . . 0.0 110.271 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.37 1.98 51.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.873 -1.142 . . . . 0.0 110.689 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.13 108.54 15.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.875 -1.141 . . . . 0.0 109.085 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -82.18 154.49 25.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.087 -1.008 . . . . 0.0 109.352 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 t -61.77 138.91 58.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.426 ' O ' ' O4G' ' A' ' 320' ' ' TUX . 28.2 p90 -117.32 173.48 6.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 110.208 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.512 ' SG ' ' O4G' ' A' ' 320' ' ' TUX . 0.1 OUTLIER -161.78 159.79 27.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 0.0 109.229 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.588 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.6 m-85 -104.3 146.92 28.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.144 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 8.1 p30 -61.24 -17.89 55.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 111.218 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.3 p90 -80.13 -33.93 38.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.604 -1.31 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.602 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 pt-20 -92.88 -11.97 32.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.583 -1.323 . . . . 0.0 109.786 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.2 mt -58.03 -52.29 60.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.135 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.23 -51.24 55.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.846 -1.159 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -52.82 -52.17 57.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.961 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.56 -33.85 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -77.36 -25.47 51.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.613 -0.679 . . . . 0.0 110.268 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -78.26 -29.41 48.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 110.344 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.09 12.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.991 -1.068 . . . . 0.0 109.397 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.91 23.95 77.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.7 mt -117.3 155.28 29.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -1.12 . . . . 0.0 109.698 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.2 28.12 56.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -70.74 -20.63 62.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.738 -1.448 . . . . 0.0 109.23 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.25 -4.04 50.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.68 127.73 37.0 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.207 -1.172 . . . . 0.0 110.655 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.413 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 77.7 p -135.51 -173.9 3.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.717 -0.872 . . . . 0.0 109.249 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -82.99 -23.16 33.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -81.82 -24.36 35.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.585 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.473 ' C ' ' HG1' ' A' ' 203' ' ' THR . 0.6 OUTLIER -115.23 2.88 14.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.157 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.473 ' HG1' ' C ' ' A' ' 202' ' ' ASN . 0.7 OUTLIER -145.55 124.87 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.912 -1.118 . . . . 0.0 109.99 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.11 116.88 25.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 108.631 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.7 t -104.45 127.85 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.989 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 81.0 mt -105.54 151.62 24.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.86 154.04 17.04 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.8 OUTLIER -41.91 -33.24 0.51 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -1.156 . . . . 0.0 109.829 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 19.02 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 110.251 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -150.32 160.16 43.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.88 130.41 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -73.27 -54.23 8.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.133 -0.979 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.2 135.37 75.03 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.965 -1.085 . . . . 0.0 109.378 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.31 -8.97 23.64 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.489 2.126 . . . . 0.0 112.877 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.422 ' O ' ' OE1' ' A' ' 215' ' ' GLU . 0.0 OUTLIER -92.09 -9.33 43.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 0.0 109.97 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.64 -166.2 51.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 12.7 mt -85.68 147.78 26.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -1.038 . . . . 0.0 110.282 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.635 ' HE ' ' CA ' ' A' ' 218' ' ' ARG . 0.0 OUTLIER -83.46 -15.75 48.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.6 m-85 -149.42 151.67 34.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.036 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -63.02 -15.7 57.32 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.069 -1.019 . . . . 0.0 108.472 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.36 35.89 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.536 -0.728 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -60.45 -36.0 32.15 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.499 -0.751 . . . . 0.0 111.071 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.3 Cg_exo -70.34 -48.13 0.65 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.927 1.751 . . . . 0.0 112.547 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.4 m -73.3 -23.53 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.632 -1.292 . . . . 0.0 108.39 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -67.87 -45.03 75.68 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -59.86 -41.15 90.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.948 . . . . 0.0 109.249 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 42.7 t -58.88 -47.22 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 92.7 t80 -53.13 -38.72 62.9 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.697 0.761 . . . . 0.0 109.151 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 24.0 m-20 -68.76 -43.84 74.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.456 -0.778 . . . . 0.0 110.202 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.83 -39.23 73.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 0.0 109.235 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.406 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 77.0 mt -67.13 -34.28 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.2 -33.14 77.52 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -83.04 -26.21 31.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -1.12 . . . . 0.0 110.142 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mt -81.89 -27.33 33.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.833 -1.167 . . . . 0.0 109.732 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.3 t80 -66.94 -8.52 30.08 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.074 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 87.7 mt -52.62 -25.67 11.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.64 -23.85 59.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.894 -1.129 . . . . 0.0 108.846 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 89.18 14.64 60.15 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.2 p -158.51 146.28 13.6 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.939 -1.33 . . . . 0.0 109.637 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -42.64 131.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.289 1.992 . . . . 0.0 111.784 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.43 134.93 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 109.457 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.66 128.47 48.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.89 178.82 30.46 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -107.37 111.59 24.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -1.183 . . . . 0.0 109.954 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -112.31 148.0 35.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 122.021 0.915 . . . . 0.0 111.167 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.426 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 44.8 t80 -127.78 144.42 51.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.9 128.6 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.816 -1.177 . . . . 0.0 110.361 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.624 ' CE2' ' NH1' ' A' ' 250' ' ' ARG . 38.2 t80 -113.85 107.36 15.62 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.624 ' NH1' ' CE2' ' A' ' 249' ' ' PHE . 0.0 OUTLIER 45.78 57.18 5.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.9 148.54 21.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -116.22 171.07 13.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.562 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 82.7 m-70 -59.91 -46.13 90.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -1.224 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -55.34 35.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.358 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 60.0 tp -51.58 -39.42 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -57.8 -55.86 29.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.169 -0.957 . . . . 0.0 108.933 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 94.4 t -49.16 -41.51 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.29 -50.53 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.048 . . . . 0.0 109.062 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.8 tp -53.15 -43.13 66.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.027 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.04 -40.26 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.343 -0.848 . . . . 0.0 109.428 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -52.53 64.3 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 110.025 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.6 -43.14 94.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.613 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.02 -47.88 84.02 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.16 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.17 75.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.457 -0.777 . . . . 0.0 110.24 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -79.87 -27.61 40.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.676 -1.265 . . . . 0.0 108.95 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.6 mttp -72.95 -48.73 34.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.821 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -81.68 4.61 21.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 109.835 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -25.81 68.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.418 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.0 mt -61.53 -28.25 69.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.568 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.512 ' O4G' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.285 0.564 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.529 ' CB ' ' OE2' ' A' ' 33' ' ' GLU . 5.4 mt-10 -54.63 145.84 18.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.88 . . . . 0.0 109.776 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.0 139.13 54.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.388 0.613 . . . . 0.0 110.04 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 t -135.01 173.81 11.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 m -83.54 142.04 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.84 -1.162 . . . . 0.0 110.212 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 ttpp -77.58 -41.81 37.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.488 -0.757 . . . . 0.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -133.25 157.48 45.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.64 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -59.61 132.3 53.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.734 -0.604 . . . . 0.0 110.015 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.7 mt -119.37 153.56 34.97 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -150.72 147.47 27.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -135.65 162.49 32.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.557 -0.714 . . . . 0.0 109.76 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.88 139.09 26.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.914 -1.116 . . . . 0.0 109.515 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.28 159.19 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 p -85.88 143.7 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.999 -1.295 . . . . 0.0 111.264 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 143.33 36.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.0 OUTLIER -65.6 -38.71 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -1.079 . . . . 0.0 112.666 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.41 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 5.4 m-70 -86.15 -36.71 19.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 119.892 -1.755 . . . . 0.0 112.457 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -84.65 -40.5 17.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.661 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.87 11.32 79.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 152.22 20.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -73.24 143.45 47.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.914 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -146.0 157.55 43.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 108.826 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -136.62 146.61 46.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.201 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -121.56 148.64 44.24 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.147 -0.971 . . . . 0.0 109.034 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.441 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -135.6 126.05 43.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.4 mt -111.65 125.15 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.938 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.441 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 15.8 m-70 -120.63 149.93 51.33 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.87 159.88 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.043 1.829 . . . . 0.0 110.86 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' CG ' ' HG1' ' A' ' 88' ' ' THR . 26.4 mm-40 -134.63 179.25 6.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.027 . . . . 0.0 110.081 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.39 148.16 32.1 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.227 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' OE2' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -47.78 147.0 2.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 -179.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 58.94 25.04 58.89 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.103 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.3 m -80.46 -37.82 31.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.761 -1.435 . . . . 0.0 108.875 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.4 -177.76 32.37 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 37' ' ' ILE . 14.5 mm -97.44 124.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -140.31 139.43 35.45 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.008 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -97.78 153.71 18.09 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.6 t80 -132.28 141.22 48.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.204 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.96 140.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.57 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 58.62 28.42 17.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.406 -0.809 . . . . 0.0 109.706 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.14 30.64 69.55 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.7 t -135.53 132.19 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -1.212 . . . . 0.0 109.967 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -90.06 141.28 28.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 108.942 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.6 mt -137.77 96.98 10.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 110.355 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.75 144.93 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.182 1.921 . . . . 0.0 111.711 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.68 84.82 4.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 0.0 110.089 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -139.65 156.9 46.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 3.5 p80 -53.38 -49.74 66.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.2 mm-40 -47.54 -16.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -0.998 . . . . 0.0 110.353 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' HIS . 22.0 m-85 -97.0 7.07 47.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.918 -1.114 . . . . 0.0 109.556 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.27 127.1 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.06 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.57 -34.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.616 ' CE1' ' ND2' ' A' ' 57' ' ' ASN . 3.1 t-160 -149.54 122.37 8.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -112.35 130.93 55.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -166.84 -153.95 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' ASN . 36.1 m-70 -46.59 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.071 -1.018 . . . . 0.0 108.763 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 57' ' ' ASN . 11.7 t -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.2 m -102.64 120.33 40.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 108.826 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -117.76 136.44 53.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 110.923 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -126.07 159.38 32.97 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.7 150.92 8.84 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.158 -1.972 . . . . 0.0 111.611 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -144.6 152.55 40.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.82 -0.812 . . . . 0.0 109.486 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.5 24.01 11.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.598 -0.689 . . . . 0.0 110.842 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.39 4.69 76.74 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.697 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.451 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 9.0 mm100 -108.59 137.37 46.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -1.199 . . . . 0.0 108.21 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.79 164.29 30.51 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.853 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 44.4 mt -135.08 149.21 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -114.18 149.78 35.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.896 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 54.41 66.95 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.714 -0.616 . . . . 0.0 110.866 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.74 -1.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 109.179 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 8.5 pt-20 -71.1 -30.85 67.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.048 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 32.5 m170 -64.49 -59.44 4.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -56.87 -45.99 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.733 -1.229 . . . . 0.0 108.733 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.481 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 42.2 mt -55.28 -41.07 71.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.7 t -56.96 -45.53 82.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.38 -53.41 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 108.723 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -50.86 -44.66 59.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 108.977 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.497 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 14.7 t-160 -55.65 -47.82 76.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.453 -0.779 . . . . 0.0 110.018 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -66.54 -37.68 85.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.4 mt -81.23 -7.61 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.827 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 63.37 63.32 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.724 -1.235 . . . . 0.0 110.134 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.8 mm -104.94 130.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.473 ' OG1' ' OE1' ' A' ' 4' ' ' GLU . 23.6 p -117.43 -18.86 9.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.852 . . . . 0.0 111.731 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.617 HD21 HE22 ' A' ' 117' ' ' GLN . 8.3 m-80 -133.65 111.39 10.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.639 -1.288 . . . . 0.0 110.233 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 2.3 m -165.1 141.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.551 ' HG1' ' CG ' ' A' ' 31' ' ' GLU . 95.6 m -110.8 100.6 9.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.495 -0.753 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.7 104.42 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.401 -0.812 . . . . 0.0 109.682 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -82.31 119.44 24.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.865 -1.147 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.95 108.26 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 111.087 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.52 108.13 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.31 -160.02 23.28 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.4 -15.25 7.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.56 -0.965 . . . . 0.0 110.21 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.529 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -135.61 142.27 45.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.0 110.44 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 96' ' ' ILE . 38.7 mm -68.6 139.53 91.55 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -57.76 130.16 37.18 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.843 1.695 . . . . 0.0 111.514 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -78.64 -30.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.52 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 8.0 mt 52.8 -109.78 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.032 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -95.02 -18.59 20.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.573 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.73 -10.22 32.43 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.7 p -113.88 -172.09 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.383 -1.069 . . . . 0.0 109.869 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.48 -3.26 20.84 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -46.71 -39.99 12.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.624 -0.927 . . . . 0.0 110.8 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -63.53 -51.73 64.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 109.95 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -61.9 -45.04 95.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.917 -1.114 . . . . 0.0 108.392 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.88 -39.46 89.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.332 0.587 . . . . 0.0 110.44 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.11 -45.16 64.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.845 . . . . 0.0 111.494 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.24 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.858 -1.151 . . . . 0.0 110.551 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.16 -42.84 88.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 110.233 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -54.29 -29.57 47.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 109.816 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -85.96 -11.53 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -119.78 29.31 7.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.233 -0.917 . . . . 0.0 111.458 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.7 mt -84.4 148.02 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.379 -1.451 . . . . 0.0 110.348 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.0 tp -130.84 158.13 41.02 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -101.06 146.51 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.898 -1.127 . . . . 0.0 110.044 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.617 HE22 HD21 ' A' ' 86' ' ' ASN . 1.1 mt-30 -109.44 -169.06 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.669 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -120.09 66.98 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 110.575 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -169.37 151.04 4.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 109.259 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.42 134.11 33.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.03 -1.044 . . . . 0.0 110.295 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.6 mt -69.87 135.55 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 110.863 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -78.26 80.95 4.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -58.22 141.36 50.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.589 -0.694 . . . . 0.0 110.759 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -98.39 120.45 38.82 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.36 138.18 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 0.0 109.823 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.25 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -114.49 -10.07 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -142.82 145.91 35.6 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.427 -0.796 . . . . 0.0 108.92 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.12 177.24 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.11 1.873 . . . . 0.0 112.805 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.7 tt -165.6 144.61 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.457 0.646 . . . . 0.0 109.624 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.3 mp -132.73 118.9 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.53 113.29 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.375 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.429 ' OE2' ' N ' ' A' ' 134' ' ' ASP . 1.2 tm-20 -115.56 127.2 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' N ' ' OE2' ' A' ' 133' ' ' GLU . 1.8 t70 -174.74 158.11 2.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 59.09 19.5 7.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 110.206 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.86 2.66 86.72 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -104.01 173.7 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 8.8 tt -160.09 148.07 16.76 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.487 -1.383 . . . . 0.0 109.037 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.419 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 8.8 mt -146.19 141.48 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.639 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -130.35 139.13 50.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.48 145.59 47.11 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -142.19 138.57 16.83 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.14 147.7 63.74 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.471 1.447 . . . . 0.0 112.119 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.05 158.49 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.03 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -93.5 4.13 54.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.942 . . . . 0.0 109.899 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 147.34 46.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.08 -1.013 . . . . 0.0 109.784 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.9 tp -77.37 116.03 17.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.848 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -139.36 135.18 33.44 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.8 t -137.33 127.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.977 . . . . 0.0 110.05 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.7 m -112.28 132.05 55.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.368 -0.833 . . . . 0.0 109.294 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -119.83 129.47 54.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 162' ' ' GLN . 6.4 tp10 -114.72 104.61 12.14 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.0 155.38 21.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.583 ' CD ' HH21 ' A' ' 250' ' ' ARG . 12.9 tt0 -134.11 88.04 2.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.423 -1.045 . . . . 0.0 109.24 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -90.82 148.72 22.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -92.44 -6.92 48.97 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.86 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.9 p30 -73.9 -168.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.748 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.2 p90 -56.02 -17.53 7.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 109.754 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 14.0 mt -65.98 -51.17 60.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.06 -113.48 3.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -125.46 140.51 52.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.518 -0.989 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.48 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 8.8 tt0 -157.02 148.91 22.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -130.79 152.44 50.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -135.46 123.92 23.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 108.891 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 9.9 t -99.53 122.21 42.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 110.097 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.3 t80 -99.85 135.99 40.45 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.382 -0.824 . . . . 0.0 108.897 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.484 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.6 t -133.36 150.28 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.79 . . . . 0.0 109.155 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -53.46 122.81 10.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.77 -12.68 17.84 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -121.38 33.01 5.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.168 -1.195 . . . . 0.0 108.726 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -62.82 -35.95 81.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.699 . . . . 0.0 110.886 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -15.7 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.045 . . . . 0.0 110.829 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.73 -3.56 58.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.985 -1.072 . . . . 0.0 110.939 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.9 pt -124.29 0.85 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.068 -1.02 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -29.87 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.601 -1.312 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.6 mt -87.01 1.95 51.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.782 -1.199 . . . . 0.0 110.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.38 120.0 23.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.777 -1.202 . . . . 0.0 109.013 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.07 153.37 19.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.066 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.41 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.0 t -55.7 154.99 6.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.52 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 47.5 p90 -135.68 167.09 21.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.022 -1.049 . . . . 0.0 109.671 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.52 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 2.7 m -153.69 160.65 42.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.172 -0.955 . . . . 0.0 109.685 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.421 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 78.5 m-85 -102.84 143.41 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.213 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.46 -26.07 66.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.502 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 4.7 p90 -79.01 -25.25 43.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.694 -1.254 . . . . 0.0 110.632 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 11.8 pt-20 -98.88 -13.8 19.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.879 -1.138 . . . . 0.0 109.575 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 9.5 mt -58.51 -52.99 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.154 -0.966 . . . . 0.0 110.063 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.19 -48.56 64.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.882 -1.136 . . . . 0.0 109.097 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.34 -52.1 62.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.967 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 91.2 mt -57.96 -34.48 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.825 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.21 -25.71 51.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -74.96 -31.6 61.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.101 -1.0 . . . . 0.0 109.867 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.8 m -81.0 12.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.17 -0.956 . . . . 0.0 109.347 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.48 24.12 76.79 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.625 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 19.2 mt -121.21 159.08 26.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.15 -1.206 . . . . 0.0 109.993 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.41 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 74.18 22.22 78.01 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.22 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -63.38 -53.73 47.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.33 -1.688 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -69.9 -2.6 39.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.09 134.06 39.91 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.849 -1.383 . . . . 0.0 110.484 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 203' ' ' THR . 68.0 p -141.86 177.72 7.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.493 -1.004 . . . . 0.0 109.319 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 95.5 mt -74.6 -39.3 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.91 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -66.25 -14.46 61.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.222 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.538 ' C ' ' HG1' ' A' ' 203' ' ' THR . 0.8 OUTLIER -131.44 9.14 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.538 ' HG1' ' C ' ' A' ' 202' ' ' ASN . 0.5 OUTLIER -147.96 113.8 5.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.42 116.06 15.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 108.934 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.9 t -106.8 127.1 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 109.857 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.4 mt -110.71 149.91 29.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.14 152.21 17.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 207' ' ' GLY . 35.6 tttm -41.07 -37.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -1.113 . . . . 0.0 110.03 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -141.88 11.56 2.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.935 -1.103 . . . . 0.0 110.084 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.4 pttp -142.59 151.43 41.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.019 . . . . 0.0 109.738 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.56 127.93 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -73.0 -53.16 11.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.07 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.52 139.68 74.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.996 -1.065 . . . . 0.0 109.658 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.68 -33.96 9.72 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.522 2.148 . . . . 0.0 112.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -76.24 -9.1 58.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.046 -1.034 . . . . 0.0 110.28 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.6 -164.22 51.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.82 140.38 47.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -1.088 . . . . 0.0 109.833 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -84.59 -14.59 48.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 109.169 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.636 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 66.0 m-85 -146.09 133.83 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.436 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 1.3 mt-10 -48.03 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 108.501 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -137.19 39.33 2.51 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.9 OUTLIER -62.76 -39.58 55.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 111.935 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.0 Cg_endo -74.17 -40.37 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.997 1.132 . . . . 0.0 112.651 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.2 m -76.68 -24.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.716 -1.24 . . . . 0.0 108.463 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.636 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 36.4 mtt180 -67.4 -47.44 70.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.53 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 44.1 t60 -59.77 -40.67 88.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -46.13 90.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 109.07 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 46.4 t -62.19 -42.23 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 108.756 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.478 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 59.9 t80 -55.36 -47.32 75.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.67 -0.644 . . . . 0.0 109.433 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.592 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 12.2 m-20 -72.05 -34.56 68.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.1 tp -56.27 -36.17 68.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.707 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.497 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 89.7 mt -72.47 -48.75 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.77 9.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.3 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.105 -1.232 . . . . 0.0 109.769 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.39 -22.84 40.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.852 -1.155 . . . . 0.0 109.187 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.403 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 43.0 t80 -70.74 -8.77 54.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 108.752 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 17.2 mt -50.18 -28.18 7.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 84.9 mt -54.16 -15.82 1.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.2 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 13.53 83.08 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.0 p -158.73 146.05 13.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.211 -1.17 . . . . 0.0 109.309 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -43.19 130.22 6.21 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.066 1.844 . . . . 0.0 111.78 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 3.8 t -97.49 132.13 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.629 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -117.98 123.7 46.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.49 172.66 25.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -104.38 114.38 28.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -1.222 . . . . 0.0 109.696 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.6 m-85 -112.68 148.65 34.22 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.14 0.971 . . . . 0.0 111.486 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -130.42 144.22 51.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.0 t -142.34 129.58 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.656 -1.278 . . . . 0.0 111.077 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -112.18 114.81 27.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.583 HH21 ' CD ' ' A' ' 154' ' ' GLU . 18.2 mtt180 50.42 53.87 12.15 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.82 136.85 20.61 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -111.59 155.48 16.14 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.505 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 62.7 m-70 -52.94 -47.18 68.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -1.215 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.5 t -58.23 -55.34 36.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.056 -1.027 . . . . 0.0 108.869 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 53.6 tp -53.91 -37.12 63.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -61.15 -54.35 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 108.973 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 19.5 t -50.97 -42.67 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -55.83 -49.7 72.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 19.1 tp -52.14 -42.13 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 108.678 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.62 -46.24 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.283 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.13 -51.52 61.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.846 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -53.64 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 90.3 mt -55.53 -42.18 74.21 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.41 90.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.523 -0.736 . . . . 0.0 109.719 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -75.81 -30.16 58.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.024 . . . . 0.0 109.11 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -62.81 -45.66 91.61 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.279 -0.888 . . . . 0.0 109.877 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -89.29 9.63 25.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 110.4 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -94.32 -22.05 18.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.841 -1.162 . . . . 0.0 109.89 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.55 -58.17 9.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 109.465 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.137 -0.977 . . . . 0.0 109.535 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 4' ' ' GLU . 45.4 mt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 63.5 mt-10 -45.38 145.52 1.17 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 0.0 109.213 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HZ2' ' ND2' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -121.08 139.37 53.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 110.285 -179.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.529 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 9.0 t -138.2 175.27 9.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.529 ' H ' ' HG1' ' A' ' 6' ' ' THR . 10.4 m -86.51 141.35 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.354 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -73.87 -46.12 46.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.574 -0.704 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -126.88 153.76 45.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.41 -0.806 . . . . 0.0 110.43 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.08 138.76 58.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.62 167.71 12.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 p -156.76 149.34 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.995 -1.066 . . . . 0.0 110.338 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -135.01 155.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 135.48 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 108.759 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.79 156.16 13.0 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.122 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.29 163.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.29 -1.124 . . . . 0.0 111.029 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.64 136.98 13.35 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 197' ' ' GLY . 16.0 tt -56.21 -52.57 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.137 -1.214 . . . . 0.0 111.751 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.477 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 24.8 m-70 -87.08 -38.56 16.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.172 -1.58 . . . . 0.0 110.66 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.6 m -73.9 -35.38 64.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.952 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.07 64.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -107.53 148.55 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.58 -0.953 . . . . 0.0 108.967 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 8.1 t80 -70.83 125.78 27.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.973 . . . . 0.0 109.759 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.491 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 36.6 t -135.12 156.41 49.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.118 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -134.81 150.69 50.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 109.138 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mt -127.52 148.45 50.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 0.0 109.622 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -132.04 131.84 61.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -115.83 126.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -120.56 155.06 57.06 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.585 -0.697 . . . . 0.0 109.286 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.53 160.67 48.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.347 2.031 . . . . 0.0 110.861 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 20.4 mm-40 -135.83 -174.83 3.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.104 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.508 ' O ' ' OG1' ' A' ' 35' ' ' THR . 11.0 tptt -86.03 153.3 22.23 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 109.287 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 2.3 mp0 -46.81 145.07 2.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.091 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.582 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.36 26.1 61.32 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.826 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.508 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 39.6 m -78.7 -36.94 42.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.562 -1.552 . . . . 0.0 109.134 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.745 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 94.05 -175.56 35.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.7 mm -99.52 121.9 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.297 -1.119 . . . . 0.0 108.277 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -136.33 143.9 44.36 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.975 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.89 151.13 22.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -130.26 142.66 50.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 0.0 OUTLIER -174.59 138.22 0.51 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -178.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.12 31.59 20.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.616 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.51 74.33 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.624 -1.298 . . . . 0.0 110.034 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.13 139.41 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 109.529 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 m-85 -102.18 138.06 39.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.57 97.94 18.71 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.418 -0.801 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.74 142.75 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.22 1.947 . . . . 0.0 111.718 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.02 82.48 6.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.984 -1.073 . . . . 0.0 110.172 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -139.45 156.03 47.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.583 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.564 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.2 p80 -53.45 -49.5 67.28 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 19.5 mt-10 -44.06 -16.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.072 -1.018 . . . . 0.0 109.995 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 50' ' ' HIS . 96.6 m-85 -98.56 4.21 48.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.058 -1.026 . . . . 0.0 109.994 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 50' ' ' HIS . 6.4 t -60.73 121.02 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 108.477 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.96 -25.36 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.303 -0.873 . . . . 0.0 110.408 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -151.13 118.54 6.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -112.29 131.13 55.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.5 t-20 -166.36 -154.28 0.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 1.6 m-70 -47.96 -12.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 108.372 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -136.84 166.0 24.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.587 -0.696 . . . . 0.0 109.238 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.0 m -108.84 125.1 51.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.335 -0.853 . . . . 0.0 109.132 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.87 143.72 50.18 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.993 0.901 . . . . 0.0 111.25 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.3 mt -124.29 160.52 27.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.85 147.93 7.66 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.343 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -145.01 151.68 38.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.751 -0.852 . . . . 0.0 109.488 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt 57.12 25.36 10.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.289 -0.882 . . . . 0.0 111.196 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.49 1.95 77.18 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.631 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.471 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.2 mm100 -102.41 142.81 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.993 -1.298 . . . . 0.0 107.999 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -145.83 157.23 43.93 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.842 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.8 mt -133.27 144.5 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 9.1 mttm -110.71 155.03 23.03 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.295 -0.878 . . . . 0.0 111.317 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 47.38 72.86 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.765 -0.584 . . . . 0.0 111.169 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 m -113.02 -11.59 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 109.566 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -63.68 -18.53 64.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 110.604 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.641 ' CE1' HOH1 ' A' ' 320' ' ' TUX . 25.6 m170 -71.85 -60.65 2.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.892 -1.13 . . . . 0.0 109.413 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 4.0 tp -60.41 -44.05 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 109.138 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.464 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 12.0 mt -56.2 -38.22 70.7 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.587 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 27.3 t -60.68 -48.58 81.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.614 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.5 t -57.64 -52.99 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.972 -1.08 . . . . 0.0 108.688 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -50.68 -43.79 57.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.462 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.9 t-160 -55.1 -51.33 66.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 110.223 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.8 mt -68.36 -37.27 80.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.329 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.8 mt -76.08 -5.58 47.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.061 -1.024 . . . . 0.0 110.131 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.79 50.99 3.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 110.43 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.502 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 14.6 mm -97.59 122.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 108.501 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.456 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 71.7 p -110.78 -22.01 11.78 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.745 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 9.9 m120 -129.91 112.17 13.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.709 -1.244 . . . . 0.0 110.516 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.456 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 2.6 m -164.75 141.78 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 8.1 m -110.23 100.69 9.53 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mp -87.69 108.87 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.889 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -88.18 116.48 26.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.28 117.63 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 110.856 -178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.491 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.1 mp -97.09 112.36 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.437 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 133.93 -162.05 24.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.48 -17.64 8.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.227 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 1.5 tp10 -132.64 141.0 48.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.829 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.2 mm -67.37 125.71 91.5 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.609 -0.682 . . . . 0.0 109.34 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -45.86 131.28 13.39 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.921 1.747 . . . . 0.0 111.887 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.1 tp -76.46 -29.62 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 110.431 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.7 mt 54.89 -113.73 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.61 -15.86 23.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 110.32 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.75 -12.97 46.35 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 p -112.3 -169.18 1.42 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.012 . . . . 0.0 109.493 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.6 -3.09 25.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -47.44 -41.91 21.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.833 -0.804 . . . . 0.0 110.409 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.96 -52.37 63.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.068 . . . . 0.0 110.233 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 87.4 m-85 -61.81 -44.29 97.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.765 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -62.06 -38.91 90.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.311 0.576 . . . . 0.0 109.941 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.15 -44.94 51.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.287 -0.883 . . . . 0.0 111.828 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.25 -47.61 23.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 110.998 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.03 -40.16 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttt85 -57.38 -30.03 64.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 109.877 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 112' ' ' LYS . 24.0 tttm -80.65 -8.21 59.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 109.623 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -123.74 35.03 4.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.987 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.8 mt -90.79 147.03 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.8 -1.187 . . . . 0.0 110.643 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.2 tp -131.26 159.61 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.429 ' ND2' ' HZ2' ' A' ' 5' ' ' LYS . 8.6 m120 -109.79 146.43 35.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.552 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -108.93 -162.65 0.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.528 -0.733 . . . . 0.0 109.26 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 -1.22 11.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -85.37 138.71 32.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.86 -1.15 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.1 128.03 33.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.272 -0.892 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -70.92 139.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 111.124 -178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -94.38 98.48 10.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.74 147.05 51.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -97.33 121.46 39.25 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.02 139.36 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.17 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -113.12 -10.78 13.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.242 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -143.66 146.05 33.63 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.097 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.2 172.74 14.21 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.087 1.858 . . . . 0.0 113.135 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 130' ' ' ILE . 1.3 tt -164.27 140.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.09 126.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.28 114.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.282 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -174.35 150.88 1.51 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.084 -1.01 . . . . 0.0 110.996 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 55.65 24.92 7.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.726 -0.609 . . . . 0.0 111.077 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.98 86.32 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -106.92 169.02 8.8 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.497 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.8 tt -159.73 150.41 19.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.193 -1.567 . . . . 0.0 108.873 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.497 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 7.2 mt -145.83 139.56 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -129.6 139.62 51.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.54 140.36 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -136.47 137.41 24.04 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.9 150.1 48.1 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.56 1.507 . . . . 0.0 112.032 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.94 158.57 8.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -86.97 -1.44 57.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.726 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.4 p -136.46 155.19 50.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 109.405 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.497 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 32.6 tp -87.48 117.15 26.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 110.116 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -134.29 140.35 46.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.6 t -139.19 126.96 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.976 -1.077 . . . . 0.0 109.908 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.3 m -115.16 137.8 51.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.447 -0.783 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -125.97 129.56 49.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.727 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.31 106.18 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.4 141.15 15.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -118.94 86.69 2.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.532 -0.981 . . . . 0.0 109.17 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -91.77 143.01 26.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.732 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -92.14 -1.67 57.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.843 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 22.1 p-10 -73.12 -167.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -61.56 -24.89 66.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.92 . . . . 0.0 109.784 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.21 -46.23 87.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.319 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.61 -132.72 11.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -98.87 139.6 34.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -1.106 . . . . 0.0 109.289 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -146.02 142.64 28.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.518 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -137.29 148.41 46.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.39 127.9 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.089 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.486 ' O ' ' CG2' ' A' ' 165' ' ' THR . 10.9 t -99.87 122.03 42.21 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.013 -1.054 . . . . 0.0 109.718 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.29 136.65 34.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 108.881 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.52 153.25 34.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.645 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 4.7 mp0 -57.13 113.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.288 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.555 ' N ' ' OE2' ' A' ' 171' ' ' GLU . . . 115.89 11.29 10.26 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -137.11 28.4 2.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.183 -1.187 . . . . 0.0 108.761 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.598 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 16.9 mp0 -62.15 -36.93 83.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 110.632 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.565 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 15.6 mp0 -52.45 -15.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.82 -1.175 . . . . 0.0 110.241 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 49.1 mt-10 -91.07 -4.19 56.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 110.927 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.595 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.4 pt -121.72 6.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.14 -34.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.96 1.02 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.779 -1.201 . . . . 0.0 110.745 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.36 123.81 28.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.195 . . . . 0.0 108.962 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 154.38 17.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -51.36 158.12 0.89 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.404 ' O ' ' O3G' ' A' ' 320' ' ' TUX . 36.8 p90 -146.24 168.7 20.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.05 -1.031 . . . . 0.0 110.089 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.528 ' SG ' ' C1A' ' A' ' 320' ' ' TUX . 0.1 OUTLIER -166.08 159.0 15.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 109.595 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.521 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 60.8 m-85 -103.42 146.5 28.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.296 -0.878 . . . . 0.0 109.316 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 2.8 p30 -51.97 -51.08 59.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.794 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.664 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.2 p90 -51.83 -36.84 49.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.926 -1.109 . . . . 0.0 111.481 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.664 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 14.6 pt-20 -89.48 -17.33 28.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.636 -1.29 . . . . 0.0 109.924 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.43 -52.24 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.187 -0.946 . . . . 0.0 110.127 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -50.85 -51.16 53.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.663 -1.273 . . . . 0.0 109.5 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -52.42 -44.87 65.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 108.751 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 71.2 mt -59.99 -34.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -77.65 -27.14 50.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.726 . . . . 0.0 110.216 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.45 -24.07 46.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.005 -1.059 . . . . 0.0 110.217 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.4 m -85.68 11.19 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.548 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.87 24.82 68.52 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 120.077 -1.059 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 39.2 mt -123.53 163.28 21.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 109.921 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.15 23.96 60.32 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -69.09 -22.68 63.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.788 -1.419 . . . . 0.0 109.88 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.54 -0.56 53.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.35 130.0 50.33 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.305 -1.114 . . . . 0.0 110.685 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.2 p -140.01 -173.64 3.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.735 -0.862 . . . . 0.0 108.728 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.46 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -99.48 -4.3 31.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.89 -11.69 1.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.119 -0.988 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.4 m -126.0 116.96 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.9 tp -74.04 110.42 8.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.1 t -100.08 126.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.926 -1.109 . . . . 0.0 109.47 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.1 mt -110.15 148.81 31.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.829 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.25 159.25 15.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -23.45 1.61 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.257 -1.143 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -153.66 12.69 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 0.0 110.724 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -144.11 151.66 39.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.864 -1.148 . . . . 0.0 110.637 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.57 124.86 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -71.95 -54.78 8.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.019 -1.05 . . . . 0.0 110.34 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -55.89 132.88 73.33 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.056 . . . . 0.0 109.428 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.51 -11.19 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.418 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -84.47 -6.64 59.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.09 -162.96 54.56 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -89.45 149.76 22.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.964 . . . . 0.0 110.317 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.6 mtt-85 -94.26 -23.76 17.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -0.798 . . . . 0.0 108.929 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.578 ' C ' ' H ' ' A' ' 221' ' ' ASN . 28.3 m-85 -144.57 133.93 23.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 108.993 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.22 -9.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 108.614 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.578 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -135.01 35.66 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.844 0.83 . . . . 0.0 108.878 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.462 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.66 -49.54 88.35 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 111.804 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 20.5 Cg_endo -67.58 -34.56 25.23 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.571 1.514 . . . . 0.0 113.06 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 24.2 m -79.84 -28.22 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.51 -1.369 . . . . 0.0 107.706 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 10.1 mmm-85 -65.1 -46.84 79.41 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.582 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 36.6 t60 -61.35 -42.13 98.19 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -50.84 72.34 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.05 -1.031 . . . . 0.0 108.69 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 18.2 t -55.94 -43.95 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 79.4 t80 -57.71 -40.04 78.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.582 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.5 m-20 -74.68 -33.93 62.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.595 -0.69 . . . . 0.0 109.487 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.01 -35.85 73.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 108.688 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.43 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 75.7 mt -72.15 -47.77 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -33.27 24.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -82.14 -27.25 32.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.258 . . . . 0.0 109.582 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 mt -83.14 -23.84 32.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.881 -1.137 . . . . 0.0 109.308 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.502 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 38.1 t80 -67.51 -10.71 54.17 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 108.956 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 85.7 mt -50.45 -27.97 7.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 109.101 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 71.3 mt -58.81 -17.68 25.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.177 -0.952 . . . . 0.0 109.179 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 79.41 15.89 79.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.0 p -158.35 144.65 12.68 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.992 -1.299 . . . . 0.0 109.787 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -42.1 128.99 4.34 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.197 1.931 . . . . 0.0 111.839 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.5 t -95.88 130.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.66 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -117.67 123.72 46.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.823 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 174.1 27.91 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.62 113.33 26.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -1.183 . . . . 0.0 109.829 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.86 147.17 37.55 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.928 0.871 . . . . 0.0 111.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -129.67 143.27 50.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 128.11 19.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.646 -1.284 . . . . 0.0 110.687 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.2 t80 -112.31 116.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 249' ' ' PHE . 13.9 mmm180 46.04 55.78 6.77 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.1 152.44 22.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.0 -175.84 18.6 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -70.96 -52.22 21.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -1.215 . . . . 0.0 109.576 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 2.2 p -56.14 -54.41 45.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.162 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.442 ' N ' ' OG ' ' A' ' 254' ' ' SER . 34.1 tp -51.06 -42.37 60.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.229 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.16 -50.96 71.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 108.908 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 59.5 t -53.9 -40.8 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.865 . . . . 0.0 109.423 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -55.3 -48.15 74.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 108.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 13.4 tp -52.78 -45.25 67.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.6 t -65.83 -45.56 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -52.14 58.72 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 110.155 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -64.39 -46.49 83.12 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.062 -1.023 . . . . 0.0 109.707 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 20.4 mt -59.07 -46.38 88.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.797 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.31 -34.4 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -79.19 -27.12 42.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.66 -1.275 . . . . 0.0 109.145 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -66.94 -45.93 76.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.947 . . . . 0.0 109.995 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -85.68 11.56 10.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.955 . . . . 0.0 110.734 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -22.97 56.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.888 -1.133 . . . . 0.0 109.698 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.9 mt -75.19 -49.89 17.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 109.542 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 109.452 179.889 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.641 HOH1 ' CE1' ' A' ' 74' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 85.8 mt-10 -54.33 144.16 21.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.523 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.28 139.36 53.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.9 t -137.47 176.59 8.57 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.45 143.43 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.854 -1.154 . . . . 0.0 110.443 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -76.22 -46.52 27.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.636 -0.665 . . . . 0.0 109.593 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.93 153.69 43.89 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.521 0.676 . . . . 0.0 110.111 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.94 137.91 58.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.483 -0.76 . . . . 0.0 109.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.47 165.1 15.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.579 -0.701 . . . . 0.0 109.176 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -155.59 147.81 23.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 0.0 110.102 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -130.9 162.42 29.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.571 -0.706 . . . . 0.0 109.207 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.96 136.52 16.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.874 -1.141 . . . . 0.0 109.063 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.1 161.4 19.34 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.053 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 4.3 p -74.6 160.67 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 111.447 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.473 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -93.58 142.38 15.97 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -62.73 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.254 . . . . 0.0 112.36 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -86.7 -38.4 17.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 119.821 -1.799 . . . . 0.0 111.654 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.436 ' OG1' ' CB ' ' A' ' 95' ' ' GLU . 2.1 p -78.13 -33.32 50.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.042 -1.036 . . . . 0.0 110.099 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.15 72.02 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -116.13 154.06 30.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.956 . . . . 0.0 108.654 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -73.16 138.12 45.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.993 -1.067 . . . . 0.0 110.075 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 23.2 t -143.76 157.88 44.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 0.0 108.847 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -135.57 148.75 49.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 109.329 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.9 mt -124.98 146.34 49.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.96 130.93 61.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mt -117.02 119.02 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 109.637 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.61 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -116.92 148.64 42.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.34 161.51 23.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.231 1.954 . . . . 0.0 111.45 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -135.96 -174.08 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.9 tttp -85.61 151.66 23.73 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -49.5 150.34 1.97 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.584 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.27 23.61 57.89 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.03 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 17.0 m -80.2 -42.64 22.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.791 -1.417 . . . . 0.0 108.913 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.75 -176.81 30.06 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 37' ' ' ILE . 8.4 mm -97.33 122.57 49.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.374 -1.074 . . . . 0.0 108.122 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -138.45 140.69 39.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.046 -1.034 . . . . 0.0 110.4 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -100.05 152.92 19.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.52 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 3.1 t80 -124.93 147.41 48.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -173.78 131.26 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 109.382 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.84 29.58 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.758 -1.211 . . . . 0.0 110.198 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.02 138.55 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -1.171 . . . . 0.0 109.703 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -98.86 137.03 38.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.05 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.3 mt -129.24 97.11 26.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 110.179 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.59 142.3 24.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.156 1.904 . . . . 0.0 111.837 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.64 82.36 5.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.512 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -140.63 156.99 46.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.492 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.3 p80 -53.53 -49.87 66.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.168 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -47.0 -15.79 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.022 . . . . 0.0 109.947 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 50' ' ' HIS . 76.6 m-85 -97.53 4.22 50.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.007 -1.058 . . . . 0.0 109.495 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 t -59.02 130.46 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.198 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.87 -32.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -153.55 122.06 6.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 109.979 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.6 p -112.33 131.93 55.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 7.0 t-20 -166.87 -153.94 0.16 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 57' ' ' ASN . 23.3 m-70 -46.92 -13.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.008 -1.058 . . . . 0.0 108.452 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -137.3 166.06 24.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.485 -0.759 . . . . 0.0 109.371 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.408 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 12.3 m -105.79 123.67 48.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.377 -0.827 . . . . 0.0 108.945 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -122.19 142.43 50.43 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.995 0.902 . . . . 0.0 111.426 -178.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.5 mt -122.56 164.68 17.72 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.54 145.31 5.58 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.4 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -145.18 151.52 38.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.822 -0.811 . . . . 0.0 109.484 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm 57.44 25.59 11.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 111.002 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.03 2.2 78.26 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.49 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 8.6 mm100 -100.65 142.24 32.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.235 . . . . 0.0 108.028 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -143.55 154.05 43.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.796 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mt -133.87 144.07 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 47.8 mttp -114.9 155.01 27.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.364 -0.835 . . . . 0.0 111.256 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 m 50.89 63.86 2.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.79 -0.569 . . . . 0.0 111.152 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.9 m -112.51 1.05 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.094 -1.004 . . . . 0.0 109.092 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' OE1' ' OD2' ' A' ' 230' ' ' ASP . 0.3 OUTLIER -72.22 -31.09 65.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.944 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -61.49 -60.45 3.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.832 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.8 tp -59.64 -46.13 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 0.0 109.179 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.471 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 61.9 mt -53.79 -41.62 67.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.588 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 2.8 t -58.43 -46.31 86.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.976 . . . . 0.0 109.47 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.95 -54.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.0 mt -51.89 -43.7 63.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 108.923 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.544 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 19.1 t-160 -54.6 -47.72 73.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.63 -37.13 82.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.6 mt -77.81 -7.53 56.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.431 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.03 60.48 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 5.8 mm -104.29 131.03 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 108.65 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.468 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 40.7 p -119.71 -19.12 8.15 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.364 -0.835 . . . . 0.0 111.422 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 34' ' ' GLY . 1.2 m-80 -126.98 111.02 13.6 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.891 -1.131 . . . . 0.0 109.637 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -164.57 142.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.132 -0.98 . . . . 0.0 109.949 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.5 m -113.84 99.43 7.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.33 106.35 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.829 . . . . 0.0 109.777 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.66 118.78 25.38 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.3 t -105.0 105.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.931 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.459 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.4 mt -83.91 111.33 19.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.17 -179.18 16.23 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.32 -16.83 14.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -1.186 . . . . 0.0 110.66 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -123.77 133.48 53.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 110.41 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.57 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 mm -68.12 126.32 92.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.486 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -46.28 128.48 12.18 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.865 1.71 . . . . 0.0 112.159 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.5 tp -76.43 -25.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.444 -0.785 . . . . 0.0 110.093 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.9 mt 53.66 -113.91 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD2' ' NE ' ' A' ' 178' ' ' ARG . 18.8 t70 -94.37 -21.46 18.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 0.0 110.012 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.5 -7.71 28.29 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.582 ' OG ' ' NE ' ' A' ' 178' ' ' ARG . 5.4 p -116.69 -167.75 1.34 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -1.066 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.5 -5.37 20.98 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.495 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 67.1 t-105 -46.75 -42.0 16.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.681 -0.894 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.59 -52.25 64.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.046 . . . . 0.0 110.015 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 75.3 m-85 -62.42 -44.35 96.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.018 . . . . 0.0 108.557 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -63.49 -37.53 87.64 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.3 mm-40 -71.42 -50.25 33.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -0.824 . . . . 0.0 112.076 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.0 -51.53 13.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.713 -1.242 . . . . 0.0 110.669 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.76 -42.52 85.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.031 -1.043 . . . . 0.0 110.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -54.11 -29.36 44.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -84.79 -11.7 55.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -119.8 31.6 6.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.9 mt -88.83 148.29 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.362 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 tp -130.34 158.47 39.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -109.35 137.53 47.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -161.45 0.87 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.83 . . . . 0.0 109.047 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -121.77 0.63 9.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.86 . . . . 0.0 110.7 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 4' ' ' GLU . 5.6 ttt85 -89.04 144.18 26.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.926 -1.108 . . . . 0.0 109.925 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 132.14 34.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.492 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.6 mt -74.31 140.6 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.499 -0.75 . . . . 0.0 111.184 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -83.95 84.08 7.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -57.88 144.84 37.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.713 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -105.37 125.02 50.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.1 t -128.53 142.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.2 t -81.19 134.8 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 108.864 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.52 -11.35 11.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.084 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.76 141.76 23.36 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.337 -0.852 . . . . 0.0 109.171 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.69 169.87 20.89 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.135 1.89 . . . . 0.0 113.377 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 130' ' ' ILE . 3.1 tt -165.4 141.52 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.81 -0.556 . . . . 0.0 109.708 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.7 mt -127.6 124.9 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.402 -0.811 . . . . 0.0 109.83 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.5 m -120.03 120.79 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.443 -0.786 . . . . 0.0 109.438 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -104.33 147.27 27.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.349 -0.844 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.01 112.45 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.816 -1.178 . . . . 0.0 111.882 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 41.1 52.25 3.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.709 -0.619 . . . . 0.0 112.458 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.26 3.69 89.99 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.588 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -105.38 163.08 12.9 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.23 149.64 17.64 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.037 -1.664 . . . . 0.0 109.241 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.473 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 13.0 mt -146.85 133.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -124.88 139.72 53.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -143.57 139.29 16.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 146.47 70.47 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.653 1.568 . . . . 0.0 112.456 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.46 153.17 9.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 0.54 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -136.29 146.34 46.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.49 117.68 19.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.548 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 tt0 -139.52 133.89 31.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.83 . . . . 0.0 108.808 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.9 t -132.75 125.6 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.688 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.9 m -112.77 132.3 55.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -121.58 130.15 53.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.74 . . . . 0.0 109.986 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -114.1 103.23 10.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.07 125.42 8.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.28 84.39 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.42 -1.047 . . . . 0.0 108.865 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.19 148.22 25.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.541 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -95.83 1.31 53.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.209 -0.932 . . . . 0.0 109.782 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.448 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 15.0 p-10 -76.24 -167.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.368 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -61.23 -25.21 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.79 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 11.3 mt -59.57 -51.13 71.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.35 -128.07 9.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.553 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 12.2 mtm180 -104.05 137.28 42.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.392 -1.064 . . . . 0.0 109.23 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 8.3 mp0 -140.73 138.41 34.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.199 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.65 144.27 49.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.808 . . . . 0.0 109.472 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.656 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 52.3 t80 -138.6 128.48 25.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 61.0 m -103.14 123.1 46.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -101.77 137.64 39.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.832 . . . . 0.0 109.395 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.551 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.2 t -134.47 158.32 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.483 -0.76 . . . . 0.0 109.363 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -58.45 117.47 4.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.805 . . . . 0.0 109.45 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.39 4.06 20.38 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -134.38 29.8 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.137 -1.213 . . . . 0.0 108.835 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -63.87 -32.83 74.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 110.747 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.91 -17.46 6.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.069 -1.02 . . . . 0.0 110.832 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.2 -3.8 58.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.851 -1.155 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -125.55 -12.45 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.119 -0.988 . . . . 0.0 111.434 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -29.48 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.305 -1.497 . . . . 0.0 110.095 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.62 1.96 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.709 -1.244 . . . . 0.0 110.743 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.66 121.65 24.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 108.794 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.582 ' NE ' ' OG ' ' A' ' 102' ' ' SER . 4.4 mpt_? -88.22 149.15 24.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.83 -1.169 . . . . 0.0 109.832 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.8 t -54.14 166.3 0.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.336 -0.853 . . . . 0.0 109.057 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.74 177.4 9.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.768 -1.207 . . . . 0.0 109.963 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.626 ' SG ' ' C1A' ' A' ' 320' ' ' TUX . 0.8 OUTLIER -169.53 164.22 10.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.586 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.618 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 90.9 m-85 -104.3 145.22 30.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.565 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 18.1 p-10 -63.81 -18.24 63.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.881 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.618 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 4.5 p90 -81.1 -27.42 35.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.667 -1.271 . . . . 0.0 110.452 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 19.6 pt-20 -98.28 -15.17 19.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.888 -1.133 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.1 mt -56.47 -51.51 63.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.255 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.543 ' N ' ' OE1' ' A' ' 187' ' ' GLU . 2.9 mp0 -51.15 -52.73 41.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.549 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -52.5 -44.86 65.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.0 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.94 -33.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.373 -0.829 . . . . 0.0 109.097 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -79.83 -25.37 40.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -82.25 -25.12 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.057 -1.027 . . . . 0.0 110.219 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.1 m -80.7 8.02 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 82.16 23.24 57.53 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.13 -1.034 . . . . 0.0 110.578 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 47.5 mt -125.6 164.5 20.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.16 -1.2 . . . . 0.0 109.922 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 76.42 19.59 78.0 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.216 -0.927 . . . . 0.0 111.552 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -68.71 -20.24 64.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.598 -1.531 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.03 -5.26 50.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.77 125.16 34.47 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.072 -1.252 . . . . 0.0 110.321 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -173.73 3.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.834 -0.804 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 73.6 mt -91.56 -13.34 32.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.533 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 40.0 tttp -92.47 -1.4 57.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 201' ' ' LYS . 0.6 OUTLIER -142.48 11.92 1.91 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.27 114.54 6.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 17.0 tp -77.54 106.71 9.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -0.957 . . . . 0.0 109.136 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.1 t -99.94 130.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.001 -1.062 . . . . 0.0 109.498 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 90.7 mt -111.58 149.67 31.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.855 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.4 150.6 16.87 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 207' ' ' GLY . 5.2 tttm -42.98 -27.23 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -1.171 . . . . 0.0 110.091 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 207' ' ' GLY . 3.3 p-10 -148.65 8.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.969 -1.082 . . . . 0.0 110.376 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -141.56 149.15 40.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.017 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.79 125.74 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -72.5 -54.63 8.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 110.47 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -55.85 131.64 72.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 109.804 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.38 -12.28 27.27 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.203 1.935 . . . . 0.0 112.184 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -88.09 -7.77 56.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.66 48.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 36.2 mt -85.64 138.95 31.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.545 -0.973 . . . . 0.0 109.85 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.503 ' CZ ' HH12 ' A' ' 178' ' ' ARG . 0.5 OUTLIER -64.83 -54.71 26.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 221' ' ' ASN . 18.2 m-85 -118.45 146.66 44.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -50.35 -12.5 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.614 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 219' ' ' TYR . 4.3 m-20 -135.89 27.86 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 109.454 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.1 OUTLIER -56.05 -42.65 97.24 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -179.132 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 22.8 Cg_exo -61.58 -45.44 17.74 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.229 1.953 . . . . 0.0 112.924 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 7.4 m -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 120.717 -1.24 . . . . 0.0 108.381 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 11.2 mtt85 -66.79 -40.79 88.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.56 -42.25 95.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 tptp -56.8 -45.62 82.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.01 . . . . 0.0 108.671 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.588 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 77.4 t80 -54.98 -41.95 71.83 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -71.38 -38.12 71.54 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.729 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 27.3 tp -56.72 -35.62 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.352 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.544 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 35.5 mt -72.67 -48.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.25 -32.73 14.19 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.91 -29.5 29.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.228 -1.16 . . . . 0.0 110.143 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.7 mt -78.58 -23.29 46.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.761 -1.212 . . . . 0.0 109.889 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.481 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 22.3 t80 -67.92 -7.27 27.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.138 -0.976 . . . . 0.0 108.815 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -50.06 -32.99 16.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.446 -0.784 . . . . 0.0 108.895 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.45 -12.49 1.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.061 -1.024 . . . . 0.0 109.085 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 73.75 17.13 79.14 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.7 p -157.17 144.94 13.99 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.963 -1.316 . . . . 0.0 109.677 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -42.66 133.27 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.199 1.932 . . . . 0.0 111.82 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.07 134.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -121.24 125.23 46.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 109.448 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.75 167.54 18.88 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 148' ' ' GLU . 10.2 tttp -98.67 112.91 24.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.112 -1.228 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -112.18 148.45 34.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.015 0.912 . . . . 0.0 111.1 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -129.18 143.67 50.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 p -138.34 124.52 20.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.8 -1.188 . . . . 0.0 109.848 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 250' ' ' ARG . 1.5 t80 -112.96 112.1 23.32 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.7 OUTLIER 45.28 56.48 5.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -92.37 156.17 23.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.93 177.75 17.2 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.417 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 79.8 m-70 -66.01 -51.95 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.28 . . . . 0.0 109.552 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 49.1 p -54.53 -54.64 38.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.0 . . . . 0.0 109.117 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 35.8 tp -51.33 -41.83 60.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.54 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -58.71 -55.04 40.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.021 . . . . 0.0 108.816 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.4 t -48.55 -41.25 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -54.93 -47.85 73.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 26.6 tp -52.81 -44.37 66.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.0 t -70.8 -41.66 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -58.9 -48.18 82.36 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 110.411 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.1 -35.19 76.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.053 -1.029 . . . . 0.0 109.57 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.66 -45.61 67.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.11 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.36 -32.79 74.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.715 -0.615 . . . . 0.0 110.27 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -78.81 -30.83 45.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.734 -1.229 . . . . 0.0 108.854 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -69.91 -46.25 65.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.226 -0.921 . . . . 0.0 109.201 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 269' ' ' LEU . 0.1 OUTLIER -72.44 7.27 1.89 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.833 . . . . 0.0 109.666 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -47.15 -15.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.1 -1.0 . . . . 0.0 109.431 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 267' ' ' GLN . 69.7 mt -67.62 -26.12 66.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.626 ' C1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.584 ' OE2' ' ND2' ' A' ' 86' ' ' ASN . 8.0 mm-40 -49.44 135.13 18.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.232 -0.918 . . . . 0.0 109.044 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.35 135.46 53.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.519 -0.738 . . . . 0.0 109.889 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -137.26 171.42 14.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.7 m -81.94 130.21 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.94 -1.1 . . . . 0.0 109.964 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -59.29 -45.83 90.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.092 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -129.79 157.76 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.198 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 135.45 56.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 109.858 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 80.0 mt -116.91 169.97 8.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.438 -0.789 . . . . 0.0 109.08 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -154.04 147.08 24.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.062 . . . . 0.0 110.194 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -132.47 157.81 43.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.403 -0.811 . . . . 0.0 109.448 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.6 pm0 -151.78 136.82 17.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.37 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.2 161.85 20.31 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' A' ' 17' ' ' GLY . 7.1 p -72.46 163.94 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.283 -1.128 . . . . 0.0 111.347 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 16' ' ' VAL . . . -98.76 142.21 15.96 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 197' ' ' GLY . 15.7 tt -58.97 -52.11 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -1.169 . . . . 0.0 112.5 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.425 ' HD1' ' HA2' ' A' ' 195' ' ' GLY . 7.2 m-70 -86.82 -38.73 16.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.245 -1.535 . . . . 0.0 111.702 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.414 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . 2.5 m -73.97 -33.62 63.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 110.002 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.03 25.83 69.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -117.72 154.34 31.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.534 -0.98 . . . . 0.0 108.596 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -73.72 137.1 43.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 0.0 110.195 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 t -142.35 156.22 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 22.8 tttt -132.26 156.57 46.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.0 mt -133.9 143.13 48.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.046 -1.033 . . . . 0.0 109.097 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.487 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 22.7 mt -130.8 128.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mt -116.01 129.89 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.069 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.572 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 1.5 m-70 -125.0 148.5 60.28 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.65 159.47 28.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.238 1.959 . . . . 0.0 111.618 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.4 mm-40 -132.39 -174.13 3.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.48 ' O ' ' OG1' ' A' ' 35' ' ' THR . 69.0 tttt -90.87 155.5 18.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.587 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -50.61 149.23 3.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 110.236 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.7 61.34 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.689 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 87.1 m -81.49 -46.39 14.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.382 -1.658 . . . . 0.0 108.983 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.12 -165.49 18.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mm -103.68 122.31 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.61 149.23 47.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.067 . . . . 0.0 110.608 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -107.84 150.96 26.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.526 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 3.5 t80 -131.04 137.48 49.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.014 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.608 ' HZ1' HE22 ' A' ' 67' ' ' GLN . 16.7 ttpp -169.12 140.41 2.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.447 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.51 28.52 15.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.895 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.15 24.84 76.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.15 138.14 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.21 -1.17 . . . . 0.0 109.758 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 35.9 m-85 -97.13 134.27 40.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.187 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.6 mt -127.25 96.83 32.9 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.485 -0.759 . . . . 0.0 109.839 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -51.79 144.73 33.87 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.259 1.973 . . . . 0.0 111.654 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.2 79.35 7.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.19 149.54 52.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' VAL . 5.8 p80 -52.0 -49.37 63.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.415 -0.803 . . . . 0.0 109.789 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' HIS . 18.8 mt-10 -44.89 -33.18 1.87 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.32 6.16 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 109.902 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 50' ' ' HIS . 3.5 t -63.73 130.81 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.131 -0.981 . . . . 0.0 109.071 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.9 m -115.68 -31.66 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.47 -0.769 . . . . 0.0 110.317 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.484 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -155.0 126.03 7.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 109.602 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 p -113.87 137.07 52.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.553 -0.717 . . . . 0.0 109.107 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.565 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -166.52 -154.58 0.18 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.498 ' O ' ' NXH' ' A' ' 320' ' ' TUX . 0.1 OUTLIER -50.39 -11.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.565 ' H ' ' C ' ' A' ' 57' ' ' ASN . 40.6 m -134.8 165.75 24.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.608 -0.682 . . . . 0.0 109.294 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -103.28 121.57 42.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 0.0 109.229 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -118.14 135.67 54.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 111.192 -179.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.8 mt -122.04 162.46 21.15 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.56 144.29 5.81 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 118.35 -1.881 . . . . 0.0 111.147 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -144.68 151.18 38.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.721 -0.87 . . . . 0.0 109.506 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 mttp 57.48 23.83 9.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.704 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.68 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.331 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.608 HE22 ' HZ1' ' A' ' 41' ' ' LYS . 28.7 mm100 -97.55 143.83 27.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.311 . . . . 0.0 108.055 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.77 149.25 43.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.502 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.32 137.78 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.98 154.25 25.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.188 -0.945 . . . . 0.0 110.907 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 80.7 m 53.5 67.88 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.706 -0.621 . . . . 0.0 110.764 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.5 m -113.15 -4.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 109.093 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.3 pt-20 -69.11 -33.49 73.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 110.333 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -61.57 -60.35 3.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 110.135 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.576 ' CD1' ' CD2' ' A' ' 106' ' ' PHE . 2.5 tp -56.98 -42.63 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.904 -1.122 . . . . 0.0 108.808 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.462 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 9.5 mt -59.36 -35.28 73.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.341 -0.85 . . . . 0.0 109.83 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.602 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 11.9 t -64.46 -51.15 64.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 109.902 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.3 t -55.74 -54.74 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 108.408 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -53.28 -44.74 68.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.616 -0.678 . . . . 0.0 109.421 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -53.23 -41.41 65.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.9 mt -77.26 -35.85 54.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.449 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.3 mt -80.77 0.76 33.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.025 -1.047 . . . . 0.0 110.61 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 58.24 51.82 8.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.512 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.49 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 19.9 mm -95.73 122.02 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 108.369 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.662 ' HG1' ' H ' ' A' ' 86' ' ' ASN . 8.3 p -101.88 -76.61 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 111.169 -178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.662 ' H ' ' HG1' ' A' ' 85' ' ' THR . 1.7 m-80 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.39 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.25 134.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.491 0.662 . . . . 0.0 109.555 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.486 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.7 m -105.92 100.54 10.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.14 104.49 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -80.49 124.17 28.7 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.2 t -106.21 111.88 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.401 ' N ' ' CD1' ' A' ' 92' ' ' ILE . 2.5 mp -92.46 108.92 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.15 -158.06 21.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.19 -11.46 10.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.586 -0.95 . . . . 0.0 110.233 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -145.81 150.1 35.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.85 -1.157 . . . . 0.0 110.858 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.52 125.13 91.8 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.638 -0.664 . . . . 0.0 109.623 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -45.28 134.94 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.964 1.776 . . . . 0.0 112.37 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.02 -29.5 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.2 mt 56.77 -110.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.548 -0.72 . . . . 0.0 110.221 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -15.5 22.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.092 . . . . 0.0 111.464 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.49 -8.83 32.66 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.3 p -117.46 -170.74 1.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -1.048 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.87 -3.3 21.91 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -46.8 -39.84 12.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 110.744 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.41 -51.85 67.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.964 -1.085 . . . . 0.0 110.15 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CD2' ' CD1' ' A' ' 75' ' ' ILE . 92.6 m-85 -64.01 -43.78 94.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.024 -1.047 . . . . 0.0 108.779 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -61.51 -38.02 85.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.662 -0.649 . . . . 0.0 109.756 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -71.18 -46.72 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 111.591 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.06 15.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.709 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 110' ' ' ILE . 74.7 mt -59.7 -42.86 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 110.709 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.64 -31.69 57.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.912 -1.117 . . . . 0.0 109.348 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -83.09 -1.11 51.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.93 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -131.4 33.42 4.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.252 -0.905 . . . . 0.0 111.071 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.2 mt -91.35 142.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.473 -1.392 . . . . 0.0 109.642 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.8 tp -131.56 162.83 29.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -108.01 146.03 33.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.921 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.587 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 10.7 mt-30 -111.23 -166.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 109.444 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 10.1 t-20 -116.66 70.83 0.77 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.4 -0.812 . . . . 0.0 110.304 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -166.36 143.59 5.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.192 -0.942 . . . . 0.0 109.305 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.73 130.04 35.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.715 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.77 140.36 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.683 . . . . 0.0 110.542 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.45 90.66 8.45 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -64.71 146.66 54.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 110.812 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.515 ' CE2' ' OE1' ' A' ' 267' ' ' GLN . 9.2 t80 -102.38 123.7 46.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.13 143.8 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.128 -0.982 . . . . 0.0 110.466 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 67.9 t -84.4 135.73 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.538 -0.726 . . . . 0.0 109.101 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -114.68 -10.47 12.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.233 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.443 ' OE1' ' CG2' ' A' ' 270' ' ' THR . 11.4 pt-20 -143.84 146.45 34.64 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.03 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.28 170.7 17.66 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.389 2.059 . . . . 0.0 113.403 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 tt -165.68 144.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.291 0.567 . . . . 0.0 109.793 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.4 mt -130.64 122.28 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.5 111.92 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.354 -0.841 . . . . 0.0 109.634 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -115.87 128.6 55.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -172.39 152.2 2.66 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.959 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HB2' ' HE ' ' A' ' 137' ' ' ARG . 33.7 mm-40 56.8 22.19 6.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.641 -0.662 . . . . 0.0 110.766 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.54 -0.21 89.42 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.411 ' HE ' ' HB2' ' A' ' 135' ' ' GLU . 21.2 mtm180 -100.5 171.8 7.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -1.143 . . . . 0.0 107.984 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.67 146.57 14.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.429 -1.419 . . . . 0.0 109.249 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.426 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 3.5 mt -147.24 133.27 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 108.671 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -123.78 138.44 54.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 0.0 109.666 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.68 144.59 48.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.5 -0.75 . . . . 0.0 109.105 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 11.4 tm-20 -141.59 135.39 14.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 5.9 Cg_endo -52.82 148.12 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.39 1.393 . . . . 0.0 112.05 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.69 150.87 10.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -79.6 0.8 28.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.5 p -138.43 170.42 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.582 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 30.6 tp -99.88 119.2 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 109.519 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -139.52 137.93 35.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.3 t -137.9 125.67 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 m -112.88 140.93 47.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -126.72 131.39 51.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 106.06 13.51 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.83 158.37 17.8 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 115.66 15.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -1.057 . . . . 0.0 109.148 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.11 148.75 41.27 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.431 -0.793 . . . . 0.0 109.876 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -93.05 -7.02 46.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 109.93 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.478 HD22 ' CD1' ' A' ' 159' ' ' LEU . 20.5 p-10 -75.06 -169.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.011 . . . . 0.0 109.972 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -58.83 -21.22 56.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 110.152 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.478 ' CD1' HD22 ' A' ' 157' ' ' ASN . 6.9 mt -64.76 -54.26 34.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.017 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.06 -131.74 10.69 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -101.37 142.68 32.41 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.235 -1.156 . . . . 0.0 109.517 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -148.67 150.37 33.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.199 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -136.74 147.55 46.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.805 . . . . 0.0 109.323 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -136.06 122.5 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' A' ' 165' ' ' THR . 14.2 t -98.26 120.77 39.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.994 -1.066 . . . . 0.0 109.658 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -95.05 140.44 29.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.232 -0.918 . . . . 0.0 109.44 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.94 150.08 23.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.289 -0.882 . . . . 0.0 109.707 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 96.6 mt-10 -55.59 117.64 3.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.888 . . . . 0.0 109.368 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.501 ' C ' HD21 ' A' ' 170' ' ' ASN . . . 115.86 4.97 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.501 HD21 ' C ' ' A' ' 169' ' ' GLY . 0.8 OUTLIER -134.87 30.27 3.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.142 -1.21 . . . . 0.0 108.958 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.415 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.1 mp0 -65.99 -28.64 69.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 110.132 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -57.42 -14.5 4.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.162 -0.962 . . . . 0.0 110.789 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -96.21 -4.35 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.134 . . . . 0.0 110.941 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.414 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -118.98 3.48 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 110.906 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.02 -31.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.804 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.4 2.68 55.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.997 -1.064 . . . . 0.0 110.571 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.25 118.34 21.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.736 -1.228 . . . . 0.0 108.751 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.25 152.09 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.942 -1.099 . . . . 0.0 110.166 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 t -59.11 133.05 55.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.555 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 25.4 p90 -115.03 165.77 12.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.482 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -159.65 161.23 34.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.496 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 42.7 m-85 -103.03 145.15 30.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.052 -1.03 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.12 -17.85 62.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.206 -0.934 . . . . 0.0 111.708 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.668 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.2 p90 -81.61 -38.32 26.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.362 -1.461 . . . . 0.0 111.183 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.668 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -86.85 -14.44 42.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.596 -1.315 . . . . 0.0 109.817 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.8 mt -53.91 -48.15 63.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.144 -0.973 . . . . 0.0 109.893 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.24 -51.35 54.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.103 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -47.04 67.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 30.0 mt -60.77 -34.7 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 109.183 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -78.91 -25.92 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.842 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -75.25 -28.45 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.6 m -81.49 10.66 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.101 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.37 72.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.0 mt -120.84 159.2 25.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.596 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.425 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 78.1 27.58 57.86 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.563 ' HZ1' ' CB ' ' A' ' 196' ' ' LYS . 8.0 mtpm? -71.03 -20.59 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.765 -1.432 . . . . 0.0 109.314 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.29 -1.34 50.86 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.75 126.94 38.21 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.695 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.407 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 1.6 p -140.74 172.02 13.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.716 -0.873 . . . . 0.0 109.114 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.79 -3.56 45.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.979 . . . . 0.0 109.642 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -97.88 -10.55 24.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.407 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 0.8 OUTLIER -135.18 -9.36 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 109.486 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.0 m -126.89 115.04 18.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.713 . . . . 0.0 109.586 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.0 114.64 12.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.31 127.08 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.048 -1.033 . . . . 0.0 109.854 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 11.1 mt -104.29 151.67 23.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.09 150.74 17.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 26.4 ttpt -41.02 -29.4 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -1.123 . . . . 0.0 109.961 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.5 OUTLIER -149.41 17.47 0.93 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 110.339 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 7.4 tttp -151.26 161.88 41.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.054 -1.029 . . . . 0.0 110.122 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.24 129.88 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.08 -54.31 8.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.137 -0.977 . . . . 0.0 109.92 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -54.64 134.22 64.3 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.909 -1.12 . . . . 0.0 109.329 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.81 -9.67 25.17 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.235 1.957 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.32 -7.96 52.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.066 -1.021 . . . . 0.0 109.751 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.18 -165.01 51.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.9 mt -88.66 145.24 25.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.5 -1.0 . . . . 0.0 109.935 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.566 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.7 mmt180 -87.76 -17.02 32.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.465 -0.772 . . . . 0.0 109.558 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 27.0 m-85 -144.17 143.97 31.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.01 -19.79 54.43 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -126.96 35.67 4.56 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -60.05 -40.62 79.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.538 -0.726 . . . . 0.0 110.607 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.11 -47.98 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.43 2.087 . . . . 0.0 112.641 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -23.09 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.757 -1.214 . . . . 0.0 108.696 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -68.74 -44.64 73.34 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -60.13 -43.02 96.01 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.83 -42.18 79.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.092 -1.005 . . . . 0.0 109.071 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.94 -49.31 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.602 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.8 t80 -50.22 -40.33 47.13 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.794 0.807 . . . . 0.0 108.896 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.0 m-20 -69.68 -44.57 70.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.635 -0.666 . . . . 0.0 110.178 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.64 -38.72 72.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.111 -0.993 . . . . 0.0 109.154 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 71.8 mt -68.04 -33.44 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.12 -31.97 79.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.589 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -81.78 -25.49 35.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -1.126 . . . . 0.0 109.912 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 237' ' ' LEU . 6.1 mt -76.07 -24.52 55.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.795 -1.191 . . . . 0.0 110.698 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.49 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -65.38 -5.22 6.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.355 -1.466 . . . . 0.0 108.013 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 235' ' ' LEU . 35.4 mt -55.08 -23.7 21.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.848 -1.158 . . . . 0.0 108.929 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.17 -21.47 64.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.005 . . . . 0.0 109.186 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.76 12.05 67.16 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 21.4 p -158.2 143.99 12.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.144 -1.209 . . . . 0.0 109.578 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -42.42 135.66 4.39 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.263 1.975 . . . . 0.0 112.153 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 76.0 t -98.46 133.03 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.944 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -122.41 127.81 50.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.613 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.0 178.93 28.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -105.93 112.2 25.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -1.207 . . . . 0.0 109.968 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -112.36 148.19 34.8 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.03 0.919 . . . . 0.0 111.125 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -129.89 144.42 51.31 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -139.09 128.81 24.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.732 -1.23 . . . . 0.0 110.722 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.0 t80 -110.67 113.07 25.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 249' ' ' PHE . 42.1 mtm180 48.51 55.48 8.91 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.18 135.31 22.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -109.78 151.2 17.38 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.1 m-70 -49.05 -46.12 43.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -1.205 . . . . 0.0 109.547 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -55.29 35.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 109.413 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.7 tp -51.99 -38.14 55.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -58.64 -55.48 34.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.036 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.42 -42.94 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.754 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.58 -48.89 74.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.089 -1.007 . . . . 0.0 109.087 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 37.9 tp -52.79 -42.02 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 108.772 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.9 t -72.11 -40.17 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -58.91 -51.36 70.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.388 -0.82 . . . . 0.0 110.136 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.79 -44.74 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 109.879 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.5 -44.16 95.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.248 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.28 86.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.498 -0.751 . . . . 0.0 110.368 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -81.83 -35.29 29.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.773 -1.204 . . . . 0.0 108.868 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 267' ' ' GLN . 38.0 mtpt -70.31 -45.25 66.64 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.515 ' OE1' ' CE2' ' A' ' 124' ' ' PHE . 3.2 tt0 -41.14 -29.42 0.12 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.65 -0.656 . . . . 0.0 110.455 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -99.51 -71.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.207 . . . . 0.0 109.719 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.85 -41.85 34.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 109.412 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' THR . . . . . 0.443 ' CG2' ' OE1' ' A' ' 128' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.498 ' NXH' ' O ' ' A' ' 58' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.244 0.545 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 119' ' ' ARG . 8.0 mm-40 -45.61 129.65 8.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.342 -0.849 . . . . 0.0 108.798 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.63 126.85 54.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.639 ' HG1' ' H ' ' A' ' 7' ' ' VAL . 6.1 t -130.44 169.37 15.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.639 ' H ' ' HG1' ' A' ' 6' ' ' THR . 6.7 m -83.87 137.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.034 -1.042 . . . . 0.0 110.317 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -67.6 -45.57 75.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.472 -0.767 . . . . 0.0 110.19 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CB ' ' OD1' ' A' ' 113' ' ' ASN . 2.8 tt0 -132.27 156.1 47.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.26 -0.9 . . . . 0.0 110.511 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 133.01 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.728 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.87 165.42 14.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 109.192 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 p -156.65 150.3 24.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.57 161.68 33.23 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.46 134.73 24.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.893 -1.13 . . . . 0.0 108.857 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.04 155.34 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.33 160.66 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.18 . . . . 0.0 111.208 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.65 136.29 13.44 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 197' ' ' GLY . 14.4 tt -53.42 -53.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -1.161 . . . . 0.0 111.657 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.418 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 5.2 m-70 -87.54 -36.78 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.275 -1.516 . . . . 0.0 111.191 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.4 m -71.31 -35.42 71.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.57 65.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -111.77 150.85 29.7 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.667 -0.902 . . . . 0.0 108.86 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.2 t80 -70.25 128.92 37.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.597 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.565 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 12.1 t -135.94 157.47 46.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 109.143 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.565 ' N ' ' HG ' ' A' ' 24' ' ' SER . 4.0 ttmt -135.6 147.2 48.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -0.895 . . . . 0.0 109.307 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' N ' ' HG2' ' A' ' 25' ' ' LYS . 6.4 mt -119.65 145.99 45.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.096 -1.003 . . . . 0.0 108.838 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.458 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 7.9 mt -135.05 126.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mt -113.08 129.1 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.223 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.574 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -128.44 148.75 69.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.54 160.37 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.278 1.986 . . . . 0.0 111.835 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 6.0 mm-40 -134.76 -172.82 3.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.902 . . . . 0.0 109.837 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 54.1 tttm -84.44 149.59 25.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 7.4 mp0 -47.46 145.42 2.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.991 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.68 25.2 63.14 Favored Glycine 0 N--CA 1.493 2.465 0 O-C-N 121.47 -0.769 . . . . 0.0 111.825 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 45.4 m -80.98 -44.58 17.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.546 -1.561 . . . . 0.0 108.951 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.48 -166.55 16.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mm -103.73 125.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.313 -1.11 . . . . 0.0 108.073 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.12 139.64 30.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.162 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.56 152.69 18.2 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 4.1 t80 -135.03 141.26 46.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.609 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 146.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.312 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.07 29.31 14.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.31 23.11 73.25 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.28 133.88 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -1.202 . . . . 0.0 109.51 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -94.41 142.45 27.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.823 . . . . 0.0 109.169 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.4 mt -135.09 94.39 16.09 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -49.26 144.88 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.342 2.028 . . . . 0.0 111.654 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.44 84.32 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.95 -1.094 . . . . 0.0 110.667 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.28 154.57 49.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.552 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 p80 -51.39 -48.15 62.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 109.732 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -46.77 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.0 m-85 -95.35 1.88 54.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 109.762 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.1 t -55.22 127.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.036 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.2 m -117.42 -32.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 109.861 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -151.32 119.28 6.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 p -114.36 127.82 56.04 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.603 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.9 t-20 -167.16 -152.98 0.14 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' ASN . 12.2 m-70 -44.37 -16.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.9 t -136.77 165.6 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.491 -0.755 . . . . 0.0 109.326 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 m -110.61 125.71 53.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 150.42 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.26 -0.9 . . . . 0.0 111.178 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.4 mt -130.15 159.01 38.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.73 146.68 8.02 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.306 -1.902 . . . . 0.0 111.538 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -144.09 148.87 35.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.644 -0.916 . . . . 0.0 109.309 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.1 mttt 59.1 30.62 20.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.262 -0.899 . . . . 0.0 110.75 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.24 4.72 90.11 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.486 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 16.7 mm100 -103.93 139.94 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -1.234 . . . . 0.0 108.094 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -141.71 157.52 44.95 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.704 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.2 mt -133.77 147.26 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -114.21 150.52 34.16 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.153 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 55.05 71.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.666 -0.646 . . . . 0.0 110.995 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.97 -17.41 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.438 178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.601 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -61.18 -16.81 48.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.441 -179.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.601 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 7.8 m170 -73.18 -61.39 1.84 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.833 -1.167 . . . . 0.0 109.832 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -58.15 -41.62 81.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.819 -1.175 . . . . 0.0 108.338 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 98.0 mt -56.4 -38.28 71.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 109.466 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.569 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.2 t -61.44 -49.23 77.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.13 -53.07 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 108.515 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.2 mt -51.73 -44.62 63.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 0.0 109.512 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.458 ' ND1' ' CG2' ' A' ' 232' ' ' ILE . 10.6 t-160 -56.16 -49.34 74.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.1 -1.0 . . . . 0.0 110.401 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.49 -37.89 85.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.685 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.437 ' C ' ' OE1' ' A' ' 83' ' ' GLU . 50.2 mt -86.66 -5.43 59.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.913 -1.117 . . . . 0.0 111.151 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 82' ' ' LEU . 1.0 OUTLIER 62.69 63.0 1.03 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.731 -1.231 . . . . 0.0 110.426 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 mm -98.44 129.68 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.422 ' HG1' ' CD ' ' A' ' 4' ' ' GLU . 72.9 p -107.63 -78.21 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.041 -1.037 . . . . 0.0 110.509 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.703 HD21 HE22 ' A' ' 117' ' ' GLN . 1.5 m-80 -81.34 113.27 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.005 -1.059 . . . . 0.0 111.137 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 2.9 m -163.71 131.79 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.546 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.5 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 51.4 m -104.25 100.88 10.6 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.38 103.02 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' OE2' ' CD1' ' A' ' 40' ' ' PHE . 4.0 mt-10 -76.32 122.97 25.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.989 -1.069 . . . . 0.0 108.782 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.06 110.29 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.45 108.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.7 -167.15 24.91 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.16 -15.31 14.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.365 -1.08 . . . . 0.0 109.861 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.5 tt0 -143.71 148.68 36.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 110.034 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -68.2 128.36 93.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.456 -0.777 . . . . 0.0 109.282 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -44.19 130.35 8.49 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.047 1.831 . . . . 0.0 112.116 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.9 tp -76.33 -20.31 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.074 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.464 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 6.2 mt 47.57 -116.19 0.72 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.277 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.16 -10.05 31.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.483 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.27 -5.07 57.3 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.4 p -117.14 -171.38 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.454 -1.027 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.9 -6.14 16.97 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -47.71 -40.1 19.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.65 -0.912 . . . . 0.0 110.805 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.83 -52.06 65.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.931 -1.105 . . . . 0.0 109.828 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.4 m-85 -60.62 -43.93 96.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.012 -1.055 . . . . 0.0 108.379 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -60.88 -39.76 90.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.517 0.675 . . . . 0.0 110.051 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.89 -47.97 60.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 112.059 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 -51.19 14.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.749 -1.219 . . . . 0.0 111.105 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.49 -42.81 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -56.49 -29.54 61.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.945 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -81.23 -15.4 55.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.066 . . . . 0.0 110.453 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' CB ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -119.84 32.25 6.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.265 -0.897 . . . . 0.0 111.044 -178.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.7 mt -80.75 146.69 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.653 -1.28 . . . . 0.0 110.929 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.7 tp -132.09 162.63 30.35 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -123.49 146.6 47.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.235 -0.916 . . . . 0.0 110.446 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.703 HE22 HD21 ' A' ' 86' ' ' ASN . 0.6 OUTLIER -107.75 -157.5 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -0.789 . . . . 0.0 109.245 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.717 HD21 ' H ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 1.72 11.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.011 -1.056 . . . . 0.0 112.124 -178.266 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 4' ' ' GLU . 3.3 ttm180 -102.24 122.02 43.4 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.573 -1.329 . . . . 0.0 110.237 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -56.73 142.97 38.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.258 -0.901 . . . . 0.0 109.999 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.9 mt -81.19 145.55 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 0.0 110.481 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.58 84.43 7.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -60.72 146.06 47.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 110.552 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.677 ' CE2' ' NE2' ' A' ' 267' ' ' GLN . 12.4 t80 -101.22 120.15 39.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.72 138.84 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 109.878 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.2 140.0 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.192 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -119.7 -8.63 9.89 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.19 146.17 41.77 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.42 -0.8 . . . . 0.0 109.072 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.52 177.21 8.97 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.219 1.946 . . . . 0.0 113.08 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 8.4 tt -165.25 144.78 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.622 -0.674 . . . . 0.0 109.574 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -129.03 123.61 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.59 122.1 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.426 ' C ' ' OE1' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.35 132.02 56.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 17.2 t0 -174.21 157.8 2.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.261 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 44.2 mt-10 57.71 19.93 5.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.676 -0.64 . . . . 0.0 110.773 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.04 4.58 88.84 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -114.07 177.63 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 10.1 tt -157.77 161.09 38.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.351 -1.468 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.516 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 18.6 mt -149.8 144.97 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.952 . . . . 0.0 108.492 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -132.4 140.17 48.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.627 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.69 140.86 51.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 108.998 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.56 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 13.8 tm-20 -137.64 126.55 14.81 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.45 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 88.6 Cg_exo -46.39 152.48 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.563 1.509 . . . . 0.0 112.435 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.05 159.57 6.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -91.79 -0.29 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 p -132.85 146.41 51.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.444 -0.785 . . . . 0.0 109.166 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.9 tp -81.38 117.22 21.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.133 -0.979 . . . . 0.0 109.86 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.07 135.1 39.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 67.5 t -135.98 117.65 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.516 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.3 m -107.92 134.15 51.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -121.51 130.6 53.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -112.31 110.55 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.55 152.84 17.53 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.46 96.11 2.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.436 -1.038 . . . . 0.0 109.138 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 3.5 m-85 -98.98 148.72 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.578 -0.701 . . . . 0.0 110.126 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -85.38 -3.72 58.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.484 -0.76 . . . . 0.0 109.864 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.5 p30 -76.93 -167.64 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.915 -1.115 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -58.0 -22.01 47.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.039 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.486 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 19.8 mt -59.38 -54.73 43.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.834 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.13 -111.71 3.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -124.84 137.18 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -1.112 . . . . 0.0 109.076 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -155.32 139.33 16.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.377 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.614 ' CB ' ' HZ3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -127.69 153.73 46.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 109.169 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.496 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 86.4 t80 -135.17 116.88 14.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.0 t -92.47 120.1 32.62 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.157 -0.964 . . . . 0.0 109.376 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.74 138.38 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.561 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -135.77 153.55 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.0 109.45 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -57.22 122.82 13.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.476 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.49 -7.05 20.59 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.14 32.65 4.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -1.14 . . . . 0.0 108.768 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -66.56 -30.64 70.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.797 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -58.53 -13.6 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.015 . . . . 0.0 110.877 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.26 -4.44 54.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.915 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.39 3.75 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.16 -0.963 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.77 -32.64 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.797 -1.189 . . . . 0.0 109.934 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.55 0.17 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.978 -1.076 . . . . 0.0 110.536 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.34 117.42 18.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.798 -1.188 . . . . 0.0 108.29 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.464 HH12 ' C ' ' A' ' 201' ' ' LYS . 11.2 ttm180 -86.08 148.83 25.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 0.0 110.26 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.497 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 1.4 t -62.55 134.9 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 109.012 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.16 179.74 3.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 110.582 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.564 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.6 OUTLIER -164.93 161.32 20.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.578 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.2 m-85 -104.52 144.21 31.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -62.64 -19.27 63.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.689 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.587 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -81.44 -31.46 33.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.755 -1.216 . . . . 0.0 110.534 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.587 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 6.4 pt-20 -91.79 -14.96 28.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.836 -1.165 . . . . 0.0 109.513 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.8 mt -57.42 -52.02 62.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 110.372 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -50.64 -52.39 40.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.912 -1.117 . . . . 0.0 109.92 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -45.62 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.914 -1.116 . . . . 0.0 109.166 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.3 -33.43 61.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 109.079 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -80.52 -26.79 37.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -79.43 -21.13 45.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 110.03 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.3 13.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.752 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.82 24.46 67.0 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.788 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.0 mt -123.9 163.5 21.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.118 -1.225 . . . . 0.0 109.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.409 ' HA2' ' HD1' ' A' ' 19' ' ' HIS . . . 77.37 21.92 71.71 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -68.63 -21.31 64.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.83 -1.394 . . . . 0.0 109.735 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.68 -5.37 51.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.08 125.75 38.78 Favored Glycine 0 N--CA 1.49 2.263 0 O-C-N 121.242 -1.152 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.28 165.1 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.713 -0.875 . . . . 0.0 109.314 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.98 -8.06 50.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.504 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.464 ' C ' HH12 ' A' ' 178' ' ' ARG . 23.5 tttp -93.44 -5.61 48.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 53.8 m-20 -143.54 14.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.719 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.8 m -151.65 119.1 6.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.3 tp -80.4 109.81 15.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.133 -0.979 . . . . 0.0 108.893 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.4 t -98.11 128.56 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.9 mt -110.79 148.41 32.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.896 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.27 156.29 16.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 207' ' ' GLY . 1.6 ttpt -42.9 -30.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.912 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.7 13.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.166 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 207' ' ' GLY . 33.1 mttt -139.23 147.26 41.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.037 -1.04 . . . . 0.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.99 127.05 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -72.91 -54.31 9.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 110.061 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.39 132.42 81.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.926 -1.109 . . . . 0.0 109.44 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.4 -11.5 26.62 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.885 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -90.38 -8.72 49.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.969 -1.082 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.24 -167.94 45.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.2 mt -78.62 141.84 37.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.449 -1.03 . . . . 0.0 109.766 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.584 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.1 tpp180 -79.57 -13.06 59.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 34.3 m-85 -148.24 152.79 37.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 108.899 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 11.6 mp0 -59.25 -19.12 43.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 108.423 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 37.25 3.02 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.621 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.5 OUTLIER -59.91 -38.18 57.36 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.605 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.27 -46.45 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.158 1.906 . . . . 0.0 112.295 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 6.1 m -74.45 -23.99 18.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.776 -1.202 . . . . 0.0 108.25 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 164' ' ' PHE . 44.9 mtt180 -68.24 -43.21 78.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -61.06 -41.76 97.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -57.49 -43.4 84.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.966 -1.083 . . . . 0.0 108.753 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 28.2 t -60.84 -45.14 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.569 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 75.6 t80 -55.87 -40.56 73.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 1.1 m-20 -73.71 -37.8 65.04 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.612 -0.68 . . . . 0.0 109.597 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 28.4 tp -56.23 -34.86 66.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.458 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 61.0 mt -73.28 -47.93 44.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.66 -34.66 21.44 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.482 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 1.0 OUTLIER -81.59 -27.6 34.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -1.196 . . . . 0.0 109.95 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.6 mt -80.46 -20.92 42.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.796 -1.19 . . . . 0.0 109.631 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -73.1 -9.22 58.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.288 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.423 ' C ' ' H ' ' A' ' 239' ' ' GLY . 67.9 mt -53.5 -28.2 29.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 108.879 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 65.4 mt -55.3 -12.21 0.97 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 108.895 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.65 12.26 84.66 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 30.2 p -158.52 147.61 14.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.946 -1.326 . . . . 0.0 109.857 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -42.9 133.78 5.61 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.283 1.988 . . . . 0.0 112.081 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 42.5 t -100.32 129.03 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 109.615 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.92 123.54 47.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.38 -0.825 . . . . 0.0 109.807 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.35 173.08 26.3 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.56 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -103.14 111.93 24.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.189 -1.183 . . . . 0.0 109.463 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.6 m-85 -112.5 148.26 34.81 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.111 0.958 . . . . 0.0 111.456 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 t -131.79 128.13 38.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.86 -1.15 . . . . 0.0 110.043 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.55 ' O ' ' N ' ' A' ' 251' ' ' GLY . 1.6 t80 -109.49 117.88 35.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.538 -0.726 . . . . 0.0 109.16 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 42.83 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 111.03 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -64.03 172.55 15.82 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.595 -1.316 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -138.91 -169.2 11.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -65.66 -52.37 52.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.131 . . . . 0.0 110.008 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.416 ' H ' ' HG ' ' A' ' 254' ' ' SER . 0.2 OUTLIER -53.74 -42.5 68.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 -179.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.71 -36.13 67.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.968 -1.082 . . . . 0.0 109.009 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.8 m-20 -63.59 -44.41 94.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 108.605 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 17.0 t -57.12 -45.04 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 108.844 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -55.18 -47.3 75.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.118 -0.989 . . . . 0.0 108.844 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 17.7 tp -53.52 -44.96 69.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.374 -0.828 . . . . 0.0 109.034 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.9 t -69.57 -43.45 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -48.24 77.37 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -68.01 -39.5 83.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.643 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.2 mt -65.0 -44.85 87.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.76 74.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.429 ' HZ1' ' CB ' ' A' ' 265' ' ' LYS . 7.0 mtmp? -86.89 -30.67 21.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.764 -1.21 . . . . 0.0 109.302 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 268' ' ' LYS . 66.2 mttt -73.39 -43.47 60.47 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.266 -0.896 . . . . 0.0 109.129 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.677 ' NE2' ' CE2' ' A' ' 124' ' ' PHE . 12.5 tt0 -62.45 1.09 0.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.487 -0.758 . . . . 0.0 109.921 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -83.12 33.5 0.45 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 0.0 109.329 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 15.3 mt -72.22 -9.07 57.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 0.0 109.595 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 109.406 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.564 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 4' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 25.5 mt-10 -40.93 143.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.86 . . . . 0.0 109.678 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -119.9 140.09 51.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.595 -0.691 . . . . 0.0 109.412 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 t -139.14 178.5 7.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.23 -0.919 . . . . 0.0 109.085 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -83.59 151.05 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.8 -1.188 . . . . 0.0 109.75 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.31 -37.62 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.475 -0.766 . . . . 0.0 110.063 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.52 157.76 46.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 133.08 54.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.357 0.598 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.1 mt -123.58 159.22 29.68 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -157.26 150.84 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.11 -0.994 . . . . 0.0 110.51 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 169.01 18.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.563 -0.711 . . . . 0.0 109.718 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.69 137.89 21.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.071 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.75 157.26 14.92 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.29 140.29 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.179 -1.189 . . . . 0.0 110.752 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.94 144.09 37.48 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.5 tt -59.63 -49.11 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -1.102 . . . . 0.0 112.459 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.548 ' CD2' ' OE2' ' A' ' 95' ' ' GLU . 9.6 m-70 -86.52 -38.24 17.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.003 -1.685 . . . . 0.0 111.071 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -67.52 -37.81 83.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.71 21.94 71.41 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -119.16 154.43 33.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.724 -0.868 . . . . 0.0 109.009 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -70.88 133.67 46.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.9 t -142.63 157.25 44.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 108.883 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -126.41 160.47 30.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.232 -0.918 . . . . 0.0 110.01 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.474 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 12.1 mt -127.75 142.15 51.39 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.7 mt -137.26 127.21 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 108.838 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.51 121.24 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.732 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -119.34 149.01 46.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.83 160.78 35.42 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.082 1.854 . . . . 0.0 110.732 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 56.7 mm-40 -136.4 -172.51 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.062 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -86.31 153.27 22.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 109.355 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -47.11 143.34 3.17 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 110.291 -179.297 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 60.08 30.5 70.48 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.384 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.458 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 21.5 m -80.96 -35.83 31.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.592 -1.534 . . . . 0.0 108.584 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.757 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 91.67 179.54 42.01 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -95.43 122.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.279 -1.13 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.4 144.81 46.75 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.773 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -102.57 152.73 20.82 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 3.5 t80 -131.45 141.63 49.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 108.912 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -173.4 138.11 0.69 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.372 -0.83 . . . . 0.0 108.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.8 28.79 17.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.158 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.28 27.63 71.34 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 120.783 -1.198 . . . . 0.0 110.168 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.78 137.83 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -1.227 . . . . 0.0 109.956 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -96.63 135.3 38.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.6 mt -128.79 99.25 23.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.82 142.58 18.86 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.62 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.83 84.5 4.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 110.548 -178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -141.6 157.91 44.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 109.393 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.6 p80 -54.83 -49.14 71.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -44.9 -16.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.13 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.6 m-85 -96.83 5.89 49.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.971 -1.081 . . . . 0.0 109.891 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -60.01 124.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.163 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.86 -30.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -0.877 . . . . 0.0 109.849 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.507 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -153.56 121.95 6.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 0.0 109.475 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -114.07 133.72 55.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.618 -0.676 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.9 t-20 -166.79 -154.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.484 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 12.0 m-70 -48.08 -12.59 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.897 -1.127 . . . . 0.0 108.294 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' ASN . 84.5 p -135.32 165.26 25.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.491 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 6.4 m -106.32 124.13 49.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -0.909 . . . . 0.0 108.998 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.507 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.04 137.74 54.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 111.381 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.7 mt -127.73 159.15 35.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 178.17 151.86 9.76 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.379 -1.867 . . . . 0.0 111.667 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -144.94 152.2 39.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.98 -0.718 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.1 mttt 59.62 24.3 13.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.342 -0.849 . . . . 0.0 110.755 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.53 83.09 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.531 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.441 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 20.1 mm100 -109.87 133.4 53.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 108.061 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.79 165.17 27.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.892 -1.13 . . . . 0.0 111.838 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mt -134.77 148.55 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -114.61 150.72 34.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m 55.32 69.32 0.75 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 110.724 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.22 -12.97 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.975 -1.078 . . . . 0.0 109.356 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 3.4 pt-20 -63.2 -18.37 63.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.452 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -71.91 -60.65 2.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.919 -1.113 . . . . 0.0 109.683 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.437 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.4 tp -59.78 -43.04 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.994 -1.066 . . . . 0.0 108.953 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 15.0 mt -55.2 -41.26 71.76 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.174 -0.953 . . . . 0.0 109.331 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.9 t -58.48 -47.85 82.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.35 -54.11 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 108.703 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 mt -52.58 -44.94 66.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.586 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 19.7 t-160 -52.88 -54.32 36.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 110.224 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.16 -34.9 78.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.4 mt -79.49 -4.47 51.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 110.598 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.58 54.45 2.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.98 -1.075 . . . . 0.0 110.305 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 84' ' ' ILE . 11.4 mm -96.3 124.57 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 108.467 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.477 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 5.8 p -112.64 -21.31 11.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.315 -0.866 . . . . 0.0 111.631 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.757 HD21 ' H ' ' A' ' 36' ' ' GLY . 10.8 m120 -132.8 112.36 11.88 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.885 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.3 m -165.01 144.56 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.989 . . . . 0.0 109.839 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 64.9 m -112.85 102.86 10.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mp -92.91 117.99 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.872 . . . . 0.0 109.789 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.94 118.22 32.14 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.373 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.55 104.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.865 . . . . 0.0 110.833 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.14 110.7 19.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.83 -162.92 24.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.7 -13.88 12.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -1.06 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.548 ' OE2' ' CD2' ' A' ' 19' ' ' HIS . 40.5 tt0 -142.0 147.51 37.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.101 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -68.76 126.74 93.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 109.764 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -45.59 129.53 11.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.923 1.749 . . . . 0.0 111.887 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.26 -32.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.498 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 9.6 mt 55.12 -104.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.273 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -94.34 -28.32 15.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.195 -0.94 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.87 -3.54 25.83 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.3 p -123.5 -166.23 1.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.421 -1.047 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -2.28 22.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CD2' HD22 ' A' ' 176' ' ' LEU . 59.4 t-105 -48.69 -43.02 36.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.889 -0.771 . . . . 0.0 110.974 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.55 -52.08 64.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.964 -1.085 . . . . 0.0 110.385 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -62.93 -44.04 97.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.931 -1.105 . . . . 0.0 108.722 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 82.3 t80 -63.74 -37.22 86.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.819 -0.551 . . . . 0.0 110.251 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.74 -49.68 29.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 112.014 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.16 -46.76 40.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.808 -1.182 . . . . 0.0 111.056 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -68.69 -42.57 83.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.96 -1.087 . . . . 0.0 110.971 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 15.8 ttp85 -55.74 -27.76 52.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.0 -1.063 . . . . 0.0 110.091 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -84.19 -18.35 36.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.99 -1.069 . . . . 0.0 109.887 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -113.08 29.26 8.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.8 mt -82.26 149.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 0.0 110.28 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -130.66 160.94 32.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.53 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -105.3 137.36 43.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.093 -1.005 . . . . 0.0 109.977 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -102.6 -170.95 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.489 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -124.97 70.71 1.15 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.471 -0.768 . . . . 0.0 110.16 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -160.61 137.78 9.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.046 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 121' ' ' ILE . 43.5 tt0 -48.12 167.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.678 0.751 . . . . 0.0 111.193 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.407 ' H ' ' HG2' ' A' ' 120' ' ' GLU . 69.6 mt -128.59 122.35 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -79.37 71.93 5.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.348 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -55.58 147.05 18.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.081 -1.012 . . . . 0.0 109.414 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CE2' ' OE1' ' A' ' 267' ' ' GLN . 2.9 t80 -104.83 123.02 46.96 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 15.5 t -127.92 143.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.849 . . . . 0.0 109.51 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.81 141.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.5 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.23 -7.6 9.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -142.35 144.31 30.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 0.0 109.062 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.13 168.01 25.83 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.185 1.923 . . . . 0.0 113.536 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.1 tt -159.77 141.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.343 0.592 . . . . 0.0 109.439 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 28.6 mt -131.56 119.96 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.4 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.3 120.44 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.94 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -114.55 136.45 53.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.685 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -174.24 150.1 1.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.599 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 57.05 24.09 9.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.0 110.818 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.09 7.68 86.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.403 ' CG ' HH11 ' A' ' 137' ' ' ARG . 2.9 mtt-85 -106.89 170.25 8.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.0 tt -160.44 149.52 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.185 -1.572 . . . . 0.0 109.232 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.499 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 48.9 mt -145.83 135.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 0.0 108.626 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -124.11 140.5 52.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.971 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.58 142.13 50.96 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -139.64 127.89 13.3 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -46.73 149.1 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.661 1.574 . . . . 0.0 112.417 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.49 155.11 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -1.43 56.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -135.0 148.18 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 109.353 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.1 tp -84.08 118.63 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -137.3 138.85 40.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 54.7 t -135.52 123.35 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.142 -0.974 . . . . 0.0 110.032 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.0 m -109.87 129.34 55.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.239 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -119.17 131.43 55.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 26.6 tt0 -116.21 104.74 11.82 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.59 146.2 18.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.504 ' H ' HH11 ' A' ' 250' ' ' ARG . 1.8 tm-20 -119.59 86.11 2.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.603 -0.94 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 160' ' ' GLY . 11.7 m-85 -91.91 148.17 22.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -96.56 -4.99 40.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.277 -0.889 . . . . 0.0 109.445 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.439 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 19.3 p-10 -74.47 -167.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.8 -18.01 28.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.628 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.74 -29.0 62.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 60.82 -121.39 26.43 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -107.67 140.67 40.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -1.048 . . . . 0.0 108.878 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -149.83 157.85 43.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.096 -1.002 . . . . 0.0 109.638 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -149.05 151.76 35.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.608 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -138.3 130.39 28.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.043 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.413 ' O ' ' CG2' ' A' ' 165' ' ' THR . 14.0 t -102.05 123.43 45.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -99.08 132.73 44.18 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.333 -0.854 . . . . 0.0 108.838 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.5 147.61 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.0 109.195 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 122.13 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.86 16.39 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -117.04 31.41 6.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.27 . . . . 0.0 108.547 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -59.58 -39.02 82.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 110.673 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 172' ' ' GLU . 2.1 mp0 -52.5 -14.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.057 -1.027 . . . . 0.0 110.944 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.76 -4.05 48.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.818 -1.176 . . . . 0.0 111.153 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.6 pt -121.04 -7.73 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.046 . . . . 0.0 111.033 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.51 -28.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.552 -1.343 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.401 HD22 ' CD2' ' A' ' 104' ' ' TRP . 0.9 OUTLIER -89.46 1.23 56.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.957 -1.089 . . . . 0.0 110.849 -179.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.51 119.42 22.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.738 -1.227 . . . . 0.0 108.888 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -87.28 151.61 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.007 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -53.15 160.42 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.264 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.525 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 33.0 p90 -142.1 169.76 16.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.864 -1.147 . . . . 0.0 109.794 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.525 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -161.04 159.67 29.6 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.184 -0.948 . . . . 0.0 109.898 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.67 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 70.8 m-85 -103.98 146.04 29.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.334 -0.854 . . . . 0.0 109.376 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -18.89 64.54 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.67 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.2 p90 -79.55 -29.92 41.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.541 -1.35 . . . . 0.0 111.119 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.532 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -98.0 -11.67 22.78 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.754 -1.216 . . . . 0.0 109.764 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.1 mt -58.75 -52.59 58.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.15 -0.969 . . . . 0.0 110.008 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.01 -49.82 59.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 109.565 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -53.74 -52.86 58.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.04 -33.99 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.842 . . . . 0.0 109.074 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -75.98 -25.55 55.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.562 ' HZ1' ' CB ' ' A' ' 191' ' ' LYS . 0.2 OUTLIER -76.92 -25.91 53.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.056 -1.028 . . . . 0.0 109.875 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.62 14.98 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.32 26.88 72.61 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.922 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -119.09 157.4 27.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.21 -1.171 . . . . 0.0 109.829 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.27 24.15 64.14 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.382 -0.914 . . . . 0.0 110.956 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.401 ' CB ' ' HZ3' ' A' ' 196' ' ' LYS . 9.9 mtpm? -69.0 -20.88 64.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.669 -1.489 . . . . 0.0 109.014 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.44 -7.41 48.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.2 124.62 32.45 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.21 -1.17 . . . . 0.0 110.218 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.568 ' HG ' ' H ' ' A' ' 201' ' ' LYS . 1.0 OUTLIER -140.83 169.82 16.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.764 -0.845 . . . . 0.0 109.34 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.91 -5.68 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.634 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.568 ' H ' ' HG ' ' A' ' 199' ' ' SER . 2.0 ttpt -89.91 -4.73 57.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -153.09 18.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.445 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 1.7 m -149.59 128.65 12.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.7 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 68.3 tp -91.21 113.29 25.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.4 t -100.79 127.5 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 109.474 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 61.3 mt -104.02 146.88 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 110.192 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.51 161.23 14.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -51.08 -28.11 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.125 -1.22 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -155.07 14.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.833 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -141.22 149.28 41.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.039 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.18 128.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.2 -54.4 9.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.509 HD21 ' H ' ' A' ' 213' ' ' ASN . 1.5 m-80 -53.3 137.27 49.79 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.24 -36.35 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.435 2.09 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -70.11 -4.29 20.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.797 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.84 -161.56 53.94 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.1 mt -83.37 145.01 29.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -1.005 . . . . 0.0 109.889 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.594 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 14.1 ttt85 -80.72 -17.9 49.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 109.454 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 29.7 m-85 -148.79 164.86 33.16 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -72.79 -14.32 61.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.099 -1.0 . . . . 0.0 108.392 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 33.81 2.96 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.714 0.769 . . . . 0.0 108.96 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -55.87 -39.09 74.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.896 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.02 -41.57 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.091 1.861 . . . . 0.0 112.851 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.7 m -78.32 -25.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.716 -1.24 . . . . 0.0 108.231 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.563 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 48.5 mtt180 -66.75 -41.22 88.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -65.1 -42.74 93.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.541 -0.724 . . . . 0.0 109.156 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.542 ' CD ' HOG6 ' A' ' 320' ' ' TUX . 5.3 tptp -56.68 -48.32 77.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.252 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 70.5 t -58.62 -43.91 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.573 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.3 t80 -57.83 -36.98 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.51 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -73.3 -43.12 61.53 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.648 -0.657 . . . . 0.0 109.968 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 26.2 tp -56.19 -34.3 66.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.586 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 34.4 mt -72.76 -48.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.15 -34.65 17.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.65 -27.16 31.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.144 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.9 -23.76 41.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.739 -1.225 . . . . 0.0 110.133 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -72.45 -5.88 39.76 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.031 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 239' ' ' GLY . 33.6 mt -53.32 -27.88 25.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 108.745 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.3 -9.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.168 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.51 11.73 85.2 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.0 p -156.58 149.12 17.95 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.095 -1.238 . . . . 0.0 109.56 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -48.38 138.48 23.68 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.211 1.941 . . . . 0.0 111.785 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.91 136.26 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -124.55 127.78 47.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.433 -0.792 . . . . 0.0 109.62 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.53 177.2 30.41 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.43 112.7 25.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -1.167 . . . . 0.0 109.861 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.6 m-85 -112.59 148.86 33.67 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.031 0.92 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 25.1 t80 -128.24 144.29 51.11 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.6 t -142.46 128.99 20.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.683 -1.261 . . . . 0.0 110.778 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 250' ' ' ARG . 56.8 t80 -111.96 112.94 24.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.504 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.0 OUTLIER 47.36 56.1 7.39 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.39 149.4 23.68 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -121.69 165.33 14.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 91.3 m-70 -59.47 -44.53 92.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.3 m -59.58 -40.94 89.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.641 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.1 tp -72.26 -35.93 68.9 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.049 -1.032 . . . . 0.0 108.711 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -61.88 -46.8 87.83 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.73 -44.73 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.291 -0.88 . . . . 0.0 108.726 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -55.23 -48.28 74.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 108.927 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 26.2 tp -52.97 -43.07 66.1 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 63.4 t -69.83 -44.92 78.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.373 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -52.37 60.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.605 -0.684 . . . . 0.0 110.025 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -62.2 -46.39 89.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.01 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.2 -44.87 92.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.147 -0.971 . . . . 0.0 109.508 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.89 -30.21 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -83.31 -30.46 27.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.813 -1.179 . . . . 0.0 108.778 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 268' ' ' LYS . 34.7 mttp -56.24 -44.27 79.46 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.283 -0.886 . . . . 0.0 109.035 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.532 ' OE1' ' CE2' ' A' ' 124' ' ' PHE . 5.4 pt20 -76.06 19.68 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.492 -0.755 . . . . 0.0 109.773 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -64.07 -0.94 1.3 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.028 -1.045 . . . . 0.0 109.311 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 267' ' ' GLN . 72.0 mt -43.76 -39.79 3.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.326 -0.859 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.496 -0.752 . . . . 0.0 109.418 179.902 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.542 HOG6 ' CD ' ' A' ' 227' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 42.1 mt-10 -56.31 137.79 51.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.091 -1.005 . . . . 0.0 108.921 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.6 141.01 52.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.432 -0.793 . . . . 0.0 109.882 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -137.79 172.74 12.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.21 137.86 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.771 -1.206 . . . . 0.0 110.538 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -69.59 -47.97 61.76 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.658 -0.651 . . . . 0.0 109.785 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.93 158.37 38.03 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.626 0.727 . . . . 0.0 110.32 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -60.71 137.25 58.21 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.555 0.693 . . . . 0.0 110.315 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.07 154.63 31.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -146.71 145.1 29.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.879 -1.138 . . . . 0.0 110.126 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.51 160.45 37.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.68 135.91 22.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.911 -1.118 . . . . 0.0 109.004 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.3 158.6 18.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.17 143.06 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -1.231 . . . . 0.0 110.662 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.69 145.13 43.17 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -65.24 -41.91 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.053 -1.263 . . . . 0.0 112.073 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.526 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 3.9 m-70 -87.3 -38.85 15.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.047 -1.658 . . . . 0.0 111.073 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 p -74.21 -32.34 63.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 109.942 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.88 19.57 63.41 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.87 150.24 28.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.958 . . . . 0.0 108.804 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -70.98 135.65 47.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 109.823 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.63 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 13.0 t -143.45 157.88 44.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.211 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 17.0 tttt -132.62 157.07 45.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 2.2 mt -134.15 145.29 49.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 109.214 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.447 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -130.45 134.46 62.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.56 118.1 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 42.9 m-70 -115.23 150.11 43.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.74 158.13 48.17 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.194 1.929 . . . . 0.0 111.511 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 14.0 mm-40 -133.43 -178.04 4.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.3 tptt -83.47 149.76 26.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.25 149.64 0.98 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.0 109.748 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.687 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 59.08 23.47 57.29 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.141 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.732 ' H ' HD21 ' A' ' 86' ' ' ASN . 6.7 m -80.29 -41.83 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.735 -1.45 . . . . 0.0 109.278 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.64 -166.64 21.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 37' ' ' ILE . 10.3 mm -107.6 121.54 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.348 -1.09 . . . . 0.0 108.219 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.08 143.62 46.74 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.663 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.09 153.24 20.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.29 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.545 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.1 t80 -128.77 145.46 51.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.49 ' HZ3' ' NE2' ' A' ' 67' ' ' GLN . 16.1 tttm -172.96 135.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 109.603 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.64 29.78 14.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.889 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.58 27.93 70.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.7 t -131.62 134.58 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -94.19 140.39 29.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.221 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.9 mt -134.08 94.53 18.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.059 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 145.37 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.294 1.996 . . . . 0.0 111.599 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.67 84.23 4.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.914 -1.116 . . . . 0.0 110.53 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -136.92 152.59 50.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.977 . . . . 0.0 109.582 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 52' ' ' PHE . 10.2 p80 -51.1 -46.81 61.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -48.39 -17.16 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.059 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' HIS . 51.7 m-85 -95.66 3.53 53.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.814 -1.179 . . . . 0.0 109.641 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.42 119.27 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 108.79 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.28 -26.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 110.573 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.59 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -147.97 117.18 6.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.898 -1.126 . . . . 0.0 110.031 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' OG ' ' A' ' 254' ' ' SER . 30.1 p -113.86 125.36 53.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.612 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 t-20 -167.58 -152.41 0.12 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.593 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 9.8 t-80 -44.13 -15.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -140.27 165.37 27.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.449 -0.782 . . . . 0.0 109.119 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.603 ' N ' ' HG ' ' A' ' 59' ' ' SER . 24.1 m -110.23 126.57 54.29 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.18 -0.95 . . . . 0.0 109.102 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.5 OUTLIER -128.12 147.15 50.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.184 0.992 . . . . 0.0 111.777 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.8 mt -122.51 157.48 31.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.2 143.52 7.03 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -143.04 147.79 35.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.926 . . . . 0.0 109.44 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp 53.73 45.07 28.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.271 -0.893 . . . . 0.0 110.711 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.2 6.5 65.03 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.65 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.6 mm100 -101.26 140.91 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.973 -1.31 . . . . 0.0 108.39 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -142.84 149.66 38.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.888 -1.132 . . . . 0.0 111.52 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mt -133.7 143.2 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -114.11 152.02 31.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.235 -0.916 . . . . 0.0 111.208 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 53.57 70.04 0.64 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.778 -0.577 . . . . 0.0 111.152 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.84 -8.16 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.958 -1.089 . . . . 0.0 109.653 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.3 pt-20 -69.32 -20.43 63.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 110.518 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.33 -60.76 2.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.043 -1.036 . . . . 0.0 109.732 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -59.5 -43.77 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.072 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 50.1 mt -55.42 -39.4 70.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.554 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 1.7 t -59.71 -47.57 85.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.202 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.05 -54.45 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 108.718 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.56 -44.06 62.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.472 -0.767 . . . . 0.0 109.277 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.489 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 15.8 t-160 -55.38 -58.17 8.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.792 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.6 mt -58.63 -37.71 76.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.972 . . . . 0.0 110.001 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 10.5 mt -78.12 -7.18 56.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 110.334 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 61.17 53.2 3.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.87 -1.144 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mm -98.03 130.77 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.459 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -117.0 -19.34 9.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.315 -0.866 . . . . 0.0 112.263 -177.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.732 HD21 ' H ' ' A' ' 35' ' ' THR . 1.0 OUTLIER -126.83 111.13 13.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.72 -1.237 . . . . 0.0 110.464 -179.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -165.66 137.93 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 109.889 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.518 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.5 m -111.01 99.67 8.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mp -89.86 110.36 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -85.99 123.05 30.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.24 115.66 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.999 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 92' ' ' ILE . 2.5 mp -99.32 108.76 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.54 -163.16 24.69 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.24 -16.05 11.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.491 -1.005 . . . . 0.0 110.143 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 19' ' ' HIS . 15.7 tt0 -138.47 145.33 40.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 110.219 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.5 mm -67.91 127.13 93.33 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.55 -0.719 . . . . 0.0 109.426 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -45.94 128.9 11.82 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.851 1.701 . . . . 0.0 111.953 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.5 tp -77.45 -28.21 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.299 -0.876 . . . . 0.0 109.672 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.436 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 14.4 mt 55.21 -109.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 110.145 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.54 -19.17 20.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.728 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.61 -12.35 25.44 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.439 ' H ' ' HG ' ' A' ' 102' ' ' SER . 1.3 p -116.46 -169.3 1.59 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -1.047 . . . . 0.0 109.707 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -110.59 -4.72 28.27 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.412 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 52.7 t-105 -46.98 -39.52 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.738 -0.86 . . . . 0.0 110.421 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -61.25 -51.47 68.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.0 110.07 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -65.48 -43.58 89.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.053 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 10.8 t80 -63.25 -37.34 86.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 109.565 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.412 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 5.3 mm-40 -65.58 -54.85 22.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 0.0 111.898 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.5 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.732 -1.23 . . . . 0.0 111.135 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.13 -45.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -57.41 -29.69 64.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -80.19 -12.97 59.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.148 -0.97 . . . . 0.0 109.887 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -120.76 34.62 5.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.831 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.2 mt -87.47 147.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 110.586 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.43 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -88.69 144.05 26.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.533 ' NE2' ' OE2' ' A' ' 33' ' ' GLU . 9.7 mt-30 -107.27 -160.57 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.796 . . . . 0.0 109.207 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -120.44 3.37 10.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.274 -0.891 . . . . 0.0 110.735 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 151.16 19.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.854 -1.154 . . . . 0.0 109.966 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.5 141.06 29.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -0.941 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.31 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.531 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -90.79 93.14 9.1 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.415 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 51.2 m-85 -66.94 146.92 53.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.797 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -104.62 128.7 52.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.39 142.84 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.96 134.07 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -114.72 -10.74 12.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.35 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.568 ' CD ' ' HZ2' ' A' ' 266' ' ' LYS . 7.1 pt-20 -143.1 144.06 27.3 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.15 148.76 39.91 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.223 1.949 . . . . 0.0 113.031 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.9 tt -139.05 151.59 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.578 -0.701 . . . . 0.0 109.911 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.03 119.76 37.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.321 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.82 117.28 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.03 142.49 35.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.86 . . . . 0.0 108.96 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.85 120.3 3.41 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.605 -1.31 . . . . 0.0 112.298 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 44.97 42.91 6.75 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.0 112.345 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.64 1.94 85.06 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.387 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -102.76 163.88 11.96 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 2.6 tt -160.14 146.49 15.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.357 -1.464 . . . . 0.0 109.276 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.439 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 8.8 mt -145.91 129.7 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.34 139.39 51.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.34 151.57 36.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 108.925 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -150.34 139.52 13.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.0 145.82 97.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.692 1.595 . . . . 0.0 112.14 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.52 153.28 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.1 4.05 32.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.928 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -141.22 151.35 43.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.73 119.04 23.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.858 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -138.69 135.02 34.37 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 5.4 t -133.26 117.67 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 109.826 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.83 133.87 48.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.198 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -122.42 130.25 52.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.623 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -115.67 106.97 14.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.8 134.66 11.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -108.07 85.01 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -1.075 . . . . 0.0 109.232 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -92.12 144.14 25.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -95.96 -1.22 49.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 109.187 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -71.32 -167.77 0.26 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.237 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -60.96 -23.25 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 55.5 mt -71.13 -22.78 62.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.166 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.1 -134.17 52.37 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -98.18 144.36 27.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.462 -1.022 . . . . 0.0 109.005 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -152.46 170.5 19.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.35 153.59 23.75 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.832 . . . . 0.0 109.381 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -138.21 130.31 28.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.447 ' O ' ' CG2' ' A' ' 165' ' ' THR . 14.5 t -102.42 123.13 45.63 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 110.052 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -99.13 134.58 41.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.405 -0.809 . . . . 0.0 108.871 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.89 149.59 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -51.04 116.86 2.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.211 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.18 5.51 17.1 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -134.66 29.97 3.49 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.193 -1.18 . . . . 0.0 108.974 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -64.39 -35.17 80.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.568 -0.708 . . . . 0.0 110.854 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.2 -16.98 37.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.979 -1.076 . . . . 0.0 110.766 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -85.48 -3.71 58.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 110.337 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 174' ' ' ILE . 9.9 pt -124.03 -33.86 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.0 111.411 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -60.97 -29.98 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.479 -1.388 . . . . 0.0 110.424 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -87.48 2.66 49.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.72 -1.238 . . . . 0.0 110.517 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.56 115.19 20.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.873 -1.142 . . . . 0.0 108.957 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -86.48 153.03 22.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.863 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.0 t -59.93 131.35 50.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 109.848 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -109.89 172.62 6.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 109.855 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.573 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.5 OUTLIER -154.78 159.04 40.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.429 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 58.6 m-85 -104.25 144.35 31.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.5 OUTLIER -60.35 -24.36 65.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 110.535 -179.568 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.597 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.5 p90 -82.07 -32.0 30.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.73 -1.231 . . . . 0.0 110.449 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.597 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 18.3 pt-20 -86.55 -16.65 36.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.815 -1.178 . . . . 0.0 109.566 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 11.7 mt -57.57 -53.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.23 -50.74 58.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.775 -1.203 . . . . 0.0 109.738 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -52.73 -48.11 66.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.008 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.9 mt -60.29 -34.31 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.1 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -77.8 -29.37 50.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -21.97 53.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.047 -1.033 . . . . 0.0 110.201 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.1 m -89.15 11.14 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.958 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.04 25.39 69.15 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.773 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.2 mt -124.52 162.98 22.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.119 -1.224 . . . . 0.0 109.87 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 78.32 22.93 66.67 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.189 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -69.43 -21.04 63.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.652 -1.499 . . . . 0.0 109.779 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.0 -2.91 51.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.33 129.3 40.08 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.199 -1.177 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.01 176.81 8.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.783 -0.834 . . . . 0.0 109.257 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.34 -11.97 57.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.937 . . . . 0.0 109.72 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 14.0 tttm -92.96 -4.73 52.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 201' ' ' LYS . 10.1 m120 -134.06 -13.82 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 109.736 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.9 m -128.35 126.29 40.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.1 tp -84.4 110.33 18.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 108.866 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.59 132.15 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.587 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.14 152.72 32.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.82 161.56 15.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -50.65 -24.67 3.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.97 12.61 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.4 ttpt -144.43 152.5 40.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.115 -0.991 . . . . 0.0 110.228 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.98 127.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -73.46 -54.1 9.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 110.275 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -56.0 133.51 74.01 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.981 -1.074 . . . . 0.0 109.723 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.58 -13.06 27.3 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.37 -7.82 57.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.99 . . . . 0.0 109.89 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -167.24 51.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.7 144.3 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 110.097 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.595 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -79.86 -20.82 45.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 108.793 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 37.1 m-85 -148.53 154.91 40.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.59 -12.97 4.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 108.754 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.682 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -143.73 36.69 1.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.261 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.599 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -59.84 -35.43 28.84 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.0 Cg_exo -70.89 -46.2 0.82 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.87 1.713 . . . . 0.0 112.562 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.8 m -73.87 -22.63 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.804 -1.185 . . . . 0.0 108.195 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.682 ' NH1' ' ND2' ' A' ' 221' ' ' ASN . 5.5 mtt180 -69.88 -40.65 75.55 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.5 -42.9 95.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 108.911 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -45.62 80.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.452 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 81.3 t -61.42 -45.12 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.554 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.4 t80 -53.77 -36.68 62.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -75.02 -40.05 60.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.632 -0.667 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 27.0 tp -56.32 -37.73 70.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.208 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.489 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 85.3 mt -71.6 -48.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.6 -31.86 23.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -82.98 -26.63 31.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.941 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.3 mt -79.39 -23.58 43.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.883 -1.136 . . . . 0.0 110.2 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.466 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 7.0 t80 -70.43 -6.43 35.65 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.033 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.3 mt -53.34 -28.76 30.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.18 -18.06 23.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.0 108.73 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.96 70.64 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.5 p -156.29 150.76 20.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.118 -1.225 . . . . 0.0 109.357 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.84 136.48 59.59 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.092 1.862 . . . . 0.0 111.572 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.4 t -102.24 138.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.221 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.415 ' NZ ' ' CD2' ' A' ' 123' ' ' TYR . 8.6 mttp -125.61 128.42 47.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.768 . . . . 0.0 109.078 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.4 175.99 28.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -106.55 109.68 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.172 . . . . 0.0 109.732 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.0 m-85 -111.41 149.3 31.42 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.771 0.796 . . . . 0.0 110.835 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -126.26 144.43 50.79 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.58 125.55 24.3 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 120.751 -1.218 . . . . 0.0 110.232 -178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 250' ' ' ARG . 26.8 t80 -112.74 111.86 22.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 249' ' ' PHE . 26.5 mtp180 47.54 56.54 6.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.22 149.29 21.93 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.49 -174.6 15.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.43 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 71.1 m-70 -74.45 -42.41 59.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -1.144 . . . . 0.0 109.687 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.416 ' OG ' ' OG1' ' A' ' 56' ' ' THR . 0.2 OUTLIER -64.18 -34.92 79.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.157 -179.549 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 49.8 tp -72.76 -39.22 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.927 -1.108 . . . . 0.0 109.059 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -60.58 -50.6 72.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.298 -0.876 . . . . 0.0 108.897 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.23 -45.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -55.29 -48.87 73.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.134 -0.979 . . . . 0.0 109.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 27.0 tp -52.61 -43.76 65.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 108.921 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.96 -40.71 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -59.53 -50.13 75.08 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 110.132 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.0 -43.91 73.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.175 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 30.0 mt -57.35 -48.8 78.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -55.82 -44.27 77.73 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.608 -0.683 . . . . 0.0 109.664 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -72.65 -34.13 67.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 0.0 109.457 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.568 ' HZ2' ' CD ' ' A' ' 128' ' ' GLU . 20.5 mttm -62.77 -41.15 99.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.276 -0.89 . . . . 0.0 109.129 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 266' ' ' LYS . 0.5 OUTLIER -40.32 -40.16 1.1 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.708 -0.62 . . . . 0.0 110.893 -179.271 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -102.33 29.32 5.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.837 -1.165 . . . . 0.0 110.816 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.5 mt -105.49 26.12 9.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.197 -0.939 . . . . 0.0 109.42 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.917 . . . . 0.0 109.353 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.573 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 31.0 mt-10 -49.28 142.12 7.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 109.128 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 133.9 55.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 110.102 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -138.33 175.42 9.59 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.42 141.18 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.203 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -72.55 -44.24 62.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.51 -0.744 . . . . 0.0 110.055 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.95 160.16 35.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.738 . . . . 0.0 110.225 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 130.31 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.585 -0.697 . . . . 0.0 109.984 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.0 mt -114.95 169.81 8.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -0.783 . . . . 0.0 108.998 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -157.98 148.15 20.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.956 -1.09 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -129.69 168.0 17.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -154.93 135.05 13.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 109.182 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.79 158.23 15.41 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.502 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 8.9 p -80.95 141.52 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -1.094 . . . . 0.0 110.749 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.68 148.4 41.73 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -70.02 -40.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.0 113.043 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.401 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.0 m-70 -86.04 -38.58 17.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 119.79 -1.819 . . . . 0.0 111.858 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.462 ' OG1' ' CG ' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -85.84 -27.21 25.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.713 -1.242 . . . . 0.0 109.157 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 63.79 25.49 69.16 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -106.26 148.96 27.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.506 -0.996 . . . . 0.0 109.182 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -70.78 129.89 40.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.741 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.5 t -138.9 156.98 46.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.915 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -133.22 153.48 51.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 109.206 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mt -127.84 147.66 50.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.428 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.9 mt -137.91 122.41 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -112.13 127.4 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.554 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 2.4 m-70 -119.98 148.8 47.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.94 161.64 15.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.015 1.81 . . . . 0.0 111.096 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 5.7 mm-40 -135.02 -172.27 3.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -90.69 155.41 18.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.738 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.587 ' OE1' ' N ' ' A' ' 33' ' ' GLU . 40.3 mp0 -46.78 142.68 3.2 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.59 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.69 29.89 64.91 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.372 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 25.9 m -80.66 -37.56 30.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.631 -1.511 . . . . 0.0 108.67 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.03 -177.54 35.37 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.6 mm -100.85 124.67 54.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.02 140.09 36.13 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.311 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.11 150.01 20.71 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.487 ' CD1' ' OE1' ' A' ' 90' ' ' GLU . 16.7 t80 -134.36 139.91 45.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.36 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 16.7 ttpt -174.02 147.33 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.642 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.6 29.45 15.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.8 73.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -135.97 143.01 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 0.0 109.352 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -101.45 146.03 28.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.51 94.55 10.56 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.017 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -48.93 145.0 14.24 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.337 2.025 . . . . 0.0 111.854 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.97 81.28 5.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.92 -1.112 . . . . 0.0 110.463 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.68 155.46 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.026 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.2 p80 -52.22 -49.38 64.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.917 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 11.3 mt-10 -44.0 -16.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.197 -0.939 . . . . 0.0 110.164 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.8 m-85 -97.45 2.9 50.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.402 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.1 t -62.83 119.37 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.059 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.56 -29.36 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.855 . . . . 0.0 109.986 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 3.0 t-160 -150.82 120.82 7.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.962 . . . . 0.0 109.652 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.2 p -111.94 133.04 54.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 16.1 p-10 -166.61 -153.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' ASN . 5.2 m170 -47.47 -11.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.118 -0.989 . . . . 0.0 108.694 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -139.22 166.49 24.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.5 m -101.38 120.69 40.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.52 134.97 54.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.189 -0.945 . . . . 0.0 111.238 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 29.6 mt -123.69 156.5 35.8 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.73 145.44 7.96 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.028 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -144.67 151.5 39.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.539 -0.977 . . . . 0.0 109.891 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 55.47 24.02 6.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -0.834 . . . . 0.0 110.894 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.71 1.23 68.36 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.557 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.494 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 29.9 mm100 -96.59 137.46 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.889 -1.36 . . . . 0.0 108.299 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -130.76 144.62 51.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.23 -0.919 . . . . 0.0 111.358 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.2 mt -130.81 140.22 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -114.13 145.64 41.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 56.06 68.82 0.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.785 -0.572 . . . . 0.0 111.46 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.92 -3.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.097 -1.002 . . . . 0.0 108.99 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.491 ' OE1' ' OD1' ' A' ' 234' ' ' ASP . 10.8 pt-20 -69.45 -33.05 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.456 ' CE1' ' CE1' ' A' ' 226' ' ' HIS . 17.6 m170 -61.9 -59.9 4.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 110.099 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.9 tp -55.47 -41.73 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.669 -1.269 . . . . 0.0 108.515 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.403 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 70.3 mt -60.68 -35.05 75.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.478 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 47.1 t -61.04 -49.25 78.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 t -58.52 -52.81 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.03 -1.044 . . . . 0.0 108.594 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.6 mt -50.77 -43.11 58.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 108.999 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.546 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.0 t-160 -54.28 -56.19 20.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.578 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.35 -36.7 76.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.963 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.2 mt -79.31 -9.38 59.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.14 61.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.431 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.485 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 12.2 mm -102.38 132.29 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 48.4 p -118.82 -22.54 7.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.264 -0.897 . . . . 0.0 111.889 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.587 ' ND2' ' OG1' ' A' ' 85' ' ' THR . 1.4 m-80 -129.39 111.69 13.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.279 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.5 m -164.86 135.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.868 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.48 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 44.1 m -103.28 99.66 9.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 mt -86.82 120.94 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.89 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' OE1' ' CD1' ' A' ' 40' ' ' PHE . 7.8 mt-10 -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.813 -1.179 . . . . 0.0 108.1 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' ' CD ' ' A' ' 41' ' ' LYS . 60.0 t -105.63 107.22 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.101 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.63 109.14 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.58 -160.25 23.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.24 -15.9 7.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -1.008 . . . . 0.0 110.415 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.5 pm0 -131.94 137.6 48.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.22 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mm -68.75 129.6 92.34 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 109.768 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -46.83 129.07 14.13 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.407 2.072 . . . . 0.0 112.782 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.6 tp -76.93 -25.93 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.221 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.448 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 70.6 mt 55.33 -116.07 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.45 -0.781 . . . . 0.0 109.988 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.03 -18.09 22.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.115 -0.991 . . . . 0.0 110.13 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 -16.74 19.1 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.449 ' HG ' ' N ' ' A' ' 103' ' ' GLY . 8.5 p -108.33 -169.72 1.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -1.098 . . . . 0.0 109.516 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.449 ' N ' ' HG ' ' A' ' 102' ' ' SER . . . -114.97 -3.94 21.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.469 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 64.9 t-105 -46.68 -39.18 10.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.785 -0.832 . . . . 0.0 110.418 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.06 -51.75 66.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 109.728 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 62.5 m-85 -62.61 -45.92 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.828 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.01 -37.41 84.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.693 -0.629 . . . . 0.0 110.097 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.1 mm-40 -69.91 -48.81 57.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.313 -0.867 . . . . 0.0 111.773 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.29 -51.27 13.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.793 -1.192 . . . . 0.0 111.273 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.5 mt -62.81 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.984 -1.073 . . . . 0.0 110.875 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.18 -29.89 61.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 0.0 110.194 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.66 -13.59 56.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.064 -1.023 . . . . 0.0 110.08 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -118.0 32.2 6.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.44 -0.787 . . . . 0.0 111.206 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.6 mt -86.57 148.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.534 -1.354 . . . . 0.0 110.029 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.1 tp -131.26 158.17 41.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -103.09 142.01 34.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.62 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -109.08 -167.09 1.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 110.104 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -118.75 69.05 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.407 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 4' ' ' GLU . 23.4 ttt85 -165.78 143.91 5.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -83.84 128.8 34.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 79.0 mt -71.09 140.69 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.0 86.7 7.15 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -61.83 146.06 50.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 110.769 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.77 121.83 42.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.72 138.63 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.8 t -81.81 139.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.25 -10.57 8.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.441 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -141.12 125.61 10.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.141 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -51.12 154.33 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.007 1.804 . . . . 0.0 113.124 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.4 tt -145.49 146.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.649 -0.657 . . . . 0.0 109.638 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.55 119.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.66 120.49 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.257 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -123.0 142.07 51.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 110.517 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 1.5 t70 178.03 153.32 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 58.6 mm-40 56.37 23.55 7.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.868 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.05 7.76 86.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 69.7 mtt180 -105.16 168.6 8.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 7.0 tt -160.78 152.42 19.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.117 -1.614 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.505 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 17.9 mt -148.78 142.53 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.036 . . . . 0.0 108.74 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -130.0 137.52 50.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 0.0 109.598 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.98 151.67 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -150.05 137.22 11.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.53 144.97 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.189 1.259 . . . . 0.0 111.964 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.29 149.84 10.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.336 -0.852 . . . . 0.0 109.369 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.46 -0.33 52.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.268 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.4 p -133.29 142.77 48.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.4 tp -78.5 119.64 22.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.764 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -139.43 139.58 37.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.862 . . . . 0.0 108.77 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.9 t -137.86 122.68 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.169 -0.957 . . . . 0.0 109.543 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 99.8 m -111.37 141.11 45.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.951 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -125.56 130.27 51.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.611 -0.68 . . . . 0.0 109.896 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 16.6 tt0 -113.17 107.39 15.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.44 ' C ' ' OE2' ' A' ' 154' ' ' GLU . . . -107.14 131.37 10.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.547 ' H ' HH11 ' A' ' 250' ' ' ARG . 0.9 OUTLIER -117.8 88.25 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -1.004 . . . . 0.0 109.053 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 3.6 m-30 -85.98 148.67 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.112 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -87.25 -10.49 52.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.687 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.422 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 17.8 p-10 -66.18 -167.01 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -64.97 -23.08 67.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.403 HD13 HD22 ' A' ' 157' ' ' ASN . 9.3 mt -56.74 -50.45 72.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.997 -1.065 . . . . 0.0 109.188 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.93 -121.78 6.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 140.2 50.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.534 -0.98 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -153.15 131.66 12.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.839 . . . . 0.0 109.467 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 149.67 39.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.544 -0.722 . . . . 0.0 109.163 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -134.83 121.07 20.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.086 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 10.1 t -100.9 123.1 44.6 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.14 -0.975 . . . . 0.0 110.199 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.0 t80 -100.88 134.43 43.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 108.852 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.469 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.3 t -130.88 149.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.507 -0.746 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.69 122.68 10.38 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.55 -14.95 17.59 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.93 32.3 6.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 108.555 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.76 -34.33 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 110.474 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.9 -15.36 8.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 110.691 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.596 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 13.7 mm-40 -91.07 -4.01 56.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 110.823 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -125.0 10.22 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.945 -1.097 . . . . 0.0 111.199 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -27.99 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.853 -1.154 . . . . 0.0 109.604 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -88.5 3.72 49.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.082 . . . . 0.0 110.638 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.97 123.01 27.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.808 -1.182 . . . . 0.0 109.018 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -95.56 155.42 16.75 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.12 -0.987 . . . . 0.0 110.23 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 t -56.34 155.31 7.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.784 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.526 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 26.4 p90 -139.66 168.29 20.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.047 -1.033 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.526 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -162.7 162.27 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -102.82 147.55 26.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -64.27 -19.53 65.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.933 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.496 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 2.8 p90 -81.79 -26.01 34.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.67 -1.269 . . . . 0.0 110.449 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.415 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 25.9 pt-20 -96.8 -17.29 20.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.926 -1.109 . . . . 0.0 109.36 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 9.5 mt -56.86 -51.41 68.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.47 -0.769 . . . . 0.0 110.326 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -51.21 -52.26 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.995 -1.066 . . . . 0.0 109.553 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.509 ' HD1' ' H ' ' A' ' 188' ' ' HIS . 7.6 m80 -52.94 -45.03 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.107 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.37 -33.71 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 109.025 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -78.82 -25.7 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.894 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -80.73 -26.68 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.06 7.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.721 -179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 83.76 20.18 60.22 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.139 -0.976 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.63 163.93 20.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.055 -1.262 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.77 17.83 74.28 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.063 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -66.32 -22.18 66.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.695 -1.473 . . . . 0.0 110.279 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.31 -5.87 51.79 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.38 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.47 124.66 35.35 Favored Glycine 0 N--CA 1.491 2.366 0 O-C-N 121.055 -1.262 . . . . 0.0 110.697 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.0 p -135.44 171.94 13.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.718 -0.872 . . . . 0.0 109.204 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.1 mt -76.48 -13.74 60.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 16.9 tttp -89.05 -8.55 53.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.672 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 37.1 m-20 -141.12 12.83 2.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.5 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 8.2 m -148.99 117.75 6.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 109.564 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.3 tp -79.89 115.38 19.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -0.979 . . . . 0.0 109.185 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.3 t -100.61 125.3 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 mt -103.43 147.05 27.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.28 148.4 16.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 207' ' ' GLY . 51.9 mttm -42.32 -29.66 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -1.191 . . . . 0.0 110.045 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -147.34 11.97 1.03 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.0 110.57 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.5 tttp -147.44 156.69 43.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.023 . . . . 0.0 109.998 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.11 128.25 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.5 -54.28 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.46 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -55.02 137.16 66.63 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.002 -1.062 . . . . 0.0 109.577 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.16 -19.04 26.57 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.346 2.031 . . . . 0.0 112.545 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 109.927 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.61 -165.74 53.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 26.5 mt -79.13 145.05 33.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -1.089 . . . . 0.0 109.639 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -71.49 -57.41 4.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 108.877 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.687 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 13.1 m-85 -117.05 148.85 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.462 -0.774 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.09 -13.98 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.933 . . . . 0.0 109.164 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -132.84 38.77 3.37 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.868 0.842 . . . . 0.0 108.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.48 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.6 tp10 -57.34 -48.48 97.27 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 111.265 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 33.3 Cg_endo -69.47 -37.95 9.12 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.525 1.483 . . . . 0.0 113.218 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.8 m -79.39 -25.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.609 -1.307 . . . . 0.0 108.506 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 16.4 mtp180 -67.72 -43.75 79.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.542 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 56.2 t60 -62.86 -41.59 99.44 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -43.23 81.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 108.779 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.8 -47.54 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 42.5 t80 -49.86 -47.54 51.69 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' CD2' ' A' ' 226' ' ' HIS . 2.8 m-20 -70.61 -35.19 72.83 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.435 ' CD2' ' HG ' ' A' ' 248' ' ' SER . 21.1 tp -55.55 -35.97 66.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 108.41 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 74.4 mt -70.15 -48.16 63.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.03 -34.44 16.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.503 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 6.1 m-20 -80.58 -27.08 37.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.993 -1.298 . . . . 0.0 109.665 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -82.54 -26.31 32.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.111 . . . . 0.0 109.593 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.546 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 21.7 t80 -67.14 -7.69 25.32 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.985 . . . . 0.0 108.635 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 39.3 mt -50.24 -30.05 10.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.79 -19.88 19.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 108.712 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.83 16.29 73.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 83.1 p -158.79 145.16 12.57 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.991 -1.3 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -41.06 129.49 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.343 2.029 . . . . 0.0 111.924 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 81.9 t -97.11 130.51 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.725 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -117.91 123.09 44.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 172.58 24.86 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.26 112.19 25.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.177 -1.19 . . . . 0.0 109.95 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.2 m-85 -112.22 147.58 35.9 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.989 0.9 . . . . 0.0 110.931 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -131.85 134.71 46.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.435 ' HG ' ' CD2' ' A' ' 231' ' ' LEU . 0.2 OUTLIER -129.17 128.9 44.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.86 -1.15 . . . . 0.0 110.218 -178.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 250' ' ' ARG . 6.6 t80 -112.01 115.17 28.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.547 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.2 mmp_? 48.28 56.28 7.64 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.55 152.54 20.88 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -119.49 -169.9 14.37 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.478 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 89.5 m-70 -78.9 -49.59 12.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.256 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -33.93 71.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 42.6 tp -72.89 -40.0 65.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 108.612 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 88.2 m-20 -60.0 -51.24 70.52 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.31 -43.89 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.41 -0.806 . . . . 0.0 109.148 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -54.4 -47.68 72.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.041 . . . . 0.0 108.832 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.12 -46.35 72.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.3 -44.92 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 109.413 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -51.69 -51.71 53.88 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 110.161 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.57 -49.5 76.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.102 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.94 -42.55 98.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.489 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.4 84.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.336 -0.853 . . . . 0.0 109.858 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -76.15 -31.66 58.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.944 -1.098 . . . . 0.0 108.755 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 268' ' ' LYS . 20.1 mttp -62.96 -45.44 92.43 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.436 -0.79 . . . . 0.0 108.941 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.436 ' C ' ' H ' ' A' ' 269' ' ' LEU . 2.2 tp-100 -74.95 10.27 1.54 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.35 -0.844 . . . . 0.0 109.475 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 266' ' ' LYS . 0.6 OUTLIER -60.93 -7.09 2.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 108.88 179.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.436 ' H ' ' C ' ' A' ' 267' ' ' GLN . 18.2 mt -75.47 -59.63 2.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.414 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.464 -0.772 . . . . 0.0 109.421 179.902 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.43 ' OXH' ' OE2' ' A' ' 73' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 4' ' ' GLU . 7.5 mt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.583 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -45.11 127.94 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.992 -1.068 . . . . 0.0 109.237 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 132.82 55.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -133.6 174.41 10.46 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -83.26 132.3 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.343 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -62.32 -49.21 76.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.541 -0.724 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -126.12 155.58 41.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.548 -0.72 . . . . 0.0 110.42 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -59.53 137.57 57.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.957 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.96 162.16 19.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.56 145.68 25.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.979 -1.075 . . . . 0.0 109.971 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' C ' ' OE1' ' A' ' 14' ' ' GLU . 67.3 m-85 -128.96 161.43 29.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.752 . . . . 0.0 109.158 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 13' ' ' PHE . 4.3 pm0 -151.47 132.47 14.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.871 -1.143 . . . . 0.0 108.73 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.01 157.69 15.44 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.015 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.48 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 3.3 p -74.32 160.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -1.133 . . . . 0.0 111.317 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.05 138.69 14.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.101 -1.235 . . . . 0.0 112.236 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.408 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.2 m-70 -86.57 -37.36 18.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.103 -1.623 . . . . 0.0 110.729 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -76.22 -40.11 52.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.012 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 73.42 4.72 65.46 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.41 152.4 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.37 -1.076 . . . . 0.0 108.985 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 16.0 t80 -73.6 133.49 43.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.01 . . . . 0.0 110.141 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.574 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 18.4 t -137.47 157.82 45.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.175 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' N ' ' HG ' ' A' ' 24' ' ' SER . 9.7 ttmt -132.8 155.7 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.305 -0.872 . . . . 0.0 109.136 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mt -132.17 144.19 50.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.4 mt -134.57 123.35 41.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mt -111.73 127.58 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 109.811 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -119.63 152.67 53.63 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.66 157.8 40.38 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.275 1.983 . . . . 0.0 111.474 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.499 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.2 mm-40 -131.84 -173.15 3.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.233 -0.917 . . . . 0.0 109.832 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.506 ' O ' ' OG1' ' A' ' 35' ' ' THR . 9.5 tttt -91.66 153.77 19.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.587 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 28.1 mp0 -47.99 146.25 2.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.03 59.97 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.685 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.552 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 55.2 m -81.59 -36.96 28.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.516 -1.579 . . . . 0.0 108.875 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.483 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 92.47 -170.24 32.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 mm -100.73 124.2 54.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.26 143.17 44.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -104.26 153.25 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.55 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.8 t80 -129.48 140.79 51.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 136.42 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.021 -1.05 . . . . 0.0 109.681 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.57 29.2 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.891 . . . . 0.0 110.097 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.54 78.51 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.218 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.31 134.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -1.117 . . . . 0.0 109.74 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -86.25 147.59 26.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.5 mt -143.1 94.66 6.28 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.82 142.72 14.22 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.191 1.927 . . . . 0.0 111.848 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.54 87.42 4.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.066 -1.021 . . . . 0.0 110.345 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.51 159.24 42.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 109.418 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.6 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 3.3 p80 -53.3 -49.68 66.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -48.28 -16.14 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.048 -1.033 . . . . 0.0 110.224 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' HIS . 32.8 m-85 -97.45 5.77 49.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 109.597 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.7 t -64.2 122.71 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.861 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 m -112.61 -29.53 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -146.36 118.17 8.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.867 -1.146 . . . . 0.0 110.354 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -110.88 126.97 55.26 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 40.3 t-20 -166.36 -153.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.533 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 63.6 m-70 -46.69 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.053 . . . . 0.0 108.499 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.4 t -139.18 165.84 26.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.499 -0.751 . . . . 0.0 109.327 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.46 ' OG1' ' CD ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -108.82 125.34 51.86 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.89 146.33 49.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.04 0.924 . . . . 0.0 111.397 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.6 mt -125.92 156.33 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -175.36 147.57 8.96 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 118.203 -1.951 . . . . 0.0 111.446 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -144.48 149.5 36.07 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.773 -0.84 . . . . 0.0 109.282 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.99 32.54 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.322 -0.861 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.82 6.82 89.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.614 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.462 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 86.8 mm-40 -106.63 140.17 39.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -1.227 . . . . 0.0 107.886 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -143.22 159.74 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.031 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.26 139.55 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -108.52 148.09 30.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 0.0 111.243 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m 56.53 70.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.691 -0.63 . . . . 0.0 111.16 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.7 -4.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.022 . . . . 0.0 109.169 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.602 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.0 OUTLIER -68.19 -33.15 73.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 0.0 110.838 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.572 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 35.2 m170 -64.13 -60.25 3.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.845 -1.159 . . . . 0.0 109.988 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.472 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 11.3 tp -55.92 -45.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.853 -1.155 . . . . 0.0 108.751 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.472 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 47.1 mt -54.71 -40.92 69.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.551 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.608 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.0 t -59.61 -46.92 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -58.52 -50.84 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.2 mt -51.32 -44.13 61.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.845 . . . . 0.0 109.471 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.503 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 12.1 t-160 -56.89 -49.93 74.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 110.363 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.78 -38.02 89.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.4 mt -81.58 -5.59 58.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.0 111.025 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 62.74 59.09 1.47 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.299 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 84' ' ' ILE . 10.6 mm -98.24 125.18 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.468 ' H ' ' HG1' ' A' ' 85' ' ' THR . 0.8 OUTLIER -110.97 -23.09 11.17 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.299 -0.876 . . . . 0.0 111.394 -178.042 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 35' ' ' THR . 3.4 m120 -131.19 112.17 12.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -162.01 138.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.326 -0.859 . . . . 0.0 109.404 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 26.5 m -111.17 99.42 8.27 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.75 112.74 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.396 -0.815 . . . . 0.0 109.536 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -90.29 119.83 30.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.2 t -102.84 106.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 110.936 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.417 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.4 mp -86.75 109.79 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.78 -158.65 22.32 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.13 -14.27 7.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.966 . . . . 0.0 110.137 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -134.86 140.18 45.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 110.452 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.35 126.95 93.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_exo -46.36 128.52 12.39 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.865 1.71 . . . . 0.0 112.003 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 tp -76.24 -22.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.807 . . . . 0.0 109.724 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 73.5 mt 54.84 -118.36 1.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -94.3 -11.03 30.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 110.225 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.04 32.53 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.4 p -115.51 -169.47 1.58 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -1.039 . . . . 0.0 109.785 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.56 0.62 24.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.575 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 67.5 t-105 -46.52 -44.25 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.737 -0.861 . . . . 0.0 110.584 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -60.21 -51.36 69.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.785 -1.197 . . . . 0.0 109.719 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -61.18 -45.64 93.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 109.154 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -60.56 -39.92 89.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.962 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -74.24 -42.93 58.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 111.43 -179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.9 35.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.871 -1.143 . . . . 0.0 110.883 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.96 -39.57 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.991 -1.068 . . . . 0.0 110.853 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -56.11 -31.42 63.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.801 -1.187 . . . . 0.0 109.745 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -83.97 -5.29 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 0.0 110.221 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -126.62 31.37 5.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.423 -0.798 . . . . 0.0 111.309 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.7 mt -89.2 145.53 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.474 -1.391 . . . . 0.0 109.601 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.6 tp -131.97 158.64 40.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -106.96 145.5 32.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.113 -0.992 . . . . 0.0 109.525 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -112.39 -163.82 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 109.989 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -118.1 69.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 110.438 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.489 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -161.58 140.69 9.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -81.56 126.4 31.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.07 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.7 mt -73.48 143.0 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 110.55 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -92.9 97.26 10.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.7 146.53 52.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.63 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -99.76 123.53 44.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.5 140.88 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.302 -0.874 . . . . 0.0 110.303 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 51.0 t -83.93 137.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.134 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -116.05 -11.55 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.524 -0.735 . . . . 0.0 109.252 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.05 144.92 39.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.12 172.75 14.12 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.266 1.977 . . . . 0.0 112.814 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -165.24 142.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.619 -0.676 . . . . 0.0 109.53 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.1 mt -127.99 126.86 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 109.555 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.29 119.03 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.772 . . . . 0.0 109.679 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -117.42 138.23 51.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.364 -0.835 . . . . 0.0 109.7 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -172.1 142.69 1.44 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.001 -1.062 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 56.1 28.25 12.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.612 -0.68 . . . . 0.0 111.187 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.53 86.95 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 251' ' ' GLY . 6.7 mtt85 -104.68 168.05 9.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -160.66 149.55 16.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.066 -1.646 . . . . 0.0 109.459 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.499 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 56.0 mt -149.39 136.11 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.02 -1.05 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -126.28 142.74 51.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.68 145.63 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -142.78 136.62 14.47 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.94 146.95 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.552 1.501 . . . . 0.0 112.142 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.72 152.76 8.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.171 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.4 1.75 47.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 109.642 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.4 p -137.44 145.21 42.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.584 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.2 tp -79.09 116.81 19.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.938 . . . . 0.0 109.678 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -137.62 135.95 37.06 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 95.8 t -136.85 127.02 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 109.758 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 m -114.13 128.45 56.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.365 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -115.3 129.42 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.52 -0.738 . . . . 0.0 109.365 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -115.27 105.62 13.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.86 132.88 11.39 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -115.37 84.12 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.992 . . . . 0.0 108.977 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.503 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 2.9 m-30 -93.14 148.78 21.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.668 ' HZ2' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -85.18 -13.28 50.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.239 -179.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 159' ' ' LEU . 9.4 p-10 -66.18 -175.23 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.054 -1.029 . . . . 0.0 109.633 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -55.02 -18.37 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.696 ' H ' ' ND2' ' A' ' 157' ' ' ASN . 20.4 mt -66.79 -32.31 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.954 -1.091 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.5 -118.08 12.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -115.11 138.95 50.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.987 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -150.14 153.48 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 150.88 41.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -134.84 124.17 24.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 m -96.96 121.9 39.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.98 -1.075 . . . . 0.0 110.015 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -98.81 135.07 40.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.141 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.55 150.7 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 0.0 109.475 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -53.02 117.05 2.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.394 -0.817 . . . . 0.0 109.248 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.51 5.62 18.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -132.19 27.73 4.47 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.212 -1.17 . . . . 0.0 108.57 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 2.8 mp0 -64.84 -31.44 72.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.533 -0.73 . . . . 0.0 110.572 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.3 -15.82 39.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.993 -1.067 . . . . 0.0 110.907 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -91.52 -4.28 55.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.694 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.64 16.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.088 -1.007 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.48 -34.29 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.021 -1.049 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.7 2.44 45.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.379 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.99 112.96 18.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.788 -1.195 . . . . 0.0 108.94 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 100' ' ' ASP . 5.8 ptp180 -85.9 152.93 22.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.574 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.4 t -53.98 159.02 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.328 -0.857 . . . . 0.0 109.227 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.3 p90 -139.94 168.09 20.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.019 -1.05 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.521 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -156.72 160.0 38.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.15 -0.969 . . . . 0.0 109.749 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.59 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 93.8 m-85 -103.47 146.6 28.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 0.0 109.746 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -59.99 -24.27 64.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.109 -0.994 . . . . 0.0 110.884 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.1 p90 -80.44 -28.78 37.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.748 -1.22 . . . . 0.0 110.682 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 22.4 pt-20 -93.6 -13.84 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 8.9 mt -59.32 -53.74 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.83 -38.03 54.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.815 -1.178 . . . . 0.0 109.212 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -61.17 -59.33 5.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.25 -0.906 . . . . 0.0 108.938 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.5 mt -53.76 -33.19 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -75.0 -25.36 58.76 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -83.1 -31.68 27.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.165 -0.96 . . . . 0.0 111.028 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.97 12.54 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.606 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.65 58.32 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.168 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 5.1 mt -127.09 165.34 19.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.063 -1.257 . . . . 0.0 110.16 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.14 23.0 64.34 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.238 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -68.58 -22.32 64.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.599 -1.53 . . . . 0.0 109.504 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -5.65 50.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.31 126.86 36.7 Favored Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.124 -1.221 . . . . 0.0 110.837 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.78 -173.53 3.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.82 -0.812 . . . . 0.0 109.202 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 29.4 mt -90.18 -12.8 37.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.657 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -89.5 -3.47 58.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -145.12 13.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.696 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.433 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 0.8 OUTLIER -149.26 117.48 6.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.609 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 8.3 tp -79.0 115.72 18.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.68 123.99 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 18.0 mt -103.1 149.21 24.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.89 153.5 17.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -48.35 -24.96 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -1.203 . . . . 0.0 109.891 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.87 13.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 110.208 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 207' ' ' GLY . 13.5 pttt -149.62 159.7 44.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.958 -1.089 . . . . 0.0 109.734 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 46.2 t -107.45 130.39 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.205 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -73.13 -53.04 12.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.492 HD21 ' H ' ' A' ' 213' ' ' ASN . 2.0 m-80 -54.09 139.74 53.89 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 109.557 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.14 -31.71 11.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.476 2.117 . . . . 0.0 112.796 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.43 -9.91 59.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.135 -0.978 . . . . 0.0 110.185 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.33 -164.49 53.83 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 22.4 mt -73.6 141.59 46.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 0.0 109.847 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 15.8 mtt180 -81.81 -13.87 57.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 108.956 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.558 ' C ' ' H ' ' A' ' 221' ' ' ASN . 38.5 m-85 -147.8 142.25 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -0.782 . . . . 0.0 109.125 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.473 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 2.0 mm-40 -49.66 -11.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.038 . . . . 0.0 108.398 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -141.88 43.49 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.073 0.94 . . . . 0.0 108.803 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.1 tt0 -62.89 -36.87 28.45 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 0.0 111.928 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.4 Cg_endo -76.72 -41.07 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.398 1.398 . . . . 0.0 112.521 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 4.0 m -75.82 -23.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.869 -1.144 . . . . 0.0 108.231 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -70.36 -46.71 63.55 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.574 ' CE1' ' N ' ' A' ' 179' ' ' THR . 22.5 t60 -58.06 -42.4 85.41 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 108.91 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.68 -43.33 94.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.018 -1.052 . . . . 0.0 109.0 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 52.3 t -60.1 -47.03 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 108.745 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.608 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 47.4 t80 -49.79 -45.2 49.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.742 -0.599 . . . . 0.0 109.513 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 5.9 m-20 -73.82 -33.48 64.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 22.4 tp -56.68 -39.17 73.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 0.0 108.679 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.405 HG23 ' HD1' ' A' ' 80' ' ' HIS . 36.1 mt -71.27 -47.97 57.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.07 -32.87 9.63 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -82.28 -26.81 32.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.199 -1.177 . . . . 0.0 109.798 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.22 -23.58 32.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.851 -1.156 . . . . 0.0 109.908 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.503 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 35.0 t80 -73.52 -9.03 58.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -51.16 -25.95 6.07 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 108.589 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.3 -17.81 5.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.61 13.94 74.55 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 71.9 p -158.79 145.93 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.935 -1.332 . . . . 0.0 110.009 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -41.96 135.36 3.8 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.229 1.953 . . . . 0.0 111.655 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.5 t -103.77 132.77 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.9 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -121.05 125.51 47.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.63 179.47 32.56 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -105.37 138.98 40.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.336 -1.097 . . . . 0.0 109.737 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.7 m-85 -140.67 144.59 35.76 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.066 0.936 . . . . 0.0 111.298 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -129.27 144.23 51.15 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 127.84 20.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.643 -1.286 . . . . 0.0 110.745 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -112.83 114.67 27.31 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 51.18 55.67 9.15 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.468 ' O ' ' NE ' ' A' ' 137' ' ' ARG . . . -63.39 -167.74 0.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -169.59 165.52 38.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.602 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 21.2 m-70 -70.91 -52.32 20.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -1.18 . . . . 0.0 109.68 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -54.32 47.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 108.703 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 48.8 tp -51.45 -40.83 60.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -58.57 -55.19 38.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -0.98 . . . . 0.0 108.592 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 61.7 t -48.94 -42.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.517 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -50.0 71.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.8 tp -52.16 -43.2 63.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.684 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 46.2 t -69.83 -46.2 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.364 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.15 -51.5 64.08 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.652 -0.655 . . . . 0.0 110.147 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.62 -45.43 86.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.013 -1.054 . . . . 0.0 109.571 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 16.5 mt -58.69 -46.91 86.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.745 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.16 -30.12 68.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.79 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -88.86 -23.38 22.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.602 -1.311 . . . . 0.0 108.856 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -75.66 -45.97 34.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.436 -0.79 . . . . 0.0 109.745 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -84.15 7.65 18.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.895 . . . . 0.0 109.979 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.626 ' NZ ' ' CB ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -76.46 1.83 15.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.56 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.77 -75.1 0.27 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.146 -0.971 . . . . 0.0 109.357 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.338 -0.851 . . . . 0.0 109.459 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.374 0.606 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.575 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 9.8 mm-40 -52.33 134.77 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -117.34 132.51 56.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 0.0 109.369 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -134.16 173.71 11.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.373 -0.829 . . . . 0.0 109.106 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -81.78 144.36 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.173 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.2 ttpp -78.37 -42.36 30.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.711 . . . . 0.0 110.379 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.92 157.82 43.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' C ' ' CD ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -63.39 133.87 54.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.518 -0.739 . . . . 0.0 109.849 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.4 mt -121.04 163.22 18.66 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.441 ' HG ' ' HZ3' ' A' ' 10' ' ' LYS . 2.5 p -155.31 149.38 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 110.319 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -128.84 164.76 22.36 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -148.28 133.04 17.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 108.573 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.38 163.38 23.32 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.74 149.22 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 148.4 39.65 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -67.06 -41.28 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -1.184 . . . . 0.0 112.58 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 4.6 m-70 -86.93 -39.24 15.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.889 -1.757 . . . . 0.0 111.114 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -31.67 64.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.018 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.83 21.22 65.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.96 151.55 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.65 -0.912 . . . . 0.0 109.338 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -72.4 142.96 48.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 2.1 t -148.2 158.52 44.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -133.42 152.85 51.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.009 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mt -127.81 153.71 46.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.37 128.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.28 124.68 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.163 -0.961 . . . . 0.0 109.699 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -123.62 153.53 66.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.86 163.5 35.25 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.177 1.918 . . . . 0.0 111.171 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 30.2 mm-40 -138.81 -171.81 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.9 ttpm? -88.83 150.54 22.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.478 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 15.5 mp0 -49.34 149.91 2.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.537 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 59.69 23.66 58.92 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.431 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 28.9 m -81.8 -46.3 14.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.498 -1.589 . . . . 0.0 109.214 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.507 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 103.19 -170.63 19.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mm -98.9 126.89 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -1.174 . . . . 0.0 107.987 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -139.61 141.13 37.14 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -105.04 155.28 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.4 t80 -130.7 141.76 50.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -170.26 137.03 1.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.091 -1.005 . . . . 0.0 109.838 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.41 31.93 19.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.921 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.38 21.24 74.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.76 133.33 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.999 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -91.11 143.99 26.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.1 mt -137.75 97.69 10.04 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.09 143.16 32.84 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.169 1.913 . . . . 0.0 111.416 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.84 81.34 5.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.877 -1.139 . . . . 0.0 110.396 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -139.29 156.4 47.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.5 p80 -55.07 -50.04 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -44.9 -15.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.001 -1.062 . . . . 0.0 110.192 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' HIS . 65.5 m-85 -99.14 6.12 46.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.98 -1.075 . . . . 0.0 109.629 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 50' ' ' HIS . 31.7 t -58.65 131.66 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 108.844 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.81 -35.16 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.315 -0.866 . . . . 0.0 109.833 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -152.23 123.1 7.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.496 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -113.3 133.14 55.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.627 -0.67 . . . . 0.0 109.311 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.1 p-10 -166.81 -153.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.58 ' O ' ' NXH' ' A' ' 320' ' ' TUX . 55.8 m-70 -47.07 -12.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.055 -1.028 . . . . 0.0 108.623 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -135.02 165.75 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.553 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 52.3 m -102.51 121.38 42.24 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -118.49 135.39 54.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 111.52 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -124.1 161.05 26.41 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.55 147.32 7.25 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.395 -1.86 . . . . 0.0 111.454 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -144.68 151.21 38.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.572 -0.958 . . . . 0.0 109.407 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 58.77 24.24 12.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.499 -0.751 . . . . 0.0 110.96 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.26 1.31 75.59 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.642 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.488 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.0 mm-40 -103.15 140.15 37.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.006 -1.29 . . . . 0.0 108.394 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.28 157.17 45.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.51 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.6 mt -133.86 143.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -115.06 155.95 26.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.292 -0.88 . . . . 0.0 111.38 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.418 ' H ' ' HG ' ' A' ' 59' ' ' SER . 3.0 m 53.85 65.09 1.61 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.705 -0.622 . . . . 0.0 111.129 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.85 -4.34 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.045 -1.035 . . . . 0.0 109.475 179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.581 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 7.1 pt-20 -65.16 -34.69 79.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.879 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -59.28 -60.07 4.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.0 110.207 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.8 tp -58.46 -46.73 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.825 -1.172 . . . . 0.0 109.197 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 10.8 mt -51.97 -42.18 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.019 -1.051 . . . . 0.0 109.566 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.583 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 44.9 t -59.49 -47.45 85.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.191 -0.943 . . . . 0.0 110.02 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.44 -54.08 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.979 -1.075 . . . . 0.0 108.623 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.9 mt -52.2 -45.23 65.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.321 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -53.11 -58.12 8.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.4 mt -59.61 -35.04 73.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.9 mt -83.02 -1.47 52.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.88 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 61.92 26.7 16.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.729 -1.232 . . . . 0.0 110.75 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.4 mm -73.36 118.89 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 108.313 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.457 ' HG1' ' H ' ' A' ' 86' ' ' ASN . 47.9 p -101.98 -75.41 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 111.135 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.639 HD21 ' N ' ' A' ' 86' ' ' ASN . 1.4 m120 -81.67 113.52 19.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 111.638 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.1 m -163.86 143.35 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.711 . . . . 0.0 109.283 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.518 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 4.0 m -111.15 104.5 13.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.411 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.74 112.9 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -89.33 118.99 29.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.65 108.63 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 111.142 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 24' ' ' SER . 4.3 mp -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.57 -178.99 16.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -99.96 -10.61 21.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.272 . . . . 0.0 110.962 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -139.35 143.99 38.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.736 -1.227 . . . . 0.0 110.639 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.3 131.34 86.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.349 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -46.65 131.43 15.92 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.005 1.804 . . . . 0.0 112.499 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 tp -79.95 -29.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.424 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 88.8 mt 56.18 -116.0 0.97 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 109.702 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.26 -7.48 41.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.89 -9.71 56.83 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 p -111.18 -172.21 1.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -1.024 . . . . 0.0 109.78 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.84 -2.96 20.43 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -46.53 -41.29 14.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.733 -0.863 . . . . 0.0 111.011 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.89 -51.67 67.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.223 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.3 m-85 -62.95 -45.38 92.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.066 -1.021 . . . . 0.0 109.029 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.67 -39.21 87.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.19 -44.8 59.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 111.397 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.73 -48.35 22.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.035 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.08 -42.53 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.083 . . . . 0.0 111.08 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -57.44 -28.21 63.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.027 -1.046 . . . . 0.0 109.982 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -78.81 -14.63 59.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 109.996 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -120.45 34.14 5.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.439 -0.788 . . . . 0.0 110.809 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.0 mt -87.41 148.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.665 -1.272 . . . . 0.0 111.155 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.9 tp -131.75 165.48 23.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -118.76 142.58 47.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.29 -0.881 . . . . 0.0 109.92 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.27 -161.65 0.88 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.317 -0.864 . . . . 0.0 109.228 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -117.17 0.37 12.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 0.0 110.401 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 4' ' ' GLU . 24.0 ttm-85 -94.73 150.04 20.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -87.57 135.56 33.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 110.015 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.1 mt -77.63 145.53 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.729 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.46 96.41 9.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -69.64 147.13 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.69 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.16 127.06 47.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -131.36 145.23 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.17 135.29 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -116.44 -11.84 11.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.778 . . . . 0.0 109.162 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -141.36 141.57 23.68 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 108.849 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.96 145.84 46.02 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.958 1.772 . . . . 0.0 113.007 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.7 tt -138.01 149.11 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.62 -0.675 . . . . 0.0 109.186 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.95 122.94 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 109.915 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.44 124.94 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -123.64 140.6 52.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.602 -0.686 . . . . 0.0 110.286 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.76 154.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.244 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 56.62 22.75 7.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.601 -0.687 . . . . 0.0 110.872 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.442 ' O ' ' NH2' ' A' ' 250' ' ' ARG . . . 77.37 6.63 86.64 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.459 ' CG ' HH11 ' A' ' 137' ' ' ARG . 2.5 mtt85 -107.84 172.09 7.03 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -159.79 153.22 22.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.213 -1.554 . . . . 0.0 109.563 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.493 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 2.2 mt -144.14 143.87 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.57 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -132.51 136.91 46.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -117.38 146.1 43.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -144.15 137.73 14.3 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 143.83 77.25 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.406 1.404 . . . . 0.0 111.718 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.03 148.05 11.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.235 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -1.28 46.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -134.91 143.91 47.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.0 tp -76.88 118.24 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.001 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -139.42 138.29 36.37 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.4 t -133.94 129.05 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.6 m -115.8 135.85 53.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.346 -0.846 . . . . 0.0 109.309 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -128.84 131.8 47.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -116.86 107.49 14.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.79 124.23 7.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.66 91.58 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -1.066 . . . . 0.0 109.426 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.434 ' HB2' HD22 ' A' ' 157' ' ' ASN . 21.2 m-85 -88.97 148.5 23.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.631 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -95.88 -2.19 47.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.894 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.605 HD21 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -72.98 -173.36 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 109.461 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -59.53 -27.58 66.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.96 . . . . 0.0 109.917 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.6 mt -57.89 -45.01 87.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 108.938 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.67 -135.95 13.36 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -110.03 144.72 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.533 -0.981 . . . . 0.0 109.68 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -151.44 149.2 29.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.73 150.56 52.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.16 142.74 34.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 108.859 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.8 m -124.18 130.32 52.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.858 . . . . 0.0 110.417 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -99.38 130.81 45.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.6 151.3 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 109.168 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.75 115.67 2.29 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.506 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.56 3.28 20.67 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -130.97 29.58 4.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -1.165 . . . . 0.0 108.898 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -62.65 -35.15 78.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 110.699 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -53.39 -14.72 0.82 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.958 -1.089 . . . . 0.0 110.949 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 23.4 mt-10 -97.4 -4.24 38.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.75 -1.219 . . . . 0.0 111.543 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.8 pt -119.87 12.51 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.879 -1.138 . . . . 0.0 111.614 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.51 -28.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.891 -1.13 . . . . 0.0 109.854 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 2.65 54.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.979 -1.076 . . . . 0.0 111.259 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.41 132.89 35.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.619 -1.3 . . . . 0.0 108.554 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.64 156.55 18.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.151 -0.968 . . . . 0.0 110.626 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.1 t -57.8 156.16 9.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.643 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 49.6 p90 -140.33 166.36 24.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.192 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.533 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -157.12 160.37 38.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.492 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 71.3 m-85 -103.22 144.63 31.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -60.89 -22.91 64.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 0.0 111.7 -178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.4 p90 -75.16 -38.64 60.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.403 . . . . 0.0 111.172 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.689 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -91.58 -10.07 41.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.536 -1.352 . . . . 0.0 110.224 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 3.2 mt -53.87 -51.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.961 -1.087 . . . . 0.0 109.449 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -52.33 -46.39 66.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 108.726 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.03 -52.85 63.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 72.3 mt -54.53 -33.99 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -78.77 -27.67 44.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.649 . . . . 0.0 109.713 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -73.49 -26.92 61.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.0 . . . . 0.0 109.71 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 m -83.24 10.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.307 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 25.13 74.01 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.539 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.96 156.99 29.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.103 -1.234 . . . . 0.0 109.856 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.95 25.12 56.63 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.368 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -68.69 -21.61 64.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.589 -1.536 . . . . 0.0 109.58 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.79 -6.37 49.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -58.0 130.64 51.31 Favored Glycine 0 N--CA 1.492 2.422 0 O-C-N 121.207 -1.172 . . . . 0.0 110.582 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 203' ' ' THR . 4.5 p -141.88 163.87 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.7 -0.882 . . . . 0.0 109.089 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.4 mt -64.11 -35.09 79.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.986 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -73.25 -17.31 61.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.35 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.4 m-20 -125.53 6.72 7.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.194 -0.941 . . . . 0.0 109.991 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.533 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 24.2 m -148.94 116.22 6.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.702 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 tp -76.11 113.59 13.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.7 t -103.3 126.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.973 -1.079 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 16.2 mt -108.25 141.75 39.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -97.7 135.7 12.33 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 7.5 ttpt -40.02 -21.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -1.069 . . . . 0.0 110.264 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 207' ' ' GLY . 14.9 t0 -141.67 2.28 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.746 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 207' ' ' GLY . 31.0 mttt -149.25 157.5 43.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 0.0 110.576 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.87 126.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -73.52 -55.2 6.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.413 HD21 ' H ' ' A' ' 213' ' ' ASN . 2.5 m-80 -52.75 110.31 1.89 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -54.63 -11.89 3.8 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.752 1.635 . . . . 0.0 111.924 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.26 -6.82 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.783 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.52 -164.09 51.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.5 mt -82.53 143.32 31.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -1.013 . . . . 0.0 110.041 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -89.29 -19.94 24.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.147 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 141.03 33.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 220' ' ' GLU . 1.6 pm0 -54.59 -16.65 2.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.04 -1.038 . . . . 0.0 108.597 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.3 40.3 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.797 0.808 . . . . 0.0 109.131 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.447 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 10.6 tt0 -56.4 -56.97 26.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 111.606 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 18.4 Cg_endo -59.42 -37.1 91.87 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.995 1.797 . . . . 0.0 113.406 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -82.38 -28.2 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 120.549 -1.344 . . . . 0.0 108.756 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 173' ' ' GLU . 6.3 mtp-105 -65.32 -41.14 94.31 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.597 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 21.3 t60 -65.35 -41.34 93.98 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -56.47 -43.83 79.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.076 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.16 -49.35 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 109.115 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 44.6 t80 -50.07 -43.4 51.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.668 0.747 . . . . 0.0 109.067 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.597 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.6 m-20 -72.86 -36.37 67.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.484 -0.76 . . . . 0.0 109.842 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 24.1 tp -56.1 -35.73 67.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.943 -1.098 . . . . 0.0 108.507 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.8 -48.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.65 -32.34 10.74 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.485 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 4.9 m-20 -82.71 -26.76 31.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -1.199 . . . . 0.0 109.908 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.22 -22.62 48.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.8 -1.187 . . . . 0.0 110.088 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -71.63 -7.6 48.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 109.217 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 37.7 mt -52.6 -30.51 31.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.955 . . . . 0.0 108.797 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.1 mt -57.95 -15.8 10.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.148 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.33 14.47 78.64 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 p -155.57 150.43 20.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.153 -1.204 . . . . 0.0 109.256 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -53.67 132.46 49.27 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.145 1.896 . . . . 0.0 111.649 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.2 t -98.62 137.76 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.811 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -127.79 131.28 49.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.382 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.31 -177.84 31.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -108.83 111.1 22.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -1.158 . . . . 0.0 109.66 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.9 m-85 -112.13 149.17 32.55 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.019 0.914 . . . . 0.0 111.171 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -130.13 144.31 51.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.1 t -142.42 128.09 19.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.657 -1.277 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -110.43 115.53 29.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.442 ' NH2' ' O ' ' A' ' 136' ' ' GLY . 5.5 mtm180 49.64 56.15 8.29 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.9 141.45 21.72 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -117.19 -179.69 17.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.581 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 38.7 m-70 -73.95 -52.26 13.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.99 -1.3 . . . . 0.0 109.628 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -35.02 70.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 109.292 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.7 tp -73.34 -41.51 63.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 108.735 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.5 m-20 -60.57 -51.36 69.77 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 46.2 t -51.51 -43.75 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 0.0 109.03 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -55.45 -47.84 75.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.969 -1.082 . . . . 0.0 109.136 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.44 -50.29 62.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.08 -53.77 42.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.716 0.77 . . . . 0.0 109.329 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -46.77 -51.18 16.89 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.694 -0.629 . . . . 0.0 110.314 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.99 -35.62 79.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.7 -1.25 . . . . 0.0 109.89 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 84.7 mt -70.8 -42.92 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.862 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -77.96 -28.02 49.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 110.082 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -79.65 -35.14 39.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 108.921 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.6 mtpp -61.46 -46.41 90.19 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.211 -0.931 . . . . 0.0 109.495 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -79.39 16.2 1.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.805 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 270' ' ' THR . 39.4 tttt -85.73 -25.1 26.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.0 109.716 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.97 -9.37 1.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.958 . . . . 0.0 109.434 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 268' ' ' LYS . 42.4 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.877 . . . . 0.0 109.455 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.58 ' NXH' ' O ' ' A' ' 58' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 64.2 mt-10 -44.22 142.15 1.58 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 109.28 179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -119.94 142.63 48.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -141.86 171.81 13.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.48 -0.762 . . . . 0.0 109.058 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 m -81.68 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.946 -1.096 . . . . 0.0 110.229 -179.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -46.81 63.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 10' ' ' LYS . 1.8 tm-20 -128.66 159.05 36.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.44 -0.787 . . . . 0.0 110.571 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.578 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 5.3 ttpp -59.89 133.94 56.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.6 mt -121.04 160.75 22.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -157.02 149.55 23.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.944 -1.098 . . . . 0.0 110.558 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -129.53 166.38 19.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.02 133.58 11.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.891 -1.13 . . . . 0.0 108.74 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.32 156.64 12.68 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.09 159.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 111.218 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.9 140.61 15.12 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.513 ' O ' ' N ' ' A' ' 197' ' ' GLY . 4.4 tt -58.66 -50.53 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.128 -1.219 . . . . 0.0 111.972 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.413 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 18.4 m-70 -86.13 -38.85 17.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.312 -1.492 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.0 p -72.72 -36.54 67.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 110.157 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.57 68.21 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -116.19 153.94 30.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.589 -0.948 . . . . 0.0 108.736 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 25.5 t80 -71.05 129.34 38.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.072 -1.017 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 t -132.14 157.8 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 108.945 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.7 tttm -135.01 152.7 51.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.221 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.14 148.07 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.439 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.6 mt -135.05 129.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.227 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.2 mt -115.03 125.73 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 109.891 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.502 ' CE1' ' CD ' ' A' ' 10' ' ' LYS . 18.8 m-70 -124.23 149.5 60.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.62 160.73 31.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.181 1.921 . . . . 0.0 111.247 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.1 mm-40 -134.3 -179.21 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.762 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 35' ' ' THR . 22.0 tptt -79.97 147.87 31.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -48.32 150.89 1.16 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 -179.701 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 60.9 20.36 57.34 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.24 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 23.9 m -80.89 -46.01 15.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.611 -1.523 . . . . 0.0 109.053 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.44 -167.19 16.47 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mm -102.53 124.11 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.336 -1.096 . . . . 0.0 108.147 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.07 153.17 49.33 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.8 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CD1' ' HB ' ' A' ' 89' ' ' ILE . 42.4 m-85 -114.64 154.4 28.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.554 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.8 t80 -130.83 138.78 50.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.011 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -168.87 138.14 2.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 60.36 28.63 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.929 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.91 30.61 70.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.27 131.11 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.884 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.65 144.5 29.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 108.947 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -140.86 99.16 6.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.398 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.67 145.56 48.28 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.135 1.89 . . . . 0.0 111.324 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.25 86.85 4.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.781 -1.199 . . . . 0.0 110.511 -178.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -138.62 154.59 48.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 0.0 109.391 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -52.1 -45.94 65.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.795 . . . . 0.0 110.262 -179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -48.27 -30.94 5.28 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.231 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -82.44 4.48 24.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -61.79 128.1 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 108.74 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.34 -30.3 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.23 -0.919 . . . . 0.0 110.487 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.9 t-160 -153.61 122.26 6.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.92 -1.113 . . . . 0.0 109.566 -179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 p -113.67 131.73 56.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.639 -0.663 . . . . 0.0 109.286 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.589 ' CG ' ' H ' ' A' ' 58' ' ' HIS . 43.8 t-20 -167.29 -154.0 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.589 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 73.3 m-70 -45.53 -15.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.106 -0.996 . . . . 0.0 108.643 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.8 t -134.04 165.33 25.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.56 -0.712 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.5 m -103.22 122.06 43.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 108.724 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -120.34 138.42 53.73 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.092 0.948 . . . . 0.0 111.487 -178.719 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 82.5 mt -120.19 163.83 17.14 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.219 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.8 142.75 5.21 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 118.453 -1.832 . . . . 0.0 111.159 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -144.86 150.35 36.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.856 . . . . 0.0 109.281 179.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? 55.4 35.92 26.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 110.749 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.14 2.25 88.75 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.493 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.6 mm100 -98.44 144.23 28.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.254 . . . . 0.0 108.44 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.2 ptm85 -142.11 147.43 36.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.022 -1.049 . . . . 0.0 111.331 -178.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.12 143.1 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -114.08 152.47 31.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.003 -1.06 . . . . 0.0 111.013 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 53.21 66.22 1.29 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.694 -0.629 . . . . 0.0 110.734 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 m -113.48 -3.65 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.004 . . . . 0.0 109.132 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -70.37 -28.24 64.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.497 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 25.0 m170 -66.77 -59.85 3.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.058 -1.026 . . . . 0.0 109.767 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.5 tp -57.75 -45.03 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.845 -1.159 . . . . 0.0 108.764 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.478 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 67.9 mt -57.01 -40.99 77.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 0.0 109.807 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.586 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.6 t -58.35 -47.86 82.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 109.476 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.07 -54.33 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 108.542 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.3 mt -52.14 -45.17 64.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.483 ' ND1' ' CG2' ' A' ' 232' ' ' ILE . 20.3 t-160 -55.99 -58.55 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.566 -0.709 . . . . 0.0 110.066 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.23 -37.02 74.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.3 mt -77.79 -4.78 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 0.0 110.21 -179.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.88 34.55 14.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.424 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.2 mm -80.4 127.0 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 86' ' ' ASN . 5.9 p -105.17 -77.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 111.456 -177.814 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.612 ' N ' ' OG1' ' A' ' 85' ' ' THR . 10.9 m-80 -81.38 113.89 19.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.403 -176.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.8 m -162.82 139.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.483 -0.76 . . . . 0.0 109.622 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 30.8 m -109.15 104.46 13.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.4 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 2.5 mp -94.16 105.59 17.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 0.0 109.807 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.92 120.32 25.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 108.49 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 t -102.42 110.25 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 111.114 -178.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.49 107.67 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.18 -162.75 24.31 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -114.06 -16.21 12.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -1.045 . . . . 0.0 110.332 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -142.07 147.45 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.54 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.1 mm -69.28 128.74 92.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -45.77 131.4 13.16 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.838 1.692 . . . . 0.0 111.845 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -77.88 -24.84 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.554 -0.716 . . . . 0.0 110.558 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.5 mt 55.43 -119.17 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 57.6 t0 -94.52 -9.46 35.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.494 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.77 -4.88 32.45 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.4 p -118.47 -173.54 2.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -1.05 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 -3.97 20.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -46.67 -36.57 7.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.775 -0.838 . . . . 0.0 110.932 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.454 ' OE1' ' N ' ' A' ' 105' ' ' GLU . 2.7 mp0 -63.0 -52.0 64.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.864 -1.148 . . . . 0.0 110.268 -179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -62.23 -45.02 95.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.07 . . . . 0.0 108.874 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.44 -40.47 86.91 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.496 0.665 . . . . 0.0 109.625 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -72.8 -43.69 62.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 111.733 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.48 -49.66 15.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 111.075 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.34 -41.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -59.02 -28.48 66.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.946 -1.096 . . . . 0.0 110.122 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -78.28 -17.96 55.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.67 34.5 5.18 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.467 -0.771 . . . . 0.0 110.731 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 114' ' ' ILE . 9.5 mt -82.92 148.07 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.303 . . . . 0.0 110.526 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.1 tp -130.67 151.99 50.51 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.603 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -100.39 136.43 40.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.028 -1.045 . . . . 0.0 109.698 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.578 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 18.9 mt-30 -102.63 -166.45 1.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -120.89 72.26 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.416 -0.802 . . . . 0.0 110.923 -179.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -166.17 145.11 5.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.64 128.88 34.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.149 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.79 139.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.28 72.83 4.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -51.5 142.54 13.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.528 -0.732 . . . . 0.0 110.097 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -103.82 124.09 48.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.3 t -127.87 142.77 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 0.0 109.954 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.8 t -81.27 134.68 26.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -117.26 -11.77 10.59 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -139.74 141.66 28.62 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.412 -0.805 . . . . 0.0 108.916 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.26 169.73 20.0 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.162 1.908 . . . . 0.0 113.029 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.3 tt -163.67 143.48 2.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.469 0.652 . . . . 0.0 109.618 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.23 121.09 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.29 112.38 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.73 125.84 53.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -173.34 157.86 3.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 0.0 110.652 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.455 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 27.1 mt-10 56.63 18.74 3.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 110.771 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.67 -0.22 89.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER -102.88 172.28 6.92 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 4.8 tt -160.24 145.82 15.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.441 -1.412 . . . . 0.0 108.669 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.456 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 59.3 mt -147.92 134.81 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 108.394 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -124.05 144.16 50.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.71 148.81 44.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -148.82 138.72 12.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.14 146.17 60.99 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.462 1.441 . . . . 0.0 112.129 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.14 147.94 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.49 -1.4 37.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.471 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.7 p -136.92 159.36 42.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 109.304 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.539 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 27.0 tp -88.34 121.0 30.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 0.0 109.748 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -138.65 135.15 34.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 73.4 t -137.19 118.5 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.9 m -106.31 136.51 45.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.752 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -123.67 128.32 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.469 -0.769 . . . . 0.0 109.488 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' CD ' ' CE2' ' A' ' 249' ' ' PHE . 7.2 tt0 -115.16 104.66 12.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.41 126.68 8.98 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -110.93 84.98 2.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -1.08 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 2.3 m-30 -90.38 148.97 22.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.132 -0.98 . . . . 0.0 109.407 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -91.83 -5.81 52.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.856 . . . . 0.0 110.739 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -68.44 -167.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.725 -1.234 . . . . 0.0 109.435 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.8 p90 -59.94 -26.67 66.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.994 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.92 -51.59 69.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 108.812 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.63 -119.17 5.43 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.94 143.12 51.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.622 -0.928 . . . . 0.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -156.09 146.64 21.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.429 -0.794 . . . . 0.0 109.557 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -126.29 150.83 48.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.0 109.673 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -135.09 118.77 17.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.9 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -94.9 121.82 36.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.043 . . . . 0.0 109.735 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 4.2 t80 -99.73 139.18 35.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.356 -0.84 . . . . 0.0 109.486 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.555 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.7 t -138.94 153.06 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.39 -0.819 . . . . 0.0 109.152 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 98.4 mt-10 -53.58 120.43 6.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.597 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.41 6.68 17.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.48 28.67 1.81 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.159 -1.201 . . . . 0.0 108.671 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -63.93 -35.99 82.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 110.4 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.96 -12.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.168 -0.957 . . . . 0.0 110.517 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -90.9 -4.52 56.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.052 -1.03 . . . . 0.0 110.536 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 174' ' ' ILE . 2.8 pt -120.55 -7.13 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.164 -0.96 . . . . 0.0 110.772 -179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.13 -29.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.574 -1.328 . . . . 0.0 110.011 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.9 mt -90.03 -1.34 57.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.833 -1.167 . . . . 0.0 110.736 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.58 118.18 20.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.706 -1.246 . . . . 0.0 108.374 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.55 153.01 21.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.0 110.296 -179.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.531 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 6.2 t -53.47 158.63 1.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 0.0 109.773 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.545 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 23.3 p90 -143.32 169.44 17.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.635 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -162.09 167.95 23.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 -179.785 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.502 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 86.8 m-85 -104.21 145.08 30.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 109.203 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 51.3 p30 -63.34 -23.49 67.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.277 -0.89 . . . . 0.0 111.426 -178.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.52 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 p90 -79.33 -27.32 42.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.585 -1.322 . . . . 0.0 111.009 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.485 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 26.0 pt-20 -96.45 -13.76 22.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.688 -1.258 . . . . 0.0 109.872 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 4.6 mt -55.56 -51.65 55.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -52.43 -44.5 65.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.668 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -57.6 -51.5 69.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.943 . . . . 0.0 109.41 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.45 -34.31 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.134 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -74.43 -27.09 60.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 110.144 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.434 ' C ' ' H ' ' A' ' 193' ' ' GLY . 11.6 mttm -74.8 -33.51 62.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.018 -1.051 . . . . 0.0 109.921 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.42 12.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 109.226 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 74.43 25.35 70.66 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.556 179.001 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 86.5 mt -117.83 155.08 30.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -1.192 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.2 27.81 47.44 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.29 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -68.36 -22.46 64.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.667 -1.49 . . . . 0.0 108.929 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -103.14 -4.92 47.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.65 126.0 29.29 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 121.323 -1.104 . . . . 0.0 110.956 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.18 39.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.858 -0.789 . . . . 0.0 109.074 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.61 -13.32 1.55 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.792 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -83.46 -2.22 55.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.06 -1.025 . . . . 0.0 109.423 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -151.18 17.67 0.75 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 108.826 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.635 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 87.4 m -151.89 115.16 4.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.504 -0.747 . . . . 0.0 109.33 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.6 tp -76.57 109.76 10.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.208 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.17 131.36 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 109.941 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.5 mt -114.28 144.83 42.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.536 -0.728 . . . . 0.0 109.35 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.94 151.07 19.14 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 207' ' ' GLY . 25.7 tttt -41.42 -28.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 110.162 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 209' ' ' ASP . 1.8 p30 -146.4 8.15 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.929 -1.107 . . . . 0.0 110.399 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.6 tttt -141.93 150.61 41.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.832 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.21 127.45 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -70.66 -54.43 11.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.201 -0.937 . . . . 0.0 110.019 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.97 132.86 80.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.05 . . . . 0.0 109.462 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.85 -19.4 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.322 2.015 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.81 -6.04 58.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.669 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.84 -169.29 52.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.53 147.16 42.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.387 -1.066 . . . . 0.0 109.568 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -74.76 -62.64 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 108.848 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 221' ' ' ASN . 11.5 m-85 -117.9 142.78 46.95 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 219' ' ' TYR . 8.6 m-20 -137.7 30.41 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.483 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -60.25 -40.04 73.6 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 16.0 Cg_exo -65.22 -49.6 2.56 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.35 2.034 . . . . 0.0 112.647 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 2.5 m -73.17 -22.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.922 -1.111 . . . . 0.0 108.628 179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -70.93 -46.11 63.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.514 ' CE1' ' N ' ' A' ' 179' ' ' THR . 26.0 t60 -58.69 -38.45 78.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.534 ' HZ2' ' CE1' ' A' ' 253' ' ' HIS . 0.7 OUTLIER -62.8 -42.14 99.59 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.11 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.34 -38.9 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.185 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.586 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 48.7 t80 -56.48 -51.74 67.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.732 -0.605 . . . . 0.0 109.704 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.497 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 8.2 m-20 -70.14 -30.14 67.24 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.174 -0.954 . . . . 0.0 109.515 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 30.1 tp -56.56 -37.6 70.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.22 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.483 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 66.0 mt -73.01 -48.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.64 8.33 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.35 -29.62 30.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.728 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.8 mt -79.16 -22.41 45.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.725 -1.234 . . . . 0.0 109.253 179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.406 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.2 t80 -70.09 -8.96 53.74 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.1 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.3 mt -52.67 -27.93 19.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 108.818 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.6 mt -55.28 -18.47 6.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.021 179.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.86 12.54 77.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.0 p -158.51 147.6 14.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.139 -1.212 . . . . 0.0 109.551 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -42.99 135.18 5.42 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.344 2.029 . . . . 0.0 111.975 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.7 t -101.75 133.08 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.702 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -122.11 126.81 49.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.581 -0.699 . . . . 0.0 109.261 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 176.61 29.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -107.07 110.21 22.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -1.231 . . . . 0.0 109.833 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.7 m-85 -112.06 147.43 36.02 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.834 0.826 . . . . 0.0 111.038 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -127.42 144.1 51.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.4 m -134.84 128.11 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.704 -1.248 . . . . 0.0 110.679 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.497 ' CE2' ' CD ' ' A' ' 152' ' ' GLU . 3.0 t80 -112.44 110.58 20.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 6.5 mmm180 47.34 55.75 7.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -178.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.27 142.09 23.71 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -178.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -110.63 159.63 13.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.534 ' CE1' ' HZ2' ' A' ' 227' ' ' LYS . 76.8 m-70 -56.07 -48.93 75.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.241 . . . . 0.0 109.534 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 25.3 p -57.21 -55.16 38.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.192 -0.943 . . . . 0.0 109.106 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 54.5 tp -52.07 -37.29 53.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 4.4 m120 -58.22 -55.7 31.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.093 -1.004 . . . . 0.0 108.855 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.61 -43.1 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.494 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -49.52 71.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 9.5 tp -52.71 -41.24 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 74.2 t -71.97 -50.43 37.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.76 0.791 . . . . 0.0 109.507 179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -49.81 -45.06 49.6 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.641 -0.662 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -42.79 70.36 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.479 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 36.3 mt -62.05 -43.61 98.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.552 -0.718 . . . . 0.0 110.344 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -83.35 -34.71 25.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.625 -1.297 . . . . 0.0 108.453 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 267' ' ' GLN . 20.3 mttp -49.16 -36.5 19.57 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.604 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 266' ' ' LYS . 46.9 tt0 -40.07 -70.4 0.1 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.871 -0.518 . . . . 0.0 110.758 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -91.45 16.29 10.58 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.833 -1.167 . . . . 0.0 111.105 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 8.1 mt -108.39 24.88 12.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.149 -0.969 . . . . 0.0 109.49 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.875 . . . . 0.0 109.41 179.916 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.573 ' C2A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 4' ' ' GLU . 2.3 mt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.424 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 21.7 mm-40 -45.01 141.52 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 0.0 109.199 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -121.08 139.64 53.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -141.23 177.84 7.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.28 135.18 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 109.815 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -65.66 -45.51 82.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.766 . . . . 0.0 110.322 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.73 157.38 41.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.46 133.66 52.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.11 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.5 mt -118.24 160.14 22.12 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.552 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 p -158.1 150.44 22.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.101 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -132.42 174.88 9.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.628 -0.67 . . . . 0.0 109.707 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -150.46 135.51 17.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 108.589 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.76 156.09 12.87 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.901 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.9 p -80.93 142.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -1.083 . . . . 0.0 110.91 -178.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.24 142.9 36.63 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.0 tt -60.06 -48.01 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -1.145 . . . . 0.0 112.472 -178.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.434 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 9.6 m-70 -86.88 -37.93 17.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.229 -1.544 . . . . 0.0 111.462 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -68.13 -35.1 77.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 0.0 110.135 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.9 71.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -118.92 154.81 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 109.242 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -68.4 140.18 55.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.593 ' HG ' ' N ' ' A' ' 25' ' ' LYS . 3.9 t -147.42 157.08 43.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.041 . . . . 0.0 108.766 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.593 ' N ' ' HG ' ' A' ' 24' ' ' SER . 0.1 OUTLIER -127.58 161.98 27.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.192 -0.942 . . . . 0.0 110.014 -179.236 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.497 ' N ' ' CG ' ' A' ' 25' ' ' LYS . 12.9 mt -130.94 143.65 50.88 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.29 127.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.312 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mt -113.45 125.0 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 109.403 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -121.47 142.71 36.1 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.545 -0.722 . . . . 0.0 109.356 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -53.87 160.07 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.544 1.496 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 76.7 mt-10 -134.77 -178.75 5.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.3 ttmm -85.91 151.44 23.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.592 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -49.81 147.31 3.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 110.447 -179.591 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.76 21.84 58.89 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.551 -0.718 . . . . 0.0 111.884 178.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 98.5 m -81.19 -46.51 14.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.45 -1.618 . . . . 0.0 109.027 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.701 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 105.45 -168.2 15.29 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mm -101.63 124.66 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -1.112 . . . . 0.0 108.036 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.16 139.55 30.41 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.765 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -97.16 154.33 17.43 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.555 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.6 t80 -129.47 139.94 51.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.684 ' NZ ' ' NE2' ' A' ' 67' ' ' GLN . 46.3 tttm -168.08 137.76 2.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 -179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.435 HD21 ' HZ2' ' A' ' 41' ' ' LYS . 0.8 OUTLIER 59.14 29.18 18.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 0.0 110.102 179.683 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.01 28.36 70.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.8 t -134.08 138.27 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 109.852 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -92.14 142.45 27.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.19 179.637 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -137.42 95.13 11.65 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.439 -179.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -48.27 144.97 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.212 1.941 . . . . 0.0 111.652 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.89 84.61 4.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.542 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -141.16 157.02 45.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.008 -1.058 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.1 p80 -52.92 -50.12 64.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -46.55 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 0.0 109.999 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.7 m-85 -99.67 4.81 45.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.463 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 t -63.38 132.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 108.773 179.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -118.09 -33.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.7 t-160 -147.61 118.6 7.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 110.037 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.2 p -112.66 126.37 55.3 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.7 t-20 -167.06 -152.76 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.584 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 10.7 m-70 -44.21 -16.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 108.586 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.1 t -137.19 165.5 25.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.495 -0.753 . . . . 0.0 109.368 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 m -109.24 125.36 52.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.368 -0.832 . . . . 0.0 108.831 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 1.4 m-20 -125.59 148.02 49.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.994 0.902 . . . . 0.0 111.162 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.1 mt -125.78 161.12 28.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.99 143.59 6.37 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.541 -1.79 . . . . 0.0 110.985 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -144.81 151.85 39.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.629 -0.924 . . . . 0.0 109.72 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.81 29.74 12.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.386 -0.821 . . . . 0.0 110.599 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.52 0.54 86.32 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.569 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.684 ' NE2' ' NZ ' ' A' ' 41' ' ' LYS . 15.9 mm100 -97.01 145.44 25.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.307 . . . . 0.0 108.373 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -143.35 149.58 37.95 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.658 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -132.93 143.17 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -114.05 149.71 35.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.124 -0.985 . . . . 0.0 111.611 -178.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.8 m 53.87 71.6 0.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.716 -0.615 . . . . 0.0 111.054 178.621 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -112.81 -5.83 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 179.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.41 -23.87 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -68.98 -60.88 2.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.996 -1.065 . . . . 0.0 109.723 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.508 ' CD1' ' CG ' ' A' ' 106' ' ' PHE . 11.1 tp -59.63 -45.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.493 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 88.3 mt -54.69 -40.77 69.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 0.0 109.68 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.591 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.47 -47.93 83.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.086 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.19 -55.23 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.011 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 mt -52.47 -43.38 64.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.489 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 15.8 t-160 -55.53 -58.08 9.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.127 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.486 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 57.5 mt -55.79 -36.66 67.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.267 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.89 -4.31 51.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 110.461 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER 62.77 38.46 11.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.866 -1.146 . . . . 0.0 110.51 179.628 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.4 mm -83.31 129.74 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.9 p -107.04 -76.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.235 -0.916 . . . . 0.0 111.129 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.701 HD21 ' H ' ' A' ' 36' ' ' GLY . 2.4 m120 -81.22 113.96 19.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -176.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.05 141.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 109.623 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.551 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -109.01 103.84 12.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.488 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.68 106.03 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.87 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.68 122.01 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.075 -1.016 . . . . 0.0 108.936 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -102.96 104.92 17.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.454 -0.779 . . . . 0.0 110.422 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.03 110.84 20.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.176 -0.953 . . . . 0.0 108.582 178.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.32 -179.23 16.38 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -15.32 22.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.138 . . . . 0.0 110.349 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.4 tt0 -136.07 142.7 44.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.986 -1.071 . . . . 0.0 110.272 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mm -68.26 128.41 93.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.765 . . . . 0.0 109.654 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -45.72 127.39 9.89 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.822 1.681 . . . . 0.0 111.834 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 tp -80.1 -22.44 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.76 . . . . 0.0 110.354 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.8 mt 55.72 -118.08 1.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.854 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -94.78 -9.7 33.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.15 -0.968 . . . . 0.0 110.43 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.68 39.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.3 p -115.42 -174.55 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -1.021 . . . . 0.0 109.368 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.23 -6.96 17.55 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.547 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 72.5 t-105 -46.61 -35.21 5.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.678 -0.896 . . . . 0.0 110.09 -179.559 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.24 -51.52 68.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.906 -1.121 . . . . 0.0 109.968 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CG ' ' CD1' ' A' ' 75' ' ' ILE . 63.1 m-85 -65.03 -44.62 88.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.077 -1.014 . . . . 0.0 108.944 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -61.91 -37.81 86.03 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.456 0.646 . . . . 0.0 109.572 179.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.547 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 24.4 mm-40 -65.38 -52.75 51.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.685 . . . . 0.0 111.595 -178.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.33 -52.24 9.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.216 . . . . 0.0 110.693 -178.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 92.8 mt -50.71 -47.81 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.78 -1.2 . . . . 0.0 110.477 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -57.89 -31.3 66.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -83.78 13.51 4.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -149.46 30.68 0.75 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 10.0 mt -85.02 147.12 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.949 -1.094 . . . . 0.0 110.426 -179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.0 tp -131.7 155.69 47.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.488 -0.757 . . . . 0.0 109.161 179.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.8 OUTLIER -110.42 128.2 55.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 179.725 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.498 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -97.02 -165.73 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 118' ' ' ASN . 48.6 p30 -124.77 74.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 110.301 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -161.73 139.93 9.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.057 179.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -47.3 167.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 110.191 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.577 ' O ' ' N ' ' A' ' 123' ' ' TYR . 25.4 mt -126.12 104.23 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.94 71.28 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.429 -0.794 . . . . 0.0 110.154 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.577 ' N ' ' O ' ' A' ' 121' ' ' ILE . 93.8 m-85 -57.4 147.18 26.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -104.71 123.65 47.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 5.4 t -129.2 143.43 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.991 -179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.46 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -113.23 -11.8 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.254 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -141.32 144.71 35.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.8 172.29 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.054 1.836 . . . . 0.0 113.003 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.492 ' CD1' ' HZ3' ' A' ' 266' ' ' LYS . 9.9 tt -165.92 145.53 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.348 0.594 . . . . 0.0 109.846 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mt -128.28 125.24 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.496 -0.753 . . . . 0.0 109.361 179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -122.73 116.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 110.003 -179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -107.77 142.26 38.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' CG ' ' OE1' ' A' ' 135' ' ' GLU . 8.4 t70 -168.96 135.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.723 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER 50.94 34.89 11.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 111.509 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.73 8.06 86.2 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -103.15 172.5 6.78 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.452 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 7.2 tt -160.59 148.74 16.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.248 -1.533 . . . . 0.0 109.174 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.452 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 3.4 mt -146.87 133.78 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 108.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -125.21 138.99 54.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.772 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.95 139.55 53.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -136.25 134.04 19.83 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -53.12 148.87 29.52 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.353 1.369 . . . . 0.0 112.326 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.67 158.39 9.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.882 . . . . 0.0 108.944 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.3 2.65 54.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 109.943 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -138.06 150.03 46.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.539 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.492 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 16.8 tp -83.09 115.12 21.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -136.61 141.92 43.27 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -136.27 133.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.131 -0.981 . . . . 0.0 109.973 -179.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 m -119.1 124.72 47.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -115.1 129.85 56.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 109.983 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 153' ' ' GLY . 4.5 tp10 -113.72 105.29 13.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.562 ' N ' ' OE1' ' A' ' 152' ' ' GLU . . . -101.44 145.4 16.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -132.41 85.32 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -1.04 . . . . 0.0 109.589 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 2.7 m-30 -88.67 148.93 23.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.46 -0.775 . . . . 0.0 109.021 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 mmtt -88.93 -8.72 53.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 11.9 p-10 -66.79 -170.74 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 109.498 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 16.8 p90 -59.4 -24.63 63.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.853 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 8.5 mt -53.77 -58.39 7.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.005 . . . . 0.0 108.904 179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.92 -134.73 11.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.34 142.7 47.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.995 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.438 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 1.3 pt20 -162.12 159.51 26.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 0.0 109.547 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.51 152.97 51.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.469 -0.769 . . . . 0.0 109.315 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -133.75 120.05 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.0 108.815 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 m -98.99 121.93 41.58 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.97 -1.081 . . . . 0.0 110.34 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -95.26 138.12 33.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.57 156.51 42.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.783 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.621 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 4.9 mp0 -60.31 113.69 2.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 109.417 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.4 6.03 18.31 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -130.91 30.23 4.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.294 -1.121 . . . . 0.0 108.836 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 171' ' ' GLU . 6.1 mp0 -63.75 -34.67 78.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.471 -0.768 . . . . 0.0 110.89 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -16.49 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.918 -1.114 . . . . 0.0 110.98 -178.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.88 -4.02 55.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.91 -1.119 . . . . 0.0 111.146 -178.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.16 -5.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.031 -1.043 . . . . 0.0 111.107 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.59 -28.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.471 -1.393 . . . . 0.0 110.436 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.08 0.95 56.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 0.0 110.964 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.9 123.15 25.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.675 -1.265 . . . . 0.0 108.485 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -91.04 151.73 20.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.673 -1.267 . . . . 0.0 109.797 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 t -62.28 134.37 56.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.45 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.54 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 11.5 p90 -117.33 179.1 4.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 0.0 110.106 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -170.39 166.41 8.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.371 -0.831 . . . . 0.0 109.723 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 31.2 m-85 -103.79 146.11 29.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 0.0 109.244 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -17.73 64.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 111.216 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.3 p90 -80.67 -33.42 35.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.518 -1.364 . . . . 0.0 110.549 -179.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.588 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.1 OUTLIER -90.24 -15.73 30.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.762 -1.212 . . . . 0.0 109.504 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 7.6 mt -58.57 -51.24 74.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 110.224 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.47 -50.24 53.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.858 -1.151 . . . . 0.0 109.292 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.04 -52.0 62.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.172 -0.955 . . . . 0.0 108.83 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 61.7 mt -55.29 -34.2 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -0.917 . . . . 0.0 108.953 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -74.18 -32.71 63.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 109.863 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.05 -30.47 70.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.788 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 11.7 m -82.82 12.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.97 . . . . 0.0 109.633 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.35 70.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.293 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 20.1 mt -118.3 156.19 29.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.006 -1.291 . . . . 0.0 109.945 179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.89 25.12 53.82 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.001 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -67.55 -22.18 65.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.671 -1.488 . . . . 0.0 109.488 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -6.02 50.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.57 124.73 35.38 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.133 -1.216 . . . . 0.0 110.516 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.612 ' HG ' ' ND2' ' A' ' 202' ' ' ASN . 54.2 p -135.35 -179.7 5.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.825 -0.809 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.0 mt -82.65 -12.42 57.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -91.9 -9.93 41.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.612 ' ND2' ' HG ' ' A' ' 199' ' ' SER . 2.0 m-80 -136.37 7.92 3.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.407 ' HG1' ' H ' ' A' ' 199' ' ' SER . 1.2 m -147.28 120.16 8.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.4 tp -84.02 117.87 23.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.984 . . . . 0.0 109.127 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.19 127.67 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 109.593 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.8 mt -107.06 146.95 30.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.488 -0.757 . . . . 0.0 109.65 -179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.71 148.54 16.51 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 207' ' ' GLY . 20.4 tttt -41.13 -31.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -1.04 . . . . 0.0 109.918 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 31.9 t0 -145.61 10.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 0.0 110.282 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -144.62 153.67 42.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 109.774 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 44.7 t -106.3 131.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.091 179.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -72.6 -54.45 9.09 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.225 -0.922 . . . . 0.0 110.044 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.413 HD21 ' H ' ' A' ' 213' ' ' ASN . 3.3 m-80 -56.18 136.35 74.75 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 0.0 109.34 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.88 -25.82 19.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.311 2.008 . . . . 0.0 112.653 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.516 ' OE2' ' NH1' ' A' ' 218' ' ' ARG . 16.4 tm-20 -80.25 -9.82 59.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -165.52 52.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 11.8 mt -76.28 141.78 41.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -1.055 . . . . 0.0 109.858 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.516 ' NH1' ' OE2' ' A' ' 215' ' ' GLU . 0.1 OUTLIER -65.02 -52.23 57.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.63 179.25 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -117.85 176.8 5.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.0 -19.08 58.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.548 ' OD1' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -127.83 35.39 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.469 -0.769 . . . . 0.0 109.104 -179.985 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -59.79 -34.96 24.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 111.126 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.3 Cg_exo -73.87 -43.63 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.808 1.672 . . . . 0.0 112.342 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.09 -25.38 15.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.903 -1.123 . . . . 0.0 108.133 179.196 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.548 ' NH1' ' OD1' ' A' ' 221' ' ' ASN . 8.0 mtt180 -67.13 -44.11 80.69 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -57.65 -50.32 73.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 108.689 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.91 -48.97 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.591 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 64.3 t80 -49.99 -44.19 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -73.02 -35.53 66.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.534 -0.729 . . . . 0.0 109.571 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.46 -36.31 68.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 108.65 179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.46 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 44.1 mt -72.42 -48.25 48.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.58 -34.3 13.91 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -81.64 -28.64 33.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -1.2 . . . . 0.0 109.645 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.4 mt -80.26 -21.42 42.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.835 -1.166 . . . . 0.0 109.125 179.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.489 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.3 t80 -71.08 -9.1 57.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 108.692 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 14.1 mt -50.02 -28.78 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.102 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 96.7 mt -56.52 -14.02 2.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.088 179.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.5 15.95 80.23 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 80.8 p -158.59 144.98 12.64 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.257 . . . . 0.0 109.383 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -42.59 130.54 5.25 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.197 1.931 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 4.0 t -100.36 135.85 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.59 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -123.91 127.57 48.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.664 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.78 172.14 23.72 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -101.14 113.87 27.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.59 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.0 m-85 -112.58 147.08 37.4 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.981 0.896 . . . . 0.0 111.306 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.4 t80 -128.86 144.06 51.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.409 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 28.1 t -139.31 125.39 19.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.697 -1.252 . . . . 0.0 110.005 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 250' ' ' ARG . 71.8 t80 -110.47 113.37 25.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 249' ' ' PHE . 9.6 mmm180 46.43 56.6 6.2 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.73 150.5 21.16 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -118.38 179.82 17.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -68.66 -42.35 78.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -1.143 . . . . 0.0 109.568 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -36.32 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.204 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 57.4 tp -72.54 -36.79 68.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.016 -1.053 . . . . 0.0 108.911 179.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -60.76 -52.41 65.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.352 -0.842 . . . . 0.0 108.81 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 37.2 t -52.53 -44.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.34 -47.54 75.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.007 -1.058 . . . . 0.0 109.167 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 30.8 tp -52.51 -45.07 66.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 108.623 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.36 -53.29 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 109.465 179.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -46.7 -45.97 19.84 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.682 -0.636 . . . . 0.0 110.636 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.92 -47.96 64.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.906 -1.121 . . . . 0.0 109.503 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.7 mt -57.97 -43.66 86.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.05 74.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.282 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -86.27 -24.21 26.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.706 -1.246 . . . . 0.0 108.929 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.492 ' HZ3' ' CD1' ' A' ' 130' ' ' ILE . 22.8 mttt -71.86 -46.11 59.05 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 109.482 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 12.63 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.674 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 266' ' ' LYS . 43.8 tttp -59.32 -51.03 71.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 109.498 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.2 mt -94.37 -75.12 0.52 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.373 -0.83 . . . . 0.0 109.415 179.952 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.499 ' O6G' ' CE1' ' A' ' 180' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 55.3 mt-10 -49.59 141.1 9.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.553 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -114.14 131.33 56.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.496 -0.752 . . . . 0.0 109.061 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -132.77 168.86 17.59 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -81.38 139.79 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 110.226 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -70.12 -46.95 63.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.56 -0.712 . . . . 0.0 109.945 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -132.35 163.11 29.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.356 -0.84 . . . . 0.0 110.41 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.577 ' HZ2' ' CB ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -66.72 136.31 55.32 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.632 0.73 . . . . 0.0 110.861 -179.162 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.7 mt -117.23 164.99 13.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -150.92 146.49 26.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.813 -1.179 . . . . 0.0 110.192 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -133.69 161.08 35.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.536 -0.727 . . . . 0.0 109.464 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -149.75 136.78 19.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.918 -1.114 . . . . 0.0 109.023 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.87 158.98 18.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.3 p -85.79 144.14 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.103 -1.233 . . . . 0.0 110.996 -178.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.32 143.57 39.38 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.1 tt -63.55 -44.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 112.621 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.446 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.8 m-70 -87.08 -37.1 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.125 -1.609 . . . . 0.0 112.193 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.0 p -81.05 -26.6 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.834 -1.167 . . . . 0.0 109.721 -178.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.95 19.0 62.93 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 23' ' ' TYR . 1.9 tm-20 -104.18 148.75 25.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 4.3 t80 -71.65 134.39 46.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -141.7 158.16 44.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.09 -1.006 . . . . 0.0 109.298 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -137.77 144.85 41.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.258 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -125.25 144.91 50.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.018 . . . . 0.0 109.606 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.3 mt -126.4 132.08 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mt -113.1 134.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.049 -1.032 . . . . 0.0 109.573 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -128.62 149.72 72.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.031 179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.81 160.51 28.79 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.288 1.992 . . . . 0.0 111.226 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.6 mm-40 -135.23 -174.66 3.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 109.914 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.507 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.5 tttt -91.0 155.71 18.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.766 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.84 145.23 2.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.251 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.592 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.08 27.4 62.44 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.105 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.2 m -80.85 -38.31 28.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.684 -1.48 . . . . 0.0 108.633 179.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 -174.21 35.11 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.66 123.51 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 139.36 39.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.953 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -95.79 148.73 22.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.7 t80 -130.65 137.34 49.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -165.38 139.67 4.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.383 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.09 29.73 10.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 110.084 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.58 18.51 79.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.3 t -120.51 133.86 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -1.096 . . . . 0.0 109.753 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 15.8 m-85 -97.88 134.53 40.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 108.871 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.4 mt -127.73 94.91 36.23 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.495 -0.753 . . . . 0.0 109.4 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.91 142.3 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.095 1.863 . . . . 0.0 111.602 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.04 80.22 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.977 -1.077 . . . . 0.0 109.94 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -134.59 152.32 51.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.528 ' O ' ' N ' ' A' ' 53' ' ' VAL . 15.1 p80 -54.9 -47.16 74.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 50' ' ' HIS . 4.6 mt-10 -44.01 -20.49 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.939 -1.101 . . . . 0.0 109.706 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' HIS . 97.6 m-85 -90.57 4.66 50.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.854 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' A' ' 50' ' ' HIS . 23.3 t -60.03 120.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 108.921 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 m -111.88 -28.34 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 110.161 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -153.44 122.66 6.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.008 -1.057 . . . . 0.0 109.907 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -115.69 132.68 56.56 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.5 t-20 -166.87 -153.22 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ASN . 76.1 m-70 -45.64 -15.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -136.73 166.16 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.419 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 2.8 m -108.66 125.77 52.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.354 -0.841 . . . . 0.0 108.878 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 60' ' ' THR . 3.5 m-20 -123.47 140.45 53.0 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.073 0.94 . . . . 0.0 111.46 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.8 mt -122.11 160.24 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.87 141.1 5.83 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.812 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -144.13 149.03 35.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.974 . . . . 0.0 109.236 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.95 38.82 31.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.349 -0.844 . . . . 0.0 110.393 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.95 3.23 80.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.513 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 7.5 mm100 -96.16 144.96 25.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -1.196 . . . . 0.0 108.605 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.81 143.88 37.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.244 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.71 139.29 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -114.36 151.36 33.15 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.276 -0.89 . . . . 0.0 111.179 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m 54.75 70.22 0.64 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 178.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 m -114.29 -8.09 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.068 -1.02 . . . . 0.0 109.846 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -69.52 -19.08 63.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.158 -0.964 . . . . 0.0 111.228 -178.829 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 22.6 m170 -73.5 -58.89 3.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.753 -1.217 . . . . 0.0 109.52 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 4.6 tp -58.52 -42.43 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.844 -1.16 . . . . 0.0 108.691 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.439 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 70.5 mt -58.73 -37.53 76.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.2 t -59.91 -48.3 82.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.96 -54.16 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 108.455 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.3 mt -51.68 -45.46 63.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 0.0 109.234 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.583 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 12.1 t-160 -54.98 -51.87 64.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.787 . . . . 0.0 109.902 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.4 mt -64.9 -38.27 90.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 110.629 -179.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.9 mt -79.89 -1.1 37.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 110.612 -178.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 60.14 63.46 1.42 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.013 -1.054 . . . . 0.0 110.401 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 84' ' ' ILE . 13.3 mm -105.51 127.6 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.7 p -115.1 -21.22 10.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.314 -0.866 . . . . 0.0 112.03 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.638 HD21 HE22 ' A' ' 117' ' ' GLN . 12.2 m-80 -128.74 111.6 13.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.787 -1.195 . . . . 0.0 110.295 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 1.6 m -164.19 139.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.196 -0.94 . . . . 0.0 109.89 179.09 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 21.5 m -110.42 99.54 8.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.24 104.98 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.92 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.67 128.47 33.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.612 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.71 108.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.06 109.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.81 -155.27 20.09 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -178.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.43 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -123.04 -8.18 8.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.532 -0.981 . . . . 0.0 110.694 -179.555 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.573 ' OE2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -144.58 150.76 38.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.62 -1.3 . . . . 0.0 111.681 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.6 mm -75.88 122.26 86.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.027 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.29 133.52 12.05 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.924 1.75 . . . . 0.0 112.198 179.351 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.0 tp -76.59 -20.11 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.092 -179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.584 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 75.8 mt 54.99 -121.91 1.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.48 -7.75 40.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.46 -15.63 38.45 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -111.35 -171.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -1.044 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.07 -1.9 23.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -46.43 -40.95 13.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.694 -0.886 . . . . 0.0 110.086 -179.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.84 -52.31 64.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.838 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 57.3 m-85 -63.05 -44.47 95.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 108.762 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -62.94 -37.18 86.04 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.419 0.628 . . . . 0.0 109.77 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -72.06 -48.0 47.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 111.096 -178.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.77 -51.17 14.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.941 -1.099 . . . . 0.0 110.194 -179.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.28 -43.07 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.084 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -54.31 -32.15 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -83.06 -0.87 51.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.139 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.82 33.25 3.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.248 -0.908 . . . . 0.0 111.149 -179.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.0 mt -94.05 144.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.513 -1.367 . . . . 0.0 110.125 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -132.04 161.61 32.78 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.556 HD21 ' H ' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -108.66 146.27 33.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.059 -1.026 . . . . 0.0 110.388 -179.447 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.638 HE22 HD21 ' A' ' 86' ' ' ASN . 1.4 mt-30 -105.09 -162.41 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.078 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.03 -0.01 12.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.299 -0.875 . . . . 0.0 110.629 -179.208 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -93.28 147.49 22.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.832 -1.167 . . . . 0.0 110.043 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -84.1 131.0 34.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.423 -0.798 . . . . 0.0 109.555 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 80.1 mt -71.69 141.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.965 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.15 104.39 16.4 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -78.6 146.68 34.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 111.095 -178.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.84 121.9 33.88 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.82 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 -179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.05 136.75 22.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -116.42 -11.22 11.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.735 . . . . 0.0 109.113 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -142.07 142.82 25.77 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.28 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.82 152.64 52.77 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.033 1.822 . . . . 0.0 112.953 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 tt -145.94 141.7 21.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.672 -0.642 . . . . 0.0 109.332 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.2 mp -128.29 123.2 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 109.5 -179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.4 116.69 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.515 -0.74 . . . . 0.0 109.654 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -108.85 140.08 42.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.299 -0.876 . . . . 0.0 109.29 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.41 126.51 2.3 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.735 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.489 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 46.1 mt-10 52.75 39.14 28.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.752 -0.593 . . . . 0.0 112.389 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.52 5.22 89.35 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.424 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.489 ' NH2' ' OE1' ' A' ' 135' ' ' GLU . 5.5 mtt180 -107.05 164.24 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.509 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 5.9 tt -159.75 151.2 19.87 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 119.948 -1.72 . . . . 0.0 109.213 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.509 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 13.1 mt -146.97 130.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -122.8 140.28 53.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.161 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -116.99 148.18 41.66 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -146.19 137.03 12.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.28 144.43 71.38 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.325 1.35 . . . . 0.0 112.166 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.04 148.16 11.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.37 -1.96 43.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.3 p -136.35 150.23 48.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.6 tp -82.2 117.43 22.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.952 -179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -136.24 137.51 40.87 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 74.0 t -136.92 123.65 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 -179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 m -111.15 132.66 54.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.594 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -116.89 129.01 55.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.28 111.59 21.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.06 156.89 15.81 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 250' ' ' ARG . 36.4 mt-10 -138.33 95.16 2.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.349 -1.089 . . . . 0.0 109.387 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -94.78 148.27 22.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 109.616 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -91.17 0.48 57.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.767 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.9 p30 -78.66 -173.6 3.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.355 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -53.21 -18.92 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.208 -179.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 16.7 mt -65.43 -62.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.018 -1.051 . . . . 0.0 109.659 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.94 -125.3 8.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -109.63 139.35 44.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -1.081 . . . . 0.0 109.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.75 150.45 29.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 152.67 48.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.635 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -136.51 124.78 23.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 0.0 109.109 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.466 ' O ' ' CG2' ' A' ' 165' ' ' THR . 13.7 t -98.35 122.28 41.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.089 -1.007 . . . . 0.0 110.006 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.4 t80 -97.48 137.28 36.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 108.846 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.556 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -133.2 150.24 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -56.1 122.35 11.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 109.496 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.05 -18.85 14.0 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -116.16 36.35 4.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.069 -1.253 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.33 -31.57 72.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 110.525 -179.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.28 -14.06 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.693 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.28 -3.87 57.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 5.3 pt -122.83 10.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.992 -1.067 . . . . 0.0 111.033 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.93 -31.8 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.867 -1.146 . . . . 0.0 109.958 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.89 2.23 46.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.828 -1.17 . . . . 0.0 110.489 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.71 133.3 35.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -105.41 154.08 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 -179.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -55.65 159.6 2.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.43 166.25 25.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.017 -1.052 . . . . 0.0 110.148 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.565 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.5 OUTLIER -152.52 163.25 39.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 109.458 179.854 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.548 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 70.7 m-85 -104.53 144.03 32.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.633 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -61.28 -25.91 67.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.817 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.548 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.2 p90 -77.52 -25.32 50.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.776 -1.203 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.465 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 10.0 pt-20 -100.96 -11.9 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 109.993 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 6.9 mt -57.34 -52.36 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.116 -0.99 . . . . 0.0 110.449 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.42 -53.72 33.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 0.0 109.975 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -52.88 -42.33 65.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.073 -1.017 . . . . 0.0 109.187 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 189' ' ' ILE . 97.0 mt -66.07 -33.77 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.021 179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -78.69 -26.06 44.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.783 . . . . 0.0 110.335 -179.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 193' ' ' GLY . 0.4 OUTLIER -80.74 -32.46 35.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.995 -1.065 . . . . 0.0 110.181 -179.448 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.8 m -73.76 8.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.015 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 78.83 20.48 70.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.233 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 27.9 mt -117.22 154.86 30.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.196 -1.179 . . . . 0.0 109.764 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 83.3 23.15 55.35 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.421 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -66.2 -23.96 66.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.617 -1.519 . . . . 0.0 109.756 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.07 -5.89 49.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.83 130.69 45.6 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.129 -1.218 . . . . 0.0 110.773 -178.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 6.9 p -134.82 -173.74 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.668 -0.901 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.8 -17.48 29.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -89.11 -8.54 53.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 202' ' ' ASN . 0.5 OUTLIER -127.96 -14.18 5.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.754 -179.627 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -125.4 115.01 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.0 tp -77.14 109.97 11.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 108.668 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 44.1 t -97.64 125.92 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 110.012 -179.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 28.5 mt -99.1 143.26 29.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.623 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.64 144.46 15.82 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 3.9 pttt -41.52 -23.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -1.191 . . . . 0.0 110.299 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.2 p-10 -152.67 11.92 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.565 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -148.89 157.98 43.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.972 -1.08 . . . . 0.0 110.419 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.55 127.86 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -73.62 -54.86 7.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.028 -1.045 . . . . 0.0 110.55 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.95 111.35 2.9 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.027 . . . . 0.0 110.169 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.45 -8.49 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.864 1.709 . . . . 0.0 112.292 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -88.06 -7.74 56.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 109.869 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.88 -167.36 48.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.06 145.3 25.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.414 -1.05 . . . . 0.0 110.165 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -88.17 -17.55 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.387 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -144.95 134.41 23.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.39 -23.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.062 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.477 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -124.95 35.72 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.078 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.448 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 5.1 tt0 -55.4 -57.97 17.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 111.638 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 10.5 Cg_endo -54.19 -39.96 84.05 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.955 1.77 . . . . 0.0 113.105 -178.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.5 m -80.2 -26.66 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 120.667 -1.27 . . . . 0.0 109.017 179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 18.7 mtt180 -66.65 -43.27 85.04 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -62.01 -42.35 99.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.564 ' HZ1' ' C6G' ' A' ' 320' ' ' TUX . 3.7 mmtp -56.78 -39.04 73.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 108.931 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.41 -40.89 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.578 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.7 t80 -59.1 -37.48 77.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 91.0 m-20 -76.07 -40.87 52.18 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.563 -0.711 . . . . 0.0 109.671 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.6 tp -55.47 -36.71 66.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 108.836 -179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.498 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 77.9 mt -73.15 -47.75 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.77 -33.92 28.31 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.44 -26.81 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -1.225 . . . . 0.0 109.852 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.74 -20.71 45.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.761 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.583 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 11.9 t80 -74.24 -9.02 58.19 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.145 -0.972 . . . . 0.0 109.193 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 18.3 mt -50.91 -28.6 10.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.439 ' O ' ' NH2' ' A' ' 49' ' ' ARG . 62.9 mt -58.11 -11.26 2.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 0.0 108.947 179.211 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.54 16.04 81.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 23.1 p -158.48 150.45 17.3 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.071 -1.252 . . . . 0.0 109.219 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -53.28 139.48 63.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.999 1.799 . . . . 0.0 111.519 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.0 t -102.93 133.45 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.383 -179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -118.38 123.92 46.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.755 . . . . 0.0 109.253 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.34 170.75 22.58 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -101.57 112.72 25.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.188 -1.184 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -112.03 148.15 34.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.921 0.867 . . . . 0.0 111.209 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -130.18 144.19 51.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.8 t -137.77 127.93 26.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.0 110.502 -179.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -111.73 113.89 26.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 154' ' ' GLU . 2.3 mtt85 49.81 56.0 8.54 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.01 142.45 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.94 167.45 13.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.538 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -56.5 -45.03 81.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -59.55 -56.01 27.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.83 -36.54 70.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 -179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 62.5 m-20 -59.76 -55.5 33.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 108.721 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 36.5 t -51.05 -40.59 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.308 -0.87 . . . . 0.0 109.148 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -54.81 -47.63 73.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 108.916 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 59.3 tp -53.34 -47.31 69.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.98 -43.19 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.407 ' HZ3' ' HB3' ' A' ' 261' ' ' LYS . 0.0 OUTLIER -55.1 -51.9 64.93 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.446 -0.783 . . . . 0.0 110.384 -179.14 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.83 -43.75 95.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.817 -1.177 . . . . 0.0 110.189 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.18 -42.36 96.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.45 -32.71 58.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 110.334 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -79.26 -31.41 43.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.877 -1.139 . . . . 0.0 109.186 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 268' ' ' LYS . 20.4 mttm -61.21 -43.97 98.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.857 -1.152 . . . . 0.0 108.687 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -73.52 17.16 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.456 -0.778 . . . . 0.0 109.888 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 270' ' ' THR . 41.1 tptt -69.27 -63.07 1.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.917 -1.114 . . . . 0.0 109.087 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.1 mt -45.64 -13.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.471 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 270' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 268' ' ' LYS . 3.4 t . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.565 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.431 0.634 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 33' ' ' GLU . 10.6 mt-10 -54.99 152.39 7.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.247 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 145.9 51.5 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.517 -0.74 . . . . 0.0 109.743 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 177.8 8.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.944 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.66 147.09 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -83.05 -41.17 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.581 -0.699 . . . . 0.0 109.958 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.79 155.18 46.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.955 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -62.9 133.21 54.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.399 -0.813 . . . . 0.0 109.671 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.75 161.96 19.86 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -158.42 152.43 23.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.806 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.8 171.64 14.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.645 -0.66 . . . . 0.0 109.74 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -149.62 137.69 20.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 108.982 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.61 161.0 20.45 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.36 144.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -1.199 . . . . 0.0 111.24 -178.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.53 141.08 39.97 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.2 tt -62.16 -43.52 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -1.233 . . . . 0.0 111.325 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.411 ' H ' HG21 ' A' ' 18' ' ' ILE . 8.2 m-70 -87.98 -39.39 14.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.174 -1.579 . . . . 0.0 111.149 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 p -69.06 -40.43 78.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.27 17.49 78.86 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -114.36 152.58 31.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.989 . . . . 0.0 108.828 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.492 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 5.2 t80 -71.8 139.67 49.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.056 -1.028 . . . . 0.0 110.245 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -146.97 157.72 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 108.819 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 26' ' ' LEU . 25.2 ttpt -127.07 157.71 38.9 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 109.704 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' N ' ' HG3' ' A' ' 25' ' ' LYS . 12.6 mt -126.56 144.86 50.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.982 -1.074 . . . . 0.0 108.397 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.469 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.2 mt -138.62 132.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.015 179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mt -120.97 128.09 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 109.914 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.574 ' N ' ' CD2' ' A' ' 29' ' ' HIS . 1.4 m-70 -125.7 149.02 64.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.56 157.64 35.85 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.179 1.92 . . . . 0.0 111.38 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 41.2 mm-40 -135.83 162.9 31.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.5 tttp -64.77 150.37 47.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.5 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -47.81 148.91 1.42 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.573 -179.373 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.488 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 59.86 25.45 61.6 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.527 -0.733 . . . . 0.0 112.089 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.5 m -80.16 -37.07 34.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.467 -1.608 . . . . 0.0 109.068 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.637 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 94.23 -172.69 32.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 HG22 HD12 ' A' ' 37' ' ' ILE . 6.9 mm -100.42 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.164 -1.198 . . . . 0.0 108.338 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -139.4 143.81 37.84 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.392 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.5 153.63 19.54 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.532 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 2.8 t80 -124.3 147.93 47.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 13.5 tttt -173.75 133.48 0.46 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.777 -1.202 . . . . 0.0 109.218 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.639 ' ND2' ' O ' ' A' ' 42' ' ' ASN . 0.7 OUTLIER 52.95 29.54 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.493 -0.754 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.71 -9.88 48.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.599 ' CG2' HD22 ' A' ' 42' ' ' ASN . 20.6 t -94.43 139.34 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -1.227 . . . . 0.0 110.22 -179.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -97.36 146.2 25.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.419 -0.801 . . . . 0.0 108.923 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.5 mt -138.1 97.03 9.93 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.47 141.19 33.81 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.243 1.962 . . . . 0.0 111.499 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.19 84.31 5.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.878 -1.139 . . . . 0.0 110.58 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -141.27 157.62 44.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.135 -0.978 . . . . 0.0 109.284 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.69 ' HD1' ' H ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -52.52 -49.74 64.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.117 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.69 ' H ' ' HD1' ' A' ' 50' ' ' HIS . 16.4 mt-10 -48.77 -16.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 110.076 -179.598 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' HIS . 73.4 m-85 -97.37 6.08 48.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.052 -1.03 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -64.59 129.31 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.951 . . . . 0.0 109.383 179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.62 -29.51 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.38 -0.825 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.441 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 7.8 t-80 -152.92 122.61 6.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.788 -1.195 . . . . 0.0 109.814 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.6 p -113.34 133.12 55.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.7 t-20 -166.98 -154.04 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -47.04 -13.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.069 -1.02 . . . . 0.0 108.317 178.945 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -135.23 165.7 24.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.591 -0.693 . . . . 0.0 109.401 -179.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.446 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 7.4 m -103.93 122.24 44.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 108.604 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -120.2 136.92 54.47 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.053 0.93 . . . . 0.0 111.528 -178.692 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.8 mt -117.69 158.21 25.11 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.77 143.11 6.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.652 -1.737 . . . . 0.0 110.908 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.08 151.55 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.617 -0.931 . . . . 0.0 109.758 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp 56.79 27.61 13.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.521 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.52 -0.43 83.05 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 91.3 mm-40 -94.84 138.77 32.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.968 -1.313 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -134.28 146.7 50.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.963 . . . . 0.0 111.27 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.4 mt -134.89 145.88 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -114.61 152.75 31.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.222 -0.924 . . . . 0.0 111.799 -178.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.419 ' O ' ' CG2' ' A' ' 71' ' ' THR . 45.7 m 53.94 71.68 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.557 . . . . 0.0 111.307 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -113.5 -1.44 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.033 -1.042 . . . . 0.0 109.286 178.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.54 -39.59 73.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 110.576 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -54.38 -60.59 3.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.066 -1.021 . . . . 0.0 110.241 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -58.54 -46.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 109.232 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.49 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 64.8 mt -55.49 -38.72 69.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.074 -1.016 . . . . 0.0 109.43 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -59.01 -48.24 82.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.564 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.2 -54.18 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 108.499 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -52.39 -46.38 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.507 -0.746 . . . . 0.0 109.246 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.618 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 15.4 t-160 -55.58 -53.69 53.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.827 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.89 -38.63 91.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.363 -0.836 . . . . 0.0 110.368 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.7 mt -78.37 -4.46 48.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.736 -178.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.28 51.55 2.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.729 -1.232 . . . . 0.0 110.405 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.7 mm -98.45 124.46 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.5 p -111.55 -18.95 12.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.322 -0.861 . . . . 0.0 112.437 -177.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.637 HD21 ' H ' ' A' ' 36' ' ' GLY . 5.6 m120 -129.94 111.86 12.96 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.512 -1.367 . . . . 0.0 110.633 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 2.7 m -164.62 143.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.228 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.542 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.7 m -112.19 101.07 9.34 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mt -92.1 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.579 -0.701 . . . . 0.0 109.706 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.71 123.08 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.736 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 t -107.46 106.27 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 110.954 -178.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.22 111.02 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.12 -161.62 23.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -115.37 -14.51 11.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.534 ' OE1' ' O ' ' A' ' 96' ' ' ILE . 1.2 tm-20 -140.86 146.61 37.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.995 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.534 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 3.3 mm -68.95 124.06 89.49 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 109.97 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.57 130.99 9.64 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.083 1.855 . . . . 0.0 112.171 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.53 -30.27 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.451 -0.78 . . . . 0.0 109.727 -179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt 56.48 -108.77 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.805 . . . . 0.0 110.129 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -94.17 -22.9 18.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 110.736 -178.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.49 -10.23 19.48 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.23 -170.95 1.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -1.024 . . . . 0.0 109.757 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.07 -4.67 25.68 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -46.29 -38.8 9.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.707 -0.878 . . . . 0.0 110.302 -179.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.42 -52.04 66.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 110.013 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.56 -43.4 97.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 108.695 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 18.7 t80 -63.64 -36.71 84.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.74 -0.6 . . . . 0.0 110.014 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -72.75 -49.94 27.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.28 -0.887 . . . . 0.0 111.956 -178.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.38 -44.55 58.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.824 -1.172 . . . . 0.0 110.977 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.2 -39.97 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.073 . . . . 0.0 110.391 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 16.0 tpt180 -54.11 -32.59 55.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 0.0 109.759 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -82.1 -13.41 57.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.929 -1.107 . . . . 0.0 110.14 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -121.37 32.07 6.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 111.018 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.1 mt -82.74 148.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.509 -1.37 . . . . 0.0 110.373 179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -128.63 149.57 50.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -97.68 146.14 25.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.042 -1.036 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.56 -168.45 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.0 109.813 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -124.43 72.73 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.513 -0.742 . . . . 0.0 110.589 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 119' ' ' ARG . 6.2 ttm-85 -168.63 149.48 4.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.968 . . . . 0.0 109.461 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -83.3 126.87 33.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.4 mt -67.09 135.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.456 -0.778 . . . . 0.0 110.765 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.52 73.69 1.94 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -52.31 141.31 19.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.538 -0.726 . . . . 0.0 110.479 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -104.99 125.57 51.12 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.8 t -128.75 142.88 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.253 -0.904 . . . . 0.0 110.266 -179.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.13 135.26 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -116.53 -11.43 11.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.214 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.42 143.62 30.8 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.05 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.61 161.51 41.9 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.109 1.873 . . . . 0.0 113.182 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 130' ' ' ILE . 1.9 tt -155.4 140.0 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.65 -0.656 . . . . 0.0 109.584 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 mp -127.86 124.33 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.36 118.84 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.724 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -115.58 133.6 55.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.417 -0.802 . . . . 0.0 109.583 179.862 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 34.1 t0 -173.43 150.65 1.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.18 -0.95 . . . . 0.0 110.759 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 10.9 mt-10 57.57 22.32 8.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.541 -0.724 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.26 6.99 88.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -105.34 171.64 7.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 7.1 tt -159.63 149.57 18.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.457 -1.402 . . . . 0.0 109.028 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.466 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 12.0 mt -147.69 139.06 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -131.26 142.68 50.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.118 -0.989 . . . . 0.0 109.654 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.35 145.82 48.44 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.34 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -142.48 135.1 13.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.53 147.96 36.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.272 1.315 . . . . 0.0 112.053 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.99 154.23 8.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.364 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.98 0.73 50.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -136.98 151.79 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 34.1 tp -87.37 117.92 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 110.027 -179.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -136.18 142.93 44.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 69.5 t -135.93 118.31 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 109.907 -179.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.5 m -105.19 127.1 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.178 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -121.36 130.07 53.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -112.27 104.94 13.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.1 129.51 9.93 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.62 97.32 6.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -1.091 . . . . 0.0 109.169 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 160' ' ' GLY . 24.5 m-85 -99.63 148.92 23.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.188 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -92.87 -10.17 37.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.821 . . . . 0.0 109.934 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.691 HD21 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -70.34 -167.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.918 . . . . 0.0 110.103 -179.284 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -60.12 -24.49 64.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.355 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.434 ' HB2' HD22 ' A' ' 157' ' ' ASN . 6.6 mt -64.93 -40.65 95.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.939 -1.101 . . . . 0.0 108.871 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 76.97 -107.52 2.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -122.01 140.69 52.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.937 . . . . 0.0 109.692 -179.577 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -144.44 158.04 43.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -142.89 144.48 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -137.01 123.89 21.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.344 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 9.1 m -104.67 124.55 49.55 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.204 -0.935 . . . . 0.0 110.198 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -99.67 130.13 45.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.24 147.78 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.502 -0.749 . . . . 0.0 109.46 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.04 115.62 1.49 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.349 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.22 4.89 17.75 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.45 28.85 3.98 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.304 -1.115 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.75 -33.26 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.733 -0.604 . . . . 0.0 110.473 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -58.55 -9.97 1.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.085 -1.009 . . . . 0.0 110.697 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.38 -4.84 33.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.791 -1.193 . . . . 0.0 110.793 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.3 pt -117.65 13.05 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 110.722 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.13 -26.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.018 -1.051 . . . . 0.0 110.027 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.6 0.8 57.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.85 -1.156 . . . . 0.0 110.706 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.51 115.39 20.0 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.994 -1.067 . . . . 0.0 109.006 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -84.02 151.68 24.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.135 -0.978 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 t -59.24 132.64 54.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.323 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.542 ' CZ ' ' O6G' ' A' ' 320' ' ' TUX . 23.2 p90 -110.96 170.2 8.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.983 -179.352 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.579 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 1.8 t -154.21 162.99 40.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.441 -0.787 . . . . 0.0 109.475 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.473 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 71.5 m-85 -104.6 144.6 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.407 -0.808 . . . . 0.0 109.495 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -25.85 67.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.756 -1.215 . . . . 0.0 110.385 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.0 p90 -81.83 -30.09 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.8 -1.188 . . . . 0.0 110.413 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.5 pt-20 -87.41 -16.96 33.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.784 -1.197 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.83 -53.36 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.149 -0.969 . . . . 0.0 110.131 -179.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.52 -53.19 40.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.919 -1.113 . . . . 0.0 109.624 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.87 -44.51 66.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 109.053 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.7 mt -64.85 -33.42 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.065 179.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -78.3 -27.73 47.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -76.78 -28.15 55.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 109.937 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.4 m -82.61 9.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 109.782 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.56 72.78 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.633 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.8 157.93 27.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.211 -1.17 . . . . 0.0 109.669 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.63 21.64 63.61 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.148 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.36 -22.89 63.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.588 -1.537 . . . . 0.0 109.87 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -100.65 -3.16 55.26 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.6 128.74 35.73 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 121.086 -1.243 . . . . 0.0 110.459 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 202' ' ' ASN . 0.3 OUTLIER -138.29 162.23 34.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.738 -0.86 . . . . 0.0 109.265 179.847 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.93 -31.45 72.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.962 . . . . 0.0 110.105 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -75.47 -14.6 60.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.07 -1.019 . . . . 0.0 110.248 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.496 ' OD1' ' OG ' ' A' ' 199' ' ' SER . 0.3 OUTLIER -130.34 9.87 5.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -179.511 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.7 m -150.36 123.56 8.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.42 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.16 115.49 22.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.189 -0.944 . . . . 0.0 109.24 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.56 126.75 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.4 mt -102.44 141.91 34.51 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.456 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.06 149.6 19.1 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.1 OUTLIER -42.24 -29.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.895 -179.578 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 8.5 t0 -149.71 14.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 110.163 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 207' ' ' GLY . 9.9 mtpm? -146.85 155.71 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.038 . . . . 0.0 110.272 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.5 t -101.44 127.6 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.78 -54.63 8.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.329 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.14 131.32 68.69 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.938 -1.101 . . . . 0.0 109.325 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.03 -14.57 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.175 1.917 . . . . 0.0 112.574 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.78 -6.12 59.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.126 -0.984 . . . . 0.0 109.724 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.22 -167.93 51.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 49.6 mt -82.79 146.15 29.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -1.013 . . . . 0.0 109.935 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -89.48 -20.74 23.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.241 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.513 ' C ' ' H ' ' A' ' 221' ' ' ASN . 69.2 m-85 -141.57 139.51 33.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.377 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -11.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 108.6 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.705 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -141.87 38.03 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.731 0.777 . . . . 0.0 109.066 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.4 OUTLIER -58.18 -36.54 45.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 111.05 -179.472 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.47 -44.3 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.837 1.691 . . . . 0.0 112.54 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.14 -24.45 16.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.765 -1.209 . . . . 0.0 108.49 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.705 HH21 ' ND2' ' A' ' 221' ' ' ASN . 6.3 mtt180 -67.64 -41.87 83.2 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -63.08 -42.78 99.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -56.66 -47.63 79.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.068 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.59 -44.54 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 61.3 t80 -55.13 -37.42 66.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.645 -0.66 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 3.7 m-20 -76.34 -38.84 55.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.499 -0.751 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.92 -37.62 71.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.092 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.422 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 74.2 mt -73.1 -48.61 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.07 -34.56 16.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.22 -26.89 32.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -1.13 . . . . 0.0 110.189 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.5 mt -78.13 -22.62 48.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 109.758 179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.618 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 6.6 t80 -70.45 -5.4 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.105 -0.997 . . . . 0.0 108.83 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 14.0 mt -52.24 -30.55 28.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 87.7 mt -56.29 -17.9 9.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 82.96 14.51 74.93 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.4 p -158.31 151.89 19.25 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.245 . . . . 0.0 109.458 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -49.94 131.31 29.64 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.161 1.907 . . . . 0.0 111.511 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 19.6 t -98.07 135.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 109.877 -179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.12 126.03 47.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.466 -0.771 . . . . 0.0 109.447 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.61 170.37 21.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -99.79 113.47 26.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.048 -1.266 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.3 m-85 -112.12 148.44 33.97 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.073 0.94 . . . . 0.0 111.148 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -128.15 144.53 51.12 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.1 t -144.86 124.82 13.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.42 -1.425 . . . . 0.0 110.413 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.418 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.3 t80 -109.8 116.55 31.88 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.6 OUTLIER 45.31 56.33 5.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.314 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -88.01 152.66 23.94 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -120.0 -177.81 16.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.15 -51.51 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 0.0 109.714 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -34.54 70.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.985 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 48.6 tp -72.87 -40.34 65.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.016 . . . . 0.0 108.834 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -61.01 -51.06 70.84 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.2 t -51.32 -44.58 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.0 109.171 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -54.88 -49.11 71.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 108.905 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.9 tp -52.93 -40.14 63.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.822 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 60.7 t -74.72 -41.54 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.442 -0.786 . . . . 0.0 109.708 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.54 -48.16 82.74 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 110.158 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -47.45 73.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.932 -1.105 . . . . 0.0 109.621 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.51 -43.74 89.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.325 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.27 73.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 110.084 -179.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -84.62 -24.41 29.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.725 -1.234 . . . . 0.0 108.865 179.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -69.71 -44.96 69.3 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.274 -0.891 . . . . 0.0 109.478 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.627 ' C ' ' H ' ' A' ' 269' ' ' LEU . 11.1 tt0 -79.07 15.12 1.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 110.16 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.05 33.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.988 -1.07 . . . . 0.0 109.825 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.627 ' H ' ' C ' ' A' ' 267' ' ' GLN . 9.5 mt -65.25 -5.97 8.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 0.0 109.371 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 179.874 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.579 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 3' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 67.7 mt-10 -50.0 147.9 3.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 109.507 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.63 139.33 53.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.596 -0.69 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -138.57 173.8 11.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.459 -0.776 . . . . 0.0 108.92 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -84.41 141.39 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.722 -1.236 . . . . 0.0 110.278 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -71.15 -44.47 65.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.661 -0.649 . . . . 0.0 109.957 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.03 159.56 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 136.3 57.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.717 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 157.36 25.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -147.57 145.57 29.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 110.186 -179.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -132.17 163.37 28.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.99 135.57 19.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.889 -1.132 . . . . 0.0 108.718 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 159.13 19.08 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.62 146.8 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.243 . . . . 0.0 110.762 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.71 143.62 38.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.1 tt -67.74 -38.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.149 . . . . 0.0 112.786 -178.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.417 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.9 m-70 -85.93 -35.4 20.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 119.842 -1.786 . . . . 0.0 112.041 -177.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.476 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 5.2 m -85.21 -39.92 17.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.24 16.03 72.79 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -103.39 150.41 23.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -1.125 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.8 t80 -71.34 139.19 49.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.3 t -146.25 157.8 43.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.022 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -132.85 155.78 48.37 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.882 . . . . 0.0 109.533 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.58 144.97 50.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.032 . . . . 0.0 109.103 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.9 129.16 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.3 mt -113.43 123.55 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -117.7 153.32 50.64 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.19 159.28 47.77 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.327 2.018 . . . . 0.0 111.19 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.2 mm-40 -134.12 -178.37 5.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.016 -1.052 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.437 ' O ' ' OG1' ' A' ' 35' ' ' THR . 25.3 tttt -83.04 149.34 27.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.463 -0.773 . . . . 0.0 109.317 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.584 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -46.86 148.27 1.11 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.235 -0.916 . . . . 0.0 110.064 -179.487 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.58 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.49 24.38 59.35 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.18 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.703 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 15.5 m -80.55 -37.64 31.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.673 -1.486 . . . . 0.0 108.961 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.9 -167.09 27.87 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.426 HD12 HG23 ' A' ' 37' ' ' ILE . 2.8 mm -104.02 123.49 57.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -1.103 . . . . 0.0 108.287 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 139.09 42.08 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.969 -1.093 . . . . 0.0 110.863 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -99.7 151.54 21.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.568 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 1.1 t80 -129.49 139.52 51.55 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -170.86 138.76 1.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.016 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.48 28.65 17.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.85 . . . . 0.0 110.022 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.88 22.13 78.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 t -130.83 146.76 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.246 -1.149 . . . . 0.0 109.46 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -98.7 147.75 24.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.173 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.6 mt -140.7 94.64 8.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.77 142.55 18.72 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.206 1.937 . . . . 0.0 111.841 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.52 83.11 6.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.429 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -137.72 153.44 49.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 53' ' ' VAL . 3.0 p80 -52.78 -49.6 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 110.421 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.2 mt-10 -44.29 -30.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.084 -1.01 . . . . 0.0 109.285 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -79.43 3.94 16.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 -179.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' HIS . 9.5 t -56.62 131.65 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.1 m -122.32 -35.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.341 -0.849 . . . . 0.0 110.428 -179.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.5 t-160 -150.2 119.74 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.272 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.2 p -113.37 131.48 55.96 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.375 0.607 . . . . 0.0 109.465 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.607 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -167.1 -153.25 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.717 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 57' ' ' ASN . 13.6 m-70 -45.55 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.067 -1.02 . . . . 0.0 108.681 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 57' ' ' ASN . 10.9 t -135.41 165.7 24.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.365 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.402 ' HG1' ' CD ' ' A' ' 73' ' ' GLU . 3.8 m -104.08 122.5 45.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.778 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 3.4 m-20 -121.39 139.78 53.0 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.092 0.949 . . . . 0.0 111.434 -178.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.56 158.08 29.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.75 144.82 7.61 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.639 -1.743 . . . . 0.0 110.687 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -144.24 150.9 38.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.53 -0.983 . . . . 0.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm 56.75 23.87 8.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.0 110.941 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.98 70.45 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.718 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.495 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 17.3 mm100 -98.2 142.15 30.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.971 -1.311 . . . . 0.0 108.222 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -138.33 150.99 47.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 111.365 -179.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.63 143.04 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -110.73 149.81 29.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.223 -0.923 . . . . 0.0 111.236 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m 54.21 67.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 111.471 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.48 -3.56 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 108.997 178.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pt-20 -71.39 -26.0 62.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.318 -179.306 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -65.6 -60.51 2.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 0.0 109.635 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.6 tp -56.74 -44.1 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.124 -0.985 . . . . 0.0 108.922 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.471 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 7.7 mt -55.79 -38.23 69.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.993 . . . . 0.0 109.46 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.8 t -60.84 -49.02 79.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.656 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.0 t -57.19 -54.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.012 . . . . 0.0 108.585 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -51.63 -44.32 62.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 11.7 t-160 -54.42 -53.52 53.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.856 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.85 -36.95 84.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.9 mt -76.36 -7.48 55.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.138 -179.379 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.06 47.37 4.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.598 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.3 mm -92.4 122.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.7 p -111.26 -21.83 11.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.283 -0.885 . . . . 0.0 112.134 -177.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.703 ' ND2' ' H ' ' A' ' 35' ' ' THR . 5.7 m120 -126.22 111.35 14.49 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.789 -1.195 . . . . 0.0 109.677 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -164.69 140.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.165 -0.959 . . . . 0.0 109.957 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.5 m -110.81 99.58 8.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.03 110.1 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.9 122.27 30.54 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.65 108.44 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 111.003 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.16 110.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.91 -160.06 22.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.43 -15.26 9.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -136.19 142.1 44.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.204 -179.56 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -68.23 126.22 92.44 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.53 -0.731 . . . . 0.0 109.707 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -45.98 131.25 13.73 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.946 1.764 . . . . 0.0 112.388 179.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.34 -26.34 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.455 -0.778 . . . . 0.0 109.827 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 10.1 mt 54.65 -111.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -95.55 -17.71 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.911 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.03 0.84 33.83 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.406 ' HG ' ' H ' ' A' ' 104' ' ' TRP . 21.0 p -129.27 -167.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.982 . . . . 0.0 109.503 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -4.92 19.62 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.568 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 63.0 t-105 -47.1 -41.13 16.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.775 -0.838 . . . . 0.0 110.413 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.63 -51.89 66.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 109.967 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -62.56 -43.99 97.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 108.828 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' A' ' 107' ' ' TYR . 10.1 t80 -63.52 -39.21 93.84 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.481 0.658 . . . . 0.0 110.059 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.568 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 18.8 mm-40 -69.78 -48.63 58.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.44 -0.787 . . . . 0.0 111.479 -178.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.45 -51.35 11.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.927 -1.108 . . . . 0.0 110.965 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.92 -43.89 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.009 -1.057 . . . . 0.0 110.967 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -28.88 63.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 109.802 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -13.07 59.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.012 -1.055 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.97 34.3 5.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.594 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 114' ' ' ILE . 12.4 mt -90.77 147.54 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.797 -1.189 . . . . 0.0 110.474 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.1 tp -131.75 158.59 40.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.063 179.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.702 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -101.75 146.16 28.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.681 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.49 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.2 mt-30 -112.66 -166.42 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 0.0 109.616 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.96 72.53 1.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 110.672 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -163.3 140.68 7.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 109.748 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 121' ' ' ILE . 3.0 tm-20 -78.31 124.09 27.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.343 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.492 ' O ' ' OE2' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -71.58 141.04 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.724 -178.894 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -85.36 86.43 7.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -63.24 146.7 52.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.6 122.65 44.24 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.1 138.46 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.333 -0.854 . . . . 0.0 110.461 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.06 136.23 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -117.78 -9.12 10.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.03 143.57 28.63 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.407 -0.808 . . . . 0.0 109.162 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.66 161.63 44.65 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.232 1.955 . . . . 0.0 112.989 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.517 ' CD1' ' HZ2' ' A' ' 266' ' ' LYS . 11.5 tt -150.64 144.0 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.651 -0.656 . . . . 0.0 109.46 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.17 122.55 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.46 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.55 118.79 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.466 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -120.28 136.32 54.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.49 -0.756 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.19 150.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 110.503 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 55.94 24.45 7.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.653 . . . . 0.0 110.996 179.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.95 87.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -108.77 169.12 8.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.074 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -159.95 153.57 22.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.151 -1.593 . . . . 0.0 109.465 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.525 ' N ' ' CD2' ' A' ' 138' ' ' LEU . 37.5 mt -148.57 136.05 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -126.14 142.1 51.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.996 -179.073 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.13 148.12 44.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 5.0 tm-20 -145.97 137.48 12.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.487 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 8.3 Cg_endo -53.84 146.5 45.64 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.744 1.63 . . . . 0.0 112.605 -179.147 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.75 11.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.21 1.43 48.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.49 ' OG1' ' OE2' ' A' ' 168' ' ' GLU . 2.4 p -137.88 150.33 47.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.479 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 24.2 tp -81.88 117.16 21.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 110.042 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -138.69 136.3 35.69 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.18 139.62 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.92 . . . . 0.0 109.985 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.0 m -125.15 140.37 52.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.335 -0.853 . . . . 0.0 109.625 179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.402 ' HH ' ' HD2' ' A' ' 227' ' ' LYS . 85.7 t80 -125.51 129.97 50.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.707 . . . . 0.0 109.81 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -115.07 111.17 20.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -106.0 146.87 16.13 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -128.15 86.19 2.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -1.093 . . . . 0.0 109.233 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 2.9 m-30 -94.28 149.2 21.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.95 -9.67 47.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.521 -0.737 . . . . 0.0 110.433 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -66.48 -172.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.022 -1.049 . . . . 0.0 109.616 -179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -55.2 -24.54 27.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.05 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.93 -43.01 97.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.044 -1.035 . . . . 0.0 109.432 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.78 -119.9 5.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -114.8 140.88 48.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.421 -1.046 . . . . 0.0 109.311 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.02 140.27 16.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.813 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -124.42 151.76 44.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.521 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 81.1 t80 -136.03 121.12 18.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -0.933 . . . . 0.0 109.05 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 48.7 m -99.47 122.72 42.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 167' ' ' VAL . 2.3 t80 -95.79 134.34 38.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.527 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.8 t -129.69 157.5 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.533 -0.73 . . . . 0.0 109.319 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 168' ' ' GLU . 28.9 mp0 -60.48 116.17 4.12 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.58 6.17 17.72 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -135.87 29.74 3.13 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.037 -1.272 . . . . 0.0 108.918 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.97 -30.7 70.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 110.405 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -54.34 -9.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 110.66 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.88 -4.22 25.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.905 -1.122 . . . . 0.0 111.256 -178.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.563 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.3 pt -116.66 13.4 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.041 -1.037 . . . . 0.0 110.979 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.47 -28.6 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.071 -1.018 . . . . 0.0 109.612 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mp -91.08 0.28 57.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.737 -179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.85 119.51 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 108.239 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -88.45 150.11 23.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.197 . . . . 0.0 109.963 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 179' ' ' THR . 1.9 t -58.06 129.37 41.63 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.488 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 14.6 p90 -109.16 166.53 10.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -153.99 159.79 41.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.498 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.594 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 67.9 m-85 -104.08 147.21 27.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 49.0 p30 -60.07 -22.58 62.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.08 -1.013 . . . . 0.0 110.116 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.8 p90 -81.99 -33.08 30.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.91 -1.119 . . . . 0.0 110.53 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 24.4 pt-20 -85.16 -16.39 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.803 -1.185 . . . . 0.0 109.345 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 11.9 mt -59.24 -53.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.235 -0.915 . . . . 0.0 110.058 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 184' ' ' TRP . 2.9 mp0 -51.49 -53.57 36.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.196 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -47.66 65.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 108.924 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.29 -34.1 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.0 108.76 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -80.13 -25.87 39.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.843 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.01 -21.27 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.7 m -90.7 13.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.43 25.65 72.16 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.15 167.2 16.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.237 -1.155 . . . . 0.0 109.918 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.9 16.98 80.3 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.457 -0.777 . . . . 0.0 111.314 178.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -64.11 -51.97 61.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.601 -1.529 . . . . 0.0 109.235 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -70.2 -4.38 49.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -178.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.66 130.0 39.67 Favored Glycine 0 N--CA 1.493 2.472 0 O-C-N 120.96 -1.318 . . . . 0.0 110.641 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -143.26 173.58 11.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.749 -0.854 . . . . 0.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.71 -1.81 40.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.641 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -97.24 -10.45 25.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -139.44 13.29 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.516 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 18.0 m -149.29 133.18 17.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.139 -0.975 . . . . 0.0 109.935 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.55 117.23 29.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 108.528 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -105.92 126.59 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.962 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.05 144.15 33.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 0.0 109.396 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 208' ' ' LYS . . . -102.91 153.24 18.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 207' ' ' GLY . 18.0 pttm -41.64 -32.52 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -151.32 13.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.951 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -139.24 147.36 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.6 t -98.2 125.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.032 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -73.0 -54.63 8.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -52.41 139.13 38.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.879 -1.138 . . . . 0.0 109.508 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.21 -38.07 4.05 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.386 2.057 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.49 -4.4 22.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.51 -168.88 53.73 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.47 149.05 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -1.12 . . . . 0.0 109.618 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -58.26 3.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 108.958 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -117.5 170.84 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.94 -18.03 60.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.113 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.699 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -128.23 29.98 5.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 109.537 -179.784 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 pp20? -62.95 -25.06 1.56 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 112.537 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 1.1 Cg_endo -80.57 -46.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.079 1.421 . . . . 0.0 112.082 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.2 m -73.04 -22.1 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.885 -1.135 . . . . 0.0 108.005 179.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.699 HH21 ' ND2' ' A' ' 221' ' ' ASN . 48.8 mtt180 -71.35 -49.63 40.38 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -55.07 -42.57 72.93 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.402 ' HD2' ' HH ' ' A' ' 151' ' ' TYR . 1.0 OUTLIER -57.04 -45.49 83.14 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.288 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 30.9 t -60.76 -50.15 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.584 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 65.2 t80 -49.45 -37.36 25.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 11.1 m-20 -74.65 -39.19 62.22 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.591 -0.693 . . . . 0.0 109.737 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.499 ' CD2' ' HG ' ' A' ' 248' ' ' SER . 25.5 tp -56.64 -36.76 69.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 109.267 -179.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.453 ' CG2' ' ND1' ' A' ' 80' ' ' HIS . 96.9 mt -72.33 -48.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.67 -32.79 17.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.41 -28.07 31.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.187 -1.184 . . . . 0.0 109.899 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.1 mt -79.75 -23.04 42.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.876 -1.14 . . . . 0.0 110.055 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.526 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.4 t80 -71.44 -8.21 52.39 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.035 -1.041 . . . . 0.0 109.09 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 35.7 mt -52.85 -25.87 12.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 46.9 mt -58.56 -21.92 54.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 108.845 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.49 65.99 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.1 p -158.19 149.61 16.77 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.561 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -48.16 134.32 24.58 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.12 1.88 . . . . 0.0 111.583 179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 24.1 t -100.2 133.28 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.024 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -120.25 125.07 47.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.46 172.46 23.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -101.63 117.43 34.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.046 -1.267 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -117.49 147.73 42.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.115 0.96 . . . . 0.0 111.185 -179.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -130.08 138.26 50.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.499 ' HG ' ' CD2' ' A' ' 231' ' ' LEU . 0.3 OUTLIER -133.91 127.01 31.59 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.801 -1.187 . . . . 0.0 110.361 -178.956 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.443 ' O ' ' C ' ' A' ' 250' ' ' ARG . 43.1 t80 -109.22 114.45 28.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.2 OUTLIER 44.31 55.95 5.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.799 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.69 145.88 27.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.3 162.84 12.24 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.489 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 69.8 m-70 -56.47 -50.12 72.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 109.825 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 t -59.07 -55.88 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.656 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.56 -39.67 61.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.079 -1.013 . . . . 0.0 109.508 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -58.24 -54.73 43.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.16 -0.963 . . . . 0.0 108.421 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 13.5 t -48.8 -41.63 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.362 -0.836 . . . . 0.0 109.47 179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -55.28 -48.96 73.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 108.821 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 27.8 tp -52.36 -41.92 63.5 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.1 t -70.57 -45.31 74.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.596 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -53.62 -51.06 64.27 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.451 -0.78 . . . . 0.0 110.265 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -63.19 -47.59 81.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 109.861 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.79 -44.5 93.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.291 -0.881 . . . . 0.0 109.375 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -76.42 -25.6 54.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 108.762 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.517 ' HZ2' ' CD1' ' A' ' 130' ' ' ILE . 17.8 mttt -65.96 -48.15 72.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.593 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 267' ' ' GLN . 1.8 mp0 -83.71 11.23 7.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.046 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -89.29 -20.09 24.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.73 -10.23 55.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.435 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 320' ' ' TUX . . . . . 0.425 HZH3 ' C1A' ' A' ' 320' ' ' TUX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.593 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.31 0.576 . . . . 0.0 109.793 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 134.63 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.667 -0.646 . . . . 0.0 109.458 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -133.62 170.96 14.77 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 7' ' ' VAL . 6.4 m -81.94 132.68 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.665 -1.272 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -49.09 77.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 0.0 109.724 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -128.51 158.24 38.93 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.454 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HE3' HG23 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -58.65 138.73 56.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.573 -0.704 . . . . 0.0 110.254 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.94 161.86 24.55 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -157.91 150.02 22.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.985 -1.072 . . . . 0.0 110.374 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -137.48 160.49 38.99 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.803 . . . . 0.0 109.948 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.11 138.9 24.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.563 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.19 158.56 16.63 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.46 161.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -1.128 . . . . 0.0 111.069 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.32 140.29 14.96 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.621 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.8 tt -57.57 -52.87 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.133 -1.216 . . . . 0.0 112.451 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.621 ' N ' HG23 ' A' ' 18' ' ' ILE . 15.4 m-70 -86.63 -37.67 17.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.175 -1.578 . . . . 0.0 111.195 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m -75.01 -35.29 61.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.016 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 26.53 71.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.09 152.56 33.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.936 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.5 OUTLIER -71.75 129.56 38.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.953 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.6 t -135.86 156.43 48.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 108.943 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.567 ' C ' HD23 ' A' ' 26' ' ' LEU . 8.2 tttp -135.55 148.26 49.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.065 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.704 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.2 mt -126.18 143.88 50.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.063 -1.023 . . . . 0.0 109.072 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.521 HG23 ' HE3' ' A' ' 10' ' ' LYS . 42.3 mt -126.19 134.17 67.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mt -116.79 130.23 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.059 . . . . 0.0 109.619 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.1 154.02 74.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.71 154.23 75.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.284 1.99 . . . . 0.0 111.353 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.1 mm-40 -133.61 -174.33 3.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.0 ttpt -87.57 149.36 24.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -47.68 152.2 0.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 110.084 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 20.63 53.24 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.338 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.4 m -80.68 -42.97 21.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.641 -1.505 . . . . 0.0 108.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.46 -172.07 27.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.7 mm -99.64 121.38 50.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.979 . . . . 0.0 108.562 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -135.64 145.97 47.39 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.744 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -102.68 150.0 23.88 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -132.29 138.67 47.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.566 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 16.0 tttm -167.19 141.29 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.566 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 1.3 m120 54.23 29.53 10.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 30.11 68.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.86 125.17 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -1.059 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.53 139.18 30.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 108.977 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.45 94.16 17.81 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 110.052 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -48.69 144.41 14.63 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.251 1.967 . . . . 0.0 111.919 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.64 84.92 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.415 ' HB3' HH11 ' A' ' 49' ' ' ARG . 3.1 mmm180 -136.33 154.88 50.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 109.15 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 19.0 p-80 -50.54 -50.15 54.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.007 -1.058 . . . . 0.0 109.496 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.9 mt-10 -43.97 -32.48 1.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 109.48 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.65 3.32 19.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.325 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.17 118.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 108.796 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.05 -29.19 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.444 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.0 t-80 -150.18 123.4 8.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.616 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -112.44 136.78 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 59' ' ' SER . 45.2 t30 -166.68 -154.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -50.79 -10.03 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.0 108.17 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -137.76 166.84 22.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.462 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.0 m -105.43 122.04 45.15 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.4 OUTLIER -120.32 140.86 50.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 111.529 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 72' ' ' VAL . 27.6 mt -123.02 154.92 37.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -169.21 141.61 6.82 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.876 -1.631 . . . . 0.0 110.683 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -144.38 150.7 38.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.495 -1.003 . . . . 0.0 110.028 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.76 13.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.717 . . . . 0.0 110.758 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.36 1.02 79.07 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.541 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 28.9 mm-40 -99.79 143.96 29.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.951 -1.323 . . . . 0.0 108.668 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -138.55 149.92 45.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 111.269 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.3 mt -135.33 134.51 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -107.85 156.41 19.19 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.302 -0.874 . . . . 0.0 111.055 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.1 m 53.04 68.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.697 -0.627 . . . . 0.0 110.827 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 62' ' ' LEU . 24.4 m -113.06 -5.21 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.081 -1.012 . . . . 0.0 109.039 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.2 OUTLIER -68.55 -39.19 81.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 110.414 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -54.64 -60.73 2.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.09 -43.59 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.825 -1.172 . . . . 0.0 109.147 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 76.4 mt -57.28 -35.79 70.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.1 t -62.27 -50.26 72.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.984 . . . . 0.0 109.567 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.89 -51.2 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 0.0 108.451 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 76' ' ' LEU . 47.4 mt -51.79 -45.4 63.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.781 . . . . 0.0 109.4 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 9.3 t-160 -54.92 -51.69 65.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.8 mt -63.26 -37.19 86.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.93 . . . . 0.0 110.625 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 114' ' ' ILE . 20.7 mt -82.06 -6.82 59.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.044 -1.035 . . . . 0.0 111.091 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.82 53.99 2.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.299 . . . . 0.0 110.543 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 82' ' ' LEU . 19.0 mm -90.0 126.5 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.566 HG21 HG12 ' A' ' 121' ' ' ILE . 75.5 p -109.75 -26.86 9.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 111.705 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' HG13 ' A' ' 87' ' ' VAL . 5.0 m-80 -131.33 112.7 12.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.817 -1.177 . . . . 0.0 110.715 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -164.04 134.88 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.758 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.547 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 12.1 m -106.03 103.82 13.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -92.35 103.9 15.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 109.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.76 120.45 23.43 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.16 105.8 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.446 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.92 109.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.29 -159.81 23.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.65 -10.13 12.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.536 -0.979 . . . . 0.0 110.77 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -151.98 155.34 37.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.672 -1.268 . . . . 0.0 111.056 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 mm -73.24 124.58 90.71 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.741 -0.6 . . . . 0.0 110.164 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.704 ' CD ' HD21 ' A' ' 26' ' ' LEU . 79.0 Cg_exo -45.8 134.46 13.8 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.069 1.846 . . . . 0.0 112.177 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -80.44 -29.5 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.481 -0.762 . . . . 0.0 110.714 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 65.1 mt 57.59 -126.13 1.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.72 -23.96 39.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 110.242 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.51 -8.66 13.38 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -116.44 -171.34 1.98 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.419 -1.048 . . . . 0.0 109.786 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.76 -2.62 30.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 63.5 t-105 -46.58 -41.8 15.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.87 . . . . 0.0 110.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.67 -52.23 65.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.011 -1.056 . . . . 0.0 110.499 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -64.81 -43.27 93.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 108.894 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -63.72 -36.79 85.03 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.363 0.601 . . . . 0.0 109.958 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.488 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 4.8 mm-40 -68.41 -52.62 30.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.772 . . . . 0.0 111.873 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.71 -50.91 21.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.888 -1.132 . . . . 0.0 110.822 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.36 -43.19 89.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.66 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -53.61 -31.51 47.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.437 ' C ' HD21 ' A' ' 113' ' ' ASN . 8.2 tttm -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 110.13 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.66 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.7 OUTLIER -122.84 28.4 7.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.337 -0.852 . . . . 0.0 111.401 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.613 ' CD1' HD22 ' A' ' 82' ' ' LEU . 4.2 mt -85.73 147.19 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.636 -1.29 . . . . 0.0 109.617 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -131.23 153.71 49.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.768 . . . . 0.0 109.098 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -101.46 143.93 30.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.053 -1.029 . . . . 0.0 109.548 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.596 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 8.6 mt-30 -108.29 -166.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -116.73 70.7 0.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.797 . . . . 0.0 110.565 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -168.19 146.98 4.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.149 -0.969 . . . . 0.0 109.587 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -86.69 135.18 33.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.566 HG12 HG21 ' A' ' 85' ' ' THR . 58.6 mt -81.71 149.76 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -97.24 100.29 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -71.74 147.08 47.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 110.748 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -96.77 121.83 39.06 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.47 135.24 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.396 -0.815 . . . . 0.0 110.316 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.85 133.57 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.5 -10.75 13.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 109.301 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -142.89 143.45 25.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.44 171.88 16.82 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.38 2.053 . . . . 0.0 112.997 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.1 tt -165.74 142.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.699 -0.625 . . . . 0.0 109.694 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.76 125.86 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.509 -0.744 . . . . 0.0 109.833 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 132' ' ' VAL . 31.1 m -121.96 120.06 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.725 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.68 137.44 52.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.17 147.99 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.013 . . . . 0.0 110.829 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 56.84 24.83 9.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.6 -0.688 . . . . 0.0 110.955 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.39 85.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -109.33 169.65 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.6 tt -159.48 152.36 21.79 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.18 -1.575 . . . . 0.0 109.108 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.969 ' N ' HD23 ' A' ' 138' ' ' LEU . 41.6 mt -148.72 139.87 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.0 108.363 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -128.08 142.66 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 110.106 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -121.01 144.91 48.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -143.13 138.87 16.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 108.622 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.32 148.08 73.2 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.415 1.41 . . . . 0.0 111.735 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -167.2 155.9 9.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.1 0.05 55.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -136.44 150.46 48.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 242' ' ' VAL . 24.9 tp -81.74 116.88 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -138.65 134.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.623 ' CG1' HD23 ' A' ' 231' ' ' LEU . 45.9 t -134.63 124.6 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.2 137.55 50.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.02 129.72 49.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.488 -0.757 . . . . 0.0 110.117 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -111.82 103.89 12.18 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.15 140.72 15.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -116.46 101.53 8.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -100.9 142.98 31.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 109.939 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.94 1.86 56.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 0.0 109.561 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.643 HD22 HD12 ' A' ' 159' ' ' LEU . 40.2 p-10 -84.38 -166.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -62.7 -25.17 68.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 110.272 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.643 HD12 HD22 ' A' ' 157' ' ' ASN . 76.8 mt -66.41 -25.34 66.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.009 -1.057 . . . . 0.0 109.398 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.81 47.78 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -93.11 144.99 24.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.995 . . . . 0.0 109.837 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -150.18 137.07 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 147.23 47.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.072 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.687 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 58.3 t80 -136.62 124.11 22.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.8 m -101.64 121.92 42.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.964 . . . . 0.0 109.705 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.55 135.42 41.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.74 151.4 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 109.507 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.536 ' OE2' ' NZ ' ' A' ' 243' ' ' LYS . 19.4 mt-10 -51.67 116.56 2.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.311 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.66 7.42 15.76 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.544 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 14.6 m-80 -134.85 28.39 3.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.179 -1.189 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.578 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 2.4 mp0 -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.752 -0.593 . . . . 0.0 110.582 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.89 -15.51 31.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.624 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -94.91 -4.23 47.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.956 -1.09 . . . . 0.0 110.898 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.546 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 4.2 pt -121.46 13.65 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.946 -1.096 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.87 -25.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.958 -1.089 . . . . 0.0 109.6 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -91.26 2.02 56.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.989 -1.069 . . . . 0.0 110.533 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.48 109.38 16.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.013 -1.054 . . . . 0.0 108.895 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.513 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -82.07 153.4 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 109.917 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.8 t -54.3 156.65 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.778 . . . . 0.0 109.338 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.76 170.68 15.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.875 -1.141 . . . . 0.0 110.119 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.409 ' SG ' ' CD1' ' A' ' 189' ' ' ILE . 3.5 t -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 109.469 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.625 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.5 m-85 -105.47 144.71 31.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.559 -0.713 . . . . 0.0 109.286 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.728 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.2 p30 -60.22 -21.86 62.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.703 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.625 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.2 p90 -81.66 -33.94 31.02 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.625 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.6 pt-20 -88.83 -14.86 35.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.865 -1.147 . . . . 0.0 110.088 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.8 mt -54.79 -52.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.169 -0.957 . . . . 0.0 110.515 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.27 -47.11 62.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 109.544 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -53.65 55.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.975 . . . . 0.0 109.201 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.409 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 66.6 mt -55.43 -34.29 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 108.921 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.581 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 10.5 mmtm -77.04 -30.19 55.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.645 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -71.55 -22.24 61.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 192' ' ' VAL . 13.5 m -91.6 13.31 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.941 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 69.68 27.33 73.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.76 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.87 159.22 27.27 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.251 . . . . 0.0 109.797 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 78.63 28.1 55.73 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.31 -0.948 . . . . 0.0 110.817 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.82 -20.39 63.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.691 -1.476 . . . . 0.0 109.066 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.28 -3.12 51.03 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.86 124.74 33.38 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 203' ' ' THR . 12.0 p -138.92 174.48 10.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.755 -0.85 . . . . 0.0 109.258 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.37 -15.87 60.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.485 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.431 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.2 tttm -87.79 -18.8 28.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 201' ' ' LYS . 1.8 m-20 -124.65 -8.6 7.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.649 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 199' ' ' SER . 0.7 OUTLIER -132.47 119.47 20.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -81.09 117.04 21.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.925 . . . . 0.0 108.9 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.3 t -104.66 128.43 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.784 HD21 HD21 ' A' ' 217' ' ' LEU . 12.3 mt -108.81 148.45 30.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 109.73 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.39 156.05 16.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 207' ' ' GLY . 9.8 tttm -42.13 -33.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -1.141 . . . . 0.0 109.856 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -147.76 16.16 1.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -144.59 153.17 41.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 110.28 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 206' ' ' LEU . 84.6 t -103.12 128.45 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.549 -0.719 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -71.35 -53.97 12.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 0.0 109.996 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -58.67 133.75 86.17 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 109.411 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.43 -8.0 21.87 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.378 2.052 . . . . 0.0 112.708 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.16 -7.81 54.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 0.0 109.918 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.22 -167.68 48.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.784 HD21 HD21 ' A' ' 206' ' ' LEU . 55.4 mt -83.1 145.74 29.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.497 -1.002 . . . . 0.0 110.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -86.02 -20.08 29.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 221' ' ' ASN . 71.7 m-85 -146.22 133.19 20.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 108.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 31.7 mp0 -46.5 -16.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 108.865 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -131.63 33.54 4.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.617 0.722 . . . . 0.0 109.151 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 4.7 tt0 -53.66 -57.31 17.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_endo -54.21 -38.95 88.19 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.902 1.735 . . . . 0.0 113.036 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 228' ' ' VAL . 9.1 m -79.77 -26.46 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.528 -1.357 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 40.3 mtt-85 -64.69 -41.15 96.24 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -65.41 -43.45 90.54 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -48.36 76.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 108.979 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 224' ' ' VAL . 34.8 t -61.07 -42.74 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 108.467 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 89.2 t80 -58.72 -39.21 80.19 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 1.0 OUTLIER -73.03 -39.51 65.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.55 -0.718 . . . . 0.0 109.696 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.623 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.2 tp -56.62 -36.36 69.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.221 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.506 HG22 ' HD1' ' A' ' 80' ' ' HIS . 94.0 mt -70.67 -48.31 59.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.7 -33.28 18.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.44 -26.56 32.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.258 . . . . 0.0 109.897 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.574 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -80.49 -23.19 40.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.762 -1.212 . . . . 0.0 110.11 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.516 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 10.1 t80 -71.65 -8.59 55.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 237' ' ' LEU . 68.9 mt -52.52 -28.03 18.93 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.434 HD21 HG13 ' A' ' 260' ' ' VAL . 94.9 mt -57.27 -13.92 3.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 108.507 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 14.9 81.61 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 84.1 p -158.99 144.67 12.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.829 -1.395 . . . . 0.0 109.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.408 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 71.6 Cg_exo -43.36 129.3 6.35 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.077 1.851 . . . . 0.0 111.662 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 238' ' ' LEU . 10.6 t -96.3 135.25 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.971 . . . . 0.0 110.148 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.536 ' NZ ' ' OE2' ' A' ' 168' ' ' GLU . 26.8 mmtt -120.16 125.27 47.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.53 171.73 24.77 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -102.65 112.27 24.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.068 -1.254 . . . . 0.0 109.769 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.4 m-85 -112.67 146.75 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.825 0.821 . . . . 0.0 111.354 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -128.61 143.06 50.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.69 125.71 21.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.57 -1.331 . . . . 0.0 110.144 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 250' ' ' ARG . 8.9 t80 -109.77 115.22 29.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 17.2 mtt180 44.0 56.0 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -91.92 157.8 24.55 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.593 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -120.3 -171.56 14.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 87.5 m-70 -74.91 -52.09 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -1.207 . . . . 0.0 110.044 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.0 m -55.1 -56.12 23.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.077 -1.014 . . . . 0.0 109.406 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.1 tp -54.26 -42.57 70.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.487 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -59.07 -55.32 36.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.031 . . . . 0.0 108.7 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 7.3 t -52.28 -39.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.895 . . . . 0.0 109.158 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -54.7 -47.79 73.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 108.643 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.66 -50.16 63.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.574 HG22 HD23 ' A' ' 235' ' ' LEU . 53.1 t -61.25 -42.29 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -52.39 65.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.805 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.62 -40.84 96.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.987 -1.071 . . . . 0.0 109.786 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 263' ' ' LEU . 30.1 mt -61.89 -45.99 91.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.07 -27.63 61.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 110.627 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? . . . . . 0 N--CA 1.488 1.445 0 O-C-N 120.687 -1.258 . . . . 0.0 109.039 179.26 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 14.7 mt-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.63 134.33 54.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.568 -0.707 . . . . 0.0 110.121 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -139.2 179.04 6.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 108.766 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 7' ' ' VAL . 7.6 m -87.58 138.06 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.27 . . . . 0.0 110.456 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -73.74 -43.77 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.75 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -125.04 150.04 47.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.177 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 140.04 58.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.814 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.6 mt -122.27 168.04 12.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.586 -0.696 . . . . 0.0 109.198 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.26 148.4 23.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.06 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -135.46 158.02 45.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.498 -0.751 . . . . 0.0 109.588 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -147.89 137.73 22.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.022 -1.049 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.0 160.1 18.69 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.483 HG23 ' C ' ' A' ' 22' ' ' GLU . 9.4 p -81.51 138.61 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -1.186 . . . . 0.0 110.507 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.47 145.28 43.79 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -62.53 -47.88 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.452 -1.028 . . . . 0.0 112.682 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.8 m-70 -87.08 -38.69 16.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.02 -1.675 . . . . 0.0 111.486 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.473 HG21 HD22 ' A' ' 94' ' ' ASN . 3.5 m -74.74 -35.95 62.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.894 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 68.15 22.42 74.34 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.483 ' C ' HG23 ' A' ' 16' ' ' VAL . 9.2 tt0 -110.13 148.75 31.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.443 -1.033 . . . . 0.0 109.116 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -71.59 130.98 42.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 110.026 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -140.09 156.47 46.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' O ' HD23 ' A' ' 26' ' ' LEU . 24.2 tttm -135.31 147.13 49.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -0.974 . . . . 0.0 109.098 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.74 HD11 ' HD2' ' A' ' 97' ' ' PRO . 1.8 mt -128.19 144.53 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.964 -1.085 . . . . 0.0 109.428 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.4 mt -122.14 140.71 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.3 mt -121.03 118.84 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.109 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -117.4 154.08 50.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.2 164.04 35.53 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.296 1.997 . . . . 0.0 111.24 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 13.3 mm-40 -134.36 -175.95 4.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.993 . . . . 0.0 109.842 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 15.6 tttm -91.67 158.73 16.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.613 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -51.61 145.4 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.617 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 63.97 23.35 67.56 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.575 -0.703 . . . . 0.0 111.855 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 93.2 m -82.06 -46.36 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.365 -1.667 . . . . 0.0 109.199 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.6 -171.19 23.79 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mm -96.67 123.42 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -1.151 . . . . 0.0 108.375 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.03 140.26 32.58 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.04 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -100.52 152.32 20.53 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.4 t80 -132.22 137.76 47.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 15.6 tttt -165.76 140.21 4.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 109.478 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.6 29.35 13.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.56 12.62 82.38 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.36 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.02 139.35 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -1.141 . . . . 0.0 109.75 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -98.74 141.46 31.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.095 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 46' ' ' ILE . 12.5 mt -133.45 94.76 19.0 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.2 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -51.4 147.15 22.88 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.261 1.974 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.82 84.83 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.893 -1.129 . . . . 0.0 110.605 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -137.6 153.97 49.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.688 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 2.4 p80 -50.62 -49.36 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.564 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.688 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 86.5 mt-10 -44.38 -33.41 1.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 109.104 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -80.15 0.49 32.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.414 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 50' ' ' HIS . 4.0 t -59.25 126.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 108.746 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.59 -32.25 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 0.0 110.153 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.71 124.36 7.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.708 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 p -112.35 134.03 54.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.9 p-10 -166.63 -153.89 0.17 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' ASN . 6.5 m80 -48.59 -11.4 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.97 -1.081 . . . . 0.0 108.455 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 57' ' ' ASN . 8.5 t -138.16 166.24 24.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.497 -0.752 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.7 m -104.14 122.55 45.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.895 . . . . 0.0 108.717 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.34 141.98 50.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.266 -0.896 . . . . 0.0 111.446 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 72' ' ' VAL . 15.0 mt -125.12 156.43 38.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -170.32 140.44 6.02 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.607 -1.759 . . . . 0.0 110.886 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -144.58 150.61 37.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.963 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt 55.28 32.85 19.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.37 -0.831 . . . . 0.0 110.519 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.83 3.1 89.56 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.346 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 73.8 mm-40 -96.76 140.95 30.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.998 -1.295 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -135.52 144.39 46.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 111.147 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.3 mt -133.7 139.43 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -115.1 154.79 28.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.341 -0.849 . . . . 0.0 111.161 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m 52.41 70.35 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.602 -0.686 . . . . 0.0 110.63 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 62' ' ' LEU . 15.3 m -113.54 -8.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 109.508 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -68.16 -20.38 64.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.371 -179.23 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -71.92 -60.7 2.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.926 -1.109 . . . . 0.0 109.266 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.9 -43.98 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 108.755 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 75' ' ' ILE . 89.6 mt -58.89 -37.53 76.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.809 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.574 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.6 t -61.12 -48.71 80.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.975 . . . . 0.0 109.904 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.61 -53.56 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.95 -1.094 . . . . 0.0 108.611 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -52.45 -44.76 65.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.299 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.582 ' HD1' HG22 ' A' ' 232' ' ' ILE . 15.8 t-160 -54.29 -57.72 10.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.589 HD21 HD13 ' A' ' 232' ' ' ILE . 68.6 mt -57.36 -36.08 70.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.665 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.66 HD22 ' CD1' ' A' ' 114' ' ' ILE . 12.7 mt -82.75 0.54 43.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.72 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.4 27.5 16.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.858 -1.151 . . . . 0.0 110.708 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 82' ' ' LEU . 14.3 mm -73.91 121.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.138 . . . . 0.0 108.351 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.28 -74.63 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 111.227 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.744 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -80.19 114.11 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 111.685 -176.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 86' ' ' ASN . 6.0 m -163.95 142.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.492 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 28.2 m -111.86 101.8 10.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.98 105.97 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.639 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.84 128.5 33.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.845 -1.159 . . . . 0.0 108.329 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 68.6 t -111.52 110.68 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.438 -0.789 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.34 110.27 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.525 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 129.96 -158.14 22.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.473 HD22 HG21 ' A' ' 20' ' ' THR . 0.0 OUTLIER -120.39 -10.14 9.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.492 -1.005 . . . . 0.0 110.483 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 3.3 pm0 -145.56 150.21 35.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.68 -1.263 . . . . 0.0 110.821 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 mm -74.75 122.55 87.74 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.629 -0.67 . . . . 0.0 110.045 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.74 ' HD2' HD11 ' A' ' 26' ' ' LEU . 75.2 Cg_exo -45.97 131.67 13.89 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.118 1.879 . . . . 0.0 112.341 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.436 HD11 ' HA2' ' A' ' 101' ' ' GLY . 7.6 tp -77.39 -24.85 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -0.798 . . . . 0.0 109.981 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.639 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 19.0 mt 58.35 -113.49 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.798 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.74 -19.24 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.982 -1.074 . . . . 0.0 110.855 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 115.05 -11.49 20.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.42 -170.35 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.379 -1.071 . . . . 0.0 109.657 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.8 -4.15 21.46 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -46.62 -40.79 13.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.743 -0.857 . . . . 0.0 110.119 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.52 -51.88 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.048 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.491 ' CZ ' HD11 ' A' ' 99' ' ' LEU . 60.1 m-85 -63.59 -44.08 95.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.4 t80 -63.05 -37.72 88.32 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.465 0.65 . . . . 0.0 109.824 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.96 -49.95 53.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.544 -0.722 . . . . 0.0 111.473 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.6 -51.86 11.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.858 -1.151 . . . . 0.0 110.644 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.16 -43.41 81.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 120.976 -1.077 . . . . 0.0 110.233 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -55.58 -31.29 62.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.457 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -81.85 -5.32 58.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.583 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -127.03 35.31 4.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.425 -0.797 . . . . 0.0 110.887 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.66 ' CD1' HD22 ' A' ' 82' ' ' LEU . 10.9 mt -90.27 145.43 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.801 -1.187 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 115' ' ' LEU . 26.7 tp -131.08 156.6 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -111.6 141.94 44.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.866 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -102.66 -161.19 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.317 -0.864 . . . . 0.0 108.975 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -118.61 2.29 11.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.214 -0.929 . . . . 0.0 111.094 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 4' ' ' GLU . 10.8 ttp85 -100.24 155.99 17.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.796 -1.19 . . . . 0.0 110.136 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 121' ' ' ILE . 13.9 tm-20 -89.07 136.79 32.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.499 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 19.6 mt -76.63 142.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.74 . . . . 0.0 110.694 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -85.22 88.26 7.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.44 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 45.6 m-85 -63.23 144.96 56.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.412 -0.805 . . . . 0.0 110.651 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -102.0 125.16 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 t -129.97 143.98 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.0 135.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.7 -12.78 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.764 . . . . 0.0 109.171 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.91 142.56 28.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 108.941 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.85 159.34 52.07 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.907 1.738 . . . . 0.0 113.122 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.651 HG23 ' HB3' ' A' ' 141' ' ' ALA . 1.5 tt -155.41 138.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.1 mt -127.59 125.71 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.18 113.08 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -117.09 126.91 53.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.493 -0.754 . . . . 0.0 109.707 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -173.67 155.09 2.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.52 20.52 9.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.583 -0.698 . . . . 0.0 110.728 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.3 3.06 88.37 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.592 ' HB2' HD22 ' A' ' 255' ' ' LEU . 1.3 mtt85 -104.8 172.46 6.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.3 tt -160.04 150.39 18.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.335 -1.478 . . . . 0.0 109.015 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.836 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.2 mt -148.05 131.87 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.085 -1.01 . . . . 0.0 109.066 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -120.16 138.97 53.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 109.894 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -124.97 134.84 52.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -133.5 137.76 29.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.56 147.54 29.98 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.291 1.327 . . . . 0.0 111.96 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.44 158.22 9.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.31 2.2 56.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.782 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.2 p -131.91 139.0 48.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 0.0 109.634 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 tp -73.76 116.6 14.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.711 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -137.71 137.1 37.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 108.738 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.574 ' CG1' HD23 ' A' ' 231' ' ' LEU . 75.6 t -140.2 123.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 109.415 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.745 ' OG1' HG23 ' A' ' 165' ' ' THR . 8.9 m -115.56 145.15 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -130.75 130.93 44.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.721 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.11 140.98 48.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.28 144.47 16.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.67 84.49 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.566 -0.961 . . . . 0.0 108.971 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 160' ' ' GLY . 13.6 m-85 -87.02 148.67 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.727 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -93.33 -5.83 48.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 110.037 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.2 p30 -70.43 -167.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.893 -1.13 . . . . 0.0 109.158 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -56.9 -21.59 30.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.005 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.424 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.3 mt -61.74 -57.46 11.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.28 -99.31 2.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -125.89 136.7 53.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -1.111 . . . . 0.0 109.059 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -145.74 159.43 43.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -160.2 150.4 18.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -138.32 127.47 24.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.745 HG23 ' OG1' ' A' ' 150' ' ' THR . 29.3 m -102.12 123.44 45.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.144 -0.973 . . . . 0.0 109.509 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.3 135.99 39.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.103 -0.998 . . . . 0.0 109.537 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.519 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -133.19 154.25 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.735 . . . . 0.0 109.337 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -57.6 118.4 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -0.965 . . . . 0.0 109.666 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.68 1.27 21.4 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.77 31.42 3.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.161 -1.2 . . . . 0.0 108.883 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 175' ' ' VAL . 23.0 mt-10 -64.69 -33.52 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 110.719 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.23 -14.54 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 0.0 110.935 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.528 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 25.7 mt-10 -89.97 -3.95 57.73 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.29 -10.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.035 -1.041 . . . . 0.0 111.105 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -83.54 -29.92 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.514 -1.366 . . . . 0.0 110.316 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.47 2.73 43.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.797 -1.189 . . . . 0.0 110.282 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.68 130.26 35.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.776 -1.202 . . . . 0.0 108.681 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.695 HH21 ' N ' ' A' ' 203' ' ' THR . 15.4 ptm180 -104.84 155.12 19.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -0.891 . . . . 0.0 110.463 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.471 ' CA ' ' CE1' ' A' ' 226' ' ' HIS . 3.0 t -56.17 156.71 5.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.249 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.03 166.7 24.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.061 . . . . 0.0 110.527 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.56 ' SG ' ' OE2' ' A' ' 185' ' ' GLU . 0.5 OUTLIER -156.9 162.06 39.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.507 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -104.76 144.67 31.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.724 ' HA ' HD12 ' A' ' 186' ' ' ILE . 39.7 p30 -60.59 -21.59 62.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 111.562 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.9 p90 -76.58 -34.7 58.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.659 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.781 ' OE2' HD11 ' A' ' 189' ' ' ILE . 2.5 pt-20 -96.7 -8.3 31.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.476 -1.39 . . . . 0.0 110.261 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.5 mt -55.37 -51.12 59.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.0 -1.062 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -51.41 -51.82 51.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.237 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -49.22 66.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.157 -0.964 . . . . 0.0 108.794 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.781 HD11 ' OE2' ' A' ' 185' ' ' GLU . 63.8 mt -57.46 -33.96 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.918 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -77.21 -25.91 52.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 110.02 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -77.12 -30.45 55.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.938 . . . . 0.0 109.886 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.08 8.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.188 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.88 73.86 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.524 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 66.0 mt -118.58 157.62 27.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -1.153 . . . . 0.0 109.682 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.47 21.11 65.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -66.14 -25.04 66.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.849 -1.383 . . . . 0.0 109.705 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.4 -4.89 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.36 127.91 35.38 Favored Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.132 -1.217 . . . . 0.0 110.622 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -135.37 170.43 15.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.645 -0.915 . . . . 0.0 109.091 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.71 -36.03 81.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.074 -1.017 . . . . 0.0 109.575 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -73.32 -27.64 61.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.217 -0.927 . . . . 0.0 109.662 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.639 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 2.1 m-20 -107.41 5.4 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.892 . . . . 0.0 110.084 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.695 ' N ' HH21 ' A' ' 178' ' ' ARG . 3.4 m -153.05 122.12 6.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.918 -1.114 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.431 HD22 ' CD ' ' A' ' 222' ' ' GLU . 5.9 tp -79.35 110.8 14.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 108.693 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.6 128.41 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.973 -1.079 . . . . 0.0 109.528 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.0 mt -106.38 148.46 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.97 149.13 16.62 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 207' ' ' GLY . 23.2 tptt -42.59 -27.38 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -1.161 . . . . 0.0 110.108 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 209' ' ' ASP . 52.6 p-10 -149.96 10.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.929 -1.107 . . . . 0.0 110.272 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.9 pttm -143.67 152.83 41.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.7 t -101.44 129.58 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.889 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.95 -54.41 8.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -57.86 134.65 83.31 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.828 -1.17 . . . . 0.0 109.428 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.92 -14.22 29.36 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.337 2.024 . . . . 0.0 112.695 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -83.85 -6.46 59.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.42 -166.17 54.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.0 148.76 31.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -1.122 . . . . 0.0 109.704 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.4 ' HB3' ' CD2' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -88.12 -22.76 23.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.656 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 77.0 m-85 -149.14 134.19 18.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.0 108.839 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 219' ' ' TYR . 11.0 tt0 -45.47 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.978 -1.076 . . . . 0.0 108.607 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -130.36 35.6 4.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.49 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 3.4 tt0 -56.81 -50.78 86.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.483 -0.761 . . . . 0.0 111.743 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 27.7 Cg_endo -65.82 -39.04 21.25 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.582 1.521 . . . . 0.0 113.457 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.1 OUTLIER -78.09 -26.82 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.524 -1.36 . . . . 0.0 108.324 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 18.2 mtp180 -68.74 -44.11 74.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.471 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 17.3 t60 -59.87 -43.9 94.47 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.515 -0.741 . . . . 0.0 109.038 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -56.25 -41.43 75.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.807 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 224' ' ' VAL . 23.0 t -62.42 -46.4 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.574 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.2 t80 -55.12 -41.71 72.04 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -70.67 -39.39 73.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.466 -0.771 . . . . 0.0 109.676 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.574 HD23 ' CG1' ' A' ' 149' ' ' VAL . 30.0 tp -56.97 -35.62 69.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.463 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.589 HD13 HD21 ' A' ' 81' ' ' LEU . 95.2 mt -71.15 -48.78 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.36 -31.95 13.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.99 -28.43 29.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -1.224 . . . . 0.0 110.267 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.9 mt -79.49 -22.87 43.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.229 . . . . 0.0 109.79 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -68.64 -8.24 40.46 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.331 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.448 ' C ' ' N ' ' A' ' 239' ' ' GLY . 36.4 mt -52.86 -32.58 45.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.851 . . . . 0.0 109.194 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.698 HD12 ' CG2' ' A' ' 242' ' ' VAL . 97.4 mt -52.61 -11.92 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.952 -1.093 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 77.08 13.45 83.65 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.7 p -158.74 143.74 11.79 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.133 -1.216 . . . . 0.0 109.434 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.436 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 73.4 Cg_exo -41.25 135.0 2.82 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 112.149 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.698 ' CG2' HD12 ' A' ' 238' ' ' LEU . 2.4 t -101.3 136.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 131.02 50.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.38 -0.825 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.79 -178.39 31.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.74 112.77 25.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.149 -1.207 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -115.16 145.5 42.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.027 0.918 . . . . 0.0 110.959 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.45 ' CE2' HG21 ' A' ' 150' ' ' THR . 35.8 t80 -131.22 144.02 51.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.0 t -139.65 128.28 23.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.77 -1.206 . . . . 0.0 110.642 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 250' ' ' ARG . 46.0 t80 -108.98 117.18 33.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.4 mmm180 44.76 56.29 5.34 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.56 147.16 21.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.482 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -115.69 178.7 17.75 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.456 ' O ' HG23 ' A' ' 257' ' ' VAL . 75.4 m-70 -68.47 -50.59 51.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.276 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 66.1 m -55.39 -55.26 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.031 -1.043 . . . . 0.0 109.367 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 137' ' ' ARG . 58.9 tp -51.38 -39.32 56.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.315 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 72.8 m-20 -59.71 -53.81 53.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 108.722 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 253' ' ' HIS . 16.8 t -50.07 -43.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -55.21 -46.86 75.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.031 -1.043 . . . . 0.0 108.89 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 139' ' ' ILE . 56.4 tp -52.6 -44.72 66.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.214 -0.928 . . . . 0.0 108.569 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.04 -56.26 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -46.97 -40.74 14.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -70.51 -46.53 63.48 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.909 -1.119 . . . . 0.0 110.037 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 39.4 mt -65.74 -37.5 86.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.903 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.4 66.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.1 mttp . . . . . 0 N--CA 1.489 1.478 0 O-C-N 120.793 -1.192 . . . . 0.0 108.754 179.182 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 119' ' ' ARG . 18.4 mm-40 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.14 135.65 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.554 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.402 ' HB ' ' NE2' ' A' ' 117' ' ' GLN . 14.7 t -135.03 175.32 9.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 109.342 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 7' ' ' VAL . 10.4 m -85.68 135.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.258 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -66.73 -44.19 82.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.41 152.55 48.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.825 . . . . 0.0 109.88 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 136.03 56.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.59 168.34 10.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 p -157.97 148.69 20.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.116 -0.99 . . . . 0.0 110.242 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -129.96 158.73 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 109.285 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.66 135.62 21.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.97 -1.081 . . . . 0.0 109.212 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.13 159.98 18.56 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.5 p -70.7 161.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.265 . . . . 0.0 110.908 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -95.4 140.79 15.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 19' ' ' HIS . 12.6 tt -56.99 -52.2 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.135 -1.215 . . . . 0.0 112.246 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.605 ' N ' HG23 ' A' ' 18' ' ' ILE . 4.6 m-70 -86.46 -38.15 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.281 -1.512 . . . . 0.0 111.197 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.415 ' OG1' ' CD ' ' A' ' 95' ' ' GLU . 16.0 p -72.48 -35.03 68.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.762 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.6 24.76 68.21 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -117.52 155.09 30.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.885 . . . . 0.0 108.87 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.0 t80 -71.65 132.17 44.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 30.9 t -138.66 157.86 45.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 108.845 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.502 ' O ' HD23 ' A' ' 26' ' ' LEU . 27.5 tttp -137.18 151.9 49.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 109.503 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.691 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -127.21 151.22 48.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.174 -0.954 . . . . 0.0 109.737 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.497 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.4 mt -137.69 127.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.4 mt -112.14 118.51 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.562 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.3 m-70 -116.98 149.25 43.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.97 162.44 19.11 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.187 1.925 . . . . 0.0 111.323 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.4 mm-40 -133.94 -177.48 4.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 0.0 109.87 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 6.8 tttm -82.3 149.69 27.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.628 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 11.5 mp0 -48.48 147.27 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 110.39 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.26 24.78 61.63 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.6 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 13.6 m -81.23 -46.43 14.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.734 -1.451 . . . . 0.0 109.445 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.62 -167.23 17.41 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mm -100.75 124.09 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.139 -1.212 . . . . 0.0 107.865 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -140.54 141.51 35.27 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.643 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -101.13 153.15 19.83 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.581 ' CG ' ' OE1' ' A' ' 90' ' ' GLU . 3.3 t80 -120.31 154.92 34.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -176.06 126.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.669 -1.27 . . . . 0.0 110.192 -179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.84 37.22 16.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.31 77.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -126.23 128.77 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -1.086 . . . . 0.0 109.66 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -89.52 141.75 28.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.4 mt -136.49 95.59 12.74 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.46 144.52 9.97 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.975 1.783 . . . . 0.0 111.472 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.46 85.29 4.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.953 -1.092 . . . . 0.0 110.66 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.74 154.14 49.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.496 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 9.7 p80 -50.62 -48.81 57.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 109.694 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 50.3 mt-10 -43.2 -33.33 0.9 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.347 -0.846 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -77.78 1.85 18.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.241 -0.912 . . . . 0.0 110.275 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 257' ' ' VAL . 4.1 t -63.01 119.08 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 108.77 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.66 -30.92 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.232 -0.918 . . . . 0.0 110.524 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.583 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.3 t-160 -145.71 118.64 8.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.062 . . . . 0.0 109.63 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.1 p -112.34 132.03 55.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.445 0.64 . . . . 0.0 109.455 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 59' ' ' SER . 66.6 t30 -166.0 -154.32 0.19 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.557 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 1.4 m-70 -48.32 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.835 -1.166 . . . . 0.0 108.329 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' ASN . 16.0 t -136.66 166.03 24.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.451 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 27.0 m -106.88 122.87 47.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 108.965 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.99 138.61 54.36 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.08 0.943 . . . . 0.0 111.218 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.513 HD12 HG21 ' A' ' 72' ' ' VAL . 56.1 mt -117.34 156.42 27.87 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.6 142.74 6.74 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.347 -1.883 . . . . 0.0 111.309 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -143.24 148.75 36.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.865 . . . . 0.0 109.199 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt 56.27 39.86 30.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.0 110.597 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.24 5.63 77.38 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.745 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.7 mm-40 -102.04 140.33 36.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.951 -1.323 . . . . 0.0 108.317 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.603 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -139.37 151.86 46.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.069 -1.019 . . . . 0.0 111.568 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 mt -134.26 145.33 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -114.6 150.2 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 111.245 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 m 55.25 69.03 0.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.708 -0.62 . . . . 0.0 111.047 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.513 HG21 HD12 ' A' ' 62' ' ' LEU . 27.4 m -114.26 -7.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 109.275 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.0 pt-20 -68.65 -36.21 78.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.578 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 26.4 m170 -58.6 -59.98 4.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 110.111 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.1 tp -57.16 -42.17 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.808 -1.183 . . . . 0.0 109.07 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.477 ' N ' HG23 ' A' ' 75' ' ' ILE . 6.9 mt -60.47 -35.91 77.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 109.469 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -60.61 -47.3 86.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.577 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.448 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 38.3 t -58.99 -51.7 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.064 . . . . 0.0 108.681 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 76' ' ' LEU . 54.7 mt -51.27 -44.28 61.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.498 -0.752 . . . . 0.0 109.418 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.722 ' HD1' HG22 ' A' ' 232' ' ' ILE . 14.0 t-160 -56.23 -57.83 10.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 0.0 109.832 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.7 -38.55 72.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 110.449 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 114' ' ' ILE . 15.1 mt -79.8 -0.84 36.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.979 -1.076 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 59.81 42.58 16.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.803 -1.186 . . . . 0.0 110.027 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.37 125.82 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.7 p -106.34 -76.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.51 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' HG13 ' A' ' 87' ' ' VAL . 69.5 m-20 -81.49 113.28 19.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 111.812 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.13 141.73 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.406 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 61.1 m -111.5 103.92 12.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.477 -0.764 . . . . 0.0 109.397 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.18 114.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.202 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.581 ' OE1' ' CG ' ' A' ' 40' ' ' PHE . 1.6 mt-10 -93.07 123.79 36.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 0.0 108.75 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.66 106.79 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.52 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.13 107.71 18.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.58 -162.85 24.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -13.63 14.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.388 -1.066 . . . . 0.0 110.428 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -150.54 155.16 38.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.709 -1.245 . . . . 0.0 110.674 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -69.89 125.71 92.12 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.699 -0.625 . . . . 0.0 110.04 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.691 ' CD ' HD21 ' A' ' 26' ' ' LEU . 74.7 Cg_exo -46.23 134.71 15.41 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.85 1.7 . . . . 0.0 112.017 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.1 tp -76.85 -35.25 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.469 -0.769 . . . . 0.0 109.967 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.416 ' N ' HG23 ' A' ' 98' ' ' ILE . 51.2 mt 55.32 -105.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.431 -0.793 . . . . 0.0 109.631 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.58 ' OD1' ' NE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -94.55 -27.67 15.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.582 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.3 -1.49 28.11 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 p -123.98 -166.78 1.54 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.969 . . . . 0.0 109.292 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.44 -0.34 21.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -46.77 -43.93 18.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.723 -0.869 . . . . 0.0 110.662 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.46 -52.1 62.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.061 -1.025 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 97.3 m-85 -62.45 -45.61 92.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.896 -1.128 . . . . 0.0 108.594 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.402 ' CD2' HG11 ' A' ' 175' ' ' VAL . 15.0 t80 -59.55 -40.72 88.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.456 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -45.6 58.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.487 -0.758 . . . . 0.0 111.464 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.62 -49.75 20.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.201 . . . . 0.0 110.777 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.31 -42.54 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.01 -1.056 . . . . 0.0 111.085 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -56.6 -28.96 61.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.885 -1.134 . . . . 0.0 109.992 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -82.21 -10.16 59.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.958 -1.089 . . . . 0.0 110.047 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -123.02 32.24 5.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.401 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.565 HD11 HD22 ' A' ' 82' ' ' LEU . 13.3 mt -86.28 146.82 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.681 -1.262 . . . . 0.0 109.87 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 115' ' ' LEU . 16.4 tp -132.23 161.55 33.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.29 128.88 55.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.776 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.402 ' NE2' ' HB ' ' A' ' 6' ' ' THR . 18.5 mt-30 -96.39 -166.36 1.41 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.898 . . . . 0.0 110.009 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -124.46 69.31 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.601 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 4' ' ' GLU . 13.2 ttt180 -158.8 137.71 11.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.027 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 26.9 tt0 -47.88 167.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.776 0.798 . . . . 0.0 110.965 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.445 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 31.4 mt -126.23 120.5 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.2 76.98 8.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.602 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -58.54 147.6 31.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -106.83 125.65 51.29 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.7 t -130.49 145.1 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 73.0 t -83.68 136.37 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 0.0 109.363 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.13 -12.9 9.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.51 144.57 42.97 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.84 169.05 23.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.106 1.871 . . . . 0.0 113.174 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 141' ' ' ALA . 4.4 tt -165.24 136.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.784 -0.572 . . . . 0.0 109.485 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.21 124.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.0 109.141 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.3 m -119.36 114.87 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.456 -0.778 . . . . 0.0 109.812 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.41 131.97 55.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -173.18 152.96 2.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 55.89 23.56 6.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.596 -0.69 . . . . 0.0 110.973 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.02 2.75 83.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.525 ' HB2' HD22 ' A' ' 255' ' ' LEU . 89.8 mtt180 -104.61 172.99 6.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.988 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.2 tt -160.06 151.41 19.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.157 -1.589 . . . . 0.0 109.3 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.988 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.4 mt -147.56 130.28 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.957 . . . . 0.0 108.678 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -119.89 142.4 48.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 109.929 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -127.07 141.34 51.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.507 -0.745 . . . . 0.0 109.157 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -140.31 137.2 17.53 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.93 147.07 26.94 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.445 1.43 . . . . 0.0 112.256 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.33 152.3 10.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.922 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.69 0.66 46.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p -137.74 145.79 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.151 -0.968 . . . . 0.0 109.803 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 242' ' ' VAL . 56.2 tp -75.98 117.32 17.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -138.02 136.22 36.66 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.565 ' CG1' HD23 ' A' ' 231' ' ' LEU . 15.1 t -137.31 122.03 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -107.51 130.14 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.343 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.567 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.2 t80 -116.58 128.97 55.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.88 106.43 14.16 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.25 150.64 19.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -129.35 88.23 2.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.492 -1.004 . . . . 0.0 109.204 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -95.21 146.83 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.591 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -94.89 -2.03 51.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 182' ' ' PHE . 6.9 p30 -70.15 -166.64 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.779 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -65.71 -22.09 66.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.092 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.456 HD12 ' ND2' ' A' ' 157' ' ' ASN . 5.1 mt -66.66 -38.7 87.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.048 -1.033 . . . . 0.0 109.137 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.11 -137.95 19.23 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 161' ' ' ARG . 0.3 OUTLIER -100.11 145.34 28.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 109.421 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.483 ' OE1' ' ND2' ' A' ' 221' ' ' ASN . 0.9 OUTLIER -148.81 166.55 28.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.539 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 150.31 23.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -139.79 131.86 27.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.193 -0.942 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 165' ' ' THR . 11.4 t -102.15 123.17 45.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.184 -0.948 . . . . 0.0 109.801 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.5 t80 -101.2 134.46 44.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 108.986 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.43 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -132.67 151.2 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 109.472 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -50.54 120.76 4.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.87 6.8 26.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -134.53 27.25 3.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.206 -1.173 . . . . 0.0 108.522 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -61.68 -35.49 78.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 110.57 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.24 -18.35 10.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.951 -1.093 . . . . 0.0 110.283 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.9 -3.64 58.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 0.0 110.837 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 3.0 pt -130.49 19.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 111.947 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.1 OUTLIER -113.53 -29.13 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.803 -1.186 . . . . 0.0 109.908 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.06 2.53 53.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 110.684 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.03 127.13 32.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.605 -1.309 . . . . 0.0 109.109 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.58 ' NE ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.02 152.51 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.3 t -53.65 161.32 1.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 109.177 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.63 164.01 31.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.786 -1.196 . . . . 0.0 110.2 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 189' ' ' ILE . 0.3 OUTLIER -149.3 160.29 43.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 109.673 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.565 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.4 m-85 -104.35 144.97 30.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.721 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.753 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.7 p-10 -59.25 -26.98 65.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.958 -1.089 . . . . 0.0 110.488 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.565 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.4 p90 -81.14 -27.59 35.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.825 -1.172 . . . . 0.0 110.668 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.8 pt-20 -93.14 -14.21 27.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 109.818 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.9 mt -56.76 -52.61 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.62 -52.71 45.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.123 . . . . 0.0 109.79 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -52.82 -44.42 66.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 91.0 mt -65.51 -33.86 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -77.01 -26.88 54.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.042 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -81.0 -27.98 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.087 -1.008 . . . . 0.0 110.517 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.0 m -80.16 8.54 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.509 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.21 24.44 68.63 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.811 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 62.9 mt -121.19 159.82 25.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.24 -1.153 . . . . 0.0 109.691 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 76.94 27.7 59.99 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.03 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -71.18 -19.41 62.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.667 -1.49 . . . . 0.0 109.292 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.5 -4.19 49.75 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.14 128.74 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.273 -1.134 . . . . 0.0 110.896 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.25 -173.81 3.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.747 -0.855 . . . . 0.0 109.157 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.99 -5.59 57.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.051 -1.031 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -98.09 -13.69 20.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.339 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -127.18 -3.6 6.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -136.24 117.34 14.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.26 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.2 tp -79.42 110.54 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.54 127.56 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.08 -1.013 . . . . 0.0 109.839 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.28 146.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.363 -0.836 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.66 150.47 17.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -44.38 -28.65 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.132 . . . . 0.0 110.242 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 35.0 t0 -143.8 8.46 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 110.127 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 207' ' ' GLY . 68.4 tttt -146.01 154.72 42.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.062 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.71 128.96 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -71.98 -53.09 14.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.095 -1.003 . . . . 0.0 109.908 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -54.72 133.55 65.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.119 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.88 -24.97 20.48 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.281 1.987 . . . . 0.0 112.511 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.89 -6.65 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 109.792 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.92 -167.54 48.37 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.45 141.8 39.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -1.084 . . . . 0.0 109.63 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -83.7 -15.66 47.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.097 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 221' ' ' ASN . 70.1 m-85 -144.26 135.43 25.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.535 ' C ' HD22 ' A' ' 221' ' ' ASN . 1.5 tm-20 -49.34 -10.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 219' ' ' TYR . 1.4 m-80 -143.11 35.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.525 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 56.1 tt0 -56.1 -36.46 46.43 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 111.919 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 10.2 Cg_exo -69.27 -43.92 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.731 1.621 . . . . 0.0 112.907 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 228' ' ' VAL . 24.5 m -77.81 -25.7 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 120.706 -1.246 . . . . 0.0 108.544 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -65.12 -45.67 84.14 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.456 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 47.1 t60 -62.16 -43.15 99.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -49.85 74.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 109.335 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 224' ' ' VAL . 19.2 t -56.26 -48.18 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 108.767 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.578 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 85.0 t80 -50.5 -44.6 56.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.632 -0.668 . . . . 0.0 109.607 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.578 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 28.4 m-20 -71.48 -35.22 70.75 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 109.994 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.565 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.7 tp -56.46 -37.54 70.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.025 . . . . 0.0 108.857 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.722 HG22 ' HD1' ' A' ' 80' ' ' HIS . 55.4 mt -71.49 -47.52 58.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.13 -33.73 15.32 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.57 -26.18 32.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -1.171 . . . . 0.0 109.808 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 260' ' ' VAL . 4.7 mt -82.27 -24.55 34.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.826 -1.171 . . . . 0.0 110.193 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.443 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 28.7 t80 -69.98 -7.38 40.26 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 109.148 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.45 ' C ' ' N ' ' A' ' 239' ' ' GLY . 34.8 mt -51.04 -31.55 18.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 108.775 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.601 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 96.2 mt -53.79 -12.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 108.681 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 74.53 17.21 79.86 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.5 p -157.63 143.32 12.55 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.338 . . . . 0.0 109.812 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.419 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 55.7 Cg_exo -43.12 131.13 6.21 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.15 1.9 . . . . 0.0 111.944 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.502 ' O ' HD13 ' A' ' 147' ' ' LEU . 24.6 t -103.58 141.25 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -130.61 133.37 46.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.311 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.56 179.49 30.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -107.54 110.45 22.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.103 -1.233 . . . . 0.0 109.719 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.535 ' HB2' HG22 ' A' ' 149' ' ' VAL . 8.7 m-85 -112.18 146.96 37.17 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.928 . . . . 0.0 111.059 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -128.1 144.17 51.1 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.2 t -142.05 126.94 18.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.711 -1.243 . . . . 0.0 110.501 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.7 t80 -110.19 116.94 32.41 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 249' ' ' PHE . 6.4 mmm180 46.81 55.91 7.26 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.84 140.95 23.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.52 171.24 13.72 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 22.1 m-70 -63.99 -45.21 90.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.244 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -55.73 26.33 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.094 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' ' 137' ' ' ARG . 56.5 tp -52.06 -39.88 60.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.117 -0.989 . . . . 0.0 109.351 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.23 -55.82 30.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 108.784 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 53' ' ' VAL . 2.7 t -49.85 -41.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.47 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -49.45 71.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.067 -1.02 . . . . 0.0 109.039 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.757 HD22 HG21 ' A' ' 139' ' ' ILE . 43.8 tp -52.66 -49.65 64.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 0.0 108.677 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.531 HG22 HD23 ' A' ' 235' ' ' LEU . 48.8 t -63.62 -49.93 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.477 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -51.65 17.93 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.63 -44.34 90.84 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.89 -1.131 . . . . 0.0 109.781 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.64 -46.29 90.41 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.601 ' HB2' ' CD2' ' A' ' 238' ' ' LEU . . . -72.69 -32.78 66.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.704 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 O-C-N 120.845 -1.16 . . . . 0.0 109.157 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 36.0 mt-10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 132.16 56.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.565 -0.709 . . . . 0.0 109.316 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -136.44 175.29 9.74 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.35 -0.843 . . . . 0.0 109.271 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.3 m -83.24 138.13 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.727 -1.233 . . . . 0.0 110.367 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HZ3' ' HB2' ' A' ' 8' ' ' LYS . 6.8 ttmm -71.95 -47.02 55.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.734 . . . . 0.0 109.543 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.66 156.44 41.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.854 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 135.16 55.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.473 -0.767 . . . . 0.0 110.415 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 113' ' ' ASN . 19.1 mt -117.54 163.46 16.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -153.92 147.3 24.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.009 . . . . 0.0 110.098 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.28 161.61 31.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.254 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -149.59 136.65 19.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.915 -1.116 . . . . 0.0 108.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.09 161.27 20.28 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.7 p -73.75 161.24 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.11 -1.23 . . . . 0.0 111.176 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -92.54 140.09 14.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.8 tt -56.11 -52.25 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -1.218 . . . . 0.0 111.816 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.533 ' N ' HG23 ' A' ' 18' ' ' ILE . 10.3 m-70 -86.97 -38.63 16.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.309 -1.494 . . . . 0.0 110.879 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 22' ' ' GLU . 2.6 m -68.68 -36.6 78.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 110.054 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.61 23.09 66.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HB2' HG22 ' A' ' 20' ' ' THR . 2.0 tt0 -117.99 154.98 31.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.692 -0.887 . . . . 0.0 108.722 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.5 t80 -71.73 136.3 47.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 110.181 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.439 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.9 t -144.02 157.55 44.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 108.974 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.1 ttmt -137.22 147.16 45.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.098 -1.001 . . . . 0.0 109.292 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.715 HD11 ' HD2' ' A' ' 97' ' ' PRO . 2.3 mt -123.41 151.1 42.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.629 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.422 HG22 ' CD2' ' A' ' 29' ' ' HIS . 6.8 mt -134.84 129.44 51.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.57 110.76 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 109.812 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.422 ' CD2' HG22 ' A' ' 27' ' ' ILE . 21.7 m-70 -106.75 150.23 39.43 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 108.901 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.56 161.88 22.91 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.226 1.95 . . . . 0.0 110.816 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.558 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -140.56 159.34 42.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.886 -1.134 . . . . 0.0 110.69 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 tttt -59.7 149.31 31.06 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.516 0.674 . . . . 0.0 109.987 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.3 mp0 -48.76 148.38 2.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 110.612 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.511 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.73 25.85 59.38 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.413 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -80.46 -37.57 31.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.618 -1.519 . . . . 0.0 109.031 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.27 -177.03 33.36 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.8 mm -98.8 125.41 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 140.13 32.71 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.969 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -97.48 152.22 19.2 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -133.54 140.13 47.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -170.7 143.75 2.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 54.86 29.13 11.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.955 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.85 21.16 78.05 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.8 t -124.42 135.62 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.161 -1.2 . . . . 0.0 109.545 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -94.6 142.06 27.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 109.039 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.9 mt -135.01 94.43 16.19 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.395 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -48.7 143.3 16.86 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.324 2.016 . . . . 0.0 111.747 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.99 79.74 5.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.069 -1.019 . . . . 0.0 110.158 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.3 mtt-85 -138.7 156.38 47.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.447 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 3.3 p80 -52.86 -50.12 64.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -45.26 -15.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 110.264 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.2 m-85 -100.19 2.64 43.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.669 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 50' ' ' HIS . 9.8 t -57.73 133.35 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 108.955 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 m -120.66 -36.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 109.91 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.454 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.1 t-160 -151.19 122.11 7.61 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.348 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 p -110.75 132.6 54.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.4 t-20 -166.47 -154.71 0.19 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -48.03 -11.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 108.604 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.6 t -135.89 165.61 25.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 m -101.64 119.73 39.23 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -116.94 135.5 53.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 111.169 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD12 HG21 ' A' ' 72' ' ' VAL . 30.9 mt -124.22 158.91 31.34 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -177.83 145.62 7.15 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.963 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -144.71 151.16 38.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.883 . . . . 0.0 109.51 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 57.37 23.81 9.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 110.971 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.15 1.26 72.74 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.556 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 55.5 mm-40 -99.24 139.84 34.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.989 -1.301 . . . . 0.0 108.284 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -136.28 149.72 48.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.025 . . . . 0.0 111.426 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.84 141.68 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -114.48 151.02 33.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.185 -0.947 . . . . 0.0 111.456 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 56.45 65.84 1.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.798 -0.564 . . . . 0.0 111.284 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.422 HG21 HD12 ' A' ' 62' ' ' LEU . 28.8 m -114.08 -3.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.041 -1.037 . . . . 0.0 109.043 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pt-20 -70.63 -28.4 64.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 110.533 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -64.35 -60.52 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.907 -1.121 . . . . 0.0 109.723 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -58.74 -44.51 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.952 -1.092 . . . . 0.0 109.129 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 75' ' ' ILE . 65.4 mt -55.8 -41.46 74.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.927 . . . . 0.0 109.456 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -56.82 -46.32 81.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.292 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.88 -53.69 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.963 . . . . 0.0 108.652 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 76' ' ' LEU . 27.6 mt -51.55 -44.58 62.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.279 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.524 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.4 t-160 -53.93 -55.38 27.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.249 -0.907 . . . . 0.0 109.726 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 171' ' ' GLU . 95.1 mt -62.36 -37.24 84.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.447 HD13 HD11 ' A' ' 114' ' ' ILE . 50.1 mt -78.94 -9.84 59.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.01 -1.056 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 63.41 60.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.851 -1.156 . . . . 0.0 110.514 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 4.8 mm -104.18 133.99 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.408 HG21 HG23 ' A' ' 121' ' ' ILE . 1.2 p -119.87 -17.1 8.59 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.269 -0.895 . . . . 0.0 111.943 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.696 ' O ' HG13 ' A' ' 87' ' ' VAL . 4.0 m-80 -130.11 111.83 12.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.699 -1.25 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -165.26 136.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 110.01 178.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.558 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 23.3 m -107.21 99.53 9.06 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 mt -87.95 117.83 32.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.91 119.64 34.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.787 -1.196 . . . . 0.0 107.992 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 26' ' ' LEU . 23.0 t -104.61 104.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 111.344 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mt -87.49 107.78 17.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.74 -161.32 24.03 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -116.85 -14.52 10.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -1.045 . . . . 0.0 110.506 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.18 146.34 35.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.741 -1.224 . . . . 0.0 111.076 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.23 124.88 91.37 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.803 -0.561 . . . . 0.0 109.674 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.715 ' HD2' HD11 ' A' ' 26' ' ' LEU . 73.3 Cg_exo -46.37 129.4 13.33 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.774 1.649 . . . . 0.0 111.754 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.4 tp -77.6 -29.18 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.488 -0.757 . . . . 0.0 110.188 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 95.0 mt 55.24 -111.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.44 ' OD1' ' NH2' ' A' ' 178' ' ' ARG . 2.5 t0 -89.28 -28.58 19.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.613 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.13 -14.98 11.02 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -109.93 -166.78 1.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.37 -2.76 21.34 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -47.44 -42.37 22.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.808 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.95 -51.96 64.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.002 -1.062 . . . . 0.0 110.356 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 93.6 m-85 -63.5 -44.81 93.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 108.632 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 6.9 t80 -62.36 -38.2 88.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.718 -0.614 . . . . 0.0 109.961 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.3 -46.28 61.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.366 -0.834 . . . . 0.0 110.807 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.42 -51.56 12.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.992 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.68 -45.52 79.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.043 -1.036 . . . . 0.0 110.557 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -55.51 -29.36 58.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.209 -0.932 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -81.24 -12.96 58.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -0.992 . . . . 0.0 109.992 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.54 ' HB2' HD11 ' A' ' 11' ' ' LEU . 1.5 m120 -120.09 33.09 5.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.385 -0.822 . . . . 0.0 111.125 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.447 HD11 HD13 ' A' ' 82' ' ' LEU . 5.9 mt -90.55 148.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 110.494 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 115' ' ' LEU . 52.7 tp -131.18 158.18 41.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.27 140.22 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -103.86 -163.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -116.47 -1.38 12.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.41 ' CD ' ' OE2' ' A' ' 4' ' ' GLU . 10.2 ttm180 -94.13 149.21 21.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 109.903 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.53 136.83 32.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 85' ' ' THR . 94.8 mt -77.52 144.32 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.411 -0.805 . . . . 0.0 110.459 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.5 89.97 8.07 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -62.88 145.64 54.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.235 -0.916 . . . . 0.0 110.518 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.27 123.4 46.03 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.18 141.12 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.89 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.1 t -84.43 138.34 19.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.493 -0.755 . . . . 0.0 109.096 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -119.12 -11.15 9.66 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -140.18 144.17 36.59 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.86 173.52 12.61 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.113 1.875 . . . . 0.0 113.109 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.709 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 2.9 tt -165.3 142.17 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.685 -0.634 . . . . 0.0 109.703 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 131' ' ' ILE . 3.4 mp -129.71 125.31 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 m -121.52 114.07 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -113.47 141.8 46.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.42 -0.8 . . . . 0.0 109.845 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -175.26 137.93 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 111.074 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 57.49 29.51 17.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.642 -0.662 . . . . 0.0 111.412 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.46 9.06 86.09 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -110.39 157.71 19.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.986 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -158.69 156.13 29.37 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.953 -1.717 . . . . 0.0 109.536 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.986 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.9 mt -149.03 133.02 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -120.91 143.01 49.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 109.901 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.709 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.23 143.97 49.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -142.03 138.47 16.9 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.9 144.9 42.85 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.473 1.449 . . . . 0.0 112.276 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.06 149.83 9.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -1.88 53.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 109.61 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.8 p -134.78 142.42 46.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.45 118.78 20.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -137.73 136.82 37.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.484 ' CG1' HD23 ' A' ' 231' ' ' LEU . 60.3 t -133.98 122.53 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.014 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.401 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 9.9 m -107.84 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.337 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -127.42 129.59 47.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.793 . . . . 0.0 109.72 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -115.52 103.51 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.72 135.45 12.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -111.18 93.23 4.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.498 -1.001 . . . . 0.0 109.343 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -95.16 148.66 22.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -97.07 -3.75 40.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.949 HD22 HD12 ' A' ' 159' ' ' LEU . 24.4 p-10 -73.74 -169.4 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.675 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -60.71 -20.8 61.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.97 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.949 HD12 HD22 ' A' ' 157' ' ' ASN . 31.2 mt -70.46 -28.36 64.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.0 109.042 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.69 -132.13 31.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.18 145.11 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -1.037 . . . . 0.0 109.556 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -146.35 156.04 43.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.583 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -139.23 145.0 38.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.249 -0.907 . . . . 0.0 109.332 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -136.28 126.58 26.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.061 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 165' ' ' THR . 7.3 t -103.78 123.85 47.83 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -100.22 136.03 40.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.159 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.512 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.5 t -131.82 153.5 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -57.08 118.91 5.49 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.43 -3.79 21.79 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -125.54 31.22 5.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.259 -1.142 . . . . 0.0 108.711 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.521 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.7 OUTLIER -64.3 -32.84 74.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.543 -0.723 . . . . 0.0 110.605 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -58.2 -15.64 10.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.937 -1.102 . . . . 0.0 111.059 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -92.7 -4.13 53.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.85 -1.156 . . . . 0.0 110.894 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.23 -6.56 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.103 -0.998 . . . . 0.0 110.721 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -89.85 -29.14 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.698 -1.252 . . . . 0.0 109.933 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.03 1.99 51.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.68 -1.262 . . . . 0.0 110.415 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.07 115.62 18.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.914 -1.116 . . . . 0.0 108.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.44 ' NH2' ' OD1' ' A' ' 100' ' ' ASP . 1.9 ptm180 -86.59 154.62 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.05 . . . . 0.0 110.066 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -53.34 159.46 1.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.63 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.502 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 38.6 p90 -145.93 169.42 18.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.911 -1.118 . . . . 0.0 109.906 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.502 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -164.39 163.89 22.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.612 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 96.0 m-85 -103.7 146.08 29.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.613 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.717 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.6 OUTLIER -61.96 -20.69 64.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 111.076 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.612 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.3 p90 -81.0 -26.85 36.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.646 -1.284 . . . . 0.0 110.643 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.499 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 23.4 pt-20 -97.74 -15.85 20.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.859 -1.151 . . . . 0.0 109.474 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.7 mt -57.39 -52.12 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 110.045 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.15 -49.21 61.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.078 . . . . 0.0 109.43 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -54.46 -52.36 62.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 108.922 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 59.5 mt -57.72 -33.84 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.407 -0.808 . . . . 0.0 109.346 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -77.89 -28.95 49.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.51 ' HZ3' ' CB ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -72.69 -26.8 61.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.573 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.3 m -84.79 13.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.604 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.24 25.68 72.52 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.072 -1.061 . . . . 0.0 110.592 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.03 156.59 28.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.267 -1.137 . . . . 0.0 109.732 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.72 25.55 60.32 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.408 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.6 mtmm -69.04 -20.88 64.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.465 -1.609 . . . . 0.0 109.051 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.88 -7.28 44.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.93 129.31 43.82 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.24 -1.153 . . . . 0.0 110.771 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.4 p -143.72 169.93 16.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.79 -0.829 . . . . 0.0 109.466 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 17.0 mt -71.25 -16.46 62.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -86.08 -9.65 56.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 19.9 m-20 -138.26 12.07 2.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.648 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.475 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 28.1 m -152.97 131.69 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.57 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' A' ' 217' ' ' LEU . 6.5 tp -89.98 114.85 26.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 186' ' ' ILE . 63.4 t -100.65 125.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.063 -1.023 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.9 mt -100.73 146.13 27.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.867 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.43 150.3 16.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -46.33 -25.88 0.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.136 -1.214 . . . . 0.0 109.86 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -152.56 11.44 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 0.0 110.67 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -146.99 155.35 42.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.89 -1.131 . . . . 0.0 110.281 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.77 123.36 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -70.84 -54.35 11.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.935 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -53.49 131.36 54.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.098 -1.002 . . . . 0.0 109.391 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -24.95 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.311 2.007 . . . . 0.0 112.457 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -4.51 39.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.955 . . . . 0.0 109.289 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.89 -169.16 53.85 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.45 ' CD2' HD21 ' A' ' 204' ' ' LEU . 13.9 mt -88.05 149.81 23.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 0.0 109.745 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -60.67 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.0 108.722 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.426 ' C ' ' H ' ' A' ' 221' ' ' ASN . 7.7 m-85 -116.86 152.52 34.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 109.165 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.568 ' C ' HD21 ' A' ' 221' ' ' ASN . 3.6 mp0 -60.65 -3.93 0.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 109.423 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.584 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -137.48 29.77 2.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.867 . . . . 0.0 108.983 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.603 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.0 tt0 -54.45 -42.03 92.31 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.76 . . . . 0.0 110.863 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.5 Cg_exo -70.83 -38.52 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.508 2.139 . . . . 0.0 113.156 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -81.66 -26.87 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.675 -1.266 . . . . 0.0 108.539 179.361 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.43 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 38.1 mtt180 -67.35 -39.82 85.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.572 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 19.1 t60 -66.6 -41.03 89.06 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -42.05 76.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.036 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 224' ' ' VAL . 38.7 t -68.06 -44.6 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -55.26 -40.83 71.43 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.605 0.717 . . . . 0.0 109.067 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -71.74 -39.99 69.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.575 -0.703 . . . . 0.0 109.907 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.484 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.8 tp -56.55 -35.1 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.373 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 81.2 mt -72.15 -49.08 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.924 -1.11 . . . . 0.0 108.144 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.34 -30.95 12.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.74 -28.33 30.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -1.187 . . . . 0.0 109.854 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 260' ' ' VAL . 5.3 mt -79.17 -22.85 44.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.743 -1.223 . . . . 0.0 109.782 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.524 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 16.6 t80 -69.99 -8.0 45.46 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.068 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 237' ' ' LEU . 31.1 mt -49.76 -28.57 6.38 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.69 -20.59 65.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 108.957 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.41 17.91 76.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.9 p -154.01 138.8 11.52 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.235 . . . . 0.0 109.652 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -41.82 134.11 3.88 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.165 1.91 . . . . 0.0 111.872 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.81 136.14 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.023 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -122.3 125.71 46.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.306 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.45 26.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -102.5 112.54 25.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -1.198 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.6 m-85 -112.58 146.9 37.75 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.976 0.893 . . . . 0.0 111.048 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.401 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 26.9 t80 -126.99 144.29 51.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.0 t -138.87 126.76 22.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.684 -1.26 . . . . 0.0 110.112 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 250' ' ' ARG . 61.8 t80 -113.16 113.1 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 249' ' ' PHE . 52.8 mtp180 47.66 56.72 6.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.71 145.86 21.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.572 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -113.5 175.94 16.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.511 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.5 m-70 -66.99 -47.77 70.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -1.134 . . . . 0.0 109.998 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -55.14 37.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 109.801 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 51.6 tp -51.68 -37.86 52.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 88.4 m-20 -58.68 -55.37 35.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.119 -0.988 . . . . 0.0 108.746 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 253' ' ' HIS . 18.5 t -49.14 -41.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.415 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -55.22 -47.37 75.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 108.803 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.86 -50.56 63.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.447 HG22 HD23 ' A' ' 235' ' ' LEU . 42.1 t -63.63 -41.2 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 109.856 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -51.93 67.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.421 -0.799 . . . . 0.0 110.43 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -64.65 -45.4 86.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.845 -1.159 . . . . 0.0 109.73 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 263' ' ' LEU . 60.8 mt -58.83 -45.72 89.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.17 73.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.832 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 47.4 mttt . . . . . 0 N--CA 1.488 1.457 0 O-C-N 120.85 -1.156 . . . . 0.0 109.101 179.386 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 76.7 mt-10 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.88 139.67 52.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 109.485 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -141.15 177.57 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.468 -0.77 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.33 149.69 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 110.21 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -86.27 -42.13 14.02 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.662 -0.649 . . . . 0.0 109.758 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 10' ' ' LYS . 13.0 tt0 -129.32 153.98 47.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.517 -0.739 . . . . 0.0 109.992 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -59.98 135.64 57.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.305 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 113' ' ' ASN . 44.5 mt -124.8 166.52 16.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.473 -0.767 . . . . 0.0 109.267 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 150.24 22.34 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 110.115 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -131.21 158.43 40.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.695 -0.628 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.81 134.81 23.87 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.941 -1.1 . . . . 0.0 108.869 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.85 156.79 14.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.094 -1.603 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -81.12 141.02 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -1.229 . . . . 0.0 110.804 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.61 138.12 37.71 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.6 tt -57.91 -48.16 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.089 . . . . 0.0 112.042 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.45 ' N ' HG23 ' A' ' 18' ' ' ILE . 16.3 m-70 -86.75 -37.6 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.276 -1.515 . . . . 0.0 111.017 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.492 HG21 ' OD1' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -72.25 -32.86 67.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 110.119 -179.024 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.33 65.89 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 16' ' ' VAL . 4.8 mm-40 -113.83 151.25 32.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.948 . . . . 0.0 108.956 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -70.62 130.94 43.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.89 . . . . 0.0 110.063 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -138.63 157.55 45.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.063 -1.023 . . . . 0.0 109.381 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' O ' HD23 ' A' ' 26' ' ' LEU . 6.7 ttpp -137.09 152.03 49.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.132 -0.98 . . . . 0.0 109.541 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.738 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.3 mt -127.72 145.95 50.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.491 HG22 ' NE2' ' A' ' 29' ' ' HIS . 26.1 mt -131.35 129.05 62.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mt -117.89 133.35 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.087 -1.008 . . . . 0.0 110.139 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.491 ' NE2' HG22 ' A' ' 27' ' ' ILE . 17.7 m-70 -126.6 150.01 69.66 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.71 161.78 20.32 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.104 1.869 . . . . 0.0 111.028 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 53.5 mt-10 -133.96 -174.68 3.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -89.73 154.92 19.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.195 -0.94 . . . . 0.0 109.248 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -47.93 145.2 3.08 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 110.058 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.55 23.52 54.78 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.382 -0.824 . . . . 0.0 111.791 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 55.5 m -75.45 -46.29 33.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.589 -1.536 . . . . 0.0 109.094 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.809 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 105.23 174.94 24.32 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.98 121.79 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.446 -1.032 . . . . 0.0 108.749 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.27 138.23 34.84 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -97.22 153.0 18.28 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -130.98 139.95 50.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.155 -0.965 . . . . 0.0 109.063 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 10.7 ttmt -170.0 139.46 1.86 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.483 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.91 29.02 18.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.04 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 28.09 70.63 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.3 t -134.28 139.18 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -1.12 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -97.67 144.43 27.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.096 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.414 HG23 ' CB ' ' A' ' 64' ' ' PHE . 31.9 mt -136.91 97.62 10.99 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.306 -0.871 . . . . 0.0 110.33 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.61 143.13 29.4 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.093 1.862 . . . . 0.0 111.341 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.46 83.15 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.0 -1.062 . . . . 0.0 110.481 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -138.53 154.9 48.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.332 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.9 p80 -53.47 -49.37 67.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.24 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' CG ' ' CE1' ' A' ' 50' ' ' HIS . 8.2 mt-10 -45.55 -16.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' HIS . 89.8 m-85 -96.89 6.66 48.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.961 -1.087 . . . . 0.0 109.868 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.14 126.2 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 108.652 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.21 -32.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -149.87 119.99 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.068 -1.02 . . . . 0.0 109.63 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.4 p -112.68 131.36 55.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.427 0.632 . . . . 0.0 109.359 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 2.1 t-20 -166.07 -154.3 0.19 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 57' ' ' ASN . 10.8 m-70 -47.81 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.922 -1.111 . . . . 0.0 108.357 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.6 t -136.6 166.11 24.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.2 m -107.83 123.45 48.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 108.971 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.02 141.68 51.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.928 0.87 . . . . 0.0 110.971 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.2 mt -118.64 168.58 10.57 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.25 145.07 5.43 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.801 -1.666 . . . . 0.0 110.824 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CB ' HG23 ' A' ' 46' ' ' ILE . 54.0 t80 -144.46 150.58 37.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? 55.85 23.22 6.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.751 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.62 68.08 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.741 -1.219 . . . . 0.0 111.075 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.499 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 1.5 mm100 -92.33 144.87 24.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.483 . . . . 0.0 108.456 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.635 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -141.6 153.23 44.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.937 -1.102 . . . . 0.0 111.5 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 147.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -113.63 151.75 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.206 -0.934 . . . . 0.0 111.383 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m 52.52 68.23 0.86 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.776 -0.578 . . . . 0.0 111.037 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 HG13 ' A' ' 96' ' ' ILE . 16.1 m -113.02 -10.28 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.49 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.8 pt-20 -65.56 -24.22 67.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.413 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -67.64 -60.32 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.871 -1.143 . . . . 0.0 109.764 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.2 tp -58.32 -42.32 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.002 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HA ' HD12 ' A' ' 79' ' ' LEU . 19.5 mt -58.85 -37.99 77.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.489 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.6 t -58.35 -47.47 83.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.931 -1.106 . . . . 0.0 108.956 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.88 -51.58 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.547 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 76' ' ' LEU . 49.5 mt -51.27 -44.1 61.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 4.6 t-160 -52.62 -56.95 11.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.404 -0.81 . . . . 0.0 109.918 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.83 -35.71 79.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 110.559 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.803 HD22 ' CD1' ' A' ' 114' ' ' ILE . 13.4 mt -79.68 -9.65 59.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.021 -1.05 . . . . 0.0 110.595 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 62.74 50.35 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.781 -1.199 . . . . 0.0 110.372 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 3.3 mm -94.14 125.64 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.468 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.8 p -113.83 -18.74 11.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.168 -0.958 . . . . 0.0 112.034 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.809 HD22 ' H ' ' A' ' 36' ' ' GLY . 10.5 m120 -130.75 112.15 12.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.886 -1.134 . . . . 0.0 110.409 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -164.57 148.69 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 0.0 110.023 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.467 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 2.3 m -115.69 102.09 9.42 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.1 104.79 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.21 118.88 24.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 108.401 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.27 112.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 111.05 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -92.5 110.9 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.21 -163.16 24.87 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -116.57 -15.18 10.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -1.013 . . . . 0.0 110.101 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 19.1 tt0 -138.05 143.01 40.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 0.0 110.291 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.481 HG13 HG12 ' A' ' 72' ' ' VAL . 2.9 mm -69.36 124.71 91.06 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.468 -0.77 . . . . 0.0 109.392 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.738 ' CD ' HD21 ' A' ' 26' ' ' LEU . 50.1 Cg_exo -46.85 126.46 11.0 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.547 1.498 . . . . 0.0 111.416 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 98' ' ' ILE . 4.7 tp -79.52 -21.45 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 3.7 mt 57.06 -110.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -95.5 -8.16 36.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.046 -1.034 . . . . 0.0 111.919 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.23 -12.04 48.13 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.2 p -119.04 -168.84 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -1.01 . . . . 0.0 109.537 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.55 -4.08 23.51 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.543 ' NE1' ' CD ' ' A' ' 108' ' ' GLU . 60.5 t-105 -46.92 -42.5 17.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.664 -0.903 . . . . 0.0 110.455 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.15 -51.51 68.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.924 -1.11 . . . . 0.0 109.783 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.5 m-85 -62.29 -43.81 97.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.112 -0.993 . . . . 0.0 108.588 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -61.98 -39.3 91.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.543 ' CD ' ' NE1' ' A' ' 104' ' ' TRP . 19.0 mt-10 -68.91 -46.39 68.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 111.437 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.97 -51.82 9.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.83 -1.169 . . . . 0.0 110.97 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.72 -43.37 87.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.814 -1.178 . . . . 0.0 110.558 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -59.55 -30.28 68.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.971 -1.08 . . . . 0.0 109.317 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -83.73 11.14 7.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.695 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.64 ' HB2' HD11 ' A' ' 11' ' ' LEU . 8.7 m120 -144.37 32.18 1.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.397 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.803 ' CD1' HD22 ' A' ' 82' ' ' LEU . 6.8 mt -91.5 148.73 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.891 -1.13 . . . . 0.0 110.717 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.64 153.73 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 2.3 m-20 -105.64 146.36 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.06 -1.025 . . . . 0.0 110.012 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.479 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.4 mt-30 -105.41 -162.36 0.87 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.837 . . . . 0.0 109.09 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -117.74 2.09 12.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.092 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 4' ' ' GLU . 10.9 ttm180 -97.84 152.53 19.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.858 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -94.43 147.54 23.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.898 . . . . 0.0 109.485 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.419 HG23 HG21 ' A' ' 85' ' ' THR . 83.9 mt -89.37 153.93 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.356 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -96.84 101.81 13.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.405 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.7 m-85 -72.42 145.21 47.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.962 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -95.89 123.04 39.31 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.53 138.2 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.48 136.86 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -112.56 -7.27 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.28 147.82 24.67 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 109.188 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.35 145.48 38.44 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.173 1.915 . . . . 0.0 112.888 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.6 tt -130.73 150.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.27 117.85 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.629 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' A' ' 139' ' ' ILE . 1.8 m -118.09 109.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.7 131.64 55.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 0.0 109.293 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -179.98 159.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.062 . . . . 0.0 110.469 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 134' ' ' ASP . 11.6 mm-40 56.61 19.74 4.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.708 -0.62 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 -0.4 82.68 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.51 ' HB2' HD22 ' A' ' 255' ' ' LEU . 0.6 OUTLIER -101.04 176.79 5.14 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.01 . . . . 0.0 108.302 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.962 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.1 tt -160.35 145.97 15.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.512 -1.367 . . . . 0.0 108.769 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.962 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.6 mt -144.97 130.99 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.076 -1.015 . . . . 0.0 108.28 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -121.39 137.37 54.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 109.814 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.658 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -113.71 149.35 34.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -145.4 136.61 12.58 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.53 144.94 99.29 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.493 1.462 . . . . 0.0 112.014 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.56 156.19 7.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 12.4 p-10 -88.82 3.28 51.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.5 p -135.43 147.1 48.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.0 118.73 22.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -135.94 139.03 42.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.686 ' CG1' HD23 ' A' ' 231' ' ' LEU . 79.8 t -137.7 122.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 109.685 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.455 ' O ' ' OG ' ' A' ' 248' ' ' SER . 1.4 m -112.37 138.67 48.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -127.82 131.57 49.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.695 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -117.31 119.11 34.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -114.82 137.73 14.23 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -112.24 85.44 2.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.416 -1.049 . . . . 0.0 109.241 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.442 ' HB3' ' ND2' ' A' ' 157' ' ' ASN . 18.5 m-85 -86.2 148.45 25.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 109.915 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -97.22 -3.01 41.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 0.0 109.852 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.606 HD22 ' HB2' ' A' ' 159' ' ' LEU . 1.1 p30 -76.35 -169.94 1.33 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.084 -1.01 . . . . 0.0 109.687 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -55.7 -24.22 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.606 ' HB2' HD22 ' A' ' 157' ' ' ASN . 9.1 mt -66.49 -40.21 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.18 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 75.5 -124.98 7.81 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -114.14 145.32 41.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.955 . . . . 0.0 109.819 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.423 ' OE1' ' ND2' ' A' ' 221' ' ' ASN . 4.4 tt0 -162.21 162.14 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 0.0 109.738 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -147.86 159.81 43.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -139.39 131.65 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.096 -1.003 . . . . 0.0 109.667 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 165' ' ' THR . 13.8 t -103.7 123.22 46.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 5.9 t80 -100.53 138.56 37.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.441 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 t -137.53 150.02 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.804 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -50.43 118.2 2.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.2 6.17 18.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.85 28.41 2.64 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.17 -1.194 . . . . 0.0 108.716 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.42 -37.01 79.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.425 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.83 -16.63 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 110.45 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -88.33 -3.86 58.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.081 -1.012 . . . . 0.0 110.919 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.77 5.65 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.085 -1.009 . . . . 0.0 111.417 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -32.39 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.456 -1.403 . . . . 0.0 110.057 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.52 2.68 50.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.009 -1.057 . . . . 0.0 110.994 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.06 117.31 20.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.685 -1.259 . . . . 0.0 108.698 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -91.54 152.86 20.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.102 -0.999 . . . . 0.0 110.334 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -57.77 131.19 49.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.372 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -109.36 163.9 12.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -0.992 . . . . 0.0 110.115 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.618 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -144.71 162.36 36.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 110.495 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.554 ' N ' ' OE2' ' A' ' 185' ' ' GLU . 57.7 m-85 -105.37 144.65 31.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.674 ' HA ' HD12 ' A' ' 186' ' ' ILE . 14.8 p-10 -60.79 -26.5 67.32 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.829 -1.17 . . . . 0.0 110.213 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.482 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.1 p90 -81.31 -26.24 35.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 111.095 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 182' ' ' PHE . 10.3 pt-20 -92.7 -14.59 27.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.663 -1.273 . . . . 0.0 109.568 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.3 mt -56.19 -53.37 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.235 -0.916 . . . . 0.0 110.145 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.0 -53.32 54.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.989 -1.069 . . . . 0.0 109.449 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -52.12 -41.49 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.833 . . . . 0.0 109.214 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.86 -33.88 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -0.967 . . . . 0.0 108.862 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -79.52 -25.74 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -27.72 42.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 109.89 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.89 8.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.2 70.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.1 mt -123.85 163.17 21.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 0.0 109.664 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.29 24.43 71.07 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -70.83 -20.66 62.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.282 . . . . 0.0 109.691 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.04 -2.51 51.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.65 128.55 35.36 Favored Glycine 0 N--CA 1.492 2.387 0 O-C-N 121.204 -1.174 . . . . 0.0 111.07 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.5 p -132.45 -173.67 3.23 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.9 -12.88 29.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -91.4 -4.89 55.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 109.559 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 99' ' ' LEU . 42.5 m-20 -139.22 12.11 2.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.885 . . . . 0.0 109.375 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.618 HG22 ' SG ' ' A' ' 181' ' ' CYS . 0.6 OUTLIER -149.76 122.13 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.249 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.2 tp -82.25 112.83 19.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 t -103.67 127.88 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.957 -1.09 . . . . 0.0 109.215 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 78.6 mt -111.15 141.95 43.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 110.136 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -96.37 149.29 19.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -42.48 -25.17 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -1.222 . . . . 0.0 110.106 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.2 OUTLIER -150.49 10.12 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.833 -1.167 . . . . 0.0 110.596 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -143.21 151.83 41.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 110.098 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.6 t -96.54 123.22 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.488 -0.757 . . . . 0.0 109.066 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -72.85 -54.36 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 110.129 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -55.33 134.36 69.66 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.872 -1.142 . . . . 0.0 109.618 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.55 -23.01 20.41 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.393 2.062 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.63 -5.1 49.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 110.043 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.58 -161.56 53.66 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.2 mt -89.94 146.92 24.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.495 -1.003 . . . . 0.0 110.294 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.75 -20.99 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.631 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 48.3 m-85 -142.52 167.91 20.97 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.57 -21.44 35.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 108.412 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 221' ' ' ASN . 0.1 OUTLIER -125.18 37.55 4.37 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.591 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 30.1 tt0 -58.95 -35.76 35.65 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.447 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.5 Cg_exo -73.88 -45.52 0.38 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.714 1.61 . . . . 0.0 113.001 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 224' ' ' VAL . 16.5 m -76.43 -25.19 16.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.754 -1.216 . . . . 0.0 108.554 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.631 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 11.6 mtp180 -67.06 -46.01 75.63 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -58.29 -43.25 87.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -45.59 82.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 108.737 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.91 -48.63 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -54.32 -41.31 68.88 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.96 -39.67 79.34 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.513 -0.742 . . . . 0.0 109.671 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.686 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.4 tp -58.66 -36.21 73.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.374 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.3 -34.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -63.34 -34.42 89.92 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 3.0 m-20 -82.94 -26.77 31.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -1.143 . . . . 0.0 110.135 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.48 -25.92 35.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.853 -1.154 . . . . 0.0 109.772 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.505 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 27.8 t80 -66.85 -8.8 31.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 108.923 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 237' ' ' LEU . 71.5 mt -49.95 -30.12 9.76 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.18 -15.8 27.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 108.98 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 53.4 p -156.01 137.53 9.61 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.247 . . . . 0.0 109.503 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.431 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 78.5 Cg_exo -42.81 130.4 5.53 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.049 1.833 . . . . 0.0 112.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.88 135.98 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.815 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -118.62 123.34 44.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.755 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.22 169.86 20.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.74 114.47 28.55 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.197 -1.178 . . . . 0.0 110.047 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -111.36 150.97 28.98 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.918 0.866 . . . . 0.0 110.976 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -128.44 144.14 51.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 150' ' ' THR . 0.9 OUTLIER -137.26 127.01 25.46 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.731 -1.231 . . . . 0.0 110.475 -178.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.468 ' O ' ' C ' ' A' ' 250' ' ' ARG . 52.4 t80 -111.83 113.9 26.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.47 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 11.5 mmm180 44.45 56.12 5.23 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.46 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -83.47 146.99 23.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.587 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -119.84 177.05 16.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.539 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 29.1 m-70 -67.63 -38.21 83.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -1.154 . . . . 0.0 109.787 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.1 t -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.065 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.649 ' HG ' HD12 ' A' ' 139' ' ' ILE . 58.2 tp -72.66 -37.29 67.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 75.5 m-20 -60.57 -51.76 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 80.4 t -51.92 -44.13 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 109.138 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -55.23 -47.08 75.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.052 -1.03 . . . . 0.0 109.018 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 139' ' ' ILE . 54.1 tp -52.66 -49.67 64.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 108.824 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.4 -47.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -52.24 54.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.576 -0.703 . . . . 0.0 110.23 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.09 -50.65 73.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.982 -1.074 . . . . 0.0 110.515 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.63 -39.73 92.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.19 -34.29 72.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.336 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.0 mttp . . . . . 0 N--CA 1.486 1.36 0 O-C-N 121.025 -1.047 . . . . 0.0 108.527 179.071 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.674 ' OE2' HG23 ' A' ' 121' ' ' ILE . 7.0 mm-40 . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.19 138.82 54.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.066 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.5 t -134.15 171.43 14.24 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 7' ' ' VAL . 3.1 m -82.24 140.87 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.79 -1.194 . . . . 0.0 110.484 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -75.84 -46.54 29.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -126.54 154.48 43.78 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.744 0.783 . . . . 0.0 111.054 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HD2' ' CE1' ' A' ' 29' ' ' HIS . 9.4 tttt -54.37 135.23 45.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.698 -0.626 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mt -121.22 152.91 38.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -151.99 146.44 25.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 110.042 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -128.25 162.4 27.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.58 -0.7 . . . . 0.0 109.304 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.73 132.52 17.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.914 -1.116 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.6 157.9 16.46 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.4 p -77.7 164.28 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.943 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -91.32 137.61 13.91 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.4 tt -58.57 -48.41 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.229 -1.16 . . . . 0.0 111.928 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.477 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.1 m-70 -86.78 -38.18 17.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.205 -1.56 . . . . 0.0 110.98 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -74.47 -40.0 62.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 0.0 109.867 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.77 23.08 78.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -112.11 151.04 29.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.528 -0.983 . . . . 0.0 108.621 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -71.16 134.43 46.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 109.88 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 11.5 t -141.17 158.49 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -133.15 155.07 49.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.502 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.705 HD11 ' HD2' ' A' ' 97' ' ' PRO . 24.6 mt -128.65 152.35 48.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.955 . . . . 0.0 109.665 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.563 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.1 mt -142.05 126.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.491 -0.756 . . . . 0.0 109.014 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mt -115.29 117.72 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 0.0 109.924 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.563 ' NE2' HG22 ' A' ' 27' ' ' ILE . 11.7 m-70 -113.04 149.38 41.24 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.6 163.1 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 111.143 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.0 mm-40 -136.84 -175.17 3.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.08 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 152.07 22.91 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.432 -0.792 . . . . 0.0 109.028 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -51.66 151.04 3.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 110.407 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.533 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 63.62 19.64 62.9 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.27 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 51.9 m -81.94 -46.75 13.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.498 -1.589 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -171.77 23.26 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mm -97.52 122.12 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -1.137 . . . . 0.0 108.159 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.61 144.3 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 110.544 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.83 154.33 20.68 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.7 t80 -129.86 142.06 50.72 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 12.9 ttpt -172.35 138.24 0.92 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.95 29.76 19.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.466 -0.771 . . . . 0.0 109.824 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.99 74.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.61 139.75 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -94.04 146.83 23.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.122 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.401 HG23 ' CB ' ' A' ' 64' ' ' PHE . 8.0 mt -139.56 98.91 7.89 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.92 140.93 37.9 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.174 1.916 . . . . 0.0 111.453 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.34 79.89 8.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.91 -1.119 . . . . 0.0 110.866 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.62 155.07 49.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.914 . . . . 0.0 109.223 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 52' ' ' PHE . 4.0 p-80 -54.56 -49.58 69.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.171 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -46.56 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 109.909 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' HIS . 80.0 m-85 -98.51 7.99 45.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 62' ' ' LEU . 4.8 t -63.76 132.86 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.81 -34.06 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.0 110.119 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.45 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.6 t-80 -150.37 122.95 8.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.034 -1.041 . . . . 0.0 109.963 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.2 p -112.36 129.49 56.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 11.1 t-20 -166.67 -153.6 0.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 57' ' ' ASN . 19.2 m-70 -44.85 -16.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.218 -0.926 . . . . 0.0 108.704 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.2 t -136.19 165.56 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.48 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -102.97 121.32 42.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 108.778 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -119.39 138.22 53.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 111.033 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 53' ' ' VAL . 84.6 mt -118.34 163.52 16.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.77 146.21 6.23 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.482 -1.818 . . . . 0.0 111.211 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CB ' HG23 ' A' ' 46' ' ' ILE . 69.1 t80 -145.03 151.81 39.15 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.629 -0.924 . . . . 0.0 109.579 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt 57.57 23.66 9.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.88 . . . . 0.0 110.93 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.96 -2.22 75.57 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.888 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.469 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 96.8 mm-40 -98.93 143.75 28.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.842 -1.387 . . . . 0.0 108.258 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.49 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -142.86 155.71 44.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 111.801 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.12 145.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -110.88 150.29 29.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.112 -0.993 . . . . 0.0 111.668 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 m 54.55 68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.764 -0.585 . . . . 0.0 111.294 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.41 -9.58 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.718 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' OE2' ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER -66.28 -19.04 65.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 0.0 110.698 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -72.32 -60.86 2.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.841 -1.162 . . . . 0.0 109.641 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -56.74 -42.65 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.864 -1.148 . . . . 0.0 108.554 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.529 ' HA ' HD12 ' A' ' 79' ' ' LEU . 74.1 mt -55.05 -40.12 69.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.591 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 37.6 t -60.49 -48.74 80.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.554 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -56.55 -54.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 108.606 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 76' ' ' LEU . 14.6 mt -51.43 -44.38 62.29 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.515 ' HD1' HG22 ' A' ' 232' ' ' ILE . 11.6 t-160 -54.81 -56.5 18.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.92 -37.48 87.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.255 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 114' ' ' ILE . 14.0 mt -77.2 -6.12 51.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.993 -1.067 . . . . 0.0 110.057 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 62.96 42.37 7.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.967 -1.083 . . . . 0.0 110.096 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 82' ' ' LEU . 16.2 mm -90.01 126.1 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.505 HG21 ' OE2' ' A' ' 4' ' ' GLU . 48.1 p -107.47 -76.41 0.61 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 111.577 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.729 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -81.27 113.81 19.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.06 -1.025 . . . . 0.0 111.9 -176.522 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.71 144.37 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.541 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 3.8 m -110.93 101.65 10.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.499 -0.751 . . . . 0.0 109.27 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.99 111.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -92.21 120.0 32.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.043 -1.036 . . . . 0.0 108.633 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.402 HG22 HD22 ' A' ' 26' ' ' LEU . 94.6 t -102.32 112.37 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.991 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -91.44 109.67 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.35 -160.79 23.52 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.4 -15.97 9.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.979 . . . . 0.0 109.959 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -135.64 142.56 45.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.977 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -67.96 126.75 93.02 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.705 ' HD2' HD11 ' A' ' 26' ' ' LEU . 58.6 Cg_exo -46.28 127.82 11.46 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.709 1.606 . . . . 0.0 111.735 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.56 -25.75 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.302 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 99' ' ' LEU . 96.4 mt 54.77 -116.65 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -94.85 -8.13 38.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 0.0 110.751 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.87 -13.38 59.15 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -109.94 -171.97 1.94 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -1.059 . . . . 0.0 109.619 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.94 -7.62 16.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -46.42 -38.57 9.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.976 . . . . 0.0 110.128 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.525 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -61.85 -51.81 66.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.007 -1.058 . . . . 0.0 109.818 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 78.2 m-85 -63.34 -43.78 96.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -60.93 -39.66 90.28 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.447 0.641 . . . . 0.0 109.84 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.57 -46.6 53.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 111.829 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.09 -51.25 12.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.779 -1.201 . . . . 0.0 110.828 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 110' ' ' ILE . 60.7 mt -61.55 -42.67 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.043 -1.035 . . . . 0.0 110.708 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -57.27 -28.56 63.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 110.038 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -80.16 -12.07 59.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.221 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -123.09 34.88 5.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.836 . . . . 0.0 110.927 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 82' ' ' LEU . 17.9 mt -85.98 147.16 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.48 -1.388 . . . . 0.0 110.674 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 115' ' ' LEU . 31.9 tp -132.26 145.53 51.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.618 -0.677 . . . . 0.0 109.478 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -92.68 146.2 23.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.106 -0.996 . . . . 0.0 110.356 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -108.85 -168.23 1.32 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -119.74 69.94 0.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.418 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 4' ' ' GLU . 1.8 ttm180 -170.21 122.04 0.66 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.225 -0.922 . . . . 0.0 109.91 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.87 134.69 56.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.674 HG23 ' OE2' ' A' ' 4' ' ' GLU . 0.9 OUTLIER -75.49 143.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.462 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -86.4 89.68 7.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -63.67 147.01 52.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 110.555 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -104.77 125.09 50.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.29 142.59 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.7 t -83.65 139.88 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.459 -0.775 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -118.87 -11.05 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 109.046 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -142.56 144.95 32.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.261 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.61 160.24 44.44 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.163 1.908 . . . . 0.0 113.349 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.57 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.4 tt -153.22 140.82 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.629 HG23 HD11 ' A' ' 138' ' ' LEU . 18.1 mt -130.0 124.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.478 -0.764 . . . . 0.0 109.846 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 132' ' ' VAL . 18.3 m -122.3 117.72 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.87 156.89 16.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 109.737 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 137' ' ' ARG . 49.6 t0 -165.92 110.22 0.82 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 0.0 111.369 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 41.06 51.13 3.3 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.54 -0.725 . . . . 0.0 112.244 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.91 6.97 88.89 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.708 -1.245 . . . . 0.0 110.274 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 134' ' ' ASP . 12.5 mtt85 -118.2 132.28 56.33 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.629 HD11 HG23 ' A' ' 131' ' ' ILE . 4.8 tt -144.71 160.81 40.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.349 -1.469 . . . . 0.0 109.776 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.608 HG21 HD22 ' A' ' 259' ' ' LEU . 48.9 mt -144.57 129.63 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -116.0 142.32 46.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.36 -0.837 . . . . 0.0 110.131 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.57 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.97 143.74 50.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -142.02 138.92 17.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.93 146.16 58.67 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.394 1.396 . . . . 0.0 112.088 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -166.11 151.97 8.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.398 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 -1.29 56.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -134.1 146.25 50.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 109.259 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.46 120.18 24.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -1.0 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.95 137.96 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.715 ' CG1' HD23 ' A' ' 231' ' ' LEU . 12.4 t -137.23 118.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.711 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 m -106.03 143.91 33.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -132.06 130.94 41.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.93 105.97 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.74 155.54 20.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.428 ' HB3' ' HE ' ' A' ' 250' ' ' ARG . 3.2 tt0 -132.79 98.01 4.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -1.028 . . . . 0.0 109.116 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' GLY . 20.8 m-85 -101.38 148.6 24.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.844 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 mmtm -93.16 -5.99 48.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.992 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.535 HD21 HD12 ' A' ' 159' ' ' LEU . 10.7 p30 -74.44 -173.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.032 -1.042 . . . . 0.0 109.48 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -53.58 -17.05 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.783 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.535 HD12 HD21 ' A' ' 157' ' ' ASN . 31.7 mt -67.1 -49.98 63.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 109.506 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 82.86 -114.59 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.45 ' O ' ' CD ' ' A' ' 162' ' ' GLN . 12.4 mtm-85 -116.98 139.55 50.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.481 -1.011 . . . . 0.0 109.294 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 161' ' ' ARG . 4.3 mp0 -142.31 155.65 45.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 109.526 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 142.18 31.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.079 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -136.35 125.72 24.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.191 -0.943 . . . . 0.0 109.257 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -103.6 122.94 46.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.045 -1.034 . . . . 0.0 109.802 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -100.01 136.96 39.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.178 -0.951 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.89 156.08 41.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.556 -0.715 . . . . 0.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.28 118.9 6.47 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.145 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.83 1.32 21.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -131.42 29.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -1.112 . . . . 0.0 108.806 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -64.01 -33.58 76.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.603 -0.686 . . . . 0.0 110.611 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -52.81 -13.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 110.638 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.87 -4.12 44.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 111.139 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.1 -8.15 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.022 -1.049 . . . . 0.0 110.785 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.33 -33.11 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.66 -1.275 . . . . 0.0 109.943 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.96 1.28 54.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.797 -1.189 . . . . 0.0 110.603 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.82 116.93 20.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.927 -1.108 . . . . 0.0 108.657 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.54 153.26 20.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.034 -1.041 . . . . 0.0 110.361 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.6 t -62.07 147.66 46.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.531 -0.73 . . . . 0.0 109.457 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -130.31 176.26 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 110.402 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.89 163.09 32.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.463 -0.773 . . . . 0.0 109.581 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.63 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 89.6 m-85 -104.69 146.34 29.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 109.937 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.744 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.0 p-10 -61.7 -22.05 65.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 0.0 110.804 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.63 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.4 p90 -81.19 -28.41 34.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.793 -1.192 . . . . 0.0 110.653 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 13.6 pt-20 -95.1 -14.32 24.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.897 -1.127 . . . . 0.0 109.51 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.744 HD12 ' HA ' ' A' ' 183' ' ' ASP . 10.7 mt -58.62 -53.12 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.238 -0.914 . . . . 0.0 110.129 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.22 -52.97 49.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.773 -1.204 . . . . 0.0 109.107 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.62 -47.98 66.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -0.966 . . . . 0.0 108.707 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 76.5 mt -58.7 -34.36 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -78.55 -27.04 45.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.53 -0.731 . . . . 0.0 110.166 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -74.84 -26.82 59.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -0.999 . . . . 0.0 109.883 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.614 ' CG2' HD12 ' A' ' 194' ' ' LEU . 15.4 m -84.18 9.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.34 66.92 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.821 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.614 HD12 ' CG2' ' A' ' 192' ' ' VAL . 3.8 mt -120.02 158.29 27.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.136 -1.214 . . . . 0.0 109.688 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.02 21.41 65.58 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.462 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -68.8 -22.34 64.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.577 -1.543 . . . . 0.0 109.664 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.41 -4.75 52.8 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.05 125.98 33.23 Favored Glycine 0 N--CA 1.49 2.273 0 O-C-N 121.186 -1.184 . . . . 0.0 110.539 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -131.08 -173.64 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.768 -0.842 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.4 -2.03 57.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -100.17 -3.56 31.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -139.26 -7.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.97 . . . . 0.0 109.871 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.5 m -130.26 128.41 41.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 109.81 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 217' ' ' LEU . 60.6 tp -88.98 115.93 26.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 108.927 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 186' ' ' ILE . 47.2 t -103.01 127.88 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 30.5 mt -103.6 147.34 27.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.809 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.07 150.63 17.44 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -44.89 -22.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.141 . . . . 0.0 110.058 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.0 OUTLIER -155.13 12.74 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.948 -1.095 . . . . 0.0 110.343 -179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -146.67 155.44 42.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.85 125.56 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.03 -54.74 7.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.441 ' OD1' HD12 ' A' ' 204' ' ' LEU . 3.6 m120 -47.89 135.89 10.95 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.812 -1.18 . . . . 0.0 109.389 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.7 -41.16 2.37 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 112.05 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -65.12 -0.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.863 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.31 -166.93 54.49 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.462 ' CD2' HD21 ' A' ' 204' ' ' LEU . 43.5 mt -83.89 149.83 26.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.442 -1.034 . . . . 0.0 109.803 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -76.7 -61.37 1.99 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.947 . . . . 0.0 108.755 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.436 ' H ' ' HB2' ' A' ' 222' ' ' GLU . 6.8 m-85 -117.09 163.1 16.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.362 -0.837 . . . . 0.0 109.293 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.79 -14.6 62.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.514 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -133.55 32.77 3.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.339 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 5.8 tt0 -58.69 -37.39 53.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 111.126 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.6 Cg_exo -70.63 -43.22 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.971 1.781 . . . . 0.0 112.576 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 228' ' ' VAL . 6.3 m -78.71 -25.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.755 -1.216 . . . . 0.0 108.604 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.514 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 27.4 mtt180 -66.7 -40.71 88.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -64.81 -41.29 95.9 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -48.64 78.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.675 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 224' ' ' VAL . 59.8 t -58.3 -49.27 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.591 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.0 t80 -49.99 -38.29 36.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.502 0.667 . . . . 0.0 109.299 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.477 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 7.9 m-20 -72.68 -40.01 66.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 110.141 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.715 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.46 -37.48 70.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.343 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.515 HG22 ' HD1' ' A' ' 80' ' ' HIS . 88.9 mt -70.92 -48.49 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.886 -1.134 . . . . 0.0 108.057 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.81 -33.87 13.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.29 -26.76 32.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -1.199 . . . . 0.0 110.176 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -80.05 -21.03 43.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.668 -1.27 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -70.59 -8.32 50.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 109.143 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 237' ' ' LEU . 90.6 mt -53.18 -26.07 15.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.358 -0.839 . . . . 0.0 108.829 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.479 HD12 HG22 ' A' ' 242' ' ' VAL . 94.7 mt -61.11 -20.0 62.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.973 -1.08 . . . . 0.0 108.939 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.93 15.35 70.28 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 70.9 p -158.47 149.49 16.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.909 -1.348 . . . . 0.0 109.824 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -44.32 130.16 8.73 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.216 1.944 . . . . 0.0 111.749 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.479 HG22 HD12 ' A' ' 238' ' ' LEU . 87.0 t -98.88 133.16 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.005 -1.059 . . . . 0.0 109.697 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -121.84 125.83 47.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.73 172.59 26.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -103.58 112.9 26.03 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -1.184 . . . . 0.0 109.656 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 5.6 m-85 -113.5 148.45 35.98 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.06 0.933 . . . . 0.0 111.558 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.8 t80 -129.65 144.28 51.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.414 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 36.2 t -139.52 127.67 22.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.701 -1.249 . . . . 0.0 110.466 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 4.3 t80 -111.71 114.6 27.72 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.2 mtt-85 45.76 56.44 5.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.37 151.13 21.74 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.848 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.7 -176.24 16.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -71.03 -52.35 20.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -1.228 . . . . 0.0 110.107 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -55.01 33.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.181 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.442 ' HG ' HD12 ' A' ' 139' ' ' ILE . 55.6 tp -51.03 -41.63 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -57.87 -54.29 48.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 108.863 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.1 -43.22 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.647 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.61 -46.72 73.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.078 -1.014 . . . . 0.0 108.718 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 139' ' ' ILE . 24.7 tp -55.73 -47.92 76.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.8 . . . . 0.0 109.048 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 235' ' ' LEU . 88.0 t -66.99 -42.6 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.44 ' HZ1' ' CE ' ' A' ' 265' ' ' LYS . 0.2 OUTLIER -54.17 -48.36 70.98 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 110.671 -179.058 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.19 -45.05 70.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.841 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.45 -45.41 93.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.42 89.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.827 . . . . 0.0 109.732 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.44 ' CE ' ' HZ1' ' A' ' 261' ' ' LYS . 28.3 mttm . . . . . 0 N--CA 1.49 1.542 0 O-C-N 120.962 -1.086 . . . . 0.0 109.214 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 119' ' ' ARG . 16.1 mm-40 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HD3' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -113.25 127.67 56.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.432 -0.792 . . . . 0.0 109.128 -179.181 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -135.09 173.3 11.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -82.97 133.92 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.004 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -58.98 -48.38 81.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -133.65 163.07 30.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 132.28 48.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.521 -0.737 . . . . 0.0 109.974 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 11' ' ' LEU . 17.3 mt -117.74 164.07 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -152.97 147.59 26.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.029 . . . . 0.0 110.198 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -132.06 161.55 32.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.463 -0.773 . . . . 0.0 109.74 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.43 134.88 20.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.12 . . . . 0.0 109.365 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.09 158.92 17.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.2 p -74.96 163.02 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -1.103 . . . . 0.0 111.263 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.577 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -93.47 139.98 14.84 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.3 tt -57.81 -50.85 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.128 -1.219 . . . . 0.0 112.396 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 11.6 m-70 -86.44 -37.66 18.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.188 -1.57 . . . . 0.0 111.203 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -73.92 -34.66 64.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.0 110.215 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.49 21.33 66.64 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -109.76 149.95 29.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.544 -0.974 . . . . 0.0 109.274 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.84 132.43 45.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.891 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -139.63 157.51 45.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.569 ' O ' HD23 ' A' ' 26' ' ' LEU . 23.8 tttp -133.69 155.21 50.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.274 -0.891 . . . . 0.0 109.291 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.651 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.3 mt -131.04 146.67 52.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.044 -1.035 . . . . 0.0 109.373 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 mt -136.0 123.91 35.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mt -111.8 122.99 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.543 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -118.03 139.24 26.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.463 -0.773 . . . . 0.0 109.354 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -53.46 162.6 3.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.439 1.426 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.5 mm-40 -135.96 -171.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.1 ttmt -91.92 156.53 17.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.636 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -50.46 146.35 5.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 110.548 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 64.09 24.48 68.73 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.567 -0.708 . . . . 0.0 112.204 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.589 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 91.3 m -81.64 -46.44 14.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.346 -1.679 . . . . 0.0 109.112 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.76 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 101.52 -174.66 24.99 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.423 HD13 ' CG2' ' A' ' 87' ' ' VAL . 3.0 mm -94.86 122.65 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.189 -1.183 . . . . 0.0 108.354 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 137.28 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.077 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -98.58 154.59 17.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.554 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.7 t80 -130.12 136.99 49.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 108.815 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 4.0 ttmm -167.45 136.85 2.73 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.115 -0.991 . . . . 0.0 109.594 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.33 28.6 17.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.922 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 28.19 71.76 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.4 t -133.42 132.12 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.161 -1.199 . . . . 0.0 109.727 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -85.34 140.4 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 67' ' ' GLN . 45.2 mt -134.45 94.75 16.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.398 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.58 141.06 27.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.21 1.94 . . . . 0.0 111.494 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.09 84.39 5.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.812 -1.18 . . . . 0.0 110.374 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -139.06 155.35 48.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.501 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.9 p-80 -52.32 -49.43 64.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.286 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.3 mt-10 -44.62 -30.96 1.0 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.153 -0.967 . . . . 0.0 109.151 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 46.1 m-85 -81.48 2.42 28.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.413 -0.804 . . . . 0.0 110.176 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 50' ' ' HIS . 8.3 t -59.46 127.44 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.015 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.62 -31.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -151.97 123.07 7.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.891 -1.131 . . . . 0.0 109.975 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.9 p -111.77 131.61 55.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 31.8 p-10 -166.66 -153.64 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -48.31 -11.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.019 -1.051 . . . . 0.0 108.537 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.9 t -139.94 166.25 25.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 m -105.39 121.39 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 108.773 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.32 141.94 48.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 111.122 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 53' ' ' VAL . 57.1 mt -121.83 160.23 25.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.5 142.92 6.15 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.715 -1.707 . . . . 0.0 110.692 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -144.86 151.19 38.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.53 -0.982 . . . . 0.0 109.708 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt 56.96 23.77 8.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.833 . . . . 0.0 110.865 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.67 -2.04 69.54 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.704 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.9 mm-40 -97.05 145.46 25.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.928 -1.336 . . . . 0.0 108.482 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -141.71 151.7 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 0.0 111.601 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.8 mt -134.29 144.46 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -114.67 154.85 27.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 110.976 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 m 51.36 67.99 0.86 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.641 -0.662 . . . . 0.0 110.8 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.55 -15.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -63.74 -15.59 58.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 110.248 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 8.7 m170 -72.11 -60.57 2.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.022 . . . . 0.0 109.511 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.7 tp -59.65 -42.81 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.992 -1.068 . . . . 0.0 108.772 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.486 ' N ' HG23 ' A' ' 75' ' ' ILE . 39.3 mt -54.82 -39.21 68.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.503 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -61.7 -49.77 75.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.538 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.24 -54.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.006 . . . . 0.0 108.559 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 76' ' ' LEU . 18.1 mt -51.75 -43.82 63.07 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.488 -0.757 . . . . 0.0 109.586 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.3 -56.79 13.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.0 mt -56.64 -35.55 68.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 110.976 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.612 ' HB3' HD11 ' A' ' 84' ' ' ILE . 26.4 mt -88.06 -2.68 58.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.864 -1.148 . . . . 0.0 111.207 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.34 58.52 1.73 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.683 -1.261 . . . . 0.0 110.945 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 82' ' ' LEU . 5.0 mm -96.79 122.57 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.523 HG21 ' CG2' ' A' ' 121' ' ' ILE . 21.1 p -104.1 -77.47 0.57 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 111.047 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 2.5 m120 -82.24 113.6 20.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 111.452 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.9 m -163.79 138.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.684 -0.635 . . . . 0.0 109.327 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.5 m -106.53 101.18 10.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.38 107.51 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.657 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 40' ' ' PHE . 2.0 mm-40 -84.49 121.18 27.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.818 -1.177 . . . . 0.0 108.629 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.4 110.09 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.839 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.47 108.24 20.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.506 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 134.05 -163.37 24.55 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER -112.94 -14.97 12.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -1.034 . . . . 0.0 110.171 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.16 147.5 36.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.257 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -70.88 130.57 88.3 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.474 -0.766 . . . . 0.0 109.746 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.651 ' CD ' HD21 ' A' ' 26' ' ' LEU . 52.9 Cg_exo -46.23 128.7 12.31 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.022 1.815 . . . . 0.0 112.278 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -76.88 -29.68 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 110.015 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 50.8 mt 57.62 -116.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.0 109.942 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.28 -6.86 43.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 110.533 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.87 -10.61 52.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -117.09 -169.26 1.62 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -1.085 . . . . 0.0 109.797 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.05 -1.37 25.31 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 68.1 t-105 -46.39 -41.33 13.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.753 -0.851 . . . . 0.0 110.305 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.34 -51.97 66.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.999 -1.063 . . . . 0.0 110.131 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CG ' HD12 ' A' ' 75' ' ' ILE . 70.5 m-85 -65.02 -43.98 90.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.973 -1.079 . . . . 0.0 108.928 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.458 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.9 t80 -61.63 -37.73 85.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.4 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 20.9 mm-40 -67.0 -51.79 50.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.542 -0.724 . . . . 0.0 111.598 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 -51.98 11.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.761 -1.212 . . . . 0.0 110.871 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.54 -44.6 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 0.0 110.409 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -55.61 -31.27 62.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.116 -0.99 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -81.59 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 109.906 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -124.09 34.05 5.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.431 -0.793 . . . . 0.0 110.905 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.409 HD11 HD13 ' A' ' 82' ' ' LEU . 6.9 mt -87.73 140.5 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.708 -1.245 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 115' ' ' LEU . 46.6 tp -133.3 159.79 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -112.97 145.28 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.636 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 6.9 mt-30 -106.48 -162.67 0.87 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 109.31 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -121.0 72.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 110.735 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 4' ' ' GLU . 8.0 ttm-85 -168.02 123.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.14 126.36 27.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.474 -0.766 . . . . 0.0 110.316 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.523 ' CG2' HG21 ' A' ' 85' ' ' THR . 2.5 mt -78.55 150.48 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.376 -0.827 . . . . 0.0 109.695 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.8 86.28 6.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -60.23 147.21 40.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -101.37 120.14 39.82 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 243' ' ' LYS . 23.1 t -123.34 139.96 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.0 138.79 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 109.546 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.71 143.22 34.19 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.557 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.25 174.65 11.73 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.358 2.039 . . . . 0.0 112.64 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 141' ' ' ALA . 15.2 tt -166.07 146.04 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.493 -0.754 . . . . 0.0 109.792 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.465 ' CG2' HD11 ' A' ' 138' ' ' LEU . 3.4 mp -133.54 120.12 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 132' ' ' VAL . 33.1 m -119.81 114.99 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.804 . . . . 0.0 109.836 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.51 153.99 18.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.067 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.496 ' CB ' HD13 ' A' ' 255' ' ' LEU . 19.8 t70 -168.56 114.96 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.788 -1.195 . . . . 0.0 111.501 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 46.51 46.65 14.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.513 -0.742 . . . . 0.0 112.204 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 7.11 87.03 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.195 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.9 mtt85 -116.13 137.54 52.04 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.627 HD23 ' C ' ' A' ' 138' ' ' LEU . 2.6 tt -147.04 159.54 43.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.055 -1.653 . . . . 0.0 109.864 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.548 ' N ' HD23 ' A' ' 138' ' ' LEU . 35.6 mt -144.51 135.75 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.64 139.32 52.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 109.984 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.93 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.19 147.56 44.77 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -148.24 137.58 12.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 108.524 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.31 147.42 36.47 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.624 1.549 . . . . 0.0 112.15 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.7 153.01 8.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.336 -0.853 . . . . 0.0 109.363 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -85.72 -3.4 58.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.348 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.5 p -131.26 147.46 52.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.362 -0.836 . . . . 0.0 109.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 242' ' ' VAL . 22.2 tp -81.26 120.07 24.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.627 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -139.72 134.89 32.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.657 ' CG1' HD23 ' A' ' 231' ' ' LEU . 25.3 t -136.47 122.09 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.422 ' OG1' HG23 ' A' ' 165' ' ' THR . 87.1 m -110.74 145.87 37.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -131.85 129.87 40.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -114.41 108.73 17.27 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.64 140.51 15.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -118.04 92.83 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.547 -0.973 . . . . 0.0 108.705 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLY . 24.0 m-85 -96.25 148.39 22.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 110.331 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -91.65 -6.1 52.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.822 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.691 HD21 HD12 ' A' ' 159' ' ' LEU . 18.5 p-10 -73.4 -166.78 0.37 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -61.78 -17.61 56.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.792 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.691 HD12 HD21 ' A' ' 157' ' ' ASN . 25.5 mt -69.84 -38.86 76.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 109.341 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 70.64 -118.15 7.53 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -112.67 140.45 47.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -1.012 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.54 152.45 30.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.556 ' HB3' ' HZ3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.39 152.85 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.586 ' CE1' ' CZ ' ' A' ' 225' ' ' ARG . 64.3 t80 -136.23 125.53 24.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -0.914 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.422 HG23 ' OG1' ' A' ' 150' ' ' THR . 31.7 m -101.87 122.33 43.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.099 -1.001 . . . . 0.0 110.066 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -100.06 137.48 38.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.47 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.2 t -136.2 152.42 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.356 -0.84 . . . . 0.0 109.563 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.84 116.23 2.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.376 -0.827 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.9 8.67 13.3 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -137.49 27.91 2.77 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 0.0 108.71 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.539 ' O ' HG22 ' A' ' 175' ' ' VAL . 16.4 mp0 -62.73 -37.32 86.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.616 -0.678 . . . . 0.0 110.997 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.58 -16.35 2.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.008 -1.057 . . . . 0.0 110.366 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 1.5 mt-10 -90.58 -4.33 56.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 0.0 110.795 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.99 -2.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.099 -1.001 . . . . 0.0 110.757 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER -94.53 -29.11 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.605 -1.309 . . . . 0.0 110.018 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.9 2.14 54.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.914 -1.116 . . . . 0.0 110.608 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.75 119.86 23.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.206 . . . . 0.0 108.783 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -92.66 152.94 19.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.0 t -50.07 158.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.513 -0.742 . . . . 0.0 109.347 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.497 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 51.5 p90 -143.29 165.55 27.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -158.99 161.48 36.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.071 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.613 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 73.6 m-85 -104.35 144.79 31.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 0.0 109.266 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.776 ' HA ' HD12 ' A' ' 186' ' ' ILE . 21.0 p30 -59.27 -20.19 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 111.502 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.613 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.4 p90 -79.42 -33.24 42.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.494 -1.379 . . . . 0.0 111.529 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.593 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -94.21 -9.19 37.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.483 -1.386 . . . . 0.0 109.915 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.9 mt -60.98 -53.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.119 -0.988 . . . . 0.0 110.243 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -51.18 -45.94 61.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.587 -1.321 . . . . 0.0 109.611 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -53.86 46.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.108 -0.995 . . . . 0.0 108.968 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.89 -34.54 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 108.655 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -71.49 -25.71 62.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.307 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -76.04 -23.93 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.023 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.52 15.34 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 110.271 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 68.77 27.71 73.65 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.264 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 22.2 mt -120.13 157.73 28.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -1.228 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 80.77 23.15 60.38 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.902 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -67.18 -23.09 65.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.746 -1.444 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.98 -6.63 48.65 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.96 124.67 28.88 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 121.099 -1.236 . . . . 0.0 110.112 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.66 174.62 10.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.746 -0.855 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.93 -12.12 59.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.355 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 1.0 OUTLIER -86.05 -4.31 59.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.476 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 4.7 m-80 -150.22 16.35 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.572 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.3 m -145.04 123.51 12.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.404 HD12 ' OD1' ' A' ' 213' ' ' ASN . 12.2 tp -85.76 115.05 23.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 108.833 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.28 124.13 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.9 mt -105.38 148.69 26.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.799 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.49 163.66 13.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -55.68 -25.35 39.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.255 . . . . 0.0 109.341 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.25 12.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.673 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.18 147.88 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 110.106 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.89 128.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.862 . . . . 0.0 108.979 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.44 -55.17 6.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.15 -0.969 . . . . 0.0 110.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 204' ' ' LEU . 5.4 m120 -51.53 137.54 31.63 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.992 -1.067 . . . . 0.0 109.81 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.67 -38.73 3.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.473 2.115 . . . . 0.0 112.551 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.52 -6.65 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.32 -166.27 50.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -77.8 141.78 39.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.98 . . . . 0.0 109.736 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -85.49 -15.61 42.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 108.841 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 221' ' ' ASN . 17.8 m-85 -141.94 130.06 22.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.505 ' C ' ' ND2' ' A' ' 221' ' ' ASN . 24.0 mt-10 -46.5 -12.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 109.153 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -138.13 36.81 2.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.61 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 22.5 tt0 -61.85 -34.42 16.13 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 111.21 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.0 Cg_exo -72.01 -48.06 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.919 1.746 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 224' ' ' VAL . 4.6 m -71.91 -22.24 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.838 -1.163 . . . . 0.0 108.071 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.586 ' CZ ' ' CE1' ' A' ' 164' ' ' PHE . 15.2 mtt85 -68.03 -45.84 72.83 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.33 -41.07 92.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -44.14 84.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.902 . . . . 0.0 108.648 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 224' ' ' VAL . 89.1 t -65.5 -40.28 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.503 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.3 t80 -58.81 -39.56 81.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -73.55 -38.56 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.578 -0.701 . . . . 0.0 109.414 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.62 -37.77 71.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.28 -47.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.35 -33.51 16.53 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.6 -27.1 31.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.123 -1.222 . . . . 0.0 110.059 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.65 -24.89 41.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.714 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 35.1 t80 -67.63 -10.06 48.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 237' ' ' LEU . 26.0 mt -51.05 -26.53 6.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 242' ' ' VAL . 95.9 mt -57.9 -21.79 45.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 108.745 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.4 13.95 75.12 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 64.5 p -158.96 149.05 15.32 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 109.735 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.34 134.03 4.7 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.396 2.064 . . . . 0.0 112.072 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.66 HG22 HD12 ' A' ' 238' ' ' LEU . 70.1 t -101.5 127.59 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.942 . . . . 0.0 109.97 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.409 ' HB3' HG13 ' A' ' 125' ' ' VAL . 1.4 tppt? -116.13 122.99 46.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 109.426 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.51 178.87 32.93 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -109.09 112.95 25.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.313 -1.11 . . . . 0.0 109.833 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -114.74 146.86 40.49 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.817 0.818 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.4 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 26.5 t80 -131.07 141.4 50.17 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.7 t -135.74 128.54 31.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.791 -1.193 . . . . 0.0 110.563 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 14.3 t80 -111.69 114.53 27.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 3.2 mtp85 44.78 55.74 5.75 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.19 148.85 22.52 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -112.63 -177.61 19.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 257' ' ' VAL . 25.5 m-70 -70.5 -47.21 61.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.091 -1.241 . . . . 0.0 109.752 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 68.3 p -61.03 -54.5 44.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.308 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' A' ' 134' ' ' ASP . 58.3 tp -51.71 -39.65 58.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 109.384 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -59.72 -55.87 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -0.975 . . . . 0.0 108.865 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 253' ' ' HIS . 41.0 t -49.19 -41.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.232 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -48.47 75.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.67 -44.81 66.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 108.804 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.4 t -68.23 -49.18 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.318 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.37 -50.74 38.81 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.695 -0.628 . . . . 0.0 110.509 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.41 -50.97 65.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.987 -1.071 . . . . 0.0 109.961 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 263' ' ' LEU . 47.8 mt -56.64 -44.21 81.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.35 83.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.725 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 108.989 179.513 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.6 mt-10 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.382 0.611 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -113.18 130.93 56.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.2 t -131.23 169.68 15.62 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.376 -0.828 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 7' ' ' VAL . 4.6 m -81.58 136.26 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.826 -1.171 . . . . 0.0 110.516 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' CB ' ' HZ3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -69.78 -47.11 64.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.664 -0.648 . . . . 0.0 109.978 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -128.42 156.88 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.492 -0.755 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -62.82 134.61 56.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.682 HD21 ' OD1' ' A' ' 113' ' ' ASN . 19.7 mt -118.66 160.8 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -149.55 145.97 27.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.941 -1.1 . . . . 0.0 110.046 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -128.83 164.62 22.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.475 -0.766 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.8 12.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 109.004 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.64 159.43 17.86 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.554 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.4 p -76.07 164.32 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.047 -1.266 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -95.21 142.45 16.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.3 tt -61.23 -47.78 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.053 -1.263 . . . . 0.0 112.136 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.2 m-70 -86.99 -39.86 15.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 119.984 -1.697 . . . . 0.0 110.793 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 m -71.76 -36.79 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.383 -0.823 . . . . 0.0 110.168 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 24.22 70.09 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -115.07 152.5 32.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.632 -0.922 . . . . 0.0 108.715 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -72.35 131.61 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.889 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 t -138.35 158.91 43.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.216 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.648 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.8 ttmt -133.13 159.59 39.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.669 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.5 mt -133.31 144.12 49.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.178 -0.951 . . . . 0.0 109.235 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.552 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.5 mt -134.49 123.43 42.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.54 126.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 0.0 109.926 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.577 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.3 m-70 -122.18 149.19 53.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.14 160.16 16.73 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.055 1.837 . . . . 0.0 111.229 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 2.7 mm-40 -133.79 -176.0 4.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.599 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' OG1' ' A' ' 35' ' ' THR . 10.0 ttpp -88.01 152.31 22.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.92 145.44 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.422 -0.799 . . . . 0.0 110.227 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.641 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.42 25.55 60.71 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.213 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.6 m -80.88 -41.4 23.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.648 -1.501 . . . . 0.0 108.703 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.71 178.95 30.85 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.56 123.31 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -140.3 145.79 37.7 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.033 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -100.68 152.25 20.68 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 11.0 t80 -133.35 141.95 48.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.225 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -176.5 145.94 0.59 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m120 57.55 28.89 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.85 28.92 72.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.48 142.57 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -1.215 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.41 143.59 31.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.237 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.04 95.81 14.87 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.35 145.53 21.02 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.052 1.834 . . . . 0.0 111.267 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 82.14 5.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.93 -1.107 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.84 153.92 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 51' ' ' GLU . 17.3 p-80 -51.81 -49.61 62.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.8 mm-40 -43.87 -33.02 1.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.196 -0.94 . . . . 0.0 109.234 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -80.45 2.46 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' HIS . 2.6 t -60.7 126.16 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.021 -1.049 . . . . 0.0 108.695 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.09 -34.11 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.478 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t-80 -149.67 123.18 9.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.943 -1.098 . . . . 0.0 109.913 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -110.71 131.52 54.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.2 t-20 -166.38 -154.2 0.18 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.53 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 8.1 m170 -48.05 -11.65 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 108.513 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 43.6 t -138.15 165.94 25.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.563 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.4 m -102.92 121.14 41.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.6 OUTLIER -120.4 141.56 50.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.563 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.1 mt -123.51 155.98 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -172.88 142.28 6.65 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.944 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -144.86 151.48 38.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.631 -0.923 . . . . 0.0 109.704 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm 56.51 27.86 12.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.495 -0.753 . . . . 0.0 110.839 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.55 81.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.315 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.504 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 92.7 mm-40 -99.26 143.5 29.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.286 . . . . 0.0 108.361 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -141.99 151.24 42.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 0.0 111.198 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.51 144.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -114.27 153.73 29.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 110.896 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 53.24 68.05 0.9 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.645 -0.659 . . . . 0.0 110.812 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.42 ' O ' HD12 ' A' ' 76' ' ' LEU . 15.9 m -113.12 -5.77 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 109.464 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.571 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.5 OUTLIER -67.76 -29.27 68.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.985 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -62.63 -60.29 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.91 . . . . 0.0 109.91 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 9.6 tp -59.13 -44.29 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.035 . . . . 0.0 109.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 9.8 mt -59.58 -38.1 80.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.126 -0.984 . . . . 0.0 109.771 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.455 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -59.71 -48.03 83.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 109.531 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.53 -53.56 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 76' ' ' LEU . 28.5 mt -50.91 -43.06 59.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.065 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.625 ' HD1' HG22 ' A' ' 232' ' ' ILE . 11.8 t-160 -55.1 -56.97 13.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 109.815 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 43.0 mt -57.52 -38.54 74.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.649 HD13 HD11 ' A' ' 114' ' ' ILE . 36.5 mt -80.12 -5.88 56.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.957 -1.089 . . . . 0.0 110.892 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER 62.8 63.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.706 -1.246 . . . . 0.0 110.528 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 82' ' ' LEU . 9.7 mm -102.8 132.87 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 108.708 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.24 -23.6 7.24 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.339 -0.85 . . . . 0.0 111.633 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.689 ' O ' HG13 ' A' ' 87' ' ' VAL . 70.9 m-20 -132.21 112.76 12.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.763 -1.211 . . . . 0.0 110.453 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.7 m -164.05 137.71 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.882 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.538 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 47.2 m -106.52 100.21 9.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.76 116.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.698 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -94.29 117.88 30.77 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.675 -1.265 . . . . 0.0 108.127 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.48 107.49 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.723 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.8 mt -89.69 110.47 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.24 -164.49 25.06 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -109.02 -11.41 14.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -1.054 . . . . 0.0 110.2 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -153.15 155.89 37.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.917 -1.114 . . . . 0.0 110.306 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.57 131.91 85.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.751 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.669 ' CD ' HD21 ' A' ' 26' ' ' LEU . 76.3 Cg_exo -45.88 138.46 11.91 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.295 1.997 . . . . 0.0 112.283 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 99' ' ' LEU . 8.7 tp -75.91 -39.18 37.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.571 -0.706 . . . . 0.0 110.264 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.495 ' N ' HG23 ' A' ' 98' ' ' ILE . 80.3 mt 54.92 -155.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.481 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.95 -1.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.147 -0.971 . . . . 0.0 111.027 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 99' ' ' LEU . . . 88.27 -10.4 71.37 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.69 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.3 p -112.09 -168.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -1.082 . . . . 0.0 109.77 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -1.22 21.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.589 ' CD2' ' OE1' ' A' ' 108' ' ' GLU . 69.1 t-105 -46.81 -41.36 15.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.841 -0.799 . . . . 0.0 110.696 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.426 ' OE1' HD13 ' A' ' 99' ' ' LEU . 36.2 mt-10 -62.39 -52.04 65.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 110.303 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.6 m-85 -62.01 -45.38 93.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.924 -1.11 . . . . 0.0 108.758 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.659 ' CD2' HG11 ' A' ' 175' ' ' VAL . 6.1 t80 -59.68 -41.33 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.676 -0.64 . . . . 0.0 109.811 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -74.64 -41.68 59.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 111.418 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -48.68 25.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.858 -1.151 . . . . 0.0 110.357 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.4 mt -67.66 -40.51 84.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.12 -0.987 . . . . 0.0 110.392 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -53.05 -31.79 43.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 109.593 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -85.3 -5.89 59.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 110.102 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.682 ' OD1' HD21 ' A' ' 11' ' ' LEU . 4.1 m120 -125.47 30.29 5.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 111.385 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.649 HD11 HD13 ' A' ' 82' ' ' LEU . 4.8 mt -89.89 146.79 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.661 -1.274 . . . . 0.0 109.941 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 115' ' ' LEU . 15.1 tp -131.93 161.13 33.81 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -108.1 144.91 34.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 110.076 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -106.0 -163.77 0.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.26 -3.42 13.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.344 -0.848 . . . . 0.0 110.58 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 4' ' ' GLU . 25.7 ttm180 -89.98 143.48 26.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 0.0 110.274 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -83.03 128.56 34.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.36 -0.838 . . . . 0.0 109.859 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.5 mt -67.49 137.35 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.768 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.69 91.09 8.68 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -65.47 146.83 54.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.455 -0.778 . . . . 0.0 110.936 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -100.26 122.65 43.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.71 139.18 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.6 t -84.21 138.86 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.429 -0.794 . . . . 0.0 108.929 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -117.72 -8.67 10.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.522 -0.736 . . . . 0.0 109.444 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -144.0 144.12 25.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.953 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.91 150.66 55.59 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.196 1.931 . . . . 0.0 113.096 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 2.2 tt -140.96 144.61 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.87 125.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.81 111.27 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.778 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -113.47 133.59 55.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -179.08 156.38 0.78 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.011 -1.056 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 57.0 mm-40 56.16 20.14 4.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.54 88.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.46 ' HE ' ' C ' ' A' ' 251' ' ' GLY . 1.4 mtp85 -104.02 171.21 7.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.6 tt -159.86 146.06 15.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.503 -1.373 . . . . 0.0 108.589 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 259' ' ' LEU . 18.7 mt -147.59 126.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.024 -1.047 . . . . 0.0 108.511 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 147.06 43.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.638 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -127.75 151.87 48.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -150.11 139.14 12.9 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -51.52 144.19 33.36 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.707 1.605 . . . . 0.0 112.146 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.71 11.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.21 -0.931 . . . . 0.0 109.472 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 24.7 p-10 -86.21 -0.4 55.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.67 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.3 p -135.14 145.54 47.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.1 tp -79.72 118.03 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.92 . . . . 0.0 109.838 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -138.17 142.16 40.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 108.871 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.531 ' CG1' HD23 ' A' ' 231' ' ' LEU . 71.1 t -140.35 131.87 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.997 -1.064 . . . . 0.0 109.935 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 m -117.73 135.85 53.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.348 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.531 ' HB2' HG22 ' A' ' 228' ' ' VAL . 84.1 t80 -123.88 128.54 49.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.6 109.46 17.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.01 122.75 6.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 1.1 pm0 -102.88 114.65 29.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -1.138 . . . . 0.0 108.659 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -109.42 147.73 32.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.576 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -93.31 0.12 56.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.786 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.483 ' ND2' HD12 ' A' ' 159' ' ' LEU . 12.8 p30 -79.3 -171.54 2.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 12.2 p90 -61.68 -26.55 68.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.604 HD11 HD13 ' A' ' 206' ' ' LEU . 4.0 mt -55.61 -50.57 69.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.34 -136.09 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.447 ' O ' ' CD ' ' A' ' 162' ' ' GLN . 38.3 mtp180 -98.68 140.35 33.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -1.1 . . . . 0.0 109.575 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.447 ' CD ' ' O ' ' A' ' 161' ' ' ARG . 12.7 mp0 -139.33 131.06 27.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.368 -0.833 . . . . 0.0 109.03 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.33 52.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.527 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 71.9 t80 -138.35 126.69 23.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.183 -0.948 . . . . 0.0 109.787 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 165' ' ' THR . 7.0 t -106.03 123.93 48.77 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -97.67 133.45 42.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.93 . . . . 0.0 108.716 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.81 148.34 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.522 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -48.06 114.89 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.639 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 10.33 11.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.429 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 27.3 m-20 -136.81 26.9 3.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.988 -1.301 . . . . 0.0 108.853 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.9 mp0 -63.0 -37.82 88.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.749 . . . . 0.0 110.768 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.19 -16.33 13.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -90.29 -3.67 57.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.077 . . . . 0.0 110.917 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.85 4.67 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.047 -1.033 . . . . 0.0 111.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.659 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.1 OUTLIER -99.27 -27.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.779 -1.2 . . . . 0.0 109.799 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.65 2.47 50.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.797 -1.189 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.1 109.52 17.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.774 -1.204 . . . . 0.0 109.036 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.42 ' HG2' ' H ' ' A' ' 178' ' ' ARG . 2.2 ptp180 -79.69 153.52 29.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -55.83 154.49 7.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 108.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.544 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 39.5 p90 -135.35 170.45 15.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 109.728 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.633 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -159.29 161.94 35.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.23 -0.919 . . . . 0.0 109.754 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.535 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 61.5 m-85 -103.79 146.46 28.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.738 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.6 OUTLIER -61.64 -21.13 64.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.047 -1.033 . . . . 0.0 110.868 -178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.3 p90 -81.53 -29.6 33.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.552 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.1 pt-20 -92.15 -15.84 27.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.896 -1.128 . . . . 0.0 109.699 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' A' ' 183' ' ' ASP . 12.1 mt -58.76 -53.25 49.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 110.431 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -52.43 -47.58 66.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.579 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.22 -47.55 83.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.977 . . . . 0.0 109.137 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.96 -33.11 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 108.99 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -78.27 -31.4 49.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -74.98 -28.76 60.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.019 -1.051 . . . . 0.0 110.218 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.486 ' CG2' HD12 ' A' ' 194' ' ' LEU . 31.4 m -78.51 8.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.173 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.47 20.95 73.73 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.486 HD12 ' CG2' ' A' ' 192' ' ' VAL . 22.9 mt -119.16 157.82 27.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.478 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.67 24.34 62.78 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -67.71 -21.72 65.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.744 -1.445 . . . . 0.0 109.436 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.34 -6.12 48.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.99 126.66 42.29 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.044 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 203' ' ' THR . 60.6 p -140.88 160.76 39.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.895 . . . . 0.0 109.309 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.43 -27.76 69.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 109.968 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -76.23 -15.86 59.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 109.927 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 29.0 m120 -132.81 11.12 4.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.633 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 39.3 m -148.97 115.36 5.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.163 -0.961 . . . . 0.0 109.777 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.4 HD12 ' CG ' ' A' ' 213' ' ' ASN . 68.9 tp -75.5 112.19 11.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.58 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.2 t -103.4 128.35 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 109.223 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.604 HD13 HD11 ' A' ' 159' ' ' LEU . 92.8 mt -110.67 146.29 36.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -101.19 154.14 19.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.45 -26.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 10.8 0.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.0 110.325 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -141.12 148.68 40.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.305 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.92 123.55 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.53 -54.79 7.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.394 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.4 ' CG ' HD12 ' A' ' 204' ' ' LEU . 2.7 m120 -59.34 134.31 88.34 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.703 -1.248 . . . . 0.0 109.341 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.15 -7.32 20.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.357 2.038 . . . . 0.0 112.761 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -86.47 -7.58 58.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 0.0 110.316 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.07 -158.85 53.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.4 144.13 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -1.059 . . . . 0.0 109.949 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 109.517 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.578 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 68.1 m-85 -140.08 129.47 24.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.895 . . . . 0.0 109.042 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -52.99 -11.02 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 108.502 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.477 ' N ' ' C ' ' A' ' 219' ' ' TYR . 5.9 m120 -133.07 35.28 3.52 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.482 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 8.7 tt0 -59.26 -55.35 47.05 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.729 . . . . 0.0 111.579 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 19.6 Cg_endo -60.75 -42.14 41.06 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.73 1.62 . . . . 0.0 113.305 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 228' ' ' VAL . 4.5 m -76.99 -25.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 108.363 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.578 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 46.9 mtt180 -67.0 -43.47 82.83 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.28 -41.24 98.32 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.45 -46.26 80.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.9 t -60.76 -51.03 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.455 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 81.6 t80 -50.45 -39.85 48.99 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.886 0.85 . . . . 0.0 108.725 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.455 ' OD2' ' OE1' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.98 -39.66 69.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.65 -0.656 . . . . 0.0 109.681 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 149' ' ' VAL . 28.5 tp -57.9 -35.36 70.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.905 . . . . 0.0 109.385 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.625 HG22 ' HD1' ' A' ' 80' ' ' HIS . 86.9 mt -71.12 -48.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.41 -32.1 14.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.8 -27.03 31.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.44 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -82.94 -24.3 33.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.775 -1.203 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.452 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 44.5 t80 -68.14 -8.56 39.48 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 239' ' ' GLY . 43.9 mt -52.21 -30.26 26.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 109.163 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 242' ' ' VAL . 97.5 mt -55.02 -7.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.169 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 71.92 14.78 75.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.7 p -158.13 144.62 12.87 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -1.21 . . . . 0.0 109.402 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 77.0 Cg_exo -42.38 134.71 4.61 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.148 1.899 . . . . 0.0 111.873 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 238' ' ' LEU . 22.0 t -98.04 129.53 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -118.1 124.65 48.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 109.373 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.36 -178.5 31.96 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -105.08 138.12 41.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -1.077 . . . . 0.0 110.039 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.5 m-85 -140.21 143.46 36.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.062 0.934 . . . . 0.0 111.263 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -126.31 144.25 50.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.1 t -140.11 127.47 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 110.631 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 0.9 OUTLIER -111.71 114.2 27.06 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.46 ' CG ' ' OE1' ' A' ' 154' ' ' GLU . 2.6 mmm180 47.72 55.79 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.46 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -77.6 140.52 24.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -111.05 174.19 16.66 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.571 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 15.1 m-70 -68.58 -41.97 78.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.048 -1.266 . . . . 0.0 109.659 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -55.18 25.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' A' ' 139' ' ' ILE . 57.2 tp -51.7 -39.04 57.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 71.3 m-20 -58.71 -55.48 34.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.995 . . . . 0.0 109.018 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.73 -43.35 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.732 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -48.7 74.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.093 -1.004 . . . . 0.0 109.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 139' ' ' ILE . 38.9 tp -52.81 -43.38 65.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.358 -0.839 . . . . 0.0 109.039 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.44 HG22 HD23 ' A' ' 235' ' ' LEU . 20.2 t -71.13 -45.73 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.14 -51.45 64.23 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 109.917 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.459 ' OE1' HD11 ' A' ' 130' ' ' ILE . 62.6 mt-10 -61.04 -51.48 69.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.941 -1.099 . . . . 0.0 109.637 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.66 -43.9 80.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.49 -33.11 73.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 25.5 mttt . . . . . 0 N--CA 1.488 1.469 0 O-C-N 120.81 -1.181 . . . . 0.0 108.937 179.415 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 66.4 mt-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -120.87 138.35 54.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.414 -0.804 . . . . 0.0 109.466 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.408 HG21 HE21 ' A' ' 117' ' ' GLN . 11.5 t -139.54 177.89 7.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.78 144.7 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -74.78 -46.92 33.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.667 -0.645 . . . . 0.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.32 160.47 34.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.71 . . . . 0.0 110.219 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -64.92 135.56 55.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -0.768 . . . . 0.0 110.104 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 113' ' ' ASN . 4.9 mt -122.29 171.38 9.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -158.49 150.74 21.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 0.0 110.442 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -133.93 160.91 36.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.483 -0.761 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.12 137.21 21.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.962 -1.086 . . . . 0.0 109.141 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.73 160.79 20.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.512 -1.328 . . . . 0.0 109.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.9 p -76.3 162.98 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 0.0 111.424 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -94.76 141.4 15.53 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -59.75 -48.18 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -1.138 . . . . 0.0 112.937 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.5 m-70 -86.33 -36.51 19.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.013 -1.679 . . . . 0.0 112.374 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -80.41 -34.06 36.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.824 -1.172 . . . . 0.0 110.091 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.15 74.87 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.29 152.82 30.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.983 . . . . 0.0 108.867 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -73.81 140.92 46.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 110.202 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 9.7 t -147.88 157.64 43.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.047 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.618 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -132.21 154.71 49.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.286 -0.884 . . . . 0.0 109.239 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.674 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 0.0 108.724 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.419 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.3 mt -127.95 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mt -123.91 120.88 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.419 ' NE2' HG22 ' A' ' 27' ' ' ILE . 11.5 m-70 -117.23 149.3 44.23 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 161.19 22.71 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.112 1.874 . . . . 0.0 111.258 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.6 mm-40 -134.72 -173.73 3.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.072 -1.017 . . . . 0.0 110.081 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.8 tttm -91.94 155.75 17.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.701 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.446 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 1.2 mp0 -48.07 143.63 4.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 110.62 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.595 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.84 26.17 60.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.543 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 33.0 m -79.98 -34.93 38.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.709 -1.465 . . . . 0.0 108.595 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.88 -173.35 36.4 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mm -102.03 123.74 55.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.323 -1.104 . . . . 0.0 108.271 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -137.28 139.83 41.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.511 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.03 152.84 19.38 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -131.32 142.78 50.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.832 . . . . 0.0 109.02 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 14.0 tttm -172.54 138.92 0.92 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.48 29.8 13.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.912 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.54 19.1 77.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.45 136.91 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.282 -1.128 . . . . 0.0 109.692 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -96.79 140.53 31.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.895 . . . . 0.0 109.178 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.5 mt -132.68 95.6 19.69 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.7 142.48 24.79 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.206 1.937 . . . . 0.0 111.607 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.35 80.67 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.961 -1.087 . . . . 0.0 110.307 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.04 153.41 51.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 109.649 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' VAL . 7.7 p80 -54.68 -49.29 71.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.4 mm-40 -44.67 -31.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.989 -1.07 . . . . 0.0 109.318 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.83 4.06 15.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.922 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 7.9 t -59.37 124.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.31 -32.0 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.412 -0.805 . . . . 0.0 109.944 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.531 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.8 t-160 -152.25 123.87 7.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.688 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.3 p -111.1 134.66 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 59' ' ' SER . 20.3 p-10 -166.39 -154.44 0.18 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -10.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.942 -1.099 . . . . 0.0 108.479 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -138.85 166.96 23.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -0.8 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.1 m -101.99 120.56 40.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.05 136.93 52.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.34 -0.85 . . . . 0.0 111.199 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 53' ' ' VAL . 41.5 mt -123.39 157.67 32.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.7 143.49 6.89 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 118.484 -1.817 . . . . 0.0 111.214 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -144.29 148.99 35.54 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.747 -0.855 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm 56.62 38.33 29.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 110.783 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.55 4.4 84.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.8 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 94.0 mm-40 -102.85 140.56 36.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.934 -1.333 . . . . 0.0 108.418 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -141.91 154.31 45.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.47 146.25 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -115.1 154.63 28.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 111.113 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 m 52.38 68.85 0.76 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.734 -0.604 . . . . 0.0 111.111 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.8 -10.72 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.179 -0.95 . . . . 0.0 109.727 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 5.7 pt-20 -67.73 -16.98 64.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.439 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -72.45 -60.59 2.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.012 -1.055 . . . . 0.0 109.424 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 76' ' ' LEU . 5.0 tp -58.92 -41.14 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.99 -1.069 . . . . 0.0 108.945 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 79' ' ' LEU . 84.4 mt -59.78 -36.49 76.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.6 t -60.44 -48.69 80.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.044 -1.035 . . . . 0.0 108.841 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.31 -51.26 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.453 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 76' ' ' LEU . 44.0 mt -51.87 -44.91 63.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.513 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 8.4 t-160 -57.1 -48.46 78.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.831 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.34 -39.73 95.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 110.414 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.824 HD13 HD11 ' A' ' 114' ' ' ILE . 53.2 mt -80.7 -5.56 57.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.053 -1.03 . . . . 0.0 110.738 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.77 54.64 2.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.896 -1.127 . . . . 0.0 110.723 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 82' ' ' LEU . 8.0 mm -92.69 123.85 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.63 HG21 HG12 ' A' ' 121' ' ' ILE . 63.4 p -109.78 -23.8 11.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.274 -0.891 . . . . 0.0 111.492 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' HG13 ' A' ' 87' ' ' VAL . 49.9 m-20 -128.8 111.9 13.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.972 -1.08 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -164.03 143.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.246 -0.909 . . . . 0.0 109.898 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.519 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.7 m -113.77 100.59 8.57 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.51 105.38 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.348 -0.845 . . . . 0.0 109.985 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.54 121.73 26.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -104.21 115.14 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.456 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.754 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.3 mp -97.11 109.62 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.19 -160.62 23.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.15 -12.25 11.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.071 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -142.76 147.73 36.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.984 -1.073 . . . . 0.0 110.584 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 124.42 90.89 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.505 -0.747 . . . . 0.0 108.993 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.674 ' CD ' HD21 ' A' ' 26' ' ' LEU . 73.3 Cg_exo -44.74 131.36 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.032 1.822 . . . . 0.0 112.344 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.55 -27.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.418 -0.801 . . . . 0.0 109.675 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.45 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 22.8 mt 54.89 -112.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.274 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.36 -13.85 25.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.987 . . . . 0.0 110.699 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.74 -15.35 41.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -113.1 -168.89 1.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -1.063 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.09 -1.32 23.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -46.92 -44.39 19.8 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.788 -0.83 . . . . 0.0 110.573 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.09 -51.91 66.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.0 -1.062 . . . . 0.0 110.129 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 69.8 m-85 -61.33 -44.21 97.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 109.057 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.499 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 5.6 t80 -67.14 -37.46 83.86 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.324 0.583 . . . . 0.0 110.491 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.14 -50.98 42.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 111.351 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.84 -44.7 61.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.867 -1.145 . . . . 0.0 110.622 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.88 -39.89 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 110.033 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -53.75 -30.94 46.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.309 -0.869 . . . . 0.0 109.165 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -84.75 -11.5 55.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.32 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.418 ' HB2' HD11 ' A' ' 11' ' ' LEU . 4.3 m-80 -119.96 29.54 7.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.238 -0.914 . . . . 0.0 111.405 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.824 HD11 HD13 ' A' ' 82' ' ' LEU . 4.4 mt -87.66 147.23 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.592 -1.317 . . . . 0.0 109.827 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 116' ' ' ASN . 52.8 tp -131.58 159.96 36.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.406 ' N ' ' HG ' ' A' ' 115' ' ' LEU . 21.2 t30 -109.52 144.6 37.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.408 HE21 HG21 ' A' ' 6' ' ' THR . 18.1 mt-30 -107.01 -166.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 p30 -118.73 72.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.529 -0.732 . . . . 0.0 110.187 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 4' ' ' GLU . 20.9 ttt180 -166.04 143.98 5.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 109.42 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.32 131.45 35.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.09 -1.006 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.63 HG12 HG21 ' A' ' 85' ' ' THR . 68.8 mt -74.98 141.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.732 . . . . 0.0 110.571 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -84.04 88.53 7.17 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -61.47 145.69 51.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.6 120.51 40.43 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.18 140.71 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.266 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 97.1 t -84.24 136.3 23.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.462 -0.774 . . . . 0.0 109.212 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -113.94 -10.26 12.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.12 146.58 40.59 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.08 178.02 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.19 1.927 . . . . 0.0 112.779 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 141' ' ' ALA . 7.2 tt -165.32 147.76 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.495 -0.753 . . . . 0.0 109.799 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.515 HD11 ' HZ3' ' A' ' 140' ' ' LYS . 53.2 mt -134.91 122.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.23 116.69 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -104.23 155.01 19.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.265 -0.897 . . . . 0.0 109.896 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.513 ' HB2' HD13 ' A' ' 255' ' ' LEU . 13.3 t0 -165.52 110.98 0.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.978 -1.076 . . . . 0.0 111.499 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 41.19 51.76 3.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.427 -0.796 . . . . 0.0 112.46 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.48 6.77 88.87 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.645 -1.285 . . . . 0.0 110.448 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.8 mtt85 -118.6 130.18 55.73 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 138' ' ' LEU . 3.7 tt -144.33 160.02 41.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.416 -1.428 . . . . 0.0 110.16 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.548 ' N ' HD23 ' A' ' 138' ' ' LEU . 52.5 mt -146.26 133.01 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.515 ' HZ3' HD11 ' A' ' 131' ' ' ILE . 47.9 tttp -118.96 144.86 46.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.757 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -118.37 147.82 43.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -145.05 135.03 11.7 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.57 147.46 58.75 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.402 . . . . 0.0 112.031 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.21 154.76 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.232 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.557 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.6 OUTLIER -86.98 1.39 52.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.506 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.5 p -135.7 146.94 48.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 242' ' ' VAL . 18.2 tp -79.58 119.83 23.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.02 134.15 32.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 108.877 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.677 ' CG1' HD23 ' A' ' 231' ' ' LEU . 55.7 t -134.05 118.16 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 109.339 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.4 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 2.0 m -107.35 135.72 48.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.094 -1.004 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -123.6 129.15 50.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.47 -0.769 . . . . 0.0 109.827 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -113.92 109.64 18.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.3 155.96 19.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.556 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -134.2 91.24 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -1.089 . . . . 0.0 109.485 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.76 148.76 22.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 -10.26 35.52 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.403 -0.81 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.6 p30 -69.65 -167.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.186 -0.947 . . . . 0.0 109.521 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.99 -21.44 58.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.907 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.7 mt -64.48 -47.61 78.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.82 -126.23 7.43 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.7 mtt85 -109.44 141.09 42.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.533 -0.981 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -153.9 150.4 28.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 109.713 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -136.71 151.35 49.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.407 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 62.9 t80 -135.12 122.89 22.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 108.872 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 165' ' ' THR . 15.2 t -99.83 122.35 42.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -100.44 132.86 45.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.351 -0.843 . . . . 0.0 109.164 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.45 151.91 34.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.454 -0.779 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -51.67 116.4 2.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 8.32 14.37 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -134.04 26.24 3.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.19 -1.183 . . . . 0.0 108.312 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 171' ' ' GLU . 22.0 mt-10 -64.6 -31.72 73.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.64 -0.662 . . . . 0.0 110.735 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.68 -15.53 58.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.275 -0.89 . . . . 0.0 111.627 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.34 -4.15 49.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.587 -1.321 . . . . 0.0 111.212 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.3 pt -117.11 -9.99 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.05 -1.032 . . . . 0.0 111.132 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 175' ' ' VAL . 0.9 OUTLIER -83.11 -28.11 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.548 -1.345 . . . . 0.0 110.133 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 2.29 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.896 -1.127 . . . . 0.0 110.452 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.37 110.18 17.28 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.94 -1.1 . . . . 0.0 109.001 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 154.58 20.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.085 -1.01 . . . . 0.0 110.066 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.435 ' CA ' ' CE1' ' A' ' 226' ' ' HIS . 5.0 t -52.73 156.9 1.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -0.799 . . . . 0.0 109.537 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.524 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 34.1 p90 -141.47 167.8 21.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.087 -1.008 . . . . 0.0 109.826 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.524 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -163.82 164.12 23.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -0.931 . . . . 0.0 109.918 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.433 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 91.2 m-85 -103.14 144.43 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.354 -0.842 . . . . 0.0 109.127 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.729 ' HA ' HD12 ' A' ' 186' ' ' ILE . 28.4 p-10 -65.45 -18.75 65.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.386 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -77.58 -29.04 51.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.548 -1.345 . . . . 0.0 111.003 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -101.39 -11.45 19.37 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.853 -1.154 . . . . 0.0 110.15 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.7 mt -58.93 -51.21 75.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 110.371 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -51.01 -49.43 60.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.919 -1.113 . . . . 0.0 109.54 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -49.39 70.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 109.005 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 186' ' ' ILE . 57.0 mt -57.41 -33.81 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.966 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -75.18 -26.13 58.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 110.179 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 193' ' ' GLY . 0.6 OUTLIER -76.52 -33.83 58.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 110.004 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.1 m -74.6 10.07 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 109.037 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 76.82 22.06 72.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.18 155.63 30.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -1.178 . . . . 0.0 109.997 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.48 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.83 23.71 61.46 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.365 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -67.45 -22.17 65.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.686 -1.479 . . . . 0.0 109.618 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.83 -5.82 50.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 128.34 41.44 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.848 -1.384 . . . . 0.0 110.106 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -136.22 -177.49 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.519 -0.989 . . . . 0.0 109.605 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.2 -21.97 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.65 -6.26 58.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.861 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.1 m-20 -141.26 13.85 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.04 -1.037 . . . . 0.0 110.017 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.459 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.1 m -149.3 118.96 6.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.015 -1.053 . . . . 0.0 110.058 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.33 111.58 14.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.897 . . . . 0.0 108.909 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.2 t -103.7 127.89 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.225 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.78 151.89 28.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.72 160.98 14.11 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -48.62 -28.08 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.78 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -152.59 13.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.038 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 207' ' ' GLY . 73.6 tttt -141.19 149.36 41.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.021 -1.05 . . . . 0.0 110.068 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.2 t -99.08 125.92 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 109.038 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -72.96 -54.46 8.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 110.104 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.03 137.02 80.21 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.996 -1.065 . . . . 0.0 109.746 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.74 -13.23 26.91 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.412 2.075 . . . . 0.0 112.622 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -85.59 -7.28 58.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 110.1 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.68 -160.83 53.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.95 145.73 30.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.991 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -88.84 -24.94 22.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 108.815 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 221' ' ' ASN . 56.6 m-85 -145.99 139.37 26.09 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.75 -12.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.951 -1.093 . . . . 0.0 108.507 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -139.88 37.68 1.98 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.768 0.794 . . . . 0.0 109.122 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.592 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -55.75 -41.48 91.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_exo -69.11 -42.83 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.429 2.086 . . . . 0.0 112.966 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 228' ' ' VAL . 16.1 m -76.25 -24.81 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.735 -1.228 . . . . 0.0 108.691 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.447 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 38.6 mtt180 -69.03 -45.17 71.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.435 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 37.0 t60 -59.2 -45.06 92.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.471 -0.768 . . . . 0.0 108.959 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -56.58 -47.81 78.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 108.989 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 224' ' ' VAL . 95.6 t -58.46 -51.18 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -50.69 -39.33 50.97 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -72.05 -40.87 68.04 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.588 -0.695 . . . . 0.0 109.855 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.677 HD23 ' CG1' ' A' ' 149' ' ' VAL . 51.8 tp -57.02 -35.01 68.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.377 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 25.0 mt -71.62 -48.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.32 20.55 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.87 -28.8 29.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.263 -1.139 . . . . 0.0 109.854 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 260' ' ' VAL . 7.0 mt -79.75 -22.92 42.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.773 -1.204 . . . . 0.0 109.701 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 24.5 t80 -69.0 -10.0 55.26 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 237' ' ' LEU . 81.2 mt -51.44 -26.59 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 0.0 108.869 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.497 HD12 HG22 ' A' ' 242' ' ' VAL . 95.5 mt -59.95 -21.59 61.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.89 14.57 69.5 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 56.1 p -158.41 147.12 14.29 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.045 -1.268 . . . . 0.0 109.813 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 71.8 Cg_exo -42.66 130.87 5.41 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.203 1.935 . . . . 0.0 111.961 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.497 HG22 HD12 ' A' ' 238' ' ' LEU . 51.3 t -95.26 127.04 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.579 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -117.08 123.85 47.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.365 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.67 177.95 30.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.411 ' HG3' ' HZ2' ' A' ' 245' ' ' LYS . 21.5 tttp -110.35 111.17 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.242 -1.152 . . . . 0.0 110.352 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.9 m-85 -111.82 147.6 35.37 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.853 0.835 . . . . 0.0 110.695 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.4 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 29.4 t80 -128.35 143.25 50.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.0 t -138.13 126.18 22.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.682 -1.261 . . . . 0.0 110.219 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 250' ' ' ARG . 11.9 t80 -111.64 112.61 24.43 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.556 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 12.3 mtt180 47.39 56.67 6.67 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.47 155.14 22.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.24 -175.42 16.66 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.444 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 90.9 m-70 -72.28 -51.82 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -1.21 . . . . 0.0 109.66 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.3 t -55.57 -34.12 64.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.706 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 134' ' ' ASP . 44.0 tp -72.99 -37.47 66.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 108.99 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 29.9 m-20 -62.71 -49.71 74.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 108.922 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.79 -44.18 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.354 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -54.98 -48.53 73.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.942 -1.099 . . . . 0.0 108.844 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.82 -47.05 67.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.638 HG22 HD23 ' A' ' 235' ' ' LEU . 98.5 t -65.56 -50.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.682 0.753 . . . . 0.0 109.574 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.82 -50.54 18.23 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 110.417 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.91 -47.98 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.09 . . . . 0.0 110.29 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 72.2 mt -61.76 -43.99 97.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 109.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.59 96.74 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.381 -0.824 . . . . 0.0 109.486 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp . . . . . 0 N--CA 1.49 1.527 0 O-C-N 120.93 -1.106 . . . . 0.0 109.159 179.558 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.5 mt-10 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -126.5 141.87 51.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 t -138.61 177.79 7.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -83.06 140.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.818 -1.176 . . . . 0.0 110.163 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.465 ' CG ' HD13 ' A' ' 115' ' ' LEU . 13.9 ttpt -77.05 -43.67 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -126.2 153.23 44.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 109.842 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 139.49 58.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 110.236 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.6 mt -123.32 168.65 12.22 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -157.94 148.7 20.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 110.105 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -132.44 159.94 37.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -147.82 135.03 20.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.964 -1.085 . . . . 0.0 108.603 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.0 157.58 15.12 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG23 ' C ' ' A' ' 22' ' ' GLU . 11.2 p -81.53 141.03 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.216 -1.167 . . . . 0.0 110.755 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.18 144.92 40.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -63.89 -46.04 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.225 -1.162 . . . . 0.0 112.627 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.6 m-70 -86.8 -40.42 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 119.961 -1.712 . . . . 0.0 111.46 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -70.27 -31.64 69.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 109.954 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.04 23.89 68.16 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.542 ' C ' HG23 ' A' ' 16' ' ' VAL . 9.7 mt-10 -116.87 152.28 34.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -1.019 . . . . 0.0 109.469 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -70.69 132.72 45.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.72 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 t -140.89 158.0 44.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.0 109.252 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.721 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.9 ttpp -130.7 158.65 39.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.875 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.9 mt -135.44 141.12 45.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 108.766 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mt -126.41 135.66 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mt -118.77 112.75 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -111.97 154.58 44.13 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -68.67 162.2 42.08 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.372 2.048 . . . . 0.0 110.883 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.6 mm-40 -137.37 -177.4 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.016 -1.052 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -83.13 148.79 27.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.418 -0.801 . . . . 0.0 109.236 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.648 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.84 149.77 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.984 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.648 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.21 21.59 53.83 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.292 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.1 m -80.58 -37.35 31.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.625 -1.515 . . . . 0.0 108.803 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.75 -175.56 34.16 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -98.81 123.23 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.449 -1.03 . . . . 0.0 108.294 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -137.22 145.74 44.0 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.859 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -103.72 152.26 22.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -133.81 141.36 47.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.499 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.3 143.27 1.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 56.87 29.55 16.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.973 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.35 27.15 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.01 135.05 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -1.079 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.8 140.5 32.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 67' ' ' GLN . 42.5 mt -135.2 95.38 14.95 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.882 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.18 145.41 7.81 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.018 1.812 . . . . 0.0 111.743 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.41 82.35 5.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.0 110.292 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -139.14 156.25 47.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 109.58 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.56 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 2.1 p80 -52.78 -49.64 65.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -44.79 -16.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 25.4 m-85 -97.03 4.67 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.941 -1.099 . . . . 0.0 109.897 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.24 126.11 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.24 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.18 -34.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.374 -0.829 . . . . 0.0 110.0 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.411 ' NE2' ' HB2' ' A' ' 57' ' ' ASN . 4.8 t-160 -148.42 119.11 7.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 109.384 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -114.01 130.64 56.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 59' ' ' SER . 66.8 t30 -166.61 -153.63 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.533 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 4.8 m-70 -46.11 -15.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.383 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 57' ' ' ASN . 36.8 t -134.69 166.09 23.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.459 -0.776 . . . . 0.0 109.369 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m -109.85 125.04 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.369 -0.832 . . . . 0.0 109.225 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.2 145.98 48.99 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.958 0.885 . . . . 0.0 111.078 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.4 mt -127.21 159.55 33.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -178.55 148.25 8.3 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 118.422 -1.847 . . . . 0.0 111.572 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.2 149.68 36.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.157 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp 55.79 37.61 29.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.947 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 6.1 84.92 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.79 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 77.2 mm-40 -105.4 135.08 47.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -1.229 . . . . 0.0 108.018 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -142.23 159.77 41.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.943 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mt -136.47 147.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -114.67 154.35 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.433 -0.792 . . . . 0.0 110.949 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m 52.33 69.03 0.73 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.671 -0.643 . . . . 0.0 111.005 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.14 -11.26 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.166 -0.959 . . . . 0.0 109.28 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.562 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.1 pt-20 -66.9 -21.09 66.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.902 . . . . 0.0 110.535 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -71.28 -59.85 2.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.925 -1.109 . . . . 0.0 109.74 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.5 tp -57.87 -40.65 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.089 . . . . 0.0 108.962 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' N ' HG23 ' A' ' 75' ' ' ILE . 8.2 mt -61.55 -35.74 78.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.639 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.6 t -61.32 -48.74 79.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.032 -1.042 . . . . 0.0 109.244 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 31.9 t -58.59 -54.05 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.7 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 76' ' ' LEU . 23.6 mt -51.19 -43.44 61.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.536 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 13.2 t-160 -54.61 -52.32 62.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.784 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.53 -36.9 85.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.677 HD13 HD11 ' A' ' 114' ' ' ILE . 18.0 mt -78.08 -5.7 52.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.554 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 62.72 54.28 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.819 -1.175 . . . . 0.0 110.557 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.5 mm -96.02 126.16 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -113.19 -24.13 9.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 112.21 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.745 ' O ' HG13 ' A' ' 87' ' ' VAL . 13.4 m-80 -130.63 112.36 13.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.76 -1.212 . . . . 0.0 110.418 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.7 m -165.22 141.19 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.814 HG22 ' OE1' ' A' ' 90' ' ' GLU . 82.6 m -109.22 100.02 9.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.07 111.46 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.814 ' OE1' HG22 ' A' ' 88' ' ' THR . 0.6 OUTLIER -84.7 124.7 31.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.87 -1.144 . . . . 0.0 108.374 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 91' ' ' VAL . 3.9 t -107.85 111.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.731 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.4 mp -98.13 109.06 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.88 -162.43 24.19 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.38 -15.42 11.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.147 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.98 144.73 37.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.019 -1.051 . . . . 0.0 110.004 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.56 127.67 92.58 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 109.5 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.657 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.9 Cg_exo -45.6 128.37 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.887 1.724 . . . . 0.0 111.814 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.451 HD11 ' HA2' ' A' ' 101' ' ' GLY . 7.4 tp -79.8 -26.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.408 -0.808 . . . . 0.0 109.849 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.455 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 12.6 mt 55.42 -110.59 0.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -94.86 -18.74 20.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.081 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.451 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 111.87 -10.36 27.5 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -114.49 -169.67 1.58 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.429 -1.042 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -3.08 21.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -46.91 -42.04 16.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.842 -0.799 . . . . 0.0 110.649 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.57 -52.02 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.987 -1.071 . . . . 0.0 110.171 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 74.3 m-85 -62.27 -44.03 97.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.112 -0.993 . . . . 0.0 108.715 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 9.9 t80 -61.35 -39.46 90.66 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.44 0.638 . . . . 0.0 109.842 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.11 -46.73 40.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.465 -0.772 . . . . 0.0 111.906 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.42 -48.38 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.778 -1.201 . . . . 0.0 110.674 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.53 -40.75 89.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.359 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 1.1 ttm-85 -54.62 -29.5 52.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -0.963 . . . . 0.0 109.978 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -82.57 -8.88 59.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.421 ' HB2' HD11 ' A' ' 11' ' ' LEU . 14.6 m120 -123.18 33.96 5.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.318 -0.864 . . . . 0.0 111.279 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.677 HD11 HD13 ' A' ' 82' ' ' LEU . 10.4 mt -93.46 147.83 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 110.501 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.465 HD13 ' CG ' ' A' ' 8' ' ' LYS . 14.4 tp -131.02 163.55 27.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -112.97 144.03 43.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.95 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 33' ' ' GLU . 5.8 mt-30 -108.86 -161.45 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.169 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -122.77 1.03 9.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.255 -0.903 . . . . 0.0 110.856 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -82.66 135.46 35.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.797 -1.189 . . . . 0.0 109.849 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -74.94 124.1 26.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mt -71.82 140.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 111.278 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.81 91.18 8.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -63.53 146.08 54.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.459 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -102.21 125.78 49.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 t -129.96 143.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 92.3 t -82.94 137.85 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -119.7 -11.3 9.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.45 140.71 23.46 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 0.0 108.868 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -72.17 149.74 52.39 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.884 1.722 . . . . 0.0 113.043 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -127.95 124.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 109.64 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 132' ' ' VAL . 28.7 m -120.22 115.65 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.116 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -105.42 142.5 35.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.332 -0.855 . . . . 0.0 109.225 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.46 123.8 1.91 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.766 -1.209 . . . . 0.0 111.944 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 48.08 41.56 15.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.775 -0.578 . . . . 0.0 112.319 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.48 4.23 90.46 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.045 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.2 mtt-85 -104.17 161.46 14.0 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.7 tt -160.33 150.44 18.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.16 -1.588 . . . . 0.0 109.052 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.989 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.3 mt -147.6 132.2 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -123.43 139.24 54.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.838 . . . . 0.0 109.797 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.545 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -119.36 148.03 43.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -147.11 137.77 12.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.65 143.1 47.86 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.4 1.4 . . . . 0.0 112.115 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.68 146.21 13.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.329 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -80.2 -1.69 41.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 p -135.72 144.7 46.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.394 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.4 118.74 19.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.96 138.26 40.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.83 121.69 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.013 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -110.66 129.76 55.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.527 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 228' ' ' VAL . 72.7 t80 -114.77 129.92 56.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.615 -0.678 . . . . 0.0 109.517 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -117.06 112.91 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.546 ' C ' HH21 ' A' ' 250' ' ' ARG . . . -110.7 161.06 12.98 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.834 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.413 ' OE1' ' NH1' ' A' ' 250' ' ' ARG . 12.7 pt-20 -131.92 114.78 15.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.674 -0.898 . . . . 0.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -118.77 148.49 42.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.886 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.03 -6.62 47.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.98 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.881 HD22 HD12 ' A' ' 159' ' ' LEU . 23.0 p-10 -73.45 -168.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.02 . . . . 0.0 109.504 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -63.84 -16.87 62.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.125 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.881 HD12 HD22 ' A' ' 157' ' ' ASN . 6.2 mt -73.85 -24.83 59.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.977 -1.077 . . . . 0.0 109.109 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.73 -134.53 49.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -110.63 151.1 28.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.967 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.462 HE22 ' CD2' ' A' ' 159' ' ' LEU . 0.1 OUTLIER -169.06 160.82 10.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.831 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.64 160.12 39.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.9 126.38 25.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.41 -0.806 . . . . 0.0 108.874 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.0 m -97.05 121.94 39.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.886 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -96.71 138.69 33.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.872 . . . . 0.0 108.801 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.47 151.8 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.78 120.38 7.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.62 -1.59 21.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.459 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 15.5 m-80 -131.52 31.77 4.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -1.158 . . . . 0.0 108.87 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.62 -34.39 75.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.562 -0.711 . . . . 0.0 110.244 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 172' ' ' GLU . 2.8 mp0 -51.68 -14.55 0.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.062 -1.024 . . . . 0.0 110.577 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.516 ' N ' ' CD ' ' A' ' 173' ' ' GLU . 9.9 mp0 -93.5 -3.96 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.971 -1.081 . . . . 0.0 111.003 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.466 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -121.33 7.0 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.029 -1.044 . . . . 0.0 111.286 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.39 -32.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.711 -1.243 . . . . 0.0 110.271 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.37 1.98 51.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.873 -1.142 . . . . 0.0 110.689 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.13 108.54 15.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.875 -1.141 . . . . 0.0 109.085 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -82.18 154.49 25.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.087 -1.008 . . . . 0.0 109.352 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 t -61.77 138.91 58.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -117.32 173.48 6.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 110.208 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.78 159.79 27.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 0.0 109.229 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.588 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.6 m-85 -104.3 146.92 28.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.144 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.711 ' HA ' HD12 ' A' ' 186' ' ' ILE . 8.1 p30 -61.24 -17.89 55.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 111.218 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.3 p90 -80.13 -33.93 38.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.604 -1.31 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.602 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 pt-20 -92.88 -11.97 32.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.583 -1.323 . . . . 0.0 109.786 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 183' ' ' ASP . 7.2 mt -58.03 -52.29 60.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.135 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.23 -51.24 55.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.846 -1.159 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -52.82 -52.17 57.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.961 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.575 HD11 ' OE1' ' A' ' 185' ' ' GLU . 96.9 mt -54.56 -33.85 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -77.36 -25.47 51.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.613 -0.679 . . . . 0.0 110.268 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -78.26 -29.41 48.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 110.344 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.09 12.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.991 -1.068 . . . . 0.0 109.397 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.91 23.95 77.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.7 mt -117.3 155.28 29.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -1.12 . . . . 0.0 109.698 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.498 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.2 28.12 56.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -70.74 -20.63 62.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.738 -1.448 . . . . 0.0 109.23 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.25 -4.04 50.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.68 127.73 37.0 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.207 -1.172 . . . . 0.0 110.655 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.7 p -135.51 -173.9 3.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.717 -0.872 . . . . 0.0 109.249 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -82.99 -23.16 33.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -81.82 -24.36 35.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.585 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -115.23 2.88 14.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.157 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.55 124.87 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.912 -1.118 . . . . 0.0 109.99 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 217' ' ' LEU . 5.2 tp -87.11 116.88 25.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 108.631 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.545 HG22 HD11 ' A' ' 186' ' ' ILE . 55.7 t -104.45 127.85 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.989 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.484 HD21 HD21 ' A' ' 217' ' ' LEU . 81.0 mt -105.54 151.62 24.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.86 154.04 17.04 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.437 ' CD ' ' H ' ' A' ' 208' ' ' LYS . 0.8 OUTLIER -41.91 -33.24 0.51 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -1.156 . . . . 0.0 109.829 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 19.02 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 110.251 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -150.32 160.16 43.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.88 130.41 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -73.27 -54.23 8.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.133 -0.979 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.2 135.37 75.03 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.965 -1.085 . . . . 0.0 109.378 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.31 -8.97 23.64 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.489 2.126 . . . . 0.0 112.877 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 215' ' ' GLU . 0.0 OUTLIER -92.09 -9.33 43.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 0.0 109.97 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.64 -166.2 51.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 204' ' ' LEU . 12.7 mt -85.68 147.78 26.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -1.038 . . . . 0.0 110.282 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.655 ' HE ' ' CA ' ' A' ' 218' ' ' ARG . 0.0 OUTLIER -83.46 -15.75 48.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.6 m-85 -149.42 151.67 34.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.036 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -63.02 -15.7 57.32 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.069 -1.019 . . . . 0.0 108.472 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.36 35.89 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.536 -0.728 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -60.45 -36.0 32.15 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.499 -0.751 . . . . 0.0 111.071 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.3 Cg_exo -70.34 -48.13 0.65 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.927 1.751 . . . . 0.0 112.547 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 228' ' ' VAL . 15.4 m -73.3 -23.53 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.632 -1.292 . . . . 0.0 108.39 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -67.87 -45.03 75.68 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -59.86 -41.15 90.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.948 . . . . 0.0 109.249 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 224' ' ' VAL . 42.7 t -58.88 -47.22 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.573 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 92.7 t80 -53.13 -38.72 62.9 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.697 0.761 . . . . 0.0 109.151 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 24.0 m-20 -68.76 -43.84 74.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.456 -0.778 . . . . 0.0 110.202 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.83 -39.23 73.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 0.0 109.235 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.417 HG22 ' HD1' ' A' ' 80' ' ' HIS . 77.0 mt -67.13 -34.28 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.2 -33.14 77.52 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -83.04 -26.21 31.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -1.12 . . . . 0.0 110.142 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.611 HD23 HG22 ' A' ' 260' ' ' VAL . 9.2 mt -81.89 -27.33 33.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.833 -1.167 . . . . 0.0 109.732 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.3 t80 -66.94 -8.52 30.08 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.074 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 237' ' ' LEU . 87.7 mt -52.62 -25.67 11.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 242' ' ' VAL . 96.0 mt -58.64 -23.85 59.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.894 -1.129 . . . . 0.0 108.846 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 89.18 14.64 60.15 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.2 p -158.51 146.28 13.6 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.939 -1.33 . . . . 0.0 109.637 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.405 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.64 131.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.289 1.992 . . . . 0.0 111.784 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 238' ' ' LEU . 22.0 t -98.43 134.93 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 109.457 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.66 128.47 48.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.89 178.82 30.46 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -107.37 111.59 24.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -1.183 . . . . 0.0 109.954 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -112.31 148.0 35.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 122.021 0.915 . . . . 0.0 111.167 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.78 144.42 51.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.9 128.6 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.816 -1.177 . . . . 0.0 110.361 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.624 ' CE2' ' NH1' ' A' ' 250' ' ' ARG . 38.2 t80 -113.85 107.36 15.62 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.624 ' NH1' ' CE2' ' A' ' 249' ' ' PHE . 0.0 OUTLIER 45.78 57.18 5.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.9 148.54 21.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -116.22 171.07 13.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.562 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 82.7 m-70 -59.91 -46.13 90.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -1.224 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -55.34 35.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.358 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 255' ' ' LEU . 60.0 tp -51.58 -39.42 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -57.8 -55.86 29.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.169 -0.957 . . . . 0.0 108.933 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 94.4 t -49.16 -41.51 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.29 -50.53 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.048 . . . . 0.0 109.062 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 139' ' ' ILE . 24.8 tp -53.15 -43.13 66.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.027 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.611 HG22 HD23 ' A' ' 235' ' ' LEU . 49.1 t -70.04 -40.26 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.343 -0.848 . . . . 0.0 109.428 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -52.53 64.3 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 110.025 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.6 -43.14 94.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.613 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 263' ' ' LEU . 41.9 mt -60.02 -47.88 84.02 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.17 75.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.457 -0.777 . . . . 0.0 110.24 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 120.676 -1.265 . . . . 0.0 108.95 179.4 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.529 ' CB ' ' OE2' ' A' ' 33' ' ' GLU . 5.4 mt-10 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.421 0.629 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.0 139.13 54.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.388 0.613 . . . . 0.0 110.04 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 t -135.01 173.81 11.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 m -83.54 142.04 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.84 -1.162 . . . . 0.0 110.212 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HG3' HD13 ' A' ' 115' ' ' LEU . 19.4 ttpp -77.58 -41.81 37.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.488 -0.757 . . . . 0.0 110.565 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -133.25 157.48 45.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.64 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -59.61 132.3 53.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.734 -0.604 . . . . 0.0 110.015 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.435 HD21 HD22 ' A' ' 113' ' ' ASN . 12.7 mt -119.37 153.56 34.97 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -150.72 147.47 27.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -135.65 162.49 32.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.557 -0.714 . . . . 0.0 109.76 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.88 139.09 26.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.914 -1.116 . . . . 0.0 109.515 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.28 159.19 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 21' ' ' GLY . 1.5 p -85.88 143.7 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.999 -1.295 . . . . 0.0 111.264 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 143.33 36.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.0 OUTLIER -65.6 -38.71 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -1.079 . . . . 0.0 112.666 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.436 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.4 m-70 -86.15 -36.71 19.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 119.892 -1.755 . . . . 0.0 112.457 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -84.65 -40.5 17.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.661 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 16' ' ' VAL . . . 83.87 11.32 79.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 152.22 20.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -73.24 143.45 47.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.914 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -146.0 157.55 43.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 108.826 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.527 ' C ' HD23 ' A' ' 26' ' ' LEU . 14.0 tttt -136.62 146.61 46.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.201 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.574 HD11 ' HD2' ' A' ' 97' ' ' PRO . 1.5 mt -121.56 148.64 44.24 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.147 -0.971 . . . . 0.0 109.034 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -135.6 126.05 43.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 28' ' ' ILE . 6.4 mt -111.65 125.15 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.938 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.539 ' NE2' HG22 ' A' ' 27' ' ' ILE . 15.8 m-70 -120.63 149.93 51.33 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.87 159.88 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.043 1.829 . . . . 0.0 110.86 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 26.4 mm-40 -134.63 179.25 6.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.027 . . . . 0.0 110.081 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.39 148.16 32.1 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.227 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' OE2' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -47.78 147.0 2.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 -179.359 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 58.94 25.04 58.89 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.103 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.3 m -80.46 -37.82 31.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.761 -1.435 . . . . 0.0 108.875 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.4 -177.76 32.37 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 mm -97.44 124.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -140.31 139.43 35.45 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.008 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -97.78 153.71 18.09 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.541 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.6 t80 -132.28 141.22 48.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.204 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -170.96 140.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.57 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 58.62 28.42 17.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.406 -0.809 . . . . 0.0 109.706 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.14 30.64 69.55 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.7 t -135.53 132.19 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -1.212 . . . . 0.0 109.967 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -90.06 141.28 28.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 108.942 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 67' ' ' GLN . 10.6 mt -137.77 96.98 10.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 110.355 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.75 144.93 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.182 1.921 . . . . 0.0 111.711 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.68 84.82 4.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 0.0 110.089 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -139.65 156.9 46.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 14.7 p-80 -53.38 -49.74 66.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.2 mm-40 -47.54 -16.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -0.998 . . . . 0.0 110.353 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' HIS . 22.0 m-85 -97.0 7.07 47.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.918 -1.114 . . . . 0.0 109.556 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.27 127.1 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.06 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.57 -34.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.518 ' NE2' ' CG ' ' A' ' 57' ' ' ASN . 3.1 t-160 -149.54 122.37 8.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -112.35 130.93 55.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 59' ' ' SER . 13.5 p-10 -166.84 -153.95 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' ASN . 36.1 m-70 -46.59 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.071 -1.018 . . . . 0.0 108.763 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 57' ' ' ASN . 11.7 t -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.2 m -102.64 120.33 40.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 108.826 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -117.76 136.44 53.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 110.923 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -126.07 159.38 32.97 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.7 150.92 8.84 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.158 -1.972 . . . . 0.0 111.611 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -144.6 152.55 40.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.82 -0.812 . . . . 0.0 109.486 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.5 24.01 11.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.598 -0.689 . . . . 0.0 110.842 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.39 4.69 76.74 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.697 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.498 ' HB2' HD11 ' A' ' 46' ' ' ILE . 36.2 mm-40 -108.59 137.37 46.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -1.199 . . . . 0.0 108.21 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.79 164.29 30.51 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.853 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 91' ' ' VAL . 44.4 mt -135.08 149.21 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -114.18 149.78 35.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.896 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 54.41 66.95 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.714 -0.616 . . . . 0.0 110.866 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.74 -1.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 109.179 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 8.5 pt-20 -71.1 -30.85 67.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.048 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 32.5 m170 -64.49 -59.44 4.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -56.87 -45.99 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.733 -1.229 . . . . 0.0 108.733 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 75' ' ' ILE . 42.2 mt -55.28 -41.07 71.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.7 t -56.96 -45.53 82.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.38 -53.41 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 108.723 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -50.86 -44.66 59.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 108.977 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.694 ' HD1' HG22 ' A' ' 232' ' ' ILE . 14.7 t-160 -55.65 -47.82 76.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.453 -0.779 . . . . 0.0 110.018 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -66.54 -37.68 85.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 114' ' ' ILE . 65.4 mt -81.23 -7.61 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.827 -178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 63.37 63.32 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.724 -1.235 . . . . 0.0 110.134 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 82' ' ' LEU . 8.8 mm -104.94 130.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 121' ' ' ILE . 23.6 p -117.43 -18.86 9.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.852 . . . . 0.0 111.731 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.729 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.3 m-80 -133.65 111.39 10.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.639 -1.288 . . . . 0.0 110.233 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.3 m -165.1 141.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 95.6 m -110.8 100.6 9.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.495 -0.753 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.7 104.42 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.401 -0.812 . . . . 0.0 109.682 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -82.31 119.44 24.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.865 -1.147 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.509 HG13 HD22 ' A' ' 26' ' ' LEU . 2.8 t -102.95 108.26 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 111.087 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.52 108.13 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.31 -160.02 23.28 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.4 -15.25 7.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.56 -0.965 . . . . 0.0 110.21 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.599 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -135.61 142.27 45.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.0 110.44 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -68.6 139.53 91.55 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.574 ' HD2' HD11 ' A' ' 26' ' ' LEU . 11.4 Cg_endo -57.76 130.16 37.18 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.843 1.695 . . . . 0.0 111.514 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -78.64 -30.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.52 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 8.0 mt 52.8 -109.78 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.032 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -95.02 -18.59 20.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.573 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.73 -10.22 32.43 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.7 p -113.88 -172.09 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.383 -1.069 . . . . 0.0 109.869 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.48 -3.26 20.84 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -46.71 -39.99 12.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.624 -0.927 . . . . 0.0 110.8 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -63.53 -51.73 64.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 109.95 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -61.9 -45.04 95.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.917 -1.114 . . . . 0.0 108.392 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.88 -39.46 89.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.332 0.587 . . . . 0.0 110.44 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.11 -45.16 64.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.845 . . . . 0.0 111.494 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.24 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.858 -1.151 . . . . 0.0 110.551 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.16 -42.84 88.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 110.233 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -54.29 -29.57 47.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 109.816 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -85.96 -11.53 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.435 HD22 HD21 ' A' ' 11' ' ' LEU . 1.9 m-20 -119.78 29.31 7.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.233 -0.917 . . . . 0.0 111.458 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.594 HD11 HD13 ' A' ' 82' ' ' LEU . 4.7 mt -84.4 148.02 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.379 -1.451 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 8' ' ' LYS . 13.0 tp -130.84 158.13 41.02 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -101.06 146.51 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.898 -1.127 . . . . 0.0 110.044 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -109.44 -169.06 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.669 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -120.09 66.98 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 110.575 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -169.37 151.04 4.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 109.259 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.42 134.11 33.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.03 -1.044 . . . . 0.0 110.295 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 85' ' ' THR . 62.6 mt -69.87 135.55 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 110.863 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -78.26 80.95 4.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -58.22 141.36 50.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.589 -0.694 . . . . 0.0 110.759 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -98.39 120.45 38.82 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 243' ' ' LYS . 48.7 t -122.36 138.18 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 0.0 109.823 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.25 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -114.49 -10.07 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -142.82 145.91 35.6 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.427 -0.796 . . . . 0.0 108.92 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.12 177.24 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.11 1.873 . . . . 0.0 112.805 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.96 HG22 ' HB3' ' A' ' 141' ' ' ALA . 14.7 tt -165.6 144.61 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.457 0.646 . . . . 0.0 109.624 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.3 mp -132.73 118.9 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 132' ' ' VAL . 34.4 m -117.53 113.29 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.429 ' OE2' ' N ' ' A' ' 134' ' ' ASP . 1.2 tm-20 -115.56 127.2 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.429 ' N ' ' OE2' ' A' ' 133' ' ' GLU . 1.8 t70 -174.74 158.11 2.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 59.09 19.5 7.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 110.206 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.86 2.66 86.72 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.416 ' HB2' HD22 ' A' ' 255' ' ' LEU . 7.8 mtt180 -104.01 173.7 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.8 tt -160.09 148.07 16.76 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.487 -1.383 . . . . 0.0 109.037 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.854 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.8 mt -146.19 141.48 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.639 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -130.35 139.13 50.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.96 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.48 145.59 47.11 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -142.19 138.57 16.83 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.14 147.7 63.74 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.471 1.447 . . . . 0.0 112.119 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.05 158.49 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.03 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -93.5 4.13 54.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.942 . . . . 0.0 109.899 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 147.34 46.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.08 -1.013 . . . . 0.0 109.784 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.9 tp -77.37 116.03 17.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.848 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -139.36 135.18 33.44 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 246' ' ' PHE . 13.8 t -137.33 127.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.977 . . . . 0.0 110.05 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.7 m -112.28 132.05 55.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.368 -0.833 . . . . 0.0 109.294 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.448 ' CB ' HG22 ' A' ' 228' ' ' VAL . 81.3 t80 -119.83 129.47 54.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 162' ' ' GLN . 6.4 tp10 -114.72 104.61 12.14 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.0 155.38 21.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.604 ' CD ' HH21 ' A' ' 250' ' ' ARG . 12.9 tt0 -134.11 88.04 2.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.423 -1.045 . . . . 0.0 109.24 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -90.82 148.72 22.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -92.44 -6.92 48.97 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.86 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.9 p30 -73.9 -168.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.748 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.2 p90 -56.02 -17.53 7.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 109.754 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 14.0 mt -65.98 -51.17 60.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.06 -113.48 3.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -125.46 140.51 52.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.518 -0.989 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.48 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 52.5 tt0 -157.02 148.91 22.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -130.79 152.44 50.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -135.46 123.92 23.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 108.891 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 165' ' ' THR . 9.9 t -99.53 122.21 42.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 110.097 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.3 t80 -99.85 135.99 40.45 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.382 -0.824 . . . . 0.0 108.897 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.484 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.6 t -133.36 150.28 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.79 . . . . 0.0 109.155 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -53.46 122.81 10.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.77 -12.68 17.84 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -121.38 33.01 5.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.168 -1.195 . . . . 0.0 108.726 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -62.82 -35.95 81.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.699 . . . . 0.0 110.886 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -15.7 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.045 . . . . 0.0 110.829 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.73 -3.56 58.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.985 -1.072 . . . . 0.0 110.939 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.9 pt -124.29 0.85 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.068 -1.02 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -29.87 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.601 -1.312 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.6 mt -87.01 1.95 51.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.782 -1.199 . . . . 0.0 110.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.38 120.0 23.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.777 -1.202 . . . . 0.0 109.013 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.07 153.37 19.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.066 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.41 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.0 t -55.7 154.99 6.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.52 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 47.5 p90 -135.68 167.09 21.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.022 -1.049 . . . . 0.0 109.671 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.52 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 2.7 m -153.69 160.65 42.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.172 -0.955 . . . . 0.0 109.685 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.421 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 78.5 m-85 -102.84 143.41 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.213 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.612 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.8 OUTLIER -60.46 -26.07 66.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.502 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 4.7 p90 -79.01 -25.25 43.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.694 -1.254 . . . . 0.0 110.632 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 11.8 pt-20 -98.88 -13.8 19.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.879 -1.138 . . . . 0.0 109.575 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.5 mt -58.51 -52.99 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.154 -0.966 . . . . 0.0 110.063 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.19 -48.56 64.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.882 -1.136 . . . . 0.0 109.097 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.34 -52.1 62.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.967 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 91.2 mt -57.96 -34.48 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.825 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.21 -25.71 51.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -74.96 -31.6 61.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.101 -1.0 . . . . 0.0 109.867 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.422 ' CG2' HD12 ' A' ' 194' ' ' LEU . 6.8 m -81.0 12.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.17 -0.956 . . . . 0.0 109.347 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.48 24.12 76.79 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.625 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 192' ' ' VAL . 19.2 mt -121.21 159.08 26.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.15 -1.206 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 74.18 22.22 78.01 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.22 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -63.38 -53.73 47.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.33 -1.688 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -69.9 -2.6 39.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.09 134.06 39.91 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.849 -1.383 . . . . 0.0 110.484 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 203' ' ' THR . 68.0 p -141.86 177.72 7.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.493 -1.004 . . . . 0.0 109.319 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 200' ' ' LEU . 95.5 mt -74.6 -39.3 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.91 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -66.25 -14.46 61.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.222 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -131.44 9.14 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.433 ' CB ' ' O ' ' A' ' 199' ' ' SER . 0.5 OUTLIER -147.96 113.8 5.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.42 116.06 15.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 108.934 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.9 t -106.8 127.1 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 109.857 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.4 mt -110.71 149.91 29.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.14 152.21 17.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 207' ' ' GLY . 35.6 tttm -41.07 -37.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -1.113 . . . . 0.0 110.03 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -141.88 11.56 2.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.935 -1.103 . . . . 0.0 110.084 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.4 pttp -142.59 151.43 41.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.019 . . . . 0.0 109.738 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.503 HG11 ' HA2' ' A' ' 216' ' ' GLY . 60.9 t -102.56 127.93 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -73.0 -53.16 11.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.07 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.52 139.68 74.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.996 -1.065 . . . . 0.0 109.658 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.68 -33.96 9.72 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.522 2.148 . . . . 0.0 112.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -76.24 -9.1 58.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.046 -1.034 . . . . 0.0 110.28 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.503 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 69.6 -164.22 51.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.82 140.38 47.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -1.088 . . . . 0.0 109.833 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -84.59 -14.59 48.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 109.169 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.636 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 66.0 m-85 -146.09 133.83 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.436 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 1.3 mt-10 -48.03 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 108.501 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -137.19 39.33 2.51 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.9 OUTLIER -62.76 -39.58 55.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 111.935 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.0 Cg_endo -74.17 -40.37 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.997 1.132 . . . . 0.0 112.651 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 228' ' ' VAL . 11.2 m -76.68 -24.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.716 -1.24 . . . . 0.0 108.463 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.636 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 36.4 mtt180 -67.4 -47.44 70.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.53 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 44.1 t60 -59.77 -40.67 88.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -46.13 90.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 109.07 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 224' ' ' VAL . 46.4 t -62.19 -42.23 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 108.756 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.464 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 59.9 t80 -55.36 -47.32 75.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.67 -0.644 . . . . 0.0 109.433 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.592 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 12.2 m-20 -72.05 -34.56 68.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.406 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.1 tp -56.27 -36.17 68.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.707 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.694 HG22 ' HD1' ' A' ' 80' ' ' HIS . 89.7 mt -72.47 -48.75 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.77 9.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.3 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.105 -1.232 . . . . 0.0 109.769 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.39 -22.84 40.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.852 -1.155 . . . . 0.0 109.187 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.403 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 43.0 t80 -70.74 -8.77 54.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 108.752 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 237' ' ' LEU . 17.2 mt -50.18 -28.18 7.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.589 HD12 HG22 ' A' ' 242' ' ' VAL . 84.9 mt -54.16 -15.82 1.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.2 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 13.53 83.08 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.0 p -158.73 146.05 13.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.211 -1.17 . . . . 0.0 109.309 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 65.0 Cg_exo -43.19 130.22 6.21 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.066 1.844 . . . . 0.0 111.78 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 238' ' ' LEU . 3.8 t -97.49 132.13 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.629 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 125' ' ' VAL . 2.7 mmtt -117.98 123.7 46.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.49 172.66 25.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -104.38 114.38 28.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -1.222 . . . . 0.0 109.696 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 149' ' ' VAL . 8.6 m-85 -112.68 148.65 34.22 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.14 0.971 . . . . 0.0 111.486 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -130.42 144.22 51.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.0 t -142.34 129.58 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.656 -1.278 . . . . 0.0 111.077 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -112.18 114.81 27.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.604 HH21 ' CD ' ' A' ' 154' ' ' GLU . 18.2 mtt180 50.42 53.87 12.15 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.82 136.85 20.61 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.408 ' HA3' ' NH1' ' A' ' 137' ' ' ARG . . . -111.59 155.48 16.14 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.505 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 62.7 m-70 -52.94 -47.18 68.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -1.215 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.5 t -58.23 -55.34 36.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.056 -1.027 . . . . 0.0 108.869 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' A' ' 139' ' ' ILE . 53.6 tp -53.91 -37.12 63.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' A' ' 253' ' ' HIS . 77.0 m-20 -61.15 -54.35 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 108.973 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 19.5 t -50.97 -42.67 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -55.83 -49.7 72.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 139' ' ' ILE . 19.1 tp -52.14 -42.13 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 108.678 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.62 -46.24 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.283 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.13 -51.52 61.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.846 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -53.64 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 259' ' ' LEU . 90.3 mt -55.53 -42.18 74.21 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.41 90.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.523 -0.736 . . . . 0.0 109.719 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.024 . . . . 0.0 109.11 179.513 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 63.5 mt-10 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.37 53.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 110.285 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -138.2 175.27 9.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 7' ' ' VAL . 10.4 m -86.51 141.35 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.354 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -73.87 -46.12 46.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.574 -0.704 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -126.88 153.76 45.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.41 -0.806 . . . . 0.0 110.43 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.08 138.76 58.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.62 167.71 12.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 p -156.76 149.34 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.995 -1.066 . . . . 0.0 110.338 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -135.01 155.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 135.48 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 108.759 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.79 156.16 13.0 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.122 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.29 163.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.29 -1.124 . . . . 0.0 111.029 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.64 136.98 13.35 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.646 HG23 ' N ' ' A' ' 19' ' ' HIS . 16.0 tt -56.21 -52.57 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.137 -1.214 . . . . 0.0 111.751 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.646 ' N ' HG23 ' A' ' 18' ' ' ILE . 24.8 m-70 -87.08 -38.56 16.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.172 -1.58 . . . . 0.0 110.66 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.6 m -73.9 -35.38 64.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.952 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.07 64.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -107.53 148.55 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.58 -0.953 . . . . 0.0 108.967 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 8.1 t80 -70.83 125.78 27.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.973 . . . . 0.0 109.759 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 t -135.12 156.41 49.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.118 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' O ' HD23 ' A' ' 26' ' ' LEU . 18.1 tttp -134.81 150.69 50.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 109.138 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.709 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.7 mt -127.52 148.45 50.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 0.0 109.622 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -132.04 131.84 61.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -115.83 126.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -120.56 155.06 57.06 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.585 -0.697 . . . . 0.0 109.286 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.53 160.67 48.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.347 2.031 . . . . 0.0 110.861 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 20.4 mm-40 -135.83 -174.83 3.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.104 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 35' ' ' THR . 11.0 tptt -86.03 153.3 22.23 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 109.287 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.619 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.3 mp0 -46.81 145.07 2.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.091 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.609 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.36 26.1 61.32 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.826 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 39.6 m -78.7 -36.94 42.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.562 -1.552 . . . . 0.0 109.134 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.783 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 94.05 -175.56 35.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.7 mm -99.52 121.9 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.297 -1.119 . . . . 0.0 108.277 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -136.33 143.9 44.36 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.975 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.89 151.13 22.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -130.26 142.66 50.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -174.59 138.22 0.51 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -178.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER 57.12 31.59 20.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.616 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.51 74.33 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.624 -1.298 . . . . 0.0 110.034 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.13 139.41 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 109.529 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 m-85 -102.18 138.06 39.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.57 97.94 18.71 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.418 -0.801 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.74 142.75 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.22 1.947 . . . . 0.0 111.718 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.02 82.48 6.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.984 -1.073 . . . . 0.0 110.172 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -139.45 156.03 47.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.583 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.564 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -53.45 -49.5 67.28 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.541 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 19.5 mt-10 -44.06 -16.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.072 -1.018 . . . . 0.0 109.995 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 50' ' ' HIS . 96.6 m-85 -98.56 4.21 48.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.058 -1.026 . . . . 0.0 109.994 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 t -60.73 121.02 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 108.477 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.96 -25.36 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.303 -0.873 . . . . 0.0 110.408 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -151.13 118.54 6.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -112.29 131.13 55.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.5 t-20 -166.36 -154.28 0.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 1.6 m-70 -47.96 -12.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 108.372 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -136.84 166.0 24.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.587 -0.696 . . . . 0.0 109.238 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.0 m -108.84 125.1 51.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.335 -0.853 . . . . 0.0 109.132 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.87 143.72 50.18 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.993 0.901 . . . . 0.0 111.25 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.3 mt -124.29 160.52 27.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.85 147.93 7.66 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.343 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -145.01 151.68 38.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.751 -0.852 . . . . 0.0 109.488 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt 57.12 25.36 10.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.289 -0.882 . . . . 0.0 111.196 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.49 1.95 77.18 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.631 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.471 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.2 mm100 -102.41 142.81 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.993 -1.298 . . . . 0.0 107.999 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -145.83 157.23 43.93 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.842 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 69' ' ' ILE . 3.8 mt -133.27 144.5 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 9.1 mttm -110.71 155.03 23.03 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.295 -0.878 . . . . 0.0 111.317 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 47.38 72.86 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.765 -0.584 . . . . 0.0 111.169 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 m -113.02 -11.59 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 109.566 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -63.68 -18.53 64.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 110.604 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.595 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 25.6 m170 -71.85 -60.65 2.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.892 -1.13 . . . . 0.0 109.413 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 4.0 tp -60.41 -44.05 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 109.138 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.519 ' N ' HG23 ' A' ' 75' ' ' ILE . 12.0 mt -56.2 -38.22 70.7 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.551 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 27.3 t -60.68 -48.58 81.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.614 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.5 t -57.64 -52.99 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.972 -1.08 . . . . 0.0 108.688 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -50.68 -43.79 57.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.49 ' HD1' HG22 ' A' ' 232' ' ' ILE . 7.9 t-160 -55.1 -51.33 66.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 110.223 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.8 mt -68.36 -37.27 80.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.329 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.593 HD22 HD11 ' A' ' 114' ' ' ILE . 14.8 mt -76.08 -5.58 47.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.061 -1.024 . . . . 0.0 110.131 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.79 50.99 3.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 110.43 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 82' ' ' LEU . 14.6 mm -97.59 122.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 108.501 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.624 HG21 HG23 ' A' ' 121' ' ' ILE . 71.7 p -110.78 -22.01 11.78 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.783 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 9.9 m120 -129.91 112.17 13.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.709 -1.244 . . . . 0.0 110.516 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.6 m -164.75 141.78 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 8.1 m -110.23 100.69 9.53 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mp -87.69 108.87 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.889 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -88.18 116.48 26.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG13 HD22 ' A' ' 26' ' ' LEU . 61.9 t -106.28 117.63 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 110.856 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.09 112.36 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.93 -162.05 24.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.48 -17.64 8.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.227 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 1.5 tp10 -132.64 141.0 48.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.829 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.2 mm -67.37 125.71 91.5 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.609 -0.682 . . . . 0.0 109.34 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.709 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.4 Cg_exo -45.86 131.28 13.39 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.921 1.747 . . . . 0.0 111.887 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.1 tp -76.46 -29.62 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 110.431 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.7 mt 54.89 -113.73 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.61 -15.86 23.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 110.32 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.75 -12.97 46.35 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 p -112.3 -169.18 1.42 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.012 . . . . 0.0 109.493 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.6 -3.09 25.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -47.44 -41.91 21.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.833 -0.804 . . . . 0.0 110.409 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.96 -52.37 63.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.068 . . . . 0.0 110.233 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 87.4 m-85 -61.81 -44.29 97.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.765 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -62.06 -38.91 90.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.311 0.576 . . . . 0.0 109.941 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.15 -44.94 51.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.287 -0.883 . . . . 0.0 111.828 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.25 -47.61 23.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 110.998 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.03 -40.16 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttt85 -57.38 -30.03 64.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 109.877 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 112' ' ' LYS . 24.0 tttm -80.65 -8.21 59.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 109.623 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -123.74 35.03 4.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.987 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.593 HD11 HD22 ' A' ' 82' ' ' LEU . 17.8 mt -90.79 147.03 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.8 -1.187 . . . . 0.0 110.643 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 115' ' ' LEU . 14.2 tp -131.26 159.61 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -109.79 146.43 35.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.552 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -108.93 -162.65 0.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.528 -0.733 . . . . 0.0 109.26 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 -1.22 11.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 4' ' ' GLU . 11.5 ttt180 -85.37 138.71 32.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.86 -1.15 . . . . 0.0 109.725 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.1 128.03 33.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.272 -0.892 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.624 HG23 HG21 ' A' ' 85' ' ' THR . 0.8 OUTLIER -70.92 139.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 111.124 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -94.38 98.48 10.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.74 147.05 51.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -97.33 121.46 39.25 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.02 139.36 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.17 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -113.12 -10.78 13.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.242 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -143.66 146.05 33.63 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.097 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.2 172.74 14.21 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.087 1.858 . . . . 0.0 113.135 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.589 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.3 tt -164.27 140.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.09 126.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.28 114.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.282 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -174.35 150.88 1.51 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.084 -1.01 . . . . 0.0 110.996 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 55.65 24.92 7.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.726 -0.609 . . . . 0.0 111.077 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.98 86.32 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HB2' HD22 ' A' ' 255' ' ' LEU . 2.4 mtt180 -106.92 169.02 8.8 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.987 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.8 tt -159.73 150.41 19.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.193 -1.567 . . . . 0.0 108.873 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.987 ' N ' HD23 ' A' ' 138' ' ' LEU . 7.2 mt -145.83 139.56 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -129.6 139.62 51.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.589 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -121.54 140.36 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -136.47 137.41 24.04 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.9 150.1 48.1 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.56 1.507 . . . . 0.0 112.032 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.94 158.57 8.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -86.97 -1.44 57.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.726 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.4 p -136.46 155.19 50.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 109.405 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.497 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 32.6 tp -87.48 117.15 26.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 110.116 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -134.29 140.35 46.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.606 ' CG1' HD23 ' A' ' 231' ' ' LEU . 94.6 t -139.19 126.96 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.976 -1.077 . . . . 0.0 109.908 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.3 m -115.16 137.8 51.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.447 -0.783 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.483 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.5 t80 -125.97 129.56 49.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.727 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.31 106.18 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.4 141.15 15.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -118.94 86.69 2.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.532 -0.981 . . . . 0.0 109.17 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -91.77 143.01 26.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.732 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -92.14 -1.67 57.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.843 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 22.1 p-10 -73.12 -167.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -61.56 -24.89 66.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.92 . . . . 0.0 109.784 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.544 HD22 ' NE2' ' A' ' 162' ' ' GLN . 7.7 mt -63.21 -46.23 87.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.61 -132.72 11.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -98.87 139.6 34.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -1.106 . . . . 0.0 109.289 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.544 ' NE2' HD22 ' A' ' 159' ' ' LEU . 9.1 mt-30 -146.02 142.64 28.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.518 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -137.29 148.41 46.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.39 127.9 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.089 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 165' ' ' THR . 10.9 t -99.87 122.03 42.21 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.013 -1.054 . . . . 0.0 109.718 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.29 136.65 34.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 108.881 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.52 153.25 34.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.645 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.661 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 4.7 mp0 -57.13 113.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.288 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.555 ' N ' ' OE2' ' A' ' 171' ' ' GLU . . . 115.89 11.29 10.26 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -137.11 28.4 2.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.183 -1.187 . . . . 0.0 108.761 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.675 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 16.9 mp0 -62.15 -36.93 83.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 110.632 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 15.6 mp0 -52.45 -15.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.82 -1.175 . . . . 0.0 110.241 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 49.1 mt-10 -91.07 -4.19 56.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 110.927 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.595 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.4 pt -121.72 6.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.14 -34.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.96 1.02 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.779 -1.201 . . . . 0.0 110.745 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.36 123.81 28.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.195 . . . . 0.0 108.962 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 154.38 17.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -51.36 158.12 0.89 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -146.24 168.7 20.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.05 -1.031 . . . . 0.0 110.089 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.08 159.0 15.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 109.595 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.521 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 60.8 m-85 -103.42 146.5 28.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.296 -0.878 . . . . 0.0 109.316 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.678 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.8 p30 -51.97 -51.08 59.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.794 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.664 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.2 p90 -51.83 -36.84 49.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.926 -1.109 . . . . 0.0 111.481 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.664 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 14.6 pt-20 -89.48 -17.33 28.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.636 -1.29 . . . . 0.0 109.924 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.3 mt -59.43 -52.24 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.187 -0.946 . . . . 0.0 110.127 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -50.85 -51.16 53.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.663 -1.273 . . . . 0.0 109.5 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -52.42 -44.87 65.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 108.751 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 186' ' ' ILE . 71.2 mt -59.99 -34.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -77.65 -27.14 50.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.726 . . . . 0.0 110.216 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.45 -24.07 46.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.005 -1.059 . . . . 0.0 110.217 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.4 m -85.68 11.19 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.548 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.87 24.82 68.52 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 120.077 -1.059 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 39.2 mt -123.53 163.28 21.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 109.921 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.15 23.96 60.32 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -69.09 -22.68 63.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.788 -1.419 . . . . 0.0 109.88 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.54 -0.56 53.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.35 130.0 50.33 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.305 -1.114 . . . . 0.0 110.685 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.2 p -140.01 -173.64 3.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.735 -0.862 . . . . 0.0 108.728 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.46 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -99.48 -4.3 31.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.89 -11.69 1.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.119 -0.988 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.4 m -126.0 116.96 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.9 tp -74.04 110.42 8.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.522 HG13 HD11 ' A' ' 186' ' ' ILE . 58.1 t -100.08 126.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.926 -1.109 . . . . 0.0 109.47 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.1 mt -110.15 148.81 31.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.829 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.25 159.25 15.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -23.45 1.61 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.257 -1.143 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -153.66 12.69 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 0.0 110.724 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -144.11 151.66 39.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.864 -1.148 . . . . 0.0 110.637 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.57 124.86 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -71.95 -54.78 8.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.019 -1.05 . . . . 0.0 110.34 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -55.89 132.88 73.33 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.056 . . . . 0.0 109.428 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.51 -11.19 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.418 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -84.47 -6.64 59.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.09 -162.96 54.56 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -89.45 149.76 22.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.964 . . . . 0.0 110.317 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.6 mtt-85 -94.26 -23.76 17.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -0.798 . . . . 0.0 108.929 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.526 ' C ' ' H ' ' A' ' 221' ' ' ASN . 28.3 m-85 -144.57 133.93 23.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 108.993 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.22 -9.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 108.614 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -135.01 35.66 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.844 0.83 . . . . 0.0 108.878 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.492 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.66 -49.54 88.35 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 111.804 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 20.5 Cg_endo -67.58 -34.56 25.23 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.571 1.514 . . . . 0.0 113.06 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 228' ' ' VAL . 24.2 m -79.84 -28.22 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.51 -1.369 . . . . 0.0 107.706 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 10.1 mmm-85 -65.1 -46.84 79.41 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.582 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 36.6 t60 -61.35 -42.13 98.19 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 151' ' ' TYR . 0.6 OUTLIER -59.52 -50.84 72.34 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.05 -1.031 . . . . 0.0 108.69 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 224' ' ' VAL . 18.2 t -55.94 -43.95 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 79.4 t80 -57.71 -40.04 78.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.582 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.5 m-20 -74.68 -33.93 62.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.595 -0.69 . . . . 0.0 109.487 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.606 HD23 ' CG1' ' A' ' 149' ' ' VAL . 24.0 tp -59.01 -35.85 73.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 108.688 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' HIS . 75.7 mt -72.15 -47.77 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -33.27 24.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -82.14 -27.25 32.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.258 . . . . 0.0 109.582 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 mt -83.14 -23.84 32.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.881 -1.137 . . . . 0.0 109.308 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.502 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 38.1 t80 -67.51 -10.71 54.17 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 108.956 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 85.7 mt -50.45 -27.97 7.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 109.101 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 242' ' ' VAL . 71.3 mt -58.81 -17.68 25.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.177 -0.952 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 79.41 15.89 79.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.0 p -158.35 144.65 12.68 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.992 -1.299 . . . . 0.0 109.787 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 57.2 Cg_exo -42.1 128.99 4.34 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.197 1.931 . . . . 0.0 111.839 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.561 HG22 HD12 ' A' ' 238' ' ' LEU . 57.5 t -95.88 130.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.66 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -117.67 123.72 46.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.823 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 174.1 27.91 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.62 113.33 26.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -1.183 . . . . 0.0 109.829 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.86 147.17 37.55 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.928 0.871 . . . . 0.0 111.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -129.67 143.27 50.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 128.11 19.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.646 -1.284 . . . . 0.0 110.687 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.2 t80 -112.31 116.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 249' ' ' PHE . 13.9 mmm180 46.04 55.78 6.77 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.1 152.44 22.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.0 -175.84 18.6 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.417 ' O ' HG23 ' A' ' 257' ' ' VAL . 72.7 m-70 -70.96 -52.22 21.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -1.215 . . . . 0.0 109.576 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 2.2 p -56.14 -54.41 45.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.162 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 137' ' ' ARG . 34.1 tp -51.06 -42.37 60.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.229 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.16 -50.96 71.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 108.908 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 253' ' ' HIS . 59.5 t -53.9 -40.8 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.865 . . . . 0.0 109.423 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -55.3 -48.15 74.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 108.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 13.4 tp -52.78 -45.25 67.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.6 t -65.83 -45.56 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -52.14 58.72 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 110.155 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -64.39 -46.49 83.12 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.062 -1.023 . . . . 0.0 109.707 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 263' ' ' LEU . 20.4 mt -59.07 -46.38 88.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.31 -34.4 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm . . . . . 0 N--CA 1.488 1.463 0 O-C-N 120.66 -1.275 . . . . 0.0 109.145 179.508 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 85.8 mt-10 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.306 0.574 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.28 139.36 53.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.9 t -137.47 176.59 8.57 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.45 143.43 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.854 -1.154 . . . . 0.0 110.443 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HG3' HD13 ' A' ' 115' ' ' LEU . 2.4 ttmm -76.22 -46.52 27.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.636 -0.665 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.93 153.69 43.89 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.521 0.676 . . . . 0.0 110.111 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.94 137.91 58.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.483 -0.76 . . . . 0.0 109.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.47 165.1 15.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.579 -0.701 . . . . 0.0 109.176 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -155.59 147.81 23.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 0.0 110.102 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -130.9 162.42 29.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.571 -0.706 . . . . 0.0 109.207 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.96 136.52 16.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.874 -1.141 . . . . 0.0 109.063 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.1 161.4 19.34 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.053 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.3 p -74.6 160.67 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 111.447 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.552 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -93.58 142.38 15.97 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -62.73 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.254 . . . . 0.0 112.36 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.443 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.8 m-70 -86.7 -38.4 17.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 119.821 -1.799 . . . . 0.0 111.654 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.436 ' OG1' ' CB ' ' A' ' 95' ' ' GLU . 2.1 p -78.13 -33.32 50.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.042 -1.036 . . . . 0.0 110.099 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.15 72.02 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -116.13 154.06 30.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.956 . . . . 0.0 108.654 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -73.16 138.12 45.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.993 -1.067 . . . . 0.0 110.075 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -143.76 157.88 44.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 0.0 108.847 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 8.1 ttpp -135.57 148.75 49.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 109.329 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.663 ' CD2' HG13 ' A' ' 91' ' ' VAL . 12.9 mt -124.98 146.34 49.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.96 130.93 61.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mt -117.02 119.02 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 109.637 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -116.92 148.64 42.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.34 161.51 23.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.231 1.954 . . . . 0.0 111.45 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -135.96 -174.08 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.9 tttp -85.61 151.66 23.73 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -49.5 150.34 1.97 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.618 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.27 23.61 57.89 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.03 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 17.0 m -80.2 -42.64 22.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.791 -1.417 . . . . 0.0 108.913 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.75 -176.81 30.06 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 mm -97.33 122.57 49.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.374 -1.074 . . . . 0.0 108.122 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -138.45 140.69 39.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.046 -1.034 . . . . 0.0 110.4 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -100.05 152.92 19.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.1 t80 -124.93 147.41 48.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -173.78 131.26 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 109.382 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.84 29.58 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.758 -1.211 . . . . 0.0 110.198 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.02 138.55 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -1.171 . . . . 0.0 109.703 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -98.86 137.03 38.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.05 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 67' ' ' GLN . 58.3 mt -129.24 97.11 26.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 110.179 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.59 142.3 24.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.156 1.904 . . . . 0.0 111.837 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.64 82.36 5.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.512 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -140.63 156.99 46.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 52' ' ' PHE . 17.9 p-80 -53.53 -49.87 66.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.168 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HG2' ' CD2' ' A' ' 50' ' ' HIS . 2.2 mm-40 -47.0 -15.79 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.022 . . . . 0.0 109.947 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 50' ' ' HIS . 76.6 m-85 -97.53 4.22 50.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.007 -1.058 . . . . 0.0 109.495 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 50' ' ' HIS . 33.9 t -59.02 130.46 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.87 -32.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -153.55 122.06 6.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 109.979 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.6 p -112.33 131.93 55.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 7.0 t-20 -166.87 -153.94 0.16 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 57' ' ' ASN . 23.3 m-70 -46.92 -13.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.008 -1.058 . . . . 0.0 108.452 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -137.3 166.06 24.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.485 -0.759 . . . . 0.0 109.371 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.408 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 12.3 m -105.79 123.67 48.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.377 -0.827 . . . . 0.0 108.945 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -122.19 142.43 50.43 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.995 0.902 . . . . 0.0 111.426 -178.697 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 53' ' ' VAL . 72.5 mt -122.56 164.68 17.72 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.54 145.31 5.58 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.4 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -145.18 151.52 38.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.822 -0.811 . . . . 0.0 109.484 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm 57.44 25.59 11.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 111.002 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.03 2.2 78.26 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.594 ' HB2' HD11 ' A' ' 46' ' ' ILE . 8.6 mm100 -100.65 142.24 32.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.235 . . . . 0.0 108.028 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -143.55 154.05 43.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.796 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mt -133.87 144.07 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 47.8 mttp -114.9 155.01 27.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.364 -0.835 . . . . 0.0 111.256 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 m 50.89 63.86 2.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.79 -0.569 . . . . 0.0 111.152 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 96' ' ' ILE . 28.9 m -112.51 1.05 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.094 -1.004 . . . . 0.0 109.092 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' OE1' ' OD2' ' A' ' 230' ' ' ASP . 0.3 OUTLIER -72.22 -31.09 65.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.944 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -61.49 -60.45 3.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.832 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.576 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.8 tp -59.64 -46.13 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 0.0 109.179 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.576 ' N ' HG23 ' A' ' 75' ' ' ILE . 61.9 mt -53.79 -41.62 67.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.557 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 2.8 t -58.43 -46.31 86.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.976 . . . . 0.0 109.47 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.95 -54.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 34.0 mt -51.89 -43.7 63.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 108.923 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.563 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 19.1 t-160 -54.6 -47.72 73.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.63 -37.13 82.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 114' ' ' ILE . 58.6 mt -77.81 -7.53 56.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.431 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.03 60.48 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 82' ' ' LEU . 5.8 mm -104.29 131.03 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 108.65 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.582 HG21 HG12 ' A' ' 121' ' ' ILE . 40.7 p -119.71 -19.12 8.15 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.364 -0.835 . . . . 0.0 111.422 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.2 m-80 -126.98 111.02 13.6 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.891 -1.131 . . . . 0.0 109.637 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -164.57 142.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.132 -0.98 . . . . 0.0 109.949 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.5 m -113.84 99.43 7.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.33 106.35 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.829 . . . . 0.0 109.777 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.66 118.78 25.38 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.663 HG13 ' CD2' ' A' ' 26' ' ' LEU . 43.3 t -105.0 105.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.931 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.91 111.33 19.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.17 -179.18 16.23 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.32 -16.83 14.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -1.186 . . . . 0.0 110.66 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -123.77 133.48 53.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 110.41 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.57 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 mm -68.12 126.32 92.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.486 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HD2' HD11 ' A' ' 26' ' ' LEU . 77.9 Cg_exo -46.28 128.48 12.18 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.865 1.71 . . . . 0.0 112.159 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.5 tp -76.43 -25.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.444 -0.785 . . . . 0.0 110.093 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.9 mt 53.66 -113.91 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD2' ' NE ' ' A' ' 178' ' ' ARG . 18.8 t70 -94.37 -21.46 18.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 0.0 110.012 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.5 -7.71 28.29 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.582 ' OG ' ' NE ' ' A' ' 178' ' ' ARG . 5.4 p -116.69 -167.75 1.34 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -1.066 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.5 -5.37 20.98 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.495 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 67.1 t-105 -46.75 -42.0 16.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.681 -0.894 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.59 -52.25 64.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.046 . . . . 0.0 110.015 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 75.3 m-85 -62.42 -44.35 96.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.018 . . . . 0.0 108.557 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -63.49 -37.53 87.64 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.3 mm-40 -71.42 -50.25 33.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -0.824 . . . . 0.0 112.076 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.0 -51.53 13.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.713 -1.242 . . . . 0.0 110.669 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.76 -42.52 85.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.031 -1.043 . . . . 0.0 110.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -54.11 -29.36 44.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -84.79 -11.7 55.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -119.8 31.6 6.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.835 HD11 HD13 ' A' ' 82' ' ' LEU . 4.9 mt -88.83 148.29 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.362 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.62 HD13 ' HG3' ' A' ' 8' ' ' LYS . 15.0 tp -130.34 158.47 39.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -109.35 137.53 47.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.17 -161.45 0.87 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.83 . . . . 0.0 109.047 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -121.77 0.63 9.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.86 . . . . 0.0 110.7 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 4' ' ' GLU . 5.6 ttt85 -89.04 144.18 26.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.926 -1.108 . . . . 0.0 109.925 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 132.14 34.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.492 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 85' ' ' THR . 96.6 mt -74.31 140.6 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.499 -0.75 . . . . 0.0 111.184 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -83.95 84.08 7.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -57.88 144.84 37.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.713 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -105.37 125.02 50.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 243' ' ' LYS . 46.1 t -128.53 142.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.2 t -81.19 134.8 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 108.864 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.52 -11.35 11.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.084 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.76 141.76 23.36 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.337 -0.852 . . . . 0.0 109.171 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.69 169.87 20.89 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.135 1.89 . . . . 0.0 113.377 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.531 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 3.1 tt -165.4 141.52 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.81 -0.556 . . . . 0.0 109.708 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.435 HG23 HD21 ' A' ' 138' ' ' LEU . 5.7 mt -127.6 124.9 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.402 -0.811 . . . . 0.0 109.83 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 132' ' ' VAL . 31.5 m -120.03 120.79 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.443 -0.786 . . . . 0.0 109.438 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -104.33 147.27 27.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.349 -0.844 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 255' ' ' LEU . 4.1 t70 -157.01 112.45 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.816 -1.178 . . . . 0.0 111.882 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 41.1 52.25 3.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.709 -0.619 . . . . 0.0 112.458 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.26 3.69 89.99 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.588 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -105.38 163.08 12.9 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.972 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.23 149.64 17.64 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.037 -1.664 . . . . 0.0 109.241 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.972 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.0 mt -146.85 133.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -124.88 139.72 53.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -143.57 139.29 16.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 146.47 70.47 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.653 1.568 . . . . 0.0 112.456 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.46 153.17 9.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 0.54 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -136.29 146.34 46.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.49 117.68 19.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.548 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 tt0 -139.52 133.89 31.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.83 . . . . 0.0 108.808 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.633 ' CG1' HD23 ' A' ' 231' ' ' LEU . 22.9 t -132.75 125.6 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.688 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.9 m -112.77 132.3 55.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -121.58 130.15 53.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.74 . . . . 0.0 109.986 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -114.1 103.23 10.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.07 125.42 8.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.28 84.39 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.42 -1.047 . . . . 0.0 108.865 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.19 148.22 25.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.541 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -95.83 1.31 53.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.209 -0.932 . . . . 0.0 109.782 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.648 HD21 HD12 ' A' ' 159' ' ' LEU . 15.0 p-10 -76.24 -167.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.368 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -61.23 -25.21 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.79 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.648 HD12 HD21 ' A' ' 157' ' ' ASN . 11.3 mt -59.57 -51.13 71.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.35 -128.07 9.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.553 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 12.2 mtm180 -104.05 137.28 42.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.392 -1.064 . . . . 0.0 109.23 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 8.3 mp0 -140.73 138.41 34.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.199 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.65 144.27 49.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.808 . . . . 0.0 109.472 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.656 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 52.3 t80 -138.6 128.48 25.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 61.0 m -103.14 123.1 46.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -101.77 137.64 39.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.832 . . . . 0.0 109.395 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.551 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.2 t -134.47 158.32 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.483 -0.76 . . . . 0.0 109.363 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 167' ' ' VAL . 80.1 mt-10 -58.45 117.47 4.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.805 . . . . 0.0 109.45 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.39 4.06 20.38 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -134.38 29.8 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.137 -1.213 . . . . 0.0 108.835 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.538 ' O ' HG22 ' A' ' 175' ' ' VAL . 84.1 mt-10 -63.87 -32.83 74.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 110.747 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.91 -17.46 6.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.069 -1.02 . . . . 0.0 110.832 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.2 -3.8 58.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.851 -1.155 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -125.55 -12.45 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.119 -0.988 . . . . 0.0 111.434 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -84.42 -29.48 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.305 -1.497 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.62 1.96 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.709 -1.244 . . . . 0.0 110.743 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.66 121.65 24.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 108.794 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.582 ' NE ' ' OG ' ' A' ' 102' ' ' SER . 4.4 mpt_? -88.22 149.15 24.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.83 -1.169 . . . . 0.0 109.832 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.8 t -54.14 166.3 0.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.336 -0.853 . . . . 0.0 109.057 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.74 177.4 9.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.768 -1.207 . . . . 0.0 109.963 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.53 164.22 10.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.586 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.618 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 90.9 m-85 -104.3 145.22 30.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.565 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.682 ' HA ' HD12 ' A' ' 186' ' ' ILE . 18.1 p-10 -63.81 -18.24 63.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.881 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.618 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 4.5 p90 -81.1 -27.42 35.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.667 -1.271 . . . . 0.0 110.452 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 19.6 pt-20 -98.28 -15.17 19.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.888 -1.133 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.1 mt -56.47 -51.51 63.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.255 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 187' ' ' GLU . 2.9 mp0 -51.15 -52.73 41.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.549 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -52.5 -44.86 65.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.0 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.94 -33.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.373 -0.829 . . . . 0.0 109.097 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -79.83 -25.37 40.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -82.25 -25.12 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.057 -1.027 . . . . 0.0 110.219 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.1 m -80.7 8.02 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 82.16 23.24 57.53 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.13 -1.034 . . . . 0.0 110.578 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 47.5 mt -125.6 164.5 20.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.16 -1.2 . . . . 0.0 109.922 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.443 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 76.42 19.59 78.0 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.216 -0.927 . . . . 0.0 111.552 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -68.71 -20.24 64.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.598 -1.531 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.03 -5.26 50.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.77 125.16 34.47 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.072 -1.252 . . . . 0.0 110.321 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -173.73 3.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.834 -0.804 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 200' ' ' LEU . 73.6 mt -91.56 -13.34 32.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -92.47 -1.4 57.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.507 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.48 11.92 1.91 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.27 114.54 6.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.826 HD21 HD23 ' A' ' 217' ' ' LEU . 17.0 tp -77.54 106.71 9.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -0.957 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.518 HG22 HD11 ' A' ' 186' ' ' ILE . 51.1 t -99.94 130.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.001 -1.062 . . . . 0.0 109.498 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD21 HD21 ' A' ' 217' ' ' LEU . 90.7 mt -111.58 149.67 31.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.855 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.4 150.6 16.87 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 207' ' ' GLY . 5.2 tttm -42.98 -27.23 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -1.171 . . . . 0.0 110.091 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 207' ' ' GLY . 3.3 p-10 -148.65 8.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.969 -1.082 . . . . 0.0 110.376 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -141.56 149.15 40.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.017 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.79 125.74 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -72.5 -54.63 8.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 110.47 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -55.85 131.64 72.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 109.804 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.38 -12.28 27.27 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.203 1.935 . . . . 0.0 112.184 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -88.09 -7.77 56.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.66 48.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.826 HD23 HD21 ' A' ' 204' ' ' LEU . 36.2 mt -85.64 138.95 31.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.545 -0.973 . . . . 0.0 109.85 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.516 ' CZ ' HH12 ' A' ' 178' ' ' ARG . 0.5 OUTLIER -64.83 -54.71 26.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 221' ' ' ASN . 18.2 m-85 -118.45 146.66 44.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -50.35 -12.5 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.614 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 219' ' ' TYR . 4.3 m-20 -135.89 27.86 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 109.454 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.1 OUTLIER -56.05 -42.65 97.24 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -179.132 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 22.8 Cg_exo -61.58 -45.44 17.74 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.229 1.953 . . . . 0.0 112.924 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.452 ' H ' HG22 ' A' ' 224' ' ' VAL . 7.4 m -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 120.717 -1.24 . . . . 0.0 108.381 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 11.2 mtt85 -66.79 -40.79 88.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.56 -42.25 95.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 tptp -56.8 -45.62 82.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.01 . . . . 0.0 108.671 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.557 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 77.4 t80 -54.98 -41.95 71.83 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -71.38 -38.12 71.54 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.729 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.633 HD23 ' CG1' ' A' ' 149' ' ' VAL . 27.3 tp -56.72 -35.62 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.352 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.563 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 35.5 mt -72.67 -48.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.25 -32.73 14.19 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.91 -29.5 29.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.228 -1.16 . . . . 0.0 110.143 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.53 HD23 HG22 ' A' ' 260' ' ' VAL . 4.7 mt -78.58 -23.29 46.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.761 -1.212 . . . . 0.0 109.889 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.481 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 22.3 t80 -67.92 -7.27 27.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.138 -0.976 . . . . 0.0 108.815 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 237' ' ' LEU . 20.6 mt -50.06 -32.99 16.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.446 -0.784 . . . . 0.0 108.895 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.45 -12.49 1.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.061 -1.024 . . . . 0.0 109.085 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 73.75 17.13 79.14 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.7 p -157.17 144.94 13.99 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.963 -1.316 . . . . 0.0 109.677 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.66 133.27 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.199 1.932 . . . . 0.0 111.82 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.07 134.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.701 ' HB2' HG22 ' A' ' 125' ' ' VAL . 19.3 mmtp -121.24 125.23 46.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 109.448 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.75 167.54 18.88 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 148' ' ' GLU . 10.2 tttp -98.67 112.91 24.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.112 -1.228 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -112.18 148.45 34.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.015 0.912 . . . . 0.0 111.1 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -129.18 143.67 50.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 p -138.34 124.52 20.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.8 -1.188 . . . . 0.0 109.848 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 250' ' ' ARG . 1.5 t80 -112.96 112.1 23.32 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.7 OUTLIER 45.28 56.48 5.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -92.37 156.17 23.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.93 177.75 17.2 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.417 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 79.8 m-70 -66.01 -51.95 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.28 . . . . 0.0 109.552 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 49.1 p -54.53 -54.64 38.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.0 . . . . 0.0 109.117 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 134' ' ' ASP . 35.8 tp -51.33 -41.83 60.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.54 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -58.71 -55.04 40.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.021 . . . . 0.0 108.816 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.4 t -48.55 -41.25 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -54.93 -47.85 73.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 26.6 tp -52.81 -44.37 66.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.53 HG22 HD23 ' A' ' 235' ' ' LEU . 41.0 t -70.8 -41.66 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -58.9 -48.18 82.36 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 110.411 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.1 -35.19 76.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.053 -1.029 . . . . 0.0 109.57 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 263' ' ' LEU . 15.0 mt -69.66 -45.61 67.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.11 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.36 -32.79 74.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.715 -0.615 . . . . 0.0 110.27 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt . . . . . 0 N--CA 1.489 1.485 0 O-C-N 120.734 -1.229 . . . . 0.0 108.854 179.251 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.641 ' OE1' HG21 ' A' ' 85' ' ' THR . 8.0 mm-40 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.35 135.46 53.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.519 -0.738 . . . . 0.0 109.889 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -137.26 171.42 14.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.7 m -81.94 130.21 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.94 -1.1 . . . . 0.0 109.964 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -59.29 -45.83 90.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.092 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -129.79 157.76 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.198 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 135.45 56.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 109.858 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 113' ' ' ASN . 80.0 mt -116.91 169.97 8.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.438 -0.789 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -154.04 147.08 24.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.062 . . . . 0.0 110.194 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -132.47 157.81 43.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.403 -0.811 . . . . 0.0 109.448 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.6 pm0 -151.78 136.82 17.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.37 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.2 161.85 20.31 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 17' ' ' GLY . 7.1 p -72.46 163.94 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.283 -1.128 . . . . 0.0 111.347 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.594 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -98.76 142.21 15.96 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.623 HG23 ' N ' ' A' ' 19' ' ' HIS . 15.7 tt -58.97 -52.11 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -1.169 . . . . 0.0 112.5 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.623 ' N ' HG23 ' A' ' 18' ' ' ILE . 7.2 m-70 -86.82 -38.73 16.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.245 -1.535 . . . . 0.0 111.702 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.542 HG22 ' HG3' ' A' ' 22' ' ' GLU . 2.5 m -73.97 -33.62 63.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 110.002 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.03 25.83 69.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.542 ' HG3' HG22 ' A' ' 20' ' ' THR . 2.7 mt-10 -117.72 154.34 31.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.534 -0.98 . . . . 0.0 108.596 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -73.72 137.1 43.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 0.0 110.195 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 t -142.35 156.22 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.731 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.8 tttt -132.26 156.57 46.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.0 mt -133.9 143.13 48.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.046 -1.033 . . . . 0.0 109.097 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.622 HG22 ' NE2' ' A' ' 29' ' ' HIS . 22.7 mt -130.8 128.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mt -116.01 129.89 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.069 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.622 ' NE2' HG22 ' A' ' 27' ' ' ILE . 1.5 m-70 -125.0 148.5 60.28 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.65 159.47 28.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.238 1.959 . . . . 0.0 111.618 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.486 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.4 mm-40 -132.39 -174.13 3.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' OG1' ' A' ' 35' ' ' THR . 69.0 tttt -90.87 155.5 18.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.587 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -50.61 149.23 3.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 110.236 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.7 61.34 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.689 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 87.1 m -81.49 -46.39 14.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.382 -1.658 . . . . 0.0 108.983 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.12 -165.49 18.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 85' ' ' THR . 4.6 mm -103.68 122.31 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.61 149.23 47.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.067 . . . . 0.0 110.608 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -107.84 150.96 26.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.5 t80 -131.04 137.48 49.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.014 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 ttpp -169.12 140.41 2.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.447 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.51 28.52 15.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.895 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.15 24.84 76.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.15 138.14 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.21 -1.17 . . . . 0.0 109.758 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 35.9 m-85 -97.13 134.27 40.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.187 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.6 mt -127.25 96.83 32.9 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.485 -0.759 . . . . 0.0 109.839 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -51.79 144.73 33.87 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.259 1.973 . . . . 0.0 111.654 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.2 79.35 7.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.19 149.54 52.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' VAL . 11.5 p-80 -52.0 -49.37 63.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.415 -0.803 . . . . 0.0 109.789 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' HIS . 18.8 mt-10 -44.89 -33.18 1.87 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.32 6.16 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 109.902 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 50' ' ' HIS . 3.5 t -63.73 130.81 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.131 -0.981 . . . . 0.0 109.071 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.9 m -115.68 -31.66 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.47 -0.769 . . . . 0.0 110.317 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.484 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -155.0 126.03 7.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 109.602 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 p -113.87 137.07 52.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.553 -0.717 . . . . 0.0 109.107 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -166.52 -154.58 0.18 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.39 -11.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 57' ' ' ASN . 40.6 m -134.8 165.75 24.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.608 -0.682 . . . . 0.0 109.294 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -103.28 121.57 42.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 0.0 109.229 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -118.14 135.67 54.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 111.192 -179.059 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' HG21 ' A' ' 72' ' ' VAL . 29.8 mt -122.04 162.46 21.15 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.56 144.29 5.81 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 118.35 -1.881 . . . . 0.0 111.147 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -144.68 151.18 38.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.721 -0.87 . . . . 0.0 109.506 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 mttp 57.48 23.83 9.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.704 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.68 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.331 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.496 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 97.4 mm-40 -97.55 143.83 27.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.311 . . . . 0.0 108.055 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.77 149.25 43.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.502 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.32 137.78 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.98 154.25 25.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.188 -0.945 . . . . 0.0 110.907 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 71' ' ' THR . 80.7 m 53.5 67.88 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.706 -0.621 . . . . 0.0 110.764 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 62' ' ' LEU . 23.5 m -113.15 -4.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 109.093 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.3 pt-20 -69.11 -33.49 73.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 110.333 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -61.57 -60.35 3.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 110.135 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.576 ' CD1' ' CD2' ' A' ' 106' ' ' PHE . 2.5 tp -56.98 -42.63 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.904 -1.122 . . . . 0.0 108.808 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' HG23 ' A' ' 75' ' ' ILE . 9.5 mt -59.36 -35.28 73.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.341 -0.85 . . . . 0.0 109.83 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.592 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 11.9 t -64.46 -51.15 64.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 109.902 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.3 t -55.74 -54.74 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 108.408 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -53.28 -44.74 68.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.616 -0.678 . . . . 0.0 109.421 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.426 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 3.2 t-160 -53.23 -41.41 65.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 HD13 ' A' ' 232' ' ' ILE . 16.9 mt -77.26 -35.85 54.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.674 HD22 ' CD1' ' A' ' 114' ' ' ILE . 10.3 mt -80.77 0.76 33.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.025 -1.047 . . . . 0.0 110.61 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 58.24 51.82 8.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.512 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 82' ' ' LEU . 19.9 mm -95.73 122.02 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 108.369 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.66 ' O ' HD13 ' A' ' 37' ' ' ILE . 8.3 p -101.88 -76.61 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 111.169 -178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.717 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.7 m-80 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.39 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.25 134.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.491 0.662 . . . . 0.0 109.555 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.486 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.7 m -105.92 100.54 10.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.14 104.49 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -80.49 124.17 28.7 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.2 t -106.21 111.88 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -92.46 108.92 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.15 -158.06 21.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.19 -11.46 10.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.586 -0.95 . . . . 0.0 110.233 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -145.81 150.1 35.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.85 -1.157 . . . . 0.0 110.858 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.52 125.13 91.8 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.638 -0.664 . . . . 0.0 109.623 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.657 ' CD ' HD21 ' A' ' 26' ' ' LEU . 72.6 Cg_exo -45.28 134.94 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.964 1.776 . . . . 0.0 112.37 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.02 -29.5 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.2 mt 56.77 -110.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.548 -0.72 . . . . 0.0 110.221 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -15.5 22.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.092 . . . . 0.0 111.464 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.49 -8.83 32.66 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.3 p -117.46 -170.74 1.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -1.048 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.87 -3.3 21.91 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -46.8 -39.84 12.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 110.744 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.41 -51.85 67.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.964 -1.085 . . . . 0.0 110.15 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CD2' ' CD1' ' A' ' 75' ' ' ILE . 92.6 m-85 -64.01 -43.78 94.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.024 -1.047 . . . . 0.0 108.779 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -61.51 -38.02 85.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.662 -0.649 . . . . 0.0 109.756 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -71.18 -46.72 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 111.591 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.06 15.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.709 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.7 -42.86 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 110.709 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.64 -31.69 57.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.912 -1.117 . . . . 0.0 109.348 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -83.09 -1.11 51.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.93 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' HB2' HD11 ' A' ' 11' ' ' LEU . 5.3 m120 -131.4 33.42 4.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.252 -0.905 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.674 ' CD1' HD22 ' A' ' 82' ' ' LEU . 11.2 mt -91.35 142.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.473 -1.392 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 115' ' ' LEU . 13.8 tp -131.56 162.83 29.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -108.01 146.03 33.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.921 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.587 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 10.7 mt-30 -111.23 -166.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 109.444 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 10.1 t-20 -116.66 70.83 0.77 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.4 -0.812 . . . . 0.0 110.304 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' GLU . 3.7 ttt180 -166.36 143.59 5.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.192 -0.942 . . . . 0.0 109.305 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.73 130.04 35.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.715 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.77 140.36 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.683 . . . . 0.0 110.542 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.45 90.66 8.45 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -64.71 146.66 54.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 110.812 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -102.38 123.7 46.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.13 143.8 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.128 -0.982 . . . . 0.0 110.466 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 67.9 t -84.4 135.73 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.538 -0.726 . . . . 0.0 109.101 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -114.68 -10.47 12.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.233 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.84 146.45 34.64 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.03 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.28 170.7 17.66 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.389 2.059 . . . . 0.0 113.403 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.728 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.7 tt -165.68 144.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.291 0.567 . . . . 0.0 109.793 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 131' ' ' ILE . 1.4 mt -130.64 122.28 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.5 111.92 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.354 -0.841 . . . . 0.0 109.634 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -115.87 128.6 55.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -172.39 152.2 2.66 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.959 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB2' ' HE ' ' A' ' 137' ' ' ARG . 33.7 mm-40 56.8 22.19 6.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.641 -0.662 . . . . 0.0 110.766 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.54 -0.21 89.42 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.587 ' HB2' HD22 ' A' ' 255' ' ' LEU . 21.2 mtm180 -100.5 171.8 7.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -1.143 . . . . 0.0 107.984 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.917 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.67 146.57 14.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.429 -1.419 . . . . 0.0 109.249 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.917 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.5 mt -147.24 133.27 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 108.671 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -123.78 138.44 54.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 0.0 109.666 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.68 144.59 48.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.5 -0.75 . . . . 0.0 109.105 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 11.4 tm-20 -141.59 135.39 14.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 5.9 Cg_endo -52.82 148.12 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.39 1.393 . . . . 0.0 112.05 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.69 150.87 10.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -79.6 0.8 28.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.5 p -138.43 170.42 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.622 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 30.6 tp -99.88 119.2 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 109.519 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -139.52 137.93 35.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.542 ' CG1' HD23 ' A' ' 231' ' ' LEU . 57.3 t -137.9 125.67 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 m -112.88 140.93 47.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.537 ' CE2' HG12 ' A' ' 224' ' ' VAL . 9.9 t80 -126.72 131.39 51.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 106.06 13.51 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.83 158.37 17.8 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 115.66 15.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -1.057 . . . . 0.0 109.148 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.11 148.75 41.27 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.431 -0.793 . . . . 0.0 109.876 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -93.05 -7.02 46.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 109.93 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.853 HD21 HD12 ' A' ' 159' ' ' LEU . 20.5 p-10 -75.06 -169.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.011 . . . . 0.0 109.972 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -58.83 -21.22 56.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 110.152 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.853 HD12 HD21 ' A' ' 157' ' ' ASN . 6.9 mt -64.76 -54.26 34.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.017 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.06 -131.74 10.69 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -101.37 142.68 32.41 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.235 -1.156 . . . . 0.0 109.517 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -148.67 150.37 33.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.199 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -136.74 147.55 46.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.805 . . . . 0.0 109.323 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -136.06 122.5 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 165' ' ' THR . 14.2 t -98.26 120.77 39.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.994 -1.066 . . . . 0.0 109.658 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -95.05 140.44 29.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.232 -0.918 . . . . 0.0 109.44 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.94 150.08 23.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.289 -0.882 . . . . 0.0 109.707 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 96.6 mt-10 -55.59 117.64 3.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.888 . . . . 0.0 109.368 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.86 4.97 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -134.87 30.27 3.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.142 -1.21 . . . . 0.0 108.958 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.99 -28.64 69.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 110.132 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -57.42 -14.5 4.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.162 -0.962 . . . . 0.0 110.789 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -96.21 -4.35 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.134 . . . . 0.0 110.941 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.414 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -118.98 3.48 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 110.906 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.02 -31.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.804 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.4 2.68 55.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.997 -1.064 . . . . 0.0 110.571 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.25 118.34 21.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.736 -1.228 . . . . 0.0 108.751 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.25 152.09 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.942 -1.099 . . . . 0.0 110.166 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 t -59.11 133.05 55.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.555 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 25.4 p90 -115.03 165.77 12.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.482 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -159.65 161.23 34.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.496 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 42.7 m-85 -103.03 145.15 30.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.052 -1.03 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.741 ' HA ' HD12 ' A' ' 186' ' ' ILE . 4.1 p-10 -63.12 -17.85 62.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.206 -0.934 . . . . 0.0 111.708 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.668 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.2 p90 -81.61 -38.32 26.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.362 -1.461 . . . . 0.0 111.183 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.668 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -86.85 -14.44 42.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.596 -1.315 . . . . 0.0 109.817 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.8 mt -53.91 -48.15 63.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.144 -0.973 . . . . 0.0 109.893 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.24 -51.35 54.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.103 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -47.04 67.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 186' ' ' ILE . 30.0 mt -60.77 -34.7 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 109.183 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -78.91 -25.92 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.842 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -75.25 -28.45 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.6 m -81.49 10.66 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.101 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.37 72.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.0 mt -120.84 159.2 25.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.596 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.469 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.1 27.58 57.86 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.435 ' NZ ' ' CB ' ' A' ' 196' ' ' LYS . 8.0 mtpm? -71.03 -20.59 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.765 -1.432 . . . . 0.0 109.314 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.29 -1.34 50.86 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.75 126.94 38.21 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.695 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 p -140.74 172.02 13.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.716 -0.873 . . . . 0.0 109.114 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.79 -3.56 45.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.979 . . . . 0.0 109.642 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.482 ' C ' ' ND2' ' A' ' 202' ' ' ASN . 80.5 tttt -97.88 -10.55 24.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.425 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 201' ' ' LYS . 0.7 OUTLIER -135.18 -9.36 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 109.486 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.432 HG22 ' SG ' ' A' ' 181' ' ' CYS . 3.0 m -126.89 115.04 18.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.713 . . . . 0.0 109.586 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 205' ' ' VAL . 4.9 tp -74.0 114.64 12.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.481 ' N ' HD12 ' A' ' 204' ' ' LEU . 64.8 t -105.31 127.08 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.048 -1.033 . . . . 0.0 109.854 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 11.1 mt -104.29 151.67 23.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.09 150.74 17.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 26.4 ttpt -41.02 -29.4 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -1.123 . . . . 0.0 109.961 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.5 OUTLIER -149.41 17.47 0.93 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 110.339 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 7.4 tttp -151.26 161.88 41.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.054 -1.029 . . . . 0.0 110.122 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.24 129.88 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.08 -54.31 8.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.137 -0.977 . . . . 0.0 109.92 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -54.64 134.22 64.3 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.909 -1.12 . . . . 0.0 109.329 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.81 -9.67 25.17 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.235 1.957 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.32 -7.96 52.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.066 -1.021 . . . . 0.0 109.751 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.18 -165.01 51.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.9 mt -88.66 145.24 25.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.5 -1.0 . . . . 0.0 109.935 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.566 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.7 mmt180 -87.76 -17.02 32.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.465 -0.772 . . . . 0.0 109.558 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 27.0 m-85 -144.17 143.97 31.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.01 -19.79 54.43 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.427 ' HB2' ' HE ' ' A' ' 225' ' ' ARG . 16.5 m-20 -126.96 35.67 4.56 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -60.05 -40.62 79.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.538 -0.726 . . . . 0.0 110.607 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.11 -47.98 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.43 2.087 . . . . 0.0 112.641 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.1 OUTLIER -72.88 -23.09 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.757 -1.214 . . . . 0.0 108.696 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' A' ' 221' ' ' ASN . 11.2 mtt180 -68.74 -44.64 73.34 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -60.13 -43.02 96.01 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.83 -42.18 79.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.092 -1.005 . . . . 0.0 109.071 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.0 t -63.94 -49.31 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.592 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.8 t80 -50.22 -40.33 47.13 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.794 0.807 . . . . 0.0 108.896 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.0 m-20 -69.68 -44.57 70.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.635 -0.666 . . . . 0.0 110.178 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.542 HD23 ' CG1' ' A' ' 149' ' ' VAL . 50.7 tp -56.64 -38.72 72.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.111 -0.993 . . . . 0.0 109.154 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.42 HD13 HD21 ' A' ' 81' ' ' LEU . 71.8 mt -68.04 -33.44 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.12 -31.97 79.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.589 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -81.78 -25.49 35.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -1.126 . . . . 0.0 109.912 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.07 -24.52 55.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.795 -1.191 . . . . 0.0 110.698 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.463 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -65.38 -5.22 6.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.355 -1.466 . . . . 0.0 108.013 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 237' ' ' LEU . 35.4 mt -55.08 -23.7 21.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.848 -1.158 . . . . 0.0 108.929 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 242' ' ' VAL . 72.1 mt -68.17 -21.47 64.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.005 . . . . 0.0 109.186 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.76 12.05 67.16 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 21.4 p -158.2 143.99 12.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.144 -1.209 . . . . 0.0 109.578 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 78.0 Cg_exo -42.42 135.66 4.39 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.263 1.975 . . . . 0.0 112.153 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.474 ' O ' HD13 ' A' ' 147' ' ' LEU . 76.0 t -98.46 133.03 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.944 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -122.41 127.81 50.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.613 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.0 178.93 28.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -105.93 112.2 25.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -1.207 . . . . 0.0 109.968 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -112.36 148.19 34.8 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.03 0.919 . . . . 0.0 111.125 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -129.89 144.42 51.31 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -139.09 128.81 24.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.732 -1.23 . . . . 0.0 110.722 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.0 t80 -110.67 113.07 25.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 249' ' ' PHE . 42.1 mtm180 48.51 55.48 8.91 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.18 135.31 22.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.414 ' HA3' HH11 ' A' ' 137' ' ' ARG . . . -109.78 151.2 17.38 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.1 m-70 -49.05 -46.12 43.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -1.205 . . . . 0.0 109.547 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -55.29 35.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 109.413 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 137' ' ' ARG . 56.7 tp -51.99 -38.14 55.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -58.64 -55.48 34.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.036 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.42 -42.94 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.754 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.58 -48.89 74.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.089 -1.007 . . . . 0.0 109.087 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.679 HD22 HG21 ' A' ' 139' ' ' ILE . 37.9 tp -52.79 -42.02 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 108.772 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.9 t -72.11 -40.17 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -58.91 -51.36 70.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.388 -0.82 . . . . 0.0 110.136 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.79 -44.74 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 109.879 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 263' ' ' LEU . 72.8 mt -63.5 -44.16 95.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.248 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.28 86.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.498 -0.751 . . . . 0.0 110.368 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.6 mttt . . . . . 0 N--CA 1.49 1.564 0 O-C-N 120.773 -1.204 . . . . 0.0 108.868 179.622 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 119' ' ' ARG . 8.0 mm-40 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.485 ' HD3' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -109.63 126.85 54.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 115' ' ' LEU . 6.1 t -130.44 169.37 15.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 7' ' ' VAL . 6.7 m -83.87 137.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.034 -1.042 . . . . 0.0 110.317 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG3' HD13 ' A' ' 115' ' ' LEU . 28.4 ttmt -67.6 -45.57 75.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.472 -0.767 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CB ' ' OD1' ' A' ' 113' ' ' ASN . 2.8 tt0 -132.27 156.1 47.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.26 -0.9 . . . . 0.0 110.511 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 133.01 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.728 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.87 165.42 14.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 109.192 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 p -156.65 150.3 24.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.57 161.68 33.23 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.46 134.73 24.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.893 -1.13 . . . . 0.0 108.857 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.04 155.34 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.33 160.66 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.18 . . . . 0.0 111.208 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.65 136.29 13.44 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.604 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.4 tt -53.42 -53.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -1.161 . . . . 0.0 111.657 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.604 ' N ' HG23 ' A' ' 18' ' ' ILE . 5.2 m-70 -87.54 -36.78 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.275 -1.516 . . . . 0.0 111.191 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.4 m -71.31 -35.42 71.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.57 65.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -111.77 150.85 29.7 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.667 -0.902 . . . . 0.0 108.86 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.2 t80 -70.25 128.92 37.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.597 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 12.1 t -135.94 157.47 46.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 109.143 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 26' ' ' LEU . 4.0 ttmt -135.6 147.2 48.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -0.895 . . . . 0.0 109.307 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.535 HD11 ' HD2' ' A' ' 97' ' ' PRO . 6.4 mt -119.65 145.99 45.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.096 -1.003 . . . . 0.0 108.838 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.9 mt -135.05 126.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mt -113.08 129.1 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.223 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -128.44 148.75 69.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.54 160.37 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.278 1.986 . . . . 0.0 111.835 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 6.0 mm-40 -134.76 -172.82 3.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.902 . . . . 0.0 109.837 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' OG1' ' A' ' 35' ' ' THR . 54.1 tttm -84.44 149.59 25.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.632 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 mp0 -47.46 145.42 2.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.991 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.68 25.2 63.14 Favored Glycine 0 N--CA 1.493 2.465 0 O-C-N 121.47 -0.769 . . . . 0.0 111.825 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 45.4 m -80.98 -44.58 17.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.546 -1.561 . . . . 0.0 108.951 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.48 -166.55 16.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.605 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.5 mm -103.73 125.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.313 -1.11 . . . . 0.0 108.073 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.12 139.64 30.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.162 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.56 152.69 18.2 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 4.1 t80 -135.03 141.26 46.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.609 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 146.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.312 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.07 29.31 14.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.31 23.11 73.25 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.28 133.88 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -1.202 . . . . 0.0 109.51 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -94.41 142.45 27.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.823 . . . . 0.0 109.169 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 46' ' ' ILE . 29.4 mt -135.09 94.39 16.09 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -49.26 144.88 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.342 2.028 . . . . 0.0 111.654 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.44 84.32 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.95 -1.094 . . . . 0.0 110.667 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.28 154.57 49.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.556 ' O ' HG23 ' A' ' 53' ' ' VAL . 8.7 p-80 -51.39 -48.15 62.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 109.732 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -46.77 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.0 m-85 -95.35 1.88 54.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 109.762 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 50' ' ' HIS . 54.1 t -55.22 127.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.036 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 52' ' ' PHE . 32.2 m -117.42 -32.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 109.861 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -151.32 119.28 6.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 p -114.36 127.82 56.04 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.603 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.9 t-20 -167.16 -152.98 0.14 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' ASN . 12.2 m-70 -44.37 -16.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.9 t -136.77 165.6 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.491 -0.755 . . . . 0.0 109.326 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 m -110.61 125.71 53.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 150.42 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.26 -0.9 . . . . 0.0 111.178 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' CD1' HG21 ' A' ' 72' ' ' VAL . 34.4 mt -130.15 159.01 38.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.73 146.68 8.02 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.306 -1.902 . . . . 0.0 111.538 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -144.09 148.87 35.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.644 -0.916 . . . . 0.0 109.309 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.1 mttt 59.1 30.62 20.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.262 -0.899 . . . . 0.0 110.75 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.24 4.72 90.11 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.486 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 16.7 mm100 -103.93 139.94 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -1.234 . . . . 0.0 108.094 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -141.71 157.52 44.95 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.704 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.2 mt -133.77 147.26 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -114.21 150.52 34.16 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.153 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 55.05 71.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.666 -0.646 . . . . 0.0 110.995 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 62' ' ' LEU . 19.5 m -113.97 -17.41 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.438 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.601 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -61.18 -16.81 48.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.441 -179.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.601 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 7.8 m170 -73.18 -61.39 1.84 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.833 -1.167 . . . . 0.0 109.832 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -58.15 -41.62 81.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.819 -1.175 . . . . 0.0 108.338 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 79' ' ' LEU . 98.0 mt -56.4 -38.28 71.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 109.466 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.569 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.2 t -61.44 -49.23 77.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.13 -53.07 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 108.515 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 76' ' ' LEU . 20.2 mt -51.73 -44.62 63.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.492 ' HD1' HG22 ' A' ' 232' ' ' ILE . 10.6 t-160 -56.16 -49.34 74.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.1 -1.0 . . . . 0.0 110.401 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.49 -37.89 85.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.685 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.58 ' CB ' HD11 ' A' ' 84' ' ' ILE . 50.2 mt -86.66 -5.43 59.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.913 -1.117 . . . . 0.0 111.151 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 82' ' ' LEU . 1.0 OUTLIER 62.69 63.0 1.03 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.731 -1.231 . . . . 0.0 110.426 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.605 ' O ' HD11 ' A' ' 37' ' ' ILE . 4.6 mm -98.44 129.68 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.585 ' O ' HD13 ' A' ' 37' ' ' ILE . 72.9 p -107.63 -78.21 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.041 -1.037 . . . . 0.0 110.509 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.5 m-80 -81.34 113.27 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.005 -1.059 . . . . 0.0 111.137 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.9 m -163.71 131.79 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.546 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.5 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 51.4 m -104.25 100.88 10.6 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.38 103.02 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' OE2' ' CD1' ' A' ' 40' ' ' PHE . 4.0 mt-10 -76.32 122.97 25.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.989 -1.069 . . . . 0.0 108.782 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.06 110.29 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.45 108.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.7 -167.15 24.91 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.16 -15.31 14.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.365 -1.08 . . . . 0.0 109.861 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.5 tt0 -143.71 148.68 36.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 110.034 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -68.2 128.36 93.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.456 -0.777 . . . . 0.0 109.282 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.535 ' HD2' HD11 ' A' ' 26' ' ' LEU . 76.6 Cg_exo -44.19 130.35 8.49 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.047 1.831 . . . . 0.0 112.116 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 18' ' ' ILE . 10.9 tp -76.33 -20.31 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.074 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.464 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 6.2 mt 47.57 -116.19 0.72 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.277 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.16 -10.05 31.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.483 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.27 -5.07 57.3 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.4 p -117.14 -171.38 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.454 -1.027 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.9 -6.14 16.97 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -47.71 -40.1 19.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.65 -0.912 . . . . 0.0 110.805 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.83 -52.06 65.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.931 -1.105 . . . . 0.0 109.828 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.4 m-85 -60.62 -43.93 96.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.012 -1.055 . . . . 0.0 108.379 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.503 ' CD2' HG11 ' A' ' 175' ' ' VAL . 12.3 t80 -60.88 -39.76 90.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.517 0.675 . . . . 0.0 110.051 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.89 -47.97 60.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 112.059 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 -51.19 14.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.749 -1.219 . . . . 0.0 111.105 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.49 -42.81 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -56.49 -29.54 61.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.945 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -81.23 -15.4 55.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.066 . . . . 0.0 110.453 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' CB ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -119.84 32.25 6.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.265 -0.897 . . . . 0.0 111.044 -178.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.402 HG12 ' NZ ' ' A' ' 5' ' ' LYS . 5.7 mt -80.75 146.69 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.653 -1.28 . . . . 0.0 110.929 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' HB3' HG23 ' A' ' 6' ' ' THR . 13.7 tp -132.09 162.63 30.35 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -123.49 146.6 47.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.235 -0.916 . . . . 0.0 110.446 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.512 ' NE2' ' OE2' ' A' ' 33' ' ' GLU . 4.9 mt-30 -107.75 -157.5 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -0.789 . . . . 0.0 109.245 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -118.82 1.72 11.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.011 -1.056 . . . . 0.0 112.124 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 4' ' ' GLU . 3.3 ttm180 -102.24 122.02 43.4 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.573 -1.329 . . . . 0.0 110.237 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -56.73 142.97 38.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.258 -0.901 . . . . 0.0 109.999 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.47 HG23 HG21 ' A' ' 85' ' ' THR . 1.9 mt -81.19 145.55 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 0.0 110.481 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.58 84.43 7.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -60.72 146.06 47.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 110.552 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -101.22 120.15 39.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 243' ' ' LYS . 20.9 t -122.72 138.84 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 109.878 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.2 140.0 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.192 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -119.7 -8.63 9.89 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.418 ' N ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER -141.19 146.17 41.77 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.42 -0.8 . . . . 0.0 109.072 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.52 177.21 8.97 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.219 1.946 . . . . 0.0 113.08 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.793 HG22 ' HB3' ' A' ' 141' ' ' ALA . 8.4 tt -165.25 144.78 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.622 -0.674 . . . . 0.0 109.574 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -129.03 123.61 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.59 122.1 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.426 ' OE1' ' C ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.35 132.02 56.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 17.2 t0 -174.21 157.8 2.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.261 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 44.2 mt-10 57.71 19.93 5.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.676 -0.64 . . . . 0.0 110.773 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.04 4.58 88.84 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -114.07 177.63 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.899 HD23 ' N ' ' A' ' 139' ' ' ILE . 10.1 tt -157.77 161.09 38.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.351 -1.468 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.899 ' N ' HD23 ' A' ' 138' ' ' LEU . 18.6 mt -149.8 144.97 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.952 . . . . 0.0 108.492 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -132.4 140.17 48.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.627 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.793 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.69 140.86 51.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 108.998 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.56 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 13.8 tm-20 -137.64 126.55 14.81 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.45 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 88.6 Cg_exo -46.39 152.48 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.563 1.509 . . . . 0.0 112.435 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.05 159.57 6.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -91.79 -0.29 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 p -132.85 146.41 51.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.444 -0.785 . . . . 0.0 109.166 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.431 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 19.9 tp -81.38 117.22 21.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.133 -0.979 . . . . 0.0 109.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.07 135.1 39.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.731 ' CG1' HD23 ' A' ' 231' ' ' LEU . 67.5 t -135.98 117.65 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.516 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.3 m -107.92 134.15 51.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -121.51 130.6 53.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -112.31 110.55 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.55 152.84 17.53 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.46 96.11 2.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.436 -1.038 . . . . 0.0 109.138 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.482 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 3.5 m-85 -98.98 148.72 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.578 -0.701 . . . . 0.0 110.126 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -85.38 -3.72 58.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.484 -0.76 . . . . 0.0 109.864 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CB ' ' A' ' 155' ' ' PHE . 11.5 p30 -76.93 -167.64 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.915 -1.115 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -58.0 -22.01 47.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.039 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.38 -54.73 43.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.834 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.13 -111.71 3.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -124.84 137.18 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -1.112 . . . . 0.0 109.076 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -155.32 139.33 16.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.377 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.546 ' CB ' ' NZ ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -127.69 153.73 46.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 109.169 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.496 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 86.4 t80 -135.17 116.88 14.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 165' ' ' THR . 5.0 t -92.47 120.1 32.62 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.157 -0.964 . . . . 0.0 109.376 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.74 138.38 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.561 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -135.77 153.55 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.0 109.45 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 22.5 mt-10 -57.22 122.82 13.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.476 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.49 -7.05 20.59 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.14 32.65 4.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -1.14 . . . . 0.0 108.768 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -66.56 -30.64 70.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.797 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -58.53 -13.6 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.015 . . . . 0.0 110.877 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.26 -4.44 54.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.915 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.39 3.75 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.16 -0.963 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.503 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -96.77 -32.64 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.797 -1.189 . . . . 0.0 109.934 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.55 0.17 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.978 -1.076 . . . . 0.0 110.536 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.34 117.42 18.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.798 -1.188 . . . . 0.0 108.29 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.477 HH12 ' C ' ' A' ' 201' ' ' LYS . 11.2 ttm180 -86.08 148.83 25.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 0.0 110.26 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.4 t -62.55 134.9 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 109.012 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.16 179.74 3.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 110.582 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -164.93 161.32 20.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.578 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.2 m-85 -104.52 144.21 31.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.672 ' HA ' HD12 ' A' ' 186' ' ' ILE . 7.5 p-10 -62.64 -19.27 63.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.689 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.587 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -81.44 -31.46 33.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.755 -1.216 . . . . 0.0 110.534 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.587 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 6.4 pt-20 -91.79 -14.96 28.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.836 -1.165 . . . . 0.0 109.513 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 183' ' ' ASP . 6.8 mt -57.42 -52.02 62.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -50.64 -52.39 40.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.912 -1.117 . . . . 0.0 109.92 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -45.62 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.914 -1.116 . . . . 0.0 109.166 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.3 -33.43 61.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 109.079 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -80.52 -26.79 37.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -79.43 -21.13 45.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 110.03 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.3 13.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.752 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.82 24.46 67.0 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.788 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.0 mt -123.9 163.5 21.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.118 -1.225 . . . . 0.0 109.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 77.37 21.92 71.71 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -68.63 -21.31 64.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.83 -1.394 . . . . 0.0 109.735 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.68 -5.37 51.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.08 125.75 38.78 Favored Glycine 0 N--CA 1.49 2.263 0 O-C-N 121.242 -1.152 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.28 165.1 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.713 -0.875 . . . . 0.0 109.314 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.98 -8.06 50.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.504 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.477 ' C ' HH12 ' A' ' 178' ' ' ARG . 23.5 tttp -93.44 -5.61 48.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 53.8 m-20 -143.54 14.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.719 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.8 m -151.65 119.1 6.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.519 HD21 ' CD2' ' A' ' 217' ' ' LEU . 24.3 tp -80.4 109.81 15.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.133 -0.979 . . . . 0.0 108.893 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.4 t -98.11 128.56 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.9 mt -110.79 148.41 32.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.896 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.27 156.29 16.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 207' ' ' GLY . 1.6 ttpt -42.9 -30.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.912 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.7 13.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.166 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 207' ' ' GLY . 33.1 mttt -139.23 147.26 41.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.037 -1.04 . . . . 0.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.99 127.05 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -72.91 -54.31 9.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 110.061 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.39 132.42 81.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.926 -1.109 . . . . 0.0 109.44 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.4 -11.5 26.62 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.885 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -90.38 -8.72 49.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.969 -1.082 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.24 -167.94 45.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.519 ' CD2' HD21 ' A' ' 204' ' ' LEU . 21.2 mt -78.62 141.84 37.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.449 -1.03 . . . . 0.0 109.766 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.584 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.1 tpp180 -79.57 -13.06 59.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 34.3 m-85 -148.24 152.79 37.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 108.899 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.621 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 11.6 mp0 -59.25 -19.12 43.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 108.423 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 37.25 3.02 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.621 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.5 OUTLIER -59.91 -38.18 57.36 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.605 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.27 -46.45 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.158 1.906 . . . . 0.0 112.295 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 228' ' ' VAL . 6.1 m -74.45 -23.99 18.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.776 -1.202 . . . . 0.0 108.25 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 164' ' ' PHE . 44.9 mtt180 -68.24 -43.21 78.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -61.06 -41.76 97.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -57.49 -43.4 84.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.966 -1.083 . . . . 0.0 108.753 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 224' ' ' VAL . 28.2 t -60.84 -45.14 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.569 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 75.6 t80 -55.87 -40.56 73.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 1.1 m-20 -73.71 -37.8 65.04 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.612 -0.68 . . . . 0.0 109.597 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.731 HD23 ' CG1' ' A' ' 149' ' ' VAL . 28.4 tp -56.23 -34.86 66.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.492 HG22 ' HD1' ' A' ' 80' ' ' HIS . 61.0 mt -73.28 -47.93 44.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.66 -34.66 21.44 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.482 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 1.0 OUTLIER -81.59 -27.6 34.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -1.196 . . . . 0.0 109.95 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.649 HD23 HG22 ' A' ' 260' ' ' VAL . 6.6 mt -80.46 -20.92 42.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.796 -1.19 . . . . 0.0 109.631 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -73.1 -9.22 58.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.288 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.409 ' C ' ' N ' ' A' ' 239' ' ' GLY . 67.9 mt -53.5 -28.2 29.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 108.879 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 242' ' ' VAL . 65.4 mt -55.3 -12.21 0.97 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 108.895 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 77.65 12.26 84.66 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 30.2 p -158.52 147.61 14.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.946 -1.326 . . . . 0.0 109.857 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.9 133.78 5.61 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.283 1.988 . . . . 0.0 112.081 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 238' ' ' LEU . 42.5 t -100.32 129.03 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.435 ' HB3' HG13 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -116.92 123.54 47.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.38 -0.825 . . . . 0.0 109.807 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.35 173.08 26.3 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.56 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -103.14 111.93 24.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.189 -1.183 . . . . 0.0 109.463 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.6 m-85 -112.5 148.26 34.81 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.111 0.958 . . . . 0.0 111.456 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 139' ' ' ILE . 19.4 t80 -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 t -131.79 128.13 38.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.86 -1.15 . . . . 0.0 110.043 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.55 ' O ' ' N ' ' A' ' 251' ' ' GLY . 1.6 t80 -109.49 117.88 35.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.538 -0.726 . . . . 0.0 109.16 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 42.83 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 111.03 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -64.03 172.55 15.82 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.595 -1.316 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -138.91 -169.2 11.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.783 ' O ' HG23 ' A' ' 257' ' ' VAL . 96.6 m-70 -65.66 -52.37 52.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.131 . . . . 0.0 110.008 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -42.5 68.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.71 -36.13 67.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.968 -1.082 . . . . 0.0 109.009 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.8 m-20 -63.59 -44.41 94.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 108.605 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 253' ' ' HIS . 17.0 t -57.12 -45.04 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 108.844 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -55.18 -47.3 75.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.118 -0.989 . . . . 0.0 108.844 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 17.7 tp -53.52 -44.96 69.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.374 -0.828 . . . . 0.0 109.034 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.649 HG22 HD23 ' A' ' 235' ' ' LEU . 54.9 t -69.57 -43.45 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -48.24 77.37 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -68.01 -39.5 83.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.643 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.2 mt -65.0 -44.85 87.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.76 74.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? . . . . . 0 N--CA 1.489 1.509 0 O-C-N 120.764 -1.21 . . . . 0.0 109.302 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 25.5 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.307 0.575 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -119.9 140.09 51.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.595 -0.691 . . . . 0.0 109.412 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 t -139.14 178.5 7.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.23 -0.919 . . . . 0.0 109.085 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -83.59 151.05 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.8 -1.188 . . . . 0.0 109.75 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.31 -37.62 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.475 -0.766 . . . . 0.0 110.063 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.52 157.76 46.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 133.08 54.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.357 0.598 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 11' ' ' LEU . 28.1 mt -123.58 159.22 29.68 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -157.26 150.84 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.11 -0.994 . . . . 0.0 110.51 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 169.01 18.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.563 -0.711 . . . . 0.0 109.718 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.69 137.89 21.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.071 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.75 157.26 14.92 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.6 HG23 ' C ' ' A' ' 22' ' ' GLU . 9.8 p -79.29 140.29 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.179 -1.189 . . . . 0.0 110.752 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.94 144.09 37.48 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.5 tt -59.63 -49.11 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -1.102 . . . . 0.0 112.459 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.548 ' CD2' ' OE2' ' A' ' 95' ' ' GLU . 9.6 m-70 -86.52 -38.24 17.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.003 -1.685 . . . . 0.0 111.071 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -67.52 -37.81 83.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.71 21.94 71.41 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' C ' HG23 ' A' ' 16' ' ' VAL . 3.1 tp10 -119.16 154.43 33.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.724 -0.868 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -70.88 133.67 46.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.9 t -142.63 157.25 44.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 108.883 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -126.41 160.47 30.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.232 -0.918 . . . . 0.0 110.01 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 HG23 ' A' ' 96' ' ' ILE . 12.1 mt -127.75 142.15 51.39 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' CD2' ' A' ' 29' ' ' HIS . 8.7 mt -137.26 127.21 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 108.838 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.51 121.24 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.732 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.503 ' CD2' HG22 ' A' ' 27' ' ' ILE . 16.3 m-70 -119.34 149.01 46.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.83 160.78 35.42 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.082 1.854 . . . . 0.0 110.732 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 56.7 mm-40 -136.4 -172.51 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.062 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.3 ttpm? -86.31 153.27 22.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 109.355 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -47.11 143.34 3.17 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 110.291 -179.297 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 60.08 30.5 70.48 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.384 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.5 m -80.96 -35.83 31.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.592 -1.534 . . . . 0.0 108.584 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.852 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 91.67 179.54 42.01 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -95.43 122.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.279 -1.13 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.4 144.81 46.75 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.773 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 52.1 m-85 -102.57 152.73 20.82 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.5 t80 -131.45 141.63 49.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 108.912 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -173.4 138.11 0.69 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.372 -0.83 . . . . 0.0 108.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.8 28.79 17.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.158 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.28 27.63 71.34 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 120.783 -1.198 . . . . 0.0 110.168 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.78 137.83 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -1.227 . . . . 0.0 109.956 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -96.63 135.3 38.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.6 mt -128.79 99.25 23.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.82 142.58 18.86 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.62 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . . . -92.83 84.5 4.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 110.548 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -141.6 157.91 44.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 109.393 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 52' ' ' PHE . 14.0 p-80 -54.83 -49.14 71.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -44.9 -16.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.13 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.6 m-85 -96.83 5.89 49.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.971 -1.081 . . . . 0.0 109.891 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -60.01 124.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.163 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.86 -30.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -0.877 . . . . 0.0 109.849 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.507 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -153.56 121.95 6.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 0.0 109.475 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -114.07 133.72 55.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.618 -0.676 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.9 t-20 -166.79 -154.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.432 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 12.0 m-70 -48.08 -12.59 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.897 -1.127 . . . . 0.0 108.294 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' ASN . 84.5 p -135.32 165.26 25.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.441 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 6.4 m -106.32 124.13 49.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -0.909 . . . . 0.0 108.998 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.507 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.04 137.74 54.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 111.381 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 72' ' ' VAL . 18.7 mt -127.73 159.15 35.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 178.17 151.86 9.76 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.379 -1.867 . . . . 0.0 111.667 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -144.94 152.2 39.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.98 -0.718 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.1 mttt 59.62 24.3 13.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.342 -0.849 . . . . 0.0 110.755 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.53 83.09 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.531 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.441 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 87.6 mm-40 -109.87 133.4 53.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 108.061 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.79 165.17 27.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.892 -1.13 . . . . 0.0 111.838 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mt -134.77 148.55 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -114.61 150.72 34.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m 55.32 69.32 0.75 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 110.724 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -113.22 -12.97 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.975 -1.078 . . . . 0.0 109.356 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 3.4 pt-20 -63.2 -18.37 63.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.452 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -71.91 -60.65 2.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.919 -1.113 . . . . 0.0 109.683 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.4 tp -59.78 -43.04 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.994 -1.066 . . . . 0.0 108.953 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' HG23 ' A' ' 75' ' ' ILE . 15.0 mt -55.2 -41.26 71.76 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.174 -0.953 . . . . 0.0 109.331 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.9 t -58.48 -47.85 82.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.35 -54.11 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 108.703 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 mt -52.58 -44.94 66.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.662 ' HD1' HG22 ' A' ' 232' ' ' ILE . 19.7 t-160 -52.88 -54.32 36.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 110.224 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.16 -34.9 78.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 84' ' ' ILE . 42.4 mt -79.49 -4.47 51.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 110.598 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.58 54.45 2.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.98 -1.075 . . . . 0.0 110.305 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.4 mm -96.3 124.57 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 108.467 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.477 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 5.8 p -112.64 -21.31 11.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.315 -0.866 . . . . 0.0 111.631 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.852 HD22 ' H ' ' A' ' 36' ' ' GLY . 10.8 m120 -132.8 112.36 11.88 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.885 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.3 m -165.01 144.56 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.989 . . . . 0.0 109.839 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 64.9 m -112.85 102.86 10.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mp -92.91 117.99 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.872 . . . . 0.0 109.789 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.94 118.22 32.14 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.373 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.55 104.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.865 . . . . 0.0 110.833 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.14 110.7 19.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.83 -162.92 24.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.7 -13.88 12.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -1.06 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.548 ' OE2' ' CD2' ' A' ' 19' ' ' HIS . 40.5 tt0 -142.0 147.51 37.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.101 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.729 HG23 HD11 ' A' ' 26' ' ' LEU . 3.0 mm -68.76 126.74 93.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 109.764 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -45.59 129.53 11.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.923 1.749 . . . . 0.0 111.887 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.26 -32.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.498 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 9.6 mt 55.12 -104.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.273 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -94.34 -28.32 15.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.195 -0.94 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.87 -3.54 25.83 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.3 p -123.5 -166.23 1.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.421 -1.047 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -2.28 22.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.402 ' NE1' ' HG3' ' A' ' 108' ' ' GLU . 59.4 t-105 -48.69 -43.02 36.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.889 -0.771 . . . . 0.0 110.974 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.55 -52.08 64.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.964 -1.085 . . . . 0.0 110.385 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -62.93 -44.04 97.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.931 -1.105 . . . . 0.0 108.722 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 82.3 t80 -63.74 -37.22 86.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.819 -0.551 . . . . 0.0 110.251 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HG3' ' NE1' ' A' ' 104' ' ' TRP . 4.9 mm-40 -72.74 -49.68 29.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 112.014 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.16 -46.76 40.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.808 -1.182 . . . . 0.0 111.056 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -68.69 -42.57 83.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.96 -1.087 . . . . 0.0 110.971 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 15.8 ttp85 -55.74 -27.76 52.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.0 -1.063 . . . . 0.0 110.091 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -84.19 -18.35 36.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.99 -1.069 . . . . 0.0 109.887 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -113.08 29.26 8.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.8 mt -82.26 149.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 0.0 110.28 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 115' ' ' LEU . 12.2 tp -130.66 160.94 32.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.3 137.36 43.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.093 -1.005 . . . . 0.0 109.977 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -102.6 -170.95 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.489 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -124.97 70.71 1.15 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.471 -0.768 . . . . 0.0 110.16 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -160.61 137.78 9.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.046 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.12 167.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.678 0.751 . . . . 0.0 111.193 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.6 mt -128.59 122.35 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -79.37 71.93 5.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.348 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -55.58 147.05 18.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.081 -1.012 . . . . 0.0 109.414 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -104.83 123.02 46.96 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 243' ' ' LYS . 15.5 t -127.92 143.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.849 . . . . 0.0 109.51 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.81 141.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.5 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.23 -7.6 9.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 143' ' ' PRO . 7.3 pt-20 -142.35 144.31 30.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 0.0 109.062 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.13 168.01 25.83 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.185 1.923 . . . . 0.0 113.536 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.838 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.1 tt -159.77 141.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.343 0.592 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.469 ' CG2' HD21 ' A' ' 138' ' ' LEU . 28.6 mt -131.56 119.96 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.4 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 132' ' ' VAL . 34.3 m -118.3 120.44 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.94 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -114.55 136.45 53.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.685 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -174.24 150.1 1.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.599 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 57.05 24.09 9.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.0 110.818 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.09 7.68 86.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.41 ' CG ' HH11 ' A' ' 137' ' ' ARG . 2.9 mtt-85 -106.89 170.25 8.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.984 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.0 tt -160.44 149.52 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.185 -1.572 . . . . 0.0 109.232 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.984 ' N ' HD23 ' A' ' 138' ' ' LEU . 48.9 mt -145.83 135.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 0.0 108.626 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -124.11 140.5 52.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.971 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.838 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.58 142.13 50.96 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -139.64 127.89 13.3 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.403 ' HG3' ' N ' ' A' ' 128' ' ' GLU . 84.7 Cg_exo -46.73 149.1 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.661 1.574 . . . . 0.0 112.417 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.49 155.11 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -1.43 56.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -135.0 148.18 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 109.353 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.1 tp -84.08 118.63 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -137.3 138.85 40.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.46 ' CG1' HD23 ' A' ' 231' ' ' LEU . 54.7 t -135.52 123.35 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.142 -0.974 . . . . 0.0 110.032 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.0 m -109.87 129.34 55.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.239 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.402 ' CE1' ' HG2' ' A' ' 227' ' ' LYS . 63.8 t80 -119.17 131.43 55.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 26.6 tt0 -116.21 104.74 11.82 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.59 146.2 18.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.563 ' H ' HH11 ' A' ' 250' ' ' ARG . 1.8 tm-20 -119.59 86.11 2.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.603 -0.94 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 160' ' ' GLY . 11.7 m-85 -91.91 148.17 22.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -96.56 -4.99 40.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.277 -0.889 . . . . 0.0 109.445 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.813 HD21 HD12 ' A' ' 159' ' ' LEU . 19.3 p-10 -74.47 -167.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.8 -18.01 28.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.628 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.813 HD12 HD21 ' A' ' 157' ' ' ASN . 63.5 mt -72.74 -29.0 62.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 60.82 -121.39 26.43 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -107.67 140.67 40.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -1.048 . . . . 0.0 108.878 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -149.83 157.85 43.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.096 -1.002 . . . . 0.0 109.638 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -149.05 151.76 35.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.608 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -138.3 130.39 28.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.043 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 165' ' ' THR . 14.0 t -102.05 123.43 45.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -99.08 132.73 44.18 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.333 -0.854 . . . . 0.0 108.838 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.5 147.61 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.0 109.195 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 122.13 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.86 16.39 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -117.04 31.41 6.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.27 . . . . 0.0 108.547 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 175' ' ' VAL . 44.6 mt-10 -59.58 -39.02 82.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 110.673 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 2.1 mp0 -52.5 -14.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.057 -1.027 . . . . 0.0 110.944 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.76 -4.05 48.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.818 -1.176 . . . . 0.0 111.153 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.6 pt -121.04 -7.73 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.046 . . . . 0.0 111.033 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER -92.51 -28.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.552 -1.343 . . . . 0.0 110.104 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.46 1.23 56.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.957 -1.089 . . . . 0.0 110.849 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.51 119.42 22.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.738 -1.227 . . . . 0.0 108.888 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -87.28 151.61 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.007 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -53.15 160.42 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.264 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.525 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 33.0 p90 -142.1 169.76 16.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.864 -1.147 . . . . 0.0 109.794 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.6 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -161.04 159.67 29.6 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.184 -0.948 . . . . 0.0 109.898 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.67 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 70.8 m-85 -103.98 146.04 29.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.334 -0.854 . . . . 0.0 109.376 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.685 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.9 OUTLIER -63.79 -18.89 64.54 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.131 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.67 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.2 p90 -79.55 -29.92 41.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.541 -1.35 . . . . 0.0 111.119 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.532 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -98.0 -11.67 22.78 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.754 -1.216 . . . . 0.0 109.764 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.1 mt -58.75 -52.59 58.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.15 -0.969 . . . . 0.0 110.008 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.01 -49.82 59.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 109.565 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -53.74 -52.86 58.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.04 -33.99 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.842 . . . . 0.0 109.074 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -75.98 -25.55 55.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.92 -25.91 53.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.056 -1.028 . . . . 0.0 109.875 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.62 14.98 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.32 26.88 72.61 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.922 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -119.09 157.4 27.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.21 -1.171 . . . . 0.0 109.829 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.27 24.15 64.14 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.382 -0.914 . . . . 0.0 110.956 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -69.0 -20.88 64.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.669 -1.489 . . . . 0.0 109.014 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.44 -7.41 48.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.2 124.62 32.45 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.21 -1.17 . . . . 0.0 110.218 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.83 169.82 16.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.764 -0.845 . . . . 0.0 109.34 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.91 -5.68 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.634 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 2.0 ttpt -89.91 -4.73 57.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -153.09 18.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.6 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.7 m -149.59 128.65 12.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.7 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.588 HD21 HD23 ' A' ' 217' ' ' LEU . 68.3 tp -91.21 113.29 25.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.4 t -100.79 127.5 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 109.474 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.444 HD21 HD21 ' A' ' 217' ' ' LEU . 61.3 mt -104.02 146.88 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 110.192 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.51 161.23 14.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -51.08 -28.11 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.125 -1.22 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -155.07 14.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.833 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -141.22 149.28 41.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.039 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.18 128.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.2 -54.4 9.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -53.3 137.27 49.79 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.24 -36.35 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.435 2.09 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -70.11 -4.29 20.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.797 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.84 -161.56 53.94 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.588 HD23 HD21 ' A' ' 204' ' ' LEU . 16.1 mt -83.37 145.01 29.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -1.005 . . . . 0.0 109.889 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.594 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 14.1 ttt85 -80.72 -17.9 49.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 109.454 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 29.7 m-85 -148.79 164.86 33.16 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -72.79 -14.32 61.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.099 -1.0 . . . . 0.0 108.392 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 33.81 2.96 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.714 0.769 . . . . 0.0 108.96 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -55.87 -39.09 74.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.896 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.02 -41.57 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.091 1.861 . . . . 0.0 112.851 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.429 ' H ' HG22 ' A' ' 224' ' ' VAL . 10.7 m -78.32 -25.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.716 -1.24 . . . . 0.0 108.231 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.563 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 48.5 mtt180 -66.75 -41.22 88.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -65.1 -42.74 93.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.541 -0.724 . . . . 0.0 109.156 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.402 ' HG2' ' CE1' ' A' ' 151' ' ' TYR . 5.3 tptp -56.68 -48.32 77.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.252 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 70.5 t -58.62 -43.91 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.3 t80 -57.83 -36.98 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.51 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -73.3 -43.12 61.53 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.648 -0.657 . . . . 0.0 109.968 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.46 HD23 ' CG1' ' A' ' 149' ' ' VAL . 26.2 tp -56.19 -34.3 66.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.662 HG22 ' HD1' ' A' ' 80' ' ' HIS . 34.4 mt -72.76 -48.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.15 -34.65 17.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.65 -27.16 31.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.144 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 260' ' ' VAL . 4.9 mt -79.9 -23.76 41.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.739 -1.225 . . . . 0.0 110.133 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -72.45 -5.88 39.76 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.031 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 237' ' ' LEU . 33.6 mt -53.32 -27.88 25.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 108.745 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.3 -9.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.168 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.51 11.73 85.2 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.0 p -156.58 149.12 17.95 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.095 -1.238 . . . . 0.0 109.56 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 12.3 Cg_exo -48.38 138.48 23.68 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.211 1.941 . . . . 0.0 111.785 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.91 136.26 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.528 ' HB3' HG13 ' A' ' 125' ' ' VAL . 2.3 tppt? -124.55 127.78 47.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.433 -0.792 . . . . 0.0 109.62 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.53 177.2 30.41 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.43 112.7 25.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -1.167 . . . . 0.0 109.861 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.6 m-85 -112.59 148.86 33.67 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.031 0.92 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 25.1 t80 -128.24 144.29 51.11 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.6 t -142.46 128.99 20.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.683 -1.261 . . . . 0.0 110.778 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 250' ' ' ARG . 56.8 t80 -111.96 112.94 24.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.563 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.0 OUTLIER 47.36 56.1 7.39 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.39 149.4 23.68 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -121.69 165.33 14.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 91.3 m-70 -59.47 -44.53 92.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.3 m -59.58 -40.94 89.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.641 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.1 tp -72.26 -35.93 68.9 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.049 -1.032 . . . . 0.0 108.711 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -61.88 -46.8 87.83 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.73 -44.73 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.291 -0.88 . . . . 0.0 108.726 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -55.23 -48.28 74.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 108.927 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 139' ' ' ILE . 26.2 tp -52.97 -43.07 66.1 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 235' ' ' LEU . 63.4 t -69.83 -44.92 78.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.373 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -52.37 60.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.605 -0.684 . . . . 0.0 110.025 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -62.2 -46.39 89.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.01 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.2 -44.87 92.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.147 -0.971 . . . . 0.0 109.508 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.89 -30.21 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.0 mttt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 120.813 -1.179 . . . . 0.0 108.778 179.169 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 42.1 mt-10 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.6 141.01 52.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.432 -0.793 . . . . 0.0 109.882 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -137.79 172.74 12.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.21 137.86 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.771 -1.206 . . . . 0.0 110.538 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -69.59 -47.97 61.76 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.658 -0.651 . . . . 0.0 109.785 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.93 158.37 38.03 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.626 0.727 . . . . 0.0 110.32 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -60.71 137.25 58.21 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.555 0.693 . . . . 0.0 110.315 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.07 154.63 31.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -146.71 145.1 29.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.879 -1.138 . . . . 0.0 110.126 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.51 160.45 37.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.68 135.91 22.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.911 -1.118 . . . . 0.0 109.004 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.3 158.6 18.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.448 HG23 ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -86.17 143.06 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -1.231 . . . . 0.0 110.662 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.69 145.13 43.17 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -65.24 -41.91 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.053 -1.263 . . . . 0.0 112.073 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.543 ' CE1' HG23 ' A' ' 18' ' ' ILE . 3.9 m-70 -87.3 -38.85 15.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.047 -1.658 . . . . 0.0 111.073 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 p -74.21 -32.34 63.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 109.942 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.88 19.57 63.41 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 16' ' ' VAL . 2.8 mm-40 -109.87 150.24 28.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.958 . . . . 0.0 108.804 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -70.98 135.65 47.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 109.823 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.63 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 13.0 t -143.45 157.88 44.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.211 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.0 tttt -132.62 157.07 45.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.2 mt -134.15 145.29 49.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 109.214 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.447 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -130.45 134.46 62.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.56 118.1 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 42.9 m-70 -115.23 150.11 43.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.74 158.13 48.17 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.194 1.929 . . . . 0.0 111.511 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 14.0 mm-40 -133.43 -178.04 4.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.3 tptt -83.47 149.76 26.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.25 149.64 0.98 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.0 109.748 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.609 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.08 23.47 57.29 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.141 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 6.7 m -80.29 -41.83 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.735 -1.45 . . . . 0.0 109.278 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.64 -166.64 21.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.3 mm -107.6 121.54 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.348 -1.09 . . . . 0.0 108.219 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.08 143.62 46.74 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.663 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.09 153.24 20.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.29 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.545 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -128.77 145.46 51.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -172.96 135.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 109.603 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.64 29.78 14.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.889 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.58 27.93 70.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.7 t -131.62 134.58 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -94.19 140.39 29.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.221 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.9 mt -134.08 94.53 18.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.059 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 145.37 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.294 1.996 . . . . 0.0 111.599 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.67 84.23 4.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.914 -1.116 . . . . 0.0 110.53 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -136.92 152.59 50.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.977 . . . . 0.0 109.582 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 52' ' ' PHE . 10.2 p80 -51.1 -46.81 61.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -48.39 -17.16 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.059 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' HIS . 51.7 m-85 -95.66 3.53 53.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.814 -1.179 . . . . 0.0 109.641 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . 25.6 t -62.42 119.27 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 108.79 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.28 -26.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 110.573 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.59 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -147.97 117.18 6.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.898 -1.126 . . . . 0.0 110.031 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.1 p -113.86 125.36 53.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.612 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 t-20 -167.58 -152.41 0.12 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.593 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 9.8 t-80 -44.13 -15.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -140.27 165.37 27.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.449 -0.782 . . . . 0.0 109.119 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.1 m -110.23 126.57 54.29 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.18 -0.95 . . . . 0.0 109.102 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.5 OUTLIER -128.12 147.15 50.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.184 0.992 . . . . 0.0 111.777 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' A' ' 72' ' ' VAL . 34.8 mt -122.51 157.48 31.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.2 143.52 7.03 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -143.04 147.79 35.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.926 . . . . 0.0 109.44 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp 53.73 45.07 28.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.271 -0.893 . . . . 0.0 110.711 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.2 6.5 65.03 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.65 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 42.8 mm-40 -101.26 140.91 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.973 -1.31 . . . . 0.0 108.39 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -142.84 149.66 38.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.888 -1.132 . . . . 0.0 111.52 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mt -133.7 143.2 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -114.11 152.02 31.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.235 -0.916 . . . . 0.0 111.208 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 53.57 70.04 0.64 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.778 -0.577 . . . . 0.0 111.152 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -113.84 -8.16 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.958 -1.089 . . . . 0.0 109.653 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.3 pt-20 -69.32 -20.43 63.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 110.518 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.33 -60.76 2.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.043 -1.036 . . . . 0.0 109.732 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.507 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -59.5 -43.77 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.072 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' N ' HG23 ' A' ' 75' ' ' ILE . 50.1 mt -55.42 -39.4 70.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.535 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 1.7 t -59.71 -47.57 85.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.202 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.05 -54.45 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 108.718 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.56 -44.06 62.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.472 -0.767 . . . . 0.0 109.277 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.506 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 15.8 t-160 -55.38 -58.17 8.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.792 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.6 mt -58.63 -37.71 76.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.972 . . . . 0.0 110.001 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 114' ' ' ILE . 10.5 mt -78.12 -7.18 56.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 110.334 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 61.17 53.2 3.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.87 -1.144 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mm -98.03 130.77 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.459 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -117.0 -19.34 9.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.315 -0.866 . . . . 0.0 112.263 -177.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.692 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -126.83 111.13 13.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.72 -1.237 . . . . 0.0 110.464 -179.427 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -165.66 137.93 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 109.889 179.051 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.518 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.5 m -111.01 99.67 8.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mp -89.86 110.36 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -85.99 123.05 30.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.24 115.66 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.999 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.78 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -99.32 108.76 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.54 -163.16 24.69 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.24 -16.05 11.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.491 -1.005 . . . . 0.0 110.143 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 19' ' ' HIS . 15.7 tt0 -138.47 145.33 40.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 110.219 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 96' ' ' ILE . 28.5 mm -67.91 127.13 93.33 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.55 -0.719 . . . . 0.0 109.426 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.701 ' CD ' HD21 ' A' ' 26' ' ' LEU . 62.5 Cg_exo -45.94 128.9 11.82 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.851 1.701 . . . . 0.0 111.953 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.413 HD11 ' HA2' ' A' ' 101' ' ' GLY . 8.5 tp -77.45 -28.21 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.299 -0.876 . . . . 0.0 109.672 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.4 mt 55.21 -109.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 110.145 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.54 -19.17 20.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.728 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 112.61 -12.35 25.44 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 p -116.46 -169.3 1.59 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -1.047 . . . . 0.0 109.707 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -110.59 -4.72 28.27 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' A' ' 108' ' ' GLU . 52.7 t-105 -46.98 -39.52 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.738 -0.86 . . . . 0.0 110.421 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -61.25 -51.47 68.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.0 110.07 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -65.48 -43.58 89.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.053 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.8 t80 -63.25 -37.34 86.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 109.565 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HG3' ' CD1' ' A' ' 104' ' ' TRP . 5.3 mm-40 -65.58 -54.85 22.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 0.0 111.898 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.5 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.732 -1.23 . . . . 0.0 111.135 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.13 -45.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -57.41 -29.69 64.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -80.19 -12.97 59.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.148 -0.97 . . . . 0.0 109.887 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -120.76 34.62 5.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.831 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.613 ' CD1' HD22 ' A' ' 82' ' ' LEU . 7.2 mt -87.47 147.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 110.586 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -88.69 144.05 26.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.533 ' NE2' ' OE2' ' A' ' 33' ' ' GLU . 9.7 mt-30 -107.27 -160.57 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.796 . . . . 0.0 109.207 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -120.44 3.37 10.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.274 -0.891 . . . . 0.0 110.735 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -95.94 151.16 19.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.854 -1.154 . . . . 0.0 109.966 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.5 141.06 29.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -0.941 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 85' ' ' THR . 64.0 mt -83.31 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.531 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -90.79 93.14 9.1 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.94 146.92 53.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.797 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -104.62 128.7 52.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.39 142.84 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.96 134.07 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -114.72 -10.74 12.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.35 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -143.1 144.06 27.3 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.15 148.76 39.91 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.223 1.949 . . . . 0.0 113.031 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.911 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.9 tt -139.05 151.59 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.578 -0.701 . . . . 0.0 109.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.03 119.76 37.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.321 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.82 117.28 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.03 142.49 35.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.86 . . . . 0.0 108.96 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.85 120.3 3.41 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.605 -1.31 . . . . 0.0 112.298 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 44.97 42.91 6.75 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.0 112.345 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.64 1.94 85.06 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.387 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -102.76 163.88 11.96 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 139' ' ' ILE . 2.6 tt -160.14 146.49 15.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.357 -1.464 . . . . 0.0 109.276 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.887 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.8 mt -145.91 129.7 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.34 139.39 51.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.911 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -117.34 151.57 36.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 108.925 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -150.34 139.52 13.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.0 145.82 97.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.692 1.595 . . . . 0.0 112.14 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.52 153.28 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.1 4.05 32.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.928 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -141.22 151.35 43.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.73 119.04 23.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.858 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -138.69 135.02 34.37 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.679 ' CG1' HD23 ' A' ' 231' ' ' LEU . 5.4 t -133.26 117.67 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 109.826 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.4 OUTLIER -103.83 133.87 48.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.198 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 224' ' ' VAL . 8.8 t80 -122.42 130.25 52.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.623 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -115.67 106.97 14.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.8 134.66 11.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -108.07 85.01 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -1.075 . . . . 0.0 109.232 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -92.12 144.14 25.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -95.96 -1.22 49.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 109.187 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.632 HD21 HD12 ' A' ' 159' ' ' LEU . 29.3 p-10 -71.32 -167.77 0.26 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.237 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -60.96 -23.25 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.632 HD12 HD21 ' A' ' 157' ' ' ASN . 55.5 mt -71.13 -22.78 62.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.166 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.1 -134.17 52.37 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -98.18 144.36 27.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.462 -1.022 . . . . 0.0 109.005 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -152.46 170.5 19.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.35 153.59 23.75 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.832 . . . . 0.0 109.381 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -138.21 130.31 28.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 165' ' ' THR . 14.5 t -102.42 123.13 45.63 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 110.052 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -99.13 134.58 41.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.405 -0.809 . . . . 0.0 108.871 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.89 149.59 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -51.04 116.86 2.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.211 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.18 5.51 17.1 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -134.66 29.97 3.49 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.193 -1.18 . . . . 0.0 108.974 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 175' ' ' VAL . 8.8 mt-10 -64.39 -35.17 80.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.568 -0.708 . . . . 0.0 110.854 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.2 -16.98 37.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.979 -1.076 . . . . 0.0 110.766 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 81.2 mt-10 -85.48 -3.71 58.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 110.337 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -124.03 -33.86 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.0 111.411 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -60.97 -29.98 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.479 -1.388 . . . . 0.0 110.424 -179.043 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -87.48 2.66 49.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.72 -1.238 . . . . 0.0 110.517 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.56 115.19 20.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.873 -1.142 . . . . 0.0 108.957 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.429 ' H ' ' HG2' ' A' ' 178' ' ' ARG . 26.6 ptt180 -86.48 153.03 22.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.863 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.0 t -59.93 131.35 50.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 109.848 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -109.89 172.62 6.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 109.855 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.78 159.04 40.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.429 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 58.6 m-85 -104.25 144.35 31.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.754 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.5 OUTLIER -60.35 -24.36 65.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 110.535 -179.568 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.597 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.5 p90 -82.07 -32.0 30.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.73 -1.231 . . . . 0.0 110.449 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.597 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 18.3 pt-20 -86.55 -16.65 36.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.815 -1.178 . . . . 0.0 109.566 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.7 mt -57.57 -53.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.23 -50.74 58.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.775 -1.203 . . . . 0.0 109.738 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -52.73 -48.11 66.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.008 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.9 mt -60.29 -34.31 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.1 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -77.8 -29.37 50.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -21.97 53.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.047 -1.033 . . . . 0.0 110.201 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 194' ' ' LEU . 30.1 m -89.15 11.14 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.958 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.04 25.39 69.15 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.773 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.413 HD12 ' CG2' ' A' ' 192' ' ' VAL . 28.2 mt -124.52 162.98 22.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.119 -1.224 . . . . 0.0 109.87 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.466 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.32 22.93 66.67 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.189 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -69.43 -21.04 63.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.652 -1.499 . . . . 0.0 109.779 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.0 -2.91 51.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.33 129.3 40.08 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.199 -1.177 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.01 176.81 8.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.783 -0.834 . . . . 0.0 109.257 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.34 -11.97 57.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.937 . . . . 0.0 109.72 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -92.96 -4.73 52.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -134.06 -13.82 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 109.736 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.9 m -128.35 126.29 40.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.541 HD12 ' CG ' ' A' ' 213' ' ' ASN . 7.1 tp -84.4 110.33 18.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 108.866 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.59 132.15 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.587 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.14 152.72 32.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.82 161.56 15.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -50.65 -24.67 3.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.97 12.61 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.4 ttpt -144.43 152.5 40.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.115 -0.991 . . . . 0.0 110.228 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.98 127.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -73.46 -54.1 9.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 110.275 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.541 ' CG ' HD12 ' A' ' 204' ' ' LEU . 3.7 m120 -56.0 133.51 74.01 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.981 -1.074 . . . . 0.0 109.723 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.58 -13.06 27.3 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.37 -7.82 57.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.99 . . . . 0.0 109.89 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -167.24 51.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.7 144.3 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 110.097 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.595 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -79.86 -20.82 45.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 108.793 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 37.1 m-85 -148.53 154.91 40.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.407 ' HB3' ' ND2' ' A' ' 221' ' ' ASN . 2.6 tt0 -58.59 -12.97 4.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 108.754 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.532 ' OD1' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -143.73 36.69 1.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.261 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.599 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -59.84 -35.43 28.84 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.0 Cg_exo -70.89 -46.2 0.82 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.87 1.713 . . . . 0.0 112.562 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 151' ' ' TYR . 1.8 m -73.87 -22.63 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.804 -1.185 . . . . 0.0 108.195 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.532 ' NH1' ' OD1' ' A' ' 221' ' ' ASN . 5.5 mtt180 -69.88 -40.65 75.55 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.5 -42.9 95.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 108.911 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -45.62 80.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.452 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 81.3 t -61.42 -45.12 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.535 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.4 t80 -53.77 -36.68 62.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -75.02 -40.05 60.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.632 -0.667 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.679 HD23 ' CG1' ' A' ' 149' ' ' VAL . 27.0 tp -56.32 -37.73 70.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.208 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.506 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 85.3 mt -71.6 -48.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.6 -31.86 23.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -82.98 -26.63 31.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.941 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 260' ' ' VAL . 4.3 mt -79.39 -23.58 43.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.883 -1.136 . . . . 0.0 110.2 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.466 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 7.0 t80 -70.43 -6.43 35.65 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.033 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 237' ' ' LEU . 24.3 mt -53.34 -28.76 30.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.18 -18.06 23.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.0 108.73 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.96 70.64 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.5 p -156.29 150.76 20.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.118 -1.225 . . . . 0.0 109.357 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 5.4 Cg_endo -52.84 136.48 59.59 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.092 1.862 . . . . 0.0 111.572 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.4 t -102.24 138.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.221 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -125.61 128.42 47.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.768 . . . . 0.0 109.078 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.4 175.99 28.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -106.55 109.68 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.172 . . . . 0.0 109.732 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.0 m-85 -111.41 149.3 31.42 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.771 0.796 . . . . 0.0 110.835 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -126.26 144.43 50.79 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 150' ' ' THR . 0.7 OUTLIER -136.58 125.55 24.3 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 120.751 -1.218 . . . . 0.0 110.232 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 250' ' ' ARG . 26.8 t80 -112.74 111.86 22.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 249' ' ' PHE . 26.5 mtp180 47.54 56.54 6.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.22 149.29 21.93 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.49 -174.6 15.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.43 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 71.1 m-70 -74.45 -42.41 59.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -1.144 . . . . 0.0 109.687 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -34.92 79.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.723 ' HG ' HD12 ' A' ' 139' ' ' ILE . 49.8 tp -72.76 -39.22 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.927 -1.108 . . . . 0.0 109.059 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -60.58 -50.6 72.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.298 -0.876 . . . . 0.0 108.897 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.23 -45.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -55.29 -48.87 73.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.134 -0.979 . . . . 0.0 109.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.555 HD22 HG21 ' A' ' 139' ' ' ILE . 27.0 tp -52.61 -43.76 65.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.435 HG22 HD23 ' A' ' 235' ' ' LEU . 24.3 t -69.96 -40.71 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -59.53 -50.13 75.08 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 110.132 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.0 -43.91 73.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.175 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 263' ' ' LEU . 30.0 mt -57.35 -48.8 78.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -55.82 -44.27 77.73 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.608 -0.683 . . . . 0.0 109.664 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.5 mttm . . . . . 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 0.0 109.457 -179.865 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 31.0 mt-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 133.9 55.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 110.102 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -138.33 175.42 9.59 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.42 141.18 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.203 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -72.55 -44.24 62.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.51 -0.744 . . . . 0.0 110.055 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.95 160.16 35.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.738 . . . . 0.0 110.225 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 130.31 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.585 -0.697 . . . . 0.0 109.984 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD21 ' ND2' ' A' ' 113' ' ' ASN . 13.0 mt -114.95 169.81 8.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -0.783 . . . . 0.0 108.998 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -157.98 148.15 20.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.956 -1.09 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -129.69 168.0 17.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -154.93 135.05 13.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 109.182 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.79 158.23 15.41 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.544 HG23 ' C ' ' A' ' 22' ' ' GLU . 8.9 p -80.95 141.52 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -1.094 . . . . 0.0 110.749 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.68 148.4 41.73 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -70.02 -40.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.0 113.043 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.0 m-70 -86.04 -38.58 17.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 119.79 -1.819 . . . . 0.0 111.858 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -85.84 -27.21 25.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.713 -1.242 . . . . 0.0 109.157 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 63.79 25.49 69.16 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.544 ' C ' HG23 ' A' ' 16' ' ' VAL . 3.0 tp10 -106.26 148.96 27.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.506 -0.996 . . . . 0.0 109.182 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -70.78 129.89 40.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.741 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.5 t -138.9 156.98 46.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.915 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.505 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.5 tttt -133.22 153.48 51.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 109.206 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.515 HD21 ' CD ' ' A' ' 97' ' ' PRO . 3.2 mt -127.84 147.66 50.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.428 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.472 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.9 mt -137.91 122.41 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -112.13 127.4 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.554 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 2.4 m-70 -119.98 148.8 47.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.94 161.64 15.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.015 1.81 . . . . 0.0 111.096 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 5.7 mm-40 -135.02 -172.27 3.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.69 155.41 18.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.738 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 33' ' ' GLU . 40.3 mp0 -46.78 142.68 3.2 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.598 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.69 29.89 64.91 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.372 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 25.9 m -80.66 -37.56 30.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.631 -1.511 . . . . 0.0 108.67 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.03 -177.54 35.37 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.6 mm -100.85 124.67 54.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.02 140.09 36.13 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.311 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.11 150.01 20.71 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.487 ' CD1' ' OE1' ' A' ' 90' ' ' GLU . 16.7 t80 -134.36 139.91 45.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.36 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 16.7 ttpt -174.02 147.33 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.642 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 56.6 29.45 15.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.8 73.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -135.97 143.01 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 0.0 109.352 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -101.45 146.03 28.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.51 94.55 10.56 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.017 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -48.93 145.0 14.24 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.337 2.025 . . . . 0.0 111.854 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.97 81.28 5.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.92 -1.112 . . . . 0.0 110.463 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.68 155.46 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.026 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.2 p80 -52.22 -49.38 64.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.917 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 11.3 mt-10 -44.0 -16.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.197 -0.939 . . . . 0.0 110.164 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.8 m-85 -97.45 2.9 50.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 50' ' ' HIS . 52.1 t -62.83 119.37 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.059 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.56 -29.36 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.855 . . . . 0.0 109.986 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 3.0 t-160 -150.82 120.82 7.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.962 . . . . 0.0 109.652 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.2 p -111.94 133.04 54.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 16.1 p-10 -166.61 -153.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' ASN . 5.2 m170 -47.47 -11.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.118 -0.989 . . . . 0.0 108.694 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -139.22 166.49 24.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.5 m -101.38 120.69 40.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.52 134.97 54.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.189 -0.945 . . . . 0.0 111.238 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD12 HG21 ' A' ' 72' ' ' VAL . 29.6 mt -123.69 156.5 35.8 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.73 145.44 7.96 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.028 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -144.67 151.5 39.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.539 -0.977 . . . . 0.0 109.891 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 55.47 24.02 6.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -0.834 . . . . 0.0 110.894 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.71 1.23 68.36 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.557 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.494 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 99.6 mm-40 -96.59 137.46 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.889 -1.36 . . . . 0.0 108.299 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -130.76 144.62 51.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.23 -0.919 . . . . 0.0 111.358 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.2 mt -130.81 140.22 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -114.13 145.64 41.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 56.06 68.82 0.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.785 -0.572 . . . . 0.0 111.46 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 HD12 ' A' ' 62' ' ' LEU . 34.5 m -113.92 -3.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.097 -1.002 . . . . 0.0 108.99 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.491 ' OE1' ' OD1' ' A' ' 234' ' ' ASP . 10.8 pt-20 -69.45 -33.05 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.456 ' CE1' ' CE1' ' A' ' 226' ' ' HIS . 17.6 m170 -61.9 -59.9 4.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 110.099 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.9 tp -55.47 -41.73 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.669 -1.269 . . . . 0.0 108.515 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 79' ' ' LEU . 70.3 mt -60.68 -35.05 75.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.478 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 47.1 t -61.04 -49.25 78.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.413 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 23.2 t -58.52 -52.81 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.03 -1.044 . . . . 0.0 108.594 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 76' ' ' LEU . 22.6 mt -50.77 -43.11 58.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 108.999 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.546 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.0 t-160 -54.28 -56.19 20.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.578 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.35 -36.7 76.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.963 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' A' ' 84' ' ' ILE . 35.2 mt -79.31 -9.38 59.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.14 61.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.431 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 82' ' ' LEU . 12.2 mm -102.38 132.29 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 48.4 p -118.82 -22.54 7.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.264 -0.897 . . . . 0.0 111.889 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.72 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.4 m-80 -129.39 111.69 13.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.279 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.5 m -164.86 135.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.868 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.48 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 44.1 m -103.28 99.66 9.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 mt -86.82 120.94 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.89 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.487 ' OE1' ' CD1' ' A' ' 40' ' ' PHE . 7.8 mt-10 -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.813 -1.179 . . . . 0.0 108.1 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' ' CD ' ' A' ' 41' ' ' LYS . 60.0 t -105.63 107.22 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.101 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.63 109.14 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.58 -160.25 23.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.24 -15.9 7.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -1.008 . . . . 0.0 110.415 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.5 pm0 -131.94 137.6 48.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.22 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mm -68.75 129.6 92.34 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 109.768 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.515 ' CD ' HD21 ' A' ' 26' ' ' LEU . 50.3 Cg_exo -46.83 129.07 14.13 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.407 2.072 . . . . 0.0 112.782 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 16' ' ' VAL . 7.6 tp -76.93 -25.93 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.448 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 70.6 mt 55.33 -116.07 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.45 -0.781 . . . . 0.0 109.988 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.03 -18.09 22.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.115 -0.991 . . . . 0.0 110.13 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 -16.74 19.1 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -108.33 -169.72 1.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -1.098 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.97 -3.94 21.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.469 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 64.9 t-105 -46.68 -39.18 10.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.785 -0.832 . . . . 0.0 110.418 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.06 -51.75 66.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 109.728 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 62.5 m-85 -62.61 -45.92 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.828 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.01 -37.41 84.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.693 -0.629 . . . . 0.0 110.097 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.1 mm-40 -69.91 -48.81 57.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.313 -0.867 . . . . 0.0 111.773 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.29 -51.27 13.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.793 -1.192 . . . . 0.0 111.273 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.5 mt -62.81 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.984 -1.073 . . . . 0.0 110.875 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.18 -29.89 61.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 0.0 110.194 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.66 -13.59 56.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.064 -1.023 . . . . 0.0 110.08 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.413 ' ND2' HD21 ' A' ' 11' ' ' LEU . 3.2 m-20 -118.0 32.2 6.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.44 -0.787 . . . . 0.0 111.206 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 82' ' ' LEU . 7.6 mt -86.57 148.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.534 -1.354 . . . . 0.0 110.029 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.1 tp -131.26 158.17 41.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -103.09 142.01 34.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.62 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -109.08 -167.09 1.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 110.104 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -118.75 69.05 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.407 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 4' ' ' GLU . 23.4 ttt85 -165.78 143.91 5.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -83.84 128.8 34.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.583 HG12 HG21 ' A' ' 85' ' ' THR . 79.0 mt -71.09 140.69 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.0 86.7 7.15 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -61.83 146.06 50.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 110.769 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.77 121.83 42.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.72 138.63 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.8 t -81.81 139.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.25 -10.57 8.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.441 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -141.12 125.61 10.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.141 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -51.12 154.33 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.007 1.804 . . . . 0.0 113.124 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.602 HG22 ' HB3' ' A' ' 141' ' ' ALA . 2.4 tt -145.49 146.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.649 -0.657 . . . . 0.0 109.638 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.55 119.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.66 120.49 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.257 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -123.0 142.07 51.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 110.517 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 1.5 t70 178.03 153.32 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 58.6 mm-40 56.37 23.55 7.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.868 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.05 7.76 86.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.546 ' HB2' HD22 ' A' ' 255' ' ' LEU . 69.7 mtt180 -105.16 168.6 8.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.0 tt -160.78 152.42 19.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.117 -1.614 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.985 ' N ' HD23 ' A' ' 138' ' ' LEU . 17.9 mt -148.78 142.53 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.036 . . . . 0.0 108.74 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -130.0 137.52 50.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 0.0 109.598 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -116.98 151.67 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -150.05 137.22 11.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.53 144.97 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.189 1.259 . . . . 0.0 111.964 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.29 149.84 10.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.336 -0.852 . . . . 0.0 109.369 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.46 -0.33 52.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.268 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.4 p -133.29 142.77 48.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 242' ' ' VAL . 16.4 tp -78.5 119.64 22.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.764 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -139.43 139.58 37.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.862 . . . . 0.0 108.77 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.522 ' CG1' HD23 ' A' ' 231' ' ' LEU . 13.9 t -137.86 122.68 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.169 -0.957 . . . . 0.0 109.543 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 99.8 m -111.37 141.11 45.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.951 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.499 ' HE2' HG12 ' A' ' 224' ' ' VAL . 10.5 t80 -125.56 130.27 51.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.611 -0.68 . . . . 0.0 109.896 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 16.6 tt0 -113.17 107.39 15.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.44 ' C ' ' OE2' ' A' ' 154' ' ' GLU . . . -107.14 131.37 10.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.577 ' H ' HH11 ' A' ' 250' ' ' ARG . 0.9 OUTLIER -117.8 88.25 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -1.004 . . . . 0.0 109.053 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 3.6 m-30 -85.98 148.67 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.112 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -87.25 -10.49 52.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.687 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.48 HD21 HD12 ' A' ' 159' ' ' LEU . 17.8 p-10 -66.18 -167.01 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -64.97 -23.08 67.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.48 HD12 HD21 ' A' ' 157' ' ' ASN . 9.3 mt -56.74 -50.45 72.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.997 -1.065 . . . . 0.0 109.188 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.93 -121.78 6.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 140.2 50.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.534 -0.98 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -153.15 131.66 12.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.839 . . . . 0.0 109.467 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 149.67 39.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.544 -0.722 . . . . 0.0 109.163 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -134.83 121.07 20.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.086 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 165' ' ' THR . 10.1 t -100.9 123.1 44.6 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.14 -0.975 . . . . 0.0 110.199 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.0 t80 -100.88 134.43 43.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 108.852 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.469 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.3 t -130.88 149.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.507 -0.746 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.69 122.68 10.38 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.55 -14.95 17.59 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -117.93 32.3 6.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 108.555 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.76 -34.33 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 110.474 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.9 -15.36 8.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 110.691 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.596 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 13.7 mm-40 -91.07 -4.01 56.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 110.823 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -125.0 10.22 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.945 -1.097 . . . . 0.0 111.199 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -27.99 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.853 -1.154 . . . . 0.0 109.604 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -88.5 3.72 49.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.082 . . . . 0.0 110.638 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.97 123.01 27.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.808 -1.182 . . . . 0.0 109.018 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -95.56 155.42 16.75 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.12 -0.987 . . . . 0.0 110.23 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 t -56.34 155.31 7.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.784 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.526 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 26.4 p90 -139.66 168.29 20.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.047 -1.033 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.526 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -162.7 162.27 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -102.82 147.55 26.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.719 ' HA ' HD12 ' A' ' 186' ' ' ILE . 6.9 p-10 -64.27 -19.53 65.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.933 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.496 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 2.8 p90 -81.79 -26.01 34.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.67 -1.269 . . . . 0.0 110.449 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.415 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 25.9 pt-20 -96.8 -17.29 20.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.926 -1.109 . . . . 0.0 109.36 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.5 mt -56.86 -51.41 68.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.47 -0.769 . . . . 0.0 110.326 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -51.21 -52.26 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.995 -1.066 . . . . 0.0 109.553 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.747 ' O ' HG13 ' A' ' 192' ' ' VAL . 7.6 m80 -52.94 -45.03 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.107 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.37 -33.71 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 109.025 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -78.82 -25.7 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.894 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -80.73 -26.68 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 188' ' ' HIS . 4.6 m -82.06 7.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.721 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 83.76 20.18 60.22 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.139 -0.976 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.63 163.93 20.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.055 -1.262 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.478 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.77 17.83 74.28 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.063 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -66.32 -22.18 66.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.695 -1.473 . . . . 0.0 110.279 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.31 -5.87 51.79 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.38 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.47 124.66 35.35 Favored Glycine 0 N--CA 1.491 2.366 0 O-C-N 121.055 -1.262 . . . . 0.0 110.697 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.0 p -135.44 171.94 13.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.718 -0.872 . . . . 0.0 109.204 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.1 mt -76.48 -13.74 60.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 16.9 tttp -89.05 -8.55 53.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.672 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 37.1 m-20 -141.12 12.83 2.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.5 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 8.2 m -148.99 117.75 6.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 109.564 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.704 HD21 HD23 ' A' ' 217' ' ' LEU . 7.3 tp -79.89 115.38 19.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -0.979 . . . . 0.0 109.185 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.3 t -100.61 125.3 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 217' ' ' LEU . 3.8 mt -103.43 147.05 27.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.28 148.4 16.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 207' ' ' GLY . 51.9 mttm -42.32 -29.66 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -1.191 . . . . 0.0 110.045 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -147.34 11.97 1.03 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.0 110.57 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.5 tttp -147.44 156.69 43.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.023 . . . . 0.0 109.998 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.467 HG11 ' HA2' ' A' ' 216' ' ' GLY . 62.6 t -103.11 128.25 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.5 -54.28 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.46 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.462 ' CG ' HD12 ' A' ' 204' ' ' LEU . 14.7 m120 -55.02 137.16 66.63 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.002 -1.062 . . . . 0.0 109.577 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.16 -19.04 26.57 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.346 2.031 . . . . 0.0 112.545 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 109.927 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.61 -165.74 53.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.704 HD23 HD21 ' A' ' 204' ' ' LEU . 26.5 mt -79.13 145.05 33.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -1.089 . . . . 0.0 109.639 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -71.49 -57.41 4.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 108.877 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.687 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 13.1 m-85 -117.05 148.85 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.462 -0.774 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.09 -13.98 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.933 . . . . 0.0 109.164 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -132.84 38.77 3.37 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.868 0.842 . . . . 0.0 108.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.511 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.6 tp10 -57.34 -48.48 97.27 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 111.265 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 33.3 Cg_endo -69.47 -37.95 9.12 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.525 1.483 . . . . 0.0 113.218 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.499 HG12 ' HE2' ' A' ' 151' ' ' TYR . 1.8 m -79.39 -25.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.609 -1.307 . . . . 0.0 108.506 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 16.4 mtp180 -67.72 -43.75 79.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.542 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 56.2 t60 -62.86 -41.59 99.44 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -43.23 81.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 108.779 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 224' ' ' VAL . 60.7 t -65.8 -47.54 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 42.5 t80 -49.86 -47.54 51.69 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' CD2' ' A' ' 226' ' ' HIS . 2.8 m-20 -70.61 -35.19 72.83 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.522 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.1 tp -55.55 -35.97 66.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 108.41 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.487 HG22 ' HD1' ' A' ' 80' ' ' HIS . 74.4 mt -70.15 -48.16 63.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.03 -34.44 16.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.503 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 6.1 m-20 -80.58 -27.08 37.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.993 -1.298 . . . . 0.0 109.665 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -82.54 -26.31 32.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.111 . . . . 0.0 109.593 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.546 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 21.7 t80 -67.14 -7.69 25.32 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.985 . . . . 0.0 108.635 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 237' ' ' LEU . 39.3 mt -50.24 -30.05 10.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 242' ' ' VAL . 96.5 mt -56.79 -19.88 19.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 108.712 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.83 16.29 73.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 83.1 p -158.79 145.16 12.57 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.991 -1.3 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.438 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 82.4 Cg_exo -41.06 129.49 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.343 2.029 . . . . 0.0 111.924 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 238' ' ' LEU . 81.9 t -97.11 130.51 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -117.91 123.09 44.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 172.58 24.86 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.26 112.19 25.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.177 -1.19 . . . . 0.0 109.95 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.2 m-85 -112.22 147.58 35.9 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.989 0.9 . . . . 0.0 110.931 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 139' ' ' ILE . 28.1 t80 -131.85 134.71 46.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.17 128.9 44.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.86 -1.15 . . . . 0.0 110.218 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 250' ' ' ARG . 6.6 t80 -112.01 115.17 28.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.577 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.2 mmp_? 48.28 56.28 7.64 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.55 152.54 20.88 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -119.49 -169.9 14.37 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.478 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 89.5 m-70 -78.9 -49.59 12.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.256 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -33.93 71.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 137' ' ' ARG . 42.6 tp -72.89 -40.0 65.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 108.612 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 88.2 m-20 -60.0 -51.24 70.52 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.31 -43.89 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.41 -0.806 . . . . 0.0 109.148 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -54.4 -47.68 72.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.041 . . . . 0.0 108.832 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.12 -46.35 72.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.3 -44.92 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 109.413 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -51.69 -51.71 53.88 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 110.161 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.57 -49.5 76.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.102 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.94 -42.55 98.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.489 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.4 84.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.336 -0.853 . . . . 0.0 109.858 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.9 mttm . . . . . 0 N--CA 1.489 1.516 0 O-C-N 120.944 -1.098 . . . . 0.0 108.755 179.298 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 132.82 55.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -133.6 174.41 10.46 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.9 m -83.26 132.3 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.343 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -62.32 -49.21 76.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.541 -0.724 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -126.12 155.58 41.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.548 -0.72 . . . . 0.0 110.42 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -59.53 137.57 57.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.957 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.96 162.16 19.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.56 145.68 25.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.979 -1.075 . . . . 0.0 109.971 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' C ' ' OE1' ' A' ' 14' ' ' GLU . 67.3 m-85 -128.96 161.43 29.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.752 . . . . 0.0 109.158 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 13' ' ' PHE . 4.3 pm0 -151.47 132.47 14.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.871 -1.143 . . . . 0.0 108.73 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.01 157.69 15.44 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.015 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.48 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 3.3 p -74.32 160.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -1.133 . . . . 0.0 111.317 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.05 138.69 14.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.101 -1.235 . . . . 0.0 112.236 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.494 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.2 m-70 -86.57 -37.36 18.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.103 -1.623 . . . . 0.0 110.729 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -76.22 -40.11 52.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.012 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 73.42 4.72 65.46 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.41 152.4 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.37 -1.076 . . . . 0.0 108.985 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 16.0 t80 -73.6 133.49 43.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.01 . . . . 0.0 110.141 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -137.47 157.82 45.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.175 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.711 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.7 ttmt -132.8 155.7 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.305 -0.872 . . . . 0.0 109.136 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 25' ' ' LYS . 1.9 mt -132.17 144.19 50.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.4 mt -134.57 123.35 41.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mt -111.73 127.58 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 109.811 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -119.63 152.67 53.63 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.66 157.8 40.38 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.275 1.983 . . . . 0.0 111.474 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.499 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.2 mm-40 -131.84 -173.15 3.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.233 -0.917 . . . . 0.0 109.832 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 9.5 tttt -91.66 153.77 19.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.587 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.64 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 28.1 mp0 -47.99 146.25 2.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.03 59.97 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.685 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 55.2 m -81.59 -36.96 28.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.516 -1.579 . . . . 0.0 108.875 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.47 -170.24 32.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 mm -100.73 124.2 54.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.26 143.17 44.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -104.26 153.25 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.8 t80 -129.48 140.79 51.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 136.42 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.021 -1.05 . . . . 0.0 109.681 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.57 29.2 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.891 . . . . 0.0 110.097 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.54 78.51 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.218 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.31 134.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -1.117 . . . . 0.0 109.74 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -86.25 147.59 26.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' A' ' 67' ' ' GLN . 10.5 mt -143.1 94.66 6.28 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.82 142.72 14.22 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.191 1.927 . . . . 0.0 111.848 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.54 87.42 4.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.066 -1.021 . . . . 0.0 110.345 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.51 159.24 42.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 109.418 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.441 ' CD2' ' HG3' ' A' ' 51' ' ' GLU . 5.9 p-80 -53.3 -49.68 66.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HG3' ' CD2' ' A' ' 50' ' ' HIS . 81.4 mt-10 -48.28 -16.14 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.048 -1.033 . . . . 0.0 110.224 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' HIS . 32.8 m-85 -97.45 5.77 49.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 109.597 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.407 ' HA ' HD23 ' A' ' 62' ' ' LEU . 15.7 t -64.2 122.71 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.861 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 m -112.61 -29.53 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -146.36 118.17 8.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.867 -1.146 . . . . 0.0 110.354 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -110.88 126.97 55.26 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 40.3 t-20 -166.36 -153.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.478 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 63.6 m-70 -46.69 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.053 . . . . 0.0 108.499 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.4 t -139.18 165.84 26.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.499 -0.751 . . . . 0.0 109.327 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.46 ' OG1' ' CD ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -108.82 125.34 51.86 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.89 146.33 49.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.04 0.924 . . . . 0.0 111.397 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 53' ' ' VAL . 16.6 mt -125.92 156.33 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -175.36 147.57 8.96 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 118.203 -1.951 . . . . 0.0 111.446 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -144.48 149.5 36.07 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.773 -0.84 . . . . 0.0 109.282 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.99 32.54 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.322 -0.861 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.82 6.82 89.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.614 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.534 ' HB2' HD11 ' A' ' 46' ' ' ILE . 86.8 mm-40 -106.63 140.17 39.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -1.227 . . . . 0.0 107.886 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -143.22 159.74 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.031 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.26 139.55 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -108.52 148.09 30.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 0.0 111.243 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m 56.53 70.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.691 -0.63 . . . . 0.0 111.16 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.7 -4.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.022 . . . . 0.0 109.169 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.602 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.0 OUTLIER -68.19 -33.15 73.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 0.0 110.838 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.572 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 35.2 m170 -64.13 -60.25 3.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.845 -1.159 . . . . 0.0 109.988 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 76' ' ' LEU . 11.3 tp -55.92 -45.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.853 -1.155 . . . . 0.0 108.751 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.514 ' N ' HG23 ' A' ' 75' ' ' ILE . 47.1 mt -54.71 -40.92 69.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.551 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.0 t -59.61 -46.92 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -58.52 -50.84 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 76' ' ' LEU . 46.2 mt -51.32 -44.13 61.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.845 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.764 ' HD1' HG22 ' A' ' 232' ' ' ILE . 12.1 t-160 -56.89 -49.93 74.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 110.363 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.78 -38.02 89.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.68 HD13 HD11 ' A' ' 114' ' ' ILE . 52.4 mt -81.58 -5.59 58.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.0 111.025 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 62.74 59.09 1.47 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.299 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 82' ' ' LEU . 10.6 mm -98.24 125.18 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.459 HG21 HG23 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -110.97 -23.09 11.17 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.299 -0.876 . . . . 0.0 111.394 -178.042 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.559 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.3 m-20 -131.19 112.17 12.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -162.01 138.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.326 -0.859 . . . . 0.0 109.404 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 26.5 m -111.17 99.42 8.27 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.75 112.74 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.396 -0.815 . . . . 0.0 109.536 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -90.29 119.83 30.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.2 t -102.84 106.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 110.936 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mp -86.75 109.79 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.78 -158.65 22.32 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.13 -14.27 7.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.966 . . . . 0.0 110.137 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -134.86 140.18 45.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 110.452 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.35 126.95 93.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.695 ' CD ' HD21 ' A' ' 26' ' ' LEU . 69.4 Cg_exo -46.36 128.52 12.39 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.865 1.71 . . . . 0.0 112.003 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 tp -76.24 -22.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.807 . . . . 0.0 109.724 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.406 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 73.5 mt 54.84 -118.36 1.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -94.3 -11.03 30.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 110.225 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.04 32.53 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.4 p -115.51 -169.47 1.58 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -1.039 . . . . 0.0 109.785 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.56 0.62 24.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.575 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 67.5 t-105 -46.52 -44.25 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.737 -0.861 . . . . 0.0 110.584 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -60.21 -51.36 69.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.785 -1.197 . . . . 0.0 109.719 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -61.18 -45.64 93.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 109.154 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -60.56 -39.92 89.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.962 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.575 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -74.24 -42.93 58.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 111.43 -179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.9 35.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.871 -1.143 . . . . 0.0 110.883 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 110' ' ' ILE . 53.9 mt -70.96 -39.57 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.991 -1.068 . . . . 0.0 110.853 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -56.11 -31.42 63.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.801 -1.187 . . . . 0.0 109.745 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -83.97 -5.29 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 0.0 110.221 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -126.62 31.37 5.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.423 -0.798 . . . . 0.0 111.309 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 82' ' ' LEU . 4.7 mt -89.2 145.53 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.474 -1.391 . . . . 0.0 109.601 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.6 tp -131.97 158.64 40.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -106.96 145.5 32.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.113 -0.992 . . . . 0.0 109.525 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -112.39 -163.82 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 109.989 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -118.1 69.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 110.438 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.489 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -161.58 140.69 9.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -81.56 126.4 31.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.07 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.459 HG23 HG21 ' A' ' 85' ' ' THR . 66.7 mt -73.48 143.0 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 110.55 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -92.9 97.26 10.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.7 146.53 52.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.63 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -99.76 123.53 44.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 243' ' ' LYS . 12.0 t -125.5 140.88 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.302 -0.874 . . . . 0.0 110.303 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 51.0 t -83.93 137.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.134 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -116.05 -11.55 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.524 -0.735 . . . . 0.0 109.252 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.05 144.92 39.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.12 172.75 14.12 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.266 1.977 . . . . 0.0 112.814 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.66 HG23 ' HB3' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -165.24 142.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.619 -0.676 . . . . 0.0 109.53 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.1 mt -127.99 126.86 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 109.555 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 132' ' ' VAL . 14.7 m -125.29 119.03 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.772 . . . . 0.0 109.679 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -117.42 138.23 51.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.364 -0.835 . . . . 0.0 109.7 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -172.1 142.69 1.44 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.001 -1.062 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 56.1 28.25 12.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.612 -0.68 . . . . 0.0 111.187 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.53 86.95 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 251' ' ' GLY . 6.7 mtt85 -104.68 168.05 9.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.98 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -160.66 149.55 16.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.066 -1.646 . . . . 0.0 109.459 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.98 ' N ' HD23 ' A' ' 138' ' ' LEU . 56.0 mt -149.39 136.11 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.02 -1.05 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -126.28 142.74 51.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.66 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -123.68 145.63 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -142.78 136.62 14.47 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.94 146.95 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.552 1.501 . . . . 0.0 112.142 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.72 152.76 8.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.171 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.4 1.75 47.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 109.642 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.4 p -137.44 145.21 42.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.584 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 242' ' ' VAL . 58.2 tp -79.09 116.81 19.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.938 . . . . 0.0 109.678 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -137.62 135.95 37.06 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.476 HG11 HD23 ' A' ' 231' ' ' LEU . 95.8 t -136.85 127.02 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 109.758 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 m -114.13 128.45 56.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.365 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.514 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.6 t80 -115.3 129.42 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.52 -0.738 . . . . 0.0 109.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -115.27 105.62 13.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.86 132.88 11.39 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -115.37 84.12 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.992 . . . . 0.0 108.977 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.9 m-30 -93.14 148.78 21.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.422 ' HZ2' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -85.18 -13.28 50.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.239 -179.505 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.534 HD22 ' HB2' ' A' ' 159' ' ' LEU . 2.0 p30 -66.18 -175.23 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.054 -1.029 . . . . 0.0 109.633 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -55.02 -18.37 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.534 ' HB2' HD22 ' A' ' 157' ' ' ASN . 20.4 mt -66.79 -32.31 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.954 -1.091 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.5 -118.08 12.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -115.11 138.95 50.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.987 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -150.14 153.48 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 150.88 41.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -134.84 124.17 24.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 m -96.96 121.9 39.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.98 -1.075 . . . . 0.0 110.015 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -98.81 135.07 40.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.141 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.55 150.7 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 0.0 109.475 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -53.02 117.05 2.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.394 -0.817 . . . . 0.0 109.248 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.51 5.62 18.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -132.19 27.73 4.47 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.212 -1.17 . . . . 0.0 108.57 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.84 -31.44 72.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.533 -0.73 . . . . 0.0 110.572 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.3 -15.82 39.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.993 -1.067 . . . . 0.0 110.907 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -91.52 -4.28 55.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.694 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.64 16.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.088 -1.007 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.48 -34.29 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.021 -1.049 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.7 2.44 45.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.379 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.99 112.96 18.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.788 -1.195 . . . . 0.0 108.94 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 100' ' ' ASP . 5.8 ptp180 -85.9 152.93 22.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.574 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.4 t -53.98 159.02 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.328 -0.857 . . . . 0.0 109.227 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.3 p90 -139.94 168.09 20.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.019 -1.05 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.648 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -156.72 160.0 38.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.15 -0.969 . . . . 0.0 109.749 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.59 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 93.8 m-85 -103.47 146.6 28.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 0.0 109.746 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.702 ' HA ' HD12 ' A' ' 186' ' ' ILE . 26.4 p-10 -59.99 -24.27 64.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.109 -0.994 . . . . 0.0 110.884 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.1 p90 -80.44 -28.78 37.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.748 -1.22 . . . . 0.0 110.682 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 22.4 pt-20 -93.6 -13.84 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.702 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.9 mt -59.32 -53.74 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.83 -38.03 54.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.815 -1.178 . . . . 0.0 109.212 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 192' ' ' VAL . 1.8 t-80 -61.17 -59.33 5.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.25 -0.906 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.5 mt -53.76 -33.19 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -75.0 -25.36 58.76 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -83.1 -31.68 27.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.165 -0.96 . . . . 0.0 111.028 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 188' ' ' HIS . 0.5 OUTLIER -77.97 12.54 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.606 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.65 58.32 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.168 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 5.1 mt -127.09 165.34 19.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.063 -1.257 . . . . 0.0 110.16 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.14 23.0 64.34 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.238 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -68.58 -22.32 64.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.599 -1.53 . . . . 0.0 109.504 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -5.65 50.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.31 126.86 36.7 Favored Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.124 -1.221 . . . . 0.0 110.837 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.78 -173.53 3.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.82 -0.812 . . . . 0.0 109.202 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 29.4 mt -90.18 -12.8 37.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.657 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -89.5 -3.47 58.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -145.12 13.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.696 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.648 HG22 ' SG ' ' A' ' 181' ' ' CYS . 0.8 OUTLIER -149.26 117.48 6.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.609 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.437 HD12 ' ND2' ' A' ' 213' ' ' ASN . 8.3 tp -79.0 115.72 18.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.68 123.99 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.741 HD21 HD21 ' A' ' 217' ' ' LEU . 18.0 mt -103.1 149.21 24.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.89 153.5 17.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -48.35 -24.96 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -1.203 . . . . 0.0 109.891 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.87 13.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 110.208 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 207' ' ' GLY . 13.5 pttt -149.62 159.7 44.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.958 -1.089 . . . . 0.0 109.734 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.479 HG11 ' HA2' ' A' ' 216' ' ' GLY . 46.2 t -107.45 130.39 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.205 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -73.13 -53.04 12.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.437 ' ND2' HD12 ' A' ' 204' ' ' LEU . 4.5 m120 -54.09 139.74 53.89 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 109.557 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.14 -31.71 11.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.476 2.117 . . . . 0.0 112.796 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.43 -9.91 59.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.135 -0.978 . . . . 0.0 110.185 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.33 -164.49 53.83 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.741 HD21 HD21 ' A' ' 206' ' ' LEU . 22.4 mt -73.6 141.59 46.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 0.0 109.847 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 15.8 mtt180 -81.81 -13.87 57.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 108.956 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 38.5 m-85 -147.8 142.25 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -0.782 . . . . 0.0 109.125 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.473 ' N ' ' OE1' ' A' ' 220' ' ' GLU . 2.0 mm-40 -49.66 -11.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.038 . . . . 0.0 108.398 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -141.88 43.49 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.073 0.94 . . . . 0.0 108.803 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.1 tt0 -62.89 -36.87 28.45 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 0.0 111.928 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.4 Cg_endo -76.72 -41.07 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.398 1.398 . . . . 0.0 112.521 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 228' ' ' VAL . 4.0 m -75.82 -23.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.869 -1.144 . . . . 0.0 108.231 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -70.36 -46.71 63.55 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.574 ' CE1' ' N ' ' A' ' 179' ' ' THR . 22.5 t60 -58.06 -42.4 85.41 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 108.91 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.68 -43.33 94.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.018 -1.052 . . . . 0.0 109.0 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 224' ' ' VAL . 52.3 t -60.1 -47.03 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 108.745 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 47.4 t80 -49.79 -45.2 49.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.742 -0.599 . . . . 0.0 109.513 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 5.9 m-20 -73.82 -33.48 64.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.476 HD23 HG11 ' A' ' 149' ' ' VAL . 22.4 tp -56.68 -39.17 73.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 0.0 108.679 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.764 HG22 ' HD1' ' A' ' 80' ' ' HIS . 36.1 mt -71.27 -47.97 57.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.07 -32.87 9.63 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -82.28 -26.81 32.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.199 -1.177 . . . . 0.0 109.798 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 260' ' ' VAL . 5.4 mt -83.22 -23.58 32.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.851 -1.156 . . . . 0.0 109.908 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.503 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 35.0 t80 -73.52 -9.03 58.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -51.16 -25.95 6.07 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 108.589 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.3 -17.81 5.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.61 13.94 74.55 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 71.9 p -158.79 145.93 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.935 -1.332 . . . . 0.0 110.009 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.421 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 73.0 Cg_exo -41.96 135.36 3.8 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.229 1.953 . . . . 0.0 111.655 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.507 ' O ' HD13 ' A' ' 147' ' ' LEU . 20.5 t -103.77 132.77 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.9 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.549 ' HB2' HG22 ' A' ' 125' ' ' VAL . 10.3 mmtm -121.05 125.51 47.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.63 179.47 32.56 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -105.37 138.98 40.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.336 -1.097 . . . . 0.0 109.737 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.7 m-85 -140.67 144.59 35.76 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.066 0.936 . . . . 0.0 111.298 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -129.27 144.23 51.15 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 127.84 20.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.643 -1.286 . . . . 0.0 110.745 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -112.83 114.67 27.31 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 51.18 55.67 9.15 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.468 ' O ' ' NE ' ' A' ' 137' ' ' ARG . . . -63.39 -167.74 0.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -169.59 165.52 38.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.602 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 21.2 m-70 -70.91 -52.32 20.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -1.18 . . . . 0.0 109.68 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -54.32 47.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 108.703 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 139' ' ' ILE . 48.8 tp -51.45 -40.83 60.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -58.57 -55.19 38.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -0.98 . . . . 0.0 108.592 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 61.7 t -48.94 -42.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.517 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -50.0 71.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.8 tp -52.16 -43.2 63.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.684 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.447 HG22 HD23 ' A' ' 235' ' ' LEU . 46.2 t -69.83 -46.2 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.15 -51.5 64.08 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.652 -0.655 . . . . 0.0 110.147 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.62 -45.43 86.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.013 -1.054 . . . . 0.0 109.571 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 263' ' ' LEU . 16.5 mt -58.69 -46.91 86.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.745 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.16 -30.12 68.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.79 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 120.602 -1.311 . . . . 0.0 108.856 179.485 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 119' ' ' ARG . 9.8 mm-40 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -117.34 132.51 56.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 0.0 109.369 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -134.16 173.71 11.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.373 -0.829 . . . . 0.0 109.106 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -81.78 144.36 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.173 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG3' HD13 ' A' ' 115' ' ' LEU . 18.2 ttpp -78.37 -42.36 30.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.711 . . . . 0.0 110.379 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.92 157.82 43.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.494 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -63.39 133.87 54.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.518 -0.739 . . . . 0.0 109.849 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 113' ' ' ASN . 20.4 mt -121.04 163.22 18.66 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -155.31 149.38 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -128.84 164.76 22.36 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -148.28 133.04 17.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 108.573 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.38 163.38 23.32 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.74 149.22 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 148.4 39.65 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -67.06 -41.28 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -1.184 . . . . 0.0 112.58 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.523 ' CE1' HG23 ' A' ' 18' ' ' ILE . 4.6 m-70 -86.93 -39.24 15.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.889 -1.757 . . . . 0.0 111.114 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -31.67 64.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.018 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.83 21.22 65.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.96 151.55 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.65 -0.912 . . . . 0.0 109.338 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -72.4 142.96 48.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 t -148.2 158.52 44.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 26' ' ' LEU . 56.5 tttp -133.42 152.85 51.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.009 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.624 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.1 mt -127.81 153.71 46.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.37 128.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.28 124.68 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.163 -0.961 . . . . 0.0 109.699 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -123.62 153.53 66.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.86 163.5 35.25 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.177 1.918 . . . . 0.0 111.171 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 30.2 mm-40 -138.81 -171.81 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.9 ttpm? -88.83 150.54 22.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.478 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.615 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 15.5 mp0 -49.34 149.91 2.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.537 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 59.69 23.66 58.92 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.431 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.47 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 28.9 m -81.8 -46.3 14.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.498 -1.589 . . . . 0.0 109.214 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.548 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 103.19 -170.63 19.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 85' ' ' THR . 4.0 mm -98.9 126.89 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -1.174 . . . . 0.0 107.987 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -139.61 141.13 37.14 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -105.04 155.28 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.4 t80 -130.7 141.76 50.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -170.26 137.03 1.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.091 -1.005 . . . . 0.0 109.838 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.41 31.93 19.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.921 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.38 21.24 74.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.76 133.33 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.999 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -91.11 143.99 26.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.1 mt -137.75 97.69 10.04 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.09 143.16 32.84 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.169 1.913 . . . . 0.0 111.416 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.84 81.34 5.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.877 -1.139 . . . . 0.0 110.396 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -139.29 156.4 47.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.5 p80 -55.07 -50.04 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -44.9 -15.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.001 -1.062 . . . . 0.0 110.192 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' HIS . 65.5 m-85 -99.14 6.12 46.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.98 -1.075 . . . . 0.0 109.629 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' A' ' 50' ' ' HIS . 31.7 t -58.65 131.66 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 108.844 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.81 -35.16 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.315 -0.866 . . . . 0.0 109.833 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -152.23 123.1 7.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.496 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -113.3 133.14 55.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.627 -0.67 . . . . 0.0 109.311 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.1 p-10 -166.81 -153.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.521 ' N ' ' CG ' ' A' ' 57' ' ' ASN . 55.8 m-70 -47.07 -12.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.055 -1.028 . . . . 0.0 108.623 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -135.02 165.75 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.553 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.413 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 52.3 m -102.51 121.38 42.24 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -118.49 135.39 54.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 111.52 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -124.1 161.05 26.41 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.55 147.32 7.25 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.395 -1.86 . . . . 0.0 111.454 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -144.68 151.21 38.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.572 -0.958 . . . . 0.0 109.407 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 58.77 24.24 12.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.499 -0.751 . . . . 0.0 110.96 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.421 ' C ' HE21 ' A' ' 67' ' ' GLN . . . 90.26 1.31 75.59 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.642 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.488 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.0 mm-40 -103.15 140.15 37.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.006 -1.29 . . . . 0.0 108.394 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.28 157.17 45.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.51 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.6 mt -133.86 143.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -115.06 155.95 26.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.292 -0.88 . . . . 0.0 111.38 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m 53.85 65.09 1.61 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.705 -0.622 . . . . 0.0 111.129 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.446 HG12 ' CG1' ' A' ' 96' ' ' ILE . 18.1 m -113.85 -4.34 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.045 -1.035 . . . . 0.0 109.475 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.581 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 7.1 pt-20 -65.16 -34.69 79.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.879 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -59.28 -60.07 4.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.0 110.207 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.8 tp -58.46 -46.73 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.825 -1.172 . . . . 0.0 109.197 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 10.8 mt -51.97 -42.18 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.019 -1.051 . . . . 0.0 109.566 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 44.9 t -59.49 -47.45 85.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.191 -0.943 . . . . 0.0 110.02 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.44 -54.08 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.979 -1.075 . . . . 0.0 108.623 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.9 mt -52.2 -45.23 65.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.321 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.425 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 8.2 t-160 -53.11 -58.12 8.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.4 mt -59.61 -35.04 73.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.702 HD22 ' CD1' ' A' ' 114' ' ' ILE . 12.9 mt -83.02 -1.47 52.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.88 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 61.92 26.7 16.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.729 -1.232 . . . . 0.0 110.75 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 82' ' ' LEU . 15.4 mm -73.36 118.89 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 108.313 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.456 HG21 ' OE2' ' A' ' 4' ' ' GLU . 47.9 p -101.98 -75.41 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 111.135 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.4 m120 -81.67 113.52 19.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 111.638 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.1 m -163.86 143.35 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.711 . . . . 0.0 109.283 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.568 HG22 ' OE1' ' A' ' 90' ' ' GLU . 4.0 m -111.15 104.5 13.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.411 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.74 112.9 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.568 ' OE1' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -89.33 118.99 29.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.65 108.63 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 111.142 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.57 -178.99 16.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -99.96 -10.61 21.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.272 . . . . 0.0 110.962 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -139.35 143.99 38.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.736 -1.227 . . . . 0.0 110.639 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.446 ' CG1' HG12 ' A' ' 72' ' ' VAL . 9.8 mm -71.3 131.34 86.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.349 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.624 ' CD ' HD21 ' A' ' 26' ' ' LEU . 53.0 Cg_exo -46.65 131.43 15.92 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.005 1.804 . . . . 0.0 112.499 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 tp -79.95 -29.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.424 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 88.8 mt 56.18 -116.0 0.97 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 109.702 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.26 -7.48 41.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.89 -9.71 56.83 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 p -111.18 -172.21 1.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -1.024 . . . . 0.0 109.78 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.84 -2.96 20.43 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -46.53 -41.29 14.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.733 -0.863 . . . . 0.0 111.011 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.89 -51.67 67.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.223 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.3 m-85 -62.95 -45.38 92.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.066 -1.021 . . . . 0.0 109.029 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.67 -39.21 87.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.19 -44.8 59.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 111.397 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.73 -48.35 22.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.035 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.08 -42.53 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.083 . . . . 0.0 111.08 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -57.44 -28.21 63.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.027 -1.046 . . . . 0.0 109.982 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -78.81 -14.63 59.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 109.996 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 11' ' ' LEU . 12.5 m-80 -120.45 34.14 5.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.439 -0.788 . . . . 0.0 110.809 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.702 ' CD1' HD22 ' A' ' 82' ' ' LEU . 15.0 mt -87.41 148.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.665 -1.272 . . . . 0.0 111.155 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD13 ' HG3' ' A' ' 8' ' ' LYS . 13.9 tp -131.75 165.48 23.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -118.76 142.58 47.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.29 -0.881 . . . . 0.0 109.92 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.413 ' NE2' ' HG3' ' A' ' 33' ' ' GLU . 5.0 mt-30 -101.27 -161.65 0.88 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.317 -0.864 . . . . 0.0 109.228 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -117.17 0.37 12.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 0.0 110.401 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 4' ' ' GLU . 24.0 ttm-85 -94.73 150.04 20.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -87.57 135.56 33.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 110.015 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 85' ' ' THR . 66.1 mt -77.63 145.53 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.729 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.46 96.41 9.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -69.64 147.13 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.69 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.16 127.06 47.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 243' ' ' LYS . 48.3 t -131.36 145.23 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.17 135.29 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -116.44 -11.84 11.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.778 . . . . 0.0 109.162 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -141.36 141.57 23.68 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 108.849 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.96 145.84 46.02 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.958 1.772 . . . . 0.0 113.007 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.888 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.7 tt -138.01 149.11 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.62 -0.675 . . . . 0.0 109.186 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.95 122.94 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 109.915 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.44 124.94 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -123.64 140.6 52.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.602 -0.686 . . . . 0.0 110.286 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.76 154.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.244 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 56.62 22.75 7.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.601 -0.687 . . . . 0.0 110.872 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.442 ' O ' ' NH2' ' A' ' 250' ' ' ARG . . . 77.37 6.63 86.64 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.497 ' HB2' HD22 ' A' ' 255' ' ' LEU . 2.5 mtt85 -107.84 172.09 7.03 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -159.79 153.22 22.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.213 -1.554 . . . . 0.0 109.563 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 138' ' ' LEU . 2.2 mt -144.14 143.87 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.57 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -132.51 136.91 46.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.888 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -117.38 146.1 43.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -144.15 137.73 14.3 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 143.83 77.25 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.406 1.404 . . . . 0.0 111.718 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.03 148.05 11.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.235 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -1.28 46.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -134.91 143.91 47.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 242' ' ' VAL . 34.0 tp -76.88 118.24 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.001 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -139.42 138.29 36.37 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.46 ' CG1' HD23 ' A' ' 231' ' ' LEU . 55.4 t -133.94 129.05 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.402 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 32.6 m -115.8 135.85 53.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.346 -0.846 . . . . 0.0 109.309 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 224' ' ' VAL . 8.1 t80 -128.84 131.8 47.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -116.86 107.49 14.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.79 124.23 7.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.66 91.58 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -1.066 . . . . 0.0 109.426 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 21.2 m-85 -88.97 148.5 23.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.631 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -95.88 -2.19 47.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.894 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.462 ' ND2' ' CE1' ' A' ' 182' ' ' PHE . 26.0 p30 -72.98 -173.36 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 109.461 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -59.53 -27.58 66.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.96 . . . . 0.0 109.917 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.474 HD22 ' OE1' ' A' ' 162' ' ' GLN . 7.6 mt -57.89 -45.01 87.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 108.938 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.67 -135.95 13.36 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -110.03 144.72 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.533 -0.981 . . . . 0.0 109.68 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.474 ' OE1' HD22 ' A' ' 159' ' ' LEU . 40.1 mt-30 -151.44 149.2 29.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.73 150.56 52.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.16 142.74 34.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 108.859 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.8 m -124.18 130.32 52.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.858 . . . . 0.0 110.417 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -99.38 130.81 45.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.6 151.3 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 109.168 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.75 115.67 2.29 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.506 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.56 3.28 20.67 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -130.97 29.58 4.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -1.165 . . . . 0.0 108.898 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -62.65 -35.15 78.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 110.699 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -53.39 -14.72 0.82 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.958 -1.089 . . . . 0.0 110.949 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.532 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 23.4 mt-10 -97.4 -4.24 38.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.75 -1.219 . . . . 0.0 111.543 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.8 pt -119.87 12.51 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.879 -1.138 . . . . 0.0 111.614 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.51 -28.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.891 -1.13 . . . . 0.0 109.854 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 2.65 54.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.979 -1.076 . . . . 0.0 111.259 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.473 ' HB2' ' NH1' ' A' ' 225' ' ' ARG . . . -80.41 132.89 35.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.619 -1.3 . . . . 0.0 108.554 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.64 156.55 18.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.151 -0.968 . . . . 0.0 110.626 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.1 t -57.8 156.16 9.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.643 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 49.6 p90 -140.33 166.36 24.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.192 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.533 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -157.12 160.37 38.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.492 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 71.3 m-85 -103.22 144.63 31.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.5 p-10 -60.89 -22.91 64.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 0.0 111.7 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.4 p90 -75.16 -38.64 60.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.403 . . . . 0.0 111.172 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.689 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -91.58 -10.07 41.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.536 -1.352 . . . . 0.0 110.224 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 183' ' ' ASP . 3.2 mt -53.87 -51.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.961 -1.087 . . . . 0.0 109.449 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -52.33 -46.39 66.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 108.726 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.03 -52.85 63.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 186' ' ' ILE . 72.3 mt -54.53 -33.99 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -78.77 -27.67 44.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.649 . . . . 0.0 109.713 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -73.49 -26.92 61.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.0 . . . . 0.0 109.71 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 192' ' ' VAL . 13.6 m -83.24 10.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.307 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 25.13 74.01 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.539 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.96 156.99 29.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.103 -1.234 . . . . 0.0 109.856 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.95 25.12 56.63 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.368 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -68.69 -21.61 64.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.589 -1.536 . . . . 0.0 109.58 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.79 -6.37 49.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -58.0 130.64 51.31 Favored Glycine 0 N--CA 1.492 2.422 0 O-C-N 121.207 -1.172 . . . . 0.0 110.582 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 203' ' ' THR . 4.5 p -141.88 163.87 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.7 -0.882 . . . . 0.0 109.089 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.4 mt -64.11 -35.09 79.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.986 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -73.25 -17.31 61.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.35 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.4 m-20 -125.53 6.72 7.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.194 -0.941 . . . . 0.0 109.991 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.533 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 24.2 m -148.94 116.22 6.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.702 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 tp -76.11 113.59 13.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.7 t -103.3 126.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.973 -1.079 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 16.2 mt -108.25 141.75 39.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -97.7 135.7 12.33 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 7.5 ttpt -40.02 -21.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -1.069 . . . . 0.0 110.264 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 207' ' ' GLY . 14.9 t0 -141.67 2.28 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.746 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 207' ' ' GLY . 31.0 mttt -149.25 157.5 43.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 0.0 110.576 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.87 126.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -73.52 -55.2 6.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -52.75 110.31 1.89 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -54.63 -11.89 3.8 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.752 1.635 . . . . 0.0 111.924 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.26 -6.82 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.783 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.52 -164.09 51.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.5 mt -82.53 143.32 31.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -1.013 . . . . 0.0 110.041 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -89.29 -19.94 24.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.147 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 141.03 33.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.552 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 1.6 pm0 -54.59 -16.65 2.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.04 -1.038 . . . . 0.0 108.597 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.3 40.3 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.797 0.808 . . . . 0.0 109.131 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.465 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 10.6 tt0 -56.4 -56.97 26.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 111.606 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 18.4 Cg_endo -59.42 -37.1 91.87 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.995 1.797 . . . . 0.0 113.406 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.509 HG12 ' CE2' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -82.38 -28.2 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 120.549 -1.344 . . . . 0.0 108.756 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 173' ' ' GLU . 6.3 mtp-105 -65.32 -41.14 94.31 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.597 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 21.3 t60 -65.35 -41.34 93.98 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -56.47 -43.83 79.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.076 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.16 -49.35 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 109.115 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 44.6 t80 -50.07 -43.4 51.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.668 0.747 . . . . 0.0 109.067 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.597 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.6 m-20 -72.86 -36.37 67.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.484 -0.76 . . . . 0.0 109.842 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.46 HD23 ' CG1' ' A' ' 149' ' ' VAL . 24.1 tp -56.1 -35.73 67.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.943 -1.098 . . . . 0.0 108.507 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.8 -48.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.65 -32.34 10.74 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.485 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 4.9 m-20 -82.71 -26.76 31.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -1.199 . . . . 0.0 109.908 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 260' ' ' VAL . 7.0 mt -78.22 -22.62 48.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.8 -1.187 . . . . 0.0 110.088 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -71.63 -7.6 48.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 109.217 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 237' ' ' LEU . 37.7 mt -52.6 -30.51 31.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.955 . . . . 0.0 108.797 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.676 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 97.1 mt -57.95 -15.8 10.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.148 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.33 14.47 78.64 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 p -155.57 150.43 20.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.153 -1.204 . . . . 0.0 109.256 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 6.9 Cg_endo -53.67 132.46 49.27 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.145 1.896 . . . . 0.0 111.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.422 ' O ' HD22 ' A' ' 147' ' ' LEU . 15.2 t -98.62 137.76 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.811 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.421 ' HB3' HG22 ' A' ' 125' ' ' VAL . 9.0 ttmt -127.79 131.28 49.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.382 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.31 -177.84 31.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -108.83 111.1 22.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -1.158 . . . . 0.0 109.66 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.9 m-85 -112.13 149.17 32.55 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.019 0.914 . . . . 0.0 111.171 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.402 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 21.9 t80 -130.13 144.31 51.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.1 t -142.42 128.09 19.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.657 -1.277 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -110.43 115.53 29.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.442 ' NH2' ' O ' ' A' ' 136' ' ' GLY . 5.5 mtm180 49.64 56.15 8.29 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.9 141.45 21.72 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -117.19 -179.69 17.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.581 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 38.7 m-70 -73.95 -52.26 13.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.99 -1.3 . . . . 0.0 109.628 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -35.02 70.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 109.292 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 137' ' ' ARG . 28.7 tp -73.34 -41.51 63.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 108.735 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.5 m-20 -60.57 -51.36 69.77 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 253' ' ' HIS . 46.2 t -51.51 -43.75 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 0.0 109.03 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -55.45 -47.84 75.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.969 -1.082 . . . . 0.0 109.136 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.44 -50.29 62.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 235' ' ' LEU . 54.1 t -63.08 -53.77 42.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.716 0.77 . . . . 0.0 109.329 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -46.77 -51.18 16.89 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.694 -0.629 . . . . 0.0 110.314 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.99 -35.62 79.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.7 -1.25 . . . . 0.0 109.89 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 263' ' ' LEU . 84.7 mt -70.8 -42.92 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.862 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.676 ' HB2' ' CD2' ' A' ' 238' ' ' LEU . . . -77.96 -28.02 49.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 110.082 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.6 mttt . . . . . 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 108.921 179.394 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 64.2 mt-10 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -119.94 142.63 48.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -141.86 171.81 13.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.48 -0.762 . . . . 0.0 109.058 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 7' ' ' VAL . 3.5 m -81.68 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.946 -1.096 . . . . 0.0 110.229 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' HG3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -70.37 -46.81 63.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 10' ' ' LYS . 1.8 tm-20 -128.66 159.05 36.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.44 -0.787 . . . . 0.0 110.571 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.578 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 5.3 ttpp -59.89 133.94 56.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.6 mt -121.04 160.75 22.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -157.02 149.55 23.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.944 -1.098 . . . . 0.0 110.558 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -129.53 166.38 19.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.02 133.58 11.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.891 -1.13 . . . . 0.0 108.74 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.32 156.64 12.68 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.09 159.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 111.218 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.9 140.61 15.12 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 197' ' ' GLY . 4.4 tt -58.66 -50.53 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.128 -1.219 . . . . 0.0 111.972 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 18.4 m-70 -86.13 -38.85 17.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.312 -1.492 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.0 p -72.72 -36.54 67.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 110.157 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.57 68.21 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -116.19 153.94 30.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.589 -0.948 . . . . 0.0 108.736 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 25.5 t80 -71.05 129.34 38.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.072 -1.017 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 t -132.14 157.8 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 108.945 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.702 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.7 tttm -135.01 152.7 51.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.221 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.4 mt -130.14 148.07 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.556 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.6 mt -135.05 129.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.227 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.2 mt -115.03 125.73 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 109.891 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.556 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.8 m-70 -124.23 149.5 60.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.62 160.73 31.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.181 1.921 . . . . 0.0 111.247 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.1 mm-40 -134.3 -179.21 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.762 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 22.0 tptt -79.97 147.87 31.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -48.32 150.89 1.16 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 -179.701 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 60.9 20.36 57.34 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.24 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 23.9 m -80.89 -46.01 15.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.611 -1.523 . . . . 0.0 109.053 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.44 -167.19 16.47 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 85' ' ' THR . 4.3 mm -102.53 124.11 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.336 -1.096 . . . . 0.0 108.147 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.07 153.17 49.33 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.8 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' A' ' 89' ' ' ILE . 42.4 m-85 -114.64 154.4 28.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.554 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.8 t80 -130.83 138.78 50.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.011 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 4.2 ttmt -168.87 138.14 2.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 60.36 28.63 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.929 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.91 30.61 70.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.27 131.11 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.884 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.65 144.5 29.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 108.947 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.441 HG23 ' CB ' ' A' ' 64' ' ' PHE . 19.8 mt -140.86 99.16 6.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.398 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.67 145.56 48.28 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.135 1.89 . . . . 0.0 111.324 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.25 86.85 4.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.781 -1.199 . . . . 0.0 110.511 -178.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -138.62 154.59 48.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 0.0 109.391 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.453 ' HA ' HG23 ' A' ' 53' ' ' VAL . 38.0 p-80 -52.1 -45.94 65.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.795 . . . . 0.0 110.262 -179.381 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -48.27 -30.94 5.28 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.231 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -82.44 4.48 24.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.486 ' HA ' HD23 ' A' ' 62' ' ' LEU . 5.5 t -61.79 128.1 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 108.74 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.34 -30.3 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.23 -0.919 . . . . 0.0 110.487 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' A' ' 57' ' ' ASN . 4.9 t-160 -153.61 122.26 6.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.92 -1.113 . . . . 0.0 109.566 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 p -113.67 131.73 56.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.639 -0.663 . . . . 0.0 109.286 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 43.8 t-20 -167.29 -154.0 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.544 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 73.3 m-70 -45.53 -15.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.106 -0.996 . . . . 0.0 108.643 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.8 t -134.04 165.33 25.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.56 -0.712 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.5 m -103.22 122.06 43.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 108.724 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -120.34 138.42 53.73 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.092 0.948 . . . . 0.0 111.487 -178.719 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' VAL . 82.5 mt -120.19 163.83 17.14 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.219 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.8 142.75 5.21 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 118.453 -1.832 . . . . 0.0 111.159 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.441 ' CB ' HG23 ' A' ' 46' ' ' ILE . 47.1 t80 -144.86 150.35 36.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.856 . . . . 0.0 109.281 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? 55.4 35.92 26.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 110.749 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.14 2.25 88.75 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.493 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 58.7 mm-40 -98.44 144.23 28.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.254 . . . . 0.0 108.44 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 7.2 ptm85 -142.11 147.43 36.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.022 -1.049 . . . . 0.0 111.331 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.12 143.1 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -114.08 152.47 31.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.003 -1.06 . . . . 0.0 111.013 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 53.21 66.22 1.29 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.694 -0.629 . . . . 0.0 110.734 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 m -113.48 -3.65 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.004 . . . . 0.0 109.132 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -70.37 -28.24 64.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.497 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 25.0 m170 -66.77 -59.85 3.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.058 -1.026 . . . . 0.0 109.767 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.565 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.5 tp -57.75 -45.03 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.845 -1.159 . . . . 0.0 108.764 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.565 ' N ' HG23 ' A' ' 75' ' ' ILE . 67.9 mt -57.01 -40.99 77.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 0.0 109.807 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.493 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.6 t -58.35 -47.86 82.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 109.476 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.07 -54.33 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 108.542 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.3 mt -52.14 -45.17 64.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.881 ' HD1' HG22 ' A' ' 232' ' ' ILE . 20.3 t-160 -55.99 -58.55 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.566 -0.709 . . . . 0.0 110.066 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.23 -37.02 74.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.662 HD22 HD11 ' A' ' 114' ' ' ILE . 9.3 mt -77.79 -4.78 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 0.0 110.21 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.88 34.55 14.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.424 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 82' ' ' LEU . 18.2 mm -80.4 127.0 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 86' ' ' ASN . 5.9 p -105.17 -77.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 111.456 -177.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.9 m-80 -81.38 113.89 19.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.403 -176.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.8 m -162.82 139.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.483 -0.76 . . . . 0.0 109.622 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 30.8 m -109.15 104.46 13.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 2.5 mp -94.16 105.59 17.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 0.0 109.807 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.92 120.32 25.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 108.49 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.434 HG21 HD11 ' A' ' 96' ' ' ILE . 24.5 t -102.42 110.25 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 111.114 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.49 107.67 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.18 -162.75 24.31 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -114.06 -16.21 12.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -1.045 . . . . 0.0 110.332 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -142.07 147.45 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.54 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 91' ' ' VAL . 46.1 mm -69.28 128.74 92.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.697 ' HD2' HD11 ' A' ' 26' ' ' LEU . 74.4 Cg_exo -45.77 131.4 13.16 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.838 1.692 . . . . 0.0 111.845 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -77.88 -24.84 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.554 -0.716 . . . . 0.0 110.558 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.48 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 8.5 mt 55.43 -119.17 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 57.6 t0 -94.52 -9.46 35.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.494 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.77 -4.88 32.45 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.4 p -118.47 -173.54 2.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -1.05 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 -3.97 20.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -46.67 -36.57 7.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.775 -0.838 . . . . 0.0 110.932 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.0 -52.0 64.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.864 -1.148 . . . . 0.0 110.268 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CZ ' HD11 ' A' ' 99' ' ' LEU . 73.9 m-85 -62.23 -45.02 95.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.07 . . . . 0.0 108.874 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.44 -40.47 86.91 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.496 0.665 . . . . 0.0 109.625 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -72.8 -43.69 62.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 111.733 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.48 -49.66 15.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 111.075 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.34 -41.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -59.02 -28.48 66.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.946 -1.096 . . . . 0.0 110.122 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -78.28 -17.96 55.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.67 34.5 5.18 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.467 -0.771 . . . . 0.0 110.731 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.662 HD11 HD22 ' A' ' 82' ' ' LEU . 9.5 mt -82.92 148.07 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.303 . . . . 0.0 110.526 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 8' ' ' LYS . 10.1 tp -130.67 151.99 50.51 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.48 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -100.39 136.43 40.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.028 -1.045 . . . . 0.0 109.698 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.578 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 18.9 mt-30 -102.63 -166.45 1.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -120.89 72.26 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.416 -0.802 . . . . 0.0 110.923 -179.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 4' ' ' GLU . 14.8 ttm-85 -166.17 145.11 5.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.64 128.88 34.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.149 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.79 139.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.28 72.83 4.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -51.5 142.54 13.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.528 -0.732 . . . . 0.0 110.097 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -103.82 124.09 48.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 243' ' ' LYS . 26.3 t -127.87 142.77 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 0.0 109.954 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.8 t -81.27 134.68 26.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -117.26 -11.77 10.59 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -139.74 141.66 28.62 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.412 -0.805 . . . . 0.0 108.916 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.26 169.73 20.0 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.162 1.908 . . . . 0.0 113.029 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.839 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.3 tt -163.67 143.48 2.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.469 0.652 . . . . 0.0 109.618 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.23 121.09 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.29 112.38 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.73 125.84 53.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -173.34 157.86 3.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 0.0 110.652 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.455 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 27.1 mt-10 56.63 18.74 3.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 110.771 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.67 -0.22 89.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER -102.88 172.28 6.92 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.963 HD23 ' N ' ' A' ' 139' ' ' ILE . 4.8 tt -160.24 145.82 15.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.441 -1.412 . . . . 0.0 108.669 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.963 ' N ' HD23 ' A' ' 138' ' ' LEU . 59.3 mt -147.92 134.81 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 108.394 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -124.05 144.16 50.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.71 148.81 44.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -148.82 138.72 12.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.14 146.17 60.99 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.462 1.441 . . . . 0.0 112.129 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.14 147.94 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.49 -1.4 37.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.471 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.7 p -136.92 159.36 42.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 109.304 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.574 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 27.0 tp -88.34 121.0 30.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 0.0 109.748 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -138.65 135.15 34.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.507 ' CG1' HD23 ' A' ' 231' ' ' LEU . 73.4 t -137.19 118.5 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.9 m -106.31 136.51 45.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.752 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.685 ' HB2' HG22 ' A' ' 228' ' ' VAL . 83.1 t80 -123.67 128.32 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.469 -0.769 . . . . 0.0 109.488 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' CD ' ' CE2' ' A' ' 249' ' ' PHE . 7.2 tt0 -115.16 104.66 12.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.41 126.68 8.98 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -110.93 84.98 2.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -1.08 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.3 m-30 -90.38 148.97 22.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.132 -0.98 . . . . 0.0 109.407 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -91.83 -5.81 52.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.856 . . . . 0.0 110.739 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.75 HD21 HD12 ' A' ' 159' ' ' LEU . 19.2 p-10 -68.44 -167.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.725 -1.234 . . . . 0.0 109.435 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.8 p90 -59.94 -26.67 66.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.994 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.75 HD12 HD21 ' A' ' 157' ' ' ASN . 6.5 mt -58.92 -51.59 69.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 108.812 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.63 -119.17 5.43 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.94 143.12 51.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.622 -0.928 . . . . 0.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -156.09 146.64 21.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.429 -0.794 . . . . 0.0 109.557 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -126.29 150.83 48.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.0 109.673 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -135.09 118.77 17.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.9 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -94.9 121.82 36.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.043 . . . . 0.0 109.735 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 4.2 t80 -99.73 139.18 35.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.356 -0.84 . . . . 0.0 109.486 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.555 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.7 t -138.94 153.06 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.39 -0.819 . . . . 0.0 109.152 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 98.4 mt-10 -53.58 120.43 6.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.597 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.41 6.68 17.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.48 28.67 1.81 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.159 -1.201 . . . . 0.0 108.671 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -63.93 -35.99 82.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 110.4 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.96 -12.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.168 -0.957 . . . . 0.0 110.517 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -90.9 -4.52 56.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.052 -1.03 . . . . 0.0 110.536 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.55 -7.13 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.164 -0.96 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.13 -29.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.574 -1.328 . . . . 0.0 110.011 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.9 mt -90.03 -1.34 57.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.833 -1.167 . . . . 0.0 110.736 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.58 118.18 20.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.706 -1.246 . . . . 0.0 108.374 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.55 153.01 21.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.0 110.296 -179.02 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.514 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 6.2 t -53.47 158.63 1.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 0.0 109.773 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.545 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 23.3 p90 -143.32 169.44 17.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.635 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -162.09 167.95 23.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 -179.785 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.502 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 86.8 m-85 -104.21 145.08 30.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 109.203 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.601 ' HA ' HD12 ' A' ' 186' ' ' ILE . 51.3 p30 -63.34 -23.49 67.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.277 -0.89 . . . . 0.0 111.426 -178.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.52 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 p90 -79.33 -27.32 42.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.585 -1.322 . . . . 0.0 111.009 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.485 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 26.0 pt-20 -96.45 -13.76 22.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.688 -1.258 . . . . 0.0 109.872 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.6 mt -55.56 -51.65 55.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -52.43 -44.5 65.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.668 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -57.6 -51.5 69.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.943 . . . . 0.0 109.41 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.45 -34.31 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.134 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -74.43 -27.09 60.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 110.144 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -74.8 -33.51 62.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.018 -1.051 . . . . 0.0 109.921 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.42 12.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 109.226 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.43 25.35 70.66 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.556 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 86.5 mt -117.83 155.08 30.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -1.192 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.495 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.2 27.81 47.44 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.29 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -68.36 -22.46 64.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.667 -1.49 . . . . 0.0 108.929 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -103.14 -4.92 47.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.65 126.0 29.29 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 121.323 -1.104 . . . . 0.0 110.956 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.18 39.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.858 -0.789 . . . . 0.0 109.074 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.61 -13.32 1.55 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.792 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -83.46 -2.22 55.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.06 -1.025 . . . . 0.0 109.423 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -151.18 17.67 0.75 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 108.826 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.635 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 87.4 m -151.89 115.16 4.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.504 -0.747 . . . . 0.0 109.33 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.6 tp -76.57 109.76 10.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.208 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 186' ' ' ILE . 42.6 t -103.17 131.36 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 109.941 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.5 mt -114.28 144.83 42.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.536 -0.728 . . . . 0.0 109.35 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.94 151.07 19.14 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 207' ' ' GLY . 25.7 tttt -41.42 -28.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 110.162 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 209' ' ' ASP . 1.8 p30 -146.4 8.15 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.929 -1.107 . . . . 0.0 110.399 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.6 tttt -141.93 150.61 41.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.832 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.21 127.45 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -70.66 -54.43 11.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.201 -0.937 . . . . 0.0 110.019 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.97 132.86 80.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.05 . . . . 0.0 109.462 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.85 -19.4 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.322 2.015 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.81 -6.04 58.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.669 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.84 -169.29 52.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.53 147.16 42.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.387 -1.066 . . . . 0.0 109.568 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -74.76 -62.64 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 108.848 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 221' ' ' ASN . 11.5 m-85 -117.9 142.78 46.95 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 219' ' ' TYR . 8.6 m-20 -137.7 30.41 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.483 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -60.25 -40.04 73.6 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 16.0 Cg_exo -65.22 -49.6 2.56 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.35 2.034 . . . . 0.0 112.647 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.817 ' O ' HG23 ' A' ' 228' ' ' VAL . 2.5 m -73.17 -22.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.922 -1.111 . . . . 0.0 108.628 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -70.93 -46.11 63.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.514 ' CE1' ' N ' ' A' ' 179' ' ' THR . 26.0 t60 -58.69 -38.45 78.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -42.14 99.59 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.9 t -66.34 -38.9 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.493 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 48.7 t80 -56.48 -51.74 67.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.732 -0.605 . . . . 0.0 109.704 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.497 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 8.2 m-20 -70.14 -30.14 67.24 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.174 -0.954 . . . . 0.0 109.515 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.507 HD23 ' CG1' ' A' ' 149' ' ' VAL . 30.1 tp -56.56 -37.6 70.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.881 HG22 ' HD1' ' A' ' 80' ' ' HIS . 66.0 mt -73.01 -48.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.64 8.33 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.35 -29.62 30.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.728 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.67 HD23 HG22 ' A' ' 260' ' ' VAL . 6.8 mt -79.16 -22.41 45.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.725 -1.234 . . . . 0.0 109.253 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.406 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.2 t80 -70.09 -8.96 53.74 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.1 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.3 mt -52.67 -27.93 19.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 108.818 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.403 HD12 HG22 ' A' ' 242' ' ' VAL . 96.6 mt -55.28 -18.47 6.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.021 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.86 12.54 77.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.0 p -158.51 147.6 14.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.139 -1.212 . . . . 0.0 109.551 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.417 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 57.8 Cg_exo -42.99 135.18 5.42 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.344 2.029 . . . . 0.0 111.975 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.403 HG22 HD12 ' A' ' 238' ' ' LEU . 13.7 t -101.75 133.08 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.702 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.663 ' HB2' HG22 ' A' ' 125' ' ' VAL . 32.4 mmtm -122.11 126.81 49.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.581 -0.699 . . . . 0.0 109.261 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 176.61 29.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -107.07 110.21 22.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -1.231 . . . . 0.0 109.833 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.7 m-85 -112.06 147.43 36.02 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.834 0.826 . . . . 0.0 111.038 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -127.42 144.1 51.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.4 m -134.84 128.11 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.704 -1.248 . . . . 0.0 110.679 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.497 ' CE2' ' CD ' ' A' ' 152' ' ' GLU . 3.0 t80 -112.44 110.58 20.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 6.5 mmm180 47.34 55.75 7.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -178.185 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.27 142.09 23.71 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -178.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -110.63 159.63 13.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -56.07 -48.93 75.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.241 . . . . 0.0 109.534 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 25.3 p -57.21 -55.16 38.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.192 -0.943 . . . . 0.0 109.106 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.403 ' HG ' HD12 ' A' ' 139' ' ' ILE . 54.5 tp -52.07 -37.29 53.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -58.22 -55.7 31.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.093 -1.004 . . . . 0.0 108.855 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.61 -43.1 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.494 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -49.52 71.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 139' ' ' ILE . 9.5 tp -52.71 -41.24 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.67 HG22 HD23 ' A' ' 235' ' ' LEU . 74.2 t -71.97 -50.43 37.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.76 0.791 . . . . 0.0 109.507 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -49.81 -45.06 49.6 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.641 -0.662 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -42.79 70.36 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.479 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 263' ' ' LEU . 36.3 mt -62.05 -43.61 98.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.552 -0.718 . . . . 0.0 110.344 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 22.6 mttm . . . . . 0 N--CA 1.49 1.56 0 O-C-N 120.625 -1.297 . . . . 0.0 108.453 178.992 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -121.08 139.64 53.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -141.23 177.84 7.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.28 135.18 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 109.815 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -65.66 -45.51 82.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.766 . . . . 0.0 110.322 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.73 157.38 41.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HG3' ' NE2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -64.46 133.66 52.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.11 -179.801 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 113' ' ' ASN . 40.5 mt -118.24 160.14 22.12 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 p -158.1 150.44 22.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.101 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -132.42 174.88 9.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.628 -0.67 . . . . 0.0 109.707 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -150.46 135.51 17.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 108.589 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.76 156.09 12.87 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.901 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 22' ' ' GLU . 8.9 p -80.93 142.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -1.083 . . . . 0.0 110.91 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.24 142.9 36.63 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.0 tt -60.06 -48.01 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -1.145 . . . . 0.0 112.472 -178.266 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 9.6 m-70 -86.88 -37.93 17.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.229 -1.544 . . . . 0.0 111.462 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -68.13 -35.1 77.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 0.0 110.135 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.9 71.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.615 ' C ' HG23 ' A' ' 16' ' ' VAL . 32.1 tt0 -118.92 154.81 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 109.242 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -68.4 140.18 55.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 t -147.42 157.08 43.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.041 . . . . 0.0 108.766 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -127.58 161.98 27.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.192 -0.942 . . . . 0.0 110.014 -179.236 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 96' ' ' ILE . 12.9 mt -130.94 143.65 50.88 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.29 127.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.312 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mt -113.45 125.0 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 109.403 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.4 ' NE2' ' HG3' ' A' ' 10' ' ' LYS . 17.2 m-70 -121.47 142.71 36.1 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.545 -0.722 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -53.87 160.07 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.544 1.496 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 76.7 mt-10 -134.77 -178.75 5.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.3 ttmm -85.91 151.44 23.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.648 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -49.81 147.31 3.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 110.447 -179.591 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.76 21.84 58.89 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.551 -0.718 . . . . 0.0 111.884 178.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 98.5 m -81.19 -46.51 14.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.45 -1.618 . . . . 0.0 109.027 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.45 -168.2 15.29 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mm -101.63 124.66 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -1.112 . . . . 0.0 108.036 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HE ' HG22 ' A' ' 35' ' ' THR . 0.6 OUTLIER -143.16 139.55 30.41 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.765 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -97.16 154.33 17.43 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.6 t80 -129.47 139.94 51.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 46.3 tttm -168.08 137.76 2.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 -179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.14 29.18 18.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 0.0 110.102 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.01 28.36 70.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.8 t -134.08 138.27 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 109.852 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -92.14 142.45 27.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.19 179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -137.42 95.13 11.65 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.439 -179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -48.27 144.97 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.212 1.941 . . . . 0.0 111.652 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.89 84.61 4.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.542 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -141.16 157.02 45.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.008 -1.058 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.1 p80 -52.92 -50.12 64.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -46.55 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 0.0 109.999 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.7 m-85 -99.67 4.81 45.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.463 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 50' ' ' HIS . 5.1 t -63.38 132.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 108.773 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -118.09 -33.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.7 t-160 -147.61 118.6 7.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 110.037 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.2 p -112.66 126.37 55.3 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.7 t-20 -167.06 -152.76 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.584 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 10.7 m-70 -44.21 -16.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 108.586 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.1 t -137.19 165.5 25.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.495 -0.753 . . . . 0.0 109.368 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 m -109.24 125.36 52.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.368 -0.832 . . . . 0.0 108.831 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 1.4 m-20 -125.59 148.02 49.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.994 0.902 . . . . 0.0 111.162 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' A' ' 72' ' ' VAL . 28.1 mt -125.78 161.12 28.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.99 143.59 6.37 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.541 -1.79 . . . . 0.0 110.985 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -144.81 151.85 39.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.629 -0.924 . . . . 0.0 109.72 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.81 29.74 12.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.386 -0.821 . . . . 0.0 110.599 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.52 0.54 86.32 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.569 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 84.8 mm-40 -97.01 145.44 25.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.307 . . . . 0.0 108.373 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -143.35 149.58 37.95 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.658 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -132.93 143.17 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -114.05 149.71 35.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.124 -0.985 . . . . 0.0 111.611 -178.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.8 m 53.87 71.6 0.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.716 -0.615 . . . . 0.0 111.054 178.621 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 62' ' ' LEU . 20.6 m -112.81 -5.83 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.41 -23.87 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.98 -60.88 2.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.996 -1.065 . . . . 0.0 109.723 -179.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 76' ' ' LEU . 11.1 tp -59.63 -45.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' N ' HG23 ' A' ' 75' ' ' ILE . 88.3 mt -54.69 -40.77 69.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 0.0 109.68 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.571 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.47 -47.93 83.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.086 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.19 -55.23 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.011 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 mt -52.47 -43.38 64.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.658 ' HD1' HG22 ' A' ' 232' ' ' ILE . 15.8 t-160 -55.53 -58.08 9.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.127 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.486 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 57.5 mt -55.79 -36.66 67.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.267 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.699 HD22 HD11 ' A' ' 114' ' ' ILE . 11.7 mt -79.89 -4.31 51.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 110.461 -178.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER 62.77 38.46 11.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.866 -1.146 . . . . 0.0 110.51 179.628 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 82' ' ' LEU . 16.4 mm -83.31 129.74 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.9 p -107.04 -76.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.235 -0.916 . . . . 0.0 111.129 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.708 ' O ' HG13 ' A' ' 87' ' ' VAL . 4.1 m-80 -81.22 113.96 19.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -176.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.05 141.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 109.623 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.551 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -109.01 103.84 12.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.488 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.68 106.03 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.87 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.68 122.01 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.075 -1.016 . . . . 0.0 108.936 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -102.96 104.92 17.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.454 -0.779 . . . . 0.0 110.422 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 92' ' ' ILE . 4.8 mt -86.03 110.84 20.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.176 -0.953 . . . . 0.0 108.582 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.32 -179.23 16.38 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -15.32 22.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.138 . . . . 0.0 110.349 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.4 tt0 -136.07 142.7 44.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.986 -1.071 . . . . 0.0 110.272 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.724 ' CD1' HD21 ' A' ' 26' ' ' LEU . 2.5 mm -68.26 128.41 93.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.765 . . . . 0.0 109.654 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -45.72 127.39 9.89 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.822 1.681 . . . . 0.0 111.834 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 tp -80.1 -22.44 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.76 . . . . 0.0 110.354 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.451 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 89.8 mt 55.72 -118.08 1.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.854 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -94.78 -9.7 33.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.15 -0.968 . . . . 0.0 110.43 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.68 39.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.3 p -115.42 -174.55 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -1.021 . . . . 0.0 109.368 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.23 -6.96 17.55 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.547 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 72.5 t-105 -46.61 -35.21 5.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.678 -0.896 . . . . 0.0 110.09 -179.559 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.24 -51.52 68.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.906 -1.121 . . . . 0.0 109.968 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CG ' ' CD1' ' A' ' 75' ' ' ILE . 63.1 m-85 -65.03 -44.62 88.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.077 -1.014 . . . . 0.0 108.944 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.43 ' CD2' HG11 ' A' ' 175' ' ' VAL . 9.0 t80 -61.91 -37.81 86.03 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.456 0.646 . . . . 0.0 109.572 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.547 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 24.4 mm-40 -65.38 -52.75 51.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.685 . . . . 0.0 111.595 -178.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.33 -52.24 9.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.216 . . . . 0.0 110.693 -178.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 92.8 mt -50.71 -47.81 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.78 -1.2 . . . . 0.0 110.477 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -57.89 -31.3 66.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -83.78 13.51 4.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.523 ' HB2' HD11 ' A' ' 11' ' ' LEU . 1.1 m-20 -149.46 30.68 0.75 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.699 HD11 HD22 ' A' ' 82' ' ' LEU . 10.0 mt -85.02 147.12 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.949 -1.094 . . . . 0.0 110.426 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.0 tp -131.7 155.69 47.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.488 -0.757 . . . . 0.0 109.161 179.278 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.8 OUTLIER -110.42 128.2 55.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 179.725 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.648 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 7.2 mt-30 -97.02 -165.73 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 118' ' ' ASN . 48.6 p30 -124.77 74.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 110.301 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -161.73 139.93 9.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.057 179.228 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -47.3 167.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 110.191 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.585 HG21 ' CE1' ' A' ' 123' ' ' TYR . 25.4 mt -126.12 104.23 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.94 71.28 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.429 -0.794 . . . . 0.0 110.154 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.585 ' CE1' HG21 ' A' ' 121' ' ' ILE . 93.8 m-85 -57.4 147.18 26.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -104.71 123.65 47.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 243' ' ' LYS . 5.4 t -129.2 143.43 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.991 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.46 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -113.23 -11.8 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.254 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -141.32 144.71 35.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.8 172.29 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.054 1.836 . . . . 0.0 113.003 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 141' ' ' ALA . 9.9 tt -165.92 145.53 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.348 0.594 . . . . 0.0 109.846 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 131' ' ' ILE . 1.7 mt -128.28 125.24 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.496 -0.753 . . . . 0.0 109.361 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.437 HG23 ' HB ' ' A' ' 139' ' ' ILE . 0.7 OUTLIER -122.73 116.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 110.003 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -107.77 142.26 38.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' CG ' ' OE1' ' A' ' 135' ' ' GLU . 8.4 t70 -168.96 135.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.723 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER 50.94 34.89 11.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 111.509 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.73 8.06 86.2 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -103.15 172.5 6.78 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.2 tt -160.59 148.74 16.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.248 -1.533 . . . . 0.0 109.174 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.945 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.4 mt -146.87 133.78 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 108.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -125.21 138.99 54.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.772 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.95 139.55 53.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -136.25 134.04 19.83 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -53.12 148.87 29.52 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.353 1.369 . . . . 0.0 112.326 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.67 158.39 9.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.882 . . . . 0.0 108.944 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.3 2.65 54.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 109.943 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -138.06 150.03 46.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.539 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.492 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 16.8 tp -83.09 115.12 21.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -136.61 141.92 43.27 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.556 ' CG1' HD23 ' A' ' 231' ' ' LEU . 46.6 t -136.27 133.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.131 -0.981 . . . . 0.0 109.973 -179.005 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 m -119.1 124.72 47.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.528 ' CE2' HG12 ' A' ' 224' ' ' VAL . 10.0 t80 -115.1 129.85 56.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 109.983 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 153' ' ' GLY . 4.5 tp10 -113.72 105.29 13.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.562 ' N ' ' OE1' ' A' ' 152' ' ' GLU . . . -101.44 145.4 16.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -132.41 85.32 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -1.04 . . . . 0.0 109.589 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.7 m-30 -88.67 148.93 23.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.46 -0.775 . . . . 0.0 109.021 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 mmtt -88.93 -8.72 53.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 11.9 p-10 -66.79 -170.74 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 109.498 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 16.8 p90 -59.4 -24.63 63.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.853 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.456 HD12 HD21 ' A' ' 157' ' ' ASN . 8.5 mt -53.77 -58.39 7.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.005 . . . . 0.0 108.904 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.92 -134.73 11.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.34 142.7 47.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.995 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.438 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 4.6 pt20 -162.12 159.51 26.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 0.0 109.547 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.51 152.97 51.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.469 -0.769 . . . . 0.0 109.315 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -133.75 120.05 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.0 108.815 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 m -98.99 121.93 41.58 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.97 -1.081 . . . . 0.0 110.34 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -95.26 138.12 33.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.57 156.51 42.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.783 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.658 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 4.9 mp0 -60.31 113.69 2.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 109.417 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.4 6.03 18.31 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -130.91 30.23 4.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.294 -1.121 . . . . 0.0 108.836 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 175' ' ' VAL . 6.1 mp0 -63.75 -34.67 78.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.471 -0.768 . . . . 0.0 110.89 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -16.49 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.918 -1.114 . . . . 0.0 110.98 -178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.88 -4.02 55.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.91 -1.119 . . . . 0.0 111.146 -178.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.16 -5.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.031 -1.043 . . . . 0.0 111.107 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -92.59 -28.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.471 -1.393 . . . . 0.0 110.436 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.08 0.95 56.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 0.0 110.964 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.9 123.15 25.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.675 -1.265 . . . . 0.0 108.485 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -91.04 151.73 20.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.673 -1.267 . . . . 0.0 109.797 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 t -62.28 134.37 56.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.45 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.54 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 11.5 p90 -117.33 179.1 4.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 0.0 110.106 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -170.39 166.41 8.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.371 -0.831 . . . . 0.0 109.723 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 31.2 m-85 -103.79 146.11 29.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 0.0 109.244 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.5 OUTLIER -67.67 -17.73 64.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 111.216 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.3 p90 -80.67 -33.42 35.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.518 -1.364 . . . . 0.0 110.549 -179.195 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.588 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.1 OUTLIER -90.24 -15.73 30.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.762 -1.212 . . . . 0.0 109.504 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.705 HD12 ' HA ' ' A' ' 183' ' ' ASP . 7.6 mt -58.57 -51.24 74.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.47 -50.24 53.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.858 -1.151 . . . . 0.0 109.292 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.04 -52.0 62.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.172 -0.955 . . . . 0.0 108.83 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 61.7 mt -55.29 -34.2 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -0.917 . . . . 0.0 108.953 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -74.18 -32.71 63.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 109.863 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.05 -30.47 70.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.788 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' ' 194' ' ' LEU . 11.7 m -82.82 12.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.97 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.35 70.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.293 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' ' 192' ' ' VAL . 20.1 mt -118.3 156.19 29.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.006 -1.291 . . . . 0.0 109.945 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.492 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.89 25.12 53.82 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.001 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -67.55 -22.18 65.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.671 -1.488 . . . . 0.0 109.488 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -6.02 50.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.57 124.73 35.38 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.133 -1.216 . . . . 0.0 110.516 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.2 p -135.35 -179.7 5.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.825 -0.809 . . . . 0.0 109.398 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.0 mt -82.65 -12.42 57.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -91.9 -9.93 41.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 1.8 m120 -136.37 7.92 3.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.513 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.2 m -147.28 120.16 8.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.615 HD21 HD23 ' A' ' 217' ' ' LEU . 4.4 tp -84.02 117.87 23.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.984 . . . . 0.0 109.127 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.19 127.67 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 109.593 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 211' ' ' VAL . 4.8 mt -107.06 146.95 30.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.488 -0.757 . . . . 0.0 109.65 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.71 148.54 16.51 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 207' ' ' GLY . 20.4 tttt -41.13 -31.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -1.04 . . . . 0.0 109.918 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 31.9 t0 -145.61 10.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 0.0 110.282 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -144.62 153.67 42.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 109.774 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.501 HG22 HD23 ' A' ' 206' ' ' LEU . 44.7 t -106.3 131.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.091 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -72.6 -54.45 9.09 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.225 -0.922 . . . . 0.0 110.044 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -56.18 136.35 74.75 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 0.0 109.34 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.88 -25.82 19.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.311 2.008 . . . . 0.0 112.653 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.516 ' OE2' ' NH1' ' A' ' 218' ' ' ARG . 16.4 tm-20 -80.25 -9.82 59.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -165.52 52.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.615 HD23 HD21 ' A' ' 204' ' ' LEU . 11.8 mt -76.28 141.78 41.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -1.055 . . . . 0.0 109.858 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.516 ' NH1' ' OE2' ' A' ' 215' ' ' GLU . 0.1 OUTLIER -65.02 -52.23 57.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.63 179.25 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.447 ' H ' ' HB2' ' A' ' 222' ' ' GLU . 19.2 m-85 -117.85 176.8 5.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 220' ' ' GLU . 0.4 OUTLIER -76.0 -19.08 58.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.548 ' OD1' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -127.83 35.39 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.469 -0.769 . . . . 0.0 109.104 -179.985 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -59.79 -34.96 24.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 111.126 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.3 Cg_exo -73.87 -43.63 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.808 1.672 . . . . 0.0 112.342 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.528 HG12 ' CE2' ' A' ' 151' ' ' TYR . 0.9 OUTLIER -77.09 -25.38 15.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.903 -1.123 . . . . 0.0 108.133 179.196 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.548 ' NH1' ' OD1' ' A' ' 221' ' ' ASN . 8.0 mtt180 -67.13 -44.11 80.69 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -57.65 -50.32 73.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 108.689 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 224' ' ' VAL . 60.8 t -57.91 -48.97 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.073 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.571 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 64.3 t80 -49.99 -44.19 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -73.02 -35.53 66.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.534 -0.729 . . . . 0.0 109.571 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.556 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.9 tp -56.46 -36.31 68.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 108.65 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.658 HG22 ' HD1' ' A' ' 80' ' ' HIS . 44.1 mt -72.42 -48.25 48.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.58 -34.3 13.91 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -81.64 -28.64 33.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -1.2 . . . . 0.0 109.645 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.503 HD23 HG22 ' A' ' 260' ' ' VAL . 5.4 mt -80.26 -21.42 42.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.835 -1.166 . . . . 0.0 109.125 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.489 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.3 t80 -71.08 -9.1 57.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 108.692 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 234' ' ' ASP . 14.1 mt -50.02 -28.78 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.425 HD12 HG22 ' A' ' 242' ' ' VAL . 96.7 mt -56.52 -14.02 2.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.088 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.5 15.95 80.23 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 80.8 p -158.59 144.98 12.64 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.257 . . . . 0.0 109.383 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -42.59 130.54 5.25 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.197 1.931 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.425 HG22 HD12 ' A' ' 238' ' ' LEU . 4.0 t -100.36 135.85 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.59 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 125' ' ' VAL . 5.4 mmtp -123.91 127.57 48.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.664 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.78 172.14 23.72 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -101.14 113.87 27.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.59 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.0 m-85 -112.58 147.08 37.4 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.981 0.896 . . . . 0.0 111.306 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.4 t80 -128.86 144.06 51.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 248' ' ' SER . . . . . 0.409 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 28.1 t -139.31 125.39 19.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.697 -1.252 . . . . 0.0 110.005 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 250' ' ' ARG . 71.8 t80 -110.47 113.37 25.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 249' ' ' PHE . 9.6 mmm180 46.43 56.6 6.2 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.73 150.5 21.16 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -118.38 179.82 17.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -68.66 -42.35 78.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -1.143 . . . . 0.0 109.568 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -36.32 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.204 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.703 ' HG ' HD12 ' A' ' 139' ' ' ILE . 57.4 tp -72.54 -36.79 68.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.016 -1.053 . . . . 0.0 108.911 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -60.76 -52.41 65.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.352 -0.842 . . . . 0.0 108.81 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 37.2 t -52.53 -44.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.34 -47.54 75.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.007 -1.058 . . . . 0.0 109.167 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 139' ' ' ILE . 30.8 tp -52.51 -45.07 66.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 108.623 179.397 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.503 HG22 HD23 ' A' ' 235' ' ' LEU . 40.1 t -68.36 -53.29 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 109.465 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -46.7 -45.97 19.84 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.682 -0.636 . . . . 0.0 110.636 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.92 -47.96 64.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.906 -1.121 . . . . 0.0 109.503 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 263' ' ' LEU . 19.7 mt -57.97 -43.66 86.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.05 74.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.282 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.4 mttt . . . . . 0 N--CA 1.489 1.517 0 O-C-N 120.706 -1.246 . . . . 0.0 108.929 179.307 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 55.3 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.401 0.619 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -114.14 131.33 56.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.496 -0.752 . . . . 0.0 109.061 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -132.77 168.86 17.59 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -81.38 139.79 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 110.226 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -70.12 -46.95 63.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.56 -0.712 . . . . 0.0 109.945 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -132.35 163.11 29.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.356 -0.84 . . . . 0.0 110.41 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 136.31 55.32 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.632 0.73 . . . . 0.0 110.861 -179.162 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 113' ' ' ASN . 32.7 mt -117.23 164.99 13.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -150.92 146.49 26.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.813 -1.179 . . . . 0.0 110.192 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -133.69 161.08 35.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.536 -0.727 . . . . 0.0 109.464 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -149.75 136.78 19.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.918 -1.114 . . . . 0.0 109.023 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.87 158.98 18.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 22' ' ' GLU . 1.3 p -85.79 144.14 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.103 -1.233 . . . . 0.0 110.996 -178.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.32 143.57 39.38 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.1 tt -63.55 -44.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 112.621 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.524 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.8 m-70 -87.08 -37.1 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.125 -1.609 . . . . 0.0 112.193 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.402 HG21 ' HG3' ' A' ' 95' ' ' GLU . 28.0 p -81.05 -26.6 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.834 -1.167 . . . . 0.0 109.721 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.95 19.0 62.93 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 23' ' ' TYR . 1.9 tm-20 -104.18 148.75 25.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 4.3 t80 -71.65 134.39 46.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -141.7 158.16 44.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.09 -1.006 . . . . 0.0 109.298 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -137.77 144.85 41.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.258 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.736 HD11 ' HD2' ' A' ' 97' ' ' PRO . 3.0 mt -125.25 144.91 50.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.018 . . . . 0.0 109.606 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.42 HG22 ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -126.4 132.08 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mt -113.1 134.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.049 -1.032 . . . . 0.0 109.573 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.42 ' NE2' HG22 ' A' ' 27' ' ' ILE . 22.5 m-70 -128.62 149.72 72.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.031 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.81 160.51 28.79 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.288 1.992 . . . . 0.0 111.226 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.6 mm-40 -135.23 -174.66 3.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 109.914 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.5 tttt -91.0 155.71 18.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.766 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.423 ' HG3' ' NE2' ' A' ' 117' ' ' GLN . 1.6 mp0 -47.84 145.23 2.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.251 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.62 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.08 27.4 62.44 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.105 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.2 m -80.85 -38.31 28.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.684 -1.48 . . . . 0.0 108.633 179.07 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 -174.21 35.11 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.66 123.51 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 139.36 39.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.953 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 77.6 m-85 -95.79 148.73 22.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.7 t80 -130.65 137.34 49.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -165.38 139.67 4.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.383 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.09 29.73 10.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 110.084 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.58 18.51 79.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.43 HG11 ' HG3' ' A' ' 67' ' ' GLN . 62.3 t -120.51 133.86 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -1.096 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 15.8 m-85 -97.88 134.53 40.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 108.871 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.4 mt -127.73 94.91 36.23 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.495 -0.753 . . . . 0.0 109.4 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.91 142.3 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.095 1.863 . . . . 0.0 111.602 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . . . -88.04 80.22 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.977 -1.077 . . . . 0.0 109.94 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -134.59 152.32 51.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.1 p80 -54.9 -47.16 74.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 50' ' ' HIS . 4.6 mt-10 -44.01 -20.49 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.939 -1.101 . . . . 0.0 109.706 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' HIS . 97.6 m-85 -90.57 4.66 50.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.854 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 50' ' ' HIS . 23.3 t -60.03 120.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 108.921 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 m -111.88 -28.34 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 110.161 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -153.44 122.66 6.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.008 -1.057 . . . . 0.0 109.907 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -115.69 132.68 56.56 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.5 t-20 -166.87 -153.22 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ASN . 76.1 m-70 -45.64 -15.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -136.73 166.16 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.419 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 2.8 m -108.66 125.77 52.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.354 -0.841 . . . . 0.0 108.878 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 60' ' ' THR . 3.5 m-20 -123.47 140.45 53.0 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.073 0.94 . . . . 0.0 111.46 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 72' ' ' VAL . 44.8 mt -122.11 160.24 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.87 141.1 5.83 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.812 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -144.13 149.03 35.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.974 . . . . 0.0 109.236 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.95 38.82 31.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.349 -0.844 . . . . 0.0 110.393 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.95 3.23 80.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.513 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 54.9 mm-40 -96.16 144.96 25.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -1.196 . . . . 0.0 108.605 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.81 143.88 37.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.244 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.71 139.29 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -114.36 151.36 33.15 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.276 -0.89 . . . . 0.0 111.179 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m 54.75 70.22 0.64 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 178.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' A' ' 62' ' ' LEU . 13.7 m -114.29 -8.09 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.068 -1.02 . . . . 0.0 109.846 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -69.52 -19.08 63.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.158 -0.964 . . . . 0.0 111.228 -178.829 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 22.6 m170 -73.5 -58.89 3.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.753 -1.217 . . . . 0.0 109.52 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' LEU . 4.6 tp -58.52 -42.43 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.844 -1.16 . . . . 0.0 108.691 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' ILE . 70.5 mt -58.73 -37.53 76.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.502 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.2 t -59.91 -48.3 82.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.96 -54.16 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 108.455 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.3 mt -51.68 -45.46 63.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 0.0 109.234 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.613 ' HD1' HG22 ' A' ' 232' ' ' ILE . 12.1 t-160 -54.98 -51.87 64.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.787 . . . . 0.0 109.902 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.4 mt -64.9 -38.27 90.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 110.629 -179.081 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.725 HD13 HD11 ' A' ' 114' ' ' ILE . 13.9 mt -79.89 -1.1 37.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 110.612 -178.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 60.14 63.46 1.42 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.013 -1.054 . . . . 0.0 110.401 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.559 HD11 ' HB3' ' A' ' 82' ' ' LEU . 13.3 mm -105.51 127.6 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 121' ' ' ILE . 56.7 p -115.1 -21.22 10.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.314 -0.866 . . . . 0.0 112.03 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.2 m-80 -128.74 111.6 13.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.787 -1.195 . . . . 0.0 110.295 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.6 m -164.19 139.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.196 -0.94 . . . . 0.0 109.89 179.09 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 21.5 m -110.42 99.54 8.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.24 104.98 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.92 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.67 128.47 33.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.612 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.71 108.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 92' ' ' ILE . 4.1 mp -89.06 109.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.81 -155.27 20.09 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -178.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.04 -8.18 8.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.532 -0.981 . . . . 0.0 110.694 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.573 ' OE2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -144.58 150.76 38.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.62 -1.3 . . . . 0.0 111.681 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.6 mm -75.88 122.26 86.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.027 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.736 ' HD2' HD11 ' A' ' 26' ' ' LEU . 80.9 Cg_exo -45.29 133.52 12.05 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.924 1.75 . . . . 0.0 112.198 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.0 tp -76.59 -20.11 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.092 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.584 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 75.8 mt 54.99 -121.91 1.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.48 -7.75 40.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.46 -15.63 38.45 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -111.35 -171.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -1.044 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.07 -1.9 23.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -46.43 -40.95 13.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.694 -0.886 . . . . 0.0 110.086 -179.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.84 -52.31 64.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.838 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 57.3 m-85 -63.05 -44.47 95.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 108.762 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -62.94 -37.18 86.04 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.419 0.628 . . . . 0.0 109.77 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -72.06 -48.0 47.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 111.096 -178.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.77 -51.17 14.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.941 -1.099 . . . . 0.0 110.194 -179.042 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.28 -43.07 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.084 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -54.31 -32.15 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -83.06 -0.87 51.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.139 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.552 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -131.82 33.25 3.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.248 -0.908 . . . . 0.0 111.149 -179.171 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.725 HD11 HD13 ' A' ' 82' ' ' LEU . 7.0 mt -94.05 144.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.513 -1.367 . . . . 0.0 110.125 179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 115' ' ' LEU . 13.4 tp -132.04 161.61 32.78 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -108.66 146.27 33.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.059 -1.026 . . . . 0.0 110.388 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.423 ' NE2' ' HG3' ' A' ' 33' ' ' GLU . 8.4 mt-30 -105.09 -162.41 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.078 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.03 -0.01 12.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.299 -0.875 . . . . 0.0 110.629 -179.208 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 4' ' ' GLU . 17.1 ttm180 -93.28 147.49 22.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.832 -1.167 . . . . 0.0 110.043 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -84.1 131.0 34.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.423 -0.798 . . . . 0.0 109.555 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 85' ' ' THR . 80.1 mt -71.69 141.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.965 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.15 104.39 16.4 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -78.6 146.68 34.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 111.095 -178.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.84 121.9 33.88 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 243' ' ' LYS . 22.0 t -120.82 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.05 136.75 22.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -116.42 -11.22 11.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.735 . . . . 0.0 109.113 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -142.07 142.82 25.77 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.28 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.82 152.64 52.77 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.033 1.822 . . . . 0.0 112.953 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.81 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.2 tt -145.94 141.7 21.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.672 -0.642 . . . . 0.0 109.332 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.521 ' CG2' HD21 ' A' ' 138' ' ' LEU . 1.2 mp -128.29 123.2 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 109.5 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.4 m -118.4 116.69 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.515 -0.74 . . . . 0.0 109.654 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -108.85 140.08 42.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.299 -0.876 . . . . 0.0 109.29 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.41 126.51 2.3 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.735 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.489 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 46.1 mt-10 52.75 39.14 28.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.752 -0.593 . . . . 0.0 112.389 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.52 5.22 89.35 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.424 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.489 ' NH2' ' OE1' ' A' ' 135' ' ' GLU . 5.5 mtt180 -107.05 164.24 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.527 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.005 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.9 tt -159.75 151.2 19.87 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 119.948 -1.72 . . . . 0.0 109.213 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.005 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.1 mt -146.97 130.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -122.8 140.28 53.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.161 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -116.99 148.18 41.66 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -146.19 137.03 12.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.28 144.43 71.38 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.325 1.35 . . . . 0.0 112.166 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.04 148.16 11.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.37 -1.96 43.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.3 p -136.35 150.23 48.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 242' ' ' VAL . 16.6 tp -82.2 117.43 22.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -136.24 137.51 40.87 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.682 ' CG1' HD23 ' A' ' 231' ' ' LEU . 74.0 t -136.92 123.65 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 m -111.15 132.66 54.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.594 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -116.89 129.01 55.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.28 111.59 21.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.06 156.89 15.81 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 250' ' ' ARG . 36.4 mt-10 -138.33 95.16 2.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.349 -1.089 . . . . 0.0 109.387 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -94.78 148.27 22.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 109.616 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -91.17 0.48 57.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.767 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.472 HD21 HD12 ' A' ' 159' ' ' LEU . 11.9 p30 -78.66 -173.6 3.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.355 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -53.21 -18.92 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.208 -179.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.472 HD12 HD21 ' A' ' 157' ' ' ASN . 16.7 mt -65.43 -62.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.018 -1.051 . . . . 0.0 109.659 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.94 -125.3 8.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -109.63 139.35 44.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -1.081 . . . . 0.0 109.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.75 150.45 29.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 152.67 48.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.635 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -136.51 124.78 23.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 0.0 109.109 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 165' ' ' THR . 13.7 t -98.35 122.28 41.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.089 -1.007 . . . . 0.0 110.006 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.4 t80 -97.48 137.28 36.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 108.846 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.556 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -133.2 150.24 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 14.3 mt-10 -56.1 122.35 11.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.05 -18.85 14.0 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -116.16 36.35 4.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.069 -1.253 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.33 -31.57 72.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 110.525 -179.215 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.28 -14.06 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.693 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.28 -3.87 57.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 5.3 pt -122.83 10.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.992 -1.067 . . . . 0.0 111.033 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.93 -31.8 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.867 -1.146 . . . . 0.0 109.958 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.89 2.23 46.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.828 -1.17 . . . . 0.0 110.489 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.71 133.3 35.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -105.41 154.08 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 -179.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -55.65 159.6 2.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.43 166.25 25.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.017 -1.052 . . . . 0.0 110.148 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -152.52 163.25 39.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 109.458 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.548 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 70.7 m-85 -104.53 144.03 32.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.633 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.678 ' HA ' HD12 ' A' ' 186' ' ' ILE . 10.9 p-10 -61.28 -25.91 67.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.817 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.548 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.2 p90 -77.52 -25.32 50.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.776 -1.203 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.465 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 10.0 pt-20 -100.96 -11.9 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 109.993 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 183' ' ' ASP . 6.9 mt -57.34 -52.36 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.116 -0.99 . . . . 0.0 110.449 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.42 -53.72 33.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 0.0 109.975 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -52.88 -42.33 65.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.073 -1.017 . . . . 0.0 109.187 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.07 -33.77 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.021 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -78.69 -26.06 44.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.783 . . . . 0.0 110.335 -179.427 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -32.46 35.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.995 -1.065 . . . . 0.0 110.181 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 194' ' ' LEU . 28.8 m -73.76 8.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.015 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.83 20.48 70.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 192' ' ' VAL . 27.9 mt -117.22 154.86 30.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.196 -1.179 . . . . 0.0 109.764 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 83.3 23.15 55.35 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.421 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -66.2 -23.96 66.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.617 -1.519 . . . . 0.0 109.756 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.07 -5.89 49.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.83 130.69 45.6 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.129 -1.218 . . . . 0.0 110.773 -178.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 6.9 p -134.82 -173.74 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.668 -0.901 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.8 -17.48 29.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -89.11 -8.54 53.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 202' ' ' ASN . 0.5 OUTLIER -127.96 -14.18 5.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.754 -179.627 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -125.4 115.01 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.0 tp -77.14 109.97 11.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 108.668 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 186' ' ' ILE . 44.1 t -97.64 125.92 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 110.012 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 206' ' ' LEU . 28.5 mt -99.1 143.26 29.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.623 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.64 144.46 15.82 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 3.9 pttt -41.52 -23.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -1.191 . . . . 0.0 110.299 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.2 p-10 -152.67 11.92 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.565 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -148.89 157.98 43.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.972 -1.08 . . . . 0.0 110.419 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.55 127.86 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.454 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -73.62 -54.86 7.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.028 -1.045 . . . . 0.0 110.55 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.95 111.35 2.9 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.027 . . . . 0.0 110.169 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.45 -8.49 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.864 1.709 . . . . 0.0 112.292 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -88.06 -7.74 56.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 109.869 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.88 -167.36 48.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.06 145.3 25.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.414 -1.05 . . . . 0.0 110.165 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -88.17 -17.55 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.387 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -144.95 134.41 23.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.39 -23.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.062 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.477 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -124.95 35.72 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.078 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 5.1 tt0 -55.4 -57.97 17.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 111.638 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 10.5 Cg_endo -54.19 -39.96 84.05 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.955 1.77 . . . . 0.0 113.105 -178.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 228' ' ' VAL . 11.5 m -80.2 -26.66 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 120.667 -1.27 . . . . 0.0 109.017 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 18.7 mtt180 -66.65 -43.27 85.04 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.479 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -62.01 -42.35 99.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -56.78 -39.04 73.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 224' ' ' VAL . 48.4 t -66.41 -40.89 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 88.7 t80 -59.1 -37.48 77.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 91.0 m-20 -76.07 -40.87 52.18 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.563 -0.711 . . . . 0.0 109.671 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.682 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.6 tp -55.47 -36.71 66.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 108.836 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.613 HG22 ' HD1' ' A' ' 80' ' ' HIS . 77.9 mt -73.15 -47.75 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.77 -33.92 28.31 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.44 -26.81 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -1.225 . . . . 0.0 109.852 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.74 -20.71 45.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.761 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.583 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 11.9 t80 -74.24 -9.02 58.19 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.145 -0.972 . . . . 0.0 109.193 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 234' ' ' ASP . 18.3 mt -50.91 -28.6 10.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.439 ' O ' ' NH2' ' A' ' 49' ' ' ARG . 62.9 mt -58.11 -11.26 2.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 0.0 108.947 179.211 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.54 16.04 81.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 23.1 p -158.48 150.45 17.3 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.071 -1.252 . . . . 0.0 109.219 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 6.5 Cg_endo -53.28 139.48 63.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.999 1.799 . . . . 0.0 111.519 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.501 ' O ' HD22 ' A' ' 147' ' ' LEU . 14.0 t -102.93 133.45 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.383 -179.139 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.436 ' HB2' HG22 ' A' ' 125' ' ' VAL . 3.9 mmtt -118.38 123.92 46.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.755 . . . . 0.0 109.253 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.34 170.75 22.58 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -101.57 112.72 25.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.188 -1.184 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -112.03 148.15 34.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.921 0.867 . . . . 0.0 111.209 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -130.18 144.19 51.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.8 t -137.77 127.93 26.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.0 110.502 -179.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -111.73 113.89 26.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 154' ' ' GLU . 2.3 mtt85 49.81 56.0 8.54 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.01 142.45 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.94 167.45 13.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -56.5 -45.03 81.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -59.55 -56.01 27.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.662 ' HG ' HD12 ' A' ' 139' ' ' ILE . 52.0 tp -56.83 -36.54 70.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 62.5 m-20 -59.76 -55.5 33.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 108.721 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 36.5 t -51.05 -40.59 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.308 -0.87 . . . . 0.0 109.148 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -54.81 -47.63 73.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 108.916 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 139' ' ' ILE . 59.3 tp -53.34 -47.31 69.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 50' ' ' HIS . 2.8 t -65.98 -43.19 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -51.9 64.93 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.446 -0.783 . . . . 0.0 110.384 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.83 -43.75 95.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.817 -1.177 . . . . 0.0 110.189 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.18 -42.36 96.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.45 -32.71 58.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 110.334 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp . . . . . 0 N--CA 1.489 1.501 0 O-C-N 120.877 -1.139 . . . . 0.0 109.186 179.597 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 33' ' ' GLU . 10.6 mt-10 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 145.9 51.5 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.517 -0.74 . . . . 0.0 109.743 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 177.8 8.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.944 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.66 147.09 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -83.05 -41.17 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.581 -0.699 . . . . 0.0 109.958 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.79 155.18 46.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.955 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -62.9 133.21 54.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.399 -0.813 . . . . 0.0 109.671 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.75 161.96 19.86 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -158.42 152.43 23.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.806 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.8 171.64 14.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.645 -0.66 . . . . 0.0 109.74 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -149.62 137.69 20.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 108.982 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.61 161.0 20.45 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -88.36 144.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -1.199 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.53 141.08 39.97 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.2 tt -62.16 -43.52 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -1.233 . . . . 0.0 111.325 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 8.2 m-70 -87.98 -39.39 14.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.174 -1.579 . . . . 0.0 111.149 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 p -69.06 -40.43 78.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.621 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.27 17.49 78.86 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -114.36 152.58 31.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.989 . . . . 0.0 108.828 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.492 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 5.2 t80 -71.8 139.67 49.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.056 -1.028 . . . . 0.0 110.245 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -146.97 157.72 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 108.819 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 26' ' ' LEU . 25.2 ttpt -127.07 157.71 38.9 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 109.704 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.789 HD11 HG23 ' A' ' 96' ' ' ILE . 12.6 mt -126.56 144.86 50.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.982 -1.074 . . . . 0.0 108.397 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.561 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.2 mt -138.62 132.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.015 179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 28' ' ' ILE . 6.2 mt -120.97 128.09 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 109.914 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.4 m-70 -125.7 149.02 64.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.56 157.64 35.85 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.179 1.92 . . . . 0.0 111.38 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 41.2 mm-40 -135.83 162.9 31.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.5 tttp -64.77 150.37 47.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.5 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.619 ' OE2' ' ND2' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -47.81 148.91 1.42 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.573 -179.373 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.44 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 59.86 25.45 61.6 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.527 -0.733 . . . . 0.0 112.089 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.5 m -80.16 -37.07 34.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.467 -1.608 . . . . 0.0 109.068 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 -172.69 32.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -100.42 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.164 -1.198 . . . . 0.0 108.338 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -139.4 143.81 37.84 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.392 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.5 153.63 19.54 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.8 t80 -124.3 147.93 47.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.411 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 13.5 tttt -173.75 133.48 0.46 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.777 -1.202 . . . . 0.0 109.218 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.639 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER 52.95 29.54 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.493 -0.754 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.71 -9.88 48.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.62 ' CG2' HD21 ' A' ' 42' ' ' ASN . 20.6 t -94.43 139.34 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -1.227 . . . . 0.0 110.22 -179.584 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -97.36 146.2 25.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.419 -0.801 . . . . 0.0 108.923 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 67' ' ' GLN . 53.5 mt -138.1 97.03 9.93 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.47 141.19 33.81 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.243 1.962 . . . . 0.0 111.499 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.19 84.31 5.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.878 -1.139 . . . . 0.0 110.58 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -141.27 157.62 44.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.135 -0.978 . . . . 0.0 109.284 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.648 ' ND1' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -52.52 -49.74 64.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.117 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -48.77 -16.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 110.076 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' HIS . 73.4 m-85 -97.37 6.08 48.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.052 -1.03 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 50' ' ' HIS . 22.8 t -64.59 129.31 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.951 . . . . 0.0 109.383 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.62 -29.51 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.38 -0.825 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.441 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 7.8 t-80 -152.92 122.61 6.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.788 -1.195 . . . . 0.0 109.814 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.6 p -113.34 133.12 55.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.7 t-20 -166.98 -154.04 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.599 ' CE1' HD11 ' A' ' 189' ' ' ILE . 0.2 OUTLIER -47.04 -13.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.069 -1.02 . . . . 0.0 108.317 178.945 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -135.23 165.7 24.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.591 -0.693 . . . . 0.0 109.401 -179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.446 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 7.4 m -103.93 122.24 44.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 108.604 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -120.2 136.92 54.47 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.053 0.93 . . . . 0.0 111.528 -178.692 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HG ' HG21 ' A' ' 72' ' ' VAL . 76.8 mt -117.69 158.21 25.11 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.77 143.11 6.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.652 -1.737 . . . . 0.0 110.908 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.08 151.55 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.617 -0.931 . . . . 0.0 109.758 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp 56.79 27.61 13.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.521 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.52 -0.43 83.05 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 91.3 mm-40 -94.84 138.77 32.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.968 -1.313 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -134.28 146.7 50.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.963 . . . . 0.0 111.27 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.4 mt -134.89 145.88 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -114.61 152.75 31.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.222 -0.924 . . . . 0.0 111.799 -178.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 71' ' ' THR . 45.7 m 53.94 71.68 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.557 . . . . 0.0 111.307 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.445 HG21 ' HG ' ' A' ' 62' ' ' LEU . 19.1 m -113.5 -1.44 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.033 -1.042 . . . . 0.0 109.286 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.54 -39.59 73.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 110.576 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -54.38 -60.59 3.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.066 -1.021 . . . . 0.0 110.241 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -58.54 -46.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 109.232 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' N ' HG23 ' A' ' 75' ' ' ILE . 64.8 mt -55.49 -38.72 69.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.074 -1.016 . . . . 0.0 109.43 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -59.01 -48.24 82.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.564 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.2 -54.18 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 108.499 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -52.39 -46.38 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.507 -0.746 . . . . 0.0 109.246 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.618 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 15.4 t-160 -55.58 -53.69 53.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.827 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.89 -38.63 91.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.363 -0.836 . . . . 0.0 110.368 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.633 ' HB3' HD11 ' A' ' 84' ' ' ILE . 12.7 mt -78.37 -4.46 48.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.736 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.28 51.55 2.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.729 -1.232 . . . . 0.0 110.405 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.7 mm -98.45 124.46 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.413 HG21 HG12 ' A' ' 121' ' ' ILE . 20.5 p -111.55 -18.95 12.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.322 -0.861 . . . . 0.0 112.437 -177.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.71 ' O ' HG13 ' A' ' 87' ' ' VAL . 18.3 m-20 -129.94 111.86 12.96 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.512 -1.367 . . . . 0.0 110.633 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.7 m -164.62 143.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.228 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.542 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.7 m -112.19 101.07 9.34 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.436 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mt -92.1 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.579 -0.701 . . . . 0.0 109.706 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.71 123.08 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.736 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 t -107.46 106.27 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 110.954 -178.778 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.22 111.02 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.12 -161.62 23.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -115.37 -14.51 11.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.534 ' OE1' ' O ' ' A' ' 96' ' ' ILE . 1.2 tm-20 -140.86 146.61 37.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.995 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.789 HG23 HD11 ' A' ' 26' ' ' LEU . 3.3 mm -68.95 124.06 89.49 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 109.97 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.57 130.99 9.64 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.083 1.855 . . . . 0.0 112.171 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 16' ' ' VAL . 8.2 tp -78.53 -30.27 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.451 -0.78 . . . . 0.0 109.727 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt 56.48 -108.77 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.805 . . . . 0.0 110.129 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -94.17 -22.9 18.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 110.736 -178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.44 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 115.49 -10.23 19.48 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.23 -170.95 1.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -1.024 . . . . 0.0 109.757 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.07 -4.67 25.68 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.404 ' NE1' ' HG3' ' A' ' 108' ' ' GLU . 51.2 t-105 -46.29 -38.8 9.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.707 -0.878 . . . . 0.0 110.302 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.42 -52.04 66.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 110.013 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.56 -43.4 97.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 108.695 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 18.7 t80 -63.64 -36.71 84.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.74 -0.6 . . . . 0.0 110.014 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.404 ' HG3' ' NE1' ' A' ' 104' ' ' TRP . 2.4 mm-40 -72.75 -49.94 27.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.28 -0.887 . . . . 0.0 111.956 -178.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.38 -44.55 58.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.824 -1.172 . . . . 0.0 110.977 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.2 -39.97 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.073 . . . . 0.0 110.391 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 16.0 tpt180 -54.11 -32.59 55.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 0.0 109.759 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -82.1 -13.41 57.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.929 -1.107 . . . . 0.0 110.14 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -121.37 32.07 6.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 111.018 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.559 HD11 HD13 ' A' ' 82' ' ' LEU . 6.1 mt -82.74 148.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.509 -1.37 . . . . 0.0 110.373 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -128.63 149.57 50.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -97.68 146.14 25.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.042 -1.036 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.418 ' CD ' HD21 ' A' ' 86' ' ' ASN . 1.0 OUTLIER -109.56 -168.45 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.0 109.813 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -124.43 72.73 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.513 -0.742 . . . . 0.0 110.589 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 119' ' ' ARG . 6.2 ttm-85 -168.63 149.48 4.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.968 . . . . 0.0 109.461 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -83.3 126.87 33.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.413 HG12 HG21 ' A' ' 85' ' ' THR . 18.4 mt -67.09 135.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.456 -0.778 . . . . 0.0 110.765 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.52 73.69 1.94 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -52.31 141.31 19.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.538 -0.726 . . . . 0.0 110.479 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -104.99 125.57 51.12 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 243' ' ' LYS . 67.8 t -128.75 142.88 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.253 -0.904 . . . . 0.0 110.266 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.13 135.26 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -116.53 -11.43 11.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.214 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.42 143.62 30.8 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.05 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.61 161.51 41.9 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.109 1.873 . . . . 0.0 113.182 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.9 tt -155.4 140.0 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.65 -0.656 . . . . 0.0 109.584 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 131' ' ' ILE . 2.4 mp -127.86 124.33 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.4 m -121.36 118.84 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.724 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -115.58 133.6 55.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.417 -0.802 . . . . 0.0 109.583 179.862 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 34.1 t0 -173.43 150.65 1.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.18 -0.95 . . . . 0.0 110.759 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 10.9 mt-10 57.57 22.32 8.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.541 -0.724 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.26 6.99 88.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.537 ' HB2' HD22 ' A' ' 255' ' ' LEU . 5.4 mtt85 -105.34 171.64 7.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.196 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.953 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.1 tt -159.63 149.57 18.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.457 -1.402 . . . . 0.0 109.028 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.953 ' N ' HD23 ' A' ' 138' ' ' LEU . 12.0 mt -147.69 139.06 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -131.26 142.68 50.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.118 -0.989 . . . . 0.0 109.654 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.35 145.82 48.44 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -142.48 135.1 13.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.53 147.96 36.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.272 1.315 . . . . 0.0 112.053 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.99 154.23 8.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.364 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.98 0.73 50.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -136.98 151.79 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 242' ' ' VAL . 34.1 tp -87.37 117.92 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 110.027 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -136.18 142.93 44.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.668 ' CG1' HD23 ' A' ' 231' ' ' LEU . 69.5 t -135.93 118.31 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 109.907 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 3.5 m -105.19 127.1 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.178 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -121.36 130.07 53.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -112.27 104.94 13.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.067 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.1 129.51 9.93 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.62 97.32 6.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -1.091 . . . . 0.0 109.169 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 160' ' ' GLY . 24.5 m-85 -99.63 148.92 23.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.188 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -92.87 -10.17 37.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.821 . . . . 0.0 109.934 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.554 HD22 HD12 ' A' ' 159' ' ' LEU . 38.0 p-10 -70.34 -167.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.918 . . . . 0.0 110.103 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -60.12 -24.49 64.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.355 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.554 HD12 HD22 ' A' ' 157' ' ' ASN . 6.6 mt -64.93 -40.65 95.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.939 -1.101 . . . . 0.0 108.871 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 76.97 -107.52 2.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -122.01 140.69 52.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.937 . . . . 0.0 109.692 -179.577 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -144.44 158.04 43.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -142.89 144.48 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -137.01 123.89 21.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.344 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 9.1 m -104.67 124.55 49.55 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.204 -0.935 . . . . 0.0 110.198 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -99.67 130.13 45.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.265 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.24 147.78 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.502 -0.749 . . . . 0.0 109.46 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.04 115.62 1.49 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.349 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.22 4.89 17.75 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -133.45 28.85 3.98 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.304 -1.115 . . . . 0.0 108.3 179.357 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.75 -33.26 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.733 -0.604 . . . . 0.0 110.473 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -58.55 -9.97 1.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.085 -1.009 . . . . 0.0 110.697 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.38 -4.84 33.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.791 -1.193 . . . . 0.0 110.793 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.3 pt -117.65 13.05 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 110.722 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.13 -26.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.018 -1.051 . . . . 0.0 110.027 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.6 0.8 57.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.85 -1.156 . . . . 0.0 110.706 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.51 115.39 20.0 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.994 -1.067 . . . . 0.0 109.006 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -84.02 151.68 24.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.135 -0.978 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 t -59.24 132.64 54.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.323 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -110.96 170.2 8.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.983 -179.352 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 1.8 t -154.21 162.99 40.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.441 -0.787 . . . . 0.0 109.475 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.473 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 71.5 m-85 -104.6 144.6 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.407 -0.808 . . . . 0.0 109.495 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.0 OUTLIER -61.67 -25.85 67.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.756 -1.215 . . . . 0.0 110.385 -179.372 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.0 p90 -81.83 -30.09 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.8 -1.188 . . . . 0.0 110.413 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.5 pt-20 -87.41 -16.96 33.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.784 -1.197 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.705 HD12 ' HA ' ' A' ' 183' ' ' ASP . 10.0 mt -57.83 -53.36 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.149 -0.969 . . . . 0.0 110.131 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.52 -53.19 40.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.919 -1.113 . . . . 0.0 109.624 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.87 -44.51 66.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 109.053 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 58' ' ' HIS . 3.7 mt -64.85 -33.42 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.065 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -78.3 -27.73 47.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -76.78 -28.15 55.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 109.937 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.4 m -82.61 9.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 109.782 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.56 72.78 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.633 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.8 157.93 27.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.211 -1.17 . . . . 0.0 109.669 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.63 21.64 63.61 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.148 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.36 -22.89 63.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.588 -1.537 . . . . 0.0 109.87 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -100.65 -3.16 55.26 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.6 128.74 35.73 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 121.086 -1.243 . . . . 0.0 110.459 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.29 162.23 34.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.738 -0.86 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.93 -31.45 72.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.962 . . . . 0.0 110.105 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -75.47 -14.6 60.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.07 -1.019 . . . . 0.0 110.248 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.34 9.87 5.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.7 m -150.36 123.56 8.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.42 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.16 115.49 22.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.189 -0.944 . . . . 0.0 109.24 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 186' ' ' ILE . 53.1 t -101.56 126.75 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.4 mt -102.44 141.91 34.51 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.456 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.06 149.6 19.1 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.1 OUTLIER -42.24 -29.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.895 -179.578 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 8.5 t0 -149.71 14.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 110.163 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 207' ' ' GLY . 9.9 mtpm? -146.85 155.71 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.038 . . . . 0.0 110.272 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.5 t -101.44 127.6 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.78 -54.63 8.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.329 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.14 131.32 68.69 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.938 -1.101 . . . . 0.0 109.325 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.03 -14.57 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.175 1.917 . . . . 0.0 112.574 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.78 -6.12 59.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.126 -0.984 . . . . 0.0 109.724 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.22 -167.93 51.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 49.6 mt -82.79 146.15 29.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -1.013 . . . . 0.0 109.935 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -89.48 -20.74 23.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.241 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.475 ' C ' ' N ' ' A' ' 221' ' ' ASN . 69.2 m-85 -141.57 139.51 33.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.377 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.492 ' C ' ' ND2' ' A' ' 221' ' ' ASN . 0.4 OUTLIER -52.58 -11.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 108.6 179.203 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.492 ' ND2' ' C ' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -141.87 38.03 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.731 0.777 . . . . 0.0 109.066 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.4 OUTLIER -58.18 -36.54 45.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 111.05 -179.472 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.47 -44.3 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.837 1.691 . . . . 0.0 112.54 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 228' ' ' VAL . 3.0 m -76.14 -24.45 16.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.765 -1.209 . . . . 0.0 108.49 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -67.64 -41.87 83.2 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -63.08 -42.78 99.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.78 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -56.66 -47.63 79.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.068 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 224' ' ' VAL . 58.4 t -59.59 -44.54 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.417 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 61.3 t80 -55.13 -37.42 66.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.645 -0.66 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 3.7 m-20 -76.34 -38.84 55.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.499 -0.751 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.668 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.9 tp -56.92 -37.62 71.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.092 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.57 HG22 ' HD1' ' A' ' 80' ' ' HIS . 74.2 mt -73.1 -48.61 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.07 -34.56 16.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.22 -26.89 32.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -1.13 . . . . 0.0 110.189 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 260' ' ' VAL . 5.5 mt -78.13 -22.62 48.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 109.758 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.618 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 6.6 t80 -70.45 -5.4 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.105 -0.997 . . . . 0.0 108.83 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 237' ' ' LEU . 14.0 mt -52.24 -30.55 28.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.522 HD12 HG22 ' A' ' 242' ' ' VAL . 87.7 mt -56.29 -17.9 9.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 82.96 14.51 74.93 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.4 p -158.31 151.89 19.25 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.245 . . . . 0.0 109.458 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -49.94 131.31 29.64 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.161 1.907 . . . . 0.0 111.511 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.522 HG22 HD12 ' A' ' 238' ' ' LEU . 19.6 t -98.07 135.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 109.877 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.615 ' HB3' HG22 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -122.12 126.03 47.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.466 -0.771 . . . . 0.0 109.447 179.768 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.61 170.37 21.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -99.79 113.47 26.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.048 -1.266 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.3 m-85 -112.12 148.44 33.97 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.073 0.94 . . . . 0.0 111.148 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.408 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 24.1 t80 -128.15 144.53 51.12 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.39 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.1 t -144.86 124.82 13.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.42 -1.425 . . . . 0.0 110.413 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.418 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.3 t80 -109.8 116.55 31.88 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.6 OUTLIER 45.31 56.33 5.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.314 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -88.01 152.66 23.94 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -120.0 -177.81 16.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.15 -51.51 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 0.0 109.714 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -34.54 70.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.985 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 137' ' ' ARG . 48.6 tp -72.87 -40.34 65.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.016 . . . . 0.0 108.834 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -61.01 -51.06 70.84 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.2 t -51.32 -44.58 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.0 109.171 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -54.88 -49.11 71.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 108.905 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 139' ' ' ILE . 24.9 tp -52.93 -40.14 63.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.822 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 235' ' ' LEU . 60.7 t -74.72 -41.54 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.442 -0.786 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.54 -48.16 82.74 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 110.158 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -47.45 73.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.932 -1.105 . . . . 0.0 109.621 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 263' ' ' LEU . 12.7 mt -58.51 -43.74 89.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.325 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.429 ' HB1' ' HE2' ' A' ' 50' ' ' HIS . . . -66.03 -32.27 73.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 110.084 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm . . . . . 0 N--CA 1.49 1.553 0 O-C-N 120.725 -1.234 . . . . 0.0 108.865 179.245 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 67.7 mt-10 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.63 139.33 53.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.596 -0.69 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -138.57 173.8 11.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.459 -0.776 . . . . 0.0 108.92 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -84.41 141.39 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.722 -1.236 . . . . 0.0 110.278 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -71.15 -44.47 65.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.661 -0.649 . . . . 0.0 109.957 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.03 159.56 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 136.3 57.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.717 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 157.36 25.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -147.57 145.57 29.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 110.186 -179.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -132.17 163.37 28.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.99 135.57 19.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.889 -1.132 . . . . 0.0 108.718 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 159.13 19.08 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.62 146.8 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.243 . . . . 0.0 110.762 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.71 143.62 38.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.1 tt -67.74 -38.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.149 . . . . 0.0 112.786 -178.318 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.477 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.9 m-70 -85.93 -35.4 20.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 119.842 -1.786 . . . . 0.0 112.041 -177.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.47 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 5.2 m -85.21 -39.92 17.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.24 16.03 72.79 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -103.39 150.41 23.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -1.125 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.8 t80 -71.34 139.19 49.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.3 t -146.25 157.8 43.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.022 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.68 ' O ' HD23 ' A' ' 26' ' ' LEU . 44.4 tttt -132.85 155.78 48.37 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.882 . . . . 0.0 109.533 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.691 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -132.58 144.97 50.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.032 . . . . 0.0 109.103 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.9 129.16 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.3 mt -113.43 123.55 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -117.7 153.32 50.64 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.19 159.28 47.77 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.327 2.018 . . . . 0.0 111.19 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.2 mm-40 -134.12 -178.37 5.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.016 -1.052 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' O ' ' OG1' ' A' ' 35' ' ' THR . 25.3 tttt -83.04 149.34 27.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.463 -0.773 . . . . 0.0 109.317 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.638 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.3 OUTLIER -46.86 148.27 1.11 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.235 -0.916 . . . . 0.0 110.064 -179.487 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.608 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.49 24.38 59.35 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.18 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 15.5 m -80.55 -37.64 31.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.673 -1.486 . . . . 0.0 108.961 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' C ' HD13 ' A' ' 37' ' ' ILE . . . 93.9 -167.09 27.87 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 ' C ' ' A' ' 36' ' ' GLY . 2.8 mm -104.02 123.49 57.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -1.103 . . . . 0.0 108.287 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 139.09 42.08 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.969 -1.093 . . . . 0.0 110.863 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -99.7 151.54 21.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.568 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.1 t80 -129.49 139.52 51.55 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -170.86 138.76 1.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.016 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.48 28.65 17.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.85 . . . . 0.0 110.022 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.88 22.13 78.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 t -130.83 146.76 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.246 -1.149 . . . . 0.0 109.46 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -98.7 147.75 24.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.173 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 67' ' ' GLN . 38.6 mt -140.7 94.64 8.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.77 142.55 18.72 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.206 1.937 . . . . 0.0 111.841 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.52 83.11 6.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.429 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -137.72 153.44 49.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 p80 -52.78 -49.6 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 110.421 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.2 mt-10 -44.29 -30.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.084 -1.01 . . . . 0.0 109.285 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.419 ' O ' HG13 ' A' ' 54' ' ' VAL . 58.9 m-85 -79.43 3.94 16.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 HG11 ' A' ' 257' ' ' VAL . 9.5 t -56.62 131.65 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 52' ' ' PHE . 28.1 m -122.32 -35.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.341 -0.849 . . . . 0.0 110.428 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.5 t-160 -150.2 119.74 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.272 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.2 p -113.37 131.48 55.96 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.375 0.607 . . . . 0.0 109.465 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.607 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -167.1 -153.25 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.717 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 57' ' ' ASN . 13.6 m-70 -45.55 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.067 -1.02 . . . . 0.0 108.681 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 57' ' ' ASN . 10.9 t -135.41 165.7 24.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.365 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 m -104.08 122.5 45.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.778 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 3.4 m-20 -121.39 139.78 53.0 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.092 0.949 . . . . 0.0 111.434 -178.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.56 158.08 29.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.75 144.82 7.61 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.639 -1.743 . . . . 0.0 110.687 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -144.24 150.9 38.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.53 -0.983 . . . . 0.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm 56.75 23.87 8.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.0 110.941 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.98 70.45 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.718 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.495 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 75.5 mm-40 -98.2 142.15 30.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.971 -1.311 . . . . 0.0 108.222 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -138.33 150.99 47.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 111.365 -179.054 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.63 143.04 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -110.73 149.81 29.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.223 -0.923 . . . . 0.0 111.236 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m 54.21 67.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 111.471 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 96' ' ' ILE . 16.6 m -113.48 -3.56 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 108.997 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pt-20 -71.39 -26.0 62.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.318 -179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -65.6 -60.51 2.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 0.0 109.635 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.6 tp -56.74 -44.1 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.124 -0.985 . . . . 0.0 108.922 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.516 ' N ' HG23 ' A' ' 75' ' ' ILE . 7.7 mt -55.79 -38.23 69.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.993 . . . . 0.0 109.46 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.547 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.8 t -60.84 -49.02 79.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.656 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.0 t -57.19 -54.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.012 . . . . 0.0 108.585 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -51.63 -44.32 62.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 11.7 t-160 -54.42 -53.52 53.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.856 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.85 -36.95 84.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.768 HD22 ' CD1' ' A' ' 114' ' ' ILE . 11.9 mt -76.36 -7.48 55.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.138 -179.379 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.06 47.37 4.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.598 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 82' ' ' LEU . 12.3 mm -92.4 122.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.621 HG21 HG23 ' A' ' 121' ' ' ILE . 81.7 p -111.26 -21.83 11.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.283 -0.885 . . . . 0.0 112.134 -177.531 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.636 ' O ' HG13 ' A' ' 87' ' ' VAL . 5.8 m-80 -126.22 111.35 14.49 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.789 -1.195 . . . . 0.0 109.677 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -164.69 140.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.165 -0.959 . . . . 0.0 109.957 179.407 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.5 m -110.81 99.58 8.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.03 110.1 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.9 122.27 30.54 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.65 108.44 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 111.003 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.16 110.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.91 -160.06 22.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.43 -15.26 9.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -136.19 142.1 44.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.204 -179.56 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 72' ' ' VAL . 3.0 mm -68.23 126.22 92.44 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.53 -0.731 . . . . 0.0 109.707 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.691 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.3 Cg_exo -45.98 131.25 13.73 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.946 1.764 . . . . 0.0 112.388 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.34 -26.34 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.455 -0.778 . . . . 0.0 109.827 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 10.1 mt 54.65 -111.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -95.55 -17.71 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.911 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.03 0.84 33.83 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.0 p -129.27 -167.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.982 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -4.92 19.62 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.568 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 63.0 t-105 -47.1 -41.13 16.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.775 -0.838 . . . . 0.0 110.413 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.63 -51.89 66.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 109.967 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -62.56 -43.99 97.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 108.828 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.1 t80 -63.52 -39.21 93.84 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.481 0.658 . . . . 0.0 110.059 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.568 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 18.8 mm-40 -69.78 -48.63 58.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.44 -0.787 . . . . 0.0 111.479 -178.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.45 -51.35 11.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.927 -1.108 . . . . 0.0 110.965 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.92 -43.89 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.009 -1.057 . . . . 0.0 110.967 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -28.88 63.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 109.802 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -13.07 59.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.012 -1.055 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.97 34.3 5.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.594 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.768 ' CD1' HD22 ' A' ' 82' ' ' LEU . 12.4 mt -90.77 147.54 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.797 -1.189 . . . . 0.0 110.474 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 115' ' ' LEU . 14.1 tp -131.75 158.59 40.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.063 179.137 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -101.75 146.16 28.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.681 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.638 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 9.2 mt-30 -112.66 -166.42 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 0.0 109.616 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.96 72.53 1.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 110.672 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -163.3 140.68 7.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 109.748 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 121' ' ' ILE . 3.0 tm-20 -78.31 124.09 27.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.343 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 85' ' ' THR . 1.0 OUTLIER -71.58 141.04 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.724 -178.894 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -85.36 86.43 7.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -63.24 146.7 52.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.6 122.65 44.24 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.1 138.46 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.333 -0.854 . . . . 0.0 110.461 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.06 136.23 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -117.78 -9.12 10.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.03 143.57 28.63 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.407 -0.808 . . . . 0.0 109.162 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.66 161.63 44.65 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.232 1.955 . . . . 0.0 112.989 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.971 HG22 ' HB3' ' A' ' 141' ' ' ALA . 11.5 tt -150.64 144.0 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.651 -0.656 . . . . 0.0 109.46 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -131.17 122.55 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.46 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 132' ' ' VAL . 26.9 m -123.55 118.79 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.466 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -120.28 136.32 54.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.49 -0.756 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.19 150.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 110.503 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 55.94 24.45 7.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.653 . . . . 0.0 110.996 179.047 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.95 87.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -108.77 169.12 8.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.074 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.011 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -159.95 153.57 22.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.151 -1.593 . . . . 0.0 109.465 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.011 ' N ' HD23 ' A' ' 138' ' ' LEU . 37.5 mt -148.57 136.05 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.173 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -126.14 142.1 51.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.996 -179.073 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.971 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.13 148.12 44.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 5.0 tm-20 -145.97 137.48 12.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.487 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 8.3 Cg_endo -53.84 146.5 45.64 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.744 1.63 . . . . 0.0 112.605 -179.147 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.75 11.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.21 1.43 48.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -137.88 150.33 47.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.479 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 24.2 tp -81.88 117.16 21.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 110.042 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -138.69 136.3 35.69 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.541 ' CG1' HD23 ' A' ' 231' ' ' LEU . 42.8 t -137.18 139.62 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.92 . . . . 0.0 109.985 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.0 m -125.15 140.37 52.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.335 -0.853 . . . . 0.0 109.625 179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' A' ' 228' ' ' VAL . 85.7 t80 -125.51 129.97 50.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.707 . . . . 0.0 109.81 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -115.07 111.17 20.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -106.0 146.87 16.13 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -128.15 86.19 2.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -1.093 . . . . 0.0 109.233 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.9 m-30 -94.28 149.2 21.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.95 -9.67 47.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.521 -0.737 . . . . 0.0 110.433 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.548 HD21 HD12 ' A' ' 159' ' ' LEU . 23.7 p-10 -66.48 -172.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.022 -1.049 . . . . 0.0 109.616 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -55.2 -24.54 27.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.05 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.548 HD12 HD21 ' A' ' 157' ' ' ASN . 12.4 mt -63.93 -43.01 97.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.044 -1.035 . . . . 0.0 109.432 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.78 -119.9 5.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -114.8 140.88 48.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.421 -1.046 . . . . 0.0 109.311 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.02 140.27 16.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.813 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -124.42 151.76 44.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.521 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 81.1 t80 -136.03 121.12 18.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -0.933 . . . . 0.0 109.05 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 48.7 m -99.47 122.72 42.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 167' ' ' VAL . 2.3 t80 -95.79 134.34 38.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.527 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.8 t -129.69 157.5 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.533 -0.73 . . . . 0.0 109.319 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.696 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 28.9 mp0 -60.48 116.17 4.12 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.58 6.17 17.72 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -135.87 29.74 3.13 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.037 -1.272 . . . . 0.0 108.918 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.97 -30.7 70.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 110.405 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -54.34 -9.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 110.66 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.88 -4.22 25.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.905 -1.122 . . . . 0.0 111.256 -178.625 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.563 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.3 pt -116.66 13.4 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.041 -1.037 . . . . 0.0 110.979 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.47 -28.6 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.071 -1.018 . . . . 0.0 109.612 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 104' ' ' TRP . 1.1 mp -91.08 0.28 57.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.737 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.85 119.51 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 108.239 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -88.45 150.11 23.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.197 . . . . 0.0 109.963 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 179' ' ' THR . 1.9 t -58.06 129.37 41.63 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' PHE . . . . . 0.488 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 14.6 p90 -109.16 166.53 10.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -153.99 159.79 41.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.498 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.594 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 67.9 m-85 -104.08 147.21 27.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.717 ' HA ' HD12 ' A' ' 186' ' ' ILE . 49.0 p30 -60.07 -22.58 62.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.08 -1.013 . . . . 0.0 110.116 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.8 p90 -81.99 -33.08 30.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.91 -1.119 . . . . 0.0 110.53 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 24.4 pt-20 -85.16 -16.39 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.803 -1.185 . . . . 0.0 109.345 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.9 mt -59.24 -53.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.235 -0.915 . . . . 0.0 110.058 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 184' ' ' TRP . 2.9 mp0 -51.49 -53.57 36.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.196 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -47.66 65.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 108.924 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.29 -34.1 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.0 108.76 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -80.13 -25.87 39.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.843 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.01 -21.27 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.458 ' CG2' HD12 ' A' ' 194' ' ' LEU . 23.7 m -90.7 13.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.43 25.65 72.16 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.458 HD12 ' CG2' ' A' ' 192' ' ' VAL . 23.3 mt -127.15 167.2 16.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.237 -1.155 . . . . 0.0 109.918 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.9 16.98 80.3 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.457 -0.777 . . . . 0.0 111.314 178.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -64.11 -51.97 61.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.601 -1.529 . . . . 0.0 109.235 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -70.2 -4.38 49.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -178.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.66 130.0 39.67 Favored Glycine 0 N--CA 1.493 2.472 0 O-C-N 120.96 -1.318 . . . . 0.0 110.641 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -143.26 173.58 11.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.749 -0.854 . . . . 0.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 200' ' ' LEU . 87.2 mt -79.71 -1.81 40.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.641 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -97.24 -10.45 25.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -139.44 13.29 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.516 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 18.0 m -149.29 133.18 17.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.139 -0.975 . . . . 0.0 109.935 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.55 117.23 29.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 108.528 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -105.92 126.59 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.962 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.05 144.15 33.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 0.0 109.396 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 207' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 208' ' ' LYS . . . -102.91 153.24 18.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 207' ' ' GLY . 18.0 pttm -41.64 -32.52 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -151.32 13.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.951 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -139.24 147.36 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.6 t -98.2 125.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.032 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -73.0 -54.63 8.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -52.41 139.13 38.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.879 -1.138 . . . . 0.0 109.508 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.21 -38.07 4.05 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.386 2.057 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.49 -4.4 22.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.51 -168.88 53.73 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.47 149.05 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -1.12 . . . . 0.0 109.618 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -58.26 3.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 108.958 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -117.5 170.84 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.94 -18.03 60.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.113 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.516 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -128.23 29.98 5.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 109.537 -179.784 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 pp20? -62.95 -25.06 1.56 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 112.537 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 1.1 Cg_endo -80.57 -46.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.079 1.421 . . . . 0.0 112.082 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 228' ' ' VAL . 1.2 m -73.04 -22.1 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.885 -1.135 . . . . 0.0 108.005 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.521 ' NE ' ' CE1' ' A' ' 164' ' ' PHE . 48.8 mtt180 -71.35 -49.63 40.38 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -55.07 -42.57 72.93 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.106 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -45.49 83.14 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 224' ' ' VAL . 30.9 t -60.76 -50.15 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 65.2 t80 -49.45 -37.36 25.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 11.1 m-20 -74.65 -39.19 62.22 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.591 -0.693 . . . . 0.0 109.737 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.541 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.64 -36.76 69.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 109.267 -179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' HIS . 96.9 mt -72.33 -48.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.67 -32.79 17.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.41 -28.07 31.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.187 -1.184 . . . . 0.0 109.899 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 260' ' ' VAL . 5.1 mt -79.75 -23.04 42.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.876 -1.14 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.526 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.4 t80 -71.44 -8.21 52.39 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.035 -1.041 . . . . 0.0 109.09 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 237' ' ' LEU . 35.7 mt -52.85 -25.87 12.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 242' ' ' VAL . 46.9 mt -58.56 -21.92 54.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 108.845 179.098 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.49 65.99 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.1 p -158.19 149.61 16.77 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.561 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.402 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 3.7 Cg_exo -48.16 134.32 24.58 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.12 1.88 . . . . 0.0 111.583 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 242' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 238' ' ' LEU . 24.1 t -100.2 133.28 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.024 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -120.25 125.07 47.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.46 172.46 23.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -101.63 117.43 34.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.046 -1.267 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 149' ' ' VAL . 29.9 m-85 -117.49 147.73 42.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.115 0.96 . . . . 0.0 111.185 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -130.08 138.26 50.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.91 127.01 31.59 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.801 -1.187 . . . . 0.0 110.361 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.443 ' O ' ' C ' ' A' ' 250' ' ' ARG . 43.1 t80 -109.22 114.45 28.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.482 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER 44.31 55.95 5.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.799 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.69 145.88 27.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.3 162.84 12.24 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.647 ' O ' HG23 ' A' ' 257' ' ' VAL . 69.8 m-70 -56.47 -50.12 72.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 109.825 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 t -59.07 -55.88 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.656 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.56 -39.67 61.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.079 -1.013 . . . . 0.0 109.508 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -58.24 -54.73 43.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.16 -0.963 . . . . 0.0 108.421 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 253' ' ' HIS . 13.5 t -48.8 -41.63 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.362 -0.836 . . . . 0.0 109.47 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -55.28 -48.96 73.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 108.821 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 27.8 tp -52.36 -41.92 63.5 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.445 HG22 HD23 ' A' ' 235' ' ' LEU . 41.1 t -70.57 -45.31 74.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.596 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -53.62 -51.06 64.27 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.451 -0.78 . . . . 0.0 110.265 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -63.19 -47.59 81.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 109.861 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 263' ' ' LEU . 88.3 mt -59.79 -44.5 93.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.291 -0.881 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 108.762 179.252 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.449 ' O ' HD11 ' A' ' 121' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.593 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -51.83 136.8 27.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 134.63 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.667 -0.646 . . . . 0.0 109.458 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -133.62 170.96 14.77 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 7' ' ' VAL . 6.4 m -81.94 132.68 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.665 -1.272 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -49.09 77.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 0.0 109.724 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -128.51 158.24 38.93 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.454 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HE3' HG23 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -58.65 138.73 56.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.573 -0.704 . . . . 0.0 110.254 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.94 161.86 24.55 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -157.91 150.02 22.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.985 -1.072 . . . . 0.0 110.374 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -137.48 160.49 38.99 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.803 . . . . 0.0 109.948 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.11 138.9 24.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.563 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.19 158.56 16.63 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.46 161.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -1.128 . . . . 0.0 111.069 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.32 140.29 14.96 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.621 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.8 tt -57.57 -52.87 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.133 -1.216 . . . . 0.0 112.451 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.621 ' N ' HG23 ' A' ' 18' ' ' ILE . 15.4 m-70 -86.63 -37.67 17.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.175 -1.578 . . . . 0.0 111.195 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m -75.01 -35.29 61.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.016 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 26.53 71.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.09 152.56 33.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.936 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.5 OUTLIER -71.75 129.56 38.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.953 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.6 t -135.86 156.43 48.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 108.943 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.567 ' C ' HD23 ' A' ' 26' ' ' LEU . 8.2 tttp -135.55 148.26 49.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.065 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.2 mt -126.18 143.88 50.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.063 -1.023 . . . . 0.0 109.072 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.521 HG23 ' HE3' ' A' ' 10' ' ' LYS . 42.3 mt -126.19 134.17 67.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mt -116.79 130.23 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.059 . . . . 0.0 109.619 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.1 154.02 74.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.71 154.23 75.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.284 1.99 . . . . 0.0 111.353 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.1 mm-40 -133.61 -174.33 3.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.0 ttpt -87.57 149.36 24.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -47.68 152.2 0.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 110.084 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 20.63 53.24 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.338 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.4 m -80.68 -42.97 21.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.641 -1.505 . . . . 0.0 108.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.46 -172.07 27.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.7 mm -99.64 121.38 50.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.979 . . . . 0.0 108.562 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -135.64 145.97 47.39 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.744 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -102.68 150.0 23.88 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -132.29 138.67 47.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.566 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 16.0 tttm -167.19 141.29 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.566 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 1.3 m120 54.23 29.53 10.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 30.11 68.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.86 125.17 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -1.059 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.53 139.18 30.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 108.977 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.45 94.16 17.81 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 110.052 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -48.69 144.41 14.63 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.251 1.967 . . . . 0.0 111.919 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.64 84.92 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.415 ' HB3' HH11 ' A' ' 49' ' ' ARG . 3.1 mmm180 -136.33 154.88 50.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 109.15 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 19.0 p-80 -50.54 -50.15 54.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.007 -1.058 . . . . 0.0 109.496 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.9 mt-10 -43.97 -32.48 1.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 109.48 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.65 3.32 19.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.325 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.17 118.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 108.796 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.05 -29.19 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.444 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.0 t-80 -150.18 123.4 8.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.616 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -112.44 136.78 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 59' ' ' SER . 45.2 t30 -166.68 -154.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -50.79 -10.03 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.0 108.17 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -137.76 166.84 22.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.462 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.0 m -105.43 122.04 45.15 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.4 OUTLIER -120.32 140.86 50.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 111.529 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 72' ' ' VAL . 27.6 mt -123.02 154.92 37.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -169.21 141.61 6.82 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.876 -1.631 . . . . 0.0 110.683 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -144.38 150.7 38.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.495 -1.003 . . . . 0.0 110.028 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.76 13.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.717 . . . . 0.0 110.758 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.36 1.02 79.07 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.541 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 28.9 mm-40 -99.79 143.96 29.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.951 -1.323 . . . . 0.0 108.668 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -138.55 149.92 45.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 111.269 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.3 mt -135.33 134.51 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -107.85 156.41 19.19 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.302 -0.874 . . . . 0.0 111.055 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.1 m 53.04 68.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.697 -0.627 . . . . 0.0 110.827 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 62' ' ' LEU . 24.4 m -113.06 -5.21 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.081 -1.012 . . . . 0.0 109.039 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.2 OUTLIER -68.55 -39.19 81.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 110.414 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -54.64 -60.73 2.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.09 -43.59 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.825 -1.172 . . . . 0.0 109.147 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 76.4 mt -57.28 -35.79 70.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.1 t -62.27 -50.26 72.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.984 . . . . 0.0 109.567 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.89 -51.2 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 0.0 108.451 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 76' ' ' LEU . 47.4 mt -51.79 -45.4 63.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.781 . . . . 0.0 109.4 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 9.3 t-160 -54.92 -51.69 65.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.8 mt -63.26 -37.19 86.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.93 . . . . 0.0 110.625 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 114' ' ' ILE . 20.7 mt -82.06 -6.82 59.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.044 -1.035 . . . . 0.0 111.091 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.82 53.99 2.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.299 . . . . 0.0 110.543 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 82' ' ' LEU . 19.0 mm -90.0 126.5 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.566 HG21 HG12 ' A' ' 121' ' ' ILE . 75.5 p -109.75 -26.86 9.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 111.705 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' HG13 ' A' ' 87' ' ' VAL . 5.0 m-80 -131.33 112.7 12.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.817 -1.177 . . . . 0.0 110.715 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -164.04 134.88 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.758 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.547 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 12.1 m -106.03 103.82 13.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -92.35 103.9 15.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 109.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.76 120.45 23.43 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.16 105.8 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.446 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.92 109.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.29 -159.81 23.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.65 -10.13 12.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.536 -0.979 . . . . 0.0 110.77 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -151.98 155.34 37.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.672 -1.268 . . . . 0.0 111.056 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 mm -73.24 124.58 90.71 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.741 -0.6 . . . . 0.0 110.164 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.704 ' CD ' HD21 ' A' ' 26' ' ' LEU . 79.0 Cg_exo -45.8 134.46 13.8 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.069 1.846 . . . . 0.0 112.177 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -80.44 -29.5 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.481 -0.762 . . . . 0.0 110.714 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 65.1 mt 57.59 -126.13 1.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.72 -23.96 39.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 110.242 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.51 -8.66 13.38 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -116.44 -171.34 1.98 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.419 -1.048 . . . . 0.0 109.786 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.76 -2.62 30.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 63.5 t-105 -46.58 -41.8 15.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.87 . . . . 0.0 110.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.67 -52.23 65.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.011 -1.056 . . . . 0.0 110.499 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -64.81 -43.27 93.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 108.894 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -63.72 -36.79 85.03 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.363 0.601 . . . . 0.0 109.958 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 4.8 mm-40 -68.41 -52.62 30.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.772 . . . . 0.0 111.873 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.71 -50.91 21.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.888 -1.132 . . . . 0.0 110.822 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.36 -43.19 89.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.66 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -53.61 -31.51 47.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.437 ' C ' HD21 ' A' ' 113' ' ' ASN . 8.2 tttm -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 110.13 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.66 ' N ' HD21 ' A' ' 113' ' ' ASN . 0.7 OUTLIER -122.84 28.4 7.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.337 -0.852 . . . . 0.0 111.401 -178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.613 ' CD1' HD22 ' A' ' 82' ' ' LEU . 4.2 mt -85.73 147.19 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.636 -1.29 . . . . 0.0 109.617 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -131.23 153.71 49.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.768 . . . . 0.0 109.098 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -101.46 143.93 30.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.053 -1.029 . . . . 0.0 109.548 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.596 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 8.6 mt-30 -108.29 -166.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -116.73 70.7 0.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.797 . . . . 0.0 110.565 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -168.19 146.98 4.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.149 -0.969 . . . . 0.0 109.587 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -86.69 135.18 33.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.566 HG12 HG21 ' A' ' 85' ' ' THR . 58.6 mt -81.71 149.76 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -97.24 100.29 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -71.74 147.08 47.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 110.748 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -96.77 121.83 39.06 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.47 135.24 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.396 -0.815 . . . . 0.0 110.316 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.85 133.57 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.5 -10.75 13.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 109.301 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -142.89 143.45 25.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.44 171.88 16.82 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.38 2.053 . . . . 0.0 112.997 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.1 tt -165.74 142.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.699 -0.625 . . . . 0.0 109.694 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.76 125.86 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.509 -0.744 . . . . 0.0 109.833 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 132' ' ' VAL . 31.1 m -121.96 120.06 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.725 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.68 137.44 52.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.17 147.99 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.013 . . . . 0.0 110.829 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 56.84 24.83 9.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.6 -0.688 . . . . 0.0 110.955 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.39 85.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -109.33 169.65 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.6 tt -159.48 152.36 21.79 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.18 -1.575 . . . . 0.0 109.108 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.969 ' N ' HD23 ' A' ' 138' ' ' LEU . 41.6 mt -148.72 139.87 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.0 108.363 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -128.08 142.66 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 110.106 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -121.01 144.91 48.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -143.13 138.87 16.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 108.622 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.32 148.08 73.2 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.415 1.41 . . . . 0.0 111.735 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -167.2 155.9 9.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.1 0.05 55.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -136.44 150.46 48.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 242' ' ' VAL . 24.9 tp -81.74 116.88 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -138.65 134.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.623 ' CG1' HD23 ' A' ' 231' ' ' LEU . 45.9 t -134.63 124.6 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.2 137.55 50.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.02 129.72 49.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.488 -0.757 . . . . 0.0 110.117 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -111.82 103.89 12.18 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.15 140.72 15.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -116.46 101.53 8.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -100.9 142.98 31.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 109.939 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.94 1.86 56.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 0.0 109.561 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.643 HD22 HD12 ' A' ' 159' ' ' LEU . 40.2 p-10 -84.38 -166.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -62.7 -25.17 68.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 110.272 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.643 HD12 HD22 ' A' ' 157' ' ' ASN . 76.8 mt -66.41 -25.34 66.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.009 -1.057 . . . . 0.0 109.398 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.81 47.78 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -93.11 144.99 24.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.995 . . . . 0.0 109.837 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -150.18 137.07 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 147.23 47.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.072 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.687 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 58.3 t80 -136.62 124.11 22.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.8 m -101.64 121.92 42.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.964 . . . . 0.0 109.705 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.55 135.42 41.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.74 151.4 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 109.507 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.536 ' OE2' ' NZ ' ' A' ' 243' ' ' LYS . 19.4 mt-10 -51.67 116.56 2.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.311 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.66 7.42 15.76 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.544 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 14.6 m-80 -134.85 28.39 3.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.179 -1.189 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.578 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 2.4 mp0 -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.752 -0.593 . . . . 0.0 110.582 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.89 -15.51 31.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.624 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -94.91 -4.23 47.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.956 -1.09 . . . . 0.0 110.898 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.546 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 4.2 pt -121.46 13.65 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.946 -1.096 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.87 -25.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.958 -1.089 . . . . 0.0 109.6 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -91.26 2.02 56.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.989 -1.069 . . . . 0.0 110.533 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.48 109.38 16.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.013 -1.054 . . . . 0.0 108.895 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.513 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -82.07 153.4 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 109.917 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.8 t -54.3 156.65 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.778 . . . . 0.0 109.338 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.76 170.68 15.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.875 -1.141 . . . . 0.0 110.119 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.585 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 3.5 t -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 109.469 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.625 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.5 m-85 -105.47 144.71 31.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.559 -0.713 . . . . 0.0 109.286 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.728 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.2 p30 -60.22 -21.86 62.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.703 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.625 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.2 p90 -81.66 -33.94 31.02 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.625 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.6 pt-20 -88.83 -14.86 35.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.865 -1.147 . . . . 0.0 110.088 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.8 mt -54.79 -52.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.169 -0.957 . . . . 0.0 110.515 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.27 -47.11 62.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 109.544 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -53.65 55.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.975 . . . . 0.0 109.201 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.653 HG21 H4A3 ' A' ' 320' ' ' TUX . 66.6 mt -55.43 -34.29 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 108.921 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.581 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 10.5 mmtm -77.04 -30.19 55.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.645 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -71.55 -22.24 61.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 192' ' ' VAL . 13.5 m -91.6 13.31 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.941 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 69.68 27.33 73.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.76 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.87 159.22 27.27 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.251 . . . . 0.0 109.797 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 78.63 28.1 55.73 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.31 -0.948 . . . . 0.0 110.817 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.82 -20.39 63.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.691 -1.476 . . . . 0.0 109.066 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.28 -3.12 51.03 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.86 124.74 33.38 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 203' ' ' THR . 12.0 p -138.92 174.48 10.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.755 -0.85 . . . . 0.0 109.258 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.37 -15.87 60.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.485 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.431 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.2 tttm -87.79 -18.8 28.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 201' ' ' LYS . 1.8 m-20 -124.65 -8.6 7.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.649 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 199' ' ' SER . 0.7 OUTLIER -132.47 119.47 20.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -81.09 117.04 21.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.925 . . . . 0.0 108.9 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.438 HG21 HCA3 ' A' ' 320' ' ' TUX . 74.3 t -104.66 128.43 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.702 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.784 HD21 HD21 ' A' ' 217' ' ' LEU . 12.3 mt -108.81 148.45 30.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 109.73 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.39 156.05 16.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 207' ' ' GLY . 9.8 tttm -42.13 -33.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -1.141 . . . . 0.0 109.856 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -147.76 16.16 1.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -144.59 153.17 41.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 110.28 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 206' ' ' LEU . 84.6 t -103.12 128.45 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.549 -0.719 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -71.35 -53.97 12.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 0.0 109.996 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -58.67 133.75 86.17 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 109.411 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.43 -8.0 21.87 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.378 2.052 . . . . 0.0 112.708 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.16 -7.81 54.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 0.0 109.918 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.22 -167.68 48.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.784 HD21 HD21 ' A' ' 206' ' ' LEU . 55.4 mt -83.1 145.74 29.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.497 -1.002 . . . . 0.0 110.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -86.02 -20.08 29.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 221' ' ' ASN . 71.7 m-85 -146.22 133.19 20.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 108.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 31.7 mp0 -46.5 -16.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 108.865 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -131.63 33.54 4.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.617 0.722 . . . . 0.0 109.151 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 4.7 tt0 -53.66 -57.31 17.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_endo -54.21 -38.95 88.19 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.902 1.735 . . . . 0.0 113.036 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 228' ' ' VAL . 9.1 m -79.77 -26.46 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.528 -1.357 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 40.3 mtt-85 -64.69 -41.15 96.24 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -65.41 -43.45 90.54 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -48.36 76.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 108.979 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 224' ' ' VAL . 34.8 t -61.07 -42.74 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 108.467 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 89.2 t80 -58.72 -39.21 80.19 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 1.0 OUTLIER -73.03 -39.51 65.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.55 -0.718 . . . . 0.0 109.696 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.623 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.2 tp -56.62 -36.36 69.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.221 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.506 HG22 ' HD1' ' A' ' 80' ' ' HIS . 94.0 mt -70.67 -48.31 59.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.7 -33.28 18.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.44 -26.56 32.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.258 . . . . 0.0 109.897 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.574 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -80.49 -23.19 40.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.762 -1.212 . . . . 0.0 110.11 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.516 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 10.1 t80 -71.65 -8.59 55.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 237' ' ' LEU . 68.9 mt -52.52 -28.03 18.93 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.434 HD21 HG13 ' A' ' 260' ' ' VAL . 94.9 mt -57.27 -13.92 3.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 108.507 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 14.9 81.61 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 84.1 p -158.99 144.67 12.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.829 -1.395 . . . . 0.0 109.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.408 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 71.6 Cg_exo -43.36 129.3 6.35 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.077 1.851 . . . . 0.0 111.662 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 238' ' ' LEU . 10.6 t -96.3 135.25 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.971 . . . . 0.0 110.148 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.536 ' NZ ' ' OE2' ' A' ' 168' ' ' GLU . 26.8 mmtt -120.16 125.27 47.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.53 171.73 24.77 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -102.65 112.27 24.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.068 -1.254 . . . . 0.0 109.769 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.4 m-85 -112.67 146.75 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.825 0.821 . . . . 0.0 111.354 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -128.61 143.06 50.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.69 125.71 21.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.57 -1.331 . . . . 0.0 110.144 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 250' ' ' ARG . 8.9 t80 -109.77 115.22 29.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 17.2 mtt180 44.0 56.0 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -91.92 157.8 24.55 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.593 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -120.3 -171.56 14.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 87.5 m-70 -74.91 -52.09 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -1.207 . . . . 0.0 110.044 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.0 m -55.1 -56.12 23.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.077 -1.014 . . . . 0.0 109.406 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.1 tp -54.26 -42.57 70.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.487 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -59.07 -55.32 36.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.031 . . . . 0.0 108.7 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 7.3 t -52.28 -39.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.895 . . . . 0.0 109.158 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -54.7 -47.79 73.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 108.643 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.66 -50.16 63.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.574 HG22 HD23 ' A' ' 235' ' ' LEU . 53.1 t -61.25 -42.29 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -52.39 65.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.805 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.62 -40.84 96.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.987 -1.071 . . . . 0.0 109.786 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 263' ' ' LEU . 30.1 mt -61.89 -45.99 91.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.07 -27.63 61.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 110.627 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -87.26 -26.57 23.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.687 -1.258 . . . . 0.0 109.039 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -74.15 -46.09 44.6 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.185 -0.947 . . . . 0.0 109.318 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 270' ' ' THR . 4.1 mp0 -78.16 12.92 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.615 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -60.55 -33.32 72.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.592 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 44.3 mt -63.0 -30.0 71.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.513 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 267' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.376 -0.827 . . . . 0.0 109.426 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.653 H4A3 HG21 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 14.7 mt-10 -46.94 142.24 3.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.154 -0.966 . . . . 0.0 109.466 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.63 134.33 54.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.568 -0.707 . . . . 0.0 110.121 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -139.2 179.04 6.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 108.766 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 7' ' ' VAL . 7.6 m -87.58 138.06 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.27 . . . . 0.0 110.456 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -73.74 -43.77 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.75 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -125.04 150.04 47.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.177 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 140.04 58.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.814 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.6 mt -122.27 168.04 12.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.586 -0.696 . . . . 0.0 109.198 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.26 148.4 23.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.06 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -135.46 158.02 45.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.498 -0.751 . . . . 0.0 109.588 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -147.89 137.73 22.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.022 -1.049 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.0 160.1 18.69 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.483 HG23 ' C ' ' A' ' 22' ' ' GLU . 9.4 p -81.51 138.61 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -1.186 . . . . 0.0 110.507 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.47 145.28 43.79 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -62.53 -47.88 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.452 -1.028 . . . . 0.0 112.682 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.8 m-70 -87.08 -38.69 16.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.02 -1.675 . . . . 0.0 111.486 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.473 HG21 HD22 ' A' ' 94' ' ' ASN . 3.5 m -74.74 -35.95 62.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.894 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 68.15 22.42 74.34 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.483 ' C ' HG23 ' A' ' 16' ' ' VAL . 9.2 tt0 -110.13 148.75 31.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.443 -1.033 . . . . 0.0 109.116 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -71.59 130.98 42.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 110.026 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -140.09 156.47 46.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' O ' HD23 ' A' ' 26' ' ' LEU . 24.2 tttm -135.31 147.13 49.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -0.974 . . . . 0.0 109.098 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.74 HD11 ' HD2' ' A' ' 97' ' ' PRO . 1.8 mt -128.19 144.53 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.964 -1.085 . . . . 0.0 109.428 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.4 mt -122.14 140.71 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.3 mt -121.03 118.84 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.109 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -117.4 154.08 50.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.2 164.04 35.53 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.296 1.997 . . . . 0.0 111.24 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 13.3 mm-40 -134.36 -175.95 4.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.993 . . . . 0.0 109.842 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 15.6 tttm -91.67 158.73 16.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.613 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -51.61 145.4 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.617 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 63.97 23.35 67.56 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.575 -0.703 . . . . 0.0 111.855 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 93.2 m -82.06 -46.36 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.365 -1.667 . . . . 0.0 109.199 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.6 -171.19 23.79 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mm -96.67 123.42 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -1.151 . . . . 0.0 108.375 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.03 140.26 32.58 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.04 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -100.52 152.32 20.53 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.4 t80 -132.22 137.76 47.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 15.6 tttt -165.76 140.21 4.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 109.478 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.6 29.35 13.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.56 12.62 82.38 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.36 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.02 139.35 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -1.141 . . . . 0.0 109.75 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -98.74 141.46 31.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.095 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 46' ' ' ILE . 12.5 mt -133.45 94.76 19.0 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.2 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -51.4 147.15 22.88 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.261 1.974 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.82 84.83 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.893 -1.129 . . . . 0.0 110.605 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -137.6 153.97 49.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.688 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 2.4 p80 -50.62 -49.36 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.564 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.688 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 86.5 mt-10 -44.38 -33.41 1.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 109.104 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -80.15 0.49 32.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.414 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 50' ' ' HIS . 4.0 t -59.25 126.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 108.746 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.59 -32.25 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 0.0 110.153 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.71 124.36 7.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.708 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 p -112.35 134.03 54.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.9 p-10 -166.63 -153.89 0.17 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.581 ' O ' ' NXH' ' A' ' 320' ' ' TUX . 6.5 m80 -48.59 -11.4 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.97 -1.081 . . . . 0.0 108.455 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 57' ' ' ASN . 8.5 t -138.16 166.24 24.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.497 -0.752 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.7 m -104.14 122.55 45.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.895 . . . . 0.0 108.717 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.34 141.98 50.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.266 -0.896 . . . . 0.0 111.446 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 72' ' ' VAL . 15.0 mt -125.12 156.43 38.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -170.32 140.44 6.02 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.607 -1.759 . . . . 0.0 110.886 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -144.58 150.61 37.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.963 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt 55.28 32.85 19.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.37 -0.831 . . . . 0.0 110.519 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.83 3.1 89.56 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.346 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 73.8 mm-40 -96.76 140.95 30.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.998 -1.295 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -135.52 144.39 46.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 111.147 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.3 mt -133.7 139.43 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -115.1 154.79 28.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.341 -0.849 . . . . 0.0 111.161 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m 52.41 70.35 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.602 -0.686 . . . . 0.0 110.63 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 62' ' ' LEU . 15.3 m -113.54 -8.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 109.508 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -68.16 -20.38 64.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.371 -179.23 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -71.92 -60.7 2.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.926 -1.109 . . . . 0.0 109.266 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.9 -43.98 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 108.755 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 75' ' ' ILE . 89.6 mt -58.89 -37.53 76.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.809 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.574 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.6 t -61.12 -48.71 80.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.975 . . . . 0.0 109.904 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.61 -53.56 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.95 -1.094 . . . . 0.0 108.611 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -52.45 -44.76 65.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.299 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.582 ' HD1' HG22 ' A' ' 232' ' ' ILE . 15.8 t-160 -54.29 -57.72 10.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.589 HD21 HD13 ' A' ' 232' ' ' ILE . 68.6 mt -57.36 -36.08 70.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.665 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.66 HD22 ' CD1' ' A' ' 114' ' ' ILE . 12.7 mt -82.75 0.54 43.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.72 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.4 27.5 16.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.858 -1.151 . . . . 0.0 110.708 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 82' ' ' LEU . 14.3 mm -73.91 121.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.138 . . . . 0.0 108.351 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.28 -74.63 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 111.227 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.744 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -80.19 114.11 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 111.685 -176.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 86' ' ' ASN . 6.0 m -163.95 142.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.492 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 28.2 m -111.86 101.8 10.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.98 105.97 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.639 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.84 128.5 33.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.845 -1.159 . . . . 0.0 108.329 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 68.6 t -111.52 110.68 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.438 -0.789 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.34 110.27 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.525 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 129.96 -158.14 22.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.473 HD22 HG21 ' A' ' 20' ' ' THR . 0.0 OUTLIER -120.39 -10.14 9.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.492 -1.005 . . . . 0.0 110.483 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 3.3 pm0 -145.56 150.21 35.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.68 -1.263 . . . . 0.0 110.821 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 mm -74.75 122.55 87.74 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.629 -0.67 . . . . 0.0 110.045 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.74 ' HD2' HD11 ' A' ' 26' ' ' LEU . 75.2 Cg_exo -45.97 131.67 13.89 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.118 1.879 . . . . 0.0 112.341 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.436 HD11 ' HA2' ' A' ' 101' ' ' GLY . 7.6 tp -77.39 -24.85 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -0.798 . . . . 0.0 109.981 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.639 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 19.0 mt 58.35 -113.49 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.798 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.74 -19.24 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.982 -1.074 . . . . 0.0 110.855 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 115.05 -11.49 20.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.42 -170.35 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.379 -1.071 . . . . 0.0 109.657 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.8 -4.15 21.46 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -46.62 -40.79 13.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.743 -0.857 . . . . 0.0 110.119 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.52 -51.88 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.048 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.491 ' CZ ' HD11 ' A' ' 99' ' ' LEU . 60.1 m-85 -63.59 -44.08 95.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.4 t80 -63.05 -37.72 88.32 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.465 0.65 . . . . 0.0 109.824 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.96 -49.95 53.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.544 -0.722 . . . . 0.0 111.473 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.6 -51.86 11.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.858 -1.151 . . . . 0.0 110.644 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.16 -43.41 81.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 120.976 -1.077 . . . . 0.0 110.233 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -55.58 -31.29 62.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.457 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -81.85 -5.32 58.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.583 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -127.03 35.31 4.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.425 -0.797 . . . . 0.0 110.887 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.66 ' CD1' HD22 ' A' ' 82' ' ' LEU . 10.9 mt -90.27 145.43 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.801 -1.187 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 115' ' ' LEU . 26.7 tp -131.08 156.6 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -111.6 141.94 44.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.866 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -102.66 -161.19 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.317 -0.864 . . . . 0.0 108.975 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -118.61 2.29 11.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.214 -0.929 . . . . 0.0 111.094 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 4' ' ' GLU . 10.8 ttp85 -100.24 155.99 17.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.796 -1.19 . . . . 0.0 110.136 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 121' ' ' ILE . 13.9 tm-20 -89.07 136.79 32.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.499 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 19.6 mt -76.63 142.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.74 . . . . 0.0 110.694 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -85.22 88.26 7.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.44 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 45.6 m-85 -63.23 144.96 56.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.412 -0.805 . . . . 0.0 110.651 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -102.0 125.16 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 t -129.97 143.98 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.0 135.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.7 -12.78 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.764 . . . . 0.0 109.171 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.91 142.56 28.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 108.941 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.85 159.34 52.07 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.907 1.738 . . . . 0.0 113.122 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.651 HG23 ' HB3' ' A' ' 141' ' ' ALA . 1.5 tt -155.41 138.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.1 mt -127.59 125.71 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.18 113.08 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -117.09 126.91 53.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.493 -0.754 . . . . 0.0 109.707 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -173.67 155.09 2.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.52 20.52 9.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.583 -0.698 . . . . 0.0 110.728 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.3 3.06 88.37 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.592 ' HB2' HD22 ' A' ' 255' ' ' LEU . 1.3 mtt85 -104.8 172.46 6.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.3 tt -160.04 150.39 18.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.335 -1.478 . . . . 0.0 109.015 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.836 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.2 mt -148.05 131.87 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.085 -1.01 . . . . 0.0 109.066 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -120.16 138.97 53.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 109.894 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -124.97 134.84 52.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -133.5 137.76 29.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.56 147.54 29.98 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.291 1.327 . . . . 0.0 111.96 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.44 158.22 9.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.31 2.2 56.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.782 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.2 p -131.91 139.0 48.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 0.0 109.634 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 tp -73.76 116.6 14.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.711 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -137.71 137.1 37.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 108.738 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.574 ' CG1' HD23 ' A' ' 231' ' ' LEU . 75.6 t -140.2 123.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 109.415 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.745 ' OG1' HG23 ' A' ' 165' ' ' THR . 8.9 m -115.56 145.15 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -130.75 130.93 44.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.721 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.11 140.98 48.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.28 144.47 16.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.67 84.49 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.566 -0.961 . . . . 0.0 108.971 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 160' ' ' GLY . 13.6 m-85 -87.02 148.67 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.727 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -93.33 -5.83 48.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 110.037 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.2 p30 -70.43 -167.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.893 -1.13 . . . . 0.0 109.158 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -56.9 -21.59 30.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.005 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.424 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.3 mt -61.74 -57.46 11.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.28 -99.31 2.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -125.89 136.7 53.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -1.111 . . . . 0.0 109.059 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -145.74 159.43 43.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -160.2 150.4 18.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -138.32 127.47 24.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.745 HG23 ' OG1' ' A' ' 150' ' ' THR . 29.3 m -102.12 123.44 45.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.144 -0.973 . . . . 0.0 109.509 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.3 135.99 39.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.103 -0.998 . . . . 0.0 109.537 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.519 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -133.19 154.25 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.735 . . . . 0.0 109.337 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -57.6 118.4 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -0.965 . . . . 0.0 109.666 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.68 1.27 21.4 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.77 31.42 3.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.161 -1.2 . . . . 0.0 108.883 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 175' ' ' VAL . 23.0 mt-10 -64.69 -33.52 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 110.719 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.23 -14.54 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 0.0 110.935 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.528 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 25.7 mt-10 -89.97 -3.95 57.73 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.29 -10.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.035 -1.041 . . . . 0.0 111.105 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -83.54 -29.92 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.514 -1.366 . . . . 0.0 110.316 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.47 2.73 43.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.797 -1.189 . . . . 0.0 110.282 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.68 130.26 35.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.776 -1.202 . . . . 0.0 108.681 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.695 HH21 ' N ' ' A' ' 203' ' ' THR . 15.4 ptm180 -104.84 155.12 19.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -0.891 . . . . 0.0 110.463 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.471 ' CA ' ' CE1' ' A' ' 226' ' ' HIS . 3.0 t -56.17 156.71 5.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.249 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.03 166.7 24.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.061 . . . . 0.0 110.527 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.56 ' SG ' ' OE2' ' A' ' 185' ' ' GLU . 0.5 OUTLIER -156.9 162.06 39.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.507 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -104.76 144.67 31.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.724 ' HA ' HD12 ' A' ' 186' ' ' ILE . 39.7 p30 -60.59 -21.59 62.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 111.562 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.9 p90 -76.58 -34.7 58.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.659 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.781 ' OE2' HD11 ' A' ' 189' ' ' ILE . 2.5 pt-20 -96.7 -8.3 31.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.476 -1.39 . . . . 0.0 110.261 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.5 mt -55.37 -51.12 59.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.0 -1.062 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -51.41 -51.82 51.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.237 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -49.22 66.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.157 -0.964 . . . . 0.0 108.794 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.781 HD11 ' OE2' ' A' ' 185' ' ' GLU . 63.8 mt -57.46 -33.96 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.918 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -77.21 -25.91 52.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 110.02 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -77.12 -30.45 55.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.938 . . . . 0.0 109.886 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.08 8.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.188 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.88 73.86 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.524 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 66.0 mt -118.58 157.62 27.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -1.153 . . . . 0.0 109.682 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.47 21.11 65.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -66.14 -25.04 66.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.849 -1.383 . . . . 0.0 109.705 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.4 -4.89 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.36 127.91 35.38 Favored Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.132 -1.217 . . . . 0.0 110.622 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -135.37 170.43 15.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.645 -0.915 . . . . 0.0 109.091 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.71 -36.03 81.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.074 -1.017 . . . . 0.0 109.575 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 30.3 ttmt -73.32 -27.64 61.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.217 -0.927 . . . . 0.0 109.662 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.639 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 2.1 m-20 -107.41 5.4 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.892 . . . . 0.0 110.084 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.695 ' N ' HH21 ' A' ' 178' ' ' ARG . 3.4 m -153.05 122.12 6.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.918 -1.114 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.431 HD22 ' CD ' ' A' ' 222' ' ' GLU . 5.9 tp -79.35 110.8 14.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 108.693 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.6 128.41 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.973 -1.079 . . . . 0.0 109.528 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.0 mt -106.38 148.46 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.97 149.13 16.62 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 207' ' ' GLY . 23.2 tptt -42.59 -27.38 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -1.161 . . . . 0.0 110.108 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 209' ' ' ASP . 52.6 p-10 -149.96 10.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.929 -1.107 . . . . 0.0 110.272 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.9 pttm -143.67 152.83 41.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.7 t -101.44 129.58 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.889 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.95 -54.41 8.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -57.86 134.65 83.31 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.828 -1.17 . . . . 0.0 109.428 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.92 -14.22 29.36 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.337 2.024 . . . . 0.0 112.695 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -83.85 -6.46 59.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.42 -166.17 54.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.0 148.76 31.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -1.122 . . . . 0.0 109.704 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.4 ' HB3' ' CD2' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -88.12 -22.76 23.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.656 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 77.0 m-85 -149.14 134.19 18.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.0 108.839 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 219' ' ' TYR . 11.0 tt0 -45.47 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.978 -1.076 . . . . 0.0 108.607 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -130.36 35.6 4.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.49 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 3.4 tt0 -56.81 -50.78 86.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.483 -0.761 . . . . 0.0 111.743 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 27.7 Cg_endo -65.82 -39.04 21.25 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.582 1.521 . . . . 0.0 113.457 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.1 OUTLIER -78.09 -26.82 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.524 -1.36 . . . . 0.0 108.324 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 18.2 mtp180 -68.74 -44.11 74.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.471 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 17.3 t60 -59.87 -43.9 94.47 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.515 -0.741 . . . . 0.0 109.038 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -56.25 -41.43 75.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.807 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 224' ' ' VAL . 23.0 t -62.42 -46.4 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.574 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.2 t80 -55.12 -41.71 72.04 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -70.67 -39.39 73.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.466 -0.771 . . . . 0.0 109.676 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.574 HD23 ' CG1' ' A' ' 149' ' ' VAL . 30.0 tp -56.97 -35.62 69.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.463 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.589 HD13 HD21 ' A' ' 81' ' ' LEU . 95.2 mt -71.15 -48.78 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.36 -31.95 13.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.99 -28.43 29.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -1.224 . . . . 0.0 110.267 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.9 mt -79.49 -22.87 43.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.229 . . . . 0.0 109.79 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -68.64 -8.24 40.46 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.331 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.448 ' C ' ' N ' ' A' ' 239' ' ' GLY . 36.4 mt -52.86 -32.58 45.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.851 . . . . 0.0 109.194 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.698 HD12 ' CG2' ' A' ' 242' ' ' VAL . 97.4 mt -52.61 -11.92 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.952 -1.093 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 77.08 13.45 83.65 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.7 p -158.74 143.74 11.79 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.133 -1.216 . . . . 0.0 109.434 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.436 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 73.4 Cg_exo -41.25 135.0 2.82 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 112.149 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.698 ' CG2' HD12 ' A' ' 238' ' ' LEU . 2.4 t -101.3 136.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 131.02 50.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.38 -0.825 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.79 -178.39 31.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.74 112.77 25.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.149 -1.207 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -115.16 145.5 42.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.027 0.918 . . . . 0.0 110.959 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.45 ' CE2' HG21 ' A' ' 150' ' ' THR . 35.8 t80 -131.22 144.02 51.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.0 t -139.65 128.28 23.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.77 -1.206 . . . . 0.0 110.642 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 250' ' ' ARG . 46.0 t80 -108.98 117.18 33.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.4 mmm180 44.76 56.29 5.34 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.56 147.16 21.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.482 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -115.69 178.7 17.75 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.548 ' CE1' HOH1 ' A' ' 320' ' ' TUX . 75.4 m-70 -68.47 -50.59 51.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.276 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 66.1 m -55.39 -55.26 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.031 -1.043 . . . . 0.0 109.367 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 137' ' ' ARG . 58.9 tp -51.38 -39.32 56.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.315 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 72.8 m-20 -59.71 -53.81 53.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 108.722 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 253' ' ' HIS . 16.8 t -50.07 -43.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -55.21 -46.86 75.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.031 -1.043 . . . . 0.0 108.89 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 139' ' ' ILE . 56.4 tp -52.6 -44.72 66.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.214 -0.928 . . . . 0.0 108.569 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.04 -56.26 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -46.97 -40.74 14.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -70.51 -46.53 63.48 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.909 -1.119 . . . . 0.0 110.037 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 39.4 mt -65.74 -37.5 86.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.903 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.4 66.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -86.34 -28.07 23.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.793 -1.192 . . . . 0.0 108.754 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.3 -45.07 67.03 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.482 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -79.86 13.61 2.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.849 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -105.13 -6.5 19.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 11.6 mt -45.79 -55.93 5.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.581 ' NXH' ' O ' ' A' ' 58' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.736 ' O ' HD11 ' A' ' 121' ' ' ILE . 12.2 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 3' ' ' LEU . 18.4 mm-40 -41.49 140.81 0.84 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.446 -0.783 . . . . 0.0 109.534 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.14 135.65 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.554 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.402 ' HB ' ' NE2' ' A' ' 117' ' ' GLN . 14.7 t -135.03 175.32 9.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 109.342 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 7' ' ' VAL . 10.4 m -85.68 135.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.258 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -66.73 -44.19 82.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.41 152.55 48.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.825 . . . . 0.0 109.88 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 136.03 56.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.59 168.34 10.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 p -157.97 148.69 20.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.116 -0.99 . . . . 0.0 110.242 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -129.96 158.73 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 109.285 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.66 135.62 21.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.97 -1.081 . . . . 0.0 109.212 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.13 159.98 18.56 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.5 p -70.7 161.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.265 . . . . 0.0 110.908 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -95.4 140.79 15.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 19' ' ' HIS . 12.6 tt -56.99 -52.2 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.135 -1.215 . . . . 0.0 112.246 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.605 ' N ' HG23 ' A' ' 18' ' ' ILE . 4.6 m-70 -86.46 -38.15 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.281 -1.512 . . . . 0.0 111.197 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.415 ' OG1' ' CD ' ' A' ' 95' ' ' GLU . 16.0 p -72.48 -35.03 68.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.762 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.6 24.76 68.21 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -117.52 155.09 30.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.885 . . . . 0.0 108.87 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.0 t80 -71.65 132.17 44.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 30.9 t -138.66 157.86 45.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 108.845 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' O ' HD23 ' A' ' 26' ' ' LEU . 27.5 tttp -137.18 151.9 49.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 109.503 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.691 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -127.21 151.22 48.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.174 -0.954 . . . . 0.0 109.737 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.497 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.4 mt -137.69 127.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.4 mt -112.14 118.51 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.562 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.3 m-70 -116.98 149.25 43.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.97 162.44 19.11 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.187 1.925 . . . . 0.0 111.323 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.4 mm-40 -133.94 -177.48 4.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 0.0 109.87 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 6.8 tttm -82.3 149.69 27.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.628 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 11.5 mp0 -48.48 147.27 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 110.39 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.26 24.78 61.63 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.6 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 13.6 m -81.23 -46.43 14.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.734 -1.451 . . . . 0.0 109.445 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.62 -167.23 17.41 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mm -100.75 124.09 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.139 -1.212 . . . . 0.0 107.865 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -140.54 141.51 35.27 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.643 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -101.13 153.15 19.83 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.581 ' CG ' ' OE1' ' A' ' 90' ' ' GLU . 3.3 t80 -120.31 154.92 34.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -176.06 126.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.669 -1.27 . . . . 0.0 110.192 -179.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.84 37.22 16.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.31 77.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -126.23 128.77 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -1.086 . . . . 0.0 109.66 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -89.52 141.75 28.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.4 mt -136.49 95.59 12.74 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.46 144.52 9.97 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.975 1.783 . . . . 0.0 111.472 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.46 85.29 4.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.953 -1.092 . . . . 0.0 110.66 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.74 154.14 49.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.496 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 9.7 p80 -50.62 -48.81 57.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 109.694 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 50.3 mt-10 -43.2 -33.33 0.9 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.347 -0.846 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -77.78 1.85 18.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.241 -0.912 . . . . 0.0 110.275 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 257' ' ' VAL . 4.1 t -63.01 119.08 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 108.77 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.66 -30.92 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.232 -0.918 . . . . 0.0 110.524 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.583 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.3 t-160 -145.71 118.64 8.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.062 . . . . 0.0 109.63 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.1 p -112.34 132.03 55.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.445 0.64 . . . . 0.0 109.455 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 59' ' ' SER . 66.6 t30 -166.0 -154.32 0.19 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.557 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 1.4 m-70 -48.32 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.835 -1.166 . . . . 0.0 108.329 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' ASN . 16.0 t -136.66 166.03 24.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.451 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 27.0 m -106.88 122.87 47.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 108.965 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.99 138.61 54.36 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.08 0.943 . . . . 0.0 111.218 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.513 HD12 HG21 ' A' ' 72' ' ' VAL . 56.1 mt -117.34 156.42 27.87 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.6 142.74 6.74 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.347 -1.883 . . . . 0.0 111.309 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -143.24 148.75 36.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.865 . . . . 0.0 109.199 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt 56.27 39.86 30.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.0 110.597 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.24 5.63 77.38 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.745 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.7 mm-40 -102.04 140.33 36.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.951 -1.323 . . . . 0.0 108.317 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.603 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -139.37 151.86 46.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.069 -1.019 . . . . 0.0 111.568 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 mt -134.26 145.33 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -114.6 150.2 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 111.245 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 m 55.25 69.03 0.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.708 -0.62 . . . . 0.0 111.047 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.513 HG21 HD12 ' A' ' 62' ' ' LEU . 27.4 m -114.26 -7.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 109.275 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.0 pt-20 -68.65 -36.21 78.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.578 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 26.4 m170 -58.6 -59.98 4.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 110.111 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.1 tp -57.16 -42.17 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.808 -1.183 . . . . 0.0 109.07 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.477 ' N ' HG23 ' A' ' 75' ' ' ILE . 6.9 mt -60.47 -35.91 77.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 109.469 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -60.61 -47.3 86.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.577 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.448 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 38.3 t -58.99 -51.7 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.064 . . . . 0.0 108.681 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 76' ' ' LEU . 54.7 mt -51.27 -44.28 61.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.498 -0.752 . . . . 0.0 109.418 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.722 ' HD1' HG22 ' A' ' 232' ' ' ILE . 14.0 t-160 -56.23 -57.83 10.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 0.0 109.832 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.7 -38.55 72.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 110.449 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 114' ' ' ILE . 15.1 mt -79.8 -0.84 36.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.979 -1.076 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 59.81 42.58 16.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.803 -1.186 . . . . 0.0 110.027 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.37 125.82 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.7 p -106.34 -76.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.51 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' HG13 ' A' ' 87' ' ' VAL . 69.5 m-20 -81.49 113.28 19.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 111.812 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.13 141.73 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.406 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 61.1 m -111.5 103.92 12.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.477 -0.764 . . . . 0.0 109.397 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.18 114.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.202 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.581 ' OE1' ' CG ' ' A' ' 40' ' ' PHE . 1.6 mt-10 -93.07 123.79 36.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 0.0 108.75 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.66 106.79 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.52 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.13 107.71 18.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.58 -162.85 24.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -13.63 14.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.388 -1.066 . . . . 0.0 110.428 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -150.54 155.16 38.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.709 -1.245 . . . . 0.0 110.674 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -69.89 125.71 92.12 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.699 -0.625 . . . . 0.0 110.04 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.691 ' CD ' HD21 ' A' ' 26' ' ' LEU . 74.7 Cg_exo -46.23 134.71 15.41 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.85 1.7 . . . . 0.0 112.017 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.1 tp -76.85 -35.25 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.469 -0.769 . . . . 0.0 109.967 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.416 ' N ' HG23 ' A' ' 98' ' ' ILE . 51.2 mt 55.32 -105.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.431 -0.793 . . . . 0.0 109.631 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.58 ' OD1' ' NE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -94.55 -27.67 15.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.582 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.3 -1.49 28.11 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 p -123.98 -166.78 1.54 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.969 . . . . 0.0 109.292 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.44 -0.34 21.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -46.77 -43.93 18.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.723 -0.869 . . . . 0.0 110.662 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.46 -52.1 62.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.061 -1.025 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 97.3 m-85 -62.45 -45.61 92.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.896 -1.128 . . . . 0.0 108.594 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.402 ' CD2' HG11 ' A' ' 175' ' ' VAL . 15.0 t80 -59.55 -40.72 88.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.456 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -45.6 58.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.487 -0.758 . . . . 0.0 111.464 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.62 -49.75 20.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.201 . . . . 0.0 110.777 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.31 -42.54 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.01 -1.056 . . . . 0.0 111.085 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -56.6 -28.96 61.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.885 -1.134 . . . . 0.0 109.992 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -82.21 -10.16 59.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.958 -1.089 . . . . 0.0 110.047 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -123.02 32.24 5.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.401 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.565 HD11 HD22 ' A' ' 82' ' ' LEU . 13.3 mt -86.28 146.82 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.681 -1.262 . . . . 0.0 109.87 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 115' ' ' LEU . 16.4 tp -132.23 161.55 33.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.29 128.88 55.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.776 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.402 ' NE2' ' HB ' ' A' ' 6' ' ' THR . 18.5 mt-30 -96.39 -166.36 1.41 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.898 . . . . 0.0 110.009 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -124.46 69.31 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.601 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -158.8 137.71 11.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.027 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 26.9 tt0 -47.88 167.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.776 0.798 . . . . 0.0 110.965 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.736 HD11 ' O ' ' A' ' 3' ' ' LEU . 31.4 mt -126.23 120.5 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.2 76.98 8.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.602 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -58.54 147.6 31.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -106.83 125.65 51.29 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.7 t -130.49 145.1 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 73.0 t -83.68 136.37 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 0.0 109.363 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.13 -12.9 9.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.51 144.57 42.97 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.84 169.05 23.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.106 1.871 . . . . 0.0 113.174 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 141' ' ' ALA . 4.4 tt -165.24 136.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.784 -0.572 . . . . 0.0 109.485 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.21 124.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.0 109.141 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.3 m -119.36 114.87 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.456 -0.778 . . . . 0.0 109.812 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.41 131.97 55.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -173.18 152.96 2.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 55.89 23.56 6.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.596 -0.69 . . . . 0.0 110.973 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.02 2.75 83.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.525 ' HB2' HD22 ' A' ' 255' ' ' LEU . 89.8 mtt180 -104.61 172.99 6.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.988 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.2 tt -160.06 151.41 19.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.157 -1.589 . . . . 0.0 109.3 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.988 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.4 mt -147.56 130.28 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.957 . . . . 0.0 108.678 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -119.89 142.4 48.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 109.929 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -127.07 141.34 51.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.507 -0.745 . . . . 0.0 109.157 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -140.31 137.2 17.53 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.93 147.07 26.94 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.445 1.43 . . . . 0.0 112.256 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.33 152.3 10.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.922 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.69 0.66 46.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p -137.74 145.79 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.151 -0.968 . . . . 0.0 109.803 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 242' ' ' VAL . 56.2 tp -75.98 117.32 17.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -138.02 136.22 36.66 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.565 ' CG1' HD23 ' A' ' 231' ' ' LEU . 15.1 t -137.31 122.03 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -107.51 130.14 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.343 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.567 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.2 t80 -116.58 128.97 55.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.88 106.43 14.16 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.25 150.64 19.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -129.35 88.23 2.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.492 -1.004 . . . . 0.0 109.204 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -95.21 146.83 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.591 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -94.89 -2.03 51.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 182' ' ' PHE . 6.9 p30 -70.15 -166.64 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.779 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -65.71 -22.09 66.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.092 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.456 HD12 ' ND2' ' A' ' 157' ' ' ASN . 5.1 mt -66.66 -38.7 87.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.048 -1.033 . . . . 0.0 109.137 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.11 -137.95 19.23 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 161' ' ' ARG . 0.3 OUTLIER -100.11 145.34 28.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 109.421 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.483 ' OE1' ' ND2' ' A' ' 221' ' ' ASN . 0.9 OUTLIER -148.81 166.55 28.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.539 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 150.31 23.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -139.79 131.86 27.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.193 -0.942 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 165' ' ' THR . 11.4 t -102.15 123.17 45.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.184 -0.948 . . . . 0.0 109.801 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.5 t80 -101.2 134.46 44.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 108.986 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.43 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -132.67 151.2 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 109.472 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -50.54 120.76 4.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.87 6.8 26.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -134.53 27.25 3.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.206 -1.173 . . . . 0.0 108.522 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -61.68 -35.49 78.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 110.57 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.24 -18.35 10.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.951 -1.093 . . . . 0.0 110.283 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.9 -3.64 58.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 0.0 110.837 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 3.0 pt -130.49 19.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 111.947 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.1 OUTLIER -113.53 -29.13 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.803 -1.186 . . . . 0.0 109.908 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.06 2.53 53.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 110.684 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.03 127.13 32.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.605 -1.309 . . . . 0.0 109.109 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.58 ' NE ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.02 152.51 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.3 t -53.65 161.32 1.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 109.177 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.63 164.01 31.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.786 -1.196 . . . . 0.0 110.2 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 189' ' ' ILE . 0.3 OUTLIER -149.3 160.29 43.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 109.673 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.565 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.4 m-85 -104.35 144.97 30.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.721 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.753 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.7 p-10 -59.25 -26.98 65.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.958 -1.089 . . . . 0.0 110.488 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.565 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.4 p90 -81.14 -27.59 35.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.825 -1.172 . . . . 0.0 110.668 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.8 pt-20 -93.14 -14.21 27.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 109.818 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.9 mt -56.76 -52.61 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.62 -52.71 45.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.123 . . . . 0.0 109.79 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -52.82 -44.42 66.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 91.0 mt -65.51 -33.86 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -77.01 -26.88 54.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.042 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -81.0 -27.98 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.087 -1.008 . . . . 0.0 110.517 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.0 m -80.16 8.54 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.509 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.21 24.44 68.63 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.811 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 62.9 mt -121.19 159.82 25.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.24 -1.153 . . . . 0.0 109.691 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 76.94 27.7 59.99 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.03 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -71.18 -19.41 62.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.667 -1.49 . . . . 0.0 109.292 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.5 -4.19 49.75 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.14 128.74 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.273 -1.134 . . . . 0.0 110.896 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.25 -173.81 3.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.747 -0.855 . . . . 0.0 109.157 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.99 -5.59 57.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.051 -1.031 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -98.09 -13.69 20.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.339 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -127.18 -3.6 6.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -136.24 117.34 14.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.26 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.2 tp -79.42 110.54 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.54 127.56 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.08 -1.013 . . . . 0.0 109.839 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.28 146.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.363 -0.836 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.66 150.47 17.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -44.38 -28.65 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.132 . . . . 0.0 110.242 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 35.0 t0 -143.8 8.46 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 110.127 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 207' ' ' GLY . 68.4 tttt -146.01 154.72 42.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.062 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.71 128.96 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -71.98 -53.09 14.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.095 -1.003 . . . . 0.0 109.908 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -54.72 133.55 65.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.119 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.88 -24.97 20.48 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.281 1.987 . . . . 0.0 112.511 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.89 -6.65 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 109.792 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.92 -167.54 48.37 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.45 141.8 39.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -1.084 . . . . 0.0 109.63 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -83.7 -15.66 47.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.097 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 221' ' ' ASN . 70.1 m-85 -144.26 135.43 25.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.535 ' C ' HD22 ' A' ' 221' ' ' ASN . 1.5 tm-20 -49.34 -10.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 219' ' ' TYR . 1.4 m-80 -143.11 35.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.525 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 56.1 tt0 -56.1 -36.46 46.43 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 111.919 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 10.2 Cg_exo -69.27 -43.92 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.731 1.621 . . . . 0.0 112.907 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 228' ' ' VAL . 24.5 m -77.81 -25.7 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 120.706 -1.246 . . . . 0.0 108.544 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -65.12 -45.67 84.14 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.456 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 47.1 t60 -62.16 -43.15 99.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -49.85 74.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 109.335 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 224' ' ' VAL . 19.2 t -56.26 -48.18 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 108.767 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.578 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 85.0 t80 -50.5 -44.6 56.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.632 -0.668 . . . . 0.0 109.607 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.578 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 28.4 m-20 -71.48 -35.22 70.75 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 109.994 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.565 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.7 tp -56.46 -37.54 70.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.025 . . . . 0.0 108.857 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.722 HG22 ' HD1' ' A' ' 80' ' ' HIS . 55.4 mt -71.49 -47.52 58.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.13 -33.73 15.32 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.57 -26.18 32.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -1.171 . . . . 0.0 109.808 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 260' ' ' VAL . 4.7 mt -82.27 -24.55 34.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.826 -1.171 . . . . 0.0 110.193 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.443 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 28.7 t80 -69.98 -7.38 40.26 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 109.148 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.45 ' C ' ' N ' ' A' ' 239' ' ' GLY . 34.8 mt -51.04 -31.55 18.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 108.775 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.601 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 96.2 mt -53.79 -12.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 108.681 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 74.53 17.21 79.86 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.5 p -157.63 143.32 12.55 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.338 . . . . 0.0 109.812 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.419 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 55.7 Cg_exo -43.12 131.13 6.21 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.15 1.9 . . . . 0.0 111.944 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.502 ' O ' HD13 ' A' ' 147' ' ' LEU . 24.6 t -103.58 141.25 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -130.61 133.37 46.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.311 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.56 179.49 30.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -107.54 110.45 22.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.103 -1.233 . . . . 0.0 109.719 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.535 ' HB2' HG22 ' A' ' 149' ' ' VAL . 8.7 m-85 -112.18 146.96 37.17 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.928 . . . . 0.0 111.059 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -128.1 144.17 51.1 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.2 t -142.05 126.94 18.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.711 -1.243 . . . . 0.0 110.501 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.7 t80 -110.19 116.94 32.41 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 249' ' ' PHE . 6.4 mmm180 46.81 55.91 7.26 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.84 140.95 23.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.52 171.24 13.72 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 22.1 m-70 -63.99 -45.21 90.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.244 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -55.73 26.33 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.094 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' ' 137' ' ' ARG . 56.5 tp -52.06 -39.88 60.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.117 -0.989 . . . . 0.0 109.351 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.23 -55.82 30.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 108.784 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 53' ' ' VAL . 2.7 t -49.85 -41.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.47 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -49.45 71.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.067 -1.02 . . . . 0.0 109.039 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.757 HD22 HG21 ' A' ' 139' ' ' ILE . 43.8 tp -52.66 -49.65 64.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 0.0 108.677 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.531 HG22 HD23 ' A' ' 235' ' ' LEU . 48.8 t -63.62 -49.93 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.477 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -51.65 17.93 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.63 -44.34 90.84 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.89 -1.131 . . . . 0.0 109.781 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.64 -46.29 90.41 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.601 ' HB2' ' CD2' ' A' ' 238' ' ' LEU . . . -72.69 -32.78 66.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.704 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.7 -28.4 33.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.845 -1.16 . . . . 0.0 109.157 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -66.7 -45.79 77.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.0 109.812 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -88.78 10.87 19.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 0.0 110.176 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -78.87 -27.49 44.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.098 -1.001 . . . . 0.0 109.779 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 5.6 mt -96.21 25.04 5.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 109.549 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.56 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 36.0 mt-10 -52.18 131.03 31.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.977 . . . . 0.0 109.439 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 132.16 56.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.565 -0.709 . . . . 0.0 109.316 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -136.44 175.29 9.74 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.35 -0.843 . . . . 0.0 109.271 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.3 m -83.24 138.13 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.727 -1.233 . . . . 0.0 110.367 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HZ3' ' HB2' ' A' ' 8' ' ' LYS . 6.8 ttmm -71.95 -47.02 55.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.734 . . . . 0.0 109.543 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.66 156.44 41.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.854 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 135.16 55.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.473 -0.767 . . . . 0.0 110.415 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 113' ' ' ASN . 19.1 mt -117.54 163.46 16.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -153.92 147.3 24.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.009 . . . . 0.0 110.098 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.28 161.61 31.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.254 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -149.59 136.65 19.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.915 -1.116 . . . . 0.0 108.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.09 161.27 20.28 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.7 p -73.75 161.24 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.11 -1.23 . . . . 0.0 111.176 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -92.54 140.09 14.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.8 tt -56.11 -52.25 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -1.218 . . . . 0.0 111.816 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.533 ' N ' HG23 ' A' ' 18' ' ' ILE . 10.3 m-70 -86.97 -38.63 16.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.309 -1.494 . . . . 0.0 110.879 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 22' ' ' GLU . 2.6 m -68.68 -36.6 78.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 110.054 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.61 23.09 66.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HB2' HG22 ' A' ' 20' ' ' THR . 2.0 tt0 -117.99 154.98 31.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.692 -0.887 . . . . 0.0 108.722 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.5 t80 -71.73 136.3 47.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 110.181 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.439 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.9 t -144.02 157.55 44.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 108.974 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.1 ttmt -137.22 147.16 45.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.098 -1.001 . . . . 0.0 109.292 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.715 HD11 ' HD2' ' A' ' 97' ' ' PRO . 2.3 mt -123.41 151.1 42.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.629 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.422 HG22 ' CD2' ' A' ' 29' ' ' HIS . 6.8 mt -134.84 129.44 51.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.57 110.76 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 109.812 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.422 ' CD2' HG22 ' A' ' 27' ' ' ILE . 21.7 m-70 -106.75 150.23 39.43 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 108.901 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.56 161.88 22.91 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.226 1.95 . . . . 0.0 110.816 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.558 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -140.56 159.34 42.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.886 -1.134 . . . . 0.0 110.69 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 tttt -59.7 149.31 31.06 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.516 0.674 . . . . 0.0 109.987 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.3 mp0 -48.76 148.38 2.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 110.612 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.73 25.85 59.38 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.413 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -80.46 -37.57 31.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.618 -1.519 . . . . 0.0 109.031 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.27 -177.03 33.36 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.8 mm -98.8 125.41 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 140.13 32.71 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.969 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -97.48 152.22 19.2 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -133.54 140.13 47.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -170.7 143.75 2.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 54.86 29.13 11.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.955 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.85 21.16 78.05 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.8 t -124.42 135.62 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.161 -1.2 . . . . 0.0 109.545 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -94.6 142.06 27.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 109.039 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.9 mt -135.01 94.43 16.19 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.395 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -48.7 143.3 16.86 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.324 2.016 . . . . 0.0 111.747 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.99 79.74 5.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.069 -1.019 . . . . 0.0 110.158 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.3 mtt-85 -138.7 156.38 47.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.447 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 3.3 p80 -52.86 -50.12 64.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -45.26 -15.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 110.264 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.2 m-85 -100.19 2.64 43.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.669 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 50' ' ' HIS . 9.8 t -57.73 133.35 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 108.955 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 m -120.66 -36.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 109.91 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.454 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.1 t-160 -151.19 122.11 7.61 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.348 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 p -110.75 132.6 54.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.4 t-20 -166.47 -154.71 0.19 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -48.03 -11.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 108.604 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.6 t -135.89 165.61 25.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 m -101.64 119.73 39.23 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -116.94 135.5 53.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 111.169 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD12 HG21 ' A' ' 72' ' ' VAL . 30.9 mt -124.22 158.91 31.34 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -177.83 145.62 7.15 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.963 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -144.71 151.16 38.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.883 . . . . 0.0 109.51 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 57.37 23.81 9.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 110.971 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.15 1.26 72.74 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.556 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 55.5 mm-40 -99.24 139.84 34.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.989 -1.301 . . . . 0.0 108.284 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -136.28 149.72 48.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.025 . . . . 0.0 111.426 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.84 141.68 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -114.48 151.02 33.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.185 -0.947 . . . . 0.0 111.456 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 56.45 65.84 1.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.798 -0.564 . . . . 0.0 111.284 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.422 HG21 HD12 ' A' ' 62' ' ' LEU . 28.8 m -114.08 -3.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.041 -1.037 . . . . 0.0 109.043 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pt-20 -70.63 -28.4 64.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 110.533 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -64.35 -60.52 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.907 -1.121 . . . . 0.0 109.723 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -58.74 -44.51 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.952 -1.092 . . . . 0.0 109.129 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 75' ' ' ILE . 65.4 mt -55.8 -41.46 74.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.927 . . . . 0.0 109.456 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -56.82 -46.32 81.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.292 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.88 -53.69 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.963 . . . . 0.0 108.652 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 76' ' ' LEU . 27.6 mt -51.55 -44.58 62.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.279 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.524 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.4 t-160 -53.93 -55.38 27.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.249 -0.907 . . . . 0.0 109.726 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 171' ' ' GLU . 95.1 mt -62.36 -37.24 84.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.447 HD13 HD11 ' A' ' 114' ' ' ILE . 50.1 mt -78.94 -9.84 59.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.01 -1.056 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 63.41 60.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.851 -1.156 . . . . 0.0 110.514 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 4.8 mm -104.18 133.99 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.408 HG21 HG23 ' A' ' 121' ' ' ILE . 1.2 p -119.87 -17.1 8.59 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.269 -0.895 . . . . 0.0 111.943 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.696 ' O ' HG13 ' A' ' 87' ' ' VAL . 4.0 m-80 -130.11 111.83 12.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.699 -1.25 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -165.26 136.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 110.01 178.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.558 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 23.3 m -107.21 99.53 9.06 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 mt -87.95 117.83 32.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.91 119.64 34.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.787 -1.196 . . . . 0.0 107.992 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 26' ' ' LEU . 23.0 t -104.61 104.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 111.344 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mt -87.49 107.78 17.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.74 -161.32 24.03 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -116.85 -14.52 10.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -1.045 . . . . 0.0 110.506 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.18 146.34 35.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.741 -1.224 . . . . 0.0 111.076 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.23 124.88 91.37 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.803 -0.561 . . . . 0.0 109.674 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.715 ' HD2' HD11 ' A' ' 26' ' ' LEU . 73.3 Cg_exo -46.37 129.4 13.33 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.774 1.649 . . . . 0.0 111.754 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.4 tp -77.6 -29.18 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.488 -0.757 . . . . 0.0 110.188 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 95.0 mt 55.24 -111.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.44 ' OD1' ' NH2' ' A' ' 178' ' ' ARG . 2.5 t0 -89.28 -28.58 19.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.613 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.13 -14.98 11.02 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -109.93 -166.78 1.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.37 -2.76 21.34 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -47.44 -42.37 22.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.808 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.95 -51.96 64.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.002 -1.062 . . . . 0.0 110.356 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 93.6 m-85 -63.5 -44.81 93.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 108.632 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 6.9 t80 -62.36 -38.2 88.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.718 -0.614 . . . . 0.0 109.961 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.3 -46.28 61.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.366 -0.834 . . . . 0.0 110.807 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.42 -51.56 12.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.992 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.68 -45.52 79.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.043 -1.036 . . . . 0.0 110.557 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -55.51 -29.36 58.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.209 -0.932 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -81.24 -12.96 58.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -0.992 . . . . 0.0 109.992 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.54 ' HB2' HD11 ' A' ' 11' ' ' LEU . 1.5 m120 -120.09 33.09 5.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.385 -0.822 . . . . 0.0 111.125 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.447 HD11 HD13 ' A' ' 82' ' ' LEU . 5.9 mt -90.55 148.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 110.494 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 115' ' ' LEU . 52.7 tp -131.18 158.18 41.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.27 140.22 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -103.86 -163.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -116.47 -1.38 12.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.41 ' CD ' ' OE2' ' A' ' 4' ' ' GLU . 10.2 ttm180 -94.13 149.21 21.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 109.903 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.53 136.83 32.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 85' ' ' THR . 94.8 mt -77.52 144.32 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.411 -0.805 . . . . 0.0 110.459 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.5 89.97 8.07 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -62.88 145.64 54.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.235 -0.916 . . . . 0.0 110.518 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.27 123.4 46.03 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.18 141.12 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.89 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.1 t -84.43 138.34 19.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.493 -0.755 . . . . 0.0 109.096 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -119.12 -11.15 9.66 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -140.18 144.17 36.59 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.86 173.52 12.61 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.113 1.875 . . . . 0.0 113.109 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.709 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 2.9 tt -165.3 142.17 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.685 -0.634 . . . . 0.0 109.703 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 131' ' ' ILE . 3.4 mp -129.71 125.31 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 m -121.52 114.07 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -113.47 141.8 46.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.42 -0.8 . . . . 0.0 109.845 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -175.26 137.93 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 111.074 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 57.49 29.51 17.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.642 -0.662 . . . . 0.0 111.412 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.46 9.06 86.09 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -110.39 157.71 19.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.986 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -158.69 156.13 29.37 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.953 -1.717 . . . . 0.0 109.536 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.986 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.9 mt -149.03 133.02 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -120.91 143.01 49.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 109.901 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.709 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.23 143.97 49.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -142.03 138.47 16.9 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.9 144.9 42.85 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.473 1.449 . . . . 0.0 112.276 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.06 149.83 9.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -1.88 53.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 109.61 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.8 p -134.78 142.42 46.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.45 118.78 20.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -137.73 136.82 37.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.484 ' CG1' HD23 ' A' ' 231' ' ' LEU . 60.3 t -133.98 122.53 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.014 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.401 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 9.9 m -107.84 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.337 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -127.42 129.59 47.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.793 . . . . 0.0 109.72 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -115.52 103.51 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.72 135.45 12.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -111.18 93.23 4.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.498 -1.001 . . . . 0.0 109.343 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -95.16 148.66 22.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -97.07 -3.75 40.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.949 HD22 HD12 ' A' ' 159' ' ' LEU . 24.4 p-10 -73.74 -169.4 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.675 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -60.71 -20.8 61.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.97 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.949 HD12 HD22 ' A' ' 157' ' ' ASN . 31.2 mt -70.46 -28.36 64.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.0 109.042 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.69 -132.13 31.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.18 145.11 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -1.037 . . . . 0.0 109.556 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -146.35 156.04 43.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.583 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -139.23 145.0 38.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.249 -0.907 . . . . 0.0 109.332 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -136.28 126.58 26.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.061 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 165' ' ' THR . 7.3 t -103.78 123.85 47.83 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -100.22 136.03 40.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.159 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.512 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.5 t -131.82 153.5 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -57.08 118.91 5.49 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.43 -3.79 21.79 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -125.54 31.22 5.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.259 -1.142 . . . . 0.0 108.711 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.521 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.7 OUTLIER -64.3 -32.84 74.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.543 -0.723 . . . . 0.0 110.605 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -58.2 -15.64 10.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.937 -1.102 . . . . 0.0 111.059 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -92.7 -4.13 53.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.85 -1.156 . . . . 0.0 110.894 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.23 -6.56 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.103 -0.998 . . . . 0.0 110.721 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -89.85 -29.14 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.698 -1.252 . . . . 0.0 109.933 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.03 1.99 51.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.68 -1.262 . . . . 0.0 110.415 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.07 115.62 18.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.914 -1.116 . . . . 0.0 108.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' NH2' ' OD1' ' A' ' 100' ' ' ASP . 1.9 ptm180 -86.59 154.62 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.05 . . . . 0.0 110.066 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.442 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 6.1 t -53.34 159.46 1.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.63 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.502 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 38.6 p90 -145.93 169.42 18.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.911 -1.118 . . . . 0.0 109.906 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.518 ' SG ' ' C2A' ' A' ' 320' ' ' TUX . 0.0 OUTLIER -164.39 163.89 22.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.612 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 96.0 m-85 -103.7 146.08 29.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.613 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.717 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.6 OUTLIER -61.96 -20.69 64.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 111.076 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.612 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.3 p90 -81.0 -26.85 36.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.646 -1.284 . . . . 0.0 110.643 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.499 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 23.4 pt-20 -97.74 -15.85 20.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.859 -1.151 . . . . 0.0 109.474 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.7 mt -57.39 -52.12 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 110.045 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.15 -49.21 61.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.078 . . . . 0.0 109.43 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -54.46 -52.36 62.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 108.922 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.59 HD13 ' O1A' ' A' ' 320' ' ' TUX . 59.5 mt -57.72 -33.84 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.407 -0.808 . . . . 0.0 109.346 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -77.89 -28.95 49.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.51 ' HZ3' ' CB ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -72.69 -26.8 61.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.573 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.3 m -84.79 13.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.604 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.24 25.68 72.52 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.072 -1.061 . . . . 0.0 110.592 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.03 156.59 28.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.267 -1.137 . . . . 0.0 109.732 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.72 25.55 60.32 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.408 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.6 mtmm -69.04 -20.88 64.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.465 -1.609 . . . . 0.0 109.051 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.88 -7.28 44.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.93 129.31 43.82 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.24 -1.153 . . . . 0.0 110.771 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.4 p -143.72 169.93 16.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.79 -0.829 . . . . 0.0 109.466 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 17.0 mt -71.25 -16.46 62.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -86.08 -9.65 56.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 19.9 m-20 -138.26 12.07 2.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.648 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.475 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 28.1 m -152.97 131.69 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.57 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' A' ' 217' ' ' LEU . 6.5 tp -89.98 114.85 26.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 186' ' ' ILE . 63.4 t -100.65 125.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.063 -1.023 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.9 mt -100.73 146.13 27.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.867 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.43 150.3 16.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -46.33 -25.88 0.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.136 -1.214 . . . . 0.0 109.86 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -152.56 11.44 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 0.0 110.67 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -146.99 155.35 42.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.89 -1.131 . . . . 0.0 110.281 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.77 123.36 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -70.84 -54.35 11.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.935 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -53.49 131.36 54.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.098 -1.002 . . . . 0.0 109.391 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -24.95 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.311 2.007 . . . . 0.0 112.457 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -4.51 39.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.955 . . . . 0.0 109.289 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.89 -169.16 53.85 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.45 ' CD2' HD21 ' A' ' 204' ' ' LEU . 13.9 mt -88.05 149.81 23.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 0.0 109.745 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -60.67 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.0 108.722 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.426 ' C ' ' H ' ' A' ' 221' ' ' ASN . 7.7 m-85 -116.86 152.52 34.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 109.165 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.568 ' C ' HD21 ' A' ' 221' ' ' ASN . 3.6 mp0 -60.65 -3.93 0.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 109.423 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.584 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -137.48 29.77 2.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.867 . . . . 0.0 108.983 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.603 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.0 tt0 -54.45 -42.03 92.31 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.76 . . . . 0.0 110.863 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.5 Cg_exo -70.83 -38.52 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.508 2.139 . . . . 0.0 113.156 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -81.66 -26.87 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.675 -1.266 . . . . 0.0 108.539 179.361 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.43 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 38.1 mtt180 -67.35 -39.82 85.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.572 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 19.1 t60 -66.6 -41.03 89.06 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -42.05 76.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.036 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 224' ' ' VAL . 38.7 t -68.06 -44.6 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -55.26 -40.83 71.43 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.605 0.717 . . . . 0.0 109.067 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -71.74 -39.99 69.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.575 -0.703 . . . . 0.0 109.907 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.484 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.8 tp -56.55 -35.1 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.373 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 81.2 mt -72.15 -49.08 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.924 -1.11 . . . . 0.0 108.144 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.34 -30.95 12.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.74 -28.33 30.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -1.187 . . . . 0.0 109.854 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 260' ' ' VAL . 5.3 mt -79.17 -22.85 44.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.743 -1.223 . . . . 0.0 109.782 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.524 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 16.6 t80 -69.99 -8.0 45.46 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.068 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 237' ' ' LEU . 31.1 mt -49.76 -28.57 6.38 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.69 -20.59 65.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 108.957 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.41 17.91 76.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.9 p -154.01 138.8 11.52 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.235 . . . . 0.0 109.652 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -41.82 134.11 3.88 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.165 1.91 . . . . 0.0 111.872 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.81 136.14 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.023 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -122.3 125.71 46.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.306 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.45 26.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -102.5 112.54 25.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -1.198 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.6 m-85 -112.58 146.9 37.75 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.976 0.893 . . . . 0.0 111.048 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.401 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 26.9 t80 -126.99 144.29 51.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.0 t -138.87 126.76 22.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.684 -1.26 . . . . 0.0 110.112 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 250' ' ' ARG . 61.8 t80 -113.16 113.1 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 249' ' ' PHE . 52.8 mtp180 47.66 56.72 6.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.71 145.86 21.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.572 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -113.5 175.94 16.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.511 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.5 m-70 -66.99 -47.77 70.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -1.134 . . . . 0.0 109.998 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -55.14 37.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 109.801 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 51.6 tp -51.68 -37.86 52.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.572 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 88.4 m-20 -58.68 -55.37 35.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.119 -0.988 . . . . 0.0 108.746 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 253' ' ' HIS . 18.5 t -49.14 -41.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.415 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -55.22 -47.37 75.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 108.803 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.86 -50.56 63.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.447 HG22 HD23 ' A' ' 235' ' ' LEU . 42.1 t -63.63 -41.2 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 109.856 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -51.93 67.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.421 -0.799 . . . . 0.0 110.43 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -64.65 -45.4 86.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.845 -1.159 . . . . 0.0 109.73 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 263' ' ' LEU . 60.8 mt -58.83 -45.72 89.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.17 73.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.832 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -77.89 -29.29 50.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.85 -1.156 . . . . 0.0 109.101 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -71.19 -48.73 49.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.275 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -80.66 4.61 18.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.104 -0.997 . . . . 0.0 110.249 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -68.49 -59.5 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.064 -1.023 . . . . 0.0 109.746 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.5 mt -57.36 -84.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.115 -0.991 . . . . 0.0 109.757 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.271 -0.893 . . . . 0.0 109.502 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.59 ' O1A' HD13 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 3' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 76.7 mt-10 -54.32 132.99 44.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.551 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.88 139.67 52.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 109.485 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -141.15 177.57 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.468 -0.77 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.33 149.69 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 110.21 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -86.27 -42.13 14.02 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.662 -0.649 . . . . 0.0 109.758 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 10' ' ' LYS . 13.0 tt0 -129.32 153.98 47.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.517 -0.739 . . . . 0.0 109.992 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -59.98 135.64 57.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.305 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 113' ' ' ASN . 44.5 mt -124.8 166.52 16.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.473 -0.767 . . . . 0.0 109.267 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 150.24 22.34 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 110.115 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -131.21 158.43 40.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.695 -0.628 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.81 134.81 23.87 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.941 -1.1 . . . . 0.0 108.869 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.85 156.79 14.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.094 -1.603 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -81.12 141.02 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -1.229 . . . . 0.0 110.804 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.61 138.12 37.71 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.684 HD11 H3A3 ' A' ' 320' ' ' TUX . 6.6 tt -57.91 -48.16 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.089 . . . . 0.0 112.042 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.45 ' N ' HG23 ' A' ' 18' ' ' ILE . 16.3 m-70 -86.75 -37.6 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.276 -1.515 . . . . 0.0 111.017 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.492 HG21 ' OD1' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -72.25 -32.86 67.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 110.119 -179.024 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.33 65.89 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 16' ' ' VAL . 4.8 mm-40 -113.83 151.25 32.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.948 . . . . 0.0 108.956 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -70.62 130.94 43.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.89 . . . . 0.0 110.063 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -138.63 157.55 45.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.063 -1.023 . . . . 0.0 109.381 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' O ' HD23 ' A' ' 26' ' ' LEU . 6.7 ttpp -137.09 152.03 49.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.132 -0.98 . . . . 0.0 109.541 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.738 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.3 mt -127.72 145.95 50.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.491 HG22 ' NE2' ' A' ' 29' ' ' HIS . 26.1 mt -131.35 129.05 62.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mt -117.89 133.35 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.087 -1.008 . . . . 0.0 110.139 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.491 ' NE2' HG22 ' A' ' 27' ' ' ILE . 17.7 m-70 -126.6 150.01 69.66 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.71 161.78 20.32 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.104 1.869 . . . . 0.0 111.028 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 53.5 mt-10 -133.96 -174.68 3.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -89.73 154.92 19.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.195 -0.94 . . . . 0.0 109.248 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -47.93 145.2 3.08 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 110.058 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.55 23.52 54.78 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.382 -0.824 . . . . 0.0 111.791 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 55.5 m -75.45 -46.29 33.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.589 -1.536 . . . . 0.0 109.094 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.809 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 105.23 174.94 24.32 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.98 121.79 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.446 -1.032 . . . . 0.0 108.749 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.27 138.23 34.84 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -97.22 153.0 18.28 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -130.98 139.95 50.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.155 -0.965 . . . . 0.0 109.063 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 10.7 ttmt -170.0 139.46 1.86 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.483 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.91 29.02 18.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.04 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 28.09 70.63 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.3 t -134.28 139.18 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -1.12 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -97.67 144.43 27.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.096 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.414 HG23 ' CB ' ' A' ' 64' ' ' PHE . 31.9 mt -136.91 97.62 10.99 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.306 -0.871 . . . . 0.0 110.33 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.61 143.13 29.4 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.093 1.862 . . . . 0.0 111.341 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.46 83.15 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.0 -1.062 . . . . 0.0 110.481 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -138.53 154.9 48.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.332 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.9 p80 -53.47 -49.37 67.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.24 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' CG ' ' CE1' ' A' ' 50' ' ' HIS . 8.2 mt-10 -45.55 -16.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' HIS . 89.8 m-85 -96.89 6.66 48.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.961 -1.087 . . . . 0.0 109.868 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.14 126.2 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 108.652 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.21 -32.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -149.87 119.99 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.068 -1.02 . . . . 0.0 109.63 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.4 p -112.68 131.36 55.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.427 0.632 . . . . 0.0 109.359 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 2.1 t-20 -166.07 -154.3 0.19 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 57' ' ' ASN . 10.8 m-70 -47.81 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.922 -1.111 . . . . 0.0 108.357 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.6 t -136.6 166.11 24.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.2 m -107.83 123.45 48.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 108.971 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.02 141.68 51.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.928 0.87 . . . . 0.0 110.971 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.2 mt -118.64 168.58 10.57 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.25 145.07 5.43 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.801 -1.666 . . . . 0.0 110.824 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CB ' HG23 ' A' ' 46' ' ' ILE . 54.0 t80 -144.46 150.58 37.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? 55.85 23.22 6.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.751 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.62 68.08 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.741 -1.219 . . . . 0.0 111.075 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.499 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 1.5 mm100 -92.33 144.87 24.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.483 . . . . 0.0 108.456 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.635 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -141.6 153.23 44.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.937 -1.102 . . . . 0.0 111.5 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 147.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -113.63 151.75 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.206 -0.934 . . . . 0.0 111.383 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m 52.52 68.23 0.86 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.776 -0.578 . . . . 0.0 111.037 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 HG13 ' A' ' 96' ' ' ILE . 16.1 m -113.02 -10.28 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.49 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.8 pt-20 -65.56 -24.22 67.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.413 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -67.64 -60.32 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.871 -1.143 . . . . 0.0 109.764 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.2 tp -58.32 -42.32 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.002 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HA ' HD12 ' A' ' 79' ' ' LEU . 19.5 mt -58.85 -37.99 77.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.489 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.6 t -58.35 -47.47 83.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.931 -1.106 . . . . 0.0 108.956 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.88 -51.58 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.547 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 76' ' ' LEU . 49.5 mt -51.27 -44.1 61.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 4.6 t-160 -52.62 -56.95 11.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.404 -0.81 . . . . 0.0 109.918 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.83 -35.71 79.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 110.559 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.803 HD22 ' CD1' ' A' ' 114' ' ' ILE . 13.4 mt -79.68 -9.65 59.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.021 -1.05 . . . . 0.0 110.595 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 62.74 50.35 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.781 -1.199 . . . . 0.0 110.372 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 3.3 mm -94.14 125.64 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.468 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.8 p -113.83 -18.74 11.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.168 -0.958 . . . . 0.0 112.034 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.809 HD22 ' H ' ' A' ' 36' ' ' GLY . 10.5 m120 -130.75 112.15 12.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.886 -1.134 . . . . 0.0 110.409 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -164.57 148.69 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 0.0 110.023 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.467 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 2.3 m -115.69 102.09 9.42 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.1 104.79 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.21 118.88 24.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 108.401 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.27 112.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 111.05 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -92.5 110.9 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.21 -163.16 24.87 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -116.57 -15.18 10.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -1.013 . . . . 0.0 110.101 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 19.1 tt0 -138.05 143.01 40.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 0.0 110.291 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.481 HG13 HG12 ' A' ' 72' ' ' VAL . 2.9 mm -69.36 124.71 91.06 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.468 -0.77 . . . . 0.0 109.392 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.738 ' CD ' HD21 ' A' ' 26' ' ' LEU . 50.1 Cg_exo -46.85 126.46 11.0 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.547 1.498 . . . . 0.0 111.416 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 98' ' ' ILE . 4.7 tp -79.52 -21.45 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 3.7 mt 57.06 -110.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -95.5 -8.16 36.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.046 -1.034 . . . . 0.0 111.919 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.23 -12.04 48.13 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.2 p -119.04 -168.84 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -1.01 . . . . 0.0 109.537 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.55 -4.08 23.51 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.543 ' NE1' ' CD ' ' A' ' 108' ' ' GLU . 60.5 t-105 -46.92 -42.5 17.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.664 -0.903 . . . . 0.0 110.455 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.15 -51.51 68.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.924 -1.11 . . . . 0.0 109.783 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.5 m-85 -62.29 -43.81 97.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.112 -0.993 . . . . 0.0 108.588 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -61.98 -39.3 91.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.543 ' CD ' ' NE1' ' A' ' 104' ' ' TRP . 19.0 mt-10 -68.91 -46.39 68.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 111.437 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.97 -51.82 9.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.83 -1.169 . . . . 0.0 110.97 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.72 -43.37 87.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.814 -1.178 . . . . 0.0 110.558 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -59.55 -30.28 68.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.971 -1.08 . . . . 0.0 109.317 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -83.73 11.14 7.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.695 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.64 ' HB2' HD11 ' A' ' 11' ' ' LEU . 8.7 m120 -144.37 32.18 1.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.397 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.803 ' CD1' HD22 ' A' ' 82' ' ' LEU . 6.8 mt -91.5 148.73 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.891 -1.13 . . . . 0.0 110.717 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.64 153.73 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 2.3 m-20 -105.64 146.36 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.06 -1.025 . . . . 0.0 110.012 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.479 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.4 mt-30 -105.41 -162.36 0.87 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.837 . . . . 0.0 109.09 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -117.74 2.09 12.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.092 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -97.84 152.53 19.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.858 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -94.43 147.54 23.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.898 . . . . 0.0 109.485 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.419 HG23 HG21 ' A' ' 85' ' ' THR . 83.9 mt -89.37 153.93 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.356 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -96.84 101.81 13.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.405 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.7 m-85 -72.42 145.21 47.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.962 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -95.89 123.04 39.31 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.53 138.2 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.48 136.86 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -112.56 -7.27 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.28 147.82 24.67 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 109.188 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.35 145.48 38.44 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.173 1.915 . . . . 0.0 112.888 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.6 tt -130.73 150.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.27 117.85 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.629 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' A' ' 139' ' ' ILE . 1.8 m -118.09 109.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.7 131.64 55.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 0.0 109.293 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -179.98 159.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.062 . . . . 0.0 110.469 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 134' ' ' ASP . 11.6 mm-40 56.61 19.74 4.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.708 -0.62 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 -0.4 82.68 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.51 ' HB2' HD22 ' A' ' 255' ' ' LEU . 0.6 OUTLIER -101.04 176.79 5.14 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.01 . . . . 0.0 108.302 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.962 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.1 tt -160.35 145.97 15.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.512 -1.367 . . . . 0.0 108.769 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.962 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.6 mt -144.97 130.99 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.076 -1.015 . . . . 0.0 108.28 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -121.39 137.37 54.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 109.814 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.658 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -113.71 149.35 34.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -145.4 136.61 12.58 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.53 144.94 99.29 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.493 1.462 . . . . 0.0 112.014 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.56 156.19 7.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 12.4 p-10 -88.82 3.28 51.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.5 p -135.43 147.1 48.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.0 118.73 22.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -135.94 139.03 42.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.686 ' CG1' HD23 ' A' ' 231' ' ' LEU . 79.8 t -137.7 122.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 109.685 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.455 ' O ' ' OG ' ' A' ' 248' ' ' SER . 1.4 m -112.37 138.67 48.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -127.82 131.57 49.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.695 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -117.31 119.11 34.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -114.82 137.73 14.23 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -112.24 85.44 2.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.416 -1.049 . . . . 0.0 109.241 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.442 ' HB3' ' ND2' ' A' ' 157' ' ' ASN . 18.5 m-85 -86.2 148.45 25.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 109.915 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -97.22 -3.01 41.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 0.0 109.852 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.606 HD22 ' HB2' ' A' ' 159' ' ' LEU . 1.1 p30 -76.35 -169.94 1.33 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.084 -1.01 . . . . 0.0 109.687 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -55.7 -24.22 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.606 ' HB2' HD22 ' A' ' 157' ' ' ASN . 9.1 mt -66.49 -40.21 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.18 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 75.5 -124.98 7.81 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -114.14 145.32 41.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.955 . . . . 0.0 109.819 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.423 ' OE1' ' ND2' ' A' ' 221' ' ' ASN . 4.4 tt0 -162.21 162.14 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 0.0 109.738 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -147.86 159.81 43.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -139.39 131.65 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.096 -1.003 . . . . 0.0 109.667 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 165' ' ' THR . 13.8 t -103.7 123.22 46.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 5.9 t80 -100.53 138.56 37.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.441 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 t -137.53 150.02 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.804 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -50.43 118.2 2.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.2 6.17 18.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.85 28.41 2.64 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.17 -1.194 . . . . 0.0 108.716 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.42 -37.01 79.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.425 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.83 -16.63 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 110.45 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -88.33 -3.86 58.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.081 -1.012 . . . . 0.0 110.919 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.77 5.65 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.085 -1.009 . . . . 0.0 111.417 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -32.39 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.456 -1.403 . . . . 0.0 110.057 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.52 2.68 50.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.009 -1.057 . . . . 0.0 110.994 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.06 117.31 20.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.685 -1.259 . . . . 0.0 108.698 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -91.54 152.86 20.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.102 -0.999 . . . . 0.0 110.334 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -57.77 131.19 49.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.372 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -109.36 163.9 12.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -0.992 . . . . 0.0 110.115 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.618 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -144.71 162.36 36.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 110.495 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.554 ' N ' ' OE2' ' A' ' 185' ' ' GLU . 57.7 m-85 -105.37 144.65 31.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.674 ' HA ' HD12 ' A' ' 186' ' ' ILE . 14.8 p-10 -60.79 -26.5 67.32 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.829 -1.17 . . . . 0.0 110.213 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.482 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.1 p90 -81.31 -26.24 35.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 111.095 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 182' ' ' PHE . 10.3 pt-20 -92.7 -14.59 27.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.663 -1.273 . . . . 0.0 109.568 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.3 mt -56.19 -53.37 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.235 -0.916 . . . . 0.0 110.145 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.0 -53.32 54.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.989 -1.069 . . . . 0.0 109.449 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -52.12 -41.49 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.833 . . . . 0.0 109.214 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.86 -33.88 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -0.967 . . . . 0.0 108.862 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -79.52 -25.74 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -27.72 42.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 109.89 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.89 8.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.2 70.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.1 mt -123.85 163.17 21.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 0.0 109.664 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.29 24.43 71.07 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -70.83 -20.66 62.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.282 . . . . 0.0 109.691 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.04 -2.51 51.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.65 128.55 35.36 Favored Glycine 0 N--CA 1.492 2.387 0 O-C-N 121.204 -1.174 . . . . 0.0 111.07 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.5 p -132.45 -173.67 3.23 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.9 -12.88 29.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -91.4 -4.89 55.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 109.559 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 99' ' ' LEU . 42.5 m-20 -139.22 12.11 2.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.885 . . . . 0.0 109.375 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.618 HG22 ' SG ' ' A' ' 181' ' ' CYS . 0.6 OUTLIER -149.76 122.13 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.249 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.2 tp -82.25 112.83 19.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 t -103.67 127.88 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.957 -1.09 . . . . 0.0 109.215 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 78.6 mt -111.15 141.95 43.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 110.136 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -96.37 149.29 19.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -42.48 -25.17 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -1.222 . . . . 0.0 110.106 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.2 OUTLIER -150.49 10.12 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.833 -1.167 . . . . 0.0 110.596 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -143.21 151.83 41.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 110.098 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.6 t -96.54 123.22 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.488 -0.757 . . . . 0.0 109.066 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -72.85 -54.36 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 110.129 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -55.33 134.36 69.66 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.872 -1.142 . . . . 0.0 109.618 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.55 -23.01 20.41 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.393 2.062 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.63 -5.1 49.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 110.043 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.58 -161.56 53.66 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.2 mt -89.94 146.92 24.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.495 -1.003 . . . . 0.0 110.294 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.75 -20.99 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.631 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 48.3 m-85 -142.52 167.91 20.97 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.57 -21.44 35.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 108.412 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 221' ' ' ASN . 0.1 OUTLIER -125.18 37.55 4.37 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.591 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 30.1 tt0 -58.95 -35.76 35.65 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.447 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.5 Cg_exo -73.88 -45.52 0.38 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.714 1.61 . . . . 0.0 113.001 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 224' ' ' VAL . 16.5 m -76.43 -25.19 16.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.754 -1.216 . . . . 0.0 108.554 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.631 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 11.6 mtp180 -67.06 -46.01 75.63 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -58.29 -43.25 87.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -45.59 82.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 108.737 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.91 -48.63 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -54.32 -41.31 68.88 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.96 -39.67 79.34 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.513 -0.742 . . . . 0.0 109.671 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.686 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.4 tp -58.66 -36.21 73.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.374 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.3 -34.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -63.34 -34.42 89.92 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 3.0 m-20 -82.94 -26.77 31.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -1.143 . . . . 0.0 110.135 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.48 -25.92 35.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.853 -1.154 . . . . 0.0 109.772 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.505 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 27.8 t80 -66.85 -8.8 31.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 108.923 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 237' ' ' LEU . 71.5 mt -49.95 -30.12 9.76 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.18 -15.8 27.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 108.98 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 53.4 p -156.01 137.53 9.61 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.247 . . . . 0.0 109.503 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.431 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 78.5 Cg_exo -42.81 130.4 5.53 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.049 1.833 . . . . 0.0 112.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.88 135.98 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.815 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -118.62 123.34 44.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.755 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.22 169.86 20.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.74 114.47 28.55 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.197 -1.178 . . . . 0.0 110.047 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -111.36 150.97 28.98 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.918 0.866 . . . . 0.0 110.976 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -128.44 144.14 51.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 150' ' ' THR . 0.9 OUTLIER -137.26 127.01 25.46 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.731 -1.231 . . . . 0.0 110.475 -178.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.468 ' O ' ' C ' ' A' ' 250' ' ' ARG . 52.4 t80 -111.83 113.9 26.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.47 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 11.5 mmm180 44.45 56.12 5.23 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.46 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -83.47 146.99 23.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.587 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -119.84 177.05 16.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.539 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 29.1 m-70 -67.63 -38.21 83.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -1.154 . . . . 0.0 109.787 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.1 t -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.065 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.649 ' HG ' HD12 ' A' ' 139' ' ' ILE . 58.2 tp -72.66 -37.29 67.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 75.5 m-20 -60.57 -51.76 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 80.4 t -51.92 -44.13 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 109.138 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -55.23 -47.08 75.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.052 -1.03 . . . . 0.0 109.018 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 139' ' ' ILE . 54.1 tp -52.66 -49.67 64.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 108.824 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.4 -47.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -52.24 54.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.576 -0.703 . . . . 0.0 110.23 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.09 -50.65 73.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.982 -1.074 . . . . 0.0 110.515 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.63 -39.73 92.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.19 -34.29 72.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.336 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -69.61 -35.2 75.07 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.025 -1.047 . . . . 0.0 108.527 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -58.36 -46.08 86.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.24 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -74.22 10.35 1.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.808 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -82.07 -31.02 31.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 109.914 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.81 1.7 53.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.128 -0.982 . . . . 0.0 109.459 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.605 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.684 H3A3 HD11 ' A' ' 18' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 4' ' ' GLU . 23.2 mt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.674 ' OE2' HG23 ' A' ' 121' ' ' ILE . 7.0 mm-40 -47.01 148.39 1.12 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.195 -0.941 . . . . 0.0 108.877 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.19 138.82 54.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.066 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.5 t -134.15 171.43 14.24 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 7' ' ' VAL . 3.1 m -82.24 140.87 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.79 -1.194 . . . . 0.0 110.484 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -75.84 -46.54 29.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -126.54 154.48 43.78 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.744 0.783 . . . . 0.0 111.054 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HD2' ' CE1' ' A' ' 29' ' ' HIS . 9.4 tttt -54.37 135.23 45.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.698 -0.626 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mt -121.22 152.91 38.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -151.99 146.44 25.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 110.042 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -128.25 162.4 27.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.58 -0.7 . . . . 0.0 109.304 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.73 132.52 17.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.914 -1.116 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.6 157.9 16.46 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.4 p -77.7 164.28 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.943 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -91.32 137.61 13.91 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.4 tt -58.57 -48.41 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.229 -1.16 . . . . 0.0 111.928 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.477 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.1 m-70 -86.78 -38.18 17.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.205 -1.56 . . . . 0.0 110.98 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -74.47 -40.0 62.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 0.0 109.867 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.77 23.08 78.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -112.11 151.04 29.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.528 -0.983 . . . . 0.0 108.621 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -71.16 134.43 46.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 109.88 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 11.5 t -141.17 158.49 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -133.15 155.07 49.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.502 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.705 HD11 ' HD2' ' A' ' 97' ' ' PRO . 24.6 mt -128.65 152.35 48.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.955 . . . . 0.0 109.665 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.563 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.1 mt -142.05 126.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.491 -0.756 . . . . 0.0 109.014 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mt -115.29 117.72 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 0.0 109.924 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.563 ' NE2' HG22 ' A' ' 27' ' ' ILE . 11.7 m-70 -113.04 149.38 41.24 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.6 163.1 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 111.143 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.0 mm-40 -136.84 -175.17 3.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.08 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 152.07 22.91 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.432 -0.792 . . . . 0.0 109.028 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -51.66 151.04 3.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 110.407 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.533 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 63.62 19.64 62.9 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.27 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 51.9 m -81.94 -46.75 13.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.498 -1.589 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -171.77 23.26 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mm -97.52 122.12 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -1.137 . . . . 0.0 108.159 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.61 144.3 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 110.544 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.83 154.33 20.68 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.7 t80 -129.86 142.06 50.72 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 12.9 ttpt -172.35 138.24 0.92 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.95 29.76 19.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.466 -0.771 . . . . 0.0 109.824 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.99 74.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.61 139.75 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -94.04 146.83 23.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.122 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.401 HG23 ' CB ' ' A' ' 64' ' ' PHE . 8.0 mt -139.56 98.91 7.89 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.92 140.93 37.9 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.174 1.916 . . . . 0.0 111.453 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.34 79.89 8.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.91 -1.119 . . . . 0.0 110.866 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.62 155.07 49.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.914 . . . . 0.0 109.223 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.492 ' O ' ' N ' ' A' ' 52' ' ' PHE . 4.0 p-80 -54.56 -49.58 69.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.171 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -46.56 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 109.909 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' HIS . 80.0 m-85 -98.51 7.99 45.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 62' ' ' LEU . 4.8 t -63.76 132.86 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.81 -34.06 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.0 110.119 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.45 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.6 t-80 -150.37 122.95 8.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.034 -1.041 . . . . 0.0 109.963 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.2 p -112.36 129.49 56.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 11.1 t-20 -166.67 -153.6 0.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 57' ' ' ASN . 19.2 m-70 -44.85 -16.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.218 -0.926 . . . . 0.0 108.704 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.2 t -136.19 165.56 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.48 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -102.97 121.32 42.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 108.778 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -119.39 138.22 53.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 111.033 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 53' ' ' VAL . 84.6 mt -118.34 163.52 16.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.77 146.21 6.23 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.482 -1.818 . . . . 0.0 111.211 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CB ' HG23 ' A' ' 46' ' ' ILE . 69.1 t80 -145.03 151.81 39.15 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.629 -0.924 . . . . 0.0 109.579 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt 57.57 23.66 9.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.88 . . . . 0.0 110.93 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.96 -2.22 75.57 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.888 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.469 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 96.8 mm-40 -98.93 143.75 28.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.842 -1.387 . . . . 0.0 108.258 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -142.86 155.71 44.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 111.801 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.12 145.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -110.88 150.29 29.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.112 -0.993 . . . . 0.0 111.668 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 m 54.55 68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.764 -0.585 . . . . 0.0 111.294 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.41 -9.58 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.718 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' OE2' ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER -66.28 -19.04 65.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 0.0 110.698 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -72.32 -60.86 2.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.841 -1.162 . . . . 0.0 109.641 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -56.74 -42.65 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.864 -1.148 . . . . 0.0 108.554 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.529 ' HA ' HD12 ' A' ' 79' ' ' LEU . 74.1 mt -55.05 -40.12 69.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.591 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 37.6 t -60.49 -48.74 80.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.554 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -56.55 -54.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 108.606 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 76' ' ' LEU . 14.6 mt -51.43 -44.38 62.29 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.515 ' HD1' HG22 ' A' ' 232' ' ' ILE . 11.6 t-160 -54.81 -56.5 18.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.92 -37.48 87.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.255 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 114' ' ' ILE . 14.0 mt -77.2 -6.12 51.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.993 -1.067 . . . . 0.0 110.057 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 62.96 42.37 7.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.967 -1.083 . . . . 0.0 110.096 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 82' ' ' LEU . 16.2 mm -90.01 126.1 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.505 HG21 ' OE2' ' A' ' 4' ' ' GLU . 48.1 p -107.47 -76.41 0.61 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 111.577 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.729 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -81.27 113.81 19.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.06 -1.025 . . . . 0.0 111.9 -176.522 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.71 144.37 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.541 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 3.8 m -110.93 101.65 10.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.499 -0.751 . . . . 0.0 109.27 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.99 111.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -92.21 120.0 32.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.043 -1.036 . . . . 0.0 108.633 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.402 HG22 HD22 ' A' ' 26' ' ' LEU . 94.6 t -102.32 112.37 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.991 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -91.44 109.67 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.35 -160.79 23.52 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.4 -15.97 9.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.979 . . . . 0.0 109.959 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -135.64 142.56 45.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.977 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -67.96 126.75 93.02 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.705 ' HD2' HD11 ' A' ' 26' ' ' LEU . 58.6 Cg_exo -46.28 127.82 11.46 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.709 1.606 . . . . 0.0 111.735 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.56 -25.75 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.302 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 99' ' ' LEU . 96.4 mt 54.77 -116.65 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -94.85 -8.13 38.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 0.0 110.751 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.87 -13.38 59.15 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -109.94 -171.97 1.94 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -1.059 . . . . 0.0 109.619 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.94 -7.62 16.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -46.42 -38.57 9.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.976 . . . . 0.0 110.128 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.525 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -61.85 -51.81 66.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.007 -1.058 . . . . 0.0 109.818 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 78.2 m-85 -63.34 -43.78 96.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -60.93 -39.66 90.28 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.447 0.641 . . . . 0.0 109.84 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.57 -46.6 53.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 111.829 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.09 -51.25 12.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.779 -1.201 . . . . 0.0 110.828 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 110' ' ' ILE . 60.7 mt -61.55 -42.67 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.043 -1.035 . . . . 0.0 110.708 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -57.27 -28.56 63.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 110.038 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -80.16 -12.07 59.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.221 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -123.09 34.88 5.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.836 . . . . 0.0 110.927 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 82' ' ' LEU . 17.9 mt -85.98 147.16 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.48 -1.388 . . . . 0.0 110.674 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 115' ' ' LEU . 31.9 tp -132.26 145.53 51.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.618 -0.677 . . . . 0.0 109.478 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -92.68 146.2 23.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.106 -0.996 . . . . 0.0 110.356 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -108.85 -168.23 1.32 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -119.74 69.94 0.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.418 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -170.21 122.04 0.66 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.225 -0.922 . . . . 0.0 109.91 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.87 134.69 56.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.674 HG23 ' OE2' ' A' ' 4' ' ' GLU . 0.9 OUTLIER -75.49 143.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.462 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -86.4 89.68 7.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -63.67 147.01 52.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 110.555 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -104.77 125.09 50.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.29 142.59 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.7 t -83.65 139.88 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.459 -0.775 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -118.87 -11.05 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 109.046 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -142.56 144.95 32.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.261 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.61 160.24 44.44 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.163 1.908 . . . . 0.0 113.349 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.579 HD12 ' NZ ' ' A' ' 266' ' ' LYS . 1.4 tt -153.22 140.82 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.629 HG23 HD11 ' A' ' 138' ' ' LEU . 18.1 mt -130.0 124.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.478 -0.764 . . . . 0.0 109.846 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 132' ' ' VAL . 18.3 m -122.3 117.72 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.87 156.89 16.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 109.737 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 137' ' ' ARG . 49.6 t0 -165.92 110.22 0.82 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 0.0 111.369 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 41.06 51.13 3.3 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.54 -0.725 . . . . 0.0 112.244 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.91 6.97 88.89 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.708 -1.245 . . . . 0.0 110.274 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 134' ' ' ASP . 12.5 mtt85 -118.2 132.28 56.33 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.629 HD11 HG23 ' A' ' 131' ' ' ILE . 4.8 tt -144.71 160.81 40.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.349 -1.469 . . . . 0.0 109.776 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.608 HG21 HD22 ' A' ' 259' ' ' LEU . 48.9 mt -144.57 129.63 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -116.0 142.32 46.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.36 -0.837 . . . . 0.0 110.131 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.57 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.97 143.74 50.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -142.02 138.92 17.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.93 146.16 58.67 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.394 1.396 . . . . 0.0 112.088 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -166.11 151.97 8.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.398 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 -1.29 56.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -134.1 146.25 50.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 109.259 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.46 120.18 24.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -1.0 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.95 137.96 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.715 ' CG1' HD23 ' A' ' 231' ' ' LEU . 12.4 t -137.23 118.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.711 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 m -106.03 143.91 33.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -132.06 130.94 41.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.93 105.97 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.74 155.54 20.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.428 ' HB3' ' HE ' ' A' ' 250' ' ' ARG . 3.2 tt0 -132.79 98.01 4.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -1.028 . . . . 0.0 109.116 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' GLY . 20.8 m-85 -101.38 148.6 24.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.844 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 mmtm -93.16 -5.99 48.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.992 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.535 HD21 HD12 ' A' ' 159' ' ' LEU . 10.7 p30 -74.44 -173.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.032 -1.042 . . . . 0.0 109.48 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -53.58 -17.05 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.783 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.535 HD12 HD21 ' A' ' 157' ' ' ASN . 31.7 mt -67.1 -49.98 63.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 109.506 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 82.86 -114.59 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.45 ' O ' ' CD ' ' A' ' 162' ' ' GLN . 12.4 mtm-85 -116.98 139.55 50.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.481 -1.011 . . . . 0.0 109.294 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 161' ' ' ARG . 4.3 mp0 -142.31 155.65 45.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 109.526 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 142.18 31.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.079 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -136.35 125.72 24.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.191 -0.943 . . . . 0.0 109.257 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -103.6 122.94 46.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.045 -1.034 . . . . 0.0 109.802 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -100.01 136.96 39.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.178 -0.951 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.89 156.08 41.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.556 -0.715 . . . . 0.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.28 118.9 6.47 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.145 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.83 1.32 21.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -131.42 29.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -1.112 . . . . 0.0 108.806 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -64.01 -33.58 76.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.603 -0.686 . . . . 0.0 110.611 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -52.81 -13.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 110.638 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.87 -4.12 44.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 111.139 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.1 -8.15 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.022 -1.049 . . . . 0.0 110.785 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.33 -33.11 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.66 -1.275 . . . . 0.0 109.943 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.96 1.28 54.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.797 -1.189 . . . . 0.0 110.603 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.82 116.93 20.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.927 -1.108 . . . . 0.0 108.657 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.54 153.26 20.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.034 -1.041 . . . . 0.0 110.361 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.6 t -62.07 147.66 46.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.531 -0.73 . . . . 0.0 109.457 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -130.31 176.26 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 110.402 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.562 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.6 OUTLIER -160.89 163.09 32.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.463 -0.773 . . . . 0.0 109.581 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.63 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 89.6 m-85 -104.69 146.34 29.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 109.937 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.744 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.0 p-10 -61.7 -22.05 65.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 0.0 110.804 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.63 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.4 p90 -81.19 -28.41 34.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.793 -1.192 . . . . 0.0 110.653 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 13.6 pt-20 -95.1 -14.32 24.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.897 -1.127 . . . . 0.0 109.51 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.744 HD12 ' HA ' ' A' ' 183' ' ' ASP . 10.7 mt -58.62 -53.12 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.238 -0.914 . . . . 0.0 110.129 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.22 -52.97 49.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.773 -1.204 . . . . 0.0 109.107 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.62 -47.98 66.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -0.966 . . . . 0.0 108.707 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 76.5 mt -58.7 -34.36 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -78.55 -27.04 45.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.53 -0.731 . . . . 0.0 110.166 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -74.84 -26.82 59.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -0.999 . . . . 0.0 109.883 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.614 ' CG2' HD12 ' A' ' 194' ' ' LEU . 15.4 m -84.18 9.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.34 66.92 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.821 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.614 HD12 ' CG2' ' A' ' 192' ' ' VAL . 3.8 mt -120.02 158.29 27.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.136 -1.214 . . . . 0.0 109.688 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.02 21.41 65.58 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.462 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -68.8 -22.34 64.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.577 -1.543 . . . . 0.0 109.664 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.41 -4.75 52.8 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.05 125.98 33.23 Favored Glycine 0 N--CA 1.49 2.273 0 O-C-N 121.186 -1.184 . . . . 0.0 110.539 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -131.08 -173.64 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.768 -0.842 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.4 -2.03 57.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -100.17 -3.56 31.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -139.26 -7.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.97 . . . . 0.0 109.871 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.5 m -130.26 128.41 41.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 109.81 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 217' ' ' LEU . 60.6 tp -88.98 115.93 26.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 108.927 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 186' ' ' ILE . 47.2 t -103.01 127.88 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 30.5 mt -103.6 147.34 27.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.809 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.07 150.63 17.44 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -44.89 -22.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.141 . . . . 0.0 110.058 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.0 OUTLIER -155.13 12.74 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.948 -1.095 . . . . 0.0 110.343 -179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -146.67 155.44 42.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.85 125.56 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.03 -54.74 7.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.441 ' OD1' HD12 ' A' ' 204' ' ' LEU . 3.6 m120 -47.89 135.89 10.95 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.812 -1.18 . . . . 0.0 109.389 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.7 -41.16 2.37 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 112.05 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -65.12 -0.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.863 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.31 -166.93 54.49 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.462 ' CD2' HD21 ' A' ' 204' ' ' LEU . 43.5 mt -83.89 149.83 26.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.442 -1.034 . . . . 0.0 109.803 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -76.7 -61.37 1.99 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.947 . . . . 0.0 108.755 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.436 ' H ' ' HB2' ' A' ' 222' ' ' GLU . 6.8 m-85 -117.09 163.1 16.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.362 -0.837 . . . . 0.0 109.293 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.79 -14.6 62.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.514 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -133.55 32.77 3.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.339 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 5.8 tt0 -58.69 -37.39 53.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 111.126 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.6 Cg_exo -70.63 -43.22 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.971 1.781 . . . . 0.0 112.576 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 228' ' ' VAL . 6.3 m -78.71 -25.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.755 -1.216 . . . . 0.0 108.604 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.514 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 27.4 mtt180 -66.7 -40.71 88.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -64.81 -41.29 95.9 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -48.64 78.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.675 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 224' ' ' VAL . 59.8 t -58.3 -49.27 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.591 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.0 t80 -49.99 -38.29 36.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.502 0.667 . . . . 0.0 109.299 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.477 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 7.9 m-20 -72.68 -40.01 66.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 110.141 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.715 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.46 -37.48 70.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.343 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.515 HG22 ' HD1' ' A' ' 80' ' ' HIS . 88.9 mt -70.92 -48.49 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.886 -1.134 . . . . 0.0 108.057 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.81 -33.87 13.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.29 -26.76 32.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -1.199 . . . . 0.0 110.176 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -80.05 -21.03 43.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.668 -1.27 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -70.59 -8.32 50.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 109.143 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 237' ' ' LEU . 90.6 mt -53.18 -26.07 15.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.358 -0.839 . . . . 0.0 108.829 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.479 HD12 HG22 ' A' ' 242' ' ' VAL . 94.7 mt -61.11 -20.0 62.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.973 -1.08 . . . . 0.0 108.939 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.93 15.35 70.28 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 70.9 p -158.47 149.49 16.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.909 -1.348 . . . . 0.0 109.824 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -44.32 130.16 8.73 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.216 1.944 . . . . 0.0 111.749 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.479 HG22 HD12 ' A' ' 238' ' ' LEU . 87.0 t -98.88 133.16 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.005 -1.059 . . . . 0.0 109.697 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -121.84 125.83 47.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.73 172.59 26.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -103.58 112.9 26.03 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -1.184 . . . . 0.0 109.656 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 5.6 m-85 -113.5 148.45 35.98 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.06 0.933 . . . . 0.0 111.558 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.8 t80 -129.65 144.28 51.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.414 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 36.2 t -139.52 127.67 22.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.701 -1.249 . . . . 0.0 110.466 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 4.3 t80 -111.71 114.6 27.72 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.2 mtt-85 45.76 56.44 5.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.37 151.13 21.74 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.848 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.7 -176.24 16.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -71.03 -52.35 20.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -1.228 . . . . 0.0 110.107 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -55.01 33.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.181 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.442 ' HG ' HD12 ' A' ' 139' ' ' ILE . 55.6 tp -51.03 -41.63 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -57.87 -54.29 48.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 108.863 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.1 -43.22 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.647 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.61 -46.72 73.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.078 -1.014 . . . . 0.0 108.718 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 139' ' ' ILE . 24.7 tp -55.73 -47.92 76.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.8 . . . . 0.0 109.048 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 235' ' ' LEU . 88.0 t -66.99 -42.6 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.17 -48.36 70.98 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 110.671 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.19 -45.05 70.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.841 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.45 -45.41 93.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.42 89.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.827 . . . . 0.0 109.732 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -73.71 -28.11 61.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.962 -1.086 . . . . 0.0 109.214 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.579 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 33.7 mttp -67.53 -48.2 67.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.234 -0.917 . . . . 0.0 110.06 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -85.01 4.11 35.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.115 -0.991 . . . . 0.0 110.24 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -69.87 -64.46 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.063 -1.023 . . . . 0.0 109.791 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 18.5 mt -62.23 -83.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.116 -0.99 . . . . 0.0 109.456 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.477 -0.764 . . . . 0.0 109.457 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.562 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.838 ' O ' HD11 ' A' ' 121' ' ' ILE . 2.2 mt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 119' ' ' ARG . 16.1 mm-40 -41.43 128.87 3.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 109.332 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HD3' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -113.25 127.67 56.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.432 -0.792 . . . . 0.0 109.128 -179.181 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -135.09 173.3 11.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -82.97 133.92 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.004 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -58.98 -48.38 81.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -133.65 163.07 30.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 132.28 48.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.521 -0.737 . . . . 0.0 109.974 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 11' ' ' LEU . 17.3 mt -117.74 164.07 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -152.97 147.59 26.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.029 . . . . 0.0 110.198 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -132.06 161.55 32.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.463 -0.773 . . . . 0.0 109.74 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.43 134.88 20.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.12 . . . . 0.0 109.365 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.09 158.92 17.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.2 p -74.96 163.02 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -1.103 . . . . 0.0 111.263 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.577 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -93.47 139.98 14.84 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.3 tt -57.81 -50.85 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.128 -1.219 . . . . 0.0 112.396 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 11.6 m-70 -86.44 -37.66 18.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.188 -1.57 . . . . 0.0 111.203 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -73.92 -34.66 64.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.0 110.215 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.49 21.33 66.64 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -109.76 149.95 29.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.544 -0.974 . . . . 0.0 109.274 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.84 132.43 45.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.891 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -139.63 157.51 45.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' O ' HD23 ' A' ' 26' ' ' LEU . 23.8 tttp -133.69 155.21 50.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.274 -0.891 . . . . 0.0 109.291 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.651 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.3 mt -131.04 146.67 52.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.044 -1.035 . . . . 0.0 109.373 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 mt -136.0 123.91 35.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mt -111.8 122.99 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.543 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -118.03 139.24 26.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.463 -0.773 . . . . 0.0 109.354 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -53.46 162.6 3.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.439 1.426 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.5 mm-40 -135.96 -171.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.1 ttmt -91.92 156.53 17.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.636 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -50.46 146.35 5.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 110.548 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 64.09 24.48 68.73 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.567 -0.708 . . . . 0.0 112.204 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.589 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 91.3 m -81.64 -46.44 14.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.346 -1.679 . . . . 0.0 109.112 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.76 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 101.52 -174.66 24.99 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.423 HD13 ' CG2' ' A' ' 87' ' ' VAL . 3.0 mm -94.86 122.65 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.189 -1.183 . . . . 0.0 108.354 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 137.28 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.077 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -98.58 154.59 17.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.554 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.7 t80 -130.12 136.99 49.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 108.815 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 4.0 ttmm -167.45 136.85 2.73 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.115 -0.991 . . . . 0.0 109.594 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.33 28.6 17.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.922 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 28.19 71.76 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.4 t -133.42 132.12 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.161 -1.199 . . . . 0.0 109.727 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -85.34 140.4 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 67' ' ' GLN . 45.2 mt -134.45 94.75 16.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.398 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.58 141.06 27.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.21 1.94 . . . . 0.0 111.494 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.09 84.39 5.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.812 -1.18 . . . . 0.0 110.374 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -139.06 155.35 48.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.501 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.9 p-80 -52.32 -49.43 64.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.286 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.3 mt-10 -44.62 -30.96 1.0 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.153 -0.967 . . . . 0.0 109.151 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 46.1 m-85 -81.48 2.42 28.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.413 -0.804 . . . . 0.0 110.176 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 50' ' ' HIS . 8.3 t -59.46 127.44 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.015 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.62 -31.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -151.97 123.07 7.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.891 -1.131 . . . . 0.0 109.975 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.9 p -111.77 131.61 55.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 31.8 p-10 -166.66 -153.64 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -48.31 -11.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.019 -1.051 . . . . 0.0 108.537 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.9 t -139.94 166.25 25.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 m -105.39 121.39 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 108.773 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.32 141.94 48.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 111.122 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 53' ' ' VAL . 57.1 mt -121.83 160.23 25.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.5 142.92 6.15 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.715 -1.707 . . . . 0.0 110.692 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -144.86 151.19 38.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.53 -0.982 . . . . 0.0 109.708 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt 56.96 23.77 8.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.833 . . . . 0.0 110.865 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.67 -2.04 69.54 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.704 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.9 mm-40 -97.05 145.46 25.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.928 -1.336 . . . . 0.0 108.482 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -141.71 151.7 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 0.0 111.601 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.8 mt -134.29 144.46 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -114.67 154.85 27.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 110.976 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 m 51.36 67.99 0.86 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.641 -0.662 . . . . 0.0 110.8 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.55 -15.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -63.74 -15.59 58.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 110.248 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 8.7 m170 -72.11 -60.57 2.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.022 . . . . 0.0 109.511 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.7 tp -59.65 -42.81 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.992 -1.068 . . . . 0.0 108.772 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.486 ' N ' HG23 ' A' ' 75' ' ' ILE . 39.3 mt -54.82 -39.21 68.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.503 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -61.7 -49.77 75.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.538 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.24 -54.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.006 . . . . 0.0 108.559 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 76' ' ' LEU . 18.1 mt -51.75 -43.82 63.07 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.488 -0.757 . . . . 0.0 109.586 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.3 -56.79 13.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.0 mt -56.64 -35.55 68.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 110.976 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.612 ' HB3' HD11 ' A' ' 84' ' ' ILE . 26.4 mt -88.06 -2.68 58.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.864 -1.148 . . . . 0.0 111.207 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.34 58.52 1.73 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.683 -1.261 . . . . 0.0 110.945 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 82' ' ' LEU . 5.0 mm -96.79 122.57 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.523 HG21 ' CG2' ' A' ' 121' ' ' ILE . 21.1 p -104.1 -77.47 0.57 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 111.047 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 2.5 m120 -82.24 113.6 20.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 111.452 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.9 m -163.79 138.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.684 -0.635 . . . . 0.0 109.327 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.5 m -106.53 101.18 10.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.38 107.51 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.657 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 40' ' ' PHE . 2.0 mm-40 -84.49 121.18 27.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.818 -1.177 . . . . 0.0 108.629 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.4 110.09 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.839 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.47 108.24 20.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.506 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 134.05 -163.37 24.55 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER -112.94 -14.97 12.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -1.034 . . . . 0.0 110.171 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.16 147.5 36.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.257 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -70.88 130.57 88.3 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.474 -0.766 . . . . 0.0 109.746 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.651 ' CD ' HD21 ' A' ' 26' ' ' LEU . 52.9 Cg_exo -46.23 128.7 12.31 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.022 1.815 . . . . 0.0 112.278 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -76.88 -29.68 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 110.015 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 50.8 mt 57.62 -116.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.0 109.942 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.28 -6.86 43.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 110.533 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.87 -10.61 52.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -117.09 -169.26 1.62 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -1.085 . . . . 0.0 109.797 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.05 -1.37 25.31 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 68.1 t-105 -46.39 -41.33 13.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.753 -0.851 . . . . 0.0 110.305 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.34 -51.97 66.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.999 -1.063 . . . . 0.0 110.131 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CG ' HD12 ' A' ' 75' ' ' ILE . 70.5 m-85 -65.02 -43.98 90.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.973 -1.079 . . . . 0.0 108.928 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.458 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.9 t80 -61.63 -37.73 85.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.4 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 20.9 mm-40 -67.0 -51.79 50.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.542 -0.724 . . . . 0.0 111.598 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 -51.98 11.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.761 -1.212 . . . . 0.0 110.871 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.54 -44.6 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 0.0 110.409 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -55.61 -31.27 62.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.116 -0.99 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -81.59 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 109.906 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -124.09 34.05 5.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.431 -0.793 . . . . 0.0 110.905 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.409 HD11 HD13 ' A' ' 82' ' ' LEU . 6.9 mt -87.73 140.5 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.708 -1.245 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 115' ' ' LEU . 46.6 tp -133.3 159.79 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -112.97 145.28 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.636 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 6.9 mt-30 -106.48 -162.67 0.87 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 109.31 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -121.0 72.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 110.735 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 4' ' ' GLU . 8.0 ttm-85 -168.02 123.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.14 126.36 27.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.474 -0.766 . . . . 0.0 110.316 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.838 HD11 ' O ' ' A' ' 3' ' ' LEU . 2.5 mt -78.55 150.48 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.376 -0.827 . . . . 0.0 109.695 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.8 86.28 6.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -60.23 147.21 40.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -101.37 120.14 39.82 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 243' ' ' LYS . 23.1 t -123.34 139.96 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.0 138.79 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 109.546 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.71 143.22 34.19 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.557 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.25 174.65 11.73 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.358 2.039 . . . . 0.0 112.64 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 141' ' ' ALA . 15.2 tt -166.07 146.04 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.493 -0.754 . . . . 0.0 109.792 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.465 ' CG2' HD11 ' A' ' 138' ' ' LEU . 3.4 mp -133.54 120.12 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 132' ' ' VAL . 33.1 m -119.81 114.99 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.804 . . . . 0.0 109.836 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.51 153.99 18.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.067 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.496 ' CB ' HD13 ' A' ' 255' ' ' LEU . 19.8 t70 -168.56 114.96 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.788 -1.195 . . . . 0.0 111.501 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 46.51 46.65 14.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.513 -0.742 . . . . 0.0 112.204 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 7.11 87.03 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.195 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.9 mtt85 -116.13 137.54 52.04 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.627 HD23 ' C ' ' A' ' 138' ' ' LEU . 2.6 tt -147.04 159.54 43.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.055 -1.653 . . . . 0.0 109.864 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.548 ' N ' HD23 ' A' ' 138' ' ' LEU . 35.6 mt -144.51 135.75 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.64 139.32 52.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 109.984 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.93 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.19 147.56 44.77 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -148.24 137.58 12.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 108.524 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.31 147.42 36.47 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.624 1.549 . . . . 0.0 112.15 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.7 153.01 8.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.336 -0.853 . . . . 0.0 109.363 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -85.72 -3.4 58.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.348 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.5 p -131.26 147.46 52.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.362 -0.836 . . . . 0.0 109.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 242' ' ' VAL . 22.2 tp -81.26 120.07 24.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.627 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -139.72 134.89 32.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.657 ' CG1' HD23 ' A' ' 231' ' ' LEU . 25.3 t -136.47 122.09 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.422 ' OG1' HG23 ' A' ' 165' ' ' THR . 87.1 m -110.74 145.87 37.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -131.85 129.87 40.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -114.41 108.73 17.27 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.64 140.51 15.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -118.04 92.83 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.547 -0.973 . . . . 0.0 108.705 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLY . 24.0 m-85 -96.25 148.39 22.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 110.331 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -91.65 -6.1 52.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.822 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.691 HD21 HD12 ' A' ' 159' ' ' LEU . 18.5 p-10 -73.4 -166.78 0.37 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -61.78 -17.61 56.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.792 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.691 HD12 HD21 ' A' ' 157' ' ' ASN . 25.5 mt -69.84 -38.86 76.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 109.341 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 70.64 -118.15 7.53 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -112.67 140.45 47.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -1.012 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.54 152.45 30.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.556 ' HB3' ' HZ3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.39 152.85 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.586 ' CE1' ' CZ ' ' A' ' 225' ' ' ARG . 64.3 t80 -136.23 125.53 24.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -0.914 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.422 HG23 ' OG1' ' A' ' 150' ' ' THR . 31.7 m -101.87 122.33 43.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.099 -1.001 . . . . 0.0 110.066 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -100.06 137.48 38.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.47 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.2 t -136.2 152.42 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.356 -0.84 . . . . 0.0 109.563 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.84 116.23 2.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.376 -0.827 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.9 8.67 13.3 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -137.49 27.91 2.77 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 0.0 108.71 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.539 ' O ' HG22 ' A' ' 175' ' ' VAL . 16.4 mp0 -62.73 -37.32 86.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.616 -0.678 . . . . 0.0 110.997 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.58 -16.35 2.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.008 -1.057 . . . . 0.0 110.366 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 1.5 mt-10 -90.58 -4.33 56.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 0.0 110.795 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.99 -2.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.099 -1.001 . . . . 0.0 110.757 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER -94.53 -29.11 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.605 -1.309 . . . . 0.0 110.018 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.9 2.14 54.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.914 -1.116 . . . . 0.0 110.608 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.75 119.86 23.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.206 . . . . 0.0 108.783 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -92.66 152.94 19.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.436 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 5.0 t -50.07 158.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.513 -0.742 . . . . 0.0 109.347 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.497 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 51.5 p90 -143.29 165.55 27.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -158.99 161.48 36.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.071 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.613 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 73.6 m-85 -104.35 144.79 31.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 0.0 109.266 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.776 ' HA ' HD12 ' A' ' 186' ' ' ILE . 21.0 p30 -59.27 -20.19 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 111.502 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.613 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.4 p90 -79.42 -33.24 42.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.494 -1.379 . . . . 0.0 111.529 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.593 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -94.21 -9.19 37.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.483 -1.386 . . . . 0.0 109.915 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.9 mt -60.98 -53.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.119 -0.988 . . . . 0.0 110.243 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -51.18 -45.94 61.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.587 -1.321 . . . . 0.0 109.611 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -53.86 46.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.108 -0.995 . . . . 0.0 108.968 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.89 -34.54 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 108.655 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -71.49 -25.71 62.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.307 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -76.04 -23.93 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.023 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.52 15.34 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 110.271 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 68.77 27.71 73.65 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.264 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 22.2 mt -120.13 157.73 28.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -1.228 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 80.77 23.15 60.38 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.902 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -67.18 -23.09 65.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.746 -1.444 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.98 -6.63 48.65 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.96 124.67 28.88 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 121.099 -1.236 . . . . 0.0 110.112 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.66 174.62 10.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.746 -0.855 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.93 -12.12 59.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.355 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 1.0 OUTLIER -86.05 -4.31 59.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.476 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 4.7 m-80 -150.22 16.35 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.572 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.3 m -145.04 123.51 12.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.404 HD12 ' OD1' ' A' ' 213' ' ' ASN . 12.2 tp -85.76 115.05 23.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 108.833 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.663 HG21 HCA3 ' A' ' 320' ' ' TUX . 46.3 t -103.28 124.13 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.9 mt -105.38 148.69 26.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.799 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.49 163.66 13.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -55.68 -25.35 39.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.255 . . . . 0.0 109.341 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.25 12.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.673 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.18 147.88 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 110.106 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.89 128.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.862 . . . . 0.0 108.979 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.44 -55.17 6.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.15 -0.969 . . . . 0.0 110.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 204' ' ' LEU . 5.4 m120 -51.53 137.54 31.63 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.992 -1.067 . . . . 0.0 109.81 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.67 -38.73 3.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.473 2.115 . . . . 0.0 112.551 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.52 -6.65 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.32 -166.27 50.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -77.8 141.78 39.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.98 . . . . 0.0 109.736 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -85.49 -15.61 42.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 108.841 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 221' ' ' ASN . 17.8 m-85 -141.94 130.06 22.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.505 ' C ' ' ND2' ' A' ' 221' ' ' ASN . 24.0 mt-10 -46.5 -12.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 109.153 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.591 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -138.13 36.81 2.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.61 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 22.5 tt0 -61.85 -34.42 16.13 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 111.21 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.0 Cg_exo -72.01 -48.06 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.919 1.746 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 224' ' ' VAL . 4.6 m -71.91 -22.24 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.838 -1.163 . . . . 0.0 108.071 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.586 ' CZ ' ' CE1' ' A' ' 164' ' ' PHE . 15.2 mtt85 -68.03 -45.84 72.83 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.33 -41.07 92.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -44.14 84.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.902 . . . . 0.0 108.648 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 224' ' ' VAL . 89.1 t -65.5 -40.28 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.503 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.3 t80 -58.81 -39.56 81.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -73.55 -38.56 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.578 -0.701 . . . . 0.0 109.414 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.62 -37.77 71.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.28 -47.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.35 -33.51 16.53 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.6 -27.1 31.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.123 -1.222 . . . . 0.0 110.059 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.65 -24.89 41.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.714 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 35.1 t80 -67.63 -10.06 48.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 237' ' ' LEU . 26.0 mt -51.05 -26.53 6.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 242' ' ' VAL . 95.9 mt -57.9 -21.79 45.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 108.745 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.4 13.95 75.12 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 64.5 p -158.96 149.05 15.32 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 109.735 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.34 134.03 4.7 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.396 2.064 . . . . 0.0 112.072 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.66 HG22 HD12 ' A' ' 238' ' ' LEU . 70.1 t -101.5 127.59 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.942 . . . . 0.0 109.97 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.409 ' HB3' HG13 ' A' ' 125' ' ' VAL . 1.4 tppt? -116.13 122.99 46.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 109.426 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.51 178.87 32.93 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -109.09 112.95 25.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.313 -1.11 . . . . 0.0 109.833 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -114.74 146.86 40.49 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.817 0.818 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.4 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 26.5 t80 -131.07 141.4 50.17 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.7 t -135.74 128.54 31.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.791 -1.193 . . . . 0.0 110.563 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 14.3 t80 -111.69 114.53 27.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 3.2 mtp85 44.78 55.74 5.75 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.19 148.85 22.52 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -112.63 -177.61 19.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 257' ' ' VAL . 25.5 m-70 -70.5 -47.21 61.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.091 -1.241 . . . . 0.0 109.752 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 68.3 p -61.03 -54.5 44.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.308 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' A' ' 134' ' ' ASP . 58.3 tp -51.71 -39.65 58.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 109.384 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -59.72 -55.87 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -0.975 . . . . 0.0 108.865 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 253' ' ' HIS . 41.0 t -49.19 -41.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.232 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -48.47 75.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.67 -44.81 66.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 108.804 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.4 t -68.23 -49.18 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.318 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.37 -50.74 38.81 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.695 -0.628 . . . . 0.0 110.509 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.41 -50.97 65.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.987 -1.071 . . . . 0.0 109.961 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 263' ' ' LEU . 47.8 mt -56.64 -44.21 81.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.35 83.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.725 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -78.91 -26.61 43.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 108.989 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -68.53 -47.4 67.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.195 -0.94 . . . . 0.0 109.382 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.29 11.63 1.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -73.88 -10.48 59.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.847 . . . . 0.0 109.771 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 7.4 mt -84.43 18.08 2.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.123 -0.986 . . . . 0.0 109.458 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.441 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.663 HCA3 HG21 ' A' ' 205' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.456 HD22 ' C ' ' A' ' 118' ' ' ASN . 5.3 mt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.6 mt-10 -43.5 144.88 0.68 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 109.376 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -113.18 130.93 56.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.2 t -131.23 169.68 15.62 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.376 -0.828 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 7' ' ' VAL . 4.6 m -81.58 136.26 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.826 -1.171 . . . . 0.0 110.516 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' CB ' ' HZ3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -69.78 -47.11 64.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.664 -0.648 . . . . 0.0 109.978 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -128.42 156.88 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.492 -0.755 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -62.82 134.61 56.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.682 HD21 ' OD1' ' A' ' 113' ' ' ASN . 19.7 mt -118.66 160.8 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -149.55 145.97 27.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.941 -1.1 . . . . 0.0 110.046 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -128.83 164.62 22.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.475 -0.766 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.8 12.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 109.004 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.64 159.43 17.86 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.554 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.4 p -76.07 164.32 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.047 -1.266 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -95.21 142.45 16.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.3 tt -61.23 -47.78 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.053 -1.263 . . . . 0.0 112.136 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.2 m-70 -86.99 -39.86 15.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 119.984 -1.697 . . . . 0.0 110.793 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 m -71.76 -36.79 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.383 -0.823 . . . . 0.0 110.168 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 24.22 70.09 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -115.07 152.5 32.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.632 -0.922 . . . . 0.0 108.715 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -72.35 131.61 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.889 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 t -138.35 158.91 43.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.216 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.648 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.8 ttmt -133.13 159.59 39.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.669 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.5 mt -133.31 144.12 49.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.178 -0.951 . . . . 0.0 109.235 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.552 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.5 mt -134.49 123.43 42.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.54 126.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 0.0 109.926 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.577 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.3 m-70 -122.18 149.19 53.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.14 160.16 16.73 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.055 1.837 . . . . 0.0 111.229 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 2.7 mm-40 -133.79 -176.0 4.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.599 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' OG1' ' A' ' 35' ' ' THR . 10.0 ttpp -88.01 152.31 22.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.92 145.44 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.422 -0.799 . . . . 0.0 110.227 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.641 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.42 25.55 60.71 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.213 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.6 m -80.88 -41.4 23.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.648 -1.501 . . . . 0.0 108.703 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.71 178.95 30.85 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.56 123.31 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -140.3 145.79 37.7 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.033 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -100.68 152.25 20.68 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 11.0 t80 -133.35 141.95 48.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.225 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -176.5 145.94 0.59 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 m120 57.55 28.89 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.85 28.92 72.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.48 142.57 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -1.215 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.41 143.59 31.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.237 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.04 95.81 14.87 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.35 145.53 21.02 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.052 1.834 . . . . 0.0 111.267 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 82.14 5.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.93 -1.107 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.84 153.92 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 51' ' ' GLU . 17.3 p-80 -51.81 -49.61 62.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.8 mm-40 -43.87 -33.02 1.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.196 -0.94 . . . . 0.0 109.234 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -80.45 2.46 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' HIS . 2.6 t -60.7 126.16 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.021 -1.049 . . . . 0.0 108.695 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.09 -34.11 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.478 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t-80 -149.67 123.18 9.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.943 -1.098 . . . . 0.0 109.913 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -110.71 131.52 54.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.2 t-20 -166.38 -154.2 0.18 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.53 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 8.1 m170 -48.05 -11.65 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 108.513 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 43.6 t -138.15 165.94 25.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.563 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.4 m -102.92 121.14 41.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.6 OUTLIER -120.4 141.56 50.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.563 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.1 mt -123.51 155.98 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -172.88 142.28 6.65 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.944 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -144.86 151.48 38.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.631 -0.923 . . . . 0.0 109.704 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm 56.51 27.86 12.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.495 -0.753 . . . . 0.0 110.839 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.55 81.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.315 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.504 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 92.7 mm-40 -99.26 143.5 29.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.286 . . . . 0.0 108.361 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -141.99 151.24 42.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 0.0 111.198 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.51 144.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -114.27 153.73 29.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 110.896 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 53.24 68.05 0.9 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.645 -0.659 . . . . 0.0 110.812 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.42 ' O ' HD12 ' A' ' 76' ' ' LEU . 15.9 m -113.12 -5.77 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 109.464 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.571 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.5 OUTLIER -67.76 -29.27 68.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.985 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.63 -60.29 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.91 . . . . 0.0 109.91 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 9.6 tp -59.13 -44.29 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.035 . . . . 0.0 109.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.504 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 9.8 mt -59.58 -38.1 80.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.126 -0.984 . . . . 0.0 109.771 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.455 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -59.71 -48.03 83.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 109.531 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.53 -53.56 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 76' ' ' LEU . 28.5 mt -50.91 -43.06 59.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.065 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.625 ' HD1' HG22 ' A' ' 232' ' ' ILE . 11.8 t-160 -55.1 -56.97 13.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 109.815 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 43.0 mt -57.52 -38.54 74.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.649 HD13 HD11 ' A' ' 114' ' ' ILE . 36.5 mt -80.12 -5.88 56.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.957 -1.089 . . . . 0.0 110.892 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER 62.8 63.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.706 -1.246 . . . . 0.0 110.528 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 82' ' ' LEU . 9.7 mm -102.8 132.87 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 108.708 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.24 -23.6 7.24 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.339 -0.85 . . . . 0.0 111.633 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.689 ' O ' HG13 ' A' ' 87' ' ' VAL . 70.9 m-20 -132.21 112.76 12.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.763 -1.211 . . . . 0.0 110.453 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.7 m -164.05 137.71 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.882 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.538 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 47.2 m -106.52 100.21 9.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.76 116.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.698 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -94.29 117.88 30.77 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.675 -1.265 . . . . 0.0 108.127 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.48 107.49 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.723 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.8 mt -89.69 110.47 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.24 -164.49 25.06 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -109.02 -11.41 14.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -1.054 . . . . 0.0 110.2 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -153.15 155.89 37.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.917 -1.114 . . . . 0.0 110.306 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.57 131.91 85.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.751 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.669 ' CD ' HD21 ' A' ' 26' ' ' LEU . 76.3 Cg_exo -45.88 138.46 11.91 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.295 1.997 . . . . 0.0 112.283 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 99' ' ' LEU . 8.7 tp -75.91 -39.18 37.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.571 -0.706 . . . . 0.0 110.264 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.495 ' N ' HG23 ' A' ' 98' ' ' ILE . 80.3 mt 54.92 -155.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.481 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.95 -1.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.147 -0.971 . . . . 0.0 111.027 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 99' ' ' LEU . . . 88.27 -10.4 71.37 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.69 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.3 p -112.09 -168.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -1.082 . . . . 0.0 109.77 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -1.22 21.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.589 ' CD2' ' OE1' ' A' ' 108' ' ' GLU . 69.1 t-105 -46.81 -41.36 15.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.841 -0.799 . . . . 0.0 110.696 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' OE1' HD13 ' A' ' 99' ' ' LEU . 36.2 mt-10 -62.39 -52.04 65.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 110.303 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.6 m-85 -62.01 -45.38 93.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.924 -1.11 . . . . 0.0 108.758 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.659 ' CD2' HG11 ' A' ' 175' ' ' VAL . 6.1 t80 -59.68 -41.33 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.676 -0.64 . . . . 0.0 109.811 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -74.64 -41.68 59.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 111.418 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -48.68 25.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.858 -1.151 . . . . 0.0 110.357 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.4 mt -67.66 -40.51 84.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.12 -0.987 . . . . 0.0 110.392 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -53.05 -31.79 43.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 109.593 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -85.3 -5.89 59.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 110.102 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.682 ' OD1' HD21 ' A' ' 11' ' ' LEU . 4.1 m120 -125.47 30.29 5.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 111.385 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.649 HD11 HD13 ' A' ' 82' ' ' LEU . 4.8 mt -89.89 146.79 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.661 -1.274 . . . . 0.0 109.941 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 115' ' ' LEU . 15.1 tp -131.93 161.13 33.81 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 3' ' ' LEU . 6.4 t-20 -108.1 144.91 34.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 110.076 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -106.0 -163.77 0.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.456 ' C ' HD22 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -114.26 -3.42 13.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.344 -0.848 . . . . 0.0 110.58 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 4' ' ' GLU . 25.7 ttm180 -89.98 143.48 26.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 0.0 110.274 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -83.03 128.56 34.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.36 -0.838 . . . . 0.0 109.859 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.5 mt -67.49 137.35 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.768 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.69 91.09 8.68 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -65.47 146.83 54.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.455 -0.778 . . . . 0.0 110.936 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -100.26 122.65 43.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.71 139.18 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.6 t -84.21 138.86 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.429 -0.794 . . . . 0.0 108.929 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -117.72 -8.67 10.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.522 -0.736 . . . . 0.0 109.444 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -144.0 144.12 25.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.953 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.91 150.66 55.59 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.196 1.931 . . . . 0.0 113.096 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 2.2 tt -140.96 144.61 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.87 125.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.81 111.27 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.778 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -113.47 133.59 55.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -179.08 156.38 0.78 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.011 -1.056 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 57.0 mm-40 56.16 20.14 4.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.54 88.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.46 ' HE ' ' C ' ' A' ' 251' ' ' GLY . 1.4 mtp85 -104.02 171.21 7.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.6 tt -159.86 146.06 15.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.503 -1.373 . . . . 0.0 108.589 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 259' ' ' LEU . 18.7 mt -147.59 126.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.024 -1.047 . . . . 0.0 108.511 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 147.06 43.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.638 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -127.75 151.87 48.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -150.11 139.14 12.9 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -51.52 144.19 33.36 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.707 1.605 . . . . 0.0 112.146 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.71 11.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.21 -0.931 . . . . 0.0 109.472 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 24.7 p-10 -86.21 -0.4 55.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.67 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.3 p -135.14 145.54 47.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.1 tp -79.72 118.03 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.92 . . . . 0.0 109.838 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -138.17 142.16 40.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 108.871 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.531 ' CG1' HD23 ' A' ' 231' ' ' LEU . 71.1 t -140.35 131.87 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.997 -1.064 . . . . 0.0 109.935 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 m -117.73 135.85 53.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.348 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.531 ' HB2' HG22 ' A' ' 228' ' ' VAL . 84.1 t80 -123.88 128.54 49.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.6 109.46 17.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.01 122.75 6.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 1.1 pm0 -102.88 114.65 29.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -1.138 . . . . 0.0 108.659 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -109.42 147.73 32.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.576 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -93.31 0.12 56.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.786 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.483 ' ND2' HD12 ' A' ' 159' ' ' LEU . 12.8 p30 -79.3 -171.54 2.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 12.2 p90 -61.68 -26.55 68.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.604 HD11 HD13 ' A' ' 206' ' ' LEU . 4.0 mt -55.61 -50.57 69.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.34 -136.09 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.447 ' O ' ' CD ' ' A' ' 162' ' ' GLN . 38.3 mtp180 -98.68 140.35 33.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -1.1 . . . . 0.0 109.575 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.447 ' CD ' ' O ' ' A' ' 161' ' ' ARG . 12.7 mp0 -139.33 131.06 27.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.368 -0.833 . . . . 0.0 109.03 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.33 52.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.527 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 71.9 t80 -138.35 126.69 23.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.183 -0.948 . . . . 0.0 109.787 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 165' ' ' THR . 7.0 t -106.03 123.93 48.77 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -97.67 133.45 42.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.93 . . . . 0.0 108.716 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.81 148.34 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.522 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -48.06 114.89 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.639 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 10.33 11.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.429 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 27.3 m-20 -136.81 26.9 3.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.988 -1.301 . . . . 0.0 108.853 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.9 mp0 -63.0 -37.82 88.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.749 . . . . 0.0 110.768 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.19 -16.33 13.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -90.29 -3.67 57.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.077 . . . . 0.0 110.917 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.85 4.67 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.047 -1.033 . . . . 0.0 111.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.659 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.1 OUTLIER -99.27 -27.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.779 -1.2 . . . . 0.0 109.799 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.65 2.47 50.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.797 -1.189 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.1 109.52 17.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.774 -1.204 . . . . 0.0 109.036 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.42 ' HG2' ' H ' ' A' ' 178' ' ' ARG . 2.2 ptp180 -79.69 153.52 29.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -55.83 154.49 7.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 108.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.544 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 39.5 p90 -135.35 170.45 15.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 109.728 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.633 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -159.29 161.94 35.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.23 -0.919 . . . . 0.0 109.754 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.535 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 61.5 m-85 -103.79 146.46 28.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.738 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.6 OUTLIER -61.64 -21.13 64.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.047 -1.033 . . . . 0.0 110.868 -178.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.3 p90 -81.53 -29.6 33.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.552 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.1 pt-20 -92.15 -15.84 27.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.896 -1.128 . . . . 0.0 109.699 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' A' ' 183' ' ' ASP . 12.1 mt -58.76 -53.25 49.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 110.431 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -52.43 -47.58 66.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.579 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.22 -47.55 83.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.977 . . . . 0.0 109.137 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.96 -33.11 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 108.99 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -78.27 -31.4 49.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -74.98 -28.76 60.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.019 -1.051 . . . . 0.0 110.218 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.486 ' CG2' HD12 ' A' ' 194' ' ' LEU . 31.4 m -78.51 8.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.173 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.47 20.95 73.73 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.486 HD12 ' CG2' ' A' ' 192' ' ' VAL . 22.9 mt -119.16 157.82 27.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.478 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.67 24.34 62.78 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -67.71 -21.72 65.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.744 -1.445 . . . . 0.0 109.436 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.34 -6.12 48.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.99 126.66 42.29 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.044 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 203' ' ' THR . 60.6 p -140.88 160.76 39.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.895 . . . . 0.0 109.309 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.43 -27.76 69.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 109.968 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -76.23 -15.86 59.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 109.927 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 29.0 m120 -132.81 11.12 4.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.633 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 39.3 m -148.97 115.36 5.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.163 -0.961 . . . . 0.0 109.777 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.4 HD12 ' CG ' ' A' ' 213' ' ' ASN . 68.9 tp -75.5 112.19 11.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.58 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.2 t -103.4 128.35 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 109.223 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.604 HD13 HD11 ' A' ' 159' ' ' LEU . 92.8 mt -110.67 146.29 36.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -101.19 154.14 19.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.45 -26.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 10.8 0.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.0 110.325 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -141.12 148.68 40.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.305 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.92 123.55 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.53 -54.79 7.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.394 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.4 ' CG ' HD12 ' A' ' 204' ' ' LEU . 2.7 m120 -59.34 134.31 88.34 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.703 -1.248 . . . . 0.0 109.341 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.15 -7.32 20.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.357 2.038 . . . . 0.0 112.761 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -86.47 -7.58 58.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 0.0 110.316 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.07 -158.85 53.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.4 144.13 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -1.059 . . . . 0.0 109.949 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 109.517 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.578 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 68.1 m-85 -140.08 129.47 24.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.895 . . . . 0.0 109.042 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -52.99 -11.02 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 108.502 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.477 ' N ' ' C ' ' A' ' 219' ' ' TYR . 5.9 m120 -133.07 35.28 3.52 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.482 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 8.7 tt0 -59.26 -55.35 47.05 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.729 . . . . 0.0 111.579 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 19.6 Cg_endo -60.75 -42.14 41.06 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.73 1.62 . . . . 0.0 113.305 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 228' ' ' VAL . 4.5 m -76.99 -25.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 108.363 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.578 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 46.9 mtt180 -67.0 -43.47 82.83 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.28 -41.24 98.32 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.45 -46.26 80.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.9 t -60.76 -51.03 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.455 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 81.6 t80 -50.45 -39.85 48.99 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.886 0.85 . . . . 0.0 108.725 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.455 ' OD2' ' OE1' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.98 -39.66 69.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.65 -0.656 . . . . 0.0 109.681 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 149' ' ' VAL . 28.5 tp -57.9 -35.36 70.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.905 . . . . 0.0 109.385 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.625 HG22 ' HD1' ' A' ' 80' ' ' HIS . 86.9 mt -71.12 -48.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.41 -32.1 14.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.8 -27.03 31.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.44 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -82.94 -24.3 33.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.775 -1.203 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.452 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 44.5 t80 -68.14 -8.56 39.48 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 239' ' ' GLY . 43.9 mt -52.21 -30.26 26.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 109.163 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 242' ' ' VAL . 97.5 mt -55.02 -7.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.169 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 71.92 14.78 75.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.7 p -158.13 144.62 12.87 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -1.21 . . . . 0.0 109.402 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 77.0 Cg_exo -42.38 134.71 4.61 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.148 1.899 . . . . 0.0 111.873 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 238' ' ' LEU . 22.0 t -98.04 129.53 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -118.1 124.65 48.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 109.373 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.36 -178.5 31.96 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -105.08 138.12 41.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -1.077 . . . . 0.0 110.039 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.5 m-85 -140.21 143.46 36.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.062 0.934 . . . . 0.0 111.263 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -126.31 144.25 50.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.1 t -140.11 127.47 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 110.631 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 0.9 OUTLIER -111.71 114.2 27.06 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.46 ' CG ' ' OE1' ' A' ' 154' ' ' GLU . 2.6 mmm180 47.72 55.79 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.46 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -77.6 140.52 24.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -111.05 174.19 16.66 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.571 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 15.1 m-70 -68.58 -41.97 78.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.048 -1.266 . . . . 0.0 109.659 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -55.18 25.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' A' ' 139' ' ' ILE . 57.2 tp -51.7 -39.04 57.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 71.3 m-20 -58.71 -55.48 34.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.995 . . . . 0.0 109.018 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.73 -43.35 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.732 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -48.7 74.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.093 -1.004 . . . . 0.0 109.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 139' ' ' ILE . 38.9 tp -52.81 -43.38 65.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.358 -0.839 . . . . 0.0 109.039 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.44 HG22 HD23 ' A' ' 235' ' ' LEU . 20.2 t -71.13 -45.73 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.14 -51.45 64.23 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 109.917 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.459 ' OE1' HD11 ' A' ' 130' ' ' ILE . 62.6 mt-10 -61.04 -51.48 69.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.941 -1.099 . . . . 0.0 109.637 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.66 -43.9 80.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.49 -33.11 73.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -84.36 -23.04 30.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.81 -1.181 . . . . 0.0 108.937 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.11 -45.4 60.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.363 -0.836 . . . . 0.0 109.642 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.48 10.35 23.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 110.143 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -79.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 109.416 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 60.0 mt -85.02 -66.98 0.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.964 . . . . 0.0 109.477 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.617 ' C1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.654 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 66.4 mt-10 -48.45 141.45 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.072 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -120.87 138.35 54.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.414 -0.804 . . . . 0.0 109.466 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.408 HG21 HE21 ' A' ' 117' ' ' GLN . 11.5 t -139.54 177.89 7.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.78 144.7 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -74.78 -46.92 33.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.667 -0.645 . . . . 0.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.32 160.47 34.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.71 . . . . 0.0 110.219 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -64.92 135.56 55.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -0.768 . . . . 0.0 110.104 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 113' ' ' ASN . 4.9 mt -122.29 171.38 9.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -158.49 150.74 21.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 0.0 110.442 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -133.93 160.91 36.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.483 -0.761 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.12 137.21 21.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.962 -1.086 . . . . 0.0 109.141 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.73 160.79 20.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.512 -1.328 . . . . 0.0 109.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.9 p -76.3 162.98 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 0.0 111.424 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -94.76 141.4 15.53 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -59.75 -48.18 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -1.138 . . . . 0.0 112.937 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.5 m-70 -86.33 -36.51 19.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.013 -1.679 . . . . 0.0 112.374 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -80.41 -34.06 36.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.824 -1.172 . . . . 0.0 110.091 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.15 74.87 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.29 152.82 30.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.983 . . . . 0.0 108.867 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -73.81 140.92 46.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 110.202 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 9.7 t -147.88 157.64 43.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.047 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.618 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -132.21 154.71 49.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.286 -0.884 . . . . 0.0 109.239 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.674 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 0.0 108.724 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.419 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.3 mt -127.95 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mt -123.91 120.88 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.419 ' NE2' HG22 ' A' ' 27' ' ' ILE . 11.5 m-70 -117.23 149.3 44.23 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 161.19 22.71 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.112 1.874 . . . . 0.0 111.258 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.6 mm-40 -134.72 -173.73 3.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.072 -1.017 . . . . 0.0 110.081 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.8 tttm -91.94 155.75 17.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.701 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.446 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 1.2 mp0 -48.07 143.63 4.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 110.62 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.595 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.84 26.17 60.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.543 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 33.0 m -79.98 -34.93 38.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.709 -1.465 . . . . 0.0 108.595 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.88 -173.35 36.4 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mm -102.03 123.74 55.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.323 -1.104 . . . . 0.0 108.271 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -137.28 139.83 41.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.511 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.03 152.84 19.38 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -131.32 142.78 50.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.832 . . . . 0.0 109.02 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 14.0 tttm -172.54 138.92 0.92 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.48 29.8 13.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.912 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.54 19.1 77.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.45 136.91 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.282 -1.128 . . . . 0.0 109.692 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -96.79 140.53 31.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.895 . . . . 0.0 109.178 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.5 mt -132.68 95.6 19.69 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.7 142.48 24.79 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.206 1.937 . . . . 0.0 111.607 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.35 80.67 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.961 -1.087 . . . . 0.0 110.307 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.04 153.41 51.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 109.649 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' VAL . 7.7 p80 -54.68 -49.29 71.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.4 mm-40 -44.67 -31.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.989 -1.07 . . . . 0.0 109.318 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.83 4.06 15.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.922 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 7.9 t -59.37 124.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.31 -32.0 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.412 -0.805 . . . . 0.0 109.944 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.531 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.8 t-160 -152.25 123.87 7.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.688 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.3 p -111.1 134.66 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 59' ' ' SER . 20.3 p-10 -166.39 -154.44 0.18 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -10.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.942 -1.099 . . . . 0.0 108.479 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -138.85 166.96 23.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -0.8 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.1 m -101.99 120.56 40.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.05 136.93 52.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.34 -0.85 . . . . 0.0 111.199 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 53' ' ' VAL . 41.5 mt -123.39 157.67 32.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.7 143.49 6.89 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 118.484 -1.817 . . . . 0.0 111.214 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -144.29 148.99 35.54 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.747 -0.855 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm 56.62 38.33 29.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 110.783 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.55 4.4 84.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.8 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 94.0 mm-40 -102.85 140.56 36.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.934 -1.333 . . . . 0.0 108.418 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -141.91 154.31 45.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.47 146.25 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -115.1 154.63 28.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 111.113 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 m 52.38 68.85 0.76 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.734 -0.604 . . . . 0.0 111.111 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.8 -10.72 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.179 -0.95 . . . . 0.0 109.727 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 5.7 pt-20 -67.73 -16.98 64.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.439 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -72.45 -60.59 2.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.012 -1.055 . . . . 0.0 109.424 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 76' ' ' LEU . 5.0 tp -58.92 -41.14 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.99 -1.069 . . . . 0.0 108.945 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 79' ' ' LEU . 84.4 mt -59.78 -36.49 76.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.6 t -60.44 -48.69 80.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.044 -1.035 . . . . 0.0 108.841 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.31 -51.26 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.453 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 76' ' ' LEU . 44.0 mt -51.87 -44.91 63.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.513 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 8.4 t-160 -57.1 -48.46 78.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.831 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.34 -39.73 95.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 110.414 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.824 HD13 HD11 ' A' ' 114' ' ' ILE . 53.2 mt -80.7 -5.56 57.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.053 -1.03 . . . . 0.0 110.738 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.77 54.64 2.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.896 -1.127 . . . . 0.0 110.723 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 82' ' ' LEU . 8.0 mm -92.69 123.85 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.63 HG21 HG12 ' A' ' 121' ' ' ILE . 63.4 p -109.78 -23.8 11.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.274 -0.891 . . . . 0.0 111.492 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.606 ' O ' HG13 ' A' ' 87' ' ' VAL . 49.9 m-20 -128.8 111.9 13.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.972 -1.08 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -164.03 143.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.246 -0.909 . . . . 0.0 109.898 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.519 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.7 m -113.77 100.59 8.57 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.51 105.38 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.348 -0.845 . . . . 0.0 109.985 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.54 121.73 26.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -104.21 115.14 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.456 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.754 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.3 mp -97.11 109.62 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.19 -160.62 23.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.15 -12.25 11.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.071 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -142.76 147.73 36.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.984 -1.073 . . . . 0.0 110.584 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 124.42 90.89 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.505 -0.747 . . . . 0.0 108.993 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.674 ' CD ' HD21 ' A' ' 26' ' ' LEU . 73.3 Cg_exo -44.74 131.36 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.032 1.822 . . . . 0.0 112.344 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.55 -27.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.418 -0.801 . . . . 0.0 109.675 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.45 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 22.8 mt 54.89 -112.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.274 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.36 -13.85 25.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.987 . . . . 0.0 110.699 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.74 -15.35 41.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -113.1 -168.89 1.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -1.063 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.09 -1.32 23.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -46.92 -44.39 19.8 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.788 -0.83 . . . . 0.0 110.573 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.09 -51.91 66.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.0 -1.062 . . . . 0.0 110.129 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 69.8 m-85 -61.33 -44.21 97.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 109.057 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.499 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 5.6 t80 -67.14 -37.46 83.86 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.324 0.583 . . . . 0.0 110.491 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.14 -50.98 42.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 111.351 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.84 -44.7 61.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.867 -1.145 . . . . 0.0 110.622 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.88 -39.89 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 110.033 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -53.75 -30.94 46.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.309 -0.869 . . . . 0.0 109.165 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -84.75 -11.5 55.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.32 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.418 ' HB2' HD11 ' A' ' 11' ' ' LEU . 4.3 m-80 -119.96 29.54 7.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.238 -0.914 . . . . 0.0 111.405 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.824 HD11 HD13 ' A' ' 82' ' ' LEU . 4.4 mt -87.66 147.23 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.592 -1.317 . . . . 0.0 109.827 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 116' ' ' ASN . 52.8 tp -131.58 159.96 36.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.505 HD21 HD12 ' A' ' 3' ' ' LEU . 21.2 t30 -109.52 144.6 37.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.408 HE21 HG21 ' A' ' 6' ' ' THR . 18.1 mt-30 -107.01 -166.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 p30 -118.73 72.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.529 -0.732 . . . . 0.0 110.187 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 4' ' ' GLU . 20.9 ttt180 -166.04 143.98 5.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 109.42 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.32 131.45 35.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.09 -1.006 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.63 HG12 HG21 ' A' ' 85' ' ' THR . 68.8 mt -74.98 141.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.732 . . . . 0.0 110.571 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -84.04 88.53 7.17 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -61.47 145.69 51.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.6 120.51 40.43 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.18 140.71 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.266 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 97.1 t -84.24 136.3 23.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.462 -0.774 . . . . 0.0 109.212 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -113.94 -10.26 12.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.12 146.58 40.59 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.08 178.02 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.19 1.927 . . . . 0.0 112.779 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 141' ' ' ALA . 7.2 tt -165.32 147.76 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.495 -0.753 . . . . 0.0 109.799 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.515 HD11 ' HZ3' ' A' ' 140' ' ' LYS . 53.2 mt -134.91 122.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.23 116.69 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -104.23 155.01 19.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.265 -0.897 . . . . 0.0 109.896 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.513 ' HB2' HD13 ' A' ' 255' ' ' LEU . 13.3 t0 -165.52 110.98 0.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.978 -1.076 . . . . 0.0 111.499 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 41.19 51.76 3.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.427 -0.796 . . . . 0.0 112.46 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.48 6.77 88.87 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.645 -1.285 . . . . 0.0 110.448 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.8 mtt85 -118.6 130.18 55.73 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 138' ' ' LEU . 3.7 tt -144.33 160.02 41.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.416 -1.428 . . . . 0.0 110.16 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.548 ' N ' HD23 ' A' ' 138' ' ' LEU . 52.5 mt -146.26 133.01 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.515 ' HZ3' HD11 ' A' ' 131' ' ' ILE . 47.9 tttp -118.96 144.86 46.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.757 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -118.37 147.82 43.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -145.05 135.03 11.7 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.57 147.46 58.75 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.402 . . . . 0.0 112.031 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.21 154.76 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.232 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.557 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.6 OUTLIER -86.98 1.39 52.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.506 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.5 p -135.7 146.94 48.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 242' ' ' VAL . 18.2 tp -79.58 119.83 23.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.02 134.15 32.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 108.877 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.677 ' CG1' HD23 ' A' ' 231' ' ' LEU . 55.7 t -134.05 118.16 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 109.339 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.4 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 2.0 m -107.35 135.72 48.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.094 -1.004 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -123.6 129.15 50.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.47 -0.769 . . . . 0.0 109.827 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -113.92 109.64 18.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.3 155.96 19.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.556 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -134.2 91.24 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -1.089 . . . . 0.0 109.485 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.76 148.76 22.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 -10.26 35.52 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.403 -0.81 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.6 p30 -69.65 -167.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.186 -0.947 . . . . 0.0 109.521 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.99 -21.44 58.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.907 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.7 mt -64.48 -47.61 78.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.82 -126.23 7.43 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.7 mtt85 -109.44 141.09 42.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.533 -0.981 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -153.9 150.4 28.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 109.713 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -136.71 151.35 49.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.407 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 62.9 t80 -135.12 122.89 22.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 108.872 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 165' ' ' THR . 15.2 t -99.83 122.35 42.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -100.44 132.86 45.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.351 -0.843 . . . . 0.0 109.164 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.45 151.91 34.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.454 -0.779 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -51.67 116.4 2.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 8.32 14.37 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -134.04 26.24 3.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.19 -1.183 . . . . 0.0 108.312 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 171' ' ' GLU . 22.0 mt-10 -64.6 -31.72 73.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.64 -0.662 . . . . 0.0 110.735 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.68 -15.53 58.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.275 -0.89 . . . . 0.0 111.627 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.34 -4.15 49.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.587 -1.321 . . . . 0.0 111.212 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.3 pt -117.11 -9.99 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.05 -1.032 . . . . 0.0 111.132 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 175' ' ' VAL . 0.9 OUTLIER -83.11 -28.11 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.548 -1.345 . . . . 0.0 110.133 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 2.29 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.896 -1.127 . . . . 0.0 110.452 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.37 110.18 17.28 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.94 -1.1 . . . . 0.0 109.001 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 154.58 20.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.085 -1.01 . . . . 0.0 110.066 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.493 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 5.0 t -52.73 156.9 1.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -0.799 . . . . 0.0 109.537 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.524 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 34.1 p90 -141.47 167.8 21.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.087 -1.008 . . . . 0.0 109.826 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.524 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -163.82 164.12 23.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -0.931 . . . . 0.0 109.918 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.433 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 91.2 m-85 -103.14 144.43 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.354 -0.842 . . . . 0.0 109.127 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.729 ' HA ' HD12 ' A' ' 186' ' ' ILE . 28.4 p-10 -65.45 -18.75 65.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.386 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -77.58 -29.04 51.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.548 -1.345 . . . . 0.0 111.003 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -101.39 -11.45 19.37 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.853 -1.154 . . . . 0.0 110.15 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.7 mt -58.93 -51.21 75.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 110.371 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -51.01 -49.43 60.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.919 -1.113 . . . . 0.0 109.54 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -49.39 70.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 109.005 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 186' ' ' ILE . 57.0 mt -57.41 -33.81 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.966 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -75.18 -26.13 58.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 110.179 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 193' ' ' GLY . 0.6 OUTLIER -76.52 -33.83 58.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 110.004 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.1 m -74.6 10.07 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 109.037 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 76.82 22.06 72.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.18 155.63 30.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -1.178 . . . . 0.0 109.997 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.48 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.83 23.71 61.46 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.365 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -67.45 -22.17 65.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.686 -1.479 . . . . 0.0 109.618 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.83 -5.82 50.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 128.34 41.44 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.848 -1.384 . . . . 0.0 110.106 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -136.22 -177.49 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.519 -0.989 . . . . 0.0 109.605 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.2 -21.97 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.65 -6.26 58.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.861 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.1 m-20 -141.26 13.85 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.04 -1.037 . . . . 0.0 110.017 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.459 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.1 m -149.3 118.96 6.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.015 -1.053 . . . . 0.0 110.058 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.33 111.58 14.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.897 . . . . 0.0 108.909 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.2 t -103.7 127.89 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.225 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.78 151.89 28.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.72 160.98 14.11 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -48.62 -28.08 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.78 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -152.59 13.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.038 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 207' ' ' GLY . 73.6 tttt -141.19 149.36 41.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.021 -1.05 . . . . 0.0 110.068 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.2 t -99.08 125.92 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 109.038 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -72.96 -54.46 8.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 110.104 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.03 137.02 80.21 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.996 -1.065 . . . . 0.0 109.746 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.74 -13.23 26.91 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.412 2.075 . . . . 0.0 112.622 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -85.59 -7.28 58.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 110.1 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.68 -160.83 53.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.95 145.73 30.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.991 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -88.84 -24.94 22.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 108.815 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 221' ' ' ASN . 56.6 m-85 -145.99 139.37 26.09 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.75 -12.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.951 -1.093 . . . . 0.0 108.507 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -139.88 37.68 1.98 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.768 0.794 . . . . 0.0 109.122 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.592 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -55.75 -41.48 91.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_exo -69.11 -42.83 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.429 2.086 . . . . 0.0 112.966 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 228' ' ' VAL . 16.1 m -76.25 -24.81 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.735 -1.228 . . . . 0.0 108.691 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.447 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 38.6 mtt180 -69.03 -45.17 71.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.435 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 37.0 t60 -59.2 -45.06 92.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.471 -0.768 . . . . 0.0 108.959 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -56.58 -47.81 78.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 108.989 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 224' ' ' VAL . 95.6 t -58.46 -51.18 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -50.69 -39.33 50.97 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -72.05 -40.87 68.04 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.588 -0.695 . . . . 0.0 109.855 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.677 HD23 ' CG1' ' A' ' 149' ' ' VAL . 51.8 tp -57.02 -35.01 68.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.377 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 25.0 mt -71.62 -48.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.32 20.55 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.87 -28.8 29.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.263 -1.139 . . . . 0.0 109.854 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 260' ' ' VAL . 7.0 mt -79.75 -22.92 42.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.773 -1.204 . . . . 0.0 109.701 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 24.5 t80 -69.0 -10.0 55.26 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 237' ' ' LEU . 81.2 mt -51.44 -26.59 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 0.0 108.869 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.497 HD12 HG22 ' A' ' 242' ' ' VAL . 95.5 mt -59.95 -21.59 61.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.89 14.57 69.5 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 56.1 p -158.41 147.12 14.29 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.045 -1.268 . . . . 0.0 109.813 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 71.8 Cg_exo -42.66 130.87 5.41 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.203 1.935 . . . . 0.0 111.961 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.497 HG22 HD12 ' A' ' 238' ' ' LEU . 51.3 t -95.26 127.04 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.579 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -117.08 123.85 47.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.365 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.67 177.95 30.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.411 ' HG3' ' HZ2' ' A' ' 245' ' ' LYS . 21.5 tttp -110.35 111.17 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.242 -1.152 . . . . 0.0 110.352 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.9 m-85 -111.82 147.6 35.37 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.853 0.835 . . . . 0.0 110.695 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.4 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 29.4 t80 -128.35 143.25 50.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.0 t -138.13 126.18 22.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.682 -1.261 . . . . 0.0 110.219 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 250' ' ' ARG . 11.9 t80 -111.64 112.61 24.43 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.556 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 12.3 mtt180 47.39 56.67 6.67 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.47 155.14 22.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.433 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.24 -175.42 16.66 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.444 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 90.9 m-70 -72.28 -51.82 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -1.21 . . . . 0.0 109.66 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.3 t -55.57 -34.12 64.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.706 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 134' ' ' ASP . 44.0 tp -72.99 -37.47 66.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 108.99 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 29.9 m-20 -62.71 -49.71 74.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 108.922 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.79 -44.18 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.354 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -54.98 -48.53 73.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.942 -1.099 . . . . 0.0 108.844 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.82 -47.05 67.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.638 HG22 HD23 ' A' ' 235' ' ' LEU . 98.5 t -65.56 -50.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.682 0.753 . . . . 0.0 109.574 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.82 -50.54 18.23 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 110.417 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.91 -47.98 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.09 . . . . 0.0 110.29 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 72.2 mt -61.76 -43.99 97.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 109.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.59 96.74 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.381 -0.824 . . . . 0.0 109.486 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp -68.83 -23.71 64.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.93 -1.106 . . . . 0.0 109.159 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.557 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 13.7 mttp -70.89 -49.01 50.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.201 -0.937 . . . . 0.0 110.089 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -95.56 1.89 54.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.025 -1.047 . . . . 0.0 111.094 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -80.07 -41.06 26.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.681 -1.262 . . . . 0.0 109.819 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.02 -84.05 0.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.508 ' C2A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.605 ' O ' HD11 ' A' ' 121' ' ' ILE . 11.2 mt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.5 mt-10 -47.87 146.08 2.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 109.326 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -126.5 141.87 51.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 t -138.61 177.79 7.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -83.06 140.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.818 -1.176 . . . . 0.0 110.163 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' CG ' HD13 ' A' ' 115' ' ' LEU . 13.9 ttpt -77.05 -43.67 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -126.2 153.23 44.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 109.842 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 139.49 58.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 110.236 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.6 mt -123.32 168.65 12.22 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -157.94 148.7 20.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 110.105 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -132.44 159.94 37.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -147.82 135.03 20.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.964 -1.085 . . . . 0.0 108.603 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.0 157.58 15.12 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG23 ' C ' ' A' ' 22' ' ' GLU . 11.2 p -81.53 141.03 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.216 -1.167 . . . . 0.0 110.755 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.18 144.92 40.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.681 HD11 H3A3 ' A' ' 320' ' ' TUX . 3.5 tt -63.89 -46.04 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.225 -1.162 . . . . 0.0 112.627 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.6 m-70 -86.8 -40.42 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 119.961 -1.712 . . . . 0.0 111.46 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -70.27 -31.64 69.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 109.954 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.04 23.89 68.16 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.542 ' C ' HG23 ' A' ' 16' ' ' VAL . 9.7 mt-10 -116.87 152.28 34.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -1.019 . . . . 0.0 109.469 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -70.69 132.72 45.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.72 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 t -140.89 158.0 44.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.0 109.252 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.721 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.9 ttpp -130.7 158.65 39.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.875 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.9 mt -135.44 141.12 45.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 108.766 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mt -126.41 135.66 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mt -118.77 112.75 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -111.97 154.58 44.13 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -68.67 162.2 42.08 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.372 2.048 . . . . 0.0 110.883 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.6 mm-40 -137.37 -177.4 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.016 -1.052 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -83.13 148.79 27.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.418 -0.801 . . . . 0.0 109.236 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.648 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.84 149.77 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.984 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.648 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.21 21.59 53.83 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.292 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.1 m -80.58 -37.35 31.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.625 -1.515 . . . . 0.0 108.803 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.75 -175.56 34.16 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -98.81 123.23 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.449 -1.03 . . . . 0.0 108.294 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -137.22 145.74 44.0 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.859 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -103.72 152.26 22.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -133.81 141.36 47.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.499 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.3 143.27 1.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 56.87 29.55 16.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.973 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.35 27.15 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.01 135.05 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -1.079 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.8 140.5 32.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 67' ' ' GLN . 42.5 mt -135.2 95.38 14.95 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.882 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.18 145.41 7.81 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.018 1.812 . . . . 0.0 111.743 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.41 82.35 5.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.0 110.292 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -139.14 156.25 47.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 109.58 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.56 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 2.1 p80 -52.78 -49.64 65.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -44.79 -16.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 25.4 m-85 -97.03 4.67 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.941 -1.099 . . . . 0.0 109.897 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.24 126.11 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.24 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.18 -34.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.374 -0.829 . . . . 0.0 110.0 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.411 ' NE2' ' HB2' ' A' ' 57' ' ' ASN . 4.8 t-160 -148.42 119.11 7.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 109.384 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -114.01 130.64 56.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 59' ' ' SER . 66.8 t30 -166.61 -153.63 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.533 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 4.8 m-70 -46.11 -15.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.383 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 57' ' ' ASN . 36.8 t -134.69 166.09 23.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.459 -0.776 . . . . 0.0 109.369 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m -109.85 125.04 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.369 -0.832 . . . . 0.0 109.225 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.2 145.98 48.99 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.958 0.885 . . . . 0.0 111.078 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.4 mt -127.21 159.55 33.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -178.55 148.25 8.3 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 118.422 -1.847 . . . . 0.0 111.572 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.2 149.68 36.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.157 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp 55.79 37.61 29.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.947 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 6.1 84.92 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.79 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 77.2 mm-40 -105.4 135.08 47.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -1.229 . . . . 0.0 108.018 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -142.23 159.77 41.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.943 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mt -136.47 147.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -114.67 154.35 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.433 -0.792 . . . . 0.0 110.949 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m 52.33 69.03 0.73 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.671 -0.643 . . . . 0.0 111.005 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.14 -11.26 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.166 -0.959 . . . . 0.0 109.28 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.1 pt-20 -66.9 -21.09 66.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.902 . . . . 0.0 110.535 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -71.28 -59.85 2.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.925 -1.109 . . . . 0.0 109.74 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.5 tp -57.87 -40.65 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.089 . . . . 0.0 108.962 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' N ' HG23 ' A' ' 75' ' ' ILE . 8.2 mt -61.55 -35.74 78.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.639 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.6 t -61.32 -48.74 79.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.032 -1.042 . . . . 0.0 109.244 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 31.9 t -58.59 -54.05 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.7 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 76' ' ' LEU . 23.6 mt -51.19 -43.44 61.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.536 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 13.2 t-160 -54.61 -52.32 62.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.784 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.53 -36.9 85.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.677 HD13 HD11 ' A' ' 114' ' ' ILE . 18.0 mt -78.08 -5.7 52.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.554 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 62.72 54.28 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.819 -1.175 . . . . 0.0 110.557 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.5 mm -96.02 126.16 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -113.19 -24.13 9.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 112.21 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.745 ' O ' HG13 ' A' ' 87' ' ' VAL . 13.4 m-80 -130.63 112.36 13.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.76 -1.212 . . . . 0.0 110.418 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.7 m -165.22 141.19 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.814 HG22 ' OE1' ' A' ' 90' ' ' GLU . 82.6 m -109.22 100.02 9.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.07 111.46 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.814 ' OE1' HG22 ' A' ' 88' ' ' THR . 0.6 OUTLIER -84.7 124.7 31.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.87 -1.144 . . . . 0.0 108.374 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 91' ' ' VAL . 3.9 t -107.85 111.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.731 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.4 mp -98.13 109.06 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.88 -162.43 24.19 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.38 -15.42 11.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.147 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.98 144.73 37.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.019 -1.051 . . . . 0.0 110.004 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.56 127.67 92.58 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 109.5 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.657 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.9 Cg_exo -45.6 128.37 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.887 1.724 . . . . 0.0 111.814 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.451 HD11 ' HA2' ' A' ' 101' ' ' GLY . 7.4 tp -79.8 -26.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.408 -0.808 . . . . 0.0 109.849 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.455 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 12.6 mt 55.42 -110.59 0.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -94.86 -18.74 20.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.081 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.451 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 111.87 -10.36 27.5 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -114.49 -169.67 1.58 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.429 -1.042 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -3.08 21.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -46.91 -42.04 16.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.842 -0.799 . . . . 0.0 110.649 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.57 -52.02 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.987 -1.071 . . . . 0.0 110.171 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 74.3 m-85 -62.27 -44.03 97.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.112 -0.993 . . . . 0.0 108.715 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 9.9 t80 -61.35 -39.46 90.66 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.44 0.638 . . . . 0.0 109.842 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.11 -46.73 40.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.465 -0.772 . . . . 0.0 111.906 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.42 -48.38 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.778 -1.201 . . . . 0.0 110.674 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.53 -40.75 89.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.359 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 1.1 ttm-85 -54.62 -29.5 52.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -0.963 . . . . 0.0 109.978 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -82.57 -8.88 59.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.421 ' HB2' HD11 ' A' ' 11' ' ' LEU . 14.6 m120 -123.18 33.96 5.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.318 -0.864 . . . . 0.0 111.279 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.677 HD11 HD13 ' A' ' 82' ' ' LEU . 10.4 mt -93.46 147.83 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 110.501 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.465 HD13 ' CG ' ' A' ' 8' ' ' LYS . 14.4 tp -131.02 163.55 27.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -112.97 144.03 43.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.95 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 33' ' ' GLU . 5.8 mt-30 -108.86 -161.45 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.169 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -122.77 1.03 9.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.255 -0.903 . . . . 0.0 110.856 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -82.66 135.46 35.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.797 -1.189 . . . . 0.0 109.849 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -74.94 124.1 26.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.605 HD11 ' O ' ' A' ' 3' ' ' LEU . 4.2 mt -71.82 140.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 111.278 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.81 91.18 8.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -63.53 146.08 54.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.459 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -102.21 125.78 49.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 t -129.96 143.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 92.3 t -82.94 137.85 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -119.7 -11.3 9.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.45 140.71 23.46 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 0.0 108.868 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -72.17 149.74 52.39 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.884 1.722 . . . . 0.0 113.043 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.885 HD12 ' NZ ' ' A' ' 266' ' ' LYS . 0.9 OUTLIER -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -127.95 124.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 109.64 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 132' ' ' VAL . 28.7 m -120.22 115.65 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.116 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -105.42 142.5 35.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.332 -0.855 . . . . 0.0 109.225 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.46 123.8 1.91 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.766 -1.209 . . . . 0.0 111.944 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 48.08 41.56 15.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.775 -0.578 . . . . 0.0 112.319 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.48 4.23 90.46 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.045 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.2 mtt-85 -104.17 161.46 14.0 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.7 tt -160.33 150.44 18.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.16 -1.588 . . . . 0.0 109.052 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.989 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.3 mt -147.6 132.2 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -123.43 139.24 54.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.838 . . . . 0.0 109.797 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.545 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -119.36 148.03 43.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -147.11 137.77 12.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.65 143.1 47.86 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.4 1.4 . . . . 0.0 112.115 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.68 146.21 13.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.329 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -80.2 -1.69 41.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 p -135.72 144.7 46.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.394 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.4 118.74 19.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.96 138.26 40.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.83 121.69 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.013 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -110.66 129.76 55.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.527 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 228' ' ' VAL . 72.7 t80 -114.77 129.92 56.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.615 -0.678 . . . . 0.0 109.517 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -117.06 112.91 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.546 ' C ' HH21 ' A' ' 250' ' ' ARG . . . -110.7 161.06 12.98 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.834 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.413 ' OE1' ' NH1' ' A' ' 250' ' ' ARG . 12.7 pt-20 -131.92 114.78 15.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.674 -0.898 . . . . 0.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -118.77 148.49 42.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.886 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.03 -6.62 47.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.98 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.881 HD22 HD12 ' A' ' 159' ' ' LEU . 23.0 p-10 -73.45 -168.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.02 . . . . 0.0 109.504 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -63.84 -16.87 62.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.125 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.881 HD12 HD22 ' A' ' 157' ' ' ASN . 6.2 mt -73.85 -24.83 59.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.977 -1.077 . . . . 0.0 109.109 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.73 -134.53 49.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -110.63 151.1 28.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.967 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.462 HE22 ' CD2' ' A' ' 159' ' ' LEU . 0.1 OUTLIER -169.06 160.82 10.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.831 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.64 160.12 39.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.9 126.38 25.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.41 -0.806 . . . . 0.0 108.874 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.0 m -97.05 121.94 39.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.886 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -96.71 138.69 33.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.872 . . . . 0.0 108.801 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.47 151.8 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.78 120.38 7.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.62 -1.59 21.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.459 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 15.5 m-80 -131.52 31.77 4.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -1.158 . . . . 0.0 108.87 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.62 -34.39 75.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.562 -0.711 . . . . 0.0 110.244 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 172' ' ' GLU . 2.8 mp0 -51.68 -14.55 0.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.062 -1.024 . . . . 0.0 110.577 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.516 ' N ' ' CD ' ' A' ' 173' ' ' GLU . 9.9 mp0 -93.5 -3.96 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.971 -1.081 . . . . 0.0 111.003 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.466 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -121.33 7.0 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.029 -1.044 . . . . 0.0 111.286 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.39 -32.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.711 -1.243 . . . . 0.0 110.271 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.37 1.98 51.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.873 -1.142 . . . . 0.0 110.689 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.13 108.54 15.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.875 -1.141 . . . . 0.0 109.085 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -82.18 154.49 25.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.087 -1.008 . . . . 0.0 109.352 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.505 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 1.7 t -61.77 138.91 58.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -117.32 173.48 6.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 110.208 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.434 ' SG ' H2A3 ' A' ' 320' ' ' TUX . 0.1 OUTLIER -161.78 159.79 27.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 0.0 109.229 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.588 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.6 m-85 -104.3 146.92 28.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.144 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.711 ' HA ' HD12 ' A' ' 186' ' ' ILE . 8.1 p30 -61.24 -17.89 55.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 111.218 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.3 p90 -80.13 -33.93 38.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.604 -1.31 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.602 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 pt-20 -92.88 -11.97 32.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.583 -1.323 . . . . 0.0 109.786 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 183' ' ' ASP . 7.2 mt -58.03 -52.29 60.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.135 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.23 -51.24 55.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.846 -1.159 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -52.82 -52.17 57.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.961 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.575 HD11 ' OE1' ' A' ' 185' ' ' GLU . 96.9 mt -54.56 -33.85 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -77.36 -25.47 51.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.613 -0.679 . . . . 0.0 110.268 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -78.26 -29.41 48.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 110.344 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.09 12.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.991 -1.068 . . . . 0.0 109.397 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.91 23.95 77.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.7 mt -117.3 155.28 29.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -1.12 . . . . 0.0 109.698 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.498 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.2 28.12 56.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -70.74 -20.63 62.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.738 -1.448 . . . . 0.0 109.23 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.25 -4.04 50.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.68 127.73 37.0 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.207 -1.172 . . . . 0.0 110.655 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 77.7 p -135.51 -173.9 3.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.717 -0.872 . . . . 0.0 109.249 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -82.99 -23.16 33.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -81.82 -24.36 35.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.585 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.6 OUTLIER -115.23 2.88 14.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.157 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.55 124.87 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.912 -1.118 . . . . 0.0 109.99 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 217' ' ' LEU . 5.2 tp -87.11 116.88 25.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 108.631 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.545 HG22 HD11 ' A' ' 186' ' ' ILE . 55.7 t -104.45 127.85 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.989 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.484 HD21 HD21 ' A' ' 217' ' ' LEU . 81.0 mt -105.54 151.62 24.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.86 154.04 17.04 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.437 ' CD ' ' H ' ' A' ' 208' ' ' LYS . 0.8 OUTLIER -41.91 -33.24 0.51 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -1.156 . . . . 0.0 109.829 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 19.02 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 110.251 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -150.32 160.16 43.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.88 130.41 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -73.27 -54.23 8.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.133 -0.979 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.2 135.37 75.03 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.965 -1.085 . . . . 0.0 109.378 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.31 -8.97 23.64 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.489 2.126 . . . . 0.0 112.877 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 215' ' ' GLU . 0.0 OUTLIER -92.09 -9.33 43.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 0.0 109.97 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.64 -166.2 51.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 204' ' ' LEU . 12.7 mt -85.68 147.78 26.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -1.038 . . . . 0.0 110.282 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.655 ' HE ' ' CA ' ' A' ' 218' ' ' ARG . 0.0 OUTLIER -83.46 -15.75 48.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.6 m-85 -149.42 151.67 34.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.036 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -63.02 -15.7 57.32 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.069 -1.019 . . . . 0.0 108.472 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.36 35.89 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.536 -0.728 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -60.45 -36.0 32.15 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.499 -0.751 . . . . 0.0 111.071 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.3 Cg_exo -70.34 -48.13 0.65 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.927 1.751 . . . . 0.0 112.547 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 228' ' ' VAL . 15.4 m -73.3 -23.53 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.632 -1.292 . . . . 0.0 108.39 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -67.87 -45.03 75.68 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -59.86 -41.15 90.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.948 . . . . 0.0 109.249 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 224' ' ' VAL . 42.7 t -58.88 -47.22 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.573 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 92.7 t80 -53.13 -38.72 62.9 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.697 0.761 . . . . 0.0 109.151 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 24.0 m-20 -68.76 -43.84 74.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.456 -0.778 . . . . 0.0 110.202 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.83 -39.23 73.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 0.0 109.235 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.417 HG22 ' HD1' ' A' ' 80' ' ' HIS . 77.0 mt -67.13 -34.28 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.2 -33.14 77.52 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -83.04 -26.21 31.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -1.12 . . . . 0.0 110.142 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.611 HD23 HG22 ' A' ' 260' ' ' VAL . 9.2 mt -81.89 -27.33 33.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.833 -1.167 . . . . 0.0 109.732 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.3 t80 -66.94 -8.52 30.08 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.074 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 237' ' ' LEU . 87.7 mt -52.62 -25.67 11.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 242' ' ' VAL . 96.0 mt -58.64 -23.85 59.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.894 -1.129 . . . . 0.0 108.846 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 89.18 14.64 60.15 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.2 p -158.51 146.28 13.6 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.939 -1.33 . . . . 0.0 109.637 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.405 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.64 131.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.289 1.992 . . . . 0.0 111.784 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 238' ' ' LEU . 22.0 t -98.43 134.93 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 109.457 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.66 128.47 48.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.89 178.82 30.46 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -107.37 111.59 24.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -1.183 . . . . 0.0 109.954 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -112.31 148.0 35.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 122.021 0.915 . . . . 0.0 111.167 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.78 144.42 51.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.9 128.6 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.816 -1.177 . . . . 0.0 110.361 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.624 ' CE2' ' NH1' ' A' ' 250' ' ' ARG . 38.2 t80 -113.85 107.36 15.62 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.624 ' NH1' ' CE2' ' A' ' 249' ' ' PHE . 0.0 OUTLIER 45.78 57.18 5.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.9 148.54 21.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -116.22 171.07 13.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.562 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 82.7 m-70 -59.91 -46.13 90.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -1.224 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -55.34 35.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.358 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 255' ' ' LEU . 60.0 tp -51.58 -39.42 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -57.8 -55.86 29.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.169 -0.957 . . . . 0.0 108.933 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 94.4 t -49.16 -41.51 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.29 -50.53 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.048 . . . . 0.0 109.062 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 139' ' ' ILE . 24.8 tp -53.15 -43.13 66.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.027 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.611 HG22 HD23 ' A' ' 235' ' ' LEU . 49.1 t -70.04 -40.26 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.343 -0.848 . . . . 0.0 109.428 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -52.53 64.3 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 110.025 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.6 -43.14 94.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.613 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 263' ' ' LEU . 41.9 mt -60.02 -47.88 84.02 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.17 75.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.457 -0.777 . . . . 0.0 110.24 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -79.87 -27.61 40.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.676 -1.265 . . . . 0.0 108.95 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.885 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 15.6 mttp -72.95 -48.73 34.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.821 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -81.68 4.61 21.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 109.835 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -25.81 68.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.418 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.0 mt -61.53 -28.25 69.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.568 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.681 H3A3 HD11 ' A' ' 18' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.285 0.564 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.529 ' CB ' ' OE2' ' A' ' 33' ' ' GLU . 5.4 mt-10 -54.63 145.84 18.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.88 . . . . 0.0 109.776 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.0 139.13 54.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.388 0.613 . . . . 0.0 110.04 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 t -135.01 173.81 11.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 m -83.54 142.04 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.84 -1.162 . . . . 0.0 110.212 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HG3' HD13 ' A' ' 115' ' ' LEU . 19.4 ttpp -77.58 -41.81 37.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.488 -0.757 . . . . 0.0 110.565 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -133.25 157.48 45.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.64 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -59.61 132.3 53.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.734 -0.604 . . . . 0.0 110.015 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.435 HD21 HD22 ' A' ' 113' ' ' ASN . 12.7 mt -119.37 153.56 34.97 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -150.72 147.47 27.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -135.65 162.49 32.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.557 -0.714 . . . . 0.0 109.76 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.88 139.09 26.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.914 -1.116 . . . . 0.0 109.515 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.28 159.19 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 21' ' ' GLY . 1.5 p -85.88 143.7 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.999 -1.295 . . . . 0.0 111.264 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 143.33 36.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.0 OUTLIER -65.6 -38.71 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -1.079 . . . . 0.0 112.666 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.436 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.4 m-70 -86.15 -36.71 19.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 119.892 -1.755 . . . . 0.0 112.457 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -84.65 -40.5 17.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.661 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 16' ' ' VAL . . . 83.87 11.32 79.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 152.22 20.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -73.24 143.45 47.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.914 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -146.0 157.55 43.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 108.826 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.527 ' C ' HD23 ' A' ' 26' ' ' LEU . 14.0 tttt -136.62 146.61 46.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.201 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.574 HD11 ' HD2' ' A' ' 97' ' ' PRO . 1.5 mt -121.56 148.64 44.24 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.147 -0.971 . . . . 0.0 109.034 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -135.6 126.05 43.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 28' ' ' ILE . 6.4 mt -111.65 125.15 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.938 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.539 ' NE2' HG22 ' A' ' 27' ' ' ILE . 15.8 m-70 -120.63 149.93 51.33 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.87 159.88 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.043 1.829 . . . . 0.0 110.86 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 26.4 mm-40 -134.63 179.25 6.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.027 . . . . 0.0 110.081 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.39 148.16 32.1 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.227 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' OE2' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -47.78 147.0 2.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 -179.359 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 58.94 25.04 58.89 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.103 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.3 m -80.46 -37.82 31.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.761 -1.435 . . . . 0.0 108.875 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.4 -177.76 32.37 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 mm -97.44 124.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -140.31 139.43 35.45 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.008 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -97.78 153.71 18.09 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.541 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.6 t80 -132.28 141.22 48.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.204 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -170.96 140.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.57 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 58.62 28.42 17.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.406 -0.809 . . . . 0.0 109.706 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.14 30.64 69.55 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.7 t -135.53 132.19 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -1.212 . . . . 0.0 109.967 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -90.06 141.28 28.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 108.942 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 67' ' ' GLN . 10.6 mt -137.77 96.98 10.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 110.355 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.75 144.93 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.182 1.921 . . . . 0.0 111.711 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.68 84.82 4.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 0.0 110.089 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -139.65 156.9 46.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 14.7 p-80 -53.38 -49.74 66.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.2 mm-40 -47.54 -16.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -0.998 . . . . 0.0 110.353 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' HIS . 22.0 m-85 -97.0 7.07 47.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.918 -1.114 . . . . 0.0 109.556 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.27 127.1 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.06 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.57 -34.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.518 ' NE2' ' CG ' ' A' ' 57' ' ' ASN . 3.1 t-160 -149.54 122.37 8.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -112.35 130.93 55.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.597 ' O ' ' N ' ' A' ' 59' ' ' SER . 13.5 p-10 -166.84 -153.95 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' ASN . 36.1 m-70 -46.59 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.071 -1.018 . . . . 0.0 108.763 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 57' ' ' ASN . 11.7 t -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.2 m -102.64 120.33 40.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 108.826 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -117.76 136.44 53.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 110.923 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -126.07 159.38 32.97 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.7 150.92 8.84 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.158 -1.972 . . . . 0.0 111.611 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -144.6 152.55 40.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.82 -0.812 . . . . 0.0 109.486 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.5 24.01 11.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.598 -0.689 . . . . 0.0 110.842 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.39 4.69 76.74 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.697 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.498 ' HB2' HD11 ' A' ' 46' ' ' ILE . 36.2 mm-40 -108.59 137.37 46.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -1.199 . . . . 0.0 108.21 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.79 164.29 30.51 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.853 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 91' ' ' VAL . 44.4 mt -135.08 149.21 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -114.18 149.78 35.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.896 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 54.41 66.95 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.714 -0.616 . . . . 0.0 110.866 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.74 -1.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 109.179 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 8.5 pt-20 -71.1 -30.85 67.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.048 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 32.5 m170 -64.49 -59.44 4.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -56.87 -45.99 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.733 -1.229 . . . . 0.0 108.733 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 75' ' ' ILE . 42.2 mt -55.28 -41.07 71.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.7 t -56.96 -45.53 82.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.38 -53.41 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 108.723 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -50.86 -44.66 59.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 108.977 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.694 ' HD1' HG22 ' A' ' 232' ' ' ILE . 14.7 t-160 -55.65 -47.82 76.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.453 -0.779 . . . . 0.0 110.018 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -66.54 -37.68 85.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 114' ' ' ILE . 65.4 mt -81.23 -7.61 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.827 -178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 63.37 63.32 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.724 -1.235 . . . . 0.0 110.134 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 82' ' ' LEU . 8.8 mm -104.94 130.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 121' ' ' ILE . 23.6 p -117.43 -18.86 9.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.852 . . . . 0.0 111.731 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.729 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.3 m-80 -133.65 111.39 10.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.639 -1.288 . . . . 0.0 110.233 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.3 m -165.1 141.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 95.6 m -110.8 100.6 9.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.495 -0.753 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.7 104.42 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.401 -0.812 . . . . 0.0 109.682 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -82.31 119.44 24.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.865 -1.147 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.509 HG13 HD22 ' A' ' 26' ' ' LEU . 2.8 t -102.95 108.26 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 111.087 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.52 108.13 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.31 -160.02 23.28 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.4 -15.25 7.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.56 -0.965 . . . . 0.0 110.21 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.599 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -135.61 142.27 45.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.0 110.44 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -68.6 139.53 91.55 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.574 ' HD2' HD11 ' A' ' 26' ' ' LEU . 11.4 Cg_endo -57.76 130.16 37.18 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.843 1.695 . . . . 0.0 111.514 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -78.64 -30.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.52 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 8.0 mt 52.8 -109.78 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.032 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -95.02 -18.59 20.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.573 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.73 -10.22 32.43 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.7 p -113.88 -172.09 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.383 -1.069 . . . . 0.0 109.869 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.48 -3.26 20.84 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -46.71 -39.99 12.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.624 -0.927 . . . . 0.0 110.8 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -63.53 -51.73 64.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 109.95 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -61.9 -45.04 95.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.917 -1.114 . . . . 0.0 108.392 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.88 -39.46 89.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.332 0.587 . . . . 0.0 110.44 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.11 -45.16 64.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.845 . . . . 0.0 111.494 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.24 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.858 -1.151 . . . . 0.0 110.551 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.16 -42.84 88.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 110.233 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -54.29 -29.57 47.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 109.816 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -85.96 -11.53 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.435 HD22 HD21 ' A' ' 11' ' ' LEU . 1.9 m-20 -119.78 29.31 7.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.233 -0.917 . . . . 0.0 111.458 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.594 HD11 HD13 ' A' ' 82' ' ' LEU . 4.7 mt -84.4 148.02 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.379 -1.451 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 8' ' ' LYS . 13.0 tp -130.84 158.13 41.02 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -101.06 146.51 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.898 -1.127 . . . . 0.0 110.044 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -109.44 -169.06 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.669 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -120.09 66.98 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 110.575 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -169.37 151.04 4.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 109.259 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.42 134.11 33.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.03 -1.044 . . . . 0.0 110.295 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 85' ' ' THR . 62.6 mt -69.87 135.55 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 110.863 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -78.26 80.95 4.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -58.22 141.36 50.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.589 -0.694 . . . . 0.0 110.759 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -98.39 120.45 38.82 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 243' ' ' LYS . 48.7 t -122.36 138.18 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 0.0 109.823 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.25 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -114.49 -10.07 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -142.82 145.91 35.6 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.427 -0.796 . . . . 0.0 108.92 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.12 177.24 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.11 1.873 . . . . 0.0 112.805 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.96 HG22 ' HB3' ' A' ' 141' ' ' ALA . 14.7 tt -165.6 144.61 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.457 0.646 . . . . 0.0 109.624 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.3 mp -132.73 118.9 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 132' ' ' VAL . 34.4 m -117.53 113.29 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.429 ' OE2' ' N ' ' A' ' 134' ' ' ASP . 1.2 tm-20 -115.56 127.2 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' N ' ' OE2' ' A' ' 133' ' ' GLU . 1.8 t70 -174.74 158.11 2.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 59.09 19.5 7.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 110.206 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.86 2.66 86.72 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.416 ' HB2' HD22 ' A' ' 255' ' ' LEU . 7.8 mtt180 -104.01 173.7 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.8 tt -160.09 148.07 16.76 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.487 -1.383 . . . . 0.0 109.037 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.854 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.8 mt -146.19 141.48 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.639 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -130.35 139.13 50.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.96 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.48 145.59 47.11 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -142.19 138.57 16.83 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.14 147.7 63.74 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.471 1.447 . . . . 0.0 112.119 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.05 158.49 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.03 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -93.5 4.13 54.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.942 . . . . 0.0 109.899 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 147.34 46.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.08 -1.013 . . . . 0.0 109.784 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.9 tp -77.37 116.03 17.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.848 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -139.36 135.18 33.44 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 246' ' ' PHE . 13.8 t -137.33 127.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.977 . . . . 0.0 110.05 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.7 m -112.28 132.05 55.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.368 -0.833 . . . . 0.0 109.294 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.448 ' CB ' HG22 ' A' ' 228' ' ' VAL . 81.3 t80 -119.83 129.47 54.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 162' ' ' GLN . 6.4 tp10 -114.72 104.61 12.14 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.0 155.38 21.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.604 ' CD ' HH21 ' A' ' 250' ' ' ARG . 12.9 tt0 -134.11 88.04 2.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.423 -1.045 . . . . 0.0 109.24 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -90.82 148.72 22.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -92.44 -6.92 48.97 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.86 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.9 p30 -73.9 -168.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.748 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.2 p90 -56.02 -17.53 7.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 109.754 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 14.0 mt -65.98 -51.17 60.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.06 -113.48 3.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -125.46 140.51 52.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.518 -0.989 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.48 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 52.5 tt0 -157.02 148.91 22.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -130.79 152.44 50.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -135.46 123.92 23.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 108.891 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 165' ' ' THR . 9.9 t -99.53 122.21 42.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 110.097 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.3 t80 -99.85 135.99 40.45 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.382 -0.824 . . . . 0.0 108.897 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.484 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.6 t -133.36 150.28 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.79 . . . . 0.0 109.155 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -53.46 122.81 10.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.77 -12.68 17.84 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -121.38 33.01 5.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.168 -1.195 . . . . 0.0 108.726 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -62.82 -35.95 81.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.699 . . . . 0.0 110.886 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -15.7 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.045 . . . . 0.0 110.829 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.73 -3.56 58.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.985 -1.072 . . . . 0.0 110.939 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.9 pt -124.29 0.85 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.068 -1.02 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -29.87 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.601 -1.312 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.6 mt -87.01 1.95 51.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.782 -1.199 . . . . 0.0 110.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.38 120.0 23.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.777 -1.202 . . . . 0.0 109.013 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.07 153.37 19.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.066 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.41 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.0 t -55.7 154.99 6.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.52 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 47.5 p90 -135.68 167.09 21.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.022 -1.049 . . . . 0.0 109.671 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.52 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 2.7 m -153.69 160.65 42.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.172 -0.955 . . . . 0.0 109.685 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.421 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 78.5 m-85 -102.84 143.41 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.213 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.612 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.8 OUTLIER -60.46 -26.07 66.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.502 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 4.7 p90 -79.01 -25.25 43.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.694 -1.254 . . . . 0.0 110.632 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 11.8 pt-20 -98.88 -13.8 19.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.879 -1.138 . . . . 0.0 109.575 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.5 mt -58.51 -52.99 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.154 -0.966 . . . . 0.0 110.063 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.19 -48.56 64.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.882 -1.136 . . . . 0.0 109.097 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.34 -52.1 62.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.967 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 91.2 mt -57.96 -34.48 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.825 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.21 -25.71 51.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -74.96 -31.6 61.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.101 -1.0 . . . . 0.0 109.867 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.422 ' CG2' HD12 ' A' ' 194' ' ' LEU . 6.8 m -81.0 12.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.17 -0.956 . . . . 0.0 109.347 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.48 24.12 76.79 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.625 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 192' ' ' VAL . 19.2 mt -121.21 159.08 26.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.15 -1.206 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 74.18 22.22 78.01 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.22 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -63.38 -53.73 47.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.33 -1.688 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -69.9 -2.6 39.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.09 134.06 39.91 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.849 -1.383 . . . . 0.0 110.484 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 203' ' ' THR . 68.0 p -141.86 177.72 7.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.493 -1.004 . . . . 0.0 109.319 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 200' ' ' LEU . 95.5 mt -74.6 -39.3 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.91 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -66.25 -14.46 61.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.222 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -131.44 9.14 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.433 ' CB ' ' O ' ' A' ' 199' ' ' SER . 0.5 OUTLIER -147.96 113.8 5.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.42 116.06 15.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 108.934 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.9 t -106.8 127.1 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 109.857 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.4 mt -110.71 149.91 29.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.14 152.21 17.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 207' ' ' GLY . 35.6 tttm -41.07 -37.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -1.113 . . . . 0.0 110.03 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -141.88 11.56 2.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.935 -1.103 . . . . 0.0 110.084 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.4 pttp -142.59 151.43 41.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.019 . . . . 0.0 109.738 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.503 HG11 ' HA2' ' A' ' 216' ' ' GLY . 60.9 t -102.56 127.93 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -73.0 -53.16 11.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.07 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.52 139.68 74.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.996 -1.065 . . . . 0.0 109.658 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.68 -33.96 9.72 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.522 2.148 . . . . 0.0 112.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -76.24 -9.1 58.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.046 -1.034 . . . . 0.0 110.28 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.503 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 69.6 -164.22 51.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.82 140.38 47.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -1.088 . . . . 0.0 109.833 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -84.59 -14.59 48.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 109.169 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.636 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 66.0 m-85 -146.09 133.83 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.436 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 1.3 mt-10 -48.03 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 108.501 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -137.19 39.33 2.51 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.9 OUTLIER -62.76 -39.58 55.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 111.935 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.0 Cg_endo -74.17 -40.37 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.997 1.132 . . . . 0.0 112.651 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 228' ' ' VAL . 11.2 m -76.68 -24.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.716 -1.24 . . . . 0.0 108.463 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.636 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 36.4 mtt180 -67.4 -47.44 70.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.53 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 44.1 t60 -59.77 -40.67 88.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -46.13 90.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 109.07 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 224' ' ' VAL . 46.4 t -62.19 -42.23 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 108.756 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.464 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 59.9 t80 -55.36 -47.32 75.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.67 -0.644 . . . . 0.0 109.433 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.592 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 12.2 m-20 -72.05 -34.56 68.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.406 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.1 tp -56.27 -36.17 68.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.707 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.694 HG22 ' HD1' ' A' ' 80' ' ' HIS . 89.7 mt -72.47 -48.75 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.77 9.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.3 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.105 -1.232 . . . . 0.0 109.769 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.39 -22.84 40.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.852 -1.155 . . . . 0.0 109.187 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.403 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 43.0 t80 -70.74 -8.77 54.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 108.752 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 237' ' ' LEU . 17.2 mt -50.18 -28.18 7.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.589 HD12 HG22 ' A' ' 242' ' ' VAL . 84.9 mt -54.16 -15.82 1.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.2 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 13.53 83.08 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.0 p -158.73 146.05 13.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.211 -1.17 . . . . 0.0 109.309 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 65.0 Cg_exo -43.19 130.22 6.21 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.066 1.844 . . . . 0.0 111.78 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 238' ' ' LEU . 3.8 t -97.49 132.13 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.629 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 125' ' ' VAL . 2.7 mmtt -117.98 123.7 46.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.49 172.66 25.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -104.38 114.38 28.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -1.222 . . . . 0.0 109.696 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 149' ' ' VAL . 8.6 m-85 -112.68 148.65 34.22 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.14 0.971 . . . . 0.0 111.486 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -130.42 144.22 51.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.0 t -142.34 129.58 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.656 -1.278 . . . . 0.0 111.077 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -112.18 114.81 27.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.604 HH21 ' CD ' ' A' ' 154' ' ' GLU . 18.2 mtt180 50.42 53.87 12.15 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.82 136.85 20.61 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.408 ' HA3' ' NH1' ' A' ' 137' ' ' ARG . . . -111.59 155.48 16.14 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.505 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 62.7 m-70 -52.94 -47.18 68.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -1.215 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.5 t -58.23 -55.34 36.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.056 -1.027 . . . . 0.0 108.869 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' A' ' 139' ' ' ILE . 53.6 tp -53.91 -37.12 63.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.435 HD21 ' HA ' ' A' ' 253' ' ' HIS . 77.0 m-20 -61.15 -54.35 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 108.973 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 19.5 t -50.97 -42.67 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -55.83 -49.7 72.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 139' ' ' ILE . 19.1 tp -52.14 -42.13 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 108.678 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.62 -46.24 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.283 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.13 -51.52 61.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.846 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -53.64 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 259' ' ' LEU . 90.3 mt -55.53 -42.18 74.21 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.41 90.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.523 -0.736 . . . . 0.0 109.719 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -75.81 -30.16 58.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.024 . . . . 0.0 109.11 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -62.81 -45.66 91.61 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.279 -0.888 . . . . 0.0 109.877 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -89.29 9.63 25.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 110.4 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -94.32 -22.05 18.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.841 -1.162 . . . . 0.0 109.89 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.55 -58.17 9.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 109.465 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.137 -0.977 . . . . 0.0 109.535 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.438 HOH1 ' CE1' ' A' ' 253' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' O ' HD11 ' A' ' 121' ' ' ILE . 45.4 mt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 63.5 mt-10 -45.38 145.52 1.17 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 0.0 109.213 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.37 53.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 110.285 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -138.2 175.27 9.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 7' ' ' VAL . 10.4 m -86.51 141.35 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.354 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -73.87 -46.12 46.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.574 -0.704 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -126.88 153.76 45.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.41 -0.806 . . . . 0.0 110.43 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.08 138.76 58.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.62 167.71 12.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 p -156.76 149.34 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.995 -1.066 . . . . 0.0 110.338 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -135.01 155.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 135.48 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 108.759 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.79 156.16 13.0 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.122 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.29 163.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.29 -1.124 . . . . 0.0 111.029 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.64 136.98 13.35 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.646 HG23 ' N ' ' A' ' 19' ' ' HIS . 16.0 tt -56.21 -52.57 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.137 -1.214 . . . . 0.0 111.751 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.646 ' N ' HG23 ' A' ' 18' ' ' ILE . 24.8 m-70 -87.08 -38.56 16.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.172 -1.58 . . . . 0.0 110.66 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.6 m -73.9 -35.38 64.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.952 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.07 64.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -107.53 148.55 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.58 -0.953 . . . . 0.0 108.967 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 8.1 t80 -70.83 125.78 27.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.973 . . . . 0.0 109.759 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 t -135.12 156.41 49.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.118 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' O ' HD23 ' A' ' 26' ' ' LEU . 18.1 tttp -134.81 150.69 50.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 109.138 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.709 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.7 mt -127.52 148.45 50.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 0.0 109.622 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -132.04 131.84 61.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -115.83 126.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -120.56 155.06 57.06 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.585 -0.697 . . . . 0.0 109.286 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.53 160.67 48.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.347 2.031 . . . . 0.0 110.861 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 20.4 mm-40 -135.83 -174.83 3.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.104 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 35' ' ' THR . 11.0 tptt -86.03 153.3 22.23 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 109.287 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.619 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.3 mp0 -46.81 145.07 2.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.091 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.609 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.36 26.1 61.32 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.826 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 39.6 m -78.7 -36.94 42.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.562 -1.552 . . . . 0.0 109.134 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.783 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 94.05 -175.56 35.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.7 mm -99.52 121.9 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.297 -1.119 . . . . 0.0 108.277 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -136.33 143.9 44.36 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.975 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.89 151.13 22.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -130.26 142.66 50.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -174.59 138.22 0.51 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -178.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER 57.12 31.59 20.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.616 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.51 74.33 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.624 -1.298 . . . . 0.0 110.034 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.13 139.41 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 109.529 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 m-85 -102.18 138.06 39.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.57 97.94 18.71 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.418 -0.801 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.74 142.75 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.22 1.947 . . . . 0.0 111.718 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.02 82.48 6.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.984 -1.073 . . . . 0.0 110.172 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -139.45 156.03 47.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.583 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.564 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -53.45 -49.5 67.28 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.541 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 19.5 mt-10 -44.06 -16.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.072 -1.018 . . . . 0.0 109.995 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 50' ' ' HIS . 96.6 m-85 -98.56 4.21 48.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.058 -1.026 . . . . 0.0 109.994 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 t -60.73 121.02 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 108.477 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.96 -25.36 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.303 -0.873 . . . . 0.0 110.408 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -151.13 118.54 6.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -112.29 131.13 55.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.5 t-20 -166.36 -154.28 0.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 1.6 m-70 -47.96 -12.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 108.372 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -136.84 166.0 24.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.587 -0.696 . . . . 0.0 109.238 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.0 m -108.84 125.1 51.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.335 -0.853 . . . . 0.0 109.132 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.87 143.72 50.18 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.993 0.901 . . . . 0.0 111.25 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.3 mt -124.29 160.52 27.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.85 147.93 7.66 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.343 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -145.01 151.68 38.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.751 -0.852 . . . . 0.0 109.488 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt 57.12 25.36 10.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.289 -0.882 . . . . 0.0 111.196 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.49 1.95 77.18 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.631 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.471 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.2 mm100 -102.41 142.81 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.993 -1.298 . . . . 0.0 107.999 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -145.83 157.23 43.93 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.842 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 69' ' ' ILE . 3.8 mt -133.27 144.5 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 9.1 mttm -110.71 155.03 23.03 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.295 -0.878 . . . . 0.0 111.317 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 47.38 72.86 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.765 -0.584 . . . . 0.0 111.169 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 m -113.02 -11.59 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 109.566 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -63.68 -18.53 64.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 110.604 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.595 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 25.6 m170 -71.85 -60.65 2.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.892 -1.13 . . . . 0.0 109.413 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 4.0 tp -60.41 -44.05 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 109.138 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.519 ' N ' HG23 ' A' ' 75' ' ' ILE . 12.0 mt -56.2 -38.22 70.7 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.551 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 27.3 t -60.68 -48.58 81.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.614 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.5 t -57.64 -52.99 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.972 -1.08 . . . . 0.0 108.688 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -50.68 -43.79 57.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.49 ' HD1' HG22 ' A' ' 232' ' ' ILE . 7.9 t-160 -55.1 -51.33 66.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 110.223 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.8 mt -68.36 -37.27 80.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.329 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.593 HD22 HD11 ' A' ' 114' ' ' ILE . 14.8 mt -76.08 -5.58 47.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.061 -1.024 . . . . 0.0 110.131 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.79 50.99 3.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 110.43 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 82' ' ' LEU . 14.6 mm -97.59 122.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 108.501 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.624 HG21 HG23 ' A' ' 121' ' ' ILE . 71.7 p -110.78 -22.01 11.78 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.783 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 9.9 m120 -129.91 112.17 13.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.709 -1.244 . . . . 0.0 110.516 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.6 m -164.75 141.78 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 8.1 m -110.23 100.69 9.53 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mp -87.69 108.87 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.889 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -88.18 116.48 26.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG13 HD22 ' A' ' 26' ' ' LEU . 61.9 t -106.28 117.63 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 110.856 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.09 112.36 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.93 -162.05 24.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.48 -17.64 8.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.227 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 1.5 tp10 -132.64 141.0 48.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.829 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.2 mm -67.37 125.71 91.5 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.609 -0.682 . . . . 0.0 109.34 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.709 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.4 Cg_exo -45.86 131.28 13.39 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.921 1.747 . . . . 0.0 111.887 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.1 tp -76.46 -29.62 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 110.431 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.7 mt 54.89 -113.73 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.61 -15.86 23.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 110.32 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.75 -12.97 46.35 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 p -112.3 -169.18 1.42 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.012 . . . . 0.0 109.493 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.6 -3.09 25.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -47.44 -41.91 21.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.833 -0.804 . . . . 0.0 110.409 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.96 -52.37 63.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.068 . . . . 0.0 110.233 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 87.4 m-85 -61.81 -44.29 97.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.765 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -62.06 -38.91 90.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.311 0.576 . . . . 0.0 109.941 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.15 -44.94 51.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.287 -0.883 . . . . 0.0 111.828 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.25 -47.61 23.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 110.998 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.03 -40.16 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttt85 -57.38 -30.03 64.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 109.877 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 112' ' ' LYS . 24.0 tttm -80.65 -8.21 59.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 109.623 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -123.74 35.03 4.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.987 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.593 HD11 HD22 ' A' ' 82' ' ' LEU . 17.8 mt -90.79 147.03 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.8 -1.187 . . . . 0.0 110.643 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 115' ' ' LEU . 14.2 tp -131.26 159.61 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -109.79 146.43 35.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.552 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -108.93 -162.65 0.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.528 -0.733 . . . . 0.0 109.26 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 -1.22 11.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -85.37 138.71 32.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.86 -1.15 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.1 128.03 33.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.272 -0.892 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.624 HG23 HG21 ' A' ' 85' ' ' THR . 0.8 OUTLIER -70.92 139.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 111.124 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -94.38 98.48 10.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.74 147.05 51.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -97.33 121.46 39.25 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.02 139.36 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.17 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -113.12 -10.78 13.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.242 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -143.66 146.05 33.63 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.097 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.2 172.74 14.21 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.087 1.858 . . . . 0.0 113.135 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.589 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.3 tt -164.27 140.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.09 126.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.28 114.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.282 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -174.35 150.88 1.51 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.084 -1.01 . . . . 0.0 110.996 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 55.65 24.92 7.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.726 -0.609 . . . . 0.0 111.077 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.98 86.32 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HB2' HD22 ' A' ' 255' ' ' LEU . 2.4 mtt180 -106.92 169.02 8.8 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.987 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.8 tt -159.73 150.41 19.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.193 -1.567 . . . . 0.0 108.873 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.987 ' N ' HD23 ' A' ' 138' ' ' LEU . 7.2 mt -145.83 139.56 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -129.6 139.62 51.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.589 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -121.54 140.36 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -136.47 137.41 24.04 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.9 150.1 48.1 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.56 1.507 . . . . 0.0 112.032 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.94 158.57 8.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -86.97 -1.44 57.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.726 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.4 p -136.46 155.19 50.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 109.405 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.497 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 32.6 tp -87.48 117.15 26.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 110.116 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -134.29 140.35 46.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.606 ' CG1' HD23 ' A' ' 231' ' ' LEU . 94.6 t -139.19 126.96 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.976 -1.077 . . . . 0.0 109.908 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.3 m -115.16 137.8 51.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.447 -0.783 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.483 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.5 t80 -125.97 129.56 49.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.727 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.31 106.18 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.4 141.15 15.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -118.94 86.69 2.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.532 -0.981 . . . . 0.0 109.17 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -91.77 143.01 26.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.732 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -92.14 -1.67 57.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.843 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 22.1 p-10 -73.12 -167.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -61.56 -24.89 66.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.92 . . . . 0.0 109.784 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.544 HD22 ' NE2' ' A' ' 162' ' ' GLN . 7.7 mt -63.21 -46.23 87.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.61 -132.72 11.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -98.87 139.6 34.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -1.106 . . . . 0.0 109.289 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.544 ' NE2' HD22 ' A' ' 159' ' ' LEU . 9.1 mt-30 -146.02 142.64 28.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.518 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -137.29 148.41 46.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.39 127.9 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.089 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 165' ' ' THR . 10.9 t -99.87 122.03 42.21 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.013 -1.054 . . . . 0.0 109.718 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.29 136.65 34.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 108.881 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.52 153.25 34.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.645 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.661 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 4.7 mp0 -57.13 113.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.288 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.555 ' N ' ' OE2' ' A' ' 171' ' ' GLU . . . 115.89 11.29 10.26 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -137.11 28.4 2.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.183 -1.187 . . . . 0.0 108.761 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.675 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 16.9 mp0 -62.15 -36.93 83.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 110.632 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 15.6 mp0 -52.45 -15.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.82 -1.175 . . . . 0.0 110.241 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 49.1 mt-10 -91.07 -4.19 56.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 110.927 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.595 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.4 pt -121.72 6.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.14 -34.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.96 1.02 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.779 -1.201 . . . . 0.0 110.745 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.36 123.81 28.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.195 . . . . 0.0 108.962 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 154.38 17.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -51.36 158.12 0.89 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.404 ' O ' ' O3G' ' A' ' 320' ' ' TUX . 36.8 p90 -146.24 168.7 20.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.05 -1.031 . . . . 0.0 110.089 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.528 ' SG ' ' C1A' ' A' ' 320' ' ' TUX . 0.1 OUTLIER -166.08 159.0 15.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 109.595 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.521 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 60.8 m-85 -103.42 146.5 28.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.296 -0.878 . . . . 0.0 109.316 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.678 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.8 p30 -51.97 -51.08 59.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.794 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.664 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.2 p90 -51.83 -36.84 49.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.926 -1.109 . . . . 0.0 111.481 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.664 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 14.6 pt-20 -89.48 -17.33 28.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.636 -1.29 . . . . 0.0 109.924 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.3 mt -59.43 -52.24 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.187 -0.946 . . . . 0.0 110.127 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -50.85 -51.16 53.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.663 -1.273 . . . . 0.0 109.5 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -52.42 -44.87 65.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 108.751 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.566 HD13 H3A3 ' A' ' 320' ' ' TUX . 71.2 mt -59.99 -34.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -77.65 -27.14 50.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.726 . . . . 0.0 110.216 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.45 -24.07 46.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.005 -1.059 . . . . 0.0 110.217 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.4 m -85.68 11.19 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.548 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.87 24.82 68.52 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 120.077 -1.059 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 39.2 mt -123.53 163.28 21.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 109.921 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.15 23.96 60.32 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -69.09 -22.68 63.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.788 -1.419 . . . . 0.0 109.88 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.54 -0.56 53.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.35 130.0 50.33 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.305 -1.114 . . . . 0.0 110.685 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.2 p -140.01 -173.64 3.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.735 -0.862 . . . . 0.0 108.728 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.46 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -99.48 -4.3 31.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.89 -11.69 1.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.119 -0.988 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.4 m -126.0 116.96 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.9 tp -74.04 110.42 8.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.522 HG13 HD11 ' A' ' 186' ' ' ILE . 58.1 t -100.08 126.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.926 -1.109 . . . . 0.0 109.47 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.1 mt -110.15 148.81 31.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.829 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.25 159.25 15.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -23.45 1.61 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.257 -1.143 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -153.66 12.69 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 0.0 110.724 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -144.11 151.66 39.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.864 -1.148 . . . . 0.0 110.637 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.57 124.86 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -71.95 -54.78 8.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.019 -1.05 . . . . 0.0 110.34 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -55.89 132.88 73.33 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.056 . . . . 0.0 109.428 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.51 -11.19 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.418 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -84.47 -6.64 59.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.09 -162.96 54.56 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -89.45 149.76 22.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.964 . . . . 0.0 110.317 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.6 mtt-85 -94.26 -23.76 17.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -0.798 . . . . 0.0 108.929 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.526 ' C ' ' H ' ' A' ' 221' ' ' ASN . 28.3 m-85 -144.57 133.93 23.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 108.993 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.22 -9.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 108.614 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -135.01 35.66 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.844 0.83 . . . . 0.0 108.878 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.492 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.66 -49.54 88.35 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 111.804 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 20.5 Cg_endo -67.58 -34.56 25.23 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.571 1.514 . . . . 0.0 113.06 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 228' ' ' VAL . 24.2 m -79.84 -28.22 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.51 -1.369 . . . . 0.0 107.706 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 10.1 mmm-85 -65.1 -46.84 79.41 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.582 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 36.6 t60 -61.35 -42.13 98.19 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 151' ' ' TYR . 0.6 OUTLIER -59.52 -50.84 72.34 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.05 -1.031 . . . . 0.0 108.69 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 224' ' ' VAL . 18.2 t -55.94 -43.95 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 79.4 t80 -57.71 -40.04 78.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.582 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.5 m-20 -74.68 -33.93 62.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.595 -0.69 . . . . 0.0 109.487 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.606 HD23 ' CG1' ' A' ' 149' ' ' VAL . 24.0 tp -59.01 -35.85 73.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 108.688 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' HIS . 75.7 mt -72.15 -47.77 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -33.27 24.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -82.14 -27.25 32.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.258 . . . . 0.0 109.582 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 mt -83.14 -23.84 32.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.881 -1.137 . . . . 0.0 109.308 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.502 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 38.1 t80 -67.51 -10.71 54.17 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 108.956 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 85.7 mt -50.45 -27.97 7.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 109.101 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 242' ' ' VAL . 71.3 mt -58.81 -17.68 25.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.177 -0.952 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 79.41 15.89 79.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.0 p -158.35 144.65 12.68 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.992 -1.299 . . . . 0.0 109.787 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 57.2 Cg_exo -42.1 128.99 4.34 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.197 1.931 . . . . 0.0 111.839 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.561 HG22 HD12 ' A' ' 238' ' ' LEU . 57.5 t -95.88 130.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.66 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -117.67 123.72 46.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.823 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 174.1 27.91 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.62 113.33 26.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -1.183 . . . . 0.0 109.829 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.86 147.17 37.55 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.928 0.871 . . . . 0.0 111.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -129.67 143.27 50.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 128.11 19.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.646 -1.284 . . . . 0.0 110.687 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.2 t80 -112.31 116.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 249' ' ' PHE . 13.9 mmm180 46.04 55.78 6.77 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.1 152.44 22.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.0 -175.84 18.6 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.417 ' O ' HG23 ' A' ' 257' ' ' VAL . 72.7 m-70 -70.96 -52.22 21.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -1.215 . . . . 0.0 109.576 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 2.2 p -56.14 -54.41 45.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.162 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 137' ' ' ARG . 34.1 tp -51.06 -42.37 60.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.229 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.16 -50.96 71.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 108.908 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 253' ' ' HIS . 59.5 t -53.9 -40.8 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.865 . . . . 0.0 109.423 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -55.3 -48.15 74.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 108.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 13.4 tp -52.78 -45.25 67.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.6 t -65.83 -45.56 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -52.14 58.72 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 110.155 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -64.39 -46.49 83.12 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.062 -1.023 . . . . 0.0 109.707 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 263' ' ' LEU . 20.4 mt -59.07 -46.38 88.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.31 -34.4 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -79.19 -27.12 42.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.66 -1.275 . . . . 0.0 109.145 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -66.94 -45.93 76.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.947 . . . . 0.0 109.995 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -85.68 11.56 10.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.955 . . . . 0.0 110.734 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -22.97 56.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.888 -1.133 . . . . 0.0 109.698 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.9 mt -75.19 -49.89 17.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 109.542 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 109.452 179.889 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.566 H3A3 HD13 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 85.8 mt-10 -54.33 144.16 21.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.523 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.28 139.36 53.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.9 t -137.47 176.59 8.57 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.45 143.43 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.854 -1.154 . . . . 0.0 110.443 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HG3' HD13 ' A' ' 115' ' ' LEU . 2.4 ttmm -76.22 -46.52 27.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.636 -0.665 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.93 153.69 43.89 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.521 0.676 . . . . 0.0 110.111 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.94 137.91 58.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.483 -0.76 . . . . 0.0 109.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.47 165.1 15.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.579 -0.701 . . . . 0.0 109.176 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -155.59 147.81 23.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 0.0 110.102 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -130.9 162.42 29.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.571 -0.706 . . . . 0.0 109.207 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.96 136.52 16.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.874 -1.141 . . . . 0.0 109.063 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.1 161.4 19.34 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.053 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.3 p -74.6 160.67 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 111.447 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.552 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -93.58 142.38 15.97 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -62.73 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.254 . . . . 0.0 112.36 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.443 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.8 m-70 -86.7 -38.4 17.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 119.821 -1.799 . . . . 0.0 111.654 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.436 ' OG1' ' CB ' ' A' ' 95' ' ' GLU . 2.1 p -78.13 -33.32 50.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.042 -1.036 . . . . 0.0 110.099 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.15 72.02 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -116.13 154.06 30.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.956 . . . . 0.0 108.654 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -73.16 138.12 45.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.993 -1.067 . . . . 0.0 110.075 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -143.76 157.88 44.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 0.0 108.847 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 8.1 ttpp -135.57 148.75 49.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 109.329 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.663 ' CD2' HG13 ' A' ' 91' ' ' VAL . 12.9 mt -124.98 146.34 49.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.96 130.93 61.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mt -117.02 119.02 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 109.637 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -116.92 148.64 42.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.34 161.51 23.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.231 1.954 . . . . 0.0 111.45 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -135.96 -174.08 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.9 tttp -85.61 151.66 23.73 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -49.5 150.34 1.97 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.618 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.27 23.61 57.89 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.03 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 17.0 m -80.2 -42.64 22.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.791 -1.417 . . . . 0.0 108.913 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.75 -176.81 30.06 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 mm -97.33 122.57 49.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.374 -1.074 . . . . 0.0 108.122 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -138.45 140.69 39.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.046 -1.034 . . . . 0.0 110.4 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -100.05 152.92 19.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.1 t80 -124.93 147.41 48.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -173.78 131.26 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 109.382 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.84 29.58 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.758 -1.211 . . . . 0.0 110.198 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.02 138.55 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -1.171 . . . . 0.0 109.703 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -98.86 137.03 38.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.05 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 67' ' ' GLN . 58.3 mt -129.24 97.11 26.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 110.179 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.59 142.3 24.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.156 1.904 . . . . 0.0 111.837 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.64 82.36 5.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.512 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -140.63 156.99 46.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 52' ' ' PHE . 17.9 p-80 -53.53 -49.87 66.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.168 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HG2' ' CD2' ' A' ' 50' ' ' HIS . 2.2 mm-40 -47.0 -15.79 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.022 . . . . 0.0 109.947 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 50' ' ' HIS . 76.6 m-85 -97.53 4.22 50.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.007 -1.058 . . . . 0.0 109.495 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 50' ' ' HIS . 33.9 t -59.02 130.46 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.87 -32.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -153.55 122.06 6.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 109.979 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.6 p -112.33 131.93 55.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 7.0 t-20 -166.87 -153.94 0.16 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 57' ' ' ASN . 23.3 m-70 -46.92 -13.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.008 -1.058 . . . . 0.0 108.452 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -137.3 166.06 24.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.485 -0.759 . . . . 0.0 109.371 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.408 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 12.3 m -105.79 123.67 48.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.377 -0.827 . . . . 0.0 108.945 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -122.19 142.43 50.43 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.995 0.902 . . . . 0.0 111.426 -178.697 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 53' ' ' VAL . 72.5 mt -122.56 164.68 17.72 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.54 145.31 5.58 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.4 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -145.18 151.52 38.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.822 -0.811 . . . . 0.0 109.484 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm 57.44 25.59 11.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 111.002 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.03 2.2 78.26 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.594 ' HB2' HD11 ' A' ' 46' ' ' ILE . 8.6 mm100 -100.65 142.24 32.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.235 . . . . 0.0 108.028 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -143.55 154.05 43.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.796 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mt -133.87 144.07 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 47.8 mttp -114.9 155.01 27.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.364 -0.835 . . . . 0.0 111.256 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 m 50.89 63.86 2.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.79 -0.569 . . . . 0.0 111.152 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 96' ' ' ILE . 28.9 m -112.51 1.05 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.094 -1.004 . . . . 0.0 109.092 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' OE1' ' OD2' ' A' ' 230' ' ' ASP . 0.3 OUTLIER -72.22 -31.09 65.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.944 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -61.49 -60.45 3.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.832 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.576 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.8 tp -59.64 -46.13 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 0.0 109.179 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.576 ' N ' HG23 ' A' ' 75' ' ' ILE . 61.9 mt -53.79 -41.62 67.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.557 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 2.8 t -58.43 -46.31 86.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.976 . . . . 0.0 109.47 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.95 -54.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 34.0 mt -51.89 -43.7 63.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 108.923 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.563 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 19.1 t-160 -54.6 -47.72 73.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.63 -37.13 82.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 114' ' ' ILE . 58.6 mt -77.81 -7.53 56.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.431 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.03 60.48 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 82' ' ' LEU . 5.8 mm -104.29 131.03 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 108.65 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.582 HG21 HG12 ' A' ' 121' ' ' ILE . 40.7 p -119.71 -19.12 8.15 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.364 -0.835 . . . . 0.0 111.422 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.2 m-80 -126.98 111.02 13.6 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.891 -1.131 . . . . 0.0 109.637 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -164.57 142.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.132 -0.98 . . . . 0.0 109.949 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.5 m -113.84 99.43 7.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.33 106.35 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.829 . . . . 0.0 109.777 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.66 118.78 25.38 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.663 HG13 ' CD2' ' A' ' 26' ' ' LEU . 43.3 t -105.0 105.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.931 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.91 111.33 19.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.17 -179.18 16.23 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.32 -16.83 14.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -1.186 . . . . 0.0 110.66 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -123.77 133.48 53.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 110.41 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.57 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 mm -68.12 126.32 92.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.486 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HD2' HD11 ' A' ' 26' ' ' LEU . 77.9 Cg_exo -46.28 128.48 12.18 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.865 1.71 . . . . 0.0 112.159 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.5 tp -76.43 -25.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.444 -0.785 . . . . 0.0 110.093 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.9 mt 53.66 -113.91 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD2' ' NE ' ' A' ' 178' ' ' ARG . 18.8 t70 -94.37 -21.46 18.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 0.0 110.012 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.5 -7.71 28.29 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.582 ' OG ' ' NE ' ' A' ' 178' ' ' ARG . 5.4 p -116.69 -167.75 1.34 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -1.066 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.5 -5.37 20.98 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.495 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 67.1 t-105 -46.75 -42.0 16.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.681 -0.894 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.59 -52.25 64.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.046 . . . . 0.0 110.015 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 75.3 m-85 -62.42 -44.35 96.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.018 . . . . 0.0 108.557 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -63.49 -37.53 87.64 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.3 mm-40 -71.42 -50.25 33.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -0.824 . . . . 0.0 112.076 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.0 -51.53 13.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.713 -1.242 . . . . 0.0 110.669 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.76 -42.52 85.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.031 -1.043 . . . . 0.0 110.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -54.11 -29.36 44.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -84.79 -11.7 55.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -119.8 31.6 6.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.835 HD11 HD13 ' A' ' 82' ' ' LEU . 4.9 mt -88.83 148.29 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.362 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.62 HD13 ' HG3' ' A' ' 8' ' ' LYS . 15.0 tp -130.34 158.47 39.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -109.35 137.53 47.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -100.17 -161.45 0.87 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.83 . . . . 0.0 109.047 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -121.77 0.63 9.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.86 . . . . 0.0 110.7 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 4' ' ' GLU . 5.6 ttt85 -89.04 144.18 26.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.926 -1.108 . . . . 0.0 109.925 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 132.14 34.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.492 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 85' ' ' THR . 96.6 mt -74.31 140.6 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.499 -0.75 . . . . 0.0 111.184 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -83.95 84.08 7.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -57.88 144.84 37.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.713 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -105.37 125.02 50.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 243' ' ' LYS . 46.1 t -128.53 142.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.2 t -81.19 134.8 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 108.864 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.52 -11.35 11.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.084 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.76 141.76 23.36 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.337 -0.852 . . . . 0.0 109.171 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.69 169.87 20.89 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.135 1.89 . . . . 0.0 113.377 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.531 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 3.1 tt -165.4 141.52 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.81 -0.556 . . . . 0.0 109.708 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.435 HG23 HD21 ' A' ' 138' ' ' LEU . 5.7 mt -127.6 124.9 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.402 -0.811 . . . . 0.0 109.83 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 132' ' ' VAL . 31.5 m -120.03 120.79 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.443 -0.786 . . . . 0.0 109.438 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -104.33 147.27 27.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.349 -0.844 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 255' ' ' LEU . 4.1 t70 -157.01 112.45 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.816 -1.178 . . . . 0.0 111.882 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 41.1 52.25 3.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.709 -0.619 . . . . 0.0 112.458 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.26 3.69 89.99 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.588 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -105.38 163.08 12.9 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.972 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.23 149.64 17.64 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.037 -1.664 . . . . 0.0 109.241 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.972 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.0 mt -146.85 133.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -124.88 139.72 53.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -143.57 139.29 16.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 146.47 70.47 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.653 1.568 . . . . 0.0 112.456 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.46 153.17 9.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 0.54 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -136.29 146.34 46.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.49 117.68 19.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.548 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 tt0 -139.52 133.89 31.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.83 . . . . 0.0 108.808 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.633 ' CG1' HD23 ' A' ' 231' ' ' LEU . 22.9 t -132.75 125.6 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.688 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.9 m -112.77 132.3 55.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -121.58 130.15 53.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.74 . . . . 0.0 109.986 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -114.1 103.23 10.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.07 125.42 8.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.28 84.39 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.42 -1.047 . . . . 0.0 108.865 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.19 148.22 25.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.541 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -95.83 1.31 53.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.209 -0.932 . . . . 0.0 109.782 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.648 HD21 HD12 ' A' ' 159' ' ' LEU . 15.0 p-10 -76.24 -167.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.368 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -61.23 -25.21 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.79 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.648 HD12 HD21 ' A' ' 157' ' ' ASN . 11.3 mt -59.57 -51.13 71.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.35 -128.07 9.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.553 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 12.2 mtm180 -104.05 137.28 42.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.392 -1.064 . . . . 0.0 109.23 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 8.3 mp0 -140.73 138.41 34.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.199 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.65 144.27 49.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.808 . . . . 0.0 109.472 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.656 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 52.3 t80 -138.6 128.48 25.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 61.0 m -103.14 123.1 46.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -101.77 137.64 39.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.832 . . . . 0.0 109.395 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.551 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.2 t -134.47 158.32 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.483 -0.76 . . . . 0.0 109.363 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 167' ' ' VAL . 80.1 mt-10 -58.45 117.47 4.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.805 . . . . 0.0 109.45 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.39 4.06 20.38 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -134.38 29.8 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.137 -1.213 . . . . 0.0 108.835 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.538 ' O ' HG22 ' A' ' 175' ' ' VAL . 84.1 mt-10 -63.87 -32.83 74.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 110.747 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.91 -17.46 6.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.069 -1.02 . . . . 0.0 110.832 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.2 -3.8 58.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.851 -1.155 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -125.55 -12.45 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.119 -0.988 . . . . 0.0 111.434 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -84.42 -29.48 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.305 -1.497 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.62 1.96 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.709 -1.244 . . . . 0.0 110.743 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.66 121.65 24.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 108.794 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.582 ' NE ' ' OG ' ' A' ' 102' ' ' SER . 4.4 mpt_? -88.22 149.15 24.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.83 -1.169 . . . . 0.0 109.832 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.8 t -54.14 166.3 0.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.336 -0.853 . . . . 0.0 109.057 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.74 177.4 9.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.768 -1.207 . . . . 0.0 109.963 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.626 ' SG ' ' C1A' ' A' ' 320' ' ' TUX . 0.8 OUTLIER -169.53 164.22 10.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.586 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.618 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 90.9 m-85 -104.3 145.22 30.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.565 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.682 ' HA ' HD12 ' A' ' 186' ' ' ILE . 18.1 p-10 -63.81 -18.24 63.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.881 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.618 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 4.5 p90 -81.1 -27.42 35.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.667 -1.271 . . . . 0.0 110.452 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 19.6 pt-20 -98.28 -15.17 19.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.888 -1.133 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.1 mt -56.47 -51.51 63.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.255 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 187' ' ' GLU . 2.9 mp0 -51.15 -52.73 41.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.549 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -52.5 -44.86 65.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.0 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.516 HD13 ' O1A' ' A' ' 320' ' ' TUX . 95.9 mt -63.94 -33.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.373 -0.829 . . . . 0.0 109.097 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -79.83 -25.37 40.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -82.25 -25.12 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.057 -1.027 . . . . 0.0 110.219 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.1 m -80.7 8.02 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 82.16 23.24 57.53 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.13 -1.034 . . . . 0.0 110.578 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 47.5 mt -125.6 164.5 20.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.16 -1.2 . . . . 0.0 109.922 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.443 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 76.42 19.59 78.0 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.216 -0.927 . . . . 0.0 111.552 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -68.71 -20.24 64.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.598 -1.531 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.03 -5.26 50.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.77 125.16 34.47 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.072 -1.252 . . . . 0.0 110.321 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -173.73 3.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.834 -0.804 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 200' ' ' LEU . 73.6 mt -91.56 -13.34 32.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 40.0 tttp -92.47 -1.4 57.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.507 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.48 11.92 1.91 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.27 114.54 6.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.826 HD21 HD23 ' A' ' 217' ' ' LEU . 17.0 tp -77.54 106.71 9.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -0.957 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.518 HG22 HD11 ' A' ' 186' ' ' ILE . 51.1 t -99.94 130.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.001 -1.062 . . . . 0.0 109.498 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD21 HD21 ' A' ' 217' ' ' LEU . 90.7 mt -111.58 149.67 31.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.855 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.4 150.6 16.87 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 207' ' ' GLY . 5.2 tttm -42.98 -27.23 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -1.171 . . . . 0.0 110.091 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 207' ' ' GLY . 3.3 p-10 -148.65 8.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.969 -1.082 . . . . 0.0 110.376 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -141.56 149.15 40.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.017 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.79 125.74 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -72.5 -54.63 8.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 110.47 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -55.85 131.64 72.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 109.804 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.38 -12.28 27.27 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.203 1.935 . . . . 0.0 112.184 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -88.09 -7.77 56.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.66 48.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.826 HD23 HD21 ' A' ' 204' ' ' LEU . 36.2 mt -85.64 138.95 31.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.545 -0.973 . . . . 0.0 109.85 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.516 ' CZ ' HH12 ' A' ' 178' ' ' ARG . 0.5 OUTLIER -64.83 -54.71 26.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 221' ' ' ASN . 18.2 m-85 -118.45 146.66 44.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -50.35 -12.5 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.614 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 219' ' ' TYR . 4.3 m-20 -135.89 27.86 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 109.454 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.1 OUTLIER -56.05 -42.65 97.24 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -179.132 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 22.8 Cg_exo -61.58 -45.44 17.74 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.229 1.953 . . . . 0.0 112.924 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.452 ' H ' HG22 ' A' ' 224' ' ' VAL . 7.4 m -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 120.717 -1.24 . . . . 0.0 108.381 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 11.2 mtt85 -66.79 -40.79 88.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.56 -42.25 95.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 tptp -56.8 -45.62 82.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.01 . . . . 0.0 108.671 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.557 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 77.4 t80 -54.98 -41.95 71.83 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -71.38 -38.12 71.54 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.729 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.633 HD23 ' CG1' ' A' ' 149' ' ' VAL . 27.3 tp -56.72 -35.62 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.352 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.563 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 35.5 mt -72.67 -48.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.25 -32.73 14.19 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.91 -29.5 29.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.228 -1.16 . . . . 0.0 110.143 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.53 HD23 HG22 ' A' ' 260' ' ' VAL . 4.7 mt -78.58 -23.29 46.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.761 -1.212 . . . . 0.0 109.889 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.481 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 22.3 t80 -67.92 -7.27 27.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.138 -0.976 . . . . 0.0 108.815 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 237' ' ' LEU . 20.6 mt -50.06 -32.99 16.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.446 -0.784 . . . . 0.0 108.895 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.45 -12.49 1.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.061 -1.024 . . . . 0.0 109.085 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 73.75 17.13 79.14 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.7 p -157.17 144.94 13.99 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.963 -1.316 . . . . 0.0 109.677 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.66 133.27 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.199 1.932 . . . . 0.0 111.82 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.07 134.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.701 ' HB2' HG22 ' A' ' 125' ' ' VAL . 19.3 mmtp -121.24 125.23 46.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 109.448 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.75 167.54 18.88 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 148' ' ' GLU . 10.2 tttp -98.67 112.91 24.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.112 -1.228 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -112.18 148.45 34.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.015 0.912 . . . . 0.0 111.1 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -129.18 143.67 50.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 p -138.34 124.52 20.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.8 -1.188 . . . . 0.0 109.848 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 250' ' ' ARG . 1.5 t80 -112.96 112.1 23.32 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.7 OUTLIER 45.28 56.48 5.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -92.37 156.17 23.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.93 177.75 17.2 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.417 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 79.8 m-70 -66.01 -51.95 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.28 . . . . 0.0 109.552 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 49.1 p -54.53 -54.64 38.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.0 . . . . 0.0 109.117 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 134' ' ' ASP . 35.8 tp -51.33 -41.83 60.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.54 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -58.71 -55.04 40.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.021 . . . . 0.0 108.816 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.4 t -48.55 -41.25 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -54.93 -47.85 73.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 26.6 tp -52.81 -44.37 66.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.53 HG22 HD23 ' A' ' 235' ' ' LEU . 41.0 t -70.8 -41.66 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -58.9 -48.18 82.36 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 110.411 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.1 -35.19 76.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.053 -1.029 . . . . 0.0 109.57 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 263' ' ' LEU . 15.0 mt -69.66 -45.61 67.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.11 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.36 -32.79 74.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.715 -0.615 . . . . 0.0 110.27 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -78.81 -30.83 45.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.734 -1.229 . . . . 0.0 108.854 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -69.91 -46.25 65.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.226 -0.921 . . . . 0.0 109.201 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 269' ' ' LEU . 0.1 OUTLIER -72.44 7.27 1.89 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.833 . . . . 0.0 109.666 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -47.15 -15.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.1 -1.0 . . . . 0.0 109.431 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 267' ' ' GLN . 69.7 mt -67.62 -26.12 66.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.626 ' C1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.492 ' O ' HD11 ' A' ' 121' ' ' ILE . 2.3 mm? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.641 ' OE1' HG21 ' A' ' 85' ' ' THR . 8.0 mm-40 -49.44 135.13 18.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.232 -0.918 . . . . 0.0 109.044 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.35 135.46 53.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.519 -0.738 . . . . 0.0 109.889 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -137.26 171.42 14.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.7 m -81.94 130.21 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.94 -1.1 . . . . 0.0 109.964 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -59.29 -45.83 90.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.092 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -129.79 157.76 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.198 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 135.45 56.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 109.858 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 113' ' ' ASN . 80.0 mt -116.91 169.97 8.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.438 -0.789 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -154.04 147.08 24.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.062 . . . . 0.0 110.194 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -132.47 157.81 43.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.403 -0.811 . . . . 0.0 109.448 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.6 pm0 -151.78 136.82 17.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.37 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.2 161.85 20.31 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 17' ' ' GLY . 7.1 p -72.46 163.94 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.283 -1.128 . . . . 0.0 111.347 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.594 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -98.76 142.21 15.96 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.623 HG23 ' N ' ' A' ' 19' ' ' HIS . 15.7 tt -58.97 -52.11 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -1.169 . . . . 0.0 112.5 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.623 ' N ' HG23 ' A' ' 18' ' ' ILE . 7.2 m-70 -86.82 -38.73 16.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.245 -1.535 . . . . 0.0 111.702 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.542 HG22 ' HG3' ' A' ' 22' ' ' GLU . 2.5 m -73.97 -33.62 63.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 110.002 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.03 25.83 69.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.542 ' HG3' HG22 ' A' ' 20' ' ' THR . 2.7 mt-10 -117.72 154.34 31.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.534 -0.98 . . . . 0.0 108.596 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -73.72 137.1 43.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 0.0 110.195 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 t -142.35 156.22 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.731 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.8 tttt -132.26 156.57 46.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.0 mt -133.9 143.13 48.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.046 -1.033 . . . . 0.0 109.097 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.622 HG22 ' NE2' ' A' ' 29' ' ' HIS . 22.7 mt -130.8 128.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mt -116.01 129.89 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.069 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.622 ' NE2' HG22 ' A' ' 27' ' ' ILE . 1.5 m-70 -125.0 148.5 60.28 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.65 159.47 28.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.238 1.959 . . . . 0.0 111.618 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.4 mm-40 -132.39 -174.13 3.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' OG1' ' A' ' 35' ' ' THR . 69.0 tttt -90.87 155.5 18.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.587 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -50.61 149.23 3.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 110.236 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.7 61.34 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.689 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 87.1 m -81.49 -46.39 14.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.382 -1.658 . . . . 0.0 108.983 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.12 -165.49 18.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 85' ' ' THR . 4.6 mm -103.68 122.31 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.61 149.23 47.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.067 . . . . 0.0 110.608 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -107.84 150.96 26.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.5 t80 -131.04 137.48 49.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.014 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 ttpp -169.12 140.41 2.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.447 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.51 28.52 15.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.895 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.15 24.84 76.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.15 138.14 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.21 -1.17 . . . . 0.0 109.758 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 35.9 m-85 -97.13 134.27 40.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.187 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.6 mt -127.25 96.83 32.9 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.485 -0.759 . . . . 0.0 109.839 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -51.79 144.73 33.87 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.259 1.973 . . . . 0.0 111.654 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.2 79.35 7.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.19 149.54 52.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' VAL . 11.5 p-80 -52.0 -49.37 63.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.415 -0.803 . . . . 0.0 109.789 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' HIS . 18.8 mt-10 -44.89 -33.18 1.87 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.32 6.16 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 109.902 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 50' ' ' HIS . 3.5 t -63.73 130.81 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.131 -0.981 . . . . 0.0 109.071 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.9 m -115.68 -31.66 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.47 -0.769 . . . . 0.0 110.317 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.484 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -155.0 126.03 7.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 109.602 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 p -113.87 137.07 52.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.553 -0.717 . . . . 0.0 109.107 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -166.52 -154.58 0.18 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.498 ' O ' ' NXH' ' A' ' 320' ' ' TUX . 0.1 OUTLIER -50.39 -11.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 57' ' ' ASN . 40.6 m -134.8 165.75 24.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.608 -0.682 . . . . 0.0 109.294 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -103.28 121.57 42.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 0.0 109.229 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -118.14 135.67 54.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 111.192 -179.059 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' HG21 ' A' ' 72' ' ' VAL . 29.8 mt -122.04 162.46 21.15 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.56 144.29 5.81 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 118.35 -1.881 . . . . 0.0 111.147 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -144.68 151.18 38.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.721 -0.87 . . . . 0.0 109.506 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 mttp 57.48 23.83 9.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.704 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.68 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.331 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.496 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 97.4 mm-40 -97.55 143.83 27.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.311 . . . . 0.0 108.055 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.77 149.25 43.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.502 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.32 137.78 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.98 154.25 25.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.188 -0.945 . . . . 0.0 110.907 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 71' ' ' THR . 80.7 m 53.5 67.88 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.706 -0.621 . . . . 0.0 110.764 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 62' ' ' LEU . 23.5 m -113.15 -4.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 109.093 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.3 pt-20 -69.11 -33.49 73.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 110.333 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -61.57 -60.35 3.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 110.135 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.576 ' CD1' ' CD2' ' A' ' 106' ' ' PHE . 2.5 tp -56.98 -42.63 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.904 -1.122 . . . . 0.0 108.808 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' HG23 ' A' ' 75' ' ' ILE . 9.5 mt -59.36 -35.28 73.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.341 -0.85 . . . . 0.0 109.83 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.592 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 11.9 t -64.46 -51.15 64.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 109.902 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.3 t -55.74 -54.74 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 108.408 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -53.28 -44.74 68.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.616 -0.678 . . . . 0.0 109.421 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.426 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 3.2 t-160 -53.23 -41.41 65.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 HD13 ' A' ' 232' ' ' ILE . 16.9 mt -77.26 -35.85 54.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.674 HD22 ' CD1' ' A' ' 114' ' ' ILE . 10.3 mt -80.77 0.76 33.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.025 -1.047 . . . . 0.0 110.61 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 58.24 51.82 8.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.512 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 82' ' ' LEU . 19.9 mm -95.73 122.02 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 108.369 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.66 ' O ' HD13 ' A' ' 37' ' ' ILE . 8.3 p -101.88 -76.61 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 111.169 -178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.717 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.7 m-80 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.39 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.25 134.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.491 0.662 . . . . 0.0 109.555 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.486 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.7 m -105.92 100.54 10.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.14 104.49 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -80.49 124.17 28.7 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.2 t -106.21 111.88 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -92.46 108.92 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.15 -158.06 21.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.19 -11.46 10.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.586 -0.95 . . . . 0.0 110.233 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -145.81 150.1 35.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.85 -1.157 . . . . 0.0 110.858 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.52 125.13 91.8 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.638 -0.664 . . . . 0.0 109.623 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.657 ' CD ' HD21 ' A' ' 26' ' ' LEU . 72.6 Cg_exo -45.28 134.94 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.964 1.776 . . . . 0.0 112.37 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.02 -29.5 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.2 mt 56.77 -110.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.548 -0.72 . . . . 0.0 110.221 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -15.5 22.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.092 . . . . 0.0 111.464 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.49 -8.83 32.66 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.3 p -117.46 -170.74 1.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -1.048 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.87 -3.3 21.91 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -46.8 -39.84 12.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 110.744 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.41 -51.85 67.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.964 -1.085 . . . . 0.0 110.15 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CD2' ' CD1' ' A' ' 75' ' ' ILE . 92.6 m-85 -64.01 -43.78 94.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.024 -1.047 . . . . 0.0 108.779 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -61.51 -38.02 85.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.662 -0.649 . . . . 0.0 109.756 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -71.18 -46.72 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 111.591 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.06 15.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.709 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.7 -42.86 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 110.709 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.64 -31.69 57.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.912 -1.117 . . . . 0.0 109.348 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -83.09 -1.11 51.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.93 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' HB2' HD11 ' A' ' 11' ' ' LEU . 5.3 m120 -131.4 33.42 4.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.252 -0.905 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.674 ' CD1' HD22 ' A' ' 82' ' ' LEU . 11.2 mt -91.35 142.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.473 -1.392 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 115' ' ' LEU . 13.8 tp -131.56 162.83 29.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -108.01 146.03 33.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.921 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.587 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 10.7 mt-30 -111.23 -166.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 109.444 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 10.1 t-20 -116.66 70.83 0.77 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.4 -0.812 . . . . 0.0 110.304 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -166.36 143.59 5.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.192 -0.942 . . . . 0.0 109.305 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.73 130.04 35.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.715 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 3' ' ' LEU . 55.5 mt -70.77 140.36 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.683 . . . . 0.0 110.542 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.45 90.66 8.45 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -64.71 146.66 54.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 110.812 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.515 ' CE2' ' OE1' ' A' ' 267' ' ' GLN . 9.2 t80 -102.38 123.7 46.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.13 143.8 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.128 -0.982 . . . . 0.0 110.466 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 67.9 t -84.4 135.73 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.538 -0.726 . . . . 0.0 109.101 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -114.68 -10.47 12.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.233 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.443 ' OE1' ' CG2' ' A' ' 270' ' ' THR . 11.4 pt-20 -143.84 146.45 34.64 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.03 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.28 170.7 17.66 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.389 2.059 . . . . 0.0 113.403 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.728 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.7 tt -165.68 144.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.291 0.567 . . . . 0.0 109.793 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 131' ' ' ILE . 1.4 mt -130.64 122.28 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.5 111.92 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.354 -0.841 . . . . 0.0 109.634 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -115.87 128.6 55.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -172.39 152.2 2.66 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.959 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB2' ' HE ' ' A' ' 137' ' ' ARG . 33.7 mm-40 56.8 22.19 6.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.641 -0.662 . . . . 0.0 110.766 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.54 -0.21 89.42 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.587 ' HB2' HD22 ' A' ' 255' ' ' LEU . 21.2 mtm180 -100.5 171.8 7.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -1.143 . . . . 0.0 107.984 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.917 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.67 146.57 14.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.429 -1.419 . . . . 0.0 109.249 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.917 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.5 mt -147.24 133.27 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 108.671 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -123.78 138.44 54.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 0.0 109.666 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.68 144.59 48.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.5 -0.75 . . . . 0.0 109.105 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 11.4 tm-20 -141.59 135.39 14.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 5.9 Cg_endo -52.82 148.12 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.39 1.393 . . . . 0.0 112.05 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.69 150.87 10.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -79.6 0.8 28.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.5 p -138.43 170.42 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.622 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 30.6 tp -99.88 119.2 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 109.519 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -139.52 137.93 35.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.542 ' CG1' HD23 ' A' ' 231' ' ' LEU . 57.3 t -137.9 125.67 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 m -112.88 140.93 47.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.537 ' CE2' HG12 ' A' ' 224' ' ' VAL . 9.9 t80 -126.72 131.39 51.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 106.06 13.51 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.83 158.37 17.8 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 115.66 15.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -1.057 . . . . 0.0 109.148 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.11 148.75 41.27 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.431 -0.793 . . . . 0.0 109.876 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -93.05 -7.02 46.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 109.93 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.853 HD21 HD12 ' A' ' 159' ' ' LEU . 20.5 p-10 -75.06 -169.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.011 . . . . 0.0 109.972 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -58.83 -21.22 56.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 110.152 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.853 HD12 HD21 ' A' ' 157' ' ' ASN . 6.9 mt -64.76 -54.26 34.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.017 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.06 -131.74 10.69 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -101.37 142.68 32.41 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.235 -1.156 . . . . 0.0 109.517 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -148.67 150.37 33.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.199 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -136.74 147.55 46.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.805 . . . . 0.0 109.323 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -136.06 122.5 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 165' ' ' THR . 14.2 t -98.26 120.77 39.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.994 -1.066 . . . . 0.0 109.658 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -95.05 140.44 29.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.232 -0.918 . . . . 0.0 109.44 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.94 150.08 23.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.289 -0.882 . . . . 0.0 109.707 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 96.6 mt-10 -55.59 117.64 3.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.888 . . . . 0.0 109.368 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.86 4.97 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -134.87 30.27 3.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.142 -1.21 . . . . 0.0 108.958 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.99 -28.64 69.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 110.132 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -57.42 -14.5 4.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.162 -0.962 . . . . 0.0 110.789 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -96.21 -4.35 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.134 . . . . 0.0 110.941 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.414 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -118.98 3.48 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 110.906 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.02 -31.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.804 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.4 2.68 55.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.997 -1.064 . . . . 0.0 110.571 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.25 118.34 21.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.736 -1.228 . . . . 0.0 108.751 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.25 152.09 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.942 -1.099 . . . . 0.0 110.166 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 t -59.11 133.05 55.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.555 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 25.4 p90 -115.03 165.77 12.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.482 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -159.65 161.23 34.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.496 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 42.7 m-85 -103.03 145.15 30.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.052 -1.03 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.741 ' HA ' HD12 ' A' ' 186' ' ' ILE . 4.1 p-10 -63.12 -17.85 62.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.206 -0.934 . . . . 0.0 111.708 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.668 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.2 p90 -81.61 -38.32 26.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.362 -1.461 . . . . 0.0 111.183 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.668 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -86.85 -14.44 42.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.596 -1.315 . . . . 0.0 109.817 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.8 mt -53.91 -48.15 63.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.144 -0.973 . . . . 0.0 109.893 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.24 -51.35 54.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.103 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -47.04 67.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 186' ' ' ILE . 30.0 mt -60.77 -34.7 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 109.183 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -78.91 -25.92 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.842 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -75.25 -28.45 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.6 m -81.49 10.66 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.101 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.37 72.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.0 mt -120.84 159.2 25.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.596 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.469 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.1 27.58 57.86 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.435 ' NZ ' ' CB ' ' A' ' 196' ' ' LYS . 8.0 mtpm? -71.03 -20.59 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.765 -1.432 . . . . 0.0 109.314 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.29 -1.34 50.86 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.75 126.94 38.21 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.695 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.6 p -140.74 172.02 13.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.716 -0.873 . . . . 0.0 109.114 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.79 -3.56 45.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.979 . . . . 0.0 109.642 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.482 ' C ' ' ND2' ' A' ' 202' ' ' ASN . 80.5 tttt -97.88 -10.55 24.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.425 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.482 ' ND2' ' C ' ' A' ' 201' ' ' LYS . 0.7 OUTLIER -135.18 -9.36 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 109.486 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.432 HG22 ' SG ' ' A' ' 181' ' ' CYS . 3.0 m -126.89 115.04 18.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.713 . . . . 0.0 109.586 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 205' ' ' VAL . 4.9 tp -74.0 114.64 12.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.481 ' N ' HD12 ' A' ' 204' ' ' LEU . 64.8 t -105.31 127.08 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.048 -1.033 . . . . 0.0 109.854 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 11.1 mt -104.29 151.67 23.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.09 150.74 17.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 26.4 ttpt -41.02 -29.4 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -1.123 . . . . 0.0 109.961 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.5 OUTLIER -149.41 17.47 0.93 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 110.339 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 7.4 tttp -151.26 161.88 41.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.054 -1.029 . . . . 0.0 110.122 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.24 129.88 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.08 -54.31 8.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.137 -0.977 . . . . 0.0 109.92 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -54.64 134.22 64.3 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.909 -1.12 . . . . 0.0 109.329 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.81 -9.67 25.17 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.235 1.957 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.32 -7.96 52.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.066 -1.021 . . . . 0.0 109.751 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.18 -165.01 51.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.9 mt -88.66 145.24 25.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.5 -1.0 . . . . 0.0 109.935 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.566 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.7 mmt180 -87.76 -17.02 32.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.465 -0.772 . . . . 0.0 109.558 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 27.0 m-85 -144.17 143.97 31.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.01 -19.79 54.43 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.427 ' HB2' ' HE ' ' A' ' 225' ' ' ARG . 16.5 m-20 -126.96 35.67 4.56 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -60.05 -40.62 79.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.538 -0.726 . . . . 0.0 110.607 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.11 -47.98 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.43 2.087 . . . . 0.0 112.641 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.1 OUTLIER -72.88 -23.09 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.757 -1.214 . . . . 0.0 108.696 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' A' ' 221' ' ' ASN . 11.2 mtt180 -68.74 -44.64 73.34 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -60.13 -43.02 96.01 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.83 -42.18 79.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.092 -1.005 . . . . 0.0 109.071 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.0 t -63.94 -49.31 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.592 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.8 t80 -50.22 -40.33 47.13 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.794 0.807 . . . . 0.0 108.896 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.0 m-20 -69.68 -44.57 70.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.635 -0.666 . . . . 0.0 110.178 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.542 HD23 ' CG1' ' A' ' 149' ' ' VAL . 50.7 tp -56.64 -38.72 72.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.111 -0.993 . . . . 0.0 109.154 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.42 HD13 HD21 ' A' ' 81' ' ' LEU . 71.8 mt -68.04 -33.44 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.12 -31.97 79.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.589 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -81.78 -25.49 35.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -1.126 . . . . 0.0 109.912 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.07 -24.52 55.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.795 -1.191 . . . . 0.0 110.698 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.463 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -65.38 -5.22 6.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.355 -1.466 . . . . 0.0 108.013 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 237' ' ' LEU . 35.4 mt -55.08 -23.7 21.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.848 -1.158 . . . . 0.0 108.929 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 242' ' ' VAL . 72.1 mt -68.17 -21.47 64.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.005 . . . . 0.0 109.186 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.76 12.05 67.16 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 21.4 p -158.2 143.99 12.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.144 -1.209 . . . . 0.0 109.578 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 78.0 Cg_exo -42.42 135.66 4.39 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.263 1.975 . . . . 0.0 112.153 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.474 ' O ' HD13 ' A' ' 147' ' ' LEU . 76.0 t -98.46 133.03 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.944 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -122.41 127.81 50.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.613 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.0 178.93 28.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -105.93 112.2 25.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -1.207 . . . . 0.0 109.968 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -112.36 148.19 34.8 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.03 0.919 . . . . 0.0 111.125 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -129.89 144.42 51.31 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -139.09 128.81 24.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.732 -1.23 . . . . 0.0 110.722 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.0 t80 -110.67 113.07 25.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 249' ' ' PHE . 42.1 mtm180 48.51 55.48 8.91 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.18 135.31 22.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.414 ' HA3' HH11 ' A' ' 137' ' ' ARG . . . -109.78 151.2 17.38 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.1 m-70 -49.05 -46.12 43.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -1.205 . . . . 0.0 109.547 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -55.29 35.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 109.413 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 137' ' ' ARG . 56.7 tp -51.99 -38.14 55.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -58.64 -55.48 34.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.036 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.42 -42.94 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.754 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.58 -48.89 74.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.089 -1.007 . . . . 0.0 109.087 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.679 HD22 HG21 ' A' ' 139' ' ' ILE . 37.9 tp -52.79 -42.02 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 108.772 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.9 t -72.11 -40.17 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -58.91 -51.36 70.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.388 -0.82 . . . . 0.0 110.136 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.79 -44.74 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 109.879 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 263' ' ' LEU . 72.8 mt -63.5 -44.16 95.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.248 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.28 86.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.498 -0.751 . . . . 0.0 110.368 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -81.83 -35.29 29.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.773 -1.204 . . . . 0.0 108.868 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.459 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 38.0 mtpt -70.31 -45.25 66.64 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.515 ' OE1' ' CE2' ' A' ' 124' ' ' PHE . 3.2 tt0 -41.14 -29.42 0.12 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.65 -0.656 . . . . 0.0 110.455 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -99.51 -71.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.207 . . . . 0.0 109.719 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.85 -41.85 34.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 109.412 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' THR . . . . . 0.443 ' CG2' ' OE1' ' A' ' 128' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.498 ' NXH' ' O ' ' A' ' 58' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 117' ' ' GLN . 3.3 mm? . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.244 0.545 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 119' ' ' ARG . 8.0 mm-40 -45.61 129.65 8.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.342 -0.849 . . . . 0.0 108.798 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.485 ' HD3' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -109.63 126.85 54.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 115' ' ' LEU . 6.1 t -130.44 169.37 15.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 7' ' ' VAL . 6.7 m -83.87 137.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.034 -1.042 . . . . 0.0 110.317 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG3' HD13 ' A' ' 115' ' ' LEU . 28.4 ttmt -67.6 -45.57 75.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.472 -0.767 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CB ' ' OD1' ' A' ' 113' ' ' ASN . 2.8 tt0 -132.27 156.1 47.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.26 -0.9 . . . . 0.0 110.511 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 133.01 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.728 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.87 165.42 14.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 109.192 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 p -156.65 150.3 24.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.57 161.68 33.23 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.46 134.73 24.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.893 -1.13 . . . . 0.0 108.857 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.04 155.34 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.33 160.66 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.18 . . . . 0.0 111.208 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.65 136.29 13.44 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.604 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.4 tt -53.42 -53.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -1.161 . . . . 0.0 111.657 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.604 ' N ' HG23 ' A' ' 18' ' ' ILE . 5.2 m-70 -87.54 -36.78 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.275 -1.516 . . . . 0.0 111.191 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.4 m -71.31 -35.42 71.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.57 65.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -111.77 150.85 29.7 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.667 -0.902 . . . . 0.0 108.86 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.2 t80 -70.25 128.92 37.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.597 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 12.1 t -135.94 157.47 46.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 109.143 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 26' ' ' LEU . 4.0 ttmt -135.6 147.2 48.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -0.895 . . . . 0.0 109.307 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.535 HD11 ' HD2' ' A' ' 97' ' ' PRO . 6.4 mt -119.65 145.99 45.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.096 -1.003 . . . . 0.0 108.838 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.9 mt -135.05 126.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mt -113.08 129.1 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.223 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -128.44 148.75 69.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.54 160.37 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.278 1.986 . . . . 0.0 111.835 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 6.0 mm-40 -134.76 -172.82 3.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.902 . . . . 0.0 109.837 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' OG1' ' A' ' 35' ' ' THR . 54.1 tttm -84.44 149.59 25.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.632 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 mp0 -47.46 145.42 2.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.991 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.68 25.2 63.14 Favored Glycine 0 N--CA 1.493 2.465 0 O-C-N 121.47 -0.769 . . . . 0.0 111.825 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 45.4 m -80.98 -44.58 17.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.546 -1.561 . . . . 0.0 108.951 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.48 -166.55 16.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.605 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.5 mm -103.73 125.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.313 -1.11 . . . . 0.0 108.073 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.12 139.64 30.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.162 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.56 152.69 18.2 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 4.1 t80 -135.03 141.26 46.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.609 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 146.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.312 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.07 29.31 14.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.31 23.11 73.25 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.28 133.88 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -1.202 . . . . 0.0 109.51 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -94.41 142.45 27.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.823 . . . . 0.0 109.169 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 46' ' ' ILE . 29.4 mt -135.09 94.39 16.09 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -49.26 144.88 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.342 2.028 . . . . 0.0 111.654 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.44 84.32 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.95 -1.094 . . . . 0.0 110.667 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.28 154.57 49.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.556 ' O ' HG23 ' A' ' 53' ' ' VAL . 8.7 p-80 -51.39 -48.15 62.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 109.732 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -46.77 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.0 m-85 -95.35 1.88 54.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 109.762 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 50' ' ' HIS . 54.1 t -55.22 127.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.036 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 52' ' ' PHE . 32.2 m -117.42 -32.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 109.861 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -151.32 119.28 6.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 p -114.36 127.82 56.04 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.603 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.9 t-20 -167.16 -152.98 0.14 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' ASN . 12.2 m-70 -44.37 -16.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.9 t -136.77 165.6 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.491 -0.755 . . . . 0.0 109.326 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 m -110.61 125.71 53.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 150.42 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.26 -0.9 . . . . 0.0 111.178 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' CD1' HG21 ' A' ' 72' ' ' VAL . 34.4 mt -130.15 159.01 38.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.73 146.68 8.02 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.306 -1.902 . . . . 0.0 111.538 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -144.09 148.87 35.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.644 -0.916 . . . . 0.0 109.309 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.1 mttt 59.1 30.62 20.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.262 -0.899 . . . . 0.0 110.75 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.24 4.72 90.11 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.486 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 16.7 mm100 -103.93 139.94 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -1.234 . . . . 0.0 108.094 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -141.71 157.52 44.95 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.704 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.2 mt -133.77 147.26 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -114.21 150.52 34.16 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.153 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 55.05 71.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.666 -0.646 . . . . 0.0 110.995 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 62' ' ' LEU . 19.5 m -113.97 -17.41 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.438 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.601 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -61.18 -16.81 48.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.441 -179.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.601 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 7.8 m170 -73.18 -61.39 1.84 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.833 -1.167 . . . . 0.0 109.832 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -58.15 -41.62 81.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.819 -1.175 . . . . 0.0 108.338 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 79' ' ' LEU . 98.0 mt -56.4 -38.28 71.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 109.466 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.569 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.2 t -61.44 -49.23 77.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.13 -53.07 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 108.515 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 76' ' ' LEU . 20.2 mt -51.73 -44.62 63.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.492 ' HD1' HG22 ' A' ' 232' ' ' ILE . 10.6 t-160 -56.16 -49.34 74.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.1 -1.0 . . . . 0.0 110.401 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.49 -37.89 85.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.685 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.58 ' CB ' HD11 ' A' ' 84' ' ' ILE . 50.2 mt -86.66 -5.43 59.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.913 -1.117 . . . . 0.0 111.151 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 82' ' ' LEU . 1.0 OUTLIER 62.69 63.0 1.03 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.731 -1.231 . . . . 0.0 110.426 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.605 ' O ' HD11 ' A' ' 37' ' ' ILE . 4.6 mm -98.44 129.68 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.585 ' O ' HD13 ' A' ' 37' ' ' ILE . 72.9 p -107.63 -78.21 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.041 -1.037 . . . . 0.0 110.509 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.702 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.5 m-80 -81.34 113.27 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.005 -1.059 . . . . 0.0 111.137 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.9 m -163.71 131.79 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.546 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.5 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 51.4 m -104.25 100.88 10.6 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.38 103.02 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' OE2' ' CD1' ' A' ' 40' ' ' PHE . 4.0 mt-10 -76.32 122.97 25.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.989 -1.069 . . . . 0.0 108.782 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.06 110.29 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.45 108.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.7 -167.15 24.91 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.16 -15.31 14.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.365 -1.08 . . . . 0.0 109.861 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.5 tt0 -143.71 148.68 36.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 110.034 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -68.2 128.36 93.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.456 -0.777 . . . . 0.0 109.282 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.535 ' HD2' HD11 ' A' ' 26' ' ' LEU . 76.6 Cg_exo -44.19 130.35 8.49 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.047 1.831 . . . . 0.0 112.116 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 18' ' ' ILE . 10.9 tp -76.33 -20.31 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.074 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.464 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 6.2 mt 47.57 -116.19 0.72 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.277 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.16 -10.05 31.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.483 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.27 -5.07 57.3 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.4 p -117.14 -171.38 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.454 -1.027 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.9 -6.14 16.97 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -47.71 -40.1 19.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.65 -0.912 . . . . 0.0 110.805 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.83 -52.06 65.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.931 -1.105 . . . . 0.0 109.828 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.4 m-85 -60.62 -43.93 96.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.012 -1.055 . . . . 0.0 108.379 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.503 ' CD2' HG11 ' A' ' 175' ' ' VAL . 12.3 t80 -60.88 -39.76 90.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.517 0.675 . . . . 0.0 110.051 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.89 -47.97 60.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 112.059 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 -51.19 14.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.749 -1.219 . . . . 0.0 111.105 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.49 -42.81 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -56.49 -29.54 61.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.945 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -81.23 -15.4 55.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.066 . . . . 0.0 110.453 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' CB ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -119.84 32.25 6.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.265 -0.897 . . . . 0.0 111.044 -178.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.402 HG12 ' NZ ' ' A' ' 5' ' ' LYS . 5.7 mt -80.75 146.69 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.653 -1.28 . . . . 0.0 110.929 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' HB3' HG23 ' A' ' 6' ' ' THR . 13.7 tp -132.09 162.63 30.35 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -123.49 146.6 47.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.235 -0.916 . . . . 0.0 110.446 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.755 ' O ' HD12 ' A' ' 3' ' ' LEU . 4.9 mt-30 -107.75 -157.5 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -0.789 . . . . 0.0 109.245 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 42.2 p-10 -118.82 1.72 11.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.011 -1.056 . . . . 0.0 112.124 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 4' ' ' GLU . 3.3 ttm180 -102.24 122.02 43.4 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.573 -1.329 . . . . 0.0 110.237 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -56.73 142.97 38.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.258 -0.901 . . . . 0.0 109.999 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.47 HG23 HG21 ' A' ' 85' ' ' THR . 1.9 mt -81.19 145.55 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 0.0 110.481 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.58 84.43 7.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -60.72 146.06 47.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 110.552 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.533 ' CZ ' ' CD ' ' A' ' 267' ' ' GLN . 12.4 t80 -101.22 120.15 39.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 243' ' ' LYS . 20.9 t -122.72 138.84 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 109.878 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.2 140.0 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.192 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -119.7 -8.63 9.89 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.429 ' OE2' HD11 ' A' ' 269' ' ' LEU . 0.9 OUTLIER -141.19 146.17 41.77 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.42 -0.8 . . . . 0.0 109.072 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.52 177.21 8.97 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.219 1.946 . . . . 0.0 113.08 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.793 HG22 ' HB3' ' A' ' 141' ' ' ALA . 8.4 tt -165.25 144.78 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.622 -0.674 . . . . 0.0 109.574 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -129.03 123.61 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.59 122.1 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.426 ' OE1' ' C ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.35 132.02 56.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 17.2 t0 -174.21 157.8 2.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.261 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 44.2 mt-10 57.71 19.93 5.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.676 -0.64 . . . . 0.0 110.773 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.04 4.58 88.84 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -114.07 177.63 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.899 HD23 ' N ' ' A' ' 139' ' ' ILE . 10.1 tt -157.77 161.09 38.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.351 -1.468 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.899 ' N ' HD23 ' A' ' 138' ' ' LEU . 18.6 mt -149.8 144.97 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.952 . . . . 0.0 108.492 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -132.4 140.17 48.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.627 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.793 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.69 140.86 51.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 108.998 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.56 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 13.8 tm-20 -137.64 126.55 14.81 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.45 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 88.6 Cg_exo -46.39 152.48 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.563 1.509 . . . . 0.0 112.435 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.05 159.57 6.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -91.79 -0.29 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 p -132.85 146.41 51.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.444 -0.785 . . . . 0.0 109.166 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.431 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 19.9 tp -81.38 117.22 21.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.133 -0.979 . . . . 0.0 109.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.07 135.1 39.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.731 ' CG1' HD23 ' A' ' 231' ' ' LEU . 67.5 t -135.98 117.65 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.516 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.3 m -107.92 134.15 51.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -121.51 130.6 53.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -112.31 110.55 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.55 152.84 17.53 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.46 96.11 2.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.436 -1.038 . . . . 0.0 109.138 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.482 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 3.5 m-85 -98.98 148.72 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.578 -0.701 . . . . 0.0 110.126 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -85.38 -3.72 58.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.484 -0.76 . . . . 0.0 109.864 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CB ' ' A' ' 155' ' ' PHE . 11.5 p30 -76.93 -167.64 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.915 -1.115 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -58.0 -22.01 47.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.039 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.38 -54.73 43.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.834 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.13 -111.71 3.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -124.84 137.18 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -1.112 . . . . 0.0 109.076 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -155.32 139.33 16.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.377 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.546 ' CB ' ' NZ ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -127.69 153.73 46.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 109.169 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.496 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 86.4 t80 -135.17 116.88 14.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 165' ' ' THR . 5.0 t -92.47 120.1 32.62 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.157 -0.964 . . . . 0.0 109.376 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.74 138.38 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.561 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -135.77 153.55 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.0 109.45 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 22.5 mt-10 -57.22 122.82 13.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.476 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.49 -7.05 20.59 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.14 32.65 4.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -1.14 . . . . 0.0 108.768 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -66.56 -30.64 70.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.797 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -58.53 -13.6 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.015 . . . . 0.0 110.877 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.26 -4.44 54.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.915 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.39 3.75 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.16 -0.963 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.503 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -96.77 -32.64 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.797 -1.189 . . . . 0.0 109.934 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.55 0.17 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.978 -1.076 . . . . 0.0 110.536 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.34 117.42 18.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.798 -1.188 . . . . 0.0 108.29 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.477 HH12 ' C ' ' A' ' 201' ' ' LYS . 11.2 ttm180 -86.08 148.83 25.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 0.0 110.26 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.4 t -62.55 134.9 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 109.012 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.16 179.74 3.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 110.582 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.564 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.6 OUTLIER -164.93 161.32 20.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.578 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.2 m-85 -104.52 144.21 31.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.672 ' HA ' HD12 ' A' ' 186' ' ' ILE . 7.5 p-10 -62.64 -19.27 63.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.689 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.587 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -81.44 -31.46 33.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.755 -1.216 . . . . 0.0 110.534 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.587 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 6.4 pt-20 -91.79 -14.96 28.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.836 -1.165 . . . . 0.0 109.513 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 183' ' ' ASP . 6.8 mt -57.42 -52.02 62.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -50.64 -52.39 40.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.912 -1.117 . . . . 0.0 109.92 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -45.62 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.914 -1.116 . . . . 0.0 109.166 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.3 -33.43 61.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 109.079 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -80.52 -26.79 37.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -79.43 -21.13 45.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 110.03 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.3 13.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.752 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.82 24.46 67.0 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.788 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.0 mt -123.9 163.5 21.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.118 -1.225 . . . . 0.0 109.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 77.37 21.92 71.71 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -68.63 -21.31 64.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.83 -1.394 . . . . 0.0 109.735 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.68 -5.37 51.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.08 125.75 38.78 Favored Glycine 0 N--CA 1.49 2.263 0 O-C-N 121.242 -1.152 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.28 165.1 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.713 -0.875 . . . . 0.0 109.314 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.98 -8.06 50.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.504 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.477 ' C ' HH12 ' A' ' 178' ' ' ARG . 23.5 tttp -93.44 -5.61 48.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 53.8 m-20 -143.54 14.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.719 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.8 m -151.65 119.1 6.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.519 HD21 ' CD2' ' A' ' 217' ' ' LEU . 24.3 tp -80.4 109.81 15.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.133 -0.979 . . . . 0.0 108.893 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.4 t -98.11 128.56 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.9 mt -110.79 148.41 32.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.896 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.27 156.29 16.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 207' ' ' GLY . 1.6 ttpt -42.9 -30.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.912 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.7 13.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.166 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 207' ' ' GLY . 33.1 mttt -139.23 147.26 41.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.037 -1.04 . . . . 0.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.99 127.05 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.602 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 31.2 m-85 -72.91 -54.31 9.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 110.061 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.39 132.42 81.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.926 -1.109 . . . . 0.0 109.44 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.4 -11.5 26.62 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.885 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -90.38 -8.72 49.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.969 -1.082 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.24 -167.94 45.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.519 ' CD2' HD21 ' A' ' 204' ' ' LEU . 21.2 mt -78.62 141.84 37.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.449 -1.03 . . . . 0.0 109.766 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.584 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.1 tpp180 -79.57 -13.06 59.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 34.3 m-85 -148.24 152.79 37.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 108.899 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.621 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 11.6 mp0 -59.25 -19.12 43.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 108.423 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 37.25 3.02 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.621 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.5 OUTLIER -59.91 -38.18 57.36 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.605 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.27 -46.45 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.158 1.906 . . . . 0.0 112.295 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 228' ' ' VAL . 6.1 m -74.45 -23.99 18.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.776 -1.202 . . . . 0.0 108.25 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 164' ' ' PHE . 44.9 mtt180 -68.24 -43.21 78.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -61.06 -41.76 97.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -57.49 -43.4 84.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.966 -1.083 . . . . 0.0 108.753 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 224' ' ' VAL . 28.2 t -60.84 -45.14 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.569 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 75.6 t80 -55.87 -40.56 73.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 1.1 m-20 -73.71 -37.8 65.04 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.612 -0.68 . . . . 0.0 109.597 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.731 HD23 ' CG1' ' A' ' 149' ' ' VAL . 28.4 tp -56.23 -34.86 66.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.492 HG22 ' HD1' ' A' ' 80' ' ' HIS . 61.0 mt -73.28 -47.93 44.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.66 -34.66 21.44 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.482 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 1.0 OUTLIER -81.59 -27.6 34.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -1.196 . . . . 0.0 109.95 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.649 HD23 HG22 ' A' ' 260' ' ' VAL . 6.6 mt -80.46 -20.92 42.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.796 -1.19 . . . . 0.0 109.631 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -73.1 -9.22 58.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.288 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.409 ' C ' ' N ' ' A' ' 239' ' ' GLY . 67.9 mt -53.5 -28.2 29.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 108.879 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 242' ' ' VAL . 65.4 mt -55.3 -12.21 0.97 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 108.895 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 77.65 12.26 84.66 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 30.2 p -158.52 147.61 14.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.946 -1.326 . . . . 0.0 109.857 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.9 133.78 5.61 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.283 1.988 . . . . 0.0 112.081 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 238' ' ' LEU . 42.5 t -100.32 129.03 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.435 ' HB3' HG13 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -116.92 123.54 47.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.38 -0.825 . . . . 0.0 109.807 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.35 173.08 26.3 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.56 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -103.14 111.93 24.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.189 -1.183 . . . . 0.0 109.463 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.6 m-85 -112.5 148.26 34.81 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.111 0.958 . . . . 0.0 111.456 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 139' ' ' ILE . 19.4 t80 -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 t -131.79 128.13 38.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.86 -1.15 . . . . 0.0 110.043 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.55 ' O ' ' N ' ' A' ' 251' ' ' GLY . 1.6 t80 -109.49 117.88 35.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.538 -0.726 . . . . 0.0 109.16 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 42.83 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 111.03 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -64.03 172.55 15.82 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.595 -1.316 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -138.91 -169.2 11.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.783 ' O ' HG23 ' A' ' 257' ' ' VAL . 96.6 m-70 -65.66 -52.37 52.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.131 . . . . 0.0 110.008 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -42.5 68.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.71 -36.13 67.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.968 -1.082 . . . . 0.0 109.009 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.8 m-20 -63.59 -44.41 94.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 108.605 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 253' ' ' HIS . 17.0 t -57.12 -45.04 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 108.844 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -55.18 -47.3 75.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.118 -0.989 . . . . 0.0 108.844 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 17.7 tp -53.52 -44.96 69.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.374 -0.828 . . . . 0.0 109.034 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.649 HG22 HD23 ' A' ' 235' ' ' LEU . 54.9 t -69.57 -43.45 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -48.24 77.37 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -68.01 -39.5 83.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.643 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.2 mt -65.0 -44.85 87.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.76 74.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -86.89 -30.67 21.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.764 -1.21 . . . . 0.0 109.302 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 268' ' ' LYS . 66.2 mttt -73.39 -43.47 60.47 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.266 -0.896 . . . . 0.0 109.129 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.533 ' CD ' ' CZ ' ' A' ' 124' ' ' PHE . 3.9 tt0 -62.45 1.09 0.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.487 -0.758 . . . . 0.0 109.921 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -83.12 33.5 0.45 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 0.0 109.329 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.429 HD11 ' OE2' ' A' ' 128' ' ' GLU . 15.3 mt -72.22 -9.07 57.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 0.0 109.595 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 109.406 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.602 HEA1 ' CE2' ' A' ' 212' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.743 ' C ' HD11 ' A' ' 121' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 25.5 mt-10 -40.93 143.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.86 . . . . 0.0 109.678 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -119.9 140.09 51.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.595 -0.691 . . . . 0.0 109.412 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 t -139.14 178.5 7.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.23 -0.919 . . . . 0.0 109.085 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -83.59 151.05 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.8 -1.188 . . . . 0.0 109.75 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.31 -37.62 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.475 -0.766 . . . . 0.0 110.063 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.52 157.76 46.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 133.08 54.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.357 0.598 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 11' ' ' LEU . 28.1 mt -123.58 159.22 29.68 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -157.26 150.84 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.11 -0.994 . . . . 0.0 110.51 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 169.01 18.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.563 -0.711 . . . . 0.0 109.718 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.69 137.89 21.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.071 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.75 157.26 14.92 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.6 HG23 ' C ' ' A' ' 22' ' ' GLU . 9.8 p -79.29 140.29 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.179 -1.189 . . . . 0.0 110.752 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.94 144.09 37.48 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.5 tt -59.63 -49.11 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -1.102 . . . . 0.0 112.459 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.548 ' CD2' ' OE2' ' A' ' 95' ' ' GLU . 9.6 m-70 -86.52 -38.24 17.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.003 -1.685 . . . . 0.0 111.071 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -67.52 -37.81 83.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.71 21.94 71.41 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' C ' HG23 ' A' ' 16' ' ' VAL . 3.1 tp10 -119.16 154.43 33.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.724 -0.868 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -70.88 133.67 46.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.9 t -142.63 157.25 44.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 108.883 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -126.41 160.47 30.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.232 -0.918 . . . . 0.0 110.01 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 HG23 ' A' ' 96' ' ' ILE . 12.1 mt -127.75 142.15 51.39 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' CD2' ' A' ' 29' ' ' HIS . 8.7 mt -137.26 127.21 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 108.838 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.51 121.24 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.732 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.503 ' CD2' HG22 ' A' ' 27' ' ' ILE . 16.3 m-70 -119.34 149.01 46.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.83 160.78 35.42 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.082 1.854 . . . . 0.0 110.732 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 56.7 mm-40 -136.4 -172.51 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.062 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.3 ttpm? -86.31 153.27 22.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 109.355 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -47.11 143.34 3.17 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 110.291 -179.297 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 60.08 30.5 70.48 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.384 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.5 m -80.96 -35.83 31.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.592 -1.534 . . . . 0.0 108.584 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.852 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 91.67 179.54 42.01 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -95.43 122.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.279 -1.13 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.4 144.81 46.75 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.773 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 52.1 m-85 -102.57 152.73 20.82 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.5 t80 -131.45 141.63 49.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 108.912 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -173.4 138.11 0.69 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.372 -0.83 . . . . 0.0 108.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.8 28.79 17.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.158 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.28 27.63 71.34 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 120.783 -1.198 . . . . 0.0 110.168 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.78 137.83 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -1.227 . . . . 0.0 109.956 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -96.63 135.3 38.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.6 mt -128.79 99.25 23.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.82 142.58 18.86 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.62 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . . . -92.83 84.5 4.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 110.548 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -141.6 157.91 44.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 109.393 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.54 ' O ' ' N ' ' A' ' 52' ' ' PHE . 14.0 p-80 -54.83 -49.14 71.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -44.9 -16.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.13 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.6 m-85 -96.83 5.89 49.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.971 -1.081 . . . . 0.0 109.891 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -60.01 124.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.163 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.86 -30.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -0.877 . . . . 0.0 109.849 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.507 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -153.56 121.95 6.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 0.0 109.475 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -114.07 133.72 55.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.618 -0.676 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.9 t-20 -166.79 -154.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.432 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 12.0 m-70 -48.08 -12.59 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.897 -1.127 . . . . 0.0 108.294 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' ASN . 84.5 p -135.32 165.26 25.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.441 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 6.4 m -106.32 124.13 49.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -0.909 . . . . 0.0 108.998 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.507 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.04 137.74 54.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 111.381 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 72' ' ' VAL . 18.7 mt -127.73 159.15 35.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 178.17 151.86 9.76 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.379 -1.867 . . . . 0.0 111.667 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -144.94 152.2 39.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.98 -0.718 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.1 mttt 59.62 24.3 13.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.342 -0.849 . . . . 0.0 110.755 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.53 83.09 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.531 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.441 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 87.6 mm-40 -109.87 133.4 53.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 108.061 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.79 165.17 27.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.892 -1.13 . . . . 0.0 111.838 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mt -134.77 148.55 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -114.61 150.72 34.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m 55.32 69.32 0.75 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 110.724 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -113.22 -12.97 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.975 -1.078 . . . . 0.0 109.356 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 3.4 pt-20 -63.2 -18.37 63.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.452 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -71.91 -60.65 2.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.919 -1.113 . . . . 0.0 109.683 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.4 tp -59.78 -43.04 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.994 -1.066 . . . . 0.0 108.953 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' HG23 ' A' ' 75' ' ' ILE . 15.0 mt -55.2 -41.26 71.76 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.174 -0.953 . . . . 0.0 109.331 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.9 t -58.48 -47.85 82.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.35 -54.11 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 108.703 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 mt -52.58 -44.94 66.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.662 ' HD1' HG22 ' A' ' 232' ' ' ILE . 19.7 t-160 -52.88 -54.32 36.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 110.224 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.16 -34.9 78.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 84' ' ' ILE . 42.4 mt -79.49 -4.47 51.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 110.598 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.58 54.45 2.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.98 -1.075 . . . . 0.0 110.305 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.4 mm -96.3 124.57 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 108.467 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.477 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 5.8 p -112.64 -21.31 11.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.315 -0.866 . . . . 0.0 111.631 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.852 HD22 ' H ' ' A' ' 36' ' ' GLY . 10.8 m120 -132.8 112.36 11.88 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.885 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.3 m -165.01 144.56 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.989 . . . . 0.0 109.839 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 64.9 m -112.85 102.86 10.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mp -92.91 117.99 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.872 . . . . 0.0 109.789 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.94 118.22 32.14 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.373 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.55 104.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.865 . . . . 0.0 110.833 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.14 110.7 19.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.83 -162.92 24.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.7 -13.88 12.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -1.06 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.548 ' OE2' ' CD2' ' A' ' 19' ' ' HIS . 40.5 tt0 -142.0 147.51 37.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.101 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.729 HG23 HD11 ' A' ' 26' ' ' LEU . 3.0 mm -68.76 126.74 93.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 109.764 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -45.59 129.53 11.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.923 1.749 . . . . 0.0 111.887 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.26 -32.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.498 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 9.6 mt 55.12 -104.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.273 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -94.34 -28.32 15.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.195 -0.94 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.87 -3.54 25.83 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.3 p -123.5 -166.23 1.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.421 -1.047 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -2.28 22.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.402 ' NE1' ' HG3' ' A' ' 108' ' ' GLU . 59.4 t-105 -48.69 -43.02 36.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.889 -0.771 . . . . 0.0 110.974 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.55 -52.08 64.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.964 -1.085 . . . . 0.0 110.385 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -62.93 -44.04 97.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.931 -1.105 . . . . 0.0 108.722 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 82.3 t80 -63.74 -37.22 86.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.819 -0.551 . . . . 0.0 110.251 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HG3' ' NE1' ' A' ' 104' ' ' TRP . 4.9 mm-40 -72.74 -49.68 29.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 112.014 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.16 -46.76 40.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.808 -1.182 . . . . 0.0 111.056 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -68.69 -42.57 83.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.96 -1.087 . . . . 0.0 110.971 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 15.8 ttp85 -55.74 -27.76 52.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.0 -1.063 . . . . 0.0 110.091 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -84.19 -18.35 36.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.99 -1.069 . . . . 0.0 109.887 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -113.08 29.26 8.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.8 mt -82.26 149.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 0.0 110.28 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 115' ' ' LEU . 12.2 tp -130.66 160.94 32.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.3 137.36 43.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.093 -1.005 . . . . 0.0 109.977 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -102.6 -170.95 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.489 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -124.97 70.71 1.15 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.471 -0.768 . . . . 0.0 110.16 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -160.61 137.78 9.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.046 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.12 167.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.678 0.751 . . . . 0.0 111.193 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.743 HD11 ' C ' ' A' ' 3' ' ' LEU . 69.6 mt -128.59 122.35 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -79.37 71.93 5.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.348 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -55.58 147.05 18.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.081 -1.012 . . . . 0.0 109.414 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CE2' ' OE1' ' A' ' 267' ' ' GLN . 2.9 t80 -104.83 123.02 46.96 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 243' ' ' LYS . 15.5 t -127.92 143.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.849 . . . . 0.0 109.51 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.81 141.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.5 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.23 -7.6 9.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 143' ' ' PRO . 7.3 pt-20 -142.35 144.31 30.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 0.0 109.062 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.13 168.01 25.83 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.185 1.923 . . . . 0.0 113.536 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.838 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.1 tt -159.77 141.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.343 0.592 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.469 ' CG2' HD21 ' A' ' 138' ' ' LEU . 28.6 mt -131.56 119.96 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.4 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 132' ' ' VAL . 34.3 m -118.3 120.44 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.94 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -114.55 136.45 53.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.685 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -174.24 150.1 1.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.599 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 57.05 24.09 9.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.0 110.818 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.09 7.68 86.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.41 ' CG ' HH11 ' A' ' 137' ' ' ARG . 2.9 mtt-85 -106.89 170.25 8.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.984 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.0 tt -160.44 149.52 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.185 -1.572 . . . . 0.0 109.232 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.984 ' N ' HD23 ' A' ' 138' ' ' LEU . 48.9 mt -145.83 135.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 0.0 108.626 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -124.11 140.5 52.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.971 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.838 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.58 142.13 50.96 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -139.64 127.89 13.3 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.403 ' HG3' ' N ' ' A' ' 128' ' ' GLU . 84.7 Cg_exo -46.73 149.1 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.661 1.574 . . . . 0.0 112.417 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.49 155.11 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -1.43 56.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -135.0 148.18 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 109.353 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.1 tp -84.08 118.63 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -137.3 138.85 40.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.46 ' CG1' HD23 ' A' ' 231' ' ' LEU . 54.7 t -135.52 123.35 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.142 -0.974 . . . . 0.0 110.032 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.0 m -109.87 129.34 55.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.239 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.402 ' CE1' ' HG2' ' A' ' 227' ' ' LYS . 63.8 t80 -119.17 131.43 55.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 26.6 tt0 -116.21 104.74 11.82 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.59 146.2 18.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.563 ' H ' HH11 ' A' ' 250' ' ' ARG . 1.8 tm-20 -119.59 86.11 2.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.603 -0.94 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 160' ' ' GLY . 11.7 m-85 -91.91 148.17 22.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -96.56 -4.99 40.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.277 -0.889 . . . . 0.0 109.445 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.813 HD21 HD12 ' A' ' 159' ' ' LEU . 19.3 p-10 -74.47 -167.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.8 -18.01 28.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.628 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.813 HD12 HD21 ' A' ' 157' ' ' ASN . 63.5 mt -72.74 -29.0 62.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 60.82 -121.39 26.43 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -107.67 140.67 40.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -1.048 . . . . 0.0 108.878 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -149.83 157.85 43.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.096 -1.002 . . . . 0.0 109.638 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -149.05 151.76 35.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.608 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -138.3 130.39 28.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.043 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 165' ' ' THR . 14.0 t -102.05 123.43 45.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -99.08 132.73 44.18 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.333 -0.854 . . . . 0.0 108.838 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.5 147.61 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.0 109.195 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 122.13 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.86 16.39 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -117.04 31.41 6.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.27 . . . . 0.0 108.547 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 175' ' ' VAL . 44.6 mt-10 -59.58 -39.02 82.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 110.673 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 2.1 mp0 -52.5 -14.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.057 -1.027 . . . . 0.0 110.944 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.76 -4.05 48.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.818 -1.176 . . . . 0.0 111.153 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.6 pt -121.04 -7.73 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.046 . . . . 0.0 111.033 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER -92.51 -28.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.552 -1.343 . . . . 0.0 110.104 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.46 1.23 56.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.957 -1.089 . . . . 0.0 110.849 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.51 119.42 22.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.738 -1.227 . . . . 0.0 108.888 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -87.28 151.61 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.007 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -53.15 160.42 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.264 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.525 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 33.0 p90 -142.1 169.76 16.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.864 -1.147 . . . . 0.0 109.794 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.6 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -161.04 159.67 29.6 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.184 -0.948 . . . . 0.0 109.898 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.67 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 70.8 m-85 -103.98 146.04 29.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.334 -0.854 . . . . 0.0 109.376 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.685 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.9 OUTLIER -63.79 -18.89 64.54 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.131 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.67 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.2 p90 -79.55 -29.92 41.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.541 -1.35 . . . . 0.0 111.119 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.532 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -98.0 -11.67 22.78 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.754 -1.216 . . . . 0.0 109.764 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.1 mt -58.75 -52.59 58.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.15 -0.969 . . . . 0.0 110.008 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.01 -49.82 59.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 109.565 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -53.74 -52.86 58.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.04 -33.99 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.842 . . . . 0.0 109.074 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -75.98 -25.55 55.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.92 -25.91 53.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.056 -1.028 . . . . 0.0 109.875 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.62 14.98 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.32 26.88 72.61 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.922 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -119.09 157.4 27.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.21 -1.171 . . . . 0.0 109.829 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.27 24.15 64.14 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.382 -0.914 . . . . 0.0 110.956 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -69.0 -20.88 64.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.669 -1.489 . . . . 0.0 109.014 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.44 -7.41 48.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.2 124.62 32.45 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.21 -1.17 . . . . 0.0 110.218 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.83 169.82 16.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.764 -0.845 . . . . 0.0 109.34 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.91 -5.68 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.634 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 2.0 ttpt -89.91 -4.73 57.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -153.09 18.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.6 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.7 m -149.59 128.65 12.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.7 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.588 HD21 HD23 ' A' ' 217' ' ' LEU . 68.3 tp -91.21 113.29 25.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.455 HG11 HEA3 ' A' ' 320' ' ' TUX . 63.4 t -100.79 127.5 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 109.474 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.444 HD21 HD21 ' A' ' 217' ' ' LEU . 61.3 mt -104.02 146.88 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 110.192 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.51 161.23 14.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -51.08 -28.11 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.125 -1.22 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -155.07 14.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.833 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -141.22 149.28 41.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.039 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.18 128.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.6 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 33.7 m-85 -72.2 -54.4 9.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -53.3 137.27 49.79 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.24 -36.35 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.435 2.09 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -70.11 -4.29 20.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.797 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.84 -161.56 53.94 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.588 HD23 HD21 ' A' ' 204' ' ' LEU . 16.1 mt -83.37 145.01 29.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -1.005 . . . . 0.0 109.889 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.594 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 14.1 ttt85 -80.72 -17.9 49.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 109.454 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 29.7 m-85 -148.79 164.86 33.16 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -72.79 -14.32 61.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.099 -1.0 . . . . 0.0 108.392 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 33.81 2.96 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.714 0.769 . . . . 0.0 108.96 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -55.87 -39.09 74.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.896 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.02 -41.57 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.091 1.861 . . . . 0.0 112.851 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.429 ' H ' HG22 ' A' ' 224' ' ' VAL . 10.7 m -78.32 -25.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.716 -1.24 . . . . 0.0 108.231 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.563 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 48.5 mtt180 -66.75 -41.22 88.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -65.1 -42.74 93.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.541 -0.724 . . . . 0.0 109.156 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.402 ' HG2' ' CE1' ' A' ' 151' ' ' TYR . 5.3 tptp -56.68 -48.32 77.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.252 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 70.5 t -58.62 -43.91 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.3 t80 -57.83 -36.98 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.51 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -73.3 -43.12 61.53 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.648 -0.657 . . . . 0.0 109.968 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.46 HD23 ' CG1' ' A' ' 149' ' ' VAL . 26.2 tp -56.19 -34.3 66.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.662 HG22 ' HD1' ' A' ' 80' ' ' HIS . 34.4 mt -72.76 -48.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.15 -34.65 17.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.65 -27.16 31.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.144 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 260' ' ' VAL . 4.9 mt -79.9 -23.76 41.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.739 -1.225 . . . . 0.0 110.133 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -72.45 -5.88 39.76 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.031 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 237' ' ' LEU . 33.6 mt -53.32 -27.88 25.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 108.745 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.3 -9.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.168 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.51 11.73 85.2 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.0 p -156.58 149.12 17.95 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.095 -1.238 . . . . 0.0 109.56 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 12.3 Cg_exo -48.38 138.48 23.68 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.211 1.941 . . . . 0.0 111.785 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.91 136.26 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.528 ' HB3' HG13 ' A' ' 125' ' ' VAL . 2.3 tppt? -124.55 127.78 47.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.433 -0.792 . . . . 0.0 109.62 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.53 177.2 30.41 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.43 112.7 25.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -1.167 . . . . 0.0 109.861 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.6 m-85 -112.59 148.86 33.67 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.031 0.92 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 25.1 t80 -128.24 144.29 51.11 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.6 t -142.46 128.99 20.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.683 -1.261 . . . . 0.0 110.778 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 250' ' ' ARG . 56.8 t80 -111.96 112.94 24.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.563 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.0 OUTLIER 47.36 56.1 7.39 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.39 149.4 23.68 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -121.69 165.33 14.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 91.3 m-70 -59.47 -44.53 92.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.3 m -59.58 -40.94 89.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.641 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.1 tp -72.26 -35.93 68.9 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.049 -1.032 . . . . 0.0 108.711 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -61.88 -46.8 87.83 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.73 -44.73 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.291 -0.88 . . . . 0.0 108.726 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -55.23 -48.28 74.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 108.927 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 139' ' ' ILE . 26.2 tp -52.97 -43.07 66.1 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 235' ' ' LEU . 63.4 t -69.83 -44.92 78.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.373 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -52.37 60.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.605 -0.684 . . . . 0.0 110.025 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -62.2 -46.39 89.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.01 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.2 -44.87 92.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.147 -0.971 . . . . 0.0 109.508 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.89 -30.21 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -83.31 -30.46 27.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.813 -1.179 . . . . 0.0 108.778 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 268' ' ' LYS . 34.7 mttp -56.24 -44.27 79.46 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.283 -0.886 . . . . 0.0 109.035 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.532 ' OE1' ' CE2' ' A' ' 124' ' ' PHE . 5.4 pt20 -76.06 19.68 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.492 -0.755 . . . . 0.0 109.773 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 269' ' ' LEU . 0.0 OUTLIER -64.07 -0.94 1.3 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.028 -1.045 . . . . 0.0 109.311 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 268' ' ' LYS . 72.0 mt -43.76 -39.79 3.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.326 -0.859 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.496 -0.752 . . . . 0.0 109.418 179.902 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.6 HEA1 ' CE2' ' A' ' 212' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 42.1 mt-10 -56.31 137.79 51.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.091 -1.005 . . . . 0.0 108.921 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.6 141.01 52.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.432 -0.793 . . . . 0.0 109.882 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -137.79 172.74 12.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.21 137.86 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.771 -1.206 . . . . 0.0 110.538 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -69.59 -47.97 61.76 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.658 -0.651 . . . . 0.0 109.785 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.93 158.37 38.03 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.626 0.727 . . . . 0.0 110.32 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -60.71 137.25 58.21 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.555 0.693 . . . . 0.0 110.315 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.07 154.63 31.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -146.71 145.1 29.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.879 -1.138 . . . . 0.0 110.126 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.51 160.45 37.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.68 135.91 22.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.911 -1.118 . . . . 0.0 109.004 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.3 158.6 18.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.448 HG23 ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -86.17 143.06 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -1.231 . . . . 0.0 110.662 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.69 145.13 43.17 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -65.24 -41.91 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.053 -1.263 . . . . 0.0 112.073 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.543 ' CE1' HG23 ' A' ' 18' ' ' ILE . 3.9 m-70 -87.3 -38.85 15.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.047 -1.658 . . . . 0.0 111.073 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 p -74.21 -32.34 63.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 109.942 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.88 19.57 63.41 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 16' ' ' VAL . 2.8 mm-40 -109.87 150.24 28.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.958 . . . . 0.0 108.804 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -70.98 135.65 47.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 109.823 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.63 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 13.0 t -143.45 157.88 44.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.211 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.0 tttt -132.62 157.07 45.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.2 mt -134.15 145.29 49.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 109.214 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.447 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -130.45 134.46 62.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.56 118.1 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 42.9 m-70 -115.23 150.11 43.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.74 158.13 48.17 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.194 1.929 . . . . 0.0 111.511 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 14.0 mm-40 -133.43 -178.04 4.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.3 tptt -83.47 149.76 26.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.25 149.64 0.98 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.0 109.748 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.609 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.08 23.47 57.29 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.141 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 6.7 m -80.29 -41.83 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.735 -1.45 . . . . 0.0 109.278 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.64 -166.64 21.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.3 mm -107.6 121.54 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.348 -1.09 . . . . 0.0 108.219 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.08 143.62 46.74 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.663 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.09 153.24 20.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.29 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.545 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -128.77 145.46 51.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -172.96 135.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 109.603 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.64 29.78 14.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.889 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.58 27.93 70.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.7 t -131.62 134.58 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -94.19 140.39 29.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.221 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.9 mt -134.08 94.53 18.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.059 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 145.37 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.294 1.996 . . . . 0.0 111.599 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.67 84.23 4.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.914 -1.116 . . . . 0.0 110.53 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -136.92 152.59 50.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.977 . . . . 0.0 109.582 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 52' ' ' PHE . 10.2 p80 -51.1 -46.81 61.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -48.39 -17.16 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.059 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' HIS . 51.7 m-85 -95.66 3.53 53.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.814 -1.179 . . . . 0.0 109.641 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . 25.6 t -62.42 119.27 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 108.79 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.28 -26.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 110.573 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.59 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -147.97 117.18 6.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.898 -1.126 . . . . 0.0 110.031 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.1 p -113.86 125.36 53.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.612 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 t-20 -167.58 -152.41 0.12 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.593 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 9.8 t-80 -44.13 -15.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -140.27 165.37 27.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.449 -0.782 . . . . 0.0 109.119 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.1 m -110.23 126.57 54.29 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.18 -0.95 . . . . 0.0 109.102 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.5 OUTLIER -128.12 147.15 50.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.184 0.992 . . . . 0.0 111.777 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' A' ' 72' ' ' VAL . 34.8 mt -122.51 157.48 31.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.2 143.52 7.03 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -143.04 147.79 35.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.926 . . . . 0.0 109.44 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp 53.73 45.07 28.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.271 -0.893 . . . . 0.0 110.711 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.2 6.5 65.03 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.65 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 42.8 mm-40 -101.26 140.91 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.973 -1.31 . . . . 0.0 108.39 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -142.84 149.66 38.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.888 -1.132 . . . . 0.0 111.52 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mt -133.7 143.2 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -114.11 152.02 31.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.235 -0.916 . . . . 0.0 111.208 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 53.57 70.04 0.64 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.778 -0.577 . . . . 0.0 111.152 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -113.84 -8.16 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.958 -1.089 . . . . 0.0 109.653 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.3 pt-20 -69.32 -20.43 63.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 110.518 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -60.76 2.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.043 -1.036 . . . . 0.0 109.732 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.507 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -59.5 -43.77 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.072 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' N ' HG23 ' A' ' 75' ' ' ILE . 50.1 mt -55.42 -39.4 70.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.535 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 1.7 t -59.71 -47.57 85.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.202 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.05 -54.45 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 108.718 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.56 -44.06 62.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.472 -0.767 . . . . 0.0 109.277 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.506 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 15.8 t-160 -55.38 -58.17 8.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.792 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.6 mt -58.63 -37.71 76.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.972 . . . . 0.0 110.001 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 114' ' ' ILE . 10.5 mt -78.12 -7.18 56.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 110.334 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 61.17 53.2 3.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.87 -1.144 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mm -98.03 130.77 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.459 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -117.0 -19.34 9.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.315 -0.866 . . . . 0.0 112.263 -177.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.692 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -126.83 111.13 13.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.72 -1.237 . . . . 0.0 110.464 -179.427 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -165.66 137.93 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 109.889 179.051 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.518 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.5 m -111.01 99.67 8.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mp -89.86 110.36 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -85.99 123.05 30.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.24 115.66 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.999 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.78 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -99.32 108.76 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.54 -163.16 24.69 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.24 -16.05 11.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.491 -1.005 . . . . 0.0 110.143 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 19' ' ' HIS . 15.7 tt0 -138.47 145.33 40.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 110.219 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 96' ' ' ILE . 28.5 mm -67.91 127.13 93.33 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.55 -0.719 . . . . 0.0 109.426 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.701 ' CD ' HD21 ' A' ' 26' ' ' LEU . 62.5 Cg_exo -45.94 128.9 11.82 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.851 1.701 . . . . 0.0 111.953 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.413 HD11 ' HA2' ' A' ' 101' ' ' GLY . 8.5 tp -77.45 -28.21 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.299 -0.876 . . . . 0.0 109.672 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.4 mt 55.21 -109.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 110.145 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.54 -19.17 20.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.728 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 112.61 -12.35 25.44 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 p -116.46 -169.3 1.59 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -1.047 . . . . 0.0 109.707 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -110.59 -4.72 28.27 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' A' ' 108' ' ' GLU . 52.7 t-105 -46.98 -39.52 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.738 -0.86 . . . . 0.0 110.421 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -61.25 -51.47 68.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.0 110.07 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -65.48 -43.58 89.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.053 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.8 t80 -63.25 -37.34 86.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 109.565 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HG3' ' CD1' ' A' ' 104' ' ' TRP . 5.3 mm-40 -65.58 -54.85 22.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 0.0 111.898 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.5 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.732 -1.23 . . . . 0.0 111.135 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.13 -45.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -57.41 -29.69 64.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -80.19 -12.97 59.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.148 -0.97 . . . . 0.0 109.887 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -120.76 34.62 5.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.831 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.613 ' CD1' HD22 ' A' ' 82' ' ' LEU . 7.2 mt -87.47 147.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 110.586 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -88.69 144.05 26.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.533 ' NE2' ' OE2' ' A' ' 33' ' ' GLU . 9.7 mt-30 -107.27 -160.57 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.796 . . . . 0.0 109.207 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -120.44 3.37 10.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.274 -0.891 . . . . 0.0 110.735 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 151.16 19.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.854 -1.154 . . . . 0.0 109.966 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.5 141.06 29.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -0.941 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 85' ' ' THR . 64.0 mt -83.31 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.531 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -90.79 93.14 9.1 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.94 146.92 53.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.797 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -104.62 128.7 52.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.39 142.84 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.96 134.07 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -114.72 -10.74 12.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.35 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.447 ' CD ' ' HZ3' ' A' ' 266' ' ' LYS . 7.1 pt-20 -143.1 144.06 27.3 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.15 148.76 39.91 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.223 1.949 . . . . 0.0 113.031 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.911 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.9 tt -139.05 151.59 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.578 -0.701 . . . . 0.0 109.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.03 119.76 37.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.321 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.82 117.28 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.03 142.49 35.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.86 . . . . 0.0 108.96 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.85 120.3 3.41 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.605 -1.31 . . . . 0.0 112.298 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 44.97 42.91 6.75 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.0 112.345 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.64 1.94 85.06 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.387 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -102.76 163.88 11.96 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 139' ' ' ILE . 2.6 tt -160.14 146.49 15.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.357 -1.464 . . . . 0.0 109.276 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.887 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.8 mt -145.91 129.7 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.34 139.39 51.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.911 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -117.34 151.57 36.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 108.925 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -150.34 139.52 13.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.0 145.82 97.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.692 1.595 . . . . 0.0 112.14 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.52 153.28 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.1 4.05 32.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.928 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -141.22 151.35 43.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.73 119.04 23.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.858 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -138.69 135.02 34.37 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.679 ' CG1' HD23 ' A' ' 231' ' ' LEU . 5.4 t -133.26 117.67 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 109.826 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.4 OUTLIER -103.83 133.87 48.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.198 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 224' ' ' VAL . 8.8 t80 -122.42 130.25 52.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.623 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -115.67 106.97 14.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.8 134.66 11.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -108.07 85.01 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -1.075 . . . . 0.0 109.232 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -92.12 144.14 25.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -95.96 -1.22 49.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 109.187 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.632 HD21 HD12 ' A' ' 159' ' ' LEU . 29.3 p-10 -71.32 -167.77 0.26 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.237 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -60.96 -23.25 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.632 HD12 HD21 ' A' ' 157' ' ' ASN . 55.5 mt -71.13 -22.78 62.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.166 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.1 -134.17 52.37 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -98.18 144.36 27.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.462 -1.022 . . . . 0.0 109.005 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -152.46 170.5 19.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.35 153.59 23.75 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.832 . . . . 0.0 109.381 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -138.21 130.31 28.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 165' ' ' THR . 14.5 t -102.42 123.13 45.63 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 110.052 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -99.13 134.58 41.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.405 -0.809 . . . . 0.0 108.871 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.89 149.59 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -51.04 116.86 2.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.211 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.18 5.51 17.1 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -134.66 29.97 3.49 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.193 -1.18 . . . . 0.0 108.974 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 175' ' ' VAL . 8.8 mt-10 -64.39 -35.17 80.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.568 -0.708 . . . . 0.0 110.854 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.2 -16.98 37.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.979 -1.076 . . . . 0.0 110.766 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 81.2 mt-10 -85.48 -3.71 58.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 110.337 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -124.03 -33.86 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.0 111.411 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -60.97 -29.98 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.479 -1.388 . . . . 0.0 110.424 -179.043 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -87.48 2.66 49.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.72 -1.238 . . . . 0.0 110.517 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.56 115.19 20.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.873 -1.142 . . . . 0.0 108.957 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.429 ' H ' ' HG2' ' A' ' 178' ' ' ARG . 26.6 ptt180 -86.48 153.03 22.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.863 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.0 t -59.93 131.35 50.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 109.848 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -109.89 172.62 6.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 109.855 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.573 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.5 OUTLIER -154.78 159.04 40.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.429 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 58.6 m-85 -104.25 144.35 31.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.754 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.5 OUTLIER -60.35 -24.36 65.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 110.535 -179.568 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.597 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.5 p90 -82.07 -32.0 30.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.73 -1.231 . . . . 0.0 110.449 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.597 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 18.3 pt-20 -86.55 -16.65 36.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.815 -1.178 . . . . 0.0 109.566 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.7 mt -57.57 -53.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.23 -50.74 58.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.775 -1.203 . . . . 0.0 109.738 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -52.73 -48.11 66.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.008 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.433 HG21 H4A2 ' A' ' 320' ' ' TUX . 9.9 mt -60.29 -34.31 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.1 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -77.8 -29.37 50.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -21.97 53.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.047 -1.033 . . . . 0.0 110.201 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 194' ' ' LEU . 30.1 m -89.15 11.14 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.958 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.04 25.39 69.15 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.773 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.413 HD12 ' CG2' ' A' ' 192' ' ' VAL . 28.2 mt -124.52 162.98 22.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.119 -1.224 . . . . 0.0 109.87 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.466 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.32 22.93 66.67 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.189 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -69.43 -21.04 63.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.652 -1.499 . . . . 0.0 109.779 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.0 -2.91 51.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.33 129.3 40.08 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.199 -1.177 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.01 176.81 8.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.783 -0.834 . . . . 0.0 109.257 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.34 -11.97 57.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.937 . . . . 0.0 109.72 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -92.96 -4.73 52.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -134.06 -13.82 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 109.736 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.9 m -128.35 126.29 40.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.541 HD12 ' CG ' ' A' ' 213' ' ' ASN . 7.1 tp -84.4 110.33 18.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 108.866 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.59 132.15 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.587 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.14 152.72 32.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.82 161.56 15.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -50.65 -24.67 3.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.97 12.61 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.4 ttpt -144.43 152.5 40.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.115 -0.991 . . . . 0.0 110.228 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.98 127.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.446 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 30.1 m-85 -73.46 -54.1 9.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 110.275 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.541 ' CG ' HD12 ' A' ' 204' ' ' LEU . 3.7 m120 -56.0 133.51 74.01 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.981 -1.074 . . . . 0.0 109.723 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.58 -13.06 27.3 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.37 -7.82 57.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.99 . . . . 0.0 109.89 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -167.24 51.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.7 144.3 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 110.097 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.595 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -79.86 -20.82 45.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 108.793 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 37.1 m-85 -148.53 154.91 40.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.407 ' HB3' ' ND2' ' A' ' 221' ' ' ASN . 2.6 tt0 -58.59 -12.97 4.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 108.754 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.532 ' OD1' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -143.73 36.69 1.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.261 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.599 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -59.84 -35.43 28.84 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.0 Cg_exo -70.89 -46.2 0.82 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.87 1.713 . . . . 0.0 112.562 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 151' ' ' TYR . 1.8 m -73.87 -22.63 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.804 -1.185 . . . . 0.0 108.195 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.532 ' NH1' ' OD1' ' A' ' 221' ' ' ASN . 5.5 mtt180 -69.88 -40.65 75.55 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.5 -42.9 95.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 108.911 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -45.62 80.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.452 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 81.3 t -61.42 -45.12 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.535 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.4 t80 -53.77 -36.68 62.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -75.02 -40.05 60.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.632 -0.667 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.679 HD23 ' CG1' ' A' ' 149' ' ' VAL . 27.0 tp -56.32 -37.73 70.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.208 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.506 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 85.3 mt -71.6 -48.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.6 -31.86 23.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -82.98 -26.63 31.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.941 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 260' ' ' VAL . 4.3 mt -79.39 -23.58 43.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.883 -1.136 . . . . 0.0 110.2 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.466 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 7.0 t80 -70.43 -6.43 35.65 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.033 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 237' ' ' LEU . 24.3 mt -53.34 -28.76 30.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.18 -18.06 23.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.0 108.73 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.96 70.64 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.5 p -156.29 150.76 20.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.118 -1.225 . . . . 0.0 109.357 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 5.4 Cg_endo -52.84 136.48 59.59 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.092 1.862 . . . . 0.0 111.572 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.4 t -102.24 138.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.221 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -125.61 128.42 47.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.768 . . . . 0.0 109.078 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.4 175.99 28.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -106.55 109.68 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.172 . . . . 0.0 109.732 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.0 m-85 -111.41 149.3 31.42 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.771 0.796 . . . . 0.0 110.835 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -126.26 144.43 50.79 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 150' ' ' THR . 0.7 OUTLIER -136.58 125.55 24.3 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 120.751 -1.218 . . . . 0.0 110.232 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 250' ' ' ARG . 26.8 t80 -112.74 111.86 22.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 249' ' ' PHE . 26.5 mtp180 47.54 56.54 6.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.22 149.29 21.93 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.49 -174.6 15.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.43 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 71.1 m-70 -74.45 -42.41 59.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -1.144 . . . . 0.0 109.687 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -34.92 79.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.723 ' HG ' HD12 ' A' ' 139' ' ' ILE . 49.8 tp -72.76 -39.22 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.927 -1.108 . . . . 0.0 109.059 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -60.58 -50.6 72.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.298 -0.876 . . . . 0.0 108.897 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.23 -45.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -55.29 -48.87 73.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.134 -0.979 . . . . 0.0 109.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.555 HD22 HG21 ' A' ' 139' ' ' ILE . 27.0 tp -52.61 -43.76 65.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.435 HG22 HD23 ' A' ' 235' ' ' LEU . 24.3 t -69.96 -40.71 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -59.53 -50.13 75.08 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 110.132 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.0 -43.91 73.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.175 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 263' ' ' LEU . 30.0 mt -57.35 -48.8 78.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -55.82 -44.27 77.73 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.608 -0.683 . . . . 0.0 109.664 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -72.65 -34.13 67.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 0.0 109.457 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.739 ' HA ' HD12 ' A' ' 269' ' ' LEU . 20.5 mttm -62.77 -41.15 99.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.276 -0.89 . . . . 0.0 109.129 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 266' ' ' LYS . 0.5 OUTLIER -40.32 -40.16 1.1 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.708 -0.62 . . . . 0.0 110.893 -179.271 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -102.33 29.32 5.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.837 -1.165 . . . . 0.0 110.816 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 266' ' ' LYS . 9.5 mt -105.49 26.12 9.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.197 -0.939 . . . . 0.0 109.42 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.917 . . . . 0.0 109.353 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.573 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 31.0 mt-10 -49.28 142.12 7.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 109.128 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 133.9 55.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 110.102 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -138.33 175.42 9.59 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.42 141.18 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.203 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -72.55 -44.24 62.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.51 -0.744 . . . . 0.0 110.055 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.95 160.16 35.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.738 . . . . 0.0 110.225 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 130.31 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.585 -0.697 . . . . 0.0 109.984 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD21 ' ND2' ' A' ' 113' ' ' ASN . 13.0 mt -114.95 169.81 8.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -0.783 . . . . 0.0 108.998 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -157.98 148.15 20.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.956 -1.09 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -129.69 168.0 17.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -154.93 135.05 13.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 109.182 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.79 158.23 15.41 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.544 HG23 ' C ' ' A' ' 22' ' ' GLU . 8.9 p -80.95 141.52 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -1.094 . . . . 0.0 110.749 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.68 148.4 41.73 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -70.02 -40.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.0 113.043 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.0 m-70 -86.04 -38.58 17.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 119.79 -1.819 . . . . 0.0 111.858 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -85.84 -27.21 25.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.713 -1.242 . . . . 0.0 109.157 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 63.79 25.49 69.16 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.544 ' C ' HG23 ' A' ' 16' ' ' VAL . 3.0 tp10 -106.26 148.96 27.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.506 -0.996 . . . . 0.0 109.182 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -70.78 129.89 40.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.741 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.5 t -138.9 156.98 46.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.915 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.505 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.5 tttt -133.22 153.48 51.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 109.206 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.515 HD21 ' CD ' ' A' ' 97' ' ' PRO . 3.2 mt -127.84 147.66 50.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.428 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.472 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.9 mt -137.91 122.41 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -112.13 127.4 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.554 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 2.4 m-70 -119.98 148.8 47.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.94 161.64 15.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.015 1.81 . . . . 0.0 111.096 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 5.7 mm-40 -135.02 -172.27 3.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.69 155.41 18.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.738 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 33' ' ' GLU . 40.3 mp0 -46.78 142.68 3.2 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.598 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.69 29.89 64.91 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.372 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 25.9 m -80.66 -37.56 30.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.631 -1.511 . . . . 0.0 108.67 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.03 -177.54 35.37 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.6 mm -100.85 124.67 54.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.02 140.09 36.13 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.311 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.11 150.01 20.71 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.487 ' CD1' ' OE1' ' A' ' 90' ' ' GLU . 16.7 t80 -134.36 139.91 45.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.36 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 16.7 ttpt -174.02 147.33 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.642 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 56.6 29.45 15.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.8 73.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -135.97 143.01 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 0.0 109.352 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -101.45 146.03 28.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.51 94.55 10.56 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.017 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -48.93 145.0 14.24 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.337 2.025 . . . . 0.0 111.854 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.97 81.28 5.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.92 -1.112 . . . . 0.0 110.463 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.68 155.46 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.026 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.2 p80 -52.22 -49.38 64.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.917 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 11.3 mt-10 -44.0 -16.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.197 -0.939 . . . . 0.0 110.164 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.8 m-85 -97.45 2.9 50.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 50' ' ' HIS . 52.1 t -62.83 119.37 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.059 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.56 -29.36 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.855 . . . . 0.0 109.986 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 3.0 t-160 -150.82 120.82 7.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.962 . . . . 0.0 109.652 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.2 p -111.94 133.04 54.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 16.1 p-10 -166.61 -153.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' ASN . 5.2 m170 -47.47 -11.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.118 -0.989 . . . . 0.0 108.694 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -139.22 166.49 24.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.5 m -101.38 120.69 40.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.52 134.97 54.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.189 -0.945 . . . . 0.0 111.238 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD12 HG21 ' A' ' 72' ' ' VAL . 29.6 mt -123.69 156.5 35.8 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.73 145.44 7.96 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.028 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -144.67 151.5 39.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.539 -0.977 . . . . 0.0 109.891 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 55.47 24.02 6.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -0.834 . . . . 0.0 110.894 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.71 1.23 68.36 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.557 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.494 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 99.6 mm-40 -96.59 137.46 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.889 -1.36 . . . . 0.0 108.299 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -130.76 144.62 51.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.23 -0.919 . . . . 0.0 111.358 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.2 mt -130.81 140.22 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -114.13 145.64 41.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 56.06 68.82 0.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.785 -0.572 . . . . 0.0 111.46 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 HD12 ' A' ' 62' ' ' LEU . 34.5 m -113.92 -3.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.097 -1.002 . . . . 0.0 108.99 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.491 ' OE1' ' OD1' ' A' ' 234' ' ' ASP . 10.8 pt-20 -69.45 -33.05 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.456 ' CE1' ' CE1' ' A' ' 226' ' ' HIS . 17.6 m170 -61.9 -59.9 4.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 110.099 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.9 tp -55.47 -41.73 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.669 -1.269 . . . . 0.0 108.515 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 79' ' ' LEU . 70.3 mt -60.68 -35.05 75.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.478 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 47.1 t -61.04 -49.25 78.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.413 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 23.2 t -58.52 -52.81 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.03 -1.044 . . . . 0.0 108.594 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 76' ' ' LEU . 22.6 mt -50.77 -43.11 58.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 108.999 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.546 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.0 t-160 -54.28 -56.19 20.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.578 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.35 -36.7 76.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.963 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' A' ' 84' ' ' ILE . 35.2 mt -79.31 -9.38 59.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.14 61.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.431 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 82' ' ' LEU . 12.2 mm -102.38 132.29 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 48.4 p -118.82 -22.54 7.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.264 -0.897 . . . . 0.0 111.889 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.72 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.4 m-80 -129.39 111.69 13.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.279 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.5 m -164.86 135.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.868 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.48 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 44.1 m -103.28 99.66 9.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 mt -86.82 120.94 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.89 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' OE1' ' CD1' ' A' ' 40' ' ' PHE . 7.8 mt-10 -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.813 -1.179 . . . . 0.0 108.1 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' ' CD ' ' A' ' 41' ' ' LYS . 60.0 t -105.63 107.22 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.101 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.63 109.14 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.58 -160.25 23.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.24 -15.9 7.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -1.008 . . . . 0.0 110.415 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.5 pm0 -131.94 137.6 48.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.22 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mm -68.75 129.6 92.34 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 109.768 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.515 ' CD ' HD21 ' A' ' 26' ' ' LEU . 50.3 Cg_exo -46.83 129.07 14.13 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.407 2.072 . . . . 0.0 112.782 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 16' ' ' VAL . 7.6 tp -76.93 -25.93 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.448 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 70.6 mt 55.33 -116.07 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.45 -0.781 . . . . 0.0 109.988 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.03 -18.09 22.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.115 -0.991 . . . . 0.0 110.13 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 -16.74 19.1 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -108.33 -169.72 1.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -1.098 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.97 -3.94 21.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.469 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 64.9 t-105 -46.68 -39.18 10.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.785 -0.832 . . . . 0.0 110.418 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.06 -51.75 66.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 109.728 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 62.5 m-85 -62.61 -45.92 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.828 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.01 -37.41 84.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.693 -0.629 . . . . 0.0 110.097 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.1 mm-40 -69.91 -48.81 57.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.313 -0.867 . . . . 0.0 111.773 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.29 -51.27 13.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.793 -1.192 . . . . 0.0 111.273 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.5 mt -62.81 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.984 -1.073 . . . . 0.0 110.875 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.18 -29.89 61.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 0.0 110.194 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.66 -13.59 56.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.064 -1.023 . . . . 0.0 110.08 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.413 ' ND2' HD21 ' A' ' 11' ' ' LEU . 3.2 m-20 -118.0 32.2 6.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.44 -0.787 . . . . 0.0 111.206 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 82' ' ' LEU . 7.6 mt -86.57 148.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.534 -1.354 . . . . 0.0 110.029 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.1 tp -131.26 158.17 41.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -103.09 142.01 34.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.62 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -109.08 -167.09 1.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 110.104 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -118.75 69.05 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.407 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 4' ' ' GLU . 23.4 ttt85 -165.78 143.91 5.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -83.84 128.8 34.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.583 HG12 HG21 ' A' ' 85' ' ' THR . 79.0 mt -71.09 140.69 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.0 86.7 7.15 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -61.83 146.06 50.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 110.769 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.77 121.83 42.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.72 138.63 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.8 t -81.81 139.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.25 -10.57 8.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.441 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -141.12 125.61 10.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.141 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -51.12 154.33 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.007 1.804 . . . . 0.0 113.124 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.602 HG22 ' HB3' ' A' ' 141' ' ' ALA . 2.4 tt -145.49 146.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.649 -0.657 . . . . 0.0 109.638 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.55 119.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.66 120.49 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.257 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -123.0 142.07 51.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 110.517 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 1.5 t70 178.03 153.32 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 58.6 mm-40 56.37 23.55 7.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.868 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.05 7.76 86.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.546 ' HB2' HD22 ' A' ' 255' ' ' LEU . 69.7 mtt180 -105.16 168.6 8.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.0 tt -160.78 152.42 19.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.117 -1.614 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.985 ' N ' HD23 ' A' ' 138' ' ' LEU . 17.9 mt -148.78 142.53 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.036 . . . . 0.0 108.74 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -130.0 137.52 50.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 0.0 109.598 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -116.98 151.67 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -150.05 137.22 11.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.53 144.97 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.189 1.259 . . . . 0.0 111.964 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.29 149.84 10.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.336 -0.852 . . . . 0.0 109.369 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.46 -0.33 52.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.268 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.4 p -133.29 142.77 48.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 242' ' ' VAL . 16.4 tp -78.5 119.64 22.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.764 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -139.43 139.58 37.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.862 . . . . 0.0 108.77 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.522 ' CG1' HD23 ' A' ' 231' ' ' LEU . 13.9 t -137.86 122.68 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.169 -0.957 . . . . 0.0 109.543 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 99.8 m -111.37 141.11 45.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.951 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.499 ' HE2' HG12 ' A' ' 224' ' ' VAL . 10.5 t80 -125.56 130.27 51.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.611 -0.68 . . . . 0.0 109.896 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 16.6 tt0 -113.17 107.39 15.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.44 ' C ' ' OE2' ' A' ' 154' ' ' GLU . . . -107.14 131.37 10.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.577 ' H ' HH11 ' A' ' 250' ' ' ARG . 0.9 OUTLIER -117.8 88.25 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -1.004 . . . . 0.0 109.053 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 3.6 m-30 -85.98 148.67 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.112 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -87.25 -10.49 52.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.687 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.48 HD21 HD12 ' A' ' 159' ' ' LEU . 17.8 p-10 -66.18 -167.01 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -64.97 -23.08 67.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.48 HD12 HD21 ' A' ' 157' ' ' ASN . 9.3 mt -56.74 -50.45 72.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.997 -1.065 . . . . 0.0 109.188 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.93 -121.78 6.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 140.2 50.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.534 -0.98 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -153.15 131.66 12.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.839 . . . . 0.0 109.467 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 149.67 39.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.544 -0.722 . . . . 0.0 109.163 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -134.83 121.07 20.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.086 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 165' ' ' THR . 10.1 t -100.9 123.1 44.6 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.14 -0.975 . . . . 0.0 110.199 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.0 t80 -100.88 134.43 43.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 108.852 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.469 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.3 t -130.88 149.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.507 -0.746 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.69 122.68 10.38 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.55 -14.95 17.59 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -117.93 32.3 6.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 108.555 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.76 -34.33 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 110.474 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.9 -15.36 8.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 110.691 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.596 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 13.7 mm-40 -91.07 -4.01 56.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 110.823 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -125.0 10.22 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.945 -1.097 . . . . 0.0 111.199 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -27.99 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.853 -1.154 . . . . 0.0 109.604 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -88.5 3.72 49.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.082 . . . . 0.0 110.638 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.97 123.01 27.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.808 -1.182 . . . . 0.0 109.018 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -95.56 155.42 16.75 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.12 -0.987 . . . . 0.0 110.23 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 t -56.34 155.31 7.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.784 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.526 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 26.4 p90 -139.66 168.29 20.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.047 -1.033 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.526 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -162.7 162.27 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -102.82 147.55 26.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.719 ' HA ' HD12 ' A' ' 186' ' ' ILE . 6.9 p-10 -64.27 -19.53 65.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.933 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.496 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 2.8 p90 -81.79 -26.01 34.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.67 -1.269 . . . . 0.0 110.449 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.415 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 25.9 pt-20 -96.8 -17.29 20.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.926 -1.109 . . . . 0.0 109.36 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.5 mt -56.86 -51.41 68.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.47 -0.769 . . . . 0.0 110.326 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -51.21 -52.26 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.995 -1.066 . . . . 0.0 109.553 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.747 ' O ' HG13 ' A' ' 192' ' ' VAL . 7.6 m80 -52.94 -45.03 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.107 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.37 -33.71 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 109.025 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -78.82 -25.7 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.894 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -80.73 -26.68 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 188' ' ' HIS . 4.6 m -82.06 7.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.721 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 83.76 20.18 60.22 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.139 -0.976 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.63 163.93 20.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.055 -1.262 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.478 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.77 17.83 74.28 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.063 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -66.32 -22.18 66.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.695 -1.473 . . . . 0.0 110.279 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.31 -5.87 51.79 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.38 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.47 124.66 35.35 Favored Glycine 0 N--CA 1.491 2.366 0 O-C-N 121.055 -1.262 . . . . 0.0 110.697 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.0 p -135.44 171.94 13.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.718 -0.872 . . . . 0.0 109.204 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.1 mt -76.48 -13.74 60.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 16.9 tttp -89.05 -8.55 53.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.672 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 37.1 m-20 -141.12 12.83 2.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.5 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 8.2 m -148.99 117.75 6.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 109.564 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.704 HD21 HD23 ' A' ' 217' ' ' LEU . 7.3 tp -79.89 115.38 19.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -0.979 . . . . 0.0 109.185 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.464 HG21 HCA3 ' A' ' 320' ' ' TUX . 84.3 t -100.61 125.3 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 217' ' ' LEU . 3.8 mt -103.43 147.05 27.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.28 148.4 16.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 207' ' ' GLY . 51.9 mttm -42.32 -29.66 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -1.191 . . . . 0.0 110.045 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -147.34 11.97 1.03 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.0 110.57 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.5 tttp -147.44 156.69 43.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.023 . . . . 0.0 109.998 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.467 HG11 ' HA2' ' A' ' 216' ' ' GLY . 62.6 t -103.11 128.25 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.5 -54.28 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.46 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.462 ' CG ' HD12 ' A' ' 204' ' ' LEU . 14.7 m120 -55.02 137.16 66.63 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.002 -1.062 . . . . 0.0 109.577 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.16 -19.04 26.57 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.346 2.031 . . . . 0.0 112.545 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 109.927 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.61 -165.74 53.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.704 HD23 HD21 ' A' ' 204' ' ' LEU . 26.5 mt -79.13 145.05 33.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -1.089 . . . . 0.0 109.639 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -71.49 -57.41 4.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 108.877 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.687 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 13.1 m-85 -117.05 148.85 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.462 -0.774 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.09 -13.98 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.933 . . . . 0.0 109.164 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -132.84 38.77 3.37 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.868 0.842 . . . . 0.0 108.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.511 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.6 tp10 -57.34 -48.48 97.27 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 111.265 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 33.3 Cg_endo -69.47 -37.95 9.12 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.525 1.483 . . . . 0.0 113.218 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.499 HG12 ' HE2' ' A' ' 151' ' ' TYR . 1.8 m -79.39 -25.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.609 -1.307 . . . . 0.0 108.506 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 16.4 mtp180 -67.72 -43.75 79.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.542 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 56.2 t60 -62.86 -41.59 99.44 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -43.23 81.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 108.779 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 224' ' ' VAL . 60.7 t -65.8 -47.54 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 42.5 t80 -49.86 -47.54 51.69 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' CD2' ' A' ' 226' ' ' HIS . 2.8 m-20 -70.61 -35.19 72.83 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.522 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.1 tp -55.55 -35.97 66.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 108.41 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.487 HG22 ' HD1' ' A' ' 80' ' ' HIS . 74.4 mt -70.15 -48.16 63.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.03 -34.44 16.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.503 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 6.1 m-20 -80.58 -27.08 37.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.993 -1.298 . . . . 0.0 109.665 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -82.54 -26.31 32.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.111 . . . . 0.0 109.593 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.546 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 21.7 t80 -67.14 -7.69 25.32 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.985 . . . . 0.0 108.635 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 237' ' ' LEU . 39.3 mt -50.24 -30.05 10.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 242' ' ' VAL . 96.5 mt -56.79 -19.88 19.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 108.712 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.83 16.29 73.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 83.1 p -158.79 145.16 12.57 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.991 -1.3 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.438 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 82.4 Cg_exo -41.06 129.49 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.343 2.029 . . . . 0.0 111.924 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 238' ' ' LEU . 81.9 t -97.11 130.51 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -117.91 123.09 44.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 172.58 24.86 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.26 112.19 25.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.177 -1.19 . . . . 0.0 109.95 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.2 m-85 -112.22 147.58 35.9 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.989 0.9 . . . . 0.0 110.931 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 139' ' ' ILE . 28.1 t80 -131.85 134.71 46.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.17 128.9 44.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.86 -1.15 . . . . 0.0 110.218 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 250' ' ' ARG . 6.6 t80 -112.01 115.17 28.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.577 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.2 mmp_? 48.28 56.28 7.64 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.55 152.54 20.88 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -119.49 -169.9 14.37 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.478 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 89.5 m-70 -78.9 -49.59 12.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.256 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -33.93 71.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 137' ' ' ARG . 42.6 tp -72.89 -40.0 65.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 108.612 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 88.2 m-20 -60.0 -51.24 70.52 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.31 -43.89 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.41 -0.806 . . . . 0.0 109.148 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -54.4 -47.68 72.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.041 . . . . 0.0 108.832 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.12 -46.35 72.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.3 -44.92 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 109.413 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -51.69 -51.71 53.88 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 110.161 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.57 -49.5 76.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.102 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.94 -42.55 98.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.489 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.4 84.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.336 -0.853 . . . . 0.0 109.858 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -76.15 -31.66 58.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.944 -1.098 . . . . 0.0 108.755 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -62.96 -45.44 92.43 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.436 -0.79 . . . . 0.0 108.941 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 269' ' ' LEU . 2.2 tp-100 -74.95 10.27 1.54 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.35 -0.844 . . . . 0.0 109.475 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.93 -7.09 2.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 108.88 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 267' ' ' GLN . 18.2 mt -75.47 -59.63 2.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.414 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.464 -0.772 . . . . 0.0 109.421 179.902 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.464 HCA3 HG21 ' A' ' 205' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.572 ' O ' HD11 ' A' ' 121' ' ' ILE . 7.5 mt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -45.11 127.94 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.992 -1.068 . . . . 0.0 109.237 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 132.82 55.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -133.6 174.41 10.46 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.9 m -83.26 132.3 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.343 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -62.32 -49.21 76.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.541 -0.724 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -126.12 155.58 41.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.548 -0.72 . . . . 0.0 110.42 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -59.53 137.57 57.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.957 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.96 162.16 19.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.56 145.68 25.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.979 -1.075 . . . . 0.0 109.971 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' C ' ' OE1' ' A' ' 14' ' ' GLU . 67.3 m-85 -128.96 161.43 29.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.752 . . . . 0.0 109.158 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 13' ' ' PHE . 4.3 pm0 -151.47 132.47 14.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.871 -1.143 . . . . 0.0 108.73 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.01 157.69 15.44 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.015 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.48 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 3.3 p -74.32 160.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -1.133 . . . . 0.0 111.317 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.05 138.69 14.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.101 -1.235 . . . . 0.0 112.236 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.494 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.2 m-70 -86.57 -37.36 18.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.103 -1.623 . . . . 0.0 110.729 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -76.22 -40.11 52.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.012 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 73.42 4.72 65.46 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.41 152.4 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.37 -1.076 . . . . 0.0 108.985 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 16.0 t80 -73.6 133.49 43.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.01 . . . . 0.0 110.141 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -137.47 157.82 45.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.175 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.711 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.7 ttmt -132.8 155.7 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.305 -0.872 . . . . 0.0 109.136 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 25' ' ' LYS . 1.9 mt -132.17 144.19 50.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.4 mt -134.57 123.35 41.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mt -111.73 127.58 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 109.811 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -119.63 152.67 53.63 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.66 157.8 40.38 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.275 1.983 . . . . 0.0 111.474 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.499 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.2 mm-40 -131.84 -173.15 3.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.233 -0.917 . . . . 0.0 109.832 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 9.5 tttt -91.66 153.77 19.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.587 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.64 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 28.1 mp0 -47.99 146.25 2.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.03 59.97 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.685 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 55.2 m -81.59 -36.96 28.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.516 -1.579 . . . . 0.0 108.875 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.47 -170.24 32.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 mm -100.73 124.2 54.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.26 143.17 44.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -104.26 153.25 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.8 t80 -129.48 140.79 51.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 136.42 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.021 -1.05 . . . . 0.0 109.681 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.57 29.2 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.891 . . . . 0.0 110.097 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.54 78.51 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.218 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.31 134.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -1.117 . . . . 0.0 109.74 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -86.25 147.59 26.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' A' ' 67' ' ' GLN . 10.5 mt -143.1 94.66 6.28 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.82 142.72 14.22 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.191 1.927 . . . . 0.0 111.848 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.54 87.42 4.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.066 -1.021 . . . . 0.0 110.345 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.51 159.24 42.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 109.418 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.441 ' CD2' ' HG3' ' A' ' 51' ' ' GLU . 5.9 p-80 -53.3 -49.68 66.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HG3' ' CD2' ' A' ' 50' ' ' HIS . 81.4 mt-10 -48.28 -16.14 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.048 -1.033 . . . . 0.0 110.224 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' HIS . 32.8 m-85 -97.45 5.77 49.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 109.597 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.407 ' HA ' HD23 ' A' ' 62' ' ' LEU . 15.7 t -64.2 122.71 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.861 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 m -112.61 -29.53 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -146.36 118.17 8.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.867 -1.146 . . . . 0.0 110.354 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -110.88 126.97 55.26 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 40.3 t-20 -166.36 -153.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.478 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 63.6 m-70 -46.69 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.053 . . . . 0.0 108.499 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.4 t -139.18 165.84 26.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.499 -0.751 . . . . 0.0 109.327 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.46 ' OG1' ' CD ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -108.82 125.34 51.86 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.89 146.33 49.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.04 0.924 . . . . 0.0 111.397 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 53' ' ' VAL . 16.6 mt -125.92 156.33 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -175.36 147.57 8.96 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 118.203 -1.951 . . . . 0.0 111.446 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -144.48 149.5 36.07 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.773 -0.84 . . . . 0.0 109.282 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.99 32.54 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.322 -0.861 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.82 6.82 89.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.614 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.534 ' HB2' HD11 ' A' ' 46' ' ' ILE . 86.8 mm-40 -106.63 140.17 39.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -1.227 . . . . 0.0 107.886 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -143.22 159.74 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.031 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.26 139.55 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -108.52 148.09 30.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 0.0 111.243 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m 56.53 70.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.691 -0.63 . . . . 0.0 111.16 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.7 -4.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.022 . . . . 0.0 109.169 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.602 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.0 OUTLIER -68.19 -33.15 73.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 0.0 110.838 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.572 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 35.2 m170 -64.13 -60.25 3.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.845 -1.159 . . . . 0.0 109.988 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 76' ' ' LEU . 11.3 tp -55.92 -45.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.853 -1.155 . . . . 0.0 108.751 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.514 ' N ' HG23 ' A' ' 75' ' ' ILE . 47.1 mt -54.71 -40.92 69.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.551 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.0 t -59.61 -46.92 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -58.52 -50.84 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 76' ' ' LEU . 46.2 mt -51.32 -44.13 61.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.845 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.764 ' HD1' HG22 ' A' ' 232' ' ' ILE . 12.1 t-160 -56.89 -49.93 74.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 110.363 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.78 -38.02 89.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.68 HD13 HD11 ' A' ' 114' ' ' ILE . 52.4 mt -81.58 -5.59 58.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.0 111.025 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 62.74 59.09 1.47 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.299 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 82' ' ' LEU . 10.6 mm -98.24 125.18 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.459 HG21 HG23 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -110.97 -23.09 11.17 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.299 -0.876 . . . . 0.0 111.394 -178.042 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.559 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.3 m-20 -131.19 112.17 12.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -162.01 138.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.326 -0.859 . . . . 0.0 109.404 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 26.5 m -111.17 99.42 8.27 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.75 112.74 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.396 -0.815 . . . . 0.0 109.536 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -90.29 119.83 30.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.2 t -102.84 106.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 110.936 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mp -86.75 109.79 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.78 -158.65 22.32 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.13 -14.27 7.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.966 . . . . 0.0 110.137 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -134.86 140.18 45.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 110.452 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.35 126.95 93.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.695 ' CD ' HD21 ' A' ' 26' ' ' LEU . 69.4 Cg_exo -46.36 128.52 12.39 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.865 1.71 . . . . 0.0 112.003 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 tp -76.24 -22.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.807 . . . . 0.0 109.724 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.406 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 73.5 mt 54.84 -118.36 1.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -94.3 -11.03 30.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 110.225 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.04 32.53 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.4 p -115.51 -169.47 1.58 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -1.039 . . . . 0.0 109.785 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.56 0.62 24.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.575 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 67.5 t-105 -46.52 -44.25 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.737 -0.861 . . . . 0.0 110.584 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -60.21 -51.36 69.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.785 -1.197 . . . . 0.0 109.719 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -61.18 -45.64 93.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 109.154 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -60.56 -39.92 89.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.962 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -74.24 -42.93 58.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 111.43 -179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.9 35.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.871 -1.143 . . . . 0.0 110.883 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 110' ' ' ILE . 53.9 mt -70.96 -39.57 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.991 -1.068 . . . . 0.0 110.853 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -56.11 -31.42 63.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.801 -1.187 . . . . 0.0 109.745 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -83.97 -5.29 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 0.0 110.221 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -126.62 31.37 5.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.423 -0.798 . . . . 0.0 111.309 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 82' ' ' LEU . 4.7 mt -89.2 145.53 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.474 -1.391 . . . . 0.0 109.601 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.6 tp -131.97 158.64 40.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -106.96 145.5 32.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.113 -0.992 . . . . 0.0 109.525 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -112.39 -163.82 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 109.989 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -118.1 69.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 110.438 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.489 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -161.58 140.69 9.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -81.56 126.4 31.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.07 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.572 HD11 ' O ' ' A' ' 3' ' ' LEU . 66.7 mt -73.48 143.0 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 110.55 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -92.9 97.26 10.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.7 146.53 52.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.63 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -99.76 123.53 44.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 243' ' ' LYS . 12.0 t -125.5 140.88 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.302 -0.874 . . . . 0.0 110.303 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 51.0 t -83.93 137.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.134 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -116.05 -11.55 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.524 -0.735 . . . . 0.0 109.252 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.05 144.92 39.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.12 172.75 14.12 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.266 1.977 . . . . 0.0 112.814 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.66 HG23 ' HB3' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -165.24 142.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.619 -0.676 . . . . 0.0 109.53 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.1 mt -127.99 126.86 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 109.555 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 132' ' ' VAL . 14.7 m -125.29 119.03 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.772 . . . . 0.0 109.679 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -117.42 138.23 51.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.364 -0.835 . . . . 0.0 109.7 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -172.1 142.69 1.44 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.001 -1.062 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 56.1 28.25 12.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.612 -0.68 . . . . 0.0 111.187 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.53 86.95 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 251' ' ' GLY . 6.7 mtt85 -104.68 168.05 9.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.98 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -160.66 149.55 16.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.066 -1.646 . . . . 0.0 109.459 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.98 ' N ' HD23 ' A' ' 138' ' ' LEU . 56.0 mt -149.39 136.11 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.02 -1.05 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -126.28 142.74 51.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.66 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -123.68 145.63 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -142.78 136.62 14.47 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.94 146.95 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.552 1.501 . . . . 0.0 112.142 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.72 152.76 8.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.171 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.4 1.75 47.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 109.642 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.4 p -137.44 145.21 42.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.584 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 242' ' ' VAL . 58.2 tp -79.09 116.81 19.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.938 . . . . 0.0 109.678 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -137.62 135.95 37.06 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.476 HG11 HD23 ' A' ' 231' ' ' LEU . 95.8 t -136.85 127.02 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 109.758 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 m -114.13 128.45 56.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.365 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.514 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.6 t80 -115.3 129.42 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.52 -0.738 . . . . 0.0 109.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -115.27 105.62 13.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.86 132.88 11.39 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -115.37 84.12 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.992 . . . . 0.0 108.977 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.9 m-30 -93.14 148.78 21.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.422 ' HZ2' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -85.18 -13.28 50.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.239 -179.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.534 HD22 ' HB2' ' A' ' 159' ' ' LEU . 2.0 p30 -66.18 -175.23 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.054 -1.029 . . . . 0.0 109.633 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -55.02 -18.37 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.534 ' HB2' HD22 ' A' ' 157' ' ' ASN . 20.4 mt -66.79 -32.31 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.954 -1.091 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.5 -118.08 12.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -115.11 138.95 50.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.987 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -150.14 153.48 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 150.88 41.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -134.84 124.17 24.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 m -96.96 121.9 39.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.98 -1.075 . . . . 0.0 110.015 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -98.81 135.07 40.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.141 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.55 150.7 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 0.0 109.475 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -53.02 117.05 2.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.394 -0.817 . . . . 0.0 109.248 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.51 5.62 18.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -132.19 27.73 4.47 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.212 -1.17 . . . . 0.0 108.57 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.84 -31.44 72.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.533 -0.73 . . . . 0.0 110.572 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.3 -15.82 39.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.993 -1.067 . . . . 0.0 110.907 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -91.52 -4.28 55.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.694 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.64 16.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.088 -1.007 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.48 -34.29 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.021 -1.049 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.7 2.44 45.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.379 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.99 112.96 18.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.788 -1.195 . . . . 0.0 108.94 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 100' ' ' ASP . 5.8 ptp180 -85.9 152.93 22.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.574 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.4 t -53.98 159.02 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.328 -0.857 . . . . 0.0 109.227 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.3 p90 -139.94 168.09 20.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.019 -1.05 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.648 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -156.72 160.0 38.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.15 -0.969 . . . . 0.0 109.749 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.59 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 93.8 m-85 -103.47 146.6 28.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 0.0 109.746 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.702 ' HA ' HD12 ' A' ' 186' ' ' ILE . 26.4 p-10 -59.99 -24.27 64.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.109 -0.994 . . . . 0.0 110.884 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.1 p90 -80.44 -28.78 37.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.748 -1.22 . . . . 0.0 110.682 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 22.4 pt-20 -93.6 -13.84 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.702 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.9 mt -59.32 -53.74 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.83 -38.03 54.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.815 -1.178 . . . . 0.0 109.212 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 192' ' ' VAL . 1.8 t-80 -61.17 -59.33 5.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.25 -0.906 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.5 mt -53.76 -33.19 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -75.0 -25.36 58.76 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -83.1 -31.68 27.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.165 -0.96 . . . . 0.0 111.028 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 188' ' ' HIS . 0.5 OUTLIER -77.97 12.54 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.606 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.65 58.32 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.168 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 5.1 mt -127.09 165.34 19.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.063 -1.257 . . . . 0.0 110.16 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.14 23.0 64.34 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.238 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -68.58 -22.32 64.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.599 -1.53 . . . . 0.0 109.504 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -5.65 50.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.31 126.86 36.7 Favored Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.124 -1.221 . . . . 0.0 110.837 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.78 -173.53 3.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.82 -0.812 . . . . 0.0 109.202 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 29.4 mt -90.18 -12.8 37.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.657 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -89.5 -3.47 58.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.4 OUTLIER -145.12 13.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.696 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.648 HG22 ' SG ' ' A' ' 181' ' ' CYS . 0.8 OUTLIER -149.26 117.48 6.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.609 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.437 HD12 ' ND2' ' A' ' 213' ' ' ASN . 8.3 tp -79.0 115.72 18.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.567 HG11 HEA3 ' A' ' 320' ' ' TUX . 77.4 t -102.68 123.99 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 109.596 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.741 HD21 HD21 ' A' ' 217' ' ' LEU . 18.0 mt -103.1 149.21 24.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.89 153.5 17.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -48.35 -24.96 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -1.203 . . . . 0.0 109.891 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.87 13.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 110.208 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 207' ' ' GLY . 13.5 pttt -149.62 159.7 44.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.958 -1.089 . . . . 0.0 109.734 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.479 HG11 ' HA2' ' A' ' 216' ' ' GLY . 46.2 t -107.45 130.39 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.205 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.612 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 27.3 m-85 -73.13 -53.04 12.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 109.721 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.437 ' ND2' HD12 ' A' ' 204' ' ' LEU . 4.5 m120 -54.09 139.74 53.89 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 109.557 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.14 -31.71 11.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.476 2.117 . . . . 0.0 112.796 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.43 -9.91 59.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.135 -0.978 . . . . 0.0 110.185 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.33 -164.49 53.83 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.741 HD21 HD21 ' A' ' 206' ' ' LEU . 22.4 mt -73.6 141.59 46.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 0.0 109.847 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 15.8 mtt180 -81.81 -13.87 57.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 108.956 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 38.5 m-85 -147.8 142.25 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -0.782 . . . . 0.0 109.125 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.473 ' N ' ' OE1' ' A' ' 220' ' ' GLU . 2.0 mm-40 -49.66 -11.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.038 . . . . 0.0 108.398 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -141.88 43.49 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.073 0.94 . . . . 0.0 108.803 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.1 tt0 -62.89 -36.87 28.45 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 0.0 111.928 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.4 Cg_endo -76.72 -41.07 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.398 1.398 . . . . 0.0 112.521 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 228' ' ' VAL . 4.0 m -75.82 -23.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.869 -1.144 . . . . 0.0 108.231 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -70.36 -46.71 63.55 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.574 ' CE1' ' N ' ' A' ' 179' ' ' THR . 22.5 t60 -58.06 -42.4 85.41 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 108.91 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.68 -43.33 94.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.018 -1.052 . . . . 0.0 109.0 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 224' ' ' VAL . 52.3 t -60.1 -47.03 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 108.745 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 47.4 t80 -49.79 -45.2 49.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.742 -0.599 . . . . 0.0 109.513 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 5.9 m-20 -73.82 -33.48 64.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.476 HD23 HG11 ' A' ' 149' ' ' VAL . 22.4 tp -56.68 -39.17 73.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 0.0 108.679 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.764 HG22 ' HD1' ' A' ' 80' ' ' HIS . 36.1 mt -71.27 -47.97 57.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.07 -32.87 9.63 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -82.28 -26.81 32.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.199 -1.177 . . . . 0.0 109.798 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 260' ' ' VAL . 5.4 mt -83.22 -23.58 32.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.851 -1.156 . . . . 0.0 109.908 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.503 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 35.0 t80 -73.52 -9.03 58.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -51.16 -25.95 6.07 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 108.589 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.3 -17.81 5.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.61 13.94 74.55 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 71.9 p -158.79 145.93 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.935 -1.332 . . . . 0.0 110.009 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.421 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 73.0 Cg_exo -41.96 135.36 3.8 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.229 1.953 . . . . 0.0 111.655 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.507 ' O ' HD13 ' A' ' 147' ' ' LEU . 20.5 t -103.77 132.77 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.9 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.549 ' HB2' HG22 ' A' ' 125' ' ' VAL . 10.3 mmtm -121.05 125.51 47.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.63 179.47 32.56 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -105.37 138.98 40.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.336 -1.097 . . . . 0.0 109.737 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.7 m-85 -140.67 144.59 35.76 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.066 0.936 . . . . 0.0 111.298 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -129.27 144.23 51.15 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 127.84 20.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.643 -1.286 . . . . 0.0 110.745 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -112.83 114.67 27.31 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 51.18 55.67 9.15 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.468 ' O ' ' NE ' ' A' ' 137' ' ' ARG . . . -63.39 -167.74 0.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -169.59 165.52 38.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.602 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 21.2 m-70 -70.91 -52.32 20.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -1.18 . . . . 0.0 109.68 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -54.32 47.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 108.703 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 139' ' ' ILE . 48.8 tp -51.45 -40.83 60.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -58.57 -55.19 38.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -0.98 . . . . 0.0 108.592 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 61.7 t -48.94 -42.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.517 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -50.0 71.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.8 tp -52.16 -43.2 63.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.684 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.447 HG22 HD23 ' A' ' 235' ' ' LEU . 46.2 t -69.83 -46.2 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.15 -51.5 64.08 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.652 -0.655 . . . . 0.0 110.147 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.62 -45.43 86.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.013 -1.054 . . . . 0.0 109.571 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 263' ' ' LEU . 16.5 mt -58.69 -46.91 86.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.745 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.16 -30.12 68.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.79 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -88.86 -23.38 22.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.602 -1.311 . . . . 0.0 108.856 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -75.66 -45.97 34.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.436 -0.79 . . . . 0.0 109.745 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -84.15 7.65 18.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.895 . . . . 0.0 109.979 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.626 ' CB ' ' NZ ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -76.46 1.83 15.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.56 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.77 -75.1 0.27 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.146 -0.971 . . . . 0.0 109.357 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.338 -0.851 . . . . 0.0 109.459 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.612 HEA1 ' CE2' ' A' ' 212' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.929 HD12 ' OD1' ' A' ' 116' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.374 0.606 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.575 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 9.8 mm-40 -52.33 134.77 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -117.34 132.51 56.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 0.0 109.369 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -134.16 173.71 11.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.373 -0.829 . . . . 0.0 109.106 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -81.78 144.36 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.173 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG3' HD13 ' A' ' 115' ' ' LEU . 18.2 ttpp -78.37 -42.36 30.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.711 . . . . 0.0 110.379 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.92 157.82 43.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -63.39 133.87 54.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.518 -0.739 . . . . 0.0 109.849 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 113' ' ' ASN . 20.4 mt -121.04 163.22 18.66 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -155.31 149.38 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -128.84 164.76 22.36 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -148.28 133.04 17.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 108.573 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.38 163.38 23.32 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.74 149.22 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 148.4 39.65 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -67.06 -41.28 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -1.184 . . . . 0.0 112.58 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.523 ' CE1' HG23 ' A' ' 18' ' ' ILE . 4.6 m-70 -86.93 -39.24 15.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.889 -1.757 . . . . 0.0 111.114 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -31.67 64.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.018 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.83 21.22 65.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.96 151.55 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.65 -0.912 . . . . 0.0 109.338 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -72.4 142.96 48.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 t -148.2 158.52 44.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 26' ' ' LEU . 56.5 tttp -133.42 152.85 51.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.009 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.624 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.1 mt -127.81 153.71 46.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.37 128.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.28 124.68 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.163 -0.961 . . . . 0.0 109.699 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -123.62 153.53 66.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.86 163.5 35.25 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.177 1.918 . . . . 0.0 111.171 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 30.2 mm-40 -138.81 -171.81 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.9 ttpm? -88.83 150.54 22.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.478 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.615 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 15.5 mp0 -49.34 149.91 2.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.537 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 59.69 23.66 58.92 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.431 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.47 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 28.9 m -81.8 -46.3 14.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.498 -1.589 . . . . 0.0 109.214 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.548 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 103.19 -170.63 19.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 85' ' ' THR . 4.0 mm -98.9 126.89 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -1.174 . . . . 0.0 107.987 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -139.61 141.13 37.14 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -105.04 155.28 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.4 t80 -130.7 141.76 50.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -170.26 137.03 1.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.091 -1.005 . . . . 0.0 109.838 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.41 31.93 19.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.921 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.38 21.24 74.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.76 133.33 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.999 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -91.11 143.99 26.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.1 mt -137.75 97.69 10.04 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.09 143.16 32.84 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.169 1.913 . . . . 0.0 111.416 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.84 81.34 5.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.877 -1.139 . . . . 0.0 110.396 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -139.29 156.4 47.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.5 p80 -55.07 -50.04 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -44.9 -15.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.001 -1.062 . . . . 0.0 110.192 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' HIS . 65.5 m-85 -99.14 6.12 46.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.98 -1.075 . . . . 0.0 109.629 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' A' ' 50' ' ' HIS . 31.7 t -58.65 131.66 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 108.844 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.81 -35.16 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.315 -0.866 . . . . 0.0 109.833 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -152.23 123.1 7.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.496 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -113.3 133.14 55.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.627 -0.67 . . . . 0.0 109.311 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.1 p-10 -166.81 -153.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.58 ' O ' ' NXH' ' A' ' 320' ' ' TUX . 55.8 m-70 -47.07 -12.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.055 -1.028 . . . . 0.0 108.623 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -135.02 165.75 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.553 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.413 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 52.3 m -102.51 121.38 42.24 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -118.49 135.39 54.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 111.52 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -124.1 161.05 26.41 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.55 147.32 7.25 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.395 -1.86 . . . . 0.0 111.454 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -144.68 151.21 38.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.572 -0.958 . . . . 0.0 109.407 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 58.77 24.24 12.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.499 -0.751 . . . . 0.0 110.96 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' C ' HE21 ' A' ' 67' ' ' GLN . . . 90.26 1.31 75.59 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.642 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.488 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.0 mm-40 -103.15 140.15 37.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.006 -1.29 . . . . 0.0 108.394 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.28 157.17 45.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.51 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.6 mt -133.86 143.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -115.06 155.95 26.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.292 -0.88 . . . . 0.0 111.38 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m 53.85 65.09 1.61 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.705 -0.622 . . . . 0.0 111.129 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG12 ' CG1' ' A' ' 96' ' ' ILE . 18.1 m -113.85 -4.34 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.045 -1.035 . . . . 0.0 109.475 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.581 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 7.1 pt-20 -65.16 -34.69 79.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.879 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -59.28 -60.07 4.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.0 110.207 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.8 tp -58.46 -46.73 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.825 -1.172 . . . . 0.0 109.197 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 10.8 mt -51.97 -42.18 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.019 -1.051 . . . . 0.0 109.566 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 44.9 t -59.49 -47.45 85.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.191 -0.943 . . . . 0.0 110.02 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.44 -54.08 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.979 -1.075 . . . . 0.0 108.623 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.9 mt -52.2 -45.23 65.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.321 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.425 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 8.2 t-160 -53.11 -58.12 8.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.4 mt -59.61 -35.04 73.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.702 HD22 ' CD1' ' A' ' 114' ' ' ILE . 12.9 mt -83.02 -1.47 52.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.88 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 61.92 26.7 16.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.729 -1.232 . . . . 0.0 110.75 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 82' ' ' LEU . 15.4 mm -73.36 118.89 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 108.313 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.456 HG21 ' OE2' ' A' ' 4' ' ' GLU . 47.9 p -101.98 -75.41 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 111.135 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.4 m120 -81.67 113.52 19.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 111.638 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.1 m -163.86 143.35 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.711 . . . . 0.0 109.283 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.568 HG22 ' OE1' ' A' ' 90' ' ' GLU . 4.0 m -111.15 104.5 13.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.411 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.74 112.9 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.568 ' OE1' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -89.33 118.99 29.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.65 108.63 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 111.142 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.57 -178.99 16.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -99.96 -10.61 21.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.272 . . . . 0.0 110.962 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -139.35 143.99 38.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.736 -1.227 . . . . 0.0 110.639 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.446 ' CG1' HG12 ' A' ' 72' ' ' VAL . 9.8 mm -71.3 131.34 86.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.349 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.624 ' CD ' HD21 ' A' ' 26' ' ' LEU . 53.0 Cg_exo -46.65 131.43 15.92 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.005 1.804 . . . . 0.0 112.499 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 tp -79.95 -29.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.424 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 88.8 mt 56.18 -116.0 0.97 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 109.702 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.26 -7.48 41.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.89 -9.71 56.83 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 p -111.18 -172.21 1.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -1.024 . . . . 0.0 109.78 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.84 -2.96 20.43 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -46.53 -41.29 14.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.733 -0.863 . . . . 0.0 111.011 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.89 -51.67 67.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.223 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.3 m-85 -62.95 -45.38 92.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.066 -1.021 . . . . 0.0 109.029 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.67 -39.21 87.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.19 -44.8 59.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 111.397 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.73 -48.35 22.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.035 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.08 -42.53 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.083 . . . . 0.0 111.08 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -57.44 -28.21 63.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.027 -1.046 . . . . 0.0 109.982 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -78.81 -14.63 59.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 109.996 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 11' ' ' LEU . 12.5 m-80 -120.45 34.14 5.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.439 -0.788 . . . . 0.0 110.809 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.702 ' CD1' HD22 ' A' ' 82' ' ' LEU . 15.0 mt -87.41 148.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.665 -1.272 . . . . 0.0 111.155 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD13 ' HG3' ' A' ' 8' ' ' LYS . 13.9 tp -131.75 165.48 23.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.929 ' OD1' HD12 ' A' ' 3' ' ' LEU . 29.6 t-20 -118.76 142.58 47.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.29 -0.881 . . . . 0.0 109.92 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.413 ' NE2' ' HG3' ' A' ' 33' ' ' GLU . 5.0 mt-30 -101.27 -161.65 0.88 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.317 -0.864 . . . . 0.0 109.228 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -117.17 0.37 12.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 0.0 110.401 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 4' ' ' GLU . 24.0 ttm-85 -94.73 150.04 20.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -87.57 135.56 33.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 110.015 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 85' ' ' THR . 66.1 mt -77.63 145.53 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.729 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.46 96.41 9.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -69.64 147.13 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.69 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.16 127.06 47.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 243' ' ' LYS . 48.3 t -131.36 145.23 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.17 135.29 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -116.44 -11.84 11.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.778 . . . . 0.0 109.162 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -141.36 141.57 23.68 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 108.849 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.96 145.84 46.02 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.958 1.772 . . . . 0.0 113.007 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.888 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.7 tt -138.01 149.11 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.62 -0.675 . . . . 0.0 109.186 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.95 122.94 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 109.915 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.44 124.94 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -123.64 140.6 52.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.602 -0.686 . . . . 0.0 110.286 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.76 154.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.244 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 56.62 22.75 7.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.601 -0.687 . . . . 0.0 110.872 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.442 ' O ' ' NH2' ' A' ' 250' ' ' ARG . . . 77.37 6.63 86.64 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.497 ' HB2' HD22 ' A' ' 255' ' ' LEU . 2.5 mtt85 -107.84 172.09 7.03 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -159.79 153.22 22.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.213 -1.554 . . . . 0.0 109.563 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 138' ' ' LEU . 2.2 mt -144.14 143.87 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.57 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -132.51 136.91 46.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.888 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -117.38 146.1 43.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -144.15 137.73 14.3 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 143.83 77.25 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.406 1.404 . . . . 0.0 111.718 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.03 148.05 11.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.235 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -1.28 46.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -134.91 143.91 47.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 242' ' ' VAL . 34.0 tp -76.88 118.24 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.001 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -139.42 138.29 36.37 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.46 ' CG1' HD23 ' A' ' 231' ' ' LEU . 55.4 t -133.94 129.05 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.402 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 32.6 m -115.8 135.85 53.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.346 -0.846 . . . . 0.0 109.309 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 224' ' ' VAL . 8.1 t80 -128.84 131.8 47.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -116.86 107.49 14.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.79 124.23 7.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.66 91.58 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -1.066 . . . . 0.0 109.426 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 155' ' ' PHE . 21.2 m-85 -88.97 148.5 23.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.631 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -95.88 -2.19 47.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.894 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.462 ' ND2' ' CE1' ' A' ' 182' ' ' PHE . 26.0 p30 -72.98 -173.36 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 109.461 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -59.53 -27.58 66.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.96 . . . . 0.0 109.917 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.474 HD22 ' OE1' ' A' ' 162' ' ' GLN . 7.6 mt -57.89 -45.01 87.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 108.938 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.67 -135.95 13.36 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -110.03 144.72 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.533 -0.981 . . . . 0.0 109.68 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.474 ' OE1' HD22 ' A' ' 159' ' ' LEU . 40.1 mt-30 -151.44 149.2 29.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.73 150.56 52.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.16 142.74 34.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 108.859 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.8 m -124.18 130.32 52.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.858 . . . . 0.0 110.417 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -99.38 130.81 45.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.6 151.3 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 109.168 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.75 115.67 2.29 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.506 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.56 3.28 20.67 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -130.97 29.58 4.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -1.165 . . . . 0.0 108.898 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -62.65 -35.15 78.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 110.699 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -53.39 -14.72 0.82 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.958 -1.089 . . . . 0.0 110.949 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 23.4 mt-10 -97.4 -4.24 38.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.75 -1.219 . . . . 0.0 111.543 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.8 pt -119.87 12.51 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.879 -1.138 . . . . 0.0 111.614 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.51 -28.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.891 -1.13 . . . . 0.0 109.854 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 2.65 54.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.979 -1.076 . . . . 0.0 111.259 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.473 ' HB2' ' NH1' ' A' ' 225' ' ' ARG . . . -80.41 132.89 35.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.619 -1.3 . . . . 0.0 108.554 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.64 156.55 18.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.151 -0.968 . . . . 0.0 110.626 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.1 t -57.8 156.16 9.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.643 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 49.6 p90 -140.33 166.36 24.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.192 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.533 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -157.12 160.37 38.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.492 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 71.3 m-85 -103.22 144.63 31.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.5 p-10 -60.89 -22.91 64.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 0.0 111.7 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.4 p90 -75.16 -38.64 60.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.403 . . . . 0.0 111.172 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.689 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -91.58 -10.07 41.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.536 -1.352 . . . . 0.0 110.224 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 183' ' ' ASP . 3.2 mt -53.87 -51.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.961 -1.087 . . . . 0.0 109.449 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -52.33 -46.39 66.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 108.726 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.03 -52.85 63.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.83 HD13 ' O1A' ' A' ' 320' ' ' TUX . 72.3 mt -54.53 -33.99 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -78.77 -27.67 44.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.649 . . . . 0.0 109.713 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -73.49 -26.92 61.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.0 . . . . 0.0 109.71 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 192' ' ' VAL . 13.6 m -83.24 10.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.307 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 25.13 74.01 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.539 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.96 156.99 29.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.103 -1.234 . . . . 0.0 109.856 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.95 25.12 56.63 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.368 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -68.69 -21.61 64.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.589 -1.536 . . . . 0.0 109.58 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.79 -6.37 49.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -58.0 130.64 51.31 Favored Glycine 0 N--CA 1.492 2.422 0 O-C-N 121.207 -1.172 . . . . 0.0 110.582 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 203' ' ' THR . 4.5 p -141.88 163.87 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.7 -0.882 . . . . 0.0 109.089 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.4 mt -64.11 -35.09 79.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.986 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -73.25 -17.31 61.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.35 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.4 m-20 -125.53 6.72 7.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.194 -0.941 . . . . 0.0 109.991 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.533 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 24.2 m -148.94 116.22 6.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.702 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 tp -76.11 113.59 13.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.7 t -103.3 126.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.973 -1.079 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 16.2 mt -108.25 141.75 39.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -97.7 135.7 12.33 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 7.5 ttpt -40.02 -21.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -1.069 . . . . 0.0 110.264 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 207' ' ' GLY . 14.9 t0 -141.67 2.28 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.746 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 207' ' ' GLY . 31.0 mttt -149.25 157.5 43.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 0.0 110.576 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.87 126.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.453 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 19.4 m-85 -73.52 -55.2 6.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -52.75 110.31 1.89 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -54.63 -11.89 3.8 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.752 1.635 . . . . 0.0 111.924 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.26 -6.82 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.783 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.52 -164.09 51.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.5 mt -82.53 143.32 31.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -1.013 . . . . 0.0 110.041 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -89.29 -19.94 24.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.147 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 141.03 33.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.552 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 1.6 pm0 -54.59 -16.65 2.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.04 -1.038 . . . . 0.0 108.597 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.3 40.3 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.797 0.808 . . . . 0.0 109.131 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.465 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 10.6 tt0 -56.4 -56.97 26.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 111.606 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 18.4 Cg_endo -59.42 -37.1 91.87 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.995 1.797 . . . . 0.0 113.406 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.509 HG12 ' CE2' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -82.38 -28.2 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 120.549 -1.344 . . . . 0.0 108.756 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 173' ' ' GLU . 6.3 mtp-105 -65.32 -41.14 94.31 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.597 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 21.3 t60 -65.35 -41.34 93.98 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -56.47 -43.83 79.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.076 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.16 -49.35 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 109.115 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 44.6 t80 -50.07 -43.4 51.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.668 0.747 . . . . 0.0 109.067 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.597 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.6 m-20 -72.86 -36.37 67.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.484 -0.76 . . . . 0.0 109.842 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.46 HD23 ' CG1' ' A' ' 149' ' ' VAL . 24.1 tp -56.1 -35.73 67.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.943 -1.098 . . . . 0.0 108.507 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.8 -48.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.65 -32.34 10.74 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.485 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 4.9 m-20 -82.71 -26.76 31.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -1.199 . . . . 0.0 109.908 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 260' ' ' VAL . 7.0 mt -78.22 -22.62 48.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.8 -1.187 . . . . 0.0 110.088 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -71.63 -7.6 48.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 109.217 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 237' ' ' LEU . 37.7 mt -52.6 -30.51 31.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.955 . . . . 0.0 108.797 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.676 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 97.1 mt -57.95 -15.8 10.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.148 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.33 14.47 78.64 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 p -155.57 150.43 20.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.153 -1.204 . . . . 0.0 109.256 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 6.9 Cg_endo -53.67 132.46 49.27 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.145 1.896 . . . . 0.0 111.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.422 ' O ' HD22 ' A' ' 147' ' ' LEU . 15.2 t -98.62 137.76 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.811 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.421 ' HB3' HG22 ' A' ' 125' ' ' VAL . 9.0 ttmt -127.79 131.28 49.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.382 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.31 -177.84 31.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -108.83 111.1 22.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -1.158 . . . . 0.0 109.66 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.9 m-85 -112.13 149.17 32.55 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.019 0.914 . . . . 0.0 111.171 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.402 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 21.9 t80 -130.13 144.31 51.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.1 t -142.42 128.09 19.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.657 -1.277 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -110.43 115.53 29.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.442 ' NH2' ' O ' ' A' ' 136' ' ' GLY . 5.5 mtm180 49.64 56.15 8.29 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.9 141.45 21.72 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -117.19 -179.69 17.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.581 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 38.7 m-70 -73.95 -52.26 13.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.99 -1.3 . . . . 0.0 109.628 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -35.02 70.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 109.292 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 137' ' ' ARG . 28.7 tp -73.34 -41.51 63.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 108.735 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.5 m-20 -60.57 -51.36 69.77 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 253' ' ' HIS . 46.2 t -51.51 -43.75 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 0.0 109.03 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -55.45 -47.84 75.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.969 -1.082 . . . . 0.0 109.136 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.44 -50.29 62.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 235' ' ' LEU . 54.1 t -63.08 -53.77 42.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.716 0.77 . . . . 0.0 109.329 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -46.77 -51.18 16.89 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.694 -0.629 . . . . 0.0 110.314 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.99 -35.62 79.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.7 -1.25 . . . . 0.0 109.89 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 263' ' ' LEU . 84.7 mt -70.8 -42.92 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.862 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.676 ' HB2' ' CD2' ' A' ' 238' ' ' LEU . . . -77.96 -28.02 49.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 110.082 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -79.65 -35.14 39.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 108.921 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.6 mtpp -61.46 -46.41 90.19 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.211 -0.931 . . . . 0.0 109.495 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -79.39 16.2 1.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.805 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -85.73 -25.1 26.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.0 109.716 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.97 -9.37 1.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.958 . . . . 0.0 109.434 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 42.4 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.877 . . . . 0.0 109.455 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.83 ' O1A' HD13 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 3' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 64.2 mt-10 -44.22 142.15 1.58 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 109.28 179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -119.94 142.63 48.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -141.86 171.81 13.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.48 -0.762 . . . . 0.0 109.058 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 7' ' ' VAL . 3.5 m -81.68 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.946 -1.096 . . . . 0.0 110.229 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' HG3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -70.37 -46.81 63.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 10' ' ' LYS . 1.8 tm-20 -128.66 159.05 36.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.44 -0.787 . . . . 0.0 110.571 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.578 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 5.3 ttpp -59.89 133.94 56.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.6 mt -121.04 160.75 22.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -157.02 149.55 23.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.944 -1.098 . . . . 0.0 110.558 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -129.53 166.38 19.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.02 133.58 11.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.891 -1.13 . . . . 0.0 108.74 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.32 156.64 12.68 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.09 159.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 111.218 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.9 140.61 15.12 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 197' ' ' GLY . 4.4 tt -58.66 -50.53 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.128 -1.219 . . . . 0.0 111.972 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 18.4 m-70 -86.13 -38.85 17.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.312 -1.492 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.0 p -72.72 -36.54 67.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 110.157 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.57 68.21 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -116.19 153.94 30.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.589 -0.948 . . . . 0.0 108.736 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 25.5 t80 -71.05 129.34 38.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.072 -1.017 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 t -132.14 157.8 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 108.945 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.702 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.7 tttm -135.01 152.7 51.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.221 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.4 mt -130.14 148.07 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.556 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.6 mt -135.05 129.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.227 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.2 mt -115.03 125.73 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 109.891 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.556 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.8 m-70 -124.23 149.5 60.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.62 160.73 31.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.181 1.921 . . . . 0.0 111.247 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.1 mm-40 -134.3 -179.21 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.762 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 22.0 tptt -79.97 147.87 31.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -48.32 150.89 1.16 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 -179.701 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 60.9 20.36 57.34 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.24 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 23.9 m -80.89 -46.01 15.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.611 -1.523 . . . . 0.0 109.053 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.44 -167.19 16.47 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 85' ' ' THR . 4.3 mm -102.53 124.11 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.336 -1.096 . . . . 0.0 108.147 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.07 153.17 49.33 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.8 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' A' ' 89' ' ' ILE . 42.4 m-85 -114.64 154.4 28.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.554 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.8 t80 -130.83 138.78 50.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.011 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 4.2 ttmt -168.87 138.14 2.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 60.36 28.63 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.929 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.91 30.61 70.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.27 131.11 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.884 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.65 144.5 29.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 108.947 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.441 HG23 ' CB ' ' A' ' 64' ' ' PHE . 19.8 mt -140.86 99.16 6.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.398 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.67 145.56 48.28 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.135 1.89 . . . . 0.0 111.324 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.25 86.85 4.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.781 -1.199 . . . . 0.0 110.511 -178.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -138.62 154.59 48.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 0.0 109.391 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.453 ' HA ' HG23 ' A' ' 53' ' ' VAL . 38.0 p-80 -52.1 -45.94 65.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.795 . . . . 0.0 110.262 -179.381 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -48.27 -30.94 5.28 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.231 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -82.44 4.48 24.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.486 ' HA ' HD23 ' A' ' 62' ' ' LEU . 5.5 t -61.79 128.1 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 108.74 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.34 -30.3 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.23 -0.919 . . . . 0.0 110.487 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' A' ' 57' ' ' ASN . 4.9 t-160 -153.61 122.26 6.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.92 -1.113 . . . . 0.0 109.566 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 p -113.67 131.73 56.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.639 -0.663 . . . . 0.0 109.286 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 43.8 t-20 -167.29 -154.0 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.544 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 73.3 m-70 -45.53 -15.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.106 -0.996 . . . . 0.0 108.643 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.8 t -134.04 165.33 25.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.56 -0.712 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.5 m -103.22 122.06 43.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 108.724 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -120.34 138.42 53.73 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.092 0.948 . . . . 0.0 111.487 -178.719 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' VAL . 82.5 mt -120.19 163.83 17.14 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.219 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.8 142.75 5.21 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 118.453 -1.832 . . . . 0.0 111.159 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.441 ' CB ' HG23 ' A' ' 46' ' ' ILE . 47.1 t80 -144.86 150.35 36.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.856 . . . . 0.0 109.281 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? 55.4 35.92 26.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 110.749 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.14 2.25 88.75 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.493 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 58.7 mm-40 -98.44 144.23 28.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.254 . . . . 0.0 108.44 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 7.2 ptm85 -142.11 147.43 36.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.022 -1.049 . . . . 0.0 111.331 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.12 143.1 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -114.08 152.47 31.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.003 -1.06 . . . . 0.0 111.013 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 53.21 66.22 1.29 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.694 -0.629 . . . . 0.0 110.734 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 m -113.48 -3.65 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.004 . . . . 0.0 109.132 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -70.37 -28.24 64.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.497 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 25.0 m170 -66.77 -59.85 3.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.058 -1.026 . . . . 0.0 109.767 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.565 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.5 tp -57.75 -45.03 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.845 -1.159 . . . . 0.0 108.764 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.565 ' N ' HG23 ' A' ' 75' ' ' ILE . 67.9 mt -57.01 -40.99 77.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 0.0 109.807 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.493 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.6 t -58.35 -47.86 82.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 109.476 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.07 -54.33 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 108.542 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.3 mt -52.14 -45.17 64.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.881 ' HD1' HG22 ' A' ' 232' ' ' ILE . 20.3 t-160 -55.99 -58.55 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.566 -0.709 . . . . 0.0 110.066 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.23 -37.02 74.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.662 HD22 HD11 ' A' ' 114' ' ' ILE . 9.3 mt -77.79 -4.78 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 0.0 110.21 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.88 34.55 14.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.424 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 82' ' ' LEU . 18.2 mm -80.4 127.0 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 86' ' ' ASN . 5.9 p -105.17 -77.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 111.456 -177.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.9 m-80 -81.38 113.89 19.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.403 -176.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.8 m -162.82 139.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.483 -0.76 . . . . 0.0 109.622 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 30.8 m -109.15 104.46 13.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 2.5 mp -94.16 105.59 17.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 0.0 109.807 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.92 120.32 25.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 108.49 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.434 HG21 HD11 ' A' ' 96' ' ' ILE . 24.5 t -102.42 110.25 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 111.114 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.49 107.67 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.18 -162.75 24.31 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -114.06 -16.21 12.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -1.045 . . . . 0.0 110.332 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -142.07 147.45 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.54 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 91' ' ' VAL . 46.1 mm -69.28 128.74 92.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.697 ' HD2' HD11 ' A' ' 26' ' ' LEU . 74.4 Cg_exo -45.77 131.4 13.16 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.838 1.692 . . . . 0.0 111.845 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -77.88 -24.84 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.554 -0.716 . . . . 0.0 110.558 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.48 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 8.5 mt 55.43 -119.17 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 57.6 t0 -94.52 -9.46 35.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.494 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.77 -4.88 32.45 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.4 p -118.47 -173.54 2.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -1.05 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 -3.97 20.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -46.67 -36.57 7.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.775 -0.838 . . . . 0.0 110.932 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.0 -52.0 64.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.864 -1.148 . . . . 0.0 110.268 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CZ ' HD11 ' A' ' 99' ' ' LEU . 73.9 m-85 -62.23 -45.02 95.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.07 . . . . 0.0 108.874 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.44 -40.47 86.91 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.496 0.665 . . . . 0.0 109.625 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -72.8 -43.69 62.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 111.733 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.48 -49.66 15.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 111.075 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.34 -41.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -59.02 -28.48 66.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.946 -1.096 . . . . 0.0 110.122 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -78.28 -17.96 55.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.67 34.5 5.18 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.467 -0.771 . . . . 0.0 110.731 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.662 HD11 HD22 ' A' ' 82' ' ' LEU . 9.5 mt -82.92 148.07 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.303 . . . . 0.0 110.526 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 8' ' ' LYS . 10.1 tp -130.67 151.99 50.51 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.48 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -100.39 136.43 40.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.028 -1.045 . . . . 0.0 109.698 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.578 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 18.9 mt-30 -102.63 -166.45 1.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -120.89 72.26 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.416 -0.802 . . . . 0.0 110.923 -179.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -166.17 145.11 5.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.64 128.88 34.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.149 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.79 139.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.28 72.83 4.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -51.5 142.54 13.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.528 -0.732 . . . . 0.0 110.097 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -103.82 124.09 48.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 243' ' ' LYS . 26.3 t -127.87 142.77 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 0.0 109.954 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.8 t -81.27 134.68 26.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -117.26 -11.77 10.59 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -139.74 141.66 28.62 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.412 -0.805 . . . . 0.0 108.916 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.26 169.73 20.0 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.162 1.908 . . . . 0.0 113.029 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.839 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.3 tt -163.67 143.48 2.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.469 0.652 . . . . 0.0 109.618 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.23 121.09 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.29 112.38 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.73 125.84 53.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -173.34 157.86 3.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 0.0 110.652 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.455 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 27.1 mt-10 56.63 18.74 3.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 110.771 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.67 -0.22 89.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER -102.88 172.28 6.92 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.963 HD23 ' N ' ' A' ' 139' ' ' ILE . 4.8 tt -160.24 145.82 15.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.441 -1.412 . . . . 0.0 108.669 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.963 ' N ' HD23 ' A' ' 138' ' ' LEU . 59.3 mt -147.92 134.81 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 108.394 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -124.05 144.16 50.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.71 148.81 44.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -148.82 138.72 12.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.14 146.17 60.99 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.462 1.441 . . . . 0.0 112.129 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.14 147.94 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.49 -1.4 37.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.471 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.7 p -136.92 159.36 42.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 109.304 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.574 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 27.0 tp -88.34 121.0 30.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 0.0 109.748 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -138.65 135.15 34.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.507 ' CG1' HD23 ' A' ' 231' ' ' LEU . 73.4 t -137.19 118.5 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.9 m -106.31 136.51 45.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.752 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.685 ' HB2' HG22 ' A' ' 228' ' ' VAL . 83.1 t80 -123.67 128.32 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.469 -0.769 . . . . 0.0 109.488 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' CD ' ' CE2' ' A' ' 249' ' ' PHE . 7.2 tt0 -115.16 104.66 12.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.41 126.68 8.98 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -110.93 84.98 2.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -1.08 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.3 m-30 -90.38 148.97 22.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.132 -0.98 . . . . 0.0 109.407 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -91.83 -5.81 52.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.856 . . . . 0.0 110.739 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.75 HD21 HD12 ' A' ' 159' ' ' LEU . 19.2 p-10 -68.44 -167.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.725 -1.234 . . . . 0.0 109.435 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.8 p90 -59.94 -26.67 66.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.994 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.75 HD12 HD21 ' A' ' 157' ' ' ASN . 6.5 mt -58.92 -51.59 69.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 108.812 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.63 -119.17 5.43 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.94 143.12 51.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.622 -0.928 . . . . 0.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -156.09 146.64 21.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.429 -0.794 . . . . 0.0 109.557 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -126.29 150.83 48.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.0 109.673 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -135.09 118.77 17.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.9 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -94.9 121.82 36.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.043 . . . . 0.0 109.735 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 4.2 t80 -99.73 139.18 35.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.356 -0.84 . . . . 0.0 109.486 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.555 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.7 t -138.94 153.06 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.39 -0.819 . . . . 0.0 109.152 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 98.4 mt-10 -53.58 120.43 6.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.597 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.41 6.68 17.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.48 28.67 1.81 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.159 -1.201 . . . . 0.0 108.671 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -63.93 -35.99 82.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 110.4 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.96 -12.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.168 -0.957 . . . . 0.0 110.517 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -90.9 -4.52 56.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.052 -1.03 . . . . 0.0 110.536 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.55 -7.13 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.164 -0.96 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.13 -29.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.574 -1.328 . . . . 0.0 110.011 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.9 mt -90.03 -1.34 57.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.833 -1.167 . . . . 0.0 110.736 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.58 118.18 20.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.706 -1.246 . . . . 0.0 108.374 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.55 153.01 21.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.0 110.296 -179.02 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.516 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 6.2 t -53.47 158.63 1.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 0.0 109.773 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.545 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 23.3 p90 -143.32 169.44 17.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.635 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -162.09 167.95 23.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 -179.785 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.502 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 86.8 m-85 -104.21 145.08 30.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 109.203 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.601 ' HA ' HD12 ' A' ' 186' ' ' ILE . 51.3 p30 -63.34 -23.49 67.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.277 -0.89 . . . . 0.0 111.426 -178.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.52 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 p90 -79.33 -27.32 42.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.585 -1.322 . . . . 0.0 111.009 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.485 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 26.0 pt-20 -96.45 -13.76 22.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.688 -1.258 . . . . 0.0 109.872 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.6 mt -55.56 -51.65 55.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -52.43 -44.5 65.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.668 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -57.6 -51.5 69.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.943 . . . . 0.0 109.41 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.615 HD13 ' O1A' ' A' ' 320' ' ' TUX . 18.9 mt -59.45 -34.31 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.134 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -74.43 -27.09 60.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 110.144 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -74.8 -33.51 62.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.018 -1.051 . . . . 0.0 109.921 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.42 12.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 109.226 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.43 25.35 70.66 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.556 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 86.5 mt -117.83 155.08 30.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -1.192 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.495 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.2 27.81 47.44 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.29 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -68.36 -22.46 64.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.667 -1.49 . . . . 0.0 108.929 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -103.14 -4.92 47.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.65 126.0 29.29 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 121.323 -1.104 . . . . 0.0 110.956 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.18 39.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.858 -0.789 . . . . 0.0 109.074 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.462 HD21 ' CCA' ' A' ' 320' ' ' TUX . 39.5 mt -55.61 -13.32 1.55 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.792 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -83.46 -2.22 55.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.06 -1.025 . . . . 0.0 109.423 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -151.18 17.67 0.75 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 108.826 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.635 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 87.4 m -151.89 115.16 4.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.504 -0.747 . . . . 0.0 109.33 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.6 tp -76.57 109.76 10.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.208 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 186' ' ' ILE . 42.6 t -103.17 131.36 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 109.941 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.5 mt -114.28 144.83 42.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.536 -0.728 . . . . 0.0 109.35 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.94 151.07 19.14 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 207' ' ' GLY . 25.7 tttt -41.42 -28.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 110.162 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 209' ' ' ASP . 1.8 p30 -146.4 8.15 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.929 -1.107 . . . . 0.0 110.399 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.6 tttt -141.93 150.61 41.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.832 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.21 127.45 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.444 ' CD2' HEA2 ' A' ' 320' ' ' TUX . 15.9 m-85 -70.66 -54.43 11.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.201 -0.937 . . . . 0.0 110.019 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.97 132.86 80.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.05 . . . . 0.0 109.462 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.85 -19.4 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.322 2.015 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.81 -6.04 58.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.669 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.84 -169.29 52.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.53 147.16 42.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.387 -1.066 . . . . 0.0 109.568 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -74.76 -62.64 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 108.848 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 221' ' ' ASN . 11.5 m-85 -117.9 142.78 46.95 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 219' ' ' TYR . 8.6 m-20 -137.7 30.41 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.483 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -60.25 -40.04 73.6 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 16.0 Cg_exo -65.22 -49.6 2.56 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.35 2.034 . . . . 0.0 112.647 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.817 ' O ' HG23 ' A' ' 228' ' ' VAL . 2.5 m -73.17 -22.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.922 -1.111 . . . . 0.0 108.628 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -70.93 -46.11 63.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.514 ' CE1' ' N ' ' A' ' 179' ' ' THR . 26.0 t60 -58.69 -38.45 78.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -42.14 99.59 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.9 t -66.34 -38.9 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.493 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 48.7 t80 -56.48 -51.74 67.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.732 -0.605 . . . . 0.0 109.704 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.497 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 8.2 m-20 -70.14 -30.14 67.24 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.174 -0.954 . . . . 0.0 109.515 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.507 HD23 ' CG1' ' A' ' 149' ' ' VAL . 30.1 tp -56.56 -37.6 70.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.881 HG22 ' HD1' ' A' ' 80' ' ' HIS . 66.0 mt -73.01 -48.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.64 8.33 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.35 -29.62 30.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.728 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.67 HD23 HG22 ' A' ' 260' ' ' VAL . 6.8 mt -79.16 -22.41 45.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.725 -1.234 . . . . 0.0 109.253 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.406 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.2 t80 -70.09 -8.96 53.74 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.1 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.3 mt -52.67 -27.93 19.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 108.818 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.403 HD12 HG22 ' A' ' 242' ' ' VAL . 96.6 mt -55.28 -18.47 6.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.021 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.86 12.54 77.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.0 p -158.51 147.6 14.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.139 -1.212 . . . . 0.0 109.551 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.417 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 57.8 Cg_exo -42.99 135.18 5.42 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.344 2.029 . . . . 0.0 111.975 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.403 HG22 HD12 ' A' ' 238' ' ' LEU . 13.7 t -101.75 133.08 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.702 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.663 ' HB2' HG22 ' A' ' 125' ' ' VAL . 32.4 mmtm -122.11 126.81 49.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.581 -0.699 . . . . 0.0 109.261 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 176.61 29.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -107.07 110.21 22.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -1.231 . . . . 0.0 109.833 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.7 m-85 -112.06 147.43 36.02 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.834 0.826 . . . . 0.0 111.038 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -127.42 144.1 51.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.4 m -134.84 128.11 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.704 -1.248 . . . . 0.0 110.679 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.497 ' CE2' ' CD ' ' A' ' 152' ' ' GLU . 3.0 t80 -112.44 110.58 20.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 6.5 mmm180 47.34 55.75 7.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -178.185 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.27 142.09 23.71 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -178.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -110.63 159.63 13.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -56.07 -48.93 75.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.241 . . . . 0.0 109.534 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 25.3 p -57.21 -55.16 38.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.192 -0.943 . . . . 0.0 109.106 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.403 ' HG ' HD12 ' A' ' 139' ' ' ILE . 54.5 tp -52.07 -37.29 53.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -58.22 -55.7 31.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.093 -1.004 . . . . 0.0 108.855 179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.61 -43.1 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.494 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -49.52 71.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 139' ' ' ILE . 9.5 tp -52.71 -41.24 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.67 HG22 HD23 ' A' ' 235' ' ' LEU . 74.2 t -71.97 -50.43 37.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.76 0.791 . . . . 0.0 109.507 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -49.81 -45.06 49.6 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.641 -0.662 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -42.79 70.36 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.479 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 263' ' ' LEU . 36.3 mt -62.05 -43.61 98.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.552 -0.718 . . . . 0.0 110.344 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -83.35 -34.71 25.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.625 -1.297 . . . . 0.0 108.453 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 267' ' ' GLN . 20.3 mttp -49.16 -36.5 19.57 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.604 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 266' ' ' LYS . 46.9 tt0 -40.07 -70.4 0.1 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.871 -0.518 . . . . 0.0 110.758 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -91.45 16.29 10.58 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.833 -1.167 . . . . 0.0 111.105 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 269' ' ' LEU . 8.1 mt -108.39 24.88 12.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.149 -0.969 . . . . 0.0 109.49 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.875 . . . . 0.0 109.41 179.916 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.615 ' O1A' HD13 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.642 ' O ' HD11 ' A' ' 121' ' ' ILE . 2.3 mt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 3' ' ' LEU . 21.7 mm-40 -45.01 141.52 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 0.0 109.199 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -121.08 139.64 53.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -141.23 177.84 7.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.28 135.18 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 109.815 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -65.66 -45.51 82.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.766 . . . . 0.0 110.322 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.73 157.38 41.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HG3' ' NE2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -64.46 133.66 52.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.11 -179.801 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 113' ' ' ASN . 40.5 mt -118.24 160.14 22.12 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.552 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 p -158.1 150.44 22.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.101 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -132.42 174.88 9.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.628 -0.67 . . . . 0.0 109.707 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -150.46 135.51 17.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 108.589 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.76 156.09 12.87 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.901 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 22' ' ' GLU . 8.9 p -80.93 142.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -1.083 . . . . 0.0 110.91 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.24 142.9 36.63 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.0 tt -60.06 -48.01 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -1.145 . . . . 0.0 112.472 -178.266 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 9.6 m-70 -86.88 -37.93 17.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.229 -1.544 . . . . 0.0 111.462 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -68.13 -35.1 77.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 0.0 110.135 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.9 71.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.615 ' C ' HG23 ' A' ' 16' ' ' VAL . 32.1 tt0 -118.92 154.81 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 109.242 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -68.4 140.18 55.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 t -147.42 157.08 43.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.041 . . . . 0.0 108.766 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -127.58 161.98 27.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.192 -0.942 . . . . 0.0 110.014 -179.236 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 96' ' ' ILE . 12.9 mt -130.94 143.65 50.88 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.29 127.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.312 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mt -113.45 125.0 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 109.403 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.4 ' NE2' ' HG3' ' A' ' 10' ' ' LYS . 17.2 m-70 -121.47 142.71 36.1 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.545 -0.722 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -53.87 160.07 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.544 1.496 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 76.7 mt-10 -134.77 -178.75 5.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.3 ttmm -85.91 151.44 23.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.648 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -49.81 147.31 3.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 110.447 -179.591 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.76 21.84 58.89 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.551 -0.718 . . . . 0.0 111.884 178.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 98.5 m -81.19 -46.51 14.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.45 -1.618 . . . . 0.0 109.027 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.45 -168.2 15.29 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mm -101.63 124.66 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -1.112 . . . . 0.0 108.036 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HE ' HG22 ' A' ' 35' ' ' THR . 0.6 OUTLIER -143.16 139.55 30.41 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.765 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -97.16 154.33 17.43 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.6 t80 -129.47 139.94 51.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 46.3 tttm -168.08 137.76 2.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 -179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.14 29.18 18.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 0.0 110.102 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.01 28.36 70.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.8 t -134.08 138.27 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 109.852 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -92.14 142.45 27.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.19 179.637 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -137.42 95.13 11.65 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.439 -179.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -48.27 144.97 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.212 1.941 . . . . 0.0 111.652 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.89 84.61 4.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.542 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -141.16 157.02 45.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.008 -1.058 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.1 p80 -52.92 -50.12 64.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -46.55 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 0.0 109.999 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.7 m-85 -99.67 4.81 45.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.463 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 50' ' ' HIS . 5.1 t -63.38 132.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 108.773 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -118.09 -33.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.7 t-160 -147.61 118.6 7.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 110.037 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.2 p -112.66 126.37 55.3 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.7 t-20 -167.06 -152.76 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.584 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 10.7 m-70 -44.21 -16.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 108.586 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.1 t -137.19 165.5 25.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.495 -0.753 . . . . 0.0 109.368 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 m -109.24 125.36 52.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.368 -0.832 . . . . 0.0 108.831 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 1.4 m-20 -125.59 148.02 49.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.994 0.902 . . . . 0.0 111.162 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' A' ' 72' ' ' VAL . 28.1 mt -125.78 161.12 28.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.99 143.59 6.37 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.541 -1.79 . . . . 0.0 110.985 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -144.81 151.85 39.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.629 -0.924 . . . . 0.0 109.72 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.81 29.74 12.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.386 -0.821 . . . . 0.0 110.599 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.52 0.54 86.32 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.569 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 84.8 mm-40 -97.01 145.44 25.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.307 . . . . 0.0 108.373 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -143.35 149.58 37.95 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.658 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -132.93 143.17 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -114.05 149.71 35.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.124 -0.985 . . . . 0.0 111.611 -178.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.8 m 53.87 71.6 0.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.716 -0.615 . . . . 0.0 111.054 178.621 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 62' ' ' LEU . 20.6 m -112.81 -5.83 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.41 -23.87 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -68.98 -60.88 2.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.996 -1.065 . . . . 0.0 109.723 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 76' ' ' LEU . 11.1 tp -59.63 -45.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' N ' HG23 ' A' ' 75' ' ' ILE . 88.3 mt -54.69 -40.77 69.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 0.0 109.68 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.571 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.47 -47.93 83.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.086 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.19 -55.23 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.011 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 mt -52.47 -43.38 64.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.658 ' HD1' HG22 ' A' ' 232' ' ' ILE . 15.8 t-160 -55.53 -58.08 9.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.127 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.486 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 57.5 mt -55.79 -36.66 67.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.267 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.699 HD22 HD11 ' A' ' 114' ' ' ILE . 11.7 mt -79.89 -4.31 51.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 110.461 -178.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER 62.77 38.46 11.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.866 -1.146 . . . . 0.0 110.51 179.628 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 82' ' ' LEU . 16.4 mm -83.31 129.74 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.9 p -107.04 -76.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.235 -0.916 . . . . 0.0 111.129 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.708 ' O ' HG13 ' A' ' 87' ' ' VAL . 4.1 m-80 -81.22 113.96 19.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -176.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.05 141.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 109.623 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.551 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -109.01 103.84 12.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.488 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.68 106.03 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.87 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.68 122.01 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.075 -1.016 . . . . 0.0 108.936 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -102.96 104.92 17.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.454 -0.779 . . . . 0.0 110.422 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 92' ' ' ILE . 4.8 mt -86.03 110.84 20.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.176 -0.953 . . . . 0.0 108.582 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.32 -179.23 16.38 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -15.32 22.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.138 . . . . 0.0 110.349 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.4 tt0 -136.07 142.7 44.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.986 -1.071 . . . . 0.0 110.272 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.724 ' CD1' HD21 ' A' ' 26' ' ' LEU . 2.5 mm -68.26 128.41 93.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.765 . . . . 0.0 109.654 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -45.72 127.39 9.89 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.822 1.681 . . . . 0.0 111.834 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 tp -80.1 -22.44 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.76 . . . . 0.0 110.354 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.451 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 89.8 mt 55.72 -118.08 1.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.854 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -94.78 -9.7 33.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.15 -0.968 . . . . 0.0 110.43 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.68 39.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.3 p -115.42 -174.55 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -1.021 . . . . 0.0 109.368 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.23 -6.96 17.55 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.547 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 72.5 t-105 -46.61 -35.21 5.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.678 -0.896 . . . . 0.0 110.09 -179.559 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.24 -51.52 68.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.906 -1.121 . . . . 0.0 109.968 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CG ' ' CD1' ' A' ' 75' ' ' ILE . 63.1 m-85 -65.03 -44.62 88.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.077 -1.014 . . . . 0.0 108.944 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.43 ' CD2' HG11 ' A' ' 175' ' ' VAL . 9.0 t80 -61.91 -37.81 86.03 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.456 0.646 . . . . 0.0 109.572 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.547 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 24.4 mm-40 -65.38 -52.75 51.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.685 . . . . 0.0 111.595 -178.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.33 -52.24 9.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.216 . . . . 0.0 110.693 -178.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 92.8 mt -50.71 -47.81 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.78 -1.2 . . . . 0.0 110.477 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -57.89 -31.3 66.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -83.78 13.51 4.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.523 ' HB2' HD11 ' A' ' 11' ' ' LEU . 1.1 m-20 -149.46 30.68 0.75 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.699 HD11 HD22 ' A' ' 82' ' ' LEU . 10.0 mt -85.02 147.12 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.949 -1.094 . . . . 0.0 110.426 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.0 tp -131.7 155.69 47.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.488 -0.757 . . . . 0.0 109.161 179.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.8 OUTLIER -110.42 128.2 55.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 179.725 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.648 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 7.2 mt-30 -97.02 -165.73 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 118' ' ' ASN . 48.6 p30 -124.77 74.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 110.301 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -161.73 139.93 9.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.057 179.228 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -47.3 167.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 110.191 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.642 HD11 ' O ' ' A' ' 3' ' ' LEU . 25.4 mt -126.12 104.23 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.94 71.28 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.429 -0.794 . . . . 0.0 110.154 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.585 ' CE1' HG21 ' A' ' 121' ' ' ILE . 93.8 m-85 -57.4 147.18 26.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -104.71 123.65 47.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 243' ' ' LYS . 5.4 t -129.2 143.43 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.991 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.46 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -113.23 -11.8 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.254 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -141.32 144.71 35.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.8 172.29 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.054 1.836 . . . . 0.0 113.003 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 141' ' ' ALA . 9.9 tt -165.92 145.53 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.348 0.594 . . . . 0.0 109.846 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 131' ' ' ILE . 1.7 mt -128.28 125.24 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.496 -0.753 . . . . 0.0 109.361 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.437 HG23 ' HB ' ' A' ' 139' ' ' ILE . 0.7 OUTLIER -122.73 116.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 110.003 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -107.77 142.26 38.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' CG ' ' OE1' ' A' ' 135' ' ' GLU . 8.4 t70 -168.96 135.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.723 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER 50.94 34.89 11.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 111.509 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.73 8.06 86.2 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -103.15 172.5 6.78 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.2 tt -160.59 148.74 16.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.248 -1.533 . . . . 0.0 109.174 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.945 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.4 mt -146.87 133.78 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 108.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -125.21 138.99 54.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.772 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.95 139.55 53.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -136.25 134.04 19.83 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -53.12 148.87 29.52 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.353 1.369 . . . . 0.0 112.326 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.67 158.39 9.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.882 . . . . 0.0 108.944 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.3 2.65 54.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 109.943 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -138.06 150.03 46.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.539 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.492 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 16.8 tp -83.09 115.12 21.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -136.61 141.92 43.27 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.556 ' CG1' HD23 ' A' ' 231' ' ' LEU . 46.6 t -136.27 133.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.131 -0.981 . . . . 0.0 109.973 -179.005 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 m -119.1 124.72 47.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.528 ' CE2' HG12 ' A' ' 224' ' ' VAL . 10.0 t80 -115.1 129.85 56.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 109.983 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 153' ' ' GLY . 4.5 tp10 -113.72 105.29 13.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.562 ' N ' ' OE1' ' A' ' 152' ' ' GLU . . . -101.44 145.4 16.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -132.41 85.32 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -1.04 . . . . 0.0 109.589 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.7 m-30 -88.67 148.93 23.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.46 -0.775 . . . . 0.0 109.021 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 mmtt -88.93 -8.72 53.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 11.9 p-10 -66.79 -170.74 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 109.498 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 16.8 p90 -59.4 -24.63 63.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.853 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.456 HD12 HD21 ' A' ' 157' ' ' ASN . 8.5 mt -53.77 -58.39 7.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.005 . . . . 0.0 108.904 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.92 -134.73 11.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.34 142.7 47.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.995 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.438 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 4.6 pt20 -162.12 159.51 26.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 0.0 109.547 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.51 152.97 51.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.469 -0.769 . . . . 0.0 109.315 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -133.75 120.05 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.0 108.815 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 m -98.99 121.93 41.58 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.97 -1.081 . . . . 0.0 110.34 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -95.26 138.12 33.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.57 156.51 42.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.783 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.658 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 4.9 mp0 -60.31 113.69 2.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 109.417 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.4 6.03 18.31 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -130.91 30.23 4.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.294 -1.121 . . . . 0.0 108.836 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 175' ' ' VAL . 6.1 mp0 -63.75 -34.67 78.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.471 -0.768 . . . . 0.0 110.89 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -16.49 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.918 -1.114 . . . . 0.0 110.98 -178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.88 -4.02 55.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.91 -1.119 . . . . 0.0 111.146 -178.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.16 -5.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.031 -1.043 . . . . 0.0 111.107 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -92.59 -28.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.471 -1.393 . . . . 0.0 110.436 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.08 0.95 56.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 0.0 110.964 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.9 123.15 25.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.675 -1.265 . . . . 0.0 108.485 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -91.04 151.73 20.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.673 -1.267 . . . . 0.0 109.797 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 t -62.28 134.37 56.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.45 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.54 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 11.5 p90 -117.33 179.1 4.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 0.0 110.106 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -170.39 166.41 8.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.371 -0.831 . . . . 0.0 109.723 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 31.2 m-85 -103.79 146.11 29.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 0.0 109.244 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.5 OUTLIER -67.67 -17.73 64.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 111.216 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.3 p90 -80.67 -33.42 35.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.518 -1.364 . . . . 0.0 110.549 -179.195 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.588 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.1 OUTLIER -90.24 -15.73 30.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.762 -1.212 . . . . 0.0 109.504 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.705 HD12 ' HA ' ' A' ' 183' ' ' ASP . 7.6 mt -58.57 -51.24 74.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.47 -50.24 53.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.858 -1.151 . . . . 0.0 109.292 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.04 -52.0 62.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.172 -0.955 . . . . 0.0 108.83 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 61.7 mt -55.29 -34.2 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -0.917 . . . . 0.0 108.953 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -74.18 -32.71 63.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 109.863 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.05 -30.47 70.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.788 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' ' 194' ' ' LEU . 11.7 m -82.82 12.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.97 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.35 70.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.293 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' ' 192' ' ' VAL . 20.1 mt -118.3 156.19 29.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.006 -1.291 . . . . 0.0 109.945 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.492 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.89 25.12 53.82 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.001 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -67.55 -22.18 65.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.671 -1.488 . . . . 0.0 109.488 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -6.02 50.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.57 124.73 35.38 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.133 -1.216 . . . . 0.0 110.516 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 54.2 p -135.35 -179.7 5.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.825 -0.809 . . . . 0.0 109.398 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.0 mt -82.65 -12.42 57.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -91.9 -9.93 41.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 1.8 m120 -136.37 7.92 3.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.513 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.2 m -147.28 120.16 8.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.615 HD21 HD23 ' A' ' 217' ' ' LEU . 4.4 tp -84.02 117.87 23.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.984 . . . . 0.0 109.127 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.504 HG21 HCA3 ' A' ' 320' ' ' TUX . 58.2 t -103.19 127.67 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 109.593 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 211' ' ' VAL . 4.8 mt -107.06 146.95 30.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.488 -0.757 . . . . 0.0 109.65 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.71 148.54 16.51 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 207' ' ' GLY . 20.4 tttt -41.13 -31.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -1.04 . . . . 0.0 109.918 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 31.9 t0 -145.61 10.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 0.0 110.282 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -144.62 153.67 42.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 109.774 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.501 HG22 HD23 ' A' ' 206' ' ' LEU . 44.7 t -106.3 131.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.091 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -72.6 -54.45 9.09 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.225 -0.922 . . . . 0.0 110.044 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -56.18 136.35 74.75 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 0.0 109.34 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.88 -25.82 19.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.311 2.008 . . . . 0.0 112.653 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.516 ' OE2' ' NH1' ' A' ' 218' ' ' ARG . 16.4 tm-20 -80.25 -9.82 59.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -165.52 52.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.615 HD23 HD21 ' A' ' 204' ' ' LEU . 11.8 mt -76.28 141.78 41.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -1.055 . . . . 0.0 109.858 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.516 ' NH1' ' OE2' ' A' ' 215' ' ' GLU . 0.1 OUTLIER -65.02 -52.23 57.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.63 179.25 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.447 ' H ' ' HB2' ' A' ' 222' ' ' GLU . 19.2 m-85 -117.85 176.8 5.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 220' ' ' GLU . 0.4 OUTLIER -76.0 -19.08 58.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.548 ' OD1' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -127.83 35.39 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.469 -0.769 . . . . 0.0 109.104 -179.985 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -59.79 -34.96 24.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 111.126 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.3 Cg_exo -73.87 -43.63 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.808 1.672 . . . . 0.0 112.342 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.528 HG12 ' CE2' ' A' ' 151' ' ' TYR . 0.9 OUTLIER -77.09 -25.38 15.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.903 -1.123 . . . . 0.0 108.133 179.196 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.548 ' NH1' ' OD1' ' A' ' 221' ' ' ASN . 8.0 mtt180 -67.13 -44.11 80.69 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -57.65 -50.32 73.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 108.689 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 224' ' ' VAL . 60.8 t -57.91 -48.97 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.073 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.571 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 64.3 t80 -49.99 -44.19 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -73.02 -35.53 66.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.534 -0.729 . . . . 0.0 109.571 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.556 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.9 tp -56.46 -36.31 68.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 108.65 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.658 HG22 ' HD1' ' A' ' 80' ' ' HIS . 44.1 mt -72.42 -48.25 48.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.58 -34.3 13.91 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -81.64 -28.64 33.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -1.2 . . . . 0.0 109.645 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.503 HD23 HG22 ' A' ' 260' ' ' VAL . 5.4 mt -80.26 -21.42 42.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.835 -1.166 . . . . 0.0 109.125 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.489 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.3 t80 -71.08 -9.1 57.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 108.692 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 234' ' ' ASP . 14.1 mt -50.02 -28.78 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.425 HD12 HG22 ' A' ' 242' ' ' VAL . 96.7 mt -56.52 -14.02 2.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.088 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.5 15.95 80.23 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 80.8 p -158.59 144.98 12.64 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.257 . . . . 0.0 109.383 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -42.59 130.54 5.25 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.197 1.931 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.425 HG22 HD12 ' A' ' 238' ' ' LEU . 4.0 t -100.36 135.85 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.59 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 125' ' ' VAL . 5.4 mmtp -123.91 127.57 48.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.664 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.78 172.14 23.72 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -101.14 113.87 27.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.59 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.0 m-85 -112.58 147.08 37.4 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.981 0.896 . . . . 0.0 111.306 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.4 t80 -128.86 144.06 51.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.409 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 28.1 t -139.31 125.39 19.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.697 -1.252 . . . . 0.0 110.005 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 250' ' ' ARG . 71.8 t80 -110.47 113.37 25.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 249' ' ' PHE . 9.6 mmm180 46.43 56.6 6.2 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.73 150.5 21.16 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -118.38 179.82 17.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -68.66 -42.35 78.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -1.143 . . . . 0.0 109.568 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -36.32 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.204 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.703 ' HG ' HD12 ' A' ' 139' ' ' ILE . 57.4 tp -72.54 -36.79 68.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.016 -1.053 . . . . 0.0 108.911 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -60.76 -52.41 65.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.352 -0.842 . . . . 0.0 108.81 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 37.2 t -52.53 -44.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.34 -47.54 75.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.007 -1.058 . . . . 0.0 109.167 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 139' ' ' ILE . 30.8 tp -52.51 -45.07 66.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 108.623 179.397 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.503 HG22 HD23 ' A' ' 235' ' ' LEU . 40.1 t -68.36 -53.29 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 109.465 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -46.7 -45.97 19.84 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.682 -0.636 . . . . 0.0 110.636 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.92 -47.96 64.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.906 -1.121 . . . . 0.0 109.503 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 263' ' ' LEU . 19.7 mt -57.97 -43.66 86.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.05 74.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.282 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -86.27 -24.21 26.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.706 -1.246 . . . . 0.0 108.929 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.492 ' HZ3' ' HB ' ' A' ' 130' ' ' ILE . 22.8 mttt -71.86 -46.11 59.05 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 109.482 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -74.01 12.63 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.674 -179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 266' ' ' LYS . 43.8 tttp -59.32 -51.03 71.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 109.498 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.2 mt -94.37 -75.12 0.52 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 270' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 270' ' ' THR . 3.7 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.373 -0.83 . . . . 0.0 109.415 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.504 HCA3 HG21 ' A' ' 205' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 55.3 mt-10 -49.59 141.1 9.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.553 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -114.14 131.33 56.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.496 -0.752 . . . . 0.0 109.061 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -132.77 168.86 17.59 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -81.38 139.79 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 110.226 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -70.12 -46.95 63.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.56 -0.712 . . . . 0.0 109.945 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -132.35 163.11 29.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.356 -0.84 . . . . 0.0 110.41 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 136.31 55.32 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.632 0.73 . . . . 0.0 110.861 -179.162 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 113' ' ' ASN . 32.7 mt -117.23 164.99 13.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -150.92 146.49 26.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.813 -1.179 . . . . 0.0 110.192 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -133.69 161.08 35.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.536 -0.727 . . . . 0.0 109.464 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -149.75 136.78 19.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.918 -1.114 . . . . 0.0 109.023 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.87 158.98 18.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 22' ' ' GLU . 1.3 p -85.79 144.14 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.103 -1.233 . . . . 0.0 110.996 -178.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.32 143.57 39.38 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.1 tt -63.55 -44.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 112.621 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.524 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.8 m-70 -87.08 -37.1 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.125 -1.609 . . . . 0.0 112.193 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.402 HG21 ' HG3' ' A' ' 95' ' ' GLU . 28.0 p -81.05 -26.6 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.834 -1.167 . . . . 0.0 109.721 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.95 19.0 62.93 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 23' ' ' TYR . 1.9 tm-20 -104.18 148.75 25.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 4.3 t80 -71.65 134.39 46.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -141.7 158.16 44.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.09 -1.006 . . . . 0.0 109.298 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -137.77 144.85 41.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.258 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.736 HD11 ' HD2' ' A' ' 97' ' ' PRO . 3.0 mt -125.25 144.91 50.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.018 . . . . 0.0 109.606 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.42 HG22 ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -126.4 132.08 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mt -113.1 134.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.049 -1.032 . . . . 0.0 109.573 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.42 ' NE2' HG22 ' A' ' 27' ' ' ILE . 22.5 m-70 -128.62 149.72 72.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.031 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.81 160.51 28.79 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.288 1.992 . . . . 0.0 111.226 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.6 mm-40 -135.23 -174.66 3.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 109.914 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.5 tttt -91.0 155.71 18.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.766 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.423 ' HG3' ' NE2' ' A' ' 117' ' ' GLN . 1.6 mp0 -47.84 145.23 2.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.251 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.62 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.08 27.4 62.44 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.105 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.2 m -80.85 -38.31 28.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.684 -1.48 . . . . 0.0 108.633 179.07 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 -174.21 35.11 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.66 123.51 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 139.36 39.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.953 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 77.6 m-85 -95.79 148.73 22.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.7 t80 -130.65 137.34 49.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -165.38 139.67 4.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.383 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.09 29.73 10.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 110.084 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.58 18.51 79.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.43 HG11 ' HG3' ' A' ' 67' ' ' GLN . 62.3 t -120.51 133.86 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -1.096 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 15.8 m-85 -97.88 134.53 40.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 108.871 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.4 mt -127.73 94.91 36.23 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.495 -0.753 . . . . 0.0 109.4 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.91 142.3 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.095 1.863 . . . . 0.0 111.602 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . . . -88.04 80.22 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.977 -1.077 . . . . 0.0 109.94 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -134.59 152.32 51.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.1 p80 -54.9 -47.16 74.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 50' ' ' HIS . 4.6 mt-10 -44.01 -20.49 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.939 -1.101 . . . . 0.0 109.706 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' HIS . 97.6 m-85 -90.57 4.66 50.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.854 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 50' ' ' HIS . 23.3 t -60.03 120.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 108.921 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 m -111.88 -28.34 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 110.161 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -153.44 122.66 6.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.008 -1.057 . . . . 0.0 109.907 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -115.69 132.68 56.56 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.5 t-20 -166.87 -153.22 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ASN . 76.1 m-70 -45.64 -15.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -136.73 166.16 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.419 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 2.8 m -108.66 125.77 52.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.354 -0.841 . . . . 0.0 108.878 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 60' ' ' THR . 3.5 m-20 -123.47 140.45 53.0 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.073 0.94 . . . . 0.0 111.46 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 72' ' ' VAL . 44.8 mt -122.11 160.24 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.87 141.1 5.83 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.812 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -144.13 149.03 35.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.974 . . . . 0.0 109.236 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.95 38.82 31.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.349 -0.844 . . . . 0.0 110.393 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.95 3.23 80.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.513 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 54.9 mm-40 -96.16 144.96 25.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -1.196 . . . . 0.0 108.605 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.81 143.88 37.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.244 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.71 139.29 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -114.36 151.36 33.15 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.276 -0.89 . . . . 0.0 111.179 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m 54.75 70.22 0.64 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 178.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' A' ' 62' ' ' LEU . 13.7 m -114.29 -8.09 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.068 -1.02 . . . . 0.0 109.846 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -69.52 -19.08 63.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.158 -0.964 . . . . 0.0 111.228 -178.829 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 22.6 m170 -73.5 -58.89 3.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.753 -1.217 . . . . 0.0 109.52 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' LEU . 4.6 tp -58.52 -42.43 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.844 -1.16 . . . . 0.0 108.691 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' ILE . 70.5 mt -58.73 -37.53 76.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.502 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.2 t -59.91 -48.3 82.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.96 -54.16 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 108.455 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.3 mt -51.68 -45.46 63.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 0.0 109.234 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.613 ' HD1' HG22 ' A' ' 232' ' ' ILE . 12.1 t-160 -54.98 -51.87 64.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.787 . . . . 0.0 109.902 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.4 mt -64.9 -38.27 90.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 110.629 -179.081 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.725 HD13 HD11 ' A' ' 114' ' ' ILE . 13.9 mt -79.89 -1.1 37.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 110.612 -178.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 60.14 63.46 1.42 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.013 -1.054 . . . . 0.0 110.401 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.559 HD11 ' HB3' ' A' ' 82' ' ' LEU . 13.3 mm -105.51 127.6 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 121' ' ' ILE . 56.7 p -115.1 -21.22 10.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.314 -0.866 . . . . 0.0 112.03 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.2 m-80 -128.74 111.6 13.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.787 -1.195 . . . . 0.0 110.295 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.6 m -164.19 139.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.196 -0.94 . . . . 0.0 109.89 179.09 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 21.5 m -110.42 99.54 8.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.24 104.98 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.92 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.67 128.47 33.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.612 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.71 108.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 92' ' ' ILE . 4.1 mp -89.06 109.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.81 -155.27 20.09 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -178.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.04 -8.18 8.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.532 -0.981 . . . . 0.0 110.694 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.573 ' OE2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -144.58 150.76 38.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.62 -1.3 . . . . 0.0 111.681 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.6 mm -75.88 122.26 86.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.027 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.736 ' HD2' HD11 ' A' ' 26' ' ' LEU . 80.9 Cg_exo -45.29 133.52 12.05 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.924 1.75 . . . . 0.0 112.198 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.0 tp -76.59 -20.11 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.092 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.584 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 75.8 mt 54.99 -121.91 1.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.48 -7.75 40.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.46 -15.63 38.45 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -111.35 -171.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -1.044 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.07 -1.9 23.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -46.43 -40.95 13.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.694 -0.886 . . . . 0.0 110.086 -179.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.84 -52.31 64.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.838 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 57.3 m-85 -63.05 -44.47 95.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 108.762 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -62.94 -37.18 86.04 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.419 0.628 . . . . 0.0 109.77 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -72.06 -48.0 47.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 111.096 -178.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.77 -51.17 14.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.941 -1.099 . . . . 0.0 110.194 -179.042 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.28 -43.07 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.084 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -54.31 -32.15 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -83.06 -0.87 51.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.139 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.552 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -131.82 33.25 3.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.248 -0.908 . . . . 0.0 111.149 -179.171 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.725 HD11 HD13 ' A' ' 82' ' ' LEU . 7.0 mt -94.05 144.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.513 -1.367 . . . . 0.0 110.125 179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 115' ' ' LEU . 13.4 tp -132.04 161.61 32.78 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -108.66 146.27 33.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.059 -1.026 . . . . 0.0 110.388 -179.447 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.423 ' NE2' ' HG3' ' A' ' 33' ' ' GLU . 8.4 mt-30 -105.09 -162.41 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.078 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.03 -0.01 12.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.299 -0.875 . . . . 0.0 110.629 -179.208 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -93.28 147.49 22.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.832 -1.167 . . . . 0.0 110.043 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -84.1 131.0 34.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.423 -0.798 . . . . 0.0 109.555 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 85' ' ' THR . 80.1 mt -71.69 141.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.965 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.15 104.39 16.4 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -78.6 146.68 34.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 111.095 -178.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.84 121.9 33.88 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 243' ' ' LYS . 22.0 t -120.82 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.05 136.75 22.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -116.42 -11.22 11.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.735 . . . . 0.0 109.113 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -142.07 142.82 25.77 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.28 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.82 152.64 52.77 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.033 1.822 . . . . 0.0 112.953 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.81 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.2 tt -145.94 141.7 21.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.672 -0.642 . . . . 0.0 109.332 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.521 ' CG2' HD21 ' A' ' 138' ' ' LEU . 1.2 mp -128.29 123.2 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 109.5 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.4 m -118.4 116.69 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.515 -0.74 . . . . 0.0 109.654 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -108.85 140.08 42.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.299 -0.876 . . . . 0.0 109.29 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.41 126.51 2.3 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.735 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.489 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 46.1 mt-10 52.75 39.14 28.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.752 -0.593 . . . . 0.0 112.389 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.52 5.22 89.35 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.424 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.489 ' NH2' ' OE1' ' A' ' 135' ' ' GLU . 5.5 mtt180 -107.05 164.24 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.005 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.9 tt -159.75 151.2 19.87 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 119.948 -1.72 . . . . 0.0 109.213 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.005 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.1 mt -146.97 130.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -122.8 140.28 53.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.161 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -116.99 148.18 41.66 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -146.19 137.03 12.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.28 144.43 71.38 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.325 1.35 . . . . 0.0 112.166 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.04 148.16 11.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.37 -1.96 43.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.3 p -136.35 150.23 48.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 242' ' ' VAL . 16.6 tp -82.2 117.43 22.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -136.24 137.51 40.87 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.682 ' CG1' HD23 ' A' ' 231' ' ' LEU . 74.0 t -136.92 123.65 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 m -111.15 132.66 54.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.594 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -116.89 129.01 55.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.28 111.59 21.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.06 156.89 15.81 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 250' ' ' ARG . 36.4 mt-10 -138.33 95.16 2.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.349 -1.089 . . . . 0.0 109.387 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -94.78 148.27 22.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 109.616 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -91.17 0.48 57.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.767 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.472 HD21 HD12 ' A' ' 159' ' ' LEU . 11.9 p30 -78.66 -173.6 3.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.355 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -53.21 -18.92 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.208 -179.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.472 HD12 HD21 ' A' ' 157' ' ' ASN . 16.7 mt -65.43 -62.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.018 -1.051 . . . . 0.0 109.659 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.94 -125.3 8.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -109.63 139.35 44.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -1.081 . . . . 0.0 109.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.75 150.45 29.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 152.67 48.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.635 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -136.51 124.78 23.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 0.0 109.109 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 165' ' ' THR . 13.7 t -98.35 122.28 41.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.089 -1.007 . . . . 0.0 110.006 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.4 t80 -97.48 137.28 36.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 108.846 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.556 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -133.2 150.24 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 14.3 mt-10 -56.1 122.35 11.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.05 -18.85 14.0 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -116.16 36.35 4.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.069 -1.253 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.33 -31.57 72.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 110.525 -179.215 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.28 -14.06 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.693 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.28 -3.87 57.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 5.3 pt -122.83 10.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.992 -1.067 . . . . 0.0 111.033 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.93 -31.8 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.867 -1.146 . . . . 0.0 109.958 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.89 2.23 46.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.828 -1.17 . . . . 0.0 110.489 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.71 133.3 35.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -105.41 154.08 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 -179.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -55.65 159.6 2.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.43 166.25 25.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.017 -1.052 . . . . 0.0 110.148 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.565 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.5 OUTLIER -152.52 163.25 39.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 109.458 179.854 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.548 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 70.7 m-85 -104.53 144.03 32.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.633 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.678 ' HA ' HD12 ' A' ' 186' ' ' ILE . 10.9 p-10 -61.28 -25.91 67.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.817 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.548 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.2 p90 -77.52 -25.32 50.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.776 -1.203 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.465 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 10.0 pt-20 -100.96 -11.9 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 109.993 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 183' ' ' ASP . 6.9 mt -57.34 -52.36 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.116 -0.99 . . . . 0.0 110.449 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.42 -53.72 33.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 0.0 109.975 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -52.88 -42.33 65.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.073 -1.017 . . . . 0.0 109.187 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.07 -33.77 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.021 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -78.69 -26.06 44.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.783 . . . . 0.0 110.335 -179.427 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -32.46 35.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.995 -1.065 . . . . 0.0 110.181 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 194' ' ' LEU . 28.8 m -73.76 8.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.015 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.83 20.48 70.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 192' ' ' VAL . 27.9 mt -117.22 154.86 30.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.196 -1.179 . . . . 0.0 109.764 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 83.3 23.15 55.35 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.421 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -66.2 -23.96 66.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.617 -1.519 . . . . 0.0 109.756 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.07 -5.89 49.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.83 130.69 45.6 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.129 -1.218 . . . . 0.0 110.773 -178.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 6.9 p -134.82 -173.74 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.668 -0.901 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.8 -17.48 29.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -89.11 -8.54 53.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 202' ' ' ASN . 0.5 OUTLIER -127.96 -14.18 5.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.754 -179.627 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -125.4 115.01 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.0 tp -77.14 109.97 11.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 108.668 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 186' ' ' ILE . 44.1 t -97.64 125.92 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 110.012 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 206' ' ' LEU . 28.5 mt -99.1 143.26 29.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.623 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.64 144.46 15.82 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 3.9 pttt -41.52 -23.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -1.191 . . . . 0.0 110.299 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.2 p-10 -152.67 11.92 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.565 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -148.89 157.98 43.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.972 -1.08 . . . . 0.0 110.419 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.55 127.86 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.454 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -73.62 -54.86 7.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.028 -1.045 . . . . 0.0 110.55 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.95 111.35 2.9 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.027 . . . . 0.0 110.169 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.45 -8.49 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.864 1.709 . . . . 0.0 112.292 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -88.06 -7.74 56.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 109.869 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.88 -167.36 48.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.06 145.3 25.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.414 -1.05 . . . . 0.0 110.165 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -88.17 -17.55 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.387 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -144.95 134.41 23.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.39 -23.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.062 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.477 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -124.95 35.72 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.078 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 5.1 tt0 -55.4 -57.97 17.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 111.638 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 10.5 Cg_endo -54.19 -39.96 84.05 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.955 1.77 . . . . 0.0 113.105 -178.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 228' ' ' VAL . 11.5 m -80.2 -26.66 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 120.667 -1.27 . . . . 0.0 109.017 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 18.7 mtt180 -66.65 -43.27 85.04 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -62.01 -42.35 99.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -56.78 -39.04 73.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 224' ' ' VAL . 48.4 t -66.41 -40.89 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 88.7 t80 -59.1 -37.48 77.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 91.0 m-20 -76.07 -40.87 52.18 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.563 -0.711 . . . . 0.0 109.671 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.682 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.6 tp -55.47 -36.71 66.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 108.836 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.613 HG22 ' HD1' ' A' ' 80' ' ' HIS . 77.9 mt -73.15 -47.75 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.77 -33.92 28.31 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.44 -26.81 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -1.225 . . . . 0.0 109.852 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.74 -20.71 45.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.761 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.583 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 11.9 t80 -74.24 -9.02 58.19 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.145 -0.972 . . . . 0.0 109.193 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 234' ' ' ASP . 18.3 mt -50.91 -28.6 10.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.439 ' O ' ' NH2' ' A' ' 49' ' ' ARG . 62.9 mt -58.11 -11.26 2.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 0.0 108.947 179.211 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.54 16.04 81.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 23.1 p -158.48 150.45 17.3 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.071 -1.252 . . . . 0.0 109.219 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 6.5 Cg_endo -53.28 139.48 63.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.999 1.799 . . . . 0.0 111.519 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.501 ' O ' HD22 ' A' ' 147' ' ' LEU . 14.0 t -102.93 133.45 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.383 -179.139 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.436 ' HB2' HG22 ' A' ' 125' ' ' VAL . 3.9 mmtt -118.38 123.92 46.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.755 . . . . 0.0 109.253 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.34 170.75 22.58 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -101.57 112.72 25.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.188 -1.184 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -112.03 148.15 34.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.921 0.867 . . . . 0.0 111.209 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -130.18 144.19 51.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.8 t -137.77 127.93 26.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.0 110.502 -179.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -111.73 113.89 26.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 154' ' ' GLU . 2.3 mtt85 49.81 56.0 8.54 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.01 142.45 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.94 167.45 13.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.538 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -56.5 -45.03 81.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -59.55 -56.01 27.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.662 ' HG ' HD12 ' A' ' 139' ' ' ILE . 52.0 tp -56.83 -36.54 70.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 62.5 m-20 -59.76 -55.5 33.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 108.721 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 36.5 t -51.05 -40.59 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.308 -0.87 . . . . 0.0 109.148 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -54.81 -47.63 73.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 108.916 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 139' ' ' ILE . 59.3 tp -53.34 -47.31 69.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 50' ' ' HIS . 2.8 t -65.98 -43.19 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -51.9 64.93 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.446 -0.783 . . . . 0.0 110.384 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.83 -43.75 95.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.817 -1.177 . . . . 0.0 110.189 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.18 -42.36 96.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.45 -32.71 58.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 110.334 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -79.26 -31.41 43.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.877 -1.139 . . . . 0.0 109.186 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 268' ' ' LYS . 20.4 mttm -61.21 -43.97 98.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.857 -1.152 . . . . 0.0 108.687 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -73.52 17.16 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.456 -0.778 . . . . 0.0 109.888 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 270' ' ' THR . 41.1 tptt -69.27 -63.07 1.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.917 -1.114 . . . . 0.0 109.087 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.1 mt -45.64 -13.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.471 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 270' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 268' ' ' LYS . 3.4 t . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.565 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.431 0.634 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 33' ' ' GLU . 10.6 mt-10 -54.99 152.39 7.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.247 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 145.9 51.5 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.517 -0.74 . . . . 0.0 109.743 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 177.8 8.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.944 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.66 147.09 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -83.05 -41.17 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.581 -0.699 . . . . 0.0 109.958 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.79 155.18 46.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.955 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -62.9 133.21 54.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.399 -0.813 . . . . 0.0 109.671 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.75 161.96 19.86 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -158.42 152.43 23.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.806 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.8 171.64 14.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.645 -0.66 . . . . 0.0 109.74 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -149.62 137.69 20.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 108.982 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.61 161.0 20.45 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -88.36 144.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -1.199 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.53 141.08 39.97 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.2 tt -62.16 -43.52 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -1.233 . . . . 0.0 111.325 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 8.2 m-70 -87.98 -39.39 14.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.174 -1.579 . . . . 0.0 111.149 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 p -69.06 -40.43 78.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.27 17.49 78.86 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -114.36 152.58 31.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.989 . . . . 0.0 108.828 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.492 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 5.2 t80 -71.8 139.67 49.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.056 -1.028 . . . . 0.0 110.245 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -146.97 157.72 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 108.819 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 26' ' ' LEU . 25.2 ttpt -127.07 157.71 38.9 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 109.704 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.789 HD11 HG23 ' A' ' 96' ' ' ILE . 12.6 mt -126.56 144.86 50.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.982 -1.074 . . . . 0.0 108.397 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.561 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.2 mt -138.62 132.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.015 179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 28' ' ' ILE . 6.2 mt -120.97 128.09 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 109.914 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.4 m-70 -125.7 149.02 64.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.56 157.64 35.85 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.179 1.92 . . . . 0.0 111.38 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 41.2 mm-40 -135.83 162.9 31.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.5 tttp -64.77 150.37 47.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.5 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.619 ' OE2' ' ND2' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -47.81 148.91 1.42 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.573 -179.373 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 59.86 25.45 61.6 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.527 -0.733 . . . . 0.0 112.089 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.5 m -80.16 -37.07 34.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.467 -1.608 . . . . 0.0 109.068 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.23 -172.69 32.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -100.42 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.164 -1.198 . . . . 0.0 108.338 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -139.4 143.81 37.84 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.392 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.5 153.63 19.54 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.8 t80 -124.3 147.93 47.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.411 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 13.5 tttt -173.75 133.48 0.46 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.777 -1.202 . . . . 0.0 109.218 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.639 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER 52.95 29.54 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.493 -0.754 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.71 -9.88 48.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.62 ' CG2' HD21 ' A' ' 42' ' ' ASN . 20.6 t -94.43 139.34 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -1.227 . . . . 0.0 110.22 -179.584 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -97.36 146.2 25.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.419 -0.801 . . . . 0.0 108.923 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 67' ' ' GLN . 53.5 mt -138.1 97.03 9.93 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.47 141.19 33.81 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.243 1.962 . . . . 0.0 111.499 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.19 84.31 5.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.878 -1.139 . . . . 0.0 110.58 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -141.27 157.62 44.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.135 -0.978 . . . . 0.0 109.284 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.648 ' ND1' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -52.52 -49.74 64.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.117 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -48.77 -16.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 110.076 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' HIS . 73.4 m-85 -97.37 6.08 48.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.052 -1.03 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 50' ' ' HIS . 22.8 t -64.59 129.31 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.951 . . . . 0.0 109.383 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.62 -29.51 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.38 -0.825 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.441 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 7.8 t-80 -152.92 122.61 6.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.788 -1.195 . . . . 0.0 109.814 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.6 p -113.34 133.12 55.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.7 t-20 -166.98 -154.04 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.599 ' CE1' HD11 ' A' ' 189' ' ' ILE . 0.2 OUTLIER -47.04 -13.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.069 -1.02 . . . . 0.0 108.317 178.945 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -135.23 165.7 24.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.591 -0.693 . . . . 0.0 109.401 -179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.446 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 7.4 m -103.93 122.24 44.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 108.604 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -120.2 136.92 54.47 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.053 0.93 . . . . 0.0 111.528 -178.692 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HG ' HG21 ' A' ' 72' ' ' VAL . 76.8 mt -117.69 158.21 25.11 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.77 143.11 6.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.652 -1.737 . . . . 0.0 110.908 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.08 151.55 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.617 -0.931 . . . . 0.0 109.758 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp 56.79 27.61 13.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.521 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.52 -0.43 83.05 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 91.3 mm-40 -94.84 138.77 32.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.968 -1.313 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -134.28 146.7 50.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.963 . . . . 0.0 111.27 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.4 mt -134.89 145.88 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -114.61 152.75 31.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.222 -0.924 . . . . 0.0 111.799 -178.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 71' ' ' THR . 45.7 m 53.94 71.68 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.557 . . . . 0.0 111.307 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.445 HG21 ' HG ' ' A' ' 62' ' ' LEU . 19.1 m -113.5 -1.44 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.033 -1.042 . . . . 0.0 109.286 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.54 -39.59 73.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 110.576 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -54.38 -60.59 3.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.066 -1.021 . . . . 0.0 110.241 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -58.54 -46.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 109.232 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' N ' HG23 ' A' ' 75' ' ' ILE . 64.8 mt -55.49 -38.72 69.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.074 -1.016 . . . . 0.0 109.43 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -59.01 -48.24 82.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.564 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.2 -54.18 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 108.499 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -52.39 -46.38 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.507 -0.746 . . . . 0.0 109.246 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.618 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 15.4 t-160 -55.58 -53.69 53.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.827 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.89 -38.63 91.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.363 -0.836 . . . . 0.0 110.368 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.633 ' HB3' HD11 ' A' ' 84' ' ' ILE . 12.7 mt -78.37 -4.46 48.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.736 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.28 51.55 2.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.729 -1.232 . . . . 0.0 110.405 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.7 mm -98.45 124.46 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.413 HG21 HG12 ' A' ' 121' ' ' ILE . 20.5 p -111.55 -18.95 12.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.322 -0.861 . . . . 0.0 112.437 -177.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.71 ' O ' HG13 ' A' ' 87' ' ' VAL . 18.3 m-20 -129.94 111.86 12.96 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.512 -1.367 . . . . 0.0 110.633 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.7 m -164.62 143.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.228 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.542 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.7 m -112.19 101.07 9.34 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mt -92.1 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.579 -0.701 . . . . 0.0 109.706 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.71 123.08 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.736 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 t -107.46 106.27 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 110.954 -178.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.22 111.02 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.12 -161.62 23.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -115.37 -14.51 11.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.534 ' OE1' ' O ' ' A' ' 96' ' ' ILE . 1.2 tm-20 -140.86 146.61 37.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.995 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.789 HG23 HD11 ' A' ' 26' ' ' LEU . 3.3 mm -68.95 124.06 89.49 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 109.97 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.57 130.99 9.64 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.083 1.855 . . . . 0.0 112.171 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 16' ' ' VAL . 8.2 tp -78.53 -30.27 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.451 -0.78 . . . . 0.0 109.727 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt 56.48 -108.77 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.805 . . . . 0.0 110.129 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -94.17 -22.9 18.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 110.736 -178.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.44 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 115.49 -10.23 19.48 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.23 -170.95 1.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -1.024 . . . . 0.0 109.757 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.07 -4.67 25.68 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.404 ' NE1' ' HG3' ' A' ' 108' ' ' GLU . 51.2 t-105 -46.29 -38.8 9.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.707 -0.878 . . . . 0.0 110.302 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.42 -52.04 66.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 110.013 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.56 -43.4 97.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 108.695 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 18.7 t80 -63.64 -36.71 84.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.74 -0.6 . . . . 0.0 110.014 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.404 ' HG3' ' NE1' ' A' ' 104' ' ' TRP . 2.4 mm-40 -72.75 -49.94 27.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.28 -0.887 . . . . 0.0 111.956 -178.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.38 -44.55 58.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.824 -1.172 . . . . 0.0 110.977 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.2 -39.97 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.073 . . . . 0.0 110.391 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 16.0 tpt180 -54.11 -32.59 55.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 0.0 109.759 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -82.1 -13.41 57.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.929 -1.107 . . . . 0.0 110.14 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -121.37 32.07 6.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 111.018 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.559 HD11 HD13 ' A' ' 82' ' ' LEU . 6.1 mt -82.74 148.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.509 -1.37 . . . . 0.0 110.373 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -128.63 149.57 50.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -97.68 146.14 25.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.042 -1.036 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.418 ' CD ' HD21 ' A' ' 86' ' ' ASN . 1.0 OUTLIER -109.56 -168.45 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.0 109.813 -179.997 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -124.43 72.73 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.513 -0.742 . . . . 0.0 110.589 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 119' ' ' ARG . 6.2 ttm-85 -168.63 149.48 4.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.968 . . . . 0.0 109.461 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -83.3 126.87 33.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.413 HG12 HG21 ' A' ' 85' ' ' THR . 18.4 mt -67.09 135.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.456 -0.778 . . . . 0.0 110.765 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.52 73.69 1.94 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -52.31 141.31 19.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.538 -0.726 . . . . 0.0 110.479 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -104.99 125.57 51.12 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 243' ' ' LYS . 67.8 t -128.75 142.88 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.253 -0.904 . . . . 0.0 110.266 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.13 135.26 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -116.53 -11.43 11.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.214 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.42 143.62 30.8 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.05 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.61 161.51 41.9 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.109 1.873 . . . . 0.0 113.182 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.9 tt -155.4 140.0 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.65 -0.656 . . . . 0.0 109.584 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 131' ' ' ILE . 2.4 mp -127.86 124.33 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.4 m -121.36 118.84 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.724 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -115.58 133.6 55.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.417 -0.802 . . . . 0.0 109.583 179.862 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 34.1 t0 -173.43 150.65 1.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.18 -0.95 . . . . 0.0 110.759 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 10.9 mt-10 57.57 22.32 8.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.541 -0.724 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.26 6.99 88.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.537 ' HB2' HD22 ' A' ' 255' ' ' LEU . 5.4 mtt85 -105.34 171.64 7.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.196 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.953 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.1 tt -159.63 149.57 18.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.457 -1.402 . . . . 0.0 109.028 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.953 ' N ' HD23 ' A' ' 138' ' ' LEU . 12.0 mt -147.69 139.06 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -131.26 142.68 50.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.118 -0.989 . . . . 0.0 109.654 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.35 145.82 48.44 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -142.48 135.1 13.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.53 147.96 36.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.272 1.315 . . . . 0.0 112.053 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.99 154.23 8.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.364 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.98 0.73 50.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -136.98 151.79 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 242' ' ' VAL . 34.1 tp -87.37 117.92 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 110.027 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -136.18 142.93 44.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.668 ' CG1' HD23 ' A' ' 231' ' ' LEU . 69.5 t -135.93 118.31 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 109.907 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 3.5 m -105.19 127.1 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.178 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -121.36 130.07 53.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -112.27 104.94 13.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.067 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.1 129.51 9.93 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.62 97.32 6.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -1.091 . . . . 0.0 109.169 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.497 ' O ' ' O ' ' A' ' 160' ' ' GLY . 24.5 m-85 -99.63 148.92 23.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.188 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -92.87 -10.17 37.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.821 . . . . 0.0 109.934 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.554 HD22 HD12 ' A' ' 159' ' ' LEU . 38.0 p-10 -70.34 -167.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.918 . . . . 0.0 110.103 -179.284 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -60.12 -24.49 64.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.355 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.554 HD12 HD22 ' A' ' 157' ' ' ASN . 6.6 mt -64.93 -40.65 95.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.939 -1.101 . . . . 0.0 108.871 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 76.97 -107.52 2.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -122.01 140.69 52.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.937 . . . . 0.0 109.692 -179.577 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -144.44 158.04 43.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -142.89 144.48 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -137.01 123.89 21.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.344 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 9.1 m -104.67 124.55 49.55 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.204 -0.935 . . . . 0.0 110.198 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -99.67 130.13 45.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.265 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.24 147.78 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.502 -0.749 . . . . 0.0 109.46 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.04 115.62 1.49 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.349 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.22 4.89 17.75 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -133.45 28.85 3.98 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.304 -1.115 . . . . 0.0 108.3 179.357 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.75 -33.26 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.733 -0.604 . . . . 0.0 110.473 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -58.55 -9.97 1.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.085 -1.009 . . . . 0.0 110.697 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.38 -4.84 33.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.791 -1.193 . . . . 0.0 110.793 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.3 pt -117.65 13.05 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 110.722 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.13 -26.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.018 -1.051 . . . . 0.0 110.027 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.6 0.8 57.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.85 -1.156 . . . . 0.0 110.706 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.51 115.39 20.0 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.994 -1.067 . . . . 0.0 109.006 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -84.02 151.68 24.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.135 -0.978 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 t -59.24 132.64 54.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.323 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.504 ' CZ ' ' O6G' ' A' ' 320' ' ' TUX . 23.2 p90 -110.96 170.2 8.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.983 -179.352 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.577 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 1.8 t -154.21 162.99 40.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.441 -0.787 . . . . 0.0 109.475 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.473 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 71.5 m-85 -104.6 144.6 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.407 -0.808 . . . . 0.0 109.495 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.0 OUTLIER -61.67 -25.85 67.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.756 -1.215 . . . . 0.0 110.385 -179.372 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.0 p90 -81.83 -30.09 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.8 -1.188 . . . . 0.0 110.413 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.5 pt-20 -87.41 -16.96 33.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.784 -1.197 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.705 HD12 ' HA ' ' A' ' 183' ' ' ASP . 10.0 mt -57.83 -53.36 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.149 -0.969 . . . . 0.0 110.131 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.52 -53.19 40.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.919 -1.113 . . . . 0.0 109.624 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.87 -44.51 66.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 109.053 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 58' ' ' HIS . 3.7 mt -64.85 -33.42 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.065 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -78.3 -27.73 47.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -76.78 -28.15 55.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 109.937 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.4 m -82.61 9.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 109.782 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.56 72.78 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.633 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.8 157.93 27.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.211 -1.17 . . . . 0.0 109.669 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.63 21.64 63.61 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.148 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.36 -22.89 63.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.588 -1.537 . . . . 0.0 109.87 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -100.65 -3.16 55.26 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.6 128.74 35.73 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 121.086 -1.243 . . . . 0.0 110.459 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.29 162.23 34.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.738 -0.86 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.93 -31.45 72.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.962 . . . . 0.0 110.105 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -75.47 -14.6 60.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.07 -1.019 . . . . 0.0 110.248 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.34 9.87 5.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.7 m -150.36 123.56 8.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.42 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.16 115.49 22.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.189 -0.944 . . . . 0.0 109.24 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 186' ' ' ILE . 53.1 t -101.56 126.75 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.4 mt -102.44 141.91 34.51 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.456 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.06 149.6 19.1 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.1 OUTLIER -42.24 -29.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.895 -179.578 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 8.5 t0 -149.71 14.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 110.163 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 207' ' ' GLY . 9.9 mtpm? -146.85 155.71 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.038 . . . . 0.0 110.272 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.5 t -101.44 127.6 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.78 -54.63 8.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.329 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.14 131.32 68.69 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.938 -1.101 . . . . 0.0 109.325 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.03 -14.57 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.175 1.917 . . . . 0.0 112.574 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.78 -6.12 59.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.126 -0.984 . . . . 0.0 109.724 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.22 -167.93 51.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 49.6 mt -82.79 146.15 29.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -1.013 . . . . 0.0 109.935 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -89.48 -20.74 23.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.241 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.475 ' C ' ' N ' ' A' ' 221' ' ' ASN . 69.2 m-85 -141.57 139.51 33.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.377 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.492 ' C ' ' ND2' ' A' ' 221' ' ' ASN . 0.4 OUTLIER -52.58 -11.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 108.6 179.203 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.492 ' ND2' ' C ' ' A' ' 220' ' ' GLU . 0.0 OUTLIER -141.87 38.03 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.731 0.777 . . . . 0.0 109.066 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.4 OUTLIER -58.18 -36.54 45.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 111.05 -179.472 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.47 -44.3 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.837 1.691 . . . . 0.0 112.54 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 228' ' ' VAL . 3.0 m -76.14 -24.45 16.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.765 -1.209 . . . . 0.0 108.49 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -67.64 -41.87 83.2 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -63.08 -42.78 99.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -56.66 -47.63 79.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.068 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 224' ' ' VAL . 58.4 t -59.59 -44.54 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.417 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 61.3 t80 -55.13 -37.42 66.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.645 -0.66 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 3.7 m-20 -76.34 -38.84 55.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.499 -0.751 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.668 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.9 tp -56.92 -37.62 71.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.092 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.57 HG22 ' HD1' ' A' ' 80' ' ' HIS . 74.2 mt -73.1 -48.61 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.07 -34.56 16.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.22 -26.89 32.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -1.13 . . . . 0.0 110.189 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 260' ' ' VAL . 5.5 mt -78.13 -22.62 48.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 109.758 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.618 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 6.6 t80 -70.45 -5.4 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.105 -0.997 . . . . 0.0 108.83 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 237' ' ' LEU . 14.0 mt -52.24 -30.55 28.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.522 HD12 HG22 ' A' ' 242' ' ' VAL . 87.7 mt -56.29 -17.9 9.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 82.96 14.51 74.93 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.4 p -158.31 151.89 19.25 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.245 . . . . 0.0 109.458 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -49.94 131.31 29.64 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.161 1.907 . . . . 0.0 111.511 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.522 HG22 HD12 ' A' ' 238' ' ' LEU . 19.6 t -98.07 135.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 109.877 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.615 ' HB3' HG22 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -122.12 126.03 47.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.466 -0.771 . . . . 0.0 109.447 179.768 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.61 170.37 21.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -99.79 113.47 26.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.048 -1.266 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.3 m-85 -112.12 148.44 33.97 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.073 0.94 . . . . 0.0 111.148 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.408 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 24.1 t80 -128.15 144.53 51.12 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.39 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.1 t -144.86 124.82 13.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.42 -1.425 . . . . 0.0 110.413 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.418 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.3 t80 -109.8 116.55 31.88 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.6 OUTLIER 45.31 56.33 5.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.314 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -88.01 152.66 23.94 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -120.0 -177.81 16.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.15 -51.51 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 0.0 109.714 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -34.54 70.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.985 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 137' ' ' ARG . 48.6 tp -72.87 -40.34 65.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.016 . . . . 0.0 108.834 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -61.01 -51.06 70.84 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.2 t -51.32 -44.58 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.0 109.171 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -54.88 -49.11 71.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 108.905 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 139' ' ' ILE . 24.9 tp -52.93 -40.14 63.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.822 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 235' ' ' LEU . 60.7 t -74.72 -41.54 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.442 -0.786 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.54 -48.16 82.74 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 110.158 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -47.45 73.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.932 -1.105 . . . . 0.0 109.621 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 263' ' ' LEU . 12.7 mt -58.51 -43.74 89.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.325 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.429 ' HB1' ' HE2' ' A' ' 50' ' ' HIS . . . -66.03 -32.27 73.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 110.084 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -84.62 -24.41 29.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.725 -1.234 . . . . 0.0 108.865 179.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -69.71 -44.96 69.3 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.274 -0.891 . . . . 0.0 109.478 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.578 ' C ' ' H ' ' A' ' 269' ' ' LEU . 11.1 tt0 -79.07 15.12 1.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 110.16 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.05 33.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.988 -1.07 . . . . 0.0 109.825 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 267' ' ' GLN . 9.5 mt -65.25 -5.97 8.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 0.0 109.371 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 270' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 270' ' ' THR . 11.0 t . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.577 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.644 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 67.7 mt-10 -50.0 147.9 3.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 109.507 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.63 139.33 53.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.596 -0.69 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -138.57 173.8 11.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.459 -0.776 . . . . 0.0 108.92 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -84.41 141.39 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.722 -1.236 . . . . 0.0 110.278 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -71.15 -44.47 65.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.661 -0.649 . . . . 0.0 109.957 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.03 159.56 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 136.3 57.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.717 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 157.36 25.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -147.57 145.57 29.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 110.186 -179.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -132.17 163.37 28.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.99 135.57 19.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.889 -1.132 . . . . 0.0 108.718 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 159.13 19.08 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.62 146.8 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.243 . . . . 0.0 110.762 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.71 143.62 38.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.1 tt -67.74 -38.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.149 . . . . 0.0 112.786 -178.318 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.477 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.9 m-70 -85.93 -35.4 20.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 119.842 -1.786 . . . . 0.0 112.041 -177.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.47 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 5.2 m -85.21 -39.92 17.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.24 16.03 72.79 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -103.39 150.41 23.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -1.125 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.8 t80 -71.34 139.19 49.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.3 t -146.25 157.8 43.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.022 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.68 ' O ' HD23 ' A' ' 26' ' ' LEU . 44.4 tttt -132.85 155.78 48.37 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.882 . . . . 0.0 109.533 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.691 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -132.58 144.97 50.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.032 . . . . 0.0 109.103 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.9 129.16 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.3 mt -113.43 123.55 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -117.7 153.32 50.64 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.19 159.28 47.77 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.327 2.018 . . . . 0.0 111.19 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.2 mm-40 -134.12 -178.37 5.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.016 -1.052 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' O ' ' OG1' ' A' ' 35' ' ' THR . 25.3 tttt -83.04 149.34 27.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.463 -0.773 . . . . 0.0 109.317 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.638 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.3 OUTLIER -46.86 148.27 1.11 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.235 -0.916 . . . . 0.0 110.064 -179.487 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.608 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.49 24.38 59.35 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.18 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 15.5 m -80.55 -37.64 31.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.673 -1.486 . . . . 0.0 108.961 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' C ' HD13 ' A' ' 37' ' ' ILE . . . 93.9 -167.09 27.87 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 ' C ' ' A' ' 36' ' ' GLY . 2.8 mm -104.02 123.49 57.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -1.103 . . . . 0.0 108.287 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 139.09 42.08 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.969 -1.093 . . . . 0.0 110.863 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -99.7 151.54 21.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.568 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.1 t80 -129.49 139.52 51.55 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -170.86 138.76 1.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.016 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.48 28.65 17.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.85 . . . . 0.0 110.022 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.88 22.13 78.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 t -130.83 146.76 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.246 -1.149 . . . . 0.0 109.46 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -98.7 147.75 24.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.173 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 67' ' ' GLN . 38.6 mt -140.7 94.64 8.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.77 142.55 18.72 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.206 1.937 . . . . 0.0 111.841 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.52 83.11 6.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.429 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -137.72 153.44 49.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 p80 -52.78 -49.6 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 110.421 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.2 mt-10 -44.29 -30.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.084 -1.01 . . . . 0.0 109.285 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.419 ' O ' HG13 ' A' ' 54' ' ' VAL . 58.9 m-85 -79.43 3.94 16.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 HG11 ' A' ' 257' ' ' VAL . 9.5 t -56.62 131.65 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 52' ' ' PHE . 28.1 m -122.32 -35.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.341 -0.849 . . . . 0.0 110.428 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.5 t-160 -150.2 119.74 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.272 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.2 p -113.37 131.48 55.96 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.375 0.607 . . . . 0.0 109.465 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.607 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -167.1 -153.25 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.717 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 57' ' ' ASN . 13.6 m-70 -45.55 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.067 -1.02 . . . . 0.0 108.681 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 57' ' ' ASN . 10.9 t -135.41 165.7 24.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.365 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 m -104.08 122.5 45.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.778 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 3.4 m-20 -121.39 139.78 53.0 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.092 0.949 . . . . 0.0 111.434 -178.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.56 158.08 29.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.75 144.82 7.61 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.639 -1.743 . . . . 0.0 110.687 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -144.24 150.9 38.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.53 -0.983 . . . . 0.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm 56.75 23.87 8.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.0 110.941 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.98 70.45 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.718 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.495 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 75.5 mm-40 -98.2 142.15 30.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.971 -1.311 . . . . 0.0 108.222 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -138.33 150.99 47.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 111.365 -179.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.63 143.04 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -110.73 149.81 29.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.223 -0.923 . . . . 0.0 111.236 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m 54.21 67.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 111.471 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 96' ' ' ILE . 16.6 m -113.48 -3.56 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 108.997 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pt-20 -71.39 -26.0 62.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.318 -179.306 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -65.6 -60.51 2.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 0.0 109.635 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.6 tp -56.74 -44.1 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.124 -0.985 . . . . 0.0 108.922 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.516 ' N ' HG23 ' A' ' 75' ' ' ILE . 7.7 mt -55.79 -38.23 69.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.993 . . . . 0.0 109.46 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.547 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.8 t -60.84 -49.02 79.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.656 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.0 t -57.19 -54.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.012 . . . . 0.0 108.585 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -51.63 -44.32 62.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 11.7 t-160 -54.42 -53.52 53.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.856 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.85 -36.95 84.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.768 HD22 ' CD1' ' A' ' 114' ' ' ILE . 11.9 mt -76.36 -7.48 55.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.138 -179.379 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.06 47.37 4.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.598 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 82' ' ' LEU . 12.3 mm -92.4 122.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.621 HG21 HG23 ' A' ' 121' ' ' ILE . 81.7 p -111.26 -21.83 11.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.283 -0.885 . . . . 0.0 112.134 -177.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.636 ' O ' HG13 ' A' ' 87' ' ' VAL . 5.8 m-80 -126.22 111.35 14.49 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.789 -1.195 . . . . 0.0 109.677 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -164.69 140.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.165 -0.959 . . . . 0.0 109.957 179.407 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.5 m -110.81 99.58 8.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.03 110.1 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.9 122.27 30.54 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.65 108.44 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 111.003 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.16 110.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.91 -160.06 22.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.43 -15.26 9.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -136.19 142.1 44.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.204 -179.56 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 72' ' ' VAL . 3.0 mm -68.23 126.22 92.44 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.53 -0.731 . . . . 0.0 109.707 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.691 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.3 Cg_exo -45.98 131.25 13.73 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.946 1.764 . . . . 0.0 112.388 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.34 -26.34 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.455 -0.778 . . . . 0.0 109.827 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 10.1 mt 54.65 -111.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -95.55 -17.71 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.911 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.03 0.84 33.83 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.0 p -129.27 -167.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.982 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -4.92 19.62 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.568 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 63.0 t-105 -47.1 -41.13 16.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.775 -0.838 . . . . 0.0 110.413 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.63 -51.89 66.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 109.967 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -62.56 -43.99 97.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 108.828 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.1 t80 -63.52 -39.21 93.84 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.481 0.658 . . . . 0.0 110.059 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.568 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 18.8 mm-40 -69.78 -48.63 58.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.44 -0.787 . . . . 0.0 111.479 -178.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.45 -51.35 11.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.927 -1.108 . . . . 0.0 110.965 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.92 -43.89 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.009 -1.057 . . . . 0.0 110.967 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -28.88 63.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 109.802 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -13.07 59.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.012 -1.055 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.97 34.3 5.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.594 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.768 ' CD1' HD22 ' A' ' 82' ' ' LEU . 12.4 mt -90.77 147.54 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.797 -1.189 . . . . 0.0 110.474 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 115' ' ' LEU . 14.1 tp -131.75 158.59 40.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.063 179.137 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -101.75 146.16 28.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.681 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.638 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 9.2 mt-30 -112.66 -166.42 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 0.0 109.616 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.96 72.53 1.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 110.672 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -163.3 140.68 7.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 109.748 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 121' ' ' ILE . 3.0 tm-20 -78.31 124.09 27.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.343 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 85' ' ' THR . 1.0 OUTLIER -71.58 141.04 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.724 -178.894 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -85.36 86.43 7.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -63.24 146.7 52.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.6 122.65 44.24 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.1 138.46 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.333 -0.854 . . . . 0.0 110.461 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.06 136.23 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -117.78 -9.12 10.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.03 143.57 28.63 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.407 -0.808 . . . . 0.0 109.162 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.66 161.63 44.65 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.232 1.955 . . . . 0.0 112.989 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.971 HG22 ' HB3' ' A' ' 141' ' ' ALA . 11.5 tt -150.64 144.0 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.651 -0.656 . . . . 0.0 109.46 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -131.17 122.55 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.46 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 132' ' ' VAL . 26.9 m -123.55 118.79 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.466 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -120.28 136.32 54.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.49 -0.756 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.19 150.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 110.503 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 55.94 24.45 7.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.653 . . . . 0.0 110.996 179.047 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.95 87.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -108.77 169.12 8.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.074 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.011 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -159.95 153.57 22.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.151 -1.593 . . . . 0.0 109.465 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.011 ' N ' HD23 ' A' ' 138' ' ' LEU . 37.5 mt -148.57 136.05 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.173 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -126.14 142.1 51.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.996 -179.073 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.971 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.13 148.12 44.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 5.0 tm-20 -145.97 137.48 12.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.487 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 8.3 Cg_endo -53.84 146.5 45.64 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.744 1.63 . . . . 0.0 112.605 -179.147 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.75 11.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.21 1.43 48.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -137.88 150.33 47.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.479 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 24.2 tp -81.88 117.16 21.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 110.042 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -138.69 136.3 35.69 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.541 ' CG1' HD23 ' A' ' 231' ' ' LEU . 42.8 t -137.18 139.62 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.92 . . . . 0.0 109.985 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.0 m -125.15 140.37 52.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.335 -0.853 . . . . 0.0 109.625 179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' A' ' 228' ' ' VAL . 85.7 t80 -125.51 129.97 50.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.707 . . . . 0.0 109.81 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -115.07 111.17 20.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -106.0 146.87 16.13 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -128.15 86.19 2.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -1.093 . . . . 0.0 109.233 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.9 m-30 -94.28 149.2 21.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.95 -9.67 47.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.521 -0.737 . . . . 0.0 110.433 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.548 HD21 HD12 ' A' ' 159' ' ' LEU . 23.7 p-10 -66.48 -172.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.022 -1.049 . . . . 0.0 109.616 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -55.2 -24.54 27.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.05 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.548 HD12 HD21 ' A' ' 157' ' ' ASN . 12.4 mt -63.93 -43.01 97.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.044 -1.035 . . . . 0.0 109.432 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.78 -119.9 5.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -114.8 140.88 48.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.421 -1.046 . . . . 0.0 109.311 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.02 140.27 16.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.813 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -124.42 151.76 44.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.521 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 81.1 t80 -136.03 121.12 18.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -0.933 . . . . 0.0 109.05 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 48.7 m -99.47 122.72 42.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 167' ' ' VAL . 2.3 t80 -95.79 134.34 38.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.527 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.8 t -129.69 157.5 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.533 -0.73 . . . . 0.0 109.319 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.696 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 28.9 mp0 -60.48 116.17 4.12 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.58 6.17 17.72 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -135.87 29.74 3.13 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.037 -1.272 . . . . 0.0 108.918 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.97 -30.7 70.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 110.405 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -54.34 -9.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 110.66 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.88 -4.22 25.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.905 -1.122 . . . . 0.0 111.256 -178.625 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.563 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.3 pt -116.66 13.4 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.041 -1.037 . . . . 0.0 110.979 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.47 -28.6 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.071 -1.018 . . . . 0.0 109.612 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 104' ' ' TRP . 1.1 mp -91.08 0.28 57.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.737 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.85 119.51 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 108.239 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -88.45 150.11 23.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.197 . . . . 0.0 109.963 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 179' ' ' THR . 1.9 t -58.06 129.37 41.63 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.488 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 14.6 p90 -109.16 166.53 10.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -153.99 159.79 41.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.498 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.594 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 67.9 m-85 -104.08 147.21 27.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.717 ' HA ' HD12 ' A' ' 186' ' ' ILE . 49.0 p30 -60.07 -22.58 62.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.08 -1.013 . . . . 0.0 110.116 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.8 p90 -81.99 -33.08 30.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.91 -1.119 . . . . 0.0 110.53 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 24.4 pt-20 -85.16 -16.39 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.803 -1.185 . . . . 0.0 109.345 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.9 mt -59.24 -53.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.235 -0.915 . . . . 0.0 110.058 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 184' ' ' TRP . 2.9 mp0 -51.49 -53.57 36.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.196 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -47.66 65.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 108.924 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.29 -34.1 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.0 108.76 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -80.13 -25.87 39.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.843 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.01 -21.27 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.458 ' CG2' HD12 ' A' ' 194' ' ' LEU . 23.7 m -90.7 13.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.43 25.65 72.16 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.458 HD12 ' CG2' ' A' ' 192' ' ' VAL . 23.3 mt -127.15 167.2 16.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.237 -1.155 . . . . 0.0 109.918 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.9 16.98 80.3 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.457 -0.777 . . . . 0.0 111.314 178.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -64.11 -51.97 61.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.601 -1.529 . . . . 0.0 109.235 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -70.2 -4.38 49.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -178.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.66 130.0 39.67 Favored Glycine 0 N--CA 1.493 2.472 0 O-C-N 120.96 -1.318 . . . . 0.0 110.641 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -143.26 173.58 11.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.749 -0.854 . . . . 0.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.428 HD11 HDA3 ' A' ' 320' ' ' TUX . 87.2 mt -79.71 -1.81 40.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.641 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -97.24 -10.45 25.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -139.44 13.29 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.516 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 18.0 m -149.29 133.18 17.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.139 -0.975 . . . . 0.0 109.935 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.55 117.23 29.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 108.528 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -105.92 126.59 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.962 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.05 144.15 33.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 0.0 109.396 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 207' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 208' ' ' LYS . . . -102.91 153.24 18.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 207' ' ' GLY . 18.0 pttm -41.64 -32.52 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -151.32 13.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.951 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -139.24 147.36 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.6 t -98.2 125.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.032 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -73.0 -54.63 8.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -52.41 139.13 38.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.879 -1.138 . . . . 0.0 109.508 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.21 -38.07 4.05 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.386 2.057 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.49 -4.4 22.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.51 -168.88 53.73 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.47 149.05 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -1.12 . . . . 0.0 109.618 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -58.26 3.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 108.958 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -117.5 170.84 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.94 -18.03 60.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.113 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.516 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -128.23 29.98 5.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 109.537 -179.784 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 pp20? -62.95 -25.06 1.56 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 112.537 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 1.1 Cg_endo -80.57 -46.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.079 1.421 . . . . 0.0 112.082 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 228' ' ' VAL . 1.2 m -73.04 -22.1 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.885 -1.135 . . . . 0.0 108.005 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.521 ' NE ' ' CE1' ' A' ' 164' ' ' PHE . 48.8 mtt180 -71.35 -49.63 40.38 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -55.07 -42.57 72.93 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.106 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -45.49 83.14 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 224' ' ' VAL . 30.9 t -60.76 -50.15 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 65.2 t80 -49.45 -37.36 25.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 11.1 m-20 -74.65 -39.19 62.22 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.591 -0.693 . . . . 0.0 109.737 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.541 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.64 -36.76 69.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 109.267 -179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' HIS . 96.9 mt -72.33 -48.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.67 -32.79 17.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.41 -28.07 31.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.187 -1.184 . . . . 0.0 109.899 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 260' ' ' VAL . 5.1 mt -79.75 -23.04 42.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.876 -1.14 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.526 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.4 t80 -71.44 -8.21 52.39 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.035 -1.041 . . . . 0.0 109.09 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 237' ' ' LEU . 35.7 mt -52.85 -25.87 12.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 242' ' ' VAL . 46.9 mt -58.56 -21.92 54.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 108.845 179.098 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.49 65.99 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.1 p -158.19 149.61 16.77 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.561 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.402 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 3.7 Cg_exo -48.16 134.32 24.58 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.12 1.88 . . . . 0.0 111.583 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 238' ' ' LEU . 24.1 t -100.2 133.28 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.024 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -120.25 125.07 47.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.46 172.46 23.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -101.63 117.43 34.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.046 -1.267 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 149' ' ' VAL . 29.9 m-85 -117.49 147.73 42.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.115 0.96 . . . . 0.0 111.185 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -130.08 138.26 50.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.91 127.01 31.59 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.801 -1.187 . . . . 0.0 110.361 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.443 ' O ' ' C ' ' A' ' 250' ' ' ARG . 43.1 t80 -109.22 114.45 28.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.482 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER 44.31 55.95 5.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.799 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.69 145.88 27.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.3 162.84 12.24 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.647 ' O ' HG23 ' A' ' 257' ' ' VAL . 69.8 m-70 -56.47 -50.12 72.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 109.825 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 t -59.07 -55.88 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.656 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.56 -39.67 61.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.079 -1.013 . . . . 0.0 109.508 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 42.6 m-20 -58.24 -54.73 43.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.16 -0.963 . . . . 0.0 108.421 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 253' ' ' HIS . 13.5 t -48.8 -41.63 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.362 -0.836 . . . . 0.0 109.47 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -55.28 -48.96 73.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 108.821 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 27.8 tp -52.36 -41.92 63.5 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.445 HG22 HD23 ' A' ' 235' ' ' LEU . 41.1 t -70.57 -45.31 74.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.596 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -53.62 -51.06 64.27 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.451 -0.78 . . . . 0.0 110.265 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -63.19 -47.59 81.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 109.861 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 263' ' ' LEU . 88.3 mt -59.79 -44.5 93.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.291 -0.881 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -76.42 -25.6 54.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 108.762 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.822 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 17.8 mttt -65.96 -48.15 72.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.593 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 267' ' ' GLN . 1.8 mp0 -83.71 11.23 7.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.046 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -89.29 -20.09 24.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.73 -10.23 55.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.435 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 320' ' ' TUX . . . . . 0.522 HZH3 ' C1A' ' A' ' 320' ' ' TUX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.593 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.31 0.576 . . . . 0.0 109.793 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 134.63 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.667 -0.646 . . . . 0.0 109.458 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -133.62 170.96 14.77 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 7' ' ' VAL . 6.4 m -81.94 132.68 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.665 -1.272 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -49.09 77.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 0.0 109.724 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.584 ' CG ' HD22 ' A' ' 113' ' ' ASN . 8.4 pt-20 -128.51 158.24 38.93 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.454 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HE3' HG23 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -58.65 138.73 56.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.573 -0.704 . . . . 0.0 110.254 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.94 161.86 24.55 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -157.91 150.02 22.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.985 -1.072 . . . . 0.0 110.374 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -137.48 160.49 38.99 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.803 . . . . 0.0 109.948 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.11 138.9 24.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.563 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.19 158.56 16.63 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.46 161.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -1.128 . . . . 0.0 111.069 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.32 140.29 14.96 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.621 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.8 tt -57.57 -52.87 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.133 -1.216 . . . . 0.0 112.451 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.621 ' N ' HG23 ' A' ' 18' ' ' ILE . 15.4 m-70 -86.63 -37.67 17.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.175 -1.578 . . . . 0.0 111.195 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m -75.01 -35.29 61.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.016 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 26.53 71.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.09 152.56 33.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.936 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.5 OUTLIER -71.75 129.56 38.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.953 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.6 t -135.86 156.43 48.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 108.943 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.567 ' C ' HD23 ' A' ' 26' ' ' LEU . 8.2 tttp -135.55 148.26 49.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.065 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.704 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.2 mt -126.18 143.88 50.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.063 -1.023 . . . . 0.0 109.072 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.521 HG23 ' HE3' ' A' ' 10' ' ' LYS . 42.3 mt -126.19 134.17 67.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mt -116.79 130.23 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.059 . . . . 0.0 109.619 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.1 154.02 74.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.71 154.23 75.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.284 1.99 . . . . 0.0 111.353 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.547 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.1 mm-40 -133.61 -174.33 3.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.0 ttpt -87.57 149.36 24.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -47.68 152.2 0.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 110.084 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 20.63 53.24 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.338 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.4 m -80.68 -42.97 21.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.641 -1.505 . . . . 0.0 108.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.46 -172.07 27.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.7 mm -99.64 121.38 50.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.979 . . . . 0.0 108.562 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -135.64 145.97 47.39 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.744 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -102.68 150.0 23.88 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -132.29 138.67 47.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.566 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 16.0 tttm -167.19 141.29 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.566 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 1.3 m120 54.23 29.53 10.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 30.11 68.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.86 125.17 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -1.059 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.53 139.18 30.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 108.977 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.45 94.16 17.81 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 110.052 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -48.69 144.41 14.63 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.251 1.967 . . . . 0.0 111.919 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.64 84.92 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.415 ' HB3' HH11 ' A' ' 49' ' ' ARG . 3.1 mmm180 -136.33 154.88 50.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 109.15 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 4.8 p80 -50.54 -50.15 54.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.007 -1.058 . . . . 0.0 109.496 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.9 mt-10 -43.97 -32.48 1.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 109.48 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.65 3.32 19.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.325 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.17 118.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 108.796 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.05 -29.19 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.444 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.0 t-80 -150.18 123.4 8.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.616 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -112.44 136.78 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 59' ' ' SER . 45.2 t30 -166.68 -154.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -50.79 -10.03 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.0 108.17 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -137.76 166.84 22.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.462 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.0 m -105.43 122.04 45.15 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.4 OUTLIER -120.32 140.86 50.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 111.529 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 72' ' ' VAL . 27.6 mt -123.02 154.92 37.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -169.21 141.61 6.82 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.876 -1.631 . . . . 0.0 110.683 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -144.38 150.7 38.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.495 -1.003 . . . . 0.0 110.028 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.76 13.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.717 . . . . 0.0 110.758 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.36 1.02 79.07 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.541 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 28.9 mm-40 -99.79 143.96 29.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.951 -1.323 . . . . 0.0 108.668 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -138.55 149.92 45.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 111.269 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.3 mt -135.33 134.51 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -107.85 156.41 19.19 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.302 -0.874 . . . . 0.0 111.055 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.1 m 53.04 68.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.697 -0.627 . . . . 0.0 110.827 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 62' ' ' LEU . 24.4 m -113.06 -5.21 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.081 -1.012 . . . . 0.0 109.039 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.2 OUTLIER -68.55 -39.19 81.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 110.414 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -54.64 -60.73 2.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.09 -43.59 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.825 -1.172 . . . . 0.0 109.147 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 76.4 mt -57.28 -35.79 70.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.1 t -62.27 -50.26 72.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.984 . . . . 0.0 109.567 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.89 -51.2 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 0.0 108.451 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 76' ' ' LEU . 47.4 mt -51.79 -45.4 63.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.781 . . . . 0.0 109.4 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 9.3 t-160 -54.92 -51.69 65.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.8 mt -63.26 -37.19 86.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.93 . . . . 0.0 110.625 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 114' ' ' ILE . 20.7 mt -82.06 -6.82 59.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.044 -1.035 . . . . 0.0 111.091 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.82 53.99 2.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.299 . . . . 0.0 110.543 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 82' ' ' LEU . 19.0 mm -90.0 126.5 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.566 HG21 HG12 ' A' ' 121' ' ' ILE . 75.5 p -109.75 -26.86 9.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 111.705 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' HG13 ' A' ' 87' ' ' VAL . 5.0 m-80 -131.33 112.7 12.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.817 -1.177 . . . . 0.0 110.715 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -164.04 134.88 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.758 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.547 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 12.1 m -106.03 103.82 13.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -92.35 103.9 15.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 109.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.76 120.45 23.43 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.16 105.8 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.446 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.92 109.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.29 -159.81 23.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.65 -10.13 12.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.536 -0.979 . . . . 0.0 110.77 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -151.98 155.34 37.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.672 -1.268 . . . . 0.0 111.056 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 mm -73.24 124.58 90.71 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.741 -0.6 . . . . 0.0 110.164 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.704 ' CD ' HD21 ' A' ' 26' ' ' LEU . 79.0 Cg_exo -45.8 134.46 13.8 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.069 1.846 . . . . 0.0 112.177 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -80.44 -29.5 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.481 -0.762 . . . . 0.0 110.714 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 65.1 mt 57.59 -126.13 1.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.72 -23.96 39.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 110.242 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.51 -8.66 13.38 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -116.44 -171.34 1.98 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.419 -1.048 . . . . 0.0 109.786 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.76 -2.62 30.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 63.5 t-105 -46.58 -41.8 15.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.87 . . . . 0.0 110.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.67 -52.23 65.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.011 -1.056 . . . . 0.0 110.499 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -64.81 -43.27 93.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 108.894 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -63.72 -36.79 85.03 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.363 0.601 . . . . 0.0 109.958 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.488 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 4.8 mm-40 -68.41 -52.62 30.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.772 . . . . 0.0 111.873 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.71 -50.91 21.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.888 -1.132 . . . . 0.0 110.822 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.36 -43.19 89.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.66 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -53.61 -31.51 47.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 110.13 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.584 HD22 ' CG ' ' A' ' 9' ' ' GLU . 2.6 m120 -122.84 28.4 7.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.337 -0.852 . . . . 0.0 111.401 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.613 ' CD1' HD22 ' A' ' 82' ' ' LEU . 4.2 mt -85.73 147.19 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.636 -1.29 . . . . 0.0 109.617 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -131.23 153.71 49.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.768 . . . . 0.0 109.098 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -101.46 143.93 30.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.053 -1.029 . . . . 0.0 109.548 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.596 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 8.6 mt-30 -108.29 -166.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -116.73 70.7 0.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.797 . . . . 0.0 110.565 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -168.19 146.98 4.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.149 -0.969 . . . . 0.0 109.587 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -86.69 135.18 33.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.566 HG12 HG21 ' A' ' 85' ' ' THR . 58.6 mt -81.71 149.76 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -97.24 100.29 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -71.74 147.08 47.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 110.748 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -96.77 121.83 39.06 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.47 135.24 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.396 -0.815 . . . . 0.0 110.316 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.85 133.57 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.5 -10.75 13.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 109.301 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -142.89 143.45 25.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.44 171.88 16.82 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.38 2.053 . . . . 0.0 112.997 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.1 tt -165.74 142.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.699 -0.625 . . . . 0.0 109.694 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.76 125.86 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.509 -0.744 . . . . 0.0 109.833 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 132' ' ' VAL . 31.1 m -121.96 120.06 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.725 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.68 137.44 52.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.17 147.99 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.013 . . . . 0.0 110.829 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 56.84 24.83 9.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.6 -0.688 . . . . 0.0 110.955 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.39 85.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -109.33 169.65 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.6 tt -159.48 152.36 21.79 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.18 -1.575 . . . . 0.0 109.108 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.969 ' N ' HD23 ' A' ' 138' ' ' LEU . 41.6 mt -148.72 139.87 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.0 108.363 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -128.08 142.66 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 110.106 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -121.01 144.91 48.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -143.13 138.87 16.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 108.622 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.32 148.08 73.2 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.415 1.41 . . . . 0.0 111.735 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -167.2 155.9 9.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.1 0.05 55.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -136.44 150.46 48.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 242' ' ' VAL . 24.9 tp -81.74 116.88 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -138.65 134.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.623 ' CG1' HD23 ' A' ' 231' ' ' LEU . 45.9 t -134.63 124.6 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.2 137.55 50.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.02 129.72 49.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.488 -0.757 . . . . 0.0 110.117 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -111.82 103.89 12.18 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.15 140.72 15.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -116.46 101.53 8.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.452 ' HB2' HD21 ' A' ' 157' ' ' ASN . 48.8 m-85 -100.9 142.98 31.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 109.939 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.94 1.86 56.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 0.0 109.561 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.714 HD22 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -84.38 -166.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -62.7 -25.17 68.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 110.272 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HB2' HD21 ' A' ' 157' ' ' ASN . 76.8 mt -66.41 -25.34 66.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.009 -1.057 . . . . 0.0 109.398 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.81 47.78 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -93.11 144.99 24.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.995 . . . . 0.0 109.837 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -150.18 137.07 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 147.23 47.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.072 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.687 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 58.3 t80 -136.62 124.11 22.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.8 m -101.64 121.92 42.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.964 . . . . 0.0 109.705 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.55 135.42 41.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.74 151.4 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 109.507 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.536 ' OE2' ' NZ ' ' A' ' 243' ' ' LYS . 19.4 mt-10 -51.67 116.56 2.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.311 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.66 7.42 15.76 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.544 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 14.6 m-80 -134.85 28.39 3.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.179 -1.189 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.578 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 2.4 mp0 -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.752 -0.593 . . . . 0.0 110.582 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.89 -15.51 31.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.624 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -94.91 -4.23 47.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.956 -1.09 . . . . 0.0 110.898 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.546 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 4.2 pt -121.46 13.65 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.946 -1.096 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.87 -25.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.958 -1.089 . . . . 0.0 109.6 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -91.26 2.02 56.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.989 -1.069 . . . . 0.0 110.533 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.48 109.38 16.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.013 -1.054 . . . . 0.0 108.895 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.513 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -82.07 153.4 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 109.917 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.8 t -54.3 156.65 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.778 . . . . 0.0 109.338 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.76 170.68 15.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.875 -1.141 . . . . 0.0 110.119 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.409 ' SG ' ' CD1' ' A' ' 189' ' ' ILE . 3.5 t -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 109.469 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.625 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.5 m-85 -105.47 144.71 31.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.559 -0.713 . . . . 0.0 109.286 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.728 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.2 p30 -60.22 -21.86 62.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.703 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.625 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.2 p90 -81.66 -33.94 31.02 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.625 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.6 pt-20 -88.83 -14.86 35.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.865 -1.147 . . . . 0.0 110.088 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.8 mt -54.79 -52.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.169 -0.957 . . . . 0.0 110.515 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.27 -47.11 62.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 109.544 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -53.65 55.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.975 . . . . 0.0 109.201 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.409 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 66.6 mt -55.43 -34.29 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 108.921 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.581 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 10.5 mmtm -77.04 -30.19 55.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.645 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -71.55 -22.24 61.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 192' ' ' VAL . 13.5 m -91.6 13.31 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.941 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 69.68 27.33 73.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.76 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.87 159.22 27.27 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.251 . . . . 0.0 109.797 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 78.63 28.1 55.73 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.31 -0.948 . . . . 0.0 110.817 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.82 -20.39 63.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.691 -1.476 . . . . 0.0 109.066 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.28 -3.12 51.03 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.86 124.74 33.38 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 203' ' ' THR . 12.0 p -138.92 174.48 10.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.755 -0.85 . . . . 0.0 109.258 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.37 -15.87 60.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.485 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.431 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.2 tttm -87.79 -18.8 28.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 201' ' ' LYS . 1.8 m-20 -124.65 -8.6 7.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.649 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 199' ' ' SER . 0.7 OUTLIER -132.47 119.47 20.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -81.09 117.04 21.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.925 . . . . 0.0 108.9 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.3 t -104.66 128.43 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.702 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.784 HD21 HD21 ' A' ' 217' ' ' LEU . 12.3 mt -108.81 148.45 30.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 109.73 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.39 156.05 16.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 207' ' ' GLY . 9.8 tttm -42.13 -33.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -1.141 . . . . 0.0 109.856 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -147.76 16.16 1.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -144.59 153.17 41.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 110.28 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 206' ' ' LEU . 84.6 t -103.12 128.45 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.549 -0.719 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -71.35 -53.97 12.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 0.0 109.996 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.67 133.75 86.17 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 109.411 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.43 -8.0 21.87 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.378 2.052 . . . . 0.0 112.708 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.16 -7.81 54.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 0.0 109.918 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.22 -167.68 48.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.784 HD21 HD21 ' A' ' 206' ' ' LEU . 55.4 mt -83.1 145.74 29.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.497 -1.002 . . . . 0.0 110.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -86.02 -20.08 29.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 221' ' ' ASN . 71.7 m-85 -146.22 133.19 20.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 108.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 31.7 mp0 -46.5 -16.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 108.865 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -131.63 33.54 4.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.617 0.722 . . . . 0.0 109.151 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 4.7 tt0 -53.66 -57.31 17.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_endo -54.21 -38.95 88.19 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.902 1.735 . . . . 0.0 113.036 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 228' ' ' VAL . 9.1 m -79.77 -26.46 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.528 -1.357 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 40.3 mtt-85 -64.69 -41.15 96.24 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -65.41 -43.45 90.54 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -48.36 76.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 108.979 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 224' ' ' VAL . 34.8 t -61.07 -42.74 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 108.467 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 89.2 t80 -58.72 -39.21 80.19 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 1.0 OUTLIER -73.03 -39.51 65.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.55 -0.718 . . . . 0.0 109.696 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.623 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.2 tp -56.62 -36.36 69.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.221 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.506 HG22 ' HD1' ' A' ' 80' ' ' HIS . 94.0 mt -70.67 -48.31 59.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.7 -33.28 18.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.44 -26.56 32.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.258 . . . . 0.0 109.897 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.574 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -80.49 -23.19 40.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.762 -1.212 . . . . 0.0 110.11 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.516 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 10.1 t80 -71.65 -8.59 55.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 237' ' ' LEU . 68.9 mt -52.52 -28.03 18.93 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.434 HD21 HG13 ' A' ' 260' ' ' VAL . 94.9 mt -57.27 -13.92 3.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 108.507 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 14.9 81.61 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 84.1 p -158.99 144.67 12.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.829 -1.395 . . . . 0.0 109.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.408 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 71.6 Cg_exo -43.36 129.3 6.35 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.077 1.851 . . . . 0.0 111.662 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 238' ' ' LEU . 10.6 t -96.3 135.25 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.971 . . . . 0.0 110.148 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.536 ' NZ ' ' OE2' ' A' ' 168' ' ' GLU . 26.8 mmtt -120.16 125.27 47.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.53 171.73 24.77 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -102.65 112.27 24.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.068 -1.254 . . . . 0.0 109.769 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.4 m-85 -112.67 146.75 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.825 0.821 . . . . 0.0 111.354 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -128.61 143.06 50.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.69 125.71 21.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.57 -1.331 . . . . 0.0 110.144 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 250' ' ' ARG . 8.9 t80 -109.77 115.22 29.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 17.2 mtt180 44.0 56.0 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -91.92 157.8 24.55 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.593 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -120.3 -171.56 14.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 87.5 m-70 -74.91 -52.09 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -1.207 . . . . 0.0 110.044 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.0 m -55.1 -56.12 23.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.077 -1.014 . . . . 0.0 109.406 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.1 tp -54.26 -42.57 70.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.487 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -59.07 -55.32 36.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.031 . . . . 0.0 108.7 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 7.3 t -52.28 -39.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.895 . . . . 0.0 109.158 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -54.7 -47.79 73.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 108.643 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.66 -50.16 63.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.574 HG22 HD23 ' A' ' 235' ' ' LEU . 53.1 t -61.25 -42.29 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -52.39 65.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.805 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.62 -40.84 96.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.987 -1.071 . . . . 0.0 109.786 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 263' ' ' LEU . 30.1 mt -61.89 -45.99 91.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.07 -27.63 61.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 110.627 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? . . . . . 0 N--CA 1.488 1.445 0 O-C-N 120.687 -1.258 . . . . 0.0 109.039 179.26 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 14.7 mt-10 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.63 134.33 54.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.568 -0.707 . . . . 0.0 110.121 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -139.2 179.04 6.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 108.766 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 7' ' ' VAL . 7.6 m -87.58 138.06 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.27 . . . . 0.0 110.456 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -73.74 -43.77 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.75 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -125.04 150.04 47.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.177 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 140.04 58.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.814 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.6 mt -122.27 168.04 12.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.586 -0.696 . . . . 0.0 109.198 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.26 148.4 23.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.06 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -135.46 158.02 45.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.498 -0.751 . . . . 0.0 109.588 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -147.89 137.73 22.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.022 -1.049 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.0 160.1 18.69 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.483 HG23 ' C ' ' A' ' 22' ' ' GLU . 9.4 p -81.51 138.61 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -1.186 . . . . 0.0 110.507 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.47 145.28 43.79 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -62.53 -47.88 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.452 -1.028 . . . . 0.0 112.682 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.8 m-70 -87.08 -38.69 16.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.02 -1.675 . . . . 0.0 111.486 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.473 HG21 HD22 ' A' ' 94' ' ' ASN . 3.5 m -74.74 -35.95 62.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.894 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.476 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 68.15 22.42 74.34 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.483 ' C ' HG23 ' A' ' 16' ' ' VAL . 9.2 tt0 -110.13 148.75 31.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.443 -1.033 . . . . 0.0 109.116 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -71.59 130.98 42.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 110.026 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -140.09 156.47 46.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' O ' HD23 ' A' ' 26' ' ' LEU . 24.2 tttm -135.31 147.13 49.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -0.974 . . . . 0.0 109.098 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.74 HD11 ' HD2' ' A' ' 97' ' ' PRO . 1.8 mt -128.19 144.53 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.964 -1.085 . . . . 0.0 109.428 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.4 mt -122.14 140.71 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.3 mt -121.03 118.84 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.109 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -117.4 154.08 50.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.2 164.04 35.53 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.296 1.997 . . . . 0.0 111.24 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.492 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 13.3 mm-40 -134.36 -175.95 4.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.993 . . . . 0.0 109.842 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 15.6 tttm -91.67 158.73 16.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.613 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -51.61 145.4 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.617 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 63.97 23.35 67.56 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.575 -0.703 . . . . 0.0 111.855 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 93.2 m -82.06 -46.36 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.365 -1.667 . . . . 0.0 109.199 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.6 -171.19 23.79 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mm -96.67 123.42 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -1.151 . . . . 0.0 108.375 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.03 140.26 32.58 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.04 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -100.52 152.32 20.53 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.4 t80 -132.22 137.76 47.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 15.6 tttt -165.76 140.21 4.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 109.478 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.6 29.35 13.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.56 12.62 82.38 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.36 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.02 139.35 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -1.141 . . . . 0.0 109.75 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -98.74 141.46 31.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.095 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 46' ' ' ILE . 12.5 mt -133.45 94.76 19.0 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.2 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -51.4 147.15 22.88 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.261 1.974 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.82 84.83 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.893 -1.129 . . . . 0.0 110.605 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -137.6 153.97 49.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.688 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 2.4 p80 -50.62 -49.36 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.564 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.688 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 86.5 mt-10 -44.38 -33.41 1.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 109.104 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -80.15 0.49 32.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.414 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 50' ' ' HIS . 4.0 t -59.25 126.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 108.746 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.59 -32.25 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 0.0 110.153 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.71 124.36 7.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.708 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 p -112.35 134.03 54.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.639 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -166.63 -153.89 0.17 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' ASN . 6.5 m80 -48.59 -11.4 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.97 -1.081 . . . . 0.0 108.455 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 57' ' ' ASN . 8.5 t -138.16 166.24 24.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.497 -0.752 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.7 m -104.14 122.55 45.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.895 . . . . 0.0 108.717 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.34 141.98 50.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.266 -0.896 . . . . 0.0 111.446 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 72' ' ' VAL . 15.0 mt -125.12 156.43 38.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -170.32 140.44 6.02 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.607 -1.759 . . . . 0.0 110.886 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -144.58 150.61 37.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.963 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt 55.28 32.85 19.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.37 -0.831 . . . . 0.0 110.519 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.83 3.1 89.56 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.346 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 73.8 mm-40 -96.76 140.95 30.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.998 -1.295 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -135.52 144.39 46.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 111.147 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.3 mt -133.7 139.43 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -115.1 154.79 28.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.341 -0.849 . . . . 0.0 111.161 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m 52.41 70.35 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.602 -0.686 . . . . 0.0 110.63 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 62' ' ' LEU . 15.3 m -113.54 -8.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 109.508 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -68.16 -20.38 64.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.371 -179.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -71.92 -60.7 2.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.926 -1.109 . . . . 0.0 109.266 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.9 -43.98 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 108.755 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 75' ' ' ILE . 89.6 mt -58.89 -37.53 76.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.809 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.574 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.6 t -61.12 -48.71 80.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.975 . . . . 0.0 109.904 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.61 -53.56 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.95 -1.094 . . . . 0.0 108.611 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -52.45 -44.76 65.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.299 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.582 ' HD1' HG22 ' A' ' 232' ' ' ILE . 15.8 t-160 -54.29 -57.72 10.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.589 HD21 HD13 ' A' ' 232' ' ' ILE . 68.6 mt -57.36 -36.08 70.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.665 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.66 HD22 ' CD1' ' A' ' 114' ' ' ILE . 12.7 mt -82.75 0.54 43.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.72 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.4 27.5 16.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.858 -1.151 . . . . 0.0 110.708 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 82' ' ' LEU . 14.3 mm -73.91 121.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.138 . . . . 0.0 108.351 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.28 -74.63 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 111.227 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.744 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -80.19 114.11 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 111.685 -176.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 86' ' ' ASN . 6.0 m -163.95 142.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.492 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 28.2 m -111.86 101.8 10.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.98 105.97 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.639 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.84 128.5 33.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.845 -1.159 . . . . 0.0 108.329 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 68.6 t -111.52 110.68 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.438 -0.789 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.34 110.27 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.525 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 129.96 -158.14 22.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.473 HD22 HG21 ' A' ' 20' ' ' THR . 0.0 OUTLIER -120.39 -10.14 9.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.492 -1.005 . . . . 0.0 110.483 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 3.3 pm0 -145.56 150.21 35.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.68 -1.263 . . . . 0.0 110.821 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 mm -74.75 122.55 87.74 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.629 -0.67 . . . . 0.0 110.045 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.74 ' HD2' HD11 ' A' ' 26' ' ' LEU . 75.2 Cg_exo -45.97 131.67 13.89 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.118 1.879 . . . . 0.0 112.341 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.436 HD11 ' HA2' ' A' ' 101' ' ' GLY . 7.6 tp -77.39 -24.85 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -0.798 . . . . 0.0 109.981 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.491 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 19.0 mt 58.35 -113.49 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.798 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.74 -19.24 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.982 -1.074 . . . . 0.0 110.855 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 115.05 -11.49 20.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.42 -170.35 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.379 -1.071 . . . . 0.0 109.657 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.8 -4.15 21.46 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -46.62 -40.79 13.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.743 -0.857 . . . . 0.0 110.119 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.52 -51.88 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.048 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.491 ' CZ ' HD11 ' A' ' 99' ' ' LEU . 60.1 m-85 -63.59 -44.08 95.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.4 t80 -63.05 -37.72 88.32 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.465 0.65 . . . . 0.0 109.824 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.96 -49.95 53.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.544 -0.722 . . . . 0.0 111.473 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.6 -51.86 11.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.858 -1.151 . . . . 0.0 110.644 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.16 -43.41 81.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 120.976 -1.077 . . . . 0.0 110.233 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -55.58 -31.29 62.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.457 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -81.85 -5.32 58.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.583 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -127.03 35.31 4.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.425 -0.797 . . . . 0.0 110.887 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.66 ' CD1' HD22 ' A' ' 82' ' ' LEU . 10.9 mt -90.27 145.43 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.801 -1.187 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 115' ' ' LEU . 26.7 tp -131.08 156.6 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -111.6 141.94 44.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.866 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -102.66 -161.19 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.317 -0.864 . . . . 0.0 108.975 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -118.61 2.29 11.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.214 -0.929 . . . . 0.0 111.094 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 4' ' ' GLU . 10.8 ttp85 -100.24 155.99 17.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.796 -1.19 . . . . 0.0 110.136 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 121' ' ' ILE . 13.9 tm-20 -89.07 136.79 32.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.499 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 19.6 mt -76.63 142.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.74 . . . . 0.0 110.694 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -85.22 88.26 7.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.44 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 45.6 m-85 -63.23 144.96 56.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.412 -0.805 . . . . 0.0 110.651 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -102.0 125.16 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 t -129.97 143.98 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.0 135.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.7 -12.78 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.764 . . . . 0.0 109.171 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.91 142.56 28.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 108.941 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.85 159.34 52.07 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.907 1.738 . . . . 0.0 113.122 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.651 HG23 ' HB3' ' A' ' 141' ' ' ALA . 1.5 tt -155.41 138.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.1 mt -127.59 125.71 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.18 113.08 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -117.09 126.91 53.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.493 -0.754 . . . . 0.0 109.707 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -173.67 155.09 2.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.52 20.52 9.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.583 -0.698 . . . . 0.0 110.728 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.3 3.06 88.37 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.592 ' HB2' HD22 ' A' ' 255' ' ' LEU . 1.3 mtt85 -104.8 172.46 6.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.3 tt -160.04 150.39 18.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.335 -1.478 . . . . 0.0 109.015 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.836 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.2 mt -148.05 131.87 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.085 -1.01 . . . . 0.0 109.066 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -120.16 138.97 53.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 109.894 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -124.97 134.84 52.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -133.5 137.76 29.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.56 147.54 29.98 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.291 1.327 . . . . 0.0 111.96 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.44 158.22 9.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.31 2.2 56.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.782 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.2 p -131.91 139.0 48.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 0.0 109.634 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 tp -73.76 116.6 14.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.711 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -137.71 137.1 37.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 108.738 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.574 ' CG1' HD23 ' A' ' 231' ' ' LEU . 75.6 t -140.2 123.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 109.415 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.745 ' OG1' HG23 ' A' ' 165' ' ' THR . 8.9 m -115.56 145.15 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -130.75 130.93 44.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.721 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.11 140.98 48.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.28 144.47 16.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.67 84.49 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.566 -0.961 . . . . 0.0 108.971 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 160' ' ' GLY . 13.6 m-85 -87.02 148.67 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.727 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -93.33 -5.83 48.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 110.037 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.2 p30 -70.43 -167.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.893 -1.13 . . . . 0.0 109.158 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -56.9 -21.59 30.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.005 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.424 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.3 mt -61.74 -57.46 11.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.28 -99.31 2.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.421 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.4 OUTLIER -125.89 136.7 53.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -1.111 . . . . 0.0 109.059 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -145.74 159.43 43.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.721 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -160.2 150.4 18.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -138.32 127.47 24.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.745 HG23 ' OG1' ' A' ' 150' ' ' THR . 29.3 m -102.12 123.44 45.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.144 -0.973 . . . . 0.0 109.509 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.3 135.99 39.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.103 -0.998 . . . . 0.0 109.537 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.519 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -133.19 154.25 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.735 . . . . 0.0 109.337 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -57.6 118.4 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -0.965 . . . . 0.0 109.666 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.68 1.27 21.4 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.77 31.42 3.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.161 -1.2 . . . . 0.0 108.883 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 175' ' ' VAL . 23.0 mt-10 -64.69 -33.52 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 110.719 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.23 -14.54 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 0.0 110.935 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.528 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 25.7 mt-10 -89.97 -3.95 57.73 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.29 -10.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.035 -1.041 . . . . 0.0 111.105 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -83.54 -29.92 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.514 -1.366 . . . . 0.0 110.316 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.47 2.73 43.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.797 -1.189 . . . . 0.0 110.282 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.68 130.26 35.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.776 -1.202 . . . . 0.0 108.681 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.695 HH21 ' N ' ' A' ' 203' ' ' THR . 15.4 ptm180 -104.84 155.12 19.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -0.891 . . . . 0.0 110.463 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.471 ' CA ' ' CE1' ' A' ' 226' ' ' HIS . 3.0 t -56.17 156.71 5.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.249 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.03 166.7 24.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.061 . . . . 0.0 110.527 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.56 ' SG ' ' OE2' ' A' ' 185' ' ' GLU . 0.5 OUTLIER -156.9 162.06 39.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.507 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -104.76 144.67 31.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.724 ' HA ' HD12 ' A' ' 186' ' ' ILE . 39.7 p30 -60.59 -21.59 62.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 111.562 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.9 p90 -76.58 -34.7 58.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.659 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.781 ' OE2' HD11 ' A' ' 189' ' ' ILE . 2.5 pt-20 -96.7 -8.3 31.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.476 -1.39 . . . . 0.0 110.261 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.5 mt -55.37 -51.12 59.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.0 -1.062 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -51.41 -51.82 51.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.237 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -49.22 66.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.157 -0.964 . . . . 0.0 108.794 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.781 HD11 ' OE2' ' A' ' 185' ' ' GLU . 63.8 mt -57.46 -33.96 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.918 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -77.21 -25.91 52.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 110.02 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -77.12 -30.45 55.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.938 . . . . 0.0 109.886 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.08 8.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.188 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.88 73.86 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.524 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 66.0 mt -118.58 157.62 27.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -1.153 . . . . 0.0 109.682 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.47 21.11 65.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -66.14 -25.04 66.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.849 -1.383 . . . . 0.0 109.705 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.4 -4.89 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.36 127.91 35.38 Favored Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.132 -1.217 . . . . 0.0 110.622 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -135.37 170.43 15.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.645 -0.915 . . . . 0.0 109.091 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.71 -36.03 81.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.074 -1.017 . . . . 0.0 109.575 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.584 ' C ' HD22 ' A' ' 202' ' ' ASN . 30.3 ttmt -73.32 -27.64 61.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.217 -0.927 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.776 ' N ' HD22 ' A' ' 202' ' ' ASN . 0.6 OUTLIER -107.41 5.4 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.892 . . . . 0.0 110.084 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.695 ' N ' HH21 ' A' ' 178' ' ' ARG . 3.4 m -153.05 122.12 6.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.918 -1.114 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.431 HD22 ' CD ' ' A' ' 222' ' ' GLU . 5.9 tp -79.35 110.8 14.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 108.693 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.6 128.41 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.973 -1.079 . . . . 0.0 109.528 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.0 mt -106.38 148.46 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.97 149.13 16.62 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 207' ' ' GLY . 23.2 tptt -42.59 -27.38 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -1.161 . . . . 0.0 110.108 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 209' ' ' ASP . 52.6 p-10 -149.96 10.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.929 -1.107 . . . . 0.0 110.272 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.9 pttm -143.67 152.83 41.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.7 t -101.44 129.58 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.889 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.95 -54.41 8.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -57.86 134.65 83.31 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.828 -1.17 . . . . 0.0 109.428 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.92 -14.22 29.36 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.337 2.024 . . . . 0.0 112.695 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -83.85 -6.46 59.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.42 -166.17 54.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.0 148.76 31.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -1.122 . . . . 0.0 109.704 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.4 ' HB3' ' CD2' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -88.12 -22.76 23.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.656 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 77.0 m-85 -149.14 134.19 18.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.0 108.839 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 219' ' ' TYR . 11.0 tt0 -45.47 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.978 -1.076 . . . . 0.0 108.607 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -130.36 35.6 4.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.49 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 3.4 tt0 -56.81 -50.78 86.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.483 -0.761 . . . . 0.0 111.743 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 27.7 Cg_endo -65.82 -39.04 21.25 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.582 1.521 . . . . 0.0 113.457 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.1 OUTLIER -78.09 -26.82 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.524 -1.36 . . . . 0.0 108.324 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 18.2 mtp180 -68.74 -44.11 74.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.471 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 17.3 t60 -59.87 -43.9 94.47 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.515 -0.741 . . . . 0.0 109.038 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -56.25 -41.43 75.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.807 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 224' ' ' VAL . 23.0 t -62.42 -46.4 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.574 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.2 t80 -55.12 -41.71 72.04 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -70.67 -39.39 73.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.466 -0.771 . . . . 0.0 109.676 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.574 HD23 ' CG1' ' A' ' 149' ' ' VAL . 30.0 tp -56.97 -35.62 69.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.463 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.589 HD13 HD21 ' A' ' 81' ' ' LEU . 95.2 mt -71.15 -48.78 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.36 -31.95 13.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.99 -28.43 29.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -1.224 . . . . 0.0 110.267 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.9 mt -79.49 -22.87 43.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.229 . . . . 0.0 109.79 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -68.64 -8.24 40.46 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.331 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.448 ' C ' ' N ' ' A' ' 239' ' ' GLY . 36.4 mt -52.86 -32.58 45.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.851 . . . . 0.0 109.194 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.698 HD12 ' CG2' ' A' ' 242' ' ' VAL . 97.4 mt -52.61 -11.92 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.952 -1.093 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 77.08 13.45 83.65 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.7 p -158.74 143.74 11.79 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.133 -1.216 . . . . 0.0 109.434 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.436 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 73.4 Cg_exo -41.25 135.0 2.82 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 112.149 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.698 ' CG2' HD12 ' A' ' 238' ' ' LEU . 2.4 t -101.3 136.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 131.02 50.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.38 -0.825 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.79 -178.39 31.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.74 112.77 25.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.149 -1.207 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -115.16 145.5 42.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.027 0.918 . . . . 0.0 110.959 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.45 ' CE2' HG21 ' A' ' 150' ' ' THR . 35.8 t80 -131.22 144.02 51.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.0 t -139.65 128.28 23.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.77 -1.206 . . . . 0.0 110.642 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 250' ' ' ARG . 46.0 t80 -108.98 117.18 33.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.4 mmm180 44.76 56.29 5.34 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.56 147.16 21.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -115.69 178.7 17.75 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.456 ' O ' HG23 ' A' ' 257' ' ' VAL . 75.4 m-70 -68.47 -50.59 51.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.276 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 66.1 m -55.39 -55.26 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.031 -1.043 . . . . 0.0 109.367 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 137' ' ' ARG . 58.9 tp -51.38 -39.32 56.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.315 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 10.9 m120 -59.71 -53.81 53.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 108.722 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 253' ' ' HIS . 16.8 t -50.07 -43.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -55.21 -46.86 75.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.031 -1.043 . . . . 0.0 108.89 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 139' ' ' ILE . 56.4 tp -52.6 -44.72 66.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.214 -0.928 . . . . 0.0 108.569 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.04 -56.26 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -46.97 -40.74 14.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -70.51 -46.53 63.48 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.909 -1.119 . . . . 0.0 110.037 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 39.4 mt -65.74 -37.5 86.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.903 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.4 66.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.1 mttp . . . . . 0 N--CA 1.489 1.478 0 O-C-N 120.793 -1.192 . . . . 0.0 108.754 179.182 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 119' ' ' ARG . 18.4 mm-40 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.14 135.65 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.554 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.7 t -135.03 175.32 9.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 109.342 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 7' ' ' VAL . 10.4 m -85.68 135.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.258 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -66.73 -44.19 82.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.41 152.55 48.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.825 . . . . 0.0 109.88 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 136.03 56.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.59 168.34 10.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 p -157.97 148.69 20.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.116 -0.99 . . . . 0.0 110.242 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -129.96 158.73 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 109.285 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.66 135.62 21.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.97 -1.081 . . . . 0.0 109.212 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.13 159.98 18.56 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.5 p -70.7 161.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.265 . . . . 0.0 110.908 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -95.4 140.79 15.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 19' ' ' HIS . 12.6 tt -56.99 -52.2 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.135 -1.215 . . . . 0.0 112.246 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.605 ' N ' HG23 ' A' ' 18' ' ' ILE . 4.6 m-70 -86.46 -38.15 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.281 -1.512 . . . . 0.0 111.197 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.415 ' OG1' ' CD ' ' A' ' 95' ' ' GLU . 16.0 p -72.48 -35.03 68.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.762 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.6 24.76 68.21 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -117.52 155.09 30.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.885 . . . . 0.0 108.87 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.0 t80 -71.65 132.17 44.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 30.9 t -138.66 157.86 45.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 108.845 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.502 ' O ' HD23 ' A' ' 26' ' ' LEU . 27.5 tttp -137.18 151.9 49.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 109.503 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.691 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -127.21 151.22 48.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.174 -0.954 . . . . 0.0 109.737 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.497 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.4 mt -137.69 127.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.4 mt -112.14 118.51 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.562 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.3 m-70 -116.98 149.25 43.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.97 162.44 19.11 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.187 1.925 . . . . 0.0 111.323 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.4 mm-40 -133.94 -177.48 4.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 0.0 109.87 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 6.8 tttm -82.3 149.69 27.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.628 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 11.5 mp0 -48.48 147.27 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 110.39 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.26 24.78 61.63 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.6 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 13.6 m -81.23 -46.43 14.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.734 -1.451 . . . . 0.0 109.445 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.62 -167.23 17.41 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mm -100.75 124.09 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.139 -1.212 . . . . 0.0 107.865 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -140.54 141.51 35.27 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.643 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -101.13 153.15 19.83 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.581 ' CG ' ' OE1' ' A' ' 90' ' ' GLU . 3.3 t80 -120.31 154.92 34.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.534 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -176.06 126.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.669 -1.27 . . . . 0.0 110.192 -179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.84 37.22 16.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.31 77.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -126.23 128.77 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -1.086 . . . . 0.0 109.66 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -89.52 141.75 28.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.4 mt -136.49 95.59 12.74 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.46 144.52 9.97 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.975 1.783 . . . . 0.0 111.472 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.46 85.29 4.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.953 -1.092 . . . . 0.0 110.66 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.74 154.14 49.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.496 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 9.7 p80 -50.62 -48.81 57.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 109.694 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 50.3 mt-10 -43.2 -33.33 0.9 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.347 -0.846 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -77.78 1.85 18.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.241 -0.912 . . . . 0.0 110.275 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 257' ' ' VAL . 4.1 t -63.01 119.08 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 108.77 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.66 -30.92 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.232 -0.918 . . . . 0.0 110.524 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.583 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.3 t-160 -145.71 118.64 8.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.062 . . . . 0.0 109.63 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.1 p -112.34 132.03 55.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.445 0.64 . . . . 0.0 109.455 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 59' ' ' SER . 4.8 t-20 -166.0 -154.32 0.19 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.557 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 1.4 m-70 -48.32 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.835 -1.166 . . . . 0.0 108.329 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' ASN . 16.0 t -136.66 166.03 24.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.451 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 27.0 m -106.88 122.87 47.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 108.965 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.99 138.61 54.36 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.08 0.943 . . . . 0.0 111.218 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.513 HD12 HG21 ' A' ' 72' ' ' VAL . 56.1 mt -117.34 156.42 27.87 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.6 142.74 6.74 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.347 -1.883 . . . . 0.0 111.309 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -143.24 148.75 36.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.865 . . . . 0.0 109.199 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt 56.27 39.86 30.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.0 110.597 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.24 5.63 77.38 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.745 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.7 mm-40 -102.04 140.33 36.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.951 -1.323 . . . . 0.0 108.317 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.603 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -139.37 151.86 46.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.069 -1.019 . . . . 0.0 111.568 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 mt -134.26 145.33 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -114.6 150.2 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 111.245 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 m 55.25 69.03 0.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.708 -0.62 . . . . 0.0 111.047 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.513 HG21 HD12 ' A' ' 62' ' ' LEU . 27.4 m -114.26 -7.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 109.275 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.0 pt-20 -68.65 -36.21 78.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.578 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 26.4 m170 -58.6 -59.98 4.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 110.111 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.1 tp -57.16 -42.17 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.808 -1.183 . . . . 0.0 109.07 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.477 ' N ' HG23 ' A' ' 75' ' ' ILE . 6.9 mt -60.47 -35.91 77.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 109.469 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -60.61 -47.3 86.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.577 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.448 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 38.3 t -58.99 -51.7 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.064 . . . . 0.0 108.681 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 76' ' ' LEU . 54.7 mt -51.27 -44.28 61.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.498 -0.752 . . . . 0.0 109.418 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.722 ' HD1' HG22 ' A' ' 232' ' ' ILE . 14.0 t-160 -56.23 -57.83 10.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 0.0 109.832 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.7 -38.55 72.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 110.449 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 114' ' ' ILE . 15.1 mt -79.8 -0.84 36.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.979 -1.076 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 59.81 42.58 16.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.803 -1.186 . . . . 0.0 110.027 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.37 125.82 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.7 p -106.34 -76.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.51 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.813 HD22 HE22 ' A' ' 117' ' ' GLN . 69.5 m-20 -81.49 113.28 19.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 111.812 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.13 141.73 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.406 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 61.1 m -111.5 103.92 12.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.477 -0.764 . . . . 0.0 109.397 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.18 114.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.202 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.581 ' OE1' ' CG ' ' A' ' 40' ' ' PHE . 1.6 mt-10 -93.07 123.79 36.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 0.0 108.75 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.66 106.79 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.52 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.13 107.71 18.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.58 -162.85 24.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -13.63 14.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.388 -1.066 . . . . 0.0 110.428 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -150.54 155.16 38.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.709 -1.245 . . . . 0.0 110.674 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -69.89 125.71 92.12 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.699 -0.625 . . . . 0.0 110.04 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.691 ' CD ' HD21 ' A' ' 26' ' ' LEU . 74.7 Cg_exo -46.23 134.71 15.41 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.85 1.7 . . . . 0.0 112.017 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.1 tp -76.85 -35.25 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.469 -0.769 . . . . 0.0 109.967 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.416 ' N ' HG23 ' A' ' 98' ' ' ILE . 51.2 mt 55.32 -105.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.431 -0.793 . . . . 0.0 109.631 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.58 ' OD1' ' NE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -94.55 -27.67 15.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.582 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.3 -1.49 28.11 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 p -123.98 -166.78 1.54 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.969 . . . . 0.0 109.292 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.44 -0.34 21.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -46.77 -43.93 18.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.723 -0.869 . . . . 0.0 110.662 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.46 -52.1 62.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.061 -1.025 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 97.3 m-85 -62.45 -45.61 92.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.896 -1.128 . . . . 0.0 108.594 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.402 ' CD2' HG11 ' A' ' 175' ' ' VAL . 15.0 t80 -59.55 -40.72 88.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.456 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -45.6 58.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.487 -0.758 . . . . 0.0 111.464 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.62 -49.75 20.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.201 . . . . 0.0 110.777 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.31 -42.54 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.01 -1.056 . . . . 0.0 111.085 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -56.6 -28.96 61.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.885 -1.134 . . . . 0.0 109.992 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -82.21 -10.16 59.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.958 -1.089 . . . . 0.0 110.047 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -123.02 32.24 5.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.401 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.565 HD11 HD22 ' A' ' 82' ' ' LEU . 13.3 mt -86.28 146.82 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.681 -1.262 . . . . 0.0 109.87 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 115' ' ' LEU . 16.4 tp -132.23 161.55 33.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.29 128.88 55.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.776 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.813 HE22 HD22 ' A' ' 86' ' ' ASN . 4.1 mt-30 -96.39 -166.36 1.41 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.898 . . . . 0.0 110.009 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -124.46 69.31 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.601 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 4' ' ' GLU . 13.2 ttt180 -158.8 137.71 11.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.027 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 26.9 tt0 -47.88 167.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.776 0.798 . . . . 0.0 110.965 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.445 ' N ' ' CG ' ' A' ' 120' ' ' GLU . 31.4 mt -126.23 120.5 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.2 76.98 8.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.602 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -58.54 147.6 31.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -106.83 125.65 51.29 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.7 t -130.49 145.1 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 73.0 t -83.68 136.37 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 0.0 109.363 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.13 -12.9 9.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.51 144.57 42.97 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.84 169.05 23.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.106 1.871 . . . . 0.0 113.174 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 141' ' ' ALA . 4.4 tt -165.24 136.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.784 -0.572 . . . . 0.0 109.485 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.21 124.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.0 109.141 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.3 m -119.36 114.87 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.456 -0.778 . . . . 0.0 109.812 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.41 131.97 55.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -173.18 152.96 2.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 55.89 23.56 6.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.596 -0.69 . . . . 0.0 110.973 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.02 2.75 83.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.525 ' HB2' HD22 ' A' ' 255' ' ' LEU . 89.8 mtt180 -104.61 172.99 6.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.988 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.2 tt -160.06 151.41 19.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.157 -1.589 . . . . 0.0 109.3 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.988 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.4 mt -147.56 130.28 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.957 . . . . 0.0 108.678 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -119.89 142.4 48.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 109.929 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -127.07 141.34 51.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.507 -0.745 . . . . 0.0 109.157 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -140.31 137.2 17.53 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.93 147.07 26.94 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.445 1.43 . . . . 0.0 112.256 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.33 152.3 10.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.922 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.69 0.66 46.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p -137.74 145.79 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.151 -0.968 . . . . 0.0 109.803 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 242' ' ' VAL . 56.2 tp -75.98 117.32 17.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -138.02 136.22 36.66 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.565 ' CG1' HD23 ' A' ' 231' ' ' LEU . 15.1 t -137.31 122.03 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -107.51 130.14 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.343 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.567 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.2 t80 -116.58 128.97 55.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.88 106.43 14.16 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.25 150.64 19.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -129.35 88.23 2.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.492 -1.004 . . . . 0.0 109.204 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -95.21 146.83 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.591 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -94.89 -2.03 51.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 182' ' ' PHE . 6.9 p30 -70.15 -166.64 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.779 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -65.71 -22.09 66.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.092 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.456 HD12 ' ND2' ' A' ' 157' ' ' ASN . 5.1 mt -66.66 -38.7 87.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.048 -1.033 . . . . 0.0 109.137 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.11 -137.95 19.23 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 161' ' ' ARG . 0.3 OUTLIER -100.11 145.34 28.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 109.421 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.483 ' OE1' ' ND2' ' A' ' 221' ' ' ASN . 0.9 OUTLIER -148.81 166.55 28.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.539 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 150.31 23.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -139.79 131.86 27.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.193 -0.942 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 165' ' ' THR . 11.4 t -102.15 123.17 45.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.184 -0.948 . . . . 0.0 109.801 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.5 t80 -101.2 134.46 44.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 108.986 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.43 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -132.67 151.2 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 109.472 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -50.54 120.76 4.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.87 6.8 26.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -134.53 27.25 3.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.206 -1.173 . . . . 0.0 108.522 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -61.68 -35.49 78.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 110.57 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.24 -18.35 10.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.951 -1.093 . . . . 0.0 110.283 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.9 -3.64 58.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 0.0 110.837 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 3.0 pt -130.49 19.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 111.947 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.1 OUTLIER -113.53 -29.13 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.803 -1.186 . . . . 0.0 109.908 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.06 2.53 53.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 110.684 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.03 127.13 32.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.605 -1.309 . . . . 0.0 109.109 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.58 ' NE ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.02 152.51 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.3 t -53.65 161.32 1.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 109.177 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.63 164.01 31.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.786 -1.196 . . . . 0.0 110.2 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 189' ' ' ILE . 0.3 OUTLIER -149.3 160.29 43.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 109.673 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.565 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.4 m-85 -104.35 144.97 30.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.721 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.753 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.7 p-10 -59.25 -26.98 65.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.958 -1.089 . . . . 0.0 110.488 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.565 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.4 p90 -81.14 -27.59 35.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.825 -1.172 . . . . 0.0 110.668 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.8 pt-20 -93.14 -14.21 27.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 109.818 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.9 mt -56.76 -52.61 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.62 -52.71 45.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.123 . . . . 0.0 109.79 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -52.82 -44.42 66.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 91.0 mt -65.51 -33.86 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -77.01 -26.88 54.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.042 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -81.0 -27.98 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.087 -1.008 . . . . 0.0 110.517 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.0 m -80.16 8.54 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.509 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.21 24.44 68.63 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.811 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 62.9 mt -121.19 159.82 25.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.24 -1.153 . . . . 0.0 109.691 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 76.94 27.7 59.99 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.03 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -71.18 -19.41 62.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.667 -1.49 . . . . 0.0 109.292 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.5 -4.19 49.75 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.14 128.74 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.273 -1.134 . . . . 0.0 110.896 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.25 -173.81 3.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.747 -0.855 . . . . 0.0 109.157 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.99 -5.59 57.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.051 -1.031 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -98.09 -13.69 20.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.339 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -127.18 -3.6 6.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -136.24 117.34 14.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.26 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.2 tp -79.42 110.54 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.54 127.56 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.08 -1.013 . . . . 0.0 109.839 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.28 146.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.363 -0.836 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.66 150.47 17.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -44.38 -28.65 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.132 . . . . 0.0 110.242 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 35.0 t0 -143.8 8.46 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 110.127 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 207' ' ' GLY . 68.4 tttt -146.01 154.72 42.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.062 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.71 128.96 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -71.98 -53.09 14.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.095 -1.003 . . . . 0.0 109.908 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 213' ' ' ASN . 1.0 OUTLIER -54.72 133.55 65.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.119 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.88 -24.97 20.48 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.281 1.987 . . . . 0.0 112.511 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.89 -6.65 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 109.792 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.92 -167.54 48.37 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.45 141.8 39.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -1.084 . . . . 0.0 109.63 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -83.7 -15.66 47.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.097 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 221' ' ' ASN . 70.1 m-85 -144.26 135.43 25.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.535 ' C ' HD22 ' A' ' 221' ' ' ASN . 1.5 tm-20 -49.34 -10.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 219' ' ' TYR . 1.4 m-80 -143.11 35.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.525 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 56.1 tt0 -56.1 -36.46 46.43 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 111.919 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 10.2 Cg_exo -69.27 -43.92 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.731 1.621 . . . . 0.0 112.907 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 228' ' ' VAL . 24.5 m -77.81 -25.7 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 120.706 -1.246 . . . . 0.0 108.544 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -65.12 -45.67 84.14 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.456 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 47.1 t60 -62.16 -43.15 99.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -49.85 74.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 109.335 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 224' ' ' VAL . 19.2 t -56.26 -48.18 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 108.767 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.578 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 85.0 t80 -50.5 -44.6 56.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.632 -0.668 . . . . 0.0 109.607 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.578 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 28.4 m-20 -71.48 -35.22 70.75 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 109.994 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.565 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.7 tp -56.46 -37.54 70.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.025 . . . . 0.0 108.857 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.722 HG22 ' HD1' ' A' ' 80' ' ' HIS . 55.4 mt -71.49 -47.52 58.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.13 -33.73 15.32 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.57 -26.18 32.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -1.171 . . . . 0.0 109.808 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 260' ' ' VAL . 4.7 mt -82.27 -24.55 34.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.826 -1.171 . . . . 0.0 110.193 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.443 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 28.7 t80 -69.98 -7.38 40.26 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 109.148 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.45 ' C ' ' N ' ' A' ' 239' ' ' GLY . 34.8 mt -51.04 -31.55 18.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 108.775 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.601 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 96.2 mt -53.79 -12.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 108.681 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 74.53 17.21 79.86 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.5 p -157.63 143.32 12.55 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.338 . . . . 0.0 109.812 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.419 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 55.7 Cg_exo -43.12 131.13 6.21 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.15 1.9 . . . . 0.0 111.944 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.502 ' O ' HD13 ' A' ' 147' ' ' LEU . 24.6 t -103.58 141.25 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -130.61 133.37 46.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.311 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.56 179.49 30.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -107.54 110.45 22.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.103 -1.233 . . . . 0.0 109.719 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.535 ' HB2' HG22 ' A' ' 149' ' ' VAL . 8.7 m-85 -112.18 146.96 37.17 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.928 . . . . 0.0 111.059 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -128.1 144.17 51.1 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.2 t -142.05 126.94 18.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.711 -1.243 . . . . 0.0 110.501 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.7 t80 -110.19 116.94 32.41 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 249' ' ' PHE . 6.4 mmm180 46.81 55.91 7.26 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.84 140.95 23.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.52 171.24 13.72 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 22.1 m-70 -63.99 -45.21 90.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.244 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -55.73 26.33 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.094 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' ' 137' ' ' ARG . 56.5 tp -52.06 -39.88 60.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.117 -0.989 . . . . 0.0 109.351 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.23 -55.82 30.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 108.784 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 53' ' ' VAL . 2.7 t -49.85 -41.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.47 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -49.45 71.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.067 -1.02 . . . . 0.0 109.039 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.757 HD22 HG21 ' A' ' 139' ' ' ILE . 43.8 tp -52.66 -49.65 64.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 0.0 108.677 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.531 HG22 HD23 ' A' ' 235' ' ' LEU . 48.8 t -63.62 -49.93 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.477 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -51.65 17.93 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.63 -44.34 90.84 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.89 -1.131 . . . . 0.0 109.781 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.64 -46.29 90.41 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.601 ' HB2' ' CD2' ' A' ' 238' ' ' LEU . . . -72.69 -32.78 66.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.704 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 O-C-N 120.845 -1.16 . . . . 0.0 109.157 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 36.0 mt-10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 132.16 56.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.565 -0.709 . . . . 0.0 109.316 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -136.44 175.29 9.74 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.35 -0.843 . . . . 0.0 109.271 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.3 m -83.24 138.13 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.727 -1.233 . . . . 0.0 110.367 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HZ3' ' HB2' ' A' ' 8' ' ' LYS . 6.8 ttmm -71.95 -47.02 55.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.734 . . . . 0.0 109.543 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.66 156.44 41.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.854 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 135.16 55.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.473 -0.767 . . . . 0.0 110.415 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 113' ' ' ASN . 19.1 mt -117.54 163.46 16.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -153.92 147.3 24.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.009 . . . . 0.0 110.098 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.28 161.61 31.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.254 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -149.59 136.65 19.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.915 -1.116 . . . . 0.0 108.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.09 161.27 20.28 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.7 p -73.75 161.24 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.11 -1.23 . . . . 0.0 111.176 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -92.54 140.09 14.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.8 tt -56.11 -52.25 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -1.218 . . . . 0.0 111.816 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.533 ' N ' HG23 ' A' ' 18' ' ' ILE . 10.3 m-70 -86.97 -38.63 16.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.309 -1.494 . . . . 0.0 110.879 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 22' ' ' GLU . 2.6 m -68.68 -36.6 78.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 110.054 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.61 23.09 66.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HB2' HG22 ' A' ' 20' ' ' THR . 2.0 tt0 -117.99 154.98 31.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.692 -0.887 . . . . 0.0 108.722 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.5 t80 -71.73 136.3 47.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 110.181 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.439 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.9 t -144.02 157.55 44.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 108.974 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.1 ttmt -137.22 147.16 45.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.098 -1.001 . . . . 0.0 109.292 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.715 HD11 ' HD2' ' A' ' 97' ' ' PRO . 2.3 mt -123.41 151.1 42.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.629 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.422 HG22 ' CD2' ' A' ' 29' ' ' HIS . 6.8 mt -134.84 129.44 51.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.57 110.76 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 109.812 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.422 ' CD2' HG22 ' A' ' 27' ' ' ILE . 21.7 m-70 -106.75 150.23 39.43 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 108.901 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.56 161.88 22.91 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.226 1.95 . . . . 0.0 110.816 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.558 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -140.56 159.34 42.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.886 -1.134 . . . . 0.0 110.69 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 tttt -59.7 149.31 31.06 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.516 0.674 . . . . 0.0 109.987 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.3 mp0 -48.76 148.38 2.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 110.612 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.511 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.73 25.85 59.38 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.413 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -80.46 -37.57 31.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.618 -1.519 . . . . 0.0 109.031 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.27 -177.03 33.36 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.8 mm -98.8 125.41 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 140.13 32.71 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.969 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -97.48 152.22 19.2 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -133.54 140.13 47.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -170.7 143.75 2.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 54.86 29.13 11.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.955 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.85 21.16 78.05 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.8 t -124.42 135.62 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.161 -1.2 . . . . 0.0 109.545 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -94.6 142.06 27.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 109.039 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.9 mt -135.01 94.43 16.19 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.395 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -48.7 143.3 16.86 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.324 2.016 . . . . 0.0 111.747 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.99 79.74 5.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.069 -1.019 . . . . 0.0 110.158 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.3 mtt-85 -138.7 156.38 47.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.447 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 3.3 p80 -52.86 -50.12 64.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -45.26 -15.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 110.264 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.2 m-85 -100.19 2.64 43.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.669 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 50' ' ' HIS . 9.8 t -57.73 133.35 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 108.955 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 m -120.66 -36.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 109.91 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.454 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.1 t-160 -151.19 122.11 7.61 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.348 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 p -110.75 132.6 54.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.4 t-20 -166.47 -154.71 0.19 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -48.03 -11.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 108.604 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.6 t -135.89 165.61 25.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 m -101.64 119.73 39.23 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -116.94 135.5 53.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 111.169 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD12 HG21 ' A' ' 72' ' ' VAL . 30.9 mt -124.22 158.91 31.34 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -177.83 145.62 7.15 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.963 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -144.71 151.16 38.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.883 . . . . 0.0 109.51 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 57.37 23.81 9.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 110.971 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.15 1.26 72.74 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.556 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 55.5 mm-40 -99.24 139.84 34.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.989 -1.301 . . . . 0.0 108.284 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -136.28 149.72 48.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.025 . . . . 0.0 111.426 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.84 141.68 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -114.48 151.02 33.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.185 -0.947 . . . . 0.0 111.456 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 56.45 65.84 1.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.798 -0.564 . . . . 0.0 111.284 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.422 HG21 HD12 ' A' ' 62' ' ' LEU . 28.8 m -114.08 -3.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.041 -1.037 . . . . 0.0 109.043 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pt-20 -70.63 -28.4 64.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 110.533 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -64.35 -60.52 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.907 -1.121 . . . . 0.0 109.723 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -58.74 -44.51 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.952 -1.092 . . . . 0.0 109.129 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 75' ' ' ILE . 65.4 mt -55.8 -41.46 74.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.927 . . . . 0.0 109.456 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -56.82 -46.32 81.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.292 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.88 -53.69 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.963 . . . . 0.0 108.652 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 76' ' ' LEU . 27.6 mt -51.55 -44.58 62.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.279 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.524 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.4 t-160 -53.93 -55.38 27.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.249 -0.907 . . . . 0.0 109.726 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 171' ' ' GLU . 95.1 mt -62.36 -37.24 84.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.447 HD13 HD11 ' A' ' 114' ' ' ILE . 50.1 mt -78.94 -9.84 59.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.01 -1.056 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 63.41 60.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.851 -1.156 . . . . 0.0 110.514 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 4.8 mm -104.18 133.99 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.408 HG21 HG23 ' A' ' 121' ' ' ILE . 1.2 p -119.87 -17.1 8.59 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.269 -0.895 . . . . 0.0 111.943 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.696 ' O ' HG13 ' A' ' 87' ' ' VAL . 4.0 m-80 -130.11 111.83 12.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.699 -1.25 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -165.26 136.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 110.01 178.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.558 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 23.3 m -107.21 99.53 9.06 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 mt -87.95 117.83 32.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.91 119.64 34.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.787 -1.196 . . . . 0.0 107.992 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 26' ' ' LEU . 23.0 t -104.61 104.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 111.344 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mt -87.49 107.78 17.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.74 -161.32 24.03 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -116.85 -14.52 10.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -1.045 . . . . 0.0 110.506 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.18 146.34 35.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.741 -1.224 . . . . 0.0 111.076 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.23 124.88 91.37 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.803 -0.561 . . . . 0.0 109.674 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.715 ' HD2' HD11 ' A' ' 26' ' ' LEU . 73.3 Cg_exo -46.37 129.4 13.33 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.774 1.649 . . . . 0.0 111.754 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.4 tp -77.6 -29.18 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.488 -0.757 . . . . 0.0 110.188 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.587 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 95.0 mt 55.24 -111.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.44 ' OD1' ' NH2' ' A' ' 178' ' ' ARG . 2.5 t0 -89.28 -28.58 19.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.613 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.13 -14.98 11.02 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -109.93 -166.78 1.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.37 -2.76 21.34 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -47.44 -42.37 22.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.808 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.95 -51.96 64.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.002 -1.062 . . . . 0.0 110.356 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 93.6 m-85 -63.5 -44.81 93.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 108.632 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 6.9 t80 -62.36 -38.2 88.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.718 -0.614 . . . . 0.0 109.961 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.3 -46.28 61.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.366 -0.834 . . . . 0.0 110.807 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.42 -51.56 12.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.992 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.68 -45.52 79.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.043 -1.036 . . . . 0.0 110.557 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -55.51 -29.36 58.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.209 -0.932 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -81.24 -12.96 58.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -0.992 . . . . 0.0 109.992 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.54 ' HB2' HD11 ' A' ' 11' ' ' LEU . 1.5 m120 -120.09 33.09 5.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.385 -0.822 . . . . 0.0 111.125 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.447 HD11 HD13 ' A' ' 82' ' ' LEU . 5.9 mt -90.55 148.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 110.494 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 115' ' ' LEU . 52.7 tp -131.18 158.18 41.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.27 140.22 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -103.86 -163.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.618 ' H ' HD22 ' A' ' 118' ' ' ASN . 0.1 OUTLIER -116.47 -1.38 12.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.41 ' CD ' ' OE2' ' A' ' 4' ' ' GLU . 10.2 ttm180 -94.13 149.21 21.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 109.903 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.53 136.83 32.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 85' ' ' THR . 94.8 mt -77.52 144.32 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.411 -0.805 . . . . 0.0 110.459 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.5 89.97 8.07 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -62.88 145.64 54.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.235 -0.916 . . . . 0.0 110.518 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.27 123.4 46.03 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.18 141.12 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.89 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.1 t -84.43 138.34 19.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.493 -0.755 . . . . 0.0 109.096 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -119.12 -11.15 9.66 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -140.18 144.17 36.59 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.86 173.52 12.61 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.113 1.875 . . . . 0.0 113.109 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.709 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 2.9 tt -165.3 142.17 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.685 -0.634 . . . . 0.0 109.703 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 131' ' ' ILE . 3.4 mp -129.71 125.31 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 m -121.52 114.07 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -113.47 141.8 46.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.42 -0.8 . . . . 0.0 109.845 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -175.26 137.93 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 111.074 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 57.49 29.51 17.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.642 -0.662 . . . . 0.0 111.412 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.46 9.06 86.09 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -110.39 157.71 19.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.986 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -158.69 156.13 29.37 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.953 -1.717 . . . . 0.0 109.536 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.986 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.9 mt -149.03 133.02 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -120.91 143.01 49.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 109.901 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.709 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.23 143.97 49.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -142.03 138.47 16.9 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.9 144.9 42.85 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.473 1.449 . . . . 0.0 112.276 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.06 149.83 9.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -1.88 53.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 109.61 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.8 p -134.78 142.42 46.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.45 118.78 20.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -137.73 136.82 37.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.484 ' CG1' HD23 ' A' ' 231' ' ' LEU . 60.3 t -133.98 122.53 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.014 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.401 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 9.9 m -107.84 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.337 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -127.42 129.59 47.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.793 . . . . 0.0 109.72 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -115.52 103.51 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.72 135.45 12.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -111.18 93.23 4.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.498 -1.001 . . . . 0.0 109.343 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.455 ' HB2' HD21 ' A' ' 157' ' ' ASN . 20.5 m-85 -95.16 148.66 22.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.446 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -97.07 -3.75 40.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.836 HD22 ' H ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -73.74 -169.4 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.675 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -60.71 -20.8 61.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.97 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.534 HD12 ' OD1' ' A' ' 157' ' ' ASN . 31.2 mt -70.46 -28.36 64.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.0 109.042 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.69 -132.13 31.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.18 145.11 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -1.037 . . . . 0.0 109.556 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -146.35 156.04 43.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.583 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -139.23 145.0 38.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.249 -0.907 . . . . 0.0 109.332 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -136.28 126.58 26.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.061 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 165' ' ' THR . 7.3 t -103.78 123.85 47.83 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -100.22 136.03 40.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.159 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.512 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.5 t -131.82 153.5 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -57.08 118.91 5.49 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.43 -3.79 21.79 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -125.54 31.22 5.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.259 -1.142 . . . . 0.0 108.711 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.521 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.7 OUTLIER -64.3 -32.84 74.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.543 -0.723 . . . . 0.0 110.605 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -58.2 -15.64 10.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.937 -1.102 . . . . 0.0 111.059 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -92.7 -4.13 53.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.85 -1.156 . . . . 0.0 110.894 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.23 -6.56 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.103 -0.998 . . . . 0.0 110.721 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -89.85 -29.14 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.698 -1.252 . . . . 0.0 109.933 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.03 1.99 51.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.68 -1.262 . . . . 0.0 110.415 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.07 115.62 18.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.914 -1.116 . . . . 0.0 108.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.44 ' NH2' ' OD1' ' A' ' 100' ' ' ASP . 1.9 ptm180 -86.59 154.62 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.05 . . . . 0.0 110.066 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -53.34 159.46 1.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.63 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.502 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 38.6 p90 -145.93 169.42 18.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.911 -1.118 . . . . 0.0 109.906 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.502 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -164.39 163.89 22.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.612 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 96.0 m-85 -103.7 146.08 29.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.613 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.717 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.6 OUTLIER -61.96 -20.69 64.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 111.076 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.612 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.3 p90 -81.0 -26.85 36.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.646 -1.284 . . . . 0.0 110.643 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.499 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 23.4 pt-20 -97.74 -15.85 20.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.859 -1.151 . . . . 0.0 109.474 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.7 mt -57.39 -52.12 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 110.045 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.15 -49.21 61.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.078 . . . . 0.0 109.43 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -54.46 -52.36 62.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 108.922 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 59.5 mt -57.72 -33.84 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.407 -0.808 . . . . 0.0 109.346 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -77.89 -28.95 49.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.51 ' HZ3' ' CB ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -72.69 -26.8 61.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.573 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.3 m -84.79 13.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.604 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.24 25.68 72.52 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.072 -1.061 . . . . 0.0 110.592 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.03 156.59 28.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.267 -1.137 . . . . 0.0 109.732 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.72 25.55 60.32 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.408 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.6 mtmm -69.04 -20.88 64.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.465 -1.609 . . . . 0.0 109.051 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.88 -7.28 44.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.93 129.31 43.82 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.24 -1.153 . . . . 0.0 110.771 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.4 p -143.72 169.93 16.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.79 -0.829 . . . . 0.0 109.466 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 17.0 mt -71.25 -16.46 62.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.455 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 48.5 tttp -86.08 -9.65 56.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 6.1 m120 -138.26 12.07 2.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.648 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.475 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 28.1 m -152.97 131.69 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.57 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' A' ' 217' ' ' LEU . 6.5 tp -89.98 114.85 26.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 186' ' ' ILE . 63.4 t -100.65 125.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.063 -1.023 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.9 mt -100.73 146.13 27.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.867 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.43 150.3 16.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -46.33 -25.88 0.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.136 -1.214 . . . . 0.0 109.86 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -152.56 11.44 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 0.0 110.67 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -146.99 155.35 42.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.89 -1.131 . . . . 0.0 110.281 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.77 123.36 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -70.84 -54.35 11.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.935 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.427 ' ND2' ' H ' ' A' ' 205' ' ' VAL . 47.0 m-80 -53.49 131.36 54.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.098 -1.002 . . . . 0.0 109.391 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -24.95 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.311 2.007 . . . . 0.0 112.457 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -4.51 39.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.955 . . . . 0.0 109.289 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.89 -169.16 53.85 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.45 ' CD2' HD21 ' A' ' 204' ' ' LEU . 13.9 mt -88.05 149.81 23.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 0.0 109.745 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -60.67 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.0 108.722 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.426 ' C ' ' H ' ' A' ' 221' ' ' ASN . 7.7 m-85 -116.86 152.52 34.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 109.165 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.6 mp0 -60.65 -3.93 0.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 109.423 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.78 HD22 ' HE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -137.48 29.77 2.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.867 . . . . 0.0 108.983 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.603 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.0 tt0 -54.45 -42.03 92.31 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.76 . . . . 0.0 110.863 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.5 Cg_exo -70.83 -38.52 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.508 2.139 . . . . 0.0 113.156 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -81.66 -26.87 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.675 -1.266 . . . . 0.0 108.539 179.361 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.78 ' HE ' HD22 ' A' ' 221' ' ' ASN . 38.1 mtt180 -67.35 -39.82 85.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.572 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 19.1 t60 -66.6 -41.03 89.06 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -42.05 76.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.036 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 224' ' ' VAL . 38.7 t -68.06 -44.6 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -55.26 -40.83 71.43 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.605 0.717 . . . . 0.0 109.067 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -71.74 -39.99 69.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.575 -0.703 . . . . 0.0 109.907 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.484 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.8 tp -56.55 -35.1 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.373 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 81.2 mt -72.15 -49.08 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.924 -1.11 . . . . 0.0 108.144 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.34 -30.95 12.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.74 -28.33 30.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -1.187 . . . . 0.0 109.854 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 260' ' ' VAL . 5.3 mt -79.17 -22.85 44.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.743 -1.223 . . . . 0.0 109.782 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.524 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 16.6 t80 -69.99 -8.0 45.46 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.068 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 237' ' ' LEU . 31.1 mt -49.76 -28.57 6.38 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.69 -20.59 65.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 108.957 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.41 17.91 76.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.9 p -154.01 138.8 11.52 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.235 . . . . 0.0 109.652 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -41.82 134.11 3.88 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.165 1.91 . . . . 0.0 111.872 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.81 136.14 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.023 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -122.3 125.71 46.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.306 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.45 26.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -102.5 112.54 25.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -1.198 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.6 m-85 -112.58 146.9 37.75 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.976 0.893 . . . . 0.0 111.048 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.401 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 26.9 t80 -126.99 144.29 51.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.0 t -138.87 126.76 22.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.684 -1.26 . . . . 0.0 110.112 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 250' ' ' ARG . 61.8 t80 -113.16 113.1 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 249' ' ' PHE . 52.8 mtp180 47.66 56.72 6.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.71 145.86 21.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.422 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -113.5 175.94 16.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.511 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.5 m-70 -66.99 -47.77 70.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -1.134 . . . . 0.0 109.998 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -55.14 37.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 109.801 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 51.6 tp -51.68 -37.86 52.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 16.1 m120 -58.68 -55.37 35.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.119 -0.988 . . . . 0.0 108.746 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 253' ' ' HIS . 18.5 t -49.14 -41.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.415 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -55.22 -47.37 75.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 108.803 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.86 -50.56 63.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.447 HG22 HD23 ' A' ' 235' ' ' LEU . 42.1 t -63.63 -41.2 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 109.856 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -51.93 67.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.421 -0.799 . . . . 0.0 110.43 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -64.65 -45.4 86.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.845 -1.159 . . . . 0.0 109.73 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 263' ' ' LEU . 60.8 mt -58.83 -45.72 89.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.17 73.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.832 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 47.4 mttt . . . . . 0 N--CA 1.488 1.457 0 O-C-N 120.85 -1.156 . . . . 0.0 109.101 179.386 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 76.7 mt-10 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.88 139.67 52.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 109.485 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -141.15 177.57 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.468 -0.77 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.33 149.69 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 110.21 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -86.27 -42.13 14.02 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.662 -0.649 . . . . 0.0 109.758 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 10' ' ' LYS . 13.0 tt0 -129.32 153.98 47.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.517 -0.739 . . . . 0.0 109.992 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -59.98 135.64 57.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.305 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 113' ' ' ASN . 44.5 mt -124.8 166.52 16.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.473 -0.767 . . . . 0.0 109.267 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 150.24 22.34 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 110.115 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -131.21 158.43 40.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.695 -0.628 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.81 134.81 23.87 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.941 -1.1 . . . . 0.0 108.869 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.85 156.79 14.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.094 -1.603 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -81.12 141.02 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -1.229 . . . . 0.0 110.804 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.61 138.12 37.71 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.598 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.6 tt -57.91 -48.16 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.089 . . . . 0.0 112.042 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.45 ' N ' HG23 ' A' ' 18' ' ' ILE . 16.3 m-70 -86.75 -37.6 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.276 -1.515 . . . . 0.0 111.017 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.492 HG21 ' OD1' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -72.25 -32.86 67.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 110.119 -179.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.33 65.89 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 16' ' ' VAL . 4.8 mm-40 -113.83 151.25 32.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.948 . . . . 0.0 108.956 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -70.62 130.94 43.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.89 . . . . 0.0 110.063 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -138.63 157.55 45.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.063 -1.023 . . . . 0.0 109.381 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' O ' HD23 ' A' ' 26' ' ' LEU . 6.7 ttpp -137.09 152.03 49.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.132 -0.98 . . . . 0.0 109.541 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.738 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.3 mt -127.72 145.95 50.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.491 HG22 ' NE2' ' A' ' 29' ' ' HIS . 26.1 mt -131.35 129.05 62.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mt -117.89 133.35 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.087 -1.008 . . . . 0.0 110.139 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.491 ' NE2' HG22 ' A' ' 27' ' ' ILE . 17.7 m-70 -126.6 150.01 69.66 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.71 161.78 20.32 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.104 1.869 . . . . 0.0 111.028 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 53.5 mt-10 -133.96 -174.68 3.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -89.73 154.92 19.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.195 -0.94 . . . . 0.0 109.248 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -47.93 145.2 3.08 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 110.058 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.55 23.52 54.78 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.382 -0.824 . . . . 0.0 111.791 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 55.5 m -75.45 -46.29 33.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.589 -1.536 . . . . 0.0 109.094 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.809 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 105.23 174.94 24.32 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.98 121.79 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.446 -1.032 . . . . 0.0 108.749 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.27 138.23 34.84 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -97.22 153.0 18.28 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -130.98 139.95 50.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.155 -0.965 . . . . 0.0 109.063 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 10.7 ttmt -170.0 139.46 1.86 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.483 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.91 29.02 18.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.04 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 28.09 70.63 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.3 t -134.28 139.18 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -1.12 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -97.67 144.43 27.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.096 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.414 HG23 ' CB ' ' A' ' 64' ' ' PHE . 31.9 mt -136.91 97.62 10.99 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.306 -0.871 . . . . 0.0 110.33 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.61 143.13 29.4 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.093 1.862 . . . . 0.0 111.341 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.46 83.15 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.0 -1.062 . . . . 0.0 110.481 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -138.53 154.9 48.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.332 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.9 p80 -53.47 -49.37 67.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.24 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' CG ' ' CE1' ' A' ' 50' ' ' HIS . 8.2 mt-10 -45.55 -16.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' HIS . 89.8 m-85 -96.89 6.66 48.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.961 -1.087 . . . . 0.0 109.868 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.14 126.2 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 108.652 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.21 -32.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -149.87 119.99 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.068 -1.02 . . . . 0.0 109.63 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.4 p -112.68 131.36 55.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.427 0.632 . . . . 0.0 109.359 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 2.1 t-20 -166.07 -154.3 0.19 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 57' ' ' ASN . 10.8 m-70 -47.81 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.922 -1.111 . . . . 0.0 108.357 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.6 t -136.6 166.11 24.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.2 m -107.83 123.45 48.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 108.971 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.02 141.68 51.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.928 0.87 . . . . 0.0 110.971 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.2 mt -118.64 168.58 10.57 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.25 145.07 5.43 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.801 -1.666 . . . . 0.0 110.824 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CB ' HG23 ' A' ' 46' ' ' ILE . 54.0 t80 -144.46 150.58 37.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? 55.85 23.22 6.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.751 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.62 68.08 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.741 -1.219 . . . . 0.0 111.075 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.499 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 1.5 mm100 -92.33 144.87 24.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.483 . . . . 0.0 108.456 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.635 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -141.6 153.23 44.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.937 -1.102 . . . . 0.0 111.5 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 147.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -113.63 151.75 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.206 -0.934 . . . . 0.0 111.383 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m 52.52 68.23 0.86 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.776 -0.578 . . . . 0.0 111.037 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 HG13 ' A' ' 96' ' ' ILE . 16.1 m -113.02 -10.28 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.49 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.8 pt-20 -65.56 -24.22 67.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.413 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -67.64 -60.32 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.871 -1.143 . . . . 0.0 109.764 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.2 tp -58.32 -42.32 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.002 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HA ' HD12 ' A' ' 79' ' ' LEU . 19.5 mt -58.85 -37.99 77.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.489 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.6 t -58.35 -47.47 83.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.931 -1.106 . . . . 0.0 108.956 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.88 -51.58 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.547 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 76' ' ' LEU . 49.5 mt -51.27 -44.1 61.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 4.6 t-160 -52.62 -56.95 11.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.404 -0.81 . . . . 0.0 109.918 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.83 -35.71 79.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 110.559 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.803 HD22 ' CD1' ' A' ' 114' ' ' ILE . 13.4 mt -79.68 -9.65 59.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.021 -1.05 . . . . 0.0 110.595 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 62.74 50.35 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.781 -1.199 . . . . 0.0 110.372 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 3.3 mm -94.14 125.64 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.468 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.8 p -113.83 -18.74 11.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.168 -0.958 . . . . 0.0 112.034 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.809 HD22 ' H ' ' A' ' 36' ' ' GLY . 10.5 m120 -130.75 112.15 12.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.886 -1.134 . . . . 0.0 110.409 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -164.57 148.69 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 0.0 110.023 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.467 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 2.3 m -115.69 102.09 9.42 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.1 104.79 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.21 118.88 24.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 108.401 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.27 112.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 111.05 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -92.5 110.9 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.21 -163.16 24.87 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -116.57 -15.18 10.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -1.013 . . . . 0.0 110.101 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 19.1 tt0 -138.05 143.01 40.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 0.0 110.291 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.481 HG13 HG12 ' A' ' 72' ' ' VAL . 2.9 mm -69.36 124.71 91.06 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.468 -0.77 . . . . 0.0 109.392 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.738 ' CD ' HD21 ' A' ' 26' ' ' LEU . 50.1 Cg_exo -46.85 126.46 11.0 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.547 1.498 . . . . 0.0 111.416 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 98' ' ' ILE . 4.7 tp -79.52 -21.45 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.407 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 3.7 mt 57.06 -110.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -95.5 -8.16 36.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.046 -1.034 . . . . 0.0 111.919 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.23 -12.04 48.13 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.2 p -119.04 -168.84 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -1.01 . . . . 0.0 109.537 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.55 -4.08 23.51 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.543 ' NE1' ' CD ' ' A' ' 108' ' ' GLU . 60.5 t-105 -46.92 -42.5 17.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.664 -0.903 . . . . 0.0 110.455 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.15 -51.51 68.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.924 -1.11 . . . . 0.0 109.783 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.5 m-85 -62.29 -43.81 97.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.112 -0.993 . . . . 0.0 108.588 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -61.98 -39.3 91.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.543 ' CD ' ' NE1' ' A' ' 104' ' ' TRP . 19.0 mt-10 -68.91 -46.39 68.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 111.437 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.97 -51.82 9.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.83 -1.169 . . . . 0.0 110.97 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.72 -43.37 87.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.814 -1.178 . . . . 0.0 110.558 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -59.55 -30.28 68.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.971 -1.08 . . . . 0.0 109.317 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -83.73 11.14 7.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.695 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.64 ' HB2' HD11 ' A' ' 11' ' ' LEU . 8.7 m120 -144.37 32.18 1.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.397 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.803 ' CD1' HD22 ' A' ' 82' ' ' LEU . 6.8 mt -91.5 148.73 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.891 -1.13 . . . . 0.0 110.717 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.64 153.73 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 2.3 m-20 -105.64 146.36 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.06 -1.025 . . . . 0.0 110.012 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.479 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.4 mt-30 -105.41 -162.36 0.87 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.837 . . . . 0.0 109.09 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -117.74 2.09 12.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.092 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 4' ' ' GLU . 10.9 ttm180 -97.84 152.53 19.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.858 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -94.43 147.54 23.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.898 . . . . 0.0 109.485 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.419 HG23 HG21 ' A' ' 85' ' ' THR . 83.9 mt -89.37 153.93 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.356 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -96.84 101.81 13.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.405 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.7 m-85 -72.42 145.21 47.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.962 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -95.89 123.04 39.31 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.53 138.2 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.48 136.86 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -112.56 -7.27 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.28 147.82 24.67 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 109.188 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.35 145.48 38.44 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.173 1.915 . . . . 0.0 112.888 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.6 tt -130.73 150.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.27 117.85 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.629 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' A' ' 139' ' ' ILE . 1.8 m -118.09 109.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.7 131.64 55.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 0.0 109.293 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -179.98 159.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.062 . . . . 0.0 110.469 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 134' ' ' ASP . 11.6 mm-40 56.61 19.74 4.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.708 -0.62 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 -0.4 82.68 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.51 ' HB2' HD22 ' A' ' 255' ' ' LEU . 0.6 OUTLIER -101.04 176.79 5.14 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.01 . . . . 0.0 108.302 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.962 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.1 tt -160.35 145.97 15.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.512 -1.367 . . . . 0.0 108.769 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.962 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.6 mt -144.97 130.99 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.076 -1.015 . . . . 0.0 108.28 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -121.39 137.37 54.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 109.814 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.658 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -113.71 149.35 34.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -145.4 136.61 12.58 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.53 144.94 99.29 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.493 1.462 . . . . 0.0 112.014 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.56 156.19 7.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 12.4 p-10 -88.82 3.28 51.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.5 p -135.43 147.1 48.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.0 118.73 22.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -135.94 139.03 42.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.686 ' CG1' HD23 ' A' ' 231' ' ' LEU . 79.8 t -137.7 122.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 109.685 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.455 ' O ' ' OG ' ' A' ' 248' ' ' SER . 1.4 m -112.37 138.67 48.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -127.82 131.57 49.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.695 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -117.31 119.11 34.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -114.82 137.73 14.23 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -112.24 85.44 2.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.416 -1.049 . . . . 0.0 109.241 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 160' ' ' GLY . 18.5 m-85 -86.2 148.45 25.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 109.915 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -97.22 -3.01 41.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 0.0 109.852 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.718 ' ND2' ' H ' ' A' ' 159' ' ' LEU . 11.4 p-10 -76.35 -169.94 1.33 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.084 -1.01 . . . . 0.0 109.687 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -55.7 -24.22 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.718 ' H ' ' ND2' ' A' ' 157' ' ' ASN . 9.1 mt -66.49 -40.21 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.18 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 75.5 -124.98 7.81 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -114.14 145.32 41.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.955 . . . . 0.0 109.819 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.573 ' NE2' ' ND2' ' A' ' 221' ' ' ASN . 22.8 tt0 -162.21 162.14 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 0.0 109.738 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -147.86 159.81 43.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -139.39 131.65 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.096 -1.003 . . . . 0.0 109.667 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 165' ' ' THR . 13.8 t -103.7 123.22 46.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 5.9 t80 -100.53 138.56 37.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.441 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 t -137.53 150.02 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.804 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -50.43 118.2 2.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.2 6.17 18.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.85 28.41 2.64 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.17 -1.194 . . . . 0.0 108.716 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.42 -37.01 79.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.425 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.83 -16.63 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 110.45 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -88.33 -3.86 58.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.081 -1.012 . . . . 0.0 110.919 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.77 5.65 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.085 -1.009 . . . . 0.0 111.417 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -32.39 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.456 -1.403 . . . . 0.0 110.057 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.52 2.68 50.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.009 -1.057 . . . . 0.0 110.994 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.06 117.31 20.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.685 -1.259 . . . . 0.0 108.698 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -91.54 152.86 20.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.102 -0.999 . . . . 0.0 110.334 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -57.77 131.19 49.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.372 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -109.36 163.9 12.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -0.992 . . . . 0.0 110.115 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.618 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -144.71 162.36 36.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 110.495 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.554 ' N ' ' OE2' ' A' ' 185' ' ' GLU . 57.7 m-85 -105.37 144.65 31.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.674 ' HA ' HD12 ' A' ' 186' ' ' ILE . 14.8 p-10 -60.79 -26.5 67.32 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.829 -1.17 . . . . 0.0 110.213 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.482 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.1 p90 -81.31 -26.24 35.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 111.095 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 182' ' ' PHE . 10.3 pt-20 -92.7 -14.59 27.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.663 -1.273 . . . . 0.0 109.568 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.3 mt -56.19 -53.37 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.235 -0.916 . . . . 0.0 110.145 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.0 -53.32 54.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.989 -1.069 . . . . 0.0 109.449 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -52.12 -41.49 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.833 . . . . 0.0 109.214 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.86 -33.88 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -0.967 . . . . 0.0 108.862 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -79.52 -25.74 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -27.72 42.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 109.89 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.89 8.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.2 70.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.1 mt -123.85 163.17 21.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 0.0 109.664 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.29 24.43 71.07 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -70.83 -20.66 62.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.282 . . . . 0.0 109.691 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.04 -2.51 51.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.65 128.55 35.36 Favored Glycine 0 N--CA 1.492 2.387 0 O-C-N 121.204 -1.174 . . . . 0.0 111.07 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.5 p -132.45 -173.67 3.23 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.9 -12.88 29.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -91.4 -4.89 55.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 109.559 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 99' ' ' LEU . 42.5 m-20 -139.22 12.11 2.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.885 . . . . 0.0 109.375 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.618 HG22 ' SG ' ' A' ' 181' ' ' CYS . 0.6 OUTLIER -149.76 122.13 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.249 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.2 tp -82.25 112.83 19.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 t -103.67 127.88 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.957 -1.09 . . . . 0.0 109.215 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 78.6 mt -111.15 141.95 43.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 110.136 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -96.37 149.29 19.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -42.48 -25.17 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -1.222 . . . . 0.0 110.106 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.2 OUTLIER -150.49 10.12 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.833 -1.167 . . . . 0.0 110.596 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -143.21 151.83 41.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 110.098 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.6 t -96.54 123.22 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.488 -0.757 . . . . 0.0 109.066 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -72.85 -54.36 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 110.129 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -55.33 134.36 69.66 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.872 -1.142 . . . . 0.0 109.618 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.55 -23.01 20.41 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.393 2.062 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.63 -5.1 49.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 110.043 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.58 -161.56 53.66 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.2 mt -89.94 146.92 24.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.495 -1.003 . . . . 0.0 110.294 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.75 -20.99 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.631 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 48.3 m-85 -142.52 167.91 20.97 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.57 -21.44 35.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 108.412 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.573 ' ND2' ' NE2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -125.18 37.55 4.37 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.591 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 30.1 tt0 -58.95 -35.76 35.65 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.447 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.5 Cg_exo -73.88 -45.52 0.38 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.714 1.61 . . . . 0.0 113.001 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 224' ' ' VAL . 16.5 m -76.43 -25.19 16.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.754 -1.216 . . . . 0.0 108.554 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.631 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 11.6 mtp180 -67.06 -46.01 75.63 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -58.29 -43.25 87.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -45.59 82.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 108.737 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.91 -48.63 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -54.32 -41.31 68.88 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.96 -39.67 79.34 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.513 -0.742 . . . . 0.0 109.671 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.686 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.4 tp -58.66 -36.21 73.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.374 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.3 -34.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -63.34 -34.42 89.92 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 3.0 m-20 -82.94 -26.77 31.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -1.143 . . . . 0.0 110.135 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.48 -25.92 35.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.853 -1.154 . . . . 0.0 109.772 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.505 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 27.8 t80 -66.85 -8.8 31.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 108.923 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 237' ' ' LEU . 71.5 mt -49.95 -30.12 9.76 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.18 -15.8 27.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 108.98 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 53.4 p -156.01 137.53 9.61 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.247 . . . . 0.0 109.503 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.431 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 78.5 Cg_exo -42.81 130.4 5.53 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.049 1.833 . . . . 0.0 112.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.88 135.98 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.815 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -118.62 123.34 44.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.755 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.22 169.86 20.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.74 114.47 28.55 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.197 -1.178 . . . . 0.0 110.047 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -111.36 150.97 28.98 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.918 0.866 . . . . 0.0 110.976 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -128.44 144.14 51.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 150' ' ' THR . 0.9 OUTLIER -137.26 127.01 25.46 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.731 -1.231 . . . . 0.0 110.475 -178.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.468 ' O ' ' C ' ' A' ' 250' ' ' ARG . 52.4 t80 -111.83 113.9 26.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.47 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 11.5 mmm180 44.45 56.12 5.23 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.46 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -83.47 146.99 23.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.587 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -119.84 177.05 16.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.539 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 29.1 m-70 -67.63 -38.21 83.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -1.154 . . . . 0.0 109.787 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.1 t -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.065 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.649 ' HG ' HD12 ' A' ' 139' ' ' ILE . 58.2 tp -72.66 -37.29 67.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 75.5 m-20 -60.57 -51.76 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 80.4 t -51.92 -44.13 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 109.138 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -55.23 -47.08 75.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.052 -1.03 . . . . 0.0 109.018 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 139' ' ' ILE . 54.1 tp -52.66 -49.67 64.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 108.824 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.4 -47.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -52.24 54.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.576 -0.703 . . . . 0.0 110.23 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.09 -50.65 73.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.982 -1.074 . . . . 0.0 110.515 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.63 -39.73 92.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.19 -34.29 72.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.336 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.0 mttp . . . . . 0 N--CA 1.486 1.36 0 O-C-N 121.025 -1.047 . . . . 0.0 108.527 179.071 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.674 ' OE2' HG23 ' A' ' 121' ' ' ILE . 7.0 mm-40 . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.19 138.82 54.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.066 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.5 t -134.15 171.43 14.24 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 7' ' ' VAL . 3.1 m -82.24 140.87 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.79 -1.194 . . . . 0.0 110.484 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -75.84 -46.54 29.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -126.54 154.48 43.78 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.744 0.783 . . . . 0.0 111.054 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HD2' ' CE1' ' A' ' 29' ' ' HIS . 9.4 tttt -54.37 135.23 45.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.698 -0.626 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mt -121.22 152.91 38.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -151.99 146.44 25.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 110.042 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -128.25 162.4 27.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.58 -0.7 . . . . 0.0 109.304 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.73 132.52 17.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.914 -1.116 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.6 157.9 16.46 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.4 p -77.7 164.28 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.943 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -91.32 137.61 13.91 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.4 tt -58.57 -48.41 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.229 -1.16 . . . . 0.0 111.928 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.477 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.1 m-70 -86.78 -38.18 17.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.205 -1.56 . . . . 0.0 110.98 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -74.47 -40.0 62.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 0.0 109.867 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.77 23.08 78.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -112.11 151.04 29.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.528 -0.983 . . . . 0.0 108.621 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -71.16 134.43 46.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 109.88 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 11.5 t -141.17 158.49 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -133.15 155.07 49.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.502 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.705 HD11 ' HD2' ' A' ' 97' ' ' PRO . 24.6 mt -128.65 152.35 48.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.955 . . . . 0.0 109.665 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.563 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.1 mt -142.05 126.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.491 -0.756 . . . . 0.0 109.014 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mt -115.29 117.72 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 0.0 109.924 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.563 ' NE2' HG22 ' A' ' 27' ' ' ILE . 11.7 m-70 -113.04 149.38 41.24 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.6 163.1 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 111.143 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.541 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.0 mm-40 -136.84 -175.17 3.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.08 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 152.07 22.91 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.432 -0.792 . . . . 0.0 109.028 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -51.66 151.04 3.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 110.407 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.533 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 63.62 19.64 62.9 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.27 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 51.9 m -81.94 -46.75 13.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.498 -1.589 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -171.77 23.26 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mm -97.52 122.12 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -1.137 . . . . 0.0 108.159 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.61 144.3 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 110.544 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.83 154.33 20.68 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.7 t80 -129.86 142.06 50.72 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 12.9 ttpt -172.35 138.24 0.92 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.95 29.76 19.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.466 -0.771 . . . . 0.0 109.824 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.99 74.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.61 139.75 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -94.04 146.83 23.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.122 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.401 HG23 ' CB ' ' A' ' 64' ' ' PHE . 8.0 mt -139.56 98.91 7.89 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.92 140.93 37.9 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.174 1.916 . . . . 0.0 111.453 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.34 79.89 8.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.91 -1.119 . . . . 0.0 110.866 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.62 155.07 49.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.914 . . . . 0.0 109.223 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.674 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 2.6 p80 -54.56 -49.58 69.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.171 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -46.56 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 109.909 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' HIS . 80.0 m-85 -98.51 7.99 45.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 62' ' ' LEU . 4.8 t -63.76 132.86 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.81 -34.06 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.0 110.119 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.45 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.6 t-80 -150.37 122.95 8.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.034 -1.041 . . . . 0.0 109.963 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.2 p -112.36 129.49 56.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 11.1 t-20 -166.67 -153.6 0.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 57' ' ' ASN . 19.2 m-70 -44.85 -16.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.218 -0.926 . . . . 0.0 108.704 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.2 t -136.19 165.56 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.48 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -102.97 121.32 42.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 108.778 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -119.39 138.22 53.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 111.033 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 53' ' ' VAL . 84.6 mt -118.34 163.52 16.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.77 146.21 6.23 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.482 -1.818 . . . . 0.0 111.211 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CB ' HG23 ' A' ' 46' ' ' ILE . 69.1 t80 -145.03 151.81 39.15 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.629 -0.924 . . . . 0.0 109.579 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt 57.57 23.66 9.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.88 . . . . 0.0 110.93 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.96 -2.22 75.57 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.888 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.469 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 96.8 mm-40 -98.93 143.75 28.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.842 -1.387 . . . . 0.0 108.258 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.49 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -142.86 155.71 44.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 111.801 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.12 145.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -110.88 150.29 29.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.112 -0.993 . . . . 0.0 111.668 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 m 54.55 68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.764 -0.585 . . . . 0.0 111.294 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.41 -9.58 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.718 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.477 ' OE2' ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER -66.28 -19.04 65.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 0.0 110.698 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -72.32 -60.86 2.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.841 -1.162 . . . . 0.0 109.641 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -56.74 -42.65 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.864 -1.148 . . . . 0.0 108.554 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.529 ' HA ' HD12 ' A' ' 79' ' ' LEU . 74.1 mt -55.05 -40.12 69.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.591 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 37.6 t -60.49 -48.74 80.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.554 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -56.55 -54.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 108.606 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 76' ' ' LEU . 14.6 mt -51.43 -44.38 62.29 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.515 ' HD1' HG22 ' A' ' 232' ' ' ILE . 11.6 t-160 -54.81 -56.5 18.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.92 -37.48 87.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.255 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 114' ' ' ILE . 14.0 mt -77.2 -6.12 51.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.993 -1.067 . . . . 0.0 110.057 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 62.96 42.37 7.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.967 -1.083 . . . . 0.0 110.096 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 82' ' ' LEU . 16.2 mm -90.01 126.1 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.505 HG21 ' OE2' ' A' ' 4' ' ' GLU . 48.1 p -107.47 -76.41 0.61 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 111.577 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.729 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -81.27 113.81 19.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.06 -1.025 . . . . 0.0 111.9 -176.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.71 144.37 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.541 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 3.8 m -110.93 101.65 10.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.499 -0.751 . . . . 0.0 109.27 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.99 111.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -92.21 120.0 32.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.043 -1.036 . . . . 0.0 108.633 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.402 HG22 HD22 ' A' ' 26' ' ' LEU . 94.6 t -102.32 112.37 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.991 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -91.44 109.67 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.35 -160.79 23.52 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.4 -15.97 9.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.979 . . . . 0.0 109.959 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -135.64 142.56 45.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.977 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -67.96 126.75 93.02 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.705 ' HD2' HD11 ' A' ' 26' ' ' LEU . 58.6 Cg_exo -46.28 127.82 11.46 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.709 1.606 . . . . 0.0 111.735 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.56 -25.75 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.302 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 96.4 mt 54.77 -116.65 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -94.85 -8.13 38.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 0.0 110.751 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.87 -13.38 59.15 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -109.94 -171.97 1.94 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -1.059 . . . . 0.0 109.619 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.94 -7.62 16.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -46.42 -38.57 9.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.976 . . . . 0.0 110.128 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.525 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -61.85 -51.81 66.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.007 -1.058 . . . . 0.0 109.818 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 78.2 m-85 -63.34 -43.78 96.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -60.93 -39.66 90.28 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.447 0.641 . . . . 0.0 109.84 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.57 -46.6 53.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 111.829 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.09 -51.25 12.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.779 -1.201 . . . . 0.0 110.828 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 110' ' ' ILE . 60.7 mt -61.55 -42.67 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.043 -1.035 . . . . 0.0 110.708 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -57.27 -28.56 63.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 110.038 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -80.16 -12.07 59.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.221 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -123.09 34.88 5.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.836 . . . . 0.0 110.927 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 82' ' ' LEU . 17.9 mt -85.98 147.16 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.48 -1.388 . . . . 0.0 110.674 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 115' ' ' LEU . 31.9 tp -132.26 145.53 51.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.618 -0.677 . . . . 0.0 109.478 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -92.68 146.2 23.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.106 -0.996 . . . . 0.0 110.356 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -108.85 -168.23 1.32 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.528 ' O ' ' ND2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -119.74 69.94 0.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.418 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 4' ' ' GLU . 1.8 ttm180 -170.21 122.04 0.66 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.225 -0.922 . . . . 0.0 109.91 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.87 134.69 56.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.674 HG23 ' OE2' ' A' ' 4' ' ' GLU . 0.9 OUTLIER -75.49 143.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.462 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -86.4 89.68 7.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -63.67 147.01 52.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 110.555 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -104.77 125.09 50.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.29 142.59 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.7 t -83.65 139.88 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.459 -0.775 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -118.87 -11.05 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 109.046 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -142.56 144.95 32.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.261 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.61 160.24 44.44 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.163 1.908 . . . . 0.0 113.349 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.57 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.4 tt -153.22 140.82 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.629 HG23 HD11 ' A' ' 138' ' ' LEU . 18.1 mt -130.0 124.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.478 -0.764 . . . . 0.0 109.846 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 132' ' ' VAL . 18.3 m -122.3 117.72 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.87 156.89 16.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 109.737 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 137' ' ' ARG . 49.6 t0 -165.92 110.22 0.82 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 0.0 111.369 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 41.06 51.13 3.3 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.54 -0.725 . . . . 0.0 112.244 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.91 6.97 88.89 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.708 -1.245 . . . . 0.0 110.274 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 134' ' ' ASP . 12.5 mtt85 -118.2 132.28 56.33 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.629 HD11 HG23 ' A' ' 131' ' ' ILE . 4.8 tt -144.71 160.81 40.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.349 -1.469 . . . . 0.0 109.776 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.608 HG21 HD22 ' A' ' 259' ' ' LEU . 48.9 mt -144.57 129.63 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -116.0 142.32 46.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.36 -0.837 . . . . 0.0 110.131 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.57 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.97 143.74 50.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -142.02 138.92 17.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.93 146.16 58.67 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.394 1.396 . . . . 0.0 112.088 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -166.11 151.97 8.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.398 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 -1.29 56.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -134.1 146.25 50.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 109.259 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.46 120.18 24.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -1.0 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.95 137.96 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.715 ' CG1' HD23 ' A' ' 231' ' ' LEU . 12.4 t -137.23 118.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.711 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 m -106.03 143.91 33.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -132.06 130.94 41.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.93 105.97 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.74 155.54 20.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.428 ' HB3' ' HE ' ' A' ' 250' ' ' ARG . 3.2 tt0 -132.79 98.01 4.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -1.028 . . . . 0.0 109.116 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' GLY . 20.8 m-85 -101.38 148.6 24.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.844 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 mmtm -93.16 -5.99 48.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.992 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.535 HD21 HD12 ' A' ' 159' ' ' LEU . 10.7 p30 -74.44 -173.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.032 -1.042 . . . . 0.0 109.48 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -53.58 -17.05 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.783 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.535 HD12 HD21 ' A' ' 157' ' ' ASN . 31.7 mt -67.1 -49.98 63.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 109.506 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 82.86 -114.59 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.45 ' O ' ' CD ' ' A' ' 162' ' ' GLN . 12.4 mtm-85 -116.98 139.55 50.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.481 -1.011 . . . . 0.0 109.294 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 161' ' ' ARG . 4.3 mp0 -142.31 155.65 45.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 109.526 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 142.18 31.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.079 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -136.35 125.72 24.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.191 -0.943 . . . . 0.0 109.257 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -103.6 122.94 46.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.045 -1.034 . . . . 0.0 109.802 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -100.01 136.96 39.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.178 -0.951 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.89 156.08 41.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.556 -0.715 . . . . 0.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.28 118.9 6.47 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.145 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.83 1.32 21.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -131.42 29.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -1.112 . . . . 0.0 108.806 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -64.01 -33.58 76.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.603 -0.686 . . . . 0.0 110.611 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -52.81 -13.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 110.638 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.87 -4.12 44.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 111.139 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.1 -8.15 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.022 -1.049 . . . . 0.0 110.785 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.33 -33.11 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.66 -1.275 . . . . 0.0 109.943 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.96 1.28 54.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.797 -1.189 . . . . 0.0 110.603 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.82 116.93 20.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.927 -1.108 . . . . 0.0 108.657 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.54 153.26 20.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.034 -1.041 . . . . 0.0 110.361 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.6 t -62.07 147.66 46.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.531 -0.73 . . . . 0.0 109.457 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -130.31 176.26 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 110.402 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.89 163.09 32.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.463 -0.773 . . . . 0.0 109.581 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.63 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 89.6 m-85 -104.69 146.34 29.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 109.937 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.744 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.0 p-10 -61.7 -22.05 65.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 0.0 110.804 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.63 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.4 p90 -81.19 -28.41 34.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.793 -1.192 . . . . 0.0 110.653 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 13.6 pt-20 -95.1 -14.32 24.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.897 -1.127 . . . . 0.0 109.51 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.744 HD12 ' HA ' ' A' ' 183' ' ' ASP . 10.7 mt -58.62 -53.12 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.238 -0.914 . . . . 0.0 110.129 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.22 -52.97 49.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.773 -1.204 . . . . 0.0 109.107 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.62 -47.98 66.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -0.966 . . . . 0.0 108.707 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 76.5 mt -58.7 -34.36 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -78.55 -27.04 45.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.53 -0.731 . . . . 0.0 110.166 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -74.84 -26.82 59.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -0.999 . . . . 0.0 109.883 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.614 ' CG2' HD12 ' A' ' 194' ' ' LEU . 15.4 m -84.18 9.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.34 66.92 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.821 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.614 HD12 ' CG2' ' A' ' 192' ' ' VAL . 3.8 mt -120.02 158.29 27.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.136 -1.214 . . . . 0.0 109.688 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.02 21.41 65.58 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.462 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -68.8 -22.34 64.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.577 -1.543 . . . . 0.0 109.664 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.41 -4.75 52.8 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.05 125.98 33.23 Favored Glycine 0 N--CA 1.49 2.273 0 O-C-N 121.186 -1.184 . . . . 0.0 110.539 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -131.08 -173.64 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.768 -0.842 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.4 -2.03 57.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 1.3 ttpp -100.17 -3.56 31.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 4.3 m120 -139.26 -7.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.97 . . . . 0.0 109.871 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.5 m -130.26 128.41 41.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 109.81 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 217' ' ' LEU . 60.6 tp -88.98 115.93 26.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 108.927 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 186' ' ' ILE . 47.2 t -103.01 127.88 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 30.5 mt -103.6 147.34 27.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.809 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.07 150.63 17.44 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -44.89 -22.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.141 . . . . 0.0 110.058 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.0 OUTLIER -155.13 12.74 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.948 -1.095 . . . . 0.0 110.343 -179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -146.67 155.44 42.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.85 125.56 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.03 -54.74 7.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.441 ' OD1' HD12 ' A' ' 204' ' ' LEU . 3.6 m120 -47.89 135.89 10.95 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.812 -1.18 . . . . 0.0 109.389 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.7 -41.16 2.37 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 112.05 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -65.12 -0.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.863 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.31 -166.93 54.49 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.462 ' CD2' HD21 ' A' ' 204' ' ' LEU . 43.5 mt -83.89 149.83 26.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.442 -1.034 . . . . 0.0 109.803 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -76.7 -61.37 1.99 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.947 . . . . 0.0 108.755 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.436 ' H ' ' HB2' ' A' ' 222' ' ' GLU . 6.8 m-85 -117.09 163.1 16.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.362 -0.837 . . . . 0.0 109.293 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.79 -14.6 62.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.668 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -133.55 32.77 3.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.339 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 5.8 tt0 -58.69 -37.39 53.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 111.126 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.6 Cg_exo -70.63 -43.22 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.971 1.781 . . . . 0.0 112.576 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 228' ' ' VAL . 6.3 m -78.71 -25.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.755 -1.216 . . . . 0.0 108.604 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.668 HH21 ' ND2' ' A' ' 221' ' ' ASN . 27.4 mtt180 -66.7 -40.71 88.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -64.81 -41.29 95.9 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -48.64 78.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.675 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 224' ' ' VAL . 59.8 t -58.3 -49.27 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.591 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.0 t80 -49.99 -38.29 36.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.502 0.667 . . . . 0.0 109.299 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.477 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 7.9 m-20 -72.68 -40.01 66.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 110.141 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.715 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.46 -37.48 70.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.343 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.515 HG22 ' HD1' ' A' ' 80' ' ' HIS . 88.9 mt -70.92 -48.49 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.886 -1.134 . . . . 0.0 108.057 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.81 -33.87 13.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.29 -26.76 32.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -1.199 . . . . 0.0 110.176 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -80.05 -21.03 43.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.668 -1.27 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -70.59 -8.32 50.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 109.143 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 237' ' ' LEU . 90.6 mt -53.18 -26.07 15.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.358 -0.839 . . . . 0.0 108.829 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.479 HD12 HG22 ' A' ' 242' ' ' VAL . 94.7 mt -61.11 -20.0 62.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.973 -1.08 . . . . 0.0 108.939 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.93 15.35 70.28 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 70.9 p -158.47 149.49 16.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.909 -1.348 . . . . 0.0 109.824 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -44.32 130.16 8.73 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.216 1.944 . . . . 0.0 111.749 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.479 HG22 HD12 ' A' ' 238' ' ' LEU . 87.0 t -98.88 133.16 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.005 -1.059 . . . . 0.0 109.697 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -121.84 125.83 47.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.73 172.59 26.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -103.58 112.9 26.03 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -1.184 . . . . 0.0 109.656 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 5.6 m-85 -113.5 148.45 35.98 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.06 0.933 . . . . 0.0 111.558 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.8 t80 -129.65 144.28 51.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.414 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 36.2 t -139.52 127.67 22.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.701 -1.249 . . . . 0.0 110.466 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 4.3 t80 -111.71 114.6 27.72 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.2 mtt-85 45.76 56.44 5.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.37 151.13 21.74 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.848 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.7 -176.24 16.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -71.03 -52.35 20.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -1.228 . . . . 0.0 110.107 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -55.01 33.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.181 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.442 ' HG ' HD12 ' A' ' 139' ' ' ILE . 55.6 tp -51.03 -41.63 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -57.87 -54.29 48.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 108.863 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.1 -43.22 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.647 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.61 -46.72 73.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.078 -1.014 . . . . 0.0 108.718 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 139' ' ' ILE . 24.7 tp -55.73 -47.92 76.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.8 . . . . 0.0 109.048 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 235' ' ' LEU . 88.0 t -66.99 -42.6 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.44 ' HZ1' ' CE ' ' A' ' 265' ' ' LYS . 0.2 OUTLIER -54.17 -48.36 70.98 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 110.671 -179.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.19 -45.05 70.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.841 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.45 -45.41 93.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.42 89.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.827 . . . . 0.0 109.732 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.44 ' CE ' ' HZ1' ' A' ' 261' ' ' LYS . 28.3 mttm . . . . . 0 N--CA 1.49 1.542 0 O-C-N 120.962 -1.086 . . . . 0.0 109.214 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 119' ' ' ARG . 16.1 mm-40 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HD3' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -113.25 127.67 56.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.432 -0.792 . . . . 0.0 109.128 -179.181 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -135.09 173.3 11.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -82.97 133.92 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.004 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -58.98 -48.38 81.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -133.65 163.07 30.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 132.28 48.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.521 -0.737 . . . . 0.0 109.974 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 11' ' ' LEU . 17.3 mt -117.74 164.07 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -152.97 147.59 26.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.029 . . . . 0.0 110.198 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -132.06 161.55 32.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.463 -0.773 . . . . 0.0 109.74 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.43 134.88 20.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.12 . . . . 0.0 109.365 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.09 158.92 17.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.2 p -74.96 163.02 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -1.103 . . . . 0.0 111.263 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.577 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -93.47 139.98 14.84 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.3 tt -57.81 -50.85 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.128 -1.219 . . . . 0.0 112.396 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 11.6 m-70 -86.44 -37.66 18.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.188 -1.57 . . . . 0.0 111.203 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -73.92 -34.66 64.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.0 110.215 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.49 21.33 66.64 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -109.76 149.95 29.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.544 -0.974 . . . . 0.0 109.274 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.84 132.43 45.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.891 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -139.63 157.51 45.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.569 ' O ' HD23 ' A' ' 26' ' ' LEU . 23.8 tttp -133.69 155.21 50.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.274 -0.891 . . . . 0.0 109.291 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.651 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.3 mt -131.04 146.67 52.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.044 -1.035 . . . . 0.0 109.373 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 mt -136.0 123.91 35.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mt -111.8 122.99 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.543 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -118.03 139.24 26.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.463 -0.773 . . . . 0.0 109.354 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -53.46 162.6 3.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.439 1.426 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.5 mm-40 -135.96 -171.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.1 ttmt -91.92 156.53 17.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.586 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -50.46 146.35 5.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 110.548 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 64.09 24.48 68.73 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.567 -0.708 . . . . 0.0 112.204 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.589 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 91.3 m -81.64 -46.44 14.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.346 -1.679 . . . . 0.0 109.112 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.76 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 101.52 -174.66 24.99 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.423 HD13 ' CG2' ' A' ' 87' ' ' VAL . 3.0 mm -94.86 122.65 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.189 -1.183 . . . . 0.0 108.354 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 137.28 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.077 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -98.58 154.59 17.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.554 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.7 t80 -130.12 136.99 49.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 108.815 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 4.0 ttmm -167.45 136.85 2.73 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.115 -0.991 . . . . 0.0 109.594 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.33 28.6 17.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.922 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 28.19 71.76 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.4 t -133.42 132.12 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.161 -1.199 . . . . 0.0 109.727 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -85.34 140.4 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 67' ' ' GLN . 45.2 mt -134.45 94.75 16.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.398 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.58 141.06 27.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.21 1.94 . . . . 0.0 111.494 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.09 84.39 5.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.812 -1.18 . . . . 0.0 110.374 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -139.06 155.35 48.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.511 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 6.9 p80 -52.32 -49.43 64.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.286 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.3 mt-10 -44.62 -30.96 1.0 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.153 -0.967 . . . . 0.0 109.151 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 46.1 m-85 -81.48 2.42 28.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.413 -0.804 . . . . 0.0 110.176 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 50' ' ' HIS . 8.3 t -59.46 127.44 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.015 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.62 -31.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -151.97 123.07 7.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.891 -1.131 . . . . 0.0 109.975 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.9 p -111.77 131.61 55.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.752 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -166.66 -153.64 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -48.31 -11.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.019 -1.051 . . . . 0.0 108.537 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.588 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 9.9 t -139.94 166.25 25.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 m -105.39 121.39 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 108.773 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.32 141.94 48.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 111.122 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 53' ' ' VAL . 57.1 mt -121.83 160.23 25.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.5 142.92 6.15 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.715 -1.707 . . . . 0.0 110.692 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -144.86 151.19 38.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.53 -0.982 . . . . 0.0 109.708 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt 56.96 23.77 8.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.833 . . . . 0.0 110.865 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.67 -2.04 69.54 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.704 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.9 mm-40 -97.05 145.46 25.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.928 -1.336 . . . . 0.0 108.482 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -141.71 151.7 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 0.0 111.601 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.8 mt -134.29 144.46 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -114.67 154.85 27.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 110.976 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 m 51.36 67.99 0.86 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.641 -0.662 . . . . 0.0 110.8 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.55 -15.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -63.74 -15.59 58.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 110.248 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 8.7 m170 -72.11 -60.57 2.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.022 . . . . 0.0 109.511 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.7 tp -59.65 -42.81 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.992 -1.068 . . . . 0.0 108.772 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.486 ' N ' HG23 ' A' ' 75' ' ' ILE . 39.3 mt -54.82 -39.21 68.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.503 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -61.7 -49.77 75.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.538 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.24 -54.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.006 . . . . 0.0 108.559 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 76' ' ' LEU . 18.1 mt -51.75 -43.82 63.07 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.488 -0.757 . . . . 0.0 109.586 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.3 -56.79 13.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.0 mt -56.64 -35.55 68.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 110.976 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.612 ' HB3' HD11 ' A' ' 84' ' ' ILE . 26.4 mt -88.06 -2.68 58.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.864 -1.148 . . . . 0.0 111.207 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.34 58.52 1.73 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.683 -1.261 . . . . 0.0 110.945 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 82' ' ' LEU . 5.0 mm -96.79 122.57 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.523 HG21 ' CG2' ' A' ' 121' ' ' ILE . 21.1 p -104.1 -77.47 0.57 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 111.047 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 2.5 m120 -82.24 113.6 20.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 111.452 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.9 m -163.79 138.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.684 -0.635 . . . . 0.0 109.327 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.5 m -106.53 101.18 10.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.38 107.51 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.657 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 40' ' ' PHE . 2.0 mm-40 -84.49 121.18 27.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.818 -1.177 . . . . 0.0 108.629 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.4 110.09 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.839 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.47 108.24 20.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.506 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 134.05 -163.37 24.55 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER -112.94 -14.97 12.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -1.034 . . . . 0.0 110.171 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.16 147.5 36.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.257 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -70.88 130.57 88.3 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.474 -0.766 . . . . 0.0 109.746 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.651 ' CD ' HD21 ' A' ' 26' ' ' LEU . 52.9 Cg_exo -46.23 128.7 12.31 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.022 1.815 . . . . 0.0 112.278 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -76.88 -29.68 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 110.015 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 50.8 mt 57.62 -116.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.0 109.942 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.28 -6.86 43.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 110.533 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.87 -10.61 52.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -117.09 -169.26 1.62 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -1.085 . . . . 0.0 109.797 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.05 -1.37 25.31 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 68.1 t-105 -46.39 -41.33 13.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.753 -0.851 . . . . 0.0 110.305 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.34 -51.97 66.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.999 -1.063 . . . . 0.0 110.131 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CG ' HD12 ' A' ' 75' ' ' ILE . 70.5 m-85 -65.02 -43.98 90.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.973 -1.079 . . . . 0.0 108.928 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.458 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.9 t80 -61.63 -37.73 85.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.4 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 20.9 mm-40 -67.0 -51.79 50.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.542 -0.724 . . . . 0.0 111.598 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 -51.98 11.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.761 -1.212 . . . . 0.0 110.871 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.54 -44.6 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 0.0 110.409 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -55.61 -31.27 62.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.116 -0.99 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -81.59 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 109.906 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -124.09 34.05 5.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.431 -0.793 . . . . 0.0 110.905 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.409 HD11 HD13 ' A' ' 82' ' ' LEU . 6.9 mt -87.73 140.5 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.708 -1.245 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 115' ' ' LEU . 46.6 tp -133.3 159.79 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.97 145.28 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.499 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -106.48 -162.67 0.87 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 109.31 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -121.0 72.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 110.735 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 4' ' ' GLU . 8.0 ttm-85 -168.02 123.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.14 126.36 27.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.474 -0.766 . . . . 0.0 110.316 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.523 ' CG2' HG21 ' A' ' 85' ' ' THR . 2.5 mt -78.55 150.48 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.376 -0.827 . . . . 0.0 109.695 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.8 86.28 6.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -60.23 147.21 40.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -101.37 120.14 39.82 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 243' ' ' LYS . 23.1 t -123.34 139.96 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.0 138.79 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 109.546 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.71 143.22 34.19 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.557 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.25 174.65 11.73 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.358 2.039 . . . . 0.0 112.64 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 141' ' ' ALA . 15.2 tt -166.07 146.04 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.493 -0.754 . . . . 0.0 109.792 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.465 ' CG2' HD11 ' A' ' 138' ' ' LEU . 3.4 mp -133.54 120.12 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 132' ' ' VAL . 33.1 m -119.81 114.99 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.804 . . . . 0.0 109.836 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.51 153.99 18.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.067 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.496 ' CB ' HD13 ' A' ' 255' ' ' LEU . 19.8 t70 -168.56 114.96 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.788 -1.195 . . . . 0.0 111.501 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 46.51 46.65 14.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.513 -0.742 . . . . 0.0 112.204 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 7.11 87.03 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.195 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.9 mtt85 -116.13 137.54 52.04 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.627 HD23 ' C ' ' A' ' 138' ' ' LEU . 2.6 tt -147.04 159.54 43.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.055 -1.653 . . . . 0.0 109.864 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.548 ' N ' HD23 ' A' ' 138' ' ' LEU . 35.6 mt -144.51 135.75 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.64 139.32 52.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 109.984 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.93 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.19 147.56 44.77 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -148.24 137.58 12.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 108.524 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.31 147.42 36.47 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.624 1.549 . . . . 0.0 112.15 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.7 153.01 8.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.336 -0.853 . . . . 0.0 109.363 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -85.72 -3.4 58.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.348 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.5 p -131.26 147.46 52.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.362 -0.836 . . . . 0.0 109.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 242' ' ' VAL . 22.2 tp -81.26 120.07 24.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.627 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -139.72 134.89 32.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.657 ' CG1' HD23 ' A' ' 231' ' ' LEU . 25.3 t -136.47 122.09 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.422 ' OG1' HG23 ' A' ' 165' ' ' THR . 87.1 m -110.74 145.87 37.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -131.85 129.87 40.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -114.41 108.73 17.27 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.64 140.51 15.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -118.04 92.83 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.547 -0.973 . . . . 0.0 108.705 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLY . 24.0 m-85 -96.25 148.39 22.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 110.331 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -91.65 -6.1 52.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.822 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.691 HD21 HD12 ' A' ' 159' ' ' LEU . 18.5 p-10 -73.4 -166.78 0.37 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -61.78 -17.61 56.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.792 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.691 HD12 HD21 ' A' ' 157' ' ' ASN . 25.5 mt -69.84 -38.86 76.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 109.341 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 70.64 -118.15 7.53 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -112.67 140.45 47.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -1.012 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.54 152.45 30.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.556 ' HB3' ' HZ3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.39 152.85 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.586 ' CE1' ' CZ ' ' A' ' 225' ' ' ARG . 64.3 t80 -136.23 125.53 24.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -0.914 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.422 HG23 ' OG1' ' A' ' 150' ' ' THR . 31.7 m -101.87 122.33 43.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.099 -1.001 . . . . 0.0 110.066 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -100.06 137.48 38.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.47 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.2 t -136.2 152.42 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.356 -0.84 . . . . 0.0 109.563 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.84 116.23 2.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.376 -0.827 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.9 8.67 13.3 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -137.49 27.91 2.77 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 0.0 108.71 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.539 ' O ' HG22 ' A' ' 175' ' ' VAL . 16.4 mp0 -62.73 -37.32 86.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.616 -0.678 . . . . 0.0 110.997 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.58 -16.35 2.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.008 -1.057 . . . . 0.0 110.366 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 1.5 mt-10 -90.58 -4.33 56.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 0.0 110.795 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.99 -2.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.099 -1.001 . . . . 0.0 110.757 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER -94.53 -29.11 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.605 -1.309 . . . . 0.0 110.018 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.9 2.14 54.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.914 -1.116 . . . . 0.0 110.608 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.75 119.86 23.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.206 . . . . 0.0 108.783 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -92.66 152.94 19.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.0 t -50.07 158.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.513 -0.742 . . . . 0.0 109.347 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.497 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 51.5 p90 -143.29 165.55 27.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -158.99 161.48 36.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.071 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.613 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 73.6 m-85 -104.35 144.79 31.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 0.0 109.266 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.776 ' HA ' HD12 ' A' ' 186' ' ' ILE . 21.0 p30 -59.27 -20.19 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 111.502 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.613 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.4 p90 -79.42 -33.24 42.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.494 -1.379 . . . . 0.0 111.529 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.593 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -94.21 -9.19 37.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.483 -1.386 . . . . 0.0 109.915 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.9 mt -60.98 -53.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.119 -0.988 . . . . 0.0 110.243 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -51.18 -45.94 61.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.587 -1.321 . . . . 0.0 109.611 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -53.86 46.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.108 -0.995 . . . . 0.0 108.968 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.89 -34.54 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 108.655 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -71.49 -25.71 62.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.307 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -76.04 -23.93 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.023 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.52 15.34 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 110.271 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 68.77 27.71 73.65 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.264 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 22.2 mt -120.13 157.73 28.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -1.228 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 80.77 23.15 60.38 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.902 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -67.18 -23.09 65.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.746 -1.444 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.98 -6.63 48.65 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.96 124.67 28.88 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 121.099 -1.236 . . . . 0.0 110.112 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.66 174.62 10.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.746 -0.855 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.93 -12.12 59.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.355 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 1.0 OUTLIER -86.05 -4.31 59.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.476 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 4.7 m-80 -150.22 16.35 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.572 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.3 m -145.04 123.51 12.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.404 HD12 ' OD1' ' A' ' 213' ' ' ASN . 12.2 tp -85.76 115.05 23.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 108.833 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.28 124.13 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.9 mt -105.38 148.69 26.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.799 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.49 163.66 13.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -55.68 -25.35 39.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.255 . . . . 0.0 109.341 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.25 12.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.673 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.18 147.88 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 110.106 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.89 128.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.862 . . . . 0.0 108.979 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.44 -55.17 6.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.15 -0.969 . . . . 0.0 110.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 204' ' ' LEU . 5.4 m120 -51.53 137.54 31.63 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.992 -1.067 . . . . 0.0 109.81 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.67 -38.73 3.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.473 2.115 . . . . 0.0 112.551 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.52 -6.65 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.32 -166.27 50.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -77.8 141.78 39.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.98 . . . . 0.0 109.736 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -85.49 -15.61 42.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 108.841 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 221' ' ' ASN . 17.8 m-85 -141.94 130.06 22.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -46.5 -12.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 109.153 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.711 HD22 ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -138.13 36.81 2.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.61 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 22.5 tt0 -61.85 -34.42 16.13 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 111.21 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.0 Cg_exo -72.01 -48.06 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.919 1.746 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 224' ' ' VAL . 4.6 m -71.91 -22.24 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.838 -1.163 . . . . 0.0 108.071 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.711 ' NH1' HD22 ' A' ' 221' ' ' ASN . 15.2 mtt85 -68.03 -45.84 72.83 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.33 -41.07 92.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -44.14 84.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.902 . . . . 0.0 108.648 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 224' ' ' VAL . 89.1 t -65.5 -40.28 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.503 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.3 t80 -58.81 -39.56 81.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -73.55 -38.56 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.578 -0.701 . . . . 0.0 109.414 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.62 -37.77 71.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.28 -47.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.35 -33.51 16.53 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.6 -27.1 31.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.123 -1.222 . . . . 0.0 110.059 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.65 -24.89 41.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.714 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 35.1 t80 -67.63 -10.06 48.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 237' ' ' LEU . 26.0 mt -51.05 -26.53 6.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 242' ' ' VAL . 95.9 mt -57.9 -21.79 45.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 108.745 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.4 13.95 75.12 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 64.5 p -158.96 149.05 15.32 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 109.735 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.34 134.03 4.7 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.396 2.064 . . . . 0.0 112.072 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.66 HG22 HD12 ' A' ' 238' ' ' LEU . 70.1 t -101.5 127.59 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.942 . . . . 0.0 109.97 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.409 ' HB3' HG13 ' A' ' 125' ' ' VAL . 1.4 tppt? -116.13 122.99 46.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 109.426 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.51 178.87 32.93 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -109.09 112.95 25.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.313 -1.11 . . . . 0.0 109.833 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -114.74 146.86 40.49 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.817 0.818 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.4 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 26.5 t80 -131.07 141.4 50.17 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.7 t -135.74 128.54 31.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.791 -1.193 . . . . 0.0 110.563 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 14.3 t80 -111.69 114.53 27.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 3.2 mtp85 44.78 55.74 5.75 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.19 148.85 22.52 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -112.63 -177.61 19.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 257' ' ' VAL . 25.5 m-70 -70.5 -47.21 61.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.091 -1.241 . . . . 0.0 109.752 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 68.3 p -61.03 -54.5 44.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.308 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' A' ' 134' ' ' ASP . 58.3 tp -51.71 -39.65 58.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 109.384 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.72 -55.87 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -0.975 . . . . 0.0 108.865 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 253' ' ' HIS . 41.0 t -49.19 -41.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.232 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -48.47 75.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.67 -44.81 66.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 108.804 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.4 t -68.23 -49.18 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.318 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.37 -50.74 38.81 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.695 -0.628 . . . . 0.0 110.509 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.41 -50.97 65.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.987 -1.071 . . . . 0.0 109.961 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 263' ' ' LEU . 47.8 mt -56.64 -44.21 81.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.35 83.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.725 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 108.989 179.513 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.6 mt-10 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.382 0.611 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -113.18 130.93 56.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.2 t -131.23 169.68 15.62 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.376 -0.828 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 7' ' ' VAL . 4.6 m -81.58 136.26 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.826 -1.171 . . . . 0.0 110.516 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' CB ' ' HZ3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -69.78 -47.11 64.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.664 -0.648 . . . . 0.0 109.978 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -128.42 156.88 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.492 -0.755 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -62.82 134.61 56.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.824 HD21 ' ND2' ' A' ' 113' ' ' ASN . 19.7 mt -118.66 160.8 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -149.55 145.97 27.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.941 -1.1 . . . . 0.0 110.046 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -128.83 164.62 22.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.475 -0.766 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.8 12.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 109.004 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.64 159.43 17.86 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.554 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.4 p -76.07 164.32 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.047 -1.266 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -95.21 142.45 16.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.3 tt -61.23 -47.78 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.053 -1.263 . . . . 0.0 112.136 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.2 m-70 -86.99 -39.86 15.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 119.984 -1.697 . . . . 0.0 110.793 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 m -71.76 -36.79 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.383 -0.823 . . . . 0.0 110.168 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 24.22 70.09 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -115.07 152.5 32.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.632 -0.922 . . . . 0.0 108.715 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -72.35 131.61 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.889 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 t -138.35 158.91 43.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.216 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.648 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.8 ttmt -133.13 159.59 39.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.669 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.5 mt -133.31 144.12 49.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.178 -0.951 . . . . 0.0 109.235 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.552 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.5 mt -134.49 123.43 42.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.54 126.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 0.0 109.926 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.577 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.3 m-70 -122.18 149.19 53.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.14 160.16 16.73 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.055 1.837 . . . . 0.0 111.229 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 2.7 mm-40 -133.79 -176.0 4.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.599 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' OG1' ' A' ' 35' ' ' THR . 10.0 ttpp -88.01 152.31 22.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.92 145.44 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.422 -0.799 . . . . 0.0 110.227 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.641 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.42 25.55 60.71 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.213 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.6 m -80.88 -41.4 23.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.648 -1.501 . . . . 0.0 108.703 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.71 178.95 30.85 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.56 123.31 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -140.3 145.79 37.7 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.033 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -100.68 152.25 20.68 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 11.0 t80 -133.35 141.95 48.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.225 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -176.5 145.94 0.59 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.55 28.89 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.85 28.92 72.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.48 142.57 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -1.215 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.41 143.59 31.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.237 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.04 95.81 14.87 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.35 145.53 21.02 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.052 1.834 . . . . 0.0 111.267 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 82.14 5.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.93 -1.107 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.84 153.92 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.545 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 6.3 p80 -51.81 -49.61 62.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.8 mm-40 -43.87 -33.02 1.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.196 -0.94 . . . . 0.0 109.234 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -80.45 2.46 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' HIS . 2.6 t -60.7 126.16 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.021 -1.049 . . . . 0.0 108.695 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.09 -34.11 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.478 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t-80 -149.67 123.18 9.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.943 -1.098 . . . . 0.0 109.913 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -110.71 131.52 54.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.2 t-20 -166.38 -154.2 0.18 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.53 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 8.1 m170 -48.05 -11.65 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 108.513 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 43.6 t -138.15 165.94 25.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.563 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.4 m -102.92 121.14 41.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.6 OUTLIER -120.4 141.56 50.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.563 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.1 mt -123.51 155.98 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -172.88 142.28 6.65 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.944 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -144.86 151.48 38.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.631 -0.923 . . . . 0.0 109.704 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm 56.51 27.86 12.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.495 -0.753 . . . . 0.0 110.839 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.55 81.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.315 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.504 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 92.7 mm-40 -99.26 143.5 29.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.286 . . . . 0.0 108.361 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -141.99 151.24 42.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 0.0 111.198 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.51 144.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -114.27 153.73 29.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 110.896 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 53.24 68.05 0.9 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.645 -0.659 . . . . 0.0 110.812 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.42 ' O ' HD12 ' A' ' 76' ' ' LEU . 15.9 m -113.12 -5.77 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 109.464 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.571 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.5 OUTLIER -67.76 -29.27 68.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.985 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -62.63 -60.29 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.91 . . . . 0.0 109.91 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 9.6 tp -59.13 -44.29 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.035 . . . . 0.0 109.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 9.8 mt -59.58 -38.1 80.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.126 -0.984 . . . . 0.0 109.771 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.455 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -59.71 -48.03 83.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 109.531 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.53 -53.56 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 76' ' ' LEU . 28.5 mt -50.91 -43.06 59.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.065 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.625 ' HD1' HG22 ' A' ' 232' ' ' ILE . 11.8 t-160 -55.1 -56.97 13.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 109.815 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 43.0 mt -57.52 -38.54 74.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.649 HD13 HD11 ' A' ' 114' ' ' ILE . 36.5 mt -80.12 -5.88 56.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.957 -1.089 . . . . 0.0 110.892 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER 62.8 63.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.706 -1.246 . . . . 0.0 110.528 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 82' ' ' LEU . 9.7 mm -102.8 132.87 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 108.708 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.24 -23.6 7.24 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.339 -0.85 . . . . 0.0 111.633 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.689 ' O ' HG13 ' A' ' 87' ' ' VAL . 70.9 m-20 -132.21 112.76 12.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.763 -1.211 . . . . 0.0 110.453 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.7 m -164.05 137.71 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.882 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.538 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 47.2 m -106.52 100.21 9.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.76 116.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.698 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -94.29 117.88 30.77 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.675 -1.265 . . . . 0.0 108.127 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.48 107.49 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.723 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.8 mt -89.69 110.47 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.24 -164.49 25.06 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -109.02 -11.41 14.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -1.054 . . . . 0.0 110.2 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -153.15 155.89 37.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.917 -1.114 . . . . 0.0 110.306 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.57 131.91 85.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.751 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.669 ' CD ' HD21 ' A' ' 26' ' ' LEU . 76.3 Cg_exo -45.88 138.46 11.91 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.295 1.997 . . . . 0.0 112.283 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 99' ' ' LEU . 8.7 tp -75.91 -39.18 37.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.571 -0.706 . . . . 0.0 110.264 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.495 ' N ' HG23 ' A' ' 98' ' ' ILE . 80.3 mt 54.92 -155.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.481 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.95 -1.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.147 -0.971 . . . . 0.0 111.027 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 99' ' ' LEU . . . 88.27 -10.4 71.37 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.69 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.3 p -112.09 -168.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -1.082 . . . . 0.0 109.77 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -1.22 21.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.589 ' CD2' ' OE1' ' A' ' 108' ' ' GLU . 69.1 t-105 -46.81 -41.36 15.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.841 -0.799 . . . . 0.0 110.696 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.426 ' OE1' HD13 ' A' ' 99' ' ' LEU . 36.2 mt-10 -62.39 -52.04 65.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 110.303 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.6 m-85 -62.01 -45.38 93.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.924 -1.11 . . . . 0.0 108.758 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.659 ' CD2' HG11 ' A' ' 175' ' ' VAL . 6.1 t80 -59.68 -41.33 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.676 -0.64 . . . . 0.0 109.811 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -74.64 -41.68 59.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 111.418 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -48.68 25.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.858 -1.151 . . . . 0.0 110.357 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.4 mt -67.66 -40.51 84.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.12 -0.987 . . . . 0.0 110.392 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -53.05 -31.79 43.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 109.593 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -85.3 -5.89 59.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 110.102 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.824 ' ND2' HD21 ' A' ' 11' ' ' LEU . 71.7 m-20 -125.47 30.29 5.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 111.385 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.649 HD11 HD13 ' A' ' 82' ' ' LEU . 4.8 mt -89.89 146.79 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.661 -1.274 . . . . 0.0 109.941 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 115' ' ' LEU . 15.1 tp -131.93 161.13 33.81 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -108.1 144.91 34.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 110.076 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -106.0 -163.77 0.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.26 -3.42 13.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.344 -0.848 . . . . 0.0 110.58 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.54 ' O ' ' N ' ' A' ' 4' ' ' GLU . 25.7 ttm180 -89.98 143.48 26.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 0.0 110.274 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -83.03 128.56 34.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.36 -0.838 . . . . 0.0 109.859 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.5 mt -67.49 137.35 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.768 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.69 91.09 8.68 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -65.47 146.83 54.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.455 -0.778 . . . . 0.0 110.936 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -100.26 122.65 43.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.71 139.18 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.6 t -84.21 138.86 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.429 -0.794 . . . . 0.0 108.929 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -117.72 -8.67 10.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.522 -0.736 . . . . 0.0 109.444 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -144.0 144.12 25.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.953 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.91 150.66 55.59 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.196 1.931 . . . . 0.0 113.096 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 2.2 tt -140.96 144.61 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.87 125.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.81 111.27 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.778 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -113.47 133.59 55.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -179.08 156.38 0.78 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.011 -1.056 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 57.0 mm-40 56.16 20.14 4.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.54 88.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.46 ' HE ' ' C ' ' A' ' 251' ' ' GLY . 1.4 mtp85 -104.02 171.21 7.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.6 tt -159.86 146.06 15.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.503 -1.373 . . . . 0.0 108.589 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 259' ' ' LEU . 18.7 mt -147.59 126.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.024 -1.047 . . . . 0.0 108.511 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 147.06 43.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.638 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -127.75 151.87 48.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -150.11 139.14 12.9 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -51.52 144.19 33.36 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.707 1.605 . . . . 0.0 112.146 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.71 11.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.21 -0.931 . . . . 0.0 109.472 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 24.7 p-10 -86.21 -0.4 55.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.67 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.3 p -135.14 145.54 47.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.1 tp -79.72 118.03 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.92 . . . . 0.0 109.838 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -138.17 142.16 40.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 108.871 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.531 ' CG1' HD23 ' A' ' 231' ' ' LEU . 71.1 t -140.35 131.87 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.997 -1.064 . . . . 0.0 109.935 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 m -117.73 135.85 53.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.348 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.531 ' HB2' HG22 ' A' ' 228' ' ' VAL . 84.1 t80 -123.88 128.54 49.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.6 109.46 17.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.01 122.75 6.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 1.1 pm0 -102.88 114.65 29.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -1.138 . . . . 0.0 108.659 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -109.42 147.73 32.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.576 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -93.31 0.12 56.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.786 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.483 ' ND2' HD12 ' A' ' 159' ' ' LEU . 12.8 p30 -79.3 -171.54 2.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 12.2 p90 -61.68 -26.55 68.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.604 HD11 HD13 ' A' ' 206' ' ' LEU . 4.0 mt -55.61 -50.57 69.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.497 ' C ' HE22 ' A' ' 162' ' ' GLN . . . 87.34 -136.09 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.521 ' C ' ' NE2' ' A' ' 162' ' ' GLN . 38.3 mtp180 -98.68 140.35 33.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -1.1 . . . . 0.0 109.575 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 161' ' ' ARG . 1.7 mp0 -139.33 131.06 27.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.368 -0.833 . . . . 0.0 109.03 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.33 52.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.527 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 71.9 t80 -138.35 126.69 23.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.183 -0.948 . . . . 0.0 109.787 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 165' ' ' THR . 7.0 t -106.03 123.93 48.77 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -97.67 133.45 42.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.93 . . . . 0.0 108.716 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.81 148.34 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.522 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -48.06 114.89 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.639 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 10.33 11.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.429 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 27.3 m-20 -136.81 26.9 3.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.988 -1.301 . . . . 0.0 108.853 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.9 mp0 -63.0 -37.82 88.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.749 . . . . 0.0 110.768 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.19 -16.33 13.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -90.29 -3.67 57.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.077 . . . . 0.0 110.917 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.85 4.67 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.047 -1.033 . . . . 0.0 111.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.659 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.1 OUTLIER -99.27 -27.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.779 -1.2 . . . . 0.0 109.799 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.65 2.47 50.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.797 -1.189 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.1 109.52 17.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.774 -1.204 . . . . 0.0 109.036 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.42 ' HG2' ' H ' ' A' ' 178' ' ' ARG . 2.2 ptp180 -79.69 153.52 29.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -55.83 154.49 7.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 108.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.544 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 39.5 p90 -135.35 170.45 15.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 109.728 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.633 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -159.29 161.94 35.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.23 -0.919 . . . . 0.0 109.754 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.535 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 61.5 m-85 -103.79 146.46 28.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.738 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.6 OUTLIER -61.64 -21.13 64.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.047 -1.033 . . . . 0.0 110.868 -178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.3 p90 -81.53 -29.6 33.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.552 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.1 pt-20 -92.15 -15.84 27.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.896 -1.128 . . . . 0.0 109.699 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' A' ' 183' ' ' ASP . 12.1 mt -58.76 -53.25 49.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 110.431 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -52.43 -47.58 66.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.579 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.22 -47.55 83.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.977 . . . . 0.0 109.137 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.96 -33.11 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 108.99 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -78.27 -31.4 49.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -74.98 -28.76 60.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.019 -1.051 . . . . 0.0 110.218 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.486 ' CG2' HD12 ' A' ' 194' ' ' LEU . 31.4 m -78.51 8.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.173 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.47 20.95 73.73 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.486 HD12 ' CG2' ' A' ' 192' ' ' VAL . 22.9 mt -119.16 157.82 27.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.478 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.67 24.34 62.78 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -67.71 -21.72 65.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.744 -1.445 . . . . 0.0 109.436 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.34 -6.12 48.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.99 126.66 42.29 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.044 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 203' ' ' THR . 60.6 p -140.88 160.76 39.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.895 . . . . 0.0 109.309 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.43 -27.76 69.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 109.968 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -76.23 -15.86 59.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 109.927 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 29.0 m120 -132.81 11.12 4.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.633 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 39.3 m -148.97 115.36 5.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.163 -0.961 . . . . 0.0 109.777 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.4 HD12 ' CG ' ' A' ' 213' ' ' ASN . 68.9 tp -75.5 112.19 11.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.58 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.2 t -103.4 128.35 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 109.223 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.604 HD13 HD11 ' A' ' 159' ' ' LEU . 92.8 mt -110.67 146.29 36.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -101.19 154.14 19.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.45 -26.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 10.8 0.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.0 110.325 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -141.12 148.68 40.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.305 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.92 123.55 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.53 -54.79 7.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.394 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.4 ' CG ' HD12 ' A' ' 204' ' ' LEU . 2.7 m120 -59.34 134.31 88.34 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.703 -1.248 . . . . 0.0 109.341 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.15 -7.32 20.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.357 2.038 . . . . 0.0 112.761 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -86.47 -7.58 58.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 0.0 110.316 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.07 -158.85 53.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.4 144.13 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -1.059 . . . . 0.0 109.949 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 109.517 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.578 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 68.1 m-85 -140.08 129.47 24.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.895 . . . . 0.0 109.042 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -52.99 -11.02 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 108.502 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.477 ' N ' ' C ' ' A' ' 219' ' ' TYR . 5.9 m120 -133.07 35.28 3.52 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.482 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 8.7 tt0 -59.26 -55.35 47.05 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.729 . . . . 0.0 111.579 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 19.6 Cg_endo -60.75 -42.14 41.06 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.73 1.62 . . . . 0.0 113.305 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 228' ' ' VAL . 4.5 m -76.99 -25.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 108.363 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.578 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 46.9 mtt180 -67.0 -43.47 82.83 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.28 -41.24 98.32 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.45 -46.26 80.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.9 t -60.76 -51.03 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.455 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 81.6 t80 -50.45 -39.85 48.99 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.886 0.85 . . . . 0.0 108.725 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.455 ' OD2' ' OE1' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.98 -39.66 69.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.65 -0.656 . . . . 0.0 109.681 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 149' ' ' VAL . 28.5 tp -57.9 -35.36 70.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.905 . . . . 0.0 109.385 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.625 HG22 ' HD1' ' A' ' 80' ' ' HIS . 86.9 mt -71.12 -48.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.41 -32.1 14.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.8 -27.03 31.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.44 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -82.94 -24.3 33.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.775 -1.203 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.452 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 44.5 t80 -68.14 -8.56 39.48 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 239' ' ' GLY . 43.9 mt -52.21 -30.26 26.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 109.163 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 242' ' ' VAL . 97.5 mt -55.02 -7.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.169 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 71.92 14.78 75.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.7 p -158.13 144.62 12.87 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -1.21 . . . . 0.0 109.402 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 77.0 Cg_exo -42.38 134.71 4.61 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.148 1.899 . . . . 0.0 111.873 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 238' ' ' LEU . 22.0 t -98.04 129.53 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -118.1 124.65 48.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 109.373 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.36 -178.5 31.96 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -105.08 138.12 41.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -1.077 . . . . 0.0 110.039 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.5 m-85 -140.21 143.46 36.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.062 0.934 . . . . 0.0 111.263 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -126.31 144.25 50.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.1 t -140.11 127.47 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 110.631 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 0.9 OUTLIER -111.71 114.2 27.06 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.46 ' CG ' ' OE1' ' A' ' 154' ' ' GLU . 2.6 mmm180 47.72 55.79 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.46 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -77.6 140.52 24.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -111.05 174.19 16.66 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.571 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 15.1 m-70 -68.58 -41.97 78.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.048 -1.266 . . . . 0.0 109.659 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -55.18 25.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' A' ' 139' ' ' ILE . 57.2 tp -51.7 -39.04 57.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 71.3 m-20 -58.71 -55.48 34.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.995 . . . . 0.0 109.018 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.73 -43.35 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.732 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -48.7 74.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.093 -1.004 . . . . 0.0 109.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 139' ' ' ILE . 38.9 tp -52.81 -43.38 65.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.358 -0.839 . . . . 0.0 109.039 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.44 HG22 HD23 ' A' ' 235' ' ' LEU . 20.2 t -71.13 -45.73 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.14 -51.45 64.23 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 109.917 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.459 ' OE1' HD11 ' A' ' 130' ' ' ILE . 62.6 mt-10 -61.04 -51.48 69.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.941 -1.099 . . . . 0.0 109.637 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.66 -43.9 80.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.49 -33.11 73.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 25.5 mttt . . . . . 0 N--CA 1.488 1.469 0 O-C-N 120.81 -1.181 . . . . 0.0 108.937 179.415 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 66.4 mt-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -120.87 138.35 54.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.414 -0.804 . . . . 0.0 109.466 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 t -139.54 177.89 7.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.78 144.7 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -74.78 -46.92 33.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.667 -0.645 . . . . 0.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.32 160.47 34.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.71 . . . . 0.0 110.219 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -64.92 135.56 55.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -0.768 . . . . 0.0 110.104 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 113' ' ' ASN . 4.9 mt -122.29 171.38 9.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -158.49 150.74 21.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 0.0 110.442 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -133.93 160.91 36.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.483 -0.761 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.12 137.21 21.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.962 -1.086 . . . . 0.0 109.141 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.73 160.79 20.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.512 -1.328 . . . . 0.0 109.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.9 p -76.3 162.98 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 0.0 111.424 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.565 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -94.76 141.4 15.53 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -59.75 -48.18 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -1.138 . . . . 0.0 112.937 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.5 m-70 -86.33 -36.51 19.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.013 -1.679 . . . . 0.0 112.374 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -80.41 -34.06 36.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.824 -1.172 . . . . 0.0 110.091 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.15 74.87 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.29 152.82 30.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.983 . . . . 0.0 108.867 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -73.81 140.92 46.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 110.202 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 9.7 t -147.88 157.64 43.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.047 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.618 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -132.21 154.71 49.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.286 -0.884 . . . . 0.0 109.239 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.674 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 0.0 108.724 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.419 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.3 mt -127.95 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mt -123.91 120.88 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.419 ' NE2' HG22 ' A' ' 27' ' ' ILE . 11.5 m-70 -117.23 149.3 44.23 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 161.19 22.71 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.112 1.874 . . . . 0.0 111.258 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.6 mm-40 -134.72 -173.73 3.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.072 -1.017 . . . . 0.0 110.081 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.8 tttm -91.94 155.75 17.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.701 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -48.07 143.63 4.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 110.62 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.595 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.84 26.17 60.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.543 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.622 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 33.0 m -79.98 -34.93 38.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.709 -1.465 . . . . 0.0 108.595 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.823 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 91.88 -173.35 36.4 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mm -102.03 123.74 55.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.323 -1.104 . . . . 0.0 108.271 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -137.28 139.83 41.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.511 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.03 152.84 19.38 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -131.32 142.78 50.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.832 . . . . 0.0 109.02 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 14.0 tttm -172.54 138.92 0.92 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.48 29.8 13.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.912 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.54 19.1 77.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.45 136.91 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.282 -1.128 . . . . 0.0 109.692 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -96.79 140.53 31.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.895 . . . . 0.0 109.178 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.5 mt -132.68 95.6 19.69 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.7 142.48 24.79 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.206 1.937 . . . . 0.0 111.607 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.35 80.67 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.961 -1.087 . . . . 0.0 110.307 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.04 153.41 51.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 109.649 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' VAL . 7.7 p80 -54.68 -49.29 71.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.4 mm-40 -44.67 -31.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.989 -1.07 . . . . 0.0 109.318 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.83 4.06 15.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.922 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 7.9 t -59.37 124.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.31 -32.0 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.412 -0.805 . . . . 0.0 109.944 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.531 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.8 t-160 -152.25 123.87 7.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.688 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.3 p -111.1 134.66 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 59' ' ' SER . 20.3 p-10 -166.39 -154.44 0.18 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -10.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.942 -1.099 . . . . 0.0 108.479 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -138.85 166.96 23.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -0.8 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.1 m -101.99 120.56 40.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.05 136.93 52.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.34 -0.85 . . . . 0.0 111.199 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 53' ' ' VAL . 41.5 mt -123.39 157.67 32.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.7 143.49 6.89 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 118.484 -1.817 . . . . 0.0 111.214 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -144.29 148.99 35.54 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.747 -0.855 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm 56.62 38.33 29.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 110.783 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.55 4.4 84.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.8 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 94.0 mm-40 -102.85 140.56 36.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.934 -1.333 . . . . 0.0 108.418 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -141.91 154.31 45.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.47 146.25 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -115.1 154.63 28.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 111.113 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 m 52.38 68.85 0.76 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.734 -0.604 . . . . 0.0 111.111 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.8 -10.72 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.179 -0.95 . . . . 0.0 109.727 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 5.7 pt-20 -67.73 -16.98 64.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.439 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -72.45 -60.59 2.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.012 -1.055 . . . . 0.0 109.424 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 76' ' ' LEU . 5.0 tp -58.92 -41.14 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.99 -1.069 . . . . 0.0 108.945 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 79' ' ' LEU . 84.4 mt -59.78 -36.49 76.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.6 t -60.44 -48.69 80.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.044 -1.035 . . . . 0.0 108.841 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.31 -51.26 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.453 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 76' ' ' LEU . 44.0 mt -51.87 -44.91 63.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.513 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 8.4 t-160 -57.1 -48.46 78.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.831 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.34 -39.73 95.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 110.414 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.824 HD13 HD11 ' A' ' 114' ' ' ILE . 53.2 mt -80.7 -5.56 57.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.053 -1.03 . . . . 0.0 110.738 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.77 54.64 2.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.896 -1.127 . . . . 0.0 110.723 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 82' ' ' LEU . 8.0 mm -92.69 123.85 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.63 HG21 HG12 ' A' ' 121' ' ' ILE . 63.4 p -109.78 -23.8 11.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.274 -0.891 . . . . 0.0 111.492 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.823 HD22 ' H ' ' A' ' 36' ' ' GLY . 11.6 m120 -128.8 111.9 13.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.972 -1.08 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -164.03 143.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.246 -0.909 . . . . 0.0 109.898 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.519 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.7 m -113.77 100.59 8.57 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.51 105.38 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.348 -0.845 . . . . 0.0 109.985 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.54 121.73 26.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -104.21 115.14 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.456 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.754 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.3 mp -97.11 109.62 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.19 -160.62 23.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.15 -12.25 11.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.071 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -142.76 147.73 36.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.984 -1.073 . . . . 0.0 110.584 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 124.42 90.89 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.505 -0.747 . . . . 0.0 108.993 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.674 ' CD ' HD21 ' A' ' 26' ' ' LEU . 73.3 Cg_exo -44.74 131.36 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.032 1.822 . . . . 0.0 112.344 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.55 -27.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.418 -0.801 . . . . 0.0 109.675 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.45 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 22.8 mt 54.89 -112.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.274 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.36 -13.85 25.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.987 . . . . 0.0 110.699 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.74 -15.35 41.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -113.1 -168.89 1.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -1.063 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.09 -1.32 23.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -46.92 -44.39 19.8 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.788 -0.83 . . . . 0.0 110.573 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.09 -51.91 66.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.0 -1.062 . . . . 0.0 110.129 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 69.8 m-85 -61.33 -44.21 97.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 109.057 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.499 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 5.6 t80 -67.14 -37.46 83.86 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.324 0.583 . . . . 0.0 110.491 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.14 -50.98 42.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 111.351 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.84 -44.7 61.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.867 -1.145 . . . . 0.0 110.622 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.88 -39.89 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 110.033 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -53.75 -30.94 46.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.309 -0.869 . . . . 0.0 109.165 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -84.75 -11.5 55.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.32 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.418 ' HB2' HD11 ' A' ' 11' ' ' LEU . 4.3 m-80 -119.96 29.54 7.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.238 -0.914 . . . . 0.0 111.405 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.824 HD11 HD13 ' A' ' 82' ' ' LEU . 4.4 mt -87.66 147.23 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.592 -1.317 . . . . 0.0 109.827 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 116' ' ' ASN . 52.8 tp -131.58 159.96 36.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.406 ' N ' ' HG ' ' A' ' 115' ' ' LEU . 21.2 t30 -109.52 144.6 37.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.404 ' NE2' ' OD1' ' A' ' 86' ' ' ASN . 4.0 mt-30 -107.01 -166.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 p30 -118.73 72.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.529 -0.732 . . . . 0.0 110.187 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 4' ' ' GLU . 20.9 ttt180 -166.04 143.98 5.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 109.42 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.32 131.45 35.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.09 -1.006 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.63 HG12 HG21 ' A' ' 85' ' ' THR . 68.8 mt -74.98 141.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.732 . . . . 0.0 110.571 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -84.04 88.53 7.17 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -61.47 145.69 51.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.6 120.51 40.43 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.18 140.71 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.266 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 97.1 t -84.24 136.3 23.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.462 -0.774 . . . . 0.0 109.212 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -113.94 -10.26 12.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.12 146.58 40.59 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.08 178.02 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.19 1.927 . . . . 0.0 112.779 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 141' ' ' ALA . 7.2 tt -165.32 147.76 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.495 -0.753 . . . . 0.0 109.799 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.515 HD11 ' HZ3' ' A' ' 140' ' ' LYS . 53.2 mt -134.91 122.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.23 116.69 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -104.23 155.01 19.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.265 -0.897 . . . . 0.0 109.896 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.513 ' HB2' HD13 ' A' ' 255' ' ' LEU . 13.3 t0 -165.52 110.98 0.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.978 -1.076 . . . . 0.0 111.499 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 41.19 51.76 3.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.427 -0.796 . . . . 0.0 112.46 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.48 6.77 88.87 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.645 -1.285 . . . . 0.0 110.448 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.8 mtt85 -118.6 130.18 55.73 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 138' ' ' LEU . 3.7 tt -144.33 160.02 41.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.416 -1.428 . . . . 0.0 110.16 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.548 ' N ' HD23 ' A' ' 138' ' ' LEU . 52.5 mt -146.26 133.01 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.515 ' HZ3' HD11 ' A' ' 131' ' ' ILE . 47.9 tttp -118.96 144.86 46.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.757 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -118.37 147.82 43.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -145.05 135.03 11.7 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.57 147.46 58.75 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.402 . . . . 0.0 112.031 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.21 154.76 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.232 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.557 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.6 OUTLIER -86.98 1.39 52.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.506 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.5 p -135.7 146.94 48.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 242' ' ' VAL . 18.2 tp -79.58 119.83 23.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.02 134.15 32.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 108.877 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.677 ' CG1' HD23 ' A' ' 231' ' ' LEU . 55.7 t -134.05 118.16 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 109.339 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.4 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 2.0 m -107.35 135.72 48.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.094 -1.004 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -123.6 129.15 50.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.47 -0.769 . . . . 0.0 109.827 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -113.92 109.64 18.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.3 155.96 19.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.556 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -134.2 91.24 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -1.089 . . . . 0.0 109.485 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.76 148.76 22.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 -10.26 35.52 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.403 -0.81 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.6 p30 -69.65 -167.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.186 -0.947 . . . . 0.0 109.521 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.99 -21.44 58.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.907 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.7 mt -64.48 -47.61 78.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.82 -126.23 7.43 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.7 mtt85 -109.44 141.09 42.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.533 -0.981 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -153.9 150.4 28.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 109.713 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -136.71 151.35 49.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.407 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 62.9 t80 -135.12 122.89 22.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 108.872 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 165' ' ' THR . 15.2 t -99.83 122.35 42.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -100.44 132.86 45.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.351 -0.843 . . . . 0.0 109.164 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.45 151.91 34.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.454 -0.779 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -51.67 116.4 2.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 8.32 14.37 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.404 HD22 ' CD ' ' A' ' 173' ' ' GLU . 4.8 m120 -134.04 26.24 3.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.19 -1.183 . . . . 0.0 108.312 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 171' ' ' GLU . 22.0 mt-10 -64.6 -31.72 73.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.64 -0.662 . . . . 0.0 110.735 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.68 -15.53 58.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.275 -0.89 . . . . 0.0 111.627 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.404 ' CD ' HD22 ' A' ' 170' ' ' ASN . 80.3 mt-10 -94.34 -4.15 49.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.587 -1.321 . . . . 0.0 111.212 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.3 pt -117.11 -9.99 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.05 -1.032 . . . . 0.0 111.132 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 175' ' ' VAL . 0.9 OUTLIER -83.11 -28.11 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.548 -1.345 . . . . 0.0 110.133 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 2.29 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.896 -1.127 . . . . 0.0 110.452 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.37 110.18 17.28 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.94 -1.1 . . . . 0.0 109.001 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 154.58 20.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.085 -1.01 . . . . 0.0 110.066 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.435 ' CA ' ' CE1' ' A' ' 226' ' ' HIS . 5.0 t -52.73 156.9 1.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -0.799 . . . . 0.0 109.537 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.524 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 34.1 p90 -141.47 167.8 21.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.087 -1.008 . . . . 0.0 109.826 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.524 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -163.82 164.12 23.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -0.931 . . . . 0.0 109.918 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.433 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 91.2 m-85 -103.14 144.43 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.354 -0.842 . . . . 0.0 109.127 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.729 ' HA ' HD12 ' A' ' 186' ' ' ILE . 28.4 p-10 -65.45 -18.75 65.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.386 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -77.58 -29.04 51.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.548 -1.345 . . . . 0.0 111.003 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -101.39 -11.45 19.37 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.853 -1.154 . . . . 0.0 110.15 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.7 mt -58.93 -51.21 75.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 110.371 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -51.01 -49.43 60.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.919 -1.113 . . . . 0.0 109.54 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -49.39 70.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 109.005 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 186' ' ' ILE . 57.0 mt -57.41 -33.81 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.966 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -75.18 -26.13 58.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 110.179 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 193' ' ' GLY . 0.6 OUTLIER -76.52 -33.83 58.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 110.004 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.1 m -74.6 10.07 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 109.037 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 76.82 22.06 72.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.18 155.63 30.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -1.178 . . . . 0.0 109.997 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.48 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.83 23.71 61.46 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.365 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -67.45 -22.17 65.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.686 -1.479 . . . . 0.0 109.618 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.83 -5.82 50.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 128.34 41.44 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.848 -1.384 . . . . 0.0 110.106 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -136.22 -177.49 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.519 -0.989 . . . . 0.0 109.605 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.2 -21.97 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.65 -6.26 58.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.861 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.1 m-20 -141.26 13.85 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.04 -1.037 . . . . 0.0 110.017 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.459 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.1 m -149.3 118.96 6.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.015 -1.053 . . . . 0.0 110.058 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.33 111.58 14.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.897 . . . . 0.0 108.909 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.2 t -103.7 127.89 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.225 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.78 151.89 28.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.72 160.98 14.11 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -48.62 -28.08 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.78 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -152.59 13.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.038 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 207' ' ' GLY . 73.6 tttt -141.19 149.36 41.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.021 -1.05 . . . . 0.0 110.068 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.2 t -99.08 125.92 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 109.038 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -72.96 -54.46 8.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 110.104 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.03 137.02 80.21 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.996 -1.065 . . . . 0.0 109.746 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.74 -13.23 26.91 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.412 2.075 . . . . 0.0 112.622 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -85.59 -7.28 58.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 110.1 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.68 -160.83 53.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.95 145.73 30.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.991 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -88.84 -24.94 22.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 108.815 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 221' ' ' ASN . 56.6 m-85 -145.99 139.37 26.09 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.75 -12.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.951 -1.093 . . . . 0.0 108.507 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.581 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.88 37.68 1.98 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.768 0.794 . . . . 0.0 109.122 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.592 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -55.75 -41.48 91.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_exo -69.11 -42.83 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.429 2.086 . . . . 0.0 112.966 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 228' ' ' VAL . 16.1 m -76.25 -24.81 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.735 -1.228 . . . . 0.0 108.691 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.471 ' NH2' ' ND2' ' A' ' 221' ' ' ASN . 38.6 mtt180 -69.03 -45.17 71.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.435 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 37.0 t60 -59.2 -45.06 92.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.471 -0.768 . . . . 0.0 108.959 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -56.58 -47.81 78.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 108.989 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 224' ' ' VAL . 95.6 t -58.46 -51.18 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -50.69 -39.33 50.97 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -72.05 -40.87 68.04 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.588 -0.695 . . . . 0.0 109.855 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.677 HD23 ' CG1' ' A' ' 149' ' ' VAL . 51.8 tp -57.02 -35.01 68.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.377 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 25.0 mt -71.62 -48.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.32 20.55 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.87 -28.8 29.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.263 -1.139 . . . . 0.0 109.854 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 260' ' ' VAL . 7.0 mt -79.75 -22.92 42.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.773 -1.204 . . . . 0.0 109.701 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 24.5 t80 -69.0 -10.0 55.26 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 237' ' ' LEU . 81.2 mt -51.44 -26.59 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 0.0 108.869 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.497 HD12 HG22 ' A' ' 242' ' ' VAL . 95.5 mt -59.95 -21.59 61.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.89 14.57 69.5 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 56.1 p -158.41 147.12 14.29 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.045 -1.268 . . . . 0.0 109.813 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 71.8 Cg_exo -42.66 130.87 5.41 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.203 1.935 . . . . 0.0 111.961 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.497 HG22 HD12 ' A' ' 238' ' ' LEU . 51.3 t -95.26 127.04 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.579 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -117.08 123.85 47.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.365 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.67 177.95 30.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.411 ' HG3' ' HZ2' ' A' ' 245' ' ' LYS . 21.5 tttp -110.35 111.17 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.242 -1.152 . . . . 0.0 110.352 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.9 m-85 -111.82 147.6 35.37 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.853 0.835 . . . . 0.0 110.695 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.4 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 29.4 t80 -128.35 143.25 50.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.0 t -138.13 126.18 22.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.682 -1.261 . . . . 0.0 110.219 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 250' ' ' ARG . 11.9 t80 -111.64 112.61 24.43 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.556 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 12.3 mtt180 47.39 56.67 6.67 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.47 155.14 22.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.48 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -118.24 -175.42 16.66 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.444 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 90.9 m-70 -72.28 -51.82 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -1.21 . . . . 0.0 109.66 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.3 t -55.57 -34.12 64.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.706 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 134' ' ' ASP . 44.0 tp -72.99 -37.47 66.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 108.99 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 4.8 m120 -62.71 -49.71 74.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 108.922 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.79 -44.18 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.354 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -54.98 -48.53 73.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.942 -1.099 . . . . 0.0 108.844 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.82 -47.05 67.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.638 HG22 HD23 ' A' ' 235' ' ' LEU . 98.5 t -65.56 -50.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.682 0.753 . . . . 0.0 109.574 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.82 -50.54 18.23 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 110.417 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.91 -47.98 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.09 . . . . 0.0 110.29 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 72.2 mt -61.76 -43.99 97.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 109.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.59 96.74 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.381 -0.824 . . . . 0.0 109.486 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp . . . . . 0 N--CA 1.49 1.527 0 O-C-N 120.93 -1.106 . . . . 0.0 109.159 179.558 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.5 mt-10 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -126.5 141.87 51.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 t -138.61 177.79 7.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -83.06 140.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.818 -1.176 . . . . 0.0 110.163 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.465 ' CG ' HD13 ' A' ' 115' ' ' LEU . 13.9 ttpt -77.05 -43.67 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -126.2 153.23 44.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 109.842 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 139.49 58.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 110.236 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.467 HD11 HD22 ' A' ' 113' ' ' ASN . 12.6 mt -123.32 168.65 12.22 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -157.94 148.7 20.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 110.105 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -132.44 159.94 37.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -147.82 135.03 20.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.964 -1.085 . . . . 0.0 108.603 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.0 157.58 15.12 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG23 ' C ' ' A' ' 22' ' ' GLU . 11.2 p -81.53 141.03 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.216 -1.167 . . . . 0.0 110.755 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.18 144.92 40.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -63.89 -46.04 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.225 -1.162 . . . . 0.0 112.627 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.498 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.6 m-70 -86.8 -40.42 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 119.961 -1.712 . . . . 0.0 111.46 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -70.27 -31.64 69.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 109.954 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.04 23.89 68.16 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.542 ' C ' HG23 ' A' ' 16' ' ' VAL . 9.7 mt-10 -116.87 152.28 34.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -1.019 . . . . 0.0 109.469 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -70.69 132.72 45.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.72 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 t -140.89 158.0 44.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.0 109.252 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.721 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.9 ttpp -130.7 158.65 39.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.875 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.9 mt -135.44 141.12 45.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 108.766 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mt -126.41 135.66 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mt -118.77 112.75 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -111.97 154.58 44.13 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -68.67 162.2 42.08 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.372 2.048 . . . . 0.0 110.883 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.548 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.6 mm-40 -137.37 -177.4 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.016 -1.052 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -83.13 148.79 27.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.418 -0.801 . . . . 0.0 109.236 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.648 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.84 149.77 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.984 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.648 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.21 21.59 53.83 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.292 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.688 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 19.1 m -80.58 -37.35 31.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.625 -1.515 . . . . 0.0 108.803 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.539 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 94.75 -175.56 34.16 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -98.81 123.23 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.449 -1.03 . . . . 0.0 108.294 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -137.22 145.74 44.0 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.859 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -103.72 152.26 22.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -133.81 141.36 47.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.499 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.3 143.27 1.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.87 29.55 16.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.973 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.35 27.15 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.01 135.05 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -1.079 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.8 140.5 32.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 67' ' ' GLN . 42.5 mt -135.2 95.38 14.95 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.882 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.18 145.41 7.81 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.018 1.812 . . . . 0.0 111.743 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.41 82.35 5.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.0 110.292 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -139.14 156.25 47.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 109.58 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.56 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 2.1 p80 -52.78 -49.64 65.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -44.79 -16.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 25.4 m-85 -97.03 4.67 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.941 -1.099 . . . . 0.0 109.897 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.24 126.11 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.24 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.18 -34.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.374 -0.829 . . . . 0.0 110.0 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.411 ' NE2' ' HB2' ' A' ' 57' ' ' ASN . 4.8 t-160 -148.42 119.11 7.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 109.384 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -114.01 130.64 56.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 59' ' ' SER . 66.8 t30 -166.61 -153.63 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.533 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 4.8 m-70 -46.11 -15.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.383 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 57' ' ' ASN . 36.8 t -134.69 166.09 23.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.459 -0.776 . . . . 0.0 109.369 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m -109.85 125.04 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.369 -0.832 . . . . 0.0 109.225 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.2 145.98 48.99 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.958 0.885 . . . . 0.0 111.078 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.4 mt -127.21 159.55 33.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -178.55 148.25 8.3 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 118.422 -1.847 . . . . 0.0 111.572 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.2 149.68 36.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.157 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp 55.79 37.61 29.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.947 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 6.1 84.92 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.79 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 18.9 mm100 -105.4 135.08 47.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -1.229 . . . . 0.0 108.018 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -142.23 159.77 41.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.943 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mt -136.47 147.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -114.67 154.35 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.433 -0.792 . . . . 0.0 110.949 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m 52.33 69.03 0.73 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.671 -0.643 . . . . 0.0 111.005 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.14 -11.26 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.166 -0.959 . . . . 0.0 109.28 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.562 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.1 pt-20 -66.9 -21.09 66.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.902 . . . . 0.0 110.535 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -71.28 -59.85 2.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.925 -1.109 . . . . 0.0 109.74 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.5 tp -57.87 -40.65 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.089 . . . . 0.0 108.962 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.445 ' N ' HG23 ' A' ' 75' ' ' ILE . 8.2 mt -61.55 -35.74 78.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.639 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.6 t -61.32 -48.74 79.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.032 -1.042 . . . . 0.0 109.244 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 31.9 t -58.59 -54.05 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.7 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 76' ' ' LEU . 23.6 mt -51.19 -43.44 61.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.536 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 13.2 t-160 -54.61 -52.32 62.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.784 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.53 -36.9 85.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.677 HD13 HD11 ' A' ' 114' ' ' ILE . 18.0 mt -78.08 -5.7 52.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.554 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 62.72 54.28 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.819 -1.175 . . . . 0.0 110.557 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.5 mm -96.02 126.16 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -113.19 -24.13 9.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 112.21 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.745 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.5 m120 -130.63 112.36 13.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.76 -1.212 . . . . 0.0 110.418 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.7 m -165.22 141.19 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.814 HG22 ' OE1' ' A' ' 90' ' ' GLU . 82.6 m -109.22 100.02 9.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.07 111.46 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.814 ' OE1' HG22 ' A' ' 88' ' ' THR . 0.6 OUTLIER -84.7 124.7 31.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.87 -1.144 . . . . 0.0 108.374 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 91' ' ' VAL . 3.9 t -107.85 111.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.731 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.4 mp -98.13 109.06 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.88 -162.43 24.19 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.486 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -115.38 -15.42 11.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.147 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.98 144.73 37.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.019 -1.051 . . . . 0.0 110.004 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.56 127.67 92.58 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 109.5 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.657 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.9 Cg_exo -45.6 128.37 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.887 1.724 . . . . 0.0 111.814 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.451 HD11 ' HA2' ' A' ' 101' ' ' GLY . 7.4 tp -79.8 -26.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.408 -0.808 . . . . 0.0 109.849 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.6 mt 55.42 -110.59 0.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -94.86 -18.74 20.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.081 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.451 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 111.87 -10.36 27.5 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -114.49 -169.67 1.58 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.429 -1.042 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -3.08 21.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -46.91 -42.04 16.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.842 -0.799 . . . . 0.0 110.649 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.57 -52.02 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.987 -1.071 . . . . 0.0 110.171 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 74.3 m-85 -62.27 -44.03 97.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.112 -0.993 . . . . 0.0 108.715 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 9.9 t80 -61.35 -39.46 90.66 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.44 0.638 . . . . 0.0 109.842 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.11 -46.73 40.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.465 -0.772 . . . . 0.0 111.906 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.42 -48.38 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.778 -1.201 . . . . 0.0 110.674 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.53 -40.75 89.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.359 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 1.1 ttm-85 -54.62 -29.5 52.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -0.963 . . . . 0.0 109.978 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -82.57 -8.88 59.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.467 HD22 HD11 ' A' ' 11' ' ' LEU . 47.9 m-80 -123.18 33.96 5.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.318 -0.864 . . . . 0.0 111.279 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.677 HD11 HD13 ' A' ' 82' ' ' LEU . 10.4 mt -93.46 147.83 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 110.501 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.465 HD13 ' CG ' ' A' ' 8' ' ' LYS . 14.4 tp -131.02 163.55 27.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -112.97 144.03 43.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.95 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -161.45 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.169 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -122.77 1.03 9.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.255 -0.903 . . . . 0.0 110.856 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -82.66 135.46 35.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.797 -1.189 . . . . 0.0 109.849 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -74.94 124.1 26.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mt -71.82 140.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 111.278 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.81 91.18 8.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -63.53 146.08 54.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.459 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -102.21 125.78 49.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 t -129.96 143.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 92.3 t -82.94 137.85 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -119.7 -11.3 9.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.45 140.71 23.46 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 0.0 108.868 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -72.17 149.74 52.39 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.884 1.722 . . . . 0.0 113.043 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.545 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 0.9 OUTLIER -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -127.95 124.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 109.64 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 132' ' ' VAL . 28.7 m -120.22 115.65 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.116 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -105.42 142.5 35.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.332 -0.855 . . . . 0.0 109.225 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.46 123.8 1.91 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.766 -1.209 . . . . 0.0 111.944 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 48.08 41.56 15.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.775 -0.578 . . . . 0.0 112.319 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.48 4.23 90.46 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.045 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.2 mtt-85 -104.17 161.46 14.0 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.7 tt -160.33 150.44 18.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.16 -1.588 . . . . 0.0 109.052 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.989 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.3 mt -147.6 132.2 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -123.43 139.24 54.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.838 . . . . 0.0 109.797 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.545 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -119.36 148.03 43.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -147.11 137.77 12.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.65 143.1 47.86 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.4 1.4 . . . . 0.0 112.115 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.68 146.21 13.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.329 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -80.2 -1.69 41.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 p -135.72 144.7 46.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.394 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.4 118.74 19.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.96 138.26 40.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.83 121.69 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.013 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -110.66 129.76 55.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.527 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 228' ' ' VAL . 72.7 t80 -114.77 129.92 56.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.615 -0.678 . . . . 0.0 109.517 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -117.06 112.91 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.546 ' C ' HH21 ' A' ' 250' ' ' ARG . . . -110.7 161.06 12.98 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.834 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.413 ' OE1' ' NH1' ' A' ' 250' ' ' ARG . 12.7 pt-20 -131.92 114.78 15.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.674 -0.898 . . . . 0.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 157' ' ' ASN . 23.9 m-85 -118.77 148.49 42.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.886 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.03 -6.62 47.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.98 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.796 HD22 ' H ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -73.45 -168.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.02 . . . . 0.0 109.504 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -63.84 -16.87 62.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.125 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.521 HD12 ' OD1' ' A' ' 157' ' ' ASN . 6.2 mt -73.85 -24.83 59.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.977 -1.077 . . . . 0.0 109.109 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.73 -134.53 49.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -110.63 151.1 28.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.967 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.462 HE22 ' CD2' ' A' ' 159' ' ' LEU . 0.1 OUTLIER -169.06 160.82 10.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.831 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.64 160.12 39.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.9 126.38 25.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.41 -0.806 . . . . 0.0 108.874 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.0 m -97.05 121.94 39.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.886 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -96.71 138.69 33.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.872 . . . . 0.0 108.801 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.47 151.8 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.78 120.38 7.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.62 -1.59 21.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.459 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 15.5 m-80 -131.52 31.77 4.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -1.158 . . . . 0.0 108.87 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.62 -34.39 75.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.562 -0.711 . . . . 0.0 110.244 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 172' ' ' GLU . 2.8 mp0 -51.68 -14.55 0.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.062 -1.024 . . . . 0.0 110.577 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.516 ' N ' ' CD ' ' A' ' 173' ' ' GLU . 9.9 mp0 -93.5 -3.96 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.971 -1.081 . . . . 0.0 111.003 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.466 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -121.33 7.0 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.029 -1.044 . . . . 0.0 111.286 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.39 -32.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.711 -1.243 . . . . 0.0 110.271 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.37 1.98 51.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.873 -1.142 . . . . 0.0 110.689 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.13 108.54 15.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.875 -1.141 . . . . 0.0 109.085 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -82.18 154.49 25.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.087 -1.008 . . . . 0.0 109.352 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.7 t -61.77 138.91 58.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -117.32 173.48 6.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 110.208 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.78 159.79 27.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 0.0 109.229 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.588 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.6 m-85 -104.3 146.92 28.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.144 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.711 ' HA ' HD12 ' A' ' 186' ' ' ILE . 8.1 p30 -61.24 -17.89 55.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 111.218 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.3 p90 -80.13 -33.93 38.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.604 -1.31 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.602 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 pt-20 -92.88 -11.97 32.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.583 -1.323 . . . . 0.0 109.786 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 183' ' ' ASP . 7.2 mt -58.03 -52.29 60.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.135 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.23 -51.24 55.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.846 -1.159 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -52.82 -52.17 57.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.961 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.575 HD11 ' OE1' ' A' ' 185' ' ' GLU . 96.9 mt -54.56 -33.85 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -77.36 -25.47 51.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.613 -0.679 . . . . 0.0 110.268 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -78.26 -29.41 48.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 110.344 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.09 12.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.991 -1.068 . . . . 0.0 109.397 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.91 23.95 77.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.7 mt -117.3 155.28 29.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -1.12 . . . . 0.0 109.698 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.498 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.2 28.12 56.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -70.74 -20.63 62.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.738 -1.448 . . . . 0.0 109.23 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.25 -4.04 50.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.68 127.73 37.0 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.207 -1.172 . . . . 0.0 110.655 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.413 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 77.7 p -135.51 -173.9 3.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.717 -0.872 . . . . 0.0 109.249 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -82.99 -23.16 33.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -81.82 -24.36 35.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.585 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.413 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 0.6 OUTLIER -115.23 2.88 14.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.157 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.55 124.87 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.912 -1.118 . . . . 0.0 109.99 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 217' ' ' LEU . 5.2 tp -87.11 116.88 25.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 108.631 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.545 HG22 HD11 ' A' ' 186' ' ' ILE . 55.7 t -104.45 127.85 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.989 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.484 HD21 HD21 ' A' ' 217' ' ' LEU . 81.0 mt -105.54 151.62 24.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.86 154.04 17.04 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.437 ' CD ' ' H ' ' A' ' 208' ' ' LYS . 0.8 OUTLIER -41.91 -33.24 0.51 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -1.156 . . . . 0.0 109.829 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 19.02 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 110.251 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -150.32 160.16 43.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.88 130.41 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -73.27 -54.23 8.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.133 -0.979 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.2 135.37 75.03 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.965 -1.085 . . . . 0.0 109.378 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.31 -8.97 23.64 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.489 2.126 . . . . 0.0 112.877 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 215' ' ' GLU . 0.0 OUTLIER -92.09 -9.33 43.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 0.0 109.97 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.64 -166.2 51.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 204' ' ' LEU . 12.7 mt -85.68 147.78 26.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -1.038 . . . . 0.0 110.282 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.655 ' HE ' ' CA ' ' A' ' 218' ' ' ARG . 0.0 OUTLIER -83.46 -15.75 48.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.6 m-85 -149.42 151.67 34.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.036 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -63.02 -15.7 57.32 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.069 -1.019 . . . . 0.0 108.472 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.36 35.89 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.536 -0.728 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -60.45 -36.0 32.15 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.499 -0.751 . . . . 0.0 111.071 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.3 Cg_exo -70.34 -48.13 0.65 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.927 1.751 . . . . 0.0 112.547 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 228' ' ' VAL . 15.4 m -73.3 -23.53 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.632 -1.292 . . . . 0.0 108.39 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -67.87 -45.03 75.68 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -59.86 -41.15 90.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.948 . . . . 0.0 109.249 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 224' ' ' VAL . 42.7 t -58.88 -47.22 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.573 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 92.7 t80 -53.13 -38.72 62.9 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.697 0.761 . . . . 0.0 109.151 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 24.0 m-20 -68.76 -43.84 74.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.456 -0.778 . . . . 0.0 110.202 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.83 -39.23 73.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 0.0 109.235 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.417 HG22 ' HD1' ' A' ' 80' ' ' HIS . 77.0 mt -67.13 -34.28 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.2 -33.14 77.52 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -83.04 -26.21 31.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -1.12 . . . . 0.0 110.142 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.611 HD23 HG22 ' A' ' 260' ' ' VAL . 9.2 mt -81.89 -27.33 33.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.833 -1.167 . . . . 0.0 109.732 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.3 t80 -66.94 -8.52 30.08 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.074 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 237' ' ' LEU . 87.7 mt -52.62 -25.67 11.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 242' ' ' VAL . 96.0 mt -58.64 -23.85 59.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.894 -1.129 . . . . 0.0 108.846 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 89.18 14.64 60.15 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.2 p -158.51 146.28 13.6 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.939 -1.33 . . . . 0.0 109.637 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.405 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.64 131.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.289 1.992 . . . . 0.0 111.784 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 238' ' ' LEU . 22.0 t -98.43 134.93 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 109.457 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.66 128.47 48.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.89 178.82 30.46 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -107.37 111.59 24.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -1.183 . . . . 0.0 109.954 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -112.31 148.0 35.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 122.021 0.915 . . . . 0.0 111.167 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.78 144.42 51.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.9 128.6 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.816 -1.177 . . . . 0.0 110.361 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.624 ' CE2' ' NH1' ' A' ' 250' ' ' ARG . 38.2 t80 -113.85 107.36 15.62 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.624 ' NH1' ' CE2' ' A' ' 249' ' ' PHE . 0.0 OUTLIER 45.78 57.18 5.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.9 148.54 21.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -116.22 171.07 13.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.562 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 82.7 m-70 -59.91 -46.13 90.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -1.224 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -55.34 35.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.358 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 255' ' ' LEU . 60.0 tp -51.58 -39.42 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.407 HD22 ' CD1' ' A' ' 139' ' ' ILE . 9.4 m120 -57.8 -55.86 29.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.169 -0.957 . . . . 0.0 108.933 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 94.4 t -49.16 -41.51 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.29 -50.53 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.048 . . . . 0.0 109.062 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 139' ' ' ILE . 24.8 tp -53.15 -43.13 66.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.027 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.611 HG22 HD23 ' A' ' 235' ' ' LEU . 49.1 t -70.04 -40.26 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.343 -0.848 . . . . 0.0 109.428 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -52.53 64.3 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 110.025 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.6 -43.14 94.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.613 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 263' ' ' LEU . 41.9 mt -60.02 -47.88 84.02 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.17 75.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.457 -0.777 . . . . 0.0 110.24 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 120.676 -1.265 . . . . 0.0 108.95 179.4 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.529 ' CB ' ' OE2' ' A' ' 33' ' ' GLU . 5.4 mt-10 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.421 0.629 . . . . 0.0 109.776 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.0 139.13 54.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.388 0.613 . . . . 0.0 110.04 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 t -135.01 173.81 11.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 m -83.54 142.04 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.84 -1.162 . . . . 0.0 110.212 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HG3' HD13 ' A' ' 115' ' ' LEU . 19.4 ttpp -77.58 -41.81 37.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.488 -0.757 . . . . 0.0 110.565 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -133.25 157.48 45.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.64 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -59.61 132.3 53.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.734 -0.604 . . . . 0.0 110.015 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.435 HD21 HD22 ' A' ' 113' ' ' ASN . 12.7 mt -119.37 153.56 34.97 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -150.72 147.47 27.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -135.65 162.49 32.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.557 -0.714 . . . . 0.0 109.76 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.88 139.09 26.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.914 -1.116 . . . . 0.0 109.515 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.28 159.19 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 21' ' ' GLY . 1.5 p -85.88 143.7 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.999 -1.295 . . . . 0.0 111.264 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 143.33 36.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.0 OUTLIER -65.6 -38.71 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -1.079 . . . . 0.0 112.666 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.436 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.4 m-70 -86.15 -36.71 19.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 119.892 -1.755 . . . . 0.0 112.457 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -84.65 -40.5 17.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.661 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 16' ' ' VAL . . . 83.87 11.32 79.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 152.22 20.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -73.24 143.45 47.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.914 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -146.0 157.55 43.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 108.826 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.527 ' C ' HD23 ' A' ' 26' ' ' LEU . 14.0 tttt -136.62 146.61 46.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.201 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.574 HD11 ' HD2' ' A' ' 97' ' ' PRO . 1.5 mt -121.56 148.64 44.24 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.147 -0.971 . . . . 0.0 109.034 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -135.6 126.05 43.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 28' ' ' ILE . 6.4 mt -111.65 125.15 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.938 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.539 ' NE2' HG22 ' A' ' 27' ' ' ILE . 15.8 m-70 -120.63 149.93 51.33 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.87 159.88 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.043 1.829 . . . . 0.0 110.86 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 26.4 mm-40 -134.63 179.25 6.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.027 . . . . 0.0 110.081 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.39 148.16 32.1 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.227 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' OE2' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -47.78 147.0 2.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 -179.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 58.94 25.04 58.89 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.103 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.3 m -80.46 -37.82 31.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.761 -1.435 . . . . 0.0 108.875 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.4 -177.76 32.37 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 mm -97.44 124.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -140.31 139.43 35.45 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.008 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -97.78 153.71 18.09 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.541 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.6 t80 -132.28 141.22 48.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.204 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -170.96 140.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.57 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 58.62 28.42 17.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.406 -0.809 . . . . 0.0 109.706 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.14 30.64 69.55 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.7 t -135.53 132.19 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -1.212 . . . . 0.0 109.967 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -90.06 141.28 28.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 108.942 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 67' ' ' GLN . 10.6 mt -137.77 96.98 10.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 110.355 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.75 144.93 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.182 1.921 . . . . 0.0 111.711 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.68 84.82 4.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 0.0 110.089 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -139.65 156.9 46.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 3.5 p80 -53.38 -49.74 66.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.2 mm-40 -47.54 -16.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -0.998 . . . . 0.0 110.353 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' HIS . 22.0 m-85 -97.0 7.07 47.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.918 -1.114 . . . . 0.0 109.556 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.27 127.1 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.06 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.57 -34.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.616 ' CE1' ' ND2' ' A' ' 57' ' ' ASN . 3.1 t-160 -149.54 122.37 8.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -112.35 130.93 55.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -166.84 -153.95 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' ASN . 36.1 m-70 -46.59 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.071 -1.018 . . . . 0.0 108.763 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 57' ' ' ASN . 11.7 t -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.2 m -102.64 120.33 40.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 108.826 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -117.76 136.44 53.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 110.923 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -126.07 159.38 32.97 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.7 150.92 8.84 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.158 -1.972 . . . . 0.0 111.611 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -144.6 152.55 40.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.82 -0.812 . . . . 0.0 109.486 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.5 24.01 11.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.598 -0.689 . . . . 0.0 110.842 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.39 4.69 76.74 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.697 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.498 ' HB2' HD11 ' A' ' 46' ' ' ILE . 9.0 mm100 -108.59 137.37 46.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -1.199 . . . . 0.0 108.21 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.79 164.29 30.51 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.853 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 91' ' ' VAL . 44.4 mt -135.08 149.21 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -114.18 149.78 35.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.896 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 54.41 66.95 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.714 -0.616 . . . . 0.0 110.866 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.74 -1.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 109.179 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 8.5 pt-20 -71.1 -30.85 67.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.048 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 32.5 m170 -64.49 -59.44 4.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -56.87 -45.99 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.733 -1.229 . . . . 0.0 108.733 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 75' ' ' ILE . 42.2 mt -55.28 -41.07 71.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.7 t -56.96 -45.53 82.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.38 -53.41 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 108.723 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -50.86 -44.66 59.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 108.977 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.694 ' HD1' HG22 ' A' ' 232' ' ' ILE . 14.7 t-160 -55.65 -47.82 76.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.453 -0.779 . . . . 0.0 110.018 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -66.54 -37.68 85.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 114' ' ' ILE . 65.4 mt -81.23 -7.61 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.827 -178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 63.37 63.32 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.724 -1.235 . . . . 0.0 110.134 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 82' ' ' LEU . 8.8 mm -104.94 130.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 121' ' ' ILE . 23.6 p -117.43 -18.86 9.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.852 . . . . 0.0 111.731 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.729 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.3 m-80 -133.65 111.39 10.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.639 -1.288 . . . . 0.0 110.233 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.3 m -165.1 141.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 95.6 m -110.8 100.6 9.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.495 -0.753 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.7 104.42 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.401 -0.812 . . . . 0.0 109.682 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -82.31 119.44 24.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.865 -1.147 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.509 HG13 HD22 ' A' ' 26' ' ' LEU . 2.8 t -102.95 108.26 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 111.087 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.52 108.13 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.31 -160.02 23.28 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.4 -15.25 7.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.56 -0.965 . . . . 0.0 110.21 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.599 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -135.61 142.27 45.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.0 110.44 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -68.6 139.53 91.55 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.574 ' HD2' HD11 ' A' ' 26' ' ' LEU . 11.4 Cg_endo -57.76 130.16 37.18 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.843 1.695 . . . . 0.0 111.514 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -78.64 -30.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.52 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 8.0 mt 52.8 -109.78 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.032 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -95.02 -18.59 20.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.573 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.73 -10.22 32.43 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.7 p -113.88 -172.09 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.383 -1.069 . . . . 0.0 109.869 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.48 -3.26 20.84 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -46.71 -39.99 12.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.624 -0.927 . . . . 0.0 110.8 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -63.53 -51.73 64.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 109.95 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -61.9 -45.04 95.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.917 -1.114 . . . . 0.0 108.392 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.88 -39.46 89.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.332 0.587 . . . . 0.0 110.44 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.11 -45.16 64.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.845 . . . . 0.0 111.494 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.24 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.858 -1.151 . . . . 0.0 110.551 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.16 -42.84 88.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 110.233 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -54.29 -29.57 47.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 109.816 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -85.96 -11.53 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.435 HD22 HD21 ' A' ' 11' ' ' LEU . 1.9 m-20 -119.78 29.31 7.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.233 -0.917 . . . . 0.0 111.458 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.594 HD11 HD13 ' A' ' 82' ' ' LEU . 4.7 mt -84.4 148.02 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.379 -1.451 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 8' ' ' LYS . 13.0 tp -130.84 158.13 41.02 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -101.06 146.51 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.898 -1.127 . . . . 0.0 110.044 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.679 HE22 HD22 ' A' ' 86' ' ' ASN . 1.1 mt-30 -109.44 -169.06 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.669 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -120.09 66.98 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 110.575 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -169.37 151.04 4.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 109.259 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.42 134.11 33.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.03 -1.044 . . . . 0.0 110.295 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 85' ' ' THR . 62.6 mt -69.87 135.55 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 110.863 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -78.26 80.95 4.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -58.22 141.36 50.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.589 -0.694 . . . . 0.0 110.759 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -98.39 120.45 38.82 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 243' ' ' LYS . 48.7 t -122.36 138.18 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 0.0 109.823 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.25 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -114.49 -10.07 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -142.82 145.91 35.6 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.427 -0.796 . . . . 0.0 108.92 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.12 177.24 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.11 1.873 . . . . 0.0 112.805 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.96 HG22 ' HB3' ' A' ' 141' ' ' ALA . 14.7 tt -165.6 144.61 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.457 0.646 . . . . 0.0 109.624 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.3 mp -132.73 118.9 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 132' ' ' VAL . 34.4 m -117.53 113.29 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.429 ' OE2' ' N ' ' A' ' 134' ' ' ASP . 1.2 tm-20 -115.56 127.2 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.429 ' N ' ' OE2' ' A' ' 133' ' ' GLU . 1.8 t70 -174.74 158.11 2.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 59.09 19.5 7.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 110.206 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.86 2.66 86.72 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.416 ' HB2' HD22 ' A' ' 255' ' ' LEU . 7.8 mtt180 -104.01 173.7 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.8 tt -160.09 148.07 16.76 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.487 -1.383 . . . . 0.0 109.037 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.854 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.8 mt -146.19 141.48 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.639 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -130.35 139.13 50.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.96 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.48 145.59 47.11 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -142.19 138.57 16.83 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.14 147.7 63.74 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.471 1.447 . . . . 0.0 112.119 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.05 158.49 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.03 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -93.5 4.13 54.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.942 . . . . 0.0 109.899 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 147.34 46.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.08 -1.013 . . . . 0.0 109.784 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.9 tp -77.37 116.03 17.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.848 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -139.36 135.18 33.44 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 246' ' ' PHE . 13.8 t -137.33 127.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.977 . . . . 0.0 110.05 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.7 m -112.28 132.05 55.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.368 -0.833 . . . . 0.0 109.294 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.448 ' CB ' HG22 ' A' ' 228' ' ' VAL . 81.3 t80 -119.83 129.47 54.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 162' ' ' GLN . 6.4 tp10 -114.72 104.61 12.14 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.0 155.38 21.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.604 ' CD ' HH21 ' A' ' 250' ' ' ARG . 12.9 tt0 -134.11 88.04 2.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.423 -1.045 . . . . 0.0 109.24 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -90.82 148.72 22.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -92.44 -6.92 48.97 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.86 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.9 p30 -73.9 -168.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.748 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.2 p90 -56.02 -17.53 7.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 109.754 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 14.0 mt -65.98 -51.17 60.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.06 -113.48 3.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -125.46 140.51 52.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.518 -0.989 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.48 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 8.8 tt0 -157.02 148.91 22.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -130.79 152.44 50.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -135.46 123.92 23.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 108.891 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 165' ' ' THR . 9.9 t -99.53 122.21 42.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 110.097 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.3 t80 -99.85 135.99 40.45 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.382 -0.824 . . . . 0.0 108.897 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.484 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.6 t -133.36 150.28 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.79 . . . . 0.0 109.155 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -53.46 122.81 10.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.77 -12.68 17.84 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -121.38 33.01 5.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.168 -1.195 . . . . 0.0 108.726 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -62.82 -35.95 81.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.699 . . . . 0.0 110.886 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -15.7 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.045 . . . . 0.0 110.829 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.73 -3.56 58.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.985 -1.072 . . . . 0.0 110.939 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.9 pt -124.29 0.85 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.068 -1.02 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -29.87 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.601 -1.312 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.6 mt -87.01 1.95 51.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.782 -1.199 . . . . 0.0 110.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.38 120.0 23.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.777 -1.202 . . . . 0.0 109.013 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.07 153.37 19.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.066 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.41 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.0 t -55.7 154.99 6.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.52 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 47.5 p90 -135.68 167.09 21.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.022 -1.049 . . . . 0.0 109.671 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.52 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 2.7 m -153.69 160.65 42.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.172 -0.955 . . . . 0.0 109.685 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.421 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 78.5 m-85 -102.84 143.41 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.213 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.612 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.8 OUTLIER -60.46 -26.07 66.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.502 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 4.7 p90 -79.01 -25.25 43.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.694 -1.254 . . . . 0.0 110.632 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 11.8 pt-20 -98.88 -13.8 19.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.879 -1.138 . . . . 0.0 109.575 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.5 mt -58.51 -52.99 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.154 -0.966 . . . . 0.0 110.063 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.19 -48.56 64.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.882 -1.136 . . . . 0.0 109.097 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.34 -52.1 62.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.967 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 91.2 mt -57.96 -34.48 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.825 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.21 -25.71 51.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -74.96 -31.6 61.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.101 -1.0 . . . . 0.0 109.867 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.422 ' CG2' HD12 ' A' ' 194' ' ' LEU . 6.8 m -81.0 12.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.17 -0.956 . . . . 0.0 109.347 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.48 24.12 76.79 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.625 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 192' ' ' VAL . 19.2 mt -121.21 159.08 26.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.15 -1.206 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 74.18 22.22 78.01 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.22 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -63.38 -53.73 47.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.33 -1.688 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -69.9 -2.6 39.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.09 134.06 39.91 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.849 -1.383 . . . . 0.0 110.484 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 203' ' ' THR . 68.0 p -141.86 177.72 7.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.493 -1.004 . . . . 0.0 109.319 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 200' ' ' LEU . 95.5 mt -74.6 -39.3 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.91 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -66.25 -14.46 61.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.222 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -131.44 9.14 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.433 ' CB ' ' O ' ' A' ' 199' ' ' SER . 0.5 OUTLIER -147.96 113.8 5.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.42 116.06 15.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 108.934 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.9 t -106.8 127.1 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 109.857 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.4 mt -110.71 149.91 29.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.14 152.21 17.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 207' ' ' GLY . 35.6 tttm -41.07 -37.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -1.113 . . . . 0.0 110.03 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -141.88 11.56 2.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.935 -1.103 . . . . 0.0 110.084 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.4 pttp -142.59 151.43 41.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.019 . . . . 0.0 109.738 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.503 HG11 ' HA2' ' A' ' 216' ' ' GLY . 60.9 t -102.56 127.93 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -73.0 -53.16 11.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.07 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.52 139.68 74.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.996 -1.065 . . . . 0.0 109.658 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.68 -33.96 9.72 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.522 2.148 . . . . 0.0 112.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -76.24 -9.1 58.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.046 -1.034 . . . . 0.0 110.28 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.503 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 69.6 -164.22 51.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.82 140.38 47.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -1.088 . . . . 0.0 109.833 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -84.59 -14.59 48.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 109.169 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.636 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 66.0 m-85 -146.09 133.83 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.436 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 1.3 mt-10 -48.03 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 108.501 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -137.19 39.33 2.51 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.9 OUTLIER -62.76 -39.58 55.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 111.935 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.0 Cg_endo -74.17 -40.37 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.997 1.132 . . . . 0.0 112.651 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 228' ' ' VAL . 11.2 m -76.68 -24.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.716 -1.24 . . . . 0.0 108.463 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.636 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 36.4 mtt180 -67.4 -47.44 70.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.53 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 44.1 t60 -59.77 -40.67 88.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -46.13 90.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 109.07 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 224' ' ' VAL . 46.4 t -62.19 -42.23 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 108.756 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.464 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 59.9 t80 -55.36 -47.32 75.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.67 -0.644 . . . . 0.0 109.433 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.592 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 12.2 m-20 -72.05 -34.56 68.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.406 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.1 tp -56.27 -36.17 68.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.707 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.694 HG22 ' HD1' ' A' ' 80' ' ' HIS . 89.7 mt -72.47 -48.75 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.77 9.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.3 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.105 -1.232 . . . . 0.0 109.769 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.39 -22.84 40.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.852 -1.155 . . . . 0.0 109.187 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.403 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 43.0 t80 -70.74 -8.77 54.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 108.752 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 237' ' ' LEU . 17.2 mt -50.18 -28.18 7.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.589 HD12 HG22 ' A' ' 242' ' ' VAL . 84.9 mt -54.16 -15.82 1.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.2 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 13.53 83.08 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.0 p -158.73 146.05 13.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.211 -1.17 . . . . 0.0 109.309 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 65.0 Cg_exo -43.19 130.22 6.21 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.066 1.844 . . . . 0.0 111.78 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 238' ' ' LEU . 3.8 t -97.49 132.13 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.629 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 125' ' ' VAL . 2.7 mmtt -117.98 123.7 46.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.49 172.66 25.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -104.38 114.38 28.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -1.222 . . . . 0.0 109.696 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 149' ' ' VAL . 8.6 m-85 -112.68 148.65 34.22 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.14 0.971 . . . . 0.0 111.486 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -130.42 144.22 51.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.0 t -142.34 129.58 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.656 -1.278 . . . . 0.0 111.077 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -112.18 114.81 27.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.604 HH21 ' CD ' ' A' ' 154' ' ' GLU . 18.2 mtt180 50.42 53.87 12.15 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.82 136.85 20.61 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.408 ' HA3' ' NH1' ' A' ' 137' ' ' ARG . . . -111.59 155.48 16.14 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.505 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 62.7 m-70 -52.94 -47.18 68.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -1.215 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.5 t -58.23 -55.34 36.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.056 -1.027 . . . . 0.0 108.869 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' A' ' 139' ' ' ILE . 53.6 tp -53.91 -37.12 63.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -61.15 -54.35 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 108.973 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 19.5 t -50.97 -42.67 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -55.83 -49.7 72.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 139' ' ' ILE . 19.1 tp -52.14 -42.13 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 108.678 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.62 -46.24 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.283 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.13 -51.52 61.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.846 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -53.64 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 259' ' ' LEU . 90.3 mt -55.53 -42.18 74.21 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.41 90.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.523 -0.736 . . . . 0.0 109.719 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.024 . . . . 0.0 109.11 179.513 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 63.5 mt-10 . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.37 53.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 110.285 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -138.2 175.27 9.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 7' ' ' VAL . 10.4 m -86.51 141.35 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.354 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -73.87 -46.12 46.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.574 -0.704 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -126.88 153.76 45.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.41 -0.806 . . . . 0.0 110.43 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.08 138.76 58.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.62 167.71 12.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 p -156.76 149.34 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.995 -1.066 . . . . 0.0 110.338 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -135.01 155.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 135.48 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 108.759 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.79 156.16 13.0 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.122 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.29 163.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.29 -1.124 . . . . 0.0 111.029 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.64 136.98 13.35 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.646 HG23 ' N ' ' A' ' 19' ' ' HIS . 16.0 tt -56.21 -52.57 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.137 -1.214 . . . . 0.0 111.751 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.646 ' N ' HG23 ' A' ' 18' ' ' ILE . 24.8 m-70 -87.08 -38.56 16.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.172 -1.58 . . . . 0.0 110.66 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.6 m -73.9 -35.38 64.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.952 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.07 64.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -107.53 148.55 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.58 -0.953 . . . . 0.0 108.967 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 8.1 t80 -70.83 125.78 27.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.973 . . . . 0.0 109.759 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 t -135.12 156.41 49.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.118 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.515 ' O ' HD23 ' A' ' 26' ' ' LEU . 18.1 tttp -134.81 150.69 50.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 109.138 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.709 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.7 mt -127.52 148.45 50.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 0.0 109.622 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -132.04 131.84 61.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -115.83 126.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -120.56 155.06 57.06 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.585 -0.697 . . . . 0.0 109.286 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.53 160.67 48.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.347 2.031 . . . . 0.0 110.861 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 20.4 mm-40 -135.83 -174.83 3.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.104 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 35' ' ' THR . 11.0 tptt -86.03 153.3 22.23 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 109.287 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.619 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.3 mp0 -46.81 145.07 2.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.091 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.609 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.36 26.1 61.32 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.826 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 39.6 m -78.7 -36.94 42.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.562 -1.552 . . . . 0.0 109.134 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.783 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 94.05 -175.56 35.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.7 mm -99.52 121.9 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.297 -1.119 . . . . 0.0 108.277 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -136.33 143.9 44.36 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.975 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.89 151.13 22.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -130.26 142.66 50.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -174.59 138.22 0.51 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -178.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.403 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER 57.12 31.59 20.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.616 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.51 74.33 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.624 -1.298 . . . . 0.0 110.034 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.13 139.41 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 109.529 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 m-85 -102.18 138.06 39.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.57 97.94 18.71 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.418 -0.801 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.74 142.75 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.22 1.947 . . . . 0.0 111.718 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.02 82.48 6.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.984 -1.073 . . . . 0.0 110.172 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -139.45 156.03 47.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.583 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 3.2 p80 -53.45 -49.5 67.28 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.566 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 19.5 mt-10 -44.06 -16.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.072 -1.018 . . . . 0.0 109.995 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 50' ' ' HIS . 96.6 m-85 -98.56 4.21 48.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.058 -1.026 . . . . 0.0 109.994 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 t -60.73 121.02 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 108.477 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.96 -25.36 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.303 -0.873 . . . . 0.0 110.408 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -151.13 118.54 6.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -112.29 131.13 55.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.5 t-20 -166.36 -154.28 0.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 1.6 m-70 -47.96 -12.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 108.372 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -136.84 166.0 24.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.587 -0.696 . . . . 0.0 109.238 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.0 m -108.84 125.1 51.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.335 -0.853 . . . . 0.0 109.132 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.87 143.72 50.18 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.993 0.901 . . . . 0.0 111.25 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.3 mt -124.29 160.52 27.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.85 147.93 7.66 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.343 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -145.01 151.68 38.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.751 -0.852 . . . . 0.0 109.488 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt 57.12 25.36 10.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.289 -0.882 . . . . 0.0 111.196 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.49 1.95 77.18 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.631 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.471 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.2 mm100 -102.41 142.81 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.993 -1.298 . . . . 0.0 107.999 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -145.83 157.23 43.93 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.842 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 69' ' ' ILE . 3.8 mt -133.27 144.5 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 9.1 mttm -110.71 155.03 23.03 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.295 -0.878 . . . . 0.0 111.317 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 47.38 72.86 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.765 -0.584 . . . . 0.0 111.169 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 m -113.02 -11.59 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 109.566 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -63.68 -18.53 64.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 110.604 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.595 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 25.6 m170 -71.85 -60.65 2.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.892 -1.13 . . . . 0.0 109.413 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 4.0 tp -60.41 -44.05 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 109.138 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.519 ' N ' HG23 ' A' ' 75' ' ' ILE . 12.0 mt -56.2 -38.22 70.7 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.551 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 27.3 t -60.68 -48.58 81.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.614 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.5 t -57.64 -52.99 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.972 -1.08 . . . . 0.0 108.688 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -50.68 -43.79 57.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.49 ' HD1' HG22 ' A' ' 232' ' ' ILE . 7.9 t-160 -55.1 -51.33 66.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 110.223 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.8 mt -68.36 -37.27 80.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.329 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.593 HD22 HD11 ' A' ' 114' ' ' ILE . 14.8 mt -76.08 -5.58 47.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.061 -1.024 . . . . 0.0 110.131 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.79 50.99 3.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 110.43 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 82' ' ' LEU . 14.6 mm -97.59 122.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 108.501 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.624 HG21 HG23 ' A' ' 121' ' ' ILE . 71.7 p -110.78 -22.01 11.78 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.783 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 9.9 m120 -129.91 112.17 13.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.709 -1.244 . . . . 0.0 110.516 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.6 m -164.75 141.78 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 8.1 m -110.23 100.69 9.53 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mp -87.69 108.87 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.889 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -88.18 116.48 26.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG13 HD22 ' A' ' 26' ' ' LEU . 61.9 t -106.28 117.63 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 110.856 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.09 112.36 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.93 -162.05 24.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.48 -17.64 8.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.227 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 1.5 tp10 -132.64 141.0 48.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.829 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.2 mm -67.37 125.71 91.5 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.609 -0.682 . . . . 0.0 109.34 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.709 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.4 Cg_exo -45.86 131.28 13.39 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.921 1.747 . . . . 0.0 111.887 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.1 tp -76.46 -29.62 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 110.431 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.7 mt 54.89 -113.73 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.61 -15.86 23.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 110.32 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.75 -12.97 46.35 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 p -112.3 -169.18 1.42 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.012 . . . . 0.0 109.493 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.6 -3.09 25.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -47.44 -41.91 21.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.833 -0.804 . . . . 0.0 110.409 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.96 -52.37 63.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.068 . . . . 0.0 110.233 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 87.4 m-85 -61.81 -44.29 97.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.765 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -62.06 -38.91 90.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.311 0.576 . . . . 0.0 109.941 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.15 -44.94 51.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.287 -0.883 . . . . 0.0 111.828 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.25 -47.61 23.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 110.998 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.03 -40.16 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttt85 -57.38 -30.03 64.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 109.877 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 112' ' ' LYS . 24.0 tttm -80.65 -8.21 59.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 109.623 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -123.74 35.03 4.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.987 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.593 HD11 HD22 ' A' ' 82' ' ' LEU . 17.8 mt -90.79 147.03 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.8 -1.187 . . . . 0.0 110.643 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 115' ' ' LEU . 14.2 tp -131.26 159.61 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -109.79 146.43 35.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.552 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -108.93 -162.65 0.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.528 -0.733 . . . . 0.0 109.26 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 -1.22 11.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 4' ' ' GLU . 11.5 ttt180 -85.37 138.71 32.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.86 -1.15 . . . . 0.0 109.725 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.1 128.03 33.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.272 -0.892 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.624 HG23 HG21 ' A' ' 85' ' ' THR . 0.8 OUTLIER -70.92 139.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 111.124 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -94.38 98.48 10.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.74 147.05 51.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -97.33 121.46 39.25 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.02 139.36 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.17 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -113.12 -10.78 13.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.242 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -143.66 146.05 33.63 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.097 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.2 172.74 14.21 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.087 1.858 . . . . 0.0 113.135 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.589 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.3 tt -164.27 140.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.09 126.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.28 114.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.282 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -174.35 150.88 1.51 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.084 -1.01 . . . . 0.0 110.996 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 55.65 24.92 7.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.726 -0.609 . . . . 0.0 111.077 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.98 86.32 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HB2' HD22 ' A' ' 255' ' ' LEU . 2.4 mtt180 -106.92 169.02 8.8 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.987 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.8 tt -159.73 150.41 19.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.193 -1.567 . . . . 0.0 108.873 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.987 ' N ' HD23 ' A' ' 138' ' ' LEU . 7.2 mt -145.83 139.56 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -129.6 139.62 51.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.589 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -121.54 140.36 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -136.47 137.41 24.04 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.9 150.1 48.1 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.56 1.507 . . . . 0.0 112.032 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.94 158.57 8.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -86.97 -1.44 57.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.726 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.4 p -136.46 155.19 50.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 109.405 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.497 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 32.6 tp -87.48 117.15 26.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 110.116 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -134.29 140.35 46.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.606 ' CG1' HD23 ' A' ' 231' ' ' LEU . 94.6 t -139.19 126.96 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.976 -1.077 . . . . 0.0 109.908 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.3 m -115.16 137.8 51.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.447 -0.783 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.483 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.5 t80 -125.97 129.56 49.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.727 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.31 106.18 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.4 141.15 15.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -118.94 86.69 2.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.532 -0.981 . . . . 0.0 109.17 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -91.77 143.01 26.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.732 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -92.14 -1.67 57.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.843 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 22.1 p-10 -73.12 -167.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -61.56 -24.89 66.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.92 . . . . 0.0 109.784 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.544 HD22 ' NE2' ' A' ' 162' ' ' GLN . 7.7 mt -63.21 -46.23 87.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.61 -132.72 11.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -98.87 139.6 34.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -1.106 . . . . 0.0 109.289 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.544 ' NE2' HD22 ' A' ' 159' ' ' LEU . 9.1 mt-30 -146.02 142.64 28.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.518 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -137.29 148.41 46.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.39 127.9 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.089 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 165' ' ' THR . 10.9 t -99.87 122.03 42.21 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.013 -1.054 . . . . 0.0 109.718 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.29 136.65 34.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 108.881 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.52 153.25 34.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.645 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.661 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 4.7 mp0 -57.13 113.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.288 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.555 ' N ' ' OE2' ' A' ' 171' ' ' GLU . . . 115.89 11.29 10.26 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -137.11 28.4 2.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.183 -1.187 . . . . 0.0 108.761 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.675 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 16.9 mp0 -62.15 -36.93 83.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 110.632 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 15.6 mp0 -52.45 -15.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.82 -1.175 . . . . 0.0 110.241 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 49.1 mt-10 -91.07 -4.19 56.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 110.927 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.595 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.4 pt -121.72 6.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.14 -34.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.96 1.02 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.779 -1.201 . . . . 0.0 110.745 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.36 123.81 28.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.195 . . . . 0.0 108.962 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 154.38 17.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -51.36 158.12 0.89 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -146.24 168.7 20.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.05 -1.031 . . . . 0.0 110.089 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.08 159.0 15.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 109.595 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.521 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 60.8 m-85 -103.42 146.5 28.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.296 -0.878 . . . . 0.0 109.316 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.678 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.8 p30 -51.97 -51.08 59.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.794 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.664 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.2 p90 -51.83 -36.84 49.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.926 -1.109 . . . . 0.0 111.481 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.664 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 14.6 pt-20 -89.48 -17.33 28.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.636 -1.29 . . . . 0.0 109.924 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.3 mt -59.43 -52.24 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.187 -0.946 . . . . 0.0 110.127 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -50.85 -51.16 53.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.663 -1.273 . . . . 0.0 109.5 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -52.42 -44.87 65.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 108.751 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 186' ' ' ILE . 71.2 mt -59.99 -34.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -77.65 -27.14 50.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.726 . . . . 0.0 110.216 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.45 -24.07 46.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.005 -1.059 . . . . 0.0 110.217 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.4 m -85.68 11.19 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.548 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.87 24.82 68.52 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 120.077 -1.059 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 39.2 mt -123.53 163.28 21.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 109.921 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.15 23.96 60.32 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -69.09 -22.68 63.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.788 -1.419 . . . . 0.0 109.88 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.54 -0.56 53.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.35 130.0 50.33 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.305 -1.114 . . . . 0.0 110.685 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.2 p -140.01 -173.64 3.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.735 -0.862 . . . . 0.0 108.728 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.46 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -99.48 -4.3 31.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.89 -11.69 1.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.119 -0.988 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.4 m -126.0 116.96 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.9 tp -74.04 110.42 8.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.522 HG13 HD11 ' A' ' 186' ' ' ILE . 58.1 t -100.08 126.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.926 -1.109 . . . . 0.0 109.47 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.1 mt -110.15 148.81 31.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.829 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.25 159.25 15.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -23.45 1.61 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.257 -1.143 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -153.66 12.69 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 0.0 110.724 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -144.11 151.66 39.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.864 -1.148 . . . . 0.0 110.637 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.57 124.86 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -71.95 -54.78 8.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.019 -1.05 . . . . 0.0 110.34 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -55.89 132.88 73.33 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.056 . . . . 0.0 109.428 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.51 -11.19 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.418 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -84.47 -6.64 59.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.09 -162.96 54.56 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -89.45 149.76 22.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.964 . . . . 0.0 110.317 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.6 mtt-85 -94.26 -23.76 17.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -0.798 . . . . 0.0 108.929 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.526 ' C ' ' H ' ' A' ' 221' ' ' ASN . 28.3 m-85 -144.57 133.93 23.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 108.993 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.22 -9.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 108.614 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -135.01 35.66 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.844 0.83 . . . . 0.0 108.878 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.492 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.66 -49.54 88.35 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 111.804 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 20.5 Cg_endo -67.58 -34.56 25.23 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.571 1.514 . . . . 0.0 113.06 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 228' ' ' VAL . 24.2 m -79.84 -28.22 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.51 -1.369 . . . . 0.0 107.706 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 10.1 mmm-85 -65.1 -46.84 79.41 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.582 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 36.6 t60 -61.35 -42.13 98.19 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 151' ' ' TYR . 0.6 OUTLIER -59.52 -50.84 72.34 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.05 -1.031 . . . . 0.0 108.69 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 224' ' ' VAL . 18.2 t -55.94 -43.95 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 79.4 t80 -57.71 -40.04 78.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.582 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.5 m-20 -74.68 -33.93 62.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.595 -0.69 . . . . 0.0 109.487 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.606 HD23 ' CG1' ' A' ' 149' ' ' VAL . 24.0 tp -59.01 -35.85 73.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 108.688 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' HIS . 75.7 mt -72.15 -47.77 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -33.27 24.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -82.14 -27.25 32.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.258 . . . . 0.0 109.582 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 mt -83.14 -23.84 32.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.881 -1.137 . . . . 0.0 109.308 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.502 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 38.1 t80 -67.51 -10.71 54.17 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 108.956 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 85.7 mt -50.45 -27.97 7.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 109.101 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 242' ' ' VAL . 71.3 mt -58.81 -17.68 25.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.177 -0.952 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 79.41 15.89 79.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.0 p -158.35 144.65 12.68 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.992 -1.299 . . . . 0.0 109.787 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 57.2 Cg_exo -42.1 128.99 4.34 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.197 1.931 . . . . 0.0 111.839 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.561 HG22 HD12 ' A' ' 238' ' ' LEU . 57.5 t -95.88 130.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.66 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -117.67 123.72 46.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.823 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 174.1 27.91 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.62 113.33 26.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -1.183 . . . . 0.0 109.829 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.86 147.17 37.55 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.928 0.871 . . . . 0.0 111.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -129.67 143.27 50.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 128.11 19.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.646 -1.284 . . . . 0.0 110.687 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.2 t80 -112.31 116.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 249' ' ' PHE . 13.9 mmm180 46.04 55.78 6.77 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.1 152.44 22.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.0 -175.84 18.6 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.417 ' O ' HG23 ' A' ' 257' ' ' VAL . 72.7 m-70 -70.96 -52.22 21.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -1.215 . . . . 0.0 109.576 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 2.2 p -56.14 -54.41 45.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.162 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 137' ' ' ARG . 34.1 tp -51.06 -42.37 60.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.229 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.16 -50.96 71.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 108.908 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 253' ' ' HIS . 59.5 t -53.9 -40.8 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.865 . . . . 0.0 109.423 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -55.3 -48.15 74.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 108.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 13.4 tp -52.78 -45.25 67.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.6 t -65.83 -45.56 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -52.14 58.72 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 110.155 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -64.39 -46.49 83.12 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.062 -1.023 . . . . 0.0 109.707 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 263' ' ' LEU . 20.4 mt -59.07 -46.38 88.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.31 -34.4 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm . . . . . 0 N--CA 1.488 1.463 0 O-C-N 120.66 -1.275 . . . . 0.0 109.145 179.508 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 85.8 mt-10 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.306 0.574 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.28 139.36 53.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.9 t -137.47 176.59 8.57 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.45 143.43 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.854 -1.154 . . . . 0.0 110.443 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HG3' HD13 ' A' ' 115' ' ' LEU . 2.4 ttmm -76.22 -46.52 27.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.636 -0.665 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.93 153.69 43.89 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.521 0.676 . . . . 0.0 110.111 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.94 137.91 58.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.483 -0.76 . . . . 0.0 109.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.47 165.1 15.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.579 -0.701 . . . . 0.0 109.176 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -155.59 147.81 23.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 0.0 110.102 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -130.9 162.42 29.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.571 -0.706 . . . . 0.0 109.207 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.96 136.52 16.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.874 -1.141 . . . . 0.0 109.063 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.1 161.4 19.34 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.053 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.3 p -74.6 160.67 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 111.447 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.552 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -93.58 142.38 15.97 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -62.73 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.254 . . . . 0.0 112.36 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.443 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.8 m-70 -86.7 -38.4 17.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 119.821 -1.799 . . . . 0.0 111.654 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.436 ' OG1' ' CB ' ' A' ' 95' ' ' GLU . 2.1 p -78.13 -33.32 50.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.042 -1.036 . . . . 0.0 110.099 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.15 72.02 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -116.13 154.06 30.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.956 . . . . 0.0 108.654 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -73.16 138.12 45.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.993 -1.067 . . . . 0.0 110.075 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -143.76 157.88 44.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 0.0 108.847 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 8.1 ttpp -135.57 148.75 49.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 109.329 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.663 ' CD2' HG13 ' A' ' 91' ' ' VAL . 12.9 mt -124.98 146.34 49.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.96 130.93 61.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mt -117.02 119.02 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 109.637 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -116.92 148.64 42.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.34 161.51 23.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.231 1.954 . . . . 0.0 111.45 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -135.96 -174.08 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.9 tttp -85.61 151.66 23.73 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -49.5 150.34 1.97 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.618 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.27 23.61 57.89 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.03 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 17.0 m -80.2 -42.64 22.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.791 -1.417 . . . . 0.0 108.913 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.75 -176.81 30.06 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 mm -97.33 122.57 49.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.374 -1.074 . . . . 0.0 108.122 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -138.45 140.69 39.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.046 -1.034 . . . . 0.0 110.4 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -100.05 152.92 19.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.1 t80 -124.93 147.41 48.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -173.78 131.26 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 109.382 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.84 29.58 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.758 -1.211 . . . . 0.0 110.198 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.02 138.55 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -1.171 . . . . 0.0 109.703 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -98.86 137.03 38.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.05 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 67' ' ' GLN . 58.3 mt -129.24 97.11 26.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 110.179 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.59 142.3 24.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.156 1.904 . . . . 0.0 111.837 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.64 82.36 5.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.512 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -140.63 156.99 46.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.553 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 6.3 p80 -53.53 -49.87 66.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.168 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -47.0 -15.79 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.022 . . . . 0.0 109.947 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 50' ' ' HIS . 76.6 m-85 -97.53 4.22 50.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.007 -1.058 . . . . 0.0 109.495 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 50' ' ' HIS . 33.9 t -59.02 130.46 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.87 -32.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -153.55 122.06 6.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 109.979 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.6 p -112.33 131.93 55.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 7.0 t-20 -166.87 -153.94 0.16 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 57' ' ' ASN . 23.3 m-70 -46.92 -13.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.008 -1.058 . . . . 0.0 108.452 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -137.3 166.06 24.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.485 -0.759 . . . . 0.0 109.371 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.408 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 12.3 m -105.79 123.67 48.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.377 -0.827 . . . . 0.0 108.945 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -122.19 142.43 50.43 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.995 0.902 . . . . 0.0 111.426 -178.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 53' ' ' VAL . 72.5 mt -122.56 164.68 17.72 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.54 145.31 5.58 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.4 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -145.18 151.52 38.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.822 -0.811 . . . . 0.0 109.484 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm 57.44 25.59 11.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 111.002 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.03 2.2 78.26 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.594 ' HB2' HD11 ' A' ' 46' ' ' ILE . 8.6 mm100 -100.65 142.24 32.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.235 . . . . 0.0 108.028 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -143.55 154.05 43.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.796 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mt -133.87 144.07 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 47.8 mttp -114.9 155.01 27.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.364 -0.835 . . . . 0.0 111.256 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 m 50.89 63.86 2.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.79 -0.569 . . . . 0.0 111.152 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 96' ' ' ILE . 28.9 m -112.51 1.05 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.094 -1.004 . . . . 0.0 109.092 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' OE1' ' OD2' ' A' ' 230' ' ' ASP . 0.3 OUTLIER -72.22 -31.09 65.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.944 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -61.49 -60.45 3.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.832 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.576 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.8 tp -59.64 -46.13 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 0.0 109.179 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.576 ' N ' HG23 ' A' ' 75' ' ' ILE . 61.9 mt -53.79 -41.62 67.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.557 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 2.8 t -58.43 -46.31 86.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.976 . . . . 0.0 109.47 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.95 -54.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 34.0 mt -51.89 -43.7 63.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 108.923 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.563 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 19.1 t-160 -54.6 -47.72 73.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.63 -37.13 82.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 114' ' ' ILE . 58.6 mt -77.81 -7.53 56.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.431 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.03 60.48 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 82' ' ' LEU . 5.8 mm -104.29 131.03 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 108.65 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.582 HG21 HG12 ' A' ' 121' ' ' ILE . 40.7 p -119.71 -19.12 8.15 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.364 -0.835 . . . . 0.0 111.422 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.2 m-80 -126.98 111.02 13.6 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.891 -1.131 . . . . 0.0 109.637 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -164.57 142.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.132 -0.98 . . . . 0.0 109.949 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.5 m -113.84 99.43 7.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.33 106.35 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.829 . . . . 0.0 109.777 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.66 118.78 25.38 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.663 HG13 ' CD2' ' A' ' 26' ' ' LEU . 43.3 t -105.0 105.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.931 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.91 111.33 19.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.17 -179.18 16.23 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.32 -16.83 14.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -1.186 . . . . 0.0 110.66 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -123.77 133.48 53.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 110.41 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.57 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 mm -68.12 126.32 92.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.486 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HD2' HD11 ' A' ' 26' ' ' LEU . 77.9 Cg_exo -46.28 128.48 12.18 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.865 1.71 . . . . 0.0 112.159 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.5 tp -76.43 -25.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.444 -0.785 . . . . 0.0 110.093 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.9 mt 53.66 -113.91 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD2' ' NE ' ' A' ' 178' ' ' ARG . 18.8 t70 -94.37 -21.46 18.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 0.0 110.012 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.5 -7.71 28.29 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.582 ' OG ' ' NE ' ' A' ' 178' ' ' ARG . 5.4 p -116.69 -167.75 1.34 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -1.066 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.5 -5.37 20.98 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.495 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 67.1 t-105 -46.75 -42.0 16.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.681 -0.894 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.59 -52.25 64.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.046 . . . . 0.0 110.015 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 75.3 m-85 -62.42 -44.35 96.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.018 . . . . 0.0 108.557 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -63.49 -37.53 87.64 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.3 mm-40 -71.42 -50.25 33.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -0.824 . . . . 0.0 112.076 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.0 -51.53 13.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.713 -1.242 . . . . 0.0 110.669 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.76 -42.52 85.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.031 -1.043 . . . . 0.0 110.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -54.11 -29.36 44.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -84.79 -11.7 55.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -119.8 31.6 6.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.835 HD11 HD13 ' A' ' 82' ' ' LEU . 4.9 mt -88.83 148.29 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.362 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.62 HD13 ' HG3' ' A' ' 8' ' ' LYS . 15.0 tp -130.34 158.47 39.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -109.35 137.53 47.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -161.45 0.87 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.83 . . . . 0.0 109.047 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -121.77 0.63 9.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.86 . . . . 0.0 110.7 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 4' ' ' GLU . 5.6 ttt85 -89.04 144.18 26.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.926 -1.108 . . . . 0.0 109.925 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 132.14 34.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.492 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 85' ' ' THR . 96.6 mt -74.31 140.6 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.499 -0.75 . . . . 0.0 111.184 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -83.95 84.08 7.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -57.88 144.84 37.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.713 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -105.37 125.02 50.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 243' ' ' LYS . 46.1 t -128.53 142.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.2 t -81.19 134.8 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 108.864 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.52 -11.35 11.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.084 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.76 141.76 23.36 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.337 -0.852 . . . . 0.0 109.171 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.69 169.87 20.89 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.135 1.89 . . . . 0.0 113.377 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.531 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 3.1 tt -165.4 141.52 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.81 -0.556 . . . . 0.0 109.708 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.435 HG23 HD21 ' A' ' 138' ' ' LEU . 5.7 mt -127.6 124.9 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.402 -0.811 . . . . 0.0 109.83 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 132' ' ' VAL . 31.5 m -120.03 120.79 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.443 -0.786 . . . . 0.0 109.438 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -104.33 147.27 27.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.349 -0.844 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 255' ' ' LEU . 4.1 t70 -157.01 112.45 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.816 -1.178 . . . . 0.0 111.882 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 41.1 52.25 3.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.709 -0.619 . . . . 0.0 112.458 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.26 3.69 89.99 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.588 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -105.38 163.08 12.9 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.972 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.23 149.64 17.64 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.037 -1.664 . . . . 0.0 109.241 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.972 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.0 mt -146.85 133.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -124.88 139.72 53.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -143.57 139.29 16.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 146.47 70.47 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.653 1.568 . . . . 0.0 112.456 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.46 153.17 9.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 0.54 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -136.29 146.34 46.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.49 117.68 19.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.548 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 tt0 -139.52 133.89 31.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.83 . . . . 0.0 108.808 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.633 ' CG1' HD23 ' A' ' 231' ' ' LEU . 22.9 t -132.75 125.6 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.688 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.9 m -112.77 132.3 55.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -121.58 130.15 53.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.74 . . . . 0.0 109.986 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -114.1 103.23 10.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.07 125.42 8.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.28 84.39 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.42 -1.047 . . . . 0.0 108.865 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.19 148.22 25.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.541 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -95.83 1.31 53.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.209 -0.932 . . . . 0.0 109.782 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.648 HD21 HD12 ' A' ' 159' ' ' LEU . 15.0 p-10 -76.24 -167.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.368 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -61.23 -25.21 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.79 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.648 HD12 HD21 ' A' ' 157' ' ' ASN . 11.3 mt -59.57 -51.13 71.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.35 -128.07 9.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.553 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 12.2 mtm180 -104.05 137.28 42.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.392 -1.064 . . . . 0.0 109.23 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 8.3 mp0 -140.73 138.41 34.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.199 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.65 144.27 49.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.808 . . . . 0.0 109.472 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.656 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 52.3 t80 -138.6 128.48 25.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 61.0 m -103.14 123.1 46.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -101.77 137.64 39.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.832 . . . . 0.0 109.395 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.551 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.2 t -134.47 158.32 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.483 -0.76 . . . . 0.0 109.363 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 167' ' ' VAL . 80.1 mt-10 -58.45 117.47 4.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.805 . . . . 0.0 109.45 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.39 4.06 20.38 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -134.38 29.8 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.137 -1.213 . . . . 0.0 108.835 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.538 ' O ' HG22 ' A' ' 175' ' ' VAL . 84.1 mt-10 -63.87 -32.83 74.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 110.747 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.91 -17.46 6.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.069 -1.02 . . . . 0.0 110.832 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.2 -3.8 58.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.851 -1.155 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -125.55 -12.45 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.119 -0.988 . . . . 0.0 111.434 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -84.42 -29.48 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.305 -1.497 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.62 1.96 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.709 -1.244 . . . . 0.0 110.743 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.66 121.65 24.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 108.794 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.582 ' NE ' ' OG ' ' A' ' 102' ' ' SER . 4.4 mpt_? -88.22 149.15 24.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.83 -1.169 . . . . 0.0 109.832 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.8 t -54.14 166.3 0.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.336 -0.853 . . . . 0.0 109.057 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.74 177.4 9.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.768 -1.207 . . . . 0.0 109.963 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.53 164.22 10.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.586 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.618 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 90.9 m-85 -104.3 145.22 30.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.565 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.682 ' HA ' HD12 ' A' ' 186' ' ' ILE . 18.1 p-10 -63.81 -18.24 63.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.881 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.618 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 4.5 p90 -81.1 -27.42 35.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.667 -1.271 . . . . 0.0 110.452 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 19.6 pt-20 -98.28 -15.17 19.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.888 -1.133 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.1 mt -56.47 -51.51 63.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.255 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 187' ' ' GLU . 2.9 mp0 -51.15 -52.73 41.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.549 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -52.5 -44.86 65.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.0 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.94 -33.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.373 -0.829 . . . . 0.0 109.097 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -79.83 -25.37 40.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -82.25 -25.12 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.057 -1.027 . . . . 0.0 110.219 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.1 m -80.7 8.02 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 82.16 23.24 57.53 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.13 -1.034 . . . . 0.0 110.578 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 47.5 mt -125.6 164.5 20.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.16 -1.2 . . . . 0.0 109.922 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.443 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 76.42 19.59 78.0 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.216 -0.927 . . . . 0.0 111.552 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -68.71 -20.24 64.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.598 -1.531 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.03 -5.26 50.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.77 125.16 34.47 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.072 -1.252 . . . . 0.0 110.321 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -173.73 3.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.834 -0.804 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 200' ' ' LEU . 73.6 mt -91.56 -13.34 32.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.533 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 40.0 tttp -92.47 -1.4 57.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 201' ' ' LYS . 0.6 OUTLIER -142.48 11.92 1.91 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.27 114.54 6.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.826 HD21 HD23 ' A' ' 217' ' ' LEU . 17.0 tp -77.54 106.71 9.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -0.957 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.518 HG22 HD11 ' A' ' 186' ' ' ILE . 51.1 t -99.94 130.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.001 -1.062 . . . . 0.0 109.498 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD21 HD21 ' A' ' 217' ' ' LEU . 90.7 mt -111.58 149.67 31.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.855 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.4 150.6 16.87 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 207' ' ' GLY . 5.2 tttm -42.98 -27.23 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -1.171 . . . . 0.0 110.091 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 207' ' ' GLY . 3.3 p-10 -148.65 8.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.969 -1.082 . . . . 0.0 110.376 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -141.56 149.15 40.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.017 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.79 125.74 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -72.5 -54.63 8.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 110.47 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -55.85 131.64 72.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 109.804 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.38 -12.28 27.27 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.203 1.935 . . . . 0.0 112.184 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -88.09 -7.77 56.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.66 48.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.826 HD23 HD21 ' A' ' 204' ' ' LEU . 36.2 mt -85.64 138.95 31.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.545 -0.973 . . . . 0.0 109.85 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.516 ' CZ ' HH12 ' A' ' 178' ' ' ARG . 0.5 OUTLIER -64.83 -54.71 26.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 221' ' ' ASN . 18.2 m-85 -118.45 146.66 44.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -50.35 -12.5 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.614 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 219' ' ' TYR . 4.3 m-20 -135.89 27.86 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 109.454 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.1 OUTLIER -56.05 -42.65 97.24 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -179.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 22.8 Cg_exo -61.58 -45.44 17.74 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.229 1.953 . . . . 0.0 112.924 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.452 ' H ' HG22 ' A' ' 224' ' ' VAL . 7.4 m -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 120.717 -1.24 . . . . 0.0 108.381 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 11.2 mtt85 -66.79 -40.79 88.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.56 -42.25 95.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 tptp -56.8 -45.62 82.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.01 . . . . 0.0 108.671 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.557 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 77.4 t80 -54.98 -41.95 71.83 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -71.38 -38.12 71.54 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.729 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.633 HD23 ' CG1' ' A' ' 149' ' ' VAL . 27.3 tp -56.72 -35.62 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.352 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.563 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 35.5 mt -72.67 -48.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.25 -32.73 14.19 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.91 -29.5 29.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.228 -1.16 . . . . 0.0 110.143 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.53 HD23 HG22 ' A' ' 260' ' ' VAL . 4.7 mt -78.58 -23.29 46.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.761 -1.212 . . . . 0.0 109.889 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.481 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 22.3 t80 -67.92 -7.27 27.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.138 -0.976 . . . . 0.0 108.815 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 237' ' ' LEU . 20.6 mt -50.06 -32.99 16.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.446 -0.784 . . . . 0.0 108.895 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.45 -12.49 1.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.061 -1.024 . . . . 0.0 109.085 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 73.75 17.13 79.14 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.7 p -157.17 144.94 13.99 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.963 -1.316 . . . . 0.0 109.677 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.66 133.27 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.199 1.932 . . . . 0.0 111.82 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.07 134.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.701 ' HB2' HG22 ' A' ' 125' ' ' VAL . 19.3 mmtp -121.24 125.23 46.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 109.448 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.75 167.54 18.88 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 148' ' ' GLU . 10.2 tttp -98.67 112.91 24.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.112 -1.228 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -112.18 148.45 34.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.015 0.912 . . . . 0.0 111.1 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -129.18 143.67 50.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 p -138.34 124.52 20.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.8 -1.188 . . . . 0.0 109.848 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 250' ' ' ARG . 1.5 t80 -112.96 112.1 23.32 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.7 OUTLIER 45.28 56.48 5.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -92.37 156.17 23.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.93 177.75 17.2 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.417 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 79.8 m-70 -66.01 -51.95 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.28 . . . . 0.0 109.552 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 49.1 p -54.53 -54.64 38.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.0 . . . . 0.0 109.117 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 134' ' ' ASP . 35.8 tp -51.33 -41.83 60.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.54 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -58.71 -55.04 40.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.021 . . . . 0.0 108.816 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.4 t -48.55 -41.25 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -54.93 -47.85 73.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 26.6 tp -52.81 -44.37 66.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.53 HG22 HD23 ' A' ' 235' ' ' LEU . 41.0 t -70.8 -41.66 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -58.9 -48.18 82.36 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 110.411 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.1 -35.19 76.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.053 -1.029 . . . . 0.0 109.57 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 263' ' ' LEU . 15.0 mt -69.66 -45.61 67.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.11 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.36 -32.79 74.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.715 -0.615 . . . . 0.0 110.27 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt . . . . . 0 N--CA 1.489 1.485 0 O-C-N 120.734 -1.229 . . . . 0.0 108.854 179.251 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.641 ' OE1' HG21 ' A' ' 85' ' ' THR . 8.0 mm-40 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.35 135.46 53.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.519 -0.738 . . . . 0.0 109.889 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -137.26 171.42 14.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.7 m -81.94 130.21 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.94 -1.1 . . . . 0.0 109.964 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -59.29 -45.83 90.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.092 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -129.79 157.76 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.198 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 135.45 56.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 109.858 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 113' ' ' ASN . 80.0 mt -116.91 169.97 8.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.438 -0.789 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -154.04 147.08 24.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.062 . . . . 0.0 110.194 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -132.47 157.81 43.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.403 -0.811 . . . . 0.0 109.448 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.6 pm0 -151.78 136.82 17.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.37 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.2 161.85 20.31 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 17' ' ' GLY . 7.1 p -72.46 163.94 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.283 -1.128 . . . . 0.0 111.347 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.594 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -98.76 142.21 15.96 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.623 HG23 ' N ' ' A' ' 19' ' ' HIS . 15.7 tt -58.97 -52.11 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -1.169 . . . . 0.0 112.5 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.623 ' N ' HG23 ' A' ' 18' ' ' ILE . 7.2 m-70 -86.82 -38.73 16.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.245 -1.535 . . . . 0.0 111.702 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.542 HG22 ' HG3' ' A' ' 22' ' ' GLU . 2.5 m -73.97 -33.62 63.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 110.002 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.03 25.83 69.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.542 ' HG3' HG22 ' A' ' 20' ' ' THR . 2.7 mt-10 -117.72 154.34 31.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.534 -0.98 . . . . 0.0 108.596 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -73.72 137.1 43.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 0.0 110.195 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 t -142.35 156.22 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.731 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.8 tttt -132.26 156.57 46.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.0 mt -133.9 143.13 48.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.046 -1.033 . . . . 0.0 109.097 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.622 HG22 ' NE2' ' A' ' 29' ' ' HIS . 22.7 mt -130.8 128.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mt -116.01 129.89 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.069 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.622 ' NE2' HG22 ' A' ' 27' ' ' ILE . 1.5 m-70 -125.0 148.5 60.28 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.65 159.47 28.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.238 1.959 . . . . 0.0 111.618 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.486 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.4 mm-40 -132.39 -174.13 3.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' OG1' ' A' ' 35' ' ' THR . 69.0 tttt -90.87 155.5 18.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.587 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -50.61 149.23 3.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 110.236 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.7 61.34 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.689 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 87.1 m -81.49 -46.39 14.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.382 -1.658 . . . . 0.0 108.983 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.12 -165.49 18.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 85' ' ' THR . 4.6 mm -103.68 122.31 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.61 149.23 47.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.067 . . . . 0.0 110.608 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -107.84 150.96 26.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.5 t80 -131.04 137.48 49.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.014 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 ttpp -169.12 140.41 2.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.447 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.51 28.52 15.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.895 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.15 24.84 76.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.15 138.14 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.21 -1.17 . . . . 0.0 109.758 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 35.9 m-85 -97.13 134.27 40.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.187 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.6 mt -127.25 96.83 32.9 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.485 -0.759 . . . . 0.0 109.839 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -51.79 144.73 33.87 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.259 1.973 . . . . 0.0 111.654 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.2 79.35 7.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.19 149.54 52.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.554 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 5.8 p80 -52.0 -49.37 63.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.415 -0.803 . . . . 0.0 109.789 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' HIS . 18.8 mt-10 -44.89 -33.18 1.87 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.32 6.16 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 109.902 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 50' ' ' HIS . 3.5 t -63.73 130.81 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.131 -0.981 . . . . 0.0 109.071 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.9 m -115.68 -31.66 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.47 -0.769 . . . . 0.0 110.317 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.484 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -155.0 126.03 7.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 109.602 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 p -113.87 137.07 52.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.553 -0.717 . . . . 0.0 109.107 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -166.52 -154.58 0.18 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.39 -11.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 57' ' ' ASN . 40.6 m -134.8 165.75 24.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.608 -0.682 . . . . 0.0 109.294 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -103.28 121.57 42.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 0.0 109.229 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -118.14 135.67 54.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 111.192 -179.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' HG21 ' A' ' 72' ' ' VAL . 29.8 mt -122.04 162.46 21.15 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.56 144.29 5.81 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 118.35 -1.881 . . . . 0.0 111.147 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -144.68 151.18 38.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.721 -0.87 . . . . 0.0 109.506 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 mttp 57.48 23.83 9.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.704 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.68 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.331 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.496 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 28.7 mm100 -97.55 143.83 27.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.311 . . . . 0.0 108.055 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.77 149.25 43.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.502 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.32 137.78 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.98 154.25 25.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.188 -0.945 . . . . 0.0 110.907 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 71' ' ' THR . 80.7 m 53.5 67.88 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.706 -0.621 . . . . 0.0 110.764 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 62' ' ' LEU . 23.5 m -113.15 -4.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 109.093 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.3 pt-20 -69.11 -33.49 73.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 110.333 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -61.57 -60.35 3.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 110.135 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.576 ' CD1' ' CD2' ' A' ' 106' ' ' PHE . 2.5 tp -56.98 -42.63 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.904 -1.122 . . . . 0.0 108.808 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' HG23 ' A' ' 75' ' ' ILE . 9.5 mt -59.36 -35.28 73.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.341 -0.85 . . . . 0.0 109.83 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.592 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 11.9 t -64.46 -51.15 64.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 109.902 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.3 t -55.74 -54.74 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 108.408 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -53.28 -44.74 68.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.616 -0.678 . . . . 0.0 109.421 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.426 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 3.2 t-160 -53.23 -41.41 65.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 HD13 ' A' ' 232' ' ' ILE . 16.9 mt -77.26 -35.85 54.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.674 HD22 ' CD1' ' A' ' 114' ' ' ILE . 10.3 mt -80.77 0.76 33.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.025 -1.047 . . . . 0.0 110.61 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 58.24 51.82 8.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.512 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 82' ' ' LEU . 19.9 mm -95.73 122.02 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 108.369 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.66 ' O ' HD13 ' A' ' 37' ' ' ILE . 8.3 p -101.88 -76.61 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 111.169 -178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.717 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.7 m-80 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.39 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.25 134.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.491 0.662 . . . . 0.0 109.555 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.486 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.7 m -105.92 100.54 10.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.14 104.49 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -80.49 124.17 28.7 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.2 t -106.21 111.88 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -92.46 108.92 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.15 -158.06 21.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.19 -11.46 10.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.586 -0.95 . . . . 0.0 110.233 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -145.81 150.1 35.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.85 -1.157 . . . . 0.0 110.858 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.52 125.13 91.8 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.638 -0.664 . . . . 0.0 109.623 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.657 ' CD ' HD21 ' A' ' 26' ' ' LEU . 72.6 Cg_exo -45.28 134.94 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.964 1.776 . . . . 0.0 112.37 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.02 -29.5 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.2 mt 56.77 -110.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.548 -0.72 . . . . 0.0 110.221 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -15.5 22.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.092 . . . . 0.0 111.464 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.49 -8.83 32.66 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.3 p -117.46 -170.74 1.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -1.048 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.87 -3.3 21.91 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -46.8 -39.84 12.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 110.744 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.41 -51.85 67.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.964 -1.085 . . . . 0.0 110.15 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CD2' ' CD1' ' A' ' 75' ' ' ILE . 92.6 m-85 -64.01 -43.78 94.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.024 -1.047 . . . . 0.0 108.779 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -61.51 -38.02 85.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.662 -0.649 . . . . 0.0 109.756 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -71.18 -46.72 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 111.591 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.06 15.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.709 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.7 -42.86 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 110.709 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.64 -31.69 57.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.912 -1.117 . . . . 0.0 109.348 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -83.09 -1.11 51.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.93 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' HB2' HD11 ' A' ' 11' ' ' LEU . 5.3 m120 -131.4 33.42 4.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.252 -0.905 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.674 ' CD1' HD22 ' A' ' 82' ' ' LEU . 11.2 mt -91.35 142.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.473 -1.392 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 115' ' ' LEU . 13.8 tp -131.56 162.83 29.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -108.01 146.03 33.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.921 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.587 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 10.7 mt-30 -111.23 -166.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 109.444 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 10.1 t-20 -116.66 70.83 0.77 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.4 -0.812 . . . . 0.0 110.304 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.401 ' O ' ' N ' ' A' ' 4' ' ' GLU . 3.7 ttt180 -166.36 143.59 5.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.192 -0.942 . . . . 0.0 109.305 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.73 130.04 35.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.715 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 55.5 mt -70.77 140.36 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.683 . . . . 0.0 110.542 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.45 90.66 8.45 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -64.71 146.66 54.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 110.812 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -102.38 123.7 46.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.13 143.8 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.128 -0.982 . . . . 0.0 110.466 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 67.9 t -84.4 135.73 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.538 -0.726 . . . . 0.0 109.101 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -114.68 -10.47 12.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.233 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.84 146.45 34.64 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.03 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.28 170.7 17.66 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.389 2.059 . . . . 0.0 113.403 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.728 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.7 tt -165.68 144.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.291 0.567 . . . . 0.0 109.793 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 131' ' ' ILE . 1.4 mt -130.64 122.28 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.5 111.92 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.354 -0.841 . . . . 0.0 109.634 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -115.87 128.6 55.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -172.39 152.2 2.66 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.959 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB2' ' HE ' ' A' ' 137' ' ' ARG . 33.7 mm-40 56.8 22.19 6.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.641 -0.662 . . . . 0.0 110.766 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.54 -0.21 89.42 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.587 ' HB2' HD22 ' A' ' 255' ' ' LEU . 21.2 mtm180 -100.5 171.8 7.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -1.143 . . . . 0.0 107.984 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.917 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.67 146.57 14.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.429 -1.419 . . . . 0.0 109.249 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.917 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.5 mt -147.24 133.27 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 108.671 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -123.78 138.44 54.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 0.0 109.666 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.68 144.59 48.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.5 -0.75 . . . . 0.0 109.105 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 11.4 tm-20 -141.59 135.39 14.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 5.9 Cg_endo -52.82 148.12 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.39 1.393 . . . . 0.0 112.05 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.69 150.87 10.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -79.6 0.8 28.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.5 p -138.43 170.42 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.622 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 30.6 tp -99.88 119.2 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 109.519 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -139.52 137.93 35.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.542 ' CG1' HD23 ' A' ' 231' ' ' LEU . 57.3 t -137.9 125.67 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 m -112.88 140.93 47.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.537 ' CE2' HG12 ' A' ' 224' ' ' VAL . 9.9 t80 -126.72 131.39 51.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 106.06 13.51 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.83 158.37 17.8 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 115.66 15.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -1.057 . . . . 0.0 109.148 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.11 148.75 41.27 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.431 -0.793 . . . . 0.0 109.876 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -93.05 -7.02 46.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 109.93 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.853 HD21 HD12 ' A' ' 159' ' ' LEU . 20.5 p-10 -75.06 -169.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.011 . . . . 0.0 109.972 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -58.83 -21.22 56.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 110.152 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.853 HD12 HD21 ' A' ' 157' ' ' ASN . 6.9 mt -64.76 -54.26 34.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.017 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.06 -131.74 10.69 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -101.37 142.68 32.41 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.235 -1.156 . . . . 0.0 109.517 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -148.67 150.37 33.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.199 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -136.74 147.55 46.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.805 . . . . 0.0 109.323 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -136.06 122.5 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 165' ' ' THR . 14.2 t -98.26 120.77 39.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.994 -1.066 . . . . 0.0 109.658 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -95.05 140.44 29.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.232 -0.918 . . . . 0.0 109.44 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.94 150.08 23.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.289 -0.882 . . . . 0.0 109.707 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 96.6 mt-10 -55.59 117.64 3.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.888 . . . . 0.0 109.368 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.536 ' C ' HD22 ' A' ' 170' ' ' ASN . . . 115.86 4.97 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.536 HD22 ' C ' ' A' ' 169' ' ' GLY . 0.8 OUTLIER -134.87 30.27 3.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.142 -1.21 . . . . 0.0 108.958 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.99 -28.64 69.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 110.132 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -57.42 -14.5 4.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.162 -0.962 . . . . 0.0 110.789 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -96.21 -4.35 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.134 . . . . 0.0 110.941 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.414 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -118.98 3.48 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 110.906 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.02 -31.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.804 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.4 2.68 55.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.997 -1.064 . . . . 0.0 110.571 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.25 118.34 21.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.736 -1.228 . . . . 0.0 108.751 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.25 152.09 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.942 -1.099 . . . . 0.0 110.166 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 t -59.11 133.05 55.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.555 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 25.4 p90 -115.03 165.77 12.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.482 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -159.65 161.23 34.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.496 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 42.7 m-85 -103.03 145.15 30.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.052 -1.03 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.741 ' HA ' HD12 ' A' ' 186' ' ' ILE . 4.1 p-10 -63.12 -17.85 62.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.206 -0.934 . . . . 0.0 111.708 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.668 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.2 p90 -81.61 -38.32 26.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.362 -1.461 . . . . 0.0 111.183 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.668 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -86.85 -14.44 42.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.596 -1.315 . . . . 0.0 109.817 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.8 mt -53.91 -48.15 63.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.144 -0.973 . . . . 0.0 109.893 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.24 -51.35 54.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.103 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -47.04 67.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 186' ' ' ILE . 30.0 mt -60.77 -34.7 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 109.183 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -78.91 -25.92 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.842 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -75.25 -28.45 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.6 m -81.49 10.66 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.101 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.37 72.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.0 mt -120.84 159.2 25.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.596 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.469 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.1 27.58 57.86 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.435 ' NZ ' ' CB ' ' A' ' 196' ' ' LYS . 8.0 mtpm? -71.03 -20.59 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.765 -1.432 . . . . 0.0 109.314 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.29 -1.34 50.86 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.75 126.94 38.21 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.695 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.407 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 1.6 p -140.74 172.02 13.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.716 -0.873 . . . . 0.0 109.114 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.79 -3.56 45.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.979 . . . . 0.0 109.642 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -97.88 -10.55 24.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.407 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 0.8 OUTLIER -135.18 -9.36 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 109.486 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.432 HG22 ' SG ' ' A' ' 181' ' ' CYS . 3.0 m -126.89 115.04 18.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.713 . . . . 0.0 109.586 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 205' ' ' VAL . 4.9 tp -74.0 114.64 12.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.481 ' N ' HD12 ' A' ' 204' ' ' LEU . 64.8 t -105.31 127.08 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.048 -1.033 . . . . 0.0 109.854 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 11.1 mt -104.29 151.67 23.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.09 150.74 17.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 26.4 ttpt -41.02 -29.4 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -1.123 . . . . 0.0 109.961 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.5 OUTLIER -149.41 17.47 0.93 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 110.339 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 7.4 tttp -151.26 161.88 41.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.054 -1.029 . . . . 0.0 110.122 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.24 129.88 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.08 -54.31 8.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.137 -0.977 . . . . 0.0 109.92 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -54.64 134.22 64.3 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.909 -1.12 . . . . 0.0 109.329 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.81 -9.67 25.17 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.235 1.957 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.32 -7.96 52.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.066 -1.021 . . . . 0.0 109.751 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.18 -165.01 51.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.9 mt -88.66 145.24 25.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.5 -1.0 . . . . 0.0 109.935 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.566 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.7 mmt180 -87.76 -17.02 32.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.465 -0.772 . . . . 0.0 109.558 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 27.0 m-85 -144.17 143.97 31.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.01 -19.79 54.43 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.427 ' HB2' ' HE ' ' A' ' 225' ' ' ARG . 16.5 m-20 -126.96 35.67 4.56 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -60.05 -40.62 79.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.538 -0.726 . . . . 0.0 110.607 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.11 -47.98 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.43 2.087 . . . . 0.0 112.641 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.1 OUTLIER -72.88 -23.09 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.757 -1.214 . . . . 0.0 108.696 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' A' ' 221' ' ' ASN . 11.2 mtt180 -68.74 -44.64 73.34 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -60.13 -43.02 96.01 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.83 -42.18 79.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.092 -1.005 . . . . 0.0 109.071 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.0 t -63.94 -49.31 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.592 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.8 t80 -50.22 -40.33 47.13 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.794 0.807 . . . . 0.0 108.896 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.0 m-20 -69.68 -44.57 70.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.635 -0.666 . . . . 0.0 110.178 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.542 HD23 ' CG1' ' A' ' 149' ' ' VAL . 50.7 tp -56.64 -38.72 72.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.111 -0.993 . . . . 0.0 109.154 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.42 HD13 HD21 ' A' ' 81' ' ' LEU . 71.8 mt -68.04 -33.44 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.12 -31.97 79.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.589 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -81.78 -25.49 35.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -1.126 . . . . 0.0 109.912 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.07 -24.52 55.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.795 -1.191 . . . . 0.0 110.698 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.463 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -65.38 -5.22 6.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.355 -1.466 . . . . 0.0 108.013 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 237' ' ' LEU . 35.4 mt -55.08 -23.7 21.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.848 -1.158 . . . . 0.0 108.929 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 242' ' ' VAL . 72.1 mt -68.17 -21.47 64.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.005 . . . . 0.0 109.186 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.76 12.05 67.16 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 21.4 p -158.2 143.99 12.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.144 -1.209 . . . . 0.0 109.578 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 78.0 Cg_exo -42.42 135.66 4.39 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.263 1.975 . . . . 0.0 112.153 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.474 ' O ' HD13 ' A' ' 147' ' ' LEU . 76.0 t -98.46 133.03 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.944 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -122.41 127.81 50.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.613 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.0 178.93 28.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -105.93 112.2 25.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -1.207 . . . . 0.0 109.968 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -112.36 148.19 34.8 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.03 0.919 . . . . 0.0 111.125 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -129.89 144.42 51.31 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -139.09 128.81 24.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.732 -1.23 . . . . 0.0 110.722 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.0 t80 -110.67 113.07 25.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 249' ' ' PHE . 42.1 mtm180 48.51 55.48 8.91 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.18 135.31 22.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.414 ' HA3' HH11 ' A' ' 137' ' ' ARG . . . -109.78 151.2 17.38 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.1 m-70 -49.05 -46.12 43.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -1.205 . . . . 0.0 109.547 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -55.29 35.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 109.413 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 137' ' ' ARG . 56.7 tp -51.99 -38.14 55.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -58.64 -55.48 34.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.036 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.42 -42.94 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.754 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.58 -48.89 74.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.089 -1.007 . . . . 0.0 109.087 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.679 HD22 HG21 ' A' ' 139' ' ' ILE . 37.9 tp -52.79 -42.02 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 108.772 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.9 t -72.11 -40.17 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -58.91 -51.36 70.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.388 -0.82 . . . . 0.0 110.136 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.79 -44.74 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 109.879 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 263' ' ' LEU . 72.8 mt -63.5 -44.16 95.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.248 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.28 86.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.498 -0.751 . . . . 0.0 110.368 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.6 mttt . . . . . 0 N--CA 1.49 1.564 0 O-C-N 120.773 -1.204 . . . . 0.0 108.868 179.622 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 119' ' ' ARG . 8.0 mm-40 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.485 ' HD3' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -109.63 126.85 54.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 115' ' ' LEU . 6.1 t -130.44 169.37 15.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 7' ' ' VAL . 6.7 m -83.87 137.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.034 -1.042 . . . . 0.0 110.317 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG3' HD13 ' A' ' 115' ' ' LEU . 28.4 ttmt -67.6 -45.57 75.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.472 -0.767 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CB ' ' OD1' ' A' ' 113' ' ' ASN . 2.8 tt0 -132.27 156.1 47.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.26 -0.9 . . . . 0.0 110.511 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 133.01 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.728 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.87 165.42 14.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 109.192 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 p -156.65 150.3 24.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.57 161.68 33.23 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.46 134.73 24.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.893 -1.13 . . . . 0.0 108.857 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.04 155.34 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.33 160.66 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.18 . . . . 0.0 111.208 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.65 136.29 13.44 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.604 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.4 tt -53.42 -53.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -1.161 . . . . 0.0 111.657 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.604 ' N ' HG23 ' A' ' 18' ' ' ILE . 5.2 m-70 -87.54 -36.78 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.275 -1.516 . . . . 0.0 111.191 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.4 m -71.31 -35.42 71.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.57 65.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -111.77 150.85 29.7 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.667 -0.902 . . . . 0.0 108.86 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.2 t80 -70.25 128.92 37.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.597 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 12.1 t -135.94 157.47 46.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 109.143 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 26' ' ' LEU . 4.0 ttmt -135.6 147.2 48.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -0.895 . . . . 0.0 109.307 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.535 HD11 ' HD2' ' A' ' 97' ' ' PRO . 6.4 mt -119.65 145.99 45.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.096 -1.003 . . . . 0.0 108.838 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.9 mt -135.05 126.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mt -113.08 129.1 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.223 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -128.44 148.75 69.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.54 160.37 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.278 1.986 . . . . 0.0 111.835 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 6.0 mm-40 -134.76 -172.82 3.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.902 . . . . 0.0 109.837 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' OG1' ' A' ' 35' ' ' THR . 54.1 tttm -84.44 149.59 25.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.632 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 mp0 -47.46 145.42 2.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.991 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.68 25.2 63.14 Favored Glycine 0 N--CA 1.493 2.465 0 O-C-N 121.47 -0.769 . . . . 0.0 111.825 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 45.4 m -80.98 -44.58 17.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.546 -1.561 . . . . 0.0 108.951 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.48 -166.55 16.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.605 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.5 mm -103.73 125.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.313 -1.11 . . . . 0.0 108.073 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.12 139.64 30.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.162 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.56 152.69 18.2 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 4.1 t80 -135.03 141.26 46.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.609 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 146.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.312 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.07 29.31 14.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.31 23.11 73.25 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.28 133.88 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -1.202 . . . . 0.0 109.51 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -94.41 142.45 27.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.823 . . . . 0.0 109.169 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 46' ' ' ILE . 29.4 mt -135.09 94.39 16.09 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -49.26 144.88 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.342 2.028 . . . . 0.0 111.654 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.44 84.32 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.95 -1.094 . . . . 0.0 110.667 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.28 154.57 49.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.599 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 4.4 p80 -51.39 -48.15 62.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 109.732 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -46.77 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.0 m-85 -95.35 1.88 54.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 109.762 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 50' ' ' HIS . 54.1 t -55.22 127.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.036 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 52' ' ' PHE . 32.2 m -117.42 -32.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 109.861 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -151.32 119.28 6.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 p -114.36 127.82 56.04 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.603 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.9 t-20 -167.16 -152.98 0.14 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' ASN . 12.2 m-70 -44.37 -16.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.9 t -136.77 165.6 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.491 -0.755 . . . . 0.0 109.326 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 m -110.61 125.71 53.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 150.42 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.26 -0.9 . . . . 0.0 111.178 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' CD1' HG21 ' A' ' 72' ' ' VAL . 34.4 mt -130.15 159.01 38.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.73 146.68 8.02 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.306 -1.902 . . . . 0.0 111.538 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -144.09 148.87 35.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.644 -0.916 . . . . 0.0 109.309 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.1 mttt 59.1 30.62 20.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.262 -0.899 . . . . 0.0 110.75 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.24 4.72 90.11 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.486 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 16.7 mm100 -103.93 139.94 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -1.234 . . . . 0.0 108.094 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -141.71 157.52 44.95 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.704 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.2 mt -133.77 147.26 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -114.21 150.52 34.16 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.153 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 55.05 71.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.666 -0.646 . . . . 0.0 110.995 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 62' ' ' LEU . 19.5 m -113.97 -17.41 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.438 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.601 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -61.18 -16.81 48.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.441 -179.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.601 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 7.8 m170 -73.18 -61.39 1.84 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.833 -1.167 . . . . 0.0 109.832 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -58.15 -41.62 81.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.819 -1.175 . . . . 0.0 108.338 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 79' ' ' LEU . 98.0 mt -56.4 -38.28 71.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 109.466 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.569 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.2 t -61.44 -49.23 77.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.13 -53.07 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 108.515 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 76' ' ' LEU . 20.2 mt -51.73 -44.62 63.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.492 ' HD1' HG22 ' A' ' 232' ' ' ILE . 10.6 t-160 -56.16 -49.34 74.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.1 -1.0 . . . . 0.0 110.401 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.49 -37.89 85.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.685 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.58 ' CB ' HD11 ' A' ' 84' ' ' ILE . 50.2 mt -86.66 -5.43 59.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.913 -1.117 . . . . 0.0 111.151 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 82' ' ' LEU . 1.0 OUTLIER 62.69 63.0 1.03 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.731 -1.231 . . . . 0.0 110.426 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.605 ' O ' HD11 ' A' ' 37' ' ' ILE . 4.6 mm -98.44 129.68 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.585 ' O ' HD13 ' A' ' 37' ' ' ILE . 72.9 p -107.63 -78.21 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.041 -1.037 . . . . 0.0 110.509 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.743 HD22 HE22 ' A' ' 117' ' ' GLN . 1.5 m-80 -81.34 113.27 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.005 -1.059 . . . . 0.0 111.137 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.9 m -163.71 131.79 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.546 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.5 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 51.4 m -104.25 100.88 10.6 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.38 103.02 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' OE2' ' CD1' ' A' ' 40' ' ' PHE . 4.0 mt-10 -76.32 122.97 25.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.989 -1.069 . . . . 0.0 108.782 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.06 110.29 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.45 108.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.7 -167.15 24.91 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.16 -15.31 14.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.365 -1.08 . . . . 0.0 109.861 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.5 tt0 -143.71 148.68 36.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 110.034 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -68.2 128.36 93.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.456 -0.777 . . . . 0.0 109.282 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.535 ' HD2' HD11 ' A' ' 26' ' ' LEU . 76.6 Cg_exo -44.19 130.35 8.49 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.047 1.831 . . . . 0.0 112.116 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 18' ' ' ILE . 10.9 tp -76.33 -20.31 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.074 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.464 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 6.2 mt 47.57 -116.19 0.72 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.277 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.16 -10.05 31.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.483 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.27 -5.07 57.3 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.4 p -117.14 -171.38 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.454 -1.027 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.9 -6.14 16.97 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -47.71 -40.1 19.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.65 -0.912 . . . . 0.0 110.805 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.83 -52.06 65.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.931 -1.105 . . . . 0.0 109.828 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.4 m-85 -60.62 -43.93 96.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.012 -1.055 . . . . 0.0 108.379 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.503 ' CD2' HG11 ' A' ' 175' ' ' VAL . 12.3 t80 -60.88 -39.76 90.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.517 0.675 . . . . 0.0 110.051 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.89 -47.97 60.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 112.059 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 -51.19 14.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.749 -1.219 . . . . 0.0 111.105 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.49 -42.81 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -56.49 -29.54 61.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.945 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -81.23 -15.4 55.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.066 . . . . 0.0 110.453 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' CB ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -119.84 32.25 6.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.265 -0.897 . . . . 0.0 111.044 -178.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.402 HG12 ' NZ ' ' A' ' 5' ' ' LYS . 5.7 mt -80.75 146.69 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.653 -1.28 . . . . 0.0 110.929 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.44 ' HB3' HG23 ' A' ' 6' ' ' THR . 13.7 tp -132.09 162.63 30.35 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -123.49 146.6 47.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.235 -0.916 . . . . 0.0 110.446 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.743 HE22 HD22 ' A' ' 86' ' ' ASN . 0.6 OUTLIER -107.75 -157.5 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -0.789 . . . . 0.0 109.245 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.827 ' H ' HD22 ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 1.72 11.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.011 -1.056 . . . . 0.0 112.124 -178.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 4' ' ' GLU . 3.3 ttm180 -102.24 122.02 43.4 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.573 -1.329 . . . . 0.0 110.237 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -56.73 142.97 38.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.258 -0.901 . . . . 0.0 109.999 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.47 HG23 HG21 ' A' ' 85' ' ' THR . 1.9 mt -81.19 145.55 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 0.0 110.481 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.58 84.43 7.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -60.72 146.06 47.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 110.552 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -101.22 120.15 39.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 243' ' ' LYS . 20.9 t -122.72 138.84 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 109.878 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.2 140.0 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.192 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -119.7 -8.63 9.89 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.418 ' N ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER -141.19 146.17 41.77 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.42 -0.8 . . . . 0.0 109.072 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.52 177.21 8.97 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.219 1.946 . . . . 0.0 113.08 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.793 HG22 ' HB3' ' A' ' 141' ' ' ALA . 8.4 tt -165.25 144.78 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.622 -0.674 . . . . 0.0 109.574 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -129.03 123.61 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.59 122.1 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.426 ' OE1' ' C ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.35 132.02 56.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 17.2 t0 -174.21 157.8 2.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.261 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 44.2 mt-10 57.71 19.93 5.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.676 -0.64 . . . . 0.0 110.773 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.04 4.58 88.84 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -114.07 177.63 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.899 HD23 ' N ' ' A' ' 139' ' ' ILE . 10.1 tt -157.77 161.09 38.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.351 -1.468 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.899 ' N ' HD23 ' A' ' 138' ' ' LEU . 18.6 mt -149.8 144.97 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.952 . . . . 0.0 108.492 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -132.4 140.17 48.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.627 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.793 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.69 140.86 51.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 108.998 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.56 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 13.8 tm-20 -137.64 126.55 14.81 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.45 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 88.6 Cg_exo -46.39 152.48 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.563 1.509 . . . . 0.0 112.435 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.05 159.57 6.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -91.79 -0.29 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 p -132.85 146.41 51.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.444 -0.785 . . . . 0.0 109.166 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.431 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 19.9 tp -81.38 117.22 21.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.133 -0.979 . . . . 0.0 109.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.07 135.1 39.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.731 ' CG1' HD23 ' A' ' 231' ' ' LEU . 67.5 t -135.98 117.65 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.516 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.3 m -107.92 134.15 51.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -121.51 130.6 53.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -112.31 110.55 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.55 152.84 17.53 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.46 96.11 2.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.436 -1.038 . . . . 0.0 109.138 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.482 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 3.5 m-85 -98.98 148.72 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.578 -0.701 . . . . 0.0 110.126 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -85.38 -3.72 58.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.484 -0.76 . . . . 0.0 109.864 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CB ' ' A' ' 155' ' ' PHE . 11.5 p30 -76.93 -167.64 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.915 -1.115 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -58.0 -22.01 47.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.039 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.38 -54.73 43.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.834 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.13 -111.71 3.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -124.84 137.18 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -1.112 . . . . 0.0 109.076 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -155.32 139.33 16.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.377 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.546 ' CB ' ' NZ ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -127.69 153.73 46.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 109.169 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.496 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 86.4 t80 -135.17 116.88 14.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 165' ' ' THR . 5.0 t -92.47 120.1 32.62 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.157 -0.964 . . . . 0.0 109.376 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.74 138.38 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.561 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -135.77 153.55 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.0 109.45 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 22.5 mt-10 -57.22 122.82 13.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.476 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.49 -7.05 20.59 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.14 32.65 4.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -1.14 . . . . 0.0 108.768 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -66.56 -30.64 70.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.797 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -58.53 -13.6 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.015 . . . . 0.0 110.877 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.26 -4.44 54.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.915 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.39 3.75 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.16 -0.963 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.503 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -96.77 -32.64 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.797 -1.189 . . . . 0.0 109.934 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.55 0.17 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.978 -1.076 . . . . 0.0 110.536 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.34 117.42 18.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.798 -1.188 . . . . 0.0 108.29 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.477 HH12 ' C ' ' A' ' 201' ' ' LYS . 11.2 ttm180 -86.08 148.83 25.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 0.0 110.26 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.4 t -62.55 134.9 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 109.012 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.16 179.74 3.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 110.582 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -164.93 161.32 20.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.578 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.2 m-85 -104.52 144.21 31.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.672 ' HA ' HD12 ' A' ' 186' ' ' ILE . 7.5 p-10 -62.64 -19.27 63.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.689 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.587 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -81.44 -31.46 33.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.755 -1.216 . . . . 0.0 110.534 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.587 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 6.4 pt-20 -91.79 -14.96 28.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.836 -1.165 . . . . 0.0 109.513 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 183' ' ' ASP . 6.8 mt -57.42 -52.02 62.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -50.64 -52.39 40.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.912 -1.117 . . . . 0.0 109.92 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -45.62 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.914 -1.116 . . . . 0.0 109.166 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.3 -33.43 61.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 109.079 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -80.52 -26.79 37.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -79.43 -21.13 45.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 110.03 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.3 13.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.752 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.82 24.46 67.0 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.788 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.0 mt -123.9 163.5 21.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.118 -1.225 . . . . 0.0 109.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 77.37 21.92 71.71 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -68.63 -21.31 64.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.83 -1.394 . . . . 0.0 109.735 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.68 -5.37 51.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.08 125.75 38.78 Favored Glycine 0 N--CA 1.49 2.263 0 O-C-N 121.242 -1.152 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.28 165.1 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.713 -0.875 . . . . 0.0 109.314 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.98 -8.06 50.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.504 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.477 ' C ' HH12 ' A' ' 178' ' ' ARG . 23.5 tttp -93.44 -5.61 48.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 53.8 m-20 -143.54 14.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.719 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.8 m -151.65 119.1 6.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.519 HD21 ' CD2' ' A' ' 217' ' ' LEU . 24.3 tp -80.4 109.81 15.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.133 -0.979 . . . . 0.0 108.893 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.4 t -98.11 128.56 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.9 mt -110.79 148.41 32.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.896 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.27 156.29 16.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 207' ' ' GLY . 1.6 ttpt -42.9 -30.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.912 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.7 13.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.166 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 207' ' ' GLY . 33.1 mttt -139.23 147.26 41.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.037 -1.04 . . . . 0.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.99 127.05 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -72.91 -54.31 9.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 110.061 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.39 132.42 81.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.926 -1.109 . . . . 0.0 109.44 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.4 -11.5 26.62 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.885 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -90.38 -8.72 49.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.969 -1.082 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.24 -167.94 45.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.519 ' CD2' HD21 ' A' ' 204' ' ' LEU . 21.2 mt -78.62 141.84 37.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.449 -1.03 . . . . 0.0 109.766 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.584 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.1 tpp180 -79.57 -13.06 59.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 34.3 m-85 -148.24 152.79 37.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 108.899 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.621 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 11.6 mp0 -59.25 -19.12 43.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 108.423 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 37.25 3.02 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.621 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.5 OUTLIER -59.91 -38.18 57.36 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.605 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.27 -46.45 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.158 1.906 . . . . 0.0 112.295 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 228' ' ' VAL . 6.1 m -74.45 -23.99 18.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.776 -1.202 . . . . 0.0 108.25 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 164' ' ' PHE . 44.9 mtt180 -68.24 -43.21 78.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -61.06 -41.76 97.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -57.49 -43.4 84.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.966 -1.083 . . . . 0.0 108.753 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 224' ' ' VAL . 28.2 t -60.84 -45.14 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.569 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 75.6 t80 -55.87 -40.56 73.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 1.1 m-20 -73.71 -37.8 65.04 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.612 -0.68 . . . . 0.0 109.597 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.731 HD23 ' CG1' ' A' ' 149' ' ' VAL . 28.4 tp -56.23 -34.86 66.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.492 HG22 ' HD1' ' A' ' 80' ' ' HIS . 61.0 mt -73.28 -47.93 44.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.66 -34.66 21.44 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.482 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 1.0 OUTLIER -81.59 -27.6 34.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -1.196 . . . . 0.0 109.95 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.649 HD23 HG22 ' A' ' 260' ' ' VAL . 6.6 mt -80.46 -20.92 42.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.796 -1.19 . . . . 0.0 109.631 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -73.1 -9.22 58.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.288 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.409 ' C ' ' N ' ' A' ' 239' ' ' GLY . 67.9 mt -53.5 -28.2 29.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 108.879 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 242' ' ' VAL . 65.4 mt -55.3 -12.21 0.97 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 108.895 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 77.65 12.26 84.66 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 30.2 p -158.52 147.61 14.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.946 -1.326 . . . . 0.0 109.857 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.9 133.78 5.61 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.283 1.988 . . . . 0.0 112.081 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 238' ' ' LEU . 42.5 t -100.32 129.03 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.435 ' HB3' HG13 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -116.92 123.54 47.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.38 -0.825 . . . . 0.0 109.807 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.35 173.08 26.3 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.56 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -103.14 111.93 24.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.189 -1.183 . . . . 0.0 109.463 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.6 m-85 -112.5 148.26 34.81 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.111 0.958 . . . . 0.0 111.456 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 139' ' ' ILE . 19.4 t80 -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 t -131.79 128.13 38.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.86 -1.15 . . . . 0.0 110.043 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.55 ' O ' ' N ' ' A' ' 251' ' ' GLY . 1.6 t80 -109.49 117.88 35.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.538 -0.726 . . . . 0.0 109.16 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 42.83 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 111.03 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -64.03 172.55 15.82 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.595 -1.316 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -138.91 -169.2 11.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.783 ' O ' HG23 ' A' ' 257' ' ' VAL . 96.6 m-70 -65.66 -52.37 52.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.131 . . . . 0.0 110.008 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -42.5 68.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.71 -36.13 67.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.968 -1.082 . . . . 0.0 109.009 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.8 m-20 -63.59 -44.41 94.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 108.605 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 253' ' ' HIS . 17.0 t -57.12 -45.04 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 108.844 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -55.18 -47.3 75.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.118 -0.989 . . . . 0.0 108.844 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 17.7 tp -53.52 -44.96 69.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.374 -0.828 . . . . 0.0 109.034 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.649 HG22 HD23 ' A' ' 235' ' ' LEU . 54.9 t -69.57 -43.45 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -48.24 77.37 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -68.01 -39.5 83.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.643 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.2 mt -65.0 -44.85 87.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.76 74.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? . . . . . 0 N--CA 1.489 1.509 0 O-C-N 120.764 -1.21 . . . . 0.0 109.302 179.528 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 25.5 mt-10 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.307 0.575 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -119.9 140.09 51.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.595 -0.691 . . . . 0.0 109.412 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 t -139.14 178.5 7.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.23 -0.919 . . . . 0.0 109.085 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -83.59 151.05 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.8 -1.188 . . . . 0.0 109.75 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.31 -37.62 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.475 -0.766 . . . . 0.0 110.063 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.52 157.76 46.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 133.08 54.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.357 0.598 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 11' ' ' LEU . 28.1 mt -123.58 159.22 29.68 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -157.26 150.84 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.11 -0.994 . . . . 0.0 110.51 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 169.01 18.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.563 -0.711 . . . . 0.0 109.718 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.69 137.89 21.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.071 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.75 157.26 14.92 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.6 HG23 ' C ' ' A' ' 22' ' ' GLU . 9.8 p -79.29 140.29 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.179 -1.189 . . . . 0.0 110.752 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.94 144.09 37.48 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.5 tt -59.63 -49.11 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -1.102 . . . . 0.0 112.459 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.548 ' CD2' ' OE2' ' A' ' 95' ' ' GLU . 9.6 m-70 -86.52 -38.24 17.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.003 -1.685 . . . . 0.0 111.071 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -67.52 -37.81 83.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.71 21.94 71.41 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' C ' HG23 ' A' ' 16' ' ' VAL . 3.1 tp10 -119.16 154.43 33.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.724 -0.868 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -70.88 133.67 46.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.9 t -142.63 157.25 44.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 108.883 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -126.41 160.47 30.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.232 -0.918 . . . . 0.0 110.01 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 HG23 ' A' ' 96' ' ' ILE . 12.1 mt -127.75 142.15 51.39 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' CD2' ' A' ' 29' ' ' HIS . 8.7 mt -137.26 127.21 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 108.838 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.51 121.24 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.732 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.503 ' CD2' HG22 ' A' ' 27' ' ' ILE . 16.3 m-70 -119.34 149.01 46.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.83 160.78 35.42 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.082 1.854 . . . . 0.0 110.732 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 56.7 mm-40 -136.4 -172.51 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.062 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.3 ttpm? -86.31 153.27 22.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 109.355 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -47.11 143.34 3.17 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 110.291 -179.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 60.08 30.5 70.48 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.384 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.5 m -80.96 -35.83 31.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.592 -1.534 . . . . 0.0 108.584 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.852 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 91.67 179.54 42.01 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -95.43 122.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.279 -1.13 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.4 144.81 46.75 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.773 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 52.1 m-85 -102.57 152.73 20.82 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.5 t80 -131.45 141.63 49.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 108.912 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -173.4 138.11 0.69 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.372 -0.83 . . . . 0.0 108.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.8 28.79 17.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.158 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.28 27.63 71.34 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 120.783 -1.198 . . . . 0.0 110.168 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.78 137.83 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -1.227 . . . . 0.0 109.956 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -96.63 135.3 38.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.6 mt -128.79 99.25 23.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.82 142.58 18.86 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.62 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . . . -92.83 84.5 4.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 110.548 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -141.6 157.91 44.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 109.393 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.604 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 5.6 p80 -54.83 -49.14 71.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -44.9 -16.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.13 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.6 m-85 -96.83 5.89 49.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.971 -1.081 . . . . 0.0 109.891 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -60.01 124.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.163 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.86 -30.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -0.877 . . . . 0.0 109.849 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.507 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -153.56 121.95 6.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 0.0 109.475 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -114.07 133.72 55.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.618 -0.676 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.9 t-20 -166.79 -154.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.432 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 12.0 m-70 -48.08 -12.59 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.897 -1.127 . . . . 0.0 108.294 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' ASN . 84.5 p -135.32 165.26 25.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.441 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 6.4 m -106.32 124.13 49.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -0.909 . . . . 0.0 108.998 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.507 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.04 137.74 54.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 111.381 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 72' ' ' VAL . 18.7 mt -127.73 159.15 35.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 178.17 151.86 9.76 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.379 -1.867 . . . . 0.0 111.667 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -144.94 152.2 39.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.98 -0.718 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.1 mttt 59.62 24.3 13.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.342 -0.849 . . . . 0.0 110.755 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.53 83.09 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.531 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.441 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 20.1 mm100 -109.87 133.4 53.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 108.061 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.79 165.17 27.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.892 -1.13 . . . . 0.0 111.838 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mt -134.77 148.55 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -114.61 150.72 34.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m 55.32 69.32 0.75 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 110.724 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -113.22 -12.97 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.975 -1.078 . . . . 0.0 109.356 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 3.4 pt-20 -63.2 -18.37 63.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.452 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -71.91 -60.65 2.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.919 -1.113 . . . . 0.0 109.683 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.4 tp -59.78 -43.04 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.994 -1.066 . . . . 0.0 108.953 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' HG23 ' A' ' 75' ' ' ILE . 15.0 mt -55.2 -41.26 71.76 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.174 -0.953 . . . . 0.0 109.331 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.9 t -58.48 -47.85 82.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.35 -54.11 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 108.703 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 mt -52.58 -44.94 66.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.662 ' HD1' HG22 ' A' ' 232' ' ' ILE . 19.7 t-160 -52.88 -54.32 36.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 110.224 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.16 -34.9 78.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 84' ' ' ILE . 42.4 mt -79.49 -4.47 51.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 110.598 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.58 54.45 2.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.98 -1.075 . . . . 0.0 110.305 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.4 mm -96.3 124.57 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 108.467 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.477 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 5.8 p -112.64 -21.31 11.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.315 -0.866 . . . . 0.0 111.631 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.852 HD22 ' H ' ' A' ' 36' ' ' GLY . 10.8 m120 -132.8 112.36 11.88 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.885 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.3 m -165.01 144.56 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.989 . . . . 0.0 109.839 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 64.9 m -112.85 102.86 10.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mp -92.91 117.99 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.872 . . . . 0.0 109.789 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.94 118.22 32.14 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.373 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.55 104.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.865 . . . . 0.0 110.833 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.14 110.7 19.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.83 -162.92 24.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.7 -13.88 12.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -1.06 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.548 ' OE2' ' CD2' ' A' ' 19' ' ' HIS . 40.5 tt0 -142.0 147.51 37.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.101 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.729 HG23 HD11 ' A' ' 26' ' ' LEU . 3.0 mm -68.76 126.74 93.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 109.764 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -45.59 129.53 11.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.923 1.749 . . . . 0.0 111.887 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.26 -32.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.498 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 9.6 mt 55.12 -104.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.273 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -94.34 -28.32 15.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.195 -0.94 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.87 -3.54 25.83 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.3 p -123.5 -166.23 1.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.421 -1.047 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -2.28 22.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.402 ' NE1' ' HG3' ' A' ' 108' ' ' GLU . 59.4 t-105 -48.69 -43.02 36.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.889 -0.771 . . . . 0.0 110.974 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.55 -52.08 64.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.964 -1.085 . . . . 0.0 110.385 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -62.93 -44.04 97.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.931 -1.105 . . . . 0.0 108.722 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 82.3 t80 -63.74 -37.22 86.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.819 -0.551 . . . . 0.0 110.251 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HG3' ' NE1' ' A' ' 104' ' ' TRP . 4.9 mm-40 -72.74 -49.68 29.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 112.014 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.16 -46.76 40.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.808 -1.182 . . . . 0.0 111.056 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -68.69 -42.57 83.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.96 -1.087 . . . . 0.0 110.971 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 15.8 ttp85 -55.74 -27.76 52.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.0 -1.063 . . . . 0.0 110.091 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -84.19 -18.35 36.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.99 -1.069 . . . . 0.0 109.887 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -113.08 29.26 8.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.8 mt -82.26 149.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 0.0 110.28 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 115' ' ' LEU . 12.2 tp -130.66 160.94 32.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.53 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -105.3 137.36 43.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.093 -1.005 . . . . 0.0 109.977 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -102.6 -170.95 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.489 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -124.97 70.71 1.15 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.471 -0.768 . . . . 0.0 110.16 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -160.61 137.78 9.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.046 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.12 167.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.678 0.751 . . . . 0.0 111.193 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.6 mt -128.59 122.35 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -79.37 71.93 5.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.348 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -55.58 147.05 18.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.081 -1.012 . . . . 0.0 109.414 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -104.83 123.02 46.96 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 243' ' ' LYS . 15.5 t -127.92 143.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.849 . . . . 0.0 109.51 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.81 141.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.5 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.23 -7.6 9.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 143' ' ' PRO . 7.3 pt-20 -142.35 144.31 30.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 0.0 109.062 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.13 168.01 25.83 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.185 1.923 . . . . 0.0 113.536 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.838 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.1 tt -159.77 141.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.343 0.592 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.469 ' CG2' HD21 ' A' ' 138' ' ' LEU . 28.6 mt -131.56 119.96 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.4 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 132' ' ' VAL . 34.3 m -118.3 120.44 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.94 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -114.55 136.45 53.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.685 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -174.24 150.1 1.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.599 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 57.05 24.09 9.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.0 110.818 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.09 7.68 86.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.41 ' CG ' HH11 ' A' ' 137' ' ' ARG . 2.9 mtt-85 -106.89 170.25 8.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.984 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.0 tt -160.44 149.52 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.185 -1.572 . . . . 0.0 109.232 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.984 ' N ' HD23 ' A' ' 138' ' ' LEU . 48.9 mt -145.83 135.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 0.0 108.626 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -124.11 140.5 52.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.971 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.838 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.58 142.13 50.96 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -139.64 127.89 13.3 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.403 ' HG3' ' N ' ' A' ' 128' ' ' GLU . 84.7 Cg_exo -46.73 149.1 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.661 1.574 . . . . 0.0 112.417 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.49 155.11 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -1.43 56.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -135.0 148.18 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 109.353 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.1 tp -84.08 118.63 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -137.3 138.85 40.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.46 ' CG1' HD23 ' A' ' 231' ' ' LEU . 54.7 t -135.52 123.35 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.142 -0.974 . . . . 0.0 110.032 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.0 m -109.87 129.34 55.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.239 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.402 ' CE1' ' HG2' ' A' ' 227' ' ' LYS . 63.8 t80 -119.17 131.43 55.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 26.6 tt0 -116.21 104.74 11.82 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.59 146.2 18.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.563 ' H ' HH11 ' A' ' 250' ' ' ARG . 1.8 tm-20 -119.59 86.11 2.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.603 -0.94 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 160' ' ' GLY . 11.7 m-85 -91.91 148.17 22.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -96.56 -4.99 40.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.277 -0.889 . . . . 0.0 109.445 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.813 HD21 HD12 ' A' ' 159' ' ' LEU . 19.3 p-10 -74.47 -167.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.8 -18.01 28.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.628 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.813 HD12 HD21 ' A' ' 157' ' ' ASN . 63.5 mt -72.74 -29.0 62.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 60.82 -121.39 26.43 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -107.67 140.67 40.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -1.048 . . . . 0.0 108.878 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -149.83 157.85 43.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.096 -1.002 . . . . 0.0 109.638 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -149.05 151.76 35.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.608 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -138.3 130.39 28.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.043 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 165' ' ' THR . 14.0 t -102.05 123.43 45.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -99.08 132.73 44.18 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.333 -0.854 . . . . 0.0 108.838 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.5 147.61 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.0 109.195 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 122.13 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.86 16.39 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -117.04 31.41 6.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.27 . . . . 0.0 108.547 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 175' ' ' VAL . 44.6 mt-10 -59.58 -39.02 82.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 110.673 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 2.1 mp0 -52.5 -14.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.057 -1.027 . . . . 0.0 110.944 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.76 -4.05 48.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.818 -1.176 . . . . 0.0 111.153 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.6 pt -121.04 -7.73 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.046 . . . . 0.0 111.033 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER -92.51 -28.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.552 -1.343 . . . . 0.0 110.104 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.46 1.23 56.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.957 -1.089 . . . . 0.0 110.849 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.51 119.42 22.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.738 -1.227 . . . . 0.0 108.888 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -87.28 151.61 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.007 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -53.15 160.42 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.264 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.525 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 33.0 p90 -142.1 169.76 16.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.864 -1.147 . . . . 0.0 109.794 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.6 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -161.04 159.67 29.6 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.184 -0.948 . . . . 0.0 109.898 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.67 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 70.8 m-85 -103.98 146.04 29.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.334 -0.854 . . . . 0.0 109.376 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.685 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.9 OUTLIER -63.79 -18.89 64.54 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.67 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.2 p90 -79.55 -29.92 41.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.541 -1.35 . . . . 0.0 111.119 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.532 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -98.0 -11.67 22.78 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.754 -1.216 . . . . 0.0 109.764 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.1 mt -58.75 -52.59 58.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.15 -0.969 . . . . 0.0 110.008 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.01 -49.82 59.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 109.565 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -53.74 -52.86 58.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.04 -33.99 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.842 . . . . 0.0 109.074 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -75.98 -25.55 55.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.92 -25.91 53.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.056 -1.028 . . . . 0.0 109.875 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.62 14.98 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.32 26.88 72.61 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.922 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -119.09 157.4 27.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.21 -1.171 . . . . 0.0 109.829 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.27 24.15 64.14 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.382 -0.914 . . . . 0.0 110.956 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -69.0 -20.88 64.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.669 -1.489 . . . . 0.0 109.014 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.44 -7.41 48.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.2 124.62 32.45 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.21 -1.17 . . . . 0.0 110.218 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.83 169.82 16.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.764 -0.845 . . . . 0.0 109.34 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.91 -5.68 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.634 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 2.0 ttpt -89.91 -4.73 57.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -153.09 18.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.6 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.7 m -149.59 128.65 12.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.7 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.588 HD21 HD23 ' A' ' 217' ' ' LEU . 68.3 tp -91.21 113.29 25.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 63.4 t -100.79 127.5 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 109.474 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.444 HD21 HD21 ' A' ' 217' ' ' LEU . 61.3 mt -104.02 146.88 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 110.192 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.51 161.23 14.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -51.08 -28.11 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.125 -1.22 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -155.07 14.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.833 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -141.22 149.28 41.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.039 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.18 128.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.2 -54.4 9.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.582 HD22 ' H ' ' A' ' 213' ' ' ASN . 1.5 m-80 -53.3 137.27 49.79 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.24 -36.35 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.435 2.09 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -70.11 -4.29 20.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.797 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.84 -161.56 53.94 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.588 HD23 HD21 ' A' ' 204' ' ' LEU . 16.1 mt -83.37 145.01 29.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -1.005 . . . . 0.0 109.889 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.594 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 14.1 ttt85 -80.72 -17.9 49.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 109.454 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 29.7 m-85 -148.79 164.86 33.16 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -72.79 -14.32 61.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.099 -1.0 . . . . 0.0 108.392 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 33.81 2.96 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.714 0.769 . . . . 0.0 108.96 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -55.87 -39.09 74.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.896 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.02 -41.57 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.091 1.861 . . . . 0.0 112.851 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.429 ' H ' HG22 ' A' ' 224' ' ' VAL . 10.7 m -78.32 -25.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.716 -1.24 . . . . 0.0 108.231 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.563 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 48.5 mtt180 -66.75 -41.22 88.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -65.1 -42.74 93.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.541 -0.724 . . . . 0.0 109.156 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.402 ' HG2' ' CE1' ' A' ' 151' ' ' TYR . 5.3 tptp -56.68 -48.32 77.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.252 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 70.5 t -58.62 -43.91 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.3 t80 -57.83 -36.98 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.51 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -73.3 -43.12 61.53 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.648 -0.657 . . . . 0.0 109.968 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.46 HD23 ' CG1' ' A' ' 149' ' ' VAL . 26.2 tp -56.19 -34.3 66.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.662 HG22 ' HD1' ' A' ' 80' ' ' HIS . 34.4 mt -72.76 -48.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.15 -34.65 17.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.65 -27.16 31.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.144 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 260' ' ' VAL . 4.9 mt -79.9 -23.76 41.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.739 -1.225 . . . . 0.0 110.133 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -72.45 -5.88 39.76 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.031 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 237' ' ' LEU . 33.6 mt -53.32 -27.88 25.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 108.745 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.3 -9.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.168 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.51 11.73 85.2 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.0 p -156.58 149.12 17.95 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.095 -1.238 . . . . 0.0 109.56 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 12.3 Cg_exo -48.38 138.48 23.68 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.211 1.941 . . . . 0.0 111.785 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.91 136.26 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.528 ' HB3' HG13 ' A' ' 125' ' ' VAL . 2.3 tppt? -124.55 127.78 47.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.433 -0.792 . . . . 0.0 109.62 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.53 177.2 30.41 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.43 112.7 25.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -1.167 . . . . 0.0 109.861 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.6 m-85 -112.59 148.86 33.67 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.031 0.92 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 25.1 t80 -128.24 144.29 51.11 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.6 t -142.46 128.99 20.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.683 -1.261 . . . . 0.0 110.778 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 250' ' ' ARG . 56.8 t80 -111.96 112.94 24.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.563 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.0 OUTLIER 47.36 56.1 7.39 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.39 149.4 23.68 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -121.69 165.33 14.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 91.3 m-70 -59.47 -44.53 92.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.3 m -59.58 -40.94 89.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.641 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.1 tp -72.26 -35.93 68.9 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.049 -1.032 . . . . 0.0 108.711 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -61.88 -46.8 87.83 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.73 -44.73 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.291 -0.88 . . . . 0.0 108.726 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -55.23 -48.28 74.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 108.927 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 139' ' ' ILE . 26.2 tp -52.97 -43.07 66.1 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 235' ' ' LEU . 63.4 t -69.83 -44.92 78.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.373 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -52.37 60.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.605 -0.684 . . . . 0.0 110.025 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -62.2 -46.39 89.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.01 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.2 -44.87 92.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.147 -0.971 . . . . 0.0 109.508 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.89 -30.21 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.0 mttt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 120.813 -1.179 . . . . 0.0 108.778 179.169 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 42.1 mt-10 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.6 141.01 52.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.432 -0.793 . . . . 0.0 109.882 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -137.79 172.74 12.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.21 137.86 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.771 -1.206 . . . . 0.0 110.538 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -69.59 -47.97 61.76 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.658 -0.651 . . . . 0.0 109.785 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.93 158.37 38.03 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.626 0.727 . . . . 0.0 110.32 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -60.71 137.25 58.21 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.555 0.693 . . . . 0.0 110.315 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.07 154.63 31.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -146.71 145.1 29.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.879 -1.138 . . . . 0.0 110.126 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.51 160.45 37.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.68 135.91 22.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.911 -1.118 . . . . 0.0 109.004 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.3 158.6 18.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.448 HG23 ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -86.17 143.06 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -1.231 . . . . 0.0 110.662 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.69 145.13 43.17 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -65.24 -41.91 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.053 -1.263 . . . . 0.0 112.073 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.543 ' CE1' HG23 ' A' ' 18' ' ' ILE . 3.9 m-70 -87.3 -38.85 15.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.047 -1.658 . . . . 0.0 111.073 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 p -74.21 -32.34 63.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 109.942 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.88 19.57 63.41 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 16' ' ' VAL . 2.8 mm-40 -109.87 150.24 28.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.958 . . . . 0.0 108.804 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -70.98 135.65 47.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 109.823 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.63 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 13.0 t -143.45 157.88 44.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.211 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.0 tttt -132.62 157.07 45.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.2 mt -134.15 145.29 49.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 109.214 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.447 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -130.45 134.46 62.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.56 118.1 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 42.9 m-70 -115.23 150.11 43.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.74 158.13 48.17 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.194 1.929 . . . . 0.0 111.511 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 14.0 mm-40 -133.43 -178.04 4.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.3 tptt -83.47 149.76 26.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.25 149.64 0.98 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.0 109.748 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.705 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 59.08 23.47 57.29 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.141 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.8 ' H ' HD22 ' A' ' 86' ' ' ASN . 6.7 m -80.29 -41.83 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.735 -1.45 . . . . 0.0 109.278 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.64 -166.64 21.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.3 mm -107.6 121.54 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.348 -1.09 . . . . 0.0 108.219 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.08 143.62 46.74 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.663 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.09 153.24 20.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.29 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.545 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -128.77 145.46 51.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -172.96 135.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 109.603 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.64 29.78 14.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.889 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.58 27.93 70.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.7 t -131.62 134.58 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -94.19 140.39 29.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.221 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.9 mt -134.08 94.53 18.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.059 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 145.37 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.294 1.996 . . . . 0.0 111.599 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.67 84.23 4.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.914 -1.116 . . . . 0.0 110.53 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -136.92 152.59 50.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.977 . . . . 0.0 109.582 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 52' ' ' PHE . 10.2 p80 -51.1 -46.81 61.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -48.39 -17.16 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.059 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' HIS . 51.7 m-85 -95.66 3.53 53.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.814 -1.179 . . . . 0.0 109.641 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . 25.6 t -62.42 119.27 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 108.79 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.28 -26.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 110.573 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.59 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -147.97 117.18 6.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.898 -1.126 . . . . 0.0 110.031 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.1 p -113.86 125.36 53.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.612 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 t-20 -167.58 -152.41 0.12 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.593 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 9.8 t-80 -44.13 -15.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -140.27 165.37 27.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.449 -0.782 . . . . 0.0 109.119 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.1 m -110.23 126.57 54.29 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.18 -0.95 . . . . 0.0 109.102 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.5 OUTLIER -128.12 147.15 50.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.184 0.992 . . . . 0.0 111.777 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' A' ' 72' ' ' VAL . 34.8 mt -122.51 157.48 31.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.2 143.52 7.03 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -143.04 147.79 35.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.926 . . . . 0.0 109.44 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp 53.73 45.07 28.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.271 -0.893 . . . . 0.0 110.711 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.2 6.5 65.03 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.65 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.6 mm100 -101.26 140.91 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.973 -1.31 . . . . 0.0 108.39 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -142.84 149.66 38.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.888 -1.132 . . . . 0.0 111.52 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mt -133.7 143.2 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -114.11 152.02 31.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.235 -0.916 . . . . 0.0 111.208 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 53.57 70.04 0.64 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.778 -0.577 . . . . 0.0 111.152 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -113.84 -8.16 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.958 -1.089 . . . . 0.0 109.653 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.43 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.3 pt-20 -69.32 -20.43 63.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 110.518 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.33 -60.76 2.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.043 -1.036 . . . . 0.0 109.732 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.507 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -59.5 -43.77 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.072 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' N ' HG23 ' A' ' 75' ' ' ILE . 50.1 mt -55.42 -39.4 70.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.535 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 1.7 t -59.71 -47.57 85.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.202 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.05 -54.45 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 108.718 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.56 -44.06 62.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.472 -0.767 . . . . 0.0 109.277 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.506 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 15.8 t-160 -55.38 -58.17 8.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.792 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.6 mt -58.63 -37.71 76.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.972 . . . . 0.0 110.001 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 114' ' ' ILE . 10.5 mt -78.12 -7.18 56.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 110.334 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 61.17 53.2 3.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.87 -1.144 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mm -98.03 130.77 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.459 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -117.0 -19.34 9.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.315 -0.866 . . . . 0.0 112.263 -177.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.8 HD22 ' H ' ' A' ' 35' ' ' THR . 1.0 OUTLIER -126.83 111.13 13.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.72 -1.237 . . . . 0.0 110.464 -179.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -165.66 137.93 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 109.889 179.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.518 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.5 m -111.01 99.67 8.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mp -89.86 110.36 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -85.99 123.05 30.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.24 115.66 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.999 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.78 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -99.32 108.76 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.54 -163.16 24.69 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.24 -16.05 11.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.491 -1.005 . . . . 0.0 110.143 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 19' ' ' HIS . 15.7 tt0 -138.47 145.33 40.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 110.219 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 96' ' ' ILE . 28.5 mm -67.91 127.13 93.33 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.55 -0.719 . . . . 0.0 109.426 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.701 ' CD ' HD21 ' A' ' 26' ' ' LEU . 62.5 Cg_exo -45.94 128.9 11.82 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.851 1.701 . . . . 0.0 111.953 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.413 HD11 ' HA2' ' A' ' 101' ' ' GLY . 8.5 tp -77.45 -28.21 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.299 -0.876 . . . . 0.0 109.672 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.436 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 14.4 mt 55.21 -109.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 110.145 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.54 -19.17 20.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.728 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 112.61 -12.35 25.44 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 p -116.46 -169.3 1.59 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -1.047 . . . . 0.0 109.707 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -110.59 -4.72 28.27 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' A' ' 108' ' ' GLU . 52.7 t-105 -46.98 -39.52 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.738 -0.86 . . . . 0.0 110.421 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -61.25 -51.47 68.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.0 110.07 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -65.48 -43.58 89.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.053 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.8 t80 -63.25 -37.34 86.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 109.565 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HG3' ' CD1' ' A' ' 104' ' ' TRP . 5.3 mm-40 -65.58 -54.85 22.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 0.0 111.898 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.5 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.732 -1.23 . . . . 0.0 111.135 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.13 -45.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -57.41 -29.69 64.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -80.19 -12.97 59.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.148 -0.97 . . . . 0.0 109.887 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -120.76 34.62 5.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.831 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.613 ' CD1' HD22 ' A' ' 82' ' ' LEU . 7.2 mt -87.47 147.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 110.586 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.494 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.5 OUTLIER -88.69 144.05 26.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.533 ' NE2' ' OE2' ' A' ' 33' ' ' GLU . 9.7 mt-30 -107.27 -160.57 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.796 . . . . 0.0 109.207 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -120.44 3.37 10.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.274 -0.891 . . . . 0.0 110.735 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.419 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -95.94 151.16 19.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.854 -1.154 . . . . 0.0 109.966 -179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.5 141.06 29.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -0.941 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 85' ' ' THR . 64.0 mt -83.31 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.531 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -90.79 93.14 9.1 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.94 146.92 53.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.797 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -104.62 128.7 52.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.39 142.84 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.96 134.07 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -114.72 -10.74 12.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.35 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -143.1 144.06 27.3 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.15 148.76 39.91 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.223 1.949 . . . . 0.0 113.031 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.911 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.9 tt -139.05 151.59 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.578 -0.701 . . . . 0.0 109.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.03 119.76 37.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.321 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.82 117.28 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.03 142.49 35.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.86 . . . . 0.0 108.96 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.85 120.3 3.41 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.605 -1.31 . . . . 0.0 112.298 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 44.97 42.91 6.75 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.0 112.345 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.64 1.94 85.06 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.387 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -102.76 163.88 11.96 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 139' ' ' ILE . 2.6 tt -160.14 146.49 15.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.357 -1.464 . . . . 0.0 109.276 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.887 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.8 mt -145.91 129.7 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.34 139.39 51.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.911 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -117.34 151.57 36.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 108.925 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -150.34 139.52 13.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.0 145.82 97.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.692 1.595 . . . . 0.0 112.14 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.52 153.28 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.1 4.05 32.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.928 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -141.22 151.35 43.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.73 119.04 23.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.858 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -138.69 135.02 34.37 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.679 ' CG1' HD23 ' A' ' 231' ' ' LEU . 5.4 t -133.26 117.67 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 109.826 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.4 OUTLIER -103.83 133.87 48.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.198 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 224' ' ' VAL . 8.8 t80 -122.42 130.25 52.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.623 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -115.67 106.97 14.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.8 134.66 11.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -108.07 85.01 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -1.075 . . . . 0.0 109.232 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -92.12 144.14 25.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -95.96 -1.22 49.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 109.187 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.632 HD21 HD12 ' A' ' 159' ' ' LEU . 29.3 p-10 -71.32 -167.77 0.26 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.237 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -60.96 -23.25 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.632 HD12 HD21 ' A' ' 157' ' ' ASN . 55.5 mt -71.13 -22.78 62.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.166 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.1 -134.17 52.37 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -98.18 144.36 27.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.462 -1.022 . . . . 0.0 109.005 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -152.46 170.5 19.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.35 153.59 23.75 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.832 . . . . 0.0 109.381 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -138.21 130.31 28.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 165' ' ' THR . 14.5 t -102.42 123.13 45.63 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 110.052 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -99.13 134.58 41.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.405 -0.809 . . . . 0.0 108.871 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.89 149.59 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -51.04 116.86 2.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.211 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.18 5.51 17.1 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -134.66 29.97 3.49 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.193 -1.18 . . . . 0.0 108.974 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 175' ' ' VAL . 8.8 mt-10 -64.39 -35.17 80.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.568 -0.708 . . . . 0.0 110.854 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.2 -16.98 37.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.979 -1.076 . . . . 0.0 110.766 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 81.2 mt-10 -85.48 -3.71 58.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 110.337 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -124.03 -33.86 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.0 111.411 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -60.97 -29.98 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.479 -1.388 . . . . 0.0 110.424 -179.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -87.48 2.66 49.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.72 -1.238 . . . . 0.0 110.517 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.56 115.19 20.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.873 -1.142 . . . . 0.0 108.957 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.429 ' H ' ' HG2' ' A' ' 178' ' ' ARG . 26.6 ptt180 -86.48 153.03 22.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.863 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.0 t -59.93 131.35 50.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 109.848 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -109.89 172.62 6.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 109.855 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.78 159.04 40.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.429 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 58.6 m-85 -104.25 144.35 31.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.754 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.5 OUTLIER -60.35 -24.36 65.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 110.535 -179.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.597 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.5 p90 -82.07 -32.0 30.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.73 -1.231 . . . . 0.0 110.449 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.597 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 18.3 pt-20 -86.55 -16.65 36.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.815 -1.178 . . . . 0.0 109.566 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.7 mt -57.57 -53.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.23 -50.74 58.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.775 -1.203 . . . . 0.0 109.738 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -52.73 -48.11 66.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.008 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 9.9 mt -60.29 -34.31 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.1 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -77.8 -29.37 50.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -21.97 53.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.047 -1.033 . . . . 0.0 110.201 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 194' ' ' LEU . 30.1 m -89.15 11.14 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.958 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.04 25.39 69.15 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.773 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.413 HD12 ' CG2' ' A' ' 192' ' ' VAL . 28.2 mt -124.52 162.98 22.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.119 -1.224 . . . . 0.0 109.87 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.466 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.32 22.93 66.67 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.189 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -69.43 -21.04 63.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.652 -1.499 . . . . 0.0 109.779 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.0 -2.91 51.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.33 129.3 40.08 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.199 -1.177 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.01 176.81 8.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.783 -0.834 . . . . 0.0 109.257 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.34 -11.97 57.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.937 . . . . 0.0 109.72 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 14.0 tttm -92.96 -4.73 52.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 201' ' ' LYS . 10.1 m120 -134.06 -13.82 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 109.736 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.9 m -128.35 126.29 40.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.541 HD12 ' CG ' ' A' ' 213' ' ' ASN . 7.1 tp -84.4 110.33 18.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 108.866 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.59 132.15 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.587 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.14 152.72 32.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.82 161.56 15.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -50.65 -24.67 3.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.97 12.61 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.4 ttpt -144.43 152.5 40.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.115 -0.991 . . . . 0.0 110.228 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.98 127.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -73.46 -54.1 9.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 110.275 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.541 ' CG ' HD12 ' A' ' 204' ' ' LEU . 3.7 m120 -56.0 133.51 74.01 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.981 -1.074 . . . . 0.0 109.723 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.58 -13.06 27.3 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.37 -7.82 57.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.99 . . . . 0.0 109.89 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -167.24 51.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.7 144.3 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 110.097 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.595 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -79.86 -20.82 45.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 108.793 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 37.1 m-85 -148.53 154.91 40.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.59 -12.97 4.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 108.754 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.682 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -143.73 36.69 1.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.261 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.599 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -59.84 -35.43 28.84 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.0 Cg_exo -70.89 -46.2 0.82 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.87 1.713 . . . . 0.0 112.562 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 151' ' ' TYR . 1.8 m -73.87 -22.63 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.804 -1.185 . . . . 0.0 108.195 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.682 ' NH1' ' ND2' ' A' ' 221' ' ' ASN . 5.5 mtt180 -69.88 -40.65 75.55 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.5 -42.9 95.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 108.911 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -45.62 80.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.452 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 81.3 t -61.42 -45.12 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.535 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.4 t80 -53.77 -36.68 62.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -75.02 -40.05 60.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.632 -0.667 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.679 HD23 ' CG1' ' A' ' 149' ' ' VAL . 27.0 tp -56.32 -37.73 70.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.208 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.506 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 85.3 mt -71.6 -48.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.6 -31.86 23.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -82.98 -26.63 31.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.941 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 260' ' ' VAL . 4.3 mt -79.39 -23.58 43.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.883 -1.136 . . . . 0.0 110.2 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.466 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 7.0 t80 -70.43 -6.43 35.65 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.033 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 237' ' ' LEU . 24.3 mt -53.34 -28.76 30.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.18 -18.06 23.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.0 108.73 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.96 70.64 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.5 p -156.29 150.76 20.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.118 -1.225 . . . . 0.0 109.357 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 5.4 Cg_endo -52.84 136.48 59.59 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.092 1.862 . . . . 0.0 111.572 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.4 t -102.24 138.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.221 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -125.61 128.42 47.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.768 . . . . 0.0 109.078 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.4 175.99 28.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -106.55 109.68 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.172 . . . . 0.0 109.732 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.0 m-85 -111.41 149.3 31.42 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.771 0.796 . . . . 0.0 110.835 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -126.26 144.43 50.79 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 150' ' ' THR . 0.7 OUTLIER -136.58 125.55 24.3 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 120.751 -1.218 . . . . 0.0 110.232 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 250' ' ' ARG . 26.8 t80 -112.74 111.86 22.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 249' ' ' PHE . 26.5 mtp180 47.54 56.54 6.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.22 149.29 21.93 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.49 -174.6 15.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.43 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 71.1 m-70 -74.45 -42.41 59.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -1.144 . . . . 0.0 109.687 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -34.92 79.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.723 ' HG ' HD12 ' A' ' 139' ' ' ILE . 49.8 tp -72.76 -39.22 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.927 -1.108 . . . . 0.0 109.059 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -60.58 -50.6 72.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.298 -0.876 . . . . 0.0 108.897 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.23 -45.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -55.29 -48.87 73.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.134 -0.979 . . . . 0.0 109.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.555 HD22 HG21 ' A' ' 139' ' ' ILE . 27.0 tp -52.61 -43.76 65.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.435 HG22 HD23 ' A' ' 235' ' ' LEU . 24.3 t -69.96 -40.71 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -59.53 -50.13 75.08 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 110.132 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.0 -43.91 73.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.175 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 263' ' ' LEU . 30.0 mt -57.35 -48.8 78.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -55.82 -44.27 77.73 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.608 -0.683 . . . . 0.0 109.664 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.5 mttm . . . . . 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 0.0 109.457 -179.865 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 31.0 mt-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 133.9 55.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 110.102 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -138.33 175.42 9.59 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.42 141.18 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.203 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -72.55 -44.24 62.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.51 -0.744 . . . . 0.0 110.055 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.95 160.16 35.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.738 . . . . 0.0 110.225 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 130.31 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.585 -0.697 . . . . 0.0 109.984 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.413 HD21 ' ND2' ' A' ' 113' ' ' ASN . 13.0 mt -114.95 169.81 8.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -0.783 . . . . 0.0 108.998 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -157.98 148.15 20.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.956 -1.09 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -129.69 168.0 17.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -154.93 135.05 13.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 109.182 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.79 158.23 15.41 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.544 HG23 ' C ' ' A' ' 22' ' ' GLU . 8.9 p -80.95 141.52 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -1.094 . . . . 0.0 110.749 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.68 148.4 41.73 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -70.02 -40.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.0 113.043 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.0 m-70 -86.04 -38.58 17.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 119.79 -1.819 . . . . 0.0 111.858 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -85.84 -27.21 25.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.713 -1.242 . . . . 0.0 109.157 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 63.79 25.49 69.16 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.544 ' C ' HG23 ' A' ' 16' ' ' VAL . 3.0 tp10 -106.26 148.96 27.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.506 -0.996 . . . . 0.0 109.182 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -70.78 129.89 40.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.741 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.5 t -138.9 156.98 46.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.915 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.505 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.5 tttt -133.22 153.48 51.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 109.206 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.515 HD21 ' CD ' ' A' ' 97' ' ' PRO . 3.2 mt -127.84 147.66 50.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.428 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.472 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.9 mt -137.91 122.41 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -112.13 127.4 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.554 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 2.4 m-70 -119.98 148.8 47.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.94 161.64 15.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.015 1.81 . . . . 0.0 111.096 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 5.7 mm-40 -135.02 -172.27 3.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.69 155.41 18.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.738 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 33' ' ' GLU . 40.3 mp0 -46.78 142.68 3.2 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.598 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.69 29.89 64.91 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.372 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 25.9 m -80.66 -37.56 30.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.631 -1.511 . . . . 0.0 108.67 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.03 -177.54 35.37 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.6 mm -100.85 124.67 54.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.02 140.09 36.13 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.311 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.11 150.01 20.71 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.487 ' CD1' ' OE1' ' A' ' 90' ' ' GLU . 16.7 t80 -134.36 139.91 45.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.36 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 16.7 ttpt -174.02 147.33 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.642 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.6 29.45 15.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.8 73.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -135.97 143.01 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 0.0 109.352 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -101.45 146.03 28.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.51 94.55 10.56 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.017 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -48.93 145.0 14.24 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.337 2.025 . . . . 0.0 111.854 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.97 81.28 5.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.92 -1.112 . . . . 0.0 110.463 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.68 155.46 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.026 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.2 p80 -52.22 -49.38 64.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.917 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 11.3 mt-10 -44.0 -16.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.197 -0.939 . . . . 0.0 110.164 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.8 m-85 -97.45 2.9 50.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 50' ' ' HIS . 52.1 t -62.83 119.37 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.059 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.56 -29.36 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.855 . . . . 0.0 109.986 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 3.0 t-160 -150.82 120.82 7.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.962 . . . . 0.0 109.652 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.2 p -111.94 133.04 54.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 16.1 p-10 -166.61 -153.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' ASN . 5.2 m170 -47.47 -11.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.118 -0.989 . . . . 0.0 108.694 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -139.22 166.49 24.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.5 m -101.38 120.69 40.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.52 134.97 54.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.189 -0.945 . . . . 0.0 111.238 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.569 HD12 HG21 ' A' ' 72' ' ' VAL . 29.6 mt -123.69 156.5 35.8 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.73 145.44 7.96 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.028 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -144.67 151.5 39.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.539 -0.977 . . . . 0.0 109.891 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 55.47 24.02 6.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -0.834 . . . . 0.0 110.894 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.71 1.23 68.36 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.557 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.494 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 29.9 mm100 -96.59 137.46 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.889 -1.36 . . . . 0.0 108.299 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -130.76 144.62 51.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.23 -0.919 . . . . 0.0 111.358 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.2 mt -130.81 140.22 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -114.13 145.64 41.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 56.06 68.82 0.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.785 -0.572 . . . . 0.0 111.46 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 HD12 ' A' ' 62' ' ' LEU . 34.5 m -113.92 -3.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.097 -1.002 . . . . 0.0 108.99 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.491 ' OE1' ' OD1' ' A' ' 234' ' ' ASP . 10.8 pt-20 -69.45 -33.05 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.456 ' CE1' ' CE1' ' A' ' 226' ' ' HIS . 17.6 m170 -61.9 -59.9 4.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 110.099 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.9 tp -55.47 -41.73 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.669 -1.269 . . . . 0.0 108.515 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 79' ' ' LEU . 70.3 mt -60.68 -35.05 75.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.478 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 47.1 t -61.04 -49.25 78.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.413 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 23.2 t -58.52 -52.81 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.03 -1.044 . . . . 0.0 108.594 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 76' ' ' LEU . 22.6 mt -50.77 -43.11 58.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 108.999 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.546 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.0 t-160 -54.28 -56.19 20.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.578 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.35 -36.7 76.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.963 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' A' ' 84' ' ' ILE . 35.2 mt -79.31 -9.38 59.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.14 61.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.431 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 82' ' ' LEU . 12.2 mm -102.38 132.29 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 48.4 p -118.82 -22.54 7.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.264 -0.897 . . . . 0.0 111.889 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.72 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.4 m-80 -129.39 111.69 13.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.279 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.5 m -164.86 135.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.868 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.48 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 44.1 m -103.28 99.66 9.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 mt -86.82 120.94 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.89 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.487 ' OE1' ' CD1' ' A' ' 40' ' ' PHE . 7.8 mt-10 -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.813 -1.179 . . . . 0.0 108.1 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' ' CD ' ' A' ' 41' ' ' LYS . 60.0 t -105.63 107.22 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.101 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.63 109.14 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.58 -160.25 23.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.24 -15.9 7.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -1.008 . . . . 0.0 110.415 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.5 pm0 -131.94 137.6 48.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.22 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mm -68.75 129.6 92.34 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 109.768 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.515 ' CD ' HD21 ' A' ' 26' ' ' LEU . 50.3 Cg_exo -46.83 129.07 14.13 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.407 2.072 . . . . 0.0 112.782 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 16' ' ' VAL . 7.6 tp -76.93 -25.93 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.448 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 70.6 mt 55.33 -116.07 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.45 -0.781 . . . . 0.0 109.988 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.03 -18.09 22.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.115 -0.991 . . . . 0.0 110.13 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 -16.74 19.1 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -108.33 -169.72 1.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -1.098 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.97 -3.94 21.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.469 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 64.9 t-105 -46.68 -39.18 10.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.785 -0.832 . . . . 0.0 110.418 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.06 -51.75 66.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 109.728 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 62.5 m-85 -62.61 -45.92 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.828 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.01 -37.41 84.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.693 -0.629 . . . . 0.0 110.097 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.1 mm-40 -69.91 -48.81 57.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.313 -0.867 . . . . 0.0 111.773 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.29 -51.27 13.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.793 -1.192 . . . . 0.0 111.273 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.5 mt -62.81 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.984 -1.073 . . . . 0.0 110.875 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.18 -29.89 61.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 0.0 110.194 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.66 -13.59 56.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.064 -1.023 . . . . 0.0 110.08 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.413 ' ND2' HD21 ' A' ' 11' ' ' LEU . 3.2 m-20 -118.0 32.2 6.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.44 -0.787 . . . . 0.0 111.206 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 82' ' ' LEU . 7.6 mt -86.57 148.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.534 -1.354 . . . . 0.0 110.029 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.1 tp -131.26 158.17 41.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -103.09 142.01 34.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.62 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -109.08 -167.09 1.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 110.104 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -118.75 69.05 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.407 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.581 ' O ' ' N ' ' A' ' 4' ' ' GLU . 23.4 ttt85 -165.78 143.91 5.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -83.84 128.8 34.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.583 HG12 HG21 ' A' ' 85' ' ' THR . 79.0 mt -71.09 140.69 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.0 86.7 7.15 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -61.83 146.06 50.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 110.769 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.77 121.83 42.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.72 138.63 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.8 t -81.81 139.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.25 -10.57 8.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.441 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -141.12 125.61 10.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.141 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -51.12 154.33 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.007 1.804 . . . . 0.0 113.124 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.602 HG22 ' HB3' ' A' ' 141' ' ' ALA . 2.4 tt -145.49 146.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.649 -0.657 . . . . 0.0 109.638 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.55 119.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.66 120.49 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.257 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -123.0 142.07 51.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 110.517 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 1.5 t70 178.03 153.32 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 58.6 mm-40 56.37 23.55 7.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.868 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.05 7.76 86.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.546 ' HB2' HD22 ' A' ' 255' ' ' LEU . 69.7 mtt180 -105.16 168.6 8.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.0 tt -160.78 152.42 19.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.117 -1.614 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.985 ' N ' HD23 ' A' ' 138' ' ' LEU . 17.9 mt -148.78 142.53 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.036 . . . . 0.0 108.74 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -130.0 137.52 50.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 0.0 109.598 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -116.98 151.67 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -150.05 137.22 11.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.53 144.97 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.189 1.259 . . . . 0.0 111.964 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.29 149.84 10.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.336 -0.852 . . . . 0.0 109.369 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.46 -0.33 52.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.268 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.4 p -133.29 142.77 48.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 242' ' ' VAL . 16.4 tp -78.5 119.64 22.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.764 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -139.43 139.58 37.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.862 . . . . 0.0 108.77 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.522 ' CG1' HD23 ' A' ' 231' ' ' LEU . 13.9 t -137.86 122.68 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.169 -0.957 . . . . 0.0 109.543 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 99.8 m -111.37 141.11 45.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.951 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.499 ' HE2' HG12 ' A' ' 224' ' ' VAL . 10.5 t80 -125.56 130.27 51.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.611 -0.68 . . . . 0.0 109.896 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 16.6 tt0 -113.17 107.39 15.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.44 ' C ' ' OE2' ' A' ' 154' ' ' GLU . . . -107.14 131.37 10.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.577 ' H ' HH11 ' A' ' 250' ' ' ARG . 0.9 OUTLIER -117.8 88.25 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -1.004 . . . . 0.0 109.053 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 3.6 m-30 -85.98 148.67 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.112 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -87.25 -10.49 52.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.687 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.48 HD21 HD12 ' A' ' 159' ' ' LEU . 17.8 p-10 -66.18 -167.01 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -64.97 -23.08 67.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.48 HD12 HD21 ' A' ' 157' ' ' ASN . 9.3 mt -56.74 -50.45 72.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.997 -1.065 . . . . 0.0 109.188 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.93 -121.78 6.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 140.2 50.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.534 -0.98 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -153.15 131.66 12.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.839 . . . . 0.0 109.467 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 149.67 39.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.544 -0.722 . . . . 0.0 109.163 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -134.83 121.07 20.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.086 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 165' ' ' THR . 10.1 t -100.9 123.1 44.6 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.14 -0.975 . . . . 0.0 110.199 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.0 t80 -100.88 134.43 43.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 108.852 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.469 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.3 t -130.88 149.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.507 -0.746 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.69 122.68 10.38 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.55 -14.95 17.59 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.93 32.3 6.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 108.555 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.76 -34.33 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 110.474 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.9 -15.36 8.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 110.691 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.596 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 13.7 mm-40 -91.07 -4.01 56.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 110.823 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -125.0 10.22 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.945 -1.097 . . . . 0.0 111.199 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -27.99 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.853 -1.154 . . . . 0.0 109.604 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -88.5 3.72 49.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.082 . . . . 0.0 110.638 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.97 123.01 27.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.808 -1.182 . . . . 0.0 109.018 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -95.56 155.42 16.75 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.12 -0.987 . . . . 0.0 110.23 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 t -56.34 155.31 7.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.784 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.526 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 26.4 p90 -139.66 168.29 20.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.047 -1.033 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.526 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -162.7 162.27 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -102.82 147.55 26.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.719 ' HA ' HD12 ' A' ' 186' ' ' ILE . 6.9 p-10 -64.27 -19.53 65.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.933 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.496 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 2.8 p90 -81.79 -26.01 34.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.67 -1.269 . . . . 0.0 110.449 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.415 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 25.9 pt-20 -96.8 -17.29 20.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.926 -1.109 . . . . 0.0 109.36 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.5 mt -56.86 -51.41 68.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.47 -0.769 . . . . 0.0 110.326 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -51.21 -52.26 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.995 -1.066 . . . . 0.0 109.553 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.747 ' O ' HG13 ' A' ' 192' ' ' VAL . 7.6 m80 -52.94 -45.03 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.107 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.37 -33.71 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 109.025 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -78.82 -25.7 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.894 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -80.73 -26.68 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 188' ' ' HIS . 4.6 m -82.06 7.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.721 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 83.76 20.18 60.22 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.139 -0.976 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.63 163.93 20.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.055 -1.262 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.478 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.77 17.83 74.28 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.063 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -66.32 -22.18 66.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.695 -1.473 . . . . 0.0 110.279 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.31 -5.87 51.79 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.38 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.47 124.66 35.35 Favored Glycine 0 N--CA 1.491 2.366 0 O-C-N 121.055 -1.262 . . . . 0.0 110.697 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.0 p -135.44 171.94 13.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.718 -0.872 . . . . 0.0 109.204 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.1 mt -76.48 -13.74 60.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 16.9 tttp -89.05 -8.55 53.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.672 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 37.1 m-20 -141.12 12.83 2.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.5 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 8.2 m -148.99 117.75 6.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 109.564 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.704 HD21 HD23 ' A' ' 217' ' ' LEU . 7.3 tp -79.89 115.38 19.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -0.979 . . . . 0.0 109.185 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.3 t -100.61 125.3 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 217' ' ' LEU . 3.8 mt -103.43 147.05 27.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.28 148.4 16.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 207' ' ' GLY . 51.9 mttm -42.32 -29.66 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -1.191 . . . . 0.0 110.045 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -147.34 11.97 1.03 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.0 110.57 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.5 tttp -147.44 156.69 43.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.023 . . . . 0.0 109.998 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.467 HG11 ' HA2' ' A' ' 216' ' ' GLY . 62.6 t -103.11 128.25 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.5 -54.28 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.46 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.462 ' CG ' HD12 ' A' ' 204' ' ' LEU . 14.7 m120 -55.02 137.16 66.63 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.002 -1.062 . . . . 0.0 109.577 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.16 -19.04 26.57 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.346 2.031 . . . . 0.0 112.545 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 109.927 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.61 -165.74 53.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.704 HD23 HD21 ' A' ' 204' ' ' LEU . 26.5 mt -79.13 145.05 33.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -1.089 . . . . 0.0 109.639 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -71.49 -57.41 4.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 108.877 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.687 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 13.1 m-85 -117.05 148.85 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.462 -0.774 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.09 -13.98 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.933 . . . . 0.0 109.164 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -132.84 38.77 3.37 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.868 0.842 . . . . 0.0 108.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.511 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.6 tp10 -57.34 -48.48 97.27 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 111.265 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 33.3 Cg_endo -69.47 -37.95 9.12 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.525 1.483 . . . . 0.0 113.218 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.499 HG12 ' HE2' ' A' ' 151' ' ' TYR . 1.8 m -79.39 -25.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.609 -1.307 . . . . 0.0 108.506 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 16.4 mtp180 -67.72 -43.75 79.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.542 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 56.2 t60 -62.86 -41.59 99.44 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -43.23 81.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 108.779 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 224' ' ' VAL . 60.7 t -65.8 -47.54 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 42.5 t80 -49.86 -47.54 51.69 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' CD2' ' A' ' 226' ' ' HIS . 2.8 m-20 -70.61 -35.19 72.83 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.522 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.1 tp -55.55 -35.97 66.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 108.41 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.487 HG22 ' HD1' ' A' ' 80' ' ' HIS . 74.4 mt -70.15 -48.16 63.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.03 -34.44 16.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.503 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 6.1 m-20 -80.58 -27.08 37.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.993 -1.298 . . . . 0.0 109.665 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -82.54 -26.31 32.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.111 . . . . 0.0 109.593 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.546 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 21.7 t80 -67.14 -7.69 25.32 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.985 . . . . 0.0 108.635 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 237' ' ' LEU . 39.3 mt -50.24 -30.05 10.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 242' ' ' VAL . 96.5 mt -56.79 -19.88 19.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 108.712 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.83 16.29 73.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 83.1 p -158.79 145.16 12.57 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.991 -1.3 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.438 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 82.4 Cg_exo -41.06 129.49 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.343 2.029 . . . . 0.0 111.924 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 238' ' ' LEU . 81.9 t -97.11 130.51 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -117.91 123.09 44.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 172.58 24.86 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.26 112.19 25.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.177 -1.19 . . . . 0.0 109.95 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.2 m-85 -112.22 147.58 35.9 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.989 0.9 . . . . 0.0 110.931 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 139' ' ' ILE . 28.1 t80 -131.85 134.71 46.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.17 128.9 44.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.86 -1.15 . . . . 0.0 110.218 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 250' ' ' ARG . 6.6 t80 -112.01 115.17 28.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.577 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.2 mmp_? 48.28 56.28 7.64 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.55 152.54 20.88 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -119.49 -169.9 14.37 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.478 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 89.5 m-70 -78.9 -49.59 12.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.256 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -33.93 71.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 137' ' ' ARG . 42.6 tp -72.89 -40.0 65.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 108.612 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 88.2 m-20 -60.0 -51.24 70.52 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.31 -43.89 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.41 -0.806 . . . . 0.0 109.148 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -54.4 -47.68 72.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.041 . . . . 0.0 108.832 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.12 -46.35 72.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.3 -44.92 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 109.413 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -51.69 -51.71 53.88 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 110.161 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.57 -49.5 76.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.102 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.94 -42.55 98.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.489 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.4 84.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.336 -0.853 . . . . 0.0 109.858 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.9 mttm . . . . . 0 N--CA 1.489 1.516 0 O-C-N 120.944 -1.098 . . . . 0.0 108.755 179.298 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 132.82 55.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -133.6 174.41 10.46 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.9 m -83.26 132.3 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.343 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -62.32 -49.21 76.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.541 -0.724 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -126.12 155.58 41.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.548 -0.72 . . . . 0.0 110.42 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -59.53 137.57 57.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.957 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.96 162.16 19.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.56 145.68 25.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.979 -1.075 . . . . 0.0 109.971 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.432 ' C ' ' OE1' ' A' ' 14' ' ' GLU . 67.3 m-85 -128.96 161.43 29.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.752 . . . . 0.0 109.158 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 13' ' ' PHE . 4.3 pm0 -151.47 132.47 14.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.871 -1.143 . . . . 0.0 108.73 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.01 157.69 15.44 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.015 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.48 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 3.3 p -74.32 160.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -1.133 . . . . 0.0 111.317 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.05 138.69 14.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.101 -1.235 . . . . 0.0 112.236 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.494 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.2 m-70 -86.57 -37.36 18.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.103 -1.623 . . . . 0.0 110.729 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -76.22 -40.11 52.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.012 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.48 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 73.42 4.72 65.46 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.41 152.4 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.37 -1.076 . . . . 0.0 108.985 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 16.0 t80 -73.6 133.49 43.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.01 . . . . 0.0 110.141 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -137.47 157.82 45.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.175 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.711 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.7 ttmt -132.8 155.7 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.305 -0.872 . . . . 0.0 109.136 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 25' ' ' LYS . 1.9 mt -132.17 144.19 50.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.4 mt -134.57 123.35 41.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mt -111.73 127.58 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 109.811 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -119.63 152.67 53.63 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.66 157.8 40.38 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.275 1.983 . . . . 0.0 111.474 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.499 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.2 mm-40 -131.84 -173.15 3.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.233 -0.917 . . . . 0.0 109.832 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 9.5 tttt -91.66 153.77 19.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.587 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.64 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 28.1 mp0 -47.99 146.25 2.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.03 59.97 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.685 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.557 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 55.2 m -81.59 -36.96 28.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.516 -1.579 . . . . 0.0 108.875 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.534 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 92.47 -170.24 32.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 mm -100.73 124.2 54.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.26 143.17 44.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -104.26 153.25 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.8 t80 -129.48 140.79 51.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 136.42 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.021 -1.05 . . . . 0.0 109.681 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.57 29.2 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.891 . . . . 0.0 110.097 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.54 78.51 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.218 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.31 134.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -1.117 . . . . 0.0 109.74 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -86.25 147.59 26.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' A' ' 67' ' ' GLN . 10.5 mt -143.1 94.66 6.28 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.82 142.72 14.22 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.191 1.927 . . . . 0.0 111.848 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.54 87.42 4.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.066 -1.021 . . . . 0.0 110.345 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.51 159.24 42.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 109.418 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.671 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 3.3 p80 -53.3 -49.68 66.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -48.28 -16.14 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.048 -1.033 . . . . 0.0 110.224 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' HIS . 32.8 m-85 -97.45 5.77 49.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 109.597 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.407 ' HA ' HD23 ' A' ' 62' ' ' LEU . 15.7 t -64.2 122.71 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.861 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 m -112.61 -29.53 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -146.36 118.17 8.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.867 -1.146 . . . . 0.0 110.354 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -110.88 126.97 55.26 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 40.3 t-20 -166.36 -153.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.478 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 63.6 m-70 -46.69 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.053 . . . . 0.0 108.499 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.4 t -139.18 165.84 26.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.499 -0.751 . . . . 0.0 109.327 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.46 ' OG1' ' CD ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -108.82 125.34 51.86 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.89 146.33 49.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.04 0.924 . . . . 0.0 111.397 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 53' ' ' VAL . 16.6 mt -125.92 156.33 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -175.36 147.57 8.96 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 118.203 -1.951 . . . . 0.0 111.446 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -144.48 149.5 36.07 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.773 -0.84 . . . . 0.0 109.282 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.99 32.54 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.322 -0.861 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.82 6.82 89.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.614 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.534 ' HB2' HD11 ' A' ' 46' ' ' ILE . 86.8 mm-40 -106.63 140.17 39.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -1.227 . . . . 0.0 107.886 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.403 ' CZ ' HD21 ' A' ' 94' ' ' ASN . 23.3 ptt-85 -143.22 159.74 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.031 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.26 139.55 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -108.52 148.09 30.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 0.0 111.243 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m 56.53 70.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.691 -0.63 . . . . 0.0 111.16 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.7 -4.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.022 . . . . 0.0 109.169 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.602 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.0 OUTLIER -68.19 -33.15 73.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 0.0 110.838 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.572 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 35.2 m170 -64.13 -60.25 3.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.845 -1.159 . . . . 0.0 109.988 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 76' ' ' LEU . 11.3 tp -55.92 -45.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.853 -1.155 . . . . 0.0 108.751 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.514 ' N ' HG23 ' A' ' 75' ' ' ILE . 47.1 mt -54.71 -40.92 69.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.551 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.0 t -59.61 -46.92 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -58.52 -50.84 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 76' ' ' LEU . 46.2 mt -51.32 -44.13 61.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.845 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.764 ' HD1' HG22 ' A' ' 232' ' ' ILE . 12.1 t-160 -56.89 -49.93 74.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 110.363 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.78 -38.02 89.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.68 HD13 HD11 ' A' ' 114' ' ' ILE . 52.4 mt -81.58 -5.59 58.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.0 111.025 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 62.74 59.09 1.47 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.299 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 82' ' ' LEU . 10.6 mm -98.24 125.18 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.459 HG21 HG23 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -110.97 -23.09 11.17 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.299 -0.876 . . . . 0.0 111.394 -178.042 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.559 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.4 m120 -131.19 112.17 12.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -162.01 138.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.326 -0.859 . . . . 0.0 109.404 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 26.5 m -111.17 99.42 8.27 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.75 112.74 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.396 -0.815 . . . . 0.0 109.536 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -90.29 119.83 30.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.2 t -102.84 106.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 110.936 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mp -86.75 109.79 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.78 -158.65 22.32 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.403 HD21 ' CZ ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -122.13 -14.27 7.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.966 . . . . 0.0 110.137 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -134.86 140.18 45.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 110.452 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.35 126.95 93.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.695 ' CD ' HD21 ' A' ' 26' ' ' LEU . 69.4 Cg_exo -46.36 128.52 12.39 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.865 1.71 . . . . 0.0 112.003 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 tp -76.24 -22.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.807 . . . . 0.0 109.724 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 73.5 mt 54.84 -118.36 1.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -94.3 -11.03 30.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 110.225 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.04 32.53 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.4 p -115.51 -169.47 1.58 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -1.039 . . . . 0.0 109.785 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.56 0.62 24.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.575 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 67.5 t-105 -46.52 -44.25 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.737 -0.861 . . . . 0.0 110.584 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -60.21 -51.36 69.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.785 -1.197 . . . . 0.0 109.719 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -61.18 -45.64 93.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 109.154 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -60.56 -39.92 89.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.962 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.575 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -74.24 -42.93 58.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 111.43 -179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.9 35.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.871 -1.143 . . . . 0.0 110.883 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 110' ' ' ILE . 53.9 mt -70.96 -39.57 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.991 -1.068 . . . . 0.0 110.853 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -56.11 -31.42 63.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.801 -1.187 . . . . 0.0 109.745 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -83.97 -5.29 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 0.0 110.221 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -126.62 31.37 5.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.423 -0.798 . . . . 0.0 111.309 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 82' ' ' LEU . 4.7 mt -89.2 145.53 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.474 -1.391 . . . . 0.0 109.601 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.6 tp -131.97 158.64 40.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -106.96 145.5 32.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.113 -0.992 . . . . 0.0 109.525 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -112.39 -163.82 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 109.989 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -118.1 69.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 110.438 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.489 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -161.58 140.69 9.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -81.56 126.4 31.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.07 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.459 HG23 HG21 ' A' ' 85' ' ' THR . 66.7 mt -73.48 143.0 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 110.55 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -92.9 97.26 10.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.7 146.53 52.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.63 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -99.76 123.53 44.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 243' ' ' LYS . 12.0 t -125.5 140.88 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.302 -0.874 . . . . 0.0 110.303 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 51.0 t -83.93 137.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.134 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -116.05 -11.55 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.524 -0.735 . . . . 0.0 109.252 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.05 144.92 39.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.12 172.75 14.12 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.266 1.977 . . . . 0.0 112.814 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.66 HG23 ' HB3' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -165.24 142.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.619 -0.676 . . . . 0.0 109.53 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.1 mt -127.99 126.86 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 109.555 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 132' ' ' VAL . 14.7 m -125.29 119.03 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.772 . . . . 0.0 109.679 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -117.42 138.23 51.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.364 -0.835 . . . . 0.0 109.7 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -172.1 142.69 1.44 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.001 -1.062 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 56.1 28.25 12.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.612 -0.68 . . . . 0.0 111.187 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.53 86.95 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 251' ' ' GLY . 6.7 mtt85 -104.68 168.05 9.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.98 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -160.66 149.55 16.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.066 -1.646 . . . . 0.0 109.459 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.98 ' N ' HD23 ' A' ' 138' ' ' LEU . 56.0 mt -149.39 136.11 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.02 -1.05 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -126.28 142.74 51.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.66 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -123.68 145.63 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -142.78 136.62 14.47 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.94 146.95 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.552 1.501 . . . . 0.0 112.142 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.72 152.76 8.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.171 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.4 1.75 47.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 109.642 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.4 p -137.44 145.21 42.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.584 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 242' ' ' VAL . 58.2 tp -79.09 116.81 19.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.938 . . . . 0.0 109.678 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -137.62 135.95 37.06 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.476 HG11 HD23 ' A' ' 231' ' ' LEU . 95.8 t -136.85 127.02 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 109.758 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 m -114.13 128.45 56.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.365 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.514 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.6 t80 -115.3 129.42 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.52 -0.738 . . . . 0.0 109.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -115.27 105.62 13.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.86 132.88 11.39 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -115.37 84.12 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.992 . . . . 0.0 108.977 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.9 m-30 -93.14 148.78 21.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.422 ' HZ2' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -85.18 -13.28 50.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.239 -179.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 159' ' ' LEU . 9.4 p-10 -66.18 -175.23 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.054 -1.029 . . . . 0.0 109.633 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -55.02 -18.37 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.752 ' H ' ' ND2' ' A' ' 157' ' ' ASN . 20.4 mt -66.79 -32.31 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.954 -1.091 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.5 -118.08 12.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -115.11 138.95 50.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.987 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -150.14 153.48 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 150.88 41.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -134.84 124.17 24.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 m -96.96 121.9 39.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.98 -1.075 . . . . 0.0 110.015 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -98.81 135.07 40.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.141 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.55 150.7 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 0.0 109.475 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -53.02 117.05 2.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.394 -0.817 . . . . 0.0 109.248 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.51 5.62 18.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -132.19 27.73 4.47 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.212 -1.17 . . . . 0.0 108.57 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.84 -31.44 72.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.533 -0.73 . . . . 0.0 110.572 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.3 -15.82 39.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.993 -1.067 . . . . 0.0 110.907 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -91.52 -4.28 55.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.694 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.64 16.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.088 -1.007 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.48 -34.29 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.021 -1.049 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.7 2.44 45.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.379 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.99 112.96 18.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.788 -1.195 . . . . 0.0 108.94 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 100' ' ' ASP . 5.8 ptp180 -85.9 152.93 22.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.574 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.4 t -53.98 159.02 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.328 -0.857 . . . . 0.0 109.227 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.3 p90 -139.94 168.09 20.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.019 -1.05 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.648 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -156.72 160.0 38.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.15 -0.969 . . . . 0.0 109.749 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.59 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 93.8 m-85 -103.47 146.6 28.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 0.0 109.746 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.702 ' HA ' HD12 ' A' ' 186' ' ' ILE . 26.4 p-10 -59.99 -24.27 64.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.109 -0.994 . . . . 0.0 110.884 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.1 p90 -80.44 -28.78 37.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.748 -1.22 . . . . 0.0 110.682 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 22.4 pt-20 -93.6 -13.84 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.702 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.9 mt -59.32 -53.74 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.83 -38.03 54.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.815 -1.178 . . . . 0.0 109.212 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 192' ' ' VAL . 1.8 t-80 -61.17 -59.33 5.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.25 -0.906 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.5 mt -53.76 -33.19 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -75.0 -25.36 58.76 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -83.1 -31.68 27.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.165 -0.96 . . . . 0.0 111.028 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 188' ' ' HIS . 0.5 OUTLIER -77.97 12.54 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.606 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.65 58.32 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.168 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 5.1 mt -127.09 165.34 19.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.063 -1.257 . . . . 0.0 110.16 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.14 23.0 64.34 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.238 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -68.58 -22.32 64.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.599 -1.53 . . . . 0.0 109.504 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -5.65 50.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.31 126.86 36.7 Favored Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.124 -1.221 . . . . 0.0 110.837 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.78 -173.53 3.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.82 -0.812 . . . . 0.0 109.202 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 29.4 mt -90.18 -12.8 37.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.657 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -89.5 -3.47 58.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -145.12 13.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.696 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.648 HG22 ' SG ' ' A' ' 181' ' ' CYS . 0.8 OUTLIER -149.26 117.48 6.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.609 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.415 HD12 ' CG ' ' A' ' 213' ' ' ASN . 8.3 tp -79.0 115.72 18.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.68 123.99 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 109.596 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.741 HD21 HD21 ' A' ' 217' ' ' LEU . 18.0 mt -103.1 149.21 24.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.89 153.5 17.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -48.35 -24.96 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -1.203 . . . . 0.0 109.891 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.87 13.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 110.208 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 207' ' ' GLY . 13.5 pttt -149.62 159.7 44.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.958 -1.089 . . . . 0.0 109.734 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.479 HG11 ' HA2' ' A' ' 216' ' ' GLY . 46.2 t -107.45 130.39 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.205 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -73.13 -53.04 12.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 109.721 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.567 HD22 ' H ' ' A' ' 213' ' ' ASN . 2.0 m-80 -54.09 139.74 53.89 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 109.557 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.14 -31.71 11.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.476 2.117 . . . . 0.0 112.796 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.43 -9.91 59.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.135 -0.978 . . . . 0.0 110.185 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.33 -164.49 53.83 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.741 HD21 HD21 ' A' ' 206' ' ' LEU . 22.4 mt -73.6 141.59 46.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 0.0 109.847 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 15.8 mtt180 -81.81 -13.87 57.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 108.956 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 38.5 m-85 -147.8 142.25 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -0.782 . . . . 0.0 109.125 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.473 ' N ' ' OE1' ' A' ' 220' ' ' GLU . 2.0 mm-40 -49.66 -11.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.038 . . . . 0.0 108.398 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -141.88 43.49 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.073 0.94 . . . . 0.0 108.803 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.1 tt0 -62.89 -36.87 28.45 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 0.0 111.928 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.4 Cg_endo -76.72 -41.07 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.398 1.398 . . . . 0.0 112.521 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 228' ' ' VAL . 4.0 m -75.82 -23.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.869 -1.144 . . . . 0.0 108.231 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -70.36 -46.71 63.55 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.574 ' CE1' ' N ' ' A' ' 179' ' ' THR . 22.5 t60 -58.06 -42.4 85.41 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 108.91 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.68 -43.33 94.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.018 -1.052 . . . . 0.0 109.0 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 224' ' ' VAL . 52.3 t -60.1 -47.03 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 108.745 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 47.4 t80 -49.79 -45.2 49.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.742 -0.599 . . . . 0.0 109.513 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 5.9 m-20 -73.82 -33.48 64.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.476 HD23 HG11 ' A' ' 149' ' ' VAL . 22.4 tp -56.68 -39.17 73.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 0.0 108.679 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.764 HG22 ' HD1' ' A' ' 80' ' ' HIS . 36.1 mt -71.27 -47.97 57.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.07 -32.87 9.63 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -82.28 -26.81 32.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.199 -1.177 . . . . 0.0 109.798 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 260' ' ' VAL . 5.4 mt -83.22 -23.58 32.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.851 -1.156 . . . . 0.0 109.908 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.503 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 35.0 t80 -73.52 -9.03 58.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -51.16 -25.95 6.07 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 108.589 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.3 -17.81 5.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.61 13.94 74.55 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 71.9 p -158.79 145.93 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.935 -1.332 . . . . 0.0 110.009 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.421 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 73.0 Cg_exo -41.96 135.36 3.8 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.229 1.953 . . . . 0.0 111.655 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.507 ' O ' HD13 ' A' ' 147' ' ' LEU . 20.5 t -103.77 132.77 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.9 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.549 ' HB2' HG22 ' A' ' 125' ' ' VAL . 10.3 mmtm -121.05 125.51 47.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.63 179.47 32.56 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -105.37 138.98 40.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.336 -1.097 . . . . 0.0 109.737 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.7 m-85 -140.67 144.59 35.76 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.066 0.936 . . . . 0.0 111.298 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -129.27 144.23 51.15 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 127.84 20.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.643 -1.286 . . . . 0.0 110.745 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -112.83 114.67 27.31 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 51.18 55.67 9.15 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.468 ' O ' ' NE ' ' A' ' 137' ' ' ARG . . . -63.39 -167.74 0.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -169.59 165.52 38.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.602 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 21.2 m-70 -70.91 -52.32 20.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -1.18 . . . . 0.0 109.68 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -54.32 47.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 108.703 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 139' ' ' ILE . 48.8 tp -51.45 -40.83 60.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -58.57 -55.19 38.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -0.98 . . . . 0.0 108.592 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 61.7 t -48.94 -42.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.517 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -50.0 71.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.8 tp -52.16 -43.2 63.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.684 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.447 HG22 HD23 ' A' ' 235' ' ' LEU . 46.2 t -69.83 -46.2 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.15 -51.5 64.08 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.652 -0.655 . . . . 0.0 110.147 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.62 -45.43 86.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.013 -1.054 . . . . 0.0 109.571 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 263' ' ' LEU . 16.5 mt -58.69 -46.91 86.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.745 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.16 -30.12 68.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.79 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt . . . . . 0 N--CA 1.49 1.526 0 O-C-N 120.602 -1.311 . . . . 0.0 108.856 179.485 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 119' ' ' ARG . 9.8 mm-40 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -117.34 132.51 56.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 0.0 109.369 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -134.16 173.71 11.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.373 -0.829 . . . . 0.0 109.106 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -81.78 144.36 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.173 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG3' HD13 ' A' ' 115' ' ' LEU . 18.2 ttpp -78.37 -42.36 30.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.711 . . . . 0.0 110.379 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.92 157.82 43.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.494 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -63.39 133.87 54.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.518 -0.739 . . . . 0.0 109.849 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 113' ' ' ASN . 20.4 mt -121.04 163.22 18.66 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -155.31 149.38 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -128.84 164.76 22.36 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -148.28 133.04 17.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 108.573 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.38 163.38 23.32 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.74 149.22 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 148.4 39.65 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -67.06 -41.28 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -1.184 . . . . 0.0 112.58 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.523 ' CE1' HG23 ' A' ' 18' ' ' ILE . 4.6 m-70 -86.93 -39.24 15.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.889 -1.757 . . . . 0.0 111.114 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -31.67 64.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.018 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.83 21.22 65.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.96 151.55 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.65 -0.912 . . . . 0.0 109.338 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -72.4 142.96 48.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 t -148.2 158.52 44.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 26' ' ' LEU . 56.5 tttp -133.42 152.85 51.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.009 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.624 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.1 mt -127.81 153.71 46.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.37 128.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.28 124.68 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.163 -0.961 . . . . 0.0 109.699 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -123.62 153.53 66.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.86 163.5 35.25 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.177 1.918 . . . . 0.0 111.171 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 30.2 mm-40 -138.81 -171.81 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.9 ttpm? -88.83 150.54 22.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.478 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.615 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 15.5 mp0 -49.34 149.91 2.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.537 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 59.69 23.66 58.92 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.431 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.47 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 28.9 m -81.8 -46.3 14.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.498 -1.589 . . . . 0.0 109.214 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.548 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 103.19 -170.63 19.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 85' ' ' THR . 4.0 mm -98.9 126.89 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -1.174 . . . . 0.0 107.987 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -139.61 141.13 37.14 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -105.04 155.28 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.4 t80 -130.7 141.76 50.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -170.26 137.03 1.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.091 -1.005 . . . . 0.0 109.838 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.41 31.93 19.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.921 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.38 21.24 74.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.76 133.33 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.999 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -91.11 143.99 26.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.1 mt -137.75 97.69 10.04 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.09 143.16 32.84 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.169 1.913 . . . . 0.0 111.416 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.84 81.34 5.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.877 -1.139 . . . . 0.0 110.396 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -139.29 156.4 47.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.5 p80 -55.07 -50.04 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -44.9 -15.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.001 -1.062 . . . . 0.0 110.192 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' HIS . 65.5 m-85 -99.14 6.12 46.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.98 -1.075 . . . . 0.0 109.629 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' A' ' 50' ' ' HIS . 31.7 t -58.65 131.66 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 108.844 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.81 -35.16 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.315 -0.866 . . . . 0.0 109.833 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -152.23 123.1 7.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.496 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -113.3 133.14 55.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.627 -0.67 . . . . 0.0 109.311 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.1 p-10 -166.81 -153.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.521 ' N ' ' CG ' ' A' ' 57' ' ' ASN . 55.8 m-70 -47.07 -12.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.055 -1.028 . . . . 0.0 108.623 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -135.02 165.75 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.553 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.413 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 52.3 m -102.51 121.38 42.24 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -118.49 135.39 54.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 111.52 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -124.1 161.05 26.41 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.55 147.32 7.25 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.395 -1.86 . . . . 0.0 111.454 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -144.68 151.21 38.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.572 -0.958 . . . . 0.0 109.407 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 58.77 24.24 12.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.499 -0.751 . . . . 0.0 110.96 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.421 ' C ' HE21 ' A' ' 67' ' ' GLN . . . 90.26 1.31 75.59 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.642 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.488 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.0 mm-40 -103.15 140.15 37.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.006 -1.29 . . . . 0.0 108.394 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.28 157.17 45.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.51 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.6 mt -133.86 143.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -115.06 155.95 26.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.292 -0.88 . . . . 0.0 111.38 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m 53.85 65.09 1.61 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.705 -0.622 . . . . 0.0 111.129 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.446 HG12 ' CG1' ' A' ' 96' ' ' ILE . 18.1 m -113.85 -4.34 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.045 -1.035 . . . . 0.0 109.475 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.581 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 7.1 pt-20 -65.16 -34.69 79.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.879 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -59.28 -60.07 4.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.0 110.207 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.8 tp -58.46 -46.73 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.825 -1.172 . . . . 0.0 109.197 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 10.8 mt -51.97 -42.18 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.019 -1.051 . . . . 0.0 109.566 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 44.9 t -59.49 -47.45 85.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.191 -0.943 . . . . 0.0 110.02 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.44 -54.08 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.979 -1.075 . . . . 0.0 108.623 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.9 mt -52.2 -45.23 65.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.321 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.425 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 8.2 t-160 -53.11 -58.12 8.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.4 mt -59.61 -35.04 73.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.702 HD22 ' CD1' ' A' ' 114' ' ' ILE . 12.9 mt -83.02 -1.47 52.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.88 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 61.92 26.7 16.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.729 -1.232 . . . . 0.0 110.75 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 82' ' ' LEU . 15.4 mm -73.36 118.89 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 108.313 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.456 HG21 ' OE2' ' A' ' 4' ' ' GLU . 47.9 p -101.98 -75.41 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 111.135 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.4 m120 -81.67 113.52 19.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 111.638 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.1 m -163.86 143.35 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.711 . . . . 0.0 109.283 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.568 HG22 ' OE1' ' A' ' 90' ' ' GLU . 4.0 m -111.15 104.5 13.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.411 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.74 112.9 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.568 ' OE1' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -89.33 118.99 29.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.65 108.63 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 111.142 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.57 -178.99 16.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -99.96 -10.61 21.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.272 . . . . 0.0 110.962 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -139.35 143.99 38.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.736 -1.227 . . . . 0.0 110.639 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.446 ' CG1' HG12 ' A' ' 72' ' ' VAL . 9.8 mm -71.3 131.34 86.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.349 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.624 ' CD ' HD21 ' A' ' 26' ' ' LEU . 53.0 Cg_exo -46.65 131.43 15.92 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.005 1.804 . . . . 0.0 112.499 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 tp -79.95 -29.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.424 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 88.8 mt 56.18 -116.0 0.97 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 109.702 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.26 -7.48 41.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.89 -9.71 56.83 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 p -111.18 -172.21 1.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -1.024 . . . . 0.0 109.78 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.84 -2.96 20.43 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -46.53 -41.29 14.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.733 -0.863 . . . . 0.0 111.011 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.89 -51.67 67.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.223 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.3 m-85 -62.95 -45.38 92.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.066 -1.021 . . . . 0.0 109.029 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.67 -39.21 87.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.19 -44.8 59.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 111.397 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.73 -48.35 22.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.035 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.08 -42.53 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.083 . . . . 0.0 111.08 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -57.44 -28.21 63.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.027 -1.046 . . . . 0.0 109.982 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -78.81 -14.63 59.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 109.996 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 11' ' ' LEU . 12.5 m-80 -120.45 34.14 5.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.439 -0.788 . . . . 0.0 110.809 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.702 ' CD1' HD22 ' A' ' 82' ' ' LEU . 15.0 mt -87.41 148.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.665 -1.272 . . . . 0.0 111.155 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD13 ' HG3' ' A' ' 8' ' ' LYS . 13.9 tp -131.75 165.48 23.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -118.76 142.58 47.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.29 -0.881 . . . . 0.0 109.92 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.27 -161.65 0.88 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.317 -0.864 . . . . 0.0 109.228 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -117.17 0.37 12.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 0.0 110.401 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 4' ' ' GLU . 24.0 ttm-85 -94.73 150.04 20.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -87.57 135.56 33.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 110.015 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 85' ' ' THR . 66.1 mt -77.63 145.53 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.729 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.46 96.41 9.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -69.64 147.13 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.69 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.16 127.06 47.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 243' ' ' LYS . 48.3 t -131.36 145.23 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.17 135.29 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -116.44 -11.84 11.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.778 . . . . 0.0 109.162 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -141.36 141.57 23.68 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 108.849 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.96 145.84 46.02 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.958 1.772 . . . . 0.0 113.007 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.888 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.7 tt -138.01 149.11 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.62 -0.675 . . . . 0.0 109.186 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.95 122.94 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 109.915 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.44 124.94 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -123.64 140.6 52.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.602 -0.686 . . . . 0.0 110.286 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.76 154.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.244 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 56.62 22.75 7.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.601 -0.687 . . . . 0.0 110.872 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.442 ' O ' ' NH2' ' A' ' 250' ' ' ARG . . . 77.37 6.63 86.64 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.497 ' HB2' HD22 ' A' ' 255' ' ' LEU . 2.5 mtt85 -107.84 172.09 7.03 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -159.79 153.22 22.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.213 -1.554 . . . . 0.0 109.563 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 138' ' ' LEU . 2.2 mt -144.14 143.87 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.57 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -132.51 136.91 46.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.888 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -117.38 146.1 43.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -144.15 137.73 14.3 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 143.83 77.25 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.406 1.404 . . . . 0.0 111.718 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.03 148.05 11.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.235 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -1.28 46.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -134.91 143.91 47.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 242' ' ' VAL . 34.0 tp -76.88 118.24 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.001 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -139.42 138.29 36.37 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.46 ' CG1' HD23 ' A' ' 231' ' ' LEU . 55.4 t -133.94 129.05 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.402 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 32.6 m -115.8 135.85 53.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.346 -0.846 . . . . 0.0 109.309 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 224' ' ' VAL . 8.1 t80 -128.84 131.8 47.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -116.86 107.49 14.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.79 124.23 7.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.66 91.58 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -1.066 . . . . 0.0 109.426 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.496 ' HB2' HD21 ' A' ' 157' ' ' ASN . 21.2 m-85 -88.97 148.5 23.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.631 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -95.88 -2.19 47.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.894 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.611 HD22 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -72.98 -173.36 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 109.461 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -59.53 -27.58 66.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.96 . . . . 0.0 109.917 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.624 HD22 ' NE2' ' A' ' 162' ' ' GLN . 7.6 mt -57.89 -45.01 87.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 108.938 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.67 -135.95 13.36 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -110.03 144.72 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.533 -0.981 . . . . 0.0 109.68 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.624 ' NE2' HD22 ' A' ' 159' ' ' LEU . 12.2 mt-30 -151.44 149.2 29.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.73 150.56 52.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.16 142.74 34.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 108.859 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.8 m -124.18 130.32 52.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.858 . . . . 0.0 110.417 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -99.38 130.81 45.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.6 151.3 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 109.168 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.75 115.67 2.29 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.506 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.56 3.28 20.67 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -130.97 29.58 4.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -1.165 . . . . 0.0 108.898 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -62.65 -35.15 78.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 110.699 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -53.39 -14.72 0.82 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.958 -1.089 . . . . 0.0 110.949 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.532 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 23.4 mt-10 -97.4 -4.24 38.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.75 -1.219 . . . . 0.0 111.543 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.8 pt -119.87 12.51 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.879 -1.138 . . . . 0.0 111.614 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.51 -28.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.891 -1.13 . . . . 0.0 109.854 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 2.65 54.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.979 -1.076 . . . . 0.0 111.259 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.473 ' HB2' ' NH1' ' A' ' 225' ' ' ARG . . . -80.41 132.89 35.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.619 -1.3 . . . . 0.0 108.554 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.64 156.55 18.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.151 -0.968 . . . . 0.0 110.626 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.1 t -57.8 156.16 9.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.643 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 49.6 p90 -140.33 166.36 24.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.192 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.533 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -157.12 160.37 38.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.492 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 71.3 m-85 -103.22 144.63 31.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.5 p-10 -60.89 -22.91 64.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 0.0 111.7 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.4 p90 -75.16 -38.64 60.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.403 . . . . 0.0 111.172 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.689 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -91.58 -10.07 41.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.536 -1.352 . . . . 0.0 110.224 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 183' ' ' ASP . 3.2 mt -53.87 -51.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.961 -1.087 . . . . 0.0 109.449 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -52.33 -46.39 66.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 108.726 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.03 -52.85 63.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 186' ' ' ILE . 72.3 mt -54.53 -33.99 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -78.77 -27.67 44.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.649 . . . . 0.0 109.713 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -73.49 -26.92 61.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.0 . . . . 0.0 109.71 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 192' ' ' VAL . 13.6 m -83.24 10.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.307 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 25.13 74.01 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.539 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.96 156.99 29.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.103 -1.234 . . . . 0.0 109.856 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.95 25.12 56.63 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.368 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -68.69 -21.61 64.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.589 -1.536 . . . . 0.0 109.58 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.79 -6.37 49.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -58.0 130.64 51.31 Favored Glycine 0 N--CA 1.492 2.422 0 O-C-N 121.207 -1.172 . . . . 0.0 110.582 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 203' ' ' THR . 4.5 p -141.88 163.87 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.7 -0.882 . . . . 0.0 109.089 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.4 mt -64.11 -35.09 79.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.986 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -73.25 -17.31 61.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.35 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.4 m-20 -125.53 6.72 7.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.194 -0.941 . . . . 0.0 109.991 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.533 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 24.2 m -148.94 116.22 6.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.702 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 tp -76.11 113.59 13.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.7 t -103.3 126.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.973 -1.079 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 16.2 mt -108.25 141.75 39.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -97.7 135.7 12.33 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 7.5 ttpt -40.02 -21.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -1.069 . . . . 0.0 110.264 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 207' ' ' GLY . 14.9 t0 -141.67 2.28 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.746 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 207' ' ' GLY . 31.0 mttt -149.25 157.5 43.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 0.0 110.576 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.87 126.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -73.52 -55.2 6.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.485 HD22 ' H ' ' A' ' 213' ' ' ASN . 2.5 m-80 -52.75 110.31 1.89 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -54.63 -11.89 3.8 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.752 1.635 . . . . 0.0 111.924 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.26 -6.82 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.783 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.52 -164.09 51.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.5 mt -82.53 143.32 31.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -1.013 . . . . 0.0 110.041 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -89.29 -19.94 24.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.147 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 141.03 33.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.552 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 1.6 pm0 -54.59 -16.65 2.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.04 -1.038 . . . . 0.0 108.597 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.3 40.3 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.797 0.808 . . . . 0.0 109.131 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.465 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 10.6 tt0 -56.4 -56.97 26.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 111.606 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 18.4 Cg_endo -59.42 -37.1 91.87 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.995 1.797 . . . . 0.0 113.406 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.509 HG12 ' CE2' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -82.38 -28.2 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 120.549 -1.344 . . . . 0.0 108.756 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 173' ' ' GLU . 6.3 mtp-105 -65.32 -41.14 94.31 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.597 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 21.3 t60 -65.35 -41.34 93.98 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -56.47 -43.83 79.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.076 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.16 -49.35 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 109.115 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 44.6 t80 -50.07 -43.4 51.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.668 0.747 . . . . 0.0 109.067 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.597 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.6 m-20 -72.86 -36.37 67.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.484 -0.76 . . . . 0.0 109.842 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.46 HD23 ' CG1' ' A' ' 149' ' ' VAL . 24.1 tp -56.1 -35.73 67.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.943 -1.098 . . . . 0.0 108.507 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.8 -48.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.65 -32.34 10.74 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.485 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 4.9 m-20 -82.71 -26.76 31.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -1.199 . . . . 0.0 109.908 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 260' ' ' VAL . 7.0 mt -78.22 -22.62 48.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.8 -1.187 . . . . 0.0 110.088 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -71.63 -7.6 48.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 109.217 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 237' ' ' LEU . 37.7 mt -52.6 -30.51 31.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.955 . . . . 0.0 108.797 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.676 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 97.1 mt -57.95 -15.8 10.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.148 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.33 14.47 78.64 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 p -155.57 150.43 20.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.153 -1.204 . . . . 0.0 109.256 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 6.9 Cg_endo -53.67 132.46 49.27 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.145 1.896 . . . . 0.0 111.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.422 ' O ' HD22 ' A' ' 147' ' ' LEU . 15.2 t -98.62 137.76 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.811 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.421 ' HB3' HG22 ' A' ' 125' ' ' VAL . 9.0 ttmt -127.79 131.28 49.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.382 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.31 -177.84 31.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -108.83 111.1 22.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -1.158 . . . . 0.0 109.66 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.9 m-85 -112.13 149.17 32.55 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.019 0.914 . . . . 0.0 111.171 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.402 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 21.9 t80 -130.13 144.31 51.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.1 t -142.42 128.09 19.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.657 -1.277 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -110.43 115.53 29.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.442 ' NH2' ' O ' ' A' ' 136' ' ' GLY . 5.5 mtm180 49.64 56.15 8.29 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.9 141.45 21.72 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -117.19 -179.69 17.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.581 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 38.7 m-70 -73.95 -52.26 13.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.99 -1.3 . . . . 0.0 109.628 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -35.02 70.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 109.292 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 137' ' ' ARG . 28.7 tp -73.34 -41.51 63.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 108.735 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.5 m-20 -60.57 -51.36 69.77 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 253' ' ' HIS . 46.2 t -51.51 -43.75 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 0.0 109.03 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -55.45 -47.84 75.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.969 -1.082 . . . . 0.0 109.136 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.44 -50.29 62.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 235' ' ' LEU . 54.1 t -63.08 -53.77 42.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.716 0.77 . . . . 0.0 109.329 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -46.77 -51.18 16.89 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.694 -0.629 . . . . 0.0 110.314 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.99 -35.62 79.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.7 -1.25 . . . . 0.0 109.89 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 263' ' ' LEU . 84.7 mt -70.8 -42.92 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.862 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.676 ' HB2' ' CD2' ' A' ' 238' ' ' LEU . . . -77.96 -28.02 49.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 110.082 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.6 mttt . . . . . 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 108.921 179.394 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 64.2 mt-10 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -119.94 142.63 48.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -141.86 171.81 13.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.48 -0.762 . . . . 0.0 109.058 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 7' ' ' VAL . 3.5 m -81.68 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.946 -1.096 . . . . 0.0 110.229 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' HG3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -70.37 -46.81 63.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 10' ' ' LYS . 1.8 tm-20 -128.66 159.05 36.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.44 -0.787 . . . . 0.0 110.571 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.578 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 5.3 ttpp -59.89 133.94 56.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.6 mt -121.04 160.75 22.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -157.02 149.55 23.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.944 -1.098 . . . . 0.0 110.558 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -129.53 166.38 19.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.02 133.58 11.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.891 -1.13 . . . . 0.0 108.74 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.32 156.64 12.68 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.09 159.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 111.218 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.9 140.61 15.12 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 197' ' ' GLY . 4.4 tt -58.66 -50.53 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.128 -1.219 . . . . 0.0 111.972 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.495 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 18.4 m-70 -86.13 -38.85 17.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.312 -1.492 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.0 p -72.72 -36.54 67.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 110.157 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.57 68.21 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -116.19 153.94 30.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.589 -0.948 . . . . 0.0 108.736 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 25.5 t80 -71.05 129.34 38.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.072 -1.017 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 t -132.14 157.8 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 108.945 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.702 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.7 tttm -135.01 152.7 51.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.221 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.4 mt -130.14 148.07 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.556 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.6 mt -135.05 129.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.2 mt -115.03 125.73 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 109.891 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.556 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.8 m-70 -124.23 149.5 60.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.62 160.73 31.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.181 1.921 . . . . 0.0 111.247 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.1 mm-40 -134.3 -179.21 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.762 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 22.0 tptt -79.97 147.87 31.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -48.32 150.89 1.16 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 -179.701 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 60.9 20.36 57.34 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.24 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 23.9 m -80.89 -46.01 15.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.611 -1.523 . . . . 0.0 109.053 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.44 -167.19 16.47 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 85' ' ' THR . 4.3 mm -102.53 124.11 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.336 -1.096 . . . . 0.0 108.147 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.07 153.17 49.33 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.8 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' A' ' 89' ' ' ILE . 42.4 m-85 -114.64 154.4 28.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.554 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.8 t80 -130.83 138.78 50.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.011 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 4.2 ttmt -168.87 138.14 2.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 60.36 28.63 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.929 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.91 30.61 70.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.27 131.11 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.884 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.65 144.5 29.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 108.947 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.441 HG23 ' CB ' ' A' ' 64' ' ' PHE . 19.8 mt -140.86 99.16 6.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.398 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.67 145.56 48.28 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.135 1.89 . . . . 0.0 111.324 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.25 86.85 4.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.781 -1.199 . . . . 0.0 110.511 -178.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -138.62 154.59 48.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 0.0 109.391 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.453 ' HA ' HG23 ' A' ' 53' ' ' VAL . 11.2 p80 -52.1 -45.94 65.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.795 . . . . 0.0 110.262 -179.381 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -48.27 -30.94 5.28 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.231 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -82.44 4.48 24.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.486 ' HA ' HD23 ' A' ' 62' ' ' LEU . 5.5 t -61.79 128.1 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 108.74 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.34 -30.3 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.23 -0.919 . . . . 0.0 110.487 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' A' ' 57' ' ' ASN . 4.9 t-160 -153.61 122.26 6.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.92 -1.113 . . . . 0.0 109.566 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 p -113.67 131.73 56.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.639 -0.663 . . . . 0.0 109.286 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 43.8 t-20 -167.29 -154.0 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.544 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 73.3 m-70 -45.53 -15.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.106 -0.996 . . . . 0.0 108.643 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.8 t -134.04 165.33 25.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.56 -0.712 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.5 m -103.22 122.06 43.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 108.724 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -120.34 138.42 53.73 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.092 0.948 . . . . 0.0 111.487 -178.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' VAL . 82.5 mt -120.19 163.83 17.14 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.8 142.75 5.21 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 118.453 -1.832 . . . . 0.0 111.159 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.441 ' CB ' HG23 ' A' ' 46' ' ' ILE . 47.1 t80 -144.86 150.35 36.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.856 . . . . 0.0 109.281 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? 55.4 35.92 26.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 110.749 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.14 2.25 88.75 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.493 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.6 mm100 -98.44 144.23 28.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.254 . . . . 0.0 108.44 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 7.2 ptm85 -142.11 147.43 36.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.022 -1.049 . . . . 0.0 111.331 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.12 143.1 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -114.08 152.47 31.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.003 -1.06 . . . . 0.0 111.013 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 53.21 66.22 1.29 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.694 -0.629 . . . . 0.0 110.734 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 m -113.48 -3.65 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.004 . . . . 0.0 109.132 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -70.37 -28.24 64.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.497 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 25.0 m170 -66.77 -59.85 3.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.058 -1.026 . . . . 0.0 109.767 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.565 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.5 tp -57.75 -45.03 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.845 -1.159 . . . . 0.0 108.764 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.565 ' N ' HG23 ' A' ' 75' ' ' ILE . 67.9 mt -57.01 -40.99 77.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 0.0 109.807 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.493 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.6 t -58.35 -47.86 82.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 109.476 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.07 -54.33 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 108.542 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.3 mt -52.14 -45.17 64.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.881 ' HD1' HG22 ' A' ' 232' ' ' ILE . 20.3 t-160 -55.99 -58.55 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.566 -0.709 . . . . 0.0 110.066 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.23 -37.02 74.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.662 HD22 HD11 ' A' ' 114' ' ' ILE . 9.3 mt -77.79 -4.78 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 0.0 110.21 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.88 34.55 14.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.424 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 82' ' ' LEU . 18.2 mm -80.4 127.0 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 86' ' ' ASN . 5.9 p -105.17 -77.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 111.456 -177.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.9 m-80 -81.38 113.89 19.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.403 -176.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.8 m -162.82 139.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.483 -0.76 . . . . 0.0 109.622 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 30.8 m -109.15 104.46 13.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 2.5 mp -94.16 105.59 17.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 0.0 109.807 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.92 120.32 25.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 108.49 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.434 HG21 HD11 ' A' ' 96' ' ' ILE . 24.5 t -102.42 110.25 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 111.114 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.49 107.67 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.18 -162.75 24.31 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -114.06 -16.21 12.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -1.045 . . . . 0.0 110.332 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -142.07 147.45 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.54 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 91' ' ' VAL . 46.1 mm -69.28 128.74 92.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.697 ' HD2' HD11 ' A' ' 26' ' ' LEU . 74.4 Cg_exo -45.77 131.4 13.16 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.838 1.692 . . . . 0.0 111.845 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -77.88 -24.84 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.554 -0.716 . . . . 0.0 110.558 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.48 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 8.5 mt 55.43 -119.17 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 57.6 t0 -94.52 -9.46 35.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.494 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.77 -4.88 32.45 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.4 p -118.47 -173.54 2.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -1.05 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 -3.97 20.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -46.67 -36.57 7.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.775 -0.838 . . . . 0.0 110.932 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.0 -52.0 64.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.864 -1.148 . . . . 0.0 110.268 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CZ ' HD11 ' A' ' 99' ' ' LEU . 73.9 m-85 -62.23 -45.02 95.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.07 . . . . 0.0 108.874 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.44 -40.47 86.91 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.496 0.665 . . . . 0.0 109.625 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -72.8 -43.69 62.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 111.733 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.48 -49.66 15.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 111.075 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.34 -41.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -59.02 -28.48 66.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.946 -1.096 . . . . 0.0 110.122 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -78.28 -17.96 55.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.67 34.5 5.18 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.467 -0.771 . . . . 0.0 110.731 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.662 HD11 HD22 ' A' ' 82' ' ' LEU . 9.5 mt -82.92 148.07 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.303 . . . . 0.0 110.526 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 8' ' ' LYS . 10.1 tp -130.67 151.99 50.51 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.603 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -100.39 136.43 40.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.028 -1.045 . . . . 0.0 109.698 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.578 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 18.9 mt-30 -102.63 -166.45 1.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -120.89 72.26 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.416 -0.802 . . . . 0.0 110.923 -179.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 4' ' ' GLU . 14.8 ttm-85 -166.17 145.11 5.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 178.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.64 128.88 34.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.149 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.79 139.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.28 72.83 4.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -51.5 142.54 13.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.528 -0.732 . . . . 0.0 110.097 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -103.82 124.09 48.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 243' ' ' LYS . 26.3 t -127.87 142.77 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 0.0 109.954 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.8 t -81.27 134.68 26.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -117.26 -11.77 10.59 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -139.74 141.66 28.62 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.412 -0.805 . . . . 0.0 108.916 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.26 169.73 20.0 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.162 1.908 . . . . 0.0 113.029 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.839 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.3 tt -163.67 143.48 2.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.469 0.652 . . . . 0.0 109.618 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.23 121.09 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.29 112.38 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.73 125.84 53.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -173.34 157.86 3.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 0.0 110.652 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.455 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 27.1 mt-10 56.63 18.74 3.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 110.771 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.67 -0.22 89.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER -102.88 172.28 6.92 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.963 HD23 ' N ' ' A' ' 139' ' ' ILE . 4.8 tt -160.24 145.82 15.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.441 -1.412 . . . . 0.0 108.669 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.963 ' N ' HD23 ' A' ' 138' ' ' LEU . 59.3 mt -147.92 134.81 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 108.394 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -124.05 144.16 50.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.71 148.81 44.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -148.82 138.72 12.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.14 146.17 60.99 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.462 1.441 . . . . 0.0 112.129 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.14 147.94 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.49 -1.4 37.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.471 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.7 p -136.92 159.36 42.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 109.304 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.574 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 27.0 tp -88.34 121.0 30.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 0.0 109.748 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -138.65 135.15 34.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.507 ' CG1' HD23 ' A' ' 231' ' ' LEU . 73.4 t -137.19 118.5 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.9 m -106.31 136.51 45.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.752 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.685 ' HB2' HG22 ' A' ' 228' ' ' VAL . 83.1 t80 -123.67 128.32 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.469 -0.769 . . . . 0.0 109.488 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' CD ' ' CE2' ' A' ' 249' ' ' PHE . 7.2 tt0 -115.16 104.66 12.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.41 126.68 8.98 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -110.93 84.98 2.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -1.08 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.3 m-30 -90.38 148.97 22.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.132 -0.98 . . . . 0.0 109.407 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -91.83 -5.81 52.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.856 . . . . 0.0 110.739 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.75 HD21 HD12 ' A' ' 159' ' ' LEU . 19.2 p-10 -68.44 -167.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.725 -1.234 . . . . 0.0 109.435 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.8 p90 -59.94 -26.67 66.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.994 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.75 HD12 HD21 ' A' ' 157' ' ' ASN . 6.5 mt -58.92 -51.59 69.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 108.812 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.63 -119.17 5.43 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.94 143.12 51.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.622 -0.928 . . . . 0.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -156.09 146.64 21.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.429 -0.794 . . . . 0.0 109.557 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -126.29 150.83 48.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.0 109.673 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -135.09 118.77 17.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.9 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -94.9 121.82 36.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.043 . . . . 0.0 109.735 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 4.2 t80 -99.73 139.18 35.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.356 -0.84 . . . . 0.0 109.486 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.555 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.7 t -138.94 153.06 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.39 -0.819 . . . . 0.0 109.152 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 98.4 mt-10 -53.58 120.43 6.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.597 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.41 6.68 17.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.48 28.67 1.81 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.159 -1.201 . . . . 0.0 108.671 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -63.93 -35.99 82.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 110.4 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.96 -12.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.168 -0.957 . . . . 0.0 110.517 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -90.9 -4.52 56.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.052 -1.03 . . . . 0.0 110.536 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.55 -7.13 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.164 -0.96 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.13 -29.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.574 -1.328 . . . . 0.0 110.011 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.9 mt -90.03 -1.34 57.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.833 -1.167 . . . . 0.0 110.736 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.58 118.18 20.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.706 -1.246 . . . . 0.0 108.374 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.55 153.01 21.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.0 110.296 -179.02 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.514 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 6.2 t -53.47 158.63 1.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 0.0 109.773 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.545 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 23.3 p90 -143.32 169.44 17.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.635 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -162.09 167.95 23.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 -179.785 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.502 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 86.8 m-85 -104.21 145.08 30.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 109.203 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.601 ' HA ' HD12 ' A' ' 186' ' ' ILE . 51.3 p30 -63.34 -23.49 67.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.277 -0.89 . . . . 0.0 111.426 -178.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.52 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 p90 -79.33 -27.32 42.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.585 -1.322 . . . . 0.0 111.009 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.485 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 26.0 pt-20 -96.45 -13.76 22.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.688 -1.258 . . . . 0.0 109.872 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.6 mt -55.56 -51.65 55.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -52.43 -44.5 65.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.668 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -57.6 -51.5 69.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.943 . . . . 0.0 109.41 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.9 mt -59.45 -34.31 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.134 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -74.43 -27.09 60.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 110.144 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -74.8 -33.51 62.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.018 -1.051 . . . . 0.0 109.921 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.42 12.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 109.226 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.43 25.35 70.66 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.556 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 86.5 mt -117.83 155.08 30.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -1.192 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.495 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.2 27.81 47.44 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.29 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -68.36 -22.46 64.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.667 -1.49 . . . . 0.0 108.929 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -103.14 -4.92 47.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.65 126.0 29.29 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 121.323 -1.104 . . . . 0.0 110.956 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.18 39.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.858 -0.789 . . . . 0.0 109.074 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.61 -13.32 1.55 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.792 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -83.46 -2.22 55.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.06 -1.025 . . . . 0.0 109.423 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -151.18 17.67 0.75 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 108.826 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.635 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 87.4 m -151.89 115.16 4.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.504 -0.747 . . . . 0.0 109.33 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.6 tp -76.57 109.76 10.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.208 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 186' ' ' ILE . 42.6 t -103.17 131.36 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 109.941 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.5 mt -114.28 144.83 42.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.536 -0.728 . . . . 0.0 109.35 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.94 151.07 19.14 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 207' ' ' GLY . 25.7 tttt -41.42 -28.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 110.162 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 209' ' ' ASP . 1.8 p30 -146.4 8.15 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.929 -1.107 . . . . 0.0 110.399 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.6 tttt -141.93 150.61 41.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.832 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.21 127.45 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -70.66 -54.43 11.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.201 -0.937 . . . . 0.0 110.019 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.97 132.86 80.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.05 . . . . 0.0 109.462 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.85 -19.4 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.322 2.015 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.81 -6.04 58.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.669 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.84 -169.29 52.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.53 147.16 42.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.387 -1.066 . . . . 0.0 109.568 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -74.76 -62.64 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 108.848 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 221' ' ' ASN . 11.5 m-85 -117.9 142.78 46.95 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 219' ' ' TYR . 8.6 m-20 -137.7 30.41 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.483 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -60.25 -40.04 73.6 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 16.0 Cg_exo -65.22 -49.6 2.56 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.35 2.034 . . . . 0.0 112.647 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.817 ' O ' HG23 ' A' ' 228' ' ' VAL . 2.5 m -73.17 -22.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.922 -1.111 . . . . 0.0 108.628 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -70.93 -46.11 63.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.514 ' CE1' ' N ' ' A' ' 179' ' ' THR . 26.0 t60 -58.69 -38.45 78.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -42.14 99.59 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.9 t -66.34 -38.9 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.493 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 48.7 t80 -56.48 -51.74 67.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.732 -0.605 . . . . 0.0 109.704 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.497 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 8.2 m-20 -70.14 -30.14 67.24 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.174 -0.954 . . . . 0.0 109.515 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.507 HD23 ' CG1' ' A' ' 149' ' ' VAL . 30.1 tp -56.56 -37.6 70.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.881 HG22 ' HD1' ' A' ' 80' ' ' HIS . 66.0 mt -73.01 -48.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.64 8.33 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.35 -29.62 30.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.728 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.67 HD23 HG22 ' A' ' 260' ' ' VAL . 6.8 mt -79.16 -22.41 45.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.725 -1.234 . . . . 0.0 109.253 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.406 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.2 t80 -70.09 -8.96 53.74 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.1 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.3 mt -52.67 -27.93 19.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 108.818 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.403 HD12 HG22 ' A' ' 242' ' ' VAL . 96.6 mt -55.28 -18.47 6.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.021 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.86 12.54 77.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.0 p -158.51 147.6 14.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.139 -1.212 . . . . 0.0 109.551 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.417 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 57.8 Cg_exo -42.99 135.18 5.42 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.344 2.029 . . . . 0.0 111.975 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.403 HG22 HD12 ' A' ' 238' ' ' LEU . 13.7 t -101.75 133.08 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.702 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.663 ' HB2' HG22 ' A' ' 125' ' ' VAL . 32.4 mmtm -122.11 126.81 49.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.581 -0.699 . . . . 0.0 109.261 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 176.61 29.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -107.07 110.21 22.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -1.231 . . . . 0.0 109.833 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.7 m-85 -112.06 147.43 36.02 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.834 0.826 . . . . 0.0 111.038 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -127.42 144.1 51.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.4 m -134.84 128.11 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.704 -1.248 . . . . 0.0 110.679 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.497 ' CE2' ' CD ' ' A' ' 152' ' ' GLU . 3.0 t80 -112.44 110.58 20.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 6.5 mmm180 47.34 55.75 7.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -178.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.27 142.09 23.71 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -178.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -110.63 159.63 13.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -56.07 -48.93 75.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.241 . . . . 0.0 109.534 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 25.3 p -57.21 -55.16 38.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.192 -0.943 . . . . 0.0 109.106 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.403 ' HG ' HD12 ' A' ' 139' ' ' ILE . 54.5 tp -52.07 -37.29 53.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 4.4 m120 -58.22 -55.7 31.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.093 -1.004 . . . . 0.0 108.855 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.61 -43.1 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.494 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -49.52 71.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 139' ' ' ILE . 9.5 tp -52.71 -41.24 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.67 HG22 HD23 ' A' ' 235' ' ' LEU . 74.2 t -71.97 -50.43 37.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.76 0.791 . . . . 0.0 109.507 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -49.81 -45.06 49.6 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.641 -0.662 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -42.79 70.36 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.479 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 263' ' ' LEU . 36.3 mt -62.05 -43.61 98.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.552 -0.718 . . . . 0.0 110.344 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 22.6 mttm . . . . . 0 N--CA 1.49 1.56 0 O-C-N 120.625 -1.297 . . . . 0.0 108.453 178.992 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.424 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 21.7 mm-40 . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -121.08 139.64 53.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -141.23 177.84 7.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.28 135.18 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 109.815 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -65.66 -45.51 82.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.766 . . . . 0.0 110.322 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.73 157.38 41.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HG3' ' NE2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -64.46 133.66 52.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.11 -179.801 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 113' ' ' ASN . 40.5 mt -118.24 160.14 22.12 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 p -158.1 150.44 22.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.101 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -132.42 174.88 9.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.628 -0.67 . . . . 0.0 109.707 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -150.46 135.51 17.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 108.589 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.76 156.09 12.87 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.901 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 22' ' ' GLU . 8.9 p -80.93 142.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -1.083 . . . . 0.0 110.91 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.24 142.9 36.63 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.0 tt -60.06 -48.01 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -1.145 . . . . 0.0 112.472 -178.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.492 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 9.6 m-70 -86.88 -37.93 17.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.229 -1.544 . . . . 0.0 111.462 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -68.13 -35.1 77.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 0.0 110.135 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.9 71.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.615 ' C ' HG23 ' A' ' 16' ' ' VAL . 32.1 tt0 -118.92 154.81 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 109.242 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -68.4 140.18 55.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 t -147.42 157.08 43.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.041 . . . . 0.0 108.766 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -127.58 161.98 27.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.192 -0.942 . . . . 0.0 110.014 -179.236 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 96' ' ' ILE . 12.9 mt -130.94 143.65 50.88 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.29 127.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.312 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mt -113.45 125.0 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 109.403 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.4 ' NE2' ' HG3' ' A' ' 10' ' ' LYS . 17.2 m-70 -121.47 142.71 36.1 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.545 -0.722 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -53.87 160.07 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.544 1.496 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 76.7 mt-10 -134.77 -178.75 5.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.3 ttmm -85.91 151.44 23.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.592 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -49.81 147.31 3.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 110.447 -179.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.76 21.84 58.89 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.551 -0.718 . . . . 0.0 111.884 178.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 98.5 m -81.19 -46.51 14.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.45 -1.618 . . . . 0.0 109.027 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.765 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 105.45 -168.2 15.29 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mm -101.63 124.66 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -1.112 . . . . 0.0 108.036 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HE ' HG22 ' A' ' 35' ' ' THR . 0.6 OUTLIER -143.16 139.55 30.41 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.765 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -97.16 154.33 17.43 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.6 t80 -129.47 139.94 51.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.751 ' HZ3' ' NE2' ' A' ' 67' ' ' GLN . 46.3 tttm -168.08 137.76 2.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 -179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.14 29.18 18.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 0.0 110.102 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.01 28.36 70.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.8 t -134.08 138.27 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 109.852 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -92.14 142.45 27.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.19 179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -137.42 95.13 11.65 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.439 -179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -48.27 144.97 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.212 1.941 . . . . 0.0 111.652 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.89 84.61 4.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.542 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -141.16 157.02 45.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.008 -1.058 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.1 p80 -52.92 -50.12 64.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -46.55 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 0.0 109.999 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.7 m-85 -99.67 4.81 45.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.463 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 50' ' ' HIS . 5.1 t -63.38 132.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 108.773 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -118.09 -33.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.7 t-160 -147.61 118.6 7.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 110.037 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.2 p -112.66 126.37 55.3 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.7 t-20 -167.06 -152.76 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.584 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 10.7 m-70 -44.21 -16.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 108.586 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.1 t -137.19 165.5 25.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.495 -0.753 . . . . 0.0 109.368 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 m -109.24 125.36 52.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.368 -0.832 . . . . 0.0 108.831 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 1.4 m-20 -125.59 148.02 49.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.994 0.902 . . . . 0.0 111.162 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' A' ' 72' ' ' VAL . 28.1 mt -125.78 161.12 28.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.99 143.59 6.37 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.541 -1.79 . . . . 0.0 110.985 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -144.81 151.85 39.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.629 -0.924 . . . . 0.0 109.72 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.81 29.74 12.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.386 -0.821 . . . . 0.0 110.599 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.52 0.54 86.32 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.569 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.751 ' NE2' ' HZ3' ' A' ' 41' ' ' LYS . 15.9 mm100 -97.01 145.44 25.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.307 . . . . 0.0 108.373 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -143.35 149.58 37.95 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.658 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -132.93 143.17 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -114.05 149.71 35.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.124 -0.985 . . . . 0.0 111.611 -178.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.8 m 53.87 71.6 0.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.716 -0.615 . . . . 0.0 111.054 178.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 62' ' ' LEU . 20.6 m -112.81 -5.83 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.41 -23.87 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -68.98 -60.88 2.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.996 -1.065 . . . . 0.0 109.723 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 76' ' ' LEU . 11.1 tp -59.63 -45.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' N ' HG23 ' A' ' 75' ' ' ILE . 88.3 mt -54.69 -40.77 69.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 0.0 109.68 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.571 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.47 -47.93 83.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.086 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.19 -55.23 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.011 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 mt -52.47 -43.38 64.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.658 ' HD1' HG22 ' A' ' 232' ' ' ILE . 15.8 t-160 -55.53 -58.08 9.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.127 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.486 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 57.5 mt -55.79 -36.66 67.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.267 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.699 HD22 HD11 ' A' ' 114' ' ' ILE . 11.7 mt -79.89 -4.31 51.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 110.461 -178.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER 62.77 38.46 11.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.866 -1.146 . . . . 0.0 110.51 179.628 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 82' ' ' LEU . 16.4 mm -83.31 129.74 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.9 p -107.04 -76.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.235 -0.916 . . . . 0.0 111.129 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.765 HD22 ' H ' ' A' ' 36' ' ' GLY . 2.4 m120 -81.22 113.96 19.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -176.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.05 141.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 109.623 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.551 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -109.01 103.84 12.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.488 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.68 106.03 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.87 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.68 122.01 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.075 -1.016 . . . . 0.0 108.936 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -102.96 104.92 17.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.454 -0.779 . . . . 0.0 110.422 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 92' ' ' ILE . 4.8 mt -86.03 110.84 20.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.176 -0.953 . . . . 0.0 108.582 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.32 -179.23 16.38 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -15.32 22.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.138 . . . . 0.0 110.349 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.4 tt0 -136.07 142.7 44.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.986 -1.071 . . . . 0.0 110.272 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.724 ' CD1' HD21 ' A' ' 26' ' ' LEU . 2.5 mm -68.26 128.41 93.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.765 . . . . 0.0 109.654 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -45.72 127.39 9.89 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.822 1.681 . . . . 0.0 111.834 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 tp -80.1 -22.44 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.76 . . . . 0.0 110.354 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.8 mt 55.72 -118.08 1.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.854 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -94.78 -9.7 33.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.15 -0.968 . . . . 0.0 110.43 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.68 39.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.3 p -115.42 -174.55 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -1.021 . . . . 0.0 109.368 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.23 -6.96 17.55 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.547 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 72.5 t-105 -46.61 -35.21 5.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.678 -0.896 . . . . 0.0 110.09 -179.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.24 -51.52 68.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.906 -1.121 . . . . 0.0 109.968 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CG ' ' CD1' ' A' ' 75' ' ' ILE . 63.1 m-85 -65.03 -44.62 88.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.077 -1.014 . . . . 0.0 108.944 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.43 ' CD2' HG11 ' A' ' 175' ' ' VAL . 9.0 t80 -61.91 -37.81 86.03 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.456 0.646 . . . . 0.0 109.572 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.547 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 24.4 mm-40 -65.38 -52.75 51.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.685 . . . . 0.0 111.595 -178.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.33 -52.24 9.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.216 . . . . 0.0 110.693 -178.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 92.8 mt -50.71 -47.81 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.78 -1.2 . . . . 0.0 110.477 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -57.89 -31.3 66.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -83.78 13.51 4.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.523 ' HB2' HD11 ' A' ' 11' ' ' LEU . 1.1 m-20 -149.46 30.68 0.75 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.699 HD11 HD22 ' A' ' 82' ' ' LEU . 10.0 mt -85.02 147.12 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.949 -1.094 . . . . 0.0 110.426 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.0 tp -131.7 155.69 47.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.488 -0.757 . . . . 0.0 109.161 179.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.8 OUTLIER -110.42 128.2 55.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 179.725 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.498 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -97.02 -165.73 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 118' ' ' ASN . 48.6 p30 -124.77 74.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 110.301 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -161.73 139.93 9.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.057 179.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -47.3 167.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 110.191 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.585 HG21 ' CE1' ' A' ' 123' ' ' TYR . 25.4 mt -126.12 104.23 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.94 71.28 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.429 -0.794 . . . . 0.0 110.154 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.585 ' CE1' HG21 ' A' ' 121' ' ' ILE . 93.8 m-85 -57.4 147.18 26.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -104.71 123.65 47.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 243' ' ' LYS . 5.4 t -129.2 143.43 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.991 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.46 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -113.23 -11.8 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.254 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -141.32 144.71 35.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.8 172.29 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.054 1.836 . . . . 0.0 113.003 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 141' ' ' ALA . 9.9 tt -165.92 145.53 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.348 0.594 . . . . 0.0 109.846 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 131' ' ' ILE . 1.7 mt -128.28 125.24 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.496 -0.753 . . . . 0.0 109.361 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.437 HG23 ' HB ' ' A' ' 139' ' ' ILE . 0.7 OUTLIER -122.73 116.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 110.003 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -107.77 142.26 38.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' CG ' ' OE1' ' A' ' 135' ' ' GLU . 8.4 t70 -168.96 135.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.723 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER 50.94 34.89 11.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 111.509 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.73 8.06 86.2 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -103.15 172.5 6.78 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.2 tt -160.59 148.74 16.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.248 -1.533 . . . . 0.0 109.174 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.945 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.4 mt -146.87 133.78 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 108.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -125.21 138.99 54.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.772 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.95 139.55 53.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -136.25 134.04 19.83 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -53.12 148.87 29.52 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.353 1.369 . . . . 0.0 112.326 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.67 158.39 9.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.882 . . . . 0.0 108.944 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.3 2.65 54.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 109.943 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -138.06 150.03 46.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.539 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.492 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 16.8 tp -83.09 115.12 21.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -136.61 141.92 43.27 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.556 ' CG1' HD23 ' A' ' 231' ' ' LEU . 46.6 t -136.27 133.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.131 -0.981 . . . . 0.0 109.973 -179.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 m -119.1 124.72 47.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.528 ' CE2' HG12 ' A' ' 224' ' ' VAL . 10.0 t80 -115.1 129.85 56.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 109.983 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 153' ' ' GLY . 4.5 tp10 -113.72 105.29 13.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.562 ' N ' ' OE1' ' A' ' 152' ' ' GLU . . . -101.44 145.4 16.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -132.41 85.32 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -1.04 . . . . 0.0 109.589 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.7 m-30 -88.67 148.93 23.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.46 -0.775 . . . . 0.0 109.021 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 mmtt -88.93 -8.72 53.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 11.9 p-10 -66.79 -170.74 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 109.498 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 16.8 p90 -59.4 -24.63 63.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.853 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.456 HD12 HD21 ' A' ' 157' ' ' ASN . 8.5 mt -53.77 -58.39 7.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.005 . . . . 0.0 108.904 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.92 -134.73 11.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.34 142.7 47.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.995 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.438 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 1.3 pt20 -162.12 159.51 26.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 0.0 109.547 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.51 152.97 51.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.469 -0.769 . . . . 0.0 109.315 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -133.75 120.05 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.0 108.815 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 m -98.99 121.93 41.58 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.97 -1.081 . . . . 0.0 110.34 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -95.26 138.12 33.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.57 156.51 42.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.783 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.658 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 4.9 mp0 -60.31 113.69 2.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 109.417 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.4 6.03 18.31 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -130.91 30.23 4.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.294 -1.121 . . . . 0.0 108.836 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 175' ' ' VAL . 6.1 mp0 -63.75 -34.67 78.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.471 -0.768 . . . . 0.0 110.89 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -16.49 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.918 -1.114 . . . . 0.0 110.98 -178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.88 -4.02 55.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.91 -1.119 . . . . 0.0 111.146 -178.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.16 -5.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.031 -1.043 . . . . 0.0 111.107 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -92.59 -28.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.471 -1.393 . . . . 0.0 110.436 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.08 0.95 56.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 0.0 110.964 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.9 123.15 25.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.675 -1.265 . . . . 0.0 108.485 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -91.04 151.73 20.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.673 -1.267 . . . . 0.0 109.797 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 t -62.28 134.37 56.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.45 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.54 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 11.5 p90 -117.33 179.1 4.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 0.0 110.106 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -170.39 166.41 8.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.371 -0.831 . . . . 0.0 109.723 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 31.2 m-85 -103.79 146.11 29.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 0.0 109.244 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.5 OUTLIER -67.67 -17.73 64.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 111.216 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.3 p90 -80.67 -33.42 35.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.518 -1.364 . . . . 0.0 110.549 -179.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.588 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.1 OUTLIER -90.24 -15.73 30.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.762 -1.212 . . . . 0.0 109.504 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.705 HD12 ' HA ' ' A' ' 183' ' ' ASP . 7.6 mt -58.57 -51.24 74.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.47 -50.24 53.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.858 -1.151 . . . . 0.0 109.292 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.04 -52.0 62.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.172 -0.955 . . . . 0.0 108.83 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 61.7 mt -55.29 -34.2 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -0.917 . . . . 0.0 108.953 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -74.18 -32.71 63.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 109.863 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.05 -30.47 70.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.788 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' ' 194' ' ' LEU . 11.7 m -82.82 12.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.97 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.35 70.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.293 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' ' 192' ' ' VAL . 20.1 mt -118.3 156.19 29.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.006 -1.291 . . . . 0.0 109.945 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.492 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.89 25.12 53.82 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.001 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -67.55 -22.18 65.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.671 -1.488 . . . . 0.0 109.488 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -6.02 50.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.57 124.73 35.38 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.133 -1.216 . . . . 0.0 110.516 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.437 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 54.2 p -135.35 -179.7 5.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.825 -0.809 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.0 mt -82.65 -12.42 57.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -91.9 -9.93 41.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.437 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 2.0 m-80 -136.37 7.92 3.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.513 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.2 m -147.28 120.16 8.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.615 HD21 HD23 ' A' ' 217' ' ' LEU . 4.4 tp -84.02 117.87 23.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.984 . . . . 0.0 109.127 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.19 127.67 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 109.593 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 211' ' ' VAL . 4.8 mt -107.06 146.95 30.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.488 -0.757 . . . . 0.0 109.65 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.71 148.54 16.51 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 207' ' ' GLY . 20.4 tttt -41.13 -31.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -1.04 . . . . 0.0 109.918 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 31.9 t0 -145.61 10.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 0.0 110.282 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -144.62 153.67 42.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 109.774 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.501 HG22 HD23 ' A' ' 206' ' ' LEU . 44.7 t -106.3 131.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.091 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -72.6 -54.45 9.09 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.225 -0.922 . . . . 0.0 110.044 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.487 HD22 ' H ' ' A' ' 213' ' ' ASN . 3.3 m-80 -56.18 136.35 74.75 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 0.0 109.34 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.88 -25.82 19.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.311 2.008 . . . . 0.0 112.653 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.516 ' OE2' ' NH1' ' A' ' 218' ' ' ARG . 16.4 tm-20 -80.25 -9.82 59.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -165.52 52.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.615 HD23 HD21 ' A' ' 204' ' ' LEU . 11.8 mt -76.28 141.78 41.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -1.055 . . . . 0.0 109.858 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.516 ' NH1' ' OE2' ' A' ' 215' ' ' GLU . 0.1 OUTLIER -65.02 -52.23 57.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.63 179.25 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.447 ' H ' ' HB2' ' A' ' 222' ' ' GLU . 19.2 m-85 -117.85 176.8 5.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 220' ' ' GLU . 0.4 OUTLIER -76.0 -19.08 58.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.548 ' OD1' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -127.83 35.39 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.469 -0.769 . . . . 0.0 109.104 -179.985 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -59.79 -34.96 24.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 111.126 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.3 Cg_exo -73.87 -43.63 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.808 1.672 . . . . 0.0 112.342 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.528 HG12 ' CE2' ' A' ' 151' ' ' TYR . 0.9 OUTLIER -77.09 -25.38 15.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.903 -1.123 . . . . 0.0 108.133 179.196 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.548 ' NH1' ' OD1' ' A' ' 221' ' ' ASN . 8.0 mtt180 -67.13 -44.11 80.69 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -57.65 -50.32 73.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 108.689 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 224' ' ' VAL . 60.8 t -57.91 -48.97 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.571 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 64.3 t80 -49.99 -44.19 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -73.02 -35.53 66.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.534 -0.729 . . . . 0.0 109.571 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.556 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.9 tp -56.46 -36.31 68.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 108.65 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.658 HG22 ' HD1' ' A' ' 80' ' ' HIS . 44.1 mt -72.42 -48.25 48.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.58 -34.3 13.91 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -81.64 -28.64 33.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -1.2 . . . . 0.0 109.645 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.503 HD23 HG22 ' A' ' 260' ' ' VAL . 5.4 mt -80.26 -21.42 42.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.835 -1.166 . . . . 0.0 109.125 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.489 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.3 t80 -71.08 -9.1 57.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 108.692 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 234' ' ' ASP . 14.1 mt -50.02 -28.78 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.425 HD12 HG22 ' A' ' 242' ' ' VAL . 96.7 mt -56.52 -14.02 2.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.088 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.5 15.95 80.23 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 80.8 p -158.59 144.98 12.64 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.257 . . . . 0.0 109.383 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -42.59 130.54 5.25 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.197 1.931 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.425 HG22 HD12 ' A' ' 238' ' ' LEU . 4.0 t -100.36 135.85 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.59 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 125' ' ' VAL . 5.4 mmtp -123.91 127.57 48.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.664 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.78 172.14 23.72 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -101.14 113.87 27.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.59 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.0 m-85 -112.58 147.08 37.4 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.981 0.896 . . . . 0.0 111.306 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.4 t80 -128.86 144.06 51.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . 0.409 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 28.1 t -139.31 125.39 19.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.697 -1.252 . . . . 0.0 110.005 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 250' ' ' ARG . 71.8 t80 -110.47 113.37 25.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 249' ' ' PHE . 9.6 mmm180 46.43 56.6 6.2 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.73 150.5 21.16 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -118.38 179.82 17.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -68.66 -42.35 78.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -1.143 . . . . 0.0 109.568 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -36.32 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.204 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.703 ' HG ' HD12 ' A' ' 139' ' ' ILE . 57.4 tp -72.54 -36.79 68.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.016 -1.053 . . . . 0.0 108.911 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -60.76 -52.41 65.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.352 -0.842 . . . . 0.0 108.81 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 37.2 t -52.53 -44.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.34 -47.54 75.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.007 -1.058 . . . . 0.0 109.167 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 139' ' ' ILE . 30.8 tp -52.51 -45.07 66.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 108.623 179.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.503 HG22 HD23 ' A' ' 235' ' ' LEU . 40.1 t -68.36 -53.29 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 109.465 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -46.7 -45.97 19.84 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.682 -0.636 . . . . 0.0 110.636 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.92 -47.96 64.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.906 -1.121 . . . . 0.0 109.503 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 263' ' ' LEU . 19.7 mt -57.97 -43.66 86.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.05 74.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.282 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.4 mttt . . . . . 0 N--CA 1.489 1.517 0 O-C-N 120.706 -1.246 . . . . 0.0 108.929 179.307 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 55.3 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.401 0.619 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -114.14 131.33 56.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.496 -0.752 . . . . 0.0 109.061 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -132.77 168.86 17.59 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -81.38 139.79 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 110.226 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -70.12 -46.95 63.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.56 -0.712 . . . . 0.0 109.945 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -132.35 163.11 29.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.356 -0.84 . . . . 0.0 110.41 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 136.31 55.32 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.632 0.73 . . . . 0.0 110.861 -179.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 113' ' ' ASN . 32.7 mt -117.23 164.99 13.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -150.92 146.49 26.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.813 -1.179 . . . . 0.0 110.192 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -133.69 161.08 35.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.536 -0.727 . . . . 0.0 109.464 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -149.75 136.78 19.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.918 -1.114 . . . . 0.0 109.023 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.87 158.98 18.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 22' ' ' GLU . 1.3 p -85.79 144.14 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.103 -1.233 . . . . 0.0 110.996 -178.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.32 143.57 39.38 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.1 tt -63.55 -44.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 112.621 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.524 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.8 m-70 -87.08 -37.1 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.125 -1.609 . . . . 0.0 112.193 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.402 HG21 ' HG3' ' A' ' 95' ' ' GLU . 28.0 p -81.05 -26.6 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.834 -1.167 . . . . 0.0 109.721 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.95 19.0 62.93 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 23' ' ' TYR . 1.9 tm-20 -104.18 148.75 25.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.578 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 4.3 t80 -71.65 134.39 46.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -141.7 158.16 44.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.09 -1.006 . . . . 0.0 109.298 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -137.77 144.85 41.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.258 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.736 HD11 ' HD2' ' A' ' 97' ' ' PRO . 3.0 mt -125.25 144.91 50.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.018 . . . . 0.0 109.606 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.42 HG22 ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -126.4 132.08 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mt -113.1 134.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.049 -1.032 . . . . 0.0 109.573 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.42 ' NE2' HG22 ' A' ' 27' ' ' ILE . 22.5 m-70 -128.62 149.72 72.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.031 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.81 160.51 28.79 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.288 1.992 . . . . 0.0 111.226 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.6 mm-40 -135.23 -174.66 3.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 109.914 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.5 tttt -91.0 155.71 18.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.766 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.84 145.23 2.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.251 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.62 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.08 27.4 62.44 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.105 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.2 m -80.85 -38.31 28.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.684 -1.48 . . . . 0.0 108.633 179.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 -174.21 35.11 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.66 123.51 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 139.36 39.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.953 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 77.6 m-85 -95.79 148.73 22.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.7 t80 -130.65 137.34 49.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -165.38 139.67 4.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.383 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.09 29.73 10.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 110.084 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.58 18.51 79.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.43 HG11 ' HG3' ' A' ' 67' ' ' GLN . 62.3 t -120.51 133.86 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -1.096 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 15.8 m-85 -97.88 134.53 40.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 108.871 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.4 mt -127.73 94.91 36.23 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.495 -0.753 . . . . 0.0 109.4 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.91 142.3 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.095 1.863 . . . . 0.0 111.602 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . . . -88.04 80.22 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.977 -1.077 . . . . 0.0 109.94 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -134.59 152.32 51.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.1 p80 -54.9 -47.16 74.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 50' ' ' HIS . 4.6 mt-10 -44.01 -20.49 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.939 -1.101 . . . . 0.0 109.706 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' HIS . 97.6 m-85 -90.57 4.66 50.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.854 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 50' ' ' HIS . 23.3 t -60.03 120.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 108.921 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 m -111.88 -28.34 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 110.161 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -153.44 122.66 6.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.008 -1.057 . . . . 0.0 109.907 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -115.69 132.68 56.56 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.5 t-20 -166.87 -153.22 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ASN . 76.1 m-70 -45.64 -15.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -136.73 166.16 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.419 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 2.8 m -108.66 125.77 52.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.354 -0.841 . . . . 0.0 108.878 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 60' ' ' THR . 3.5 m-20 -123.47 140.45 53.0 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.073 0.94 . . . . 0.0 111.46 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 72' ' ' VAL . 44.8 mt -122.11 160.24 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.87 141.1 5.83 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.812 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -144.13 149.03 35.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.974 . . . . 0.0 109.236 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.95 38.82 31.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.349 -0.844 . . . . 0.0 110.393 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.95 3.23 80.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.513 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 7.5 mm100 -96.16 144.96 25.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -1.196 . . . . 0.0 108.605 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.81 143.88 37.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.244 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.71 139.29 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -114.36 151.36 33.15 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.276 -0.89 . . . . 0.0 111.179 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m 54.75 70.22 0.64 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 178.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' A' ' 62' ' ' LEU . 13.7 m -114.29 -8.09 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.068 -1.02 . . . . 0.0 109.846 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -69.52 -19.08 63.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.158 -0.964 . . . . 0.0 111.228 -178.829 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 22.6 m170 -73.5 -58.89 3.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.753 -1.217 . . . . 0.0 109.52 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' LEU . 4.6 tp -58.52 -42.43 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.844 -1.16 . . . . 0.0 108.691 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' ILE . 70.5 mt -58.73 -37.53 76.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.502 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.2 t -59.91 -48.3 82.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.96 -54.16 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 108.455 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.3 mt -51.68 -45.46 63.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 0.0 109.234 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.613 ' HD1' HG22 ' A' ' 232' ' ' ILE . 12.1 t-160 -54.98 -51.87 64.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.787 . . . . 0.0 109.902 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.4 mt -64.9 -38.27 90.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 110.629 -179.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.725 HD13 HD11 ' A' ' 114' ' ' ILE . 13.9 mt -79.89 -1.1 37.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 110.612 -178.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 60.14 63.46 1.42 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.013 -1.054 . . . . 0.0 110.401 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.559 HD11 ' HB3' ' A' ' 82' ' ' LEU . 13.3 mm -105.51 127.6 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 121' ' ' ILE . 56.7 p -115.1 -21.22 10.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.314 -0.866 . . . . 0.0 112.03 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.2 m-80 -128.74 111.6 13.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.787 -1.195 . . . . 0.0 110.295 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.6 m -164.19 139.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.196 -0.94 . . . . 0.0 109.89 179.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 21.5 m -110.42 99.54 8.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.24 104.98 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.92 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.67 128.47 33.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.612 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.71 108.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 92' ' ' ILE . 4.1 mp -89.06 109.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.81 -155.27 20.09 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -178.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.43 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -123.04 -8.18 8.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.532 -0.981 . . . . 0.0 110.694 -179.555 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.573 ' OE2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -144.58 150.76 38.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.62 -1.3 . . . . 0.0 111.681 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.6 mm -75.88 122.26 86.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.027 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.736 ' HD2' HD11 ' A' ' 26' ' ' LEU . 80.9 Cg_exo -45.29 133.52 12.05 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.924 1.75 . . . . 0.0 112.198 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.0 tp -76.59 -20.11 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.092 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.584 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 75.8 mt 54.99 -121.91 1.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.48 -7.75 40.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.46 -15.63 38.45 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -111.35 -171.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -1.044 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.07 -1.9 23.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -46.43 -40.95 13.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.694 -0.886 . . . . 0.0 110.086 -179.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.84 -52.31 64.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.838 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 57.3 m-85 -63.05 -44.47 95.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 108.762 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -62.94 -37.18 86.04 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.419 0.628 . . . . 0.0 109.77 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -72.06 -48.0 47.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 111.096 -178.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.77 -51.17 14.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.941 -1.099 . . . . 0.0 110.194 -179.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.28 -43.07 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.084 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -54.31 -32.15 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -83.06 -0.87 51.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.139 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.552 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -131.82 33.25 3.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.248 -0.908 . . . . 0.0 111.149 -179.171 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.725 HD11 HD13 ' A' ' 82' ' ' LEU . 7.0 mt -94.05 144.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.513 -1.367 . . . . 0.0 110.125 179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 115' ' ' LEU . 13.4 tp -132.04 161.61 32.78 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.573 HD22 ' H ' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -108.66 146.27 33.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.059 -1.026 . . . . 0.0 110.388 -179.447 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.689 HE22 HD22 ' A' ' 86' ' ' ASN . 1.4 mt-30 -105.09 -162.41 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.078 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.03 -0.01 12.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.299 -0.875 . . . . 0.0 110.629 -179.208 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' A' ' 4' ' ' GLU . 17.1 ttm180 -93.28 147.49 22.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.832 -1.167 . . . . 0.0 110.043 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -84.1 131.0 34.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.423 -0.798 . . . . 0.0 109.555 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 85' ' ' THR . 80.1 mt -71.69 141.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.965 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.15 104.39 16.4 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -78.6 146.68 34.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 111.095 -178.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.84 121.9 33.88 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 243' ' ' LYS . 22.0 t -120.82 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.05 136.75 22.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -116.42 -11.22 11.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.735 . . . . 0.0 109.113 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -142.07 142.82 25.77 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.28 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.82 152.64 52.77 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.033 1.822 . . . . 0.0 112.953 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.81 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.2 tt -145.94 141.7 21.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.672 -0.642 . . . . 0.0 109.332 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.521 ' CG2' HD21 ' A' ' 138' ' ' LEU . 1.2 mp -128.29 123.2 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 109.5 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.4 m -118.4 116.69 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.515 -0.74 . . . . 0.0 109.654 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -108.85 140.08 42.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.299 -0.876 . . . . 0.0 109.29 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.41 126.51 2.3 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.735 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.489 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 46.1 mt-10 52.75 39.14 28.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.752 -0.593 . . . . 0.0 112.389 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.52 5.22 89.35 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.424 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.489 ' NH2' ' OE1' ' A' ' 135' ' ' GLU . 5.5 mtt180 -107.05 164.24 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.005 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.9 tt -159.75 151.2 19.87 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 119.948 -1.72 . . . . 0.0 109.213 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.005 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.1 mt -146.97 130.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -122.8 140.28 53.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.161 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -116.99 148.18 41.66 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -146.19 137.03 12.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.28 144.43 71.38 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.325 1.35 . . . . 0.0 112.166 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.04 148.16 11.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.37 -1.96 43.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.3 p -136.35 150.23 48.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 242' ' ' VAL . 16.6 tp -82.2 117.43 22.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -136.24 137.51 40.87 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.682 ' CG1' HD23 ' A' ' 231' ' ' LEU . 74.0 t -136.92 123.65 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 m -111.15 132.66 54.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.594 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -116.89 129.01 55.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.28 111.59 21.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.06 156.89 15.81 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 250' ' ' ARG . 36.4 mt-10 -138.33 95.16 2.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.349 -1.089 . . . . 0.0 109.387 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -94.78 148.27 22.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 109.616 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -91.17 0.48 57.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.767 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.472 HD21 HD12 ' A' ' 159' ' ' LEU . 11.9 p30 -78.66 -173.6 3.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.355 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -53.21 -18.92 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.208 -179.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.472 HD12 HD21 ' A' ' 157' ' ' ASN . 16.7 mt -65.43 -62.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.018 -1.051 . . . . 0.0 109.659 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.94 -125.3 8.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -109.63 139.35 44.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -1.081 . . . . 0.0 109.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.75 150.45 29.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 152.67 48.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.635 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -136.51 124.78 23.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 0.0 109.109 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 165' ' ' THR . 13.7 t -98.35 122.28 41.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.089 -1.007 . . . . 0.0 110.006 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.4 t80 -97.48 137.28 36.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 108.846 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.556 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -133.2 150.24 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 14.3 mt-10 -56.1 122.35 11.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.05 -18.85 14.0 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -116.16 36.35 4.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.069 -1.253 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.33 -31.57 72.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 110.525 -179.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.28 -14.06 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.693 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.28 -3.87 57.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 5.3 pt -122.83 10.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.992 -1.067 . . . . 0.0 111.033 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.93 -31.8 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.867 -1.146 . . . . 0.0 109.958 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.89 2.23 46.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.828 -1.17 . . . . 0.0 110.489 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.71 133.3 35.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -105.41 154.08 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 -179.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -55.65 159.6 2.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.43 166.25 25.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.017 -1.052 . . . . 0.0 110.148 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -152.52 163.25 39.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 109.458 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.548 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 70.7 m-85 -104.53 144.03 32.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.633 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.678 ' HA ' HD12 ' A' ' 186' ' ' ILE . 10.9 p-10 -61.28 -25.91 67.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.817 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.548 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.2 p90 -77.52 -25.32 50.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.776 -1.203 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.465 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 10.0 pt-20 -100.96 -11.9 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 109.993 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 183' ' ' ASP . 6.9 mt -57.34 -52.36 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.116 -0.99 . . . . 0.0 110.449 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.42 -53.72 33.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 0.0 109.975 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -52.88 -42.33 65.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.073 -1.017 . . . . 0.0 109.187 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.07 -33.77 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.021 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -78.69 -26.06 44.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.783 . . . . 0.0 110.335 -179.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -32.46 35.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.995 -1.065 . . . . 0.0 110.181 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 194' ' ' LEU . 28.8 m -73.76 8.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.015 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.83 20.48 70.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 192' ' ' VAL . 27.9 mt -117.22 154.86 30.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.196 -1.179 . . . . 0.0 109.764 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 83.3 23.15 55.35 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.421 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -66.2 -23.96 66.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.617 -1.519 . . . . 0.0 109.756 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.07 -5.89 49.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.83 130.69 45.6 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.129 -1.218 . . . . 0.0 110.773 -178.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 6.9 p -134.82 -173.74 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.668 -0.901 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.8 -17.48 29.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -89.11 -8.54 53.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 202' ' ' ASN . 0.5 OUTLIER -127.96 -14.18 5.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.754 -179.627 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -125.4 115.01 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.0 tp -77.14 109.97 11.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 108.668 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 186' ' ' ILE . 44.1 t -97.64 125.92 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 110.012 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 206' ' ' LEU . 28.5 mt -99.1 143.26 29.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.623 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.64 144.46 15.82 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 3.9 pttt -41.52 -23.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -1.191 . . . . 0.0 110.299 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.2 p-10 -152.67 11.92 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.565 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -148.89 157.98 43.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.972 -1.08 . . . . 0.0 110.419 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.55 127.86 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -73.62 -54.86 7.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.028 -1.045 . . . . 0.0 110.55 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.95 111.35 2.9 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.027 . . . . 0.0 110.169 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.45 -8.49 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.864 1.709 . . . . 0.0 112.292 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -88.06 -7.74 56.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 109.869 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.88 -167.36 48.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.06 145.3 25.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.414 -1.05 . . . . 0.0 110.165 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -88.17 -17.55 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.387 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -144.95 134.41 23.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.39 -23.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.062 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.477 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -124.95 35.72 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.078 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 5.1 tt0 -55.4 -57.97 17.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 111.638 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 10.5 Cg_endo -54.19 -39.96 84.05 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.955 1.77 . . . . 0.0 113.105 -178.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 228' ' ' VAL . 11.5 m -80.2 -26.66 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 120.667 -1.27 . . . . 0.0 109.017 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 18.7 mtt180 -66.65 -43.27 85.04 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -62.01 -42.35 99.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -56.78 -39.04 73.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 224' ' ' VAL . 48.4 t -66.41 -40.89 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 88.7 t80 -59.1 -37.48 77.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 91.0 m-20 -76.07 -40.87 52.18 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.563 -0.711 . . . . 0.0 109.671 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.682 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.6 tp -55.47 -36.71 66.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 108.836 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.613 HG22 ' HD1' ' A' ' 80' ' ' HIS . 77.9 mt -73.15 -47.75 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.77 -33.92 28.31 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.44 -26.81 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -1.225 . . . . 0.0 109.852 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.74 -20.71 45.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.761 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.583 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 11.9 t80 -74.24 -9.02 58.19 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.145 -0.972 . . . . 0.0 109.193 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 234' ' ' ASP . 18.3 mt -50.91 -28.6 10.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.439 ' O ' ' NH2' ' A' ' 49' ' ' ARG . 62.9 mt -58.11 -11.26 2.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 0.0 108.947 179.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.54 16.04 81.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 23.1 p -158.48 150.45 17.3 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.071 -1.252 . . . . 0.0 109.219 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 6.5 Cg_endo -53.28 139.48 63.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.999 1.799 . . . . 0.0 111.519 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.501 ' O ' HD22 ' A' ' 147' ' ' LEU . 14.0 t -102.93 133.45 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.383 -179.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.436 ' HB2' HG22 ' A' ' 125' ' ' VAL . 3.9 mmtt -118.38 123.92 46.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.755 . . . . 0.0 109.253 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.34 170.75 22.58 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -101.57 112.72 25.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.188 -1.184 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -112.03 148.15 34.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.921 0.867 . . . . 0.0 111.209 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -130.18 144.19 51.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.8 t -137.77 127.93 26.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.0 110.502 -179.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -111.73 113.89 26.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 154' ' ' GLU . 2.3 mtt85 49.81 56.0 8.54 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.01 142.45 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.94 167.45 13.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -56.5 -45.03 81.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -59.55 -56.01 27.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.662 ' HG ' HD12 ' A' ' 139' ' ' ILE . 52.0 tp -56.83 -36.54 70.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 62.5 m-20 -59.76 -55.5 33.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 108.721 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 36.5 t -51.05 -40.59 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.308 -0.87 . . . . 0.0 109.148 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -54.81 -47.63 73.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 108.916 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 139' ' ' ILE . 59.3 tp -53.34 -47.31 69.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 50' ' ' HIS . 2.8 t -65.98 -43.19 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -51.9 64.93 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.446 -0.783 . . . . 0.0 110.384 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.83 -43.75 95.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.817 -1.177 . . . . 0.0 110.189 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.18 -42.36 96.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.45 -32.71 58.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 110.334 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp . . . . . 0 N--CA 1.489 1.501 0 O-C-N 120.877 -1.139 . . . . 0.0 109.186 179.597 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 33' ' ' GLU . 10.6 mt-10 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 145.9 51.5 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.517 -0.74 . . . . 0.0 109.743 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 177.8 8.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.944 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.66 147.09 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -83.05 -41.17 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.581 -0.699 . . . . 0.0 109.958 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.79 155.18 46.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.955 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -62.9 133.21 54.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.399 -0.813 . . . . 0.0 109.671 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.75 161.96 19.86 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -158.42 152.43 23.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.806 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.8 171.64 14.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.645 -0.66 . . . . 0.0 109.74 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -149.62 137.69 20.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 108.982 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.61 161.0 20.45 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -88.36 144.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -1.199 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.53 141.08 39.97 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.2 tt -62.16 -43.52 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -1.233 . . . . 0.0 111.325 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 8.2 m-70 -87.98 -39.39 14.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.174 -1.579 . . . . 0.0 111.149 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 p -69.06 -40.43 78.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.27 17.49 78.86 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -114.36 152.58 31.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.989 . . . . 0.0 108.828 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.492 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 5.2 t80 -71.8 139.67 49.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.056 -1.028 . . . . 0.0 110.245 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -146.97 157.72 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 108.819 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 26' ' ' LEU . 25.2 ttpt -127.07 157.71 38.9 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 109.704 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.789 HD11 HG23 ' A' ' 96' ' ' ILE . 12.6 mt -126.56 144.86 50.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.982 -1.074 . . . . 0.0 108.397 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.561 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.2 mt -138.62 132.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.015 179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 28' ' ' ILE . 6.2 mt -120.97 128.09 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 109.914 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.4 m-70 -125.7 149.02 64.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.56 157.64 35.85 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.179 1.92 . . . . 0.0 111.38 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 41.2 mm-40 -135.83 162.9 31.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.5 tttp -64.77 150.37 47.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.5 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -47.81 148.91 1.42 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.573 -179.373 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.44 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 59.86 25.45 61.6 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.527 -0.733 . . . . 0.0 112.089 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.5 m -80.16 -37.07 34.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.467 -1.608 . . . . 0.0 109.068 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.72 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 94.23 -172.69 32.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -100.42 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.164 -1.198 . . . . 0.0 108.338 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -139.4 143.81 37.84 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.392 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.5 153.63 19.54 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.8 t80 -124.3 147.93 47.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 13.5 tttt -173.75 133.48 0.46 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.777 -1.202 . . . . 0.0 109.218 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.639 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER 52.95 29.54 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.493 -0.754 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.71 -9.88 48.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.62 ' CG2' HD21 ' A' ' 42' ' ' ASN . 20.6 t -94.43 139.34 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -1.227 . . . . 0.0 110.22 -179.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -97.36 146.2 25.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.419 -0.801 . . . . 0.0 108.923 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 67' ' ' GLN . 53.5 mt -138.1 97.03 9.93 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.47 141.19 33.81 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.243 1.962 . . . . 0.0 111.499 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.19 84.31 5.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.878 -1.139 . . . . 0.0 110.58 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -141.27 157.62 44.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.135 -0.978 . . . . 0.0 109.284 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.648 ' ND1' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -52.52 -49.74 64.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.117 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -48.77 -16.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 110.076 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' HIS . 73.4 m-85 -97.37 6.08 48.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.052 -1.03 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 50' ' ' HIS . 22.8 t -64.59 129.31 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.951 . . . . 0.0 109.383 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.62 -29.51 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.38 -0.825 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.441 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 7.8 t-80 -152.92 122.61 6.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.788 -1.195 . . . . 0.0 109.814 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.6 p -113.34 133.12 55.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.7 t-20 -166.98 -154.04 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.599 ' CE1' HD11 ' A' ' 189' ' ' ILE . 0.2 OUTLIER -47.04 -13.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.069 -1.02 . . . . 0.0 108.317 178.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -135.23 165.7 24.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.591 -0.693 . . . . 0.0 109.401 -179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.446 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 7.4 m -103.93 122.24 44.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 108.604 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -120.2 136.92 54.47 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.053 0.93 . . . . 0.0 111.528 -178.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HG ' HG21 ' A' ' 72' ' ' VAL . 76.8 mt -117.69 158.21 25.11 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.77 143.11 6.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.652 -1.737 . . . . 0.0 110.908 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.08 151.55 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.617 -0.931 . . . . 0.0 109.758 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp 56.79 27.61 13.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.521 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.52 -0.43 83.05 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 91.3 mm-40 -94.84 138.77 32.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.968 -1.313 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -134.28 146.7 50.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.963 . . . . 0.0 111.27 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.4 mt -134.89 145.88 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -114.61 152.75 31.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.222 -0.924 . . . . 0.0 111.799 -178.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 71' ' ' THR . 45.7 m 53.94 71.68 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.557 . . . . 0.0 111.307 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.445 HG21 ' HG ' ' A' ' 62' ' ' LEU . 19.1 m -113.5 -1.44 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.033 -1.042 . . . . 0.0 109.286 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.54 -39.59 73.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 110.576 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -54.38 -60.59 3.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.066 -1.021 . . . . 0.0 110.241 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -58.54 -46.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 109.232 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' N ' HG23 ' A' ' 75' ' ' ILE . 64.8 mt -55.49 -38.72 69.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.074 -1.016 . . . . 0.0 109.43 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -59.01 -48.24 82.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.564 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.2 -54.18 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 108.499 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -52.39 -46.38 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.507 -0.746 . . . . 0.0 109.246 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.618 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 15.4 t-160 -55.58 -53.69 53.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.827 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.89 -38.63 91.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.363 -0.836 . . . . 0.0 110.368 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.633 ' HB3' HD11 ' A' ' 84' ' ' ILE . 12.7 mt -78.37 -4.46 48.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.736 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.28 51.55 2.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.729 -1.232 . . . . 0.0 110.405 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.7 mm -98.45 124.46 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.413 HG21 HG12 ' A' ' 121' ' ' ILE . 20.5 p -111.55 -18.95 12.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.322 -0.861 . . . . 0.0 112.437 -177.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.72 HD22 ' H ' ' A' ' 36' ' ' GLY . 5.6 m120 -129.94 111.86 12.96 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.512 -1.367 . . . . 0.0 110.633 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.7 m -164.62 143.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.228 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.542 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.7 m -112.19 101.07 9.34 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mt -92.1 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.579 -0.701 . . . . 0.0 109.706 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.71 123.08 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.736 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 t -107.46 106.27 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 110.954 -178.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.22 111.02 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.12 -161.62 23.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -115.37 -14.51 11.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.534 ' OE1' ' O ' ' A' ' 96' ' ' ILE . 1.2 tm-20 -140.86 146.61 37.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.995 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.789 HG23 HD11 ' A' ' 26' ' ' LEU . 3.3 mm -68.95 124.06 89.49 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 109.97 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.57 130.99 9.64 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.083 1.855 . . . . 0.0 112.171 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 16' ' ' VAL . 8.2 tp -78.53 -30.27 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.451 -0.78 . . . . 0.0 109.727 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt 56.48 -108.77 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.805 . . . . 0.0 110.129 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -94.17 -22.9 18.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 110.736 -178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.44 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 115.49 -10.23 19.48 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.23 -170.95 1.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -1.024 . . . . 0.0 109.757 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.07 -4.67 25.68 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.404 ' NE1' ' HG3' ' A' ' 108' ' ' GLU . 51.2 t-105 -46.29 -38.8 9.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.707 -0.878 . . . . 0.0 110.302 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.42 -52.04 66.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 110.013 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.56 -43.4 97.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 108.695 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 18.7 t80 -63.64 -36.71 84.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.74 -0.6 . . . . 0.0 110.014 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.404 ' HG3' ' NE1' ' A' ' 104' ' ' TRP . 2.4 mm-40 -72.75 -49.94 27.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.28 -0.887 . . . . 0.0 111.956 -178.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.38 -44.55 58.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.824 -1.172 . . . . 0.0 110.977 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.2 -39.97 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.073 . . . . 0.0 110.391 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 16.0 tpt180 -54.11 -32.59 55.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 0.0 109.759 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -82.1 -13.41 57.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.929 -1.107 . . . . 0.0 110.14 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -121.37 32.07 6.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 111.018 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.559 HD11 HD13 ' A' ' 82' ' ' LEU . 6.1 mt -82.74 148.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.509 -1.37 . . . . 0.0 110.373 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -128.63 149.57 50.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -97.68 146.14 25.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.042 -1.036 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.56 -168.45 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.0 109.813 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -124.43 72.73 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.513 -0.742 . . . . 0.0 110.589 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 119' ' ' ARG . 6.2 ttm-85 -168.63 149.48 4.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.968 . . . . 0.0 109.461 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -83.3 126.87 33.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.413 HG12 HG21 ' A' ' 85' ' ' THR . 18.4 mt -67.09 135.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.456 -0.778 . . . . 0.0 110.765 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.52 73.69 1.94 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -52.31 141.31 19.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.538 -0.726 . . . . 0.0 110.479 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -104.99 125.57 51.12 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 243' ' ' LYS . 67.8 t -128.75 142.88 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.253 -0.904 . . . . 0.0 110.266 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.13 135.26 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -116.53 -11.43 11.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.214 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.42 143.62 30.8 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.05 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.61 161.51 41.9 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.109 1.873 . . . . 0.0 113.182 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.9 tt -155.4 140.0 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.65 -0.656 . . . . 0.0 109.584 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 131' ' ' ILE . 2.4 mp -127.86 124.33 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.4 m -121.36 118.84 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.724 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -115.58 133.6 55.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.417 -0.802 . . . . 0.0 109.583 179.862 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 34.1 t0 -173.43 150.65 1.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.18 -0.95 . . . . 0.0 110.759 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 10.9 mt-10 57.57 22.32 8.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.541 -0.724 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.26 6.99 88.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.537 ' HB2' HD22 ' A' ' 255' ' ' LEU . 5.4 mtt85 -105.34 171.64 7.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.953 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.1 tt -159.63 149.57 18.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.457 -1.402 . . . . 0.0 109.028 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.953 ' N ' HD23 ' A' ' 138' ' ' LEU . 12.0 mt -147.69 139.06 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -131.26 142.68 50.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.118 -0.989 . . . . 0.0 109.654 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.35 145.82 48.44 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -142.48 135.1 13.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.53 147.96 36.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.272 1.315 . . . . 0.0 112.053 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.99 154.23 8.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.364 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.98 0.73 50.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -136.98 151.79 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 242' ' ' VAL . 34.1 tp -87.37 117.92 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 110.027 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -136.18 142.93 44.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.668 ' CG1' HD23 ' A' ' 231' ' ' LEU . 69.5 t -135.93 118.31 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 109.907 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 3.5 m -105.19 127.1 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.178 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -121.36 130.07 53.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -112.27 104.94 13.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.1 129.51 9.93 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.62 97.32 6.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -1.091 . . . . 0.0 109.169 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.506 ' HB2' HD21 ' A' ' 157' ' ' ASN . 24.5 m-85 -99.63 148.92 23.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.188 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -92.87 -10.17 37.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.821 . . . . 0.0 109.934 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.717 HD22 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -70.34 -167.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.918 . . . . 0.0 110.103 -179.284 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -60.12 -24.49 64.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.355 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.474 ' HB2' HD21 ' A' ' 157' ' ' ASN . 6.6 mt -64.93 -40.65 95.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.939 -1.101 . . . . 0.0 108.871 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 76.97 -107.52 2.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -122.01 140.69 52.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.937 . . . . 0.0 109.692 -179.577 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -144.44 158.04 43.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -142.89 144.48 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -137.01 123.89 21.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.344 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 9.1 m -104.67 124.55 49.55 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.204 -0.935 . . . . 0.0 110.198 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -99.67 130.13 45.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.24 147.78 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.502 -0.749 . . . . 0.0 109.46 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.04 115.62 1.49 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.349 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.22 4.89 17.75 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.45 28.85 3.98 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.304 -1.115 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.75 -33.26 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.733 -0.604 . . . . 0.0 110.473 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -58.55 -9.97 1.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.085 -1.009 . . . . 0.0 110.697 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.38 -4.84 33.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.791 -1.193 . . . . 0.0 110.793 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.3 pt -117.65 13.05 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 110.722 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.13 -26.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.018 -1.051 . . . . 0.0 110.027 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.6 0.8 57.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.85 -1.156 . . . . 0.0 110.706 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.51 115.39 20.0 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.994 -1.067 . . . . 0.0 109.006 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -84.02 151.68 24.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.135 -0.978 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 t -59.24 132.64 54.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.323 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -110.96 170.2 8.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.983 -179.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 1.8 t -154.21 162.99 40.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.441 -0.787 . . . . 0.0 109.475 179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.473 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 71.5 m-85 -104.6 144.6 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.407 -0.808 . . . . 0.0 109.495 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.0 OUTLIER -61.67 -25.85 67.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.756 -1.215 . . . . 0.0 110.385 -179.372 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.0 p90 -81.83 -30.09 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.8 -1.188 . . . . 0.0 110.413 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.5 pt-20 -87.41 -16.96 33.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.784 -1.197 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.705 HD12 ' HA ' ' A' ' 183' ' ' ASP . 10.0 mt -57.83 -53.36 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.149 -0.969 . . . . 0.0 110.131 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.52 -53.19 40.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.919 -1.113 . . . . 0.0 109.624 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.87 -44.51 66.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 109.053 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 58' ' ' HIS . 3.7 mt -64.85 -33.42 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.065 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -78.3 -27.73 47.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -76.78 -28.15 55.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 109.937 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.4 m -82.61 9.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 109.782 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.56 72.78 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.633 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.8 157.93 27.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.211 -1.17 . . . . 0.0 109.669 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.63 21.64 63.61 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.148 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.36 -22.89 63.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.588 -1.537 . . . . 0.0 109.87 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -100.65 -3.16 55.26 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.6 128.74 35.73 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 121.086 -1.243 . . . . 0.0 110.459 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.29 162.23 34.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.738 -0.86 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.93 -31.45 72.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.962 . . . . 0.0 110.105 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -75.47 -14.6 60.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.07 -1.019 . . . . 0.0 110.248 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.34 9.87 5.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.7 m -150.36 123.56 8.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.42 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.16 115.49 22.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.189 -0.944 . . . . 0.0 109.24 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 186' ' ' ILE . 53.1 t -101.56 126.75 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.4 mt -102.44 141.91 34.51 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.456 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.06 149.6 19.1 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.1 OUTLIER -42.24 -29.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.895 -179.578 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 8.5 t0 -149.71 14.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 110.163 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 207' ' ' GLY . 9.9 mtpm? -146.85 155.71 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.038 . . . . 0.0 110.272 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.5 t -101.44 127.6 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.78 -54.63 8.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.329 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.14 131.32 68.69 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.938 -1.101 . . . . 0.0 109.325 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.03 -14.57 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.175 1.917 . . . . 0.0 112.574 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.78 -6.12 59.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.126 -0.984 . . . . 0.0 109.724 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.22 -167.93 51.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 49.6 mt -82.79 146.15 29.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -1.013 . . . . 0.0 109.935 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -89.48 -20.74 23.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.241 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.475 ' C ' ' N ' ' A' ' 221' ' ' ASN . 69.2 m-85 -141.57 139.51 33.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.377 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -11.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 108.6 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.716 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -141.87 38.03 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.731 0.777 . . . . 0.0 109.066 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.4 OUTLIER -58.18 -36.54 45.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 111.05 -179.472 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.47 -44.3 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.837 1.691 . . . . 0.0 112.54 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 228' ' ' VAL . 3.0 m -76.14 -24.45 16.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.765 -1.209 . . . . 0.0 108.49 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.716 HH21 ' ND2' ' A' ' 221' ' ' ASN . 6.3 mtt180 -67.64 -41.87 83.2 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -63.08 -42.78 99.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -56.66 -47.63 79.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.068 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 224' ' ' VAL . 58.4 t -59.59 -44.54 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 61.3 t80 -55.13 -37.42 66.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.645 -0.66 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 3.7 m-20 -76.34 -38.84 55.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.499 -0.751 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.668 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.9 tp -56.92 -37.62 71.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.092 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.57 HG22 ' HD1' ' A' ' 80' ' ' HIS . 74.2 mt -73.1 -48.61 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.07 -34.56 16.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.22 -26.89 32.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -1.13 . . . . 0.0 110.189 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 260' ' ' VAL . 5.5 mt -78.13 -22.62 48.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 109.758 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.618 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 6.6 t80 -70.45 -5.4 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.105 -0.997 . . . . 0.0 108.83 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 237' ' ' LEU . 14.0 mt -52.24 -30.55 28.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.522 HD12 HG22 ' A' ' 242' ' ' VAL . 87.7 mt -56.29 -17.9 9.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 82.96 14.51 74.93 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.4 p -158.31 151.89 19.25 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.245 . . . . 0.0 109.458 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -49.94 131.31 29.64 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.161 1.907 . . . . 0.0 111.511 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.522 HG22 HD12 ' A' ' 238' ' ' LEU . 19.6 t -98.07 135.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 109.877 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.615 ' HB3' HG22 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -122.12 126.03 47.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.466 -0.771 . . . . 0.0 109.447 179.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.61 170.37 21.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -99.79 113.47 26.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.048 -1.266 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.3 m-85 -112.12 148.44 33.97 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.073 0.94 . . . . 0.0 111.148 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.408 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 24.1 t80 -128.15 144.53 51.12 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.39 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.1 t -144.86 124.82 13.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.42 -1.425 . . . . 0.0 110.413 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.418 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.3 t80 -109.8 116.55 31.88 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.6 OUTLIER 45.31 56.33 5.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.314 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -88.01 152.66 23.94 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -120.0 -177.81 16.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.15 -51.51 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 0.0 109.714 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -34.54 70.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.985 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 137' ' ' ARG . 48.6 tp -72.87 -40.34 65.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.016 . . . . 0.0 108.834 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -61.01 -51.06 70.84 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.2 t -51.32 -44.58 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.0 109.171 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -54.88 -49.11 71.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 108.905 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 139' ' ' ILE . 24.9 tp -52.93 -40.14 63.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.822 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 235' ' ' LEU . 60.7 t -74.72 -41.54 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.442 -0.786 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.54 -48.16 82.74 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 110.158 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -47.45 73.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.932 -1.105 . . . . 0.0 109.621 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 263' ' ' LEU . 12.7 mt -58.51 -43.74 89.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.325 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.429 ' HB1' ' HE2' ' A' ' 50' ' ' HIS . . . -66.03 -32.27 73.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 110.084 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm . . . . . 0 N--CA 1.49 1.553 0 O-C-N 120.725 -1.234 . . . . 0.0 108.865 179.245 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 67.7 mt-10 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.63 139.33 53.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.596 -0.69 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -138.57 173.8 11.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.459 -0.776 . . . . 0.0 108.92 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -84.41 141.39 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.722 -1.236 . . . . 0.0 110.278 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -71.15 -44.47 65.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.661 -0.649 . . . . 0.0 109.957 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.03 159.56 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 136.3 57.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.717 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 157.36 25.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -147.57 145.57 29.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 110.186 -179.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -132.17 163.37 28.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.99 135.57 19.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.889 -1.132 . . . . 0.0 108.718 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 159.13 19.08 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.62 146.8 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.243 . . . . 0.0 110.762 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.71 143.62 38.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.1 tt -67.74 -38.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.149 . . . . 0.0 112.786 -178.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.477 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.9 m-70 -85.93 -35.4 20.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 119.842 -1.786 . . . . 0.0 112.041 -177.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.47 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 5.2 m -85.21 -39.92 17.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.24 16.03 72.79 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -103.39 150.41 23.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -1.125 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.8 t80 -71.34 139.19 49.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.3 t -146.25 157.8 43.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.022 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.68 ' O ' HD23 ' A' ' 26' ' ' LEU . 44.4 tttt -132.85 155.78 48.37 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.882 . . . . 0.0 109.533 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.691 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -132.58 144.97 50.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.032 . . . . 0.0 109.103 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.9 129.16 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.3 mt -113.43 123.55 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -117.7 153.32 50.64 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.19 159.28 47.77 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.327 2.018 . . . . 0.0 111.19 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.2 mm-40 -134.12 -178.37 5.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.016 -1.052 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.478 ' O ' ' OG1' ' A' ' 35' ' ' THR . 25.3 tttt -83.04 149.34 27.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.463 -0.773 . . . . 0.0 109.317 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.584 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -46.86 148.27 1.11 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.235 -0.916 . . . . 0.0 110.064 -179.487 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.608 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.49 24.38 59.35 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.18 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.756 ' H ' HD22 ' A' ' 86' ' ' ASN . 15.5 m -80.55 -37.64 31.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.673 -1.486 . . . . 0.0 108.961 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.45 ' C ' HD13 ' A' ' 37' ' ' ILE . . . 93.9 -167.09 27.87 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 ' C ' ' A' ' 36' ' ' GLY . 2.8 mm -104.02 123.49 57.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -1.103 . . . . 0.0 108.287 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 139.09 42.08 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.969 -1.093 . . . . 0.0 110.863 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -99.7 151.54 21.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.568 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.1 t80 -129.49 139.52 51.55 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -170.86 138.76 1.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.016 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.48 28.65 17.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.85 . . . . 0.0 110.022 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.88 22.13 78.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 t -130.83 146.76 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.246 -1.149 . . . . 0.0 109.46 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -98.7 147.75 24.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.173 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 67' ' ' GLN . 38.6 mt -140.7 94.64 8.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.77 142.55 18.72 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.206 1.937 . . . . 0.0 111.841 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.52 83.11 6.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.429 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -137.72 153.44 49.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 p80 -52.78 -49.6 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 110.421 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.2 mt-10 -44.29 -30.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.084 -1.01 . . . . 0.0 109.285 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.419 ' O ' HG13 ' A' ' 54' ' ' VAL . 58.9 m-85 -79.43 3.94 16.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 HG11 ' A' ' 257' ' ' VAL . 9.5 t -56.62 131.65 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 52' ' ' PHE . 28.1 m -122.32 -35.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.341 -0.849 . . . . 0.0 110.428 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.5 t-160 -150.2 119.74 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.272 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.2 p -113.37 131.48 55.96 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.375 0.607 . . . . 0.0 109.465 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.607 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -167.1 -153.25 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.717 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 57' ' ' ASN . 13.6 m-70 -45.55 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.067 -1.02 . . . . 0.0 108.681 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 57' ' ' ASN . 10.9 t -135.41 165.7 24.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.365 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 m -104.08 122.5 45.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.778 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 3.4 m-20 -121.39 139.78 53.0 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.092 0.949 . . . . 0.0 111.434 -178.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.56 158.08 29.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.75 144.82 7.61 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.639 -1.743 . . . . 0.0 110.687 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -144.24 150.9 38.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.53 -0.983 . . . . 0.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm 56.75 23.87 8.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.0 110.941 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.98 70.45 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.718 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.495 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 17.3 mm100 -98.2 142.15 30.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.971 -1.311 . . . . 0.0 108.222 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -138.33 150.99 47.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 111.365 -179.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.63 143.04 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -110.73 149.81 29.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.223 -0.923 . . . . 0.0 111.236 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m 54.21 67.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 111.471 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 96' ' ' ILE . 16.6 m -113.48 -3.56 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 108.997 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.489 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pt-20 -71.39 -26.0 62.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.318 -179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -65.6 -60.51 2.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 0.0 109.635 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.6 tp -56.74 -44.1 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.124 -0.985 . . . . 0.0 108.922 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.516 ' N ' HG23 ' A' ' 75' ' ' ILE . 7.7 mt -55.79 -38.23 69.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.993 . . . . 0.0 109.46 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.547 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.8 t -60.84 -49.02 79.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.656 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.0 t -57.19 -54.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.012 . . . . 0.0 108.585 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -51.63 -44.32 62.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 11.7 t-160 -54.42 -53.52 53.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.856 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.85 -36.95 84.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.768 HD22 ' CD1' ' A' ' 114' ' ' ILE . 11.9 mt -76.36 -7.48 55.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.138 -179.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.06 47.37 4.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.598 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 82' ' ' LEU . 12.3 mm -92.4 122.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.621 HG21 HG23 ' A' ' 121' ' ' ILE . 81.7 p -111.26 -21.83 11.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.283 -0.885 . . . . 0.0 112.134 -177.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.756 HD22 ' H ' ' A' ' 35' ' ' THR . 5.7 m120 -126.22 111.35 14.49 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.789 -1.195 . . . . 0.0 109.677 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -164.69 140.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.165 -0.959 . . . . 0.0 109.957 179.407 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.5 m -110.81 99.58 8.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.03 110.1 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.9 122.27 30.54 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.65 108.44 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 111.003 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.16 110.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.91 -160.06 22.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.43 -15.26 9.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -136.19 142.1 44.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.204 -179.56 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 72' ' ' VAL . 3.0 mm -68.23 126.22 92.44 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.53 -0.731 . . . . 0.0 109.707 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.691 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.3 Cg_exo -45.98 131.25 13.73 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.946 1.764 . . . . 0.0 112.388 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.34 -26.34 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.455 -0.778 . . . . 0.0 109.827 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 10.1 mt 54.65 -111.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -95.55 -17.71 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.911 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.03 0.84 33.83 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.0 p -129.27 -167.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.982 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -4.92 19.62 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.568 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 63.0 t-105 -47.1 -41.13 16.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.775 -0.838 . . . . 0.0 110.413 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.63 -51.89 66.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 109.967 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -62.56 -43.99 97.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 108.828 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.1 t80 -63.52 -39.21 93.84 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.481 0.658 . . . . 0.0 110.059 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.568 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 18.8 mm-40 -69.78 -48.63 58.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.44 -0.787 . . . . 0.0 111.479 -178.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.45 -51.35 11.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.927 -1.108 . . . . 0.0 110.965 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.92 -43.89 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.009 -1.057 . . . . 0.0 110.967 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -28.88 63.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 109.802 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -13.07 59.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.012 -1.055 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.97 34.3 5.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.594 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.768 ' CD1' HD22 ' A' ' 82' ' ' LEU . 12.4 mt -90.77 147.54 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.797 -1.189 . . . . 0.0 110.474 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 115' ' ' LEU . 14.1 tp -131.75 158.59 40.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.063 179.137 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.794 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.0 OUTLIER -101.75 146.16 28.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.681 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.49 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.2 mt-30 -112.66 -166.42 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 0.0 109.616 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.96 72.53 1.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 110.672 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -163.3 140.68 7.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 109.748 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 121' ' ' ILE . 3.0 tm-20 -78.31 124.09 27.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.343 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 85' ' ' THR . 1.0 OUTLIER -71.58 141.04 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.724 -178.894 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -85.36 86.43 7.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -63.24 146.7 52.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.6 122.65 44.24 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.1 138.46 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.333 -0.854 . . . . 0.0 110.461 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.06 136.23 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -117.78 -9.12 10.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.03 143.57 28.63 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.407 -0.808 . . . . 0.0 109.162 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.66 161.63 44.65 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.232 1.955 . . . . 0.0 112.989 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.971 HG22 ' HB3' ' A' ' 141' ' ' ALA . 11.5 tt -150.64 144.0 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.651 -0.656 . . . . 0.0 109.46 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -131.17 122.55 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.46 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 132' ' ' VAL . 26.9 m -123.55 118.79 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.466 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -120.28 136.32 54.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.49 -0.756 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.19 150.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 110.503 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 55.94 24.45 7.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.653 . . . . 0.0 110.996 179.047 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.95 87.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -108.77 169.12 8.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.074 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.011 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -159.95 153.57 22.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.151 -1.593 . . . . 0.0 109.465 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.011 ' N ' HD23 ' A' ' 138' ' ' LEU . 37.5 mt -148.57 136.05 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -126.14 142.1 51.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.996 -179.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.971 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.13 148.12 44.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 5.0 tm-20 -145.97 137.48 12.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.487 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 8.3 Cg_endo -53.84 146.5 45.64 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.744 1.63 . . . . 0.0 112.605 -179.147 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.75 11.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.21 1.43 48.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -137.88 150.33 47.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.479 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 24.2 tp -81.88 117.16 21.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 110.042 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -138.69 136.3 35.69 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.541 ' CG1' HD23 ' A' ' 231' ' ' LEU . 42.8 t -137.18 139.62 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.92 . . . . 0.0 109.985 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.0 m -125.15 140.37 52.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.335 -0.853 . . . . 0.0 109.625 179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' A' ' 228' ' ' VAL . 85.7 t80 -125.51 129.97 50.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.707 . . . . 0.0 109.81 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -115.07 111.17 20.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -106.0 146.87 16.13 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -128.15 86.19 2.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -1.093 . . . . 0.0 109.233 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.9 m-30 -94.28 149.2 21.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.95 -9.67 47.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.521 -0.737 . . . . 0.0 110.433 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.548 HD21 HD12 ' A' ' 159' ' ' LEU . 23.7 p-10 -66.48 -172.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.022 -1.049 . . . . 0.0 109.616 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -55.2 -24.54 27.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.05 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.548 HD12 HD21 ' A' ' 157' ' ' ASN . 12.4 mt -63.93 -43.01 97.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.044 -1.035 . . . . 0.0 109.432 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.78 -119.9 5.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -114.8 140.88 48.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.421 -1.046 . . . . 0.0 109.311 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.02 140.27 16.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.813 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -124.42 151.76 44.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.521 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 81.1 t80 -136.03 121.12 18.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -0.933 . . . . 0.0 109.05 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 48.7 m -99.47 122.72 42.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 167' ' ' VAL . 2.3 t80 -95.79 134.34 38.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.527 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.8 t -129.69 157.5 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.533 -0.73 . . . . 0.0 109.319 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.696 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 28.9 mp0 -60.48 116.17 4.12 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.58 6.17 17.72 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -135.87 29.74 3.13 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.037 -1.272 . . . . 0.0 108.918 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.97 -30.7 70.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 110.405 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -54.34 -9.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 110.66 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.88 -4.22 25.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.905 -1.122 . . . . 0.0 111.256 -178.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.563 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.3 pt -116.66 13.4 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.041 -1.037 . . . . 0.0 110.979 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.47 -28.6 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.071 -1.018 . . . . 0.0 109.612 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 104' ' ' TRP . 1.1 mp -91.08 0.28 57.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.737 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.85 119.51 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 108.239 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -88.45 150.11 23.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.197 . . . . 0.0 109.963 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 179' ' ' THR . 1.9 t -58.06 129.37 41.63 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . 0.488 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 14.6 p90 -109.16 166.53 10.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -153.99 159.79 41.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.498 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.594 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 67.9 m-85 -104.08 147.21 27.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.717 ' HA ' HD12 ' A' ' 186' ' ' ILE . 49.0 p30 -60.07 -22.58 62.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.08 -1.013 . . . . 0.0 110.116 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.8 p90 -81.99 -33.08 30.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.91 -1.119 . . . . 0.0 110.53 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 24.4 pt-20 -85.16 -16.39 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.803 -1.185 . . . . 0.0 109.345 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.9 mt -59.24 -53.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.235 -0.915 . . . . 0.0 110.058 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 184' ' ' TRP . 2.9 mp0 -51.49 -53.57 36.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.196 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -47.66 65.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 108.924 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.29 -34.1 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.0 108.76 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -80.13 -25.87 39.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.843 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.01 -21.27 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.458 ' CG2' HD12 ' A' ' 194' ' ' LEU . 23.7 m -90.7 13.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.43 25.65 72.16 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.458 HD12 ' CG2' ' A' ' 192' ' ' VAL . 23.3 mt -127.15 167.2 16.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.237 -1.155 . . . . 0.0 109.918 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.9 16.98 80.3 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.457 -0.777 . . . . 0.0 111.314 178.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -64.11 -51.97 61.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.601 -1.529 . . . . 0.0 109.235 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -70.2 -4.38 49.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -178.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.66 130.0 39.67 Favored Glycine 0 N--CA 1.493 2.472 0 O-C-N 120.96 -1.318 . . . . 0.0 110.641 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -143.26 173.58 11.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.749 -0.854 . . . . 0.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 200' ' ' LEU . 87.2 mt -79.71 -1.81 40.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.641 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -97.24 -10.45 25.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -139.44 13.29 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.516 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 18.0 m -149.29 133.18 17.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.139 -0.975 . . . . 0.0 109.935 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.55 117.23 29.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 108.528 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -105.92 126.59 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.962 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.05 144.15 33.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 0.0 109.396 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 208' ' ' LYS . . . -102.91 153.24 18.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 207' ' ' GLY . 18.0 pttm -41.64 -32.52 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -151.32 13.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.951 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -139.24 147.36 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.6 t -98.2 125.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.032 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -73.0 -54.63 8.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -52.41 139.13 38.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.879 -1.138 . . . . 0.0 109.508 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.21 -38.07 4.05 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.386 2.057 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.49 -4.4 22.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.51 -168.88 53.73 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.47 149.05 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -1.12 . . . . 0.0 109.618 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -58.26 3.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 108.958 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -117.5 170.84 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.94 -18.03 60.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.113 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.704 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -128.23 29.98 5.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 109.537 -179.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 pp20? -62.95 -25.06 1.56 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 112.537 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 1.1 Cg_endo -80.57 -46.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.079 1.421 . . . . 0.0 112.082 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 228' ' ' VAL . 1.2 m -73.04 -22.1 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.885 -1.135 . . . . 0.0 108.005 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.704 HH21 ' ND2' ' A' ' 221' ' ' ASN . 48.8 mtt180 -71.35 -49.63 40.38 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -55.07 -42.57 72.93 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -45.49 83.14 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 224' ' ' VAL . 30.9 t -60.76 -50.15 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 65.2 t80 -49.45 -37.36 25.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 11.1 m-20 -74.65 -39.19 62.22 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.591 -0.693 . . . . 0.0 109.737 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.541 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.64 -36.76 69.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 109.267 -179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' HIS . 96.9 mt -72.33 -48.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.67 -32.79 17.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.41 -28.07 31.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.187 -1.184 . . . . 0.0 109.899 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 260' ' ' VAL . 5.1 mt -79.75 -23.04 42.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.876 -1.14 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.526 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.4 t80 -71.44 -8.21 52.39 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.035 -1.041 . . . . 0.0 109.09 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 237' ' ' LEU . 35.7 mt -52.85 -25.87 12.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 242' ' ' VAL . 46.9 mt -58.56 -21.92 54.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 108.845 179.098 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.49 65.99 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.1 p -158.19 149.61 16.77 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.561 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.402 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 3.7 Cg_exo -48.16 134.32 24.58 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.12 1.88 . . . . 0.0 111.583 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 238' ' ' LEU . 24.1 t -100.2 133.28 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.024 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -120.25 125.07 47.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.46 172.46 23.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -101.63 117.43 34.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.046 -1.267 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 149' ' ' VAL . 29.9 m-85 -117.49 147.73 42.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.115 0.96 . . . . 0.0 111.185 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -130.08 138.26 50.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.91 127.01 31.59 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.801 -1.187 . . . . 0.0 110.361 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.443 ' O ' ' C ' ' A' ' 250' ' ' ARG . 43.1 t80 -109.22 114.45 28.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.482 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER 44.31 55.95 5.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.69 145.88 27.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.3 162.84 12.24 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.647 ' O ' HG23 ' A' ' 257' ' ' VAL . 69.8 m-70 -56.47 -50.12 72.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 109.825 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 t -59.07 -55.88 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.656 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.56 -39.67 61.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.079 -1.013 . . . . 0.0 109.508 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -58.24 -54.73 43.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.16 -0.963 . . . . 0.0 108.421 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 253' ' ' HIS . 13.5 t -48.8 -41.63 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.362 -0.836 . . . . 0.0 109.47 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -55.28 -48.96 73.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 108.821 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 27.8 tp -52.36 -41.92 63.5 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.445 HG22 HD23 ' A' ' 235' ' ' LEU . 41.1 t -70.57 -45.31 74.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.596 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -53.62 -51.06 64.27 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.451 -0.78 . . . . 0.0 110.265 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -63.19 -47.59 81.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 109.861 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 263' ' ' LEU . 88.3 mt -59.79 -44.5 93.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.291 -0.881 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt . . . . . 0 N--CA 1.489 1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 108.762 179.252 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.449 ' O ' HD11 ' A' ' 121' ' ' ILE . 2.6 mp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.593 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -51.83 136.8 27.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.79 134.63 54.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.667 -0.646 . . . . 0.0 109.458 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -133.62 170.96 14.77 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 7' ' ' VAL . 6.4 m -81.94 132.68 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.665 -1.272 . . . . 0.0 110.199 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -49.09 77.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.467 -0.771 . . . . 0.0 109.724 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.584 ' CG ' HD22 ' A' ' 113' ' ' ASN . 8.4 pt-20 -128.51 158.24 38.93 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.668 0.747 . . . . 0.0 110.454 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.521 ' HE3' HG23 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -58.65 138.73 56.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.573 -0.704 . . . . 0.0 110.254 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.94 161.86 24.55 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.7 p -157.91 150.02 22.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.985 -1.072 . . . . 0.0 110.374 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -137.48 160.49 38.99 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.803 . . . . 0.0 109.948 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.11 138.9 24.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.086 -1.009 . . . . 0.0 109.563 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.19 158.56 16.63 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.46 161.51 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.282 -1.128 . . . . 0.0 111.069 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.32 140.29 14.96 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.621 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.8 tt -57.57 -52.87 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.133 -1.216 . . . . 0.0 112.451 -178.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.621 ' N ' HG23 ' A' ' 18' ' ' ILE . 15.4 m-70 -86.63 -37.67 17.82 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.175 -1.578 . . . . 0.0 111.195 -178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 m -75.01 -35.29 61.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 110.016 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 26.53 71.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.09 152.56 33.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.608 -0.936 . . . . 0.0 108.95 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.5 OUTLIER -71.75 129.56 38.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.953 -179.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.564 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.6 t -135.86 156.43 48.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.297 -0.877 . . . . 0.0 108.943 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.567 ' C ' HD23 ' A' ' 26' ' ' LEU . 8.2 tttp -135.55 148.26 49.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 109.065 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.2 mt -126.18 143.88 50.97 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.063 -1.023 . . . . 0.0 109.072 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.521 HG23 ' HE3' ' A' ' 10' ' ' LYS . 42.3 mt -126.19 134.17 67.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 7.4 mt -116.79 130.23 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.005 -1.059 . . . . 0.0 109.619 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -126.1 154.02 74.12 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.71 154.23 75.18 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.284 1.99 . . . . 0.0 111.353 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.547 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.1 mm-40 -133.61 -174.33 3.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.954 . . . . 0.0 109.894 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.0 ttpt -87.57 149.36 24.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -0.787 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.4 OUTLIER -47.68 152.2 0.74 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 110.084 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 20.63 53.24 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.338 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.4 m -80.68 -42.97 21.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.641 -1.505 . . . . 0.0 108.854 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.46 -172.07 27.21 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.7 mm -99.64 121.38 50.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.535 -0.979 . . . . 0.0 108.562 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -135.64 145.97 47.39 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.744 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -102.68 150.0 23.88 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.528 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -132.29 138.67 47.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.222 -0.924 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.566 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 16.0 tttm -167.19 141.29 3.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.419 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.566 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 1.3 m120 54.23 29.53 10.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.64 30.11 68.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.9 t -130.86 125.17 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.4 -1.059 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -88.53 139.18 30.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 108.977 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.45 94.16 17.81 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 110.052 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -48.69 144.41 14.63 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.251 1.967 . . . . 0.0 111.919 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.64 84.92 4.03 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.169 -0.957 . . . . 0.0 110.499 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.415 ' HB3' HH11 ' A' ' 49' ' ' ARG . 3.1 mmm180 -136.33 154.88 50.72 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 109.15 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 4.8 p80 -50.54 -50.15 54.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.007 -1.058 . . . . 0.0 109.496 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.9 mt-10 -43.97 -32.48 1.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.33 -0.856 . . . . 0.0 109.48 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -79.65 3.32 19.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.163 -0.961 . . . . 0.0 110.325 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 t -63.17 118.09 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.082 -1.011 . . . . 0.0 108.796 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.7 m -109.05 -29.19 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.37 -0.831 . . . . 0.0 110.016 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.444 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.0 t-80 -150.18 123.4 8.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.147 -0.971 . . . . 0.0 109.616 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -112.44 136.78 51.52 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 59' ' ' SER . 45.2 t30 -166.68 -154.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -50.79 -10.03 0.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.0 108.17 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.559 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -137.76 166.84 22.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.588 -0.695 . . . . 0.0 109.462 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 72' ' ' VAL . 2.0 m -105.43 122.04 45.15 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.4 OUTLIER -120.32 140.86 50.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.29 -0.881 . . . . 0.0 111.529 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' HG ' HG21 ' A' ' 72' ' ' VAL . 27.6 mt -123.02 154.92 37.83 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -169.21 141.61 6.82 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.876 -1.631 . . . . 0.0 110.683 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -144.38 150.7 38.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.495 -1.003 . . . . 0.0 110.028 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.97 27.76 13.69 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.552 -0.717 . . . . 0.0 110.758 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.36 1.02 79.07 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.541 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 28.9 mm-40 -99.79 143.96 29.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.951 -1.323 . . . . 0.0 108.668 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -138.55 149.92 45.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 111.269 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.3 mt -135.33 134.51 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -107.85 156.41 19.19 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.302 -0.874 . . . . 0.0 111.055 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.1 m 53.04 68.79 0.78 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.697 -0.627 . . . . 0.0 110.827 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.447 HG21 ' HG ' ' A' ' 62' ' ' LEU . 24.4 m -113.06 -5.21 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.081 -1.012 . . . . 0.0 109.039 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.2 OUTLIER -68.55 -39.19 81.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.875 . . . . 0.0 110.414 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -54.64 -60.73 2.96 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.089 -1.007 . . . . 0.0 110.299 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.482 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.09 -43.59 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.825 -1.172 . . . . 0.0 109.147 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.482 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 76.4 mt -57.28 -35.79 70.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.515 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.1 t -62.27 -50.26 72.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.126 -0.984 . . . . 0.0 109.567 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.89 -51.2 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 0.0 108.451 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.477 HD12 ' HA ' ' A' ' 76' ' ' LEU . 47.4 mt -51.79 -45.4 63.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.781 . . . . 0.0 109.4 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 9.3 t-160 -54.92 -51.69 65.29 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.52 -0.737 . . . . 0.0 110.341 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.8 mt -63.26 -37.19 86.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.93 . . . . 0.0 110.625 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 114' ' ' ILE . 20.7 mt -82.06 -6.82 59.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.044 -1.035 . . . . 0.0 111.091 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.82 53.99 2.36 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.622 -1.299 . . . . 0.0 110.543 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 82' ' ' LEU . 19.0 mm -90.0 126.5 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.566 HG21 HG12 ' A' ' 121' ' ' ILE . 75.5 p -109.75 -26.86 9.62 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.227 -0.921 . . . . 0.0 111.705 -177.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.673 ' O ' HG13 ' A' ' 87' ' ' VAL . 5.0 m-80 -131.33 112.7 12.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.817 -1.177 . . . . 0.0 110.715 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.8 OUTLIER -164.04 134.88 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.758 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.547 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 12.1 m -106.03 103.82 13.39 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.4 mt -92.35 103.9 15.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.329 -0.857 . . . . 0.0 109.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.76 120.45 23.43 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.2 t -105.16 105.8 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 110.446 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -87.92 109.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.29 -159.81 23.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.65 -10.13 12.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.536 -0.979 . . . . 0.0 110.77 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -151.98 155.34 37.82 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.672 -1.268 . . . . 0.0 111.056 -179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.2 mm -73.24 124.58 90.71 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.741 -0.6 . . . . 0.0 110.164 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.704 ' CD ' HD21 ' A' ' 26' ' ' LEU . 79.0 Cg_exo -45.8 134.46 13.8 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 122.069 1.846 . . . . 0.0 112.177 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -80.44 -29.5 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.481 -0.762 . . . . 0.0 110.714 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 65.1 mt 57.59 -126.13 1.69 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.218 -0.926 . . . . 0.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -80.72 -23.96 39.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.197 -0.939 . . . . 0.0 110.242 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 118.51 -8.66 13.38 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -116.44 -171.34 1.98 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.419 -1.048 . . . . 0.0 109.786 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -109.76 -2.62 30.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.488 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 63.5 t-105 -46.58 -41.8 15.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.87 . . . . 0.0 110.235 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.67 -52.23 65.18 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.011 -1.056 . . . . 0.0 110.499 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -64.81 -43.27 93.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.98 -1.075 . . . . 0.0 108.894 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -63.72 -36.79 85.03 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.363 0.601 . . . . 0.0 109.958 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 4.8 mm-40 -68.41 -52.62 30.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.466 -0.772 . . . . 0.0 111.873 -178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.71 -50.91 21.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.888 -1.132 . . . . 0.0 110.822 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.4 mt -59.36 -43.19 89.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.119 -0.988 . . . . 0.0 110.66 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -53.61 -31.51 47.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.122 -0.986 . . . . 0.0 110.13 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.584 HD22 ' CG ' ' A' ' 9' ' ' GLU . 2.6 m120 -122.84 28.4 7.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.337 -0.852 . . . . 0.0 111.401 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.613 ' CD1' HD22 ' A' ' 82' ' ' LEU . 4.2 mt -85.73 147.19 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.636 -1.29 . . . . 0.0 109.617 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.2 tp -131.23 153.71 49.2 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.472 -0.768 . . . . 0.0 109.098 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -101.46 143.93 30.86 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.053 -1.029 . . . . 0.0 109.548 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.596 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 8.6 mt-30 -108.29 -166.69 1.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -116.73 70.7 0.77 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.426 -0.797 . . . . 0.0 110.565 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -168.19 146.98 4.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.149 -0.969 . . . . 0.0 109.587 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -86.69 135.18 33.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.278 -0.889 . . . . 0.0 110.146 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.566 HG12 HG21 ' A' ' 85' ' ' THR . 58.6 mt -81.71 149.76 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.81 . . . . 0.0 110.463 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -97.24 100.29 11.75 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -71.74 147.08 47.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 110.748 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -96.77 121.83 39.06 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.47 135.24 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.396 -0.815 . . . . 0.0 110.316 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.9 t -78.85 133.57 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.5 -10.75 13.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.434 -0.791 . . . . 0.0 109.301 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -142.89 143.45 25.4 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.202 -0.936 . . . . 0.0 109.408 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.44 171.88 16.82 Favored 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 122.38 2.053 . . . . 0.0 112.997 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.1 tt -165.74 142.93 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.699 -0.625 . . . . 0.0 109.694 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.76 125.86 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.509 -0.744 . . . . 0.0 109.833 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 132' ' ' VAL . 31.1 m -121.96 120.06 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.541 -0.725 . . . . 0.0 109.364 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.68 137.44 52.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.5 -0.75 . . . . 0.0 109.668 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.17 147.99 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.013 . . . . 0.0 110.829 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 56.84 24.83 9.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.6 -0.688 . . . . 0.0 110.955 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.39 85.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -109.33 169.65 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.969 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.6 tt -159.48 152.36 21.79 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.18 -1.575 . . . . 0.0 109.108 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.969 ' N ' HD23 ' A' ' 138' ' ' LEU . 41.6 mt -148.72 139.87 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.127 -0.983 . . . . 0.0 108.363 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 tttm -128.08 142.66 51.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.949 . . . . 0.0 110.106 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -121.01 144.91 48.28 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -143.13 138.87 16.09 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.278 -0.888 . . . . 0.0 108.622 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.32 148.08 73.2 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 121.415 1.41 . . . . 0.0 111.735 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -167.2 155.9 9.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -87.1 0.05 55.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.824 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -136.44 150.46 48.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 109.555 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 242' ' ' VAL . 24.9 tp -81.74 116.88 21.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 109.647 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -138.65 134.9 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.623 ' CG1' HD23 ' A' ' 231' ' ' LEU . 45.9 t -134.63 124.6 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 53.0 m -112.2 137.55 50.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.0 109.576 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -126.02 129.72 49.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.488 -0.757 . . . . 0.0 110.117 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -111.82 103.89 12.18 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.15 140.72 15.16 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.543 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -116.46 101.53 8.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.467 -1.019 . . . . 0.0 108.935 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.452 ' HB2' HD21 ' A' ' 157' ' ' ASN . 48.8 m-85 -100.9 142.98 31.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 109.939 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.94 1.86 56.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.379 -0.826 . . . . 0.0 109.561 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.714 HD22 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -84.38 -166.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 109.485 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -62.7 -25.17 68.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.958 . . . . 0.0 110.272 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HB2' HD21 ' A' ' 157' ' ' ASN . 76.8 mt -66.41 -25.34 66.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.009 -1.057 . . . . 0.0 109.398 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.09 -138.81 47.78 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -93.11 144.99 24.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.508 -0.995 . . . . 0.0 109.837 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -150.18 137.07 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.292 -0.88 . . . . 0.0 109.41 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.56 147.23 47.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.51 -0.744 . . . . 0.0 109.072 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.687 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 58.3 t80 -136.62 124.11 22.17 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -0.977 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.8 m -101.64 121.92 42.91 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.158 -0.964 . . . . 0.0 109.705 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.55 135.42 41.0 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.274 -0.891 . . . . 0.0 109.142 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.74 151.4 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 109.507 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.536 ' OE2' ' NZ ' ' A' ' 243' ' ' LYS . 19.4 mt-10 -51.67 116.56 2.18 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.311 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.66 7.42 15.76 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.544 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 14.6 m-80 -134.85 28.39 3.54 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.179 -1.189 . . . . 0.0 108.668 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.578 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 2.4 mp0 -66.02 -31.09 71.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.752 -0.593 . . . . 0.0 110.582 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -60.89 -15.51 31.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.624 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -94.91 -4.23 47.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.956 -1.09 . . . . 0.0 110.898 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.546 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 4.2 pt -121.46 13.65 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.946 -1.096 . . . . 0.0 111.226 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.87 -25.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.958 -1.089 . . . . 0.0 109.6 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -91.26 2.02 56.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.989 -1.069 . . . . 0.0 110.533 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.48 109.38 16.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.013 -1.054 . . . . 0.0 108.895 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.513 ' CG ' HH11 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -82.07 153.4 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 109.917 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 4.8 t -54.3 156.65 3.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.454 -0.778 . . . . 0.0 109.338 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -139.76 170.68 15.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.875 -1.141 . . . . 0.0 110.119 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.585 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 3.5 t -157.27 162.41 39.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 109.469 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.625 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.5 m-85 -105.47 144.71 31.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.559 -0.713 . . . . 0.0 109.286 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.728 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.2 p30 -60.22 -21.86 62.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.085 -1.009 . . . . 0.0 110.703 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.625 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.2 p90 -81.66 -33.94 31.02 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.875 -1.141 . . . . 0.0 110.912 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.625 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.6 pt-20 -88.83 -14.86 35.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.865 -1.147 . . . . 0.0 110.088 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.8 mt -54.79 -52.22 44.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.169 -0.957 . . . . 0.0 110.515 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.27 -47.11 62.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.941 -1.099 . . . . 0.0 109.544 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -53.65 55.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.141 -0.975 . . . . 0.0 109.201 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.653 HG21 H4A3 ' A' ' 320' ' ' TUX . 66.6 mt -55.43 -34.29 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 108.921 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.581 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 10.5 mmtm -77.04 -30.19 55.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.645 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -71.55 -22.24 61.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.193 -0.942 . . . . 0.0 109.889 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 192' ' ' VAL . 13.5 m -91.6 13.31 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.109 -0.994 . . . . 0.0 109.941 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 69.68 27.33 73.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.76 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 85.0 mt -121.87 159.22 27.27 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.074 -1.251 . . . . 0.0 109.797 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.581 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 78.63 28.1 55.73 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.31 -0.948 . . . . 0.0 110.817 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -69.82 -20.39 63.44 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.691 -1.476 . . . . 0.0 109.066 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.28 -3.12 51.03 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.86 124.74 33.38 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 203' ' ' THR . 12.0 p -138.92 174.48 10.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.755 -0.85 . . . . 0.0 109.258 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.37 -15.87 60.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.485 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.431 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.2 tttm -87.79 -18.8 28.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.639 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 201' ' ' LYS . 1.8 m-20 -124.65 -8.6 7.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -0.835 . . . . 0.0 109.649 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.423 ' N ' ' O ' ' A' ' 199' ' ' SER . 0.7 OUTLIER -132.47 119.47 20.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -81.09 117.04 21.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.925 . . . . 0.0 108.9 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.438 HG21 HCA3 ' A' ' 320' ' ' TUX . 74.3 t -104.66 128.43 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.702 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.784 HD21 HD21 ' A' ' 217' ' ' LEU . 12.3 mt -108.81 148.45 30.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.426 -0.796 . . . . 0.0 109.73 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.39 156.05 16.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 207' ' ' GLY . 9.8 tttm -42.13 -33.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -1.141 . . . . 0.0 109.856 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -147.76 16.16 1.11 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.085 -1.009 . . . . 0.0 109.991 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -144.59 153.17 41.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.032 -1.042 . . . . 0.0 110.28 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.457 HG22 HD23 ' A' ' 206' ' ' LEU . 84.6 t -103.12 128.45 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.549 -0.719 . . . . 0.0 109.139 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -71.35 -53.97 12.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 0.0 109.996 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -58.67 133.75 86.17 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.057 . . . . 0.0 109.411 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.43 -8.0 21.87 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.378 2.052 . . . . 0.0 112.708 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -89.16 -7.81 54.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.069 -1.019 . . . . 0.0 109.918 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.22 -167.68 48.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.784 HD21 HD21 ' A' ' 206' ' ' LEU . 55.4 mt -83.1 145.74 29.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.497 -1.002 . . . . 0.0 110.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.7 ttt85 -86.02 -20.08 29.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.347 -0.846 . . . . 0.0 109.278 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 221' ' ' ASN . 71.7 m-85 -146.22 133.19 20.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 108.921 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 31.7 mp0 -46.5 -16.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.986 -1.071 . . . . 0.0 108.865 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.55 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -131.63 33.54 4.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.617 0.722 . . . . 0.0 109.151 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 4.7 tt0 -53.66 -57.31 17.93 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.367 -0.833 . . . . 0.0 111.432 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_endo -54.21 -38.95 88.19 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 121.902 1.735 . . . . 0.0 113.036 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 228' ' ' VAL . 9.1 m -79.77 -26.46 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.528 -1.357 . . . . 0.0 108.8 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 40.3 mtt-85 -64.69 -41.15 96.24 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -65.41 -43.45 90.54 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.32 -48.36 76.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 108.979 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 224' ' ' VAL . 34.8 t -61.07 -42.74 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 108.467 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 89.2 t80 -58.72 -39.21 80.19 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 1.0 OUTLIER -73.03 -39.51 65.91 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.55 -0.718 . . . . 0.0 109.696 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.623 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.2 tp -56.62 -36.36 69.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.16 -0.962 . . . . 0.0 109.221 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.506 HG22 ' HD1' ' A' ' 80' ' ' HIS . 94.0 mt -70.67 -48.31 59.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.7 -33.28 18.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.44 -26.56 32.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.061 -1.258 . . . . 0.0 109.897 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.574 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -80.49 -23.19 40.32 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.762 -1.212 . . . . 0.0 110.11 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.516 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 10.1 t80 -71.65 -8.59 55.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 237' ' ' LEU . 68.9 mt -52.52 -28.03 18.93 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.434 HD21 HG13 ' A' ' 260' ' ' VAL . 94.9 mt -57.27 -13.92 3.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 108.507 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 14.9 81.61 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 84.1 p -158.99 144.67 12.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.829 -1.395 . . . . 0.0 109.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.408 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 71.6 Cg_exo -43.36 129.3 6.35 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 122.077 1.851 . . . . 0.0 111.662 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 238' ' ' LEU . 10.6 t -96.3 135.25 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.147 -0.971 . . . . 0.0 110.148 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.536 ' NZ ' ' OE2' ' A' ' 168' ' ' GLU . 26.8 mmtt -120.16 125.27 47.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 0.0 109.616 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.53 171.73 24.77 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.3 tttp -102.65 112.27 24.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.068 -1.254 . . . . 0.0 109.769 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.4 m-85 -112.67 146.75 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.825 0.821 . . . . 0.0 111.354 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -128.61 143.06 50.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.69 125.71 21.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.57 -1.331 . . . . 0.0 110.144 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.461 ' O ' ' C ' ' A' ' 250' ' ' ARG . 8.9 t80 -109.77 115.22 29.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.543 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 17.2 mtt180 44.0 56.0 4.98 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -91.92 157.8 24.55 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 120.137 -1.03 . . . . 0.0 110.593 -178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -120.3 -171.56 14.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 87.5 m-70 -74.91 -52.09 12.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.148 -1.207 . . . . 0.0 110.044 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.0 m -55.1 -56.12 23.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.077 -1.014 . . . . 0.0 109.406 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.1 tp -54.26 -42.57 70.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.487 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -59.07 -55.32 36.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.051 -1.031 . . . . 0.0 108.7 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 7.3 t -52.28 -39.35 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.895 . . . . 0.0 109.158 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -54.7 -47.79 73.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 108.643 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 7.1 tp -52.66 -50.16 63.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.574 HG22 HD23 ' A' ' 235' ' ' LEU . 53.1 t -61.25 -42.29 92.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.468 -0.77 . . . . 0.0 109.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -52.39 65.36 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.805 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -64.62 -40.84 96.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.987 -1.071 . . . . 0.0 109.786 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 263' ' ' LEU . 30.1 mt -61.89 -45.99 91.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.417 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.07 -27.63 61.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 110.627 -178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -87.26 -26.57 23.41 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.687 -1.258 . . . . 0.0 109.039 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -74.15 -46.09 44.6 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.185 -0.947 . . . . 0.0 109.318 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.457 ' O ' ' O ' ' A' ' 270' ' ' THR . 4.1 mp0 -78.16 12.92 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.615 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -60.55 -33.32 72.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.931 . . . . 0.0 109.592 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 44.3 mt -63.0 -30.0 71.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.105 -0.997 . . . . 0.0 109.513 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 267' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.376 -0.827 . . . . 0.0 109.426 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.653 H4A3 HG21 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.617 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 14.7 mt-10 -46.94 142.24 3.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.154 -0.966 . . . . 0.0 109.466 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.63 134.33 54.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.568 -0.707 . . . . 0.0 110.121 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -139.2 179.04 6.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.364 -0.835 . . . . 0.0 108.766 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 7' ' ' VAL . 7.6 m -87.58 138.06 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.669 -1.27 . . . . 0.0 110.456 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -73.74 -43.77 58.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.499 -0.75 . . . . 0.0 110.048 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -125.04 150.04 47.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 0.0 110.177 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.23 140.04 58.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.502 -0.749 . . . . 0.0 109.814 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 11' ' ' LEU . 12.6 mt -122.27 168.04 12.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.586 -0.696 . . . . 0.0 109.198 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.26 148.4 23.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.139 -0.976 . . . . 0.0 110.06 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -135.46 158.02 45.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.498 -0.751 . . . . 0.0 109.588 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -147.89 137.73 22.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.022 -1.049 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.0 160.1 18.69 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.483 HG23 ' C ' ' A' ' 22' ' ' GLU . 9.4 p -81.51 138.61 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -1.186 . . . . 0.0 110.507 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.47 145.28 43.79 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -62.53 -47.88 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.452 -1.028 . . . . 0.0 112.682 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.8 m-70 -87.08 -38.69 16.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.02 -1.675 . . . . 0.0 111.486 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.473 HG21 HD22 ' A' ' 94' ' ' ASN . 3.5 m -74.74 -35.95 62.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.894 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.476 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 68.15 22.42 74.34 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.483 ' C ' HG23 ' A' ' 16' ' ' VAL . 9.2 tt0 -110.13 148.75 31.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.443 -1.033 . . . . 0.0 109.116 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -71.59 130.98 42.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.354 -0.841 . . . . 0.0 110.026 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 t -140.09 156.47 46.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' O ' HD23 ' A' ' 26' ' ' LEU . 24.2 tttm -135.31 147.13 49.07 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.141 -0.974 . . . . 0.0 109.098 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.74 HD11 ' HD2' ' A' ' 97' ' ' PRO . 1.8 mt -128.19 144.53 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.964 -1.085 . . . . 0.0 109.428 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.4 mt -122.14 140.71 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.3 mt -121.03 118.84 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.167 -0.958 . . . . 0.0 110.109 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -117.4 154.08 50.33 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -69.2 164.04 35.53 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.296 1.997 . . . . 0.0 111.24 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.492 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 13.3 mm-40 -134.36 -175.95 4.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.112 -0.993 . . . . 0.0 109.842 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 15.6 tttm -91.67 158.73 16.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.613 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -51.61 145.4 9.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.405 -0.809 . . . . 0.0 110.503 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.617 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 63.97 23.35 67.56 Favored Glycine 0 N--CA 1.493 2.443 0 O-C-N 121.575 -0.703 . . . . 0.0 111.855 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 93.2 m -82.06 -46.36 14.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.365 -1.667 . . . . 0.0 109.199 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.6 -171.19 23.79 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.3 mm -96.67 123.42 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -1.151 . . . . 0.0 108.375 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.03 140.26 32.58 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.722 -1.191 . . . . 0.0 111.04 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -100.52 152.32 20.53 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.4 t80 -132.22 137.76 47.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.288 -0.883 . . . . 0.0 109.569 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.525 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 15.6 tttt -165.76 140.21 4.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 109.478 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.6 29.35 13.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.56 12.62 82.38 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.36 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.0 t -117.02 139.35 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.26 -1.141 . . . . 0.0 109.75 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -98.74 141.46 31.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.095 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 46' ' ' ILE . 12.5 mt -133.45 94.76 19.0 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.288 -0.883 . . . . 0.0 110.2 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -51.4 147.15 22.88 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.261 1.974 . . . . 0.0 111.395 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.82 84.83 3.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.893 -1.129 . . . . 0.0 110.605 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -137.6 153.97 49.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.139 -0.976 . . . . 0.0 109.61 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.688 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 2.4 p80 -50.62 -49.36 56.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.293 -0.879 . . . . 0.0 109.564 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.688 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 86.5 mt-10 -44.38 -33.41 1.65 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.201 -0.937 . . . . 0.0 109.104 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -80.15 0.49 32.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.263 -0.898 . . . . 0.0 110.414 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 50' ' ' HIS . 4.0 t -59.25 126.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.985 -1.072 . . . . 0.0 108.746 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.2 m -113.59 -32.25 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 0.0 110.153 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.71 124.36 7.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 0.0 109.708 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.1 p -112.35 134.03 54.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.639 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -166.63 -153.89 0.17 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.581 ' O ' ' NXH' ' A' ' 320' ' ' TUX . 6.5 m80 -48.59 -11.4 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.97 -1.081 . . . . 0.0 108.455 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.582 ' N ' ' O ' ' A' ' 57' ' ' ASN . 8.5 t -138.16 166.24 24.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.497 -0.752 . . . . 0.0 109.44 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.7 m -104.14 122.55 45.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.895 . . . . 0.0 108.717 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.34 141.98 50.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.266 -0.896 . . . . 0.0 111.446 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 72' ' ' VAL . 15.0 mt -125.12 156.43 38.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -170.32 140.44 6.02 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.607 -1.759 . . . . 0.0 110.886 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -144.58 150.61 37.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.963 . . . . 0.0 109.928 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt 55.28 32.85 19.47 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.37 -0.831 . . . . 0.0 110.519 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.83 3.1 89.56 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.346 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 73.8 mm-40 -96.76 140.95 30.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.998 -1.295 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -135.52 144.39 46.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 111.147 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 47.3 mt -133.7 139.43 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 0.7 OUTLIER -115.1 154.79 28.26 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.341 -0.849 . . . . 0.0 111.161 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.4 m 52.41 70.35 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.602 -0.686 . . . . 0.0 110.63 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.401 HG21 ' HG ' ' A' ' 62' ' ' LEU . 15.3 m -113.54 -8.74 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.181 -0.949 . . . . 0.0 109.508 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -68.16 -20.38 64.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.371 -179.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.5 m170 -71.92 -60.7 2.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.926 -1.109 . . . . 0.0 109.266 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.4 tp -58.9 -43.98 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 108.755 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 75' ' ' ILE . 89.6 mt -58.89 -37.53 76.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.809 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.574 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.6 t -61.12 -48.71 80.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.975 . . . . 0.0 109.904 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -58.61 -53.56 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.95 -1.094 . . . . 0.0 108.611 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 87.6 mt -52.45 -44.76 65.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.491 -0.756 . . . . 0.0 109.299 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.582 ' HD1' HG22 ' A' ' 232' ' ' ILE . 15.8 t-160 -54.29 -57.72 10.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.451 -0.781 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.589 HD21 HD13 ' A' ' 232' ' ' ILE . 68.6 mt -57.36 -36.08 70.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 110.665 -179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.66 HD22 ' CD1' ' A' ' 114' ' ' ILE . 12.7 mt -82.75 0.54 43.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 0.0 110.72 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.4 27.5 16.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.858 -1.151 . . . . 0.0 110.708 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 82' ' ' LEU . 14.3 mm -73.91 121.15 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.88 -1.138 . . . . 0.0 108.351 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.28 -74.63 0.64 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 0.0 111.227 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.744 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -80.19 114.11 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 0.0 111.685 -176.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 86' ' ' ASN . 6.0 m -163.95 142.49 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.492 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 28.2 m -111.86 101.8 10.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 0.0 109.081 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.98 105.97 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.639 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.84 128.5 33.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.845 -1.159 . . . . 0.0 108.329 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 68.6 t -111.52 110.68 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.438 -0.789 . . . . 0.0 111.235 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.34 110.27 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.525 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 129.96 -158.14 22.18 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.473 HD22 HG21 ' A' ' 20' ' ' THR . 0.0 OUTLIER -120.39 -10.14 9.35 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.492 -1.005 . . . . 0.0 110.483 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 3.3 pm0 -145.56 150.21 35.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.68 -1.263 . . . . 0.0 110.821 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.9 mm -74.75 122.55 87.74 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.629 -0.67 . . . . 0.0 110.045 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.74 ' HD2' HD11 ' A' ' 26' ' ' LEU . 75.2 Cg_exo -45.97 131.67 13.89 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.118 1.879 . . . . 0.0 112.341 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.436 HD11 ' HA2' ' A' ' 101' ' ' GLY . 7.6 tp -77.39 -24.85 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.424 -0.798 . . . . 0.0 109.981 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.491 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 19.0 mt 58.35 -113.49 0.7 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.84 . . . . 0.0 109.798 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -94.74 -19.24 20.55 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.982 -1.074 . . . . 0.0 110.855 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 115.05 -11.49 20.23 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.42 -170.35 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.379 -1.071 . . . . 0.0 109.657 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.8 -4.15 21.46 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.6 t-105 -46.62 -40.79 13.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.743 -0.857 . . . . 0.0 110.119 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -61.52 -51.88 66.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.048 . . . . 0.0 110.184 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.491 ' CZ ' HD11 ' A' ' 99' ' ' LEU . 60.1 m-85 -63.59 -44.08 95.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.121 -0.987 . . . . 0.0 108.948 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.473 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.4 t80 -63.05 -37.72 88.32 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.465 0.65 . . . . 0.0 109.824 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -68.96 -49.95 53.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.544 -0.722 . . . . 0.0 111.473 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.6 -51.86 11.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.858 -1.151 . . . . 0.0 110.644 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.3 mt -57.16 -43.41 81.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 120.976 -1.077 . . . . 0.0 110.233 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.3 ttt85 -55.58 -31.29 62.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 109.457 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.6 tttp -81.85 -5.32 58.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 109.583 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -127.03 35.31 4.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.425 -0.797 . . . . 0.0 110.887 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.66 ' CD1' HD22 ' A' ' 82' ' ' LEU . 10.9 mt -90.27 145.43 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.801 -1.187 . . . . 0.0 110.548 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 115' ' ' LEU . 26.7 tp -131.08 156.6 44.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -111.6 141.94 44.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.192 -0.942 . . . . 0.0 109.866 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -102.66 -161.19 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.317 -0.864 . . . . 0.0 108.975 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -118.61 2.29 11.72 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.214 -0.929 . . . . 0.0 111.094 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 4' ' ' GLU . 10.8 ttp85 -100.24 155.99 17.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.796 -1.19 . . . . 0.0 110.136 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 121' ' ' ILE . 13.9 tm-20 -89.07 136.79 32.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.499 ' O ' ' OE1' ' A' ' 120' ' ' GLU . 19.6 mt -76.63 142.75 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.517 -0.74 . . . . 0.0 110.694 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -85.22 88.26 7.46 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.44 ' CE2' ' OE2' ' A' ' 120' ' ' GLU . 45.6 m-85 -63.23 144.96 56.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.412 -0.805 . . . . 0.0 110.651 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -102.0 125.16 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 t -129.97 143.98 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.0 110.359 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.0 135.26 25.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -114.7 -12.78 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.477 -0.764 . . . . 0.0 109.171 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -140.91 142.56 28.38 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 108.941 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.85 159.34 52.07 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.907 1.738 . . . . 0.0 113.122 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.651 HG23 ' HB3' ' A' ' 141' ' ' ALA . 1.5 tt -155.41 138.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.1 mt -127.59 125.71 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.476 -0.765 . . . . 0.0 109.77 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.18 113.08 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.57 -0.706 . . . . 0.0 109.309 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -117.09 126.91 53.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.493 -0.754 . . . . 0.0 109.707 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -173.67 155.09 2.62 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.93 . . . . 0.0 110.347 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 59.52 20.52 9.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.583 -0.698 . . . . 0.0 110.728 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.3 3.06 88.37 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.592 ' HB2' HD22 ' A' ' 255' ' ' LEU . 1.3 mtt85 -104.8 172.46 6.78 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.836 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.3 tt -160.04 150.39 18.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.335 -1.478 . . . . 0.0 109.015 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.836 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.2 mt -148.05 131.87 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.085 -1.01 . . . . 0.0 109.066 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -120.16 138.97 53.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.447 -0.783 . . . . 0.0 109.894 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -124.97 134.84 52.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -133.5 137.76 29.7 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -52.56 147.54 29.98 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.291 1.327 . . . . 0.0 111.96 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.44 158.22 9.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 109.372 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -93.31 2.2 56.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.782 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.2 p -131.91 139.0 48.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 0.0 109.634 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.9 tp -73.76 116.6 14.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.343 -0.848 . . . . 0.0 109.711 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -137.71 137.1 37.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 0.0 108.738 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.574 ' CG1' HD23 ' A' ' 231' ' ' LEU . 75.6 t -140.2 123.72 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.004 -1.06 . . . . 0.0 109.415 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.745 ' OG1' HG23 ' A' ' 165' ' ' THR . 8.9 m -115.56 145.15 42.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.286 -0.884 . . . . 0.0 110.229 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -130.75 130.93 44.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.529 -0.732 . . . . 0.0 109.721 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -114.11 140.98 48.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.28 144.47 16.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.67 84.49 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.566 -0.961 . . . . 0.0 108.971 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 160' ' ' GLY . 13.6 m-85 -87.02 148.67 25.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.727 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -93.33 -5.83 48.73 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.257 -0.902 . . . . 0.0 110.037 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.424 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 11.2 p30 -70.43 -167.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.893 -1.13 . . . . 0.0 109.158 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -56.9 -21.59 30.83 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.092 -1.005 . . . . 0.0 109.566 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.424 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.3 mt -61.74 -57.46 11.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.17 -0.956 . . . . 0.0 109.505 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.28 -99.31 2.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.421 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 0.4 OUTLIER -125.89 136.7 53.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -1.111 . . . . 0.0 109.059 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 0.4 OUTLIER -145.74 159.43 43.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.721 -179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -160.2 150.4 18.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.238 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -138.32 127.47 24.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 109.465 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.745 HG23 ' OG1' ' A' ' 150' ' ' THR . 29.3 m -102.12 123.44 45.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.144 -0.973 . . . . 0.0 109.509 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.3 135.99 39.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.103 -0.998 . . . . 0.0 109.537 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.519 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -133.19 154.25 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.525 -0.735 . . . . 0.0 109.337 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -57.6 118.4 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -0.965 . . . . 0.0 109.666 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.68 1.27 21.4 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -133.77 31.42 3.64 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.161 -1.2 . . . . 0.0 108.883 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 175' ' ' VAL . 23.0 mt-10 -64.69 -33.52 76.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.45 -0.781 . . . . 0.0 110.719 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -58.23 -14.54 7.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.024 -1.048 . . . . 0.0 110.935 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.528 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 25.7 mt-10 -89.97 -3.95 57.73 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 pt -121.29 -10.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.035 -1.041 . . . . 0.0 111.105 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -83.54 -29.92 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.514 -1.366 . . . . 0.0 110.316 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -85.47 2.73 43.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.797 -1.189 . . . . 0.0 110.282 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.68 130.26 35.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.776 -1.202 . . . . 0.0 108.681 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.695 HH21 ' N ' ' A' ' 203' ' ' THR . 15.4 ptm180 -104.84 155.12 19.2 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -0.891 . . . . 0.0 110.463 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.471 ' CA ' ' CE1' ' A' ' 226' ' ' HIS . 3.0 t -56.17 156.71 5.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.557 -0.714 . . . . 0.0 109.249 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -141.03 166.7 24.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.061 . . . . 0.0 110.527 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.56 ' SG ' ' OE2' ' A' ' 185' ' ' GLU . 0.5 OUTLIER -156.9 162.06 39.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.446 -0.784 . . . . 0.0 109.077 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.507 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -104.76 144.67 31.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.214 -0.929 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.724 ' HA ' HD12 ' A' ' 186' ' ' ILE . 39.7 p30 -60.59 -21.59 62.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 111.562 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.9 p90 -76.58 -34.7 58.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.659 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.781 ' OE2' HD11 ' A' ' 189' ' ' ILE . 2.5 pt-20 -96.7 -8.3 31.78 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.476 -1.39 . . . . 0.0 110.261 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.5 mt -55.37 -51.12 59.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.0 -1.062 . . . . 0.0 109.819 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -51.41 -51.82 51.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.091 -1.006 . . . . 0.0 109.237 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -49.22 66.79 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.157 -0.964 . . . . 0.0 108.794 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.781 HD11 ' OE2' ' A' ' 185' ' ' GLU . 63.8 mt -57.46 -33.96 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.918 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -77.21 -25.91 52.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 110.02 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -77.12 -30.45 55.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.2 -0.938 . . . . 0.0 109.886 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.08 8.64 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.188 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.88 73.86 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.524 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 66.0 mt -118.58 157.62 27.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.241 -1.153 . . . . 0.0 109.682 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.47 21.11 65.08 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -66.14 -25.04 66.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.849 -1.383 . . . . 0.0 109.705 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.4 -4.89 49.67 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.36 127.91 35.38 Favored Glycine 0 N--CA 1.492 2.37 0 O-C-N 121.132 -1.217 . . . . 0.0 110.622 -178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.4 p -135.37 170.43 15.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.645 -0.915 . . . . 0.0 109.091 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.3 mt -66.71 -36.03 81.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.074 -1.017 . . . . 0.0 109.575 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.584 ' C ' HD22 ' A' ' 202' ' ' ASN . 30.3 ttmt -73.32 -27.64 61.64 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.217 -0.927 . . . . 0.0 109.662 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.776 ' N ' HD22 ' A' ' 202' ' ' ASN . 0.6 OUTLIER -107.41 5.4 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.892 . . . . 0.0 110.084 -179.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.695 ' N ' HH21 ' A' ' 178' ' ' ARG . 3.4 m -153.05 122.12 6.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.918 -1.114 . . . . 0.0 109.906 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.431 HD22 ' CD ' ' A' ' 222' ' ' GLU . 5.9 tp -79.35 110.8 14.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -0.917 . . . . 0.0 108.693 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.6 128.41 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.973 -1.079 . . . . 0.0 109.528 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.0 mt -106.38 148.46 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.369 -0.832 . . . . 0.0 109.824 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.97 149.13 16.62 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 207' ' ' GLY . 23.2 tptt -42.59 -27.38 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -1.161 . . . . 0.0 110.108 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 209' ' ' ASP . 52.6 p-10 -149.96 10.39 0.71 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.929 -1.107 . . . . 0.0 110.272 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.9 pttm -143.67 152.83 41.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.201 -0.937 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.7 t -101.44 129.58 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 0.0 108.889 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -72.95 -54.41 8.72 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.163 -0.961 . . . . 0.0 110.488 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -57.86 134.65 83.31 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 120.828 -1.17 . . . . 0.0 109.428 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.92 -14.22 29.36 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.337 2.024 . . . . 0.0 112.695 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -83.85 -6.46 59.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.42 -166.17 54.01 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 16.6 mt -80.0 148.76 31.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -1.122 . . . . 0.0 109.704 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.4 ' HB3' ' CD2' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -88.12 -22.76 23.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.656 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 77.0 m-85 -149.14 134.19 18.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.0 108.839 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 219' ' ' TYR . 11.0 tt0 -45.47 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.978 -1.076 . . . . 0.0 108.607 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.58 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -130.36 35.6 4.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.49 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 3.4 tt0 -56.81 -50.78 86.07 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.483 -0.761 . . . . 0.0 111.743 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 27.7 Cg_endo -65.82 -39.04 21.25 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.582 1.521 . . . . 0.0 113.457 -178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.649 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.1 OUTLIER -78.09 -26.82 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.524 -1.36 . . . . 0.0 108.324 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 18.2 mtp180 -68.74 -44.11 74.47 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.471 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 17.3 t60 -59.87 -43.9 94.47 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.515 -0.741 . . . . 0.0 109.038 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -56.25 -41.43 75.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.138 -0.976 . . . . 0.0 108.807 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 224' ' ' VAL . 23.0 t -62.42 -46.4 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.574 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.2 t80 -55.12 -41.71 72.04 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.47 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -70.67 -39.39 73.57 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.466 -0.771 . . . . 0.0 109.676 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.574 HD23 ' CG1' ' A' ' 149' ' ' VAL . 30.0 tp -56.97 -35.62 69.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.463 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.589 HD13 HD21 ' A' ' 81' ' ' LEU . 95.2 mt -71.15 -48.78 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.36 -31.95 13.92 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.99 -28.43 29.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.119 -1.224 . . . . 0.0 110.267 -179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.9 mt -79.49 -22.87 43.45 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.733 -1.229 . . . . 0.0 109.79 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -68.64 -8.24 40.46 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.331 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.448 ' C ' ' N ' ' A' ' 239' ' ' GLY . 36.4 mt -52.86 -32.58 45.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.339 -0.851 . . . . 0.0 109.194 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.698 HD12 ' CG2' ' A' ' 242' ' ' VAL . 97.4 mt -52.61 -11.92 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.952 -1.093 . . . . 0.0 109.212 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.448 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 77.08 13.45 83.65 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 69.7 p -158.74 143.74 11.79 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.133 -1.216 . . . . 0.0 109.434 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.436 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 73.4 Cg_exo -41.25 135.0 2.82 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.213 1.942 . . . . 0.0 112.149 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.698 ' CG2' HD12 ' A' ' 238' ' ' LEU . 2.4 t -101.3 136.64 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.207 -0.933 . . . . 0.0 109.551 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.39 131.02 50.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.38 -0.825 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.79 -178.39 31.54 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.74 112.77 25.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.149 -1.207 . . . . 0.0 109.766 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -115.16 145.5 42.32 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.027 0.918 . . . . 0.0 110.959 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.45 ' CE2' HG21 ' A' ' 150' ' ' THR . 35.8 t80 -131.22 144.02 51.01 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.0 t -139.65 128.28 23.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.77 -1.206 . . . . 0.0 110.642 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 250' ' ' ARG . 46.0 t80 -108.98 117.18 33.54 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.4 mmm180 44.76 56.29 5.34 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.56 147.16 21.99 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -115.69 178.7 17.75 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.548 ' CE1' HOH1 ' A' ' 320' ' ' TUX . 75.4 m-70 -68.47 -50.59 51.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.031 -1.276 . . . . 0.0 109.704 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 66.1 m -55.39 -55.26 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.031 -1.043 . . . . 0.0 109.367 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 137' ' ' ARG . 58.9 tp -51.38 -39.32 56.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.315 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.428 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 10.9 m120 -59.71 -53.81 53.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.184 -0.947 . . . . 0.0 108.722 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 253' ' ' HIS . 16.8 t -50.07 -43.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.628 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -55.21 -46.86 75.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.031 -1.043 . . . . 0.0 108.89 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 139' ' ' ILE . 56.4 tp -52.6 -44.72 66.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.214 -0.928 . . . . 0.0 108.569 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.04 -56.26 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.401 -0.812 . . . . 0.0 109.156 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.8 mttm -46.97 -40.74 14.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.32 0.581 . . . . 0.0 110.475 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -70.51 -46.53 63.48 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.909 -1.119 . . . . 0.0 110.037 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 39.4 mt -65.74 -37.5 86.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.903 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.13 -32.4 66.9 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.223 -0.923 . . . . 0.0 110.223 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -86.34 -28.07 23.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.793 -1.192 . . . . 0.0 108.754 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -70.3 -45.07 67.03 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.386 -0.821 . . . . 0.0 109.482 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -79.86 13.61 2.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 109.849 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -105.13 -6.5 19.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.563 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 11.6 mt -45.79 -55.93 5.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.581 ' NXH' ' O ' ' A' ' 58' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.736 ' O ' HD11 ' A' ' 121' ' ' ILE . 12.2 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 3' ' ' LEU . 18.4 mm-40 -41.49 140.81 0.84 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.446 -0.783 . . . . 0.0 109.534 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.14 135.65 53.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.353 -0.842 . . . . 0.0 109.554 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.7 t -135.03 175.32 9.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.424 -0.798 . . . . 0.0 109.342 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 7' ' ' VAL . 10.4 m -85.68 135.58 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.023 -1.048 . . . . 0.0 110.258 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -66.73 -44.19 82.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.516 -0.74 . . . . 0.0 109.959 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -129.41 152.55 48.83 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.381 -0.825 . . . . 0.0 109.88 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.22 136.03 56.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.59 168.34 10.79 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 p -157.97 148.69 20.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.116 -0.99 . . . . 0.0 110.242 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -129.96 158.73 38.76 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.494 -0.754 . . . . 0.0 109.285 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.66 135.62 21.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.97 -1.081 . . . . 0.0 109.212 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.13 159.98 18.56 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.5 p -70.7 161.91 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.049 -1.265 . . . . 0.0 110.908 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -95.4 140.79 15.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 19' ' ' HIS . 12.6 tt -56.99 -52.2 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.135 -1.215 . . . . 0.0 112.246 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.605 ' N ' HG23 ' A' ' 18' ' ' ILE . 4.6 m-70 -86.46 -38.15 17.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.281 -1.512 . . . . 0.0 111.197 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.415 ' OG1' ' CD ' ' A' ' 95' ' ' GLU . 16.0 p -72.48 -35.03 68.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.223 -0.923 . . . . 0.0 109.762 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.6 24.76 68.21 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -117.52 155.09 30.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.696 -0.885 . . . . 0.0 108.87 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.0 t80 -71.65 132.17 44.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.184 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 30.9 t -138.66 157.86 45.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -0.91 . . . . 0.0 108.845 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' O ' HD23 ' A' ' 26' ' ' LEU . 27.5 tttp -137.18 151.9 49.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.215 -0.928 . . . . 0.0 109.503 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.691 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -127.21 151.22 48.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.174 -0.954 . . . . 0.0 109.737 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.497 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.4 mt -137.69 127.34 35.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.4 mt -112.14 118.51 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.164 -0.96 . . . . 0.0 109.762 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.562 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.3 m-70 -116.98 149.25 43.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -60.97 162.44 19.11 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.187 1.925 . . . . 0.0 111.323 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.4 mm-40 -133.94 -177.48 4.59 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.227 -0.921 . . . . 0.0 109.87 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 6.8 tttm -82.3 149.69 27.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.293 -0.88 . . . . 0.0 109.556 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.628 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 11.5 mp0 -48.48 147.27 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.441 -0.787 . . . . 0.0 110.39 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.26 24.78 61.63 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.6 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 13.6 m -81.23 -46.43 14.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.734 -1.451 . . . . 0.0 109.445 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.62 -167.23 17.41 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mm -100.75 124.09 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.139 -1.212 . . . . 0.0 107.865 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -140.54 141.51 35.27 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.967 -1.093 . . . . 0.0 110.643 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -101.13 153.15 19.83 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.581 ' CG ' ' OE1' ' A' ' 90' ' ' GLU . 3.3 t80 -120.31 154.92 34.33 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.534 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -176.06 126.69 0.21 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.669 -1.27 . . . . 0.0 110.192 -179.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.84 37.22 16.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.31 77.99 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.2 t -126.23 128.77 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.353 -1.086 . . . . 0.0 109.66 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -89.52 141.75 28.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 109.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.4 mt -136.49 95.59 12.74 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.233 -0.917 . . . . 0.0 110.23 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.46 144.52 9.97 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.975 1.783 . . . . 0.0 111.472 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.46 85.29 4.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.953 -1.092 . . . . 0.0 110.66 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.74 154.14 49.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.096 -1.003 . . . . 0.0 109.408 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.496 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 9.7 p80 -50.62 -48.81 57.84 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.108 -0.995 . . . . 0.0 109.694 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 50.3 mt-10 -43.2 -33.33 0.9 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.347 -0.846 . . . . 0.0 109.366 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -77.78 1.85 18.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.241 -0.912 . . . . 0.0 110.275 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 257' ' ' VAL . 4.1 t -63.01 119.08 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -0.964 . . . . 0.0 108.77 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.66 -30.92 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.232 -0.918 . . . . 0.0 110.524 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.583 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.3 t-160 -145.71 118.64 8.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.062 . . . . 0.0 109.63 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.1 p -112.34 132.03 55.21 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.445 0.64 . . . . 0.0 109.455 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.584 ' O ' ' N ' ' A' ' 59' ' ' SER . 4.8 t-20 -166.0 -154.32 0.19 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.557 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 1.4 m-70 -48.32 -12.16 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.835 -1.166 . . . . 0.0 108.329 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 57' ' ' ASN . 16.0 t -136.66 166.03 24.5 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.481 -0.762 . . . . 0.0 109.366 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.451 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 27.0 m -106.88 122.87 47.28 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 108.965 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.99 138.61 54.36 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.08 0.943 . . . . 0.0 111.218 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.513 HD12 HG21 ' A' ' 72' ' ' VAL . 56.1 mt -117.34 156.42 27.87 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.6 142.74 6.74 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 118.347 -1.883 . . . . 0.0 111.309 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -143.24 148.75 36.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.729 -0.865 . . . . 0.0 109.199 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt 56.27 39.86 30.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.284 -0.885 . . . . 0.0 110.597 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.24 5.63 77.38 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.745 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.7 mm-40 -102.04 140.33 36.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.951 -1.323 . . . . 0.0 108.317 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.603 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -139.37 151.86 46.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.069 -1.019 . . . . 0.0 111.568 -178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.1 mt -134.26 145.33 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -114.6 150.2 35.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 111.245 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 m 55.25 69.03 0.78 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.708 -0.62 . . . . 0.0 111.047 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.513 HG21 HD12 ' A' ' 62' ' ' LEU . 27.4 m -114.26 -7.16 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.13 -0.981 . . . . 0.0 109.275 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.0 pt-20 -68.65 -36.21 78.28 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 110.523 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.578 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 26.4 m170 -58.6 -59.98 4.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.998 -1.064 . . . . 0.0 110.111 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.1 tp -57.16 -42.17 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.808 -1.183 . . . . 0.0 109.07 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.477 ' N ' HG23 ' A' ' 75' ' ' ILE . 6.9 mt -60.47 -35.91 77.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.071 -1.018 . . . . 0.0 109.469 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -60.61 -47.3 86.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.043 -1.036 . . . . 0.0 109.577 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.448 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 38.3 t -58.99 -51.7 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.997 -1.064 . . . . 0.0 108.681 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 76' ' ' LEU . 54.7 mt -51.27 -44.28 61.76 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.498 -0.752 . . . . 0.0 109.418 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.722 ' HD1' HG22 ' A' ' 232' ' ' ILE . 14.0 t-160 -56.23 -57.83 10.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 0.0 109.832 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.3 mt -56.7 -38.55 72.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -0.852 . . . . 0.0 110.449 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.565 HD22 HD11 ' A' ' 114' ' ' ILE . 15.1 mt -79.8 -0.84 36.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.979 -1.076 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 59.81 42.58 16.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.803 -1.186 . . . . 0.0 110.027 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 mm -88.37 125.82 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.7 p -106.34 -76.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 0.0 111.51 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.813 HD22 HE22 ' A' ' 117' ' ' GLN . 69.5 m-20 -81.49 113.28 19.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.132 -0.98 . . . . 0.0 111.812 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.13 141.73 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.577 -0.702 . . . . 0.0 109.406 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 61.1 m -111.5 103.92 12.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.477 -0.764 . . . . 0.0 109.397 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mp -90.18 114.63 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.202 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.581 ' OE1' ' CG ' ' A' ' 40' ' ' PHE . 1.6 mt-10 -93.07 123.79 36.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.945 -1.097 . . . . 0.0 108.75 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -104.66 106.79 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.52 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.13 107.71 18.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.58 -162.85 24.43 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.71 -13.63 14.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.388 -1.066 . . . . 0.0 110.428 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -150.54 155.16 38.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.709 -1.245 . . . . 0.0 110.674 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -69.89 125.71 92.12 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.699 -0.625 . . . . 0.0 110.04 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.691 ' CD ' HD21 ' A' ' 26' ' ' LEU . 74.7 Cg_exo -46.23 134.71 15.41 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.85 1.7 . . . . 0.0 112.017 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.1 tp -76.85 -35.25 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.469 -0.769 . . . . 0.0 109.967 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.416 ' N ' HG23 ' A' ' 98' ' ' ILE . 51.2 mt 55.32 -105.68 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.431 -0.793 . . . . 0.0 109.631 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.58 ' OD1' ' NE ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -94.55 -27.67 15.82 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.157 -0.964 . . . . 0.0 110.582 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.3 -1.49 28.11 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.9 p -123.98 -166.78 1.54 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.552 -0.969 . . . . 0.0 109.292 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.44 -0.34 21.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -46.77 -43.93 18.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.723 -0.869 . . . . 0.0 110.662 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -63.46 -52.1 62.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.061 -1.025 . . . . 0.0 110.357 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.55 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 97.3 m-85 -62.45 -45.61 92.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.896 -1.128 . . . . 0.0 108.594 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.402 ' CD2' HG11 ' A' ' 175' ' ' VAL . 15.0 t80 -59.55 -40.72 88.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.511 0.672 . . . . 0.0 109.456 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -72.67 -45.6 58.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.487 -0.758 . . . . 0.0 111.464 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.62 -49.75 20.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.778 -1.201 . . . . 0.0 110.777 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.31 -42.54 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.01 -1.056 . . . . 0.0 111.085 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -56.6 -28.96 61.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.885 -1.134 . . . . 0.0 109.992 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 tttm -82.21 -10.16 59.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.958 -1.089 . . . . 0.0 110.047 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -123.02 32.24 5.76 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 111.401 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.565 HD11 HD22 ' A' ' 82' ' ' LEU . 13.3 mt -86.28 146.82 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.681 -1.262 . . . . 0.0 109.87 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 115' ' ' LEU . 16.4 tp -132.23 161.55 33.16 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -109.29 128.88 55.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.776 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.813 HE22 HD22 ' A' ' 86' ' ' ASN . 4.1 mt-30 -96.39 -166.36 1.41 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.898 . . . . 0.0 110.009 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -124.46 69.31 1.09 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.601 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -158.8 137.71 11.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.09 -1.006 . . . . 0.0 110.027 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 121' ' ' ILE . 26.9 tt0 -47.88 167.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.776 0.798 . . . . 0.0 110.965 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.736 HD11 ' O ' ' A' ' 3' ' ' LEU . 31.4 mt -126.23 120.5 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -81.2 76.98 8.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.602 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -58.54 147.6 31.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -0.967 . . . . 0.0 109.534 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -106.83 125.65 51.29 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.7 t -130.49 145.1 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.292 -0.88 . . . . 0.0 110.029 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 73.0 t -83.68 136.37 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.408 -0.807 . . . . 0.0 109.363 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.13 -12.9 9.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -138.51 144.57 42.97 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.84 169.05 23.01 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.106 1.871 . . . . 0.0 113.174 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.733 HG22 ' HB3' ' A' ' 141' ' ' ALA . 4.4 tt -165.24 136.58 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.784 -0.572 . . . . 0.0 109.485 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.21 124.61 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.331 -0.856 . . . . 0.0 109.141 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.3 m -119.36 114.87 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.456 -0.778 . . . . 0.0 109.812 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -113.41 131.97 55.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -173.18 152.96 2.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 110.556 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 55.89 23.56 6.67 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.596 -0.69 . . . . 0.0 110.973 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.02 2.75 83.39 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.525 ' HB2' HD22 ' A' ' 255' ' ' LEU . 89.8 mtt180 -104.61 172.99 6.49 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.988 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.2 tt -160.06 151.41 19.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.157 -1.589 . . . . 0.0 109.3 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.988 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.4 mt -147.56 130.28 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.957 . . . . 0.0 108.678 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.2 tttm -119.89 142.4 48.72 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 109.929 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -127.07 141.34 51.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.507 -0.745 . . . . 0.0 109.157 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -140.31 137.2 17.53 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.93 147.07 26.94 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.445 1.43 . . . . 0.0 112.256 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.33 152.3 10.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 108.922 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.69 0.66 46.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 109.96 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p -137.74 145.79 42.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.151 -0.968 . . . . 0.0 109.803 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 242' ' ' VAL . 56.2 tp -75.98 117.32 17.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.371 -0.831 . . . . 0.0 109.533 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -138.02 136.22 36.66 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.565 ' CG1' HD23 ' A' ' 231' ' ' LEU . 15.1 t -137.31 122.03 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.0 109.759 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.8 m -107.51 130.14 54.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 0.0 109.343 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.567 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.2 t80 -116.58 128.97 55.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -114.88 106.43 14.16 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.25 150.64 19.87 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -129.35 88.23 2.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.492 -1.004 . . . . 0.0 109.204 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -95.21 146.83 24.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.591 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 22.3 mttp -94.89 -2.03 51.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.252 -0.905 . . . . 0.0 109.307 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CE1' ' A' ' 182' ' ' PHE . 6.9 p30 -70.15 -166.64 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.804 . . . . 0.0 109.779 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -65.71 -22.09 66.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.888 . . . . 0.0 110.092 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.456 HD12 ' ND2' ' A' ' 157' ' ' ASN . 5.1 mt -66.66 -38.7 87.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.048 -1.033 . . . . 0.0 109.137 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.11 -137.95 19.23 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.418 ' HD3' ' H ' ' A' ' 161' ' ' ARG . 0.3 OUTLIER -100.11 145.34 28.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.386 -1.067 . . . . 0.0 109.421 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.483 ' OE1' ' ND2' ' A' ' 221' ' ' ASN . 0.9 OUTLIER -148.81 166.55 28.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 0.0 109.539 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.1 150.31 23.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.417 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -139.79 131.86 27.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.193 -0.942 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 165' ' ' THR . 11.4 t -102.15 123.17 45.53 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.184 -0.948 . . . . 0.0 109.801 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.5 t80 -101.2 134.46 44.21 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.324 -0.86 . . . . 0.0 108.986 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.43 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -132.67 151.2 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 109.472 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -50.54 120.76 4.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.275 -0.89 . . . . 0.0 109.416 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.87 6.8 26.11 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -134.53 27.25 3.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.206 -1.173 . . . . 0.0 108.522 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -61.68 -35.49 78.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.566 -0.709 . . . . 0.0 110.57 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.24 -18.35 10.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.951 -1.093 . . . . 0.0 110.283 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -84.9 -3.64 58.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.096 -1.002 . . . . 0.0 110.837 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.486 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 3.0 pt -130.49 19.79 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.02 -1.05 . . . . 0.0 111.947 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.1 OUTLIER -113.53 -29.13 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.803 -1.186 . . . . 0.0 109.908 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.06 2.53 53.92 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.801 -1.187 . . . . 0.0 110.684 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.03 127.13 32.26 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.605 -1.309 . . . . 0.0 109.109 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.58 ' NE ' ' OD1' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.02 152.51 18.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.141 -0.974 . . . . 0.0 109.72 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.3 t -53.65 161.32 1.1 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.331 -0.855 . . . . 0.0 109.177 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -141.63 164.01 31.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.786 -1.196 . . . . 0.0 110.2 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 189' ' ' ILE . 0.3 OUTLIER -149.3 160.29 43.53 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 109.673 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.565 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 63.4 m-85 -104.35 144.97 30.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.721 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.753 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.7 p-10 -59.25 -26.98 65.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.958 -1.089 . . . . 0.0 110.488 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.565 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.4 p90 -81.14 -27.59 35.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.825 -1.172 . . . . 0.0 110.668 -179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.8 pt-20 -93.14 -14.21 27.48 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 109.818 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.753 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.9 mt -56.76 -52.61 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.324 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.62 -52.71 45.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.123 . . . . 0.0 109.79 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -52.82 -44.42 66.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 181' ' ' CYS . 91.0 mt -65.51 -33.86 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.213 -0.929 . . . . 0.0 109.112 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -77.01 -26.88 54.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.832 . . . . 0.0 110.042 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -81.0 -27.98 35.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.087 -1.008 . . . . 0.0 110.517 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 29.0 m -80.16 8.54 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.509 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.21 24.44 68.63 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 120.034 -1.079 . . . . 0.0 110.811 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 62.9 mt -121.19 159.82 25.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.24 -1.153 . . . . 0.0 109.691 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 76.94 27.7 59.99 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.03 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -71.18 -19.41 62.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.667 -1.49 . . . . 0.0 109.292 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.5 -4.19 49.75 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.14 128.74 44.99 Favored Glycine 0 N--CA 1.491 2.322 0 O-C-N 121.273 -1.134 . . . . 0.0 110.896 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.25 -173.81 3.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.747 -0.855 . . . . 0.0 109.157 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.99 -5.59 57.84 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.051 -1.031 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -98.09 -13.69 20.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 0.0 109.339 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -127.18 -3.6 6.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.372 -0.83 . . . . 0.0 109.669 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -136.24 117.34 14.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 110.26 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.2 tp -79.42 110.54 14.82 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.54 127.56 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.08 -1.013 . . . . 0.0 109.839 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 23.1 mt -110.28 146.9 34.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.363 -0.836 . . . . 0.0 109.572 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.66 150.47 17.56 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -44.38 -28.65 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.132 . . . . 0.0 110.242 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 35.0 t0 -143.8 8.46 1.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 110.127 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 207' ' ' GLY . 68.4 tttt -146.01 154.72 42.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.116 -0.99 . . . . 0.0 110.062 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 59.3 t -103.71 128.96 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -71.98 -53.09 14.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.095 -1.003 . . . . 0.0 109.908 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 213' ' ' ASN . 1.0 OUTLIER -54.72 133.55 65.17 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.078 -1.014 . . . . 0.0 109.119 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -71.88 -24.97 20.48 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.281 1.987 . . . . 0.0 112.511 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.89 -6.65 56.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 109.792 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.92 -167.54 48.37 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.45 141.8 39.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.358 -1.084 . . . . 0.0 109.63 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 42.9 mtp85 -83.7 -15.66 47.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.097 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 221' ' ' ASN . 70.1 m-85 -144.26 135.43 25.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.535 ' C ' HD22 ' A' ' 221' ' ' ASN . 1.5 tm-20 -49.34 -10.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.108 -0.995 . . . . 0.0 109.055 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.551 ' N ' ' O ' ' A' ' 219' ' ' TYR . 1.4 m-80 -143.11 35.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.374 -0.829 . . . . 0.0 109.525 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 56.1 tt0 -56.1 -36.46 46.43 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.325 -0.859 . . . . 0.0 111.919 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 10.2 Cg_exo -69.27 -43.92 2.75 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.731 1.621 . . . . 0.0 112.907 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 228' ' ' VAL . 24.5 m -77.81 -25.7 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 120.706 -1.246 . . . . 0.0 108.544 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -65.12 -45.67 84.14 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.456 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 47.1 t60 -62.16 -43.15 99.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -49.85 74.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.98 . . . . 0.0 109.335 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 224' ' ' VAL . 19.2 t -56.26 -48.18 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 108.767 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.578 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 85.0 t80 -50.5 -44.6 56.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.632 -0.668 . . . . 0.0 109.607 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.578 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 28.4 m-20 -71.48 -35.22 70.75 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 109.994 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.565 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.7 tp -56.46 -37.54 70.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.061 -1.025 . . . . 0.0 108.857 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.722 HG22 ' HD1' ' A' ' 80' ' ' HIS . 55.4 mt -71.49 -47.52 58.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.13 -33.73 15.32 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.57 -26.18 32.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.209 -1.171 . . . . 0.0 109.808 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 260' ' ' VAL . 4.7 mt -82.27 -24.55 34.68 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.826 -1.171 . . . . 0.0 110.193 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.443 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 28.7 t80 -69.98 -7.38 40.26 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.036 -1.04 . . . . 0.0 109.148 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.45 ' C ' ' N ' ' A' ' 239' ' ' GLY . 34.8 mt -51.04 -31.55 18.84 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.348 -0.845 . . . . 0.0 108.775 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.601 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 96.2 mt -53.79 -12.06 0.48 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.017 -1.052 . . . . 0.0 108.681 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.45 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 74.53 17.21 79.86 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.5 p -157.63 143.32 12.55 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 120.925 -1.338 . . . . 0.0 109.812 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.419 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 55.7 Cg_exo -43.12 131.13 6.21 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 122.15 1.9 . . . . 0.0 111.944 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.502 ' O ' HD13 ' A' ' 147' ' ' LEU . 24.6 t -103.58 141.25 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 109.821 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -130.61 133.37 46.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.311 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.56 179.49 30.71 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.779 -1.729 . . . . 0.0 108.779 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -107.54 110.45 22.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.103 -1.233 . . . . 0.0 109.719 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.535 ' HB2' HG22 ' A' ' 149' ' ' VAL . 8.7 m-85 -112.18 146.96 37.17 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.05 0.928 . . . . 0.0 111.059 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -128.1 144.17 51.1 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.2 t -142.05 126.94 18.23 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.711 -1.243 . . . . 0.0 110.501 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.7 t80 -110.19 116.94 32.41 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 249' ' ' PHE . 6.4 mmm180 46.81 55.91 7.26 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.84 140.95 23.85 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.52 171.24 13.72 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 22.1 m-70 -63.99 -45.21 90.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.086 -1.244 . . . . 0.0 109.633 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -55.73 26.33 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.05 -1.031 . . . . 0.0 109.094 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.525 HD22 ' HB2' ' A' ' 137' ' ' ARG . 56.5 tp -52.06 -39.88 60.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.117 -0.989 . . . . 0.0 109.351 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -58.23 -55.82 30.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 108.784 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.543 HG21 HG21 ' A' ' 53' ' ' VAL . 2.7 t -49.85 -41.78 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.394 -0.816 . . . . 0.0 109.47 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -49.45 71.93 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.067 -1.02 . . . . 0.0 109.039 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.757 HD22 HG21 ' A' ' 139' ' ' ILE . 43.8 tp -52.66 -49.65 64.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 0.0 108.677 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.531 HG22 HD23 ' A' ' 235' ' ' LEU . 48.8 t -63.62 -49.93 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.428 -0.795 . . . . 0.0 109.477 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.2 -51.65 17.93 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.689 -0.632 . . . . 0.0 110.376 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -64.63 -44.34 90.84 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.89 -1.131 . . . . 0.0 109.781 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 93.2 mt -61.64 -46.29 90.41 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.187 -0.945 . . . . 0.0 110.148 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.601 ' HB2' ' CD2' ' A' ' 238' ' ' LEU . . . -72.69 -32.78 66.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.704 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.7 -28.4 33.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.845 -1.16 . . . . 0.0 109.157 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -66.7 -45.79 77.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.0 109.812 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -88.78 10.87 19.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 0.0 110.176 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 30.9 tttp -78.87 -27.49 44.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.098 -1.001 . . . . 0.0 109.779 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 5.6 mt -96.21 25.04 5.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -0.966 . . . . 0.0 109.549 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.423 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.56 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 36.0 mt-10 -52.18 131.03 31.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.977 . . . . 0.0 109.439 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.87 132.16 56.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.565 -0.709 . . . . 0.0 109.316 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -136.44 175.29 9.74 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.35 -0.843 . . . . 0.0 109.271 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.3 m -83.24 138.13 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.727 -1.233 . . . . 0.0 110.367 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' HZ3' ' HB2' ' A' ' 8' ' ' LYS . 6.8 ttmm -71.95 -47.02 55.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.734 . . . . 0.0 109.543 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -126.66 156.44 41.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.625 -0.672 . . . . 0.0 109.854 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.13 135.16 55.17 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.473 -0.767 . . . . 0.0 110.415 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 113' ' ' ASN . 19.1 mt -117.54 163.46 16.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 0.0 109.078 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.4 p -153.92 147.3 24.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.009 . . . . 0.0 110.098 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -131.28 161.61 31.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.533 -0.729 . . . . 0.0 109.254 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -149.59 136.65 19.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.915 -1.116 . . . . 0.0 108.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.09 161.27 20.28 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.7 p -73.75 161.24 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.11 -1.23 . . . . 0.0 111.176 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -92.54 140.09 14.95 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.8 tt -56.11 -52.25 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.129 -1.218 . . . . 0.0 111.816 -178.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.533 ' N ' HG23 ' A' ' 18' ' ' ILE . 10.3 m-70 -86.97 -38.63 16.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.309 -1.494 . . . . 0.0 110.879 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 22' ' ' GLU . 2.6 m -68.68 -36.6 78.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.318 -0.864 . . . . 0.0 110.054 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.61 23.09 66.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HB2' HG22 ' A' ' 20' ' ' THR . 2.0 tt0 -117.99 154.98 31.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.692 -0.887 . . . . 0.0 108.722 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.439 ' CD1' ' N ' ' A' ' 24' ' ' SER . 2.5 t80 -71.73 136.3 47.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 0.0 110.181 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.439 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 1.9 t -144.02 157.55 44.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 0.0 108.974 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' C ' HD23 ' A' ' 26' ' ' LEU . 1.1 ttmt -137.22 147.16 45.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.098 -1.001 . . . . 0.0 109.292 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.715 HD11 ' HD2' ' A' ' 97' ' ' PRO . 2.3 mt -123.41 151.1 42.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.198 -0.939 . . . . 0.0 109.629 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.422 HG22 ' CD2' ' A' ' 29' ' ' HIS . 6.8 mt -134.84 129.44 51.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.4 mt -113.57 110.76 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.937 . . . . 0.0 109.812 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.422 ' CD2' HG22 ' A' ' 27' ' ' ILE . 21.7 m-70 -106.75 150.23 39.43 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 108.901 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -61.56 161.88 22.91 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.226 1.95 . . . . 0.0 110.816 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.558 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -140.56 159.34 42.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.886 -1.134 . . . . 0.0 110.69 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.44 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 tttt -59.7 149.31 31.06 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.516 0.674 . . . . 0.0 109.987 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.569 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.3 mp0 -48.76 148.38 2.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 110.612 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.73 25.85 59.38 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.413 177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -80.46 -37.57 31.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.618 -1.519 . . . . 0.0 109.031 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.27 -177.03 33.36 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.8 mm -98.8 125.41 52.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 140.13 32.71 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.969 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -97.48 152.22 19.2 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -133.54 140.13 47.01 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.198 -0.939 . . . . 0.0 109.576 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -170.7 143.75 2.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.357 -0.839 . . . . 0.0 109.527 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 54.86 29.13 11.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 109.955 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.85 21.16 78.05 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.008 -1.092 . . . . 0.0 110.521 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 84.8 t -124.42 135.62 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.161 -1.2 . . . . 0.0 109.545 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -94.6 142.06 27.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.267 -0.895 . . . . 0.0 109.039 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.9 mt -135.01 94.43 16.19 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.395 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -48.7 143.3 16.86 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.324 2.016 . . . . 0.0 111.747 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.99 79.74 5.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.069 -1.019 . . . . 0.0 110.158 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.3 mtt-85 -138.7 156.38 47.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 0.0 109.447 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 3.3 p80 -52.86 -50.12 64.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.869 . . . . 0.0 110.251 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -45.26 -15.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 110.264 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.2 m-85 -100.19 2.64 43.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.669 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 50' ' ' HIS . 9.8 t -57.73 133.35 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 108.955 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.7 m -120.66 -36.33 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 0.0 109.91 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.454 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 6.1 t-160 -151.19 122.11 7.61 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.164 -0.96 . . . . 0.0 109.348 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.2 p -110.75 132.6 54.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.4 t-20 -166.47 -154.71 0.19 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -48.03 -11.95 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.981 -1.074 . . . . 0.0 108.604 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.58 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.6 t -135.89 165.61 25.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.401 -0.812 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.7 m -101.64 119.73 39.23 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -116.94 135.5 53.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -0.94 . . . . 0.0 111.169 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD12 HG21 ' A' ' 72' ' ' VAL . 30.9 mt -124.22 158.91 31.34 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -177.83 145.62 7.15 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.963 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -144.71 151.16 38.49 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.698 -0.883 . . . . 0.0 109.51 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 57.37 23.81 9.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.338 -0.851 . . . . 0.0 110.971 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.15 1.26 72.74 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.556 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 55.5 mm-40 -99.24 139.84 34.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.989 -1.301 . . . . 0.0 108.284 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.9 ptt-85 -136.28 149.72 48.59 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.059 -1.025 . . . . 0.0 111.426 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -131.84 141.68 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.3 mttp -114.48 151.02 33.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.185 -0.947 . . . . 0.0 111.456 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 56.45 65.84 1.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.798 -0.564 . . . . 0.0 111.284 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.422 HG21 HD12 ' A' ' 62' ' ' LEU . 28.8 m -114.08 -3.65 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.041 -1.037 . . . . 0.0 109.043 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.511 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pt-20 -70.63 -28.4 64.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.403 -0.811 . . . . 0.0 110.533 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -64.35 -60.52 3.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.907 -1.121 . . . . 0.0 109.723 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.509 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -58.74 -44.51 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.952 -1.092 . . . . 0.0 109.129 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.509 ' N ' HG23 ' A' ' 75' ' ' ILE . 65.4 mt -55.8 -41.46 74.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.927 . . . . 0.0 109.456 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -56.82 -46.32 81.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.063 -1.023 . . . . 0.0 109.292 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.88 -53.69 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.158 -0.963 . . . . 0.0 108.652 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.502 HD12 HD23 ' A' ' 76' ' ' LEU . 27.6 mt -51.55 -44.58 62.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.4 -0.812 . . . . 0.0 109.279 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.524 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.4 t-160 -53.93 -55.38 27.56 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.249 -0.907 . . . . 0.0 109.726 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 171' ' ' GLU . 95.1 mt -62.36 -37.24 84.94 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 110.033 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.447 HD13 HD11 ' A' ' 114' ' ' ILE . 50.1 mt -78.94 -9.84 59.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.01 -1.056 . . . . 0.0 110.098 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 63.41 60.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.851 -1.156 . . . . 0.0 110.514 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 4.8 mm -104.18 133.99 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.408 HG21 HG23 ' A' ' 121' ' ' ILE . 1.2 p -119.87 -17.1 8.59 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.269 -0.895 . . . . 0.0 111.943 -178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.696 ' O ' HG13 ' A' ' 87' ' ' VAL . 4.0 m-80 -130.11 111.83 12.84 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.699 -1.25 . . . . 0.0 110.557 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.696 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.6 OUTLIER -165.26 136.63 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 110.01 178.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.558 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 23.3 m -107.21 99.53 9.06 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 mt -87.95 117.83 32.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.35 -0.844 . . . . 0.0 109.451 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -95.91 119.64 34.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.787 -1.196 . . . . 0.0 107.992 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 HD22 ' A' ' 26' ' ' LEU . 23.0 t -104.61 104.75 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 111.344 -178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 mt -87.49 107.78 17.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.74 -161.32 24.03 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.572 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -116.85 -14.52 10.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -1.045 . . . . 0.0 110.506 -179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.18 146.34 35.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.741 -1.224 . . . . 0.0 111.076 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.3 mm -69.23 124.88 91.37 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.803 -0.561 . . . . 0.0 109.674 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.715 ' HD2' HD11 ' A' ' 26' ' ' LEU . 73.3 Cg_exo -46.37 129.4 13.33 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 121.774 1.649 . . . . 0.0 111.754 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.4 tp -77.6 -29.18 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.488 -0.757 . . . . 0.0 110.188 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.587 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 95.0 mt 55.24 -111.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.258 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.44 ' OD1' ' NH2' ' A' ' 178' ' ' ARG . 2.5 t0 -89.28 -28.58 19.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 0.0 110.613 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 119.13 -14.98 11.02 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -109.93 -166.78 1.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -1.06 . . . . 0.0 109.592 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.37 -2.76 21.34 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.623 -1.791 . . . . 0.0 108.623 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -47.44 -42.37 22.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.826 -0.808 . . . . 0.0 110.817 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.95 -51.96 64.87 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.002 -1.062 . . . . 0.0 110.356 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 93.6 m-85 -63.5 -44.81 93.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 0.0 108.632 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.487 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 6.9 t80 -62.36 -38.2 88.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.718 -0.614 . . . . 0.0 109.961 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.3 -46.28 61.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.366 -0.834 . . . . 0.0 110.807 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.42 -51.56 12.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.947 -1.096 . . . . 0.0 109.992 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.68 -45.52 79.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.043 -1.036 . . . . 0.0 110.557 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -55.51 -29.36 58.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.209 -0.932 . . . . 0.0 109.33 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -81.24 -12.96 58.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.113 -0.992 . . . . 0.0 109.992 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.54 ' HB2' HD11 ' A' ' 11' ' ' LEU . 1.5 m120 -120.09 33.09 5.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.385 -0.822 . . . . 0.0 111.125 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.447 HD11 HD13 ' A' ' 82' ' ' LEU . 5.9 mt -90.55 148.11 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.652 -1.28 . . . . 0.0 110.494 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 115' ' ' LEU . 52.7 tp -131.18 158.18 41.2 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -108.27 140.22 41.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -103.86 -163.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.296 -0.877 . . . . 0.0 109.271 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.618 ' H ' HD22 ' A' ' 118' ' ' ASN . 0.1 OUTLIER -116.47 -1.38 12.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.299 -0.876 . . . . 0.0 110.795 -179.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.41 ' CD ' ' OE2' ' A' ' 4' ' ' GLU . 10.2 ttm180 -94.13 149.21 21.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.836 -1.165 . . . . 0.0 109.903 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.53 136.83 32.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.362 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.408 HG23 HG21 ' A' ' 85' ' ' THR . 94.8 mt -77.52 144.32 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.411 -0.805 . . . . 0.0 110.459 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -86.5 89.97 8.07 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -62.88 145.64 54.67 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.235 -0.916 . . . . 0.0 110.518 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -102.27 123.4 46.03 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.7 t -126.18 141.12 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.89 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.1 t -84.43 138.34 19.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.493 -0.755 . . . . 0.0 109.096 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -119.12 -11.15 9.66 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -140.18 144.17 36.59 Favored Pre-proline 0 N--CA 1.488 1.437 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.86 173.52 12.61 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.113 1.875 . . . . 0.0 113.109 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.709 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 2.9 tt -165.3 142.17 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.685 -0.634 . . . . 0.0 109.703 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 131' ' ' ILE . 3.4 mp -129.71 125.31 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.472 -0.768 . . . . 0.0 109.757 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 m -121.52 114.07 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.43 -0.794 . . . . 0.0 109.187 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -113.47 141.8 46.68 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.42 -0.8 . . . . 0.0 109.845 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -175.26 137.93 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.092 -1.005 . . . . 0.0 111.074 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 57.49 29.51 17.18 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.642 -0.662 . . . . 0.0 111.412 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.46 9.06 86.09 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -110.39 157.71 19.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.986 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -158.69 156.13 29.37 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 119.953 -1.717 . . . . 0.0 109.536 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.986 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.9 mt -149.03 133.02 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -120.91 143.01 49.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 109.901 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.709 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.23 143.97 49.69 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -142.03 138.47 16.9 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.9 144.9 42.85 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.473 1.449 . . . . 0.0 112.276 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.06 149.83 9.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.444 -0.785 . . . . 0.0 109.173 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -1.88 53.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.216 -0.928 . . . . 0.0 109.61 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.8 p -134.78 142.42 46.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 109.431 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.45 118.78 20.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.079 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -137.73 136.82 37.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.484 ' CG1' HD23 ' A' ' 231' ' ' LEU . 60.3 t -133.98 122.53 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.133 -0.98 . . . . 0.0 110.014 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.401 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 9.9 m -107.84 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.489 -0.757 . . . . 0.0 109.337 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -127.42 129.59 47.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.43 -0.793 . . . . 0.0 109.72 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -115.52 103.51 10.81 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.72 135.45 12.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -111.18 93.23 4.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.498 -1.001 . . . . 0.0 109.343 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.455 ' HB2' HD21 ' A' ' 157' ' ' ASN . 20.5 m-85 -95.16 148.66 22.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.446 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -97.07 -3.75 40.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.865 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.836 HD22 ' H ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -73.74 -169.4 0.71 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.154 -0.966 . . . . 0.0 109.675 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -60.71 -20.8 61.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.97 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.534 HD12 ' OD1' ' A' ' 157' ' ' ASN . 31.2 mt -70.46 -28.36 64.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.0 109.042 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 66.69 -132.13 31.84 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -104.18 145.11 30.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -1.037 . . . . 0.0 109.556 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -146.35 156.04 43.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.583 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -139.23 145.0 38.7 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.249 -0.907 . . . . 0.0 109.332 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -136.28 126.58 26.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.909 . . . . 0.0 109.061 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.587 HG23 ' O ' ' A' ' 165' ' ' THR . 7.3 t -103.78 123.85 47.83 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 0.0 109.836 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -100.22 136.03 40.73 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.338 -0.851 . . . . 0.0 109.159 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.512 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.5 t -131.82 153.5 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.338 -0.851 . . . . 0.0 109.482 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -57.08 118.91 5.49 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.332 -0.855 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.43 -3.79 21.79 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -125.54 31.22 5.58 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.259 -1.142 . . . . 0.0 108.711 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.521 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.7 OUTLIER -64.3 -32.84 74.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.543 -0.723 . . . . 0.0 110.605 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -58.2 -15.64 10.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.937 -1.102 . . . . 0.0 111.059 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -92.7 -4.13 53.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.85 -1.156 . . . . 0.0 110.894 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -121.23 -6.56 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.103 -0.998 . . . . 0.0 110.721 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -89.85 -29.14 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.698 -1.252 . . . . 0.0 109.933 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.03 1.99 51.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.68 -1.262 . . . . 0.0 110.415 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.07 115.62 18.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.914 -1.116 . . . . 0.0 108.659 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' NH2' ' OD1' ' A' ' 100' ' ' ASP . 1.9 ptm180 -86.59 154.62 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.021 -1.05 . . . . 0.0 110.066 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.442 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 6.1 t -53.34 159.46 1.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.427 -0.795 . . . . 0.0 109.63 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.502 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 38.6 p90 -145.93 169.42 18.63 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.911 -1.118 . . . . 0.0 109.906 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.518 ' SG ' ' C2A' ' A' ' 320' ' ' TUX . 0.0 OUTLIER -164.39 163.89 22.25 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 109.884 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.612 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 96.0 m-85 -103.7 146.08 29.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.409 -0.807 . . . . 0.0 109.613 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.717 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.6 OUTLIER -61.96 -20.69 64.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 0.0 111.076 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.612 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.3 p90 -81.0 -26.85 36.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.646 -1.284 . . . . 0.0 110.643 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.499 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 23.4 pt-20 -97.74 -15.85 20.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.859 -1.151 . . . . 0.0 109.474 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.7 mt -57.39 -52.12 60.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.343 -0.848 . . . . 0.0 110.045 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.15 -49.21 61.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.976 -1.078 . . . . 0.0 109.43 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -54.46 -52.36 62.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 108.922 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.59 HD13 ' O1A' ' A' ' 320' ' ' TUX . 59.5 mt -57.72 -33.84 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.407 -0.808 . . . . 0.0 109.346 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -77.89 -28.95 49.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -0.879 . . . . 0.0 110.052 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.51 ' HZ3' ' CB ' ' A' ' 191' ' ' LYS . 0.1 OUTLIER -72.69 -26.8 61.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 109.573 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.3 m -84.79 13.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.437 -0.79 . . . . 0.0 109.604 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.24 25.68 72.52 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 120.072 -1.061 . . . . 0.0 110.592 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.03 156.59 28.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.267 -1.137 . . . . 0.0 109.732 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.472 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.72 25.55 60.32 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.408 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.6 mtmm -69.04 -20.88 64.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.465 -1.609 . . . . 0.0 109.051 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.88 -7.28 44.7 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.93 129.31 43.82 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.24 -1.153 . . . . 0.0 110.771 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.4 p -143.72 169.93 16.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.79 -0.829 . . . . 0.0 109.466 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 17.0 mt -71.25 -16.46 62.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.455 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 48.5 tttp -86.08 -9.65 56.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.177 -0.952 . . . . 0.0 109.619 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 6.1 m120 -138.26 12.07 2.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.162 -0.961 . . . . 0.0 109.648 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.475 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 28.1 m -152.97 131.69 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.57 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.45 HD21 ' CD2' ' A' ' 217' ' ' LEU . 6.5 tp -89.98 114.85 26.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.284 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.501 HG22 HD11 ' A' ' 186' ' ' ILE . 63.4 t -100.65 125.07 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.063 -1.023 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.9 mt -100.73 146.13 27.62 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.342 -0.849 . . . . 0.0 109.867 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.43 150.3 16.8 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -46.33 -25.88 0.72 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.136 -1.214 . . . . 0.0 109.86 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -152.56 11.44 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 0.0 110.67 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.9 tttt -146.99 155.35 42.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.89 -1.131 . . . . 0.0 110.281 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.9 t -97.77 123.36 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -70.84 -54.35 11.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.199 -0.938 . . . . 0.0 109.935 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.427 ' ND2' ' H ' ' A' ' 205' ' ' VAL . 47.0 m-80 -53.49 131.36 54.1 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.098 -1.002 . . . . 0.0 109.391 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.06 -24.95 19.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.311 2.007 . . . . 0.0 112.457 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.27 -4.51 39.51 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.955 . . . . 0.0 109.289 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.89 -169.16 53.85 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.45 ' CD2' HD21 ' A' ' 204' ' ' LEU . 13.9 mt -88.05 149.81 23.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.432 -1.04 . . . . 0.0 109.745 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -60.67 2.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 0.0 108.722 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.426 ' C ' ' H ' ' A' ' 221' ' ' ASN . 7.7 m-85 -116.86 152.52 34.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 109.165 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.404 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.6 mp0 -60.65 -3.93 0.82 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 0.0 109.423 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.78 HD22 ' HE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -137.48 29.77 2.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.312 -0.867 . . . . 0.0 108.983 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.603 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.0 tt0 -54.45 -42.03 92.31 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.76 . . . . 0.0 110.863 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.5 Cg_exo -70.83 -38.52 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.508 2.139 . . . . 0.0 113.156 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.2 OUTLIER -81.66 -26.87 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.675 -1.266 . . . . 0.0 108.539 179.361 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.78 ' HE ' HD22 ' A' ' 221' ' ' ASN . 38.1 mtt180 -67.35 -39.82 85.79 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.572 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 19.1 t60 -66.6 -41.03 89.06 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -42.05 76.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 0.0 109.036 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 224' ' ' VAL . 38.7 t -68.06 -44.6 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -55.26 -40.83 71.43 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.605 0.717 . . . . 0.0 109.067 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -71.74 -39.99 69.67 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.575 -0.703 . . . . 0.0 109.907 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.484 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.8 tp -56.55 -35.1 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.373 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 81.2 mt -72.15 -49.08 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.924 -1.11 . . . . 0.0 108.144 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.34 -30.95 12.34 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.593 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.74 -28.33 30.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.181 -1.187 . . . . 0.0 109.854 179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 260' ' ' VAL . 5.3 mt -79.17 -22.85 44.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.743 -1.223 . . . . 0.0 109.782 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.524 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 16.6 t80 -69.99 -8.0 45.46 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.191 -0.943 . . . . 0.0 109.068 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 237' ' ' LEU . 31.1 mt -49.76 -28.57 6.38 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.69 -20.59 65.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.0 108.957 179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.41 17.91 76.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.9 p -154.01 138.8 11.52 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.235 . . . . 0.0 109.652 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -41.82 134.11 3.88 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 122.165 1.91 . . . . 0.0 111.872 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 94.7 t -103.81 136.14 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.023 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -122.3 125.71 46.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.306 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.95 172.45 26.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -102.5 112.54 25.32 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.164 -1.198 . . . . 0.0 109.479 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.6 m-85 -112.58 146.9 37.75 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.976 0.893 . . . . 0.0 111.048 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.401 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 26.9 t80 -126.99 144.29 51.06 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.0 t -138.87 126.76 22.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.684 -1.26 . . . . 0.0 110.112 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.402 ' O ' ' C ' ' A' ' 250' ' ' ARG . 61.8 t80 -113.16 113.1 24.89 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 249' ' ' PHE . 52.8 mtp180 47.66 56.72 6.73 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.71 145.86 21.16 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.422 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -113.5 175.94 16.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.511 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.5 m-70 -66.99 -47.77 70.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.273 -1.134 . . . . 0.0 109.998 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -55.14 37.25 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.117 -0.989 . . . . 0.0 109.801 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 51.6 tp -51.68 -37.86 52.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 16.1 m120 -58.68 -55.37 35.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.119 -0.988 . . . . 0.0 108.746 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 253' ' ' HIS . 18.5 t -49.14 -41.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.415 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -55.22 -47.37 75.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.025 -1.047 . . . . 0.0 108.803 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.86 -50.56 63.53 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.447 HG22 HD23 ' A' ' 235' ' ' LEU . 42.1 t -63.63 -41.2 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.446 -0.784 . . . . 0.0 109.856 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.73 -51.93 67.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.421 -0.799 . . . . 0.0 110.43 -178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -64.65 -45.4 86.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.845 -1.159 . . . . 0.0 109.73 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 263' ' ' LEU . 60.8 mt -58.83 -45.72 89.36 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.274 -0.891 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.41 -32.17 73.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.832 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 47.4 mttt -77.89 -29.29 50.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.85 -1.156 . . . . 0.0 109.101 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -71.19 -48.73 49.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 110.275 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -80.66 4.61 18.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.104 -0.997 . . . . 0.0 110.249 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -68.49 -59.5 3.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.064 -1.023 . . . . 0.0 109.746 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.5 mt -57.36 -84.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.115 -0.991 . . . . 0.0 109.757 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.271 -0.893 . . . . 0.0 109.502 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.59 ' O1A' HD13 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 3' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 76.7 mt-10 -54.32 132.99 44.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.551 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.88 139.67 52.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.42 -0.8 . . . . 0.0 109.485 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -141.15 177.57 7.98 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.468 -0.77 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 m -81.33 149.69 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 110.21 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -86.27 -42.13 14.02 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.662 -0.649 . . . . 0.0 109.758 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 10' ' ' LYS . 13.0 tt0 -129.32 153.98 47.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.517 -0.739 . . . . 0.0 109.992 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.422 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -59.98 135.64 57.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.48 -0.763 . . . . 0.0 109.305 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 113' ' ' ASN . 44.5 mt -124.8 166.52 16.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.473 -0.767 . . . . 0.0 109.267 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 p -157.91 150.24 22.34 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.145 -0.972 . . . . 0.0 110.115 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -131.21 158.43 40.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.695 -0.628 . . . . 0.0 109.399 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -144.81 134.81 23.87 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.941 -1.1 . . . . 0.0 108.869 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 174.85 156.79 14.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.094 -1.603 . . . . 0.0 109.094 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -81.12 141.02 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.11 -1.229 . . . . 0.0 110.804 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.61 138.12 37.71 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.684 HD11 H3A3 ' A' ' 320' ' ' TUX . 6.6 tt -57.91 -48.16 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -1.089 . . . . 0.0 112.042 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.45 ' N ' HG23 ' A' ' 18' ' ' ILE . 16.3 m-70 -86.75 -37.6 17.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.276 -1.515 . . . . 0.0 111.017 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.492 HG21 ' OD1' ' A' ' 94' ' ' ASN . 0.7 OUTLIER -72.25 -32.86 67.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -0.85 . . . . 0.0 110.119 -179.024 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.62 22.33 65.89 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 16' ' ' VAL . 4.8 mm-40 -113.83 151.25 32.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.589 -0.948 . . . . 0.0 108.956 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -70.62 130.94 43.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.89 . . . . 0.0 110.063 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -138.63 157.55 45.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.063 -1.023 . . . . 0.0 109.381 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' O ' HD23 ' A' ' 26' ' ' LEU . 6.7 ttpp -137.09 152.03 49.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.132 -0.98 . . . . 0.0 109.541 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.738 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.3 mt -127.72 145.95 50.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.108 -0.995 . . . . 0.0 109.357 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.491 HG22 ' NE2' ' A' ' 29' ' ' HIS . 26.1 mt -131.35 129.05 62.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.2 mt -117.89 133.35 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.087 -1.008 . . . . 0.0 110.139 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.491 ' NE2' HG22 ' A' ' 27' ' ' ILE . 17.7 m-70 -126.6 150.01 69.66 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.71 161.78 20.32 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.104 1.869 . . . . 0.0 111.028 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 53.5 mt-10 -133.96 -174.68 3.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.121 -0.987 . . . . 0.0 109.588 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.6 OUTLIER -89.73 154.92 19.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.195 -0.94 . . . . 0.0 109.248 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -47.93 145.2 3.08 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.213 -0.929 . . . . 0.0 110.058 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.55 23.52 54.78 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.382 -0.824 . . . . 0.0 111.791 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 55.5 m -75.45 -46.29 33.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.589 -1.536 . . . . 0.0 109.094 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.809 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 105.23 174.94 24.32 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.9 mm -92.98 121.79 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.446 -1.032 . . . . 0.0 108.749 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.27 138.23 34.84 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.961 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -97.22 153.0 18.28 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -130.98 139.95 50.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.155 -0.965 . . . . 0.0 109.063 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 10.7 ttmt -170.0 139.46 1.86 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.483 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.91 29.02 18.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.401 -0.812 . . . . 0.0 110.04 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.24 28.09 70.63 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 74.3 t -134.28 139.18 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.296 -1.12 . . . . 0.0 109.669 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -97.67 144.43 27.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.796 . . . . 0.0 109.096 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.414 HG23 ' CB ' ' A' ' 64' ' ' PHE . 31.9 mt -136.91 97.62 10.99 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.306 -0.871 . . . . 0.0 110.33 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.61 143.13 29.4 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.093 1.862 . . . . 0.0 111.341 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.46 83.15 5.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.0 -1.062 . . . . 0.0 110.481 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -138.53 154.9 48.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.964 . . . . 0.0 109.332 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.52 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.9 p80 -53.47 -49.37 67.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.323 -0.861 . . . . 0.0 110.24 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' CG ' ' CE1' ' A' ' 50' ' ' HIS . 8.2 mt-10 -45.55 -16.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.176 -0.952 . . . . 0.0 109.961 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 50' ' ' HIS . 89.8 m-85 -96.89 6.66 48.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.961 -1.087 . . . . 0.0 109.868 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 t -59.14 126.2 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 0.0 108.652 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.3 m -115.21 -32.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.294 -0.879 . . . . 0.0 110.207 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -149.87 119.99 7.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.068 -1.02 . . . . 0.0 109.63 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.4 p -112.68 131.36 55.69 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.427 0.632 . . . . 0.0 109.359 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 2.1 t-20 -166.07 -154.3 0.19 Allowed 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 57' ' ' ASN . 10.8 m-70 -47.81 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.922 -1.111 . . . . 0.0 108.357 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.6 t -136.6 166.11 24.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.516 -0.74 . . . . 0.0 109.086 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.2 m -107.83 123.45 48.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.326 -0.859 . . . . 0.0 108.971 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.02 141.68 51.11 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.928 0.87 . . . . 0.0 110.971 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.2 mt -118.64 168.58 10.57 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.499 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.25 145.07 5.43 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 118.801 -1.666 . . . . 0.0 110.824 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.414 ' CB ' HG23 ' A' ' 46' ' ' ILE . 54.0 t80 -144.46 150.58 37.87 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.992 . . . . 0.0 109.288 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? 55.85 23.22 6.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.423 -0.798 . . . . 0.0 110.751 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.72 -7.62 68.08 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.741 -1.219 . . . . 0.0 111.075 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.499 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 1.5 mm100 -92.33 144.87 24.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.483 . . . . 0.0 108.456 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.635 ' N ' ' CD ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -141.6 153.23 44.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.937 -1.102 . . . . 0.0 111.5 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.23 147.37 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -113.63 151.75 31.3 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.206 -0.934 . . . . 0.0 111.383 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m 52.52 68.23 0.86 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.776 -0.578 . . . . 0.0 111.037 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG12 HG13 ' A' ' 96' ' ' ILE . 16.1 m -113.02 -10.28 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.037 -1.039 . . . . 0.0 109.49 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.539 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 6.8 pt-20 -65.56 -24.22 67.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 0.0 110.413 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -67.64 -60.32 2.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.871 -1.143 . . . . 0.0 109.764 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 3.2 tp -58.32 -42.32 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.002 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HA ' HD12 ' A' ' 79' ' ' LEU . 19.5 mt -58.85 -37.99 77.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.489 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.6 t -58.35 -47.47 83.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.931 -1.106 . . . . 0.0 108.956 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.88 -51.58 68.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.547 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 76' ' ' LEU . 49.5 mt -51.27 -44.1 61.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.46 -0.775 . . . . 0.0 108.934 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 4.6 t-160 -52.62 -56.95 11.78 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.404 -0.81 . . . . 0.0 109.918 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.0 mt -61.83 -35.71 79.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.414 -0.804 . . . . 0.0 110.559 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.803 HD22 ' CD1' ' A' ' 114' ' ' ILE . 13.4 mt -79.68 -9.65 59.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.021 -1.05 . . . . 0.0 110.595 -178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 62.74 50.35 3.43 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.781 -1.199 . . . . 0.0 110.372 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.505 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 3.3 mm -94.14 125.64 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.468 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.8 p -113.83 -18.74 11.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.168 -0.958 . . . . 0.0 112.034 -177.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.809 HD22 ' H ' ' A' ' 36' ' ' GLY . 10.5 m120 -130.75 112.15 12.81 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.886 -1.134 . . . . 0.0 110.409 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -164.57 148.69 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 0.0 110.023 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.467 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 2.3 m -115.69 102.09 9.42 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 17.6 mt -95.1 104.79 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.217 -0.927 . . . . 0.0 109.753 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.21 118.88 24.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.036 -1.04 . . . . 0.0 108.401 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.3 t -106.27 112.07 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 111.05 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mp -92.5 110.9 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.21 -163.16 24.87 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.1 OUTLIER -116.57 -15.18 10.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.478 -1.013 . . . . 0.0 110.101 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 19.1 tt0 -138.05 143.01 40.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 0.0 110.291 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.481 HG13 HG12 ' A' ' 72' ' ' VAL . 2.9 mm -69.36 124.71 91.06 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.468 -0.77 . . . . 0.0 109.392 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.738 ' CD ' HD21 ' A' ' 26' ' ' LEU . 50.1 Cg_exo -46.85 126.46 11.0 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.547 1.498 . . . . 0.0 111.416 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 98' ' ' ILE . 4.7 tp -79.52 -21.45 12.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.378 -0.826 . . . . 0.0 110.373 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.407 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 3.7 mt 57.06 -110.87 0.57 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 0.0 110.77 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -95.5 -8.16 36.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.046 -1.034 . . . . 0.0 111.919 -178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.23 -12.04 48.13 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.2 p -119.04 -168.84 1.63 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.484 -1.01 . . . . 0.0 109.537 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.55 -4.08 23.51 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.543 ' NE1' ' CD ' ' A' ' 108' ' ' GLU . 60.5 t-105 -46.92 -42.5 17.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.664 -0.903 . . . . 0.0 110.455 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.15 -51.51 68.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.924 -1.11 . . . . 0.0 109.783 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.5 m-85 -62.29 -43.81 97.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.112 -0.993 . . . . 0.0 108.588 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -61.98 -39.3 91.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.543 ' CD ' ' NE1' ' A' ' 104' ' ' TRP . 19.0 mt-10 -68.91 -46.39 68.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 111.437 -178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.97 -51.82 9.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.83 -1.169 . . . . 0.0 110.97 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.4 mt -58.72 -43.37 87.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.814 -1.178 . . . . 0.0 110.558 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -59.55 -30.28 68.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.971 -1.08 . . . . 0.0 109.317 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -83.73 11.14 7.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.695 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.64 ' HB2' HD11 ' A' ' 11' ' ' LEU . 8.7 m120 -144.37 32.18 1.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.397 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.803 ' CD1' HD22 ' A' ' 82' ' ' LEU . 6.8 mt -91.5 148.73 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.891 -1.13 . . . . 0.0 110.717 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.64 153.73 47.81 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 2.3 m-20 -105.64 146.36 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.06 -1.025 . . . . 0.0 110.012 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.479 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.4 mt-30 -105.41 -162.36 0.87 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.36 -0.837 . . . . 0.0 109.09 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -117.74 2.09 12.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.375 -0.828 . . . . 0.0 110.092 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -97.84 152.53 19.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.117 -0.989 . . . . 0.0 109.858 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -94.43 147.54 23.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.898 . . . . 0.0 109.485 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.419 HG23 HG21 ' A' ' 85' ' ' THR . 83.9 mt -89.37 153.93 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 110.356 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -96.84 101.81 13.48 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.405 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.7 m-85 -72.42 145.21 47.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.342 -0.849 . . . . 0.0 110.962 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -95.89 123.04 39.31 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.53 138.2 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.209 -0.932 . . . . 0.0 110.181 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.8 t -84.48 136.86 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -112.56 -7.27 13.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.422 -0.799 . . . . 0.0 109.499 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -149.28 147.82 24.67 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.942 . . . . 0.0 109.188 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.35 145.48 38.44 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.173 1.915 . . . . 0.0 112.888 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.658 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.6 tt -130.73 150.93 35.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 18.8 mt -135.27 117.85 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 0.0 109.629 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.425 HG23 ' HB ' ' A' ' 139' ' ' ILE . 1.8 m -118.09 109.6 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.7 131.64 55.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.455 -0.778 . . . . 0.0 109.293 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -179.98 159.32 0.8 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.062 . . . . 0.0 110.469 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 134' ' ' ASP . 11.6 mm-40 56.61 19.74 4.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.708 -0.62 . . . . 0.0 110.185 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.87 -0.4 82.68 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.51 ' HB2' HD22 ' A' ' 255' ' ' LEU . 0.6 OUTLIER -101.04 176.79 5.14 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.484 -1.01 . . . . 0.0 108.302 179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.962 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.1 tt -160.35 145.97 15.06 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.512 -1.367 . . . . 0.0 108.769 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.962 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.6 mt -144.97 130.99 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.076 -1.015 . . . . 0.0 108.28 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -121.39 137.37 54.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 109.814 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.658 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -113.71 149.35 34.88 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -145.4 136.61 12.58 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.53 144.94 99.29 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 121.493 1.462 . . . . 0.0 112.014 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.56 156.19 7.89 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 12.4 p-10 -88.82 3.28 51.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 36.5 p -135.43 147.1 48.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 109.567 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.3 tp -81.0 118.73 22.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.899 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -135.94 139.03 42.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.686 ' CG1' HD23 ' A' ' 231' ' ' LEU . 79.8 t -137.7 122.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.034 -1.041 . . . . 0.0 109.685 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.455 ' O ' ' OG ' ' A' ' 248' ' ' SER . 1.4 m -112.37 138.67 48.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 0.0 109.648 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -127.82 131.57 49.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.553 -0.717 . . . . 0.0 109.695 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -117.31 119.11 34.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.516 -0.74 . . . . 0.0 109.083 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -114.82 137.73 14.23 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -112.24 85.44 2.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.416 -1.049 . . . . 0.0 109.241 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 160' ' ' GLY . 18.5 m-85 -86.2 148.45 25.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.908 . . . . 0.0 109.915 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -97.22 -3.01 41.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 0.0 109.852 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.718 ' ND2' ' H ' ' A' ' 159' ' ' LEU . 11.4 p-10 -76.35 -169.94 1.33 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.084 -1.01 . . . . 0.0 109.687 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -55.7 -24.22 33.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -0.913 . . . . 0.0 109.778 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.718 ' H ' ' ND2' ' A' ' 157' ' ' ASN . 9.1 mt -66.49 -40.21 89.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.18 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 75.5 -124.98 7.81 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -114.14 145.32 41.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.577 -0.955 . . . . 0.0 109.819 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.573 ' NE2' ' ND2' ' A' ' 221' ' ' ASN . 22.8 tt0 -162.21 162.14 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 0.0 109.738 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -147.86 159.81 43.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.503 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -139.39 131.65 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.096 -1.003 . . . . 0.0 109.667 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 165' ' ' THR . 13.8 t -103.7 123.22 46.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 5.9 t80 -100.53 138.56 37.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.236 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.441 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.9 t -137.53 150.02 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.804 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -50.43 118.2 2.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 0.0 109.548 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.2 6.17 18.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.85 28.41 2.64 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.17 -1.194 . . . . 0.0 108.716 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -60.42 -37.01 79.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.425 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.83 -16.63 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 110.45 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -88.33 -3.86 58.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.081 -1.012 . . . . 0.0 110.919 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.77 5.65 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.085 -1.009 . . . . 0.0 111.417 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.64 -32.39 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.456 -1.403 . . . . 0.0 110.057 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -87.52 2.68 50.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.009 -1.057 . . . . 0.0 110.994 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.06 117.31 20.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.685 -1.259 . . . . 0.0 108.698 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -91.54 152.86 20.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.102 -0.999 . . . . 0.0 110.334 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -57.77 131.19 49.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 109.372 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -109.36 163.9 12.98 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -0.992 . . . . 0.0 110.115 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.618 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -144.71 162.36 36.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 0.0 110.495 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.554 ' N ' ' OE2' ' A' ' 185' ' ' GLU . 57.7 m-85 -105.37 144.65 31.85 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.674 ' HA ' HD12 ' A' ' 186' ' ' ILE . 14.8 p-10 -60.79 -26.5 67.32 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.829 -1.17 . . . . 0.0 110.213 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.482 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.1 p90 -81.31 -26.24 35.82 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.91 -1.119 . . . . 0.0 111.095 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.554 ' OE2' ' N ' ' A' ' 182' ' ' PHE . 10.3 pt-20 -92.7 -14.59 27.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.663 -1.273 . . . . 0.0 109.568 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.3 mt -56.19 -53.37 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.235 -0.916 . . . . 0.0 110.145 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.0 -53.32 54.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.989 -1.069 . . . . 0.0 109.449 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -52.12 -41.49 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.833 . . . . 0.0 109.214 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 60.9 mt -66.86 -33.88 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -0.967 . . . . 0.0 108.862 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -79.52 -25.74 41.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 110.086 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -27.72 42.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.139 -0.975 . . . . 0.0 109.89 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.89 8.28 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.57 23.2 70.85 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.1 mt -123.85 163.17 21.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -1.161 . . . . 0.0 109.664 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.446 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.29 24.43 71.07 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.1 mtpp -70.83 -20.66 62.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.02 -1.282 . . . . 0.0 109.691 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.04 -2.51 51.78 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.65 128.55 35.36 Favored Glycine 0 N--CA 1.492 2.387 0 O-C-N 121.204 -1.174 . . . . 0.0 111.07 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 82.5 p -132.45 -173.67 3.23 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 12.9 mt -92.9 -12.88 29.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.112 -0.992 . . . . 0.0 109.88 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -91.4 -4.89 55.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 109.559 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 99' ' ' LEU . 42.5 m-20 -139.22 12.11 2.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.885 . . . . 0.0 109.375 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.618 HG22 ' SG ' ' A' ' 181' ' ' CYS . 0.6 OUTLIER -149.76 122.13 8.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.249 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.2 tp -82.25 112.83 19.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.094 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 27.7 t -103.67 127.88 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.957 -1.09 . . . . 0.0 109.215 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 78.6 mt -111.15 141.95 43.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.409 -0.807 . . . . 0.0 110.136 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -96.37 149.29 19.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.0 OUTLIER -42.48 -25.17 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -1.222 . . . . 0.0 110.106 -179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.2 OUTLIER -150.49 10.12 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.833 -1.167 . . . . 0.0 110.596 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -143.21 151.83 41.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.965 -1.084 . . . . 0.0 110.098 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.6 t -96.54 123.22 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.488 -0.757 . . . . 0.0 109.066 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -72.85 -54.36 8.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 110.129 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -55.33 134.36 69.66 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.872 -1.142 . . . . 0.0 109.618 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.55 -23.01 20.41 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.393 2.062 . . . . 0.0 112.702 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -77.63 -5.1 49.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 0.0 110.043 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.58 -161.56 53.66 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 24.2 mt -89.94 146.92 24.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.495 -1.003 . . . . 0.0 110.294 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -90.75 -20.99 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.631 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 48.3 m-85 -142.52 167.91 20.97 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -82.57 -21.44 35.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.063 -1.023 . . . . 0.0 108.412 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.573 ' ND2' ' NE2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -125.18 37.55 4.37 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.591 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 30.1 tt0 -58.95 -35.76 35.65 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.447 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.5 Cg_exo -73.88 -45.52 0.38 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.714 1.61 . . . . 0.0 113.001 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.423 ' H ' HG22 ' A' ' 224' ' ' VAL . 16.5 m -76.43 -25.19 16.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.754 -1.216 . . . . 0.0 108.554 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.631 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 11.6 mtp180 -67.06 -46.01 75.63 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -58.29 -43.25 87.97 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -45.59 82.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 108.737 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 26.9 t -57.91 -48.63 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -54.32 -41.31 68.88 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.96 -39.67 79.34 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.513 -0.742 . . . . 0.0 109.671 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.686 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.4 tp -58.66 -36.21 73.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.374 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 60.5 mt -72.3 -34.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -63.34 -34.42 89.92 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 3.0 m-20 -82.94 -26.77 31.09 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.258 -1.143 . . . . 0.0 110.135 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 5.7 mt -81.48 -25.92 35.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.853 -1.154 . . . . 0.0 109.772 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.505 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 27.8 t80 -66.85 -8.8 31.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.2 -0.937 . . . . 0.0 108.923 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' A' ' 237' ' ' LEU . 71.5 mt -49.95 -30.12 9.76 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 92.0 mt -60.18 -15.8 27.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 108.98 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.01 18.12 80.22 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 53.4 p -156.01 137.53 9.61 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.08 -1.247 . . . . 0.0 109.503 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.431 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 78.5 Cg_exo -42.81 130.4 5.53 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.049 1.833 . . . . 0.0 112.184 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 39.4 t -95.88 135.98 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.948 . . . . 0.0 109.815 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -118.62 123.34 44.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.755 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.22 169.86 20.18 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -101.74 114.47 28.55 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.197 -1.178 . . . . 0.0 110.047 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -111.36 150.97 28.98 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.918 0.866 . . . . 0.0 110.976 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -128.44 144.14 51.1 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 150' ' ' THR . 0.9 OUTLIER -137.26 127.01 25.46 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.731 -1.231 . . . . 0.0 110.475 -178.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.468 ' O ' ' C ' ' A' ' 250' ' ' ARG . 52.4 t80 -111.83 113.9 26.53 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.47 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 11.5 mmm180 44.45 56.12 5.23 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.46 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -83.47 146.99 23.95 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.587 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -119.84 177.05 16.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.539 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 29.1 m-70 -67.63 -38.21 83.56 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -1.154 . . . . 0.0 109.787 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 5.1 t -67.65 -38.69 84.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.235 -0.916 . . . . 0.0 110.065 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.649 ' HG ' HD12 ' A' ' 139' ' ' ILE . 58.2 tp -72.66 -37.29 67.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.937 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 75.5 m-20 -60.57 -51.76 68.03 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 80.4 t -51.92 -44.13 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 109.138 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -55.23 -47.08 75.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.052 -1.03 . . . . 0.0 109.018 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 139' ' ' ILE . 54.1 tp -52.66 -49.67 64.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.901 . . . . 0.0 108.824 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.0 t -63.4 -47.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.384 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.31 -52.24 54.16 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.576 -0.703 . . . . 0.0 110.23 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -59.09 -50.65 73.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.982 -1.074 . . . . 0.0 110.515 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 68.3 mt -61.63 -39.73 92.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 109.423 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.19 -34.29 72.78 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.301 -0.874 . . . . 0.0 109.336 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -69.61 -35.2 75.07 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.025 -1.047 . . . . 0.0 108.527 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -58.36 -46.08 86.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.24 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -74.22 10.35 1.29 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.808 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 18.6 tptt -82.07 -31.02 31.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.139 -0.976 . . . . 0.0 109.914 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.81 1.7 53.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.128 -0.982 . . . . 0.0 109.459 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.605 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.684 H3A3 HD11 ' A' ' 18' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 4' ' ' GLU . 23.2 mt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.674 ' OE2' HG23 ' A' ' 121' ' ' ILE . 7.0 mm-40 -47.01 148.39 1.12 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.195 -0.941 . . . . 0.0 108.877 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.19 138.82 54.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 0.0 110.066 -178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.5 t -134.15 171.43 14.24 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 7' ' ' VAL . 3.1 m -82.24 140.87 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.79 -1.194 . . . . 0.0 110.484 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -75.84 -46.54 29.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.653 -0.654 . . . . 0.0 110.337 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -126.54 154.48 43.78 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.744 0.783 . . . . 0.0 111.054 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HD2' ' CE1' ' A' ' 29' ' ' HIS . 9.4 tttt -54.37 135.23 45.31 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.698 -0.626 . . . . 0.0 109.977 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mt -121.22 152.91 38.29 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.3 p -151.99 146.44 25.59 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.905 -1.122 . . . . 0.0 110.042 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -128.25 162.4 27.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.58 -0.7 . . . . 0.0 109.304 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.73 132.52 17.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.914 -1.116 . . . . 0.0 108.525 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.6 157.9 16.46 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.4 p -77.7 164.28 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -1.158 . . . . 0.0 110.943 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -91.32 137.61 13.91 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.4 tt -58.57 -48.41 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.229 -1.16 . . . . 0.0 111.928 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.477 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.1 m-70 -86.78 -38.18 17.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.205 -1.56 . . . . 0.0 110.98 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 m -74.47 -40.0 62.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 0.0 109.867 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.77 23.08 78.18 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -112.11 151.04 29.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.528 -0.983 . . . . 0.0 108.621 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -71.16 134.43 46.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.192 -0.943 . . . . 0.0 109.88 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 11.5 t -141.17 158.49 43.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.061 -1.024 . . . . 0.0 109.339 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.2 ttpp -133.15 155.07 49.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 109.502 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.705 HD11 ' HD2' ' A' ' 97' ' ' PRO . 24.6 mt -128.65 152.35 48.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.955 . . . . 0.0 109.665 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.563 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.1 mt -142.05 126.15 16.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.491 -0.756 . . . . 0.0 109.014 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mt -115.29 117.72 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.126 -0.984 . . . . 0.0 109.924 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.563 ' NE2' HG22 ' A' ' 27' ' ' ILE . 11.7 m-70 -113.04 149.38 41.24 Favored Pre-proline 0 N--CA 1.491 1.616 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.6 163.1 22.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.202 1.935 . . . . 0.0 111.143 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.541 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.0 mm-40 -136.84 -175.17 3.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.057 -1.027 . . . . 0.0 110.08 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 152.07 22.91 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.432 -0.792 . . . . 0.0 109.028 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -51.66 151.04 3.48 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.349 -0.844 . . . . 0.0 110.407 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.533 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 63.62 19.64 62.9 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.27 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 51.9 m -81.94 -46.75 13.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.498 -1.589 . . . . 0.0 109.366 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -171.77 23.26 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mm -97.52 122.12 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -1.137 . . . . 0.0 108.159 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.61 144.3 41.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.0 110.544 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -105.83 154.33 20.68 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.553 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.7 t80 -129.86 142.06 50.72 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 12.9 ttpt -172.35 138.24 0.92 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.998 -1.064 . . . . 0.0 109.72 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.95 29.76 19.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.466 -0.771 . . . . 0.0 109.824 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.45 25.99 74.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.61 139.75 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -1.159 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -94.04 146.83 23.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.122 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.401 HG23 ' CB ' ' A' ' 64' ' ' PHE . 8.0 mt -139.56 98.91 7.89 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -50.92 140.93 37.9 Favored 'Trans proline' 0 N--CA 1.494 1.559 0 C-N-CA 122.174 1.916 . . . . 0.0 111.453 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.34 79.89 8.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.91 -1.119 . . . . 0.0 110.866 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -137.62 155.07 49.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -0.914 . . . . 0.0 109.223 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.674 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 2.6 p80 -54.56 -49.58 69.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.171 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -46.56 -16.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.999 -1.063 . . . . 0.0 109.909 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' HIS . 80.0 m-85 -98.51 7.99 45.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.001 -1.062 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.512 ' HA ' HD23 ' A' ' 62' ' ' LEU . 4.8 t -63.76 132.86 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.1 m -115.81 -34.06 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.271 -0.893 . . . . 0.0 110.119 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.45 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 10.6 t-80 -150.37 122.95 8.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.034 -1.041 . . . . 0.0 109.963 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.2 p -112.36 129.49 56.29 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 11.1 t-20 -166.67 -153.6 0.16 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 57' ' ' ASN . 19.2 m-70 -44.85 -16.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.218 -0.926 . . . . 0.0 108.704 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.2 t -136.19 165.56 25.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.514 -0.741 . . . . 0.0 109.48 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 87.5 m -102.97 121.32 42.3 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.306 -0.871 . . . . 0.0 108.778 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -119.39 138.22 53.23 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.324 -0.86 . . . . 0.0 111.033 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 53' ' ' VAL . 84.6 mt -118.34 163.52 16.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.469 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.77 146.21 6.23 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 118.482 -1.818 . . . . 0.0 111.211 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.401 ' CB ' HG23 ' A' ' 46' ' ' ILE . 69.1 t80 -145.03 151.81 39.15 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.629 -0.924 . . . . 0.0 109.579 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.9 mmmt 57.57 23.66 9.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.291 -0.88 . . . . 0.0 110.93 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.96 -2.22 75.57 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.888 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.469 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 96.8 mm-40 -98.93 143.75 28.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.842 -1.387 . . . . 0.0 108.258 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.49 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 0.2 OUTLIER -142.86 155.71 44.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.0 111.801 -178.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mt -132.12 145.58 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -110.88 150.29 29.4 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.112 -0.993 . . . . 0.0 111.668 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 m 54.55 68.95 0.78 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.764 -0.585 . . . . 0.0 111.294 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.41 -9.58 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.028 -1.045 . . . . 0.0 109.718 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.477 ' OE2' ' OD2' ' A' ' 230' ' ' ASP . 0.5 OUTLIER -66.28 -19.04 65.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.008 -1.057 . . . . 0.0 110.698 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -72.32 -60.86 2.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.841 -1.162 . . . . 0.0 109.641 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -56.74 -42.65 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.864 -1.148 . . . . 0.0 108.554 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.529 ' HA ' HD12 ' A' ' 79' ' ' LEU . 74.1 mt -55.05 -40.12 69.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.561 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.591 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 37.6 t -60.49 -48.74 80.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.142 -0.974 . . . . 0.0 109.554 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.5 t -56.55 -54.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 108.606 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 76' ' ' LEU . 14.6 mt -51.43 -44.38 62.29 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.515 ' HD1' HG22 ' A' ' 232' ' ' ILE . 11.6 t-160 -54.81 -56.5 18.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.401 -0.812 . . . . 0.0 110.049 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.9 mt -62.92 -37.48 87.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.255 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 114' ' ' ILE . 14.0 mt -77.2 -6.12 51.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.993 -1.067 . . . . 0.0 110.057 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 62.96 42.37 7.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.967 -1.083 . . . . 0.0 110.096 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 82' ' ' LEU . 16.2 mm -90.01 126.1 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 108.956 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.505 HG21 ' OE2' ' A' ' 4' ' ' GLU . 48.1 p -107.47 -76.41 0.61 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.365 -0.834 . . . . 0.0 111.577 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.729 HD22 ' N ' ' A' ' 86' ' ' ASN . 0.5 OUTLIER -81.27 113.81 19.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.06 -1.025 . . . . 0.0 111.9 -176.522 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.71 144.37 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.541 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 3.8 m -110.93 101.65 10.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.499 -0.751 . . . . 0.0 109.27 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.99 111.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.348 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -92.21 120.0 32.37 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.043 -1.036 . . . . 0.0 108.633 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.402 HG22 HD22 ' A' ' 26' ' ' LEU . 94.6 t -102.32 112.37 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.991 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -91.44 109.67 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.35 -160.79 23.52 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.4 -15.97 9.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.536 -0.979 . . . . 0.0 109.959 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -135.64 142.56 45.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.138 -0.977 . . . . 0.0 110.347 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mm -67.96 126.75 93.02 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.705 ' HD2' HD11 ' A' ' 26' ' ' LEU . 58.6 Cg_exo -46.28 127.82 11.46 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.709 1.606 . . . . 0.0 111.735 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.56 -25.75 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.302 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 96.4 mt 54.77 -116.65 1.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -94.85 -8.13 38.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 0.0 110.751 -179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.87 -13.38 59.15 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -109.94 -171.97 1.94 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -1.059 . . . . 0.0 109.619 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.94 -7.62 16.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -46.42 -38.57 9.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.541 -0.976 . . . . 0.0 110.128 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.525 ' N ' ' CD ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -61.85 -51.81 66.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.007 -1.058 . . . . 0.0 109.818 -179.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.499 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 78.2 m-85 -63.34 -43.78 96.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.988 -1.07 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -60.93 -39.66 90.28 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.447 0.641 . . . . 0.0 109.84 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.57 -46.6 53.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 111.829 -178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.09 -51.25 12.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.779 -1.201 . . . . 0.0 110.828 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 110' ' ' ILE . 60.7 mt -61.55 -42.67 94.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.043 -1.035 . . . . 0.0 110.708 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.3 ttt-85 -57.27 -28.56 63.09 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.088 -1.007 . . . . 0.0 110.038 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -80.16 -12.07 59.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.087 -1.008 . . . . 0.0 110.221 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -123.09 34.88 5.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.362 -0.836 . . . . 0.0 110.927 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.604 HD11 HD22 ' A' ' 82' ' ' LEU . 17.9 mt -85.98 147.16 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.48 -1.388 . . . . 0.0 110.674 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 115' ' ' LEU . 31.9 tp -132.26 145.53 51.37 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.618 -0.677 . . . . 0.0 109.478 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -92.68 146.2 23.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.106 -0.996 . . . . 0.0 110.356 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -108.85 -168.23 1.32 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.528 ' O ' ' ND2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -119.74 69.94 0.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.478 -0.764 . . . . 0.0 110.418 -179.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 ttm180 -170.21 122.04 0.66 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.225 -0.922 . . . . 0.0 109.91 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.87 134.69 56.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.674 HG23 ' OE2' ' A' ' 4' ' ' GLU . 0.9 OUTLIER -75.49 143.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.481 -0.762 . . . . 0.0 110.462 -179.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -86.4 89.68 7.96 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -63.67 147.01 52.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 110.555 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -104.77 125.09 50.49 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.29 142.59 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.456 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.7 t -83.65 139.88 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.459 -0.775 . . . . 0.0 109.1 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -118.87 -11.05 9.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 109.046 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -142.56 144.95 32.43 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.28 -0.887 . . . . 0.0 109.261 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.61 160.24 44.44 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.163 1.908 . . . . 0.0 113.349 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.579 HD12 ' NZ ' ' A' ' 266' ' ' LYS . 1.4 tt -153.22 140.82 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.629 HG23 HD11 ' A' ' 138' ' ' LEU . 18.1 mt -130.0 124.37 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.478 -0.764 . . . . 0.0 109.846 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 132' ' ' VAL . 18.3 m -122.3 117.72 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.518 -0.739 . . . . 0.0 109.507 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.87 156.89 16.89 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.246 -0.909 . . . . 0.0 109.737 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 137' ' ' ARG . 49.6 t0 -165.92 110.22 0.82 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 0.0 111.369 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 41.06 51.13 3.3 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.54 -0.725 . . . . 0.0 112.244 178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.91 6.97 88.89 Favored Glycine 0 N--CA 1.495 2.618 0 O-C-N 120.708 -1.245 . . . . 0.0 110.274 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 134' ' ' ASP . 12.5 mtt85 -118.2 132.28 56.33 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.629 HD11 HG23 ' A' ' 131' ' ' ILE . 4.8 tt -144.71 160.81 40.61 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.349 -1.469 . . . . 0.0 109.776 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.608 HG21 HD22 ' A' ' 259' ' ' LEU . 48.9 mt -144.57 129.63 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -116.0 142.32 46.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.36 -0.837 . . . . 0.0 110.131 -178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.57 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.97 143.74 50.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -142.02 138.92 17.35 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.93 146.16 58.67 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.394 1.396 . . . . 0.0 112.088 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.1 t -166.11 151.97 8.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.912 . . . . 0.0 109.398 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.06 -1.29 56.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -134.1 146.25 50.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 0.0 109.259 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.0 tp -81.46 120.18 24.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.101 -1.0 . . . . 0.0 110.026 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -137.95 137.96 38.48 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.715 ' CG1' HD23 ' A' ' 231' ' ' LEU . 12.4 t -137.23 118.6 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.004 . . . . 0.0 109.711 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 14.1 m -106.03 143.91 33.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.217 -0.927 . . . . 0.0 109.721 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -132.06 130.94 41.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.378 -0.826 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -113.93 105.97 13.88 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.74 155.54 20.47 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.428 ' HB3' ' HE ' ' A' ' 250' ' ' ARG . 3.2 tt0 -132.79 98.01 4.2 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -1.028 . . . . 0.0 109.116 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 160' ' ' GLY . 20.8 m-85 -101.38 148.6 24.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 109.844 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.2 mmtm -93.16 -5.99 48.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.992 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.535 HD21 HD12 ' A' ' 159' ' ' LEU . 10.7 p30 -74.44 -173.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.032 -1.042 . . . . 0.0 109.48 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -53.58 -17.05 1.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.304 -0.872 . . . . 0.0 109.783 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.535 HD12 HD21 ' A' ' 157' ' ' ASN . 31.7 mt -67.1 -49.98 63.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 0.0 109.506 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 82.86 -114.59 3.87 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.45 ' O ' ' CD ' ' A' ' 162' ' ' GLN . 12.4 mtm-85 -116.98 139.55 50.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.481 -1.011 . . . . 0.0 109.294 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.45 ' CD ' ' O ' ' A' ' 161' ' ' ARG . 4.3 mp0 -142.31 155.65 45.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.166 -0.959 . . . . 0.0 109.526 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 142.18 31.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.079 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -136.35 125.72 24.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.191 -0.943 . . . . 0.0 109.257 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 30.2 m -103.6 122.94 46.03 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.045 -1.034 . . . . 0.0 109.802 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -100.01 136.96 39.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.178 -0.951 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.0 t -132.89 156.08 41.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.556 -0.715 . . . . 0.0 109.256 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.28 118.9 6.47 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.323 -0.86 . . . . 0.0 109.145 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.83 1.32 21.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -131.42 29.84 4.53 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.31 -1.112 . . . . 0.0 108.806 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -64.01 -33.58 76.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.603 -0.686 . . . . 0.0 110.611 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -52.81 -13.18 0.38 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.953 -1.092 . . . . 0.0 110.638 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -95.87 -4.12 44.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 111.139 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.1 -8.15 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.022 -1.049 . . . . 0.0 110.785 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.33 -33.11 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.66 -1.275 . . . . 0.0 109.943 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -87.96 1.28 54.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.797 -1.189 . . . . 0.0 110.603 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.82 116.93 20.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.927 -1.108 . . . . 0.0 108.657 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.54 153.26 20.92 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.034 -1.041 . . . . 0.0 110.361 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.6 t -62.07 147.66 46.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.531 -0.73 . . . . 0.0 109.457 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -130.31 176.26 8.26 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 110.402 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.562 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.6 OUTLIER -160.89 163.09 32.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.463 -0.773 . . . . 0.0 109.581 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.63 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 89.6 m-85 -104.69 146.34 29.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.272 -0.893 . . . . 0.0 109.937 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.744 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.0 p-10 -61.7 -22.05 65.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 0.0 110.804 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.63 ' CH2' ' CD1' ' A' ' 182' ' ' PHE . 5.4 p90 -81.19 -28.41 34.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.793 -1.192 . . . . 0.0 110.653 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 13.6 pt-20 -95.1 -14.32 24.32 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.897 -1.127 . . . . 0.0 109.51 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.744 HD12 ' HA ' ' A' ' 183' ' ' ASP . 10.7 mt -58.62 -53.12 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.238 -0.914 . . . . 0.0 110.129 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.22 -52.97 49.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.773 -1.204 . . . . 0.0 109.107 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.62 -47.98 66.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.155 -0.966 . . . . 0.0 108.707 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 76.5 mt -58.7 -34.36 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.463 -0.773 . . . . 0.0 109.043 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -78.55 -27.04 45.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.53 -0.731 . . . . 0.0 110.166 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -74.84 -26.82 59.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.101 -0.999 . . . . 0.0 109.883 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.614 ' CG2' HD12 ' A' ' 194' ' ' LEU . 15.4 m -84.18 9.13 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.89 23.34 66.92 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.821 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.614 HD12 ' CG2' ' A' ' 192' ' ' VAL . 3.8 mt -120.02 158.29 27.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.136 -1.214 . . . . 0.0 109.688 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.02 21.41 65.58 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.462 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -68.8 -22.34 64.26 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.577 -1.543 . . . . 0.0 109.664 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.41 -4.75 52.8 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.05 125.98 33.23 Favored Glycine 0 N--CA 1.49 2.273 0 O-C-N 121.186 -1.184 . . . . 0.0 110.539 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -131.08 -173.64 3.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.768 -0.842 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 9.2 mt -91.4 -2.03 57.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.614 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.499 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 1.3 ttpp -100.17 -3.56 31.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.655 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 4.3 m120 -139.26 -7.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.97 . . . . 0.0 109.871 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 25.5 m -130.26 128.41 41.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.848 . . . . 0.0 109.81 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 217' ' ' LEU . 60.6 tp -88.98 115.93 26.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.32 -0.862 . . . . 0.0 108.927 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 186' ' ' ILE . 47.2 t -103.01 127.88 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.167 -0.958 . . . . 0.0 109.622 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 30.5 mt -103.6 147.34 27.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.809 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.07 150.63 17.44 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -44.89 -22.11 0.08 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.141 . . . . 0.0 110.058 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.0 OUTLIER -155.13 12.74 0.37 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.948 -1.095 . . . . 0.0 110.343 -179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -146.67 155.44 42.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 0.0 110.504 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.3 t -98.85 125.56 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -73.03 -54.74 7.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.111 -0.993 . . . . 0.0 110.197 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.441 ' OD1' HD12 ' A' ' 204' ' ' LEU . 3.6 m120 -47.89 135.89 10.95 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.812 -1.18 . . . . 0.0 109.389 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.7 -41.16 2.37 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 112.05 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -65.12 -0.49 1.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.863 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.31 -166.93 54.49 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.462 ' CD2' HD21 ' A' ' 204' ' ' LEU . 43.5 mt -83.89 149.83 26.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.442 -1.034 . . . . 0.0 109.803 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.4 tpt85 -76.7 -61.37 1.99 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.947 . . . . 0.0 108.755 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.436 ' H ' ' HB2' ' A' ' 222' ' ' GLU . 6.8 m-85 -117.09 163.1 16.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.362 -0.837 . . . . 0.0 109.293 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -66.79 -14.6 62.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.668 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -133.55 32.77 3.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.366 -0.834 . . . . 0.0 109.339 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 5.8 tt0 -58.69 -37.39 53.52 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.445 -0.784 . . . . 0.0 111.126 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.6 Cg_exo -70.63 -43.22 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.971 1.781 . . . . 0.0 112.576 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 228' ' ' VAL . 6.3 m -78.71 -25.89 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.755 -1.216 . . . . 0.0 108.604 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.668 HH21 ' ND2' ' A' ' 221' ' ' ASN . 27.4 mtt180 -66.7 -40.71 88.58 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -64.81 -41.29 95.9 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.16 -48.64 78.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 108.675 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 224' ' ' VAL . 59.8 t -58.3 -49.27 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.591 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.0 t80 -49.99 -38.29 36.5 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.502 0.667 . . . . 0.0 109.299 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.477 ' OD2' ' OE2' ' A' ' 73' ' ' GLU . 7.9 m-20 -72.68 -40.01 66.6 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.476 -0.765 . . . . 0.0 110.141 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.715 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.46 -37.48 70.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.071 -1.018 . . . . 0.0 109.343 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.515 HG22 ' HD1' ' A' ' 80' ' ' HIS . 88.9 mt -70.92 -48.49 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.886 -1.134 . . . . 0.0 108.057 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.81 -33.87 13.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.29 -26.76 32.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.162 -1.199 . . . . 0.0 110.176 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -80.05 -21.03 43.89 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.668 -1.27 . . . . 0.0 110.074 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -70.59 -8.32 50.7 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.034 -1.041 . . . . 0.0 109.143 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 237' ' ' LEU . 90.6 mt -53.18 -26.07 15.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.358 -0.839 . . . . 0.0 108.829 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.479 HD12 HG22 ' A' ' 242' ' ' VAL . 94.7 mt -61.11 -20.0 62.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.973 -1.08 . . . . 0.0 108.939 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.93 15.35 70.28 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 70.9 p -158.47 149.49 16.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.909 -1.348 . . . . 0.0 109.824 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -44.32 130.16 8.73 Favored 'Trans proline' 0 C--N 1.314 -1.252 0 C-N-CA 122.216 1.944 . . . . 0.0 111.749 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.479 HG22 HD12 ' A' ' 238' ' ' LEU . 87.0 t -98.88 133.16 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.005 -1.059 . . . . 0.0 109.697 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -121.84 125.83 47.37 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.758 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.73 172.59 26.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -103.58 112.9 26.03 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.187 -1.184 . . . . 0.0 109.656 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 5.6 m-85 -113.5 148.45 35.98 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.06 0.933 . . . . 0.0 111.558 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.8 t80 -129.65 144.28 51.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.414 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 36.2 t -139.52 127.67 22.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.701 -1.249 . . . . 0.0 110.466 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 4.3 t80 -111.71 114.6 27.72 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.2 mtt-85 45.76 56.44 5.92 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.37 151.13 21.74 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.848 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.7 -176.24 16.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -71.03 -52.35 20.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.112 -1.228 . . . . 0.0 110.107 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -55.01 33.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.181 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.442 ' HG ' HD12 ' A' ' 139' ' ' ILE . 55.6 tp -51.03 -41.63 59.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.24 -0.912 . . . . 0.0 109.589 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -57.87 -54.29 48.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.071 -1.018 . . . . 0.0 108.863 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.1 -43.22 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.297 -0.877 . . . . 0.0 109.647 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -54.61 -46.72 73.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.078 -1.014 . . . . 0.0 108.718 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.608 HD22 HG21 ' A' ' 139' ' ' ILE . 24.7 tp -55.73 -47.92 76.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.419 -0.8 . . . . 0.0 109.048 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 235' ' ' LEU . 88.0 t -66.99 -42.6 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.17 -48.36 70.98 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.707 -0.621 . . . . 0.0 110.671 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -69.19 -45.05 70.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.979 -1.076 . . . . 0.0 109.841 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 75.2 mt -60.45 -45.41 93.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.182 -0.949 . . . . 0.0 109.136 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -60.84 -39.42 89.0 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.827 . . . . 0.0 109.732 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -73.71 -28.11 61.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.962 -1.086 . . . . 0.0 109.214 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.579 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 33.7 mttp -67.53 -48.2 67.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.234 -0.917 . . . . 0.0 110.06 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -85.01 4.11 35.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.115 -0.991 . . . . 0.0 110.24 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -69.87 -64.46 0.88 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.063 -1.023 . . . . 0.0 109.791 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 18.5 mt -62.23 -83.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.116 -0.99 . . . . 0.0 109.456 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.477 -0.764 . . . . 0.0 109.457 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.562 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.838 ' O ' HD11 ' A' ' 121' ' ' ILE . 2.2 mt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 119' ' ' ARG . 16.1 mm-40 -41.43 128.87 3.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 109.332 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HD3' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -113.25 127.67 56.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.432 -0.792 . . . . 0.0 109.128 -179.181 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -135.09 173.3 11.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.186 -0.946 . . . . 0.0 109.55 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -82.97 133.92 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.004 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -58.98 -48.38 81.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.455 -0.778 . . . . 0.0 110.212 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -133.65 163.07 30.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.36 -0.838 . . . . 0.0 110.225 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 132.28 48.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.521 -0.737 . . . . 0.0 109.974 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 11' ' ' LEU . 17.3 mt -117.74 164.07 15.54 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -152.97 147.59 26.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.053 -1.029 . . . . 0.0 110.198 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -132.06 161.55 32.96 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.463 -0.773 . . . . 0.0 109.74 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -147.43 134.88 20.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.909 -1.12 . . . . 0.0 109.365 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.09 158.92 17.32 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.577 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.2 p -74.96 163.02 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -1.103 . . . . 0.0 111.263 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.577 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -93.47 139.98 14.84 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.597 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.3 tt -57.81 -50.85 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.128 -1.219 . . . . 0.0 112.396 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 11.6 m-70 -86.44 -37.66 18.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.188 -1.57 . . . . 0.0 111.203 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.2 p -73.92 -34.66 64.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.335 -0.853 . . . . 0.0 110.215 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.49 21.33 66.64 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -109.76 149.95 29.04 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.544 -0.974 . . . . 0.0 109.274 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -70.84 132.43 45.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.985 . . . . 0.0 109.891 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.6 t -139.63 157.51 45.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.984 -1.072 . . . . 0.0 109.507 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' O ' HD23 ' A' ' 26' ' ' LEU . 23.8 tttp -133.69 155.21 50.13 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.274 -0.891 . . . . 0.0 109.291 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.651 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.3 mt -131.04 146.67 52.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.044 -1.035 . . . . 0.0 109.373 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.2 mt -136.0 123.91 35.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mt -111.8 122.99 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.543 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.9 OUTLIER -118.03 139.24 26.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.463 -0.773 . . . . 0.0 109.354 -179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -53.46 162.6 3.15 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 121.439 1.426 . . . . 0.0 111.49 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.5 mm-40 -135.96 -171.57 2.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.1 ttmt -91.92 156.53 17.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.586 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -50.46 146.35 5.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 110.548 -179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 64.09 24.48 68.73 Favored Glycine 0 N--CA 1.495 2.574 0 O-C-N 121.567 -0.708 . . . . 0.0 112.204 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.589 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 91.3 m -81.64 -46.44 14.37 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.346 -1.679 . . . . 0.0 109.112 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.76 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 101.52 -174.66 24.99 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.423 HD13 ' CG2' ' A' ' 87' ' ' VAL . 3.0 mm -94.86 122.65 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.189 -1.183 . . . . 0.0 108.354 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 137.28 33.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.077 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -98.58 154.59 17.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.554 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.7 t80 -130.12 136.99 49.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 108.815 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 4.0 ttmm -167.45 136.85 2.73 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.115 -0.991 . . . . 0.0 109.594 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.33 28.6 17.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -0.876 . . . . 0.0 109.922 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 28.19 71.76 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 62.4 t -133.42 132.12 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.161 -1.199 . . . . 0.0 109.727 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -85.34 140.4 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 67' ' ' GLN . 45.2 mt -134.45 94.75 16.99 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.919 . . . . 0.0 110.398 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.58 141.06 27.34 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.21 1.94 . . . . 0.0 111.494 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.09 84.39 5.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.812 -1.18 . . . . 0.0 110.374 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -139.06 155.35 48.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.511 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 6.9 p80 -52.32 -49.43 64.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.286 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.3 mt-10 -44.62 -30.96 1.0 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.153 -0.967 . . . . 0.0 109.151 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 46.1 m-85 -81.48 2.42 28.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.413 -0.804 . . . . 0.0 110.176 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 50' ' ' HIS . 8.3 t -59.46 127.44 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -0.926 . . . . 0.0 109.015 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.62 -31.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.343 -0.848 . . . . 0.0 110.48 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -151.97 123.07 7.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.891 -1.131 . . . . 0.0 109.975 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.9 p -111.77 131.61 55.21 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.752 ' N ' HD22 ' A' ' 57' ' ' ASN . 0.0 OUTLIER -166.66 -153.64 0.16 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -48.31 -11.13 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.019 -1.051 . . . . 0.0 108.537 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.588 ' H ' ' ND2' ' A' ' 57' ' ' ASN . 9.9 t -139.94 166.25 25.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.555 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.1 m -105.39 121.39 43.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 108.773 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.32 141.94 48.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 111.122 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 53' ' ' VAL . 57.1 mt -121.83 160.23 25.1 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.5 142.92 6.15 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.715 -1.707 . . . . 0.0 110.692 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -144.86 151.19 38.35 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.53 -0.982 . . . . 0.0 109.708 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt 56.96 23.77 8.67 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.368 -0.833 . . . . 0.0 110.865 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.67 -2.04 69.54 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.704 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 44.9 mm-40 -97.05 145.46 25.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.928 -1.336 . . . . 0.0 108.482 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -141.71 151.7 43.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 0.0 111.601 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.8 mt -134.29 144.46 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -114.67 154.85 27.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.163 -0.961 . . . . 0.0 110.976 -178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.4 m 51.36 67.99 0.86 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.641 -0.662 . . . . 0.0 110.8 178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -113.55 -15.88 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.128 -0.983 . . . . 0.0 109.461 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.6 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.4 OUTLIER -63.74 -15.59 58.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 110.248 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.6 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 8.7 m170 -72.11 -60.57 2.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.066 -1.022 . . . . 0.0 109.511 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.7 tp -59.65 -42.81 89.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.992 -1.068 . . . . 0.0 108.772 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.486 ' N ' HG23 ' A' ' 75' ' ' ILE . 39.3 mt -54.82 -39.21 68.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.302 -0.874 . . . . 0.0 109.325 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.503 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.3 t -61.7 -49.77 75.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 109.538 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.24 -54.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.006 . . . . 0.0 108.559 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 76' ' ' LEU . 18.1 mt -51.75 -43.82 63.07 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.488 -0.757 . . . . 0.0 109.586 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -53.3 -56.79 13.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.012 . . . . 0.0 110.462 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 57.0 mt -56.64 -35.55 68.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.355 -0.841 . . . . 0.0 110.976 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.612 ' HB3' HD11 ' A' ' 84' ' ' ILE . 26.4 mt -88.06 -2.68 58.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.864 -1.148 . . . . 0.0 111.207 -178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 62.34 58.52 1.73 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.683 -1.261 . . . . 0.0 110.945 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.612 HD11 ' HB3' ' A' ' 82' ' ' LEU . 5.0 mm -96.79 122.57 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.523 HG21 ' CG2' ' A' ' 121' ' ' ILE . 21.1 p -104.1 -77.47 0.57 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 111.047 -178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.76 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 2.5 m120 -82.24 113.6 20.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 111.452 -177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.9 m -163.79 138.52 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.684 -0.635 . . . . 0.0 109.327 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.459 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.5 m -106.53 101.18 10.65 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 20.7 mt -90.38 107.51 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.417 -0.802 . . . . 0.0 109.657 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' OE2' ' CG ' ' A' ' 40' ' ' PHE . 2.0 mm-40 -84.49 121.18 27.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.818 -1.177 . . . . 0.0 108.629 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.0 t -105.4 110.09 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.284 -0.885 . . . . 0.0 110.839 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mp -93.47 108.24 20.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.506 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 134.05 -163.37 24.55 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 94' ' ' ASN . 0.4 OUTLIER -112.94 -14.97 12.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.443 -1.034 . . . . 0.0 110.171 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -142.16 147.5 36.74 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.915 -1.116 . . . . 0.0 110.257 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.0 mm -70.88 130.57 88.3 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.474 -0.766 . . . . 0.0 109.746 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.651 ' CD ' HD21 ' A' ' 26' ' ' LEU . 52.9 Cg_exo -46.23 128.7 12.31 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.022 1.815 . . . . 0.0 112.278 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.9 tp -76.88 -29.68 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 0.0 110.015 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.427 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 50.8 mt 57.62 -116.14 0.91 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.0 109.942 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.28 -6.86 43.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.052 . . . . 0.0 110.533 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.87 -10.61 52.38 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 p -117.09 -169.26 1.62 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -1.085 . . . . 0.0 109.797 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.05 -1.37 25.31 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.071 -1.612 . . . . 0.0 109.071 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CE2' ' CG ' ' A' ' 108' ' ' GLU . 68.1 t-105 -46.39 -41.33 13.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.753 -0.851 . . . . 0.0 110.305 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -61.34 -51.97 66.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.999 -1.063 . . . . 0.0 110.131 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CG ' HD12 ' A' ' 75' ' ' ILE . 70.5 m-85 -65.02 -43.98 90.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.973 -1.079 . . . . 0.0 108.928 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.458 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.9 t80 -61.63 -37.73 85.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.519 -0.738 . . . . 0.0 109.4 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CG ' ' CE2' ' A' ' 104' ' ' TRP . 20.9 mm-40 -67.0 -51.79 50.62 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.542 -0.724 . . . . 0.0 111.598 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.54 -51.98 11.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.761 -1.212 . . . . 0.0 110.871 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.54 -44.6 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 0.0 110.409 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -55.61 -31.27 62.12 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.116 -0.99 . . . . 0.0 109.441 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -81.59 -8.92 59.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.187 -0.946 . . . . 0.0 109.906 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -124.09 34.05 5.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.431 -0.793 . . . . 0.0 110.905 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.409 HD11 HD13 ' A' ' 82' ' ' LEU . 6.9 mt -87.73 140.5 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.708 -1.245 . . . . 0.0 110.575 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 115' ' ' LEU . 46.6 tp -133.3 159.79 39.21 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.97 145.28 41.09 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.201 -0.937 . . . . 0.0 109.838 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.499 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -106.48 -162.67 0.87 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.359 -0.838 . . . . 0.0 109.31 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -121.0 72.81 0.99 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.354 -0.841 . . . . 0.0 110.735 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 4' ' ' GLU . 8.0 ttm-85 -168.02 123.53 1.01 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.14 126.36 27.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.474 -0.766 . . . . 0.0 110.316 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.838 HD11 ' O ' ' A' ' 3' ' ' LEU . 2.5 mt -78.55 150.48 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.376 -0.827 . . . . 0.0 109.695 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -90.8 86.28 6.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.164 -0.96 . . . . 0.0 109.281 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -60.23 147.21 40.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.307 -0.871 . . . . 0.0 110.105 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -101.37 120.14 39.82 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 243' ' ' LYS . 23.1 t -123.34 139.96 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.369 -0.832 . . . . 0.0 109.313 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.7 t -85.0 138.79 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.35 -0.844 . . . . 0.0 109.546 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -117.92 -10.15 10.48 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.71 143.22 34.19 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.875 . . . . 0.0 109.557 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.25 174.65 11.73 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.358 2.039 . . . . 0.0 112.64 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.93 HG22 ' HB3' ' A' ' 141' ' ' ALA . 15.2 tt -166.07 146.04 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.493 -0.754 . . . . 0.0 109.792 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.465 ' CG2' HD11 ' A' ' 138' ' ' LEU . 3.4 mp -133.54 120.12 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 109.583 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 132' ' ' VAL . 33.1 m -119.81 114.99 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.804 . . . . 0.0 109.836 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -99.51 153.99 18.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.343 -0.848 . . . . 0.0 109.067 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.496 ' CB ' HD13 ' A' ' 255' ' ' LEU . 19.8 t70 -168.56 114.96 0.64 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.788 -1.195 . . . . 0.0 111.501 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 46.51 46.65 14.31 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.513 -0.742 . . . . 0.0 112.204 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 7.11 87.03 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.636 -1.268 . . . . 0.0 110.195 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.9 mtt85 -116.13 137.54 52.04 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.627 HD23 ' C ' ' A' ' 138' ' ' LEU . 2.6 tt -147.04 159.54 43.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.055 -1.653 . . . . 0.0 109.864 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.548 ' N ' HD23 ' A' ' 138' ' ' LEU . 35.6 mt -144.51 135.75 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 108.729 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -119.64 139.32 52.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 109.984 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.93 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.19 147.56 44.77 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -148.24 137.58 12.15 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.146 -0.971 . . . . 0.0 108.524 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -53.31 147.42 36.47 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.624 1.549 . . . . 0.0 112.15 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.7 153.01 8.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.336 -0.853 . . . . 0.0 109.363 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -85.72 -3.4 58.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 109.348 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.5 p -131.26 147.46 52.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.362 -0.836 . . . . 0.0 109.419 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 242' ' ' VAL . 22.2 tp -81.26 120.07 24.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.29 -0.881 . . . . 0.0 109.627 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -139.72 134.89 32.54 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.657 ' CG1' HD23 ' A' ' 231' ' ' LEU . 25.3 t -136.47 122.09 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.931 . . . . 0.0 109.548 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.422 ' OG1' HG23 ' A' ' 165' ' ' THR . 87.1 m -110.74 145.87 37.3 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.337 -0.852 . . . . 0.0 109.977 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -131.85 129.87 40.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.463 -0.773 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -114.41 108.73 17.27 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -99.64 140.51 15.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -118.04 92.83 3.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.547 -0.973 . . . . 0.0 108.705 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLY . 24.0 m-85 -96.25 148.39 22.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.44 -0.788 . . . . 0.0 110.331 -179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -91.65 -6.1 52.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.344 -0.848 . . . . 0.0 109.822 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.691 HD21 HD12 ' A' ' 159' ' ' LEU . 18.5 p-10 -73.4 -166.78 0.37 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.046 -1.034 . . . . 0.0 109.658 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -61.78 -17.61 56.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -0.876 . . . . 0.0 109.792 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.691 HD12 HD21 ' A' ' 157' ' ' ASN . 25.5 mt -69.84 -38.86 76.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.097 -1.002 . . . . 0.0 109.341 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 155' ' ' PHE . . . 70.64 -118.15 7.53 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 8.8 mtm180 -112.67 140.45 47.42 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.479 -1.012 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -154.54 152.45 30.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.849 . . . . 0.0 109.475 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.556 ' HB3' ' HZ3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.39 152.85 47.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.394 -0.816 . . . . 0.0 109.568 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.586 ' CE1' ' CZ ' ' A' ' 225' ' ' ARG . 64.3 t80 -136.23 125.53 24.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -0.914 . . . . 0.0 109.061 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.422 HG23 ' OG1' ' A' ' 150' ' ' THR . 31.7 m -101.87 122.33 43.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.099 -1.001 . . . . 0.0 110.066 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -100.06 137.48 38.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.229 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.47 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.2 t -136.2 152.42 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.356 -0.84 . . . . 0.0 109.563 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.84 116.23 2.05 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.376 -0.827 . . . . 0.0 109.473 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.9 8.67 13.3 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -137.49 27.91 2.77 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.135 -1.215 . . . . 0.0 108.71 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.539 ' O ' HG22 ' A' ' 175' ' ' VAL . 16.4 mp0 -62.73 -37.32 86.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.616 -0.678 . . . . 0.0 110.997 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.58 -16.35 2.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.008 -1.057 . . . . 0.0 110.366 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 1.5 mt-10 -90.58 -4.33 56.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 0.0 110.795 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.8 pt -123.99 -2.04 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.099 -1.001 . . . . 0.0 110.757 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER -94.53 -29.11 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.605 -1.309 . . . . 0.0 110.018 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -88.9 2.14 54.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.914 -1.116 . . . . 0.0 110.608 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.75 119.86 23.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.77 -1.206 . . . . 0.0 108.783 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptt-85 -92.66 152.94 19.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.031 -1.043 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.436 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 5.0 t -50.07 158.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.513 -0.742 . . . . 0.0 109.347 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.497 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 51.5 p90 -143.29 165.55 27.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.011 -1.056 . . . . 0.0 109.684 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.572 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -158.99 161.48 36.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.162 -0.961 . . . . 0.0 110.071 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.613 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 73.6 m-85 -104.35 144.79 31.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 0.0 109.266 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.776 ' HA ' HD12 ' A' ' 186' ' ' ILE . 21.0 p30 -59.27 -20.19 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.151 -0.968 . . . . 0.0 111.502 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.613 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.4 p90 -79.42 -33.24 42.75 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.494 -1.379 . . . . 0.0 111.529 -178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.593 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -94.21 -9.19 37.05 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.483 -1.386 . . . . 0.0 109.915 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.9 mt -60.98 -53.34 50.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.119 -0.988 . . . . 0.0 110.243 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -51.18 -45.94 61.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.587 -1.321 . . . . 0.0 109.611 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -53.8 -53.86 46.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.108 -0.995 . . . . 0.0 108.968 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 63.2 mt -53.89 -34.54 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.25 -0.906 . . . . 0.0 108.655 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -71.49 -25.71 62.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.146 -0.971 . . . . 0.0 109.307 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -76.04 -23.93 55.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.023 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.52 15.34 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.972 -1.08 . . . . 0.0 110.271 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 68.77 27.71 73.65 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.264 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 22.2 mt -120.13 157.73 28.39 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.112 -1.228 . . . . 0.0 109.82 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.498 ' O ' ' NZ ' ' A' ' 190' ' ' LYS . . . 80.77 23.15 60.38 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.902 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -67.18 -23.09 65.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.746 -1.444 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.98 -6.63 48.65 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.96 124.67 28.88 Favored Glycine 0 N--CA 1.491 2.346 0 O-C-N 121.099 -1.236 . . . . 0.0 110.112 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.66 174.62 10.42 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.746 -0.855 . . . . 0.0 109.741 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.9 mt -77.93 -12.12 59.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.355 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.486 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 1.0 OUTLIER -86.05 -4.31 59.14 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.35 -0.843 . . . . 0.0 109.476 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 4.7 m-80 -150.22 16.35 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.868 . . . . 0.0 109.486 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.572 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.3 m -145.04 123.51 12.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.329 -0.857 . . . . 0.0 109.476 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.404 HD12 ' OD1' ' A' ' 213' ' ' ASN . 12.2 tp -85.76 115.05 23.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.843 . . . . 0.0 108.833 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.663 HG21 HCA3 ' A' ' 320' ' ' TUX . 46.3 t -103.28 124.13 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.098 -1.001 . . . . 0.0 109.843 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 63.9 mt -105.38 148.69 26.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.799 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.49 163.66 13.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.0 pttt -55.68 -25.35 39.32 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.067 -1.255 . . . . 0.0 109.341 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.25 12.6 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.673 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.18 147.88 40.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.13 -0.981 . . . . 0.0 110.106 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.89 128.99 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.862 . . . . 0.0 108.979 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.44 -55.17 6.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.15 -0.969 . . . . 0.0 110.386 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.404 ' OD1' HD12 ' A' ' 204' ' ' LEU . 5.4 m120 -51.53 137.54 31.63 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.992 -1.067 . . . . 0.0 109.81 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.67 -38.73 3.0 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.473 2.115 . . . . 0.0 112.551 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.52 -6.65 45.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.201 -0.937 . . . . 0.0 109.914 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.32 -166.27 50.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -77.8 141.78 39.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.534 -0.98 . . . . 0.0 109.736 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.559 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -85.49 -15.61 42.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 108.841 179.409 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 221' ' ' ASN . 17.8 m-85 -141.94 130.06 22.1 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -46.5 -12.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.084 -1.01 . . . . 0.0 109.153 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.711 HD22 ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -138.13 36.81 2.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.473 -0.767 . . . . 0.0 109.407 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.61 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 22.5 tt0 -61.85 -34.42 16.13 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.201 -0.937 . . . . 0.0 111.21 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.61 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.0 Cg_exo -72.01 -48.06 0.4 Allowed 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 121.919 1.746 . . . . 0.0 112.465 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.459 ' H ' HG22 ' A' ' 224' ' ' VAL . 4.6 m -71.91 -22.24 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.838 -1.163 . . . . 0.0 108.071 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.711 ' NH1' HD22 ' A' ' 221' ' ' ASN . 15.2 mtt85 -68.03 -45.84 72.83 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -60.33 -41.07 92.79 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -44.14 84.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.256 -0.902 . . . . 0.0 108.648 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 224' ' ' VAL . 89.1 t -65.5 -40.28 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.503 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 87.3 t80 -58.81 -39.56 81.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.492 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -73.55 -38.56 65.19 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.578 -0.701 . . . . 0.0 109.414 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.62 -37.77 71.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.186 -0.946 . . . . 0.0 109.142 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 68.4 mt -70.28 -47.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.35 -33.51 16.53 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.6 -27.1 31.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.123 -1.222 . . . . 0.0 110.059 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.65 -24.89 41.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.671 -1.268 . . . . 0.0 109.714 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 35.1 t80 -67.63 -10.06 48.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.241 -0.912 . . . . 0.0 108.933 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 237' ' ' LEU . 26.0 mt -51.05 -26.53 6.41 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.66 HD12 HG22 ' A' ' 242' ' ' VAL . 95.9 mt -57.9 -21.79 45.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.248 -0.907 . . . . 0.0 108.745 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.4 13.95 75.12 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 64.5 p -158.96 149.05 15.32 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.084 -1.245 . . . . 0.0 109.735 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -42.34 134.03 4.7 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 122.396 2.064 . . . . 0.0 112.072 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.66 HG22 HD12 ' A' ' 238' ' ' LEU . 70.1 t -101.5 127.59 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.942 . . . . 0.0 109.97 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.409 ' HB3' HG13 ' A' ' 125' ' ' VAL . 1.4 tppt? -116.13 122.99 46.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 109.426 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.51 178.87 32.93 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -109.09 112.95 25.41 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.313 -1.11 . . . . 0.0 109.833 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -114.74 146.86 40.49 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.817 0.818 . . . . 0.0 111.394 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.4 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 26.5 t80 -131.07 141.4 50.17 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.7 t -135.74 128.54 31.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.791 -1.193 . . . . 0.0 110.563 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 250' ' ' ARG . 14.3 t80 -111.69 114.53 27.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 249' ' ' PHE . 3.2 mtp85 44.78 55.74 5.75 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.19 148.85 22.52 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -112.63 -177.61 19.76 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.402 ' O ' HG23 ' A' ' 257' ' ' VAL . 25.5 m-70 -70.5 -47.21 61.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.091 -1.241 . . . . 0.0 109.752 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 68.3 p -61.03 -54.5 44.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.308 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.496 HD13 ' CB ' ' A' ' 134' ' ' ASP . 58.3 tp -51.71 -39.65 58.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -0.949 . . . . 0.0 109.384 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.72 -55.87 28.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -0.975 . . . . 0.0 108.865 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 253' ' ' HIS . 41.0 t -49.19 -41.08 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 109.232 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.69 -48.47 75.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.152 -0.968 . . . . 0.0 109.04 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 16.8 tp -52.67 -44.81 66.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 108.804 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.4 t -68.23 -49.18 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.854 . . . . 0.0 109.318 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -49.37 -50.74 38.81 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.695 -0.628 . . . . 0.0 110.509 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -64.41 -50.97 65.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.987 -1.071 . . . . 0.0 109.961 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 263' ' ' LEU . 47.8 mt -56.64 -44.21 81.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.602 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.35 83.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.725 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 17.7 mtmm -78.91 -26.61 43.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 108.989 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 27.0 mttt -68.53 -47.4 67.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.195 -0.94 . . . . 0.0 109.382 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.29 11.63 1.16 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -73.88 -10.48 59.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.847 . . . . 0.0 109.771 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 7.4 mt -84.43 18.08 2.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.123 -0.986 . . . . 0.0 109.458 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 0.0 109.441 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.663 HCA3 HG21 ' A' ' 205' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.456 HD22 ' C ' ' A' ' 118' ' ' ASN . 5.3 mt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.641 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.6 mt-10 -43.5 144.88 0.68 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 109.376 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -113.18 130.93 56.06 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.2 t -131.23 169.68 15.62 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.376 -0.828 . . . . 0.0 109.31 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 7' ' ' VAL . 4.6 m -81.58 136.26 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.826 -1.171 . . . . 0.0 110.516 -179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' CB ' ' HZ3' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -69.78 -47.11 64.13 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.664 -0.648 . . . . 0.0 109.978 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -128.42 156.88 42.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.492 -0.755 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -62.82 134.61 56.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.627 -0.671 . . . . 0.0 110.046 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.824 HD21 ' ND2' ' A' ' 113' ' ' ASN . 19.7 mt -118.66 160.8 21.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -149.55 145.97 27.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.941 -1.1 . . . . 0.0 110.046 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -128.83 164.62 22.65 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.475 -0.766 . . . . 0.0 109.287 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 133.8 12.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.867 -1.146 . . . . 0.0 109.004 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.64 159.43 17.86 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.554 HG22 ' N ' ' A' ' 17' ' ' GLY . 2.4 p -76.07 164.32 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.047 -1.266 . . . . 0.0 110.896 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -95.21 142.45 16.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.3 tt -61.23 -47.78 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.053 -1.263 . . . . 0.0 112.136 -178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 6.2 m-70 -86.99 -39.86 15.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 119.984 -1.697 . . . . 0.0 110.793 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 m -71.76 -36.79 70.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.383 -0.823 . . . . 0.0 110.168 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.03 24.22 70.09 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -115.07 152.5 32.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.632 -0.922 . . . . 0.0 108.715 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -72.35 131.61 42.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 109.889 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.4 t -138.35 158.91 43.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.216 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.648 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.8 ttmt -133.13 159.59 39.68 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.259 -0.901 . . . . 0.0 109.881 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.669 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.5 mt -133.31 144.12 49.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.178 -0.951 . . . . 0.0 109.235 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.552 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.5 mt -134.49 123.43 42.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 53.8 mt -113.54 126.66 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.071 -1.018 . . . . 0.0 109.926 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.577 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.3 m-70 -122.18 149.19 53.91 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.14 160.16 16.73 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.055 1.837 . . . . 0.0 111.229 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 2.7 mm-40 -133.79 -176.0 4.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.0 109.599 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.403 ' O ' ' OG1' ' A' ' 35' ' ' THR . 10.0 ttpp -88.01 152.31 22.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.92 145.44 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.422 -0.799 . . . . 0.0 110.227 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.641 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.42 25.55 60.71 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.213 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.584 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.6 m -80.88 -41.4 23.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.648 -1.501 . . . . 0.0 108.703 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.71 178.95 30.85 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.3 mm -97.56 123.31 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -140.3 145.79 37.7 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.73 -1.188 . . . . 0.0 111.033 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -100.68 152.25 20.68 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.411 ' CD1' ' C ' ' A' ' 40' ' ' PHE . 11.0 t80 -133.35 141.95 48.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.204 -0.935 . . . . 0.0 109.225 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tttp -176.5 145.94 0.59 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 57.55 28.89 16.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.838 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.85 28.92 72.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.48 142.57 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -1.215 . . . . 0.0 109.598 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -101.41 143.59 31.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.237 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.0 mt -135.04 95.81 14.87 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 0.0 110.22 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.35 145.53 21.02 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 122.052 1.834 . . . . 0.0 111.267 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 82.14 5.1 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.93 -1.107 . . . . 0.0 110.588 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.84 153.92 50.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.177 -0.952 . . . . 0.0 109.497 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.545 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 6.3 p80 -51.81 -49.61 62.42 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.8 mm-40 -43.87 -33.02 1.22 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.196 -0.94 . . . . 0.0 109.234 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -80.45 2.46 25.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.382 -0.824 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' HIS . 2.6 t -60.7 126.16 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.021 -1.049 . . . . 0.0 108.695 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.09 -34.11 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.223 -0.923 . . . . 0.0 110.359 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.478 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 8.5 t-80 -149.67 123.18 9.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.943 -1.098 . . . . 0.0 109.913 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.0 p -110.71 131.52 54.98 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.2 t-20 -166.38 -154.2 0.18 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.53 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 8.1 m170 -48.05 -11.65 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.082 -1.011 . . . . 0.0 108.513 178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 43.6 t -138.15 165.94 25.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.563 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.4 m -102.92 121.14 41.9 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.6 OUTLIER -120.4 141.56 50.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.262 -0.899 . . . . 0.0 111.563 -178.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.1 mt -123.51 155.98 36.51 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.504 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -172.88 142.28 6.65 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 118.556 -1.783 . . . . 0.0 110.944 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -144.86 151.48 38.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.631 -0.923 . . . . 0.0 109.704 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.4 mmtm 56.51 27.86 12.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.495 -0.753 . . . . 0.0 110.839 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.55 81.15 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.754 -1.212 . . . . 0.0 110.315 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.504 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 92.7 mm-40 -99.26 143.5 29.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.286 . . . . 0.0 108.361 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -141.99 151.24 42.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.073 -1.017 . . . . 0.0 111.198 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.3 mt -135.51 144.03 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -114.27 153.73 29.19 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.243 -0.911 . . . . 0.0 110.896 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 53.24 68.05 0.9 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.645 -0.659 . . . . 0.0 110.812 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.42 ' O ' HD12 ' A' ' 76' ' ' LEU . 15.9 m -113.12 -5.77 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.0 109.464 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.571 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 0.5 OUTLIER -67.76 -29.27 68.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.906 . . . . 0.0 109.985 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -62.63 -60.29 3.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.91 . . . . 0.0 109.91 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.504 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 9.6 tp -59.13 -44.29 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.045 -1.035 . . . . 0.0 109.107 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.504 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 9.8 mt -59.58 -38.1 80.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.126 -0.984 . . . . 0.0 109.771 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.455 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -59.71 -48.03 83.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.967 -1.083 . . . . 0.0 109.531 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.53 -53.56 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 108.909 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 76' ' ' LEU . 28.5 mt -50.91 -43.06 59.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.065 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.625 ' HD1' HG22 ' A' ' 232' ' ' ILE . 11.8 t-160 -55.1 -56.97 13.88 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.149 -0.97 . . . . 0.0 109.815 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 43.0 mt -57.52 -38.54 74.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.394 -0.816 . . . . 0.0 110.423 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.649 HD13 HD11 ' A' ' 114' ' ' ILE . 36.5 mt -80.12 -5.88 56.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.957 -1.089 . . . . 0.0 110.892 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.465 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER 62.8 63.52 0.96 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.706 -1.246 . . . . 0.0 110.528 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 82' ' ' LEU . 9.7 mm -102.8 132.87 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.244 -0.91 . . . . 0.0 108.708 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.24 -23.6 7.24 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.339 -0.85 . . . . 0.0 111.633 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.689 ' O ' HG13 ' A' ' 87' ' ' VAL . 70.9 m-20 -132.21 112.76 12.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.763 -1.211 . . . . 0.0 110.453 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.689 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.7 m -164.05 137.71 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.966 . . . . 0.0 109.882 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.538 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 47.2 m -106.52 100.21 9.74 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.76 116.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.698 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -94.29 117.88 30.77 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.675 -1.265 . . . . 0.0 108.127 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.48 107.49 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 110.723 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.8 mt -89.69 110.47 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.24 -164.49 25.06 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -109.02 -11.41 14.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.408 -1.054 . . . . 0.0 110.2 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.587 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -153.15 155.89 37.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.917 -1.114 . . . . 0.0 110.306 -179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.6 mm -71.57 131.91 85.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.498 -0.751 . . . . 0.0 109.606 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.669 ' CD ' HD21 ' A' ' 26' ' ' LEU . 76.3 Cg_exo -45.88 138.46 11.91 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.295 1.997 . . . . 0.0 112.283 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 99' ' ' LEU . 8.7 tp -75.91 -39.18 37.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.571 -0.706 . . . . 0.0 110.264 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.495 ' N ' HG23 ' A' ' 98' ' ' ILE . 80.3 mt 54.92 -155.52 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.177 -0.952 . . . . 0.0 109.481 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.95 -1.64 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.147 -0.971 . . . . 0.0 111.027 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 99' ' ' LEU . . . 88.27 -10.4 71.37 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.69 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.3 p -112.09 -168.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.36 -1.082 . . . . 0.0 109.77 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -1.22 21.83 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.589 ' CD2' ' OE1' ' A' ' 108' ' ' GLU . 69.1 t-105 -46.81 -41.36 15.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.841 -0.799 . . . . 0.0 110.696 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' OE1' HD13 ' A' ' 99' ' ' LEU . 36.2 mt-10 -62.39 -52.04 65.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.835 -1.166 . . . . 0.0 110.303 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 80.6 m-85 -62.01 -45.38 93.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.924 -1.11 . . . . 0.0 108.758 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.659 ' CD2' HG11 ' A' ' 175' ' ' VAL . 6.1 t80 -59.68 -41.33 90.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.676 -0.64 . . . . 0.0 109.811 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.589 ' OE1' ' CD2' ' A' ' 104' ' ' TRP . 0.3 OUTLIER -74.64 -41.68 59.92 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.202 -0.936 . . . . 0.0 111.418 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -48.68 25.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.858 -1.151 . . . . 0.0 110.357 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.4 mt -67.66 -40.51 84.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.12 -0.987 . . . . 0.0 110.392 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -53.05 -31.79 43.4 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.273 -0.892 . . . . 0.0 109.593 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -85.3 -5.89 59.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.976 -1.077 . . . . 0.0 110.102 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.824 ' ND2' HD21 ' A' ' 11' ' ' LEU . 71.7 m-20 -125.47 30.29 5.81 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 111.385 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.649 HD11 HD13 ' A' ' 82' ' ' LEU . 4.8 mt -89.89 146.79 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.661 -1.274 . . . . 0.0 109.941 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 115' ' ' LEU . 15.1 tp -131.93 161.13 33.81 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.408 HD21 ' HB2' ' A' ' 3' ' ' LEU . 6.4 t-20 -108.1 144.91 34.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.035 -1.041 . . . . 0.0 110.076 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -106.0 -163.77 0.96 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.166 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.456 ' C ' HD22 ' A' ' 3' ' ' LEU . 0.8 OUTLIER -114.26 -3.42 13.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.344 -0.848 . . . . 0.0 110.58 -179.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 4' ' ' GLU . 25.7 ttm180 -89.98 143.48 26.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 0.0 110.274 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -83.03 128.56 34.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.36 -0.838 . . . . 0.0 109.859 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.5 mt -67.49 137.35 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.472 -0.768 . . . . 0.0 111.172 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.69 91.09 8.68 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -65.47 146.83 54.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.455 -0.778 . . . . 0.0 110.936 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -100.26 122.65 43.39 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.71 139.18 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.882 . . . . 0.0 110.188 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 52.6 t -84.21 138.86 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.429 -0.794 . . . . 0.0 108.929 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -117.72 -8.67 10.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.522 -0.736 . . . . 0.0 109.444 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -144.0 144.12 25.31 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.953 . . . . 0.0 109.324 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -71.91 150.66 55.59 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.196 1.931 . . . . 0.0 113.096 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 2.2 tt -140.96 144.61 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 66.3 mt -128.87 125.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 109.669 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.81 111.27 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.38 -0.825 . . . . 0.0 109.778 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -113.47 133.59 55.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 109.284 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -179.08 156.38 0.78 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.011 -1.056 . . . . 0.0 110.643 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 57.0 mm-40 56.16 20.14 4.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.588 -0.695 . . . . 0.0 110.54 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.36 3.54 88.66 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.46 ' HE ' ' C ' ' A' ' 251' ' ' GLY . 1.4 mtp85 -104.02 171.21 7.47 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.6 tt -159.86 146.06 15.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.503 -1.373 . . . . 0.0 108.589 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 259' ' ' LEU . 18.7 mt -147.59 126.86 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.024 -1.047 . . . . 0.0 108.511 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.48 147.06 43.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.638 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -127.75 151.87 48.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -150.11 139.14 12.9 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -51.52 144.19 33.36 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.707 1.605 . . . . 0.0 112.146 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.71 11.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.21 -0.931 . . . . 0.0 109.472 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 24.7 p-10 -86.21 -0.4 55.65 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.67 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.3 p -135.14 145.54 47.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.1 tp -79.72 118.03 21.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.92 . . . . 0.0 109.838 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -138.17 142.16 40.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 108.871 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.531 ' CG1' HD23 ' A' ' 231' ' ' LEU . 71.1 t -140.35 131.87 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.997 -1.064 . . . . 0.0 109.935 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 m -117.73 135.85 53.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.348 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.531 ' HB2' HG22 ' A' ' 228' ' ' VAL . 84.1 t80 -123.88 128.54 49.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.388 -0.82 . . . . 0.0 109.411 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.6 109.46 17.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.01 122.75 6.11 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 1.1 pm0 -102.88 114.65 29.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -1.138 . . . . 0.0 108.659 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -109.42 147.73 32.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.176 -0.953 . . . . 0.0 109.576 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -93.31 0.12 56.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.786 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.483 ' ND2' HD12 ' A' ' 159' ' ' LEU . 12.8 p30 -79.3 -171.54 2.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.137 -0.977 . . . . 0.0 109.486 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 12.2 p90 -61.68 -26.55 68.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.891 . . . . 0.0 109.416 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.604 HD11 HD13 ' A' ' 206' ' ' LEU . 4.0 mt -55.61 -50.57 69.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.497 ' C ' HE22 ' A' ' 162' ' ' GLN . . . 87.34 -136.09 13.66 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.521 ' C ' ' NE2' ' A' ' 162' ' ' GLN . 38.3 mtp180 -98.68 140.35 33.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -1.1 . . . . 0.0 109.575 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 161' ' ' ARG . 1.7 mp0 -139.33 131.06 27.43 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.368 -0.833 . . . . 0.0 109.03 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 141.33 52.17 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.527 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 71.9 t80 -138.35 126.69 23.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.183 -0.948 . . . . 0.0 109.787 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 165' ' ' THR . 7.0 t -106.03 123.93 48.77 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -97.67 133.45 42.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.211 -0.93 . . . . 0.0 108.716 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.4 t -133.81 148.34 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.389 -0.819 . . . . 0.0 109.522 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -48.06 114.89 1.02 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.639 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 10.33 11.59 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.429 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 27.3 m-20 -136.81 26.9 3.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.988 -1.301 . . . . 0.0 108.853 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.9 mp0 -63.0 -37.82 88.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.501 -0.749 . . . . 0.0 110.768 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -58.19 -16.33 13.22 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.034 -1.041 . . . . 0.0 110.496 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -90.29 -3.67 57.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.976 -1.077 . . . . 0.0 110.917 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.7 pt -124.85 4.67 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.047 -1.033 . . . . 0.0 111.333 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.659 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.1 OUTLIER -99.27 -27.0 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.779 -1.2 . . . . 0.0 109.799 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -87.65 2.47 50.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.797 -1.189 . . . . 0.0 110.883 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.1 109.52 17.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.774 -1.204 . . . . 0.0 109.036 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.42 ' HG2' ' H ' ' A' ' 178' ' ' ARG . 2.2 ptp180 -79.69 153.52 29.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.7 t -55.83 154.49 7.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.947 . . . . 0.0 108.999 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.544 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 39.5 p90 -135.35 170.45 15.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 109.728 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.633 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -159.29 161.94 35.97 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.23 -0.919 . . . . 0.0 109.754 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.535 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 61.5 m-85 -103.79 146.46 28.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.175 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.738 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.6 OUTLIER -61.64 -21.13 64.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.047 -1.033 . . . . 0.0 110.868 -178.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.552 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 5.3 p90 -81.53 -29.6 33.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.552 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 17.1 pt-20 -92.15 -15.84 27.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.896 -1.128 . . . . 0.0 109.699 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' A' ' 183' ' ' ASP . 12.1 mt -58.76 -53.25 49.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 110.431 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -52.43 -47.58 66.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.854 -1.154 . . . . 0.0 109.579 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -58.22 -47.55 83.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.138 -0.977 . . . . 0.0 109.137 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 95.8 mt -61.96 -33.11 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 108.99 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -78.27 -31.4 49.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.824 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -74.98 -28.76 60.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.019 -1.051 . . . . 0.0 110.218 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.486 ' CG2' HD12 ' A' ' 194' ' ' LEU . 31.4 m -78.51 8.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.173 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.47 20.95 73.73 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.486 HD12 ' CG2' ' A' ' 192' ' ' VAL . 22.9 mt -119.16 157.82 27.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.221 -1.164 . . . . 0.0 109.538 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.478 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.67 24.34 62.78 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -67.71 -21.72 65.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.744 -1.445 . . . . 0.0 109.436 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.34 -6.12 48.24 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.99 126.66 42.29 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.715 -1.231 . . . . 0.0 110.044 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 203' ' ' THR . 60.6 p -140.88 160.76 39.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.678 -0.895 . . . . 0.0 109.309 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.43 -27.76 69.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 109.968 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -76.23 -15.86 59.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.008 . . . . 0.0 109.927 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 29.0 m120 -132.81 11.12 4.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.633 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 39.3 m -148.97 115.36 5.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.163 -0.961 . . . . 0.0 109.777 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.4 HD12 ' CG ' ' A' ' 213' ' ' ASN . 68.9 tp -75.5 112.19 11.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.58 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 69.2 t -103.4 128.35 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.055 -1.028 . . . . 0.0 109.223 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.604 HD13 HD11 ' A' ' 159' ' ' LEU . 92.8 mt -110.67 146.29 36.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.978 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -101.19 154.14 19.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.45 -26.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.888 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -151.01 10.8 0.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.971 -1.081 . . . . 0.0 110.325 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 32.4 mttt -141.12 148.68 40.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 0.0 110.305 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.92 123.55 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -73.53 -54.79 7.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.044 -1.035 . . . . 0.0 110.394 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.4 ' CG ' HD12 ' A' ' 204' ' ' LEU . 2.7 m120 -59.34 134.31 88.34 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.703 -1.248 . . . . 0.0 109.341 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.15 -7.32 20.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.357 2.038 . . . . 0.0 112.761 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -86.47 -7.58 58.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 0.0 110.316 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.07 -158.85 53.08 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 70.0 mt -96.4 144.13 26.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.4 -1.059 . . . . 0.0 109.949 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 -21.14 18.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.377 -0.827 . . . . 0.0 109.517 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.578 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 68.1 m-85 -140.08 129.47 24.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.895 . . . . 0.0 109.042 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -52.99 -11.02 0.2 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.968 -1.083 . . . . 0.0 108.502 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.477 ' N ' ' C ' ' A' ' 219' ' ' TYR . 5.9 m120 -133.07 35.28 3.52 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.482 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 8.7 tt0 -59.26 -55.35 47.05 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.534 -0.729 . . . . 0.0 111.579 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 19.6 Cg_endo -60.75 -42.14 41.06 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.73 1.62 . . . . 0.0 113.305 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 228' ' ' VAL . 4.5 m -76.99 -25.33 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.611 -1.306 . . . . 0.0 108.363 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.578 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 46.9 mtt180 -67.0 -43.47 82.83 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -62.28 -41.24 98.32 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.45 -46.26 80.41 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.9 t -60.76 -51.03 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.455 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 81.6 t80 -50.45 -39.85 48.99 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.886 0.85 . . . . 0.0 108.725 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.455 ' OD2' ' OE1' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -71.98 -39.66 69.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.65 -0.656 . . . . 0.0 109.681 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 149' ' ' VAL . 28.5 tp -57.9 -35.36 70.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.253 -0.905 . . . . 0.0 109.385 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.625 HG22 ' HD1' ' A' ' 80' ' ' HIS . 86.9 mt -71.12 -48.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.41 -32.1 14.5 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.8 -27.03 31.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.44 HD23 HG22 ' A' ' 260' ' ' VAL . 4.6 mt -82.94 -24.3 33.08 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.775 -1.203 . . . . 0.0 109.86 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.452 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 44.5 t80 -68.14 -8.56 39.48 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.136 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 239' ' ' GLY . 43.9 mt -52.21 -30.26 26.5 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.337 -0.852 . . . . 0.0 109.163 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 242' ' ' VAL . 97.5 mt -55.02 -7.83 0.22 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.054 -1.029 . . . . 0.0 109.169 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 71.92 14.78 75.97 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 78.7 p -158.13 144.62 12.87 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.143 -1.21 . . . . 0.0 109.402 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 77.0 Cg_exo -42.38 134.71 4.61 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.148 1.899 . . . . 0.0 111.873 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 238' ' ' LEU . 22.0 t -98.04 129.53 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.173 -0.954 . . . . 0.0 109.616 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -118.1 124.65 48.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.375 -0.828 . . . . 0.0 109.373 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.36 -178.5 31.96 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -105.08 138.12 41.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -1.077 . . . . 0.0 110.039 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.5 m-85 -140.21 143.46 36.04 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.062 0.934 . . . . 0.0 111.263 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -126.31 144.25 50.87 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.1 t -140.11 127.47 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.68 -1.263 . . . . 0.0 110.631 -178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 0.9 OUTLIER -111.71 114.2 27.06 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.46 ' CG ' ' OE1' ' A' ' 154' ' ' GLU . 2.6 mmm180 47.72 55.79 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.46 ' C ' ' HE ' ' A' ' 137' ' ' ARG . . . -77.6 140.52 24.42 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.419 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -111.05 174.19 16.66 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.571 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 15.1 m-70 -68.58 -41.97 78.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.048 -1.266 . . . . 0.0 109.659 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -55.18 25.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.977 . . . . 0.0 109.333 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' A' ' 139' ' ' ILE . 57.2 tp -51.7 -39.04 57.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.525 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.419 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 71.3 m-20 -58.71 -55.48 34.51 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.995 . . . . 0.0 109.018 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.73 -43.35 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.732 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.66 -48.7 74.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.093 -1.004 . . . . 0.0 109.052 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 139' ' ' ILE . 38.9 tp -52.81 -43.38 65.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.358 -0.839 . . . . 0.0 109.039 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.44 HG22 HD23 ' A' ' 235' ' ' LEU . 20.2 t -71.13 -45.73 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.352 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -54.14 -51.45 64.23 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.617 -0.677 . . . . 0.0 109.917 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.459 ' OE1' HD11 ' A' ' 130' ' ' ILE . 62.6 mt-10 -61.04 -51.48 69.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.941 -1.099 . . . . 0.0 109.637 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.66 -43.9 80.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.49 -33.11 73.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.327 -0.858 . . . . 0.0 110.349 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -84.36 -23.04 30.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.81 -1.181 . . . . 0.0 108.937 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -72.11 -45.4 60.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.363 -0.836 . . . . 0.0 109.642 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -89.48 10.35 23.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 110.143 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.6 -79.41 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 109.416 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 60.0 mt -85.02 -66.98 0.83 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 0.0 109.507 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.964 . . . . 0.0 109.477 179.982 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.617 ' C1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.654 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.6 mm? . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 66.4 mt-10 -48.45 141.45 6.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.072 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -120.87 138.35 54.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.414 -0.804 . . . . 0.0 109.466 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.5 t -139.54 177.89 7.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.593 -0.692 . . . . 0.0 109.495 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.78 144.7 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.887 -1.133 . . . . 0.0 110.346 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -74.78 -46.92 33.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.667 -0.645 . . . . 0.0 110.059 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.32 160.47 34.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.564 -0.71 . . . . 0.0 110.219 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -64.92 135.56 55.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -0.768 . . . . 0.0 110.104 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 113' ' ' ASN . 4.9 mt -122.29 171.38 9.08 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -158.49 150.74 21.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.011 . . . . 0.0 110.442 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -133.93 160.91 36.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.483 -0.761 . . . . 0.0 109.475 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.12 137.21 21.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.962 -1.086 . . . . 0.0 109.141 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.73 160.79 20.07 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.512 -1.328 . . . . 0.0 109.954 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.565 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.9 p -76.3 162.98 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -1.113 . . . . 0.0 111.424 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.565 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -94.76 141.4 15.53 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.989 -1.645 . . . . 0.0 108.989 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.57 ' O ' ' N ' ' A' ' 197' ' ' GLY . 3.5 tt -59.75 -48.18 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.266 -1.138 . . . . 0.0 112.937 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.48 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.5 m-70 -86.33 -36.51 19.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.013 -1.679 . . . . 0.0 112.374 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.1 m -80.41 -34.06 36.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.824 -1.172 . . . . 0.0 110.091 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 69.17 26.15 74.87 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.29 152.82 30.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.529 -0.983 . . . . 0.0 108.867 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -73.81 140.92 46.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 110.202 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 9.7 t -147.88 157.64 43.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.356 -0.84 . . . . 0.0 109.047 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.618 ' O ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -132.21 154.71 49.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.286 -0.884 . . . . 0.0 109.239 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.674 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 0.0 108.724 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.419 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.3 mt -127.95 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mt -123.91 120.88 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.419 ' NE2' HG22 ' A' ' 27' ' ' ILE . 11.5 m-70 -117.23 149.3 44.23 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 161.19 22.71 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.112 1.874 . . . . 0.0 111.258 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.6 mm-40 -134.72 -173.73 3.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.072 -1.017 . . . . 0.0 110.081 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.8 tttm -91.94 155.75 17.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.701 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -48.07 143.63 4.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.457 -0.777 . . . . 0.0 110.62 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.595 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.84 26.17 60.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.543 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.622 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 33.0 m -79.98 -34.93 38.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.709 -1.465 . . . . 0.0 108.595 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.823 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 91.88 -173.35 36.4 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mm -102.03 123.74 55.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.323 -1.104 . . . . 0.0 108.271 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -137.28 139.83 41.19 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.511 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -99.03 152.84 19.38 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.533 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.9 t80 -131.32 142.78 50.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.832 . . . . 0.0 109.02 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.542 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 14.0 tttm -172.54 138.92 0.92 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.115 -0.991 . . . . 0.0 109.407 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 55.48 29.8 13.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -0.828 . . . . 0.0 109.912 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.54 19.1 77.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.4 t -123.45 136.91 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.282 -1.128 . . . . 0.0 109.692 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -96.79 140.53 31.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.895 . . . . 0.0 109.178 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.5 mt -132.68 95.6 19.69 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.476 -0.765 . . . . 0.0 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.7 142.48 24.79 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.206 1.937 . . . . 0.0 111.607 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.35 80.67 6.12 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.961 -1.087 . . . . 0.0 110.307 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.04 153.41 51.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.926 . . . . 0.0 109.649 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' VAL . 7.7 p80 -54.68 -49.29 71.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.382 -0.824 . . . . 0.0 110.608 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' HIS . 1.4 mm-40 -44.67 -31.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.989 -1.07 . . . . 0.0 109.318 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -78.83 4.06 15.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.922 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 7.9 t -59.37 124.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.1 m -113.31 -32.0 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.412 -0.805 . . . . 0.0 109.944 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.531 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.8 t-160 -152.25 123.87 7.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.033 -1.042 . . . . 0.0 109.688 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.3 p -111.1 134.66 52.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.576 ' O ' ' N ' ' A' ' 59' ' ' SER . 20.3 p-10 -166.39 -154.44 0.18 Allowed 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.87 -10.9 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.942 -1.099 . . . . 0.0 108.479 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -138.85 166.96 23.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.42 -0.8 . . . . 0.0 109.618 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.1 m -101.99 120.56 40.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.377 -0.827 . . . . 0.0 108.885 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.531 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.05 136.93 52.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.34 -0.85 . . . . 0.0 111.199 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 53' ' ' VAL . 41.5 mt -123.39 157.67 32.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.7 143.49 6.89 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 118.484 -1.817 . . . . 0.0 111.214 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -144.29 148.99 35.54 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.747 -0.855 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm 56.62 38.33 29.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 110.783 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.55 4.4 84.66 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.8 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.542 ' OE1' ' NZ ' ' A' ' 41' ' ' LYS . 94.0 mm-40 -102.85 140.56 36.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.934 -1.333 . . . . 0.0 108.418 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -141.91 154.31 45.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.997 -1.064 . . . . 0.0 111.321 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 73.5 mt -136.47 146.25 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -115.1 154.63 28.55 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.398 -0.814 . . . . 0.0 111.113 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 m 52.38 68.85 0.76 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.734 -0.604 . . . . 0.0 111.111 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.8 -10.72 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.179 -0.95 . . . . 0.0 109.727 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 5.7 pt-20 -67.73 -16.98 64.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.179 -0.951 . . . . 0.0 110.439 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -72.45 -60.59 2.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.012 -1.055 . . . . 0.0 109.424 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 76' ' ' LEU . 5.0 tp -58.92 -41.14 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.99 -1.069 . . . . 0.0 108.945 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 79' ' ' LEU . 84.4 mt -59.78 -36.49 76.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.6 t -60.44 -48.69 80.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.044 -1.035 . . . . 0.0 108.841 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.31 -51.26 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.453 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 76' ' ' LEU . 44.0 mt -51.87 -44.91 63.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 109.193 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.513 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 8.4 t-160 -57.1 -48.46 78.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.371 -0.831 . . . . 0.0 109.89 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.5 mt -63.34 -39.73 95.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.305 -0.872 . . . . 0.0 110.414 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.824 HD13 HD11 ' A' ' 114' ' ' ILE . 53.2 mt -80.7 -5.56 57.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.053 -1.03 . . . . 0.0 110.738 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.77 54.64 2.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.896 -1.127 . . . . 0.0 110.723 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' A' ' 82' ' ' LEU . 8.0 mm -92.69 123.85 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.63 HG21 HG12 ' A' ' 121' ' ' ILE . 63.4 p -109.78 -23.8 11.21 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.274 -0.891 . . . . 0.0 111.492 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.823 HD22 ' H ' ' A' ' 36' ' ' GLY . 11.6 m120 -128.8 111.9 13.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.972 -1.08 . . . . 0.0 109.969 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -164.03 143.08 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.246 -0.909 . . . . 0.0 109.898 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.519 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.7 m -113.77 100.59 8.57 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.51 105.38 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.348 -0.845 . . . . 0.0 109.985 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -80.54 121.73 26.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.4 t -104.21 115.14 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.111 -0.993 . . . . 0.0 110.456 -178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.754 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.3 mp -97.11 109.62 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.19 -160.62 23.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.15 -12.25 11.26 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.488 -1.007 . . . . 0.0 110.071 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -142.76 147.73 36.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.984 -1.073 . . . . 0.0 110.584 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.6 mm -71.68 124.42 90.89 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.505 -0.747 . . . . 0.0 108.993 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.674 ' CD ' HD21 ' A' ' 26' ' ' LEU . 73.3 Cg_exo -44.74 131.36 10.12 Favored 'Trans proline' 0 N--CA 1.49 1.284 0 C-N-CA 122.032 1.822 . . . . 0.0 112.344 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.55 -27.85 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.418 -0.801 . . . . 0.0 109.675 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.45 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 22.8 mt 54.89 -112.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 110.274 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -94.36 -13.85 25.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.12 -0.987 . . . . 0.0 110.699 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.74 -15.35 41.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 88.5 p -113.1 -168.89 1.39 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.393 -1.063 . . . . 0.0 109.601 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.09 -1.32 23.81 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 61.9 t-105 -46.92 -44.39 19.8 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.788 -0.83 . . . . 0.0 110.573 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.09 -51.91 66.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.0 -1.062 . . . . 0.0 110.129 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 69.8 m-85 -61.33 -44.21 97.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.016 . . . . 0.0 109.057 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.499 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 5.6 t80 -67.14 -37.46 83.86 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.324 0.583 . . . . 0.0 110.491 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -69.14 -50.98 42.95 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 111.351 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.84 -44.7 61.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.867 -1.145 . . . . 0.0 110.622 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 84.5 mt -65.88 -39.89 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.017 -1.052 . . . . 0.0 110.033 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -53.75 -30.94 46.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.309 -0.869 . . . . 0.0 109.165 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -84.75 -11.5 55.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -0.964 . . . . 0.0 110.32 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.418 ' HB2' HD11 ' A' ' 11' ' ' LEU . 4.3 m-80 -119.96 29.54 7.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.238 -0.914 . . . . 0.0 111.405 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.824 HD11 HD13 ' A' ' 82' ' ' LEU . 4.4 mt -87.66 147.23 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.592 -1.317 . . . . 0.0 109.827 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.406 ' HG ' ' N ' ' A' ' 116' ' ' ASN . 52.8 tp -131.58 159.96 36.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.505 HD21 HD12 ' A' ' 3' ' ' LEU . 21.2 t30 -109.52 144.6 37.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.404 ' NE2' ' OD1' ' A' ' 86' ' ' ASN . 4.0 mt-30 -107.01 -166.15 1.14 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 41.2 p30 -118.73 72.98 0.9 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.529 -0.732 . . . . 0.0 110.187 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 4' ' ' GLU . 20.9 ttt180 -166.04 143.98 5.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.358 -0.839 . . . . 0.0 109.42 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.32 131.45 35.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.09 -1.006 . . . . 0.0 109.467 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.63 HG12 HG21 ' A' ' 85' ' ' THR . 68.8 mt -74.98 141.09 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.528 -0.732 . . . . 0.0 110.571 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -84.04 88.53 7.17 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -61.47 145.69 51.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.341 -0.849 . . . . 0.0 110.822 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -101.6 120.51 40.43 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.18 140.71 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 0.0 110.266 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 97.1 t -84.24 136.3 23.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.462 -0.774 . . . . 0.0 109.212 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -113.94 -10.26 12.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.12 146.58 40.59 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.08 178.02 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.19 1.927 . . . . 0.0 112.779 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.757 HG22 ' HB3' ' A' ' 141' ' ' ALA . 7.2 tt -165.32 147.76 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.495 -0.753 . . . . 0.0 109.799 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.515 HD11 ' HZ3' ' A' ' 140' ' ' LYS . 53.2 mt -134.91 122.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 m -124.23 116.69 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.474 -0.766 . . . . 0.0 109.336 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -104.23 155.01 19.09 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.265 -0.897 . . . . 0.0 109.896 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.513 ' HB2' HD13 ' A' ' 255' ' ' LEU . 13.3 t0 -165.52 110.98 0.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.978 -1.076 . . . . 0.0 111.499 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 41.19 51.76 3.47 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.427 -0.796 . . . . 0.0 112.46 177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.48 6.77 88.87 Favored Glycine 0 N--CA 1.496 2.693 0 O-C-N 120.645 -1.285 . . . . 0.0 110.448 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 134' ' ' ASP . 53.8 mtt85 -118.6 130.18 55.73 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 138' ' ' LEU . 3.7 tt -144.33 160.02 41.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.416 -1.428 . . . . 0.0 110.16 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.548 ' N ' HD23 ' A' ' 138' ' ' LEU . 52.5 mt -146.26 133.01 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.515 ' HZ3' HD11 ' A' ' 131' ' ' ILE . 47.9 tttp -118.96 144.86 46.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 110.168 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.757 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -118.37 147.82 43.14 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -145.05 135.03 11.7 Favored Pre-proline 0 N--CA 1.488 1.46 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.57 147.46 58.75 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.402 1.402 . . . . 0.0 112.031 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -167.21 154.76 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.232 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.557 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.6 OUTLIER -86.98 1.39 52.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.506 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 45.5 p -135.7 146.94 48.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 242' ' ' VAL . 18.2 tp -79.58 119.83 23.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 0.0 109.681 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.02 134.15 32.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.382 -0.824 . . . . 0.0 108.877 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.677 ' CG1' HD23 ' A' ' 231' ' ' LEU . 55.7 t -134.05 118.16 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.98 . . . . 0.0 109.339 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.4 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 2.0 m -107.35 135.72 48.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.094 -1.004 . . . . 0.0 109.642 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -123.6 129.15 50.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.47 -0.769 . . . . 0.0 109.827 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -113.92 109.64 18.83 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -100.3 155.96 19.5 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.556 ' OE2' ' NH2' ' A' ' 250' ' ' ARG . 0.0 OUTLIER -134.2 91.24 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.349 -1.089 . . . . 0.0 109.485 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.76 148.76 22.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.864 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.51 -10.26 35.52 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.403 -0.81 . . . . 0.0 109.788 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.6 p30 -69.65 -167.09 0.12 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.186 -0.947 . . . . 0.0 109.521 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.99 -21.44 58.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.907 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.423 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 7.7 mt -64.48 -47.61 78.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.44 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.82 -126.23 7.43 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 52.7 mtt85 -109.44 141.09 42.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.533 -0.981 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -153.9 150.4 28.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.294 -0.879 . . . . 0.0 109.713 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -136.71 151.35 49.15 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.332 -0.855 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.407 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 62.9 t80 -135.12 122.89 22.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.39 -0.819 . . . . 0.0 108.872 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.585 HG23 ' O ' ' A' ' 165' ' ' THR . 15.2 t -99.83 122.35 42.66 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -100.44 132.86 45.59 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.351 -0.843 . . . . 0.0 109.164 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -133.45 151.91 34.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.454 -0.779 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -51.67 116.4 2.1 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.348 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.61 8.32 14.37 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.404 HD22 ' CD ' ' A' ' 173' ' ' GLU . 4.8 m120 -134.04 26.24 3.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.19 -1.183 . . . . 0.0 108.312 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HG3' ' H ' ' A' ' 171' ' ' GLU . 22.0 mt-10 -64.6 -31.72 73.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.64 -0.662 . . . . 0.0 110.735 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -63.68 -15.53 58.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.275 -0.89 . . . . 0.0 111.627 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.404 ' CD ' HD22 ' A' ' 170' ' ' ASN . 80.3 mt-10 -94.34 -4.15 49.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.587 -1.321 . . . . 0.0 111.212 -178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 23.3 pt -117.11 -9.99 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.05 -1.032 . . . . 0.0 111.132 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 175' ' ' VAL . 0.9 OUTLIER -83.11 -28.11 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.548 -1.345 . . . . 0.0 110.133 -179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 2.29 47.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.896 -1.127 . . . . 0.0 110.452 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.37 110.18 17.28 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.94 -1.1 . . . . 0.0 109.001 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 154.58 20.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.085 -1.01 . . . . 0.0 110.066 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.493 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 5.0 t -52.73 156.9 1.77 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -0.799 . . . . 0.0 109.537 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.524 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 34.1 p90 -141.47 167.8 21.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.087 -1.008 . . . . 0.0 109.826 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.524 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -163.82 164.12 23.65 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.211 -0.931 . . . . 0.0 109.918 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.433 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 91.2 m-85 -103.14 144.43 31.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.354 -0.842 . . . . 0.0 109.127 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.729 ' HA ' HD12 ' A' ' 186' ' ' ILE . 28.4 p-10 -65.45 -18.75 65.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.095 -1.003 . . . . 0.0 111.386 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.506 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -77.58 -29.04 51.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.548 -1.345 . . . . 0.0 111.003 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -101.39 -11.45 19.37 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.853 -1.154 . . . . 0.0 110.15 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.7 mt -58.93 -51.21 75.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.049 -1.032 . . . . 0.0 110.371 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -51.01 -49.43 60.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.919 -1.113 . . . . 0.0 109.54 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.46 -49.39 70.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 109.005 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.507 HD12 ' HA ' ' A' ' 186' ' ' ILE . 57.0 mt -57.41 -33.81 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 108.966 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -75.18 -26.13 58.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 110.179 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 193' ' ' GLY . 0.6 OUTLIER -76.52 -33.83 58.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 110.004 -179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.1 m -74.6 10.07 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 109.037 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 191' ' ' LYS . . . 76.82 22.06 72.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 71.1 mt -118.18 155.63 30.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -1.178 . . . . 0.0 109.997 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.48 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.83 23.71 61.46 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.365 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -67.45 -22.17 65.51 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.686 -1.479 . . . . 0.0 109.618 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.83 -5.82 50.25 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 128.34 41.44 Favored Glycine 0 N--CA 1.492 2.373 0 O-C-N 120.848 -1.384 . . . . 0.0 110.106 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.2 p -136.22 -177.49 4.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.519 -0.989 . . . . 0.0 109.605 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.2 -21.97 28.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.878 . . . . 0.0 109.756 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.65 -6.26 58.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.861 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.1 m-20 -141.26 13.85 2.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.04 -1.037 . . . . 0.0 110.017 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.459 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.1 m -149.3 118.96 6.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.015 -1.053 . . . . 0.0 110.058 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 56.7 tp -78.33 111.58 14.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.897 . . . . 0.0 108.909 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 57.2 t -103.7 127.89 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.225 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.78 151.89 28.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.72 160.98 14.11 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -48.62 -28.08 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -1.232 . . . . 0.0 109.78 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -152.59 13.89 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.04 -1.038 . . . . 0.0 109.923 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 207' ' ' GLY . 73.6 tttt -141.19 149.36 41.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.021 -1.05 . . . . 0.0 110.068 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 22.2 t -99.08 125.92 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 109.038 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -72.96 -54.46 8.59 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.263 -0.898 . . . . 0.0 110.104 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.03 137.02 80.21 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 120.996 -1.065 . . . . 0.0 109.746 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.74 -13.23 26.91 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.412 2.075 . . . . 0.0 112.622 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -85.59 -7.28 58.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.145 -0.972 . . . . 0.0 110.1 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.68 -160.83 53.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 91.3 mt -81.95 145.73 30.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.991 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -88.84 -24.94 22.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 108.815 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.557 ' O ' ' N ' ' A' ' 221' ' ' ASN . 56.6 m-85 -145.99 139.37 26.09 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.75 -12.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.951 -1.093 . . . . 0.0 108.507 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.581 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.88 37.68 1.98 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.768 0.794 . . . . 0.0 109.122 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.592 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -55.75 -41.48 91.13 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.0 110.72 -179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.5 Cg_exo -69.11 -42.83 3.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.429 2.086 . . . . 0.0 112.966 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 228' ' ' VAL . 16.1 m -76.25 -24.81 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.735 -1.228 . . . . 0.0 108.691 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.471 ' NH2' ' ND2' ' A' ' 221' ' ' ASN . 38.6 mtt180 -69.03 -45.17 71.15 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.435 ' CE1' ' CA ' ' A' ' 179' ' ' THR . 37.0 t60 -59.2 -45.06 92.07 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.471 -0.768 . . . . 0.0 108.959 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -56.58 -47.81 78.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 108.989 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 224' ' ' VAL . 95.6 t -58.46 -51.18 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 88.1 t80 -50.69 -39.33 50.97 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -72.05 -40.87 68.04 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.588 -0.695 . . . . 0.0 109.855 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.677 HD23 ' CG1' ' A' ' 149' ' ' VAL . 51.8 tp -57.02 -35.01 68.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.928 . . . . 0.0 109.377 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 25.0 mt -71.62 -48.41 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.32 20.55 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.592 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.87 -28.8 29.79 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.263 -1.139 . . . . 0.0 109.854 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 260' ' ' VAL . 7.0 mt -79.75 -22.92 42.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.773 -1.204 . . . . 0.0 109.701 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.513 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 24.5 t80 -69.0 -10.0 55.26 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 237' ' ' LEU . 81.2 mt -51.44 -26.59 8.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.325 -0.859 . . . . 0.0 108.869 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.497 HD12 HG22 ' A' ' 242' ' ' VAL . 95.5 mt -59.95 -21.59 61.39 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.89 14.57 69.5 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 56.1 p -158.41 147.12 14.29 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.045 -1.268 . . . . 0.0 109.813 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 71.8 Cg_exo -42.66 130.87 5.41 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.203 1.935 . . . . 0.0 111.961 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.497 HG22 HD12 ' A' ' 238' ' ' LEU . 51.3 t -95.26 127.04 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.579 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -117.08 123.85 47.82 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.473 -0.767 . . . . 0.0 109.365 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.67 177.95 30.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.411 ' HG3' ' HZ2' ' A' ' 245' ' ' LYS . 21.5 tttp -110.35 111.17 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.242 -1.152 . . . . 0.0 110.352 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.9 m-85 -111.82 147.6 35.37 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.853 0.835 . . . . 0.0 110.695 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.4 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 29.4 t80 -128.35 143.25 50.99 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.0 t -138.13 126.18 22.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.682 -1.261 . . . . 0.0 110.219 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 250' ' ' ARG . 11.9 t80 -111.64 112.61 24.43 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.556 ' NH2' ' OE2' ' A' ' 154' ' ' GLU . 12.3 mtt180 47.39 56.67 6.67 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.47 155.14 22.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.48 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -118.24 -175.42 16.66 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.444 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 90.9 m-70 -72.28 -51.82 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.144 -1.21 . . . . 0.0 109.66 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.3 t -55.57 -34.12 64.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -0.865 . . . . 0.0 109.706 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.513 HD13 ' HB2' ' A' ' 134' ' ' ASP . 44.0 tp -72.99 -37.47 66.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 108.99 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 4.8 m120 -62.71 -49.71 74.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 0.0 108.922 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.79 -44.18 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.29 -0.881 . . . . 0.0 109.354 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -54.98 -48.53 73.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.942 -1.099 . . . . 0.0 108.844 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.82 -47.05 67.93 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.638 HG22 HD23 ' A' ' 235' ' ' LEU . 98.5 t -65.56 -50.27 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.682 0.753 . . . . 0.0 109.574 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -46.82 -50.54 18.23 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.628 -0.67 . . . . 0.0 110.417 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.91 -47.98 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.956 -1.09 . . . . 0.0 110.29 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 72.2 mt -61.76 -43.99 97.77 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 109.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.59 96.74 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.381 -0.824 . . . . 0.0 109.486 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 12.7 mtpp -68.83 -23.71 64.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.93 -1.106 . . . . 0.0 109.159 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.557 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 13.7 mttp -70.89 -49.01 50.55 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.201 -0.937 . . . . 0.0 110.089 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -95.56 1.89 54.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.025 -1.047 . . . . 0.0 111.094 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -80.07 -41.06 26.35 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.681 -1.262 . . . . 0.0 109.819 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 11.8 mt -107.02 -84.05 0.53 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.504 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.202 -0.936 . . . . 0.0 109.5 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.508 ' C2A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.605 ' O ' HD11 ' A' ' 121' ' ' ILE . 11.2 mt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 30.5 mt-10 -47.87 146.08 2.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 109.326 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -126.5 141.87 51.73 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.0 t -138.61 177.79 7.62 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.0 m -83.06 140.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.818 -1.176 . . . . 0.0 110.163 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.465 ' CG ' HD13 ' A' ' 115' ' ' LEU . 13.9 ttpt -77.05 -43.67 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.489 -0.757 . . . . 0.0 109.501 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 -126.2 153.23 44.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 109.842 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.97 139.49 58.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.404 -0.81 . . . . 0.0 110.236 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.467 HD11 HD22 ' A' ' 113' ' ' ASN . 12.6 mt -123.32 168.65 12.22 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -157.94 148.7 20.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.122 -0.986 . . . . 0.0 110.105 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -132.44 159.94 37.84 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.389 -0.82 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -147.82 135.03 20.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.964 -1.085 . . . . 0.0 108.603 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.0 157.58 15.12 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG23 ' C ' ' A' ' 22' ' ' GLU . 11.2 p -81.53 141.03 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.216 -1.167 . . . . 0.0 110.755 -178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.18 144.92 40.26 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.681 HD11 H3A3 ' A' ' 320' ' ' TUX . 3.5 tt -63.89 -46.04 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.225 -1.162 . . . . 0.0 112.627 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.498 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.6 m-70 -86.8 -40.42 14.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 119.961 -1.712 . . . . 0.0 111.46 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 m -70.27 -31.64 69.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.365 -0.834 . . . . 0.0 109.954 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.04 23.89 68.16 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.542 ' C ' HG23 ' A' ' 16' ' ' VAL . 9.7 mt-10 -116.87 152.28 34.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.467 -1.019 . . . . 0.0 109.469 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -70.69 132.72 45.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.72 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 t -140.89 158.0 44.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.0 109.252 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.721 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.9 ttpp -130.7 158.65 39.49 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.875 . . . . 0.0 109.647 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.721 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.9 mt -135.44 141.12 45.35 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 108.766 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mt -126.41 135.66 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.2 mt -118.77 112.75 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 109.945 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -111.97 154.58 44.13 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -68.67 162.2 42.08 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.372 2.048 . . . . 0.0 110.883 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.548 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.6 mm-40 -137.37 -177.4 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.016 -1.052 . . . . 0.0 110.168 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.476 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -83.13 148.79 27.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.418 -0.801 . . . . 0.0 109.236 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.648 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.84 149.77 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.283 -0.886 . . . . 0.0 109.984 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.648 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.21 21.59 53.83 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.292 178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.688 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 19.1 m -80.58 -37.35 31.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.625 -1.515 . . . . 0.0 108.803 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.539 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 94.75 -175.56 34.16 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -98.81 123.23 51.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.449 -1.03 . . . . 0.0 108.294 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -137.22 145.74 44.0 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.859 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -103.72 152.26 22.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.538 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -133.81 141.36 47.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.499 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.3 143.27 1.43 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.565 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.87 29.55 16.36 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.398 -0.814 . . . . 0.0 109.973 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.35 27.15 73.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 70.5 t -132.01 135.05 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -1.079 . . . . 0.0 109.656 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.8 140.5 32.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.274 -0.891 . . . . 0.0 109.196 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 67' ' ' GLN . 42.5 mt -135.2 95.38 14.95 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 109.882 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.18 145.41 7.81 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.018 1.812 . . . . 0.0 111.743 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.41 82.35 5.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.0 110.292 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -139.14 156.25 47.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.11 -0.994 . . . . 0.0 109.58 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.56 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 2.1 p80 -52.78 -49.64 65.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.926 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -44.79 -16.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.932 . . . . 0.0 110.174 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 25.4 m-85 -97.03 4.67 51.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.941 -1.099 . . . . 0.0 109.897 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -58.24 126.11 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.24 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.5 m -117.18 -34.08 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.374 -0.829 . . . . 0.0 110.0 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.411 ' NE2' ' HB2' ' A' ' 57' ' ' ASN . 4.8 t-160 -148.42 119.11 7.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.105 -0.997 . . . . 0.0 109.384 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -114.01 130.64 56.53 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.592 ' O ' ' N ' ' A' ' 59' ' ' SER . 66.8 t30 -166.61 -153.63 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.533 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 4.8 m-70 -46.11 -15.08 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.383 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.592 ' N ' ' O ' ' A' ' 57' ' ' ASN . 36.8 t -134.69 166.09 23.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.459 -0.776 . . . . 0.0 109.369 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m -109.85 125.04 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.369 -0.832 . . . . 0.0 109.225 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -124.2 145.98 48.99 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.958 0.885 . . . . 0.0 111.078 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 23.4 mt -127.21 159.55 33.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -178.55 148.25 8.3 Favored Glycine 0 N--CA 1.489 2.195 0 C-N-CA 118.422 -1.847 . . . . 0.0 111.572 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -144.2 149.68 36.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.157 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp 55.79 37.61 29.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.947 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.83 6.1 84.92 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.79 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.508 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 18.9 mm100 -105.4 135.08 47.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.111 -1.229 . . . . 0.0 108.018 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -142.23 159.77 41.56 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.943 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 43.7 mt -136.47 147.35 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -114.67 154.35 28.57 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.433 -0.792 . . . . 0.0 110.949 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m 52.33 69.03 0.73 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.671 -0.643 . . . . 0.0 111.005 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.14 -11.26 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.166 -0.959 . . . . 0.0 109.28 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.562 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.1 pt-20 -66.9 -21.09 66.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.902 . . . . 0.0 110.535 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -71.28 -59.85 2.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.925 -1.109 . . . . 0.0 109.74 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.5 tp -57.87 -40.65 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.958 -1.089 . . . . 0.0 108.962 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.445 ' N ' HG23 ' A' ' 75' ' ' ILE . 8.2 mt -61.55 -35.74 78.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.639 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.6 t -61.32 -48.74 79.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.032 -1.042 . . . . 0.0 109.244 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 31.9 t -58.59 -54.05 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.7 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 76' ' ' LEU . 23.6 mt -51.19 -43.44 61.35 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.536 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 13.2 t-160 -54.61 -52.32 62.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 109.784 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.53 -36.9 85.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 110.014 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.677 HD13 HD11 ' A' ' 114' ' ' ILE . 18.0 mt -78.08 -5.7 52.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.554 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 62.72 54.28 2.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.819 -1.175 . . . . 0.0 110.557 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.5 mm -96.02 126.16 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.6 p -113.19 -24.13 9.58 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.244 -0.91 . . . . 0.0 112.21 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.745 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.5 m120 -130.63 112.36 13.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.76 -1.212 . . . . 0.0 110.418 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.7 m -165.22 141.19 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.139 -0.976 . . . . 0.0 109.904 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.814 HG22 ' OE1' ' A' ' 90' ' ' GLU . 82.6 m -109.22 100.02 9.22 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.07 111.46 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 109.685 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.814 ' OE1' HG22 ' A' ' 88' ' ' THR . 0.6 OUTLIER -84.7 124.7 31.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.87 -1.144 . . . . 0.0 108.374 179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 91' ' ' VAL . 3.9 t -107.85 111.99 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.731 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.4 mp -98.13 109.06 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.88 -162.43 24.19 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.486 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -115.38 -15.42 11.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -1.014 . . . . 0.0 110.147 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -139.98 144.73 37.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.019 -1.051 . . . . 0.0 110.004 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.3 mm -69.56 127.67 92.58 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.721 . . . . 0.0 109.5 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.657 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.9 Cg_exo -45.6 128.37 10.54 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.887 1.724 . . . . 0.0 111.814 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.451 HD11 ' HA2' ' A' ' 101' ' ' GLY . 7.4 tp -79.8 -26.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.408 -0.808 . . . . 0.0 109.849 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.6 mt 55.42 -110.59 0.57 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.256 -0.903 . . . . 0.0 110.122 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -94.86 -18.74 20.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.977 -1.077 . . . . 0.0 111.081 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.451 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 111.87 -10.36 27.5 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 p -114.49 -169.67 1.58 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.429 -1.042 . . . . 0.0 109.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -3.08 21.69 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.9 t-105 -46.91 -42.04 16.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.842 -0.799 . . . . 0.0 110.649 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -61.57 -52.02 66.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.987 -1.071 . . . . 0.0 110.171 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 74.3 m-85 -62.27 -44.03 97.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.112 -0.993 . . . . 0.0 108.715 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 9.9 t80 -61.35 -39.46 90.66 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.44 0.638 . . . . 0.0 109.842 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -74.11 -46.73 40.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.465 -0.772 . . . . 0.0 111.906 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.42 -48.38 28.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.778 -1.201 . . . . 0.0 110.674 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt -65.53 -40.75 89.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 120.996 -1.065 . . . . 0.0 110.359 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 1.1 ttm-85 -54.62 -29.5 52.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -0.963 . . . . 0.0 109.978 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp -82.57 -8.88 59.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.065 -1.022 . . . . 0.0 110.249 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.467 HD22 HD11 ' A' ' 11' ' ' LEU . 47.9 m-80 -123.18 33.96 5.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.318 -0.864 . . . . 0.0 111.279 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.677 HD11 HD13 ' A' ' 82' ' ' LEU . 10.4 mt -93.46 147.83 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.723 -1.236 . . . . 0.0 110.501 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.465 HD13 ' CG ' ' A' ' 8' ' ' LYS . 14.4 tp -131.02 163.55 27.35 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 -112.97 144.03 43.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.95 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -161.45 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.394 -0.816 . . . . 0.0 109.169 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -122.77 1.03 9.35 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.255 -0.903 . . . . 0.0 110.856 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -82.66 135.46 35.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.797 -1.189 . . . . 0.0 109.849 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -74.94 124.1 26.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.216 -0.927 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.605 HD11 ' O ' ' A' ' 3' ' ' LEU . 4.2 mt -71.82 140.61 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.384 -0.822 . . . . 0.0 111.278 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -90.81 91.18 8.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -63.53 146.08 54.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 110.459 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -102.21 125.78 49.0 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.8 t -129.96 143.52 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 110.083 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 92.3 t -82.94 137.85 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -119.7 -11.3 9.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.45 140.71 23.46 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.432 -0.792 . . . . 0.0 108.868 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -72.17 149.74 52.39 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.884 1.722 . . . . 0.0 113.043 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.885 HD12 ' NZ ' ' A' ' 266' ' ' LYS . 0.9 OUTLIER -143.37 141.65 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -127.95 124.46 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 109.64 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 132' ' ' VAL . 28.7 m -120.22 115.65 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.116 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -105.42 142.5 35.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.332 -0.855 . . . . 0.0 109.225 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -164.46 123.8 1.91 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.766 -1.209 . . . . 0.0 111.944 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 48.08 41.56 15.53 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.775 -0.578 . . . . 0.0 112.319 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.48 4.23 90.46 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.045 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 27.2 mtt-85 -104.17 161.46 14.0 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.989 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.7 tt -160.33 150.44 18.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.16 -1.588 . . . . 0.0 109.052 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.989 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.3 mt -147.6 132.2 10.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.1 tttp -123.43 139.24 54.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.838 . . . . 0.0 109.797 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.545 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -119.36 148.03 43.66 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -147.11 137.77 12.65 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.65 143.1 47.86 Favored 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.4 1.4 . . . . 0.0 112.115 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.68 146.21 13.0 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.329 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -80.2 -1.69 41.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.315 -0.866 . . . . 0.0 109.528 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 p -135.72 144.7 46.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.201 -0.937 . . . . 0.0 109.394 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.4 118.74 19.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.294 -0.879 . . . . 0.0 109.694 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -136.96 138.26 40.39 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.1 t -137.83 121.69 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.013 . . . . 0.0 109.678 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.5 m -110.66 129.76 55.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.349 -0.844 . . . . 0.0 109.527 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 228' ' ' VAL . 72.7 t80 -114.77 129.92 56.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.615 -0.678 . . . . 0.0 109.517 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -117.06 112.91 21.58 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.546 ' C ' HH21 ' A' ' 250' ' ' ARG . . . -110.7 161.06 12.98 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 120.193 -1.003 . . . . 0.0 110.834 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.413 ' OE1' ' NH1' ' A' ' 250' ' ' ARG . 12.7 pt-20 -131.92 114.78 15.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.674 -0.898 . . . . 0.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.46 ' CB ' ' ND2' ' A' ' 157' ' ' ASN . 23.9 m-85 -118.77 148.49 42.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.886 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -93.03 -6.62 47.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -0.858 . . . . 0.0 109.98 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.796 HD22 ' H ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -73.45 -168.03 0.5 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.02 . . . . 0.0 109.504 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -63.84 -16.87 62.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.129 -0.982 . . . . 0.0 110.125 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.521 HD12 ' OD1' ' A' ' 157' ' ' ASN . 6.2 mt -73.85 -24.83 59.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.977 -1.077 . . . . 0.0 109.109 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 60.73 -134.53 49.58 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -110.63 151.1 28.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.967 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.462 HE22 ' CD2' ' A' ' 159' ' ' LEU . 0.1 OUTLIER -169.06 160.82 10.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.831 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.64 160.12 39.5 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 0.0 109.599 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -136.9 126.38 25.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.41 -0.806 . . . . 0.0 108.874 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 4.0 m -97.05 121.94 39.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.034 -1.041 . . . . 0.0 109.886 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -96.71 138.69 33.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.872 . . . . 0.0 108.801 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -135.47 151.8 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.391 -0.818 . . . . 0.0 109.492 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.78 120.38 7.77 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.62 -1.59 21.8 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.459 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 15.5 m-80 -131.52 31.77 4.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -1.158 . . . . 0.0 108.87 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -61.62 -34.39 75.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.562 -0.711 . . . . 0.0 110.244 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 172' ' ' GLU . 2.8 mp0 -51.68 -14.55 0.35 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.062 -1.024 . . . . 0.0 110.577 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.516 ' N ' ' CD ' ' A' ' 173' ' ' GLU . 9.9 mp0 -93.5 -3.96 51.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.971 -1.081 . . . . 0.0 111.003 -178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.466 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -121.33 7.0 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.029 -1.044 . . . . 0.0 111.286 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.39 -32.45 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 120.711 -1.243 . . . . 0.0 110.271 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.37 1.98 51.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.873 -1.142 . . . . 0.0 110.689 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.13 108.54 15.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.875 -1.141 . . . . 0.0 109.085 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -82.18 154.49 25.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.087 -1.008 . . . . 0.0 109.352 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.505 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 1.7 t -61.77 138.91 58.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -0.965 . . . . 0.0 109.74 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -117.32 173.48 6.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.482 -0.761 . . . . 0.0 110.208 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.434 ' SG ' H2A3 ' A' ' 320' ' ' TUX . 0.1 OUTLIER -161.78 159.79 27.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.384 -0.823 . . . . 0.0 109.229 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.588 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.6 m-85 -104.3 146.92 28.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.144 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.711 ' HA ' HD12 ' A' ' 186' ' ' ILE . 8.1 p30 -61.24 -17.89 55.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.238 -0.914 . . . . 0.0 111.218 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.602 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.3 p90 -80.13 -33.93 38.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.604 -1.31 . . . . 0.0 111.247 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.602 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 pt-20 -92.88 -11.97 32.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.583 -1.323 . . . . 0.0 109.786 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.711 HD12 ' HA ' ' A' ' 183' ' ' ASP . 7.2 mt -58.03 -52.29 60.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.219 -0.926 . . . . 0.0 110.135 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.23 -51.24 55.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.846 -1.159 . . . . 0.0 109.265 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -52.82 -52.17 57.99 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.181 -0.949 . . . . 0.0 108.961 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.575 HD11 ' OE1' ' A' ' 185' ' ' GLU . 96.9 mt -54.56 -33.85 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.437 -0.789 . . . . 0.0 108.882 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -77.36 -25.47 51.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.613 -0.679 . . . . 0.0 110.268 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -78.26 -29.41 48.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.022 -1.049 . . . . 0.0 110.344 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 6.4 m -82.09 12.48 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.991 -1.068 . . . . 0.0 109.397 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.91 23.95 77.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.7 mt -117.3 155.28 29.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -1.12 . . . . 0.0 109.698 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.498 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.2 28.12 56.62 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -70.74 -20.63 62.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.738 -1.448 . . . . 0.0 109.23 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.25 -4.04 50.59 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.68 127.73 37.0 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.207 -1.172 . . . . 0.0 110.655 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.413 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 77.7 p -135.51 -173.9 3.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.717 -0.872 . . . . 0.0 109.249 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 7.1 mt -82.99 -23.16 33.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.621 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -81.82 -24.36 35.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.916 . . . . 0.0 109.585 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.413 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 0.6 OUTLIER -115.23 2.88 14.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.332 -0.855 . . . . 0.0 110.157 -179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.55 124.87 13.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.912 -1.118 . . . . 0.0 109.99 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.488 HD21 HD23 ' A' ' 217' ' ' LEU . 5.2 tp -87.11 116.88 25.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 108.631 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.545 HG22 HD11 ' A' ' 186' ' ' ILE . 55.7 t -104.45 127.85 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.132 -0.98 . . . . 0.0 109.989 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.484 HD21 HD21 ' A' ' 217' ' ' LEU . 81.0 mt -105.54 151.62 24.08 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.399 -0.813 . . . . 0.0 109.511 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.86 154.04 17.04 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.437 ' CD ' ' H ' ' A' ' 208' ' ' LYS . 0.8 OUTLIER -41.91 -33.24 0.51 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -1.156 . . . . 0.0 109.829 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.19 19.02 1.4 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.051 -1.031 . . . . 0.0 110.251 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -150.32 160.16 43.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.93 -1.106 . . . . 0.0 109.927 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.0 t -105.88 130.41 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -73.27 -54.23 8.91 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.133 -0.979 . . . . 0.0 110.043 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.2 135.37 75.03 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.965 -1.085 . . . . 0.0 109.378 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.31 -8.97 23.64 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.489 2.126 . . . . 0.0 112.877 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 215' ' ' GLU . 0.0 OUTLIER -92.09 -9.33 43.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.922 -1.111 . . . . 0.0 109.97 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.64 -166.2 51.68 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.488 HD23 HD21 ' A' ' 204' ' ' LEU . 12.7 mt -85.68 147.78 26.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.436 -1.038 . . . . 0.0 110.282 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.655 ' HE ' ' CA ' ' A' ' 218' ' ' ARG . 0.0 OUTLIER -83.46 -15.75 48.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.416 -0.802 . . . . 0.0 109.15 179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.6 m-85 -149.42 151.67 34.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.036 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -63.02 -15.7 57.32 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.069 -1.019 . . . . 0.0 108.472 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.36 35.89 3.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.536 -0.728 . . . . 0.0 109.076 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -60.45 -36.0 32.15 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.499 -0.751 . . . . 0.0 111.071 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.3 Cg_exo -70.34 -48.13 0.65 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.927 1.751 . . . . 0.0 112.547 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 228' ' ' VAL . 15.4 m -73.3 -23.53 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.632 -1.292 . . . . 0.0 108.39 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -67.87 -45.03 75.68 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -59.86 -41.15 90.82 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.948 . . . . 0.0 109.249 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 224' ' ' VAL . 42.7 t -58.88 -47.22 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.573 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 92.7 t80 -53.13 -38.72 62.9 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.697 0.761 . . . . 0.0 109.151 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 24.0 m-20 -68.76 -43.84 74.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.456 -0.778 . . . . 0.0 110.202 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 10.3 tp -56.83 -39.23 73.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 0.0 109.235 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.417 HG22 ' HD1' ' A' ' 80' ' ' HIS . 77.0 mt -67.13 -34.28 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.2 -33.14 77.52 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -83.04 -26.21 31.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.297 -1.12 . . . . 0.0 110.142 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.611 HD23 HG22 ' A' ' 260' ' ' VAL . 9.2 mt -81.89 -27.33 33.48 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.833 -1.167 . . . . 0.0 109.732 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.536 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.3 t80 -66.94 -8.52 30.08 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.074 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 237' ' ' LEU . 87.7 mt -52.62 -25.67 11.35 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.404 HD12 HG22 ' A' ' 242' ' ' VAL . 96.0 mt -58.64 -23.85 59.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.894 -1.129 . . . . 0.0 108.846 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 89.18 14.64 60.15 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 68.2 p -158.51 146.28 13.6 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.939 -1.33 . . . . 0.0 109.637 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.405 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.64 131.36 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.289 1.992 . . . . 0.0 111.784 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 238' ' ' LEU . 22.0 t -98.43 134.93 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 109.457 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -124.66 128.47 48.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 109.772 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.89 178.82 30.46 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.3 tttm -107.37 111.59 24.0 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.19 -1.183 . . . . 0.0 109.954 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -112.31 148.0 35.13 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 122.021 0.915 . . . . 0.0 111.167 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -127.78 144.42 51.09 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.9 128.6 34.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.816 -1.177 . . . . 0.0 110.361 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.624 ' CE2' ' NH1' ' A' ' 250' ' ' ARG . 38.2 t80 -113.85 107.36 15.62 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.624 ' NH1' ' CE2' ' A' ' 249' ' ' PHE . 0.0 OUTLIER 45.78 57.18 5.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.9 148.54 21.69 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -116.22 171.07 13.58 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.562 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 82.7 m-70 -59.91 -46.13 90.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.119 -1.224 . . . . 0.0 109.595 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -55.34 35.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.358 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 255' ' ' LEU . 60.0 tp -51.58 -39.42 57.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.407 HD22 ' CD1' ' A' ' 139' ' ' ILE . 9.4 m120 -57.8 -55.86 29.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.169 -0.957 . . . . 0.0 108.933 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 94.4 t -49.16 -41.51 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 0.0 109.396 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.29 -50.53 69.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.024 -1.048 . . . . 0.0 109.062 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.564 HD22 HG21 ' A' ' 139' ' ' ILE . 24.8 tp -53.15 -43.13 66.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.027 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.611 HG22 HD23 ' A' ' 235' ' ' LEU . 49.1 t -70.04 -40.26 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.343 -0.848 . . . . 0.0 109.428 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -52.53 64.3 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 110.025 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -64.6 -43.14 94.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.0 109.613 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 263' ' ' LEU . 41.9 mt -60.02 -47.88 84.02 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.16 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.13 -33.17 75.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.457 -0.777 . . . . 0.0 110.24 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt -79.87 -27.61 40.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.676 -1.265 . . . . 0.0 108.95 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.885 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 15.6 mttp -72.95 -48.73 34.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.821 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -81.68 4.61 21.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.963 . . . . 0.0 109.835 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -25.81 68.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 109.418 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.0 mt -61.53 -28.25 69.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 0.0 109.568 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.512 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.681 H3A3 HD11 ' A' ' 18' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.285 0.564 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.529 ' CB ' ' OE2' ' A' ' 33' ' ' GLU . 5.4 mt-10 -54.63 145.84 18.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.293 -0.88 . . . . 0.0 109.776 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.0 139.13 54.06 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.388 0.613 . . . . 0.0 110.04 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 t -135.01 173.81 11.3 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 m -83.54 142.04 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.84 -1.162 . . . . 0.0 110.212 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' HG3' HD13 ' A' ' 115' ' ' LEU . 19.4 ttpp -77.58 -41.81 37.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.488 -0.757 . . . . 0.0 110.565 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -133.25 157.48 45.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.16 -0.962 . . . . 0.0 110.64 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -59.61 132.3 53.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.734 -0.604 . . . . 0.0 110.015 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.435 HD21 HD22 ' A' ' 113' ' ' ASN . 12.7 mt -119.37 153.56 34.97 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -150.72 147.47 27.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.911 -1.118 . . . . 0.0 110.412 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -135.65 162.49 32.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.557 -0.714 . . . . 0.0 109.76 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -145.88 139.09 26.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.914 -1.116 . . . . 0.0 109.515 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.28 159.19 19.39 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 21' ' ' GLY . 1.5 p -85.88 143.7 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.999 -1.295 . . . . 0.0 111.264 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 143.33 36.26 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.0 OUTLIER -65.6 -38.71 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -1.079 . . . . 0.0 112.666 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.436 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.4 m-70 -86.15 -36.71 19.37 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 119.892 -1.755 . . . . 0.0 112.457 -177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 m -84.65 -40.5 17.35 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.992 -1.067 . . . . 0.0 110.661 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.403 ' C ' HG23 ' A' ' 16' ' ' VAL . . . 83.87 11.32 79.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.07 152.22 20.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -73.24 143.45 47.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.199 -0.938 . . . . 0.0 109.914 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 t -146.0 157.55 43.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.377 -0.827 . . . . 0.0 108.826 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.527 ' C ' HD23 ' A' ' 26' ' ' LEU . 14.0 tttt -136.62 146.61 46.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 109.201 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.574 HD11 ' HD2' ' A' ' 97' ' ' PRO . 1.5 mt -121.56 148.64 44.24 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.147 -0.971 . . . . 0.0 109.034 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -135.6 126.05 43.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 28' ' ' ILE . 6.4 mt -111.65 125.15 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.08 -1.013 . . . . 0.0 109.938 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.539 ' NE2' HG22 ' A' ' 27' ' ' ILE . 15.8 m-70 -120.63 149.93 51.33 Favored Pre-proline 0 N--CA 1.49 1.538 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -59.87 159.88 23.64 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.043 1.829 . . . . 0.0 110.86 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 26.4 mm-40 -134.63 179.25 6.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.058 -1.027 . . . . 0.0 110.081 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.39 148.16 32.1 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.476 -0.765 . . . . 0.0 109.227 179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' OE2' ' CB ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -47.78 147.0 2.08 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.289 -0.882 . . . . 0.0 110.269 -179.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.487 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 58.94 25.04 58.89 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 120.455 -0.879 . . . . 0.0 111.103 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 17.3 m -80.46 -37.82 31.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.761 -1.435 . . . . 0.0 108.875 179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.4 -177.76 32.37 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.5 mm -97.44 124.74 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -140.31 139.43 35.45 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 118.798 -1.161 . . . . 0.0 111.008 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -97.78 153.71 18.09 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.541 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.6 t80 -132.28 141.22 48.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -0.947 . . . . 0.0 109.204 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -170.96 140.91 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.207 -0.933 . . . . 0.0 109.57 -179.709 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 58.62 28.42 17.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.406 -0.809 . . . . 0.0 109.706 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.14 30.64 69.55 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 87.7 t -135.53 132.19 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -1.212 . . . . 0.0 109.967 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -90.06 141.28 28.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 108.942 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 67' ' ' GLN . 10.6 mt -137.77 96.98 10.32 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.248 -0.907 . . . . 0.0 110.355 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.75 144.93 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.182 1.921 . . . . 0.0 111.711 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.68 84.82 4.32 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 0.0 110.089 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.7 mtp180 -139.65 156.9 46.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 3.5 p80 -53.38 -49.74 66.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.309 -0.869 . . . . 0.0 110.263 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 2.2 mm-40 -47.54 -16.19 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.104 -0.998 . . . . 0.0 110.353 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 50' ' ' HIS . 22.0 m-85 -97.0 7.07 47.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.918 -1.114 . . . . 0.0 109.556 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.27 127.1 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 0.0 109.06 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -112.57 -34.44 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.468 -0.77 . . . . 0.0 109.945 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.616 ' CE1' ' ND2' ' A' ' 57' ' ' ASN . 3.1 t-160 -149.54 122.37 8.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.5 p -112.35 130.93 55.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.616 ' ND2' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -166.84 -153.95 0.16 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 57' ' ' ASN . 36.1 m-70 -46.59 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.071 -1.018 . . . . 0.0 108.763 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.597 ' N ' ' O ' ' A' ' 57' ' ' ASN . 11.7 t -137.79 165.51 26.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.394 -0.816 . . . . 0.0 109.49 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 56.2 m -102.64 120.33 40.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 108.826 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.1 OUTLIER -117.76 136.44 53.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.35 -0.844 . . . . 0.0 110.923 -179.048 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -126.07 159.38 32.97 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 177.7 150.92 8.84 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.158 -1.972 . . . . 0.0 111.611 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -144.6 152.55 40.67 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.82 -0.812 . . . . 0.0 109.486 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.5 24.01 11.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.598 -0.689 . . . . 0.0 110.842 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.39 4.69 76.74 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.697 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.498 ' HB2' HD11 ' A' ' 46' ' ' ILE . 9.0 mm100 -108.59 137.37 46.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.162 -1.199 . . . . 0.0 108.21 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -142.79 164.29 30.51 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.853 -178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 91' ' ' VAL . 44.4 mt -135.08 149.21 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtmt -114.18 149.78 35.21 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.288 -0.883 . . . . 0.0 110.896 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 54.41 66.95 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.714 -0.616 . . . . 0.0 110.866 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.74 -1.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.183 -0.948 . . . . 0.0 109.179 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 8.5 pt-20 -71.1 -30.85 67.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -0.869 . . . . 0.0 110.048 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 32.5 m170 -64.49 -59.44 4.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.073 -1.017 . . . . 0.0 109.719 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.0 tp -56.87 -45.99 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.733 -1.229 . . . . 0.0 108.733 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.503 ' N ' HG23 ' A' ' 75' ' ' ILE . 42.2 mt -55.28 -41.07 71.79 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.182 -0.949 . . . . 0.0 109.459 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.7 t -56.96 -45.53 82.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.935 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.38 -53.41 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.975 . . . . 0.0 108.723 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -50.86 -44.66 59.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.427 -0.796 . . . . 0.0 108.977 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.694 ' HD1' HG22 ' A' ' 232' ' ' ILE . 14.7 t-160 -55.65 -47.82 76.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.453 -0.779 . . . . 0.0 110.018 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.5 mt -66.54 -37.68 85.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 0.0 110.158 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 114' ' ' ILE . 65.4 mt -81.23 -7.61 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.072 -1.017 . . . . 0.0 110.827 -178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 63.37 63.32 0.9 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.724 -1.235 . . . . 0.0 110.134 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 82' ' ' LEU . 8.8 mm -104.94 130.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 121' ' ' ILE . 23.6 p -117.43 -18.86 9.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.338 -0.852 . . . . 0.0 111.731 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.729 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.3 m-80 -133.65 111.39 10.57 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.639 -1.288 . . . . 0.0 110.233 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.3 m -165.1 141.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 109.586 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.491 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 95.6 m -110.8 100.6 9.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.495 -0.753 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.1 mt -89.7 104.42 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.401 -0.812 . . . . 0.0 109.682 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -82.31 119.44 24.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.865 -1.147 . . . . 0.0 108.658 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.509 HG13 HD22 ' A' ' 26' ' ' LEU . 2.8 t -102.95 108.26 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 111.087 -178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -88.52 108.13 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.31 -160.02 23.28 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.4 -15.25 7.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.56 -0.965 . . . . 0.0 110.21 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.599 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -135.61 142.27 45.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.147 -0.971 . . . . 0.0 110.44 -179.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -68.6 139.53 91.55 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.574 ' HD2' HD11 ' A' ' 26' ' ' LEU . 11.4 Cg_endo -57.76 130.16 37.18 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.843 1.695 . . . . 0.0 111.514 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -78.64 -30.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.52 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 8.0 mt 52.8 -109.78 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.374 -0.829 . . . . 0.0 110.032 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -95.02 -18.59 20.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.259 -0.901 . . . . 0.0 110.573 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.73 -10.22 32.43 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.7 p -113.88 -172.09 2.02 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.383 -1.069 . . . . 0.0 109.869 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.48 -3.26 20.84 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -46.71 -39.99 12.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.624 -0.927 . . . . 0.0 110.8 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -63.53 -51.73 64.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.828 -1.17 . . . . 0.0 109.95 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -61.9 -45.04 95.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.917 -1.114 . . . . 0.0 108.392 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -60.88 -39.46 89.33 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.332 0.587 . . . . 0.0 110.44 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -71.11 -45.16 64.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.845 . . . . 0.0 111.494 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.24 15.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.858 -1.151 . . . . 0.0 110.551 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.16 -42.84 88.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.104 -0.997 . . . . 0.0 110.233 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -54.29 -29.57 47.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.319 -0.863 . . . . 0.0 109.816 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.6 ttpt -85.96 -11.53 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.435 HD22 HD21 ' A' ' 11' ' ' LEU . 1.9 m-20 -119.78 29.31 7.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.233 -0.917 . . . . 0.0 111.458 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.594 HD11 HD13 ' A' ' 82' ' ' LEU . 4.7 mt -84.4 148.02 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.379 -1.451 . . . . 0.0 110.348 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 8' ' ' LYS . 13.0 tp -130.84 158.13 41.02 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -101.06 146.51 27.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.898 -1.127 . . . . 0.0 110.044 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.679 HE22 HD22 ' A' ' 86' ' ' ASN . 1.1 mt-30 -109.44 -169.06 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.436 -0.79 . . . . 0.0 109.669 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -120.09 66.98 0.82 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.479 -0.763 . . . . 0.0 110.575 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -169.37 151.04 4.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.275 -0.891 . . . . 0.0 109.259 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -87.42 134.11 33.64 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.03 -1.044 . . . . 0.0 110.295 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 85' ' ' THR . 62.6 mt -69.87 135.55 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.576 -0.703 . . . . 0.0 110.863 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -78.26 80.95 4.65 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -58.22 141.36 50.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.589 -0.694 . . . . 0.0 110.759 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -98.39 120.45 38.82 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 243' ' ' LYS . 48.7 t -122.36 138.18 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.438 -0.789 . . . . 0.0 109.823 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.8 t -83.25 136.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -114.49 -10.07 12.62 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -142.82 145.91 35.6 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.427 -0.796 . . . . 0.0 108.92 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.12 177.24 7.42 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.11 1.873 . . . . 0.0 112.805 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.96 HG22 ' HB3' ' A' ' 141' ' ' ALA . 14.7 tt -165.6 144.61 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-O 121.457 0.646 . . . . 0.0 109.624 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.3 mp -132.73 118.9 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.894 . . . . 0.0 109.192 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 132' ' ' VAL . 34.4 m -117.53 113.29 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 0.0 109.375 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.429 ' OE2' ' N ' ' A' ' 134' ' ' ASP . 1.2 tm-20 -115.56 127.2 55.09 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.355 -0.841 . . . . 0.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.429 ' N ' ' OE2' ' A' ' 133' ' ' GLU . 1.8 t70 -174.74 158.11 2.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.166 -0.959 . . . . 0.0 110.234 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 59.09 19.5 7.39 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 0.0 110.206 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.86 2.66 86.72 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.416 ' HB2' HD22 ' A' ' 255' ' ' LEU . 7.8 mtt180 -104.01 173.7 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.8 tt -160.09 148.07 16.76 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.487 -1.383 . . . . 0.0 109.037 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.854 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.8 mt -146.19 141.48 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.041 -1.037 . . . . 0.0 108.639 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.4 tttt -130.35 139.13 50.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.96 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.48 145.59 47.11 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -142.19 138.57 16.83 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.14 147.7 63.74 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.471 1.447 . . . . 0.0 112.119 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -169.05 158.49 8.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.03 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -93.5 4.13 54.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.192 -0.942 . . . . 0.0 109.899 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.6 p -137.08 147.34 46.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.08 -1.013 . . . . 0.0 109.784 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 27.9 tp -77.37 116.03 17.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.427 -0.796 . . . . 0.0 109.848 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -139.36 135.18 33.44 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.567 HG22 ' HB2' ' A' ' 246' ' ' PHE . 13.8 t -137.33 127.85 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.136 -0.977 . . . . 0.0 110.05 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 31.7 m -112.28 132.05 55.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.368 -0.833 . . . . 0.0 109.294 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.448 ' CB ' HG22 ' A' ' 228' ' ' VAL . 81.3 t80 -119.83 129.47 54.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.48 ' OE1' ' O ' ' A' ' 162' ' ' GLN . 6.4 tp10 -114.72 104.61 12.14 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.0 155.38 21.48 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.604 ' CD ' HH21 ' A' ' 250' ' ' ARG . 12.9 tt0 -134.11 88.04 2.42 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.423 -1.045 . . . . 0.0 109.24 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -90.82 148.72 22.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -92.44 -6.92 48.97 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.274 -0.891 . . . . 0.0 109.86 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 159' ' ' LEU . 10.9 p30 -73.9 -168.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.748 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.2 p90 -56.02 -17.53 7.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.324 -0.86 . . . . 0.0 109.754 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.518 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 14.0 mt -65.98 -51.17 60.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.199 -0.938 . . . . 0.0 109.402 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.06 -113.48 3.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.2 mtm-85 -125.46 140.51 52.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.518 -0.989 . . . . 0.0 109.442 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.48 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 8.8 tt0 -157.02 148.91 22.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.442 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -130.79 152.44 50.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.504 -0.747 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -135.46 123.92 23.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 0.0 108.891 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 165' ' ' THR . 9.9 t -99.53 122.21 42.27 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.1 -1.0 . . . . 0.0 110.097 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.3 t80 -99.85 135.99 40.45 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.382 -0.824 . . . . 0.0 108.897 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.484 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.6 t -133.36 150.28 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.437 -0.79 . . . . 0.0 109.155 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -53.46 122.81 10.45 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.77 -12.68 17.84 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -121.38 33.01 5.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.168 -1.195 . . . . 0.0 108.726 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -62.82 -35.95 81.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.581 -0.699 . . . . 0.0 110.886 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.38 -15.7 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.028 -1.045 . . . . 0.0 110.829 -178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.73 -3.56 58.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.985 -1.072 . . . . 0.0 110.939 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.9 pt -124.29 0.85 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.068 -1.02 . . . . 0.0 111.547 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.83 -29.87 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.601 -1.312 . . . . 0.0 110.244 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.6 mt -87.01 1.95 51.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.782 -1.199 . . . . 0.0 110.882 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.38 120.0 23.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.777 -1.202 . . . . 0.0 109.013 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.07 153.37 19.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.164 -0.96 . . . . 0.0 110.066 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.41 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.0 t -55.7 154.99 6.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.52 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 47.5 p90 -135.68 167.09 21.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.022 -1.049 . . . . 0.0 109.671 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.52 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 2.7 m -153.69 160.65 42.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.172 -0.955 . . . . 0.0 109.685 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.421 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 78.5 m-85 -102.84 143.41 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 0.0 109.213 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.612 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.8 OUTLIER -60.46 -26.07 66.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.502 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 4.7 p90 -79.01 -25.25 43.32 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.694 -1.254 . . . . 0.0 110.632 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 11.8 pt-20 -98.88 -13.8 19.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.879 -1.138 . . . . 0.0 109.575 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.5 mt -58.51 -52.99 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.154 -0.966 . . . . 0.0 110.063 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -52.19 -48.56 64.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.882 -1.136 . . . . 0.0 109.097 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -54.34 -52.1 62.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.967 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 91.2 mt -57.96 -34.48 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.825 . . . . 0.0 109.237 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.21 -25.71 51.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 0.0 110.068 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -74.96 -31.6 61.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.101 -1.0 . . . . 0.0 109.867 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.422 ' CG2' HD12 ' A' ' 194' ' ' LEU . 6.8 m -81.0 12.86 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.17 -0.956 . . . . 0.0 109.347 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.48 24.12 76.79 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.128 -1.034 . . . . 0.0 110.625 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 192' ' ' VAL . 19.2 mt -121.21 159.08 26.64 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.15 -1.206 . . . . 0.0 109.993 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.436 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 74.18 22.22 78.01 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.22 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -63.38 -53.73 47.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.33 -1.688 . . . . 0.0 109.357 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -69.9 -2.6 39.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.09 134.06 39.91 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.849 -1.383 . . . . 0.0 110.484 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 203' ' ' THR . 68.0 p -141.86 177.72 7.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.493 -1.004 . . . . 0.0 109.319 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 200' ' ' LEU . 95.5 mt -74.6 -39.3 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -0.938 . . . . 0.0 109.91 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -66.25 -14.46 61.98 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 110.222 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -131.44 9.14 4.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.433 ' CB ' ' O ' ' A' ' 199' ' ' SER . 0.5 OUTLIER -147.96 113.8 5.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.954 -1.091 . . . . 0.0 109.834 -179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.42 116.06 15.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.305 -0.872 . . . . 0.0 108.934 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 75.9 t -106.8 127.1 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.088 -1.008 . . . . 0.0 109.857 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 26.4 mt -110.71 149.91 29.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.426 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.14 152.21 17.06 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 207' ' ' GLY . 35.6 tttm -41.07 -37.03 0.78 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -1.113 . . . . 0.0 110.03 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -141.88 11.56 2.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.935 -1.103 . . . . 0.0 110.084 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 207' ' ' GLY . 3.4 pttp -142.59 151.43 41.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.019 . . . . 0.0 109.738 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.503 HG11 ' HA2' ' A' ' 216' ' ' GLY . 60.9 t -102.56 127.93 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.43 -0.794 . . . . 0.0 109.259 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -73.0 -53.16 11.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.07 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.52 139.68 74.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.996 -1.065 . . . . 0.0 109.658 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.68 -33.96 9.72 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.522 2.148 . . . . 0.0 112.72 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -76.24 -9.1 58.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.046 -1.034 . . . . 0.0 110.28 -179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.503 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 69.6 -164.22 51.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.9 mt -72.82 140.38 47.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.35 -1.088 . . . . 0.0 109.833 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -84.59 -14.59 48.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 0.0 109.169 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.636 ' CD1' ' NH1' ' A' ' 225' ' ' ARG . 66.0 m-85 -146.09 133.83 21.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.404 -0.81 . . . . 0.0 108.875 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.436 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 1.3 mt-10 -48.03 -12.86 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.96 -1.088 . . . . 0.0 108.501 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.571 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -137.19 39.33 2.51 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.483 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.9 OUTLIER -62.76 -39.58 55.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.516 -0.74 . . . . 0.0 111.935 -179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.0 Cg_endo -74.17 -40.37 1.29 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 120.997 1.132 . . . . 0.0 112.651 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.631 ' O ' HG23 ' A' ' 228' ' ' VAL . 11.2 m -76.68 -24.8 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.716 -1.24 . . . . 0.0 108.463 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.636 ' NH1' ' CD1' ' A' ' 219' ' ' TYR . 36.4 mtt180 -67.4 -47.44 70.28 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.53 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 44.1 t60 -59.77 -40.67 88.99 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.79 -46.13 90.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 109.07 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 224' ' ' VAL . 46.4 t -62.19 -42.23 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.335 -0.853 . . . . 0.0 108.756 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.464 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 59.9 t80 -55.36 -47.32 75.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.67 -0.644 . . . . 0.0 109.433 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.592 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 12.2 m-20 -72.05 -34.56 68.86 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.283 -0.886 . . . . 0.0 109.638 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.406 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.1 tp -56.27 -36.17 68.29 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.707 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.694 HG22 ' HD1' ' A' ' 80' ' ' HIS . 89.7 mt -72.47 -48.75 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.26 -31.77 9.11 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.586 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.3 OUTLIER -82.64 -29.36 30.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.105 -1.232 . . . . 0.0 109.769 179.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.39 -22.84 40.9 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.852 -1.155 . . . . 0.0 109.187 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.403 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 43.0 t80 -70.74 -8.77 54.66 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 108.752 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 237' ' ' LEU . 17.2 mt -50.18 -28.18 7.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.589 HD12 HG22 ' A' ' 242' ' ' VAL . 84.9 mt -54.16 -15.82 1.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.2 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 78.61 13.53 83.08 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 57.0 p -158.73 146.05 13.22 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.211 -1.17 . . . . 0.0 109.309 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 65.0 Cg_exo -43.19 130.22 6.21 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.066 1.844 . . . . 0.0 111.78 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 238' ' ' LEU . 3.8 t -97.49 132.13 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 109.629 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.545 ' HB2' HG22 ' A' ' 125' ' ' VAL . 2.7 mmtt -117.98 123.7 46.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.442 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.49 172.66 25.91 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -104.38 114.38 28.58 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.122 -1.222 . . . . 0.0 109.696 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.567 ' HB2' HG22 ' A' ' 149' ' ' VAL . 8.6 m-85 -112.68 148.65 34.22 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.14 0.971 . . . . 0.0 111.486 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -130.42 144.22 51.26 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.0 t -142.34 129.58 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.656 -1.278 . . . . 0.0 111.077 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -112.18 114.81 27.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.604 HH21 ' CD ' ' A' ' 154' ' ' GLU . 18.2 mtt180 50.42 53.87 12.15 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -75.82 136.85 20.61 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.408 ' HA3' ' NH1' ' A' ' 137' ' ' ARG . . . -111.59 155.48 16.14 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.505 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 62.7 m-70 -52.94 -47.18 68.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.135 -1.215 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.5 t -58.23 -55.34 36.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.056 -1.027 . . . . 0.0 108.869 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.456 ' HG ' HD12 ' A' ' 139' ' ' ILE . 53.6 tp -53.91 -37.12 63.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.401 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -61.15 -54.35 45.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 108.973 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 19.5 t -50.97 -42.67 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.907 . . . . 0.0 109.563 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -55.83 -49.7 72.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.162 -0.961 . . . . 0.0 109.048 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.537 HD22 HG21 ' A' ' 139' ' ' ILE . 19.1 tp -52.14 -42.13 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.315 -0.866 . . . . 0.0 108.678 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 5.9 t -70.62 -46.24 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.283 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.13 -51.52 61.66 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.483 -0.76 . . . . 0.0 109.846 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.48 -53.64 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 0.0 110.13 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.433 HD11 HD11 ' A' ' 259' ' ' LEU . 90.3 mt -55.53 -42.18 74.21 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 109.065 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.29 -38.41 90.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.523 -0.736 . . . . 0.0 109.719 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -75.81 -30.16 58.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.024 . . . . 0.0 109.11 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -62.81 -45.66 91.61 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.279 -0.888 . . . . 0.0 109.877 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -89.29 9.63 25.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.008 . . . . 0.0 110.4 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -94.32 -22.05 18.6 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.841 -1.162 . . . . 0.0 109.89 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.55 -58.17 9.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 109.465 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.137 -0.977 . . . . 0.0 109.535 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.438 HOH1 ' CE1' ' A' ' 253' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' O ' HD11 ' A' ' 121' ' ' ILE . 45.4 mt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 63.5 mt-10 -45.38 145.52 1.17 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 0.0 109.213 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.08 139.37 53.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 0.0 110.285 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -138.2 175.27 9.73 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.42 HG22 ' H ' ' A' ' 7' ' ' VAL . 10.4 m -86.51 141.35 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.354 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -73.87 -46.12 46.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.574 -0.704 . . . . 0.0 109.781 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -126.88 153.76 45.3 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.41 -0.806 . . . . 0.0 110.43 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.08 138.76 58.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 110.201 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.62 167.71 12.14 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.4 p -156.76 149.34 23.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.995 -1.066 . . . . 0.0 110.338 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -135.01 155.98 49.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 109.61 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.57 135.48 26.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 108.759 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.79 156.16 13.0 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.122 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -71.29 163.63 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.29 -1.124 . . . . 0.0 111.029 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -93.64 136.98 13.35 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.646 HG23 ' N ' ' A' ' 19' ' ' HIS . 16.0 tt -56.21 -52.57 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.137 -1.214 . . . . 0.0 111.751 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.646 ' N ' HG23 ' A' ' 18' ' ' ILE . 24.8 m-70 -87.08 -38.56 16.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.172 -1.58 . . . . 0.0 110.66 -179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.6 m -73.9 -35.38 64.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.952 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.07 64.79 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -107.53 148.55 29.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.58 -0.953 . . . . 0.0 108.967 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 8.1 t80 -70.83 125.78 27.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.973 . . . . 0.0 109.759 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.6 t -135.12 156.41 49.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.126 -0.984 . . . . 0.0 109.118 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.515 ' O ' HD23 ' A' ' 26' ' ' LEU . 18.1 tttp -134.81 150.69 50.54 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.25 -0.906 . . . . 0.0 109.138 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.709 HD21 ' CD ' ' A' ' 97' ' ' PRO . 1.7 mt -127.52 148.45 50.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 0.0 109.622 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 mt -132.04 131.84 61.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.3 mt -115.83 126.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -120.56 155.06 57.06 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.585 -0.697 . . . . 0.0 109.286 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -68.53 160.67 48.32 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.347 2.031 . . . . 0.0 110.861 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 20.4 mm-40 -135.83 -174.83 3.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.12 -0.987 . . . . 0.0 110.104 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.472 ' O ' ' OG1' ' A' ' 35' ' ' THR . 11.0 tptt -86.03 153.3 22.23 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.398 -0.814 . . . . 0.0 109.287 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.619 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 2.3 mp0 -46.81 145.07 2.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.176 -0.953 . . . . 0.0 110.091 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.609 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.36 26.1 61.32 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.826 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 39.6 m -78.7 -36.94 42.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.562 -1.552 . . . . 0.0 109.134 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.783 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 94.05 -175.56 35.19 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.7 mm -99.52 121.9 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.297 -1.119 . . . . 0.0 108.277 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -136.33 143.9 44.36 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.126 -1.029 . . . . 0.0 110.975 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -102.89 151.13 22.81 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -130.26 142.66 50.54 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' A' ' 42' ' ' ASN . 0.0 OUTLIER -174.59 138.22 0.51 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 -178.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.403 ' N ' ' HD3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER 57.12 31.59 20.25 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.374 -0.829 . . . . 0.0 110.616 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.77 26.51 74.33 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.624 -1.298 . . . . 0.0 110.034 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.4 t -134.13 139.41 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.155 . . . . 0.0 109.529 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 41.9 m-85 -102.18 138.06 39.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.171 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.57 97.94 18.71 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.418 -0.801 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.74 142.75 18.17 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.22 1.947 . . . . 0.0 111.718 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.02 82.48 6.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.984 -1.073 . . . . 0.0 110.172 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.7 mtt180 -139.45 156.03 47.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 0.0 109.583 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 3.2 p80 -53.45 -49.5 67.28 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.863 . . . . 0.0 110.064 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 19.5 mt-10 -44.06 -16.58 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.072 -1.018 . . . . 0.0 109.995 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 50' ' ' HIS . 96.6 m-85 -98.56 4.21 48.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.058 -1.026 . . . . 0.0 109.994 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 t -60.73 121.02 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 108.477 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.96 -25.36 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.303 -0.873 . . . . 0.0 110.408 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -151.13 118.54 6.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.884 -1.135 . . . . 0.0 109.793 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.7 p -112.29 131.13 55.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 10.5 t-20 -166.36 -154.28 0.18 Allowed 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.47 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 1.6 m-70 -47.96 -12.59 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.89 -1.131 . . . . 0.0 108.372 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER -136.84 166.0 24.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.587 -0.696 . . . . 0.0 109.238 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 22.0 m -108.84 125.1 51.61 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.335 -0.853 . . . . 0.0 109.132 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.87 143.72 50.18 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.993 0.901 . . . . 0.0 111.25 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.3 mt -124.29 160.52 27.83 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.85 147.93 7.66 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.343 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -145.01 151.68 38.95 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.751 -0.852 . . . . 0.0 109.488 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt 57.12 25.36 10.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.289 -0.882 . . . . 0.0 111.196 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.49 1.95 77.18 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.567 -1.301 . . . . 0.0 110.631 178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.471 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.2 mm100 -102.41 142.81 33.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.993 -1.298 . . . . 0.0 107.999 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -145.83 157.23 43.93 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 118.629 -1.228 . . . . 0.0 111.842 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 69' ' ' ILE . 3.8 mt -133.27 144.5 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 9.1 mttm -110.71 155.03 23.03 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.295 -0.878 . . . . 0.0 111.317 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 47.38 72.86 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.765 -0.584 . . . . 0.0 111.169 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 m -113.02 -11.59 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.173 -0.954 . . . . 0.0 109.566 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -63.68 -18.53 64.08 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.193 -0.942 . . . . 0.0 110.604 -179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.595 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 25.6 m170 -71.85 -60.65 2.12 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.892 -1.13 . . . . 0.0 109.413 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 4.0 tp -60.41 -44.05 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.079 -1.013 . . . . 0.0 109.138 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.519 ' N ' HG23 ' A' ' 75' ' ' ILE . 12.0 mt -56.2 -38.22 70.7 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 109.322 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.551 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 27.3 t -60.68 -48.58 81.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.614 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.5 t -57.64 -52.99 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.972 -1.08 . . . . 0.0 108.688 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.5 mt -50.68 -43.79 57.63 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.321 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.49 ' HD1' HG22 ' A' ' 232' ' ' ILE . 7.9 t-160 -55.1 -51.33 66.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.239 -0.913 . . . . 0.0 110.223 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.8 mt -68.36 -37.27 80.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.287 -0.883 . . . . 0.0 110.329 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.593 HD22 HD11 ' A' ' 114' ' ' ILE . 14.8 mt -76.08 -5.58 47.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.061 -1.024 . . . . 0.0 110.131 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.79 50.99 3.15 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.041 -1.037 . . . . 0.0 110.43 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.526 HD11 ' HB3' ' A' ' 82' ' ' LEU . 14.6 mm -97.59 122.14 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 108.501 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.624 HG21 HG23 ' A' ' 121' ' ' ILE . 71.7 p -110.78 -22.01 11.78 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.27 -0.894 . . . . 0.0 112.594 -177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.783 ' ND2' ' H ' ' A' ' 36' ' ' GLY . 9.9 m120 -129.91 112.17 13.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.709 -1.244 . . . . 0.0 110.516 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.6 m -164.75 141.78 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.411 -0.806 . . . . 0.0 109.687 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 8.1 m -110.23 100.69 9.53 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 mp -87.69 108.87 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.441 -0.787 . . . . 0.0 109.889 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -88.18 116.48 26.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG13 HD22 ' A' ' 26' ' ' LEU . 61.9 t -106.28 117.63 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 110.856 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.09 112.36 28.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.93 -162.05 24.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.48 -17.64 8.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.993 . . . . 0.0 110.227 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.592 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 1.5 tp10 -132.64 141.0 48.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.829 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.592 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.2 mm -67.37 125.71 91.5 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.609 -0.682 . . . . 0.0 109.34 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.709 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.4 Cg_exo -45.86 131.28 13.39 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.921 1.747 . . . . 0.0 111.887 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.1 tp -76.46 -29.62 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 110.431 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.7 mt 54.89 -113.73 0.81 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 109.438 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.61 -15.86 23.67 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 0.0 110.32 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.75 -12.97 46.35 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.6 p -112.3 -169.18 1.42 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.479 -1.012 . . . . 0.0 109.493 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.6 -3.09 25.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -47.44 -41.91 21.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.833 -0.804 . . . . 0.0 110.409 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.96 -52.37 63.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.992 -1.068 . . . . 0.0 110.233 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.645 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 87.4 m-85 -61.81 -44.29 97.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.818 -1.176 . . . . 0.0 108.765 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -62.06 -38.91 90.58 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.311 0.576 . . . . 0.0 109.941 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.15 -44.94 51.68 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.287 -0.883 . . . . 0.0 111.828 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.25 -47.61 23.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.705 -1.247 . . . . 0.0 110.998 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.0 mt -68.03 -40.16 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.963 -1.086 . . . . 0.0 110.636 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttt85 -57.38 -30.03 64.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.103 -0.998 . . . . 0.0 109.877 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.413 ' O ' ' CG ' ' A' ' 112' ' ' LYS . 24.0 tttm -80.65 -8.21 59.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.126 -0.984 . . . . 0.0 109.623 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -123.74 35.03 4.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.47 -0.769 . . . . 0.0 110.987 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.593 HD11 HD22 ' A' ' 82' ' ' LEU . 17.8 mt -90.79 147.03 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.8 -1.187 . . . . 0.0 110.643 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 115' ' ' LEU . 14.2 tp -131.26 159.61 37.32 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -109.79 146.43 35.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.552 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -108.93 -162.65 0.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.528 -0.733 . . . . 0.0 109.26 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 -1.22 11.09 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.5 ttt180 -85.37 138.71 32.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.86 -1.15 . . . . 0.0 109.725 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -78.1 128.03 33.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.272 -0.892 . . . . 0.0 109.537 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.624 HG23 HG21 ' A' ' 85' ' ' THR . 0.8 OUTLIER -70.92 139.28 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.425 -0.797 . . . . 0.0 111.124 -178.625 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -94.38 98.48 10.92 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -69.74 147.05 51.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.0 110.663 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -97.33 121.46 39.25 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.02 139.36 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 110.339 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.4 t -83.17 135.82 24.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -113.12 -10.78 13.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 0.0 109.242 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -143.66 146.05 33.63 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.097 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.2 172.74 14.21 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.087 1.858 . . . . 0.0 113.135 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.589 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.3 tt -164.27 140.89 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.09 126.98 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.288 -0.883 . . . . 0.0 109.881 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -122.28 114.46 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.512 -0.742 . . . . 0.0 109.282 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -114.14 134.25 55.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.387 -0.821 . . . . 0.0 109.713 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -174.35 150.88 1.51 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.084 -1.01 . . . . 0.0 110.996 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 55.65 24.92 7.56 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.726 -0.609 . . . . 0.0 111.077 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.98 86.32 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.461 ' HB2' HD22 ' A' ' 255' ' ' LEU . 2.4 mtt180 -106.92 169.02 8.8 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.987 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.8 tt -159.73 150.41 19.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.193 -1.567 . . . . 0.0 108.873 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.987 ' N ' HD23 ' A' ' 138' ' ' LEU . 7.2 mt -145.83 139.56 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -129.6 139.62 51.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.297 -0.877 . . . . 0.0 109.981 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.589 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -121.54 140.36 52.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -136.47 137.41 24.04 Favored Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.9 150.1 48.1 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.56 1.507 . . . . 0.0 112.032 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.94 158.57 8.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.356 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -86.97 -1.44 57.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 0.0 109.726 -179.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.4 p -136.46 155.19 50.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.153 -0.967 . . . . 0.0 109.405 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.497 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 32.6 tp -87.48 117.15 26.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.275 -0.891 . . . . 0.0 110.116 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -134.29 140.35 46.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.606 ' CG1' HD23 ' A' ' 231' ' ' LEU . 94.6 t -139.19 126.96 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.976 -1.077 . . . . 0.0 109.908 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.3 m -115.16 137.8 51.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.447 -0.783 . . . . 0.0 109.671 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.483 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.5 t80 -125.97 129.56 49.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.353 -0.842 . . . . 0.0 109.727 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -114.31 106.18 14.03 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -96.4 141.15 15.44 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -118.94 86.69 2.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.532 -0.981 . . . . 0.0 109.17 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -91.77 143.01 26.96 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.218 -0.926 . . . . 0.0 109.732 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.8 mmtm -92.14 -1.67 57.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.352 -0.843 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 22.1 p-10 -73.12 -167.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.571 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -61.56 -24.89 66.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.227 -0.92 . . . . 0.0 109.784 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.544 HD22 ' NE2' ' A' ' 162' ' ' GLN . 7.7 mt -63.21 -46.23 87.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.319 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.61 -132.72 11.28 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.4 mtt85 -98.87 139.6 34.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.32 -1.106 . . . . 0.0 109.289 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.544 ' NE2' HD22 ' A' ' 159' ' ' LEU . 9.1 mt-30 -146.02 142.64 28.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.518 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.4 pttm -137.29 148.41 46.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.251 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -137.39 127.9 26.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.089 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 165' ' ' THR . 10.9 t -99.87 122.03 42.21 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.013 -1.054 . . . . 0.0 109.718 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.29 136.65 34.34 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -0.922 . . . . 0.0 108.881 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.52 153.25 34.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.383 -0.823 . . . . 0.0 109.645 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.661 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 4.7 mp0 -57.13 113.89 1.91 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.288 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.555 ' N ' ' OE2' ' A' ' 171' ' ' GLU . . . 115.89 11.29 10.26 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -137.11 28.4 2.84 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.183 -1.187 . . . . 0.0 108.761 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.675 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 16.9 mp0 -62.15 -36.93 83.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.587 -0.696 . . . . 0.0 110.632 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 15.6 mp0 -52.45 -15.52 0.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.82 -1.175 . . . . 0.0 110.241 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 49.1 mt-10 -91.07 -4.19 56.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.089 -1.007 . . . . 0.0 110.927 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.595 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.4 pt -121.72 6.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.999 -1.063 . . . . 0.0 111.052 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.14 -34.95 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.741 -1.224 . . . . 0.0 110.175 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.7 mt -82.96 1.02 41.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.779 -1.201 . . . . 0.0 110.745 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.36 123.81 28.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.195 . . . . 0.0 108.962 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.38 154.38 17.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -51.36 158.12 0.89 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.404 ' O ' ' O3G' ' A' ' 320' ' ' TUX . 36.8 p90 -146.24 168.7 20.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.05 -1.031 . . . . 0.0 110.089 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.528 ' SG ' ' C1A' ' A' ' 320' ' ' TUX . 0.1 OUTLIER -166.08 159.0 15.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.108 -0.995 . . . . 0.0 109.595 179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.521 ' CG ' ' CH2' ' A' ' 184' ' ' TRP . 60.8 m-85 -103.42 146.5 28.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.296 -0.878 . . . . 0.0 109.316 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.678 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.8 p30 -51.97 -51.08 59.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.03 -1.044 . . . . 0.0 110.794 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.664 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.2 p90 -51.83 -36.84 49.55 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.926 -1.109 . . . . 0.0 111.481 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.664 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 14.6 pt-20 -89.48 -17.33 28.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.636 -1.29 . . . . 0.0 109.924 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.3 mt -59.43 -52.24 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.187 -0.946 . . . . 0.0 110.127 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -50.85 -51.16 53.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.663 -1.273 . . . . 0.0 109.5 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -52.42 -44.87 65.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.064 . . . . 0.0 108.751 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.566 HD13 H3A3 ' A' ' 320' ' ' TUX . 71.2 mt -59.99 -34.33 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.2 mtpt -77.65 -27.14 50.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.538 -0.726 . . . . 0.0 110.216 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -78.45 -24.07 46.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.005 -1.059 . . . . 0.0 110.217 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.4 m -85.68 11.19 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.548 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.87 24.82 68.52 Favored Glycine 0 N--CA 1.49 2.247 0 C-N-CA 120.077 -1.059 . . . . 0.0 110.488 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 39.2 mt -123.53 163.28 21.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -1.169 . . . . 0.0 109.921 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.15 23.96 60.32 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -69.09 -22.68 63.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.788 -1.419 . . . . 0.0 109.88 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.54 -0.56 53.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.35 130.0 50.33 Favored Glycine 0 N--CA 1.488 2.141 0 O-C-N 121.305 -1.114 . . . . 0.0 110.685 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.2 p -140.01 -173.64 3.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.735 -0.862 . . . . 0.0 108.728 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 45.4 mt -99.46 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -99.48 -4.3 31.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.384 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.89 -11.69 1.74 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.119 -0.988 . . . . 0.0 110.152 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 20.4 m -126.0 116.96 22.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 0.0 110.103 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 18.9 tp -74.04 110.42 8.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.522 HG13 HD11 ' A' ' 186' ' ' ILE . 58.1 t -100.08 126.66 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.926 -1.109 . . . . 0.0 109.47 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.1 mt -110.15 148.81 31.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.804 . . . . 0.0 109.829 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.25 159.25 15.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.52 -23.45 1.61 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.257 -1.143 . . . . 0.0 109.663 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -153.66 12.69 0.46 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.078 -1.014 . . . . 0.0 110.724 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -144.11 151.66 39.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.864 -1.148 . . . . 0.0 110.637 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.0 t -99.57 124.86 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -71.95 -54.78 8.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.019 -1.05 . . . . 0.0 110.34 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -55.89 132.88 73.33 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.011 -1.056 . . . . 0.0 109.428 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.51 -11.19 26.18 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.2 1.933 . . . . 0.0 112.418 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -84.47 -6.64 59.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 0.0 109.767 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.09 -162.96 54.56 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -89.45 149.76 22.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.561 -0.964 . . . . 0.0 110.317 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.6 mtt-85 -94.26 -23.76 17.73 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.424 -0.798 . . . . 0.0 108.929 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.526 ' C ' ' H ' ' A' ' 221' ' ' ASN . 28.3 m-85 -144.57 133.93 23.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 108.993 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -51.22 -9.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 0.0 108.614 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.526 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -135.01 35.66 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.844 0.83 . . . . 0.0 108.878 -179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.492 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.66 -49.54 88.35 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 0.0 111.804 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 20.5 Cg_endo -67.58 -34.56 25.23 Favored 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 121.571 1.514 . . . . 0.0 113.06 -178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 228' ' ' VAL . 24.2 m -79.84 -28.22 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 120.51 -1.369 . . . . 0.0 107.706 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 10.1 mmm-85 -65.1 -46.84 79.41 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.582 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 36.6 t60 -61.35 -42.13 98.19 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' A' ' 151' ' ' TYR . 0.6 OUTLIER -59.52 -50.84 72.34 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.05 -1.031 . . . . 0.0 108.69 179.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 224' ' ' VAL . 18.2 t -55.94 -43.95 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.595 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 79.4 t80 -57.71 -40.04 78.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.582 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.5 m-20 -74.68 -33.93 62.56 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.595 -0.69 . . . . 0.0 109.487 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.606 HD23 ' CG1' ' A' ' 149' ' ' VAL . 24.0 tp -59.01 -35.85 73.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.116 -0.99 . . . . 0.0 108.688 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' HIS . 75.7 mt -72.15 -47.77 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.39 -33.27 24.09 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.585 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -82.14 -27.25 32.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.258 . . . . 0.0 109.582 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 mt -83.14 -23.84 32.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.881 -1.137 . . . . 0.0 109.308 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.502 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 38.1 t80 -67.51 -10.71 54.17 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 108.956 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 85.7 mt -50.45 -27.97 7.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.417 -0.802 . . . . 0.0 109.101 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 242' ' ' VAL . 71.3 mt -58.81 -17.68 25.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.177 -0.952 . . . . 0.0 109.179 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 79.41 15.89 79.1 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 60.0 p -158.35 144.65 12.68 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.992 -1.299 . . . . 0.0 109.787 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 57.2 Cg_exo -42.1 128.99 4.34 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.197 1.931 . . . . 0.0 111.839 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.561 HG22 HD12 ' A' ' 238' ' ' LEU . 57.5 t -95.88 130.51 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.175 -0.953 . . . . 0.0 109.66 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -117.67 123.72 46.81 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.384 -0.823 . . . . 0.0 109.554 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 174.1 27.91 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.62 113.33 26.83 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.189 -1.183 . . . . 0.0 109.829 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -112.86 147.17 37.55 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.928 0.871 . . . . 0.0 111.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -129.67 143.27 50.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 39.9 t -142.05 128.11 19.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.646 -1.284 . . . . 0.0 110.687 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.421 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.2 t80 -112.31 116.08 29.79 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.421 ' C ' ' O ' ' A' ' 249' ' ' PHE . 13.9 mmm180 46.04 55.78 6.77 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.1 152.44 22.82 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.0 -175.84 18.6 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.417 ' O ' HG23 ' A' ' 257' ' ' VAL . 72.7 m-70 -70.96 -52.22 21.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -1.215 . . . . 0.0 109.576 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 2.2 p -56.14 -54.41 45.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.107 -0.996 . . . . 0.0 109.162 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 137' ' ' ARG . 34.1 tp -51.06 -42.37 60.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 109.229 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.16 -50.96 71.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 108.908 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 253' ' ' HIS . 59.5 t -53.9 -40.8 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.315 -0.865 . . . . 0.0 109.423 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -55.3 -48.15 74.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 0.0 108.718 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 13.4 tp -52.78 -45.25 67.05 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.6 t -65.83 -45.56 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -52.9 -52.14 58.72 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 110.155 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -64.39 -46.49 83.12 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.062 -1.023 . . . . 0.0 109.707 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 263' ' ' LEU . 20.4 mt -59.07 -46.38 88.41 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.31 -34.4 72.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 14.0 mtmm -79.19 -27.12 42.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.66 -1.275 . . . . 0.0 109.145 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -66.94 -45.93 76.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.947 . . . . 0.0 109.995 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -85.68 11.56 10.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.173 -0.955 . . . . 0.0 110.734 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -22.97 56.42 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.888 -1.133 . . . . 0.0 109.698 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.9 mt -75.19 -49.89 17.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 109.542 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 109.452 179.889 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.566 H3A3 HD13 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 85.8 mt-10 -54.33 144.16 21.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.523 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.28 139.36 53.78 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.9 t -137.47 176.59 8.57 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.45 143.43 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.854 -1.154 . . . . 0.0 110.443 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.62 ' HG3' HD13 ' A' ' 115' ' ' LEU . 2.4 ttmm -76.22 -46.52 27.86 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.636 -0.665 . . . . 0.0 109.593 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -125.93 153.69 43.89 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.521 0.676 . . . . 0.0 110.111 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -61.94 137.91 58.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.483 -0.76 . . . . 0.0 109.899 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.47 165.1 15.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.579 -0.701 . . . . 0.0 109.176 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -155.59 147.81 23.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 0.0 110.102 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -130.9 162.42 29.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.571 -0.706 . . . . 0.0 109.207 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.96 136.52 16.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.874 -1.141 . . . . 0.0 109.063 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.1 161.4 19.34 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.053 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 17' ' ' GLY . 4.3 p -74.6 160.67 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -1.214 . . . . 0.0 111.447 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.552 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -93.58 142.38 15.97 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.591 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -62.73 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.254 . . . . 0.0 112.36 -178.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.443 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.8 m-70 -86.7 -38.4 17.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 119.821 -1.799 . . . . 0.0 111.654 -178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.436 ' OG1' ' CB ' ' A' ' 95' ' ' GLU . 2.1 p -78.13 -33.32 50.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.042 -1.036 . . . . 0.0 110.099 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.77 26.15 72.02 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -116.13 154.06 30.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.574 -0.956 . . . . 0.0 108.654 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -73.16 138.12 45.52 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.993 -1.067 . . . . 0.0 110.075 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -143.76 157.88 44.08 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 0.0 108.847 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' HZ2' ' HB3' ' A' ' 25' ' ' LYS . 8.1 ttpp -135.57 148.75 49.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 109.329 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.663 ' CD2' HG13 ' A' ' 91' ' ' VAL . 12.9 mt -124.98 146.34 49.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.5 mt -131.96 130.93 61.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.9 mt -117.02 119.02 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.169 -0.957 . . . . 0.0 109.637 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.61 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.7 OUTLIER -116.92 148.64 42.57 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -61.34 161.51 23.31 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.231 1.954 . . . . 0.0 111.45 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -135.96 -174.08 3.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.9 tttp -85.61 151.66 23.73 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.264 -0.898 . . . . 0.0 109.266 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -49.5 150.34 1.97 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.894 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.618 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.27 23.61 57.89 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.03 178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 17.0 m -80.2 -42.64 22.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.791 -1.417 . . . . 0.0 108.913 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.75 -176.81 30.06 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 mm -97.33 122.57 49.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.374 -1.074 . . . . 0.0 108.122 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -138.45 140.69 39.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.046 -1.034 . . . . 0.0 110.4 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -100.05 152.92 19.66 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.52 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.1 t80 -124.93 147.41 48.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -173.78 131.26 0.42 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.836 -1.165 . . . . 0.0 109.382 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.84 29.58 16.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.124 -0.985 . . . . 0.0 110.151 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.56 72.48 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.758 -1.211 . . . . 0.0 110.198 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.02 138.55 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.209 -1.171 . . . . 0.0 109.703 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -98.86 137.03 38.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.05 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.594 HD11 ' HB2' ' A' ' 67' ' ' GLN . 58.3 mt -129.24 97.11 26.53 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.387 -0.821 . . . . 0.0 110.179 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.59 142.3 24.45 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.156 1.904 . . . . 0.0 111.837 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.64 82.36 5.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.512 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -140.63 156.99 46.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.429 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.553 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 6.3 p80 -53.53 -49.87 66.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.36 -0.837 . . . . 0.0 110.168 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -47.0 -15.79 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.022 . . . . 0.0 109.947 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 50' ' ' HIS . 76.6 m-85 -97.53 4.22 50.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.007 -1.058 . . . . 0.0 109.495 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 50' ' ' HIS . 33.9 t -59.02 130.46 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -0.906 . . . . 0.0 109.198 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.5 m -118.87 -32.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -153.55 122.06 6.29 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.111 -0.993 . . . . 0.0 109.979 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.6 p -112.33 131.93 55.26 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.598 ' O ' ' N ' ' A' ' 59' ' ' SER . 7.0 t-20 -166.87 -153.94 0.16 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.414 ' C ' ' O ' ' A' ' 57' ' ' ASN . 23.3 m-70 -46.92 -13.23 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.008 -1.058 . . . . 0.0 108.452 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.598 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -137.3 166.06 24.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.485 -0.759 . . . . 0.0 109.371 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.408 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 12.3 m -105.79 123.67 48.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.377 -0.827 . . . . 0.0 108.945 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.5 OUTLIER -122.19 142.43 50.43 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.995 0.902 . . . . 0.0 111.426 -178.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 53' ' ' VAL . 72.5 mt -122.56 164.68 17.72 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 176.54 145.31 5.58 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.4 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -145.18 151.52 38.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.822 -0.811 . . . . 0.0 109.484 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.7 mmtm 57.44 25.59 11.56 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.3 -0.875 . . . . 0.0 111.002 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.03 2.2 78.26 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.428 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.594 ' HB2' HD11 ' A' ' 46' ' ' ILE . 8.6 mm100 -100.65 142.24 32.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.235 . . . . 0.0 108.028 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -143.55 154.05 43.2 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.796 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mt -133.87 144.07 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 47.8 mttp -114.9 155.01 27.64 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.364 -0.835 . . . . 0.0 111.256 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 m 50.89 63.86 2.07 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.79 -0.569 . . . . 0.0 111.152 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 96' ' ' ILE . 28.9 m -112.51 1.05 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.094 -1.004 . . . . 0.0 109.092 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' OE1' ' OD2' ' A' ' 230' ' ' ASP . 0.3 OUTLIER -72.22 -31.09 65.53 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.407 -0.808 . . . . 0.0 109.944 -179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -61.49 -60.45 3.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.832 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.576 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.8 tp -59.64 -46.13 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 0.0 109.179 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.576 ' N ' HG23 ' A' ' 75' ' ' ILE . 61.9 mt -53.79 -41.62 67.45 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.242 -0.911 . . . . 0.0 109.479 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.557 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 2.8 t -58.43 -46.31 86.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.976 . . . . 0.0 109.47 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.95 -54.36 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.061 -1.024 . . . . 0.0 108.886 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 34.0 mt -51.89 -43.7 63.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 108.923 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.563 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 19.1 t-160 -54.6 -47.72 73.04 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -0.869 . . . . 0.0 109.85 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.6 mt -67.63 -37.13 82.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 114' ' ' ILE . 58.6 mt -77.81 -7.53 56.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.431 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 64.03 60.48 1.0 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.761 -1.212 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 82' ' ' LEU . 5.8 mm -104.29 131.03 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.909 . . . . 0.0 108.65 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.582 HG21 HG12 ' A' ' 121' ' ' ILE . 40.7 p -119.71 -19.12 8.15 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.364 -0.835 . . . . 0.0 111.422 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.645 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.2 m-80 -126.98 111.02 13.6 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.891 -1.131 . . . . 0.0 109.637 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -164.57 142.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.132 -0.98 . . . . 0.0 109.949 179.311 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 88.5 m -113.84 99.43 7.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.33 106.35 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.373 -0.829 . . . . 0.0 109.777 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -85.66 118.78 25.38 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.663 HG13 ' CD2' ' A' ' 26' ' ' LEU . 43.3 t -105.0 105.4 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.873 . . . . 0.0 110.931 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mt -83.91 111.33 19.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.17 -179.18 16.23 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -106.32 -16.83 14.46 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.183 -1.186 . . . . 0.0 110.66 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.57 ' OE1' ' N ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -123.77 133.48 53.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.183 -0.948 . . . . 0.0 110.41 -179.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.57 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 mm -68.12 126.32 92.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.359 -0.838 . . . . 0.0 109.486 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HD2' HD11 ' A' ' 26' ' ' LEU . 77.9 Cg_exo -46.28 128.48 12.18 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.865 1.71 . . . . 0.0 112.159 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.5 tp -76.43 -25.56 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.444 -0.785 . . . . 0.0 110.093 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.9 mt 53.66 -113.91 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 109.847 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD2' ' NE ' ' A' ' 178' ' ' ARG . 18.8 t70 -94.37 -21.46 18.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.171 -0.956 . . . . 0.0 110.012 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.5 -7.71 28.29 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.582 ' OG ' ' NE ' ' A' ' 178' ' ' ARG . 5.4 p -116.69 -167.75 1.34 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -1.066 . . . . 0.0 109.566 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.5 -5.37 20.98 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.495 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 67.1 t-105 -46.75 -42.0 16.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.681 -0.894 . . . . 0.0 110.414 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.59 -52.25 64.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.046 . . . . 0.0 110.015 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 75.3 m-85 -62.42 -44.35 96.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.018 . . . . 0.0 108.557 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -63.49 -37.53 87.64 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.221 0.534 . . . . 0.0 110.305 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.3 mm-40 -71.42 -50.25 33.74 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -0.824 . . . . 0.0 112.076 -178.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.0 -51.53 13.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.713 -1.242 . . . . 0.0 110.669 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 80.3 mt -58.76 -42.52 85.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.031 -1.043 . . . . 0.0 110.122 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -54.11 -29.36 44.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 0.0 109.663 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -84.79 -11.7 55.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -119.8 31.6 6.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.222 -0.924 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.835 HD11 HD13 ' A' ' 82' ' ' LEU . 4.9 mt -88.83 148.29 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.362 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.62 HD13 ' HG3' ' A' ' 8' ' ' LYS . 15.0 tp -130.34 158.47 39.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -109.35 137.53 47.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.172 -0.955 . . . . 0.0 110.513 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 -161.45 0.87 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.371 -0.83 . . . . 0.0 109.047 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.412 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 0.1 OUTLIER -121.77 0.63 9.84 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.323 -0.86 . . . . 0.0 110.7 -179.36 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 4' ' ' GLU . 5.6 ttt85 -89.04 144.18 26.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.926 -1.108 . . . . 0.0 109.925 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 132.14 34.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 109.492 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.582 HG12 HG21 ' A' ' 85' ' ' THR . 96.6 mt -74.31 140.6 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.499 -0.75 . . . . 0.0 111.184 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -83.95 84.08 7.71 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -57.88 144.84 37.55 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.47 -0.769 . . . . 0.0 110.713 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -105.37 125.02 50.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.701 HG22 ' HB2' ' A' ' 243' ' ' LYS . 46.1 t -128.53 142.56 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.2 t -81.19 134.8 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 108.864 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.52 -11.35 11.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.559 -0.713 . . . . 0.0 109.084 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -141.76 141.76 23.36 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.337 -0.852 . . . . 0.0 109.171 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.69 169.87 20.89 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.135 1.89 . . . . 0.0 113.377 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.531 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 3.1 tt -165.4 141.52 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.81 -0.556 . . . . 0.0 109.708 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.435 HG23 HD21 ' A' ' 138' ' ' LEU . 5.7 mt -127.6 124.9 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.402 -0.811 . . . . 0.0 109.83 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 132' ' ' VAL . 31.5 m -120.03 120.79 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.443 -0.786 . . . . 0.0 109.438 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -104.33 147.27 27.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.349 -0.844 . . . . 0.0 109.515 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.608 ' CB ' HD13 ' A' ' 255' ' ' LEU . 4.1 t70 -157.01 112.45 2.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.816 -1.178 . . . . 0.0 111.882 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 41.1 52.25 3.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.709 -0.619 . . . . 0.0 112.458 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.26 3.69 89.99 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.588 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.8 mtt85 -105.38 163.08 12.9 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.972 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.23 149.64 17.64 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.037 -1.664 . . . . 0.0 109.241 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.972 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.0 mt -146.85 133.2 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -124.88 139.72 53.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 109.873 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.531 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -120.76 143.53 48.76 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -143.57 139.29 16.17 Favored Pre-proline 0 N--CA 1.492 1.64 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 146.47 70.47 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.653 1.568 . . . . 0.0 112.456 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.46 153.17 9.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 0.0 109.451 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.62 0.54 54.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 109.675 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 p -136.29 146.34 46.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.5 tp -77.49 117.68 19.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.364 -0.835 . . . . 0.0 109.548 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 tt0 -139.52 133.89 31.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.373 -0.83 . . . . 0.0 108.808 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.633 ' CG1' HD23 ' A' ' 231' ' ' LEU . 22.9 t -132.75 125.6 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.285 -0.885 . . . . 0.0 109.688 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 42.9 m -112.77 132.3 55.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -121.58 130.15 53.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.74 . . . . 0.0 109.986 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -114.1 103.23 10.92 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -94.07 125.42 8.26 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.28 84.39 1.96 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.42 -1.047 . . . . 0.0 108.865 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -87.19 148.22 25.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.541 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -95.83 1.31 53.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.209 -0.932 . . . . 0.0 109.782 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.648 HD21 HD12 ' A' ' 159' ' ' LEU . 15.0 p-10 -76.24 -167.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.131 -0.98 . . . . 0.0 109.368 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -61.23 -25.21 66.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.299 -0.876 . . . . 0.0 109.79 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.648 HD12 HD21 ' A' ' 157' ' ' ASN . 11.3 mt -59.57 -51.13 71.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.572 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.35 -128.07 9.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.553 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 12.2 mtm180 -104.05 137.28 42.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.392 -1.064 . . . . 0.0 109.23 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.553 ' NE2' ' O ' ' A' ' 161' ' ' ARG . 8.3 mp0 -140.73 138.41 34.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 109.199 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -133.65 144.27 49.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.406 -0.808 . . . . 0.0 109.472 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.656 ' CE1' ' NH1' ' A' ' 225' ' ' ARG . 52.3 t80 -138.6 128.48 25.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 61.0 m -103.14 123.1 46.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.9 t80 -101.77 137.64 39.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.832 . . . . 0.0 109.395 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.551 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 21.2 t -134.47 158.32 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.483 -0.76 . . . . 0.0 109.363 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.401 ' N ' HG12 ' A' ' 167' ' ' VAL . 80.1 mt-10 -58.45 117.47 4.52 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.413 -0.805 . . . . 0.0 109.45 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.39 4.06 20.38 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -134.38 29.8 3.6 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.137 -1.213 . . . . 0.0 108.835 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.538 ' O ' HG22 ' A' ' 175' ' ' VAL . 84.1 mt-10 -63.87 -32.83 74.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 0.0 110.747 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.91 -17.46 6.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.069 -1.02 . . . . 0.0 110.832 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.2 -3.8 58.82 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.851 -1.155 . . . . 0.0 110.743 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -125.55 -12.45 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.119 -0.988 . . . . 0.0 111.434 -178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -84.42 -29.48 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.305 -1.497 . . . . 0.0 110.095 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -88.62 1.96 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.709 -1.244 . . . . 0.0 110.743 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.66 121.65 24.96 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.915 -1.116 . . . . 0.0 108.794 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.582 ' NE ' ' OG ' ' A' ' 102' ' ' SER . 4.4 mpt_? -88.22 149.15 24.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.83 -1.169 . . . . 0.0 109.832 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.8 t -54.14 166.3 0.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.336 -0.853 . . . . 0.0 109.057 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -149.74 177.4 9.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.768 -1.207 . . . . 0.0 109.963 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.626 ' SG ' ' C1A' ' A' ' 320' ' ' TUX . 0.8 OUTLIER -169.53 164.22 10.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.586 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.618 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 90.9 m-85 -104.3 145.22 30.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.403 -0.811 . . . . 0.0 109.565 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.682 ' HA ' HD12 ' A' ' 186' ' ' ILE . 18.1 p-10 -63.81 -18.24 63.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.881 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.618 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 4.5 p90 -81.1 -27.42 35.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.667 -1.271 . . . . 0.0 110.452 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.506 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 19.6 pt-20 -98.28 -15.17 19.9 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.888 -1.133 . . . . 0.0 109.633 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.682 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.1 mt -56.47 -51.51 63.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.261 -0.899 . . . . 0.0 110.255 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.59 ' H ' ' CD ' ' A' ' 187' ' ' GLU . 2.9 mp0 -51.15 -52.73 41.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.963 -1.086 . . . . 0.0 109.549 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -52.5 -44.86 65.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 109.0 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.516 HD13 ' O1A' ' A' ' 320' ' ' TUX . 95.9 mt -63.94 -33.33 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.373 -0.829 . . . . 0.0 109.097 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -79.83 -25.37 40.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 110.328 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.9 mmtt -82.25 -25.12 34.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.057 -1.027 . . . . 0.0 110.219 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.1 m -80.7 8.02 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 82.16 23.24 57.53 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.13 -1.034 . . . . 0.0 110.578 179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 47.5 mt -125.6 164.5 20.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.16 -1.2 . . . . 0.0 109.922 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.443 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 76.42 19.59 78.0 Favored Glycine 0 N--CA 1.495 2.608 0 O-C-N 121.216 -0.927 . . . . 0.0 111.552 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.7 mttp -68.71 -20.24 64.4 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.598 -1.531 . . . . 0.0 109.565 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.03 -5.26 50.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.77 125.16 34.47 Favored Glycine 0 N--CA 1.493 2.485 0 O-C-N 121.072 -1.252 . . . . 0.0 110.321 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.64 -173.73 3.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.834 -0.804 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 200' ' ' LEU . 73.6 mt -91.56 -13.34 32.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.533 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 40.0 tttp -92.47 -1.4 57.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.507 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 201' ' ' LYS . 0.6 OUTLIER -142.48 11.92 1.91 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 109.723 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.27 114.54 6.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.997 -1.064 . . . . 0.0 109.77 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.826 HD21 HD23 ' A' ' 217' ' ' LEU . 17.0 tp -77.54 106.71 9.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -0.957 . . . . 0.0 109.136 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.518 HG22 HD11 ' A' ' 186' ' ' ILE . 51.1 t -99.94 130.05 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.001 -1.062 . . . . 0.0 109.498 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD21 HD21 ' A' ' 217' ' ' LEU . 90.7 mt -111.58 149.67 31.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.855 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.4 150.6 16.87 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 207' ' ' GLY . 5.2 tttm -42.98 -27.23 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -1.171 . . . . 0.0 110.091 -179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 207' ' ' GLY . 3.3 p-10 -148.65 8.18 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.969 -1.082 . . . . 0.0 110.376 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 207' ' ' GLY . 0.9 OUTLIER -141.56 149.15 40.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.074 -1.017 . . . . 0.0 110.409 -179.392 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.0 t -98.79 125.74 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -72.5 -54.63 8.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.177 -0.952 . . . . 0.0 110.47 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -55.85 131.64 72.99 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.039 -1.038 . . . . 0.0 109.804 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -72.38 -12.28 27.27 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.203 1.935 . . . . 0.0 112.184 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -88.09 -7.77 56.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.637 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.66 48.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.826 HD23 HD21 ' A' ' 204' ' ' LEU . 36.2 mt -85.64 138.95 31.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.545 -0.973 . . . . 0.0 109.85 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.516 ' CZ ' HH12 ' A' ' 178' ' ' ARG . 0.5 OUTLIER -64.83 -54.71 26.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 221' ' ' ASN . 18.2 m-85 -118.45 146.66 44.3 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -50.35 -12.5 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.142 -0.974 . . . . 0.0 109.614 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 219' ' ' TYR . 4.3 m-20 -135.89 27.86 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.342 -0.849 . . . . 0.0 109.454 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.1 OUTLIER -56.05 -42.65 97.24 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.912 -179.132 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 22.8 Cg_exo -61.58 -45.44 17.74 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.229 1.953 . . . . 0.0 112.924 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.452 ' H ' HG22 ' A' ' 224' ' ' VAL . 7.4 m -75.45 -24.28 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 120.717 -1.24 . . . . 0.0 108.381 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.656 ' NH1' ' CE1' ' A' ' 164' ' ' PHE . 11.2 mtt85 -66.79 -40.79 88.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -64.56 -42.25 95.8 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 tptp -56.8 -45.62 82.12 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.085 -1.01 . . . . 0.0 108.671 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.1 t -62.03 -44.92 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.557 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 77.4 t80 -54.98 -41.95 71.83 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 0.8 OUTLIER -71.38 -38.12 71.54 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.729 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.633 HD23 ' CG1' ' A' ' 149' ' ' VAL . 27.3 tp -56.72 -35.62 68.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.352 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.563 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 35.5 mt -72.67 -48.58 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.25 -32.73 14.19 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.4 OUTLIER -82.91 -29.5 29.16 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.228 -1.16 . . . . 0.0 110.143 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.53 HD23 HG22 ' A' ' 260' ' ' VAL . 4.7 mt -78.58 -23.29 46.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.761 -1.212 . . . . 0.0 109.889 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.481 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 22.3 t80 -67.92 -7.27 27.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.138 -0.976 . . . . 0.0 108.815 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 237' ' ' LEU . 20.6 mt -50.06 -32.99 16.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.446 -0.784 . . . . 0.0 108.895 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 93.7 mt -56.45 -12.49 1.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.061 -1.024 . . . . 0.0 109.085 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 73.75 17.13 79.14 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 58.7 p -157.17 144.94 13.99 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.963 -1.316 . . . . 0.0 109.677 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.66 133.27 5.34 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.199 1.932 . . . . 0.0 111.82 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.1 t -102.07 134.13 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.916 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.701 ' HB2' HG22 ' A' ' 125' ' ' VAL . 19.3 mmtp -121.24 125.23 46.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.491 -0.756 . . . . 0.0 109.448 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.75 167.54 18.88 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 148' ' ' GLU . 10.2 tttp -98.67 112.91 24.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.112 -1.228 . . . . 0.0 109.623 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -112.18 148.45 34.01 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 122.015 0.912 . . . . 0.0 111.1 -179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -129.18 143.67 50.94 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.4 p -138.34 124.52 20.32 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.8 -1.188 . . . . 0.0 109.848 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 250' ' ' ARG . 1.5 t80 -112.96 112.1 23.32 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.7 OUTLIER 45.28 56.48 5.56 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -92.37 156.17 23.22 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -115.93 177.75 17.2 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.417 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 79.8 m-70 -66.01 -51.95 53.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.024 -1.28 . . . . 0.0 109.552 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 49.1 p -54.53 -54.64 38.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.1 -1.0 . . . . 0.0 109.117 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 134' ' ' ASP . 35.8 tp -51.33 -41.83 60.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.54 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -58.71 -55.04 40.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.066 -1.021 . . . . 0.0 108.816 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 23.4 t -48.55 -41.25 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -54.93 -47.85 73.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.114 -0.991 . . . . 0.0 108.713 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 26.6 tp -52.81 -44.37 66.62 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.53 HG22 HD23 ' A' ' 235' ' ' LEU . 41.0 t -70.8 -41.66 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.383 -0.823 . . . . 0.0 109.698 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -58.9 -48.18 82.36 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.607 -0.683 . . . . 0.0 110.411 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -69.1 -35.19 76.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.053 -1.029 . . . . 0.0 109.57 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 263' ' ' LEU . 15.0 mt -69.66 -45.61 67.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.11 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.36 -32.79 74.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.715 -0.615 . . . . 0.0 110.27 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -78.81 -30.83 45.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.734 -1.229 . . . . 0.0 108.854 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.5 mttm -69.91 -46.25 65.81 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.226 -0.921 . . . . 0.0 109.201 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 269' ' ' LEU . 0.1 OUTLIER -72.44 7.27 1.89 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.833 . . . . 0.0 109.666 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -47.15 -15.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.1 -1.0 . . . . 0.0 109.431 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 267' ' ' GLN . 69.7 mt -67.62 -26.12 66.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 -179.985 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.626 ' C1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.492 ' O ' HD11 ' A' ' 121' ' ' ILE . 2.3 mm? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.641 ' OE1' HG21 ' A' ' 85' ' ' THR . 8.0 mm-40 -49.44 135.13 18.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.232 -0.918 . . . . 0.0 109.044 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.35 135.46 53.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.519 -0.738 . . . . 0.0 109.889 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.7 t -137.26 171.42 14.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.7 m -81.94 130.21 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.94 -1.1 . . . . 0.0 109.964 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -59.29 -45.83 90.2 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.379 -0.826 . . . . 0.0 110.092 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -129.79 157.76 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.442 -0.786 . . . . 0.0 110.198 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.55 135.45 56.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.563 -0.711 . . . . 0.0 109.858 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 113' ' ' ASN . 80.0 mt -116.91 169.97 8.98 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.438 -0.789 . . . . 0.0 109.08 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -154.04 147.08 24.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.062 . . . . 0.0 110.194 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -132.47 157.81 43.66 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.403 -0.811 . . . . 0.0 109.448 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 14' ' ' GLU . 1.6 pm0 -151.78 136.82 17.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.867 -1.146 . . . . 0.0 109.37 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.2 161.85 20.31 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 17' ' ' GLY . 7.1 p -72.46 163.94 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.283 -1.128 . . . . 0.0 111.347 -178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.594 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -98.76 142.21 15.96 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.623 HG23 ' N ' ' A' ' 19' ' ' HIS . 15.7 tt -58.97 -52.11 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -1.169 . . . . 0.0 112.5 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.623 ' N ' HG23 ' A' ' 18' ' ' ILE . 7.2 m-70 -86.82 -38.73 16.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.245 -1.535 . . . . 0.0 111.702 -178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.542 HG22 ' HG3' ' A' ' 22' ' ' GLU . 2.5 m -73.97 -33.62 63.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 110.002 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.03 25.83 69.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.542 ' HG3' HG22 ' A' ' 20' ' ' THR . 2.7 mt-10 -117.72 154.34 31.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.534 -0.98 . . . . 0.0 108.596 179.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -73.72 137.1 43.82 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 0.0 110.195 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 t -142.35 156.22 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.731 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.8 tttt -132.26 156.57 46.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 0.0 109.313 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.731 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.0 mt -133.9 143.13 48.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.046 -1.033 . . . . 0.0 109.097 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.622 HG22 ' NE2' ' A' ' 29' ' ' HIS . 22.7 mt -130.8 128.58 63.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 mt -116.01 129.89 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.994 . . . . 0.0 110.069 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.622 ' NE2' HG22 ' A' ' 27' ' ' ILE . 1.5 m-70 -125.0 148.5 60.28 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.65 159.47 28.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.238 1.959 . . . . 0.0 111.618 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 11.4 mm-40 -132.39 -174.13 3.36 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' OG1' ' A' ' 35' ' ' THR . 69.0 tttt -90.87 155.5 18.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.206 -0.934 . . . . 0.0 109.676 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.587 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -50.61 149.23 3.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.724 . . . . 0.0 110.236 -179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.88 19.7 61.34 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.689 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 87.1 m -81.49 -46.39 14.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.382 -1.658 . . . . 0.0 108.983 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.12 -165.49 18.54 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.66 HD13 ' O ' ' A' ' 85' ' ' THR . 4.6 mm -103.68 122.31 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.61 149.23 47.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.067 . . . . 0.0 110.608 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -107.84 150.96 26.37 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.526 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.5 t80 -131.04 137.48 49.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.014 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 ttpp -169.12 140.41 2.42 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.349 -0.845 . . . . 0.0 109.447 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.51 28.52 15.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.895 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.15 24.84 76.62 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.15 138.14 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.21 -1.17 . . . . 0.0 109.758 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 35.9 m-85 -97.13 134.27 40.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.372 -0.83 . . . . 0.0 109.187 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.6 mt -127.25 96.83 32.9 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.485 -0.759 . . . . 0.0 109.839 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -51.79 144.73 33.87 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.259 1.973 . . . . 0.0 111.654 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.2 79.35 7.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.19 149.54 52.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.554 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 5.8 p80 -52.0 -49.37 63.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.415 -0.803 . . . . 0.0 109.789 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 50' ' ' HIS . 18.8 mt-10 -44.89 -33.18 1.87 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.125 -0.984 . . . . 0.0 109.333 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.32 6.16 10.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.154 -0.966 . . . . 0.0 109.902 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.525 ' N ' ' O ' ' A' ' 50' ' ' HIS . 3.5 t -63.73 130.81 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.131 -0.981 . . . . 0.0 109.071 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.9 m -115.68 -31.66 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.47 -0.769 . . . . 0.0 110.317 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.484 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -155.0 126.03 7.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.984 -1.073 . . . . 0.0 109.602 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.8 p -113.87 137.07 52.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.553 -0.717 . . . . 0.0 109.107 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -166.52 -154.58 0.18 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.498 ' O ' ' NXH' ' A' ' 320' ' ' TUX . 0.1 OUTLIER -50.39 -11.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 57' ' ' ASN . 40.6 m -134.8 165.75 24.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.608 -0.682 . . . . 0.0 109.294 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.5 m -103.28 121.57 42.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 0.0 109.229 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -118.14 135.67 54.08 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 0.0 111.192 -179.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CD1' HG21 ' A' ' 72' ' ' VAL . 29.8 mt -122.04 162.46 21.15 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.56 144.29 5.81 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 118.35 -1.881 . . . . 0.0 111.147 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -144.68 151.18 38.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.721 -0.87 . . . . 0.0 109.506 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.8 mttp 57.48 23.83 9.56 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.309 -0.869 . . . . 0.0 110.704 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.68 75.68 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.331 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.496 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 28.7 mm100 -97.55 143.83 27.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.972 -1.311 . . . . 0.0 108.055 179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.77 149.25 43.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.983 -1.073 . . . . 0.0 111.502 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.32 137.78 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.98 154.25 25.57 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.188 -0.945 . . . . 0.0 110.907 -178.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 71' ' ' THR . 80.7 m 53.5 67.88 0.93 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.706 -0.621 . . . . 0.0 110.764 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.518 HG21 ' CD1' ' A' ' 62' ' ' LEU . 23.5 m -113.15 -4.32 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.028 -1.045 . . . . 0.0 109.093 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.595 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.3 pt-20 -69.11 -33.49 73.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 110.333 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -61.57 -60.35 3.83 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.144 -0.973 . . . . 0.0 110.135 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.576 ' CD1' ' CD2' ' A' ' 106' ' ' PHE . 2.5 tp -56.98 -42.63 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 120.904 -1.122 . . . . 0.0 108.808 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' HG23 ' A' ' 75' ' ' ILE . 9.5 mt -59.36 -35.28 73.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.341 -0.85 . . . . 0.0 109.83 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.592 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 11.9 t -64.46 -51.15 64.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.939 -1.101 . . . . 0.0 109.902 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.3 t -55.74 -54.74 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.009 -1.057 . . . . 0.0 108.408 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.3 mt -53.28 -44.74 68.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.616 -0.678 . . . . 0.0 109.421 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.426 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 3.2 t-160 -53.23 -41.41 65.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.177 -0.952 . . . . 0.0 109.995 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 HD13 ' A' ' 232' ' ' ILE . 16.9 mt -77.26 -35.85 54.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.178 -0.951 . . . . 0.0 110.449 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.674 HD22 ' CD1' ' A' ' 114' ' ' ILE . 10.3 mt -80.77 0.76 33.35 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.025 -1.047 . . . . 0.0 110.61 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 58.24 51.82 8.08 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.92 -1.113 . . . . 0.0 110.512 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.515 HD11 ' HB3' ' A' ' 82' ' ' LEU . 19.9 mm -95.73 122.02 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.064 -1.022 . . . . 0.0 108.369 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.66 ' O ' HD13 ' A' ' 37' ' ' ILE . 8.3 p -101.88 -76.61 0.57 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 111.169 -178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.717 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.7 m-80 -80.21 115.19 19.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.131 -0.981 . . . . 0.0 111.39 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.6 m -164.25 134.68 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.491 0.662 . . . . 0.0 109.555 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.486 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 18.7 m -105.92 100.54 10.08 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.14 104.49 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 0.0 109.73 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -80.49 124.17 28.7 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.2 t -106.21 111.88 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 110.995 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -92.46 108.92 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.15 -158.06 21.89 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.19 -11.46 10.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.586 -0.95 . . . . 0.0 110.233 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -145.81 150.1 35.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.85 -1.157 . . . . 0.0 110.858 -179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.52 125.13 91.8 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.638 -0.664 . . . . 0.0 109.623 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.657 ' CD ' HD21 ' A' ' 26' ' ' LEU . 72.6 Cg_exo -45.28 134.94 11.85 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.964 1.776 . . . . 0.0 112.37 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.7 tp -82.02 -29.5 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.482 -0.761 . . . . 0.0 109.981 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 16.2 mt 56.77 -110.53 0.55 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.548 -0.72 . . . . 0.0 110.221 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 -15.5 22.83 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.092 . . . . 0.0 111.464 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.49 -8.83 32.66 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.3 p -117.46 -170.74 1.91 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.419 -1.048 . . . . 0.0 109.536 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.87 -3.3 21.91 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.3 t-105 -46.8 -39.84 12.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.687 -0.89 . . . . 0.0 110.744 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -61.41 -51.85 67.02 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.964 -1.085 . . . . 0.0 110.15 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CD2' ' CD1' ' A' ' 75' ' ' ILE . 92.6 m-85 -64.01 -43.78 94.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.024 -1.047 . . . . 0.0 108.779 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -61.51 -38.02 85.81 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.662 -0.649 . . . . 0.0 109.756 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -71.18 -46.72 60.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.356 -0.84 . . . . 0.0 111.591 -179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.47 -51.06 15.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.821 -1.174 . . . . 0.0 110.709 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.7 -42.86 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 110.709 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.64 -31.69 57.82 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.912 -1.117 . . . . 0.0 109.348 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -83.09 -1.11 51.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.17 -0.956 . . . . 0.0 109.93 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' HB2' HD11 ' A' ' 11' ' ' LEU . 5.3 m120 -131.4 33.42 4.08 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.252 -0.905 . . . . 0.0 111.071 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.674 ' CD1' HD22 ' A' ' 82' ' ' LEU . 11.2 mt -91.35 142.37 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 120.473 -1.392 . . . . 0.0 109.642 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 115' ' ' LEU . 13.8 tp -131.56 162.83 29.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.1 OUTLIER -108.01 146.03 33.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.15 -0.969 . . . . 0.0 109.921 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.587 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 10.7 mt-30 -111.23 -166.53 1.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 109.444 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 118' ' ' ASN . 10.1 t-20 -116.66 70.83 0.77 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.4 -0.812 . . . . 0.0 110.304 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -166.36 143.59 5.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.192 -0.942 . . . . 0.0 109.305 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -82.73 130.04 35.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.078 -1.014 . . . . 0.0 109.715 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.492 HD11 ' O ' ' A' ' 3' ' ' LEU . 55.5 mt -70.77 140.36 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.608 -0.683 . . . . 0.0 110.542 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -87.45 90.66 8.45 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -64.71 146.66 54.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.398 -0.814 . . . . 0.0 110.812 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.515 ' CE2' ' OE1' ' A' ' 267' ' ' GLN . 9.2 t80 -102.38 123.7 46.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 t -129.13 143.8 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.128 -0.982 . . . . 0.0 110.466 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 67.9 t -84.4 135.73 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.538 -0.726 . . . . 0.0 109.101 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -114.68 -10.47 12.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.233 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.443 ' OE1' ' CG2' ' A' ' 270' ' ' THR . 11.4 pt-20 -143.84 146.45 34.64 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.03 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -71.28 170.7 17.66 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.389 2.059 . . . . 0.0 113.403 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.728 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.7 tt -165.68 144.56 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 121.291 0.567 . . . . 0.0 109.793 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 131' ' ' ILE . 1.4 mt -130.64 122.28 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.5 111.92 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.354 -0.841 . . . . 0.0 109.634 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -115.87 128.6 55.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.41 -0.806 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -172.39 152.2 2.66 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.101 -1.039 . . . . 0.0 110.959 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.463 ' HB2' ' HE ' ' A' ' 137' ' ' ARG . 33.7 mm-40 56.8 22.19 6.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.641 -0.662 . . . . 0.0 110.766 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.54 -0.21 89.42 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.587 ' HB2' HD22 ' A' ' 255' ' ' LEU . 21.2 mtm180 -100.5 171.8 7.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -1.143 . . . . 0.0 107.984 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.917 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.7 tt -160.67 146.57 14.91 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.429 -1.419 . . . . 0.0 109.249 179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.917 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.5 mt -147.24 133.27 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -0.965 . . . . 0.0 108.671 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 45.3 tttt -123.78 138.44 54.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 0.0 109.666 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.68 144.59 48.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.5 -0.75 . . . . 0.0 109.105 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 11.4 tm-20 -141.59 135.39 14.73 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.454 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 5.9 Cg_endo -52.82 148.12 29.89 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.39 1.393 . . . . 0.0 112.05 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.69 150.87 10.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -79.6 0.8 28.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.971 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.5 p -138.43 170.42 16.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.419 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.622 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 30.6 tp -99.88 119.2 37.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.109 -0.994 . . . . 0.0 109.519 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -139.52 137.93 35.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.542 ' CG1' HD23 ' A' ' 231' ' ' LEU . 57.3 t -137.9 125.67 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.193 -0.942 . . . . 0.0 109.916 -179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.8 m -112.88 140.93 47.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.537 ' CE2' HG12 ' A' ' 224' ' ' VAL . 9.9 t80 -126.72 131.39 51.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.614 -0.679 . . . . 0.0 109.96 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 106.06 13.51 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.83 158.37 17.8 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.62 115.66 15.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.403 -1.057 . . . . 0.0 109.148 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -117.11 148.75 41.27 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.431 -0.793 . . . . 0.0 109.876 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -93.05 -7.02 46.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.389 -0.82 . . . . 0.0 109.93 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.853 HD21 HD12 ' A' ' 159' ' ' LEU . 20.5 p-10 -75.06 -169.77 0.99 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.082 -1.011 . . . . 0.0 109.972 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -58.83 -21.22 56.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 110.152 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.853 HD12 HD21 ' A' ' 157' ' ' ASN . 6.9 mt -64.76 -54.26 34.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.964 -1.085 . . . . 0.0 109.017 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.06 -131.74 10.69 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -101.37 142.68 32.41 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.235 -1.156 . . . . 0.0 109.517 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -148.67 150.37 33.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.199 -0.938 . . . . 0.0 109.578 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -136.74 147.55 46.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.411 -0.805 . . . . 0.0 109.323 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -136.06 122.5 20.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.198 -0.939 . . . . 0.0 109.824 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 165' ' ' THR . 14.2 t -98.26 120.77 39.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.994 -1.066 . . . . 0.0 109.658 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -95.05 140.44 29.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.232 -0.918 . . . . 0.0 109.44 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.7 t -138.94 150.08 23.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.289 -0.882 . . . . 0.0 109.707 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 96.6 mt-10 -55.59 117.64 3.78 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.888 . . . . 0.0 109.368 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.536 ' C ' HD22 ' A' ' 170' ' ' ASN . . . 115.86 4.97 18.54 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.536 HD22 ' C ' ' A' ' 169' ' ' GLY . 0.8 OUTLIER -134.87 30.27 3.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.142 -1.21 . . . . 0.0 108.958 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.99 -28.64 69.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.443 -0.785 . . . . 0.0 110.132 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -57.42 -14.5 4.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.162 -0.962 . . . . 0.0 110.789 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -96.21 -4.35 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.886 -1.134 . . . . 0.0 110.941 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.414 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.7 pt -118.98 3.48 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 110.906 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.02 -31.56 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 0.0 109.804 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -90.4 2.68 55.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.997 -1.064 . . . . 0.0 110.571 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.25 118.34 21.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.736 -1.228 . . . . 0.0 108.751 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.25 152.09 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.942 -1.099 . . . . 0.0 110.166 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.5 t -59.11 133.05 55.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 109.531 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.555 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 25.4 p90 -115.03 165.77 12.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.363 -0.835 . . . . 0.0 110.482 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.555 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -159.65 161.23 34.95 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.496 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 42.7 m-85 -103.03 145.15 30.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.052 -1.03 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.741 ' HA ' HD12 ' A' ' 186' ' ' ILE . 4.1 p-10 -63.12 -17.85 62.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.206 -0.934 . . . . 0.0 111.708 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.668 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.2 p90 -81.61 -38.32 26.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.362 -1.461 . . . . 0.0 111.183 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.668 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -86.85 -14.44 42.07 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.596 -1.315 . . . . 0.0 109.817 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.741 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.8 mt -53.91 -48.15 63.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.144 -0.973 . . . . 0.0 109.893 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.24 -51.35 54.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.966 -1.084 . . . . 0.0 109.103 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.8 -47.04 67.88 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.234 -0.916 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.461 HD12 ' HA ' ' A' ' 186' ' ' ILE . 30.0 mt -60.77 -34.7 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.421 -0.799 . . . . 0.0 109.183 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -78.91 -25.92 43.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.551 -0.718 . . . . 0.0 109.842 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttt -75.25 -28.45 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.6 m -81.49 10.66 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.307 -0.871 . . . . 0.0 109.101 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 24.37 72.96 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.0 mt -120.84 159.2 25.97 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.596 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.469 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.1 27.58 57.86 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.435 ' NZ ' ' CB ' ' A' ' 196' ' ' LYS . 8.0 mtpm? -71.03 -20.59 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.765 -1.432 . . . . 0.0 109.314 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.29 -1.34 50.86 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.75 126.94 38.21 Favored Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.695 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.407 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 1.6 p -140.74 172.02 13.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.716 -0.873 . . . . 0.0 109.114 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 91.4 mt -78.79 -3.56 45.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.133 -0.979 . . . . 0.0 109.642 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -97.88 -10.55 24.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 109.425 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.407 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 0.8 OUTLIER -135.18 -9.36 2.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 0.0 109.486 -179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.432 HG22 ' SG ' ' A' ' 181' ' ' CYS . 3.0 m -126.89 115.04 18.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.559 -0.713 . . . . 0.0 109.586 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 205' ' ' VAL . 4.9 tp -74.0 114.64 12.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.481 ' N ' HD12 ' A' ' 204' ' ' LEU . 64.8 t -105.31 127.08 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.048 -1.033 . . . . 0.0 109.854 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 11.1 mt -104.29 151.67 23.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.435 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.09 150.74 17.1 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 26.4 ttpt -41.02 -29.4 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -1.123 . . . . 0.0 109.961 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 207' ' ' GLY . 0.5 OUTLIER -149.41 17.47 0.93 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.102 -0.999 . . . . 0.0 110.339 -179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 7.4 tttp -151.26 161.88 41.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.054 -1.029 . . . . 0.0 110.122 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.24 129.88 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -73.08 -54.31 8.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.137 -0.977 . . . . 0.0 109.92 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -54.64 134.22 64.3 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.909 -1.12 . . . . 0.0 109.329 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -71.81 -9.67 25.17 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.235 1.957 . . . . 0.0 112.514 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.32 -7.96 52.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.066 -1.021 . . . . 0.0 109.751 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.18 -165.01 51.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 21.9 mt -88.66 145.24 25.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.5 -1.0 . . . . 0.0 109.935 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.566 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.7 mmt180 -87.76 -17.02 32.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.465 -0.772 . . . . 0.0 109.558 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 27.0 m-85 -144.17 143.97 31.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.01 -19.79 54.43 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.427 ' HB2' ' HE ' ' A' ' 225' ' ' ARG . 16.5 m-20 -126.96 35.67 4.56 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.628 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -60.05 -40.62 79.29 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.538 -0.726 . . . . 0.0 110.607 -179.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.11 -47.98 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.43 2.087 . . . . 0.0 112.641 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.669 ' O ' HG23 ' A' ' 228' ' ' VAL . 0.1 OUTLIER -72.88 -23.09 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.757 -1.214 . . . . 0.0 108.696 179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.427 ' HE ' ' HB2' ' A' ' 221' ' ' ASN . 11.2 mtt180 -68.74 -44.64 73.34 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -60.13 -43.02 96.01 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.83 -42.18 79.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.092 -1.005 . . . . 0.0 109.071 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.0 t -63.94 -49.31 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.592 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.8 t80 -50.22 -40.33 47.13 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.794 0.807 . . . . 0.0 108.896 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.0 m-20 -69.68 -44.57 70.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.635 -0.666 . . . . 0.0 110.178 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.542 HD23 ' CG1' ' A' ' 149' ' ' VAL . 50.7 tp -56.64 -38.72 72.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.111 -0.993 . . . . 0.0 109.154 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.42 HD13 HD21 ' A' ' 81' ' ' LEU . 71.8 mt -68.04 -33.44 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.12 -31.97 79.11 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.589 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -81.78 -25.49 35.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -1.126 . . . . 0.0 109.912 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -76.07 -24.52 55.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.795 -1.191 . . . . 0.0 110.698 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.463 ' OH ' ' O ' ' A' ' 84' ' ' ILE . 0.4 OUTLIER -65.38 -5.22 6.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.355 -1.466 . . . . 0.0 108.013 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 237' ' ' LEU . 35.4 mt -55.08 -23.7 21.74 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.848 -1.158 . . . . 0.0 108.929 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 242' ' ' VAL . 72.1 mt -68.17 -21.47 64.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.091 -1.005 . . . . 0.0 109.186 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.76 12.05 67.16 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 21.4 p -158.2 143.99 12.44 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.144 -1.209 . . . . 0.0 109.578 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 78.0 Cg_exo -42.42 135.66 4.39 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.263 1.975 . . . . 0.0 112.153 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.474 ' O ' HD13 ' A' ' 147' ' ' LEU . 76.0 t -98.46 133.03 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.944 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -122.41 127.81 50.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.738 . . . . 0.0 109.613 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.0 178.93 28.94 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -105.93 112.2 25.16 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.148 -1.207 . . . . 0.0 109.968 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -112.36 148.19 34.8 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 122.03 0.919 . . . . 0.0 111.125 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -129.89 144.42 51.31 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 15.7 t -139.09 128.81 24.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.732 -1.23 . . . . 0.0 110.722 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 250' ' ' ARG . 2.0 t80 -110.67 113.07 25.4 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 249' ' ' PHE . 42.1 mtm180 48.51 55.48 8.91 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.18 135.31 22.47 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.414 ' HA3' HH11 ' A' ' 137' ' ' ARG . . . -109.78 151.2 17.38 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.595 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.1 m-70 -49.05 -46.12 43.85 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.152 -1.205 . . . . 0.0 109.547 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.37 -55.29 35.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.17 -0.956 . . . . 0.0 109.413 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 137' ' ' ARG . 56.7 tp -51.99 -38.14 55.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -58.64 -55.48 34.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.175 -0.953 . . . . 0.0 109.036 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 57.4 t -50.42 -42.94 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.353 -0.842 . . . . 0.0 109.754 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 69.5 tttt -55.58 -48.89 74.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.089 -1.007 . . . . 0.0 109.087 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.679 HD22 HG21 ' A' ' 139' ' ' ILE . 37.9 tp -52.79 -42.02 64.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 108.772 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 19.9 t -72.11 -40.17 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -58.91 -51.36 70.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.388 -0.82 . . . . 0.0 110.136 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.79 -44.74 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.308 -0.87 . . . . 0.0 109.879 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 263' ' ' LEU . 72.8 mt -63.5 -44.16 95.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.91 . . . . 0.0 109.248 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.28 86.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.498 -0.751 . . . . 0.0 110.368 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -81.83 -35.29 29.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.773 -1.204 . . . . 0.0 108.868 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.459 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 38.0 mtpt -70.31 -45.25 66.64 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.515 ' OE1' ' CE2' ' A' ' 124' ' ' PHE . 3.2 tt0 -41.14 -29.42 0.12 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.65 -0.656 . . . . 0.0 110.455 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -99.51 -71.57 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.207 . . . . 0.0 109.719 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 11.3 mt -48.85 -41.85 34.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 109.412 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . 0.443 ' CG2' ' OE1' ' A' ' 128' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.498 ' NXH' ' O ' ' A' ' 58' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.755 HD12 ' O ' ' A' ' 117' ' ' GLN . 3.3 mm? . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.244 0.545 . . . . 0.0 109.589 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.632 ' N ' ' O ' ' A' ' 119' ' ' ARG . 8.0 mm-40 -45.61 129.65 8.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.342 -0.849 . . . . 0.0 108.798 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.485 ' HD3' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -109.63 126.85 54.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.436 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 115' ' ' LEU . 6.1 t -130.44 169.37 15.6 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.363 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 7' ' ' VAL . 6.7 m -83.87 137.14 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.034 -1.042 . . . . 0.0 110.317 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HG3' HD13 ' A' ' 115' ' ' LEU . 28.4 ttmt -67.6 -45.57 75.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.472 -0.767 . . . . 0.0 110.19 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' CB ' ' OD1' ' A' ' 113' ' ' ASN . 2.8 tt0 -132.27 156.1 47.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.26 -0.9 . . . . 0.0 110.511 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.35 133.01 51.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.728 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.5 mt -119.87 165.42 14.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 109.192 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.6 p -156.65 150.3 24.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.889 -1.132 . . . . 0.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -132.57 161.68 33.23 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.46 134.73 24.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.893 -1.13 . . . . 0.0 108.857 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.04 155.34 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -71.33 160.66 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.18 . . . . 0.0 111.208 -178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.65 136.29 13.44 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.604 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.4 tt -53.42 -53.01 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.226 -1.161 . . . . 0.0 111.657 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.604 ' N ' HG23 ' A' ' 18' ' ' ILE . 5.2 m-70 -87.54 -36.78 17.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.275 -1.516 . . . . 0.0 111.191 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.4 m -71.31 -35.42 71.26 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.223 -0.923 . . . . 0.0 110.027 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.74 21.57 65.31 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -111.77 150.85 29.7 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.667 -0.902 . . . . 0.0 108.86 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.2 t80 -70.25 128.92 37.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.597 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.407 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 12.1 t -135.94 157.47 46.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 0.0 109.143 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 26' ' ' LEU . 4.0 ttmt -135.6 147.2 48.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.268 -0.895 . . . . 0.0 109.307 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.535 HD11 ' HD2' ' A' ' 97' ' ' PRO . 6.4 mt -119.65 145.99 45.97 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.096 -1.003 . . . . 0.0 108.838 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.9 mt -135.05 126.19 46.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.3 mt -113.08 129.1 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.092 -1.005 . . . . 0.0 110.223 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 0.8 OUTLIER -128.44 148.75 69.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -59.54 160.37 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.278 1.986 . . . . 0.0 111.835 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 6.0 mm-40 -134.76 -172.82 3.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.258 -0.902 . . . . 0.0 109.837 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.451 ' O ' ' OG1' ' A' ' 35' ' ' THR . 54.1 tttm -84.44 149.59 25.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.282 -0.886 . . . . 0.0 110.047 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.632 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 7.4 mp0 -47.46 145.42 2.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.991 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.68 25.2 63.14 Favored Glycine 0 N--CA 1.493 2.465 0 O-C-N 121.47 -0.769 . . . . 0.0 111.825 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 45.4 m -80.98 -44.58 17.93 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.546 -1.561 . . . . 0.0 108.951 178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.48 -166.55 16.1 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.605 HD11 ' O ' ' A' ' 84' ' ' ILE . 4.5 mm -103.73 125.66 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.313 -1.11 . . . . 0.0 108.073 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.12 139.64 30.51 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.162 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -95.56 152.69 18.2 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 4.1 t80 -135.03 141.26 46.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.609 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.48 146.87 0.81 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.546 -0.721 . . . . 0.0 109.312 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.07 29.31 14.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 109.822 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.31 23.11 73.25 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 55.1 t -128.28 133.88 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -1.202 . . . . 0.0 109.51 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -94.41 142.45 27.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.384 -0.823 . . . . 0.0 109.169 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 46' ' ' ILE . 29.4 mt -135.09 94.39 16.09 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.27 -0.894 . . . . 0.0 110.261 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -49.26 144.88 16.23 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.342 2.028 . . . . 0.0 111.654 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.44 84.32 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.95 -1.094 . . . . 0.0 110.667 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.28 154.57 49.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.599 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 4.4 p80 -51.39 -48.15 62.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 109.732 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -46.77 -17.28 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 0.0 110.07 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.0 m-85 -95.35 1.88 54.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.965 -1.084 . . . . 0.0 109.762 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 50' ' ' HIS . 54.1 t -55.22 127.75 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.036 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 52' ' ' PHE . 32.2 m -117.42 -32.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.501 -0.749 . . . . 0.0 109.861 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -151.32 119.28 6.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.716 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.5 p -114.36 127.82 56.04 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.603 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.9 t-20 -167.16 -152.98 0.14 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' ASN . 12.2 m-70 -44.37 -16.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.132 -0.98 . . . . 0.0 108.45 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.9 t -136.77 165.6 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.491 -0.755 . . . . 0.0 109.326 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 m -110.61 125.71 53.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.316 -0.865 . . . . 0.0 109.422 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.98 150.42 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.26 -0.9 . . . . 0.0 111.178 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' CD1' HG21 ' A' ' 72' ' ' VAL . 34.4 mt -130.15 159.01 38.11 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.73 146.68 8.02 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.306 -1.902 . . . . 0.0 111.538 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -144.09 148.87 35.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.644 -0.916 . . . . 0.0 109.309 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.1 mttt 59.1 30.62 20.46 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.262 -0.899 . . . . 0.0 110.75 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.24 4.72 90.11 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.486 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 16.7 mm100 -103.93 139.94 38.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.103 -1.234 . . . . 0.0 108.094 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -141.71 157.52 44.95 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.923 -1.111 . . . . 0.0 111.704 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.2 mt -133.77 147.26 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -114.21 150.52 34.16 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.152 -0.967 . . . . 0.0 111.153 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 55.05 71.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.666 -0.646 . . . . 0.0 110.995 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.467 HG21 ' CD1' ' A' ' 62' ' ' LEU . 19.5 m -113.97 -17.41 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.175 -0.953 . . . . 0.0 109.438 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.601 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.2 OUTLIER -61.18 -16.81 48.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.121 -0.987 . . . . 0.0 110.441 -179.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.601 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 7.8 m170 -73.18 -61.39 1.84 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.833 -1.167 . . . . 0.0 109.832 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.8 tp -58.15 -41.62 81.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.819 -1.175 . . . . 0.0 108.338 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 79' ' ' LEU . 98.0 mt -56.4 -38.28 71.3 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 109.466 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.569 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 10.2 t -61.44 -49.23 77.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.095 -1.003 . . . . 0.0 109.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.13 -53.07 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.143 -0.973 . . . . 0.0 108.515 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 76' ' ' LEU . 20.2 mt -51.73 -44.62 63.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.492 ' HD1' HG22 ' A' ' 232' ' ' ILE . 10.6 t-160 -56.16 -49.34 74.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.1 -1.0 . . . . 0.0 110.401 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 83.0 mt -61.49 -37.89 85.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 110.685 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.58 ' CB ' HD11 ' A' ' 84' ' ' ILE . 50.2 mt -86.66 -5.43 59.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.913 -1.117 . . . . 0.0 111.151 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 82' ' ' LEU . 1.0 OUTLIER 62.69 63.0 1.03 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.731 -1.231 . . . . 0.0 110.426 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.605 ' O ' HD11 ' A' ' 37' ' ' ILE . 4.6 mm -98.44 129.68 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.585 ' O ' HD13 ' A' ' 37' ' ' ILE . 72.9 p -107.63 -78.21 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.041 -1.037 . . . . 0.0 110.509 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.743 HD22 HE22 ' A' ' 117' ' ' GLN . 1.5 m-80 -81.34 113.27 19.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.005 -1.059 . . . . 0.0 111.137 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.9 m -163.71 131.79 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.338 -0.851 . . . . 0.0 109.546 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.5 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 51.4 m -104.25 100.88 10.6 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mt -90.38 103.02 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' OE2' ' CD1' ' A' ' 40' ' ' PHE . 4.0 mt-10 -76.32 122.97 25.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.989 -1.069 . . . . 0.0 108.782 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -108.06 110.29 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 0.0 110.166 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -99.45 108.2 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 137.7 -167.15 24.91 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -108.16 -15.31 14.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.365 -1.08 . . . . 0.0 109.861 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.418 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.5 tt0 -143.71 148.68 36.05 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.007 -1.058 . . . . 0.0 110.034 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.8 mm -68.2 128.36 93.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.456 -0.777 . . . . 0.0 109.282 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.535 ' HD2' HD11 ' A' ' 26' ' ' LEU . 76.6 Cg_exo -44.19 130.35 8.49 Favored 'Trans proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.047 1.831 . . . . 0.0 112.116 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 ' HB ' ' A' ' 18' ' ' ILE . 10.9 tp -76.33 -20.31 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.538 -0.726 . . . . 0.0 110.074 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.464 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 6.2 mt 47.57 -116.19 0.72 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.15 -0.969 . . . . 0.0 109.277 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -95.16 -10.05 31.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.096 -1.002 . . . . 0.0 110.483 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.27 -5.07 57.3 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.4 p -117.14 -171.38 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.454 -1.027 . . . . 0.0 109.43 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.9 -6.14 16.97 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 65.9 t-105 -47.71 -40.1 19.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.65 -0.912 . . . . 0.0 110.805 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -61.83 -52.06 65.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.931 -1.105 . . . . 0.0 109.828 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.475 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.4 m-85 -60.62 -43.93 96.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.012 -1.055 . . . . 0.0 108.379 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.503 ' CD2' HG11 ' A' ' 175' ' ' VAL . 12.3 t80 -60.88 -39.76 90.44 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.517 0.675 . . . . 0.0 110.051 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -69.89 -47.97 60.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 112.059 -178.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 -51.19 14.88 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.749 -1.219 . . . . 0.0 111.105 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.49 -42.81 95.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.003 -1.06 . . . . 0.0 110.994 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -56.49 -29.54 61.92 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.994 -1.066 . . . . 0.0 109.945 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.7 ttmt -81.23 -15.4 55.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.066 . . . . 0.0 110.453 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.436 ' OD1' ' CB ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER -119.84 32.25 6.15 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.265 -0.897 . . . . 0.0 111.044 -178.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.402 HG12 ' NZ ' ' A' ' 5' ' ' LYS . 5.7 mt -80.75 146.69 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.653 -1.28 . . . . 0.0 110.929 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.44 ' HB3' HG23 ' A' ' 6' ' ' THR . 13.7 tp -132.09 162.63 30.35 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -123.49 146.6 47.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.235 -0.916 . . . . 0.0 110.446 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.755 ' O ' HD12 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -107.75 -157.5 0.62 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -0.789 . . . . 0.0 109.245 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.827 ' H ' HD22 ' A' ' 118' ' ' ASN . 0.0 OUTLIER -118.82 1.72 11.56 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.011 -1.056 . . . . 0.0 112.124 -178.266 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.632 ' O ' ' N ' ' A' ' 4' ' ' GLU . 3.3 ttm180 -102.24 122.02 43.4 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.573 -1.329 . . . . 0.0 110.237 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -56.73 142.97 38.39 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.258 -0.901 . . . . 0.0 109.999 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.47 HG23 HG21 ' A' ' 85' ' ' THR . 1.9 mt -81.19 145.55 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.234 -0.916 . . . . 0.0 110.481 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -83.58 84.43 7.54 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -60.72 146.06 47.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.409 -0.807 . . . . 0.0 110.552 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.677 ' CE2' ' NE2' ' A' ' 267' ' ' GLN . 12.4 t80 -101.22 120.15 39.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.435 HG13 ' HB3' ' A' ' 243' ' ' LYS . 20.9 t -122.72 138.84 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.336 -0.852 . . . . 0.0 109.878 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.2 140.0 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.192 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -119.7 -8.63 9.89 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.429 ' OE2' HD11 ' A' ' 269' ' ' LEU . 0.9 OUTLIER -141.19 146.17 41.77 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.42 -0.8 . . . . 0.0 109.072 179.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.52 177.21 8.97 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.219 1.946 . . . . 0.0 113.08 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.793 HG22 ' HB3' ' A' ' 141' ' ' ALA . 8.4 tt -165.25 144.78 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.622 -0.674 . . . . 0.0 109.574 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -129.03 123.61 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.519 -0.738 . . . . 0.0 109.095 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.8 m -124.59 122.1 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 0.0 109.644 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.426 ' OE1' ' C ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.35 132.02 56.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 109.747 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 17.2 t0 -174.21 157.8 2.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.261 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 44.2 mt-10 57.71 19.93 5.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.676 -0.64 . . . . 0.0 110.773 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.04 4.58 88.84 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -114.07 177.63 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.899 HD23 ' N ' ' A' ' 139' ' ' ILE . 10.1 tt -157.77 161.09 38.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.351 -1.468 . . . . 0.0 109.281 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.899 ' N ' HD23 ' A' ' 138' ' ' LEU . 18.6 mt -149.8 144.97 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.952 . . . . 0.0 108.492 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -132.4 140.17 48.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.627 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.793 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.69 140.86 51.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.388 -0.82 . . . . 0.0 108.998 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.56 ' OE1' ' NZ ' ' A' ' 245' ' ' LYS . 13.8 tm-20 -137.64 126.55 14.81 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.45 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 88.6 Cg_exo -46.39 152.48 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.563 1.509 . . . . 0.0 112.435 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.05 159.57 6.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.349 -0.844 . . . . 0.0 109.418 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -91.79 -0.29 57.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 p -132.85 146.41 51.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.444 -0.785 . . . . 0.0 109.166 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.431 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 19.9 tp -81.38 117.22 21.66 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.133 -0.979 . . . . 0.0 109.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -136.07 135.1 39.08 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.731 ' CG1' HD23 ' A' ' 231' ' ' LEU . 67.5 t -135.98 117.65 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.126 -0.984 . . . . 0.0 109.516 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.3 m -107.92 134.15 51.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 109.809 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -121.51 130.6 53.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.523 -0.736 . . . . 0.0 110.089 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -112.31 110.55 20.85 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.55 152.84 17.53 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -141.46 96.11 2.93 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.436 -1.038 . . . . 0.0 109.138 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.482 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 3.5 m-85 -98.98 148.72 23.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.578 -0.701 . . . . 0.0 110.126 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -85.38 -3.72 58.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.484 -0.76 . . . . 0.0 109.864 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.467 ' ND2' ' CB ' ' A' ' 155' ' ' PHE . 11.5 p30 -76.93 -167.64 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.915 -1.115 . . . . 0.0 109.52 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -58.0 -22.01 47.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.907 . . . . 0.0 110.039 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 19.8 mt -59.38 -54.73 43.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.0 109.834 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.13 -111.71 3.63 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -124.84 137.18 54.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.309 -1.112 . . . . 0.0 109.076 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -155.32 139.33 16.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.377 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.546 ' CB ' ' NZ ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -127.69 153.73 46.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.36 -0.837 . . . . 0.0 109.169 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.496 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 86.4 t80 -135.17 116.88 14.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 165' ' ' THR . 5.0 t -92.47 120.1 32.62 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.157 -0.964 . . . . 0.0 109.376 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.8 t80 -99.74 138.38 36.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.561 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.3 t -135.77 153.55 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.0 109.45 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 22.5 mt-10 -57.22 122.82 13.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.388 -0.82 . . . . 0.0 109.476 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.49 -7.05 20.59 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.14 32.65 4.86 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.262 -1.14 . . . . 0.0 108.768 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -66.56 -30.64 70.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.797 . . . . 0.0 110.17 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -58.53 -13.6 6.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.015 . . . . 0.0 110.877 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.26 -4.44 54.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.889 -1.132 . . . . 0.0 110.915 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.39 3.75 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.16 -0.963 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.503 HG11 ' CD2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -96.77 -32.64 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.797 -1.189 . . . . 0.0 109.934 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -85.55 0.17 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.978 -1.076 . . . . 0.0 110.536 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.34 117.42 18.0 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.798 -1.188 . . . . 0.0 108.29 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.477 HH12 ' C ' ' A' ' 201' ' ' LYS . 11.2 ttm180 -86.08 148.83 25.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 0.0 110.26 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.4 t -62.55 134.9 57.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 109.012 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -115.16 179.74 3.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.258 -0.901 . . . . 0.0 110.582 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.564 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.6 OUTLIER -164.93 161.32 20.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.499 -0.751 . . . . 0.0 109.246 179.679 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.578 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.2 m-85 -104.52 144.21 31.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.467 -0.77 . . . . 0.0 109.613 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.672 ' HA ' HD12 ' A' ' 186' ' ' ILE . 7.5 p-10 -62.64 -19.27 63.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.689 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.587 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.8 p90 -81.44 -31.46 33.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.755 -1.216 . . . . 0.0 110.534 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.587 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 6.4 pt-20 -91.79 -14.96 28.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.836 -1.165 . . . . 0.0 109.513 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' A' ' 183' ' ' ASP . 6.8 mt -57.42 -52.02 62.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.26 -0.9 . . . . 0.0 110.372 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -50.64 -52.39 40.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.912 -1.117 . . . . 0.0 109.92 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -45.62 65.8 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.914 -1.116 . . . . 0.0 109.166 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.3 -33.43 61.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.197 -0.939 . . . . 0.0 109.079 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -80.52 -26.79 37.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -79.43 -21.13 45.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.149 -0.969 . . . . 0.0 110.03 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.0 m -90.3 13.58 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.752 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 76.82 24.46 67.0 Favored Glycine 0 N--CA 1.494 2.536 0 C-N-CA 120.139 -1.029 . . . . 0.0 110.788 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.0 mt -123.9 163.5 21.16 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.118 -1.225 . . . . 0.0 109.878 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 77.37 21.92 71.71 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -68.63 -21.31 64.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.83 -1.394 . . . . 0.0 109.735 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.68 -5.37 51.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.08 125.75 38.78 Favored Glycine 0 N--CA 1.49 2.263 0 O-C-N 121.242 -1.152 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.28 165.1 28.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.713 -0.875 . . . . 0.0 109.314 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 90.9 mt -70.98 -8.06 50.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.504 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.477 ' C ' HH12 ' A' ' 178' ' ' ARG . 23.5 tttp -93.44 -5.61 48.89 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 53.8 m-20 -143.54 14.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.719 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.8 m -151.65 119.1 6.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.14 -0.975 . . . . 0.0 109.716 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.519 HD21 ' CD2' ' A' ' 217' ' ' LEU . 24.3 tp -80.4 109.81 15.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.133 -0.979 . . . . 0.0 108.893 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 93.4 t -98.11 128.56 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 0.0 109.607 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.9 mt -110.79 148.41 32.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.341 -0.849 . . . . 0.0 109.896 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.27 156.29 16.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 207' ' ' GLY . 1.6 ttpt -42.9 -30.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.912 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.7 13.31 0.72 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 110.166 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 207' ' ' GLY . 33.1 mttt -139.23 147.26 41.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.037 -1.04 . . . . 0.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.99 127.05 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.468 -0.77 . . . . 0.0 109.1 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.602 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 31.2 m-85 -72.91 -54.31 9.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.067 -1.021 . . . . 0.0 110.061 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -57.39 132.42 81.47 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.926 -1.109 . . . . 0.0 109.44 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -72.4 -11.5 26.62 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.317 2.011 . . . . 0.0 112.885 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -90.38 -8.72 49.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.969 -1.082 . . . . 0.0 109.865 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.24 -167.94 45.91 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.519 ' CD2' HD21 ' A' ' 204' ' ' LEU . 21.2 mt -78.62 141.84 37.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.449 -1.03 . . . . 0.0 109.766 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.584 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 5.1 tpp180 -79.57 -13.06 59.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.223 -0.923 . . . . 0.0 109.409 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 34.3 m-85 -148.24 152.79 37.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.369 -0.832 . . . . 0.0 108.899 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.621 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 11.6 mp0 -59.25 -19.12 43.14 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.146 -0.971 . . . . 0.0 108.423 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.05 37.25 3.02 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.621 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.5 OUTLIER -59.91 -38.18 57.36 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.238 -0.914 . . . . 0.0 110.605 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 6.8 Cg_exo -70.27 -46.45 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.158 1.906 . . . . 0.0 112.295 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 228' ' ' VAL . 6.1 m -74.45 -23.99 18.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.776 -1.202 . . . . 0.0 108.25 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.496 ' NE ' ' CE1' ' A' ' 164' ' ' PHE . 44.9 mtt180 -68.24 -43.21 78.41 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -61.06 -41.76 97.22 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -57.49 -43.4 84.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.966 -1.083 . . . . 0.0 108.753 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 224' ' ' VAL . 28.2 t -60.84 -45.14 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.569 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 75.6 t80 -55.87 -40.56 73.11 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.482 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 1.1 m-20 -73.71 -37.8 65.04 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.612 -0.68 . . . . 0.0 109.597 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.731 HD23 ' CG1' ' A' ' 149' ' ' VAL . 28.4 tp -56.23 -34.86 66.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.111 -0.993 . . . . 0.0 108.702 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.492 HG22 ' HD1' ' A' ' 80' ' ' HIS . 61.0 mt -73.28 -47.93 44.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.66 -34.66 21.44 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.482 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 1.0 OUTLIER -81.59 -27.6 34.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -1.196 . . . . 0.0 109.95 -179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.649 HD23 HG22 ' A' ' 260' ' ' VAL . 6.6 mt -80.46 -20.92 42.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.796 -1.19 . . . . 0.0 109.631 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -73.1 -9.22 58.49 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.288 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.409 ' C ' ' N ' ' A' ' 239' ' ' GLY . 67.9 mt -53.5 -28.2 29.71 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 108.879 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.582 HD12 HG22 ' A' ' 242' ' ' VAL . 65.4 mt -55.3 -12.21 0.97 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.114 -0.991 . . . . 0.0 108.895 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 237' ' ' LEU . . . 77.65 12.26 84.66 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 30.2 p -158.52 147.61 14.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.946 -1.326 . . . . 0.0 109.857 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.43 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 54.4 Cg_exo -42.9 133.78 5.61 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.283 1.988 . . . . 0.0 112.081 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.582 HG22 HD12 ' A' ' 238' ' ' LEU . 42.5 t -100.32 129.03 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 109.615 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.435 ' HB3' HG13 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -116.92 123.54 47.23 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.38 -0.825 . . . . 0.0 109.807 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.35 173.08 26.3 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.56 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -103.14 111.93 24.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.189 -1.183 . . . . 0.0 109.463 -179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.6 m-85 -112.5 148.26 34.81 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.111 0.958 . . . . 0.0 111.456 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 139' ' ' ILE . 19.4 t80 -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 t -131.79 128.13 38.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.86 -1.15 . . . . 0.0 110.043 -179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.55 ' O ' ' N ' ' A' ' 251' ' ' GLY . 1.6 t80 -109.49 117.88 35.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.538 -0.726 . . . . 0.0 109.16 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 3.3 mmm180 42.83 16.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.482 -0.761 . . . . 0.0 111.03 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -64.03 172.55 15.82 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.595 -1.316 . . . . 0.0 110.131 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -138.91 -169.2 11.49 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.783 ' O ' HG23 ' A' ' 257' ' ' VAL . 96.6 m-70 -65.66 -52.37 52.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.131 . . . . 0.0 110.008 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.74 -42.5 68.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.034 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.71 -36.13 67.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.968 -1.082 . . . . 0.0 109.009 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.411 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.8 m-20 -63.59 -44.41 94.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 108.605 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 253' ' ' HIS . 17.0 t -57.12 -45.04 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 108.844 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 38.0 mttt -55.18 -47.3 75.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.118 -0.989 . . . . 0.0 108.844 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 17.7 tp -53.52 -44.96 69.56 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.374 -0.828 . . . . 0.0 109.034 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.649 HG22 HD23 ' A' ' 235' ' ' LEU . 54.9 t -69.57 -43.45 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.41 -48.24 77.37 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.543 -0.723 . . . . 0.0 110.312 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -68.01 -39.5 83.17 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.076 -1.015 . . . . 0.0 109.643 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.2 mt -65.0 -44.85 87.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.424 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.76 74.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 110.226 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -86.89 -30.67 21.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.764 -1.21 . . . . 0.0 109.302 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.451 ' C ' ' H ' ' A' ' 268' ' ' LYS . 66.2 mttt -73.39 -43.47 60.47 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.266 -0.896 . . . . 0.0 109.129 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.677 ' NE2' ' CE2' ' A' ' 124' ' ' PHE . 12.5 tt0 -62.45 1.09 0.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.487 -0.758 . . . . 0.0 109.921 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -83.12 33.5 0.45 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.076 -1.015 . . . . 0.0 109.329 179.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.429 HD11 ' OE2' ' A' ' 128' ' ' GLU . 15.3 mt -72.22 -9.07 57.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 0.0 109.595 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.448 -0.782 . . . . 0.0 109.406 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.602 HEA1 ' CE2' ' A' ' 212' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.743 ' C ' HD11 ' A' ' 121' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 25.5 mt-10 -40.93 143.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.323 -0.86 . . . . 0.0 109.678 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -119.9 140.09 51.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.595 -0.691 . . . . 0.0 109.412 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 t -139.14 178.5 7.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.23 -0.919 . . . . 0.0 109.085 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -83.59 151.05 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.8 -1.188 . . . . 0.0 109.75 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -85.31 -37.62 19.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.475 -0.766 . . . . 0.0 110.063 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -136.52 157.76 46.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.299 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.99 133.08 54.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.357 0.598 . . . . 0.0 110.008 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 11' ' ' LEU . 28.1 mt -123.58 159.22 29.68 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -157.26 150.84 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.11 -0.994 . . . . 0.0 110.51 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -135.44 169.01 18.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.563 -0.711 . . . . 0.0 109.718 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.69 137.89 21.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -0.999 . . . . 0.0 109.071 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.75 157.26 14.92 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.6 HG23 ' C ' ' A' ' 22' ' ' GLU . 9.8 p -79.29 140.29 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.179 -1.189 . . . . 0.0 110.752 -179.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.94 144.09 37.48 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.5 tt -59.63 -49.11 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -1.102 . . . . 0.0 112.459 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.548 ' CD2' ' OE2' ' A' ' 95' ' ' GLU . 9.6 m-70 -86.52 -38.24 17.42 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.003 -1.685 . . . . 0.0 111.071 -178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -67.52 -37.81 83.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.268 -0.895 . . . . 0.0 110.328 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.71 21.94 71.41 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' C ' HG23 ' A' ' 16' ' ' VAL . 3.1 tp10 -119.16 154.43 33.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.724 -0.868 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 25' ' ' LYS . 0.9 OUTLIER -70.88 133.67 46.65 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.9 t -142.63 157.25 44.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.081 -1.012 . . . . 0.0 108.883 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' NZ ' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -126.41 160.47 30.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.232 -0.918 . . . . 0.0 110.01 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.729 HD11 HG23 ' A' ' 96' ' ' ILE . 12.1 mt -127.75 142.15 51.39 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' CD2' ' A' ' 29' ' ' HIS . 8.7 mt -137.26 127.21 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 108.838 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.7 mt -117.51 121.24 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.732 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.503 ' CD2' HG22 ' A' ' 27' ' ' ILE . 16.3 m-70 -119.34 149.01 46.66 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.83 160.78 35.42 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.082 1.854 . . . . 0.0 110.732 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 56.7 mm-40 -136.4 -172.51 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.057 -1.027 . . . . 0.0 110.062 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.3 ttpm? -86.31 153.27 22.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.46 -0.775 . . . . 0.0 109.355 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.6 OUTLIER -47.11 143.34 3.17 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 110.291 -179.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 60.08 30.5 70.48 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.384 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.5 m -80.96 -35.83 31.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.592 -1.534 . . . . 0.0 108.584 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.852 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 91.67 179.54 42.01 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 mm -95.43 122.67 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.279 -1.13 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.4 144.81 46.75 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.773 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 52.1 m-85 -102.57 152.73 20.82 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 3.5 t80 -131.45 141.63 49.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 108.912 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -173.4 138.11 0.69 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.372 -0.83 . . . . 0.0 108.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 58.8 28.79 17.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.158 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.28 27.63 71.34 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 120.783 -1.198 . . . . 0.0 110.168 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.78 137.83 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.114 -1.227 . . . . 0.0 109.956 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -96.63 135.3 38.73 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.367 -0.833 . . . . 0.0 109.28 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.6 mt -128.79 99.25 23.0 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.376 -0.827 . . . . 0.0 109.88 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.82 142.58 18.86 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.62 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . . . -92.83 84.5 4.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.866 -1.146 . . . . 0.0 110.548 -178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -141.6 157.91 44.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.241 -0.912 . . . . 0.0 109.393 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.604 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 5.6 p80 -54.83 -49.14 71.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 0.0 110.481 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -44.9 -16.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.13 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.6 m-85 -96.83 5.89 49.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.971 -1.081 . . . . 0.0 109.891 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.0 t -60.01 124.49 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 109.163 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.8 m -114.86 -30.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.297 -0.877 . . . . 0.0 109.849 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.507 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -153.56 121.95 6.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.192 -0.942 . . . . 0.0 109.475 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -114.07 133.72 55.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.618 -0.676 . . . . 0.0 109.196 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.578 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.9 t-20 -166.79 -154.35 0.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.432 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 12.0 m-70 -48.08 -12.59 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.897 -1.127 . . . . 0.0 108.294 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 57' ' ' ASN . 84.5 p -135.32 165.26 25.86 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.441 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 6.4 m -106.32 124.13 49.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.246 -0.909 . . . . 0.0 108.998 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.507 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -121.04 137.74 54.51 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.215 -0.928 . . . . 0.0 111.381 -178.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 72' ' ' VAL . 18.7 mt -127.73 159.15 35.67 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 178.17 151.86 9.76 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.379 -1.867 . . . . 0.0 111.667 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -144.94 152.2 39.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.98 -0.718 . . . . 0.0 109.123 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 61.1 mttt 59.62 24.3 13.1 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.342 -0.849 . . . . 0.0 110.755 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.62 6.53 83.09 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.531 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.441 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 20.1 mm100 -109.87 133.4 53.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 108.061 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.79 165.17 27.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.892 -1.13 . . . . 0.0 111.838 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.2 mt -134.77 148.55 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -114.61 150.72 34.64 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.324 -0.86 . . . . 0.0 111.052 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m 55.32 69.32 0.75 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.0 110.724 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -113.22 -12.97 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.975 -1.078 . . . . 0.0 109.356 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 3.4 pt-20 -63.2 -18.37 63.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 110.452 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -71.91 -60.65 2.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.919 -1.113 . . . . 0.0 109.683 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.498 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.4 tp -59.78 -43.04 90.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.994 -1.066 . . . . 0.0 108.953 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' HG23 ' A' ' 75' ' ' ILE . 15.0 mt -55.2 -41.26 71.76 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.174 -0.953 . . . . 0.0 109.331 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 14.9 t -58.48 -47.85 82.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 108.932 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.8 t -58.35 -54.11 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 108.703 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 mt -52.58 -44.94 66.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.662 ' HD1' HG22 ' A' ' 232' ' ' ILE . 19.7 t-160 -52.88 -54.32 36.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -0.83 . . . . 0.0 110.224 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.16 -34.9 78.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 110.443 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 84' ' ' ILE . 42.4 mt -79.49 -4.47 51.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.983 -1.073 . . . . 0.0 110.598 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 62.58 54.45 2.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.98 -1.075 . . . . 0.0 110.305 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.589 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.4 mm -96.3 124.57 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.162 -0.961 . . . . 0.0 108.467 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.477 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 5.8 p -112.64 -21.31 11.33 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.315 -0.866 . . . . 0.0 111.631 -178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.852 HD22 ' H ' ' A' ' 36' ' ' GLY . 10.8 m120 -132.8 112.36 11.88 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.885 -1.134 . . . . 0.0 110.519 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.3 m -165.01 144.56 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.118 -0.989 . . . . 0.0 109.839 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 64.9 m -112.85 102.86 10.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mp -92.91 117.99 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.304 -0.872 . . . . 0.0 109.789 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.94 118.22 32.14 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.007 -1.058 . . . . 0.0 108.373 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.55 104.45 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.317 -0.865 . . . . 0.0 110.833 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.14 110.7 19.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.83 -162.92 24.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.7 -13.88 12.64 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.397 -1.06 . . . . 0.0 110.141 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.548 ' OE2' ' CD2' ' A' ' 19' ' ' HIS . 40.5 tt0 -142.0 147.51 37.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.101 . . . . 0.0 110.094 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.729 HG23 HD11 ' A' ' 26' ' ' LEU . 3.0 mm -68.76 126.74 93.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.412 -0.805 . . . . 0.0 109.764 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -45.59 129.53 11.43 Favored 'Trans proline' 0 N--CA 1.489 1.229 0 C-N-CA 121.923 1.749 . . . . 0.0 111.887 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.0 tp -76.26 -32.92 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.498 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 9.6 mt 55.12 -104.32 0.22 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 110.273 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -94.34 -28.32 15.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.195 -0.94 . . . . 0.0 110.922 -178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.87 -3.54 25.83 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.3 p -123.5 -166.23 1.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.421 -1.047 . . . . 0.0 109.597 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.09 -2.28 22.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.402 ' NE1' ' HG3' ' A' ' 108' ' ' GLU . 59.4 t-105 -48.69 -43.02 36.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.889 -0.771 . . . . 0.0 110.974 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.55 -52.08 64.84 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.964 -1.085 . . . . 0.0 110.385 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -62.93 -44.04 97.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.931 -1.105 . . . . 0.0 108.722 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 82.3 t80 -63.74 -37.22 86.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.819 -0.551 . . . . 0.0 110.251 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.402 ' HG3' ' NE1' ' A' ' 104' ' ' TRP . 4.9 mm-40 -72.74 -49.68 29.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 112.014 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.16 -46.76 40.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.808 -1.182 . . . . 0.0 111.056 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -68.69 -42.57 83.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.96 -1.087 . . . . 0.0 110.971 -178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 15.8 ttp85 -55.74 -27.76 52.35 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.0 -1.063 . . . . 0.0 110.091 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -84.19 -18.35 36.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.99 -1.069 . . . . 0.0 109.887 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -113.08 29.26 8.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.402 -0.811 . . . . 0.0 110.988 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.8 mt -82.26 149.65 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 0.0 110.28 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 115' ' ' LEU . 12.2 tp -130.66 160.94 32.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.53 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -105.3 137.36 43.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.093 -1.005 . . . . 0.0 109.977 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -102.6 -170.95 1.88 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.489 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -124.97 70.71 1.15 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.471 -0.768 . . . . 0.0 110.16 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -160.61 137.78 9.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.027 -1.046 . . . . 0.0 110.209 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -48.12 167.19 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.678 0.751 . . . . 0.0 111.193 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.743 HD11 ' C ' ' A' ' 3' ' ' LEU . 69.6 mt -128.59 122.35 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -79.37 71.93 5.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.14 -0.975 . . . . 0.0 110.348 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -55.58 147.05 18.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.081 -1.012 . . . . 0.0 109.414 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.532 ' CE2' ' OE1' ' A' ' 267' ' ' GLN . 2.9 t80 -104.83 123.02 46.96 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 243' ' ' LYS . 15.5 t -127.92 143.46 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.849 . . . . 0.0 109.51 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 t -87.81 141.04 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.383 -0.823 . . . . 0.0 109.5 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -121.23 -7.6 9.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' N ' ' HG3' ' A' ' 143' ' ' PRO . 7.3 pt-20 -142.35 144.31 30.55 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.481 -0.762 . . . . 0.0 109.062 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.13 168.01 25.83 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.185 1.923 . . . . 0.0 113.536 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.838 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.1 tt -159.77 141.01 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.343 0.592 . . . . 0.0 109.439 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.469 ' CG2' HD21 ' A' ' 138' ' ' LEU . 28.6 mt -131.56 119.96 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 109.4 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 132' ' ' VAL . 34.3 m -118.3 120.44 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.51 -0.744 . . . . 0.0 109.94 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -114.55 136.45 53.02 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.495 -0.753 . . . . 0.0 109.685 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -174.24 150.1 1.47 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.599 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 57.05 24.09 9.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.583 -0.698 . . . . 0.0 110.818 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.09 7.68 86.77 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.41 ' CG ' HH11 ' A' ' 137' ' ' ARG . 2.9 mtt-85 -106.89 170.25 8.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.984 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.0 tt -160.44 149.52 17.16 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.185 -1.572 . . . . 0.0 109.232 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.984 ' N ' HD23 ' A' ' 138' ' ' LEU . 48.9 mt -145.83 135.34 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 0.0 108.626 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -124.11 140.5 52.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 0.0 109.971 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.838 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.58 142.13 50.96 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -139.64 127.89 13.3 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.403 ' HG3' ' N ' ' A' ' 128' ' ' GLU . 84.7 Cg_exo -46.73 149.1 3.25 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.661 1.574 . . . . 0.0 112.417 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -168.49 155.11 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.408 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -1.43 56.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 109.512 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p -135.0 148.18 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 109.353 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 57.1 tp -84.08 118.63 24.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.188 -0.945 . . . . 0.0 109.961 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -137.3 138.85 40.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.46 ' CG1' HD23 ' A' ' 231' ' ' LEU . 54.7 t -135.52 123.35 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.142 -0.974 . . . . 0.0 110.032 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 62.0 m -109.87 129.34 55.65 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.426 -0.796 . . . . 0.0 109.239 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.402 ' CE1' ' HG2' ' A' ' 227' ' ' LYS . 63.8 t80 -119.17 131.43 55.85 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.52 -0.738 . . . . 0.0 109.888 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.404 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 26.6 tt0 -116.21 104.74 11.82 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.59 146.2 18.01 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.563 ' H ' HH11 ' A' ' 250' ' ' ARG . 1.8 tm-20 -119.59 86.11 2.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.603 -0.94 . . . . 0.0 109.01 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.467 ' O ' ' O ' ' A' ' 160' ' ' GLY . 11.7 m-85 -91.91 148.17 22.42 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.865 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -96.56 -4.99 40.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.277 -0.889 . . . . 0.0 109.445 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.813 HD21 HD12 ' A' ' 159' ' ' LEU . 19.3 p-10 -74.47 -167.25 0.52 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.008 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -58.8 -18.01 28.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.628 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.813 HD12 HD21 ' A' ' 157' ' ' ASN . 63.5 mt -72.74 -29.0 62.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 109.364 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 60.82 -121.39 26.43 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.1 mtm-85 -107.67 140.67 40.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.418 -1.048 . . . . 0.0 108.878 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -149.83 157.85 43.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.096 -1.002 . . . . 0.0 109.638 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -149.05 151.76 35.04 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.316 -0.865 . . . . 0.0 109.608 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -138.3 130.39 28.55 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.364 -0.835 . . . . 0.0 109.043 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 165' ' ' THR . 14.0 t -102.05 123.43 45.92 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -99.08 132.73 44.18 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.333 -0.854 . . . . 0.0 108.838 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.1 t -131.5 147.61 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.369 -0.832 . . . . 0.0 109.195 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 122.13 7.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.323 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.86 16.39 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -117.04 31.41 6.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.042 -1.27 . . . . 0.0 108.547 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 175' ' ' VAL . 44.6 mt-10 -59.58 -39.02 82.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.508 -0.745 . . . . 0.0 110.673 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 2.1 mp0 -52.5 -14.76 0.53 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.057 -1.027 . . . . 0.0 110.944 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.76 -4.05 48.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.818 -1.176 . . . . 0.0 111.153 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.6 pt -121.04 -7.73 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.027 -1.046 . . . . 0.0 111.033 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.1 OUTLIER -92.51 -28.71 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.552 -1.343 . . . . 0.0 110.104 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.46 1.23 56.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.957 -1.089 . . . . 0.0 110.849 -179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.51 119.42 22.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.738 -1.227 . . . . 0.0 108.888 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -87.28 151.61 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.007 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -53.15 160.42 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.0 109.264 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.525 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 33.0 p90 -142.1 169.76 16.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.864 -1.147 . . . . 0.0 109.794 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.6 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -161.04 159.67 29.6 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.184 -0.948 . . . . 0.0 109.898 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.67 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 70.8 m-85 -103.98 146.04 29.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.334 -0.854 . . . . 0.0 109.376 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.685 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.9 OUTLIER -63.79 -18.89 64.54 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 111.078 -179.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.67 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.2 p90 -79.55 -29.92 41.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.541 -1.35 . . . . 0.0 111.119 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.532 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -98.0 -11.67 22.78 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.754 -1.216 . . . . 0.0 109.764 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.1 mt -58.75 -52.59 58.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.15 -0.969 . . . . 0.0 110.008 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -51.01 -49.82 59.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 109.565 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -53.74 -52.86 58.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.221 -0.924 . . . . 0.0 109.047 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 82.6 mt -57.04 -33.99 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.842 . . . . 0.0 109.074 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mmmt -75.98 -25.55 55.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.507 -0.746 . . . . 0.0 110.103 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.92 -25.91 53.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.056 -1.028 . . . . 0.0 109.875 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 4.8 m -86.62 14.98 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.32 26.88 72.61 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.922 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -119.09 157.4 27.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.21 -1.171 . . . . 0.0 109.829 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.27 24.15 64.14 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.382 -0.914 . . . . 0.0 110.956 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -69.0 -20.88 64.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.669 -1.489 . . . . 0.0 109.014 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.44 -7.41 48.9 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.2 124.62 32.45 Favored Glycine 0 N--CA 1.491 2.345 0 O-C-N 121.21 -1.17 . . . . 0.0 110.218 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.83 169.82 16.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.764 -0.845 . . . . 0.0 109.34 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.8 mt -73.91 -5.68 42.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.213 -0.929 . . . . 0.0 109.634 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 2.0 ttpt -89.91 -4.73 57.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.498 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -153.09 18.45 0.57 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.52 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.6 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.7 m -149.59 128.65 12.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 0.0 109.7 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.588 HD21 HD23 ' A' ' 217' ' ' LEU . 68.3 tp -91.21 113.29 25.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 0.0 109.309 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.455 HG11 HEA3 ' A' ' 320' ' ' TUX . 63.4 t -100.79 127.5 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 0.0 109.474 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.444 HD21 HD21 ' A' ' 217' ' ' LEU . 61.3 mt -104.02 146.88 28.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.374 -0.829 . . . . 0.0 110.192 -179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -106.51 161.23 14.14 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -51.08 -28.11 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.125 -1.22 . . . . 0.0 109.48 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -155.07 14.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.833 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -141.22 149.28 41.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.18 -0.95 . . . . 0.0 110.039 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.0 t -101.18 128.01 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.6 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 33.7 m-85 -72.2 -54.4 9.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 110.105 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.582 HD22 ' H ' ' A' ' 213' ' ' ASN . 1.5 m-80 -53.3 137.27 49.79 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.928 -1.107 . . . . 0.0 109.505 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.24 -36.35 5.67 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.435 2.09 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -70.11 -4.29 20.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 109.797 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.84 -161.56 53.94 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.588 HD23 HD21 ' A' ' 204' ' ' LEU . 16.1 mt -83.37 145.01 29.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.492 -1.005 . . . . 0.0 109.889 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.594 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 14.1 ttt85 -80.72 -17.9 49.56 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 109.454 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.594 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 29.7 m-85 -148.79 164.86 33.16 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -72.79 -14.32 61.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.099 -1.0 . . . . 0.0 108.392 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 33.81 2.96 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.714 0.769 . . . . 0.0 108.96 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -55.87 -39.09 74.96 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 0.0 110.896 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.02 -41.57 1.95 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.091 1.861 . . . . 0.0 112.851 -179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.429 ' H ' HG22 ' A' ' 224' ' ' VAL . 10.7 m -78.32 -25.81 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 120.716 -1.24 . . . . 0.0 108.231 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.563 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 48.5 mtt180 -66.75 -41.22 88.14 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -65.1 -42.74 93.74 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.541 -0.724 . . . . 0.0 109.156 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.402 ' HG2' ' CE1' ' A' ' 151' ' ' TYR . 5.3 tptp -56.68 -48.32 77.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.252 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 70.5 t -58.62 -43.91 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.3 t80 -57.83 -36.98 73.03 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.51 ' O ' ' OD2' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -73.3 -43.12 61.53 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.648 -0.657 . . . . 0.0 109.968 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.46 HD23 ' CG1' ' A' ' 149' ' ' VAL . 26.2 tp -56.19 -34.3 66.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.48 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.662 HG22 ' HD1' ' A' ' 80' ' ' HIS . 34.4 mt -72.76 -48.18 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.15 -34.65 17.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.51 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 0.8 OUTLIER -82.65 -27.16 31.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.068 -1.254 . . . . 0.0 110.144 -179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 260' ' ' VAL . 4.9 mt -79.9 -23.76 41.59 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.739 -1.225 . . . . 0.0 110.133 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -72.45 -5.88 39.76 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.031 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 237' ' ' LEU . 33.6 mt -53.32 -27.88 25.5 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.307 -0.871 . . . . 0.0 108.745 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 97.4 mt -53.3 -9.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.243 -0.91 . . . . 0.0 109.168 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 237' ' ' LEU . . . 77.51 11.73 85.2 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 27.0 p -156.58 149.12 17.95 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.095 -1.238 . . . . 0.0 109.56 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 12.3 Cg_exo -48.38 138.48 23.68 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.211 1.941 . . . . 0.0 111.785 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 14.9 t -104.91 136.26 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 110.111 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.528 ' HB3' HG13 ' A' ' 125' ' ' VAL . 2.3 tppt? -124.55 127.78 47.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.433 -0.792 . . . . 0.0 109.62 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.53 177.2 30.41 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttm -107.43 112.7 25.62 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.215 -1.167 . . . . 0.0 109.861 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.6 m-85 -112.59 148.86 33.67 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.031 0.92 . . . . 0.0 111.647 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.404 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 25.1 t80 -128.24 144.29 51.11 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.6 t -142.46 128.99 20.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.683 -1.261 . . . . 0.0 110.778 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 250' ' ' ARG . 56.8 t80 -111.96 112.94 24.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.563 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.0 OUTLIER 47.36 56.1 7.39 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -85.39 149.4 23.68 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -121.69 165.33 14.63 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 91.3 m-70 -59.47 -44.53 92.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -1.192 . . . . 0.0 109.483 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 24.3 m -59.58 -40.94 89.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.178 -0.951 . . . . 0.0 109.641 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.1 tp -72.26 -35.93 68.9 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.049 -1.032 . . . . 0.0 108.711 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -61.88 -46.8 87.83 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.73 -44.73 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.291 -0.88 . . . . 0.0 108.726 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -55.23 -48.28 74.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 108.927 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 139' ' ' ILE . 26.2 tp -52.97 -43.07 66.1 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 235' ' ' LEU . 63.4 t -69.83 -44.92 78.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.423 -0.798 . . . . 0.0 109.373 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.6 -52.37 60.01 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.605 -0.684 . . . . 0.0 110.025 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -62.2 -46.39 89.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.064 -1.023 . . . . 0.0 110.01 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 26.2 mt -59.2 -44.87 92.23 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.147 -0.971 . . . . 0.0 109.508 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.89 -30.21 68.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 110.16 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -83.31 -30.46 27.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.813 -1.179 . . . . 0.0 108.778 179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 268' ' ' LYS . 34.7 mttp -56.24 -44.27 79.46 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.283 -0.886 . . . . 0.0 109.035 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.532 ' OE1' ' CE2' ' A' ' 124' ' ' PHE . 5.4 pt20 -76.06 19.68 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.492 -0.755 . . . . 0.0 109.773 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 269' ' ' LEU . 0.0 OUTLIER -64.07 -0.94 1.3 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.028 -1.045 . . . . 0.0 109.311 179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 268' ' ' LYS . 72.0 mt -43.76 -39.79 3.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.326 -0.859 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.496 -0.752 . . . . 0.0 109.418 179.902 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.6 HEA1 ' CE2' ' A' ' 212' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 42.1 mt-10 -56.31 137.79 51.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.091 -1.005 . . . . 0.0 108.921 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.6 141.01 52.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.432 -0.793 . . . . 0.0 109.882 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 t -137.79 172.74 12.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.547 -0.721 . . . . 0.0 109.07 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.21 137.86 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.771 -1.206 . . . . 0.0 110.538 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tttt -69.59 -47.97 61.76 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.658 -0.651 . . . . 0.0 109.785 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.93 158.37 38.03 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.626 0.727 . . . . 0.0 110.32 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -60.71 137.25 58.21 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.555 0.693 . . . . 0.0 110.315 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.07 154.63 31.73 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -146.71 145.1 29.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.879 -1.138 . . . . 0.0 110.126 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -133.51 160.45 37.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.386 -0.821 . . . . 0.0 109.568 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.68 135.91 22.68 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.911 -1.118 . . . . 0.0 109.004 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.3 158.6 18.03 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.448 HG23 ' N ' ' A' ' 22' ' ' GLU . 0.9 OUTLIER -86.17 143.06 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -1.231 . . . . 0.0 110.662 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.69 145.13 43.17 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -65.24 -41.91 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.053 -1.263 . . . . 0.0 112.073 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.543 ' CE1' HG23 ' A' ' 18' ' ' ILE . 3.9 m-70 -87.3 -38.85 15.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.047 -1.658 . . . . 0.0 111.073 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.2 p -74.21 -32.34 63.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 109.942 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.88 19.57 63.41 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' N ' HG23 ' A' ' 16' ' ' VAL . 2.8 mm-40 -109.87 150.24 28.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.958 . . . . 0.0 108.804 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CD1' ' N ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -70.98 135.65 47.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 0.0 109.823 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.63 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 13.0 t -143.45 157.88 44.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.211 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.728 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.0 tttt -132.62 157.07 45.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.728 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.2 mt -134.15 145.29 49.14 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.003 -1.061 . . . . 0.0 109.214 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.447 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -130.45 134.46 62.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.56 118.1 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.255 -0.903 . . . . 0.0 109.534 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.447 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 42.9 m-70 -115.23 150.11 43.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.74 158.13 48.17 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.194 1.929 . . . . 0.0 111.511 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 14.0 mm-40 -133.43 -178.04 4.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.89 . . . . 0.0 109.792 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.3 tptt -83.47 149.76 26.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.384 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 20.8 mp0 -47.25 149.64 0.98 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.258 -0.901 . . . . 0.0 109.748 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.705 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 59.08 23.47 57.29 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.141 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.8 ' H ' HD22 ' A' ' 86' ' ' ASN . 6.7 m -80.29 -41.83 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.735 -1.45 . . . . 0.0 109.278 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.459 ' CA ' ' O ' ' A' ' 85' ' ' THR . . . 98.64 -166.64 21.75 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.3 mm -107.6 121.54 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.348 -1.09 . . . . 0.0 108.219 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.08 143.62 46.74 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.663 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -103.09 153.24 20.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.561 -0.712 . . . . 0.0 109.29 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.545 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.1 t80 -128.77 145.46 51.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -172.96 135.79 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.89 -1.131 . . . . 0.0 109.603 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.64 29.78 14.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.389 -0.819 . . . . 0.0 109.889 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.58 27.93 70.28 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.7 t -131.62 134.58 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.0 109.428 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -94.19 140.39 29.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.932 . . . . 0.0 109.221 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.9 mt -134.08 94.53 18.1 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 110.059 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.84 145.37 18.59 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.294 1.996 . . . . 0.0 111.599 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.67 84.23 4.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.914 -1.116 . . . . 0.0 110.53 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -136.92 152.59 50.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.136 -0.977 . . . . 0.0 109.582 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 52' ' ' PHE . 10.2 p80 -51.1 -46.81 61.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.479 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -48.39 -17.16 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 110.059 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 50' ' ' HIS . 51.7 m-85 -95.66 3.53 53.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.814 -1.179 . . . . 0.0 109.641 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . 25.6 t -62.42 119.27 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 108.79 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.28 -26.49 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.277 -0.889 . . . . 0.0 110.573 -179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.59 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.9 t-160 -147.97 117.18 6.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.898 -1.126 . . . . 0.0 110.031 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.1 p -113.86 125.36 53.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.612 ' O ' ' N ' ' A' ' 59' ' ' SER . 22.1 t-20 -167.58 -152.41 0.12 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.593 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 9.8 t-80 -44.13 -15.75 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.612 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER -140.27 165.37 27.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.449 -0.782 . . . . 0.0 109.119 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 24.1 m -110.23 126.57 54.29 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.18 -0.95 . . . . 0.0 109.102 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.59 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.5 OUTLIER -128.12 147.15 50.53 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.184 0.992 . . . . 0.0 111.777 -178.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.465 ' CD1' HG21 ' A' ' 72' ' ' VAL . 34.8 mt -122.51 157.48 31.93 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.2 143.52 7.03 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 118.381 -1.866 . . . . 0.0 111.445 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -143.04 147.79 35.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.926 . . . . 0.0 109.44 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.9 mtpp 53.73 45.07 28.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.271 -0.893 . . . . 0.0 110.711 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.2 6.5 65.03 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.65 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.521 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 2.6 mm100 -101.26 140.91 34.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.973 -1.31 . . . . 0.0 108.39 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -142.84 149.66 38.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.888 -1.132 . . . . 0.0 111.52 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.1 mt -133.7 143.2 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -114.11 152.02 31.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.235 -0.916 . . . . 0.0 111.208 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m 53.57 70.04 0.64 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.778 -0.577 . . . . 0.0 111.152 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 ' CD1' ' A' ' 62' ' ' LEU . 27.3 m -113.84 -8.16 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.958 -1.089 . . . . 0.0 109.653 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.43 ' OE1' ' CE1' ' A' ' 253' ' ' HIS . 2.3 pt-20 -69.32 -20.43 63.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.274 -0.891 . . . . 0.0 110.518 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -69.33 -60.76 2.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.043 -1.036 . . . . 0.0 109.732 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.507 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -59.5 -43.77 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.03 -1.044 . . . . 0.0 109.072 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' N ' HG23 ' A' ' 75' ' ' ILE . 50.1 mt -55.42 -39.4 70.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.426 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.535 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 1.7 t -59.71 -47.57 85.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.202 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -57.05 -54.45 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.094 -1.004 . . . . 0.0 108.718 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.56 -44.06 62.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.472 -0.767 . . . . 0.0 109.277 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.506 ' HD1' ' CG2' ' A' ' 232' ' ' ILE . 15.8 t-160 -55.38 -58.17 8.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.312 -0.868 . . . . 0.0 109.792 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.6 mt -58.63 -37.71 76.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.144 -0.972 . . . . 0.0 110.001 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.613 HD22 ' CD1' ' A' ' 114' ' ' ILE . 10.5 mt -78.12 -7.18 56.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.169 -0.957 . . . . 0.0 110.334 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 61.17 53.2 3.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.87 -1.144 . . . . 0.0 110.074 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.9 mm -98.03 130.77 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.459 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -117.0 -19.34 9.82 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.315 -0.866 . . . . 0.0 112.263 -177.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.8 HD22 ' H ' ' A' ' 35' ' ' THR . 1.0 OUTLIER -126.83 111.13 13.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.72 -1.237 . . . . 0.0 110.464 -179.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.2 OUTLIER -165.66 137.93 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.15 -0.969 . . . . 0.0 109.889 179.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.518 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 20.5 m -111.01 99.67 8.5 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mp -89.86 110.36 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.324 -0.86 . . . . 0.0 109.862 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -85.99 123.05 30.88 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.24 115.66 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 110.999 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.78 ' N ' HD12 ' A' ' 92' ' ' ILE . 2.5 mp -99.32 108.76 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.54 -163.16 24.69 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -115.24 -16.05 11.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.491 -1.005 . . . . 0.0 110.143 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 19' ' ' HIS . 15.7 tt0 -138.47 145.33 40.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.021 -1.049 . . . . 0.0 110.219 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 96' ' ' ILE . 28.5 mm -67.91 127.13 93.33 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.55 -0.719 . . . . 0.0 109.426 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.701 ' CD ' HD21 ' A' ' 26' ' ' LEU . 62.5 Cg_exo -45.94 128.9 11.82 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.851 1.701 . . . . 0.0 111.953 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.413 HD11 ' HA2' ' A' ' 101' ' ' GLY . 8.5 tp -77.45 -28.21 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.299 -0.876 . . . . 0.0 109.672 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.436 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 14.4 mt 55.21 -109.99 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.401 -0.812 . . . . 0.0 110.145 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.54 -19.17 20.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -0.974 . . . . 0.0 110.728 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 112.61 -12.35 25.44 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 p -116.46 -169.3 1.59 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.42 -1.047 . . . . 0.0 109.707 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -110.59 -4.72 28.27 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.413 ' CD1' ' HG3' ' A' ' 108' ' ' GLU . 52.7 t-105 -46.98 -39.52 12.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.738 -0.86 . . . . 0.0 110.421 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -61.25 -51.47 68.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.0 110.07 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -65.48 -43.58 89.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.053 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.8 t80 -63.25 -37.34 86.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 109.565 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HG3' ' CD1' ' A' ' 104' ' ' TRP . 5.3 mm-40 -65.58 -54.85 22.19 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 0.0 111.898 -178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.5 13.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.732 -1.23 . . . . 0.0 111.135 -178.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.13 -45.41 80.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.991 -1.068 . . . . 0.0 110.92 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 15.1 ttt-85 -57.41 -29.69 64.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 0.0 109.816 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -80.19 -12.97 59.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.148 -0.97 . . . . 0.0 109.887 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -120.76 34.62 5.15 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.503 -0.748 . . . . 0.0 110.831 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.613 ' CD1' HD22 ' A' ' 82' ' ' LEU . 7.2 mt -87.47 147.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.885 -1.134 . . . . 0.0 110.586 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -130.59 133.4 46.15 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.494 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.5 OUTLIER -88.69 144.05 26.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.196 -0.94 . . . . 0.0 110.422 -179.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.533 ' NE2' ' OE2' ' A' ' 33' ' ' GLU . 9.7 mt-30 -107.27 -160.57 0.74 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.796 . . . . 0.0 109.207 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -120.44 3.37 10.77 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.274 -0.891 . . . . 0.0 110.735 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.94 151.16 19.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.854 -1.154 . . . . 0.0 109.966 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.5 141.06 29.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.194 -0.941 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 85' ' ' THR . 64.0 mt -83.31 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 0.0 110.531 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -90.79 93.14 9.1 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -66.94 146.92 53.88 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.303 -0.873 . . . . 0.0 110.797 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -104.62 128.7 52.72 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.39 142.84 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.177 -0.952 . . . . 0.0 110.247 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.2 t -80.96 134.07 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -114.72 -10.74 12.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.514 -0.741 . . . . 0.0 109.35 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.447 ' CD ' ' HZ3' ' A' ' 266' ' ' LYS . 7.1 pt-20 -143.1 144.06 27.3 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.15 148.76 39.91 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.223 1.949 . . . . 0.0 113.031 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.911 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.9 tt -139.05 151.59 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.578 -0.701 . . . . 0.0 109.911 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -133.03 119.76 37.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.599 -0.688 . . . . 0.0 109.321 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.82 117.28 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.373 -0.829 . . . . 0.0 109.963 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -106.03 142.49 35.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.323 -0.86 . . . . 0.0 108.96 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -158.85 120.3 3.41 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.605 -1.31 . . . . 0.0 112.298 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 44.97 42.91 6.75 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.857 -0.527 . . . . 0.0 112.345 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.64 1.94 85.06 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.547 -1.311 . . . . 0.0 110.387 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 17.3 mtt85 -102.76 163.88 11.96 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.887 HD23 ' N ' ' A' ' 139' ' ' ILE . 2.6 tt -160.14 146.49 15.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.357 -1.464 . . . . 0.0 109.276 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.887 ' N ' HD23 ' A' ' 138' ' ' LEU . 8.8 mt -145.91 129.7 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.998 -1.064 . . . . 0.0 108.253 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.34 139.39 51.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.271 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.911 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -117.34 151.57 36.72 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 108.925 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -150.34 139.52 13.16 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -60.0 145.82 97.45 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.692 1.595 . . . . 0.0 112.14 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -165.52 153.28 10.92 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.32 -0.863 . . . . 0.0 109.253 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -84.1 4.05 32.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.081 -1.012 . . . . 0.0 109.928 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 p -141.22 151.35 43.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.095 -1.003 . . . . 0.0 109.479 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.73 119.04 23.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 109.858 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -138.69 135.02 34.37 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.679 ' CG1' HD23 ' A' ' 231' ' ' LEU . 5.4 t -133.26 117.67 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 109.826 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 248' ' ' SER . 0.4 OUTLIER -103.83 133.87 48.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.198 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 224' ' ' VAL . 8.8 t80 -122.42 130.25 52.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.446 -0.784 . . . . 0.0 109.623 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -115.67 106.97 14.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.8 134.66 11.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -108.07 85.01 2.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.372 -1.075 . . . . 0.0 109.232 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -92.12 144.14 25.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -0.931 . . . . 0.0 109.632 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -95.96 -1.22 49.55 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.227 -0.921 . . . . 0.0 109.187 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.632 HD21 HD12 ' A' ' 159' ' ' LEU . 29.3 p-10 -71.32 -167.77 0.26 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.235 -0.915 . . . . 0.0 109.237 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -60.96 -23.25 65.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.29 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.632 HD12 HD21 ' A' ' 157' ' ' ASN . 55.5 mt -71.13 -22.78 62.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.166 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 59.1 -134.17 52.37 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -98.18 144.36 27.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.462 -1.022 . . . . 0.0 109.005 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -152.46 170.5 19.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.38 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.35 153.59 23.75 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.832 . . . . 0.0 109.381 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -138.21 130.31 28.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.439 -0.788 . . . . 0.0 109.161 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 165' ' ' THR . 14.5 t -102.42 123.13 45.63 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.169 -0.957 . . . . 0.0 110.052 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -99.13 134.58 41.76 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.405 -0.809 . . . . 0.0 108.871 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.89 149.59 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.416 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -51.04 116.86 2.19 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.369 -0.832 . . . . 0.0 109.211 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.18 5.51 17.1 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -134.66 29.97 3.49 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.193 -1.18 . . . . 0.0 108.974 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 175' ' ' VAL . 8.8 mt-10 -64.39 -35.17 80.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.568 -0.708 . . . . 0.0 110.854 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -60.2 -16.98 37.98 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.979 -1.076 . . . . 0.0 110.766 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HB3' ' HE ' ' A' ' 225' ' ' ARG . 81.2 mt-10 -85.48 -3.71 58.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.99 -1.069 . . . . 0.0 110.337 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.9 pt -124.03 -33.86 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.135 -0.978 . . . . 0.0 111.411 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -60.97 -29.98 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.479 -1.388 . . . . 0.0 110.424 -179.043 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -87.48 2.66 49.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.72 -1.238 . . . . 0.0 110.517 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.56 115.19 20.74 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.873 -1.142 . . . . 0.0 108.957 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.429 ' H ' ' HG2' ' A' ' 178' ' ' ARG . 26.6 ptt180 -86.48 153.03 22.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.159 -0.963 . . . . 0.0 109.863 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.0 t -59.93 131.35 50.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 109.848 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -109.89 172.62 6.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.3 -0.875 . . . . 0.0 109.855 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.573 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.5 OUTLIER -154.78 159.04 40.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.429 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 58.6 m-85 -104.25 144.35 31.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.417 -0.802 . . . . 0.0 109.424 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.754 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.5 OUTLIER -60.35 -24.36 65.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.943 -1.098 . . . . 0.0 110.535 -179.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.597 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.5 p90 -82.07 -32.0 30.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.73 -1.231 . . . . 0.0 110.449 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.597 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 18.3 pt-20 -86.55 -16.65 36.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.815 -1.178 . . . . 0.0 109.566 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.7 mt -57.57 -53.02 49.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.192 -0.942 . . . . 0.0 110.295 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -51.23 -50.74 58.57 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.775 -1.203 . . . . 0.0 109.738 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -52.73 -48.11 66.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.029 . . . . 0.0 109.008 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.433 HG21 H4A2 ' A' ' 320' ' ' TUX . 9.9 mt -60.29 -34.31 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.1 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -77.8 -29.37 50.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.517 -0.739 . . . . 0.0 110.239 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.15 -21.97 53.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.047 -1.033 . . . . 0.0 110.201 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.413 ' CG2' HD12 ' A' ' 194' ' ' LEU . 30.1 m -89.15 11.14 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.068 -1.02 . . . . 0.0 109.958 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.04 25.39 69.15 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.773 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.413 HD12 ' CG2' ' A' ' 192' ' ' VAL . 28.2 mt -124.52 162.98 22.85 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.119 -1.224 . . . . 0.0 109.87 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.466 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 78.32 22.93 66.67 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.189 178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -69.43 -21.04 63.78 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.652 -1.499 . . . . 0.0 109.779 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.0 -2.91 51.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.33 129.3 40.08 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.199 -1.177 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.01 176.81 8.38 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.783 -0.834 . . . . 0.0 109.257 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 86.0 mt -83.34 -11.97 57.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.937 . . . . 0.0 109.72 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 14.0 tttm -92.96 -4.73 52.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.168 -0.958 . . . . 0.0 109.525 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 201' ' ' LYS . 10.1 m120 -134.06 -13.82 2.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.896 . . . . 0.0 109.736 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 42.9 m -128.35 126.29 40.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.302 -0.874 . . . . 0.0 109.71 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.541 HD12 ' CG ' ' A' ' 213' ' ' ASN . 7.1 tp -84.4 110.33 18.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 108.866 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.0 t -101.59 132.15 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.587 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 71.6 mt -115.14 152.72 32.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 0.0 109.859 -179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -103.82 161.56 15.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 14.6 tttm -50.65 -24.67 3.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -1.169 . . . . 0.0 109.567 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -150.97 12.61 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.4 ttpt -144.43 152.5 40.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.115 -0.991 . . . . 0.0 110.228 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.6 t -101.98 127.96 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.446 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 30.1 m-85 -73.46 -54.1 9.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 110.275 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.541 ' CG ' HD12 ' A' ' 204' ' ' LEU . 3.7 m120 -56.0 133.51 74.01 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.981 -1.074 . . . . 0.0 109.723 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.58 -13.06 27.3 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.36 2.04 . . . . 0.0 112.584 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -87.37 -7.82 57.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.99 . . . . 0.0 109.89 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -167.24 51.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.7 144.3 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -1.061 . . . . 0.0 110.097 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.595 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.1 OUTLIER -79.86 -20.82 45.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 108.793 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 37.1 m-85 -148.53 154.91 40.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -58.59 -12.97 4.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 108.754 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.682 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -143.73 36.69 1.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.548 0.69 . . . . 0.0 109.261 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.599 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -59.84 -35.43 28.84 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 111.076 -179.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 7.0 Cg_exo -70.89 -46.2 0.82 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.87 1.713 . . . . 0.0 112.562 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.487 HG12 ' CE2' ' A' ' 151' ' ' TYR . 1.8 m -73.87 -22.63 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 120.804 -1.185 . . . . 0.0 108.195 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.682 ' NH1' ' ND2' ' A' ' 221' ' ' ASN . 5.5 mtt180 -69.88 -40.65 75.55 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.5 -42.9 95.54 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.419 -0.801 . . . . 0.0 108.911 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.41 -45.62 80.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.153 -0.967 . . . . 0.0 108.452 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 81.3 t -61.42 -45.12 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.535 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 91.4 t80 -53.77 -36.68 62.65 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -75.02 -40.05 60.74 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.632 -0.667 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.679 HD23 ' CG1' ' A' ' 149' ' ' VAL . 27.0 tp -56.32 -37.73 70.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.127 -0.983 . . . . 0.0 109.208 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.506 ' CG2' ' HD1' ' A' ' 80' ' ' HIS . 85.3 mt -71.6 -48.8 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.6 -31.86 23.13 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.6 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.5 OUTLIER -82.98 -26.63 31.13 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.221 -1.164 . . . . 0.0 109.941 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 260' ' ' VAL . 4.3 mt -79.39 -23.58 43.18 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.883 -1.136 . . . . 0.0 110.2 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.466 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 7.0 t80 -70.43 -6.43 35.65 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.004 -1.06 . . . . 0.0 109.033 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 237' ' ' LEU . 24.3 mt -53.34 -28.76 30.52 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.18 -18.06 23.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.0 108.73 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.96 70.64 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 26.5 p -156.29 150.76 20.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.118 -1.225 . . . . 0.0 109.357 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 5.4 Cg_endo -52.84 136.48 59.59 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.092 1.862 . . . . 0.0 111.572 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.4 t -102.24 138.01 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.109 -0.994 . . . . 0.0 110.221 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -125.61 128.42 47.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.47 -0.768 . . . . 0.0 109.078 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.4 175.99 28.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -106.55 109.68 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.208 -1.172 . . . . 0.0 109.732 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.0 m-85 -111.41 149.3 31.42 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.771 0.796 . . . . 0.0 110.835 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -126.26 144.43 50.79 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 150' ' ' THR . 0.7 OUTLIER -136.58 125.55 24.3 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 120.751 -1.218 . . . . 0.0 110.232 -178.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 250' ' ' ARG . 26.8 t80 -112.74 111.86 22.95 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 249' ' ' PHE . 26.5 mtp180 47.54 56.54 6.9 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.22 149.29 21.93 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -119.49 -174.6 15.72 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.43 ' CE1' ' OE1' ' A' ' 73' ' ' GLU . 71.1 m-70 -74.45 -42.41 59.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -1.144 . . . . 0.0 109.687 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -34.92 79.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 110.157 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.723 ' HG ' HD12 ' A' ' 139' ' ' ILE . 49.8 tp -72.76 -39.22 66.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.927 -1.108 . . . . 0.0 109.059 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -60.58 -50.6 72.87 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.298 -0.876 . . . . 0.0 108.897 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.4 t -53.23 -45.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.342 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -55.29 -48.87 73.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.134 -0.979 . . . . 0.0 109.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.555 HD22 HG21 ' A' ' 139' ' ' ILE . 27.0 tp -52.61 -43.76 65.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.337 -0.852 . . . . 0.0 108.921 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.435 HG22 HD23 ' A' ' 235' ' ' LEU . 24.3 t -69.96 -40.71 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.681 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -59.53 -50.13 75.08 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.634 -0.667 . . . . 0.0 110.132 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -69.0 -43.91 73.87 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.175 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 263' ' ' LEU . 30.0 mt -57.35 -48.8 78.08 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -55.82 -44.27 77.73 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.608 -0.683 . . . . 0.0 109.664 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 31.5 mttm -72.65 -34.13 67.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.799 -1.188 . . . . 0.0 109.457 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.739 ' HA ' HD12 ' A' ' 269' ' ' LEU . 20.5 mttm -62.77 -41.15 99.1 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.276 -0.89 . . . . 0.0 109.129 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 266' ' ' LYS . 0.5 OUTLIER -40.32 -40.16 1.1 Allowed 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.708 -0.62 . . . . 0.0 110.893 -179.271 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -102.33 29.32 5.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.837 -1.165 . . . . 0.0 110.816 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.739 HD12 ' HA ' ' A' ' 266' ' ' LYS . 9.5 mt -105.49 26.12 9.87 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.197 -0.939 . . . . 0.0 109.42 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.917 . . . . 0.0 109.353 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.573 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 21.9 mt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 31.0 mt-10 -49.28 142.12 7.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 109.128 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 133.9 55.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.428 -0.795 . . . . 0.0 110.102 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.8 t -138.33 175.42 9.59 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.9 m -83.42 141.18 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.751 -1.218 . . . . 0.0 110.203 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -72.55 -44.24 62.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.51 -0.744 . . . . 0.0 110.055 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -130.95 160.16 35.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.518 -0.738 . . . . 0.0 110.225 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.11 130.31 42.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.585 -0.697 . . . . 0.0 109.984 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.413 HD21 ' ND2' ' A' ' 113' ' ' ASN . 13.0 mt -114.95 169.81 8.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.447 -0.783 . . . . 0.0 108.998 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p -157.98 148.15 20.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.956 -1.09 . . . . 0.0 110.12 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -129.69 168.0 17.16 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.524 -0.735 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -154.93 135.05 13.08 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.857 -1.152 . . . . 0.0 109.182 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 171.79 158.23 15.41 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.544 HG23 ' C ' ' A' ' 22' ' ' GLU . 8.9 p -80.95 141.52 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -1.094 . . . . 0.0 110.749 -178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.68 148.4 41.73 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.5 tt -70.02 -40.41 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.0 113.043 -177.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 7.0 m-70 -86.04 -38.58 17.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 119.79 -1.819 . . . . 0.0 111.858 -177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -85.84 -27.21 25.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.713 -1.242 . . . . 0.0 109.157 -179.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 63.79 25.49 69.16 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.544 ' C ' HG23 ' A' ' 16' ' ' VAL . 3.0 tp10 -106.26 148.96 27.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.506 -0.996 . . . . 0.0 109.182 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -70.78 129.89 40.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 109.741 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.5 t -138.9 156.98 46.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.025 . . . . 0.0 108.915 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.505 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.5 tttt -133.22 153.48 51.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 109.206 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.515 HD21 ' CD ' ' A' ' 97' ' ' PRO . 3.2 mt -127.84 147.66 50.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.107 -0.996 . . . . 0.0 109.428 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.472 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.9 mt -137.91 122.41 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -112.13 127.4 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.892 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.554 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 2.4 m-70 -119.98 148.8 47.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -58.94 161.64 15.15 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.015 1.81 . . . . 0.0 111.096 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 5.7 mm-40 -135.02 -172.27 3.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.215 -0.928 . . . . 0.0 109.777 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 0.3 OUTLIER -90.69 155.41 18.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.339 -0.851 . . . . 0.0 109.738 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 33' ' ' GLU . 40.3 mp0 -46.78 142.68 3.2 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.137 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.598 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 58.69 29.89 64.91 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.372 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 25.9 m -80.66 -37.56 30.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.631 -1.511 . . . . 0.0 108.67 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.03 -177.54 35.37 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.6 mm -100.85 124.67 54.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.02 140.09 36.13 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 118.608 -1.237 . . . . 0.0 111.311 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -94.11 150.01 20.71 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.487 ' CD1' ' OE1' ' A' ' 90' ' ' GLU . 16.7 t80 -134.36 139.91 45.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.36 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.465 ' CD ' ' O ' ' A' ' 91' ' ' VAL . 16.7 ttpt -174.02 147.33 1.27 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.642 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 56.6 29.45 15.62 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.388 -0.82 . . . . 0.0 109.911 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.8 73.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.8 t -135.97 143.01 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -1.165 . . . . 0.0 109.352 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -101.45 146.03 28.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mt -138.51 94.55 10.56 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.861 . . . . 0.0 110.017 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -48.93 145.0 14.24 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.337 2.025 . . . . 0.0 111.854 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.97 81.28 5.13 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.92 -1.112 . . . . 0.0 110.463 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -137.68 155.46 49.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.026 . . . . 0.0 109.503 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.566 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.2 p80 -52.22 -49.38 64.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.235 -0.916 . . . . 0.0 109.917 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CG ' ' A' ' 50' ' ' HIS . 11.3 mt-10 -44.0 -16.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.197 -0.939 . . . . 0.0 110.164 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.8 m-85 -97.45 2.9 50.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.94 -1.1 . . . . 0.0 109.804 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.449 HG23 ' HA ' ' A' ' 50' ' ' HIS . 52.1 t -62.83 119.37 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 109.059 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -111.56 -29.36 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.333 -0.855 . . . . 0.0 109.986 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 3.0 t-160 -150.82 120.82 7.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -0.962 . . . . 0.0 109.652 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.2 p -111.94 133.04 54.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 16.1 p-10 -166.61 -153.42 0.16 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.403 ' C ' ' O ' ' A' ' 57' ' ' ASN . 5.2 m170 -47.47 -11.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.118 -0.989 . . . . 0.0 108.694 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -139.22 166.49 24.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.41 -0.806 . . . . 0.0 109.768 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.5 m -101.38 120.69 40.66 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -117.52 134.97 54.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.189 -0.945 . . . . 0.0 111.238 -178.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.569 HD12 HG21 ' A' ' 72' ' ' VAL . 29.6 mt -123.69 156.5 35.8 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.494 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.73 145.44 7.96 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 118.709 -1.71 . . . . 0.0 111.028 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -144.67 151.5 39.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.539 -0.977 . . . . 0.0 109.891 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp 55.47 24.02 6.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.366 -0.834 . . . . 0.0 110.894 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.71 1.23 68.36 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.632 -1.27 . . . . 0.0 110.557 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.494 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 29.9 mm100 -96.59 137.46 35.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.889 -1.36 . . . . 0.0 108.299 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -130.76 144.62 51.58 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.23 -0.919 . . . . 0.0 111.358 -178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.2 mt -130.81 140.22 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -114.13 145.64 41.38 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.111 -0.993 . . . . 0.0 111.098 -178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m 56.06 68.82 0.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.785 -0.572 . . . . 0.0 111.46 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 HD12 ' A' ' 62' ' ' LEU . 34.5 m -113.92 -3.62 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.097 -1.002 . . . . 0.0 108.99 178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.491 ' OE1' ' OD1' ' A' ' 234' ' ' ASP . 10.8 pt-20 -69.45 -33.05 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 110.328 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.456 ' CE1' ' CE1' ' A' ' 226' ' ' HIS . 17.6 m170 -61.9 -59.9 4.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.034 -1.041 . . . . 0.0 110.099 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 106' ' ' PHE . 2.9 tp -55.47 -41.73 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.669 -1.269 . . . . 0.0 108.515 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 79' ' ' LEU . 70.3 mt -60.68 -35.05 75.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.84 . . . . 0.0 109.478 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 47.1 t -61.04 -49.25 78.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.789 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.413 HG23 ' HZ ' ' A' ' 229' ' ' PHE . 23.2 t -58.52 -52.81 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.03 -1.044 . . . . 0.0 108.594 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 76' ' ' LEU . 22.6 mt -50.77 -43.11 58.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 0.0 108.999 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.546 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 7.0 t-160 -54.28 -56.19 20.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.578 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.35 -36.7 76.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.963 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' A' ' 84' ' ' ILE . 35.2 mt -79.31 -9.38 59.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 0.0 110.549 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 63.14 61.88 1.05 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.813 -1.179 . . . . 0.0 110.431 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 82' ' ' LEU . 12.2 mm -102.38 132.29 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 48.4 p -118.82 -22.54 7.33 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.264 -0.897 . . . . 0.0 111.889 -178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.72 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.4 m-80 -129.39 111.69 13.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.924 -1.11 . . . . 0.0 110.279 -179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.72 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.5 m -164.86 135.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.868 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.48 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 44.1 m -103.28 99.66 9.52 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.0 mt -86.82 120.94 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.359 -0.838 . . . . 0.0 109.89 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' OE1' ' CD1' ' A' ' 40' ' ' PHE . 7.8 mt-10 -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.813 -1.179 . . . . 0.0 108.1 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' ' CD ' ' A' ' 41' ' ' LYS . 60.0 t -105.63 107.22 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 111.101 -178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.63 109.14 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.58 -160.25 23.09 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -123.24 -15.9 7.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -1.008 . . . . 0.0 110.415 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.54 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.5 pm0 -131.94 137.6 48.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.0 110.22 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.6 mm -68.75 129.6 92.34 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.245 -0.909 . . . . 0.0 109.768 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.515 ' CD ' HD21 ' A' ' 26' ' ' LEU . 50.3 Cg_exo -46.83 129.07 14.13 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.407 2.072 . . . . 0.0 112.782 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 16' ' ' VAL . 7.6 tp -76.93 -25.93 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.457 -0.777 . . . . 0.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.448 ' O ' ' CG ' ' A' ' 202' ' ' ASN . 70.6 mt 55.33 -116.07 1.01 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.45 -0.781 . . . . 0.0 109.988 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -94.03 -18.09 22.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.115 -0.991 . . . . 0.0 110.13 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 114.53 -16.74 19.1 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 p -108.33 -169.72 1.55 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -1.098 . . . . 0.0 109.516 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.97 -3.94 21.34 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.469 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 64.9 t-105 -46.68 -39.18 10.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.785 -0.832 . . . . 0.0 110.418 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.06 -51.75 66.73 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 109.728 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 62.5 m-85 -62.61 -45.92 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.105 -0.997 . . . . 0.0 108.828 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.01 -37.41 84.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.693 -0.629 . . . . 0.0 110.097 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 23.1 mm-40 -69.91 -48.81 57.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.313 -0.867 . . . . 0.0 111.773 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.29 -51.27 13.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.793 -1.192 . . . . 0.0 111.273 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.5 mt -62.81 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.984 -1.073 . . . . 0.0 110.875 -178.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -56.18 -29.89 61.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 0.0 110.194 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -82.66 -13.59 56.17 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.064 -1.023 . . . . 0.0 110.08 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.413 ' ND2' HD21 ' A' ' 11' ' ' LEU . 3.2 m-20 -118.0 32.2 6.28 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.44 -0.787 . . . . 0.0 111.206 -178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 82' ' ' LEU . 7.6 mt -86.57 148.49 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.534 -1.354 . . . . 0.0 110.029 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.1 tp -131.26 158.17 41.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.579 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.3 OUTLIER -103.09 142.01 34.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.179 -0.951 . . . . 0.0 109.62 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -109.08 -167.09 1.17 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 110.104 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -118.75 69.05 0.8 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.615 -0.678 . . . . 0.0 110.407 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 4' ' ' GLU . 23.4 ttt85 -165.78 143.91 5.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -83.84 128.8 34.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 109.948 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.583 HG12 HG21 ' A' ' 85' ' ' THR . 79.0 mt -71.09 140.69 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.0 86.7 7.15 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -61.83 146.06 50.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 110.769 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.77 121.83 42.8 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.4 t -124.72 138.63 53.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.541 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.8 t -81.81 139.68 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -122.25 -10.57 8.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.529 -0.732 . . . . 0.0 109.441 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -141.12 125.61 10.54 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.184 -0.947 . . . . 0.0 110.141 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -51.12 154.33 7.85 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.007 1.804 . . . . 0.0 113.124 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.602 HG22 ' HB3' ' A' ' 141' ' ' ALA . 2.4 tt -145.49 146.01 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.649 -0.657 . . . . 0.0 109.638 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.5 mt -134.55 119.54 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.364 -0.835 . . . . 0.0 109.691 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.4 m -119.66 120.49 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 0.0 109.257 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -123.0 142.07 51.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.401 -0.812 . . . . 0.0 110.517 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 1.5 t70 178.03 153.32 0.31 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 58.6 mm-40 56.37 23.55 7.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.612 -0.68 . . . . 0.0 110.868 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.05 7.76 86.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.546 ' HB2' HD22 ' A' ' 255' ' ' LEU . 69.7 mtt180 -105.16 168.6 8.96 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.985 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.0 tt -160.78 152.42 19.54 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.117 -1.614 . . . . 0.0 109.456 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.985 ' N ' HD23 ' A' ' 138' ' ' LEU . 17.9 mt -148.78 142.53 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.036 . . . . 0.0 108.74 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -130.0 137.52 50.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 0.0 109.598 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.602 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -116.98 151.67 36.24 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -150.05 137.22 11.37 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.53 144.97 49.34 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 121.189 1.259 . . . . 0.0 111.964 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.29 149.84 10.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.336 -0.852 . . . . 0.0 109.369 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.46 -0.33 52.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.273 -0.892 . . . . 0.0 109.268 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 74.4 p -133.29 142.77 48.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 242' ' ' VAL . 16.4 tp -78.5 119.64 22.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.764 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -139.43 139.58 37.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.32 -0.862 . . . . 0.0 108.77 179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.522 ' CG1' HD23 ' A' ' 231' ' ' LEU . 13.9 t -137.86 122.68 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.169 -0.957 . . . . 0.0 109.543 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 99.8 m -111.37 141.11 45.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 0.0 109.951 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.499 ' HE2' HG12 ' A' ' 224' ' ' VAL . 10.5 t80 -125.56 130.27 51.37 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.611 -0.68 . . . . 0.0 109.896 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 16.6 tt0 -113.17 107.39 15.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.44 ' C ' ' OE2' ' A' ' 154' ' ' GLU . . . -107.14 131.37 10.6 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.577 ' H ' HH11 ' A' ' 250' ' ' ARG . 0.9 OUTLIER -117.8 88.25 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -1.004 . . . . 0.0 109.053 179.087 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 3.6 m-30 -85.98 148.67 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.112 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -87.25 -10.49 52.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.343 -0.848 . . . . 0.0 110.687 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.48 HD21 HD12 ' A' ' 159' ' ' LEU . 17.8 p-10 -66.18 -167.01 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.99 -1.069 . . . . 0.0 109.461 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -64.97 -23.08 67.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.258 -0.901 . . . . 0.0 110.291 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.48 HD12 HD21 ' A' ' 157' ' ' ASN . 9.3 mt -56.74 -50.45 72.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.997 -1.065 . . . . 0.0 109.188 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 89.93 -121.78 6.29 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.16 140.2 50.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.534 -0.98 . . . . 0.0 109.791 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -153.15 131.66 12.18 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.357 -0.839 . . . . 0.0 109.467 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.09 149.67 39.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.544 -0.722 . . . . 0.0 109.163 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -134.83 121.07 20.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.831 . . . . 0.0 109.086 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.539 HG23 ' O ' ' A' ' 165' ' ' THR . 10.1 t -100.9 123.1 44.6 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.14 -0.975 . . . . 0.0 110.199 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 3.0 t80 -100.88 134.43 43.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.407 -0.808 . . . . 0.0 108.852 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.469 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.3 t -130.88 149.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.507 -0.746 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -53.69 122.68 10.38 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.283 -0.885 . . . . 0.0 109.383 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.55 -14.95 17.59 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.93 32.3 6.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -1.16 . . . . 0.0 108.555 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -63.76 -34.33 77.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.503 -0.748 . . . . 0.0 110.474 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.9 -15.36 8.39 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 0.0 110.691 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.596 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 13.7 mm-40 -91.07 -4.01 56.68 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.941 -1.099 . . . . 0.0 110.823 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.0 pt -125.0 10.22 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.945 -1.097 . . . . 0.0 111.199 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -103.03 -27.99 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.853 -1.154 . . . . 0.0 109.604 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mt -88.5 3.72 49.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.968 -1.082 . . . . 0.0 110.638 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.97 123.01 27.98 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.808 -1.182 . . . . 0.0 109.018 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 1.5 ptt-85 -95.56 155.42 16.75 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.12 -0.987 . . . . 0.0 110.23 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 t -56.34 155.31 7.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.445 -0.784 . . . . 0.0 109.493 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.526 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 26.4 p90 -139.66 168.29 20.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.047 -1.033 . . . . 0.0 109.684 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.526 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -162.7 162.27 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -102.82 147.55 26.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.272 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.719 ' HA ' HD12 ' A' ' 186' ' ' ILE . 6.9 p-10 -64.27 -19.53 65.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 110.933 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.496 ' CD1' ' C ' ' A' ' 184' ' ' TRP . 2.8 p90 -81.79 -26.01 34.77 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.67 -1.269 . . . . 0.0 110.449 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.415 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 25.9 pt-20 -96.8 -17.29 20.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.926 -1.109 . . . . 0.0 109.36 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' A' ' 183' ' ' ASP . 9.5 mt -56.86 -51.41 68.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.47 -0.769 . . . . 0.0 110.326 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -51.21 -52.26 46.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.995 -1.066 . . . . 0.0 109.553 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.747 ' O ' HG13 ' A' ' 192' ' ' VAL . 7.6 m80 -52.94 -45.03 67.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.107 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.37 -33.71 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.26 -0.9 . . . . 0.0 109.025 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -78.82 -25.7 44.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.894 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.7 mttp -80.73 -26.68 37.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.177 -0.952 . . . . 0.0 110.119 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 188' ' ' HIS . 4.6 m -82.06 7.74 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.152 -0.968 . . . . 0.0 109.721 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 83.76 20.18 60.22 Favored Glycine 0 N--CA 1.492 2.415 0 O-C-N 121.139 -0.976 . . . . 0.0 110.91 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.63 163.93 20.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.055 -1.262 . . . . 0.0 109.906 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.478 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.77 17.83 74.28 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.063 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -66.32 -22.18 66.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.695 -1.473 . . . . 0.0 110.279 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.31 -5.87 51.79 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.38 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.47 124.66 35.35 Favored Glycine 0 N--CA 1.491 2.366 0 O-C-N 121.055 -1.262 . . . . 0.0 110.697 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 52.0 p -135.44 171.94 13.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.718 -0.872 . . . . 0.0 109.204 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 13.1 mt -76.48 -13.74 60.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -0.953 . . . . 0.0 109.749 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.488 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 16.9 tttp -89.05 -8.55 53.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.672 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 37.1 m-20 -141.12 12.83 2.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.199 -0.938 . . . . 0.0 110.096 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.5 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 8.2 m -148.99 117.75 6.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.055 -1.028 . . . . 0.0 109.564 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.704 HD21 HD23 ' A' ' 217' ' ' LEU . 7.3 tp -79.89 115.38 19.45 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -0.979 . . . . 0.0 109.185 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.464 HG21 HCA3 ' A' ' 320' ' ' TUX . 84.3 t -100.61 125.3 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.141 -0.974 . . . . 0.0 109.79 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 217' ' ' LEU . 3.8 mt -103.43 147.05 27.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.497 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -106.28 148.4 16.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 207' ' ' GLY . 51.9 mttm -42.32 -29.66 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.176 -1.191 . . . . 0.0 110.045 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -147.34 11.97 1.03 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.913 -1.117 . . . . 0.0 110.57 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 207' ' ' GLY . 12.5 tttp -147.44 156.69 43.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.023 . . . . 0.0 109.998 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.467 HG11 ' HA2' ' A' ' 216' ' ' GLY . 62.6 t -103.11 128.25 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.5 -54.28 8.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.46 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.462 ' CG ' HD12 ' A' ' 204' ' ' LEU . 14.7 m120 -55.02 137.16 66.63 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.002 -1.062 . . . . 0.0 109.577 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.16 -19.04 26.57 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.346 2.031 . . . . 0.0 112.545 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -85.19 -8.88 58.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -0.987 . . . . 0.0 109.927 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.61 -165.74 53.46 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.704 HD23 HD21 ' A' ' 204' ' ' LEU . 26.5 mt -79.13 145.05 33.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.349 -1.089 . . . . 0.0 109.639 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -71.49 -57.41 4.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.936 . . . . 0.0 108.877 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.687 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 13.1 m-85 -117.05 148.85 41.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.462 -0.774 . . . . 0.0 109.029 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.09 -13.98 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.933 . . . . 0.0 109.164 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -132.84 38.77 3.37 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.868 0.842 . . . . 0.0 108.783 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.511 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 1.6 tp10 -57.34 -48.48 97.27 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.36 -0.837 . . . . 0.0 111.265 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 33.3 Cg_endo -69.47 -37.95 9.12 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.525 1.483 . . . . 0.0 113.218 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.499 HG12 ' HE2' ' A' ' 151' ' ' TYR . 1.8 m -79.39 -25.39 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.609 -1.307 . . . . 0.0 108.506 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.687 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 16.4 mtp180 -67.72 -43.75 79.24 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.542 ' CD2' ' OD2' ' A' ' 230' ' ' ASP . 56.2 t60 -62.86 -41.59 99.44 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -43.23 81.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 0.0 108.779 179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 224' ' ' VAL . 60.7 t -65.8 -47.54 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 42.5 t80 -49.86 -47.54 51.69 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' CD2' ' A' ' 226' ' ' HIS . 2.8 m-20 -70.61 -35.19 72.83 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.522 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.1 tp -55.55 -35.97 66.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.096 -1.002 . . . . 0.0 108.41 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.487 HG22 ' HD1' ' A' ' 80' ' ' HIS . 74.4 mt -70.15 -48.16 63.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.03 -34.44 16.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.503 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 6.1 m-20 -80.58 -27.08 37.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.993 -1.298 . . . . 0.0 109.665 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.1 mt -82.54 -26.31 32.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.111 . . . . 0.0 109.593 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.546 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 21.7 t80 -67.14 -7.69 25.32 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.985 . . . . 0.0 108.635 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.43 ' HA ' HD23 ' A' ' 237' ' ' LEU . 39.3 mt -50.24 -30.05 10.86 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.504 HD12 HG22 ' A' ' 242' ' ' VAL . 96.5 mt -56.79 -19.88 19.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.185 -0.947 . . . . 0.0 108.712 179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.83 16.29 73.13 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 83.1 p -158.79 145.16 12.57 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.991 -1.3 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.438 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 82.4 Cg_exo -41.06 129.49 2.99 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 122.343 2.029 . . . . 0.0 111.924 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.504 HG22 HD12 ' A' ' 238' ' ' LEU . 81.9 t -97.11 130.51 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -0.961 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -117.91 123.09 44.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.494 -0.754 . . . . 0.0 109.539 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 172.58 24.86 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.26 112.19 25.11 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.177 -1.19 . . . . 0.0 109.95 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.2 m-85 -112.22 147.58 35.9 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.989 0.9 . . . . 0.0 110.931 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 139' ' ' ILE . 28.1 t80 -131.85 134.71 46.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.17 128.9 44.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.86 -1.15 . . . . 0.0 110.218 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 250' ' ' ARG . 6.6 t80 -112.01 115.17 28.48 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.577 HH11 ' H ' ' A' ' 154' ' ' GLU . 1.2 mmp_? 48.28 56.28 7.64 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -93.55 152.54 20.88 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.443 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -119.49 -169.9 14.37 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.478 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 89.5 m-70 -78.9 -49.59 12.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.065 -1.256 . . . . 0.0 109.522 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -33.93 71.89 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.96 . . . . 0.0 109.35 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 137' ' ' ARG . 42.6 tp -72.89 -40.0 65.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 0.0 108.612 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.443 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 88.2 m-20 -60.0 -51.24 70.52 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.31 -43.89 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.41 -0.806 . . . . 0.0 109.148 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -54.4 -47.68 72.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.041 . . . . 0.0 108.832 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.12 -46.35 72.15 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.3 -44.92 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.0 109.413 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.0 ttpt -51.69 -51.71 53.88 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.555 -0.716 . . . . 0.0 110.161 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.57 -49.5 76.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.0 110.102 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.94 -42.55 98.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.002 -1.061 . . . . 0.0 109.489 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.4 84.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.336 -0.853 . . . . 0.0 109.858 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -76.15 -31.66 58.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.944 -1.098 . . . . 0.0 108.755 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.1 mttp -62.96 -45.44 92.43 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.436 -0.79 . . . . 0.0 108.941 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 269' ' ' LEU . 2.2 tp-100 -74.95 10.27 1.54 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.35 -0.844 . . . . 0.0 109.475 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.93 -7.09 2.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.184 -0.948 . . . . 0.0 108.88 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 267' ' ' GLN . 18.2 mt -75.47 -59.63 2.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 0.0 109.414 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.464 -0.772 . . . . 0.0 109.421 179.902 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.464 HCA3 HG21 ' A' ' 205' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.572 ' O ' HD11 ' A' ' 121' ' ' ILE . 7.5 mt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -45.11 127.94 7.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.992 -1.068 . . . . 0.0 109.237 179.44 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 132.82 55.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.458 -0.776 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.0 t -133.6 174.41 10.46 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 7' ' ' VAL . 2.9 m -83.26 132.3 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.821 -1.175 . . . . 0.0 110.343 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -62.32 -49.21 76.52 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.541 -0.724 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -126.12 155.58 41.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.548 -0.72 . . . . 0.0 110.42 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -59.53 137.57 57.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.63 -0.669 . . . . 0.0 109.957 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.96 162.16 19.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.56 145.68 25.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.979 -1.075 . . . . 0.0 109.971 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.432 ' C ' ' OE1' ' A' ' 14' ' ' GLU . 67.3 m-85 -128.96 161.43 29.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.752 . . . . 0.0 109.158 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' OE1' ' C ' ' A' ' 13' ' ' PHE . 4.3 pm0 -151.47 132.47 14.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.871 -1.143 . . . . 0.0 108.73 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.01 157.69 15.44 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.015 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.48 ' CG2' ' C ' ' A' ' 21' ' ' GLY . 3.3 p -74.32 160.21 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.274 -1.133 . . . . 0.0 111.317 -178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.05 138.69 14.65 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.0 tt -60.34 -46.16 95.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.101 -1.235 . . . . 0.0 112.236 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.494 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 5.2 m-70 -86.57 -37.36 18.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.103 -1.623 . . . . 0.0 110.729 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -76.22 -40.11 52.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.012 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.48 ' C ' ' CG2' ' A' ' 16' ' ' VAL . . . 73.42 4.72 65.46 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -93.41 152.4 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.37 -1.076 . . . . 0.0 108.985 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 16.0 t80 -73.6 133.49 43.51 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.085 -1.01 . . . . 0.0 110.141 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 t -137.47 157.82 45.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.175 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.711 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.7 ttmt -132.8 155.7 48.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.305 -0.872 . . . . 0.0 109.136 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 25' ' ' LYS . 1.9 mt -132.17 144.19 50.5 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.156 -0.965 . . . . 0.0 109.175 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.4 mt -134.57 123.35 41.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.8 mt -111.73 127.58 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 0.0 109.811 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -119.63 152.67 53.63 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.66 157.8 40.38 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.275 1.983 . . . . 0.0 111.474 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.499 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 8.2 mm-40 -131.84 -173.15 3.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.233 -0.917 . . . . 0.0 109.832 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.494 ' O ' ' OG1' ' A' ' 35' ' ' THR . 9.5 tttt -91.66 153.77 19.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.587 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.64 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 28.1 mp0 -47.99 146.25 2.62 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.236 -0.915 . . . . 0.0 110.239 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.4 25.03 59.97 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.685 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.557 ' H ' ' ND2' ' A' ' 86' ' ' ASN . 55.2 m -81.59 -36.96 28.39 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.516 -1.579 . . . . 0.0 108.875 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.534 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 92.47 -170.24 32.37 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 mm -100.73 124.2 54.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.26 143.17 44.13 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.454 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -104.26 153.25 21.23 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.55 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.8 t80 -129.48 140.79 51.17 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 136.42 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.021 -1.05 . . . . 0.0 109.681 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.57 29.2 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.275 -0.891 . . . . 0.0 110.097 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.17 22.54 78.51 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.869 -1.157 . . . . 0.0 110.218 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.31 134.1 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.302 -1.117 . . . . 0.0 109.74 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -86.25 147.59 26.02 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 108.955 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.534 HD11 ' HB2' ' A' ' 67' ' ' GLN . 10.5 mt -143.1 94.66 6.28 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 110.29 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.82 142.72 14.22 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.191 1.927 . . . . 0.0 111.848 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -96.54 87.42 4.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.066 -1.021 . . . . 0.0 110.345 -179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.51 159.24 42.63 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 0.0 109.418 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.671 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 3.3 p80 -53.3 -49.68 66.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.258 -0.901 . . . . 0.0 110.248 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -48.28 -16.14 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.048 -1.033 . . . . 0.0 110.224 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 50' ' ' HIS . 32.8 m-85 -97.45 5.77 49.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 109.597 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.407 ' HA ' HD23 ' A' ' 62' ' ' LEU . 15.7 t -64.2 122.71 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 108.861 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.6 m -112.61 -29.53 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.337 -0.852 . . . . 0.0 110.376 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -146.36 118.17 8.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.867 -1.146 . . . . 0.0 110.354 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.7 p -110.88 126.97 55.26 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 59' ' ' SER . 40.3 t-20 -166.36 -153.34 0.16 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.478 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 63.6 m-70 -46.69 -13.02 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.016 -1.053 . . . . 0.0 108.499 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.6 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.4 t -139.18 165.84 26.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.499 -0.751 . . . . 0.0 109.327 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.46 ' OG1' ' CD ' ' A' ' 73' ' ' GLU . 0.8 OUTLIER -108.82 125.34 51.86 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.89 146.33 49.87 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.04 0.924 . . . . 0.0 111.397 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 53' ' ' VAL . 16.6 mt -125.92 156.33 39.9 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -175.36 147.57 8.96 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 118.203 -1.951 . . . . 0.0 111.446 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -144.48 149.5 36.07 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.773 -0.84 . . . . 0.0 109.282 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.99 32.54 22.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.322 -0.861 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.82 6.82 89.17 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 119.672 -1.251 . . . . 0.0 110.614 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.534 ' HB2' HD11 ' A' ' 46' ' ' ILE . 86.8 mm-40 -106.63 140.17 39.93 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.114 -1.227 . . . . 0.0 107.886 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.403 ' CZ ' HD21 ' A' ' 94' ' ' ASN . 23.3 ptt-85 -143.22 159.74 41.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.031 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -134.26 139.55 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -108.52 148.09 30.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 0.0 111.243 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 m 56.53 70.88 0.61 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.691 -0.63 . . . . 0.0 111.16 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.9 m -113.7 -4.08 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.064 -1.022 . . . . 0.0 109.169 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.602 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 1.0 OUTLIER -68.19 -33.15 73.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.229 -0.919 . . . . 0.0 110.838 -178.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.572 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 35.2 m170 -64.13 -60.25 3.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.845 -1.159 . . . . 0.0 109.988 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 76' ' ' LEU . 11.3 tp -55.92 -45.33 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.853 -1.155 . . . . 0.0 108.751 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.514 ' N ' HG23 ' A' ' 75' ' ' ILE . 47.1 mt -54.71 -40.92 69.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.551 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.553 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.0 t -59.61 -46.92 87.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 110.012 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.3 t -58.52 -50.84 77.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 76' ' ' LEU . 46.2 mt -51.32 -44.13 61.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.347 -0.845 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.764 ' HD1' HG22 ' A' ' 232' ' ' ILE . 12.1 t-160 -56.89 -49.93 74.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 110.363 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.1 mt -63.78 -38.02 89.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.282 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.68 HD13 HD11 ' A' ' 114' ' ' ILE . 52.4 mt -81.58 -5.59 58.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.961 -1.087 . . . . 0.0 111.025 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 62.74 59.09 1.47 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.764 -1.21 . . . . 0.0 110.299 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 82' ' ' LEU . 10.6 mm -98.24 125.18 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.459 HG21 HG23 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -110.97 -23.09 11.17 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.299 -0.876 . . . . 0.0 111.394 -178.042 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.559 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.4 m120 -131.19 112.17 12.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.049 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -162.01 138.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.326 -0.859 . . . . 0.0 109.404 179.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.499 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 26.5 m -111.17 99.42 8.27 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.75 112.74 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.396 -0.815 . . . . 0.0 109.536 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -90.29 119.83 30.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.2 t -102.84 106.99 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.148 -0.97 . . . . 0.0 110.936 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 mp -86.75 109.79 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.78 -158.65 22.32 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.403 HD21 ' CZ ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -122.13 -14.27 7.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.558 -0.966 . . . . 0.0 110.137 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -134.86 140.18 45.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.066 -1.021 . . . . 0.0 110.452 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mm -68.35 126.95 93.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.531 -0.731 . . . . 0.0 109.134 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.695 ' CD ' HD21 ' A' ' 26' ' ' LEU . 69.4 Cg_exo -46.36 128.52 12.39 Favored 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.865 1.71 . . . . 0.0 112.003 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.1 tp -76.24 -22.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.41 -0.807 . . . . 0.0 109.724 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 73.5 mt 54.84 -118.36 1.29 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.487 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -94.3 -11.03 30.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.079 -1.013 . . . . 0.0 110.225 -179.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.74 -11.04 32.53 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 76.4 p -115.51 -169.47 1.58 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.433 -1.039 . . . . 0.0 109.785 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -113.56 0.62 24.82 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.575 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 67.5 t-105 -46.52 -44.25 17.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.737 -0.861 . . . . 0.0 110.584 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -60.21 -51.36 69.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.785 -1.197 . . . . 0.0 109.719 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -61.18 -45.64 93.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.075 -1.015 . . . . 0.0 109.154 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -60.56 -39.92 89.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.962 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -74.24 -42.93 58.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.242 -0.911 . . . . 0.0 111.43 -179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.61 -46.9 35.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.871 -1.143 . . . . 0.0 110.883 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 110' ' ' ILE . 53.9 mt -70.96 -39.57 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.991 -1.068 . . . . 0.0 110.853 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -56.11 -31.42 63.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.801 -1.187 . . . . 0.0 109.745 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -83.97 -5.29 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 0.0 110.221 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -126.62 31.37 5.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.423 -0.798 . . . . 0.0 111.309 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 82' ' ' LEU . 4.7 mt -89.2 145.53 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.474 -1.391 . . . . 0.0 109.601 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.6 tp -131.97 158.64 40.94 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -106.96 145.5 32.19 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.113 -0.992 . . . . 0.0 109.525 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -112.39 -163.82 0.88 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.404 -0.81 . . . . 0.0 109.989 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -118.1 69.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.577 -0.702 . . . . 0.0 110.438 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.489 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -161.58 140.69 9.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.137 -0.977 . . . . 0.0 109.348 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -81.56 126.4 31.67 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.19 -0.944 . . . . 0.0 110.07 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.572 HD11 ' O ' ' A' ' 3' ' ' LEU . 66.7 mt -73.48 143.0 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 110.55 -179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -92.9 97.26 10.63 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.7 146.53 52.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.63 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -99.76 123.53 44.1 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.549 HG22 ' HB2' ' A' ' 243' ' ' LYS . 12.0 t -125.5 140.88 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.302 -0.874 . . . . 0.0 110.303 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 51.0 t -83.93 137.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.568 -0.708 . . . . 0.0 109.134 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -116.05 -11.55 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.524 -0.735 . . . . 0.0 109.252 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.05 144.92 39.95 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.205 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.12 172.75 14.12 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.266 1.977 . . . . 0.0 112.814 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.66 HG23 ' HB3' ' A' ' 141' ' ' ALA . 0.8 OUTLIER -165.24 142.69 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.619 -0.676 . . . . 0.0 109.53 -179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.1 mt -127.99 126.86 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.477 -0.765 . . . . 0.0 109.555 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 132' ' ' VAL . 14.7 m -125.29 119.03 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.772 . . . . 0.0 109.679 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -117.42 138.23 51.97 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.364 -0.835 . . . . 0.0 109.7 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -172.1 142.69 1.44 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.001 -1.062 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 56.1 28.25 12.68 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.612 -0.68 . . . . 0.0 111.187 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.15 8.53 86.95 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.468 ' NE ' ' O ' ' A' ' 251' ' ' GLY . 6.7 mtt85 -104.68 168.05 9.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.98 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -160.66 149.55 16.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.066 -1.646 . . . . 0.0 109.459 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.98 ' N ' HD23 ' A' ' 138' ' ' LEU . 56.0 mt -149.39 136.11 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.02 -1.05 . . . . 0.0 108.435 179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.9 tttm -126.28 142.74 51.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 109.707 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.66 ' HB3' HG23 ' A' ' 130' ' ' ILE . . . -123.68 145.63 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -142.78 136.62 14.47 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -51.94 146.95 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.552 1.501 . . . . 0.0 112.142 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.72 152.76 8.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.269 -0.895 . . . . 0.0 109.171 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.4 1.75 47.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 109.642 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.4 p -137.44 145.21 42.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.584 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 242' ' ' VAL . 58.2 tp -79.09 116.81 19.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.2 -0.938 . . . . 0.0 109.678 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -137.62 135.95 37.06 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.476 HG11 HD23 ' A' ' 231' ' ' LEU . 95.8 t -136.85 127.02 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.027 -1.046 . . . . 0.0 109.758 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 m -114.13 128.45 56.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -0.823 . . . . 0.0 109.365 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.514 ' CB ' HG22 ' A' ' 228' ' ' VAL . 91.6 t80 -115.3 129.42 56.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.52 -0.738 . . . . 0.0 109.365 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -115.27 105.62 13.09 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.86 132.88 11.39 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -115.37 84.12 2.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.992 . . . . 0.0 108.977 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.9 m-30 -93.14 148.78 21.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 0.0 109.794 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.422 ' HZ2' ' CB ' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -85.18 -13.28 50.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.239 -179.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 159' ' ' LEU . 9.4 p-10 -66.18 -175.23 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.054 -1.029 . . . . 0.0 109.633 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -55.02 -18.37 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 0.0 110.253 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.752 ' H ' ' ND2' ' A' ' 157' ' ' ASN . 20.4 mt -66.79 -32.31 73.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.954 -1.091 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 63.5 -118.08 12.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -115.11 138.95 50.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.987 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -150.14 153.48 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.331 -0.856 . . . . 0.0 109.349 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.47 150.88 41.11 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 109.724 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -134.84 124.17 24.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 m -96.96 121.9 39.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.98 -1.075 . . . . 0.0 110.015 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -98.81 135.07 40.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.369 -0.832 . . . . 0.0 109.141 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.55 150.7 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.376 -0.828 . . . . 0.0 109.475 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -53.02 117.05 2.7 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.394 -0.817 . . . . 0.0 109.248 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.51 5.62 18.56 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -132.19 27.73 4.47 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.212 -1.17 . . . . 0.0 108.57 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.84 -31.44 72.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.533 -0.73 . . . . 0.0 110.572 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -61.3 -15.82 39.38 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.993 -1.067 . . . . 0.0 110.907 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -91.52 -4.28 55.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.847 -1.158 . . . . 0.0 110.694 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.1 pt -121.64 16.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.088 -1.007 . . . . 0.0 110.85 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.48 -34.29 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.021 -1.049 . . . . 0.0 109.703 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.7 2.44 45.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.916 -1.115 . . . . 0.0 110.379 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.99 112.96 18.87 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 120.788 -1.195 . . . . 0.0 108.94 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 100' ' ' ASP . 5.8 ptp180 -85.9 152.93 22.57 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.082 -1.011 . . . . 0.0 110.255 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.574 ' N ' ' CE1' ' A' ' 226' ' ' HIS . 5.4 t -53.98 159.02 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.328 -0.857 . . . . 0.0 109.227 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 10.3 p90 -139.94 168.09 20.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.019 -1.05 . . . . 0.0 109.571 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.648 ' SG ' HG22 ' A' ' 203' ' ' THR . 0.0 OUTLIER -156.72 160.0 38.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.15 -0.969 . . . . 0.0 109.749 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.59 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 93.8 m-85 -103.47 146.6 28.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.307 -0.871 . . . . 0.0 109.746 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.702 ' HA ' HD12 ' A' ' 186' ' ' ILE . 26.4 p-10 -59.99 -24.27 64.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.109 -0.994 . . . . 0.0 110.884 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.59 ' CH2' ' CD2' ' A' ' 182' ' ' PHE . 4.1 p90 -80.44 -28.78 37.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.748 -1.22 . . . . 0.0 110.682 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 22.4 pt-20 -93.6 -13.84 27.19 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.0 109.423 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.702 HD12 ' HA ' ' A' ' 183' ' ' ASP . 8.9 mt -59.32 -53.74 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 121.249 -0.907 . . . . 0.0 110.158 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.83 -38.03 54.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.815 -1.178 . . . . 0.0 109.212 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 192' ' ' VAL . 1.8 t-80 -61.17 -59.33 5.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.25 -0.906 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 20.5 mt -53.76 -33.19 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 109.493 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -75.0 -25.36 58.76 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -83.1 -31.68 27.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.165 -0.96 . . . . 0.0 111.028 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 188' ' ' HIS . 0.5 OUTLIER -77.97 12.54 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.894 -1.129 . . . . 0.0 109.606 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.65 58.32 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.168 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 5.1 mt -127.09 165.34 19.71 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.063 -1.257 . . . . 0.0 110.16 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 79.14 23.0 64.34 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.238 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -68.58 -22.32 64.47 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.599 -1.53 . . . . 0.0 109.504 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -5.65 50.73 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.31 126.86 36.7 Favored Glycine 0 N--CA 1.492 2.394 0 O-C-N 121.124 -1.221 . . . . 0.0 110.837 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.78 -173.53 3.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.82 -0.812 . . . . 0.0 109.202 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 29.4 mt -90.18 -12.8 37.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.089 -1.007 . . . . 0.0 109.657 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -89.5 -3.47 58.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 202' ' ' ASN . 0.1 OUTLIER -145.12 13.98 1.46 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 109.696 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.648 HG22 ' SG ' ' A' ' 181' ' ' CYS . 0.8 OUTLIER -149.26 117.48 6.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.138 -0.976 . . . . 0.0 109.609 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.415 HD12 ' CG ' ' A' ' 213' ' ' ASN . 8.3 tp -79.0 115.72 18.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.413 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.567 HG11 HEA3 ' A' ' 320' ' ' TUX . 77.4 t -102.68 123.99 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.078 -1.014 . . . . 0.0 109.596 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.741 HD21 HD21 ' A' ' 217' ' ' LEU . 18.0 mt -103.1 149.21 24.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.321 -0.862 . . . . 0.0 109.653 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.89 153.5 17.1 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -48.35 -24.96 1.39 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -1.203 . . . . 0.0 109.891 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.87 13.32 0.7 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 110.208 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 207' ' ' GLY . 13.5 pttt -149.62 159.7 44.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.958 -1.089 . . . . 0.0 109.734 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.479 HG11 ' HA2' ' A' ' 216' ' ' GLY . 46.2 t -107.45 130.39 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.447 -0.783 . . . . 0.0 109.205 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.612 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 27.3 m-85 -73.13 -53.04 12.01 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.203 -0.936 . . . . 0.0 109.721 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.567 HD22 ' H ' ' A' ' 213' ' ' ASN . 2.0 m-80 -54.09 139.74 53.89 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 109.557 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.14 -31.71 11.7 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.476 2.117 . . . . 0.0 112.796 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.43 -9.91 59.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.135 -0.978 . . . . 0.0 110.185 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.33 -164.49 53.83 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.741 HD21 HD21 ' A' ' 206' ' ' LEU . 22.4 mt -73.6 141.59 46.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 0.0 109.847 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 15.8 mtt180 -81.81 -13.87 57.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 108.956 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 38.5 m-85 -147.8 142.25 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -0.782 . . . . 0.0 109.125 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.473 ' N ' ' OE1' ' A' ' 220' ' ' GLU . 2.0 mm-40 -49.66 -11.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.04 -1.038 . . . . 0.0 108.398 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -141.88 43.49 1.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 122.073 0.94 . . . . 0.0 108.803 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.589 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.1 tt0 -62.89 -36.87 28.45 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.363 -0.836 . . . . 0.0 111.928 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 9.4 Cg_endo -76.72 -41.07 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 121.398 1.398 . . . . 0.0 112.521 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 228' ' ' VAL . 4.0 m -75.82 -23.8 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.869 -1.144 . . . . 0.0 108.231 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 10.7 mtt180 -70.36 -46.71 63.55 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.574 ' CE1' ' N ' ' A' ' 179' ' ' THR . 22.5 t60 -58.06 -42.4 85.41 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 108.91 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -59.68 -43.33 94.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.018 -1.052 . . . . 0.0 109.0 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 224' ' ' VAL . 52.3 t -60.1 -47.03 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.23 -0.919 . . . . 0.0 108.745 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.553 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 47.4 t80 -49.79 -45.2 49.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.742 -0.599 . . . . 0.0 109.513 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.572 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 5.9 m-20 -73.82 -33.48 64.19 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 109.68 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.476 HD23 HG11 ' A' ' 149' ' ' VAL . 22.4 tp -56.68 -39.17 73.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 0.0 108.679 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.764 HG22 ' HD1' ' A' ' 80' ' ' HIS . 36.1 mt -71.27 -47.97 57.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.07 -32.87 9.63 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.573 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -82.28 -26.81 32.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.199 -1.177 . . . . 0.0 109.798 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.447 HD23 HG22 ' A' ' 260' ' ' VAL . 5.4 mt -83.22 -23.58 32.73 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.851 -1.156 . . . . 0.0 109.908 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.503 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 35.0 t80 -73.52 -9.03 58.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.1 -1.0 . . . . 0.0 109.143 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -51.16 -25.95 6.07 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.256 -0.902 . . . . 0.0 108.589 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 77.0 mt -55.3 -17.81 5.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 108.998 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.61 13.94 74.55 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 71.9 p -158.79 145.93 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.935 -1.332 . . . . 0.0 110.009 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.421 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 73.0 Cg_exo -41.96 135.36 3.8 Favored 'Trans proline' 0 C--N 1.314 -1.263 0 C-N-CA 122.229 1.953 . . . . 0.0 111.655 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.507 ' O ' HD13 ' A' ' 147' ' ' LEU . 20.5 t -103.77 132.77 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.138 -0.976 . . . . 0.0 109.9 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.549 ' HB2' HG22 ' A' ' 125' ' ' VAL . 10.3 mmtm -121.05 125.51 47.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.465 -0.772 . . . . 0.0 109.03 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.63 179.47 32.56 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -105.37 138.98 40.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.336 -1.097 . . . . 0.0 109.737 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.7 m-85 -140.67 144.59 35.76 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.066 0.936 . . . . 0.0 111.298 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -129.27 144.23 51.15 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.4 t -140.74 127.84 20.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.643 -1.286 . . . . 0.0 110.745 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -112.83 114.67 27.31 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 6.5 mtp-105 51.18 55.67 9.15 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.468 ' O ' ' NE ' ' A' ' 137' ' ' ARG . . . -63.39 -167.74 0.98 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -169.59 165.52 38.91 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.602 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 21.2 m-70 -70.91 -52.32 20.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -1.18 . . . . 0.0 109.68 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -54.32 47.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 108.703 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 139' ' ' ILE . 48.8 tp -51.45 -40.83 60.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.471 -0.768 . . . . 0.0 109.284 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.445 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 97.0 m-20 -58.57 -55.19 38.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -0.98 . . . . 0.0 108.592 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 61.7 t -48.94 -42.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.348 -0.845 . . . . 0.0 109.517 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -50.0 71.19 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.967 -1.083 . . . . 0.0 109.131 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.8 tp -52.16 -43.2 63.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 108.684 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.447 HG22 HD23 ' A' ' 235' ' ' LEU . 46.2 t -69.83 -46.2 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.314 -0.866 . . . . 0.0 109.364 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.15 -51.5 64.08 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.652 -0.655 . . . . 0.0 110.147 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -64.62 -45.43 86.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.013 -1.054 . . . . 0.0 109.571 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 263' ' ' LEU . 16.5 mt -58.69 -46.91 86.23 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.745 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.16 -30.12 68.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 110.79 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -88.86 -23.38 22.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.602 -1.311 . . . . 0.0 108.856 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -75.66 -45.97 34.05 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.436 -0.79 . . . . 0.0 109.745 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -84.15 7.65 18.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.895 . . . . 0.0 109.979 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.626 ' CB ' ' NZ ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -76.46 1.83 15.42 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.116 -0.99 . . . . 0.0 109.56 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 97.0 mt -79.77 -75.1 0.27 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.146 -0.971 . . . . 0.0 109.357 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.338 -0.851 . . . . 0.0 109.459 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.612 HEA1 ' CE2' ' A' ' 212' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.929 HD12 ' OD1' ' A' ' 116' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.374 0.606 . . . . 0.0 109.432 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.575 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 9.8 mm-40 -52.33 134.77 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.844 . . . . 0.0 109.669 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 tttp -117.34 132.51 56.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 0.0 109.369 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -134.16 173.71 11.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.373 -0.829 . . . . 0.0 109.106 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 m -81.78 144.36 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.173 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HG3' HD13 ' A' ' 115' ' ' LEU . 18.2 ttpp -78.37 -42.36 30.6 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.711 . . . . 0.0 110.379 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -131.92 157.82 43.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' CD ' ' C ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -63.39 133.87 54.76 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.518 -0.739 . . . . 0.0 109.849 -179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 113' ' ' ASN . 20.4 mt -121.04 163.22 18.66 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -155.31 149.38 25.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.05 -1.031 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -128.84 164.76 22.36 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -148.28 133.04 17.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.897 -1.127 . . . . 0.0 108.573 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.38 163.38 23.32 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -92.74 149.22 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.99 -1.3 . . . . 0.0 111.275 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.93 148.4 39.65 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.4 tt -67.06 -41.28 86.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.186 -1.184 . . . . 0.0 112.58 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.523 ' CE1' HG23 ' A' ' 18' ' ' ILE . 4.6 m-70 -86.93 -39.24 15.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.889 -1.757 . . . . 0.0 111.114 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.08 -31.67 64.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 110.018 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.83 21.22 65.13 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -112.96 151.55 30.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.65 -0.912 . . . . 0.0 109.338 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -72.4 142.96 48.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.091 -1.006 . . . . 0.0 110.179 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 t -148.2 158.52 44.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.267 -0.896 . . . . 0.0 109.267 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' O ' HD23 ' A' ' 26' ' ' LEU . 56.5 tttp -133.42 152.85 51.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.308 -0.87 . . . . 0.0 109.009 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.624 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.1 mt -127.81 153.71 46.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.126 -0.984 . . . . 0.0 109.667 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mt -139.37 128.8 29.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.28 124.68 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.163 -0.961 . . . . 0.0 109.699 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -123.62 153.53 66.37 Favored Pre-proline 0 N--CA 1.49 1.529 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.86 163.5 35.25 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.177 1.918 . . . . 0.0 111.171 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 30.2 mm-40 -138.81 -171.81 3.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.08 -1.012 . . . . 0.0 109.869 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.9 ttpm? -88.83 150.54 22.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.478 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.615 ' H ' ' CD ' ' A' ' 33' ' ' GLU . 15.5 mp0 -49.34 149.91 2.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.372 -0.83 . . . . 0.0 110.251 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.537 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 59.69 23.66 58.92 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.431 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.47 ' H ' ' CG ' ' A' ' 86' ' ' ASN . 28.9 m -81.8 -46.3 14.37 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.498 -1.589 . . . . 0.0 109.214 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.548 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 103.19 -170.63 19.82 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 85' ' ' THR . 4.0 mm -98.9 126.89 51.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.204 -1.174 . . . . 0.0 107.987 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -139.61 141.13 37.14 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.788 -1.165 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -105.04 155.28 19.13 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.4 t80 -130.7 141.76 50.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 108.916 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -170.26 137.03 1.45 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.091 -1.005 . . . . 0.0 109.838 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.41 31.93 19.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.261 -0.899 . . . . 0.0 109.921 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.38 21.24 74.13 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 77.3 t -125.76 133.33 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.999 . . . . 0.0 109.467 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -91.11 143.99 26.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.187 -0.946 . . . . 0.0 109.29 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.1 mt -137.75 97.69 10.04 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 109.979 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.09 143.16 32.84 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.169 1.913 . . . . 0.0 111.416 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.84 81.34 5.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.877 -1.139 . . . . 0.0 110.396 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.6 ttm-85 -139.29 156.4 47.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.48 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.5 p80 -55.07 -50.04 70.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -44.9 -15.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.001 -1.062 . . . . 0.0 110.192 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' HIS . 65.5 m-85 -99.14 6.12 46.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.98 -1.075 . . . . 0.0 109.629 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' A' ' 50' ' ' HIS . 31.7 t -58.65 131.66 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 0.0 108.844 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.4 m -118.81 -35.16 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.315 -0.866 . . . . 0.0 109.833 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.568 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 6.5 t-160 -152.23 123.1 7.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.122 -0.986 . . . . 0.0 109.496 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.6 p -113.3 133.14 55.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.627 -0.67 . . . . 0.0 109.311 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.591 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.1 p-10 -166.81 -153.91 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.58 ' O ' ' NXH' ' A' ' 320' ' ' TUX . 55.8 m-70 -47.07 -12.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.055 -1.028 . . . . 0.0 108.623 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.591 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER -135.02 165.75 24.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.514 -0.741 . . . . 0.0 109.553 179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.413 ' OG1' ' OE1' ' A' ' 73' ' ' GLU . 52.3 m -102.51 121.38 42.24 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.568 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -118.49 135.39 54.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.294 -0.879 . . . . 0.0 111.52 -178.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mt -124.1 161.05 26.41 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.55 147.32 7.25 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.395 -1.86 . . . . 0.0 111.454 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -144.68 151.21 38.6 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.572 -0.958 . . . . 0.0 109.407 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mttm 58.77 24.24 12.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.499 -0.751 . . . . 0.0 110.96 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' C ' HE21 ' A' ' 67' ' ' GLN . . . 90.26 1.31 75.59 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.642 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.488 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.0 mm-40 -103.15 140.15 37.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.006 -1.29 . . . . 0.0 108.394 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.423 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -140.28 157.17 45.98 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.025 -1.07 . . . . 0.0 111.51 -179.148 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.6 mt -133.86 143.67 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -115.06 155.95 26.07 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.292 -0.88 . . . . 0.0 111.38 -178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 m 53.85 65.09 1.61 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.705 -0.622 . . . . 0.0 111.129 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG12 ' CG1' ' A' ' 96' ' ' ILE . 18.1 m -113.85 -4.34 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.045 -1.035 . . . . 0.0 109.475 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.581 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 7.1 pt-20 -65.16 -34.69 79.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.115 -0.991 . . . . 0.0 110.879 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -59.28 -60.07 4.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.0 110.207 -179.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.506 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 2.8 tp -58.46 -46.73 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.825 -1.172 . . . . 0.0 109.197 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 10.8 mt -51.97 -42.18 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.019 -1.051 . . . . 0.0 109.566 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.578 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 44.9 t -59.49 -47.45 85.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.191 -0.943 . . . . 0.0 110.02 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.44 -54.08 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.979 -1.075 . . . . 0.0 108.623 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.9 mt -52.2 -45.23 65.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.422 -0.799 . . . . 0.0 109.321 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.425 ' NE2' ' HA ' ' A' ' 241' ' ' PRO . 8.2 t-160 -53.11 -58.12 8.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 65.4 mt -59.61 -35.04 73.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.43 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.702 HD22 ' CD1' ' A' ' 114' ' ' ILE . 12.9 mt -83.02 -1.47 52.76 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.056 -1.027 . . . . 0.0 110.88 -178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 61.92 26.7 16.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.729 -1.232 . . . . 0.0 110.75 179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 82' ' ' LEU . 15.4 mm -73.36 118.89 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.737 -1.227 . . . . 0.0 108.313 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.456 HG21 ' OE2' ' A' ' 4' ' ' GLU . 47.9 p -101.98 -75.41 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.258 -0.901 . . . . 0.0 111.135 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.4 m120 -81.67 113.52 19.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 111.638 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.1 m -163.86 143.35 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.563 -0.711 . . . . 0.0 109.283 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.568 HG22 ' OE1' ' A' ' 90' ' ' GLU . 4.0 m -111.15 104.5 13.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 0.0 109.411 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.74 112.9 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.568 ' OE1' HG22 ' A' ' 88' ' ' THR . 0.2 OUTLIER -89.33 118.99 29.4 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 86.1 t -100.65 108.63 23.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 111.142 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.45 107.17 16.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.57 -178.99 16.4 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -99.96 -10.61 21.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.272 . . . . 0.0 110.962 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -139.35 143.99 38.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.736 -1.227 . . . . 0.0 110.639 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.446 ' CG1' HG12 ' A' ' 72' ' ' VAL . 9.8 mm -71.3 131.34 86.82 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.535 -0.728 . . . . 0.0 109.349 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.624 ' CD ' HD21 ' A' ' 26' ' ' LEU . 53.0 Cg_exo -46.65 131.43 15.92 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 122.005 1.804 . . . . 0.0 112.499 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 8.2 tp -79.95 -29.85 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.424 ' O ' ' OD1' ' A' ' 202' ' ' ASN . 88.8 mt 56.18 -116.0 0.97 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.268 -0.895 . . . . 0.0 109.702 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.26 -7.48 41.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.14 -0.975 . . . . 0.0 110.294 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.89 -9.71 56.83 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.7 p -111.18 -172.21 1.98 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.46 -1.024 . . . . 0.0 109.78 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.84 -2.96 20.43 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -46.53 -41.29 14.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.733 -0.863 . . . . 0.0 111.011 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.89 -51.67 67.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.846 -1.159 . . . . 0.0 110.223 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 77.3 m-85 -62.95 -45.38 92.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.066 -1.021 . . . . 0.0 109.029 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.67 -39.21 87.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.612 -0.68 . . . . 0.0 109.876 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -73.19 -44.8 59.25 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.246 -0.909 . . . . 0.0 111.397 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.73 -48.35 22.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.825 -1.172 . . . . 0.0 111.035 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.08 -42.53 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.083 . . . . 0.0 111.08 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.1 ttp85 -57.44 -28.21 63.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.027 -1.046 . . . . 0.0 109.982 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -78.81 -14.63 59.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.822 -1.174 . . . . 0.0 109.996 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.615 ' HB2' HD11 ' A' ' 11' ' ' LEU . 12.5 m-80 -120.45 34.14 5.33 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.439 -0.788 . . . . 0.0 110.809 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.702 ' CD1' HD22 ' A' ' 82' ' ' LEU . 15.0 mt -87.41 148.48 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.665 -1.272 . . . . 0.0 111.155 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD13 ' HG3' ' A' ' 8' ' ' LYS . 13.9 tp -131.75 165.48 23.67 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.929 ' OD1' HD12 ' A' ' 3' ' ' LEU . 29.6 t-20 -118.76 142.58 47.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.29 -0.881 . . . . 0.0 109.92 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.27 -161.65 0.88 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.317 -0.864 . . . . 0.0 109.228 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -117.17 0.37 12.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.391 -0.818 . . . . 0.0 110.401 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 4' ' ' GLU . 24.0 ttm-85 -94.73 150.04 20.62 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 0.0 109.857 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -87.57 135.56 33.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.227 -0.921 . . . . 0.0 110.015 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 85' ' ' THR . 66.1 mt -77.63 145.53 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.41 -0.806 . . . . 0.0 110.729 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -93.46 96.41 9.88 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -69.64 147.13 51.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.399 -0.813 . . . . 0.0 110.69 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -101.16 127.06 47.9 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 243' ' ' LYS . 48.3 t -131.36 145.23 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.164 -0.96 . . . . 0.0 110.361 -179.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.1 t -83.17 135.29 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -116.44 -11.84 11.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.456 -0.778 . . . . 0.0 109.162 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -141.36 141.57 23.68 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.384 -0.822 . . . . 0.0 108.849 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.96 145.84 46.02 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.958 1.772 . . . . 0.0 113.007 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.888 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.7 tt -138.01 149.11 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.62 -0.675 . . . . 0.0 109.186 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.95 122.94 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.521 -0.737 . . . . 0.0 109.915 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.44 124.94 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.548 -0.72 . . . . 0.0 109.29 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -123.64 140.6 52.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.602 -0.686 . . . . 0.0 110.286 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 179.76 154.42 0.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.244 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 56.62 22.75 7.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.601 -0.687 . . . . 0.0 110.872 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.442 ' O ' ' NH2' ' A' ' 250' ' ' ARG . . . 77.37 6.63 86.64 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.497 ' HB2' HD22 ' A' ' 255' ' ' LEU . 2.5 mtt85 -107.84 172.09 7.03 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.942 HD23 ' N ' ' A' ' 139' ' ' ILE . 8.6 tt -159.79 153.22 22.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.213 -1.554 . . . . 0.0 109.563 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.942 ' N ' HD23 ' A' ' 138' ' ' LEU . 2.2 mt -144.14 143.87 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 0.0 108.57 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -132.51 136.91 46.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 109.568 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.888 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -117.38 146.1 43.64 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -144.15 137.73 14.3 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -55.59 143.83 77.25 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.406 1.404 . . . . 0.0 111.718 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.03 148.05 11.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.235 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.64 -1.28 46.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.221 -0.924 . . . . 0.0 109.5 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -134.91 143.91 47.2 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.302 -0.874 . . . . 0.0 109.565 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 242' ' ' VAL . 34.0 tp -76.88 118.24 19.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.001 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -139.42 138.29 36.37 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.46 ' CG1' HD23 ' A' ' 231' ' ' LEU . 55.4 t -133.94 129.05 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.148 -0.97 . . . . 0.0 109.876 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.402 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 32.6 m -115.8 135.85 53.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.346 -0.846 . . . . 0.0 109.309 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 224' ' ' VAL . 8.1 t80 -128.84 131.8 47.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.993 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -116.86 107.49 14.67 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -104.79 124.23 7.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.66 91.58 3.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -1.066 . . . . 0.0 109.426 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.496 ' HB2' HD21 ' A' ' 157' ' ' ASN . 21.2 m-85 -88.97 148.5 23.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.631 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -95.88 -2.19 47.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 109.894 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.611 HD22 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -72.98 -173.36 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.962 . . . . 0.0 109.461 -179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -59.53 -27.58 66.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.96 . . . . 0.0 109.917 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.624 HD22 ' NE2' ' A' ' 162' ' ' GLN . 7.6 mt -57.89 -45.01 87.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.991 -1.068 . . . . 0.0 108.938 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.67 -135.95 13.36 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -110.03 144.72 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.533 -0.981 . . . . 0.0 109.68 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.624 ' NE2' HD22 ' A' ' 159' ' ' LEU . 12.2 mt-30 -151.44 149.2 29.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -132.73 150.56 52.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 0.0 109.396 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -141.16 142.74 34.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.234 -0.916 . . . . 0.0 108.859 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 13.8 m -124.18 130.32 52.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.858 . . . . 0.0 110.417 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -99.38 130.81 45.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.1 t -127.6 151.3 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.476 -0.765 . . . . 0.0 109.168 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -54.75 115.67 2.29 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.346 -0.846 . . . . 0.0 109.506 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.56 3.28 20.67 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -130.97 29.58 4.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -1.165 . . . . 0.0 108.898 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -62.65 -35.15 78.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.378 -0.826 . . . . 0.0 110.699 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -53.39 -14.72 0.82 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.958 -1.089 . . . . 0.0 110.949 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' O ' ' NH2' ' A' ' 225' ' ' ARG . 23.4 mt-10 -97.4 -4.24 38.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.75 -1.219 . . . . 0.0 111.543 -178.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.598 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.8 pt -119.87 12.51 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 120.879 -1.138 . . . . 0.0 111.614 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.51 -28.16 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.891 -1.13 . . . . 0.0 109.854 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 2.65 54.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.979 -1.076 . . . . 0.0 111.259 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.473 ' HB2' ' NH1' ' A' ' 225' ' ' ARG . . . -80.41 132.89 35.82 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.619 -1.3 . . . . 0.0 108.554 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.64 156.55 18.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.151 -0.968 . . . . 0.0 110.626 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.1 t -57.8 156.16 9.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.497 -0.752 . . . . 0.0 109.643 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.521 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 49.6 p90 -140.33 166.36 24.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.192 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.533 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -157.12 160.37 38.77 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.492 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 71.3 m-85 -103.22 144.63 31.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.115 -0.991 . . . . 0.0 109.248 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 186' ' ' ILE . 2.5 p-10 -60.89 -22.91 64.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.317 -0.864 . . . . 0.0 111.7 -178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.689 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.4 p90 -75.16 -38.64 60.86 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.454 -1.403 . . . . 0.0 111.172 -178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.689 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -91.58 -10.07 41.86 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.536 -1.352 . . . . 0.0 110.224 -179.528 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 183' ' ' ASP . 3.2 mt -53.87 -51.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 120.961 -1.087 . . . . 0.0 109.449 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -52.33 -46.39 66.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.932 . . . . 0.0 108.726 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -58.03 -52.85 63.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.83 HD13 ' O1A' ' A' ' 320' ' ' TUX . 72.3 mt -54.53 -33.99 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -78.77 -27.67 44.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.662 -0.649 . . . . 0.0 109.713 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.8 mmtt -73.49 -26.92 61.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.0 . . . . 0.0 109.71 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 192' ' ' VAL . 13.6 m -83.24 10.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.307 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 25.13 74.01 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 120.027 -1.082 . . . . 0.0 110.539 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 41.6 mt -119.96 156.99 29.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.103 -1.234 . . . . 0.0 109.856 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.95 25.12 56.63 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.368 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -68.69 -21.61 64.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.589 -1.536 . . . . 0.0 109.58 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.79 -6.37 49.61 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -58.0 130.64 51.31 Favored Glycine 0 N--CA 1.492 2.422 0 O-C-N 121.207 -1.172 . . . . 0.0 110.582 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 203' ' ' THR . 4.5 p -141.88 163.87 31.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.7 -0.882 . . . . 0.0 109.089 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 6.4 mt -64.11 -35.09 79.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 109.986 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -73.25 -17.31 61.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.0 110.35 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 99' ' ' LEU . 7.4 m-20 -125.53 6.72 7.59 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.194 -0.941 . . . . 0.0 109.991 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.533 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 24.2 m -148.94 116.22 6.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.057 -1.027 . . . . 0.0 109.702 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.8 tp -76.11 113.59 13.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.278 -0.889 . . . . 0.0 108.748 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.7 t -103.3 126.9 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.973 -1.079 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 16.2 mt -108.25 141.75 39.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.835 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -97.7 135.7 12.33 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 7.5 ttpt -40.02 -21.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -1.069 . . . . 0.0 110.264 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 207' ' ' GLY . 14.9 t0 -141.67 2.28 1.58 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.058 -1.026 . . . . 0.0 110.746 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.546 ' O ' ' N ' ' A' ' 207' ' ' GLY . 31.0 mttt -149.25 157.5 43.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 0.0 110.576 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 83.5 t -99.87 126.89 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.453 ' CE2' HEA1 ' A' ' 320' ' ' TUX . 19.4 m-85 -73.52 -55.2 6.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.027 -1.046 . . . . 0.0 110.346 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.485 HD22 ' H ' ' A' ' 213' ' ' ASN . 2.5 m-80 -52.75 110.31 1.89 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.059 -1.026 . . . . 0.0 110.164 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -54.63 -11.89 3.8 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.752 1.635 . . . . 0.0 111.924 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -85.26 -6.82 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 109.783 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.52 -164.09 51.1 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 13.5 mt -82.53 143.32 31.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.478 -1.013 . . . . 0.0 110.041 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -89.29 -19.94 24.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.147 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.88 141.03 33.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.552 ' H ' ' CD ' ' A' ' 220' ' ' GLU . 1.6 pm0 -54.59 -16.65 2.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.04 -1.038 . . . . 0.0 108.597 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.3 40.3 2.85 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.797 0.808 . . . . 0.0 109.131 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.465 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 10.6 tt0 -56.4 -56.97 26.11 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 111.606 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 18.4 Cg_endo -59.42 -37.1 91.87 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 121.995 1.797 . . . . 0.0 113.406 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.509 HG12 ' CE2' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -82.38 -28.2 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 120.549 -1.344 . . . . 0.0 108.756 179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 173' ' ' GLU . 6.3 mtp-105 -65.32 -41.14 94.31 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.597 ' NE2' ' OD1' ' A' ' 230' ' ' ASP . 21.3 t60 -65.35 -41.34 93.98 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.6 tptp -56.47 -43.83 79.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.076 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.16 -49.35 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 0.0 109.115 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.598 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 44.6 t80 -50.07 -43.4 51.28 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.668 0.747 . . . . 0.0 109.067 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.597 ' OD1' ' NE2' ' A' ' 226' ' ' HIS . 1.6 m-20 -72.86 -36.37 67.39 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.484 -0.76 . . . . 0.0 109.842 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.46 HD23 ' CG1' ' A' ' 149' ' ' VAL . 24.1 tp -56.1 -35.73 67.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.943 -1.098 . . . . 0.0 108.507 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 71.5 mt -70.8 -48.02 59.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.65 -32.34 10.74 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.485 ' OD2' ' O ' ' A' ' 230' ' ' ASP . 4.9 m-20 -82.71 -26.76 31.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -1.199 . . . . 0.0 109.908 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 260' ' ' VAL . 7.0 mt -78.22 -22.62 48.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.8 -1.187 . . . . 0.0 110.088 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -71.63 -7.6 48.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.079 -1.013 . . . . 0.0 109.217 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 237' ' ' LEU . 37.7 mt -52.6 -30.51 31.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.171 -0.955 . . . . 0.0 108.797 179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.676 ' CD2' ' HB2' ' A' ' 264' ' ' ALA . 97.1 mt -57.95 -15.8 10.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.093 -1.004 . . . . 0.0 109.148 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 81.33 14.47 78.64 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 37.3 p -155.57 150.43 20.56 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.153 -1.204 . . . . 0.0 109.256 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 6.9 Cg_endo -53.67 132.46 49.27 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.145 1.896 . . . . 0.0 111.649 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.422 ' O ' HD22 ' A' ' 147' ' ' LEU . 15.2 t -98.62 137.76 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.811 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.421 ' HB3' HG22 ' A' ' 125' ' ' VAL . 9.0 ttmt -127.79 131.28 49.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.382 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.31 -177.84 31.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 21.3 tttp -108.83 111.1 22.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.232 -1.158 . . . . 0.0 109.66 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.9 m-85 -112.13 149.17 32.55 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.019 0.914 . . . . 0.0 111.171 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.402 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 21.9 t80 -130.13 144.31 51.28 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.1 t -142.42 128.09 19.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.657 -1.277 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -110.43 115.53 29.81 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.442 ' NH2' ' O ' ' A' ' 136' ' ' GLY . 5.5 mtm180 49.64 56.15 8.29 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.9 141.45 21.72 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -117.19 -179.69 17.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.581 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 38.7 m-70 -73.95 -52.26 13.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.99 -1.3 . . . . 0.0 109.628 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.74 -35.02 70.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.105 -0.997 . . . . 0.0 109.292 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 137' ' ' ARG . 28.7 tp -73.34 -41.51 63.4 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.217 -0.927 . . . . 0.0 108.735 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 93.5 m-20 -60.57 -51.36 69.77 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 253' ' ' HIS . 46.2 t -51.51 -43.75 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.239 -0.913 . . . . 0.0 109.03 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -55.45 -47.84 75.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.969 -1.082 . . . . 0.0 109.136 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 33.3 tp -52.44 -50.29 62.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 235' ' ' LEU . 54.1 t -63.08 -53.77 42.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.716 0.77 . . . . 0.0 109.329 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.5 mttt -46.77 -51.18 16.89 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.694 -0.629 . . . . 0.0 110.314 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -61.99 -35.62 79.05 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.7 -1.25 . . . . 0.0 109.89 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 263' ' ' LEU . 84.7 mt -70.8 -42.92 69.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.91 . . . . 0.0 109.862 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.676 ' HB2' ' CD2' ' A' ' 238' ' ' LEU . . . -77.96 -28.02 49.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 110.082 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.6 mttt -79.65 -35.14 39.76 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 108.921 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.6 mtpp -61.46 -46.41 90.19 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.211 -0.931 . . . . 0.0 109.495 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 27.6 mm100 -79.39 16.2 1.08 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.805 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -85.73 -25.1 26.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.0 109.716 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.97 -9.37 1.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.958 . . . . 0.0 109.434 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 42.4 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.877 . . . . 0.0 109.455 179.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.83 ' O1A' HD13 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 3' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.516 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 64.2 mt-10 -44.22 142.15 1.58 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 109.28 179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -119.94 142.63 48.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.579 -0.701 . . . . 0.0 110.011 -179.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -141.86 171.81 13.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.48 -0.762 . . . . 0.0 109.058 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 7' ' ' VAL . 3.5 m -81.68 137.83 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.946 -1.096 . . . . 0.0 110.229 -179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' HG3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -70.37 -46.81 63.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 10' ' ' LYS . 1.8 tm-20 -128.66 159.05 36.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.44 -0.787 . . . . 0.0 110.571 -178.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.578 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 5.3 ttpp -59.89 133.94 56.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.612 -0.68 . . . . 0.0 109.815 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 22.6 mt -121.04 160.75 22.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 p -157.02 149.55 23.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.944 -1.098 . . . . 0.0 110.558 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -129.53 166.38 19.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.575 -0.703 . . . . 0.0 109.308 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.02 133.58 11.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.891 -1.13 . . . . 0.0 108.74 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.32 156.64 12.68 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.562 -1.304 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 p -67.09 159.77 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 111.218 -178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.9 140.61 15.12 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 197' ' ' GLY . 4.4 tt -58.66 -50.53 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.128 -1.219 . . . . 0.0 111.972 -178.392 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.495 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 18.4 m-70 -86.13 -38.85 17.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.312 -1.492 . . . . 0.0 110.686 -178.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.0 p -72.72 -36.54 67.81 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 110.157 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.22 23.57 68.21 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 1.0 OUTLIER -116.19 153.94 30.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.589 -0.948 . . . . 0.0 108.736 179.363 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.475 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 25.5 t80 -71.05 129.34 38.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.072 -1.017 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.9 t -132.14 157.8 43.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.303 -0.873 . . . . 0.0 108.945 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.702 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.7 tttm -135.01 152.7 51.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.221 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.4 mt -130.14 148.07 51.94 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.182 -0.949 . . . . 0.0 109.312 -179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.556 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.6 mt -135.05 129.2 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.2 mt -115.03 125.73 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.242 -0.911 . . . . 0.0 109.891 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.556 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.8 m-70 -124.23 149.5 60.97 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.62 160.73 31.07 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.181 1.921 . . . . 0.0 111.247 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 7.1 mm-40 -134.3 -179.21 5.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.762 -179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.498 ' O ' ' OG1' ' A' ' 35' ' ' THR . 22.0 tptt -79.97 147.87 31.41 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' OE1' ' NE2' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -48.32 150.89 1.16 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.213 -0.929 . . . . 0.0 110.064 -179.701 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 60.9 20.36 57.34 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.24 178.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.557 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 23.9 m -80.89 -46.01 15.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.611 -1.523 . . . . 0.0 109.053 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.44 -167.19 16.47 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.603 HD13 ' O ' ' A' ' 85' ' ' THR . 4.3 mm -102.53 124.11 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.336 -1.096 . . . . 0.0 108.147 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.07 153.17 49.33 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.8 -179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' A' ' 89' ' ' ILE . 42.4 m-85 -114.64 154.4 28.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.554 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.8 t80 -130.83 138.78 50.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.358 -0.839 . . . . 0.0 109.011 -179.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' O ' ' A' ' 68' ' ' ARG . 4.2 ttmt -168.87 138.14 2.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.176 -0.952 . . . . 0.0 109.626 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 60.36 28.63 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 0.0 109.929 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.91 30.61 70.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -136.27 131.11 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -1.156 . . . . 0.0 109.884 -179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -83.65 144.5 29.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.975 . . . . 0.0 108.947 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.441 HG23 ' CB ' ' A' ' 64' ' ' PHE . 19.8 mt -140.86 99.16 6.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 110.398 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -53.67 145.56 48.28 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.135 1.89 . . . . 0.0 111.324 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.25 86.85 4.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.781 -1.199 . . . . 0.0 110.511 -178.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -138.62 154.59 48.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 0.0 109.391 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.453 ' HA ' HG23 ' A' ' 53' ' ' VAL . 11.2 p80 -52.1 -45.94 65.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.429 -0.795 . . . . 0.0 110.262 -179.381 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -48.27 -30.94 5.28 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.231 -179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -82.44 4.48 24.02 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.268 -0.895 . . . . 0.0 110.385 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.486 ' HA ' HD23 ' A' ' 62' ' ' LEU . 5.5 t -61.79 128.1 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.966 -1.084 . . . . 0.0 108.74 179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 m -115.34 -30.3 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.23 -0.919 . . . . 0.0 110.487 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.413 ' NE2' ' HB2' ' A' ' 57' ' ' ASN . 4.9 t-160 -153.61 122.26 6.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.92 -1.113 . . . . 0.0 109.566 -179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.9 p -113.67 131.73 56.05 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.639 -0.663 . . . . 0.0 109.286 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 43.8 t-20 -167.29 -154.0 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.544 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 73.3 m-70 -45.53 -15.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.106 -0.996 . . . . 0.0 108.643 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 2.8 t -134.04 165.33 25.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.56 -0.712 . . . . 0.0 109.561 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 62.5 m -103.22 122.06 43.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 0.0 108.724 179.452 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -120.34 138.42 53.73 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.092 0.948 . . . . 0.0 111.487 -178.719 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' VAL . 82.5 mt -120.19 163.83 17.14 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 178.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . 179.8 142.75 5.21 Favored Glycine 0 N--CA 1.489 2.204 0 C-N-CA 118.453 -1.832 . . . . 0.0 111.159 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.441 ' CB ' HG23 ' A' ' 46' ' ' ILE . 47.1 t80 -144.86 150.35 36.94 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.744 -0.856 . . . . 0.0 109.281 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? 55.4 35.92 26.02 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.0 110.749 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.14 2.25 88.75 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.89 -1.148 . . . . 0.0 110.493 178.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 15.6 mm100 -98.44 144.23 28.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.254 . . . . 0.0 108.44 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . 7.2 ptm85 -142.11 147.43 36.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.022 -1.049 . . . . 0.0 111.331 -178.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.12 143.1 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -114.08 152.47 31.0 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.003 -1.06 . . . . 0.0 111.013 -178.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m 53.21 66.22 1.29 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.694 -0.629 . . . . 0.0 110.734 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 m -113.48 -3.65 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.094 -1.004 . . . . 0.0 109.132 178.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -70.37 -28.24 64.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.497 ' CD2' ' OD1' ' A' ' 230' ' ' ASP . 25.0 m170 -66.77 -59.85 3.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.058 -1.026 . . . . 0.0 109.767 -179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.565 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.5 tp -57.75 -45.03 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.845 -1.159 . . . . 0.0 108.764 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.565 ' N ' HG23 ' A' ' 75' ' ' ILE . 67.9 mt -57.01 -40.99 77.69 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.297 -0.877 . . . . 0.0 109.807 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.493 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 30.6 t -58.35 -47.86 82.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.094 -1.004 . . . . 0.0 109.476 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.07 -54.33 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 108.542 179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 88.3 mt -52.14 -45.17 64.89 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.881 ' HD1' HG22 ' A' ' 232' ' ' ILE . 20.3 t-160 -55.99 -58.55 7.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.566 -0.709 . . . . 0.0 110.066 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.1 mt -58.23 -37.02 74.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.692 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.662 HD22 HD11 ' A' ' 114' ' ' ILE . 9.3 mt -77.79 -4.78 48.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 0.0 110.21 -179.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 62.88 34.55 14.21 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.96 -1.088 . . . . 0.0 110.424 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.497 HD11 ' HB3' ' A' ' 82' ' ' LEU . 18.2 mm -80.4 127.0 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.612 ' OG1' ' N ' ' A' ' 86' ' ' ASN . 5.9 p -105.17 -77.01 0.59 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 111.456 -177.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.9 m-80 -81.38 113.89 19.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.156 -0.965 . . . . 0.0 111.403 -176.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.8 m -162.82 139.21 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.483 -0.76 . . . . 0.0 109.622 178.796 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.516 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 30.8 m -109.15 104.46 13.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.412 ' HB ' ' CD1' ' A' ' 39' ' ' PHE . 2.5 mp -94.16 105.59 17.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.402 -0.811 . . . . 0.0 109.807 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -83.92 120.32 25.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.092 -1.005 . . . . 0.0 108.49 179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.434 HG21 HD11 ' A' ' 96' ' ' ILE . 24.5 t -102.42 110.25 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 111.114 -178.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.49 107.67 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 133.18 -162.75 24.31 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.799 -1.721 . . . . 0.0 108.799 -178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -114.06 -16.21 12.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.423 -1.045 . . . . 0.0 110.332 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -142.07 147.45 36.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.54 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 91' ' ' VAL . 46.1 mm -69.28 128.74 92.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.604 -0.685 . . . . 0.0 109.392 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.697 ' HD2' HD11 ' A' ' 26' ' ' LEU . 74.4 Cg_exo -45.77 131.4 13.16 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.838 1.692 . . . . 0.0 111.845 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -77.88 -24.84 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.554 -0.716 . . . . 0.0 110.558 -178.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.48 HD11 ' CZ ' ' A' ' 106' ' ' PHE . 8.5 mt 55.43 -119.17 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 57.6 t0 -94.52 -9.46 35.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 110.494 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.77 -4.88 32.45 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.4 p -118.47 -173.54 2.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.416 -1.05 . . . . 0.0 109.828 -179.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.28 -3.97 20.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -46.67 -36.57 7.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.775 -0.838 . . . . 0.0 110.932 -179.22 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -63.0 -52.0 64.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.864 -1.148 . . . . 0.0 110.268 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CZ ' HD11 ' A' ' 99' ' ' LEU . 73.9 m-85 -62.23 -45.02 95.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.989 -1.07 . . . . 0.0 108.874 179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.44 -40.47 86.91 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.496 0.665 . . . . 0.0 109.625 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -72.8 -43.69 62.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.44 -0.788 . . . . 0.0 111.733 -178.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.48 -49.66 15.98 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 111.075 -178.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 77.6 mt -66.34 -41.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 120.953 -1.092 . . . . 0.0 111.049 -178.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -59.02 -28.48 66.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.946 -1.096 . . . . 0.0 110.122 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.3 tttm -78.28 -17.96 55.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.985 -1.072 . . . . 0.0 110.173 -179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.67 34.5 5.18 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.467 -0.771 . . . . 0.0 110.731 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.662 HD11 HD22 ' A' ' 82' ' ' LEU . 9.5 mt -82.92 148.07 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.616 -1.303 . . . . 0.0 110.526 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 8' ' ' LYS . 10.1 tp -130.67 151.99 50.51 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.292 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.603 ' ND2' ' N ' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -100.39 136.43 40.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.028 -1.045 . . . . 0.0 109.698 179.888 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.578 ' NE2' ' OE1' ' A' ' 33' ' ' GLU . 18.9 mt-30 -102.63 -166.45 1.28 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -120.89 72.26 0.96 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.416 -0.802 . . . . 0.0 110.923 -179.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.8 ttm-85 -166.17 145.11 5.85 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 178.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.64 128.88 34.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.17 -0.957 . . . . 0.0 109.149 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.79 139.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 111.263 -178.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -78.28 72.83 4.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -51.5 142.54 13.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.528 -0.732 . . . . 0.0 110.097 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -103.82 124.09 48.28 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.663 HG22 ' HB2' ' A' ' 243' ' ' LYS . 26.3 t -127.87 142.77 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 0.0 109.954 -179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.8 t -81.27 134.68 26.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -117.26 -11.77 10.59 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -139.74 141.66 28.62 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.412 -0.805 . . . . 0.0 108.916 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.26 169.73 20.0 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.162 1.908 . . . . 0.0 113.029 -179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.839 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.3 tt -163.67 143.48 2.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.469 0.652 . . . . 0.0 109.618 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 mp -130.23 121.09 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.308 -0.87 . . . . 0.0 109.329 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.0 m -117.29 112.38 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.477 -0.765 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.73 125.84 53.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.372 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -173.34 157.86 3.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 0.0 110.652 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.455 ' O ' ' NE ' ' A' ' 137' ' ' ARG . 27.1 mt-10 56.63 18.74 3.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.66 -0.65 . . . . 0.0 110.771 179.18 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.67 -0.22 89.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.561 ' CG ' ' O ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER -102.88 172.28 6.92 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.068 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.963 HD23 ' N ' ' A' ' 139' ' ' ILE . 4.8 tt -160.24 145.82 15.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.441 -1.412 . . . . 0.0 108.669 179.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.963 ' N ' HD23 ' A' ' 138' ' ' LEU . 59.3 mt -147.92 134.81 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.905 -1.122 . . . . 0.0 108.394 179.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -124.05 144.16 50.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.183 -179.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.71 148.81 44.88 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -148.82 138.72 12.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.14 146.17 60.99 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 121.462 1.441 . . . . 0.0 112.129 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.14 147.94 11.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.215 -0.928 . . . . 0.0 109.449 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.49 -1.4 37.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 109.471 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.7 p -136.92 159.36 42.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 109.304 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.574 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 27.0 tp -88.34 121.0 30.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.119 -0.988 . . . . 0.0 109.748 -179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -138.65 135.15 34.57 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.507 ' CG1' HD23 ' A' ' 231' ' ' LEU . 73.4 t -137.19 118.5 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.93 . . . . 0.0 109.486 -179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 87.9 m -106.31 136.51 45.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.752 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.685 ' HB2' HG22 ' A' ' 228' ' ' VAL . 83.1 t80 -123.67 128.32 49.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.469 -0.769 . . . . 0.0 109.488 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' CD ' ' CE2' ' A' ' 249' ' ' PHE . 7.2 tt0 -115.16 104.66 12.07 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.41 126.68 8.98 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -110.93 84.98 2.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.365 -1.08 . . . . 0.0 109.532 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.3 m-30 -90.38 148.97 22.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.132 -0.98 . . . . 0.0 109.407 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -91.83 -5.81 52.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.856 . . . . 0.0 110.739 -179.092 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.75 HD21 HD12 ' A' ' 159' ' ' LEU . 19.2 p-10 -68.44 -167.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.725 -1.234 . . . . 0.0 109.435 -179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.407 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 28.8 p90 -59.94 -26.67 66.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.994 -179.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.75 HD12 HD21 ' A' ' 157' ' ' ASN . 6.5 mt -58.92 -51.59 69.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.974 -1.078 . . . . 0.0 108.812 179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 89.63 -119.17 5.43 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.94 143.12 51.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.622 -0.928 . . . . 0.0 109.913 -179.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -156.09 146.64 21.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.429 -0.794 . . . . 0.0 109.557 179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -126.29 150.83 48.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.484 -0.76 . . . . 0.0 109.673 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -135.09 118.77 17.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.9 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 1.8 m -94.9 121.82 36.9 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.043 . . . . 0.0 109.735 -179.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.555 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 4.2 t80 -99.73 139.18 35.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.356 -0.84 . . . . 0.0 109.486 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.555 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 2.7 t -138.94 153.06 24.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.39 -0.819 . . . . 0.0 109.152 179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 98.4 mt-10 -53.58 120.43 6.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.597 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.41 6.68 17.47 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -141.48 28.67 1.81 Allowed 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.159 -1.201 . . . . 0.0 108.671 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -63.93 -35.99 82.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -0.77 . . . . 0.0 110.4 -179.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -52.96 -12.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.168 -0.957 . . . . 0.0 110.517 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -90.9 -4.52 56.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.052 -1.03 . . . . 0.0 110.536 -179.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 2.8 pt -120.55 -7.13 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.164 -0.96 . . . . 0.0 110.772 -179.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.13 -29.26 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.574 -1.328 . . . . 0.0 110.011 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.9 mt -90.03 -1.34 57.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.833 -1.167 . . . . 0.0 110.736 -179.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.58 118.18 20.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.706 -1.246 . . . . 0.0 108.374 179.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -88.55 153.01 21.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.0 110.296 -179.02 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.516 ' OG1' ' OYH' ' A' ' 320' ' ' TUX . 6.2 t -53.47 158.63 1.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.451 -0.781 . . . . 0.0 109.773 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.545 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 23.3 p90 -143.32 169.44 17.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.036 -1.04 . . . . 0.0 109.839 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.635 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -162.09 167.95 23.45 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.154 -0.966 . . . . 0.0 110.226 -179.785 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.502 ' CD2' ' CH2' ' A' ' 184' ' ' TRP . 86.8 m-85 -104.21 145.08 30.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.481 -0.762 . . . . 0.0 109.203 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.601 ' HA ' HD12 ' A' ' 186' ' ' ILE . 51.3 p30 -63.34 -23.49 67.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.277 -0.89 . . . . 0.0 111.426 -178.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.52 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 p90 -79.33 -27.32 42.07 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.585 -1.322 . . . . 0.0 111.009 -178.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.485 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 26.0 pt-20 -96.45 -13.76 22.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.688 -1.258 . . . . 0.0 109.872 -179.58 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 183' ' ' ASP . 4.6 mt -55.56 -51.65 55.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.271 -0.893 . . . . 0.0 110.039 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -52.43 -44.5 65.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.098 -1.001 . . . . 0.0 109.668 -179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -57.6 -51.5 69.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.943 . . . . 0.0 109.41 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.615 HD13 ' O1A' ' A' ' 320' ' ' TUX . 18.9 mt -59.45 -34.31 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 109.134 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -74.43 -27.09 60.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 110.144 -179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -74.8 -33.51 62.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.018 -1.051 . . . . 0.0 109.921 -179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.42 12.45 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.231 -0.918 . . . . 0.0 109.226 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.43 25.35 70.66 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.556 179.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 86.5 mt -117.83 155.08 30.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.174 -1.192 . . . . 0.0 109.876 -179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.495 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.2 27.81 47.44 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.29 178.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -68.36 -22.46 64.66 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.667 -1.49 . . . . 0.0 108.929 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -103.14 -4.92 47.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.65 126.0 29.29 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 121.323 -1.104 . . . . 0.0 110.956 -178.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 151.18 39.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.858 -0.789 . . . . 0.0 109.074 179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.462 HD21 ' CCA' ' A' ' 320' ' ' TUX . 39.5 mt -55.61 -13.32 1.55 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.955 . . . . 0.0 109.792 -179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -83.46 -2.22 55.37 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.06 -1.025 . . . . 0.0 109.423 179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -151.18 17.67 0.75 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.339 -0.851 . . . . 0.0 108.826 179.852 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.635 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 87.4 m -151.89 115.16 4.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.504 -0.747 . . . . 0.0 109.33 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.6 tp -76.57 109.76 10.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.208 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 186' ' ' ILE . 42.6 t -103.17 131.36 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.125 -0.984 . . . . 0.0 109.941 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.5 mt -114.28 144.83 42.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.536 -0.728 . . . . 0.0 109.35 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.94 151.07 19.14 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 207' ' ' GLY . 25.7 tttt -41.42 -28.96 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 110.162 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.436 ' OD1' ' C ' ' A' ' 209' ' ' ASP . 1.8 p30 -146.4 8.15 1.03 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.929 -1.107 . . . . 0.0 110.399 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.6 tttt -141.93 150.61 41.68 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 109.832 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.7 t -100.21 127.45 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.369 -0.832 . . . . 0.0 109.218 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.444 ' CD2' HEA2 ' A' ' 320' ' ' TUX . 15.9 m-85 -70.66 -54.43 11.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.201 -0.937 . . . . 0.0 110.019 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -56.97 132.86 80.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.019 -1.05 . . . . 0.0 109.462 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.85 -19.4 27.23 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.322 2.015 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.81 -6.04 58.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.669 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.84 -169.29 52.72 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.53 147.16 42.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.387 -1.066 . . . . 0.0 109.568 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -74.76 -62.64 1.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 108.848 179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.581 ' O ' ' N ' ' A' ' 221' ' ' ASN . 11.5 m-85 -117.9 142.78 46.95 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.52 -13.89 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -0.953 . . . . 0.0 109.453 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 219' ' ' TYR . 8.6 m-20 -137.7 30.41 2.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.483 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.3 OUTLIER -60.25 -40.04 73.6 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.219 -0.926 . . . . 0.0 110.274 -179.534 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 16.0 Cg_exo -65.22 -49.6 2.56 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.35 2.034 . . . . 0.0 112.647 -179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.817 ' O ' HG23 ' A' ' 228' ' ' VAL . 2.5 m -73.17 -22.12 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.922 -1.111 . . . . 0.0 108.628 179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -70.93 -46.11 63.02 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.514 ' CE1' ' N ' ' A' ' 179' ' ' THR . 26.0 t60 -58.69 -38.45 78.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.8 -42.14 99.59 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 224' ' ' VAL . 22.9 t -66.34 -38.9 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.493 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 48.7 t80 -56.48 -51.74 67.36 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.732 -0.605 . . . . 0.0 109.704 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.497 ' OD1' ' CD2' ' A' ' 74' ' ' HIS . 8.2 m-20 -70.14 -30.14 67.24 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.174 -0.954 . . . . 0.0 109.515 179.918 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.507 HD23 ' CG1' ' A' ' 149' ' ' VAL . 30.1 tp -56.56 -37.6 70.78 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.22 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.881 HG22 ' HD1' ' A' ' 80' ' ' HIS . 66.0 mt -73.01 -48.59 43.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.64 8.33 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -82.35 -29.62 30.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -1.102 . . . . 0.0 109.728 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.67 HD23 HG22 ' A' ' 260' ' ' VAL . 6.8 mt -79.16 -22.41 45.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.725 -1.234 . . . . 0.0 109.253 179.42 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.406 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.2 t80 -70.09 -8.96 53.74 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.37 -0.831 . . . . 0.0 109.1 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.3 mt -52.67 -27.93 19.48 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.361 -0.837 . . . . 0.0 108.818 179.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.403 HD12 HG22 ' A' ' 242' ' ' VAL . 96.6 mt -55.28 -18.47 6.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.021 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 83.86 12.54 77.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 75.0 p -158.51 147.6 14.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.139 -1.212 . . . . 0.0 109.551 179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.417 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 57.8 Cg_exo -42.99 135.18 5.42 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.344 2.029 . . . . 0.0 111.975 179.623 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.403 HG22 HD12 ' A' ' 238' ' ' LEU . 13.7 t -101.75 133.08 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.702 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.663 ' HB2' HG22 ' A' ' 125' ' ' VAL . 32.4 mmtm -122.11 126.81 49.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.581 -0.699 . . . . 0.0 109.261 179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.5 176.61 29.75 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -107.07 110.21 22.27 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.107 -1.231 . . . . 0.0 109.833 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.7 m-85 -112.06 147.43 36.02 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.834 0.826 . . . . 0.0 111.038 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -127.42 144.1 51.11 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.4 m -134.84 128.11 32.07 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 120.704 -1.248 . . . . 0.0 110.679 -178.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.497 ' CE2' ' CD ' ' A' ' 152' ' ' GLU . 3.0 t80 -112.44 110.58 20.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.561 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 6.5 mmm180 47.34 55.75 7.82 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -178.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.27 142.09 23.71 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -178.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.471 ' O ' ' ND2' ' A' ' 256' ' ' ASN . . . -110.63 159.63 13.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -56.07 -48.93 75.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.241 . . . . 0.0 109.534 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 25.3 p -57.21 -55.16 38.38 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.192 -0.943 . . . . 0.0 109.106 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.403 ' HG ' HD12 ' A' ' 139' ' ' ILE . 54.5 tp -52.07 -37.29 53.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 252' ' ' GLY . 4.4 m120 -58.22 -55.7 31.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.093 -1.004 . . . . 0.0 108.855 179.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 77.0 t -50.61 -43.1 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.494 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -49.52 71.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.96 -1.087 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 139' ' ' ILE . 9.5 tp -52.71 -41.24 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.67 HG22 HD23 ' A' ' 235' ' ' LEU . 74.2 t -71.97 -50.43 37.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.76 0.791 . . . . 0.0 109.507 179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -49.81 -45.06 49.6 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.641 -0.662 . . . . 0.0 110.437 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -42.79 70.36 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.479 -179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 263' ' ' LEU . 36.3 mt -62.05 -43.61 98.47 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.25 -0.906 . . . . 0.0 109.298 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.552 -0.718 . . . . 0.0 110.344 -179.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 22.6 mttm -83.35 -34.71 25.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.625 -1.297 . . . . 0.0 108.453 178.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 267' ' ' GLN . 20.3 mttp -49.16 -36.5 19.57 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.604 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 266' ' ' LYS . 46.9 tt0 -40.07 -70.4 0.1 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.871 -0.518 . . . . 0.0 110.758 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -91.45 16.29 10.58 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.833 -1.167 . . . . 0.0 111.105 -178.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 269' ' ' LEU . 8.1 mt -108.39 24.88 12.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.149 -0.969 . . . . 0.0 109.49 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.299 -0.875 . . . . 0.0 109.41 179.916 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.615 ' O1A' HD13 ' A' ' 189' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.642 ' O ' HD11 ' A' ' 121' ' ' ILE . 2.3 mt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.424 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 21.7 mm-40 -45.01 141.52 2.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 0.0 109.199 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -121.08 139.64 53.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.166 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 t -141.23 177.84 7.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -86.28 135.18 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.999 -1.063 . . . . 0.0 109.815 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -65.66 -45.51 82.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.474 -0.766 . . . . 0.0 110.322 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -128.73 157.38 41.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.245 -0.91 . . . . 0.0 110.145 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HG3' ' NE2' ' A' ' 29' ' ' HIS . 0.4 OUTLIER -64.46 133.66 52.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.473 -0.767 . . . . 0.0 110.11 -179.801 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 113' ' ' ASN . 40.5 mt -118.24 160.14 22.12 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.552 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.2 p -158.1 150.44 22.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.938 -1.101 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -132.42 174.88 9.79 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.628 -0.67 . . . . 0.0 109.707 179.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -150.46 135.51 17.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 108.589 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.76 156.09 12.87 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.901 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 22' ' ' GLU . 8.9 p -80.93 142.02 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -1.083 . . . . 0.0 110.91 -178.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.24 142.9 36.63 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 197' ' ' GLY . 6.0 tt -60.06 -48.01 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.254 -1.145 . . . . 0.0 112.472 -178.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 9.6 m-70 -86.88 -37.93 17.22 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.229 -1.544 . . . . 0.0 111.462 -178.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -68.13 -35.1 77.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.184 -0.948 . . . . 0.0 110.135 -178.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 67.04 20.9 71.28 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -179.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.615 ' C ' HG23 ' A' ' 16' ' ' VAL . 32.1 tt0 -118.92 154.81 32.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 109.242 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -68.4 140.18 55.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.93 . . . . 0.0 109.89 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.9 t -147.42 157.08 43.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.034 -1.041 . . . . 0.0 108.766 179.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -127.58 161.98 27.54 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.192 -0.942 . . . . 0.0 110.014 -179.236 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.724 HD21 ' CD1' ' A' ' 96' ' ' ILE . 12.9 mt -130.94 143.65 50.88 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mt -141.29 127.2 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.077 -1.014 . . . . 0.0 109.312 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.0 mt -113.45 125.0 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.449 -0.782 . . . . 0.0 109.403 -179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.4 ' NE2' ' HG3' ' A' ' 10' ' ' LYS . 17.2 m-70 -121.47 142.71 36.1 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.545 -0.722 . . . . 0.0 109.356 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -53.87 160.07 6.3 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.544 1.496 . . . . 0.0 111.444 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 76.7 mt-10 -134.77 -178.75 5.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.728 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.3 ttmm -85.91 151.44 23.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.356 -0.84 . . . . 0.0 109.551 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.592 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.4 OUTLIER -49.81 147.31 3.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.31 -0.869 . . . . 0.0 110.447 -179.591 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.76 21.84 58.89 Favored Glycine 0 N--CA 1.494 2.512 0 O-C-N 121.551 -0.718 . . . . 0.0 111.884 178.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 98.5 m -81.19 -46.51 14.75 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.45 -1.618 . . . . 0.0 109.027 179.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.765 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 105.45 -168.2 15.29 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 mm -101.63 124.66 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.31 -1.112 . . . . 0.0 108.036 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HE ' HG22 ' A' ' 35' ' ' THR . 0.6 OUTLIER -143.16 139.55 30.41 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.765 -179.739 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -97.16 154.33 17.43 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.555 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.6 t80 -129.47 139.94 51.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.751 ' HZ3' ' NE2' ' A' ' 67' ' ' GLN . 46.3 tttm -168.08 137.76 2.55 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.001 -1.062 . . . . 0.0 109.525 -179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.14 29.18 18.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 0.0 110.102 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.01 28.36 70.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 37.8 t -134.08 138.27 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -1.15 . . . . 0.0 109.852 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -92.14 142.45 27.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.19 179.637 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -137.42 95.13 11.65 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.439 -179.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -48.27 144.97 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.212 1.941 . . . . 0.0 111.652 179.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.89 84.61 4.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.896 -1.127 . . . . 0.0 110.542 -179.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.5 mtp85 -141.16 157.02 45.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.008 -1.058 . . . . 0.0 109.741 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.1 p80 -52.92 -50.12 64.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 110.077 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -46.55 -15.81 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.012 -1.055 . . . . 0.0 109.999 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.7 m-85 -99.67 4.81 45.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.463 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 50' ' ' HIS . 5.1 t -63.38 132.39 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 108.773 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 31.0 m -118.09 -33.5 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.477 -0.764 . . . . 0.0 110.347 -179.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 5.7 t-160 -147.61 118.6 7.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.018 -1.051 . . . . 0.0 110.037 -179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.2 p -112.66 126.37 55.3 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.7 t-20 -167.06 -152.76 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.584 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 10.7 m-70 -44.21 -16.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.146 -0.971 . . . . 0.0 108.586 179.038 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.1 t -137.19 165.5 25.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.495 -0.753 . . . . 0.0 109.368 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.2 m -109.24 125.36 52.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.368 -0.832 . . . . 0.0 108.831 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 1.4 m-20 -125.59 148.02 49.09 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.994 0.902 . . . . 0.0 111.162 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' A' ' 72' ' ' VAL . 28.1 mt -125.78 161.12 28.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -176.99 143.59 6.37 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.541 -1.79 . . . . 0.0 110.985 -179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -144.81 151.85 39.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.629 -0.924 . . . . 0.0 109.72 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.81 29.74 12.44 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.386 -0.821 . . . . 0.0 110.599 179.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.52 0.54 86.32 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.569 179.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.751 ' NE2' ' HZ3' ' A' ' 41' ' ' LYS . 15.9 mm100 -97.01 145.44 25.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.978 -1.307 . . . . 0.0 108.373 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -143.35 149.58 37.95 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 118.993 -1.083 . . . . 0.0 111.658 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -132.93 143.17 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -114.05 149.71 35.04 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.124 -0.985 . . . . 0.0 111.611 -178.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.8 m 53.87 71.6 0.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.716 -0.615 . . . . 0.0 111.054 178.621 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 62' ' ' LEU . 20.6 m -112.81 -5.83 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 179.198 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.41 -23.87 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 18.0 m170 -68.98 -60.88 2.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.996 -1.065 . . . . 0.0 109.723 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 76' ' ' LEU . 11.1 tp -59.63 -45.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.175 -0.953 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' N ' HG23 ' A' ' 75' ' ' ILE . 88.3 mt -54.69 -40.77 69.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.256 -0.902 . . . . 0.0 109.68 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.571 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.47 -47.93 83.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.086 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.6 t -57.19 -55.23 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.961 -1.087 . . . . 0.0 109.011 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.5 mt -52.47 -43.38 64.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.537 -0.727 . . . . 0.0 109.432 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.658 ' HD1' HG22 ' A' ' 232' ' ' ILE . 15.8 t-160 -55.53 -58.08 9.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 110.127 -179.659 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.486 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 57.5 mt -55.79 -36.66 67.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -0.932 . . . . 0.0 110.267 -179.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.699 HD22 HD11 ' A' ' 114' ' ' ILE . 11.7 mt -79.89 -4.31 51.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.052 -1.03 . . . . 0.0 110.461 -178.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' O ' ' A' ' 81' ' ' LEU . 1.0 OUTLIER 62.77 38.46 11.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.866 -1.146 . . . . 0.0 110.51 179.628 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 82' ' ' LEU . 16.4 mm -83.31 129.74 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.9 p -107.04 -76.6 0.61 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.235 -0.916 . . . . 0.0 111.129 -178.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.765 HD22 ' H ' ' A' ' 36' ' ' GLY . 2.4 m120 -81.22 113.96 19.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.261 -0.899 . . . . 0.0 111.632 -176.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.3 m -164.05 141.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.504 -0.747 . . . . 0.0 109.623 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.551 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 1.0 OUTLIER -109.01 103.84 12.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.488 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp -95.68 106.03 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.87 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -82.68 122.01 27.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.075 -1.016 . . . . 0.0 108.936 179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -102.96 104.92 17.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.454 -0.779 . . . . 0.0 110.422 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 92' ' ' ILE . 4.8 mt -86.03 110.84 20.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 O-C-N 121.176 -0.953 . . . . 0.0 108.582 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 126.32 -179.23 16.38 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.28 -15.32 22.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -1.138 . . . . 0.0 110.349 -179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 19' ' ' HIS . 34.4 tt0 -136.07 142.7 44.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.986 -1.071 . . . . 0.0 110.272 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.724 ' CD1' HD21 ' A' ' 26' ' ' LEU . 2.5 mm -68.26 128.41 93.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.477 -0.765 . . . . 0.0 109.654 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -45.72 127.39 9.89 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 121.822 1.681 . . . . 0.0 111.834 179.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.0 tp -80.1 -22.44 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.76 . . . . 0.0 110.354 -179.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.8 mt 55.72 -118.08 1.2 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.854 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.42 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 0.0 OUTLIER -94.78 -9.7 33.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.15 -0.968 . . . . 0.0 110.43 -179.199 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 105.93 -4.68 39.08 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.3 p -115.42 -174.55 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.464 -1.021 . . . . 0.0 109.368 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.23 -6.96 17.55 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.547 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 72.5 t-105 -46.61 -35.21 5.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.678 -0.896 . . . . 0.0 110.09 -179.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.24 -51.52 68.62 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.906 -1.121 . . . . 0.0 109.968 -179.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.508 ' CG ' ' CD1' ' A' ' 75' ' ' ILE . 63.1 m-85 -65.03 -44.62 88.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.077 -1.014 . . . . 0.0 108.944 179.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.43 ' CD2' HG11 ' A' ' 175' ' ' VAL . 9.0 t80 -61.91 -37.81 86.03 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.456 0.646 . . . . 0.0 109.572 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.547 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 24.4 mm-40 -65.38 -52.75 51.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.685 . . . . 0.0 111.595 -178.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.33 -52.24 9.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.755 -1.216 . . . . 0.0 110.693 -178.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 92.8 mt -50.71 -47.81 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.78 -1.2 . . . . 0.0 110.477 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -57.89 -31.3 66.6 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.052 -1.03 . . . . 0.0 109.048 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -83.78 13.51 4.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.148 -0.97 . . . . 0.0 109.509 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.523 ' HB2' HD11 ' A' ' 11' ' ' LEU . 1.1 m-20 -149.46 30.68 0.75 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.156 -0.965 . . . . 0.0 109.659 179.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.699 HD11 HD22 ' A' ' 82' ' ' LEU . 10.0 mt -85.02 147.12 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.949 -1.094 . . . . 0.0 110.426 -179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 37.0 tp -131.7 155.69 47.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.488 -0.757 . . . . 0.0 109.161 179.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.8 OUTLIER -110.42 128.2 55.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 179.725 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.498 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -97.02 -165.73 1.3 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.937 . . . . 0.0 109.593 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 118' ' ' ASN . 48.6 p30 -124.77 74.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.483 -0.761 . . . . 0.0 110.301 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 42.0 ttt-85 -161.73 139.93 9.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.13 -0.981 . . . . 0.0 110.057 179.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -47.3 167.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 110.191 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.642 HD11 ' O ' ' A' ' 3' ' ' LEU . 25.4 mt -126.12 104.23 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.94 71.28 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.429 -0.794 . . . . 0.0 110.154 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.585 ' CE1' HG21 ' A' ' 121' ' ' ILE . 93.8 m-85 -57.4 147.18 26.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.494 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -104.71 123.65 47.99 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.447 HG13 ' HB2' ' A' ' 243' ' ' LYS . 5.4 t -129.2 143.43 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.451 -0.781 . . . . 0.0 109.991 -179.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.46 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.592 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -113.23 -11.8 13.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.443 -0.785 . . . . 0.0 109.254 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -141.32 144.71 35.25 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.8 172.29 15.61 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.054 1.836 . . . . 0.0 113.003 -179.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.684 HG22 ' HB3' ' A' ' 141' ' ' ALA . 9.9 tt -165.92 145.53 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.348 0.594 . . . . 0.0 109.846 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 131' ' ' ILE . 1.7 mt -128.28 125.24 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.496 -0.753 . . . . 0.0 109.361 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.437 HG23 ' HB ' ' A' ' 139' ' ' ILE . 0.7 OUTLIER -122.73 116.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 110.003 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -107.77 142.26 38.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.326 -0.859 . . . . 0.0 109.129 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' CG ' ' OE1' ' A' ' 135' ' ' GLU . 8.4 t70 -168.96 135.79 1.81 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.723 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.1 OUTLIER 50.94 34.89 11.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 111.509 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.73 8.06 86.2 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -103.15 172.5 6.78 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.2 tt -160.59 148.74 16.3 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 120.248 -1.533 . . . . 0.0 109.174 179.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.945 ' N ' HD23 ' A' ' 138' ' ' LEU . 3.4 mt -146.87 133.78 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.04 -1.038 . . . . 0.0 108.348 179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -125.21 138.99 54.12 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.348 -0.845 . . . . 0.0 109.772 -179.243 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.684 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -120.95 139.55 53.1 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -136.25 134.04 19.83 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -53.12 148.87 29.52 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.353 1.369 . . . . 0.0 112.326 -179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.67 158.39 9.19 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.288 -0.882 . . . . 0.0 108.944 179.257 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.3 2.65 54.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 109.943 -179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.0 p -138.06 150.03 46.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.161 -0.962 . . . . 0.0 109.539 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.492 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 16.8 tp -83.09 115.12 21.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 110.125 -179.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -136.61 141.92 43.27 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.556 ' CG1' HD23 ' A' ' 231' ' ' LEU . 46.6 t -136.27 133.01 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.131 -0.981 . . . . 0.0 109.973 -179.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 m -119.1 124.72 47.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.24 179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.528 ' CE2' HG12 ' A' ' 224' ' ' VAL . 10.0 t80 -115.1 129.85 56.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 109.983 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' A' ' 153' ' ' GLY . 4.5 tp10 -113.72 105.29 13.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.562 ' N ' ' OE1' ' A' ' 152' ' ' GLU . . . -101.44 145.4 16.84 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -132.41 85.32 2.22 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.433 -1.04 . . . . 0.0 109.589 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.7 m-30 -88.67 148.93 23.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.46 -0.775 . . . . 0.0 109.021 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 mmtt -88.93 -8.72 53.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.492 ' N ' ' OD1' ' A' ' 157' ' ' ASN . 11.9 p-10 -66.79 -170.74 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 109.498 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 158' ' ' PHE . 16.8 p90 -59.4 -24.63 63.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.853 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.456 HD12 HD21 ' A' ' 157' ' ' ASN . 8.5 mt -53.77 -58.39 7.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.005 . . . . 0.0 108.904 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.92 -134.73 11.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.34 142.7 47.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.508 -0.995 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.438 ' O ' ' OE1' ' A' ' 152' ' ' GLU . 1.3 pt20 -162.12 159.51 26.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 0.0 109.547 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.51 152.97 51.37 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.469 -0.769 . . . . 0.0 109.315 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -133.75 120.05 20.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.0 108.815 179.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 28.2 m -98.99 121.93 41.58 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.97 -1.081 . . . . 0.0 110.34 -179.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -95.26 138.12 33.39 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.57 156.51 42.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.783 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.658 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 4.9 mp0 -60.31 113.69 2.52 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.521 -0.737 . . . . 0.0 109.417 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.4 6.03 18.31 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -130.91 30.23 4.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.294 -1.121 . . . . 0.0 108.836 179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 175' ' ' VAL . 6.1 mp0 -63.75 -34.67 78.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.471 -0.768 . . . . 0.0 110.89 -178.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -16.49 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.918 -1.114 . . . . 0.0 110.98 -178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -91.88 -4.02 55.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.91 -1.119 . . . . 0.0 111.146 -178.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -122.16 -5.6 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.031 -1.043 . . . . 0.0 111.107 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -92.59 -28.24 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.471 -1.393 . . . . 0.0 110.436 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -90.08 0.95 56.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 0.0 110.964 -178.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.9 123.15 25.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.675 -1.265 . . . . 0.0 108.485 179.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' A' ' 178' ' ' ARG . 0.7 OUTLIER -91.04 151.73 20.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.673 -1.267 . . . . 0.0 109.797 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.9 t -62.28 134.37 56.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.45 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.54 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 11.5 p90 -117.33 179.1 4.14 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.33 -0.856 . . . . 0.0 110.106 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.54 ' SG ' ' C ' ' A' ' 180' ' ' PHE . 0.0 OUTLIER -170.39 166.41 8.55 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.371 -0.831 . . . . 0.0 109.723 179.995 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.587 ' CD2' ' CZ2' ' A' ' 184' ' ' TRP . 31.2 m-85 -103.79 146.11 29.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.376 -0.828 . . . . 0.0 109.244 179.411 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.5 OUTLIER -67.67 -17.73 64.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 111.216 -179.116 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.588 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 3.3 p90 -80.67 -33.42 35.56 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.518 -1.364 . . . . 0.0 110.549 -179.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.588 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.1 OUTLIER -90.24 -15.73 30.77 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.762 -1.212 . . . . 0.0 109.504 179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.705 HD12 ' HA ' ' A' ' 183' ' ' ASP . 7.6 mt -58.57 -51.24 74.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.191 -0.943 . . . . 0.0 110.224 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.47 -50.24 53.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.858 -1.151 . . . . 0.0 109.292 -179.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -54.04 -52.0 62.26 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.172 -0.955 . . . . 0.0 108.83 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 61.7 mt -55.29 -34.2 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.233 -0.917 . . . . 0.0 108.953 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -74.18 -32.71 63.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.326 -0.859 . . . . 0.0 109.863 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.05 -30.47 70.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.788 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.465 ' CG2' HD12 ' A' ' 194' ' ' LEU . 11.7 m -82.82 12.41 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.149 -0.97 . . . . 0.0 109.633 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.26 26.35 70.71 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 120.175 -1.012 . . . . 0.0 111.293 178.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.465 HD12 ' CG2' ' A' ' 192' ' ' VAL . 20.1 mt -118.3 156.19 29.3 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.006 -1.291 . . . . 0.0 109.945 179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.492 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 81.89 25.12 53.82 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.001 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -67.55 -22.18 65.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.671 -1.488 . . . . 0.0 109.488 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -101.75 -6.02 50.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.57 124.73 35.38 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.133 -1.216 . . . . 0.0 110.516 -179.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.437 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 54.2 p -135.35 -179.7 5.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.825 -0.809 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.0 mt -82.65 -12.42 57.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.196 -0.94 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -91.9 -9.93 41.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.437 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 2.0 m-80 -136.37 7.92 3.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.186 -0.946 . . . . 0.0 109.586 -179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.513 HG22 ' SG ' ' A' ' 181' ' ' CYS . 1.2 m -147.28 120.16 8.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.163 -0.961 . . . . 0.0 109.493 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.615 HD21 HD23 ' A' ' 217' ' ' LEU . 4.4 tp -84.02 117.87 23.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.125 -0.984 . . . . 0.0 109.127 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.504 HG21 HCA3 ' A' ' 320' ' ' TUX . 58.2 t -103.19 127.67 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 109.593 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.501 HD23 HG22 ' A' ' 211' ' ' VAL . 4.8 mt -107.06 146.95 30.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.488 -0.757 . . . . 0.0 109.65 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -105.71 148.54 16.51 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 207' ' ' GLY . 20.4 tttt -41.13 -31.38 0.19 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.432 -1.04 . . . . 0.0 109.918 -179.676 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 31.9 t0 -145.61 10.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 0.0 110.282 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 207' ' ' GLY . 1.2 ttmp? -144.62 153.67 42.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 109.774 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.501 HG22 HD23 ' A' ' 206' ' ' LEU . 44.7 t -106.3 131.93 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.364 -0.835 . . . . 0.0 109.091 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -72.6 -54.45 9.09 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.225 -0.922 . . . . 0.0 110.044 -179.435 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.487 HD22 ' H ' ' A' ' 213' ' ' ASN . 3.3 m-80 -56.18 136.35 74.75 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 0.0 109.34 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.88 -25.82 19.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.311 2.008 . . . . 0.0 112.653 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.516 ' OE2' ' NH1' ' A' ' 218' ' ' ARG . 16.4 tm-20 -80.25 -9.82 59.74 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -0.973 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.82 -165.52 52.66 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.615 HD23 HD21 ' A' ' 204' ' ' LEU . 11.8 mt -76.28 141.78 41.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.406 -1.055 . . . . 0.0 109.858 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.516 ' NH1' ' OE2' ' A' ' 215' ' ' GLU . 0.1 OUTLIER -65.02 -52.23 57.18 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 108.63 179.25 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.447 ' H ' ' HB2' ' A' ' 222' ' ' GLU . 19.2 m-85 -117.85 176.8 5.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 220' ' ' GLU . 0.4 OUTLIER -76.0 -19.08 58.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 0.0 109.381 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.548 ' OD1' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -127.83 35.39 4.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.469 -0.769 . . . . 0.0 109.104 -179.985 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.598 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.0 OUTLIER -59.79 -34.96 24.44 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 111.126 -179.351 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 3.3 Cg_exo -73.87 -43.63 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 121.808 1.672 . . . . 0.0 112.342 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.528 HG12 ' CE2' ' A' ' 151' ' ' TYR . 0.9 OUTLIER -77.09 -25.38 15.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.903 -1.123 . . . . 0.0 108.133 179.196 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.548 ' NH1' ' OD1' ' A' ' 221' ' ' ASN . 8.0 mtt180 -67.13 -44.11 80.69 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -61.88 -41.04 97.4 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.5 tptp -57.65 -50.32 73.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 108.689 179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 224' ' ' VAL . 60.8 t -57.91 -48.97 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.571 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 64.3 t80 -49.99 -44.19 50.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 2.4 m-20 -73.02 -35.53 66.82 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.534 -0.729 . . . . 0.0 109.571 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.556 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.9 tp -56.46 -36.31 68.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.099 -1.001 . . . . 0.0 108.65 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.658 HG22 ' HD1' ' A' ' 80' ' ' HIS . 44.1 mt -72.42 -48.25 48.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -48.58 -34.3 13.91 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.314 -1.515 . . . . 0.0 109.314 179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.7 OUTLIER -81.64 -28.64 33.52 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -1.2 . . . . 0.0 109.645 -179.836 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.503 HD23 HG22 ' A' ' 260' ' ' VAL . 5.4 mt -80.26 -21.42 42.76 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.835 -1.166 . . . . 0.0 109.125 179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.489 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 40.3 t80 -71.08 -9.1 57.48 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.318 -0.864 . . . . 0.0 108.692 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 234' ' ' ASP . 14.1 mt -50.02 -28.78 7.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.425 HD12 HG22 ' A' ' 242' ' ' VAL . 96.7 mt -56.52 -14.02 2.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.0 109.088 179.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.5 15.95 80.23 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 80.8 p -158.59 144.98 12.64 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.063 -1.257 . . . . 0.0 109.383 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -42.59 130.54 5.25 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.197 1.931 . . . . 0.0 111.995 179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.425 HG22 HD12 ' A' ' 238' ' ' LEU . 4.0 t -100.36 135.85 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.59 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.447 ' HB2' HG13 ' A' ' 125' ' ' VAL . 5.4 mmtp -123.91 127.57 48.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -0.821 . . . . 0.0 109.664 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.78 172.14 23.72 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -101.14 113.87 27.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.59 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.0 m-85 -112.58 147.08 37.4 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.981 0.896 . . . . 0.0 111.306 -179.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 248' ' ' SER . 18.4 t80 -128.86 144.06 51.07 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 178.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.409 ' N ' ' CD1' ' A' ' 247' ' ' TYR . 28.1 t -139.31 125.39 19.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.697 -1.252 . . . . 0.0 110.005 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 250' ' ' ARG . 71.8 t80 -110.47 113.37 25.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 249' ' ' PHE . 9.6 mmm180 46.43 56.6 6.2 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -178.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.73 150.5 21.16 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -178.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -118.38 179.82 17.01 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -68.66 -42.35 78.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -1.143 . . . . 0.0 109.568 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.7 -36.32 83.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.314 -0.866 . . . . 0.0 110.204 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.703 ' HG ' HD12 ' A' ' 139' ' ' ILE . 57.4 tp -72.54 -36.79 68.38 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.016 -1.053 . . . . 0.0 108.911 179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -60.76 -52.41 65.19 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.352 -0.842 . . . . 0.0 108.81 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 37.2 t -52.53 -44.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.24 -0.913 . . . . 0.0 109.338 179.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.0 tttm -55.34 -47.54 75.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.007 -1.058 . . . . 0.0 109.167 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 139' ' ' ILE . 30.8 tp -52.51 -45.07 66.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.0 108.623 179.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.503 HG22 HD23 ' A' ' 235' ' ' LEU . 40.1 t -68.36 -53.29 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.827 . . . . 0.0 109.465 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -46.7 -45.97 19.84 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.682 -0.636 . . . . 0.0 110.636 -179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.92 -47.96 64.45 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.906 -1.121 . . . . 0.0 109.503 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 263' ' ' LEU . 19.7 mt -57.97 -43.66 86.62 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.264 -0.898 . . . . 0.0 109.476 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.05 74.9 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.46 -0.775 . . . . 0.0 110.282 -178.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 55.4 mttt -86.27 -24.21 26.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.706 -1.246 . . . . 0.0 108.929 179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.492 ' HZ3' ' HB ' ' A' ' 130' ' ' ILE . 22.8 mttt -71.86 -46.11 59.05 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 109.482 179.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 12.63 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.674 -179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 266' ' ' LYS . 43.8 tttp -59.32 -51.03 71.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.915 . . . . 0.0 109.498 179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.2 mt -94.37 -75.12 0.52 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 270' ' ' THR . 3.7 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.373 -0.83 . . . . 0.0 109.415 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.504 HCA3 HG21 ' A' ' 205' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 55.3 mt-10 -49.59 141.1 9.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.553 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -114.14 131.33 56.46 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.496 -0.752 . . . . 0.0 109.061 -179.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -132.77 168.86 17.59 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 m -81.38 139.79 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 110.226 -179.257 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -70.12 -46.95 63.72 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.56 -0.712 . . . . 0.0 109.945 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -132.35 163.11 29.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.356 -0.84 . . . . 0.0 110.41 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 136.31 55.32 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.632 0.73 . . . . 0.0 110.861 -179.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 113' ' ' ASN . 32.7 mt -117.23 164.99 13.96 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -150.92 146.49 26.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.813 -1.179 . . . . 0.0 110.192 -179.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -133.69 161.08 35.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.536 -0.727 . . . . 0.0 109.464 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -149.75 136.78 19.61 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.918 -1.114 . . . . 0.0 109.023 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.87 158.98 18.58 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG23 ' N ' ' A' ' 22' ' ' GLU . 1.3 p -85.79 144.14 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.103 -1.233 . . . . 0.0 110.996 -178.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.32 143.57 39.38 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 197' ' ' GLY . 2.1 tt -63.55 -44.49 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.324 -1.103 . . . . 0.0 112.621 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.524 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 14.8 m-70 -87.08 -37.1 17.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.125 -1.609 . . . . 0.0 112.193 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.402 HG21 ' HG3' ' A' ' 95' ' ' GLU . 28.0 p -81.05 -26.6 36.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.834 -1.167 . . . . 0.0 109.721 -178.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 63.95 19.0 62.93 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.578 ' OE1' ' N ' ' A' ' 23' ' ' TYR . 1.9 tm-20 -104.18 148.75 25.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.208 -1.172 . . . . 0.0 109.534 179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.578 ' N ' ' OE1' ' A' ' 22' ' ' GLU . 4.3 t80 -71.65 134.39 46.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.413 -0.804 . . . . 0.0 109.81 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -141.7 158.16 44.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.09 -1.006 . . . . 0.0 109.298 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -137.77 144.85 41.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.209 -0.932 . . . . 0.0 109.258 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.736 HD11 ' HD2' ' A' ' 97' ' ' PRO . 3.0 mt -125.25 144.91 50.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.072 -1.018 . . . . 0.0 109.606 179.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.42 HG22 ' NE2' ' A' ' 29' ' ' HIS . 12.3 mt -126.4 132.08 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.9 mt -113.1 134.23 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.049 -1.032 . . . . 0.0 109.573 -179.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.42 ' NE2' HG22 ' A' ' 27' ' ' ILE . 22.5 m-70 -128.62 149.72 72.71 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.443 -0.786 . . . . 0.0 109.031 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.81 160.51 28.79 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.288 1.992 . . . . 0.0 111.226 179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 10.6 mm-40 -135.23 -174.66 3.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.132 -0.98 . . . . 0.0 109.914 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' O ' ' OG1' ' A' ' 35' ' ' THR . 16.5 tttt -91.0 155.71 18.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.766 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -47.84 145.23 2.98 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.252 -0.905 . . . . 0.0 110.251 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.62 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.08 27.4 62.44 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.105 178.256 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.2 m -80.85 -38.31 28.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.684 -1.48 . . . . 0.0 108.633 179.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.24 -174.21 35.11 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.66 123.51 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.82 139.36 39.94 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.953 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 77.6 m-85 -95.79 148.73 22.27 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.7 t80 -130.65 137.34 49.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 109.217 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -165.38 139.67 4.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -0.942 . . . . 0.0 109.383 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.09 29.73 10.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 0.0 110.084 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.58 18.51 79.47 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.43 HG11 ' HG3' ' A' ' 67' ' ' GLN . 62.3 t -120.51 133.86 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.337 -1.096 . . . . 0.0 109.753 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 15.8 m-85 -97.88 134.53 40.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 0.0 108.871 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.4 mt -127.73 94.91 36.23 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.495 -0.753 . . . . 0.0 109.4 -179.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.91 142.3 15.32 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.095 1.863 . . . . 0.0 111.602 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 39' ' ' PHE . . . -88.04 80.22 7.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.977 -1.077 . . . . 0.0 109.94 -179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 238' ' ' LEU . 0.0 OUTLIER -134.59 152.32 51.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 0.0 109.902 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.1 p80 -54.9 -47.16 74.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 50' ' ' HIS . 4.6 mt-10 -44.01 -20.49 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.939 -1.101 . . . . 0.0 109.706 -179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.514 ' N ' ' O ' ' A' ' 50' ' ' HIS . 97.6 m-85 -90.57 4.66 50.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.033 -1.042 . . . . 0.0 109.854 -179.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 50' ' ' HIS . 23.3 t -60.03 120.21 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 108.921 179.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.5 m -111.88 -28.34 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.319 -0.863 . . . . 0.0 110.161 -179.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -153.44 122.66 6.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.008 -1.057 . . . . 0.0 109.907 -179.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -115.69 132.68 56.56 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.5 t-20 -166.87 -153.22 0.15 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.436 ' C ' ' O ' ' A' ' 57' ' ' ASN . 76.1 m-70 -45.64 -15.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER -136.73 166.16 24.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.549 -0.719 . . . . 0.0 109.487 179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.419 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 2.8 m -108.66 125.77 52.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.354 -0.841 . . . . 0.0 108.878 179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' OD1' ' C ' ' A' ' 60' ' ' THR . 3.5 m-20 -123.47 140.45 53.0 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.073 0.94 . . . . 0.0 111.46 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 72' ' ' VAL . 44.8 mt -122.11 160.24 25.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -173.87 141.1 5.83 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 118.677 -1.725 . . . . 0.0 110.812 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -144.13 149.03 35.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.544 -0.974 . . . . 0.0 109.236 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.95 38.82 31.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.349 -0.844 . . . . 0.0 110.393 179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.95 3.23 80.37 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.29 179.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.513 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 7.5 mm100 -96.16 144.96 25.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -1.196 . . . . 0.0 108.605 179.518 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.5 mtp180 -139.81 143.88 37.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.15 -0.969 . . . . 0.0 111.244 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.71 139.29 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -114.36 151.36 33.15 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.276 -0.89 . . . . 0.0 111.179 -178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m 54.75 70.22 0.64 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.739 -0.601 . . . . 0.0 111.225 178.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.462 HG21 ' CD1' ' A' ' 62' ' ' LEU . 13.7 m -114.29 -8.09 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.068 -1.02 . . . . 0.0 109.846 179.164 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CD2' ' A' ' 74' ' ' HIS . 0.0 OUTLIER -69.52 -19.08 63.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.158 -0.964 . . . . 0.0 111.228 -178.829 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.592 ' CD2' ' OE2' ' A' ' 73' ' ' GLU . 22.6 m170 -73.5 -58.89 3.0 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.753 -1.217 . . . . 0.0 109.52 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 76' ' ' LEU . 4.6 tp -58.52 -42.43 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.844 -1.16 . . . . 0.0 108.691 179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' ILE . 70.5 mt -58.73 -37.53 76.36 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.281 -0.887 . . . . 0.0 109.566 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.502 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.2 t -59.91 -48.3 82.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.0 t -57.96 -54.16 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.093 -1.004 . . . . 0.0 108.455 179.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.3 mt -51.68 -45.46 63.46 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.832 . . . . 0.0 109.234 179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.613 ' HD1' HG22 ' A' ' 232' ' ' ILE . 12.1 t-160 -54.98 -51.87 64.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.787 . . . . 0.0 109.902 -179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.4 mt -64.9 -38.27 90.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 110.629 -179.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.725 HD13 HD11 ' A' ' 114' ' ' ILE . 13.9 mt -79.89 -1.1 37.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 110.612 -178.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 60.14 63.46 1.42 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.013 -1.054 . . . . 0.0 110.401 179.453 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.559 HD11 ' HB3' ' A' ' 82' ' ' LEU . 13.3 mm -105.51 127.6 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 121' ' ' ILE . 56.7 p -115.1 -21.22 10.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.314 -0.866 . . . . 0.0 112.03 -178.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.694 ' O ' HG13 ' A' ' 87' ' ' VAL . 12.2 m-80 -128.74 111.6 13.31 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.787 -1.195 . . . . 0.0 110.295 -179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.694 HG13 ' O ' ' A' ' 86' ' ' ASN . 1.6 m -164.19 139.13 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.196 -0.94 . . . . 0.0 109.89 179.09 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 21.5 m -110.42 99.54 8.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -89.24 104.98 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.398 -0.814 . . . . 0.0 109.92 -179.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.67 128.47 33.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.612 179.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.71 108.65 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.367 -0.833 . . . . 0.0 111.093 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 92' ' ' ILE . 4.1 mp -89.06 109.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.81 -155.27 20.09 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -178.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.43 ' ND2' ' N ' ' A' ' 94' ' ' ASN . 0.0 OUTLIER -123.04 -8.18 8.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.532 -0.981 . . . . 0.0 110.694 -179.555 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.573 ' OE2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -144.58 150.76 38.01 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.62 -1.3 . . . . 0.0 111.681 -178.846 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.6 mm -75.88 122.26 86.65 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.888 . . . . 0.0 109.027 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.736 ' HD2' HD11 ' A' ' 26' ' ' LEU . 80.9 Cg_exo -45.29 133.52 12.05 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.924 1.75 . . . . 0.0 112.198 179.351 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 98' ' ' ILE . 11.0 tp -76.59 -20.11 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.364 -0.835 . . . . 0.0 110.092 -179.12 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.584 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 75.8 mt 54.99 -121.91 1.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.838 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.48 -7.75 40.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.195 -0.941 . . . . 0.0 110.533 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.46 -15.63 38.45 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.5 p -111.35 -171.71 1.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -1.044 . . . . 0.0 109.526 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -114.07 -1.9 23.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -46.43 -40.95 13.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.694 -0.886 . . . . 0.0 110.086 -179.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -61.84 -52.31 64.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.098 -1.001 . . . . 0.0 109.838 -179.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 75' ' ' ILE . 57.3 m-85 -63.05 -44.47 95.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.088 -1.007 . . . . 0.0 108.762 179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -62.94 -37.18 86.04 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.419 0.628 . . . . 0.0 109.77 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -72.06 -48.0 47.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.419 -0.8 . . . . 0.0 111.096 -178.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.77 -51.17 14.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.941 -1.099 . . . . 0.0 110.194 -179.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.28 -43.07 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.084 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -54.31 -32.15 55.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -83.06 -0.87 51.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 0.0 110.139 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.552 ' HB2' HD11 ' A' ' 11' ' ' LEU . 0.6 OUTLIER -131.82 33.25 3.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.248 -0.908 . . . . 0.0 111.149 -179.171 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.725 HD11 HD13 ' A' ' 82' ' ' LEU . 7.0 mt -94.05 144.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.513 -1.367 . . . . 0.0 110.125 179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 115' ' ' LEU . 13.4 tp -132.04 161.61 32.78 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.573 HD22 ' H ' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -108.66 146.27 33.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.059 -1.026 . . . . 0.0 110.388 -179.447 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.689 HE22 HD22 ' A' ' 86' ' ' ASN . 1.4 mt-30 -105.09 -162.41 0.88 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 109.078 179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.03 -0.01 12.27 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.299 -0.875 . . . . 0.0 110.629 -179.208 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -93.28 147.49 22.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.832 -1.167 . . . . 0.0 110.043 -179.654 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -84.1 131.0 34.83 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.423 -0.798 . . . . 0.0 109.555 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 85' ' ' THR . 80.1 mt -71.69 141.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.874 . . . . 0.0 110.965 -179.041 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.15 104.39 16.4 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -78.6 146.68 34.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 111.095 -178.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -91.84 121.9 33.88 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 243' ' ' LYS . 22.0 t -120.82 136.8 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.0 110.057 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -81.05 136.75 22.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -116.42 -11.22 11.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.523 -0.735 . . . . 0.0 109.113 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -142.07 142.82 25.77 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.28 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -72.82 152.64 52.77 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 122.033 1.822 . . . . 0.0 112.953 -179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.81 HG22 ' HB3' ' A' ' 141' ' ' ALA . 13.2 tt -145.94 141.7 21.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.672 -0.642 . . . . 0.0 109.332 -179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.521 ' CG2' HD21 ' A' ' 138' ' ' LEU . 1.2 mp -128.29 123.2 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.3 -0.875 . . . . 0.0 109.5 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.4 m -118.4 116.69 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.515 -0.74 . . . . 0.0 109.654 -179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -108.85 140.08 42.8 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.299 -0.876 . . . . 0.0 109.29 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -164.41 126.51 2.3 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.811 -1.155 . . . . 0.0 111.735 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.489 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 46.1 mt-10 52.75 39.14 28.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.752 -0.593 . . . . 0.0 112.389 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.52 5.22 89.35 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.565 -1.302 . . . . 0.0 110.424 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.489 ' NH2' ' OE1' ' A' ' 135' ' ' GLU . 5.5 mtt180 -107.05 164.24 12.32 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.005 HD23 ' N ' ' A' ' 139' ' ' ILE . 5.9 tt -159.75 151.2 19.87 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 119.948 -1.72 . . . . 0.0 109.213 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.005 ' N ' HD23 ' A' ' 138' ' ' LEU . 13.1 mt -146.97 130.76 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 tttm -122.8 140.28 53.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.211 -0.931 . . . . 0.0 110.161 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.81 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -116.99 148.18 41.66 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -146.19 137.03 12.49 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.28 144.43 71.38 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 121.325 1.35 . . . . 0.0 112.166 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.04 148.16 11.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 109.241 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.37 -1.96 43.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 109.665 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.3 p -136.35 150.23 48.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.332 -0.855 . . . . 0.0 109.272 179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 242' ' ' VAL . 16.6 tp -82.2 117.43 22.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.262 -0.899 . . . . 0.0 109.952 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -136.24 137.51 40.87 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.682 ' CG1' HD23 ' A' ' 231' ' ' LEU . 74.0 t -136.92 123.65 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.1 -1.0 . . . . 0.0 109.751 -179.276 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.2 m -111.15 132.66 54.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 109.594 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -116.89 129.01 55.79 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.488 -0.758 . . . . 0.0 109.491 -179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.28 111.59 21.15 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.06 156.89 15.81 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 250' ' ' ARG . 36.4 mt-10 -138.33 95.16 2.96 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.349 -1.089 . . . . 0.0 109.387 179.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -94.78 148.27 22.47 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.444 -0.785 . . . . 0.0 109.616 -179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -91.17 0.48 57.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.331 -0.856 . . . . 0.0 109.767 -179.817 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.472 HD21 HD12 ' A' ' 159' ' ' LEU . 11.9 p30 -78.66 -173.6 3.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.134 -0.979 . . . . 0.0 109.355 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -53.21 -18.92 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.276 -0.89 . . . . 0.0 110.208 -179.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.472 HD12 HD21 ' A' ' 157' ' ' ASN . 16.7 mt -65.43 -62.5 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.018 -1.051 . . . . 0.0 109.659 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 95.94 -125.3 8.36 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -109.63 139.35 44.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -1.081 . . . . 0.0 109.282 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.75 150.45 29.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.258 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.37 152.67 48.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -0.927 . . . . 0.0 109.635 -179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -136.51 124.78 23.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 0.0 109.109 179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 165' ' ' THR . 13.7 t -98.35 122.28 41.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.089 -1.007 . . . . 0.0 110.006 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 2.4 t80 -97.48 137.28 36.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.316 -0.865 . . . . 0.0 108.846 179.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.556 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 1.5 t -133.2 150.24 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 147' ' ' LEU . 14.3 mt-10 -56.1 122.35 11.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.897 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.05 -18.85 14.0 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -116.16 36.35 4.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.069 -1.253 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -66.33 -31.57 72.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 0.0 110.525 -179.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -57.28 -14.06 3.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.956 -1.09 . . . . 0.0 110.693 -179.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -90.28 -3.87 57.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.945 -1.097 . . . . 0.0 110.701 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 5.3 pt -122.83 10.73 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.992 -1.067 . . . . 0.0 111.033 -179.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.93 -31.8 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.867 -1.146 . . . . 0.0 109.958 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 mt -85.89 2.23 46.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.828 -1.17 . . . . 0.0 110.489 -179.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.71 133.3 35.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.888 -1.133 . . . . 0.0 108.932 179.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.3 ptp85 -105.41 154.08 20.8 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 -179.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -55.65 159.6 2.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.413 -0.804 . . . . 0.0 109.508 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.43 166.25 25.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.017 -1.052 . . . . 0.0 110.148 -179.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.565 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 0.5 OUTLIER -152.52 163.25 39.95 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.409 -0.807 . . . . 0.0 109.458 179.854 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.548 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 70.7 m-85 -104.53 144.03 32.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.633 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.678 ' HA ' HD12 ' A' ' 186' ' ' ILE . 10.9 p-10 -61.28 -25.91 67.42 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.817 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.548 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 5.2 p90 -77.52 -25.32 50.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.776 -1.203 . . . . 0.0 110.966 -178.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.465 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 10.0 pt-20 -100.96 -11.9 19.34 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 109.993 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 183' ' ' ASP . 6.9 mt -57.34 -52.36 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.116 -0.99 . . . . 0.0 110.449 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -51.42 -53.72 33.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 0.0 109.975 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -52.88 -42.33 65.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.073 -1.017 . . . . 0.0 109.187 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.07 -33.77 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.021 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -78.69 -26.06 44.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.783 . . . . 0.0 110.335 -179.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.74 -32.46 35.65 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.995 -1.065 . . . . 0.0 110.181 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 194' ' ' LEU . 28.8 m -73.76 8.43 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.24 -0.913 . . . . 0.0 109.015 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 78.83 20.48 70.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 179.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 192' ' ' VAL . 27.9 mt -117.22 154.86 30.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.196 -1.179 . . . . 0.0 109.764 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.524 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 83.3 23.15 55.35 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.421 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -66.2 -23.96 66.53 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.617 -1.519 . . . . 0.0 109.756 179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -102.07 -5.89 49.39 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.83 130.69 45.6 Favored Glycine 0 N--CA 1.493 2.436 0 O-C-N 121.129 -1.218 . . . . 0.0 110.773 -178.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 6.9 p -134.82 -173.74 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.668 -0.901 . . . . 0.0 109.179 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 33.1 mt -88.8 -17.48 29.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -89.11 -8.54 53.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 109.639 -179.833 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.59 ' N ' ' OD1' ' A' ' 202' ' ' ASN . 0.5 OUTLIER -127.96 -14.18 5.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 0.0 109.754 -179.627 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -125.4 115.01 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.395 -0.816 . . . . 0.0 109.947 -179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.0 tp -77.14 109.97 11.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.154 -0.966 . . . . 0.0 108.668 179.414 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 186' ' ' ILE . 44.1 t -97.64 125.92 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.058 -1.026 . . . . 0.0 110.012 -179.389 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 206' ' ' LEU . 28.5 mt -99.1 143.26 29.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.323 -0.86 . . . . 0.0 109.623 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 209' ' ' ASP . . . -104.64 144.46 15.82 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 207' ' ' GLY . 3.9 pttt -41.52 -23.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.176 -1.191 . . . . 0.0 110.299 -179.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' N ' ' O ' ' A' ' 207' ' ' GLY . 1.2 p-10 -152.67 11.92 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.914 -1.116 . . . . 0.0 110.565 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -148.89 157.98 43.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.972 -1.08 . . . . 0.0 110.419 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.55 127.86 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -73.62 -54.86 7.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.028 -1.045 . . . . 0.0 110.55 -179.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.95 111.35 2.9 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.056 -1.027 . . . . 0.0 110.169 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -54.45 -8.49 1.18 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.864 1.709 . . . . 0.0 112.292 179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -88.06 -7.74 56.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.09 -1.006 . . . . 0.0 109.869 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.88 -167.36 48.5 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.5 mt -89.06 145.3 25.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.414 -1.05 . . . . 0.0 110.165 -179.499 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -88.17 -17.55 30.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.425 -0.797 . . . . 0.0 109.387 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -144.95 134.41 23.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 108.867 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.39 -23.04 1.31 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.015 -1.053 . . . . 0.0 109.062 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.477 ' OD1' ' NH2' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -124.95 35.72 4.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.078 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.461 ' N ' ' HD2' ' A' ' 223' ' ' PRO . 5.1 tt0 -55.4 -57.97 17.75 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.505 -0.747 . . . . 0.0 111.638 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 222' ' ' GLU . 10.5 Cg_endo -54.19 -39.96 84.05 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.955 1.77 . . . . 0.0 113.105 -178.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 228' ' ' VAL . 11.5 m -80.2 -26.66 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 120.667 -1.27 . . . . 0.0 109.017 179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.477 ' NH2' ' OD1' ' A' ' 221' ' ' ASN . 18.7 mtt180 -66.65 -43.27 85.04 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -62.01 -42.35 99.06 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -56.78 -39.04 73.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.935 . . . . 0.0 108.931 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 224' ' ' VAL . 48.4 t -66.41 -40.89 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 88.7 t80 -59.1 -37.48 77.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 91.0 m-20 -76.07 -40.87 52.18 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.563 -0.711 . . . . 0.0 109.671 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.682 HD23 ' CG1' ' A' ' 149' ' ' VAL . 23.6 tp -55.47 -36.71 66.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 108.836 -179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.613 HG22 ' HD1' ' A' ' 80' ' ' HIS . 77.9 mt -73.15 -47.75 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -50.77 -33.92 28.31 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.577 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.44 -26.81 32.38 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -1.225 . . . . 0.0 109.852 179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 4.6 mt -79.74 -20.71 45.75 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.761 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.583 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 11.9 t80 -74.24 -9.02 58.19 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.145 -0.972 . . . . 0.0 109.193 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.533 HD12 ' O ' ' A' ' 234' ' ' ASP . 18.3 mt -50.91 -28.6 10.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.439 ' O ' ' NH2' ' A' ' 49' ' ' ARG . 62.9 mt -58.11 -11.26 2.4 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 0.0 108.947 179.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 76.54 16.04 81.05 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 23.1 p -158.48 150.45 17.3 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.071 -1.252 . . . . 0.0 109.219 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.426 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 6.5 Cg_endo -53.28 139.48 63.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.999 1.799 . . . . 0.0 111.519 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.501 ' O ' HD22 ' A' ' 147' ' ' LEU . 14.0 t -102.93 133.45 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 0.0 110.383 -179.139 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.436 ' HB2' HG22 ' A' ' 125' ' ' VAL . 3.9 mmtt -118.38 123.92 46.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.755 . . . . 0.0 109.253 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 157.34 170.75 22.58 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -101.57 112.72 25.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.188 -1.184 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -112.03 148.15 34.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.921 0.867 . . . . 0.0 111.209 -179.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -130.18 144.19 51.22 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 179.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.8 t -137.77 127.93 26.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.743 -1.223 . . . . 0.0 110.502 -179.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -111.73 113.89 26.54 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 154' ' ' GLU . 2.3 mtt85 49.81 56.0 8.54 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.01 142.45 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.405 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.94 167.45 13.14 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.538 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -56.5 -45.03 81.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.145 -1.209 . . . . 0.0 109.527 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -59.55 -56.01 27.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.119 -0.988 . . . . 0.0 109.425 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.662 ' HG ' HD12 ' A' ' 139' ' ' ILE . 52.0 tp -56.83 -36.54 70.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 62.5 m-20 -59.76 -55.5 33.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.112 -0.993 . . . . 0.0 108.721 179.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 36.5 t -51.05 -40.59 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.308 -0.87 . . . . 0.0 109.148 179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -54.81 -47.63 73.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 0.0 108.916 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.495 HD22 HG21 ' A' ' 139' ' ' ILE . 59.3 tp -53.34 -47.31 69.46 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.407 HG11 ' HB3' ' A' ' 50' ' ' HIS . 2.8 t -65.98 -43.19 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.382 -0.824 . . . . 0.0 109.591 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.1 -51.9 64.93 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.446 -0.783 . . . . 0.0 110.384 -179.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.83 -43.75 95.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.817 -1.177 . . . . 0.0 110.189 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 95.7 mt -64.18 -42.36 96.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.978 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.45 -32.71 58.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 110.334 -179.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -79.26 -31.41 43.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.877 -1.139 . . . . 0.0 109.186 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.432 ' C ' ' H ' ' A' ' 268' ' ' LYS . 20.4 mttm -61.21 -43.97 98.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.857 -1.152 . . . . 0.0 108.687 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -73.52 17.16 0.16 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.456 -0.778 . . . . 0.0 109.888 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.572 ' O ' ' N ' ' A' ' 270' ' ' THR . 41.1 tptt -69.27 -63.07 1.14 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.917 -1.114 . . . . 0.0 109.087 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.1 mt -45.64 -13.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.165 -0.959 . . . . 0.0 109.471 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 268' ' ' LYS . 3.4 t . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.874 . . . . 0.0 109.381 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.565 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.431 0.634 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.495 ' OE2' ' OE1' ' A' ' 33' ' ' GLU . 10.6 mt-10 -54.99 152.39 7.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -0.875 . . . . 0.0 109.247 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 145.9 51.5 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.517 -0.74 . . . . 0.0 109.743 -178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 177.8 8.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.284 -0.885 . . . . 0.0 108.944 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.66 147.09 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.9 -1.125 . . . . 0.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -83.05 -41.17 18.97 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.581 -0.699 . . . . 0.0 109.958 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -129.79 155.18 46.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.955 -179.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -62.9 133.21 54.33 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.399 -0.813 . . . . 0.0 109.671 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.75 161.96 19.86 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.1 p -158.42 152.43 23.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.071 -1.018 . . . . 0.0 110.806 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -134.8 171.64 14.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.645 -0.66 . . . . 0.0 109.74 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -149.62 137.69 20.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 108.982 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 170.61 161.0 20.45 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' O ' HG22 ' A' ' 98' ' ' ILE . 0.8 OUTLIER -88.36 144.49 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -1.199 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.53 141.08 39.97 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.2 tt -62.16 -43.52 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.105 -1.233 . . . . 0.0 111.325 -178.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 8.2 m-70 -87.98 -39.39 14.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.174 -1.579 . . . . 0.0 111.149 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 p -69.06 -40.43 78.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 110.437 -178.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.27 17.49 78.86 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -114.36 152.58 31.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.519 -0.989 . . . . 0.0 108.828 179.235 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.492 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 5.2 t80 -71.8 139.67 49.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.056 -1.028 . . . . 0.0 110.245 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -146.97 157.72 43.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.336 -0.852 . . . . 0.0 108.819 179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 26' ' ' LEU . 25.2 ttpt -127.07 157.71 38.9 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 109.704 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.789 HD11 HG23 ' A' ' 96' ' ' ILE . 12.6 mt -126.56 144.86 50.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.982 -1.074 . . . . 0.0 108.397 179.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.561 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.2 mt -138.62 132.27 40.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.015 179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 28' ' ' ILE . 6.2 mt -120.97 128.09 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.865 . . . . 0.0 109.914 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 29' ' ' HIS . 1.4 m-70 -125.7 149.02 64.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.56 157.64 35.85 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.179 1.92 . . . . 0.0 111.38 179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.542 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 41.2 mm-40 -135.83 162.9 31.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.142 -0.974 . . . . 0.0 109.989 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.5 tttp -64.77 150.37 47.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.528 -0.732 . . . . 0.0 109.5 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.495 ' OE1' ' OE2' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -47.81 148.91 1.42 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.159 -0.963 . . . . 0.0 110.573 -179.373 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' H ' ' CD ' ' A' ' 33' ' ' GLU . . . 59.86 25.45 61.6 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.527 -0.733 . . . . 0.0 112.089 177.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.5 m -80.16 -37.07 34.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.467 -1.608 . . . . 0.0 109.068 179.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.72 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 94.23 -172.69 32.21 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.9 mm -100.42 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.164 -1.198 . . . . 0.0 108.338 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -139.4 143.81 37.84 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.392 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -101.5 153.63 19.54 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 2.8 t80 -124.3 147.93 47.79 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 13.5 tttt -173.75 133.48 0.46 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.777 -1.202 . . . . 0.0 109.218 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.639 ' O ' ' ND2' ' A' ' 42' ' ' ASN . 0.7 OUTLIER 52.95 29.54 7.99 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.493 -0.754 . . . . 0.0 110.303 -179.763 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.71 -9.88 48.83 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.62 ' CG2' HD21 ' A' ' 42' ' ' ASN . 20.6 t -94.43 139.34 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.114 -1.227 . . . . 0.0 110.22 -179.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -97.36 146.2 25.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.419 -0.801 . . . . 0.0 108.923 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 67' ' ' GLN . 53.5 mt -138.1 97.03 9.93 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.147 -0.971 . . . . 0.0 110.453 -179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.47 141.19 33.81 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.243 1.962 . . . . 0.0 111.499 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.19 84.31 5.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.878 -1.139 . . . . 0.0 110.58 -179.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -141.27 157.62 44.98 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.135 -0.978 . . . . 0.0 109.284 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.648 ' ND1' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -52.52 -49.74 64.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 110.117 -179.502 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -48.77 -16.63 0.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.943 . . . . 0.0 110.076 -179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' HIS . 73.4 m-85 -97.37 6.08 48.82 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.052 -1.03 . . . . 0.0 109.775 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 50' ' ' HIS . 22.8 t -64.59 129.31 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.951 . . . . 0.0 109.383 179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 m -116.62 -29.51 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.38 -0.825 . . . . 0.0 110.248 -179.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.441 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 7.8 t-80 -152.92 122.61 6.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.788 -1.195 . . . . 0.0 109.814 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 62.6 p -113.34 133.12 55.31 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.59 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.7 t-20 -166.98 -154.04 0.16 Allowed 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.599 ' CE1' HD11 ' A' ' 189' ' ' ILE . 0.2 OUTLIER -47.04 -13.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.069 -1.02 . . . . 0.0 108.317 178.945 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -135.23 165.7 24.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.591 -0.693 . . . . 0.0 109.401 -179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.446 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 7.4 m -103.93 122.24 44.78 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.221 -0.924 . . . . 0.0 108.604 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -120.2 136.92 54.47 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.053 0.93 . . . . 0.0 111.528 -178.692 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.445 ' HG ' HG21 ' A' ' 72' ' ' VAL . 76.8 mt -117.69 158.21 25.11 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.502 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.77 143.11 6.66 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 118.652 -1.737 . . . . 0.0 110.908 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -145.08 151.55 38.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.617 -0.931 . . . . 0.0 109.758 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp 56.79 27.61 13.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.521 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.52 -0.43 83.05 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.832 -1.175 . . . . 0.0 110.509 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.502 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 91.3 mm-40 -94.84 138.77 32.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.968 -1.313 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -134.28 146.7 50.28 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.16 -0.963 . . . . 0.0 111.27 -178.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.4 mt -134.89 145.88 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -114.61 152.75 31.33 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.222 -0.924 . . . . 0.0 111.799 -178.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 71' ' ' THR . 45.7 m 53.94 71.68 0.5 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.81 -0.557 . . . . 0.0 111.307 178.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.445 HG21 ' HG ' ' A' ' 62' ' ' LEU . 19.1 m -113.5 -1.44 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.033 -1.042 . . . . 0.0 109.286 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.54 -39.59 73.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 110.576 -179.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -54.38 -60.59 3.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.066 -1.021 . . . . 0.0 110.241 -179.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 76' ' ' LEU . 3.3 tp -58.54 -46.19 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.938 -1.101 . . . . 0.0 109.232 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' N ' HG23 ' A' ' 75' ' ' ILE . 64.8 mt -55.49 -38.72 69.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.074 -1.016 . . . . 0.0 109.43 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.8 t -59.01 -48.24 82.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.101 -0.999 . . . . 0.0 109.564 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.6 t -57.2 -54.18 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 108.499 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -52.39 -46.38 66.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.507 -0.746 . . . . 0.0 109.246 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.618 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 15.4 t-160 -55.58 -53.69 53.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.373 -0.83 . . . . 0.0 109.827 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.89 -38.63 91.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.363 -0.836 . . . . 0.0 110.368 -179.364 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.633 ' HB3' HD11 ' A' ' 84' ' ' ILE . 12.7 mt -78.37 -4.46 48.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.972 -1.08 . . . . 0.0 110.736 -178.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 63.28 51.55 2.65 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.729 -1.232 . . . . 0.0 110.405 179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 82' ' ' LEU . 11.7 mm -98.45 124.46 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.413 HG21 HG12 ' A' ' 121' ' ' ILE . 20.5 p -111.55 -18.95 12.7 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.322 -0.861 . . . . 0.0 112.437 -177.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.72 HD22 ' H ' ' A' ' 36' ' ' GLY . 5.6 m120 -129.94 111.86 12.96 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.512 -1.367 . . . . 0.0 110.633 -179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 86' ' ' ASN . 2.7 m -164.62 143.53 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.204 -0.935 . . . . 0.0 110.228 178.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.542 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 10.7 m -112.19 101.07 9.34 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mt -92.1 110.7 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.579 -0.701 . . . . 0.0 109.706 -179.227 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.71 123.08 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.736 179.398 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.6 t -107.46 106.27 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 0.0 110.954 -178.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.22 111.02 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.12 -161.62 23.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -115.37 -14.51 11.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.503 -0.998 . . . . 0.0 109.989 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.534 ' OE1' ' O ' ' A' ' 96' ' ' ILE . 1.2 tm-20 -140.86 146.61 37.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.022 . . . . 0.0 109.995 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.789 HG23 HD11 ' A' ' 26' ' ' LEU . 3.3 mm -68.95 124.06 89.49 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.345 -0.847 . . . . 0.0 109.97 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.57 130.99 9.64 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.083 1.855 . . . . 0.0 112.171 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 16' ' ' VAL . 8.2 tp -78.53 -30.27 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.451 -0.78 . . . . 0.0 109.727 -179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.0 mt 56.48 -108.77 0.45 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.413 -0.805 . . . . 0.0 110.129 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -94.17 -22.9 18.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.012 -1.055 . . . . 0.0 110.736 -178.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.44 ' HA2' HD11 ' A' ' 98' ' ' ILE . . . 115.49 -10.23 19.48 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.23 -170.95 1.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -1.024 . . . . 0.0 109.757 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -112.07 -4.67 25.68 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.404 ' NE1' ' HG3' ' A' ' 108' ' ' GLU . 51.2 t-105 -46.29 -38.8 9.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.707 -0.878 . . . . 0.0 110.302 -179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.42 -52.04 66.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.907 -1.121 . . . . 0.0 110.013 -179.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -63.56 -43.4 97.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.041 -1.037 . . . . 0.0 108.695 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 18.7 t80 -63.64 -36.71 84.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.74 -0.6 . . . . 0.0 110.014 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.404 ' HG3' ' NE1' ' A' ' 104' ' ' TRP . 2.4 mm-40 -72.75 -49.94 27.73 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.28 -0.887 . . . . 0.0 111.956 -178.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.38 -44.55 58.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.824 -1.172 . . . . 0.0 110.977 -178.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.2 -39.97 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.984 -1.073 . . . . 0.0 110.391 -178.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 16.0 tpt180 -54.11 -32.59 55.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.24 -0.913 . . . . 0.0 109.759 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -82.1 -13.41 57.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.929 -1.107 . . . . 0.0 110.14 -179.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -121.37 32.07 6.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.324 -0.86 . . . . 0.0 111.018 -178.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.559 HD11 HD13 ' A' ' 82' ' ' LEU . 6.1 mt -82.74 148.36 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 120.509 -1.37 . . . . 0.0 110.373 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 66.3 tp -128.63 149.57 50.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -97.68 146.14 25.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.042 -1.036 . . . . 0.0 109.731 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.56 -168.45 1.33 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.0 109.813 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -124.43 72.73 1.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.513 -0.742 . . . . 0.0 110.589 -179.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 119' ' ' ARG . 6.2 ttm-85 -168.63 149.48 4.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.152 -0.968 . . . . 0.0 109.461 178.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -83.3 126.87 33.14 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.263 -0.898 . . . . 0.0 110.191 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.413 HG12 HG21 ' A' ' 85' ' ' THR . 18.4 mt -67.09 135.82 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.456 -0.778 . . . . 0.0 110.765 -179.548 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -74.52 73.69 1.94 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.345 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -52.31 141.31 19.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.538 -0.726 . . . . 0.0 110.479 -179.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -104.99 125.57 51.12 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.615 HG22 ' HB3' ' A' ' 243' ' ' LYS . 67.8 t -128.75 142.88 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.253 -0.904 . . . . 0.0 110.266 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.4 t -81.13 135.26 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.489 -0.757 . . . . 0.0 109.222 179.654 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -116.53 -11.43 11.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.484 -0.76 . . . . 0.0 109.214 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -141.42 143.62 30.8 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.05 179.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -73.61 161.51 41.9 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.109 1.873 . . . . 0.0 113.182 -179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.572 ' CG2' ' HB3' ' A' ' 141' ' ' ALA . 1.9 tt -155.4 140.0 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.65 -0.656 . . . . 0.0 109.584 -179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 131' ' ' ILE . 2.4 mp -127.86 124.33 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.457 -0.777 . . . . 0.0 109.612 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 132' ' ' VAL . 29.4 m -121.36 118.84 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.724 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -115.58 133.6 55.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.417 -0.802 . . . . 0.0 109.583 179.862 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 135' ' ' GLU . 34.1 t0 -173.43 150.65 1.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.18 -0.95 . . . . 0.0 110.759 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 134' ' ' ASP . 10.9 mt-10 57.57 22.32 8.04 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.541 -0.724 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.26 6.99 88.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.537 ' HB2' HD22 ' A' ' 255' ' ' LEU . 5.4 mtt85 -105.34 171.64 7.22 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.953 HD23 ' N ' ' A' ' 139' ' ' ILE . 7.1 tt -159.63 149.57 18.61 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.457 -1.402 . . . . 0.0 109.028 179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.953 ' N ' HD23 ' A' ' 138' ' ' LEU . 12.0 mt -147.69 139.06 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.995 . . . . 0.0 108.399 179.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -131.26 142.68 50.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.118 -0.989 . . . . 0.0 109.654 -179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.572 ' HB3' ' CG2' ' A' ' 130' ' ' ILE . . . -123.35 145.82 48.44 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -142.48 135.1 13.68 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.53 147.96 36.52 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.272 1.315 . . . . 0.0 112.053 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.99 154.23 8.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.364 179.463 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -84.98 0.73 50.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.878 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -136.98 151.79 49.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.52 HD22 ' O ' ' A' ' 242' ' ' VAL . 34.1 tp -87.37 117.92 26.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.0 110.027 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -136.18 142.93 44.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.668 ' CG1' HD23 ' A' ' 231' ' ' LEU . 69.5 t -135.93 118.31 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.022 -1.049 . . . . 0.0 109.907 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 247' ' ' TYR . 3.5 m -105.19 127.1 52.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 109.178 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -121.36 130.07 53.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.384 -0.823 . . . . 0.0 110.08 -179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -112.27 104.94 13.13 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.1 129.51 9.93 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.62 97.32 6.9 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -1.091 . . . . 0.0 109.169 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.506 ' HB2' HD21 ' A' ' 157' ' ' ASN . 24.5 m-85 -99.63 148.92 23.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.188 -179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -92.87 -10.17 37.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.821 . . . . 0.0 109.934 -179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.717 HD22 ' N ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -70.34 -167.95 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.23 -0.918 . . . . 0.0 110.103 -179.284 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -60.12 -24.49 64.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.355 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.474 ' HB2' HD21 ' A' ' 157' ' ' ASN . 6.6 mt -64.93 -40.65 95.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.939 -1.101 . . . . 0.0 108.871 179.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 155' ' ' PHE . . . 76.97 -107.52 2.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 161' ' ' ARG . 0.0 OUTLIER -122.01 140.69 52.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.608 -0.937 . . . . 0.0 109.692 -179.577 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -144.44 158.04 43.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.299 -0.876 . . . . 0.0 109.439 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -142.89 144.48 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -137.01 123.89 21.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.202 -0.936 . . . . 0.0 109.344 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 9.1 m -104.67 124.55 49.55 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.204 -0.935 . . . . 0.0 110.198 -179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -99.67 130.13 45.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.24 147.78 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.502 -0.749 . . . . 0.0 109.46 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -50.04 115.62 1.49 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.377 -0.827 . . . . 0.0 109.349 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 116.22 4.89 17.75 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.45 28.85 3.98 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.304 -1.115 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.75 -33.26 75.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.733 -0.604 . . . . 0.0 110.473 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -58.55 -9.97 1.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.085 -1.009 . . . . 0.0 110.697 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -98.38 -4.84 33.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.791 -1.193 . . . . 0.0 110.793 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 2.3 pt -117.65 13.05 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.068 -1.02 . . . . 0.0 110.722 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.13 -26.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.018 -1.051 . . . . 0.0 110.027 179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 mp -91.6 0.8 57.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.85 -1.156 . . . . 0.0 110.706 -179.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.51 115.39 20.0 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.994 -1.067 . . . . 0.0 109.006 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -84.02 151.68 24.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.135 -0.978 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 2.8 t -59.24 132.64 54.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.323 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.504 ' CZ ' ' O6G' ' A' ' 320' ' ' TUX . 23.2 p90 -110.96 170.2 8.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.983 -179.352 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.577 ' SG ' ' O1A' ' A' ' 320' ' ' TUX . 1.8 t -154.21 162.99 40.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.441 -0.787 . . . . 0.0 109.475 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.473 ' CD1' ' CH2' ' A' ' 184' ' ' TRP . 71.5 m-85 -104.6 144.6 31.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.407 -0.808 . . . . 0.0 109.495 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.705 ' HA ' HD12 ' A' ' 186' ' ' ILE . 1.0 OUTLIER -61.67 -25.85 67.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.756 -1.215 . . . . 0.0 110.385 -179.372 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.0 p90 -81.83 -30.09 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.8 -1.188 . . . . 0.0 110.413 -179.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 15.5 pt-20 -87.41 -16.96 33.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.784 -1.197 . . . . 0.0 109.384 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.705 HD12 ' HA ' ' A' ' 183' ' ' ASP . 10.0 mt -57.83 -53.36 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.149 -0.969 . . . . 0.0 110.131 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.52 -53.19 40.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.919 -1.113 . . . . 0.0 109.624 -179.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -52.87 -44.51 66.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 109.053 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 58' ' ' HIS . 3.7 mt -64.85 -33.42 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.065 179.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -78.3 -27.73 47.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.208 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -76.78 -28.15 55.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.065 -1.022 . . . . 0.0 109.937 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 23.4 m -82.61 9.27 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 109.782 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.3 21.56 72.78 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.633 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.0 mt -119.8 157.93 27.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.211 -1.17 . . . . 0.0 109.669 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 80.63 21.64 63.61 Favored Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.148 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.36 -22.89 63.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.588 -1.537 . . . . 0.0 109.87 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -100.65 -3.16 55.26 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.6 128.74 35.73 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 121.086 -1.243 . . . . 0.0 110.459 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.29 162.23 34.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.738 -0.86 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.93 -31.45 72.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.962 . . . . 0.0 110.105 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -75.47 -14.6 60.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.07 -1.019 . . . . 0.0 110.248 -179.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.34 9.87 5.22 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.161 -0.962 . . . . 0.0 110.011 -179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 90.7 m -150.36 123.56 8.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.42 179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 5.7 tp -85.16 115.49 22.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.189 -0.944 . . . . 0.0 109.24 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.444 HG22 HD11 ' A' ' 186' ' ' ILE . 53.1 t -101.56 126.75 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.4 mt -102.44 141.91 34.51 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.456 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 210' ' ' LYS . . . -99.06 149.6 19.1 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 179.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 207' ' ' GLY . 0.1 OUTLIER -42.24 -29.0 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.895 -179.578 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 209' ' ' ASP . 8.5 t0 -149.71 14.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.037 -1.039 . . . . 0.0 110.163 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 207' ' ' GLY . 9.9 mtpm? -146.85 155.71 42.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.039 -1.038 . . . . 0.0 110.272 -179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.5 t -101.44 127.6 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -72.78 -54.63 8.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.329 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -55.14 131.32 68.69 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 120.938 -1.101 . . . . 0.0 109.325 -179.77 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.03 -14.57 29.16 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.175 1.917 . . . . 0.0 112.574 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.78 -6.12 59.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.126 -0.984 . . . . 0.0 109.724 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.22 -167.93 51.2 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 49.6 mt -82.79 146.15 29.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.478 -1.013 . . . . 0.0 109.935 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 49.7 mtt180 -89.48 -20.74 23.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.302 -0.874 . . . . 0.0 109.241 179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.475 ' C ' ' N ' ' A' ' 221' ' ' ASN . 69.2 m-85 -141.57 139.51 33.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.377 179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -11.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 108.6 179.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.716 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -141.87 38.03 1.62 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.731 0.777 . . . . 0.0 109.066 -179.991 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.594 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.4 OUTLIER -58.18 -36.54 45.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.255 -0.903 . . . . 0.0 111.05 -179.472 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 4.4 Cg_exo -72.47 -44.3 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.837 1.691 . . . . 0.0 112.54 -179.115 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 228' ' ' VAL . 3.0 m -76.14 -24.45 16.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.765 -1.209 . . . . 0.0 108.49 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.716 HH21 ' ND2' ' A' ' 221' ' ' ASN . 6.3 mtt180 -67.64 -41.87 83.2 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -63.08 -42.78 99.72 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -56.66 -47.63 79.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.068 179.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 224' ' ' VAL . 58.4 t -59.59 -44.54 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 61.3 t80 -55.13 -37.42 66.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.645 -0.66 . . . . 0.0 109.388 179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 3.7 m-20 -76.34 -38.84 55.36 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.499 -0.751 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.668 HD23 ' CG1' ' A' ' 149' ' ' VAL . 21.9 tp -56.92 -37.62 71.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.136 -0.978 . . . . 0.0 109.092 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.57 HG22 ' HD1' ' A' ' 80' ' ' HIS . 74.2 mt -73.1 -48.61 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.916 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.07 -34.56 16.77 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.596 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.22 -26.89 32.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -1.13 . . . . 0.0 110.189 -179.722 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.603 HD23 HG22 ' A' ' 260' ' ' VAL . 5.5 mt -78.13 -22.62 48.55 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.709 -1.244 . . . . 0.0 109.758 179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.618 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 6.6 t80 -70.45 -5.4 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.105 -0.997 . . . . 0.0 108.83 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 237' ' ' LEU . 14.0 mt -52.24 -30.55 28.14 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.522 HD12 HG22 ' A' ' 242' ' ' VAL . 87.7 mt -56.29 -17.9 9.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 82.96 14.51 74.93 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 19.4 p -158.31 151.89 19.25 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.084 -1.245 . . . . 0.0 109.458 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -49.94 131.31 29.64 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.161 1.907 . . . . 0.0 111.511 179.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.522 HG22 HD12 ' A' ' 238' ' ' LEU . 19.6 t -98.07 135.22 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 109.877 -179.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.615 ' HB3' HG22 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -122.12 126.03 47.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.466 -0.771 . . . . 0.0 109.447 179.768 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.61 170.37 21.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -99.79 113.47 26.0 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.048 -1.266 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 18.3 m-85 -112.12 148.44 33.97 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.073 0.94 . . . . 0.0 111.148 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.408 ' CD2' ' HB ' ' A' ' 150' ' ' THR . 24.1 t80 -128.15 144.53 51.12 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.39 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 45.1 t -144.86 124.82 13.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.42 -1.425 . . . . 0.0 110.413 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.418 ' O ' ' C ' ' A' ' 250' ' ' ARG . 3.3 t80 -109.8 116.55 31.88 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.085 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.6 OUTLIER 45.31 56.33 5.69 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.314 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -88.01 152.66 23.94 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -120.0 -177.81 16.19 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -71.15 -51.51 24.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 0.0 109.714 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.08 -34.54 70.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.985 -179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 137' ' ' ARG . 48.6 tp -72.87 -40.34 65.7 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.016 . . . . 0.0 108.834 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -61.01 -51.06 70.84 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.2 t -51.32 -44.58 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.068 -1.02 . . . . 0.0 109.171 179.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -54.88 -49.11 71.98 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 108.905 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 139' ' ' ILE . 24.9 tp -52.93 -40.14 63.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 108.822 179.441 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.603 HG22 HD23 ' A' ' 235' ' ' LEU . 60.7 t -74.72 -41.54 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.442 -0.786 . . . . 0.0 109.708 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.54 -48.16 82.74 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.566 -0.709 . . . . 0.0 110.158 -179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.42 -47.45 73.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.932 -1.105 . . . . 0.0 109.621 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 263' ' ' LEU . 12.7 mt -58.51 -43.74 89.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.325 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.429 ' HB1' ' HE2' ' A' ' 50' ' ' HIS . . . -66.03 -32.27 73.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.415 -0.803 . . . . 0.0 110.084 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -84.62 -24.41 29.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.725 -1.234 . . . . 0.0 108.865 179.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -69.71 -44.96 69.3 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.274 -0.891 . . . . 0.0 109.478 179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.578 ' C ' ' H ' ' A' ' 269' ' ' LEU . 11.1 tt0 -79.07 15.12 1.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 110.16 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.05 33.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.988 -1.07 . . . . 0.0 109.825 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 267' ' ' GLN . 9.5 mt -65.25 -5.97 8.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 0.0 109.371 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 270' ' ' THR . 11.0 t . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.577 ' O1A' ' SG ' ' A' ' 181' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.644 ' N ' HD22 ' A' ' 3' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 67.7 mt-10 -50.0 147.9 3.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 109.507 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.63 139.33 53.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.596 -0.69 . . . . 0.0 109.95 -179.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.2 t -138.57 173.8 11.21 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.459 -0.776 . . . . 0.0 108.92 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.5 m -84.41 141.39 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.722 -1.236 . . . . 0.0 110.278 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttpp -71.15 -44.47 65.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.661 -0.649 . . . . 0.0 109.957 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.03 159.56 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.127 -179.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.47 136.3 57.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.717 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 157.36 25.23 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.296 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -147.57 145.57 29.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.094 . . . . 0.0 110.186 -179.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -132.17 163.37 28.7 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 109.325 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -148.99 135.57 19.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.889 -1.132 . . . . 0.0 108.718 179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 173.02 159.13 19.08 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.62 146.8 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.087 -1.243 . . . . 0.0 110.762 -178.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.71 143.62 38.79 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 197' ' ' GLY . 1.1 tt -67.74 -38.55 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.248 -1.149 . . . . 0.0 112.786 -178.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.477 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 13.9 m-70 -85.93 -35.4 20.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 119.842 -1.786 . . . . 0.0 112.041 -177.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.47 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 5.2 m -85.21 -39.92 17.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 110.047 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.24 16.03 72.79 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -103.39 150.41 23.84 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -1.125 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 24' ' ' SER . 1.8 t80 -71.34 139.19 49.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.435 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 2.3 t -146.25 157.8 43.83 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.162 -0.961 . . . . 0.0 109.022 179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.68 ' O ' HD23 ' A' ' 26' ' ' LEU . 44.4 tttt -132.85 155.78 48.37 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.882 . . . . 0.0 109.533 -179.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.691 HD21 ' CD ' ' A' ' 97' ' ' PRO . 2.2 mt -132.58 144.97 50.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.032 . . . . 0.0 109.103 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.0 mt -132.9 129.16 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.3 mt -113.43 123.55 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -117.7 153.32 50.64 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -65.19 159.28 47.77 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.327 2.018 . . . . 0.0 111.19 179.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.549 ' CG ' ' OG1' ' A' ' 88' ' ' THR . 39.2 mm-40 -134.12 -178.37 5.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.016 -1.052 . . . . 0.0 110.086 -179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.478 ' O ' ' OG1' ' A' ' 35' ' ' THR . 25.3 tttt -83.04 149.34 27.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.463 -0.773 . . . . 0.0 109.317 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.584 ' N ' ' OE1' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -46.86 148.27 1.11 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.235 -0.916 . . . . 0.0 110.064 -179.487 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.608 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 59.49 24.38 59.35 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.18 178.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.756 ' H ' HD22 ' A' ' 86' ' ' ASN . 15.5 m -80.55 -37.64 31.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.673 -1.486 . . . . 0.0 108.961 179.387 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.45 ' C ' HD13 ' A' ' 37' ' ' ILE . . . 93.9 -167.09 27.87 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 ' C ' ' A' ' 36' ' ' GLY . 2.8 mm -104.02 123.49 57.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.324 -1.103 . . . . 0.0 108.287 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.48 139.09 42.08 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 118.969 -1.093 . . . . 0.0 110.863 -179.533 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -99.7 151.54 21.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 179.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.568 ' C ' ' CD1' ' A' ' 40' ' ' PHE . 1.1 t80 -129.49 139.52 51.55 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -170.86 138.76 1.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.016 . . . . 0.0 109.638 -179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.48 28.65 17.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.85 . . . . 0.0 110.022 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.88 22.13 78.25 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.7 t -130.83 146.76 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.246 -1.149 . . . . 0.0 109.46 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -98.7 147.75 24.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.173 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.409 HD11 ' HB2' ' A' ' 67' ' ' GLN . 38.6 mt -140.7 94.64 8.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -48.77 142.55 18.72 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.206 1.937 . . . . 0.0 111.841 179.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.52 83.11 6.32 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.429 -179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.4 mtm180 -137.72 153.44 49.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.145 -0.972 . . . . 0.0 109.613 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' HG23 ' A' ' 53' ' ' VAL . 3.0 p80 -52.78 -49.6 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 110.421 -179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 50' ' ' HIS . 13.2 mt-10 -44.29 -30.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.084 -1.01 . . . . 0.0 109.285 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.419 ' O ' HG13 ' A' ' 54' ' ' VAL . 58.9 m-85 -79.43 3.94 16.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.84 . . . . 0.0 109.995 -179.323 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG21 HG11 ' A' ' 257' ' ' VAL . 9.5 t -56.62 131.65 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.861 . . . . 0.0 109.029 179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 52' ' ' PHE . 28.1 m -122.32 -35.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.341 -0.849 . . . . 0.0 110.428 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 61' ' ' ASP . 4.5 t-160 -150.2 119.74 6.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.272 -179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.2 p -113.37 131.48 55.96 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.375 0.607 . . . . 0.0 109.465 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.607 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.7 OUTLIER -167.1 -153.25 0.14 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.717 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.422 ' C ' ' O ' ' A' ' 57' ' ' ASN . 13.6 m-70 -45.55 -14.59 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.067 -1.02 . . . . 0.0 108.681 178.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.607 ' N ' ' O ' ' A' ' 57' ' ' ASN . 10.9 t -135.41 165.7 24.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.458 -0.776 . . . . 0.0 109.365 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.8 m -104.08 122.5 45.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.778 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 55' ' ' HIS . 3.4 m-20 -121.39 139.78 53.0 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.092 0.949 . . . . 0.0 111.434 -178.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.56 158.08 29.31 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.495 ' CA ' ' O ' ' A' ' 67' ' ' GLN . . . -174.75 144.82 7.61 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 118.639 -1.743 . . . . 0.0 110.687 -179.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -144.24 150.9 38.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.53 -0.983 . . . . 0.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 8.3 mmtm 56.75 23.87 8.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.0 110.941 179.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.98 70.45 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.718 178.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.495 ' O ' ' CA ' ' A' ' 63' ' ' GLY . 17.3 mm100 -98.2 142.15 30.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.971 -1.311 . . . . 0.0 108.222 179.117 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ptp85 -138.33 150.99 47.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.976 -1.078 . . . . 0.0 111.365 -179.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.63 143.04 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -110.73 149.81 29.96 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.223 -0.923 . . . . 0.0 111.236 -178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 m 54.21 67.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.715 -0.616 . . . . 0.0 111.471 178.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.449 HG12 HG13 ' A' ' 96' ' ' ILE . 16.6 m -113.48 -3.56 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 108.997 178.66 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pt-20 -71.39 -26.0 62.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.865 . . . . 0.0 110.318 -179.306 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -65.6 -60.51 2.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 0.0 109.635 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.516 HG23 ' N ' ' A' ' 76' ' ' LEU . 2.6 tp -56.74 -44.1 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.124 -0.985 . . . . 0.0 108.922 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.516 ' N ' HG23 ' A' ' 75' ' ' ILE . 7.7 mt -55.79 -38.23 69.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.11 -0.993 . . . . 0.0 109.46 179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.547 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.8 t -60.84 -49.02 79.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.656 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.0 t -57.19 -54.33 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.082 -1.012 . . . . 0.0 108.585 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 mt -51.63 -44.32 62.89 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.535 -0.728 . . . . 0.0 109.236 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.526 ' CG ' ' CD1' ' A' ' 236' ' ' TYR . 11.7 t-160 -54.42 -53.52 53.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 109.856 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 56.8 mt -65.85 -36.95 84.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.31 -0.869 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.768 HD22 ' CD1' ' A' ' 114' ' ' ILE . 11.9 mt -76.36 -7.48 55.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.138 -179.379 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.06 47.37 4.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.598 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 ' HB3' ' A' ' 82' ' ' LEU . 12.3 mm -92.4 122.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.621 HG21 HG23 ' A' ' 121' ' ' ILE . 81.7 p -111.26 -21.83 11.68 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.283 -0.885 . . . . 0.0 112.134 -177.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.756 HD22 ' H ' ' A' ' 35' ' ' THR . 5.7 m120 -126.22 111.35 14.49 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.789 -1.195 . . . . 0.0 109.677 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.636 HG13 ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -164.69 140.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.165 -0.959 . . . . 0.0 109.957 179.407 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' A' ' 31' ' ' GLU . 6.5 m -110.81 99.58 8.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 mt -88.03 110.1 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.533 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -86.9 122.27 30.54 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 178.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.65 108.44 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.266 -0.896 . . . . 0.0 111.003 -178.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.5 mp -90.16 110.61 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 129.91 -160.06 22.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -178.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.43 -15.26 9.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.558 ' N ' ' CD ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -136.19 142.1 44.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.069 -1.019 . . . . 0.0 110.204 -179.56 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.449 HG13 HG12 ' A' ' 72' ' ' VAL . 3.0 mm -68.23 126.22 92.44 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.53 -0.731 . . . . 0.0 109.707 -179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.691 ' CD ' HD21 ' A' ' 26' ' ' LEU . 66.3 Cg_exo -45.98 131.25 13.73 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 121.946 1.764 . . . . 0.0 112.388 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.34 -26.34 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.455 -0.778 . . . . 0.0 109.827 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.547 ' O ' ' ND2' ' A' ' 202' ' ' ASN . 10.1 mt 54.65 -111.4 0.63 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -95.55 -17.71 21.19 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.207 -0.933 . . . . 0.0 110.911 -179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.03 0.84 33.83 Favored Glycine 0 N--CA 1.497 2.752 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -178.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.0 p -129.27 -167.3 1.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.531 -0.982 . . . . 0.0 109.503 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -115.43 -4.92 19.62 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.9 -1.68 . . . . 0.0 108.9 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.568 ' CZ2' ' OE2' ' A' ' 108' ' ' GLU . 63.0 t-105 -47.1 -41.13 16.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.775 -0.838 . . . . 0.0 110.413 -179.547 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.63 -51.89 66.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.041 -1.037 . . . . 0.0 109.967 -179.401 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -62.56 -43.99 97.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.97 -1.081 . . . . 0.0 108.828 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 107' ' ' TYR . 10.1 t80 -63.52 -39.21 93.84 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.481 0.658 . . . . 0.0 110.059 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.568 ' OE2' ' CZ2' ' A' ' 104' ' ' TRP . 18.8 mm-40 -69.78 -48.63 58.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.44 -0.787 . . . . 0.0 111.479 -178.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.45 -51.35 11.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.927 -1.108 . . . . 0.0 110.965 -178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.92 -43.89 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.009 -1.057 . . . . 0.0 110.967 -178.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -28.88 63.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.96 -1.088 . . . . 0.0 109.802 -179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.54 -13.07 59.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.012 -1.055 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.97 34.3 5.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.594 -178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.768 ' CD1' HD22 ' A' ' 82' ' ' LEU . 12.4 mt -90.77 147.54 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.797 -1.189 . . . . 0.0 110.474 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 115' ' ' LEU . 14.1 tp -131.75 158.59 40.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.533 -0.729 . . . . 0.0 109.063 179.137 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.794 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.0 OUTLIER -101.75 146.16 28.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.053 -1.029 . . . . 0.0 109.681 179.688 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.49 ' OE1' ' OE1' ' A' ' 33' ' ' GLU . 1.2 mt-30 -112.66 -166.42 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 0.0 109.616 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -123.96 72.53 1.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 110.672 -179.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.7 ttt85 -163.3 140.68 7.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.268 -0.895 . . . . 0.0 109.748 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.492 ' OE2' ' O ' ' A' ' 121' ' ' ILE . 3.0 tm-20 -78.31 124.09 27.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 0.0 109.343 179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 85' ' ' THR . 1.0 OUTLIER -71.58 141.04 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.565 -0.71 . . . . 0.0 110.724 -178.894 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -85.36 86.43 7.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -63.24 146.7 52.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -101.6 122.65 44.24 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.1 138.46 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.333 -0.854 . . . . 0.0 110.461 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.5 t -82.06 136.23 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -117.78 -9.12 10.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.03 143.57 28.63 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.407 -0.808 . . . . 0.0 109.162 179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.66 161.63 44.65 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.232 1.955 . . . . 0.0 112.989 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.971 HG22 ' HB3' ' A' ' 141' ' ' ALA . 11.5 tt -150.64 144.0 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.651 -0.656 . . . . 0.0 109.46 -179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 131' ' ' ILE . 1.0 OUTLIER -131.17 122.55 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.46 -179.772 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 132' ' ' VAL . 26.9 m -123.55 118.79 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.466 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -120.28 136.32 54.71 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.49 -0.756 . . . . 0.0 110.163 -179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -173.19 150.79 1.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.867 . . . . 0.0 110.503 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 55.94 24.45 7.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.653 . . . . 0.0 110.996 179.047 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.65 7.95 87.21 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 -108.77 169.12 8.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.074 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.011 HD23 ' N ' ' A' ' 139' ' ' ILE . 6.0 tt -159.95 153.57 22.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.151 -1.593 . . . . 0.0 109.465 179.668 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.011 ' N ' HD23 ' A' ' 138' ' ' LEU . 37.5 mt -148.57 136.05 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -126.14 142.1 51.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.295 -0.878 . . . . 0.0 109.996 -179.073 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.971 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.13 148.12 44.63 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.487 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 5.0 tm-20 -145.97 137.48 12.96 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.487 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 8.3 Cg_endo -53.84 146.5 45.64 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.744 1.63 . . . . 0.0 112.605 -179.147 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.72 151.75 11.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -0.929 . . . . 0.0 109.26 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.21 1.43 48.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.199 -0.938 . . . . 0.0 109.467 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.4 p -137.88 150.33 47.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.249 -0.907 . . . . 0.0 109.402 179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.479 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 24.2 tp -81.88 117.16 21.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 110.042 -179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -138.69 136.3 35.69 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.091 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.541 ' CG1' HD23 ' A' ' 231' ' ' LEU . 42.8 t -137.18 139.62 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.92 . . . . 0.0 109.985 -179.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 51.0 m -125.15 140.37 52.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.335 -0.853 . . . . 0.0 109.625 179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' A' ' 228' ' ' VAL . 85.7 t80 -125.51 129.97 50.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.568 -0.707 . . . . 0.0 109.81 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -115.07 111.17 20.67 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -106.0 146.87 16.13 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -128.15 86.19 2.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.342 -1.093 . . . . 0.0 109.233 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 155' ' ' PHE . 2.9 m-30 -94.28 149.2 21.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.95 -9.67 47.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.521 -0.737 . . . . 0.0 110.433 -179.267 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.548 HD21 HD12 ' A' ' 159' ' ' LEU . 23.7 p-10 -66.48 -172.39 0.16 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.022 -1.049 . . . . 0.0 109.616 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -55.2 -24.54 27.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.89 . . . . 0.0 110.05 -179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.548 HD12 HD21 ' A' ' 157' ' ' ASN . 12.4 mt -63.93 -43.01 97.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.044 -1.035 . . . . 0.0 109.432 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.78 -119.9 5.85 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -114.8 140.88 48.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.421 -1.046 . . . . 0.0 109.311 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.02 140.27 16.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.813 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -124.42 151.76 44.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 0.0 109.209 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.521 ' CE1' ' NE ' ' A' ' 225' ' ' ARG . 81.1 t80 -136.03 121.12 18.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -0.933 . . . . 0.0 109.05 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 48.7 m -99.47 122.72 42.96 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.997 -1.064 . . . . 0.0 109.92 -179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.527 ' CE1' ' O ' ' A' ' 167' ' ' VAL . 2.3 t80 -95.79 134.34 38.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.527 ' O ' ' CE1' ' A' ' 166' ' ' PHE . 2.8 t -129.69 157.5 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.533 -0.73 . . . . 0.0 109.319 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.696 ' H ' ' CD ' ' A' ' 168' ' ' GLU . 28.9 mp0 -60.48 116.17 4.12 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.373 -0.829 . . . . 0.0 109.245 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 115.58 6.17 17.72 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -135.87 29.74 3.13 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.037 -1.272 . . . . 0.0 108.918 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.97 -30.7 70.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 110.405 -179.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -54.34 -9.41 0.29 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.048 -1.032 . . . . 0.0 110.66 -179.162 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -102.88 -4.22 25.12 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.905 -1.122 . . . . 0.0 111.256 -178.625 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.563 ' O ' ' CD1' ' A' ' 229' ' ' PHE . 1.3 pt -116.66 13.4 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.041 -1.037 . . . . 0.0 110.979 -179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.47 -28.6 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.071 -1.018 . . . . 0.0 109.612 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 104' ' ' TRP . 1.1 mp -91.08 0.28 57.57 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.098 -1.001 . . . . 0.0 110.737 -179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.85 119.51 19.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.841 -1.162 . . . . 0.0 108.239 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -88.45 150.11 23.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.197 . . . . 0.0 109.963 -178.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.414 ' O ' ' CG2' ' A' ' 179' ' ' THR . 1.9 t -58.06 129.37 41.63 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.488 ' C ' ' SG ' ' A' ' 181' ' ' CYS . 14.6 p90 -109.16 166.53 10.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 0.0 110.23 -179.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.516 ' SG ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -153.99 159.79 41.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.498 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.594 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 67.9 m-85 -104.08 147.21 27.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.283 -0.886 . . . . 0.0 109.64 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.717 ' HA ' HD12 ' A' ' 186' ' ' ILE . 49.0 p30 -60.07 -22.58 62.9 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.08 -1.013 . . . . 0.0 110.116 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.617 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 4.8 p90 -81.99 -33.08 30.33 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.91 -1.119 . . . . 0.0 110.53 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.617 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 24.4 pt-20 -85.16 -16.39 40.57 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.803 -1.185 . . . . 0.0 109.345 179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.717 HD12 ' HA ' ' A' ' 183' ' ' ASP . 11.9 mt -59.24 -53.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.235 -0.915 . . . . 0.0 110.058 -179.301 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 184' ' ' TRP . 2.9 mp0 -51.49 -53.57 36.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.787 -1.196 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -47.66 65.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.283 -0.886 . . . . 0.0 108.924 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.5 mt -59.29 -34.1 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.249 -0.907 . . . . 0.0 108.76 179.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -80.13 -25.87 39.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.492 -0.755 . . . . 0.0 109.843 -179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.01 -21.27 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.185 -0.947 . . . . 0.0 109.662 -179.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.458 ' CG2' HD12 ' A' ' 194' ' ' LEU . 23.7 m -90.7 13.59 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.188 -0.945 . . . . 0.0 109.562 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.43 25.65 72.16 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.458 HD12 ' CG2' ' A' ' 192' ' ' VAL . 23.3 mt -127.15 167.2 16.34 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.237 -1.155 . . . . 0.0 109.918 -179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 75.9 16.98 80.3 Favored Glycine 0 N--CA 1.493 2.481 0 O-C-N 121.457 -0.777 . . . . 0.0 111.314 178.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -64.11 -51.97 61.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.601 -1.529 . . . . 0.0 109.235 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 18' ' ' ILE . . . -70.2 -4.38 49.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -178.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.66 130.0 39.67 Favored Glycine 0 N--CA 1.493 2.472 0 O-C-N 120.96 -1.318 . . . . 0.0 110.641 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.5 p -143.26 173.58 11.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.749 -0.854 . . . . 0.0 109.13 179.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.428 HD11 HDA3 ' A' ' 320' ' ' TUX . 87.2 mt -79.71 -1.81 40.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.075 -1.015 . . . . 0.0 109.641 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -97.24 -10.45 25.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.213 -0.929 . . . . 0.0 109.247 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 99' ' ' LEU . 0.3 OUTLIER -139.44 13.29 2.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.516 ' CG2' ' SG ' ' A' ' 181' ' ' CYS . 18.0 m -149.29 133.18 17.04 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.139 -0.975 . . . . 0.0 109.935 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.55 117.23 29.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 108.528 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.6 t -105.92 126.59 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.085 -1.009 . . . . 0.0 109.962 -179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.05 144.15 33.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 0.0 109.396 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 208' ' ' LYS . . . -102.91 153.24 18.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 207' ' ' GLY . 18.0 pttm -41.64 -32.52 0.38 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -1.147 . . . . 0.0 109.699 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -151.32 13.21 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.0 109.951 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.1 mttm -139.24 147.36 41.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 0.0 109.936 -179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 38.6 t -98.2 125.39 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.032 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -73.0 -54.63 8.09 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.145 -0.972 . . . . 0.0 110.321 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -52.41 139.13 38.22 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.879 -1.138 . . . . 0.0 109.508 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.21 -38.07 4.05 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.386 2.057 . . . . 0.0 112.333 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.49 -4.4 22.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.51 -168.88 53.73 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 14.0 mt -75.47 149.05 38.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -1.12 . . . . 0.0 109.618 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -58.26 3.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 108.958 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -117.5 170.84 8.42 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -73.94 -18.03 60.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.113 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.704 ' ND2' HH21 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -128.23 29.98 5.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.0 109.537 -179.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 pp20? -62.95 -25.06 1.56 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.975 . . . . 0.0 112.537 -179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 1.1 Cg_endo -80.57 -46.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.079 1.421 . . . . 0.0 112.082 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.707 ' O ' HG23 ' A' ' 228' ' ' VAL . 1.2 m -73.04 -22.1 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.885 -1.135 . . . . 0.0 108.005 179.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.704 HH21 ' ND2' ' A' ' 221' ' ' ASN . 48.8 mtt180 -71.35 -49.63 40.38 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -55.07 -42.57 72.93 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.04 -45.49 83.14 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 224' ' ' VAL . 30.9 t -60.76 -50.15 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CD1' ' O ' ' A' ' 174' ' ' ILE . 65.2 t80 -49.45 -37.36 25.55 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 11.1 m-20 -74.65 -39.19 62.22 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.591 -0.693 . . . . 0.0 109.737 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.541 HD23 ' CG1' ' A' ' 149' ' ' VAL . 25.5 tp -56.64 -36.76 69.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.121 -0.987 . . . . 0.0 109.267 -179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.49 HG22 ' HD1' ' A' ' 80' ' ' HIS . 96.9 mt -72.33 -48.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -49.67 -32.79 17.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.584 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.6 OUTLIER -82.41 -28.07 31.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.187 -1.184 . . . . 0.0 109.899 -179.956 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 260' ' ' VAL . 5.1 mt -79.75 -23.04 42.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.876 -1.14 . . . . 0.0 110.055 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.526 ' CD1' ' CG ' ' A' ' 80' ' ' HIS . 14.4 t80 -71.44 -8.21 52.39 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.035 -1.041 . . . . 0.0 109.09 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 237' ' ' LEU . 35.7 mt -52.85 -25.87 12.89 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 242' ' ' VAL . 46.9 mt -58.56 -21.92 54.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.181 -0.949 . . . . 0.0 108.845 179.098 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.49 65.99 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 55.1 p -158.19 149.61 16.77 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.958 -1.319 . . . . 0.0 109.561 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.402 ' HA ' ' NE2' ' A' ' 80' ' ' HIS . 3.7 Cg_exo -48.16 134.32 24.58 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.12 1.88 . . . . 0.0 111.583 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 238' ' ' LEU . 24.1 t -100.2 133.28 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.024 -179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.2 mmmm -120.25 125.07 47.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.37 -0.831 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 156.46 172.46 23.84 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.209 -1.557 . . . . 0.0 109.209 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -101.63 117.43 34.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.046 -1.267 . . . . 0.0 109.917 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.519 ' HB2' HG22 ' A' ' 149' ' ' VAL . 29.9 m-85 -117.49 147.73 42.48 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 122.115 0.96 . . . . 0.0 111.185 -179.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -130.08 138.26 50.62 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 178.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.91 127.01 31.59 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.801 -1.187 . . . . 0.0 110.361 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.443 ' O ' ' C ' ' A' ' 250' ' ' ARG . 43.1 t80 -109.22 114.45 28.17 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.482 ' HA ' ' HE ' ' A' ' 250' ' ' ARG . 0.2 OUTLIER 44.31 55.95 5.25 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -79.69 145.88 27.96 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.3 162.84 12.24 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.647 ' O ' HG23 ' A' ' 257' ' ' VAL . 69.8 m-70 -56.47 -50.12 72.65 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -1.178 . . . . 0.0 109.825 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 t -59.07 -55.88 29.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.656 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.9 tp -52.56 -39.67 61.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.079 -1.013 . . . . 0.0 109.508 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -58.24 -54.73 43.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.16 -0.963 . . . . 0.0 108.421 179.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 253' ' ' HIS . 13.5 t -48.8 -41.63 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.362 -0.836 . . . . 0.0 109.47 179.461 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.0 mtmm -55.28 -48.96 73.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 108.821 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 27.8 tp -52.36 -41.92 63.5 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.445 HG22 HD23 ' A' ' 235' ' ' LEU . 41.1 t -70.57 -45.31 74.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 109.596 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -53.62 -51.06 64.27 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.451 -0.78 . . . . 0.0 110.265 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -63.19 -47.59 81.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.934 -1.104 . . . . 0.0 109.861 -179.562 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 263' ' ' LEU . 88.3 mt -59.79 -44.5 93.91 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.291 -0.881 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -64.28 -35.31 80.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 0.0 109.622 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt -76.42 -25.6 54.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.902 -1.124 . . . . 0.0 108.762 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.822 ' NZ ' HD12 ' A' ' 130' ' ' ILE . 17.8 mttt -65.96 -48.15 72.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 109.593 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.502 ' OE1' ' N ' ' A' ' 267' ' ' GLN . 1.8 mp0 -83.71 11.23 7.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.046 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -89.29 -20.09 24.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.179 -0.951 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.73 -10.23 55.92 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 270' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.435 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 319' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 320' ' ' TUX . . . . . 0.522 HZH3 ' C1A' ' A' ' 320' ' ' TUX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_